Citrus Sinensis ID: 002321

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930------
Protein Sequence
MGAMLKMKASVFSLLTFLVLAPALTRSLNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKSCPAVLPKPIVLNPNSSSDSTTSSVAPNPRHKRIILSISAIIAIGAAAVIVIGVIAITVLNLRVRSSTSRSAAALTLSAGDDFSRSPTTDANSGKLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVSMRSCKGSSRQRRRFQL
Secondary Structure (PSIPRED)
cccccccHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHcccccccccccccccccccccccEEEEccccccEEEEEEccccccEEccccccccccccEEEcccccccccccHHHHccccccEEEcccccccccccccHHHccccccEEEcccccccccccccccccccccEEEcccccccccccHHccccccccEEEcccccccccccccccccccccEEEccccccEEcccccccccccccEEEccccccEEcccccccccccccEEEccccEEEEcccHHccccccccEEEccccccEEEccccccccccccEEEcccccccccccHHccccccccEEEcccccccccccHHHHcccccEEEcccccccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHccccccEEEccccccccccHHHHHccccccEEEcccccccccccHHHHccccccEEEccccccccccHHHHHcccccccEEccccccccccHHHHcccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccHHHHccccccccccccccccccccEEEcccccHHHHHHHHccccccEEccccccEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHccccccccccEEEEEEcccccEEEEcccccccHHcccccccccccccHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccEEccccccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHHccccccEEEcccccccccccccccc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHcccccccccccccccccccccEEEEEcccccEEEEEEcccccccccccHHHHccccccEEEcccccccccccHHHHccccccEEEcccccccccccHHHHHHcccccEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccccEEcccccccccccHHHHccccccEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHHcccEEEEEccccccccccccccccHccccccEEEEEccccccccccHHHcccccccEEEEccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEccccccEEcccHHHHHcccccEEEccccEEEEEccccccHHHccHHHcccccEEEccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcHccHccccccccccccccccccccccEEEEccccccHHHHHHHHcccccEEEccccEEEEEEEcccccEEEEEEEcccccccccHHHHHHHHHHHHcccHHHHHEEEEccccccEEEEEEccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHccccEEEEEcccccEEEccccccHHHHHcHHHEccccccccccHHHEcccccccccHcEEEEEEcccccHHHHHHEHHHHHcccccccccccccccHHHHHHHHHHccccHHHccHHHcccccHHEEccc
Coil and Loop (DISEMBL)
MGAMLKMKASVFSLLTFLVLApaltrslnpslnddvLGLIVFKadiqdpngklsswsedddtpcnwfgvkcsprsnRVIELTLNGLSLTGRIGRGLLQLQFLRKLslssnnltgsispnlaklqnlrvidlsgnslsgsipdeffkqcgsLRVISLAKnrfsgkipsslslCSTLATINlssnrfssplplgiwglsalrtldlsdnllegeipkgvesLKNLRVINLsknmfsgsipdgigscsllrtidfsensfsgnlpetMQKLSLCNFMNLRknlfsgevpkwigelesletldlsgnkfsgavpisignlqrLKVLNFSanrltgslpdsmANCMNLVALdfsqnsmngdlpqwifssglnkvsfaenkiregmngpfassgssfeslqfldlshnefsgetpatiGALSGLQLlnlsrnslvgpipvaigdlkalnvldlsenwlngsippeiggayslKELRLERNFLagkiptsieNCSSLVSLILsknnltgpipIAIAKLtnlqnvdlsfnsltgglpkqLVNLVHLssfnishnhlqgelpaggffntispssvlgnpslcgsavnkscpavlpkpivlnpnsssdsttssvapnprhkrIILSISAIIAIGAAAVIVIGVIAITVLNLRVRSSTSRSAAALTLsagddfsrspttdansgklvmfsgdpdfstgthallnkdcelgrggfgaVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLgkvrhpnlvtleGYYWTQSLQLLIYEFVSggslhkhlhegsggnflswnERFNVIQGTAKSLAHLHQSNIIhynikssnvlidgsgepkvgdyglARLLPMLDRYVLSSKIQSALgymapefacrtvkitdkcdvygFGVLVLEVVtgkrplstWKMMWWFSVTWLEEHWKKAEWRNVsmrsckgssrqrrrfql
Flexible Loop (DISEMBL)
MGAMLKMKASVFSLLTFLVLAPALTRSLNPSLNDDVLGLIVFKADIQDPNGKLsswsedddtpCNWFGvkcsprsnRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGeipkgveslkNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKSCPAVLPKPivlnpnsssdsttssvapnprHKRIILSISAIIAIGAAAVIVIGVIAITVLNLRVRSSTSRSAAAltlsagddfsrspttdansgkLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTvlrdgrpvaikKLTVSSLVKSQEDFEREvkklgkvrhpnlvTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVvtgkrplstWKMMWWFSVTWLEEHWKKAEwrnvsmrsckgssrqrrrfql
Low Complexity Region (SEG)
MGAMLKMKASVFSLLTFLVLAPALTRSLNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSltgrigrgllqlqflrklslssNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKSCPAVLPKPIVLNPNsssdsttssVAPNPRHKRiilsisaiiaigaaavivigviaiTVLNLRVrsstsrsaaaltlsaGDDFSRSPTTDANSGKLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVSMRSCKGSSRQRRRFQL
Disordered region (IsUnstruct)
*******KASVFSLLTFLVLAPALTRSLNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFA***********************FLDLSH**FSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKSCPAVLPKPI*********************KRIILSISAIIAIGAAAVIVIGVIAITVLNLRVR**************************************DFSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNV*****************
Disordered Region (DISOPRED)
***********FSLLTFLVLAPALTRSLNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKSCPAVLPKPIV************************LSISAIIAIGAAAVIVIGVIAITVLNLR****************************NSGKLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSS******DFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR*VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVSMRSCKGSSRQRRRFQL
Disordered Region (DISEMBL)
MGAMLKMKASVFSLLTFLVLAPALTRSLNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKSCPAVLPKPIVLNP*************NPRHKRIILSISAIIAIGAAAVIVIGVIAITVLNLRVRSSTSRSAAALTLSAGDDFSRSPTTDANSGKLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVSM***************
Disordered Region (DISPRO)
MGAMLKMKASVFSLLTFLVLAPALTRSLNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKSCPAVLPKPIVLNPNSSSDS*********RHKRIILSISAIIAIGAAAVIVIGVIAITVLNLRVRSSTSR********************ANSGKLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVSMRSCKGSSRQRR****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGAMLKMKASVFSLLTFLVLAPALTRSLNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKSCPAVLPKPIVLNPNSSSDSTTSSVAPNPRHKRIILSISAIIAIGAAAVIVIGVIAITVLNLRVRSSTSRSAAALTLSAGDDFSRSPTTDANSGKLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVSMRSCKGSSRQRRRFQL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	936	2.2.26 [Sep-21-2011]
Q9LRT1	1016	Probably inactive leucine	no	no	0.912	0.840	0.432	0.0
C0LGE4	882	Probable LRR receptor-lik	no	no	0.810	0.860	0.337	1e-118
Q42371	976	LRR receptor-like serine/	no	no	0.907	0.869	0.319	1e-112
Q9LHP4	1141	Receptor-like protein kin	no	no	0.894	0.733	0.311	1e-111
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.850	0.635	0.323	1e-111
Q9M0G7	1013	Leucine-rich repeat recep	no	no	0.872	0.806	0.324	1e-111
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.855	0.799	0.312	1e-110
C0LGV1	1135	LRR receptor-like serine/	no	no	0.863	0.711	0.317	1e-109
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.863	0.646	0.319	1e-109
C0LGX3	993	LRR receptor-like serine/	no	no	0.846	0.797	0.319	1e-108

>sp|Q9LRT1|Y3804_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase At3g28040 OS=Arabidopsis thaliana GN=At3g28040 PE=2 SV=1

 Score =  686 bits (1771), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 393/909 (43%), Positives = 550/909 (60%), Gaps = 55/909 (6%)

Query: 32  LNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSLTGR 91
           LNDDVLGLIVFK+D+ DP   L SW+EDD+TPC+W  VKC+P+++RVIEL+L+GL+LTG+
Sbjct: 33  LNDDVLGLIVFKSDLNDPFSHLESWTEDDNTPCSWSYVKCNPKTSRVIELSLDGLALTGK 92

Query: 92  IGRGLLQLQ-----------------------FLRKLSLSSNNLTGSISPNLAKLQNLRV 128
           I RG+ +LQ                        L+KL LS NNL+G I  +L  + +L+ 
Sbjct: 93  INRGIQKLQRLKVLSLSNNNFTGNINALSNNNHLQKLDLSHNNLSGQIPSSLGSITSLQH 152

Query: 129 IDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSS- 187
           +DL+GNS SG++ D+ F  C SLR +SL+ N   G+IPS+L  CS L ++NLS NRFS  
Sbjct: 153 LDLTGNSFSGTLSDDLFNNCSSLRYLSLSHNHLEGQIPSTLFRCSVLNSLNLSRNRFSGN 212

Query: 188 -PLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSL 246
                GIW L  LR LDLS N L G IP G+ SL NL+ + L +N FSG++P  IG C  
Sbjct: 213 PSFVSGIWRLERLRALDLSSNSLSGSIPLGILSLHNLKELQLQRNQFSGALPSDIGLCPH 272

Query: 247 LRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFS 306
           L  +D S N FSG LP T+QKL   N  ++  NL SG+ P WIG++  L  LD S N+ +
Sbjct: 273 LNRVDLSSNHFSGELPRTLQKLKSLNHFDVSNNLLSGDFPPWIGDMTGLVHLDFSSNELT 332

Query: 307 GAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGL 366
           G +P SI NL+ LK LN S N+L+G +P+S+ +C  L+ +    N  +G++P   F  GL
Sbjct: 333 GKLPSSISNLRSLKDLNLSENKLSGEVPESLESCKELMIVQLKGNDFSGNIPDGFFDLGL 392

Query: 367 NKVSFAENKIREGMNGPFASSGSS-FESLQFLDLSHNEFSGETPATIGALSGLQLLNLSR 425
            ++ F+ N    G+ G      S  FESL  LDLSHN  +G  P  +G    ++ LNLS 
Sbjct: 393 QEMDFSGN----GLTGSIPRGSSRLFESLIRLDLSHNSLTGSIPGEVGLFIHMRYLNLSW 448

Query: 426 NSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIE 485
           N     +P  I  L+ L VLDL  + L GS+P +I  + SL+ L+L+ N L G IP  I 
Sbjct: 449 NHFNTRVPPEIEFLQNLTVLDLRNSALIGSVPADICESQSLQILQLDGNSLTGSIPEGIG 508

Query: 486 NCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISH 545
           NCSSL  L LS NNLTGPIP +++ L  L+ + L  N L+G +PK+L +L +L   N+S 
Sbjct: 509 NCSSLKLLSLSHNNLTGPIPKSLSNLQELKILKLEANKLSGEIPKELGDLQNLLLVNVSF 568

Query: 546 NHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKSCPAVLPKPIVLNPNSSSDSTT---- 601
           N L G LP G  F ++  S++ GN  +C   +   C   +PKP+V+NPNS  +       
Sbjct: 569 NRLIGRLPLGDVFQSLDQSAIQGNLGICSPLLRGPCTLNVPKPLVINPNSYGNGNNMPGN 628

Query: 602 -SSVAPNPRHKRIILSISAIIAIGAAAVIVIGVIAITVLNLRVRSSTSRSAAALT--LSA 658
            +S      H+R+ LS+S I+AI AA +I  GVI IT+LN  VR   +    AL    S 
Sbjct: 629 RASGGSGTFHRRMFLSVSVIVAISAAILIFSGVIIITLLNASVRRRLAFVDNALESIFSG 688

Query: 659 GDDFSRSPTTDANSGKLVMFS--------GDPDFSTGTHALLNKDCELGRGGFGAVYRTV 710
                RS       GKLV+ +           +F     +LLNK   +G G FG VY+  
Sbjct: 689 SSKSGRSLMM----GKLVLLNSRTSRSSSSSQEFERNPESLLNKASRIGEGVFGTVYKAP 744

Query: 711 L-RDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV 769
           L   GR +A+KKL  S ++++ EDF+REV+ L K +HPNLV+++GY+WT  L LL+ E++
Sbjct: 745 LGEQGRNLAVKKLVPSPILQNLEDFDREVRILAKAKHPNLVSIKGYFWTPDLHLLVSEYI 804

Query: 770 SGGSLHKHLHEGSGGN-FLSWNERFNVIQGTAKSLAHLHQS---NIIHYNIKSSNVLIDG 825
             G+L   LHE       LSW+ R+ +I GTAK LA+LH +     IH+N+K +N+L+D 
Sbjct: 805 PNGNLQSKLHEREPSTPPLSWDVRYKIILGTAKGLAYLHHTFRPTTIHFNLKPTNILLDE 864

Query: 826 SGEPKVGDYGLARLLPMLDRYVL-SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVL 884
              PK+ D+GL+RLL   D   + +++ Q+ALGY+APE  C+ +++ +KCDVYGFGVL+L
Sbjct: 865 KNNPKISDFGLSRLLTTQDGNTMNNNRFQNALGYVAPELECQNLRVNEKCDVYGFGVLIL 924

Query: 885 EVVTGKRPL 893
           E+VTG+RP+
Sbjct: 925 ELVTGRRPV 933

Arabidopsis thaliana (taxid: 3702)

>sp|C0LGE4|Y1124_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g12460 OS=Arabidopsis thaliana GN=At1g12460 PE=1 SV=1

 Score =  427 bits (1099), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 296/876 (33%), Positives = 455/876 (51%), Gaps = 117/876 (13%)

Query: 39  LIVFKADI-QDPNGKLSSWSEDDDTPCNWF-GVKCSPRSNRVIELTLNGLSLTGRIGRGL 96
           L+ FK  I  DP   L+SW  D D  CN F G+ C+P+                      
Sbjct: 30  LLQFKGSISDDPYNSLASWVSDGDL-CNSFNGITCNPQG--------------------- 67

Query: 97  LQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISL 156
               F+ K+ L + +L G+++P L+ L+ +RV++L GN                      
Sbjct: 68  ----FVDKIVLWNTSLAGTLAPGLSNLKFIRVLNLFGN---------------------- 101

Query: 157 AKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKG 216
              RF+G +P       TL TIN+SSN  S P+P  I  LS+LR LDLS N   GEIP  
Sbjct: 102 ---RFTGNLPLDYFKLQTLWTINVSSNALSGPIPEFISELSSLRFLDLSKNGFTGEIPVS 158

Query: 217 V-ESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMN 275
           + +     + ++L+ N   GSIP  I +C+ L   DFS N+  G LP  +  + +  +++
Sbjct: 159 LFKFCDKTKFVSLAHNNIFGSIPASIVNCNNLVGFDFSYNNLKGVLPPRICDIPVLEYIS 218

Query: 276 LRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPD 335
           +R NL SG+V + I + + L  +DL  N F G  P ++   + +   N S NR  G + +
Sbjct: 219 VRNNLLSGDVSEEIQKCQRLILVDLGSNLFHGLAPFAVLTFKNITYFNVSWNRFGGEIGE 278

Query: 336 SMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQ 395
            +    +L  LD S N + G +P  +                              +SL+
Sbjct: 279 IVDCSESLEFLDASSNELTGRIPTGVMGC---------------------------KSLK 311

Query: 396 FLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGS 455
            LDL  N+ +G  P +IG +  L ++ L  NS+ G IP  IG L+ L VL+L    L G 
Sbjct: 312 LLDLESNKLNGSIPGSIGKMESLSVIRLGNNSIDGVIPRDIGSLEFLQVLNLHNLNLIGE 371

Query: 456 IPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQ 515
           +P +I     L EL +  N L GKI   + N +++  L L +N L G IP  +  L+ +Q
Sbjct: 372 VPEDISNCRVLLELDVSGNDLEGKISKKLLNLTNIKILDLHRNRLNGSIPPELGNLSKVQ 431

Query: 516 NVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGS 575
            +DLS NSL+G +P  L +L  L+ FN+S+N+L G +P          S+   NP LCG 
Sbjct: 432 FLDLSQNSLSGPIPSSLGSLNTLTHFNVSYNNLSGVIPPVPMIQAFGSSAFSNNPFLCGD 491

Query: 576 AVNKSCPAVLPKPIVLNPNSSSDSTTSSVAPNPRHKRIILSISAIIAIGAAAVIVIGVIA 635
            +   C          N   ++  + +S A         LSIS II I AAAVI+ GV  
Sbjct: 492 PLVTPC----------NSRGAAAKSRNSDA---------LSISVIIVIIAAAVILFGVCI 532

Query: 636 ITVLNLRVRSSTSRSAAALTLSAGDDFSRSPTTDANSGKLVMFSGD-----PDFSTGTHA 690
           +  LNLR R    +    LT+      S   ++    GKLV+FS +      D+  GT A
Sbjct: 533 VLALNLRARKR-RKDEEILTVETTPLASSIDSSGVIIGKLVLFSKNLPSKYEDWEAGTKA 591

Query: 691 LLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           LL+K+  +G G  G+VYR     G  +A+KKL     +++QE+FE+E+ +LG ++HPNL 
Sbjct: 592 LLDKENIIGMGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFEQEIGRLGGLQHPNLS 651

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLH--------EGSGGNFLSWNERFNVIQGTAKS 802
           + +GYY++ ++QL++ EFV  GSL+ +LH           G   L+W+ RF +  GTAK+
Sbjct: 652 SFQGYYFSSTMQLILSEFVPNGSLYDNLHLRIFPGTSSSYGNTDLNWHRRFQIALGTAKA 711

Query: 803 LAHLH---QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYM 859
           L+ LH   +  I+H N+KS+N+L+D   E K+ DYGL + LP++D + L+ K  +A+GY+
Sbjct: 712 LSFLHNDCKPAILHLNVKSTNILLDERYEAKLSDYGLEKFLPVMDSFGLTKKFHNAVGYI 771

Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLST 895
           APE A ++++ ++KCDVY +GV++LE+VTG++P+ +
Sbjct: 772 APELAQQSLRASEKCDVYSYGVVLLELVTGRKPVES 807

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1

 Score =  407 bits (1046), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 291/912 (31%), Positives = 463/912 (50%), Gaps = 63/912 (6%)

Query: 39  LIVFKADIQDPNGKLSSWSEDDDTP-CNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLL 97
           L+  K   +D N  L  W+    +  C W GV C   +  V+ L L+ L+L G I   + 
Sbjct: 30  LLEIKKSFKDVNNVLYDWTTSPSSDYCVWRGVSCENVTFNVVALNLSDLNLDGEISPAIG 89

Query: 98  QLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLA 157
            L+ L  + L  N L+G I   +    +L+ +DLS N LSG IP    K    L  + L 
Sbjct: 90  DLKSLLSIDLRGNRLSGQIPDEIGDCSSLQNLDLSFNELSGDIPFSISK-LKQLEQLILK 148

Query: 158 KNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGV 217
            N+  G IPS+LS    L  ++L+ N+ S  +P  I+    L+ L L  N L G I   +
Sbjct: 149 NNQLIGPIPSTLSQIPNLKILDLAQNKLSGEIPRLIYWNEVLQYLGLRGNNLVGNISPDL 208

Query: 218 ESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLR 277
             L  L   ++  N  +GSIP+ IG+C+  + +D S N  +G +P  +  L +   ++L+
Sbjct: 209 CQLTGLWYFDVRNNSLTGSIPETIGNCTAFQVLDLSYNQLTGEIPFDIGFLQVAT-LSLQ 267

Query: 278 KNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSM 337
            N  SG++P  IG +++L  LDLSGN  SG++P  +GNL   + L   +N+LTGS+P  +
Sbjct: 268 GNQLSGKIPSVIGLMQALAVLDLSGNLLSGSIPPILGNLTFTEKLYLHSNKLTGSIPPEL 327

Query: 338 ANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVS--FAENKIREGMNGPFASSGSSFESLQ 395
            N   L  L+ + N + G +P       L K++  F  N     + GP     SS  +L 
Sbjct: 328 GNMSKLHYLELNDNHLTGHIP-----PELGKLTDLFDLNVANNDLEGPIPDHLSSCTNLN 382

Query: 396 FLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGS 455
            L++  N+FSG  P     L  +  LNLS N++ GPIPV +  +  L+ LDLS N +NG 
Sbjct: 383 SLNVHGNKFSGTIPRAFQKLESMTYLNLSSNNIKGPIPVELSRIGNLDTLDLSNNKINGI 442

Query: 456 IPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQ 515
           IP  +G    L ++ L RN + G +P    N  S++ + LS N+++GPIP  + +L N+ 
Sbjct: 443 IPSSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIMEIDLSNNDISGPIPEELNQLQNII 502

Query: 516 NVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGS 575
            + L  N+LTG +   L N + L+  N+SHN+L G++P    F+  SP S +GNP LCGS
Sbjct: 503 LLRLENNNLTGNV-GSLANCLSLTVLNVSHNNLVGDIPKNNNFSRFSPDSFIGNPGLCGS 561

Query: 576 AVNKSCPAVLPKPIVLNPNSSSDSTTSSVAPNPRHKRIILSISAIIAIGAAAVIVIGVIA 635
            +N  C                DS         R  R+ +S +AI+ I    ++++ ++ 
Sbjct: 562 WLNSPC---------------HDSR--------RTVRVSISRAAILGIAIGGLVILLMVL 598

Query: 636 ITVLNLRVRSSTSRSAAALTLSAGDDFSRSPTTDANSGKLVMFSGD------PDFSTGTH 689
           I     R  +       +L           P T  ++ KLV+   +       D    T 
Sbjct: 599 IAAC--RPHNPPPFLDGSLD---------KPVT-YSTPKLVILHMNMALHVYEDIMRMTE 646

Query: 690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNL 749
            L  K   +G G    VY+ VL++ +PVAIK+L  S   +S + FE E++ L  ++H NL
Sbjct: 647 NLSEKYI-IGHGASSTVYKCVLKNCKPVAIKRL-YSHNPQSMKQFETELEMLSSIKHRNL 704

Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
           V+L+ Y  +    LL Y+++  GSL   LH  +    L W+ R  +  G A+ LA+LH  
Sbjct: 705 VSLQAYSLSHLGSLLFYDYLENGSLWDLLHGPTKKKTLDWDTRLKIAYGAAQGLAYLHHD 764

Query: 810 ---NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
               IIH ++KSSN+L+D   E ++ D+G+A+ L +   +  S+ +   +GY+ PE+A R
Sbjct: 765 CSPRIIHRDVKSSNILLDKDLEARLTDFGIAKSLCVSKSHT-STYVMGTIGYIDPEYA-R 822

Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF--SVTWLEEHWKKAEWRNVSMRSC 924
           T ++T+K DVY +G+++LE++T ++ +     +     S T   E  + A+    S  +C
Sbjct: 823 TSRLTEKSDVYSYGIVLLELLTRRKAVDDESNLHHLIMSKTGNNEVMEMADPDITS--TC 880

Query: 925 KGSSRQRRRFQL 936
           K     ++ FQL
Sbjct: 881 KDLGVVKKVFQL 892

Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1

 Score =  404 bits (1039), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 311/997 (31%), Positives = 468/997 (46%), Gaps = 160/997 (16%)

Query: 56   WSEDDDTPCN-WFGVKCS-----------------------PRSNRVIELTLNGLSLTGR 91
            W+  D+TPCN W  + CS                       P    + +LT++G +LTG 
Sbjct: 61   WNSIDNTPCNNWTFITCSSQGFITDIDIESVPLQLSLPKNLPAFRSLQKLTISGANLTGT 120

Query: 92   IGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFK----- 146
            +   L     L+ L LSSN L G I  +L+KL+NL  + L+ N L+G IP +  K     
Sbjct: 121  LPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLK 180

Query: 147  -------------------------------------------QCGSLRVISLAKNRFSG 163
                                                        C +L V+ LA+   SG
Sbjct: 181  SLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSG 240

Query: 164  KIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNL 223
             +PSSL     L T+++ +   S  +P  +   S L  L L +N L G IP+ +  L  L
Sbjct: 241  NLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKL 300

Query: 224  RVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSG 283
              + L +N   G IP+ IG+CS L+ ID S N  SG++P ++ +LS      +  N FSG
Sbjct: 301  EQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSG 360

Query: 284  EVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNL 343
             +P  I    SL  L L  N+ SG +P  +G L +L +    +N+L GS+P  +A+C +L
Sbjct: 361  SIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDL 420

Query: 344  VALDFSQNSMNGDLPQWIFS-SGLNKVSFAEN-----------------KIREGMN---G 382
             ALD S+NS+ G +P  +F    L K+    N                 ++R G N   G
Sbjct: 421  QALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITG 480

Query: 383  PFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKAL 442
               S   S + + FLD S N   G+ P  IG+ S LQ+++LS NSL G +P  +  L  L
Sbjct: 481  EIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGL 540

Query: 443  NVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSL------------ 490
             VLD+S N  +G IP  +G   SL +L L +N  +G IPTS+  CS L            
Sbjct: 541  QVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSG 600

Query: 491  -------------VSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVH 537
                         ++L LS N LTG IP  IA L  L  +DLS N L G L   L N+ +
Sbjct: 601  EIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDLAP-LANIEN 659

Query: 538  LSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKSCPAVLPKPIVLNPNSSS 597
            L S NIS+N   G LP    F  +SP  + GN  LC S+   SC     K   L  +  +
Sbjct: 660  LVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLC-SSTQDSCFLTYRKGNGLGDDGDA 718

Query: 598  DSTTSSVAPNPRHKRIILSISAIIAIGAAAVIVIGVIAITVLNLRVRSSTSRSAAALTLS 657
              T           R +    A++      ++++G +A+    +R R +      +  L 
Sbjct: 719  SRT-----------RKLRLTLALLITLTVVLMILGAVAV----IRARRNIDNERDS-ELG 762

Query: 658  AGDDFSRSPTTDANSGKLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPV 717
                +  +P    N      FS D         L+  +  +G+G  G VYR  + +G  +
Sbjct: 763  ETYKWQFTPFQKLN------FSVDQII----RCLVEPNV-IGKGCSGVVYRADVDNGEVI 811

Query: 718  AIKKLTVSSLVKSQED--------FEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV 769
            A+KKL  + +    ++        F  EVK LG +RH N+V   G  W ++ +LL+Y+++
Sbjct: 812  AVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYM 871

Query: 770  SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN---IIHYNIKSSNVLIDGS 826
              GSL   LHE  G + L W+ R+ ++ G A+ LA+LH      I+H +IK++N+LI   
Sbjct: 872  PNGSLGSLLHERRGSS-LDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLD 930

Query: 827  GEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEV 886
             EP + D+GLA+L+   D    S+ +  + GY+APE+   ++KIT+K DVY +GV+VLEV
Sbjct: 931  FEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYG-YSMKITEKSDVYSYGVVVLEV 989

Query: 887  VTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVSMRS 923
            +TGK+P+          V W+ ++    E  + ++RS
Sbjct: 990  LTGKQPIDPTVPEGIHLVDWVRQNRGSLEVLDSTLRS 1026

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  404 bits (1038), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 303/937 (32%), Positives = 458/937 (48%), Gaps = 141/937 (15%)

Query: 81   LTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSI 140
            L L G  L G I + L +L  L+ L LSSNNLTG I     ++  L  + L+ N LSGS+
Sbjct: 269  LNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSL 328

Query: 141  PDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALR 200
            P        SL+ + L++ + SG+IP+ +S C +L  ++LS+N  +  +P  ++ L  L 
Sbjct: 329  PKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELT 388

Query: 201  TLDLSDNLLEG------------------------EIPKGVESLKNLRVINLSKNMFSGS 236
             L L++N LEG                        ++PK +  L  L ++ L +N FSG 
Sbjct: 389  NLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGE 448

Query: 237  IPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLE 296
            +P  IG+C+ L+ ID+  N  SG +P ++ +L     ++LR+N   G +P  +G    + 
Sbjct: 449  MPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMT 508

Query: 297  TLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGD 356
             +DL+ N+ SG++P S G L  L++     N L G+LPDS+ N  NL  ++FS N  NG 
Sbjct: 509  VIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGS 568

Query: 357  LPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALS 416
            +     SS        EN    G  G          +L  L L  N+F+G  P T G +S
Sbjct: 569  ISPLCGSSSYLSFDVTEN----GFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKIS 624

Query: 417  GLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWL------------------------ 452
             L LL++SRNSL G IPV +G  K L  +DL+ N+L                        
Sbjct: 625  ELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKF 684

Query: 453  ------------------------NGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCS 488
                                    NGSIP EIG   +L  L LE N L+G +P++I   S
Sbjct: 685  VGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLS 744

Query: 489  SLVSLILSKNNLTGPIPIAIAKLTNLQN-VDLSFNSLTGGLPKQLVNLVHLSSFNISHNH 547
             L  L LS+N LTG IP+ I +L +LQ+ +DLS+N+ TG +P  +  L  L S ++SHN 
Sbjct: 745  KLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQ 804

Query: 548  LQGELPAG-------GF---------------FNTISPSSVLGNPSLCGSAVNKSCPAVL 585
            L GE+P         G+               F+     + +GN  LCGS ++       
Sbjct: 805  LVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNAGLCGSPLSHC----- 859

Query: 586  PKPIVLNPNSSSDSTTSSVAPNPRHKRIILSISAIIAIGAAAVIVIGVIAITVLNL---- 641
                    N +      S++P     + ++ ISAI ++ A A++V+ +I     N     
Sbjct: 860  --------NRAGSKNQRSLSP-----KTVVIISAISSLAAIALMVLVIILFFKQNHDLFK 906

Query: 642  RVRSSTSRSAAALTLSAGDDFSRSPTTDANSGKLVMFSGDPDFSTGTHALLNKDCELGRG 701
            +VR   S  ++  + S    FS       N G       D D    TH  LN++  +G G
Sbjct: 907  KVRGGNSAFSSNSSSSQAPLFS-------NGGAKSDIKWD-DIMEATH-YLNEEFMIGSG 957

Query: 702  GFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS- 760
            G G VY+  L++G  +A+KK+     + S + F REVK LG +RH +LV L GY  +++ 
Sbjct: 958  GSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKAD 1017

Query: 761  -LQLLIYEFVSGGSLHKHLHEGSG---GNFLSWNERFNVIQGTAKSLAHLHQS---NIIH 813
             L LLIYE+++ GS+   LH          L W  R  +  G A+ + +LH      I+H
Sbjct: 1018 GLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVH 1077

Query: 814  YNIKSSNVLIDGSGEPKVGDYGLARLLP-MLDRYVLSSKI-QSALGYMAPEFACRTVKIT 871
             +IKSSNVL+D + E  +GD+GLA++L    D    S+ +   + GY+APE+A  ++K T
Sbjct: 1078 RDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYA-YSLKAT 1136

Query: 872  DKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE 908
            +K DVY  G++++E+VTGK P           V W+E
Sbjct: 1137 EKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVE 1173

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1

 Score =  403 bits (1035), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 296/911 (32%), Positives = 453/911 (49%), Gaps = 94/911 (10%)

Query: 39  LIVFKADIQDPNGKLSSWS-EDDDTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLL 97
           L+  K+ + DP   L  W   D    CNW GV+C+   N V +L L G++LTG+I   + 
Sbjct: 34  LLSVKSTLVDPLNFLKDWKLSDTSDHCNWTGVRCNSNGN-VEKLDLAGMNLTGKISDSIS 92

Query: 98  QLQFLR---------------------------------------------KLSLSSNNL 112
           QL  L                                               L+ S NNL
Sbjct: 93  QLSSLVSFNISCNGFESLLPKSIPPLKSIDISQNSFSGSLFLFSNESLGLVHLNASGNNL 152

Query: 113 TGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLC 172
           +G+++ +L  L +L V+DL GN   GS+P  F K    LR + L+ N  +G++PS L   
Sbjct: 153 SGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSF-KNLQKLRFLGLSGNNLTGELPSVLGQL 211

Query: 173 STLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNM 232
            +L T  L  N F  P+P     +++L+ LDL+   L GEIP  +  LK+L  + L +N 
Sbjct: 212 PSLETAILGYNEFKGPIPPEFGNINSLKYLDLAIGKLSGEIPSELGKLKSLETLLLYENN 271

Query: 233 FSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGEL 292
           F+G+IP  IGS + L+ +DFS+N+ +G +P  + KL     +NL +N  SG +P  I  L
Sbjct: 272 FTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNKLSGSIPPAISSL 331

Query: 293 ESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNS 352
             L+ L+L  N  SG +P  +G    L+ L+ S+N  +G +P ++ N  NL  L    N+
Sbjct: 332 AQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNT 391

Query: 353 MNGDLPQWIFS-SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPAT 411
             G +P  + +   L +V    N     +NG         E LQ L+L+ N  SG  P  
Sbjct: 392 FTGQIPATLSTCQSLVRVRMQNNL----LNGSIPIGFGKLEKLQRLELAGNRLSGGIPGD 447

Query: 412 IGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRL 471
           I     L  ++ SRN +   +P  I  +  L    +++N+++G +P +     SL  L L
Sbjct: 448 ISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQDCPSLSNLDL 507

Query: 472 ERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQ 531
             N L G IP+SI +C  LVSL L  NNLTG IP  I  ++ L  +DLS NSLTG LP+ 
Sbjct: 508 SSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPES 567

Query: 532 LVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKSCPAVLPKPIVL 591
           +     L   N+S+N L G +P  GF  TI+P  + GN  LCG         VLP     
Sbjct: 568 IGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLCG--------GVLP----- 614

Query: 592 NPNSSSDSTTSSVAPNPRHKRIILSISAIIAIGAAAVIVIGVIAITVLNLRVRSSTSRSA 651
            P S     TSS + +   KRI+    A   IG A+V+ +G++ I    L  +  ++   
Sbjct: 615 -PCSKFQRATSSHS-SLHGKRIV----AGWLIGIASVLALGILTIVTRTLYKKWYSNGFC 668

Query: 652 AALTLSAGDDFSRSPTTDANSGKLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTVL 711
              T S G+   R          L+ F      ++   A + +   +G G  G VY+  +
Sbjct: 669 GDETASKGEWPWR----------LMAFHRLGFTASDILACIKESNMIGMGATGIVYKAEM 718

Query: 712 -RDGRPVAIKKLTVSSL---VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE 767
            R    +A+KKL  S+      +  DF  EV  LGK+RH N+V L G+ +     +++YE
Sbjct: 719 SRSSTVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYE 778

Query: 768 FVSGGSLHKHLH--EGSGGNFLSWNERFNVIQGTAKSLAHLHQS---NIIHYNIKSSNVL 822
           F+  G+L   +H    +G   + W  R+N+  G A  LA+LH      +IH +IKS+N+L
Sbjct: 779 FMLNGNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNIL 838

Query: 823 IDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVL 882
           +D + + ++ D+GLAR++      V  S +  + GY+APE+   T+K+ +K D+Y +GV+
Sbjct: 839 LDANLDARIADFGLARMMARKKETV--SMVAGSYGYIAPEYG-YTLKVDEKIDIYSYGVV 895

Query: 883 VLEVVTGKRPL 893
           +LE++TG+RPL
Sbjct: 896 LLELLTGRRPL 906

Involved in the regulation of procambium maintenance and polarity during vascular-tissue development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score =  400 bits (1028), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 285/913 (31%), Positives = 445/913 (48%), Gaps = 112/913 (12%)

Query: 42  FKADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQF 101
           F  D   P   L+SW+    T C+W GV C      V  L L+GL+L+G +   +  L  
Sbjct: 38  FTIDEHSP--LLTSWNLST-TFCSWTGVTCDVSLRHVTSLDLSGLNLSGTLSSDVAHLPL 94

Query: 102 LRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRF 161
           L+ LSL++N ++G I P ++ L  LR ++LS N  +GS PDE      +LRV+ L  N  
Sbjct: 95  LQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDELSSGLVNLRVLDLYNNNL 154

Query: 162 SGKIPSSLSLCSTLATINLSSNRFSSPLP--LGIW------------------------- 194
           +G +P SL+  + L  ++L  N FS  +P   G W                         
Sbjct: 155 TGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLAVSGNELTGKIPPEIGNLT 214

Query: 195 ----------------------GLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNM 232
                                  LS L   D ++  L GEIP  +  L+ L  + L  N 
Sbjct: 215 TLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEIGKLQKLDTLFLQVNA 274

Query: 233 FSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGEL 292
           F+G+I   +G  S L+++D S N F+G +P +  +L     +NL +N   G +P++IGE+
Sbjct: 275 FTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRNKLYGAIPEFIGEM 334

Query: 293 ESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNS 352
             LE L L  N F+G++P  +G   RL +L+ S+N+LTG+LP +M +   L+ L    N 
Sbjct: 335 PELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCSGNRLMTLITLGNF 394

Query: 353 MNGDLPQWIFS-SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPAT 411
           + G +P  +     L ++   EN     +NG           L  ++L  N  +GE P +
Sbjct: 395 LFGSIPDSLGKCESLTRIRMGENF----LNGSIPKELFGLPKLSQVELQDNYLTGELPIS 450

Query: 412 IGALSG-LQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELR 470
            G +SG L  ++LS N L G +P AIG+L  +  L L  N  +GSIPPEIG    L +L 
Sbjct: 451 GGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLD 510

Query: 471 LERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPK 530
              N  +G+I   I  C  L  + LS+N L+G IP  +  +  L  ++LS N L G +P 
Sbjct: 511 FSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPV 570

Query: 531 QLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAV---NKSCPAVLPK 587
            + ++  L+S + S+N+L G +P+ G F+  + +S +GN  LCG  +    K       K
Sbjct: 571 TIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPYLGPCGKGTHQSHVK 630

Query: 588 PIVLNPNSSSDSTTSSVAPNPRHKRIILSISAIIAIGAAAVIVIGVIAITVLNLRVRSST 647
           P+       S +T   +        ++ +I AII   +                 +R+++
Sbjct: 631 PL-------SATTKLLLVLGLLFCSMVFAIVAIIKARS-----------------LRNAS 666

Query: 648 SRSAAALTLSAGDDFSRSPTTDANSGKLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVY 707
              A  LT     DF+     D+                     L +D  +G+GG G VY
Sbjct: 667 EAKAWRLTAFQRLDFTCDDVLDS---------------------LKEDNIIGKGGAGIVY 705

Query: 708 RTVLRDGRPVAIKKLTVSSLVKSQED-FEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY 766
           +  +  G  VA+K+L   S   S +  F  E++ LG++RH ++V L G+       LL+Y
Sbjct: 706 KGTMPKGDLVAVKRLATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVY 765

Query: 767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN---IIHYNIKSSNVLI 823
           E++  GSL + LH   GG+ L WN R+ +    AK L +LH      I+H ++KS+N+L+
Sbjct: 766 EYMPNGSLGEVLHGKKGGH-LHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILL 824

Query: 824 DGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLV 883
           D + E  V D+GLA+ L         S I  + GY+APE+A  T+K+ +K DVY FGV++
Sbjct: 825 DSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYA-YTLKVDEKSDVYSFGVVL 883

Query: 884 LEVVTGKRPLSTW 896
           LE++TGK+P+  +
Sbjct: 884 LELITGKKPVGEF 896

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1

 Score =  395 bits (1015), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 311/981 (31%), Positives = 461/981 (46%), Gaps = 173/981 (17%)

Query: 49  PNGKLSSWSEDDDTPCNWFGVKCSPRSNRVI-------------------------ELTL 83
           P    S W+  D  PC W  + CS   N+++                         +L +
Sbjct: 54  PPSVFSGWNPSDSDPCQWPYITCSSSDNKLVTEINVVSVQLALPFPPNISSFTSLQKLVI 113

Query: 84  NGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDE 143
           +  +LTG I   +     L  + LSSN+L G I  +L KL+NL+ + L+ N L+G IP E
Sbjct: 114 SNTNLTGAISSEIGDCSELIVIDLSSNSLVGEIPSSLGKLKNLQELCLNSNGLTGKIPPE 173

Query: 144 FFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSN-RFSSPLPLGIWGLSALRTL 202
               C SL+ + +  N  S  +P  L   STL +I    N   S  +P  I     L+ L
Sbjct: 174 -LGDCVSLKNLEIFDNYLSENLPLELGKISTLESIRAGGNSELSGKIPEEIGNCRNLKVL 232

Query: 203 DLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLP 262
            L+   + G +P  +  L  L+ +++   M SG IP  +G+CS L  +   +N  SG LP
Sbjct: 233 GLAATKISGSLPVSLGQLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLP 292

Query: 263 ETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVL 322
           + + KL     M L +N   G +P+ IG ++SL  +DLS N FSG +P S GNL  L+ L
Sbjct: 293 KELGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQEL 352

Query: 323 NFSANRLTGS------------------------------------------------LP 334
             S+N +TGS                                                +P
Sbjct: 353 MLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIP 412

Query: 335 DSMANCMNLVALDFSQNSMNGDLPQWIFS-SGLNKVSFAENKI----------------- 376
           D +A C NL ALD SQN + G LP  +F    L K+    N I                 
Sbjct: 413 DELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRL 472

Query: 377 ---REGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIP 433
                 + G         ++L FLDLS N  SG  P  I     LQ+LNLS N+L G +P
Sbjct: 473 RLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLP 532

Query: 434 VAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSL 493
           +++  L  L VLD+S N L G IP  +G   SL  L L +N   G+IP+S+ +C++L  L
Sbjct: 533 LSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLL 592

Query: 494 ILSKNNLTGPIPIAIAKLTNLQNVD----LSFNSLTGGLPKQLVNLVHLS---------- 539
            LS NN++G IP    +L ++Q++D    LS+NSL G +P+++  L  LS          
Sbjct: 593 DLSSNNISGTIP---EELFDIQDLDIALNLSWNSLDGFIPERISALNRLSVLDISHNMLS 649

Query: 540 -------------SFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKSCPAVLP 586
                        S NISHN   G LP    F  +  + + GN  LC     +SC     
Sbjct: 650 GDLSALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCSKGF-RSC----- 703

Query: 587 KPIVLNPNSSSDSTTSSVAPNPRHKRIILSISAIIAIGAAAVIVIGVIAITVLNLRVRSS 646
                  NSS  +T   V       R+ ++I  +I++  A + V+GV+A+      +R  
Sbjct: 704 ----FVSNSSQLTTQRGV----HSHRLRIAIGLLISV-TAVLAVLGVLAVIRAKQMIR-- 752

Query: 647 TSRSAAALTLSAGDDFSRSPTTDANSGKLVMFSGDPDFSTGTHAL--LNKDCELGRGGFG 704
                        DD       +  + +   F    +F T  H L  L +   +G+G  G
Sbjct: 753 -------------DDNDSETGENLWTWQFTPFQ-KLNF-TVEHVLKCLVEGNVIGKGCSG 797

Query: 705 AVYRTVLRDGRPVAIKKL---TVSSLVKS------QEDFEREVKKLGKVRHPNLVTLEGY 755
            VY+  + +   +A+KKL   TV +L +       ++ F  EVK LG +RH N+V   G 
Sbjct: 798 IVYKAEMPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGC 857

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN---II 812
            W ++ +LL+Y+++S GSL   LHE SG   L W  R+ +I G A+ LA+LH      I+
Sbjct: 858 CWNKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIV 917

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           H +IK++N+LI    EP +GD+GLA+L+   D    S+ I  + GY+APE+   ++KIT+
Sbjct: 918 HRDIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSNTIAGSYGYIAPEYG-YSMKITE 976

Query: 873 KCDVYGFGVLVLEVVTGKRPL 893
           K DVY +GV+VLEV+TGK+P+
Sbjct: 977 KSDVYSYGVVVLEVLTGKQPI 997

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  395 bits (1015), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 305/955 (31%), Positives = 461/955 (48%), Gaps = 147/955 (15%)

Query: 87   SLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFK 146
            SLTG I   L ++  L+ LSL +N L G I  +LA L NL+ +DLS N+L+G IP+EF+ 
Sbjct: 250  SLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWN 309

Query: 147  Q---------------------CGS---LRVISLAKNRFSGKIPSSLSLCSTLATINLSS 182
                                  C +   L  + L+  + SG+IP  LS C +L  ++LS+
Sbjct: 310  MSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSN 369

Query: 183  NRFSSPLPLGIWGLSALRTLDLSDNLLEG------------------------EIPKGVE 218
            N  +  +P  ++ L  L  L L +N LEG                        ++PK + 
Sbjct: 370  NSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEIS 429

Query: 219  SLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRK 278
            +L+ L V+ L +N FSG IP  IG+C+ L+ ID   N F G +P ++ +L   N ++LR+
Sbjct: 430  ALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQ 489

Query: 279  NLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMA 338
            N   G +P  +G    L  LDL+ N+ SG++P S G L+ L+ L    N L G+LPDS+ 
Sbjct: 490  NELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLI 549

Query: 339  NCMNLVALDFSQNSMNGDLPQWIFSS------------------------GLNKVSFAEN 374
            +  NL  ++ S N +NG +     SS                         L+++   +N
Sbjct: 550  SLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKN 609

Query: 375  -----------KIRE---------GMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGA 414
                       KIRE          + G         + L  +DL++N  SG  P  +G 
Sbjct: 610  QLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGK 669

Query: 415  LSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERN 474
            LS L  L LS N  V  +P  + +   L VL L  N LNGSIP EIG   +L  L L++N
Sbjct: 670  LSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKN 729

Query: 475  FLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQN-VDLSFNSLTGGLPKQLV 533
              +G +P ++   S L  L LS+N+LTG IP+ I +L +LQ+ +DLS+N+ TG +P  + 
Sbjct: 730  QFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIG 789

Query: 534  NLVHLSSFNISHNHLQGELPAG-------GFFNT---------------ISPSSVLGNPS 571
             L  L + ++SHN L GE+P         G+ N                    S LGN  
Sbjct: 790  TLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTG 849

Query: 572  LCGSAVNKSCPAVLPKPIVLNPNSSSDSTTSSVAPNPRHKRIILSISAIIAIGAAAVIVI 631
            LCGS +++ C  V              S       + R   II +ISA+ AIG   ++VI
Sbjct: 850  LCGSPLSR-CNRV-------------RSNNKQQGLSARSVVIISAISALTAIG-LMILVI 894

Query: 632  GVIAITVLNLRVRSSTSRSAAALTLSAGDDFSRSPTTDANSGKLVMFSGDPDFSTGTHAL 691
             +      +   +     +A   + S+     +    +  S   + +    D    TH  
Sbjct: 895  ALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWE---DIMEATHN- 950

Query: 692  LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
            L+++  +G GG G VY+  L +G  VA+KK+     + S + F REVK LG++RH +LV 
Sbjct: 951  LSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVK 1010

Query: 752  LEGYYWTQS--LQLLIYEFVSGGSLHKHLHEG-----SGGNFLSWNERFNVIQGTAKSLA 804
            L GY  ++S  L LLIYE++  GS+   LHE           L W  R  +  G A+ + 
Sbjct: 1011 LMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVE 1070

Query: 805  HLHQS---NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSK-IQSALGYM 859
            +LH      I+H +IKSSNVL+D + E  +GD+GLA++L    D    S+     + GY+
Sbjct: 1071 YLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYI 1130

Query: 860  APEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKA 914
            APE+A  ++K T+K DVY  G++++E+VTGK P  +        V W+E H + A
Sbjct: 1131 APEYA-YSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVA 1184

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1

 Score =  395 bits (1014), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 295/924 (31%), Positives = 448/924 (48%), Gaps = 132/924 (14%)

Query: 41  VFKADIQDPNGKLSSW--SEDDDTPCNWFGVKCSPRSNRVIELT---LNGLSLTGRIGRG 95
           V K  + DP+G L  W  + D+ +PCNW G+ C  R    + +T   L+G +++G    G
Sbjct: 34  VKKTRLFDPDGNLQDWVITGDNRSPCNWTGITCHIRKGSSLAVTTIDLSGYNISGGFPYG 93

Query: 96  LLQLQFLRKLSLSSNNLTGSISPN----LAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSL 151
             +++ L  ++LS NNL G+I        +KLQNL    L+ N+ SG +P EF  +   L
Sbjct: 94  FCRIRTLINITLSQNNLNGTIDSAPLSLCSKLQNLI---LNQNNFSGKLP-EFSPEFRKL 149

Query: 152 RVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFS------------------------- 186
           RV+ L  N F+G+IP S    + L  +NL+ N  S                         
Sbjct: 150 RVLELESNLFTGEIPQSYGRLTALQVLNLNGNPLSGIVPAFLGYLTELTRLDLAYISFDP 209

Query: 187 SPLP--LG----------------------IWGLSALRTLDLSDNLLEGEIPKGVESLKN 222
           SP+P  LG                      I  L  L  LDL+ N L GEIP+ +  L++
Sbjct: 210 SPIPSTLGNLSNLTDLRLTHSNLVGEIPDSIMNLVLLENLDLAMNSLTGEIPESIGRLES 269

Query: 223 LRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFS 282
           +  I L  N  SG +P+ IG+ + LR  D S+N+ +G LPE +  L L +F NL  N F+
Sbjct: 270 VYQIELYDNRLSGKLPESIGNLTELRNFDVSQNNLTGELPEKIAALQLISF-NLNDNFFT 328

Query: 283 GEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMN 342
           G +P  +    +L    +  N F+G +P ++G    +   + S NR +G LP  +     
Sbjct: 329 GGLPDVVALNPNLVEFKIFNNSFTGTLPRNLGKFSEISEFDVSTNRFSGELPPYLCYRRK 388

Query: 343 LVALDFSQNSMNGDLPQ-WIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSH 401
           L  +    N ++G++P+ +     LN +  A+NK+   +   F         L  L+L++
Sbjct: 389 LQKIITFSNQLSGEIPESYGDCHSLNYIRMADNKLSGEVPARFWEL-----PLTRLELAN 443

Query: 402 N-EFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEI 460
           N +  G  P +I     L  L +S N+  G IPV + DL+ L V+DLS N   GSIP  I
Sbjct: 444 NNQLQGSIPPSISKARHLSQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIPSCI 503

Query: 461 GGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLS 520
               +L+ + ++ N L G+IP+S+ +C+ L  L LS N L G IP  +  L  L  +DLS
Sbjct: 504 NKLKNLERVEMQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLDLS 563

Query: 521 FNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKS 580
            N LTG +P +L+ L  L+ FN+S N L G++P+G F   I   S LGNP+LC   ++  
Sbjct: 564 NNQLTGEIPAELLRL-KLNQFNVSDNKLYGKIPSG-FQQDIFRPSFLGNPNLCAPNLDPI 621

Query: 581 CPAVLPKPIVLNPNSSSDSTTSSVAPNPRHKRIILSISAIIAIGAAAVIVIGVIAITVLN 640
            P                        + R  R IL IS +  +     +V   I    L 
Sbjct: 622 RPCR----------------------SKRETRYILPISILCIVALTGALVWLFIKTKPL- 658

Query: 641 LRVRSSTSRSAAALTLSAGDDFSRSPTTDANSGKLVMFSGDPDFSTGTHALLNKDCELGR 700
                                F R P     + K+ +F          +  L +D  +G 
Sbjct: 659 ---------------------FKRKP---KRTNKITIFQRVGFTEEDIYPQLTEDNIIGS 694

Query: 701 GGFGAVYRTVLRDGRPVAIKKL--TVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWT 758
           GG G VYR  L+ G+ +A+KKL        +S+  F  EV+ LG+VRH N+V L      
Sbjct: 695 GGSGLVYRVKLKSGQTLAVKKLWGETGQKTESESVFRSEVETLGRVRHGNIVKLLMCCNG 754

Query: 759 QSLQLLIYEFVSGGSLHKHLH---EGSGGNFLSWNERFNVIQGTAKSLAHLHQSN---II 812
           +  + L+YEF+  GSL   LH   E    + L W  RF++  G A+ L++LH  +   I+
Sbjct: 755 EEFRFLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRFSIAVGAAQGLSYLHHDSVPPIV 814

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS----SKIQSALGYMAPEFACRTV 868
           H ++KS+N+L+D   +P+V D+GLA+ L   D   +S    S +  + GY+APE+   T 
Sbjct: 815 HRDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAGSYGYIAPEYG-YTS 873

Query: 869 KITDKCDVYGFGVLVLEVVTGKRP 892
           K+ +K DVY FGV++LE++TGKRP
Sbjct: 874 KVNEKSDVYSFGVVLLELITGKRP 897

Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	936
255559719	963	ATP binding protein, putative [Ricinus c	0.939	0.912	0.781	0.0
224146230	963	predicted protein [Populus trichocarpa]	0.919	0.894	0.787	0.0
225448703	969	PREDICTED: probably inactive leucine-ric	0.930	0.898	0.783	0.0
224126603	965	predicted protein [Populus trichocarpa]	0.919	0.892	0.772	0.0
356507516	971	PREDICTED: probably inactive leucine-ric	0.926	0.892	0.737	0.0
358249058	971	probably inactive leucine-rich repeat re	0.926	0.892	0.739	0.0
449441248	964	PREDICTED: probably inactive leucine-ric	0.927	0.900	0.725	0.0
449532759	964	PREDICTED: probably inactive leucine-ric	0.927	0.900	0.725	0.0
15228900	964	leucine-rich repeat protein kinase-like	0.933	0.906	0.711	0.0
17979045	964	unknown protein [Arabidopsis thaliana]	0.933	0.906	0.710	0.0

>gi|255559719|ref|XP_002520879.1| ATP binding protein, putative [Ricinus communis] gi|223540010|gb|EEF41588.1| ATP binding protein, putative [Ricinus communis]

 Score = 1381 bits (3574), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 697/892 (78%), Positives = 777/892 (87%), Gaps = 13/892 (1%)

Query: 4   MLKMKA--SVFSLLTFLVLAPALTRSLNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDD 61
           M+K K   S+F+LL F++       SL PSLNDDVLGLIVFKAD+QDP GKLSSW++DDD
Sbjct: 1   MVKTKELLSLFALLGFVL---QCVGSLTPSLNDDVLGLIVFKADLQDPKGKLSSWNQDDD 57

Query: 62  TPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLA 121
           TPCNW GVKC+PRSNRV ELTL+  SL+GRIGRGLLQLQFL KLSL+ NNL+G+ISPNLA
Sbjct: 58  TPCNWVGVKCNPRSNRVTELTLDDFSLSGRIGRGLLQLQFLHKLSLARNNLSGNISPNLA 117

Query: 122 KLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLS 181
           +L NLR+IDLS NSLSG IPD+FF+QCGSLRVISLAKN+FSGKIP+SL  C+TLA+++LS
Sbjct: 118 RLANLRIIDLSENSLSGPIPDDFFQQCGSLRVISLAKNKFSGKIPASLGSCATLASVDLS 177

Query: 182 SNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGI 241
           SN+FS  LP GIWGLS LR+LDLS+NLLEGEIPKG+E L NLR INLSKN F+G +PDGI
Sbjct: 178 SNQFSGSLPPGIWGLSGLRSLDLSNNLLEGEIPKGIEVLNNLRGINLSKNQFTGIVPDGI 237

Query: 242 GSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLS 301
           GSC LLR+ID S NS SG  PET+QKLSLCNFM+L  NL +GEVP WIGE++ LETLD+S
Sbjct: 238 GSCLLLRSIDLSGNSLSGEFPETIQKLSLCNFMSLSNNLLTGEVPNWIGEMKRLETLDIS 297

Query: 302 GNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWI 361
           GNK SG +P SIGNLQ LKVLNFS+N L+GSLP+SMANC +L+ALD S+NSMNGDLP W+
Sbjct: 298 GNKISGQIPTSIGNLQSLKVLNFSSNDLSGSLPESMANCGSLLALDLSRNSMNGDLPAWV 357

Query: 362 FSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLL 421
           FS GL KV   ++K+    N        S   LQ LDLS NEFSG+  ++IG LS LQ L
Sbjct: 358 FSPGLEKVLHLDSKLGGSFN--------SVPKLQVLDLSENEFSGKIASSIGVLSSLQFL 409

Query: 422 NLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIP 481
           NLS NSL GP+P  IGDLK L+VLDLS N LNGSIP EIGGA+SLKELRLERN L+G+IP
Sbjct: 410 NLSGNSLEGPLPGTIGDLKELDVLDLSGNSLNGSIPLEIGGAFSLKELRLERNLLSGQIP 469

Query: 482 TSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSF 541
           +S+ NC+SL ++ILS+NNLTG IP AIAKLT+L++VDLSFNSLTGGLPKQL NL +LSSF
Sbjct: 470 SSVGNCTSLTTMILSRNNLTGLIPAAIAKLTSLKDVDLSFNSLTGGLPKQLANLPNLSSF 529

Query: 542 NISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKSCPAVLPKPIVLNPNSSSDSTT 601
           NISHN LQGELPAGGFFNTISP SV GNPSLCG+AVNKSCPAVLPKPIVLNPNSSSDS  
Sbjct: 530 NISHNQLQGELPAGGFFNTISPYSVSGNPSLCGAAVNKSCPAVLPKPIVLNPNSSSDSAP 589

Query: 602 SSVAPNPRHKRIILSISAIIAIGAAAVIVIGVIAITVLNLRVRSSTSRSAAALTLSAGDD 661
             +  +  HKRIILSISA+IAIGAAAVIV+GVIAITVLNLRVRSSTSRSAAALT SAGDD
Sbjct: 590 GEIPQDIGHKRIILSISALIAIGAAAVIVVGVIAITVLNLRVRSSTSRSAAALTFSAGDD 649

Query: 662 FSRSPTTDANSGKLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKK 721
           FS SPTTDANSGKLVMFSGDPDFSTG HALLNKDCELGRGGFGAVYRTVLR+G PVAIKK
Sbjct: 650 FSHSPTTDANSGKLVMFSGDPDFSTGAHALLNKDCELGRGGFGAVYRTVLRNGHPVAIKK 709

Query: 722 LTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEG 781
           LTVSSLVKSQ+DFEREVKKLGKVRH NLV LEGYYWT SLQLLIYEFVSGGSL+KHLHEG
Sbjct: 710 LTVSSLVKSQDDFEREVKKLGKVRHQNLVGLEGYYWTPSLQLLIYEFVSGGSLYKHLHEG 769

Query: 782 SGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP 841
           SGG+FLSWNERFN+I GTAKSLAHLHQSNIIHYNIKSSNVL+D SGEPKVGDYGLARLLP
Sbjct: 770 SGGHFLSWNERFNIILGTAKSLAHLHQSNIIHYNIKSSNVLLDSSGEPKVGDYGLARLLP 829

Query: 842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           MLDRYVLSSKIQSALGYMAPEFACRTVKIT+KCDVYGFGVLVLE+VTGKRP+
Sbjct: 830 MLDRYVLSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEIVTGKRPV 881

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224146230|ref|XP_002325929.1| predicted protein [Populus trichocarpa] gi|222862804|gb|EEF00311.1| predicted protein [Populus trichocarpa]

 Score = 1354 bits (3505), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 684/869 (78%), Positives = 770/869 (88%), Gaps = 8/869 (0%)

Query: 25  TRSLNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLN 84
            RSLNPSLNDDVLGLIVFKAD+QDP  KLSSW++DDDTPCNWFGVKC+PRSNRV ELTL+
Sbjct: 21  VRSLNPSLNDDVLGLIVFKADLQDPMRKLSSWNQDDDTPCNWFGVKCNPRSNRVAELTLD 80

Query: 85  GLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEF 144
           GLSL+GRIGRGLLQLQFL KLSLS NNLTGSI+PNL +L++LR+IDLS NSLSG+I ++F
Sbjct: 81  GLSLSGRIGRGLLQLQFLHKLSLSRNNLTGSINPNLTRLESLRIIDLSENSLSGTISEDF 140

Query: 145 FKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDL 204
           FK+C +LR +SLA N+FSGKIP SLS C++LA+INLSSN+F+  LP GIWGL+ LR+LDL
Sbjct: 141 FKECAALRDLSLANNKFSGKIPGSLSSCASLASINLSSNQFTGSLPAGIWGLNGLRSLDL 200

Query: 205 SDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPET 264
           S NLL+GEIPKG+E L NLR INLSKN F+G +PDGIGSC LLR++DFSEN  SG++P+T
Sbjct: 201 SGNLLDGEIPKGIEVLNNLRSINLSKNRFNGGVPDGIGSCLLLRSVDFSENMLSGHIPDT 260

Query: 265 MQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNF 324
           MQKL LC++++L  N+F+GEVP WIGEL  LETLDLSGN+FSG VPISIG LQ LKVLN 
Sbjct: 261 MQKLGLCDYLSLSSNMFTGEVPNWIGELNRLETLDLSGNRFSGQVPISIGKLQLLKVLNL 320

Query: 325 SANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPF 384
           SAN L+G+LP+SMANC NL+ALDFSQN ++GDLP WIF S   KV   ENK    ++G F
Sbjct: 321 SANGLSGNLPESMANCGNLLALDFSQNLLSGDLPTWIFGSRSEKVLHLENK----LSGKF 376

Query: 385 ASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNV 444
           +S+      LQFLDLSHN+FSG+  ++IG LS LQ LNLS+NSL GP+P   GDLK L++
Sbjct: 377 SSA----PRLQFLDLSHNDFSGKIASSIGVLSSLQFLNLSKNSLFGPVPGTFGDLKELDI 432

Query: 445 LDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPI 504
           LDLS+N LNGSIP EIGGA++LKELRLERN L+G+IP SI NCSSL++LILS+NNL G I
Sbjct: 433 LDLSDNKLNGSIPTEIGGAFALKELRLERNSLSGQIPDSIGNCSSLMTLILSQNNLAGTI 492

Query: 505 PIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPS 564
           P AIAKL NL++VDLS NSLTG LPKQL NL +L SFNISHN+LQGELPAG FFNTISPS
Sbjct: 493 PAAIAKLGNLKDVDLSLNSLTGSLPKQLANLPNLISFNISHNNLQGELPAGVFFNTISPS 552

Query: 565 SVLGNPSLCGSAVNKSCPAVLPKPIVLNPNSSSDSTTSSVAPNPRHKRIILSISAIIAIG 624
           SV GNPSLCG+AVNKSCPAVLPKPIVLNPNSSSDST  S+  NP HKRIILSISA+IAIG
Sbjct: 553 SVSGNPSLCGAAVNKSCPAVLPKPIVLNPNSSSDSTPGSLPQNPGHKRIILSISALIAIG 612

Query: 625 AAAVIVIGVIAITVLNLRVRSSTSRSAAALTLSAGDDFSRSPTTDANSGKLVMFSGDPDF 684
           AAAVIV+GVIAITVLNLRVRSSTSRSAAALTLSAGD FS SPTTDANSGKLVMF+G PDF
Sbjct: 613 AAAVIVVGVIAITVLNLRVRSSTSRSAAALTLSAGDGFSDSPTTDANSGKLVMFTGKPDF 672

Query: 685 STGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV 744
           STG HALLNKDCELGRGGFGAVY+TVLRDG PVAIKKLTVSSLVKSQEDFEREVKKLGK+
Sbjct: 673 STGAHALLNKDCELGRGGFGAVYQTVLRDGHPVAIKKLTVSSLVKSQEDFEREVKKLGKI 732

Query: 745 RHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLA 804
           RH NLV LEGYYWTQSLQLLIYEFVSGGSL+KHLHEGSGG+FLSWNERFN+I GTAKSLA
Sbjct: 733 RHQNLVALEGYYWTQSLQLLIYEFVSGGSLYKHLHEGSGGHFLSWNERFNIILGTAKSLA 792

Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
           HLHQSNIIHYNIKSSNVL+D SGEPKVGD+GLARLLPMLDRYVLSSKIQSALGYMAPEFA
Sbjct: 793 HLHQSNIIHYNIKSSNVLLDSSGEPKVGDFGLARLLPMLDRYVLSSKIQSALGYMAPEFA 852

Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           CRTVKIT+KCDVYGFGVLVLE+VTGKRP+
Sbjct: 853 CRTVKITEKCDVYGFGVLVLEIVTGKRPV 881

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225448703|ref|XP_002275275.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At3g28040-like [Vitis vinifera]

 Score = 1346 bits (3483), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 684/873 (78%), Positives = 760/873 (87%), Gaps = 2/873 (0%)

Query: 22  PALTRSLNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIEL 81
           P+  +SLNPSLNDDVLGLIVFKADIQDPN KL+SW+EDDD+PCNW GVKC+PRSNRV +L
Sbjct: 16  PSCVKSLNPSLNDDVLGLIVFKADIQDPNSKLASWNEDDDSPCNWVGVKCNPRSNRVTDL 75

Query: 82  TLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIP 141
            L+G SL+G+IGRGLLQLQFLRKLSL+ NN+TGSI PNLA+LQNLR IDLS NSLSG+IP
Sbjct: 76  VLDGFSLSGKIGRGLLQLQFLRKLSLAKNNITGSIGPNLARLQNLRFIDLSENSLSGTIP 135

Query: 142 DEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRT 201
           D+FFKQCGSL  ISLAKN+FSGKIP S+  CSTLA I+ SSN+FS PLP GIW L+ LR+
Sbjct: 136 DDFFKQCGSLHAISLAKNKFSGKIPESVGSCSTLAAIDFSSNQFSGPLPSGIWSLNGLRS 195

Query: 202 LDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNL 261
           LDLSDNLLEG+IPKG++SL NLR INLSKN FSG +PDGIG C LLR IDFSENS SG+L
Sbjct: 196 LDLSDNLLEGDIPKGIDSLYNLRAINLSKNRFSGPLPDGIGGCLLLRLIDFSENSLSGSL 255

Query: 262 PETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKV 321
           P TMQKL+LCN+MNL  N F GEVP+WIGE++SLETLDLS NKFSG VP SIGNL+ LKV
Sbjct: 256 PGTMQKLTLCNYMNLHGNSFEGEVPEWIGEMKSLETLDLSANKFSGRVPTSIGNLKSLKV 315

Query: 322 LNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMN 381
           LNFS N  +GSLP+SM NC  L+ LD SQNS+ GDLP WIF  GL KV  ++N +   M+
Sbjct: 316 LNFSVNVFSGSLPESMINCEQLLVLDVSQNSLLGDLPAWIFKLGLQKVLLSKNSLSGNMD 375

Query: 382 GPFASS-GSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLK 440
            PF+SS   S + LQ LDLS+NE SG+  ++IG    LQ LN+SRNSLVG IP +IGDLK
Sbjct: 376 SPFSSSVEKSRQGLQVLDLSYNELSGDFTSSIGVFRSLQFLNISRNSLVGAIPASIGDLK 435

Query: 441 ALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNL 500
           AL+VLDLSEN LNGSIP EIGGA+SLK+LRL+ NFLAGKIP S+ENCSSL +LILS NNL
Sbjct: 436 ALDVLDLSENQLNGSIPLEIGGAFSLKDLRLKNNFLAGKIPVSLENCSSLTTLILSHNNL 495

Query: 501 TGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNT 560
           +GPIP+ I+KL+NL+NVDLS N LTG LPKQL NL HL SFNISHN LQGELPAGGFFNT
Sbjct: 496 SGPIPMGISKLSNLENVDLSLNKLTGSLPKQLANLPHLISFNISHNQLQGELPAGGFFNT 555

Query: 561 ISPSSVLGNPSLCGSAVNKSCPAVLPKPIVLNPNSSSDSTTSSVAPNPRHKRIILSISAI 620
           ISPSSV GNPSLCGSA NKSCPAVLPKPIVLNPNSSSD+T  +   +  HK+IILSISA+
Sbjct: 556 ISPSSVSGNPSLCGSAANKSCPAVLPKPIVLNPNSSSDTTAGAFPRSLAHKKIILSISAL 615

Query: 621 IAIGAAAVIVIGVIAITVLNLRVRSSTSRSAAALTLSAGDDFSRSPTTDANSGKLVMFSG 680
           IAIGAAAVIVIGVIAITVLNLRVRSS SRSAAAL LS GDD+S SPTTDANSGKLVMFSG
Sbjct: 616 IAIGAAAVIVIGVIAITVLNLRVRSSASRSAAALALSGGDDYSHSPTTDANSGKLVMFSG 675

Query: 681 DPDFSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKK 740
           DPDFS G HALLNKDCELGRGGFGAVYRTVLRDG PVAIKKLTVSSLVKSQEDFEREVKK
Sbjct: 676 DPDFSMGAHALLNKDCELGRGGFGAVYRTVLRDGHPVAIKKLTVSSLVKSQEDFEREVKK 735

Query: 741 LGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTA 800
           LGK+RH NLV LEGYYWT SLQLLIYEF+SGGSL+KHLHEG+GGNF +WNERFN+I GTA
Sbjct: 736 LGKIRHQNLVALEGYYWTPSLQLLIYEFISGGSLYKHLHEGAGGNF-TWNERFNIILGTA 794

Query: 801 KSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMA 860
           KSLAHLHQ +IIHYN+KSSNVLID SGEPKV D+GLARLLPMLDRYVLSSKIQSALGYMA
Sbjct: 795 KSLAHLHQMSIIHYNLKSSNVLIDPSGEPKVADFGLARLLPMLDRYVLSSKIQSALGYMA 854

Query: 861 PEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           PEFACRTVKIT+KCDVYGFGVLVLEVVTGKRP+
Sbjct: 855 PEFACRTVKITEKCDVYGFGVLVLEVVTGKRPV 887

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224126603|ref|XP_002319878.1| predicted protein [Populus trichocarpa] gi|222858254|gb|EEE95801.1| predicted protein [Populus trichocarpa]

 Score = 1343 bits (3476), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 671/869 (77%), Positives = 760/869 (87%), Gaps = 8/869 (0%)

Query: 25  TRSLNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLN 84
            RSLNPSLNDDV GLIVFKAD+QDP  KLSSW++DDDTPCNWFGVKC+PRSNRV EL+L+
Sbjct: 23  VRSLNPSLNDDVFGLIVFKADLQDPKRKLSSWNQDDDTPCNWFGVKCNPRSNRVTELSLD 82

Query: 85  GLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEF 144
           GLSL+G+IGRGL+QLQFL KLSLS N LTGSI+PNL +L+NLR+IDLS NSLSG+IP++F
Sbjct: 83  GLSLSGQIGRGLMQLQFLHKLSLSRNCLTGSINPNLTRLENLRIIDLSENSLSGTIPEDF 142

Query: 145 FKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDL 204
           FK CG+LR ISLAKN+FSGKIPS+LS C++LA+INLSSN+FS  LP GIWGL+ L +LDL
Sbjct: 143 FKDCGALRDISLAKNKFSGKIPSTLSSCASLASINLSSNQFSGSLPAGIWGLNGLSSLDL 202

Query: 205 SDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPET 264
           S NLL+ EIP+G+E L NLR INLSKN F+G +P+GIGSC LLR++DFSEN  SG +P+T
Sbjct: 203 SGNLLDSEIPRGIEVLNNLRNINLSKNRFNGGVPNGIGSCLLLRSVDFSENMLSGTVPDT 262

Query: 265 MQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNF 324
           MQ L LCN+++L  N+F+GEVP WIGEL  LETLDLSGN+FSG VP SIGNLQ LKV N 
Sbjct: 263 MQNLGLCNYLSLSNNMFTGEVPNWIGELNRLETLDLSGNRFSGQVPTSIGNLQSLKVFNL 322

Query: 325 SANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPF 384
           SAN L+G+LP+SM NC NL+ LD SQN ++GDLP WIF SGL KV   ENK    ++G F
Sbjct: 323 SANSLSGNLPESMTNCGNLLVLDCSQNLLSGDLPVWIFGSGLEKVLQLENK----LSGKF 378

Query: 385 ASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNV 444
           +S+    + LQ LDLSHN+FSG+  ++IG  S LQ LNLSRNSL+GPIP   GDLK L+V
Sbjct: 379 SSA----QKLQVLDLSHNDFSGKIASSIGVSSSLQFLNLSRNSLMGPIPGTFGDLKELDV 434

Query: 445 LDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPI 504
           LDLS+N LNGSIP EIGGA++LKELRLERN L+G+IP+SI  CSSL +LILS+NNL+G I
Sbjct: 435 LDLSDNKLNGSIPMEIGGAFALKELRLERNSLSGQIPSSIGTCSSLTTLILSQNNLSGTI 494

Query: 505 PIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPS 564
           P+AIAKL NLQ+VD+SFNSL+G LPKQL NL +LSSFNISHN+LQGELPA GFFNTISPS
Sbjct: 495 PVAIAKLGNLQDVDVSFNSLSGTLPKQLANLPNLSSFNISHNNLQGELPASGFFNTISPS 554

Query: 565 SVLGNPSLCGSAVNKSCPAVLPKPIVLNPNSSSDSTTSSVAPNPRHKRIILSISAIIAIG 624
            V GNPSLCG+AVNKSCPAVLPKPIVLNPNSSSDST  S+  N  HKRIILSISA+IAIG
Sbjct: 555 CVAGNPSLCGAAVNKSCPAVLPKPIVLNPNSSSDSTPGSLPQNLGHKRIILSISALIAIG 614

Query: 625 AAAVIVIGVIAITVLNLRVRSSTSRSAAALTLSAGDDFSRSPTTDANSGKLVMFSGDPDF 684
           AAAVIV+GVIAITVLNLRVRSSTSRSAAALTLSAGD FS S TTDANSGKLVMFSGD DF
Sbjct: 615 AAAVIVVGVIAITVLNLRVRSSTSRSAAALTLSAGDGFSDSSTTDANSGKLVMFSGDTDF 674

Query: 685 STGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV 744
           ST  HALLNKDCELGRGGFGAVY+TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGK+
Sbjct: 675 STEAHALLNKDCELGRGGFGAVYQTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKI 734

Query: 745 RHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLA 804
           RH NLV LEGYYWT SLQLLIYEFVSGGSL+KHLHE  GG+FLSWNERFN+I GTAKSLA
Sbjct: 735 RHQNLVALEGYYWTPSLQLLIYEFVSGGSLYKHLHERPGGHFLSWNERFNIILGTAKSLA 794

Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
           HLHQSN+IHYNIKS N+LID SGEPKVGD+GLARLLPMLDRYVLSSKIQSALGYMAPEFA
Sbjct: 795 HLHQSNVIHYNIKSRNILIDISGEPKVGDFGLARLLPMLDRYVLSSKIQSALGYMAPEFA 854

Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           CRT KIT+KCDVYGFGVL+LE+VTGKRP+
Sbjct: 855 CRTAKITEKCDVYGFGVLILEIVTGKRPV 883

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356507516|ref|XP_003522510.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At3g28040-like [Glycine max]

 Score = 1302 bits (3369), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 642/870 (73%), Positives = 752/870 (86%), Gaps = 3/870 (0%)

Query: 27  SLNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPC--NWFGVKCSPRSNRVIELTLN 84
           ++NPSLNDDVLGLIVFKADI+DP GKL+SW+EDD++ C  +W GVKC+PRSNRV+E+ L+
Sbjct: 20  AVNPSLNDDVLGLIVFKADIRDPKGKLASWNEDDESACGGSWVGVKCNPRSNRVVEVNLD 79

Query: 85  GLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEF 144
           G SL+GRIGRGL +LQFLRKLSL++NNLTG I+PN+A++ NLRVIDLSGNSLSG + ++ 
Sbjct: 80  GFSLSGRIGRGLQRLQFLRKLSLANNNLTGGINPNIARIDNLRVIDLSGNSLSGEVSEDV 139

Query: 145 FKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDL 204
           F+QCGSLR +SLA+NRFSG IPS+L  CS LA I+LS+N+FS  +P  +W LSALR+LDL
Sbjct: 140 FRQCGSLRTVSLARNRFSGSIPSTLGACSALAAIDLSNNQFSGSVPSRVWSLSALRSLDL 199

Query: 205 SDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPET 264
           SDNLLEGEIPKG+E++KNLR +++++N  +G++P G GSC LLR+ID  +NSFSG++P  
Sbjct: 200 SDNLLEGEIPKGIEAMKNLRSVSVARNRLTGNVPYGFGSCLLLRSIDLGDNSFSGSIPGD 259

Query: 265 MQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNF 324
            ++L+LC +++LR N FSG VP+WIGE+  LETLDLS N F+G VP SIGNLQ LK+LNF
Sbjct: 260 FKELTLCGYISLRGNAFSGGVPQWIGEMRGLETLDLSNNGFTGQVPSSIGNLQSLKMLNF 319

Query: 325 SANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGP- 383
           S N LTGSLP+SMANC  L+ LD S+NSM+G LP W+F S L+KV  +EN        P 
Sbjct: 320 SGNGLTGSLPESMANCTKLLVLDVSRNSMSGWLPLWVFKSDLDKVLVSENVQSGSKKSPL 379

Query: 384 FASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALN 443
           FA +  + +SLQ LDLSHN FSGE  + +G LS LQ+LNL+ NSL GPIP A+G+LK  +
Sbjct: 380 FAMAELAVQSLQVLDLSHNAFSGEITSAVGGLSSLQVLNLANNSLGGPIPPAVGELKTCS 439

Query: 444 VLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGP 503
            LDLS N LNGSIP EIGGA SLKEL LE+NFL GKIPTSIENCS L +LILS+N L+GP
Sbjct: 440 SLDLSYNKLNGSIPWEIGGAVSLKELVLEKNFLNGKIPTSIENCSLLTTLILSQNKLSGP 499

Query: 504 IPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISP 563
           IP A+AKLTNLQ VD+SFN+LTG LPKQL NL +L +FN+SHN+LQGELPAGGFFNTI+P
Sbjct: 500 IPAAVAKLTNLQTVDVSFNNLTGALPKQLANLANLLTFNLSHNNLQGELPAGGFFNTITP 559

Query: 564 SSVLGNPSLCGSAVNKSCPAVLPKPIVLNPNSSSDSTTSSVAPNPRHKRIILSISAIIAI 623
           SSV GNPSLCG+AVNKSCPAVLPKPIVLNPN+S+D+  SS+ PN  HKRIILSISA+IAI
Sbjct: 560 SSVSGNPSLCGAAVNKSCPAVLPKPIVLNPNTSTDTGPSSLPPNLGHKRIILSISALIAI 619

Query: 624 GAAAVIVIGVIAITVLNLRVRSSTSRSAAALTLSAGDDFSRSPTTDANSGKLVMFSGDPD 683
           GAAAVIVIGVI+ITVLNLRVRSSTSR AAALT SAGD+FS SPTTDANSGKLVMFSG+PD
Sbjct: 620 GAAAVIVIGVISITVLNLRVRSSTSRDAAALTFSAGDEFSHSPTTDANSGKLVMFSGEPD 679

Query: 684 FSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGK 743
           FS+G HALLNKDCELGRGGFGAVY+TVLRDG  VAIKKLTVSSLVKSQEDFEREVKKLGK
Sbjct: 680 FSSGAHALLNKDCELGRGGFGAVYQTVLRDGHSVAIKKLTVSSLVKSQEDFEREVKKLGK 739

Query: 744 VRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSL 803
           +RH NLV LEGYYWT SLQLLIYE++SGGSL+KHLHEGSGGNFLSWNERFNVI GTAK+L
Sbjct: 740 IRHQNLVELEGYYWTPSLQLLIYEYLSGGSLYKHLHEGSGGNFLSWNERFNVILGTAKAL 799

Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
           AHLH SNIIHYNIKS+NVL+D  GEPKVGD+GLARLLPMLDRYVLSSKIQSALGYMAPEF
Sbjct: 800 AHLHHSNIIHYNIKSTNVLLDSYGEPKVGDFGLARLLPMLDRYVLSSKIQSALGYMAPEF 859

Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           AC+TVKIT+KCDVYGFGVLVLE+VTGKRP+
Sbjct: 860 ACKTVKITEKCDVYGFGVLVLEIVTGKRPV 889

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358249058|ref|NP_001239730.1| probably inactive leucine-rich repeat receptor-like protein kinase At3g28040-like precursor [Glycine max] gi|223452530|gb|ACM89592.1| leucine-rich repeat transmembrane protein kinase [Glycine max]

 Score = 1300 bits (3365), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 643/870 (73%), Positives = 751/870 (86%), Gaps = 3/870 (0%)

Query: 27  SLNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPC--NWFGVKCSPRSNRVIELTLN 84
           ++NPSLNDDVLGLIVFKADI+DP GKL+SW+EDD++ C  +W GVKC+PRSNRV+E+ L+
Sbjct: 20  AVNPSLNDDVLGLIVFKADIRDPKGKLASWNEDDESACGGSWVGVKCNPRSNRVVEVNLD 79

Query: 85  GLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEF 144
           G SL+GRIGRGL +LQFLRKLSL++NNLTG I+PN+A++ NLRVIDLSGNSLSG + D+ 
Sbjct: 80  GFSLSGRIGRGLQRLQFLRKLSLANNNLTGGINPNIARIDNLRVIDLSGNSLSGEVSDDV 139

Query: 145 FKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDL 204
           F+QCGSLR +SLA+NRFSG IPS+L  CS LA+I+LS+N+FS  +P G+W LSALR+LDL
Sbjct: 140 FRQCGSLRTVSLARNRFSGSIPSTLGACSALASIDLSNNQFSGSVPSGVWSLSALRSLDL 199

Query: 205 SDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPET 264
           SDNLLEGEIPKGVE++KNLR +++++N  +G++P G GSC LLR+ID  +NSFSG++P  
Sbjct: 200 SDNLLEGEIPKGVEAMKNLRSVSMTRNRLTGNVPFGFGSCLLLRSIDLGDNSFSGSIPGD 259

Query: 265 MQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNF 324
           +++L+LC +++LR N FS EVP+WIGE+  LETLDLS N F+G VP SIGNLQ LK+LNF
Sbjct: 260 LKELTLCGYLSLRGNAFSREVPEWIGEMRGLETLDLSNNGFTGQVPSSIGNLQLLKMLNF 319

Query: 325 SANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGP- 383
           S N LTGSLP+S+ NC  L  LD S+NSM+G LP W+F S L+K   +EN        P 
Sbjct: 320 SGNGLTGSLPESIVNCTKLSVLDVSRNSMSGWLPLWVFKSDLDKGLMSENVQSGSKKSPL 379

Query: 384 FASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALN 443
           FA +  +F+SLQ LDLSHN FSGE  + +G LS LQ+LNL+ NSL GPIP AIG+LK  +
Sbjct: 380 FALAEVAFQSLQVLDLSHNAFSGEITSAVGGLSSLQVLNLANNSLGGPIPAAIGELKTCS 439

Query: 444 VLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGP 503
            LDLS N LNGSIP EIG A SLKEL LE+NFL GKIP+SIENCS L +LILS+N L+GP
Sbjct: 440 SLDLSYNKLNGSIPWEIGRAVSLKELVLEKNFLNGKIPSSIENCSLLTTLILSQNKLSGP 499

Query: 504 IPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISP 563
           IP A+AKLTNL+ VD+SFNSLTG LPKQL NL +L +FN+SHN+LQGELPAGGFFNTISP
Sbjct: 500 IPAAVAKLTNLRTVDVSFNSLTGNLPKQLANLANLLTFNLSHNNLQGELPAGGFFNTISP 559

Query: 564 SSVLGNPSLCGSAVNKSCPAVLPKPIVLNPNSSSDSTTSSVAPNPRHKRIILSISAIIAI 623
           SSV GNPSLCG+AVNKSCPAVLPKPIVLNPN+S+D+   S+ PN  HKRIILSISA+IAI
Sbjct: 560 SSVSGNPSLCGAAVNKSCPAVLPKPIVLNPNTSTDTGPGSLPPNLGHKRIILSISALIAI 619

Query: 624 GAAAVIVIGVIAITVLNLRVRSSTSRSAAALTLSAGDDFSRSPTTDANSGKLVMFSGDPD 683
           GAAAVIVIGVI+ITVLNLRVRSST R AAALT SAGD+FSRSPTTDANSGKLVMFSG+PD
Sbjct: 620 GAAAVIVIGVISITVLNLRVRSSTPRDAAALTFSAGDEFSRSPTTDANSGKLVMFSGEPD 679

Query: 684 FSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGK 743
           FS+G HALLNKDCELGRGGFGAVY+TVLRDG  VAIKKLTVSSLVKSQEDFEREVKKLGK
Sbjct: 680 FSSGAHALLNKDCELGRGGFGAVYQTVLRDGHSVAIKKLTVSSLVKSQEDFEREVKKLGK 739

Query: 744 VRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSL 803
           +RH NLV LEGYYWT SLQLLIYE+VSGGSL+KHLHEGSGGNFLSWNERFNVI GTAK+L
Sbjct: 740 IRHQNLVELEGYYWTTSLQLLIYEYVSGGSLYKHLHEGSGGNFLSWNERFNVILGTAKAL 799

Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
           AHLH SNIIHYNIKS+NVL+D  GEPKVGD+GLARLLPMLDRYVLSSKIQSALGYMAPEF
Sbjct: 800 AHLHHSNIIHYNIKSTNVLLDSYGEPKVGDFGLARLLPMLDRYVLSSKIQSALGYMAPEF 859

Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           AC+TVKIT+KCDVYGFGVLVLE+VTGKRP+
Sbjct: 860 ACKTVKITEKCDVYGFGVLVLEIVTGKRPV 889

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449441248|ref|XP_004138394.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At3g28040-like [Cucumis sativus]

 Score = 1246 bits (3223), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 633/872 (72%), Positives = 723/872 (82%), Gaps = 4/872 (0%)

Query: 26  RSLNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNG 85
           RSLNP LN+DVLGLIVFKADI+DP GKL+SW+EDDD PCNW G+KC+PRSNRV+EL L+G
Sbjct: 19  RSLNPPLNEDVLGLIVFKADIEDPEGKLASWNEDDDNPCNWVGLKCNPRSNRVVELNLDG 78

Query: 86  LSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFF 145
            SL GR+GRGLLQLQFLRKLSL++NNLTG++SPN A+ +NLRV+DLSGN   G IPD+FF
Sbjct: 79  FSLNGRLGRGLLQLQFLRKLSLANNNLTGNLSPNNARFENLRVVDLSGNGFHGMIPDDFF 138

Query: 146 KQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLS 205
           +QCGSLRVISLA N+ SGKIP SLS CS+LA +NLSSN+FS  LP GIW L+ LR+LDLS
Sbjct: 139 RQCGSLRVISLANNKISGKIPESLSSCSSLAAVNLSSNQFSGSLPSGIWSLTGLRSLDLS 198

Query: 206 DNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETM 265
           DN+LEGEIP  V+ + NLR +NL KN FSG IPDGIGSC LLR++D SENSFSGN+P TM
Sbjct: 199 DNILEGEIPPEVKGMNNLRAVNLGKNRFSGQIPDGIGSCMLLRSVDLSENSFSGNVPATM 258

Query: 266 QKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFS 325
           +KLSLC+ +NLR+NLF GEVP+WIG +E LE LDLSGN+FSG +P S GNLQ+LKVLN S
Sbjct: 259 KKLSLCSTLNLRRNLFQGEVPEWIGGMEGLEILDLSGNRFSGPIPSSFGNLQKLKVLNVS 318

Query: 326 ANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFA 385
            N LTGSL +S+    NL A+D    S+ G LP WI   G   V  ++ K R  ++    
Sbjct: 319 GNGLTGSLAESIVPSQNLSAMDLGHGSLTGVLPAWILKLGSQNVLPSDIK-RSSLS---T 374

Query: 386 SSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVL 445
           + G +  +LQ LDLSHN FSGE    IG LS LQ+LNL +NS VG IP +IG LKAL  L
Sbjct: 375 TVGKALVNLQVLDLSHNAFSGEISPDIGILSSLQVLNLCKNSFVGAIPESIGGLKALVFL 434

Query: 446 DLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIP 505
           DLSEN LNGSIP  +G   SLKELRL +N L G +P S+ NCSSLV+L +S+N LTG IP
Sbjct: 435 DLSENQLNGSIPETLGRDVSLKELRLGKNLLEGGVPNSVGNCSSLVTLDVSENRLTGSIP 494

Query: 506 IAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSS 565
             +++L NLQ VDLS N+L+G LPKQL NL +L  FNISHN+LQGELPAGGFFNTISPSS
Sbjct: 495 AELSQLINLQIVDLSTNNLSGALPKQLANLPNLLLFNISHNNLQGELPAGGFFNTISPSS 554

Query: 566 VLGNPSLCGSAVNKSCPAVLPKPIVLNPNSSSDSTTSSVAPNPRHKRIILSISAIIAIGA 625
           V GNPSLCGS V +SCP VLPKPIVLNPNSSSD+ ++S+     HKRIILSISA+IAIGA
Sbjct: 555 VAGNPSLCGSIVKRSCPGVLPKPIVLNPNSSSDAGSTSLPTTLGHKRIILSISALIAIGA 614

Query: 626 AAVIVIGVIAITVLNLRVRSSTSRSAAALTLSAGDDFSRSPTTDANSGKLVMFSGDPDFS 685
           AAVI++GV+AITV+NL VRSS +R  AA+T S GDDFS SPTTDANSGKLVMFSG+PDFS
Sbjct: 615 AAVILVGVVAITVINLHVRSSANRPEAAITFSGGDDFSHSPTTDANSGKLVMFSGEPDFS 674

Query: 686 TGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR 745
           TG HALLNKDCELGRGGFGAVY+TVLRDG PVAIKKLTVSSLVKSQE+FEREVKKLGKVR
Sbjct: 675 TGAHALLNKDCELGRGGFGAVYQTVLRDGHPVAIKKLTVSSLVKSQEEFEREVKKLGKVR 734

Query: 746 HPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAH 805
           H NLV LEGYYWT SLQLLIYEFVSGGSL+K LHEG GGN LSWNERFN+I GTAKSLAH
Sbjct: 735 HQNLVALEGYYWTPSLQLLIYEFVSGGSLYKQLHEGLGGNILSWNERFNIILGTAKSLAH 794

Query: 806 LHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFAC 865
           LHQ NIIHYNIKSSNVLID SGEPKVGD+GLARLLPMLDRYVLSSKIQSALGYMAPEFAC
Sbjct: 795 LHQMNIIHYNIKSSNVLIDSSGEPKVGDFGLARLLPMLDRYVLSSKIQSALGYMAPEFAC 854

Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWK 897
           +TVKIT+KCDVYGFGVLVLEVVTGKRP+   +
Sbjct: 855 KTVKITEKCDVYGFGVLVLEVVTGKRPVEYME 886

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449532759|ref|XP_004173348.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At3g28040-like [Cucumis sativus]

 Score = 1245 bits (3222), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 633/872 (72%), Positives = 723/872 (82%), Gaps = 4/872 (0%)

Query: 26  RSLNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNG 85
           RSLNP LN+DVLGLIVFKADI+DP GKL+SW+EDDD PCNW G+KC+PRSNRV+EL L+G
Sbjct: 19  RSLNPPLNEDVLGLIVFKADIEDPEGKLASWNEDDDNPCNWVGLKCNPRSNRVVELNLDG 78

Query: 86  LSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFF 145
            SL GR+GRGLLQLQFLRKLSL++NNLTG++SPN A+ +NLRV+DLSGN   G IPD+FF
Sbjct: 79  FSLNGRLGRGLLQLQFLRKLSLANNNLTGNLSPNNARFENLRVVDLSGNGFHGMIPDDFF 138

Query: 146 KQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLS 205
           +QCGSLRVISLA N+ SGKIP SLS CS+LA +NLSSN+FS  LP GIW L+ LR+LDLS
Sbjct: 139 RQCGSLRVISLANNKISGKIPESLSSCSSLAAVNLSSNQFSGSLPSGIWSLTGLRSLDLS 198

Query: 206 DNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETM 265
           DN+LEGEIP  V+ + NLR +NL KN FSG IPDGIGSC LLR++D SENSFSGN+P TM
Sbjct: 199 DNILEGEIPPEVKGMNNLRAVNLGKNRFSGQIPDGIGSCLLLRSVDLSENSFSGNVPATM 258

Query: 266 QKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFS 325
           +KLSLC+ +NLR+NLF GEVP+WIG +E LE LDLSGN+FSG +P S GNLQ+LKVLN S
Sbjct: 259 KKLSLCSTLNLRRNLFQGEVPEWIGGMEGLEILDLSGNRFSGPIPSSFGNLQKLKVLNVS 318

Query: 326 ANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFA 385
            N LTGSL +S+    NL A+D    S+ G LP WI   G   V  ++ K R  ++    
Sbjct: 319 GNGLTGSLAESIVPSQNLSAMDLGHGSLTGVLPAWILKLGSQNVLPSDIK-RSSLS---T 374

Query: 386 SSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVL 445
           + G +  +LQ LDLSHN FSGE    IG LS LQ+LNL +NS VG IP +IG LKAL  L
Sbjct: 375 TVGKALVNLQVLDLSHNAFSGEISPDIGILSSLQVLNLCKNSFVGAIPESIGGLKALVFL 434

Query: 446 DLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIP 505
           DLSEN LNGSIP  +G   SLKELRL +N L G +P S+ NCSSLV+L +S+N LTG IP
Sbjct: 435 DLSENQLNGSIPETLGRDVSLKELRLGKNLLEGGVPNSVGNCSSLVTLDVSENRLTGSIP 494

Query: 506 IAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSS 565
             +++L NLQ VDLS N+L+G LPKQL NL +L  FNISHN+LQGELPAGGFFNTISPSS
Sbjct: 495 AELSQLINLQIVDLSTNNLSGALPKQLANLPNLLLFNISHNNLQGELPAGGFFNTISPSS 554

Query: 566 VLGNPSLCGSAVNKSCPAVLPKPIVLNPNSSSDSTTSSVAPNPRHKRIILSISAIIAIGA 625
           V GNPSLCGS V +SCP VLPKPIVLNPNSSSD+ ++S+     HKRIILSISA+IAIGA
Sbjct: 555 VAGNPSLCGSIVKRSCPGVLPKPIVLNPNSSSDAGSTSLPTTLGHKRIILSISALIAIGA 614

Query: 626 AAVIVIGVIAITVLNLRVRSSTSRSAAALTLSAGDDFSRSPTTDANSGKLVMFSGDPDFS 685
           AAVI++GV+AITV+NL VRSS +R  AA+T S GDDFS SPTTDANSGKLVMFSG+PDFS
Sbjct: 615 AAVILVGVVAITVINLHVRSSANRPEAAITFSGGDDFSHSPTTDANSGKLVMFSGEPDFS 674

Query: 686 TGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR 745
           TG HALLNKDCELGRGGFGAVY+TVLRDG PVAIKKLTVSSLVKSQE+FEREVKKLGKVR
Sbjct: 675 TGAHALLNKDCELGRGGFGAVYQTVLRDGHPVAIKKLTVSSLVKSQEEFEREVKKLGKVR 734

Query: 746 HPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAH 805
           H NLV LEGYYWT SLQLLIYEFVSGGSL+K LHEG GGN LSWNERFN+I GTAKSLAH
Sbjct: 735 HQNLVALEGYYWTPSLQLLIYEFVSGGSLYKQLHEGLGGNILSWNERFNIILGTAKSLAH 794

Query: 806 LHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFAC 865
           LHQ NIIHYNIKSSNVLID SGEPKVGD+GLARLLPMLDRYVLSSKIQSALGYMAPEFAC
Sbjct: 795 LHQMNIIHYNIKSSNVLIDSSGEPKVGDFGLARLLPMLDRYVLSSKIQSALGYMAPEFAC 854

Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWK 897
           +TVKIT+KCDVYGFGVLVLEVVTGKRP+   +
Sbjct: 855 KTVKITEKCDVYGFGVLVLEVVTGKRPVEYME 886

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15228900|ref|NP_191196.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|7594515|emb|CAB88040.1| putative protein [Arabidopsis thaliana] gi|19032341|dbj|BAB85646.1| inflorescence and root apices receptor-like kinase [Arabidopsis thaliana] gi|19032343|dbj|BAB85647.1| inflorescence and root apices receptor-like kinase [Arabidopsis thaliana] gi|224589604|gb|ACN59335.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332645993|gb|AEE79514.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana]

 Score = 1201 bits (3107), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 633/890 (71%), Positives = 719/890 (80%), Gaps = 16/890 (1%)

Query: 8   KASVFSLLTFLVLAPALTRSLNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCNWF 67
           KA +F++L    +AP   RSL+P LNDDVLGLIVFKAD++DP  KL+SW+EDD TPC+W 
Sbjct: 3   KALIFTVLLVSAVAP--VRSLDPPLNDDVLGLIVFKADLRDPEQKLASWNEDDYTPCSWN 60

Query: 68  GVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPN-LAKLQNL 126
           GVKC PR+NRV EL L+G SL+GRIGRGLLQLQFL KLSLS+NNLTG I+PN L  L NL
Sbjct: 61  GVKCHPRTNRVTELNLDGFSLSGRIGRGLLQLQFLHKLSLSNNNLTGIINPNMLLSLVNL 120

Query: 127 RVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFS 186
           +V+DLS N LSGS+PDEFF+QCGSLRV+SLAKN+ +GKIP S+S CS+LA +NLSSN FS
Sbjct: 121 KVVDLSSNGLSGSLPDEFFRQCGSLRVLSLAKNKLTGKIPVSISSCSSLAALNLSSNGFS 180

Query: 187 SPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSL 246
             +PLGIW L+ LR+LDLS N LEGE P+ ++ L NLR ++LS+N  SG IP  IGSC L
Sbjct: 181 GSMPLGIWSLNTLRSLDLSRNELEGEFPEKIDRLNNLRALDLSRNRLSGPIPSEIGSCML 240

Query: 247 LRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFS 306
           L+TID SENS SG+LP T Q+LSLC  +NL KN   GEVPKWIGE+ SLETLDLS NKFS
Sbjct: 241 LKTIDLSENSLSGSLPNTFQQLSLCYSLNLGKNALEGEVPKWIGEMRSLETLDLSMNKFS 300

Query: 307 GAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGL 366
           G VP SIGNL  LKVLNFS N L GSLP S ANC+NL+ALD S NS+ G LP W+F  G 
Sbjct: 301 GQVPDSIGNLLALKVLNFSGNGLIGSLPVSTANCINLLALDLSGNSLTGKLPMWLFQDGS 360

Query: 367 NKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRN 426
             VS  +N           +S    + +Q LDLSHN FSGE  A +G L  L+ L+LSRN
Sbjct: 361 RDVSALKND----------NSTGGIKKIQVLDLSHNAFSGEIGAGLGDLRDLEGLHLSRN 410

Query: 427 SLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIEN 486
           SL GPIP  IG+LK L+VLD+S N LNG IP E GGA SL+ELRLE N L G IP+SI+N
Sbjct: 411 SLTGPIPSTIGELKHLSVLDVSHNQLNGMIPRETGGAVSLEELRLENNLLEGNIPSSIKN 470

Query: 487 CSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHN 546
           CSSL SLILS N L G IP  +AKLT L+ VDLSFN L G LPKQL NL +L +FNISHN
Sbjct: 471 CSSLRSLILSHNKLLGSIPPELAKLTRLEEVDLSFNELAGTLPKQLANLGYLHTFNISHN 530

Query: 547 HLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKSCPAVLPKPIVLNPNSSSDSTTSS-VA 605
           HL GELPAGG FN +SPSSV GNP +CG+ VNKSCPA+ PKPIVLNPN++ D      V 
Sbjct: 531 HLFGELPAGGIFNGLSPSSVSGNPGICGAVVNKSCPAISPKPIVLNPNATFDPYNGEIVP 590

Query: 606 PNPRHKRIILSISAIIAIGAAAVIVIGVIAITVLNLRVRSST-SRSAAALTLSAGDDFSR 664
           P   HKRI+LSIS++IAI AAA IV+GVIAITVLNLRVR+ST SRSA  LT S GDDFSR
Sbjct: 591 PGAGHKRILLSISSLIAISAAAAIVVGVIAITVLNLRVRASTVSRSAVPLTFSGGDDFSR 650

Query: 665 SPTTDANSGKLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTV 724
           SPTTD+NSGKLVMFSG+PDFSTGTHALLNKDCELGRGGFGAVYRTV+RDG PVAIKKLTV
Sbjct: 651 SPTTDSNSGKLVMFSGEPDFSTGTHALLNKDCELGRGGFGAVYRTVIRDGYPVAIKKLTV 710

Query: 725 SSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGG 784
           SSLVKSQ++FEREVKKLGK+RH NLV LEGYYWT SLQLLIYEF+SGGSL+K LHE  GG
Sbjct: 711 SSLVKSQDEFEREVKKLGKLRHSNLVKLEGYYWTTSLQLLIYEFLSGGSLYKQLHEAPGG 770

Query: 785 N-FLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML 843
           N  LSWN+RFN+I GTAK LA+LHQSNIIHYNIKSSNVL+D SGEPKVGDYGLARLLPML
Sbjct: 771 NSSLSWNDRFNIILGTAKCLAYLHQSNIIHYNIKSSNVLLDSSGEPKVGDYGLARLLPML 830

Query: 844 DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           DRYVLSSKIQSALGYMAPEFACRTVKIT+KCDVYGFGVLVLEVVTGK+P+
Sbjct: 831 DRYVLSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKKPV 880

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|17979045|gb|AAL49790.1| unknown protein [Arabidopsis thaliana]

 Score = 1199 bits (3101), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 632/890 (71%), Positives = 718/890 (80%), Gaps = 16/890 (1%)

Query: 8   KASVFSLLTFLVLAPALTRSLNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCNWF 67
           KA +F++L    +AP   RSL+P LN DVLGLIVFKAD++DP  KL+SW+EDD TPC+W 
Sbjct: 3   KALIFTVLLVSAVAP--VRSLDPPLNGDVLGLIVFKADLRDPEQKLASWNEDDYTPCSWN 60

Query: 68  GVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPN-LAKLQNL 126
           GVKC PR+NRV EL L+G SL+GRIGRGLLQLQFL KLSLS+NNLTG I+PN L  L NL
Sbjct: 61  GVKCHPRTNRVTELNLDGFSLSGRIGRGLLQLQFLHKLSLSNNNLTGIINPNMLLSLVNL 120

Query: 127 RVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFS 186
           +V+DLS N LSGS+PDEFF+QCGSLRV+SLAKN+ +GKIP S+S CS+LA +NLSSN FS
Sbjct: 121 KVVDLSSNGLSGSLPDEFFRQCGSLRVLSLAKNKLTGKIPVSISSCSSLAALNLSSNGFS 180

Query: 187 SPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSL 246
             +PLGIW L+ LR+LDLS N LEGE P+ ++ L NLR ++LS+N  SG IP  IGSC L
Sbjct: 181 GSMPLGIWSLNTLRSLDLSRNELEGEFPEKIDRLNNLRALDLSRNRLSGPIPSEIGSCML 240

Query: 247 LRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFS 306
           L+TID SENS SG+LP T Q+LSLC  +NL KN   GEVPKWIGE+ SLETLDLS NKFS
Sbjct: 241 LKTIDLSENSLSGSLPNTFQQLSLCYSLNLGKNALEGEVPKWIGEMRSLETLDLSMNKFS 300

Query: 307 GAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGL 366
           G VP SIGNL  LKVLNFS N L GSLP S ANC+NL+ALD S NS+ G LP W+F  G 
Sbjct: 301 GQVPDSIGNLLALKVLNFSGNGLIGSLPVSTANCINLLALDLSGNSLTGKLPMWLFQDGS 360

Query: 367 NKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRN 426
             VS  +N           +S    + +Q LDLSHN FSGE  A +G L  L+ L+LSRN
Sbjct: 361 RDVSALKND----------NSTGGIKKIQVLDLSHNAFSGEIGAGLGDLRDLEGLHLSRN 410

Query: 427 SLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIEN 486
           SL GPIP  IG+LK L+VLD+S N LNG IP E GGA SL+ELRLE N L G IP+SI+N
Sbjct: 411 SLTGPIPSTIGELKHLSVLDVSHNQLNGMIPRETGGAVSLEELRLENNLLEGNIPSSIKN 470

Query: 487 CSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHN 546
           CSSL SLILS N L G IP  +AKLT L+ VDLSFN L G LPKQL NL +L +FNISHN
Sbjct: 471 CSSLRSLILSHNKLLGSIPPELAKLTRLEEVDLSFNELAGTLPKQLANLGYLHTFNISHN 530

Query: 547 HLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKSCPAVLPKPIVLNPNSSSDSTTSS-VA 605
           HL GELPAGG FN +SPSSV GNP +CG+ VNKSCPA+ PKPIVLNPN++ D      V 
Sbjct: 531 HLFGELPAGGIFNGLSPSSVSGNPGICGAVVNKSCPAISPKPIVLNPNATFDPYNGEIVP 590

Query: 606 PNPRHKRIILSISAIIAIGAAAVIVIGVIAITVLNLRVRSST-SRSAAALTLSAGDDFSR 664
           P   HKRI+LSIS++IAI AAA IV+GVIAITVLNLRVR+ST SRSA  LT S GDDFSR
Sbjct: 591 PGAGHKRILLSISSLIAISAAAAIVVGVIAITVLNLRVRASTVSRSAVPLTFSGGDDFSR 650

Query: 665 SPTTDANSGKLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTV 724
           SPTTD+NSGKLVMFSG+PDFSTGTHALLNKDCELGRGGFGAVYRTV+RDG PVAIKKLTV
Sbjct: 651 SPTTDSNSGKLVMFSGEPDFSTGTHALLNKDCELGRGGFGAVYRTVIRDGYPVAIKKLTV 710

Query: 725 SSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGG 784
           SSLVKSQ++FEREVKKLGK+RH NLV LEGYYWT SLQLLIYEF+SGGSL+K LHE  GG
Sbjct: 711 SSLVKSQDEFEREVKKLGKLRHSNLVKLEGYYWTTSLQLLIYEFLSGGSLYKQLHEAPGG 770

Query: 785 N-FLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML 843
           N  LSWN+RFN+I GTAK LA+LHQSNIIHYNIKSSNVL+D SGEPKVGDYGLARLLPML
Sbjct: 771 NSSLSWNDRFNIILGTAKCLAYLHQSNIIHYNIKSSNVLLDSSGEPKVGDYGLARLLPML 830

Query: 844 DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           DRYVLSSKIQSALGYMAPEFACRTVKIT+KCDVYGFGVLVLEVVTGK+P+
Sbjct: 831 DRYVLSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKKPV 880

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	936
TAIR|locus:2102499	964	AT3G56370 [Arabidopsis thalian	0.933	0.906	0.659	9.7e-302
TAIR|locus:2181042	967	AT5G01890 [Arabidopsis thalian	0.933	0.903	0.537	1.4e-245
TAIR|locus:2091353	1016	AT3G28040 [Arabidopsis thalian	0.831	0.765	0.404	2.7e-155
TAIR|locus:2122239	1136	AT4G36180 [Arabidopsis thalian	0.498	0.411	0.392	6.3e-113
TAIR|locus:2005507	976	ER "ERECTA" [Arabidopsis thali	0.573	0.550	0.334	1e-111
TAIR|locus:2139885	1013	AT4G28650 [Arabidopsis thalian	0.494	0.457	0.360	2.1e-109
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.569	0.484	0.310	3.5e-108
TAIR|locus:2005629	1140	AT1G75640 [Arabidopsis thalian	0.503	0.413	0.367	1.4e-106
TAIR|locus:2182855	967	ERL2 "ERECTA-like 2" [Arabidop	0.608	0.589	0.311	3.1e-106
TAIR|locus:2085949	1141	AT3G24240 [Arabidopsis thalian	0.470	0.385	0.368	4.1e-106

TAIR|locus:2102499 AT3G56370 [Arabidopsis thaliana (taxid:3702)]

 Score = 2896 (1024.5 bits), Expect = 9.7e-302, P = 9.7e-302
 Identities = 587/890 (65%), Positives = 663/890 (74%)

Query:     8 KASVFSLLTFLVLAPALTRSLNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCNWF 67
             KA +F++L  LV A A  RSL+P LNDDVLGLIVFKAD++DP  KL+SW+EDD TPC+W 
Sbjct:     3 KALIFTVL--LVSAVAPVRSLDPPLNDDVLGLIVFKADLRDPEQKLASWNEDDYTPCSWN 60

Query:    68 GVKCSPRSNRVIELTLNGLSXXXXXXXXXXXXXXXXXXXXXXNNLTGSISPN-LAKLQNL 126
             GVKC PR+NRV EL L+G S                      NNLTG I+PN L  L NL
Sbjct:    61 GVKCHPRTNRVTELNLDGFSLSGRIGRGLLQLQFLHKLSLSNNNLTGIINPNMLLSLVNL 120

Query:   127 RVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFS 186
             +V+DLS N LSGS+PDEFF+QCGSLRV+SLAKN+ +GKIP S+S CS+LA +NLSSN FS
Sbjct:   121 KVVDLSSNGLSGSLPDEFFRQCGSLRVLSLAKNKLTGKIPVSISSCSSLAALNLSSNGFS 180

Query:   187 SPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSL 246
               +PLGIW L+ LR+LDLS N LEGE P+ ++ L NLR ++LS+N  SG IP  IGSC L
Sbjct:   181 GSMPLGIWSLNTLRSLDLSRNELEGEFPEKIDRLNNLRALDLSRNRLSGPIPSEIGSCML 240

Query:   247 LRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFS 306
             L+TID SENS SG+LP T Q+LSLC  +NL KN   GEVPKWIGE+ SLETLDLS NKFS
Sbjct:   241 LKTIDLSENSLSGSLPNTFQQLSLCYSLNLGKNALEGEVPKWIGEMRSLETLDLSMNKFS 300

Query:   307 GAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGL 366
             G VP SIGNL  LKVLNFS N L GSLP S ANC+NL+ALD S NS+ G LP W+F  G 
Sbjct:   301 GQVPDSIGNLLALKVLNFSGNGLIGSLPVSTANCINLLALDLSGNSLTGKLPMWLFQDGS 360

Query:   367 NKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRN 426
               VS  +N           +S    + +Q LDLSHN FSGE  A +G L  L+ L+LSRN
Sbjct:   361 RDVSALKND----------NSTGGIKKIQVLDLSHNAFSGEIGAGLGDLRDLEGLHLSRN 410

Query:   427 SLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIEN 486
             SL GPIP  IG+LK L+VLD+S N LNG IP E GGA SL+ELRLE N L G IP+SI+N
Sbjct:   411 SLTGPIPSTIGELKHLSVLDVSHNQLNGMIPRETGGAVSLEELRLENNLLEGNIPSSIKN 470

Query:   487 CSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHN 546
             CSSL SLILS N L G IP  +AKLT L+ VDLSFN L G LPKQL NL +L +FNISHN
Sbjct:   471 CSSLRSLILSHNKLLGSIPPELAKLTRLEEVDLSFNELAGTLPKQLANLGYLHTFNISHN 530

Query:   547 HLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKSCPAVLPKPIVLNPNXXXX-XXXXXVA 605
             HL GELPAGG FN +SPSSV GNP +CG+ VNKSCPA+ PKPIVLNPN          V 
Sbjct:   531 HLFGELPAGGIFNGLSPSSVSGNPGICGAVVNKSCPAISPKPIVLNPNATFDPYNGEIVP 590

Query:   606 PNPRHKRXXXXXXXXXXXXXXXXXXXXXXXXTVLNLRVXXXXXXXXXX-XXXXXGDDFSR 664
             P   HKR                        TVLNLRV                GDDFSR
Sbjct:   591 PGAGHKRILLSISSLIAISAAAAIVVGVIAITVLNLRVRASTVSRSAVPLTFSGGDDFSR 650

Query:   665 SPTTDANSGKLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTV 724
             SPTTD+NSGKLVMFSG+PDFSTGTHALLNKDCELGRGGFGAVYRTV+RDG PVAIKKLTV
Sbjct:   651 SPTTDSNSGKLVMFSGEPDFSTGTHALLNKDCELGRGGFGAVYRTVIRDGYPVAIKKLTV 710

Query:   725 SSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGG 784
             SSLVKSQ++FEREVKKLGK+RH NLV LEGYYWT SLQLLIYEF+SGGSL+K LHE  GG
Sbjct:   711 SSLVKSQDEFEREVKKLGKLRHSNLVKLEGYYWTTSLQLLIYEFLSGGSLYKQLHEAPGG 770

Query:   785 NF-LSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML 843
             N  LSWN+RFN+I GTAK LA+LHQSNIIHYNIKSSNVL+D SGEPKVGDYGLARLLPML
Sbjct:   771 NSSLSWNDRFNIILGTAKCLAYLHQSNIIHYNIKSSNVLLDSSGEPKVGDYGLARLLPML 830

Query:   844 DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
             DRYVLSSKIQSALGYMAPEFACRTVKIT+KCDVYGFGVLVLEVVTGK+P+
Sbjct:   831 DRYVLSSKIQSALGYMAPEFACRTVKITEKCDVYGFGVLVLEVVTGKKPV 880

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008356 "asymmetric cell division" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0048653 "anther development" evidence=RCA

TAIR|locus:2181042 AT5G01890 [Arabidopsis thaliana (taxid:3702)]

 Score = 2366 (837.9 bits), Expect = 1.4e-245, P = 1.4e-245
 Identities = 476/886 (53%), Positives = 601/886 (67%)

Query:    15 LTFLVLAPALTRSLNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCNWFGVKCSPR 74
             L FL LA    R+ +P+ NDDVLGLIVFKA + DP  KLSSW+ +D  PCNW G  C P 
Sbjct:     8 LLFLFLAVVSARA-DPTFNDDVLGLIVFKAGLDDPLSKLSSWNSEDYDPCNWVGCTCDPA 66

Query:    75 SNRVIELTLNGLSXXXXXXXXXXXXXXXXXXXXXXNNLTGSISPNLAKLQNLRVIDLSGN 134
             +NRV EL L+  S                      NNLTG+++P    L +L+V+D SGN
Sbjct:    67 TNRVSELRLDAFSLSGHIGRGLLRLQFLHTLVLSNNNLTGTLNPEFPHLGSLQVVDFSGN 126

Query:   135 SLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIW 194
             +LSG IPD FF+QCGSLR +SLA N+ +G IP SLS CSTL  +NLSSN+ S  LP  IW
Sbjct:   127 NLSGRIPDGFFEQCGSLRSVSLANNKLTGSIPVSLSYCSTLTHLNLSSNQLSGRLPRDIW 186

Query:   195 GLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSE 254
              L +L++LD S N L+G+IP G+  L +LR INLS+N FSG +P  IG CS L+++D SE
Sbjct:   187 FLKSLKSLDFSHNFLQGDIPDGLGGLYDLRHINLSRNWFSGDVPSDIGRCSSLKSLDLSE 246

Query:   255 NSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIG 314
             N FSGNLP++M+ L  C+ + LR N   GE+P WIG++ +LE LDLS N F+G VP S+G
Sbjct:   247 NYFSGNLPDSMKSLGSCSSIRLRGNSLIGEIPDWIGDIATLEILDLSANNFTGTVPFSLG 306

Query:   315 NLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAEN 374
             NL+ LK LN SAN L G LP +++NC NL+++D S+NS  GD+ +W+F+      S +  
Sbjct:   307 NLEFLKDLNLSANMLAGELPQTLSNCSNLISIDVSKNSFTGDVLKWMFTGNSESSSLSRF 366

Query:   375 KI--REGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPI 432
              +  R G N          + L+ LDLS N F+GE P+ I  L+ L  LN+S NSL G I
Sbjct:   367 SLHKRSG-NDTIMPIVGFLQGLRVLDLSSNGFTGELPSNIWILTSLLQLNMSTNSLFGSI 425

Query:   433 PVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVS 492
             P  IG LK   +LDLS N LNG++P EIGGA SLK+L L RN L+G+IP  I NCS+L +
Sbjct:   426 PTGIGGLKVAEILDLSSNLLNGTLPSEIGGAVSLKQLHLHRNRLSGQIPAKISNCSALNT 485

Query:   493 LILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGEL 552
             + LS+N L+G IP +I  L+NL+ +DLS N+L+G LPK++  L HL +FNISHN++ GEL
Sbjct:   486 INLSENELSGAIPGSIGSLSNLEYIDLSRNNLSGSLPKEIEKLSHLLTFNISHNNITGEL 545

Query:   553 PAGGFFNTISPSSVLGNPSLCGSAVNKSCPAVLPKPIVLNPNXXXXXXXXXVAPNPRHKR 612
             PAGGFFNTI  S+V GNPSLCGS VN+SC +V PKPIVLNPN         +    R  +
Sbjct:   546 PAGGFFNTIPLSAVTGNPSLCGSVVNRSCLSVHPKPIVLNPNSSNPTNGPALTGQIR--K 603

Query:   613 XXXXXXXXXXXXXXXXXXXXXXXXTVLNL--RVXXXXXXXXXXXXXXXGDDFSRSPTTDA 670
                                     T+LN+  R                G+ FS SP+ D 
Sbjct:   604 SVLSISALIAIGAAAVIAIGVVAVTLLNVHARSSVSRHDAAAALALSVGETFSCSPSKDQ 663

Query:   671 NSGKLVMFSGDPDF--STGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV 728
               GKLVMFSG+ D   +TG  ALLNKD ELGRGGFG VY+T L+DGRPVA+KKLTVS L+
Sbjct:   664 EFGKLVMFSGEVDVFDTTGADALLNKDSELGRGGFGVVYKTSLQDGRPVAVKKLTVSGLI 723

Query:   729 KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLS 788
             KSQE+FERE++KLGK+RH N+V ++GYYWTQSLQLLI+EFVSGGSL++HLH G     L+
Sbjct:   724 KSQEEFEREMRKLGKLRHKNVVEIKGYYWTQSLQLLIHEFVSGGSLYRHLH-GDESVCLT 782

Query:   789 WNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYV 847
             W +RF++I G A+ LA LH SNI HYN+K++NVLID +GE KV D+GLARLL   LDR V
Sbjct:   783 WRQRFSIILGIARGLAFLHSSNITHYNMKATNVLIDAAGEAKVSDFGLARLLASALDRCV 842

Query:   848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
             LS K+QSALGY APEFACRTVKITD+CDVYGFG+LVLEVVTGKRP+
Sbjct:   843 LSGKVQSALGYTAPEFACRTVKITDRCDVYGFGILVLEVVTGKRPV 888

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2091353 AT3G28040 [Arabidopsis thaliana (taxid:3702)]

 Score = 1514 (538.0 bits), Expect = 2.7e-155, P = 2.7e-155
 Identities = 326/806 (40%), Positives = 463/806 (57%)

Query:   110 NNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSL 169
             NNL+G I  +L  + +L+ +DL+GNS SG++ D+ F  C SLR +SL+ N   G+IPS+L
Sbjct:   134 NNLSGQIPSSLGSITSLQHLDLTGNSFSGTLSDDLFNNCSSLRYLSLSHNHLEGQIPSTL 193

Query:   170 SLCSTLATINLSSNRFS-SP-LPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVIN 227
               CS L ++NLS NRFS +P    GIW L  LR LDLS N L G IP G+ SL NL+ + 
Sbjct:   194 FRCSVLNSLNLSRNRFSGNPSFVSGIWRLERLRALDLSSNSLSGSIPLGILSLHNLKELQ 253

Query:   228 LSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPK 287
             L +N FSG++P  IG C  L  +D S N FSG LP T+QKL   N  ++  NL SG+ P 
Sbjct:   254 LQRNQFSGALPSDIGLCPHLNRVDLSSNHFSGELPRTLQKLKSLNHFDVSNNLLSGDFPP 313

Query:   288 WIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALD 347
             WIG++  L  LD S N+ +G +P SI NL+ LK LN S N+L+G +P+S+ +C  L+ + 
Sbjct:   314 WIGDMTGLVHLDFSSNELTGKLPSSISNLRSLKDLNLSENKLSGEVPESLESCKELMIVQ 373

Query:   348 FSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSS-FESLQFLDLSHNEFSG 406
                N  +G++P   F  GL ++ F+ N    G+ G      S  FESL  LDLSHN  +G
Sbjct:   374 LKGNDFSGNIPDGFFDLGLQEMDFSGN----GLTGSIPRGSSRLFESLIRLDLSHNSLTG 429

Query:   407 ETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSL 466
               P  +G    ++ LNLS N     +P  I  L+ L VLDL  + L GS+P +I  + SL
Sbjct:   430 SIPGEVGLFIHMRYLNLSWNHFNTRVPPEIEFLQNLTVLDLRNSALIGSVPADICESQSL 489

Query:   467 KELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTG 526
             + L+L+ N L G IP  I NCSSL  L LS NNLTGPIP +++ L  L+ + L  N L+G
Sbjct:   490 QILQLDGNSLTGSIPEGIGNCSSLKLLSLSHNNLTGPIPKSLSNLQELKILKLEANKLSG 549

Query:   527 GLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKSCPAVLP 586
              +PK+L +L +L   N+S N L G LP G  F ++  S++ GN  +C   +   C   +P
Sbjct:   550 EIPKELGDLQNLLLVNVSFNRLIGRLPLGDVFQSLDQSAIQGNLGICSPLLRGPCTLNVP 609

Query:   587 KPIVLNPNXXXXXXX-----XXVAPNPRHKRXXXXXXXXXXXXXXXXXXXXXXXXTVLNL 641
             KP+V+NPN                    H+R                        T+LN 
Sbjct:   610 KPLVINPNSYGNGNNMPGNRASGGSGTFHRRMFLSVSVIVAISAAILIFSGVIIITLLNA 669

Query:   642 RVXXXXXXXXXXXXXXXGDDFSRSPTTDANSGKLVMF--------SGDPDFSTGTHALLN 693
              V                   S+S  +    GKLV+         S   +F     +LLN
Sbjct:   670 SVRRRLAFVDNALESIFSGS-SKSGRS-LMMGKLVLLNSRTSRSSSSSQEFERNPESLLN 727

Query:   694 KDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
             K   +G G FG VY+  L + GR +A+KKL  S ++++ EDF+REV+ L K +HPNLV++
Sbjct:   728 KASRIGEGVFGTVYKAPLGEQGRNLAVKKLVPSPILQNLEDFDREVRILAKAKHPNLVSI 787

Query:   753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNF-LSWNERFNVIQGTAKSLAHLHQS-- 809
             +GY+WT  L LL+ E++  G+L   LHE       LSW+ R+ +I GTAK LA+LH +  
Sbjct:   788 KGYFWTPDLHLLVSEYIPNGNLQSKLHEREPSTPPLSWDVRYKIILGTAKGLAYLHHTFR 847

Query:   810 -NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS-KIQSALGYMAPEFACRT 867
                IH+N+K +N+L+D    PK+ D+GL+RLL   D   +++ + Q+ALGY+APE  C+ 
Sbjct:   848 PTTIHFNLKPTNILLDEKNNPKISDFGLSRLLTTQDGNTMNNNRFQNALGYVAPELECQN 907

Query:   868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
             +++ +KCDVYGFGVL+LE+VTG+RP+
Sbjct:   908 LRVNEKCDVYGFGVLILELVTGRRPV 933

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2122239 AT4G36180 [Arabidopsis thaliana (taxid:3702)]

 Score = 776 (278.2 bits), Expect = 6.3e-113, Sum P(2) = 6.3e-113
 Identities = 187/476 (39%), Positives = 266/476 (55%)

Query:   110 NNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGS-LRVISLAKNRFSGKIPSS 168
             NN +G++  +L    +L ++ L  N+ S  +  E    C + L+V+ L +NR SG+ P  
Sbjct:   268 NNFSGTVPFSLFCNTSLTIVQLGFNAFSDIVRPETTANCRTGLQVLDLQENRISGRFPLW 327

Query:   169 LSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINL 228
             L+   +L  +++S N FS  +P  I  L  L  L L++N L GEIP  ++   +L V++ 
Sbjct:   328 LTNILSLKNLDVSGNLFSGEIPPDIGNLKRLEELKLANNSLTGEIPVEIKQCGSLDVLDF 387

Query:   229 SKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKW 288
               N   G IP+ +G    L+ +    NSFSG +P +M  L     +NL +N  +G  P  
Sbjct:   388 EGNSLKGQIPEFLGYMKALKVLSLGRNSFSGYVPSSMVNLQQLERLNLGENNLNGSFPVE 447

Query:   289 IGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDF 348
             +  L SL  LDLSGN+FSGAVP+SI NL  L  LN S N  +G +P S+ N   L ALD 
Sbjct:   448 LMALTSLSELDLSGNRFSGAVPVSISNLSNLSFLNLSGNGFSGEIPASVGNLFKLTALDL 507

Query:   349 SQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGET 408
             S+ +M+G++P  +  SGL  V     +     +G      SS  SL++++LS N FSGE 
Sbjct:   508 SKQNMSGEVP--VELSGLPNVQVIALQ-GNNFSGVVPEGFSSLVSLRYVNLSSNSFSGEI 564

Query:   409 PATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKE 468
             P T G L  L  L+LS N + G IP  IG+  AL VL+L  N L G IP ++     LK 
Sbjct:   565 PQTFGFLRLLVSLSLSDNHISGSIPPEIGNCSALEVLELRSNRLMGHIPADLSRLPRLKV 624

Query:   469 LRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGL 528
             L L +N L+G+IP  I   SSL SL L  N+L+G IP + + L+NL  +DLS N+LTG +
Sbjct:   625 LDLGQNNLSGEIPPEISQSSSLNSLSLDHNHLSGVIPGSFSGLSNLTKMDLSVNNLTGEI 684

Query:   529 PKQLVNLV-HLSSFNISHNHLQGELPA--GGFFNTISPSSVLGNPSLCGSAVNKSC 581
             P  L  +  +L  FN+S N+L+GE+PA  G   N  S  S  GN  LCG  +N+ C
Sbjct:   685 PASLALISSNLVYFNVSSNNLKGEIPASLGSRINNTSEFS--GNTELCGKPLNRRC 738

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006260 "DNA replication" evidence=RCA

GO:0006306 "DNA methylation" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0008283 "cell proliferation" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0030244 "cellulose biosynthetic process" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0051567 "histone H3-K9 methylation" evidence=RCA

TAIR|locus:2005507 ER "ERECTA" [Arabidopsis thaliana (taxid:3702)]

 Score = 777 (278.6 bits), Expect = 1.0e-111, Sum P(2) = 1.0e-111
 Identities = 182/544 (33%), Positives = 277/544 (50%)

Query:    39 LIVFKADIQDPNGKLSSWSEDDDTP-CNWFGVKCSPRSNRVIELTLNGLSXXXXXXXXXX 97
             L+  K   +D N  L  W+    +  C W GV C   +  V+ L L+ L+          
Sbjct:    30 LLEIKKSFKDVNNVLYDWTTSPSSDYCVWRGVSCENVTFNVVALNLSDLNLDGEISPAIG 89

Query:    98 XXXXXXXXXXXXNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLA 157
                         N L+G I   +    +L+ +DLS N LSG IP    K    L  + L 
Sbjct:    90 DLKSLLSIDLRGNRLSGQIPDEIGDCSSLQNLDLSFNELSGDIPFSISK-LKQLEQLILK 148

Query:   158 KNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGV 217
              N+  G IPS+LS    L  ++L+ N+ S  +P  I+    L+ L L  N L G I   +
Sbjct:   149 NNQLIGPIPSTLSQIPNLKILDLAQNKLSGEIPRLIYWNEVLQYLGLRGNNLVGNISPDL 208

Query:   218 ESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLR 277
               L  L   ++  N  +GSIP+ IG+C+  + +D S N  +G +P  +  L +   ++L+
Sbjct:   209 CQLTGLWYFDVRNNSLTGSIPETIGNCTAFQVLDLSYNQLTGEIPFDIGFLQVAT-LSLQ 267

Query:   278 KNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSM 337
              N  SG++P  IG +++L  LDLSGN  SG++P  +GNL   + L   +N+LTGS+P  +
Sbjct:   268 GNQLSGKIPSVIGLMQALAVLDLSGNLLSGSIPPILGNLTFTEKLYLHSNKLTGSIPPEL 327

Query:   338 ANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFL 397
              N   L  L+ + N + G +P  +   G     F  N     + GP     SS  +L  L
Sbjct:   328 GNMSKLHYLELNDNHLTGHIPPEL---GKLTDLFDLNVANNDLEGPIPDHLSSCTNLNSL 384

Query:   398 DLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIP 457
             ++  N+FSG  P     L  +  LNLS N++ GPIPV +  +  L+ LDLS N +NG IP
Sbjct:   385 NVHGNKFSGTIPRAFQKLESMTYLNLSSNNIKGPIPVELSRIGNLDTLDLSNNKINGIIP 444

Query:   458 PEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNV 517
               +G    L ++ L RN + G +P    N  S++ + LS N+++GPIP  + +L N+  +
Sbjct:   445 SSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIMEIDLSNNDISGPIPEELNQLQNIILL 504

Query:   518 DLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAV 577
              L  N+LTG +   L N + L+  N+SHN+L G++P    F+  SP S +GNP LCGS +
Sbjct:   505 RLENNNLTGNVGS-LANCLSLTVLNVSHNNLVGDIPKNNNFSRFSPDSFIGNPGLCGSWL 563

Query:   578 NKSC 581
             N  C
Sbjct:   564 NSPC 567

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0048281 "inflorescence morphogenesis" evidence=IMP

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0005739 "mitochondrion" evidence=IDA

GO:0050832 "defense response to fungus" evidence=IMP

GO:0010103 "stomatal complex morphogenesis" evidence=RCA;IMP

GO:0001558 "regulation of cell growth" evidence=IGI;IMP

GO:0009965 "leaf morphogenesis" evidence=RCA;IMP

GO:0010148 "transpiration" evidence=IMP

GO:0030155 "regulation of cell adhesion" evidence=IMP

GO:0051302 "regulation of cell division" evidence=IGI;IMP

GO:0009664 "plant-type cell wall organization" evidence=IMP

GO:0008356 "asymmetric cell division" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0031540 "regulation of anthocyanin biosynthetic process" evidence=RCA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:2000027 "regulation of organ morphogenesis" evidence=IMP

TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)]

 Score = 755 (270.8 bits), Expect = 2.1e-109, Sum P(2) = 2.1e-109
 Identities = 169/469 (36%), Positives = 251/469 (53%)

Query:   110 NNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSL 169
             NNL+G+++ +L  L +L V+DL GN   GS+P  F K    LR + L+ N  +G++PS L
Sbjct:   150 NNLSGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSF-KNLQKLRFLGLSGNNLTGELPSVL 208

Query:   170 SLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLS 229
                 +L T  L  N F  P+P     +++L+ LDL+   L GEIP  +  LK+L  + L 
Sbjct:   209 GQLPSLETAILGYNEFKGPIPPEFGNINSLKYLDLAIGKLSGEIPSELGKLKSLETLLLY 268

Query:   230 KNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWI 289
             +N F+G+IP  IGS + L+ +DFS+N+ +G +P  + KL     +NL +N  SG +P  I
Sbjct:   269 ENNFTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNKLSGSIPPAI 328

Query:   290 GELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFS 349
               L  L+ L+L  N  SG +P  +G    L+ L+ S+N  +G +P ++ N  NL  L   
Sbjct:   329 SSLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILF 388

Query:   350 QNSMNGDLPQWIFS-SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGET 408
              N+  G +P  + +   L +V    N +    NG         E LQ L+L+ N  SG  
Sbjct:   389 NNTFTGQIPATLSTCQSLVRVRMQNNLL----NGSIPIGFGKLEKLQRLELAGNRLSGGI 444

Query:   409 PATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKE 468
             P  I     L  ++ SRN +   +P  I  +  L    +++N+++G +P +     SL  
Sbjct:   445 PGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQDCPSLSN 504

Query:   469 LRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGL 528
             L L  N L G IP+SI +C  LVSL L  NNLTG IP  I  ++ L  +DLS NSLTG L
Sbjct:   505 LDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTGVL 564

Query:   529 PKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAV 577
             P+ +     L   N+S+N L G +P  GF  TI+P  + GN  LCG  +
Sbjct:   565 PESIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLCGGVL 613

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010067 "procambium histogenesis" evidence=ISS

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 684 (245.8 bits), Expect = 3.5e-108, Sum P(2) = 3.5e-108
 Identities = 168/541 (31%), Positives = 272/541 (50%)

Query:    31 SLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSXXX 90
             SLN++   L+ FKA + D NG L+SW++ D  PCNW G+ C+     V  + LNG++   
Sbjct:    23 SLNEEGRVLLEFKAFLNDSNGYLASWNQLDSNPCNWTGIACT-HLRTVTSVDLNGMNLSG 81

Query:    91 XXXXXXXXXXXXXXXXXXXNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGS 150
                                N ++G I  +L+  ++L V+DL  N   G IP +      +
Sbjct:    82 TLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQL-TMIIT 140

Query:   151 LRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLE 210
             L+ + L +N   G IP  +   S+L  + + SN  +  +P  +  L  LR +    N   
Sbjct:   141 LKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFS 200

Query:   211 GEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSL 270
             G IP  +   ++L+V+ L++N+  GS+P  +     L  +   +N  SG +P ++  +S 
Sbjct:   201 GVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISR 260

Query:   271 CNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLT 330
                + L +N F+G +P+ IG+L  ++ L L  N+ +G +P  IGNL     ++FS N+LT
Sbjct:   261 LEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLT 320

Query:   331 GSLPDSMANCMNLVALDFSQNSMNGDLPQWIFS-SGLNKVSFAENKIREGMNGPFASSGS 389
             G +P    + +NL  L   +N + G +P+ +   + L K+  + N++    NG       
Sbjct:   321 GFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRL----NGTIPQELQ 376

Query:   390 SFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSE 449
                 L  L L  N+  G+ P  IG  S   +L++S NSL GPIP      + L +L L  
Sbjct:   377 FLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGS 436

Query:   450 NWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIA 509
             N L+G+IP ++    SL +L L  N L G +P  + N  +L +L L +N L+G I   + 
Sbjct:   437 NKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLG 496

Query:   510 KLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAG-GFFNTISPSSVLG 568
             KL NL+ + L+ N+ TG +P ++ NL  +  FNIS N L G +P   G   TI    + G
Sbjct:   497 KLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSG 556

Query:   569 N 569
             N
Sbjct:   557 N 557

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2005629 AT1G75640 [Arabidopsis thaliana (taxid:3702)]

 Score = 749 (268.7 bits), Expect = 1.4e-106, Sum P(2) = 1.4e-106
 Identities = 177/482 (36%), Positives = 264/482 (54%)

Query:   110 NNLTGSISPNL-----AKLQNLRVIDLSGNSLSG-SIPDEFFKQCGSLRVISLAKNRFSG 163
             N+ TG++  +L         ++R+I L  N+ +G + P        +L ++ + +NR +G
Sbjct:   269 NSFTGTVPVSLLCGYSGYNSSMRIIQLGVNNFTGIAKPSNAACVNPNLEILDIHENRING 328

Query:   164 KIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNL 223
               P+ L+  ++L  +++S N FS  +   +  L AL+ L +++N L GEIP  + + K+L
Sbjct:   329 DFPAWLTDLTSLVVLDISGNGFSGGVTAKVGNLMALQELRVANNSLVGEIPTSIRNCKSL 388

Query:   224 RVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSG 283
             RV++   N FSG IP  +     L TI    N FSG +P  +  L     +NL +N  +G
Sbjct:   389 RVVDFEGNKFSGQIPGFLSQLRSLTTISLGRNGFSGRIPSDLLSLYGLETLNLNENHLTG 448

Query:   284 EVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNL 343
              +P  I +L +L  L+LS N+FSG VP ++G+L+ L VLN S   LTG +P S++  M L
Sbjct:   449 AIPSEITKLANLTILNLSFNRFSGEVPSNVGDLKSLSVLNISGCGLTGRIPVSISGLMKL 508

Query:   344 VALDFSQNSMNGDLPQWIFS-SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHN 402
               LD S+  ++G LP  +F    L  V+   N +     G      SS  SL++L+LS N
Sbjct:   509 QVLDISKQRISGQLPVELFGLPDLQVVALGNNLL----GGVVPEGFSSLVSLKYLNLSSN 564

Query:   403 EFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGG 462
              FSG  P   G L  LQ+L+LS N + G IP  IG+  +L VL+L  N L G IP  +  
Sbjct:   565 LFSGHIPKNYGFLKSLQVLSLSHNRISGTIPPEIGNCSSLEVLELGSNSLKGHIPVYVSK 624

Query:   463 AYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFN 522
                LK+L L  N L G IP  I   SSL SL+L+ N+L+G IP ++++LTNL  +DLS N
Sbjct:   625 LSLLKKLDLSHNSLTGSIPDQISKDSSLESLLLNSNSLSGRIPESLSRLTNLTALDLSSN 684

Query:   523 SLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKSCP 582
              L   +P  L  L  L+ FN+S N L+GE+P        +P+  + NP LCG  +   CP
Sbjct:   685 RLNSTIPSSLSRLRFLNYFNLSRNSLEGEIPEALAARFTNPTVFVKNPGLCGKPLGIECP 744

Query:   583 AV 584
              V
Sbjct:   745 NV 746

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2182855 ERL2 "ERECTA-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 700 (251.5 bits), Expect = 3.1e-106, Sum P(2) = 3.1e-106
 Identities = 182/584 (31%), Positives = 281/584 (48%)

Query:     7 MKASVFSL--LTFLVLAPALTRSLNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTP- 63
             MK   F L  + F++L      S++P +N++   L+  KA   +    L  W +  +   
Sbjct:     7 MKGLFFCLGMVVFMLLG-----SVSP-MNNEGKALMAIKASFSNVANMLLDWDDVHNHDF 60

Query:    64 CNWFGVKCSPRSNRVIELTLNGLSXXXXXXXXXXXXXXXXXXXXXXNNLTGSISPNLAKL 123
             C+W GV C   S  V+ L L+ L+                      N L G I   +   
Sbjct:    61 CSWRGVFCDNVSLNVVSLNLSNLNLGGEISSALGDLMNLQSIDLQGNKLGGQIPDEIGNC 120

Query:   124 QNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSN 183
              +L  +D S N L G IP    K    L  ++L  N+ +G IP++L+    L T++L+ N
Sbjct:   121 VSLAYVDFSTNLLFGDIPFSISK-LKQLEFLNLKNNQLTGPIPATLTQIPNLKTLDLARN 179

Query:   184 RFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGS 243
             + +  +P  ++    L+ L L  N+L G +   +  L  L   ++  N  +G+IP+ IG+
Sbjct:   180 QLTGEIPRLLYWNEVLQYLGLRGNMLTGTLSPDMCQLTGLWYFDVRGNNLTGTIPESIGN 239

Query:   244 CSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGN 303
             C+    +D S N  +G +P  +  L +   ++L+ N  +G +P+ IG +++L  LDLS N
Sbjct:   240 CTSFEILDVSYNQITGVIPYNIGFLQVAT-LSLQGNKLTGRIPEVIGLMQALAVLDLSDN 298

Query:   304 KFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFS 363
             + +G +P  +GNL     L    N+LTG +P  + N   L  L  + N + G +P  +  
Sbjct:   299 ELTGPIPPILGNLSFTGKLYLHGNKLTGQIPPELGNMSRLSYLQLNDNELVGKIPPEL-- 356

Query:   364 SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNL 423
              G  +  F  N     + G   S+ SS  +L   ++  N  SG  P     L  L  LNL
Sbjct:   357 -GKLEQLFELNLANNNLVGLIPSNISSCAALNQFNVHGNFLSGAVPLEFRNLGSLTYLNL 415

Query:   424 SRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTS 483
             S NS  G IP  +G +  L+ LDLS N  +GSIP  +G    L  L L RN L G +P  
Sbjct:   416 SSNSFKGKIPAELGHIINLDTLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLNGTLPAE 475

Query:   484 IENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNI 543
               N  S+  + +S N L G IP  + +L N+ ++ L+ N + G +P QL N   L++ NI
Sbjct:   476 FGNLRSIQIIDVSFNFLAGVIPTELGQLQNINSLILNNNKIHGKIPDQLTNCFSLANLNI 535

Query:   544 SHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKSCPAVLPK 587
             S N+L G +P    F   SP+S  GNP LCG+ V   C   LPK
Sbjct:   536 SFNNLSGIIPPMKNFTRFSPASFFGNPFLCGNWVGSICGPSLPK 579

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IGI;RCA

GO:0009553 "embryo sac development" evidence=IGI

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009686 "gibberellin biosynthetic process" evidence=RCA

GO:0009740 "gibberellic acid mediated signaling pathway" evidence=RCA

GO:0009845 "seed germination" evidence=RCA

GO:0009886 "post-embryonic morphogenesis" evidence=RCA

GO:0009909 "regulation of flower development" evidence=RCA

GO:0009965 "leaf morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0048507 "meristem development" evidence=RCA

GO:0048608 "reproductive structure development" evidence=RCA

TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)]

 Score = 703 (252.5 bits), Expect = 4.1e-106, Sum P(2) = 4.1e-106
 Identities = 165/448 (36%), Positives = 241/448 (53%)

Query:   110 NNLTGSISPNLAKLQNLRVIDLSGNS-LSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSS 168
             N LTGSI   L KL  L VI + GN  +SG IP E    C +L V+ LA+   SG +PSS
Sbjct:   187 NLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEI-GDCSNLTVLGLAETSVSGNLPSS 245

Query:   169 LSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINL 228
             L     L T+++ +   S  +P  +   S L  L L +N L G IP+ +  L  L  + L
Sbjct:   246 LGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFL 305

Query:   229 SKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKW 288
              +N   G IP+ IG+CS L+ ID S N  SG++P ++ +LS      +  N FSG +P  
Sbjct:   306 WQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTT 365

Query:   289 IGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDF 348
             I    SL  L L  N+ SG +P  +G L +L +    +N+L GS+P  +A+C +L ALD 
Sbjct:   366 ISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDL 425

Query:   349 SQNSMNGDLPQWIFS-SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGE 407
             S+NS+ G +P  +F    L K+    N +    +G       +  SL  L L  N  +GE
Sbjct:   426 SRNSLTGTIPSGLFMLRNLTKLLLISNSL----SGFIPQEIGNCSSLVRLRLGFNRITGE 481

Query:   408 TPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLK 467
              P+ IG+L  +  L+ S N L G +P  IG    L ++DLS N L GS+P  +     L+
Sbjct:   482 IPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQ 541

Query:   468 ELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGG 527
              L +  N  +GKIP S+    SL  LILSKN  +G IP ++   + LQ +DL  N L+G 
Sbjct:   542 VLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGE 601

Query:   528 LPKQLVNLVHLS-SFNISHNHLQGELPA 554
             +P +L ++ +L  + N+S N L G++P+
Sbjct:   602 IPSELGDIENLEIALNLSSNRLTGKIPS 629

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010359 "regulation of anion channel activity" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00190594 hypothetical protein (964 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	936
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-119
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-46
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-41
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-39
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	9e-39
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-37
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-36
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-35
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-35
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-29
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-27
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-26
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-25
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-25
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-25
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-24
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-23
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-23
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-23
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-23
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-22
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-22
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-21
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-21
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-21
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-19
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-19
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-19
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-19
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-18
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-18
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-17
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-17
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-17
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-17
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-17
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-17
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-17
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-17
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-17
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-17
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-16
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-16
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-16
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-16
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-16
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-16
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	9e-16
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-15
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-15
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	9e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-14
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-14
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-14
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-14
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	8e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-13
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-13
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-13
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-13
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	9e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-12
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-12
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-12
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-11
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-11
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	6e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	7e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	9e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-10
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-10
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-10
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-10
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-10
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	5e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-10
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-10
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	9e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	6e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	9e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-08
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-08
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-08
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	9e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-07
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-07
PLN03210	1153	PLN03210, PLN03210, Resistant to P	5e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	8e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-06
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	1e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-06
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-05
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	2e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-05
PLN03210	1153	PLN03210, PLN03210, Resistant to P	5e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	7e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	7e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	9e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-04
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	3e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-04
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-04
COG5238	388	COG5238, RNA1, Ran GTPase-activating protein (RanG	6e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	7e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	0.001
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.001
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	0.001
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	0.002
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	0.002

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  387 bits (995), Expect = e-119
 Identities = 291/917 (31%), Positives = 443/917 (48%), Gaps = 136/917 (14%)

Query: 39  LIVFKADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQ 98
           L+ FK+ I DP   LS+W+   D  C W G+ C+  S+RV+ + L+G +++G+I   + +
Sbjct: 34  LLSFKSSINDPLKYLSNWNSSADV-CLWQGITCN-NSSRVVSIDLSGKNISGKISSAIFR 91

Query: 99  LQF-------------------------LRKLSLSSNNLTGSIS----PNLAKLQ----- 124
           L +                         LR L+LS+NN TGSI     PNL  L      
Sbjct: 92  LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNM 151

Query: 125 -------------NLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSL 171
                        +L+V+DL GN L G IP+       SL  ++LA N+  G+IP  L  
Sbjct: 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN-SLTNLTSLEFLTLASNQLVGQIPRELGQ 210

Query: 172 CSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKN 231
             +L  I L  N  S  +P  I GL++L  LDL  N L G IP  + +LKNL+ + L +N
Sbjct: 211 MKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQN 270

Query: 232 MFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGE 291
             SG IP  I S   L ++D S+NS SG +PE + +L     ++L  N F+G++P  +  
Sbjct: 271 KLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTS 330

Query: 292 LESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQN 351
           L  L+ L L  NKFSG +P ++G    L VL+ S N LTG +P+ + +  NL  L    N
Sbjct: 331 LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSN 390

Query: 352 SMNGDLPQWIFS-SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPA 410
           S+ G++P+ + +   L +V   +N      +G   S  +    + FLD+S+N   G   +
Sbjct: 391 SLEGEIPKSLGACRSLRRVRLQDN----SFSGELPSEFTKLPLVYFLDISNNNLQGRINS 446

Query: 411 TIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELR 470
               +  LQ+L+L+RN   G +P + G  K L  LDLS N  +G++P ++G    L +L+
Sbjct: 447 RKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLK 505

Query: 471 LERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPK 530
           L  N L+G+IP  + +C  LVSL LS N L+G IP + +++  L  +DLS N L+G +PK
Sbjct: 506 LSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPK 565

Query: 531 QLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKSCPAVLPKPIV 590
            L N+  L   NISHNHL G LP+ G F  I+ S+V GN  LCG                
Sbjct: 566 NLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGG--------------- 610

Query: 591 LNPNSSSDSTTSSVAPNPRHKRIILSIS--AIIAIGAAAVIVIGVIAITVL------NLR 642
                    TTS + P    KR+  + S    I     A +V+ ++A   +      NL 
Sbjct: 611 --------DTTSGLPPC---KRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLE 659

Query: 643 VRSSTSRSAAALTLSAGDDFSRSPTTDANSGKLVMFSGDPDFSTGTHALLNKDCELGRGG 702
           ++   +              S+S T +      ++ S            L ++  + RG 
Sbjct: 660 LKRVENEDGTWELQFFDSKVSKSITIND-----ILSS------------LKEENVISRGK 702

Query: 703 FGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDF----EREVKKLGKVRHPNLVTLEGYYWT 758
            GA Y+            K  +  +VK   D       E+  +GK++HPN+V L G   +
Sbjct: 703 KGASYKG--------KSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRS 754

Query: 759 QSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH---QSNIIHYN 815
           +    LI+E++ G +L + L        LSW  R  +  G AK+L  LH      ++  N
Sbjct: 755 EKGAYLIHEYIEGKNLSEVL------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGN 808

Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           +    ++IDG  EP +    L  LL    +  +SS       Y+APE    T  IT+K D
Sbjct: 809 LSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISS------AYVAPE-TRETKDITEKSD 860

Query: 876 VYGFGVLVLEVVTGKRP 892
           +YGFG++++E++TGK P
Sbjct: 861 IYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  165 bits (419), Expect = 2e-46
 Identities = 65/190 (34%), Positives = 105/190 (55%), Gaps = 6/190 (3%)

Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG GGFG VY    +  G+ VAIK +         E+  RE++ L K+ HPN+V L G +
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             ++   L+ E+  GGSL   L E  G   LS +E   ++    + L +LH + IIH ++
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHSNGIIHRDL 118

Query: 817 KSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           K  N+L+D  +G+ K+ D+GL++LL   D+ +L + + +   YMAPE        ++K D
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGT-PAYMAPEVLLGKGYYSEKSD 176

Query: 876 VYGFGVLVLE 885
           ++  GV++ E
Sbjct: 177 IWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  150 bits (381), Expect = 8e-41
 Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 8/197 (4%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G FG VY     + G+ VAIK +    + K +E   RE+K L K++HPN+V L   
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           +  +    L+ E+  GG L   L +      LS +E    ++    +L +LH   I+H +
Sbjct: 66  FEDEDKLYLVMEYCEGGDLFDLLKK---RGRLSEDEARFYLRQILSALEYLHSKGIVHRD 122

Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           +K  N+L+D  G  K+ D+GLAR L       L++ + +   YMAPE            D
Sbjct: 123 LKPENILLDEDGHVKLADFGLARQLD--PGEKLTTFVGT-PEYMAPE-VLLGKGYGKAVD 178

Query: 876 VYGFGVLVLEVVTGKRP 892
           ++  GV++ E++TGK P
Sbjct: 179 IWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  146 bits (371), Expect = 2e-39
 Identities = 65/199 (32%), Positives = 100/199 (50%), Gaps = 7/199 (3%)

Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQED-FEREVKKLGKVRHPNLVTLEGY 755
           LG G FG VY+   +  G+ VA+K L   S    ++    RE++ L ++ HPN+V L   
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           +  +    L+ E+  GG L  +L  G     LS +E   +     + L +LH + IIH +
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLHSNGIIHRD 123

Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           +K  N+L+D +G  K+ D+GLA+ L  L      +       YMAPE          K D
Sbjct: 124 LKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVD 181

Query: 876 VYGFGVLVLEVVTGKRPLS 894
           V+  GV++ E++TGK P S
Sbjct: 182 VWSLGVILYELLTGKPPFS 200

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  144 bits (367), Expect = 9e-39
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 9/209 (4%)

Query: 692 LNKDCELGRGGFGAVYRTVLRD-----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH 746
           L    +LG G FG VY+  L+         VA+K L   +  + +E+F  E   + K+ H
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60

Query: 747 PNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHL 806
           PN+V L G         ++ E++ GG L   L +   G  L+  +   +    AK + +L
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK--HGEKLTLKDLLQMALQIAKGMEYL 118

Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
              N +H ++ + N L+  +   K+ D+GL+R +   D Y      +  + +MAPE + +
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE-SLK 177

Query: 867 TVKITDKCDVYGFGVLVLEVVT-GKRPLS 894
             K T K DV+ FGVL+ E+ T G++P  
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYP 206

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  140 bits (355), Expect = 3e-37
 Identities = 63/207 (30%), Positives = 107/207 (51%), Gaps = 9/207 (4%)

Query: 692 LNKDCELGRGGFGAVYRTVLRDG-----RPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH 746
           L    +LG G FG VY+  L+         VA+K L   +  +  E+F RE + + K+ H
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60

Query: 747 PNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHL 806
           PN+V L G    +   +++ E++ GG L  +L + +    LS ++  +     A+ + +L
Sbjct: 61  PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYL 119

Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
              N IH ++ + N L+  +   K+ D+GL+R L   D Y +    +  + +MAPE + +
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPE-SLK 177

Query: 867 TVKITDKCDVYGFGVLVLEVVT-GKRP 892
             K T K DV+ FGVL+ E+ T G+ P
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEP 204

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  137 bits (347), Expect = 4e-36
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 22/208 (10%)

Query: 698 LGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGY 755
           LGRG FG+VY       G  +A+K + +S   + + E  ERE++ L  ++HPN+V    Y
Sbjct: 8   LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVR---Y 64

Query: 756 YWT----QSLQLLIY-EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKS----LAHL 806
           Y +    +   L I+ E+VSGGSL   L       F    E   VI+   +     LA+L
Sbjct: 65  YGSERDEEKNTLNIFLEYVSGGSLSSLLK-----KFGKLPE--PVIRKYTRQILEGLAYL 117

Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           H + I+H +IK +N+L+D  G  K+ D+G A+ L  ++    +  ++    +MAPE   R
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE-VIR 176

Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPLS 894
             +     D++  G  V+E+ TGK P S
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPPWS 204

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  134 bits (341), Expect = 2e-35
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 10/207 (4%)

Query: 692 LNKDCELGRGGFGAVYRTVLRD-----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH 746
           L    +LG G FG VY+  L+         VA+K L   +  +  E+F RE + + K+ H
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60

Query: 747 PNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHL 806
           PN+V L G    +    ++ E++ GG L  +L +      LS ++  +     A+ + +L
Sbjct: 61  PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN--RPKLSLSDLLSFALQIARGMEYL 118

Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
              N IH ++ + N L+  +   K+ D+GL+R L   D Y      +  + +MAPE + +
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPE-SLK 176

Query: 867 TVKITDKCDVYGFGVLVLEVVT-GKRP 892
             K T K DV+ FGVL+ E+ T G++P
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQP 203

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  134 bits (341), Expect = 3e-35
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 12/212 (5%)

Query: 697 ELGRGGFGAVYRTVLRDG----RPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           +LG G FG VY+  L+        VA+K L   +  + ++DF +E + + K+ HPN+V L
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHL------HEGSGGNFLSWNERFNVIQGTAKSLAHL 806
            G    +    L+ E++ GG L  +L            + LS  +  +     AK + +L
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121

Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
                +H ++ + N L+      K+ D+GL+R +   D Y   +  +  + +MAPE + +
Sbjct: 122 ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE-SLK 180

Query: 867 TVKITDKCDVYGFGVLVLEVVT-GKRPLSTWK 897
               T K DV+ FGVL+ E+ T G  P     
Sbjct: 181 DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS 212

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  123 bits (311), Expect = 2e-31
 Identities = 67/207 (32%), Positives = 104/207 (50%), Gaps = 24/207 (11%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG- 754
           ++G+GGFG VY+    R G+ VAIK + + S  + +E    E++ L K +HPN+V   G 
Sbjct: 7   KIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN------VIQGTAKSLAHLHQ 808
           Y     L +++ EF SGGSL   L         S N+         V +   K L +LH 
Sbjct: 66  YLKKDELWIVM-EFCSGGSLKDLLK--------STNQTLTESQIAYVCKELLKGLEYLHS 116

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLA-RLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
           + IIH +IK++N+L+   GE K+ D+GL+ +L     R    + +     +MAPE     
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR----NTMVGTPYWMAPEVINGK 172

Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPLS 894
                K D++  G+  +E+  GK P S
Sbjct: 173 -PYDYKADIWSLGITAIELAEGKPPYS 198

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  117 bits (295), Expect = 3e-29
 Identities = 60/217 (27%), Positives = 106/217 (48%), Gaps = 30/217 (13%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEG 754
           ++G+G FG VY      DG+   +K++ +S++  K +ED   EVK L K+ HPN++    
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEG--SGGNF-----LSWNERFNVIQGTAKSLAHLH 807
            +  +    ++ E+  GG L + + +    G  F     L W      +Q    +L +LH
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW-----FVQ-LCLALKYLH 120

Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA---LG---YMAP 861
              I+H +IK  N+ +  +G  K+GD+G+++        VLSS +  A   +G   Y++P
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISK--------VLSSTVDLAKTVVGTPYYLSP 172

Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM 898
           E  C+      K D++  G ++ E+ T K P     +
Sbjct: 173 E-LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  116 bits (294), Expect = 3e-29
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 26/208 (12%)

Query: 696 CELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLE 753
             +GRG FG VY+ + L  G  VAIK++++  + +   +   +E+  L  ++HPN+V   
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNER------FNVIQGTAKSLAHLH 807
           G   T     +I E+   GSL + +       F  + E       + V+QG    LA+LH
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIK-----KFGPFPESLVAVYVYQVLQG----LAYLH 116

Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFA 864
           +  +IH +IK++N+L    G  K+ D+G+A  L  + +        S +G   +MAPE  
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-----DDASVVGTPYWMAPE-V 170

Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRP 892
                 +   D++  G  V+E++TG  P
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  114 bits (284), Expect = 5e-27
 Identities = 73/220 (33%), Positives = 105/220 (47%), Gaps = 12/220 (5%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKL--TVSSLVKSQEDFEREVKKLGKVRHP-NLVTLE 753
           +LG G FG VY    RD + VA+K L   + S  K  E F RE++ L  + HP N+V L 
Sbjct: 7   KLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
            ++  +    L+ E+V GGSL   L +      LS +E   ++     +L +LH   IIH
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIH 124

Query: 814 YNIKSSNVLIDGSG-EPKVGDYGLARLLP----MLDRYVLSSKIQSALGYMAPEFA--CR 866
            +IK  N+L+D  G   K+ D+GLA+LLP          L S      GYMAPE      
Sbjct: 125 RDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS 184

Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW 906
               +   D++  G+ + E++TG  P    K     S T 
Sbjct: 185 LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL 224

Length = 384

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 6e-26
 Identities = 65/199 (32%), Positives = 105/199 (52%), Gaps = 12/199 (6%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           LG G FG V+  +  +  PVA+K L   ++    +DF  E + + K+RHP L+ L   Y 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQL---YA 68

Query: 758 TQSLQLLIY---EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
             +L+  IY   E +  GSL ++L  G+G   L   +  ++    A  +A+L   N IH 
Sbjct: 69  VCTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEAQNYIHR 127

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++ + NVL+  +   KV D+GLAR++   D Y      +  + + APE A    + + K 
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAPE-AALYNRFSIKS 185

Query: 875 DVYGFGVLVLEVVT-GKRP 892
           DV+ FG+L+ E+VT G+ P
Sbjct: 186 DVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  106 bits (267), Expect = 1e-25
 Identities = 69/209 (33%), Positives = 103/209 (49%), Gaps = 25/209 (11%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-LTVSSLVKSQE---DFEREVKKLGKVRHPNLVTL 752
           LG G FG+VY  + L DG   A+K+          QE     E+E+  L K++HPN+V  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ- 66

Query: 753 EGYYWTQSLQ--LLIY-EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKS----LAH 805
             Y  T+  +  L I+ E V GGSL K L +     + S+ E   VI+   +     L +
Sbjct: 67  --YLGTEREEDNLYIFLELVPGGSLAKLLKK-----YGSFPE--PVIRLYTRQILLGLEY 117

Query: 806 LHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFAC 865
           LH  N +H +IK +N+L+D +G  K+ D+G+A+ +         S   S   +MAPE   
Sbjct: 118 LHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--FAKSFKGSPY-WMAPEVIA 174

Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
           +        D++  G  VLE+ TGK P S
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWS 203

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 3e-25
 Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 18/205 (8%)

Query: 698 LGRGGFGAVYRTVLR-DGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ V   +G     PVAIK L   +  K+ ++   E   +  V HP++V L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGG----NFLSWNERFNVIQGTAKSLAHLHQ 808
            G   +  +QL I + +  G L  ++            L+W  +       AK +++L +
Sbjct: 75  LGICLSSQVQL-ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLEE 127

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTV 868
             ++H ++ + NVL+      K+ D+GLA+LL + ++   +   +  + +MA E +    
Sbjct: 128 KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE-SILHR 186

Query: 869 KITDKCDVYGFGVLVLEVVT-GKRP 892
             T K DV+ +GV V E++T G +P
Sbjct: 187 IYTHKSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  105 bits (264), Expect = 3e-25
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 15/205 (7%)

Query: 697 ELGRGGFGAVYR----TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           +LG G FG V R    T      PVA+K L    L    +DF +E   +  + H NL+ L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLS---WNERFNVIQGTAKSLAHLHQS 809
            G   T  L +++ E    GSL   L + + G+FL     +    +    A  + +L   
Sbjct: 62  YGVVLTHPL-MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLESK 116

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML-DRYVLSSKIQSALGYMAPEFACRTV 868
             IH ++ + N+L+    + K+GD+GL R LP   D YV+   ++    + APE + RT 
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE-SLRTR 175

Query: 869 KITDKCDVYGFGVLVLEVVT-GKRP 892
             +   DV+ FGV + E+ T G+ P
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 7e-25
 Identities = 66/199 (33%), Positives = 101/199 (50%), Gaps = 12/199 (6%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           LG G FG V+         VA+K L   ++  S E F +E + + K+RH  LV L   Y 
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQL---YA 68

Query: 758 TQSLQLLIY---EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
             S +  IY   E++S GSL   L  G G   L   +  ++    A+ +A+L   N IH 
Sbjct: 69  VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKK-LRLPQLVDMAAQIAEGMAYLESRNYIHR 127

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++ + N+L+  +   K+ D+GLARL+   D Y      +  + + APE A    + T K 
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLI-EDDEYTAREGAKFPIKWTAPE-AANYGRFTIKS 185

Query: 875 DVYGFGVLVLEVVT-GKRP 892
           DV+ FG+L+ E+VT G+ P
Sbjct: 186 DVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  101 bits (254), Expect = 6e-24
 Identities = 58/197 (29%), Positives = 98/197 (49%), Gaps = 6/197 (3%)

Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +G+G FG V++ V + D R  A+K++ +S +  + +E+   E + L K+    ++     
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           +  +    ++ E+   G LHK L     G  L  ++ +         LAHLH   I+H +
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLKM-QRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRD 126

Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           IKS N+ +D     K+GD G+A+LL   D    ++ I     Y++PE  C      +K D
Sbjct: 127 IKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYYLSPEL-CEDKPYNEKSD 183

Query: 876 VYGFGVLVLEVVTGKRP 892
           V+  GV++ E  TGK P
Sbjct: 184 VWALGVVLYECCTGKHP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  101 bits (254), Expect = 6e-24
 Identities = 66/204 (32%), Positives = 105/204 (51%), Gaps = 20/204 (9%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL---- 752
           +LG G FG V+  + ++   VAIK L    L+K Q+DF++EV+ L ++RH +L++L    
Sbjct: 13  KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK-QQDFQKEVQALKRLRHKHLISLFAVC 71

Query: 753 ---EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
              E  Y       +I E +  GSL   L    G   L      ++    A+ +A+L + 
Sbjct: 72  SVGEPVY-------IITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ 123

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           N IH ++ + N+L+      KV D+GLARL+   +   LSS  +    + APE A     
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIK--EDVYLSSDKKIPYKWTAPEAASHG-T 180

Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            + K DV+ FG+L+ E+ T G+ P
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQVP 204

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  100 bits (252), Expect = 1e-23
 Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 32/226 (14%)

Query: 692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           L +   LG+G  G VY+   +  G+  A+KK+ V    + ++   RE+K L     P +V
Sbjct: 3   LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVV 62

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF------NVIQGTAKSLA 804
              G ++ +    ++ E++ GGSL   L +  G       E         +++G    L 
Sbjct: 63  KCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGK----IPEPVLAYIARQILKG----LD 113

Query: 805 HLHQ-SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP-MLDRYVLSSKIQSALG---YM 859
           +LH   +IIH +IK SN+LI+  GE K+ D+G++++L   LD      +  + +G   YM
Sbjct: 114 YLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD------QCNTFVGTVTYM 167

Query: 860 APEFACRTVKITD--KCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS 903
           +PE   R    +     D++  G+ +LE   GK P        +F 
Sbjct: 168 SPE---RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFE 210

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  100 bits (251), Expect = 2e-23
 Identities = 69/222 (31%), Positives = 110/222 (49%), Gaps = 31/222 (13%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKL-TVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +G G FG VY  V L  G  +A+K++    +  K+ ++   E+K L  ++HPNLV    Y
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---Y 64

Query: 756 YWTQ--SLQLLIY-EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSL----AHLHQ 808
           Y  +    ++ I+ E+ SGG+L + L  G            +VI+     L    A+LH 
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLEHGR-------ILDEHVIRVYTLQLLEGLAYLHS 117

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLA-RLLPMLDRYVLSSKIQSALG---YMAPEFA 864
             I+H +IK +N+ +D +G  K+GD+G A +L           ++QS  G   YMAPE  
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG--EEVQSLAGTPAYMAPEVI 175

Query: 865 CRTVKITD--KCDVYGFGVLVLEVVTGKRPLS----TWKMMW 900
                       D++  G +VLE+ TGKRP S     +++M+
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF 217

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 99.8 bits (249), Expect = 3e-23
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 6/201 (2%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           +G+G FG VY+ VL+    VA+K    +     +  F +E + L +  HPN+V L G   
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIK 817
            +    ++ E V GGSL   L +      L+  +   +    A  + +L   N IH ++ 
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYLESKNCIHRDLA 120

Query: 818 SSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI-QSALGYMAPEFACRTVKITDKCDV 876
           + N L+  +   K+ D+G++R       Y +S  + Q  + + APE A    + T + DV
Sbjct: 121 ARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWTAPE-ALNYGRYTSESDV 178

Query: 877 YGFGVLVLEVVT-GKRPLSTW 896
           + +G+L+ E  + G  P    
Sbjct: 179 WSYGILLWETFSLGDTPYPGM 199

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 99.5 bits (248), Expect = 4e-23
 Identities = 66/197 (33%), Positives = 103/197 (52%), Gaps = 7/197 (3%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           ELG G FG V+    R    VAIK +   ++  S+EDF  E K + K+ HP LV L G  
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             Q    ++ EF+  G L  +L +  G   LS +   ++ Q   + + +L +++ IH ++
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYLRQRQGK--LSKDMLLSMCQDVCEGMEYLERNSFIHRDL 126

Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
            + N L+  +G  KV D+G+ R + + D Y  SS  +  + +  PE    + K + K DV
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDV 184

Query: 877 YGFGVLVLEVVT-GKRP 892
           + FGVL+ EV T GK P
Sbjct: 185 WSFGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 99.3 bits (248), Expect = 5e-23
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 8/205 (3%)

Query: 697 ELGRGGFGAVYRTVLR-DGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
            +G G FG V R  L+  G+    VAIK L   S  K + DF  E   +G+  HPN++ L
Sbjct: 11  VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           EG        ++I E++  GSL K L E  G    +  +   +++G A  + +L + N +
Sbjct: 71  EGVVTKSRPVMIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMNYV 128

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           H ++ + N+L++ +   KV D+GL+R L   +    +   +  + + APE A    K T 
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE-AIAYRKFTS 187

Query: 873 KCDVYGFGVLVLEVVT-GKRPLSTW 896
             DV+ FG+++ EV++ G+RP    
Sbjct: 188 ASDVWSFGIVMWEVMSYGERPYWDM 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 97.9 bits (244), Expect = 1e-22
 Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 7/202 (3%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           ELG G FG V+    R    VAIK +   ++  S++DF  E K + K+ HPNLV L G  
Sbjct: 11  ELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             Q    ++ E+++ G L  +L E  G     W    ++     +++ +L  +  IH ++
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNGFIHRDL 126

Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
            + N L+      KV D+GLAR + + D+Y  S   +  + +  PE    + + + K DV
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYV-LDDQYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDV 184

Query: 877 YGFGVLVLEVVT-GKRPLSTWK 897
           + FGVL+ EV + GK P   + 
Sbjct: 185 WSFGVLMWEVFSEGKMPYERFS 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 13/205 (6%)

Query: 697 ELGRGGFGAVYR---TVLRD--GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG G FG V       L D  G  VA+K L  S   + + DFERE++ L  + H N+V 
Sbjct: 11  QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70

Query: 752 LEGYYWTQ---SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
            +G        SL+L I E++  GSL  +L        L     F+      K + +L  
Sbjct: 71  YKGVCEKPGGRSLRL-IMEYLPSGSLRDYLQRHRDQINLKRLLLFS--SQICKGMDYLGS 127

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPEFACRT 867
              IH ++ + N+L++     K+ D+GLA++LP   D Y +    +S + + APE   RT
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE-CLRT 186

Query: 868 VKITDKCDVYGFGVLVLEVVTGKRP 892
            K +   DV+ FGV + E+ T   P
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDP 211

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 96.5 bits (241), Expect = 8e-22
 Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 18/201 (8%)

Query: 698 LGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G  G VY+ T    G+ VAIKK+ +    +++E    E+  +   +HPN+V     Y
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRK--QNKELIINEILIMKDCKHPNIVDYYDSY 84

Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAKSLAHLHQSNIIHY 814
                  ++ E++ GGSL   + +    NF+  NE     V +   + L +LH  N+IH 
Sbjct: 85  LVGDELWVVMEYMDGGSLTDIITQ----NFVRMNEPQIAYVCREVLQGLEYLHSQNVIHR 140

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKIT 871
           +IKS N+L+   G  K+ D+G A  L         SK  S +G   +MAPE   R     
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQLT-----KEKSKRNSVVGTPYWMAPEVIKRK-DYG 194

Query: 872 DKCDVYGFGVLVLEVVTGKRP 892
            K D++  G++ +E+  G+ P
Sbjct: 195 PKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 95.8 bits (238), Expect = 8e-22
 Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 7/197 (3%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           E+G G FG V+     + R VAIK  T+     S+EDF  E + + K+ HP LV L G  
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIK--TIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68

Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             +S   L++EF+  G L  +L    G    S      +     + +A+L  SN+IH ++
Sbjct: 69  TERSPICLVFEFMEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126

Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
            + N L+  +   KV D+G+ R + + D+Y  S+  +  + + +PE      K + K DV
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKFPVKWSSPE-VFSFSKYSSKSDV 184

Query: 877 YGFGVLVLEVVT-GKRP 892
           + FGVL+ EV + GK P
Sbjct: 185 WSFGVLMWEVFSEGKTP 201

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 95.3 bits (238), Expect = 1e-21
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 31/209 (14%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG V     +D G+  A+K L    ++K    E    E   L ++ HP +V L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAK--------SLAHL 806
            + T+    L+ E+  GG L  HL +           RF+  +  A+        +L +L
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSK---------EGRFS--EERARFYAAEIVLALEYL 109

Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEF 863
           H   II+ ++K  N+L+D  G  K+ D+GLA+ L         S+  +  G   Y+APE 
Sbjct: 110 HSLGIIYRDLKPENILLDADGHIKLTDFGLAKEL-----SSEGSRTNTFCGTPEYLAPEV 164

Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
                      D +  GVL+ E++TGK P
Sbjct: 165 LLGK-GYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 95.0 bits (236), Expect = 1e-21
 Identities = 68/209 (32%), Positives = 112/209 (53%), Gaps = 15/209 (7%)

Query: 698 LGRGGFGAVYRTVLR-DGR---PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +G G FG V+R +L+  GR    VAIK L      K ++DF  E   +G+  H N++ LE
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
           G        ++I E++  G+L K+L +   G F S+ +   +++G A  + +L   N +H
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRD-HDGEFSSY-QLVGMLRGIAAGMKYLSDMNYVH 130

Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAPEFACRTVKI 870
            ++ + N+L++ + E KV D+GL+R+L   P         KI   + + APE A    K 
Sbjct: 131 RDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAPE-AIAYRKF 187

Query: 871 TDKCDVYGFGVLVLEVVT-GKRPLSTWKM 898
           T   DV+ FG+++ EV++ G+RP   W M
Sbjct: 188 TSASDVWSFGIVMWEVMSFGERPY--WDM 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 29/216 (13%)

Query: 695 DCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
             +LG G +G+VY+ + ++ G+ VAIK + V       ++  +E+  L +   P +V   
Sbjct: 8   LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYY 64

Query: 754 GYYWTQSLQLLIYEFVSGGSL-------HKHLHEGSGGNFLSWNERFNVIQGTAKSLAHL 806
           G Y+  +   ++ E+   GS+       +K L E          E   ++  T K L +L
Sbjct: 65  GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTE---------EEIAAILYQTLKGLEYL 115

Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEF 863
           H +  IH +IK+ N+L++  G+ K+ D+G++  L   D     +K  + +G   +MAPE 
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL--TDTM---AKRNTVIGTPFWMAPEV 170

Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM 899
               +   +K D++  G+  +E+  GK P S    M
Sbjct: 171 IQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPM 205

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 20/209 (9%)

Query: 697 ELGRGGFGAVYR---TVLRDGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG G FG VY+   T   +      VAIK L  ++  K Q++F +E + +  ++HPN+V
Sbjct: 12  ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIV 71

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHL-----HEGSG--------GNFLSWNERFNVIQ 797
            L G    +    +++E+++ G LH+ L     H   G         + L  ++  ++  
Sbjct: 72  CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131

Query: 798 GTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG 857
             A  + +L   + +H ++ + N L+      K+ D+GL+R +   D Y + SK    + 
Sbjct: 132 QIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVR 191

Query: 858 YMAPEFACRTVKITDKCDVYGFGVLVLEV 886
           +M PE A    K T + D++ FGV++ E+
Sbjct: 192 WMPPE-AILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 94.8 bits (236), Expect = 3e-21
 Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 20/206 (9%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH---PNLVTLE 753
           +GRG +GAVYR   +  GR VA+K + + +      D +REV  L ++R    PN+    
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN--VIQGTAKSLAHLHQSNI 811
           G Y       +I E+  GGS+   +  G         E++   +I+    +L ++H+  +
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLMKAGP------IAEKYISVIIREVLVALKYIHKVGV 122

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTV 868
           IH +IK++N+L+  +G  K+ D+G+A LL        SSK  + +G   +MAPE      
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLN-----QNSSKRSTFVGTPYWMAPEVITEGK 177

Query: 869 KITDKCDVYGFGVLVLEVVTGKRPLS 894
               K D++  G+ + E+ TG  P S
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPPYS 203

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 7e-21
 Identities = 63/217 (29%), Positives = 107/217 (49%), Gaps = 29/217 (13%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKV-RHPNLVTLE 753
            +G G +G VY+    + G+ VAIK   +  +++  +E+ + E   L K   HPN+ T  
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIK---IMDIIEDEEEEIKEEYNILRKYSNHPNIATFY 69

Query: 754 GYYWTQSL-----QL-LIYEFVSGGS---LHKHLHEGSGGNFLSWNERFNVIQGTAKSLA 804
           G +  ++      QL L+ E   GGS   L K L +   G  L       +++ T + LA
Sbjct: 70  GAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK--GKRLKEEWIAYILRETLRGLA 127

Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAP 861
           +LH++ +IH +IK  N+L+  + E K+ D+G++     LD  +   +  + +G   +MAP
Sbjct: 128 YLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA---QLDSTL--GRRNTFIGTPYWMAP 182

Query: 862 E-FAC---RTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
           E  AC          + DV+  G+  +E+  GK PL 
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 92.8 bits (230), Expect = 2e-20
 Identities = 68/214 (31%), Positives = 105/214 (49%), Gaps = 26/214 (12%)

Query: 697 ELGRGGFGAVY--RTVLRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTL 752
           E+G G FGAVY  R V R+   VAIKK++ S    ++  +D  +EV+ L K+RHPN +  
Sbjct: 22  EIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 753 EGYYWTQSLQLLIYEFVSGGS-----LHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH 807
            G Y  +    L+ E+  G +     +HK          L   E   V  G  + LA+LH
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKKP--------LQEVEIAAVTHGALQGLAYLH 132

Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE--FAC 865
             N+IH ++K+ N+L+   G  K+GD+G A ++   + +V +        +MAPE   A 
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPY------WMAPEVILAM 186

Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM 899
              +   K DV+  G+  +E+   K PL     M
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 28/211 (13%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIK--KLTVSSLVKSQEDFE---REVKKLGKVRHPNLV 750
            +G G +G VY+   +  G  VAIK  KL         +DFE   +E+  L + RHPN+V
Sbjct: 10  RIGSGTYGDVYKARDIATGELVAIKVIKLE------PGDDFEIIQQEISMLKECRHPNIV 63

Query: 751 TLEGYYWTQSLQLL--IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
              G Y       L  + E+  GGSL        G   LS  +   V + T K LA+LH+
Sbjct: 64  AYFGSY--LRRDKLWIVMEYCGGGSLQDIYQVTRGP--LSELQIAYVCRETLKGLAYLHE 119

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFAC 865
           +  IH +IK +N+L+   G+ K+ D+G++  L         +K +S +G   +MAPE A 
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA-----TIAKRKSFIGTPYWMAPEVAA 174

Query: 866 --RTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
             R      KCD++  G+  +E+   + P+ 
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMF 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 91.1 bits (226), Expect = 3e-20
 Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 19/203 (9%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           ELG G FG V     R    VAIK +   S+  S+++F  E K + K+ H  LV L G  
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             Q    ++ E++S G L  +L E   G     ++   + +   + +A+L     IH ++
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYLRE--HGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDL 126

Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG------YMAPEFACRTVKI 870
            + N L+D  G  KV D+GL+       RYVL  +  S++G      +  PE    + K 
Sbjct: 127 AARNCLVDDQGCVKVSDFGLS-------RYVLDDEYTSSVGSKFPVRWSPPEVLLYS-KF 178

Query: 871 TDKCDVYGFGVLVLEVVT-GKRP 892
           + K DV+ FGVL+ EV + GK P
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMP 201

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 23/213 (10%)

Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           ELG G  G V + + R  G+ +A+K + +      Q+   RE+  L K   P +V   G 
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAKSLAHLH-QSNII 812
           ++      +  E++ GGSL K L E  G       ER    +     K L +LH +  II
Sbjct: 68  FYNNGDISICMEYMDGGSLDKILKEVQGR----IPERILGKIAVAVLKGLTYLHEKHKII 123

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTV- 868
           H ++K SN+L++  G+ K+ D+G++  L       ++S  ++ +G   YMAPE   R   
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQL-------VNSLAKTFVGTSSYMAPE---RIQG 173

Query: 869 -KITDKCDVYGFGVLVLEVVTGKRPLSTWKMMW 900
              + K D++  G+ ++E+ TG+ P        
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPYPPENDPP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 90.9 bits (226), Expect = 4e-20
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 7/209 (3%)

Query: 696 CELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
             +G G    VY  + L +   VAIK++ +     S ++  +EV+ + +  HPN+V    
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +       L+  ++SGGSL   +        L       V++   K L +LH +  IH 
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHR 126

Query: 815 NIKSSNVLIDGSGEPKVGDYGL-ARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKI 870
           +IK+ N+L+   G  K+ D+G+ A L    DR     K  + +G   +MAPE   +    
Sbjct: 127 DIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRK--TFVGTPCWMAPEVMEQVHGY 184

Query: 871 TDKCDVYGFGVLVLEVVTGKRPLSTWKMM 899
             K D++ FG+  +E+ TG  P S +  M
Sbjct: 185 DFKADIWSFGITAIELATGAAPYSKYPPM 213

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 91.8 bits (228), Expect = 4e-20
 Identities = 67/212 (31%), Positives = 99/212 (46%), Gaps = 34/212 (16%)

Query: 697 ELGRGGFGAVY-RTVLRDGRPVAIKKLTVSSLVKSQE---DFEREVKKLGKVRHPNLVTL 752
           E+G G FGAVY    +R    VAIKK++ S   +S E   D  +EV+ L ++RHPN +  
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 753 EGYYWTQSLQLLIYEFVSGGS------LHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHL 806
           +G Y  +    L+ E+  G +        K L E          E   +  G  + LA+L
Sbjct: 81  KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQE---------VEIAAICHGALQGLAYL 131

Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE- 862
           H    IH +IK+ N+L+   G  K+ D+G A L+         S   S +G   +MAPE 
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASLV---------SPANSFVGTPYWMAPEV 182

Query: 863 -FACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
             A    +   K DV+  G+  +E+   K PL
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 90.7 bits (225), Expect = 5e-20
 Identities = 66/212 (31%), Positives = 102/212 (48%), Gaps = 18/212 (8%)

Query: 698 LGRGGFGAVYR----TVLRDGR---PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           LG G FG VY      +L  G     VA+K L   +  + +++F +E   +    HPN+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLH----EGSGGNFLSWNERFNVIQGTAKSLAHL 806
            L G       Q +I E + GG L  +L     E  G   L+  E  ++    AK   +L
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 807 HQSNIIHYNIKSSNVLIDGSGEP-----KVGDYGLARLLPMLDRYVLSSKIQSALGYMAP 861
            Q + IH ++ + N L+   G       K+GD+GLAR +   D Y    +    + +MAP
Sbjct: 123 EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAP 182

Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           E +    K T + DV+ FGVL+ E++T G++P
Sbjct: 183 E-SLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 89.9 bits (223), Expect = 1e-19
 Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 31/218 (14%)

Query: 698 LGRGGFGAVYRTVLR-DGR---PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +G G FG V R  L+  G+    VAIK L      K + DF  E   +G+  HPN++ LE
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLAHLH 807
           G        ++I EF+  G+L   L +  G        +F VIQ      G A  + +L 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLS 123

Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG------YMAP 861
           + N +H ++ + N+L++ +   KV D+GL+R    L+         S+LG      + AP
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRF---LEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKM 898
           E A    K T   DV+ +G+++ EV++ G+RP   W M
Sbjct: 181 E-AIAYRKFTSASDVWSYGIVMWEVMSYGERPY--WDM 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 89.3 bits (221), Expect = 1e-19
 Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 6/200 (3%)

Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           L  D +LG+G FG V+         VAIK L   ++    E F +E + + K+RH  LV 
Sbjct: 8   LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVP 65

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L      + +  ++ EF+  GSL   L EG G  +L   +  ++    A  +A++ + N 
Sbjct: 66  LYAVVSEEPI-YIVTEFMGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERMNY 123

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           IH +++++N+L+  +   K+ D+GLARL+   + Y      +  + + APE A    + T
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG-RFT 181

Query: 872 DKCDVYGFGVLVLEVVTGKR 891
            K DV+ FG+L+ E+VT  R
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 21/207 (10%)

Query: 696 CELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFE-------REVKKLGKVRHP 747
             +G G +G V +   +  G  VAIKK       K  ED E       REVK L ++RH 
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKF------KESEDDEDVKKTALREVKVLRQLRHE 60

Query: 748 NLVTL-EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHL 806
           N+V L E +     L  L++E+V   +L + L    GG  L  +   + I    +++A+ 
Sbjct: 61  NIVNLKEAFRRKGRL-YLVFEYV-ERTLLELLEASPGG--LPPDAVRSYIWQLLQAIAYC 116

Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           H  NIIH +IK  N+L+  SG  K+ D+G AR L       L+  + +   Y APE    
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVG 175

Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPL 893
                   DV+  G ++ E++ G  PL
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDG-EPL 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 87.5 bits (217), Expect = 4e-19
 Identities = 51/199 (25%), Positives = 105/199 (52%), Gaps = 12/199 (6%)

Query: 698 LGRGGFG--AVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG   +YR    D   V  K++ ++ L + +  D   E+  L  ++HPN++    
Sbjct: 8   LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAKSLAHLHQSNII 812
           ++   +  L+  E+ +GG+L+  +    G  F    E      +     +++++H++ I+
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLF---EEEMVLWYLFQIVSAVSYIHKAGIL 123

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           H +IK+ N+ +  +G  K+GD+G++++  +   Y ++  +     YM+PE  C+ VK   
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPEL-CQGVKYNF 180

Query: 873 KCDVYGFGVLVLEVVTGKR 891
           K D++  G ++ E++T KR
Sbjct: 181 KSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 87.9 bits (219), Expect = 6e-19
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 38/213 (17%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK---------LTVSSLVKSQEDFEREVKKLGKVRHP 747
           LG G +G VY+    + G  VA+KK         +  ++L        RE+  L +++HP
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL--------REISLLKELKHP 58

Query: 748 NLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNE----RFNVIQGTAKSL 803
           N+V L     T+    L++E+     L K+L +  G   LS N      + +++G    L
Sbjct: 59  NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGP--LSPNLIKSIMYQLLRG----L 111

Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPE 862
           A+ H   I+H ++K  N+LI+  G  K+ D+GLAR   + L  Y  + ++ + L Y APE
Sbjct: 112 AYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVT-LWYRAPE 168

Query: 863 --FACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
                +        D++  G +  E++TGK PL
Sbjct: 169 ILLGSKHYSTA--VDIWSVGCIFAEMITGK-PL 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 87.9 bits (218), Expect = 6e-19
 Identities = 69/210 (32%), Positives = 98/210 (46%), Gaps = 19/210 (9%)

Query: 698 LGRGGFGAVY--RTVLR--DGRPVAIK---KLTVSSLVKSQEDFEREVKKLGKVRH-PNL 749
           LG G +G V+  R V     G+  A+K   K T+    K+ E    E + L  VR  P L
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
           VTL   + T +   LI ++V+GG L  HL+     +F     R   I     +L HLHQ 
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLY--QREHFTESEVRV-YIAEIVLALDHLHQL 124

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLL--PMLDR-YVLSSKIQSALGYMAPEFACR 866
            II+ +IK  N+L+D  G   + D+GL++       +R Y     I+    YMAPE    
Sbjct: 125 GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIE----YMAPEVIRG 180

Query: 867 TVKITDKC-DVYGFGVLVLEVVTGKRPLST 895
                DK  D +  GVL  E++TG  P + 
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTGASPFTV 210

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 87.0 bits (215), Expect = 8e-19
 Identities = 60/200 (30%), Positives = 105/200 (52%), Gaps = 6/200 (3%)

Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           L  + +LG+G FG V+         VAIK L   ++  S E F +E + + K+RH  LV 
Sbjct: 8   LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQ 65

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L      + +  ++ E++S GSL   L +G  G +L   +  ++    A  +A++ + N 
Sbjct: 66  LYAVVSEEPI-YIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 123

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H +++++N+L+  +   KV D+GLARL+   + Y      +  + + APE A    + T
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG-RFT 181

Query: 872 DKCDVYGFGVLVLEVVTGKR 891
            K DV+ FG+L+ E+ T  R
Sbjct: 182 IKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 88.2 bits (218), Expect = 8e-19
 Identities = 70/236 (29%), Positives = 109/236 (46%), Gaps = 33/236 (13%)

Query: 681 DPD-----FSTGTHALLNKDCELGRGGFGAVYRTVLRDGRP---VAIKKLTVSSLVKSQ- 731
           DP+     F      L     E+G G FGAVY    RD R    VAIKK++ S    ++ 
Sbjct: 11  DPEIAELFFKEDPEKLFTDLREIGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQSNEK 68

Query: 732 -EDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGS-----LHKHLHEGSGGN 785
            +D  +EVK L +++HPN +  +G Y  +    L+ E+  G +     +HK         
Sbjct: 69  WQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKP------- 121

Query: 786 FLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR 845
            L   E   +  G  + LA+LH  N+IH +IK+ N+L+   G+ K+ D+G A +    + 
Sbjct: 122 -LQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS 180

Query: 846 YVLSSKIQSALGYMAPE--FACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM 899
           +V +        +MAPE   A    +   K DV+  G+  +E+   K PL     M
Sbjct: 181 FVGTPY------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 230

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 6/195 (3%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +LG G FG V+         VA+K L   ++  S E F  E + + K+RH  LV L    
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVV 70

Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             + +  ++ E++S GSL   L +G G   L      ++    A  +A++ + N IH ++
Sbjct: 71  SEEPI-YIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIERMNYIHRDL 128

Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           +S+N+L+      K+ D+GLARL+   + Y      +  + + APE A    + T K DV
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDV 186

Query: 877 YGFGVLVLEVVTGKR 891
           + FG+L+ E+VT  R
Sbjct: 187 WSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 86.4 bits (214), Expect = 1e-18
 Identities = 65/213 (30%), Positives = 111/213 (52%), Gaps = 27/213 (12%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQED--------FEREVKKLGKVRHPN 748
           +G G FG+VY  +    G  +A+K++ + S+  S +D          RE+  L +++H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAKSLAHL 806
           +V   G         +  E+V GGS+   L+     N+ ++ E    N ++   K L +L
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLN-----NYGAFEETLVRNFVRQILKGLNYL 122

Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK-------IQSALGYM 859
           H   IIH +IK +N+L+D  G  K+ D+G+++    L+   LS+K       +Q ++ +M
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISK---KLEANSLSTKTNGARPSLQGSVFWM 179

Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
           APE   +T   T K D++  G LV+E++TGK P
Sbjct: 180 APEVVKQTSY-TRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 86.1 bits (213), Expect = 2e-18
 Identities = 63/197 (31%), Positives = 101/197 (51%), Gaps = 7/197 (3%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +LG G FG V+         VAIK L   S+  S E F  E   + +++HP LV L    
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
            TQ    +I E++  GSL   L    G   L+ N+  ++    A+ +A + + N IH ++
Sbjct: 71  -TQEPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIERKNYIHRDL 128

Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           +++N+L+  +   K+ D+GLARL+   + Y      +  + + APE A      T K DV
Sbjct: 129 RAANILVSETLCCKIADFGLARLIED-NEYTAREGAKFPIKWTAPE-AINYGTFTIKSDV 186

Query: 877 YGFGVLVLEVVT-GKRP 892
           + FG+L+ E+VT G+ P
Sbjct: 187 WSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 19/211 (9%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEG 754
           +G+G F  VY+ + L DGR VA+KK+ +  ++  K+++D  +E+  L ++ HPN++    
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHL-HEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
            +   +   ++ E    G L + + H       +     +        +L H+H   I+H
Sbjct: 70  SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMH 129

Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI---QSALG---YMAPEFACRT 867
            +IK +NV I  +G  K+GD GL R          SSK     S +G   YM+PE     
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRF--------FSSKTTAAHSLVGTPYYMSPE-RIHE 180

Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPLSTWKM 898
                K D++  G L+ E+   + P    KM
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 86.1 bits (213), Expect = 2e-18
 Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 18/213 (8%)

Query: 697 ELGRGGFGAVYR----TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           E+G G FG V        +   R V +K+L  S+    Q  F +EV+   ++ HPN++  
Sbjct: 2   EIGNGWFGKVLLGEAHRGMSKAR-VVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTA----KSLAHLHQ 808
            G        LL+ EF   G L  +L    G   ++   + +V+Q  A      L  LHQ
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRG--MVAQMAQKDVLQRMACEVASGLLWLHQ 118

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA---- 864
           ++ IH ++   N  +      K+GDYGLA      D Y+        L ++APE      
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178

Query: 865 --CRTVKITDKCDVYGFGVLVLEVVT-GKRPLS 894
                   T K +++  GV + E+ T   +P  
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP 211

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 85.7 bits (212), Expect = 2e-18
 Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 27/215 (12%)

Query: 698 LGRGGFGAVY--RTVLRDGR--PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +G G FG V   R  L   R  PVAIK L      K + DF  E   +G+  HPN++ LE
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLAHLH 807
           G        +++ E++  GSL   L +  G        +F VIQ      G A  + +L 
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLRKHDG--------QFTVIQLVGMLRGIASGMKYLS 123

Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAPEFA 864
               +H ++ + N+L++ +   KV D+GL+R+L   P         KI   + + APE A
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTAPE-A 180

Query: 865 CRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKM 898
               K T   DV+ +G+++ EV++ G+RP   W+M
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPY--WEM 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 3e-18
 Identities = 52/206 (25%), Positives = 83/206 (40%), Gaps = 24/206 (11%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFE----REVKKLGKVRHPNLVTL 752
           +G G +G VY+      G  VAIKK+    L    E       RE+K L ++ HPN++ L
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKI---KLRFESEGIPKTALREIKLLKELNHPNIIKL 63

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF-NVIQGTAKSLAHLHQSNI 811
              +  +    L++EF+                         + +    + LA  H   I
Sbjct: 64  LDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLL----PMLDRYVLSSKIQSALGYMAPEFACRT 867
           +H ++K  N+LI+  G  K+ D+GLAR           YV          Y APE     
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV------VTRWYRAPELLLGD 173

Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
              +   D++  G +  E+++  RPL
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSR-RPL 198

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 4e-18
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 26/208 (12%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
            +G+G FG VY+ +  R  + VAIK + +       ED ++E++ L + R P +    G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN------VIQGTAKSLAHLHQS 809
           +   S   +I E+  GGS    L  G          + +      +++     L +LH+ 
Sbjct: 68  FLKGSKLWIIMEYCGGGSCLDLLKPG----------KLDETYIAFILREVLLGLEYLHEE 117

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACR 866
             IH +IK++N+L+   G+ K+ D+G++  L         SK  + +G   +MAPE   +
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTS-----TMSKRNTFVGTPFWMAPEVIKQ 172

Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPLS 894
           +    +K D++  G+  +E+  G+ PLS
Sbjct: 173 S-GYDEKADIWSLGITAIELAKGEPPLS 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 84.9 bits (210), Expect = 4e-18
 Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 28/215 (13%)

Query: 697 ELGRGGFG-AVYRTVLRDGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEG 754
           ++G G FG A+      DG+   IK++ +S +  K +E+  +EV  L  ++HPN+V  + 
Sbjct: 7   KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNF-----LSWNERFNVIQGTAKSLAHLHQS 809
            +       ++ ++  GG L+K ++   G  F     L W      +Q    +L H+H  
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW-----FVQ-ICLALKHVHDR 120

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA---LG---YMAPEF 863
            I+H +IKS N+ +   G  K+GD+G+AR        VL+S ++ A   +G   Y++PE 
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIAR--------VLNSTVELARTCIGTPYYLSPEI 172

Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM 898
            C      +K D++  G ++ E+ T K       M
Sbjct: 173 -CENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 84.8 bits (210), Expect = 6e-18
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 12/202 (5%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL-EGY 755
           ELG G FG VY+   ++    A  K+      +  EDF  E+  L + +HPN+V L E Y
Sbjct: 12  ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           ++   L +LI EF  GG+L   + E   G  L+  +   V +   ++L  LH   +IH +
Sbjct: 72  FYENKLWILI-EFCDGGALDSIMLELERG--LTEPQIRYVCRQMLEALNFLHSHKVIHRD 128

Query: 816 IKSSNVLIDGSGEPKVGDYGL-ARLLPMLDRYVLSSKIQSALGYMAPE-FACRTVKITD- 872
           +K+ N+L+   G+ K+ D+G+ A+    L +    + I +   +MAPE  AC T K    
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTPY-WMAPEVVACETFKDNPY 185

Query: 873 --KCDVYGFGVLVLEVVTGKRP 892
             K D++  G+ ++E+   + P
Sbjct: 186 DYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 85.3 bits (212), Expect = 6e-18
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 29/199 (14%)

Query: 694 KDCELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQE--DFE--REVKKLGKVRHPN 748
           K  +LG G +  VY+      GR VAIKK+ +    ++++  +F   RE+K L +++HPN
Sbjct: 4   KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPN 63

Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSG----GNFLSWNERFNVIQGTAKSLA 804
           ++ L   +  +S   L++EF+    L K + + S      +  S+      +  T + L 
Sbjct: 64  IIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSY------MLMTLRGLE 116

Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE-- 862
           +LH + I+H ++K +N+LI   G  K+ D+GLAR     +R  ++ ++     Y APE  
Sbjct: 117 YLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-KMTHQV-VTRWYRAPELL 174

Query: 863 FACRTVKITDKCDVYGFGV 881
           F  R          YG GV
Sbjct: 175 FGARH---------YGVGV 184

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 55/209 (26%), Positives = 105/209 (50%), Gaps = 14/209 (6%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQED---------FEREVKKLGKVRHP 747
           +G+G +G VY  + +  G  +A+K++ + + +  + D            E++ L  + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 748 NLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH 807
           N+V   G+  T+    +  E+V GGS+   L   + G F     RF   +   + LA+LH
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--TYGRFEEQLVRF-FTEQVLEGLAYLH 125

Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
              I+H ++K+ N+L+D  G  K+ D+G+++    +     +  +Q ++ +MAPE     
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185

Query: 868 VK-ITDKCDVYGFGVLVLEVVTGKRPLST 895
            +  + K D++  G +VLE+  G+RP S 
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 14/202 (6%)

Query: 698 LGRGGFGAVYRTVLRDGR------PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           LG G FG VY  + R          VA+K L  S   + + DF  E   + K  H N+V 
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEG----SGGNFLSWNERFNVIQGTAKSLAHLH 807
           L G  + +  + ++ E ++GG L   L E        + L+  +     +  AK   +L 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 808 QSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
           +++ IH +I + N L+   G     K+ D+G+AR +     Y    +    + +M PE  
Sbjct: 134 ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAF 193

Query: 865 CRTVKITDKCDVYGFGVLVLEV 886
              +  T K DV+ FGVL+ E+
Sbjct: 194 LDGI-FTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 18/208 (8%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQED----FEREVKKLGKVRHPNLVTL 752
           LG+GGFG V    ++  G+  A KKL    L K + +     E+++  L KV    +V+L
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKI--LEKVSSRFIVSL 58

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
              + T+    L+   ++GG L  H++      F      F   Q     L HLHQ  I+
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLHQRRIV 117

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL---GYMAPEFACRTVK 869
           + ++K  NVL+D  G  ++ D GLA  L          KI+      GYMAPE     V 
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKG------GKKIKGRAGTPGYMAPEVLQGEV- 170

Query: 870 ITDKCDVYGFGVLVLEVVTGKRPLSTWK 897
                D +  G  + E++ G+ P    K
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPFRQRK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 17/204 (8%)

Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +G G FG +Y    + D     IK++ ++ + VK +E  ++EV  L K++HPN+VT    
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNF-----LSWNERFNVIQGTAKSLAHLHQSN 810
           +       ++ E+  GG L K ++   G  F     LSW      +Q  +  L H+H   
Sbjct: 68  FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW-----FVQ-ISLGLKHIHDRK 121

Query: 811 IIHYNIKSSNVLIDGSGE-PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           I+H +IKS N+ +  +G   K+GD+G+AR L   D   L+        Y++PE  C+   
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN--DSMELAYTCVGTPYYLSPEI-CQNRP 178

Query: 870 ITDKCDVYGFGVLVLEVVTGKRPL 893
             +K D++  G ++ E+ T K P 
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPF 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 82.7 bits (204), Expect = 2e-17
 Identities = 61/207 (29%), Positives = 108/207 (52%), Gaps = 13/207 (6%)

Query: 698 LGRGGFGAVYRTVLR---DGRPVAIKKLTV-SSLVKSQEDFEREVKKLGKVRHPNLVTL- 752
           +G+G +G V  +++R   DG+   IKKL + ++  + ++  E+E + L +++HPN+V   
Sbjct: 8   VGKGSYGEV--SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           E +     L  ++  F  GG L+  L E   G  L  N+        A +L +LH+ +I+
Sbjct: 66  ESWEGEDGLLYIVMGFCEGGDLYHKLKE-QKGKLLPENQVVEWFVQIAMALQYLHEKHIL 124

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE-FACRTVKIT 871
           H ++K+ NV +  +   KVGD G+AR+L   ++  ++S +     YM+PE F+ +     
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLE--NQCDMASTLIGTPYYMSPELFSNKPYNY- 181

Query: 872 DKCDVYGFGVLVLEVVTGKRPLSTWKM 898
            K DV+  G  V E+ T K   +   M
Sbjct: 182 -KSDVWALGCCVYEMATLKHAFNAKDM 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 30/207 (14%)

Query: 699 GRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLEGY 755
           G+G FG V     RD + + A+K +     V+     +   E + L ++ HP LV L  +
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL--W 66

Query: 756 YWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAK--------SLAH 805
           Y  Q  +   L+ + + GG L  HL         S   +F+  +   K        +L +
Sbjct: 67  YSFQDEENMYLVVDLLLGGDLRYHL---------SQKVKFS--EEQVKFWICEIVLALEY 115

Query: 806 LHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFAC 865
           LH   IIH +IK  N+L+D  G   + D+ +A  +       L++      GYMAPE  C
Sbjct: 116 LHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT---PDTLTTSTSGTPGYMAPEVLC 172

Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRP 892
           R    +   D +  GV   E + GKRP
Sbjct: 173 RQ-GYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 83.5 bits (206), Expect = 3e-17
 Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 30/216 (13%)

Query: 697 ELGRGGFGAVY-RTVLRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLE 753
           E+G G FGAVY  T       VA+KK++ S    ++  +D  +EVK L +++HPN +  +
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 754 GYYWTQSLQLLIYEFVSGGS-----LHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           G Y  +    L+ E+  G +     +HK          L   E   +  G  + LA+LH 
Sbjct: 88  GCYLKEHTAWLVMEYCLGSASDLLEVHKKP--------LQEVEIAAITHGALQGLAYLHS 139

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE--F 863
            N+IH +IK+ N+L+   G+ K+ D+G A           SS   S +G   +MAPE   
Sbjct: 140 HNMIHRDIKAGNILLTEPGQVKLADFGSAS---------KSSPANSFVGTPYWMAPEVIL 190

Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM 899
           A    +   K DV+  G+  +E+   K PL     M
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 226

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 54/194 (27%), Positives = 89/194 (45%), Gaps = 20/194 (10%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           +G+G FG V     R G+ VA+K L   S       F  E   +  +RHPNLV L G   
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA--FLAEASVMTTLRHPNLVQLLGVVL 70

Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIK 817
             +   ++ E+++ GSL  +L    G   ++  ++        + + +L + N +H ++ 
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLRS-RGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA 129

Query: 818 SSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG-----YMAPEFACRTVKITD 872
           + NVL+      KV D+GLA+           +      G     + APE A R  K + 
Sbjct: 130 ARNVLVSEDLVAKVSDFGLAK----------EASQGQDSGKLPVKWTAPE-ALREKKFST 178

Query: 873 KCDVYGFGVLVLEV 886
           K DV+ FG+L+ E+
Sbjct: 179 KSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 29/217 (13%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLE 753
           ++GRG F  VYR T L DG PVA+KK+ +  L+  K++ D  +E+  L ++ HPN++   
Sbjct: 9   KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHL-HEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
             +   +   ++ E    G L + + H       +     +        +L H+H   ++
Sbjct: 69  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVM 128

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG------YMAPEFACR 866
           H +IK +NV I  +G  K+GD GL R          SSK  +A        YM+PE    
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRF--------FSSKTTAAHSLVGTPYYMSPE---- 176

Query: 867 TVKITD-----KCDVYGFGVLVLEVVTGKRPLSTWKM 898
             +I +     K D++  G L+ E+   + P    KM
Sbjct: 177 --RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 82.3 bits (204), Expect = 4e-17
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 38/215 (17%)

Query: 698 LGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEG 754
           LG GGFG V    V    R  A+K +    +V    QE    E + L +  HP +V L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +  +    ++ E+  GG L   L +   G F  +  RF +      +  +LH   II+ 
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDR--GLFDEYTARFYIACVV-LAFEYLHNRGIIYR 117

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA---------LGYMAPEFAC 865
           ++K  N+L+D +G  K+ D+G A+            K++S            Y+APE   
Sbjct: 118 DLKPENLLLDSNGYVKLVDFGFAK------------KLKSGQKTWTFCGTPEYVAPEI-- 163

Query: 866 RTVKITDK-----CDVYGFGVLVLEVVTGKRPLST 895
               I +K      D +  G+L+ E++TG+ P   
Sbjct: 164 ----ILNKGYDFSVDYWSLGILLYELLTGRPPFGE 194

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 81.9 bits (202), Expect = 4e-17
 Identities = 60/208 (28%), Positives = 108/208 (51%), Gaps = 15/208 (7%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKK--LTVSSLVKSQEDFER---EVKKLGKVRHPNLVTL 752
           LG+G +G VY  +   G+ +A+K+  L  S+++ +++++E+   EV  L  ++H N+V  
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHE-GSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
            G     +   +  EFV GGS+   L+  G     +       ++ G    +A+LH + +
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDG----VAYLHNNCV 123

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI-QSALG---YMAPEFACRT 867
           +H +IK +NV++  +G  K+ D+G AR L  +  +   S + +S  G   +MAPE     
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE-VINE 182

Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPLST 895
                K D++  G  V E+ TGK PL++
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKPPLAS 210

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 82.1 bits (203), Expect = 5e-17
 Identities = 65/270 (24%), Positives = 115/270 (42%), Gaps = 40/270 (14%)

Query: 697 ELGRGGFGAVYRTVLRDGRP------VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG G FG V+        P      VA+K L  ++   +++DFERE + L   +H N+V
Sbjct: 12  ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHL-----------HEGSGGNFLSWNERFNVIQGT 799
              G        ++++E++  G L+K L              S    L+ ++   +    
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYM 859
           A  + +L   + +H ++ + N L+      K+GD+G++R +   D Y +       + +M
Sbjct: 132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWM 191

Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWLE--EHWKKAEW 916
            PE +    K T + DV+ FGV++ E+ T GK+P        W+ ++  E  E   +   
Sbjct: 192 PPE-SIMYRKFTTESDVWSFGVVLWEIFTYGKQP--------WYGLSNEEVIECITQGRL 242

Query: 917 --------RNVS--MRSC-KGSSRQRRRFQ 935
                     V   M  C K   +QR   +
Sbjct: 243 LQRPRTCPSEVYDIMLGCWKRDPQQRINIK 272

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 81.8 bits (203), Expect = 6e-17
 Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 44/222 (19%)

Query: 694 KDCELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFE----REVKKLGKVRHPN 748
           K  ++G G +G VY+    + G  VA+KK+    +   +E F     RE+K L K+RHPN
Sbjct: 3   KIAQIGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRHPN 59

Query: 749 LVTLE---------GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGT 799
           +V L+           Y       +++E++         H+ +G   L  +      +  
Sbjct: 60  IVRLKEIVTSKGKGSIY-------MVFEYMD--------HDLTG---LLDSPEVKFTESQ 101

Query: 800 AKS--------LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK 851
            K         L +LH + I+H +IK SN+LI+  G  K+ D+GLAR     +    +++
Sbjct: 102 IKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNR 161

Query: 852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           + + L Y  PE      +   + D++  G ++ E+  GK   
Sbjct: 162 VIT-LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 81.6 bits (202), Expect = 7e-17
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 42/219 (19%)

Query: 694 KDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFE------REVKKLGKVRH 746
           K  ++G G +G V++   R+ G+ VAIKK      V+S++D        RE++ L +++H
Sbjct: 5   KLSKIGEGSYGVVFKCRNRETGQIVAIKKF-----VESEDDPVIKKIALREIRMLKQLKH 59

Query: 747 PNLVTL-EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNER-------FNVIQG 798
           PNLV L E +   + L L ++E+      H  L+E      L  N R         +I  
Sbjct: 60  PNLVNLIEVFRRKRKLHL-VFEYCD----HTVLNE------LEKNPRGVPEHLIKKIIWQ 108

Query: 799 TAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL----PMLDRYVLSSKIQS 854
           T +++   H+ N IH ++K  N+LI   G+ K+ D+G AR+L         YV +     
Sbjct: 109 TLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR---- 164

Query: 855 ALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
              Y APE      +     DV+  G +  E++TG+ PL
Sbjct: 165 --WYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ-PL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 81.4 bits (202), Expect = 9e-17
 Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 26/209 (12%)

Query: 696 CELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFE-----REVKKLGKV-RHPN 748
            +LG G FG+VY    ++ G  VAIKK+      K    +E     REVK L K+  HPN
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMK-----KKFYSWEECMNLREVKSLRKLNEHPN 59

Query: 749 LVTL-EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH 807
           +V L E +     L   ++E++ G +L+  L +   G   S +   ++I    + LAH+H
Sbjct: 60  IVKLKEVFRENDELYF-VFEYMEG-NLY-QLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAPEFA 864
           +    H ++K  N+L+ G    K+ D+GLAR +   P    YV      S   Y APE  
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV------STRWYRAPEIL 170

Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
            R+   +   D++  G ++ E+ T  RPL
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTL-RPL 198

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 12/200 (6%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +LG G FG V+     +   VA+K L   ++  S + F  E   +  ++H  LV L    
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             +    +I E+++ GSL   L    GG  L   +  +     A+ +A++ + N IH ++
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNYIHRDL 129

Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE---FACRTVKITDK 873
           +++NVL+  S   K+ D+GLAR++   + Y      +  + + APE   F   T+    K
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAINFGSFTI----K 184

Query: 874 CDVYGFGVLVLEVVT-GKRP 892
            DV+ FG+L+ E+VT GK P
Sbjct: 185 SDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 58/219 (26%), Positives = 104/219 (47%), Gaps = 32/219 (14%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTV----SSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG+G FG VY     D GR +A+K++          K     E E++ L  ++H  +V  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ- 68

Query: 753 EGYYWTQSLQLLIY---EFVSGGSLHKHLHE-GSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
             YY        +    E++ GGS+   L   G+    ++      +++G    + +LH 
Sbjct: 69  --YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEG----VEYLHS 122

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFAC 865
           + I+H +IK +N+L D +G  K+GD+G ++ L  +      + ++S  G   +M+PE   
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI--CSSGTGMKSVTGTPYWMSPEV-- 178

Query: 866 RTVKITD-----KCDVYGFGVLVLEVVTGKRPLSTWKMM 899
               I+      K DV+  G  V+E++T K P + ++ M
Sbjct: 179 ----ISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM 213

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 80.8 bits (199), Expect = 2e-16
 Identities = 62/205 (30%), Positives = 106/205 (51%), Gaps = 18/205 (8%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG-Y 755
           ELG G FG VY+   ++   +A  K+  +   +  ED+  E++ L    HP +V L G +
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           YW   L ++I EF  GG++   + E   G  L+  +   + +   ++L +LH   IIH +
Sbjct: 79  YWDGKLWIMI-EFCPGGAVDAIMLELDRG--LTEPQIQVICRQMLEALQYLHSMKIIHRD 135

Query: 816 IKSSNVLIDGSGEPKVGDYGL-ARLLPMLDRYVLSSKIQSALG---YMAPEFA-CRTVKI 870
           +K+ NVL+   G+ K+ D+G+ A+ +  L R        S +G   +MAPE   C T+K 
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR------DSFIGTPYWMAPEVVMCETMKD 189

Query: 871 TD---KCDVYGFGVLVLEVVTGKRP 892
           T    K D++  G+ ++E+   + P
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPP 214

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 80.5 bits (198), Expect = 2e-16
 Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 31/218 (14%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVT-L 752
           ++GRG F  VYR T L D +PVA+KK+ +  ++  K+++D  +E+  L ++ HPN++  L
Sbjct: 9   KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHL-HEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           + +     L +++ E    G L + + +       +     +        ++ H+H   +
Sbjct: 69  DSFIEDNELNIVL-ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV 127

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG------YMAPEFAC 865
           +H +IK +NV I  +G  K+GD GL R          SSK  +A        YM+PE   
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRF--------FSSKTTAAHSLVGTPYYMSPE--- 176

Query: 866 RTVKITD-----KCDVYGFGVLVLEVVTGKRPLSTWKM 898
              +I +     K D++  G L+ E+   + P    KM
Sbjct: 177 ---RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 50/164 (30%), Positives = 79/164 (48%), Gaps = 39/164 (23%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFE----REVKKLGKVRHPNLVTL 752
           LG G FG VY+   ++ GR VA+KK+ + +    ++ F     RE+K L K++HPN+V L
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHN---EKDGFPITALREIKILKKLKHPNVVPL 72

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHL----------HEGSGGNFLSWNERFNVIQGTAK- 801
                      +  E     S  K            H+ SG   L  N    + +   K 
Sbjct: 73  ID---------MAVER-PDKSKRKRGSVYMVTPYMDHDLSG---LLENPSVKLTESQIKC 119

Query: 802 -------SLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR 838
                   + +LH+++I+H +IK++N+LID  G  K+ D+GLAR
Sbjct: 120 YMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 22/204 (10%)

Query: 698 LGRGGFGAV----YRTVLRD--GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           LG+G FG+V    Y   L+D  G  VA+KKL  S+  +   DFERE++ L  ++H N+V 
Sbjct: 12  LGKGNFGSVELCRYDP-LQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVK 69

Query: 752 LEGY-YWTQSLQL-LIYEFVSGGSL----HKHLHEGSGGNFLSWNERFNVIQGTAKSLAH 805
            +G  Y      L L+ E++  GSL     KH         L +  +        K + +
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI------CKGMEY 123

Query: 806 LHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPEFA 864
           L     +H ++ + N+L++     K+GD+GL ++LP   + Y +    +S + + APE +
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE-S 182

Query: 865 CRTVKITDKCDVYGFGVLVLEVVT 888
               K +   DV+ FGV++ E+ T
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 8/205 (3%)

Query: 691 LLNKDCELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNL 749
           L  K  ++G+G FG V++ +  R  + VAIK + +       ED ++E+  L +   P +
Sbjct: 5   LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
               G Y   +   +I E++ GGS    L  G     L   +   +++   K L +LH  
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSE 120

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
             IH +IK++NVL+   GE K+ D+G+A  L   D  +  +       +MAPE   +   
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPE-VIKQSA 177

Query: 870 ITDKCDVYGFGVLVLEVVTGKRPLS 894
              K D++  G+  +E+  G+ P S
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHS 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 51/198 (25%), Positives = 103/198 (52%), Gaps = 8/198 (4%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGY 755
           LG+G +G+VY+   L D +  A+K++ + S+ + + ED   E++ L  V HPN+++ +  
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSG-GNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           +   +   ++ E+   G L K + +       +   E + +     + L  LH+  I+H 
Sbjct: 68  FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHR 127

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++KS+N+L+  +   K+GD G++++   L + +  ++I +   YMAPE        + K 
Sbjct: 128 DLKSANILLVANDLVKIGDLGISKV---LKKNMAKTQIGTPH-YMAPEVWKGR-PYSYKS 182

Query: 875 DVYGFGVLVLEVVTGKRP 892
           D++  G L+ E+ T   P
Sbjct: 183 DIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 79.9 bits (197), Expect = 3e-16
 Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 8/203 (3%)

Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE--REVKKLGKVRHPNLVTLEG 754
           LG+GGFG V    +R  G+  A KKL    + K + +     E + L KV    +V+L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            Y T+    L+   ++GG L  H++      F      F   + T   L  LH+  I++ 
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC-GLEDLHRERIVYR 126

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+L+D  G  ++ D GLA  +P  +   +  ++   +GYMAPE   +  + T   
Sbjct: 127 DLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVV-KNERYTFSP 182

Query: 875 DVYGFGVLVLEVVTGKRPLSTWK 897
           D +G G L+ E++ GK P    K
Sbjct: 183 DWWGLGCLIYEMIEGKSPFRQRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 79.7 bits (196), Expect = 4e-16
 Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 18/205 (8%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT-LEGY 755
           ELG G FG VY+   ++   +A  K+  +   +  ED+  E+  L    HPN+V  L+ +
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           Y+  +L +LI EF +GG++   + E      L+  +   V + T ++L +LH++ IIH +
Sbjct: 72  YYENNLWILI-EFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHENKIIHRD 128

Query: 816 IKSSNVLIDGSGEPKVGDYGLA----RLLPMLDRYVLSSKIQSALGYMAPEFA-CRTVK- 869
           +K+ N+L    G+ K+ D+G++    R +   D ++ +        +MAPE   C T K 
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPY------WMAPEVVMCETSKD 182

Query: 870 --ITDKCDVYGFGVLVLEVVTGKRP 892
                K DV+  G+ ++E+   + P
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 82.6 bits (204), Expect = 4e-16
 Identities = 38/88 (43%), Positives = 52/88 (59%)

Query: 397 LDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSI 456
           L L +    G  P  I  L  LQ +NLS NS+ G IP ++G + +L VLDLS N  NGSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 457 PPEIGGAYSLKELRLERNFLAGKIPTSI 484
           P  +G   SL+ L L  N L+G++P ++
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 79.3 bits (196), Expect = 5e-16
 Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 11/200 (5%)

Query: 698 LGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +G G  G V++      G  VA+KK+ +  L         RE+K L   +HP +V L   
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           +   S  +L+ E++    L + L +      L   +  + ++   K +A++H + I+H +
Sbjct: 68  FPHGSGFVLVMEYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANGIMHRD 124

Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE--FACRTVKITDK 873
           +K +N+LI   G  K+ D+GLARL    +  + S ++ +   Y APE  +  R  K    
Sbjct: 125 LKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVAT-RWYRAPELLYGAR--KYDPG 181

Query: 874 CDVYGFGVLVLEVVTGKRPL 893
            D++  G +  E++ G  PL
Sbjct: 182 VDLWAVGCIFAELLNG-SPL 200

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 79.0 bits (194), Expect = 6e-16
 Identities = 56/213 (26%), Positives = 105/213 (49%), Gaps = 19/213 (8%)

Query: 697 ELGRGGFGAVYRTVLRDGRP------VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG G FG V+     +  P      VA+K L  +S   +++DF RE + L  ++H ++V
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIV 70

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLH----------EGSGGNFLSWNERFNVIQGTA 800
              G        ++++E++  G L+K L           EG+    L+ ++  ++ Q  A
Sbjct: 71  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 801 KSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMA 860
             + +L   + +H ++ + N L+  +   K+GD+G++R +   D Y +       + +M 
Sbjct: 131 AGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 190

Query: 861 PEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           PE +    K T + DV+  GV++ E+ T GK+P
Sbjct: 191 PE-SIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 79.3 bits (195), Expect = 6e-16
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 16/204 (7%)

Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK L  ++  K+  +F  E   +  + HP+LV L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   + ++QL + + +  G L  ++HE     G   L      N     AK + +L + 
Sbjct: 75  LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLL-----LNWCVQIAKGMMYLEER 128

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLARLL   ++   +   +  + +MA E      K
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE-CIHYRK 187

Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV + E++T G +P
Sbjct: 188 FTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 79.0 bits (195), Expect = 7e-16
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 28/208 (13%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFE------REVKKLGKVRHPNLV 750
           +G G +G V +   ++ G+ VAIKK      ++S++D        RE++ L ++RH NLV
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKF-----LESEDDKMVKKIAMREIRMLKQLRHENLV 63

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNER-FNVIQGTAKSLAHLHQS 809
            L   +  +    L++EFV    L       +G +     +  F +++G    +   H  
Sbjct: 64  NLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRG----IEFCHSH 119

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP----MLDRYVLSSKIQSALGYMAPEFAC 865
           NIIH +IK  N+L+  SG  K+ D+G AR L     +   YV +        Y APE   
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR------WYRAPELLV 173

Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRPL 893
              K     D++  G LV E++TG+ PL
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGE-PL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 79.5 bits (196), Expect = 8e-16
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 23/209 (11%)

Query: 698 LGRGGFGAVY---RTVLRD-GRPVAIKKLTVSSLVKSQEDF-----EREVKKLGKVRHPN 748
           LG+GG+G V+   +    D G+  A+K L  +++V++Q+D      ER +  L  V+HP 
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNI--LEAVKHPF 61

Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           +V L   + T     LI E++SGG L  HL     G F+     F + + +  +L HLHQ
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISL-ALEHLHQ 118

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFAC 865
             II+ ++K  N+L+D  G  K+ D+GL +     +     +   +  G   YMAPE   
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGLCK-----ESIHEGTVTHTFCGTIEYMAPEILM 173

Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
           R+       D +  G L+ +++TG  P +
Sbjct: 174 RSGHGKA-VDWWSLGALMYDMLTGAPPFT 201

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 79.2 bits (195), Expect = 9e-16
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 11/202 (5%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDF----EREV-KKLGKVRHPNLVT 751
           +G+G FG VY+   +D  R  A+K L+   +V  +E      ER +  +      P +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L+  + T S   L+ +++SGG L  HL +   G F     +F  I     +L HLH+ +I
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKE--GRFSEDRAKF-YIAELVLALEHLHKYDI 117

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           ++ ++K  N+L+D +G   + D+GL++    L     ++       Y+APE        T
Sbjct: 118 VYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYT 175

Query: 872 DKCDVYGFGVLVLEVVTGKRPL 893
              D +  GVLV E+  G  P 
Sbjct: 176 KHVDFWSLGVLVFEMCCGWSPF 197

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 14/205 (6%)

Query: 697 ELGRGGFGAVYRTVLRD------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG+G FG VY  + +          VAIK +  ++ ++ + +F  E   + +    ++V
Sbjct: 13  ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLH-------EGSGGNFLSWNERFNVIQGTAKSL 803
            L G   T    L++ E ++ G L  +L           G    +  +   +    A  +
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
           A+L     +H ++ + N ++      K+GD+G+ R +   D Y    K    + +MAPE 
Sbjct: 133 AYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE- 191

Query: 864 ACRTVKITDKCDVYGFGVLVLEVVT 888
           + +    T K DV+ FGV++ E+ T
Sbjct: 192 SLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 78.4 bits (194), Expect = 1e-15
 Identities = 65/207 (31%), Positives = 96/207 (46%), Gaps = 30/207 (14%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKS-QED-FEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     +  G+  A+K L+ + +VK  Q +    E + L  +RHP LV L G
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   L+ E+V GG L  HL     G F     RF   Q    +L +LH  +I++ 
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHLR--KSGRFPEPVARFYAAQVVL-ALEYLHSLDIVYR 125

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDR-YVLSSKIQSALG---YMAPEFACRTVKI 870
           ++K  N+L+D  G  K+ D+G A+ +    R Y L        G   Y+APE       I
Sbjct: 126 DLKPENLLLDSDGYIKITDFGFAKRVK--GRTYTLC-------GTPEYLAPE------II 170

Query: 871 TDK-----CDVYGFGVLVLEVVTGKRP 892
             K      D +  G+L+ E++ G  P
Sbjct: 171 LSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 7/204 (3%)

Query: 690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNL 749
             L  + +LG G FG V+         VA+K +   S+  S E F  E   +  ++H  L
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKL 63

Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
           V L     T+    +I EF++ GSL   L +   G+     +  +     A+ +A + Q 
Sbjct: 64  VKLHAVV-TKEPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           N IH +++++N+L+  S   K+ D+GLAR++   + Y      +  + + APE A     
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAPE-AINFGS 179

Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T K DV+ FG+L++E+VT G+ P
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 78.1 bits (192), Expect = 1e-15
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 14/206 (6%)

Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE--REVKKLGKVRHPNLVTLEG 754
           LG+GGFG V    +R  G+  A K+L    + K + +     E + L KV    +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAK---SLAHLHQSNI 811
            Y T+    L+   ++GG L  H++      F    E    +   A+    L  LH+ N 
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGF----EEERALFYAAEILCGLEDLHRENT 123

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           ++ ++K  N+L+D  G  ++ D GLA  +P  +   +  ++   +GYMAPE      + T
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SIRGRV-GTVGYMAPE-VLNNQRYT 179

Query: 872 DKCDVYGFGVLVLEVVTGKRPLSTWK 897
              D +G G L+ E++ G+ P    K
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 77.6 bits (192), Expect = 2e-15
 Identities = 50/226 (22%), Positives = 90/226 (39%), Gaps = 42/226 (18%)

Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQ-EDF---EREVKKLGKV-RHPNLV 750
            +G G F  V     +   +  AIK L    L+K +   +   E+EV  L ++  HP ++
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV--LTRLNGHPGII 65

Query: 751 TLEGYYWT---QSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNE---RFNVIQGTAKSLA 804
            L   Y+T   +     + E+   G L +++       + S +E   RF   +    +L 
Sbjct: 66  KL---YYTFQDEENLYFVLEYAPNGELLQYIR-----KYGSLDEKCTRFYAAE-ILLALE 116

Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP-------MLDRYVLSSKIQSALG 857
           +LH   IIH ++K  N+L+D     K+ D+G A++L                        
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 858 -----------YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
                      Y++PE            D++  G ++ +++TGK P
Sbjct: 177 RRFASFVGTAEYVSPE-LLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 77.8 bits (192), Expect = 3e-15
 Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 37/213 (17%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFER-EVKKL----------GKVR 745
           LGRG FG V     +  G   AIK L      K  +   R EV+ L             R
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKAL------KKGDIIARDEVESLMCEKRIFETANSER 60

Query: 746 HPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF---NVIQGTAKS 802
           HP LV L   + T+     + E+ +GG L  H+H      F      F    V+ G    
Sbjct: 61  HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDV---FSEPRAVFYAACVVLG---- 113

Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YM 859
           L +LH++ I++ ++K  N+L+D  G  K+ D+GL +     +      +  +  G   ++
Sbjct: 114 LQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-----EGMGFGDRTSTFCGTPEFL 168

Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
           APE    T   T   D +G GVL+ E++ G+ P
Sbjct: 169 APEVLTET-SYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 77.0 bits (190), Expect = 3e-15
 Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 24/218 (11%)

Query: 694 KDC-ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH-PNLV 750
           KD  E+GRG FG V + + +  G  +A+K++  +   K Q+    ++  + +    P +V
Sbjct: 7   KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIV 66

Query: 751 TLEGYYWTQSLQLLIYEF--VSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAKSLAHL 806
              G  + +    +  E   +S    +K+++E          E     +   T K+L +L
Sbjct: 67  KFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVI---PEEILGKIAVATVKALNYL 123

Query: 807 HQS-NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS-SKIQSALG---YMAP 861
            +   IIH ++K SN+L+D +G  K+ D+G++  L      V S +K + A G   YMAP
Sbjct: 124 KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL------VDSIAKTRDA-GCRPYMAP 176

Query: 862 E-FACRTVKITD-KCDVYGFGVLVLEVVTGKRPLSTWK 897
           E          D + DV+  G+ + EV TGK P   W 
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 76.9 bits (189), Expect = 3e-15
 Identities = 54/203 (26%), Positives = 100/203 (49%), Gaps = 10/203 (4%)

Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG V++ + + +G     PVAIK +   S  ++ ++    +  +G + H  +V L
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
            G     SLQL + +    GSL  H+ +      L      N     AK + +L +  ++
Sbjct: 75  LGICPGASLQL-VTQLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAKGMYYLEEHRMV 131

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           H N+ + N+L+      ++ D+G+A LL   D+    S+ ++ + +MA E +    + T 
Sbjct: 132 HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE-SILFGRYTH 190

Query: 873 KCDVYGFGVLVLEVVT-GKRPLS 894
           + DV+ +GV V E+++ G  P +
Sbjct: 191 QSDVWSYGVTVWEMMSYGAEPYA 213

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 76.9 bits (189), Expect = 3e-15
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 13/205 (6%)

Query: 692 LNKDCELGRGGFGAV--YR---TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH 746
           L K   LG G FG V  Y         G  VA+K L      ++   +++E+  L  + H
Sbjct: 6   LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYH 65

Query: 747 PNLVTLEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLA 804
            N+V  +G    Q  +   LI E+V  GSL  +L +    + L+  +     Q   + +A
Sbjct: 66  ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMA 121

Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV-LSSKIQSALGYMAPEF 863
           +LH  + IH ++ + NVL+D     K+GD+GLA+ +P    Y  +     S + + A E 
Sbjct: 122 YLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE- 180

Query: 864 ACRTVKITDKCDVYGFGVLVLEVVT 888
             +  K +   DV+ FGV + E++T
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 31/205 (15%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           +G G FGAV +     G+ VA+K +     V +Q  F  E   + K+ H NLV L G   
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVKNIKCD--VTAQA-FLEETAVMTKLHHKNLVRLLGVIL 69

Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQ------GTAKSLAHLHQS 809
              L +++ E +S G+L          NFL    R   +VIQ        A+ + +L   
Sbjct: 70  HNGLYIVM-ELMSKGNLV---------NFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK 119

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPEFACRTV 868
            ++H ++ + N+L+   G  KV D+GLAR+  M +D   L  K      + APE A +  
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPE-ALKHK 172

Query: 869 KITDKCDVYGFGVLVLEVVT-GKRP 892
           K + K DV+ +GVL+ EV + G+ P
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 76.6 bits (188), Expect = 4e-15
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 8/203 (3%)

Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE--REVKKLGKVRHPNLVTLEG 754
           LG+GGFG V    +R  G+  A KKL    + K + +     E + L KV    +V+L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            Y T+    L+   ++GG L  H++      F      F   +     L  LHQ  I++ 
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE-ICCGLEDLHQERIVYR 126

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+L+D  G  ++ D GLA  +P  +   +  ++   +GYMAPE   +  + T   
Sbjct: 127 DLKPENILLDDHGHIRISDLGLAVHVP--EGQTIKGRV-GTVGYMAPE-VVKNERYTFSP 182

Query: 875 DVYGFGVLVLEVVTGKRPLSTWK 897
           D +  G L+ E++ G+ P    K
Sbjct: 183 DWWALGCLLYEMIAGQSPFQQRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 76.2 bits (187), Expect = 5e-15
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 8/205 (3%)

Query: 691 LLNKDCELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNL 749
           L  K   +G+G FG V++ +  R  + VAIK + +       ED ++E+  L +   P +
Sbjct: 5   LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
               G Y   +   +I E++ GGS    L  G    F    +   +++   K L +LH  
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEF----QIATMLKEILKGLDYLHSE 120

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
             IH +IK++NVL+   G+ K+ D+G+A  L   D  +  +       +MAPE   ++  
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIQQSA- 177

Query: 870 ITDKCDVYGFGVLVLEVVTGKRPLS 894
              K D++  G+  +E+  G+ P S
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 77.2 bits (190), Expect = 6e-15
 Identities = 71/256 (27%), Positives = 119/256 (46%), Gaps = 37/256 (14%)

Query: 663 SRSPTTDANSGKLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKK 721
           S S ++ ++S      S     S      L +   +G G  G VY+ + R  GR  A+K 
Sbjct: 52  SSSSSSSSSSASGSAPSAAKSLSE-----LERVNRIGSGAGGTVYKVIHRPTGRLYALKV 106

Query: 722 LTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY-WTQSLQLLIYEFVSGGSLHKHLHE 780
           +  +     +    RE++ L  V HPN+V     +     +Q+L+ EF+ GGSL     E
Sbjct: 107 IYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL-EFMDGGSL-----E 160

Query: 781 GSGGNFLSWNERF--NVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR 838
           G+       +E+F  +V +     +A+LH+ +I+H +IK SN+LI+ +   K+ D+G++R
Sbjct: 161 GTH----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSR 216

Query: 839 LLPMLDRYVLSSKIQSALGYMAPEFACRTVKI-TD---------KCDVYGFGVLVLEVVT 888
           +L        SS     + YM+PE      +I TD           D++  GV +LE   
Sbjct: 217 ILAQTMDPCNSS--VGTIAYMSPE------RINTDLNHGAYDGYAGDIWSLGVSILEFYL 268

Query: 889 GKRPLSTWKMMWWFSV 904
           G+ P    +   W S+
Sbjct: 269 GRFPFGVGRQGDWASL 284

Length = 353

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 7e-15
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 33/213 (15%)

Query: 697 ELGRGGFGAVYRTVLR--DGR--PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           ELG G FG+V + V     G+   VA+K L    +   +++F RE   + ++ HP +V L
Sbjct: 2   ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAH------- 805
            G    + L +L+ E    G L K         +L       V     K LAH       
Sbjct: 62  IGVCKGEPL-MLVMELAPLGPLLK---------YLKKRREIPVS--DLKELAHQVAMGMA 109

Query: 806 -LHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA----LGYMA 860
            L   + +H ++ + NVL+    + K+ D+G++R L     Y    +  +A    L + A
Sbjct: 110 YLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY---RATTAGRWPLKWYA 166

Query: 861 PEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           PE      K + K DV+ +GV + E  + G +P
Sbjct: 167 PE-CINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 75.8 bits (186), Expect = 7e-15
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 18/205 (8%)

Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + DG     PVAIK L  ++  K+ ++   E   +  V  P +  L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSG----GNFLSWNERFNVIQGTAKSLAHLHQ 808
            G   T ++QL + + +  G L  ++ E        + L+W      +Q  AK +++L +
Sbjct: 75  LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW-----CVQ-IAKGMSYLEE 127

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTV 868
             ++H ++ + NVL+      K+ D+GLARLL + +    +   +  + +MA E      
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR- 186

Query: 869 KITDKCDVYGFGVLVLEVVT-GKRP 892
           + T + DV+ +GV V E++T G +P
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 75.5 bits (185), Expect = 8e-15
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 8/205 (3%)

Query: 691 LLNKDCELGRGGFGAVYRTVL-RDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNL 749
           L  K   +G+G FG VY+ +  R    VAIK + +       ED ++E+  L +   P +
Sbjct: 5   LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 64

Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
               G Y   +   +I E++ GGS    L  G     L       +++   K L +LH  
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLHSE 120

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
             IH +IK++NVL+   G+ K+ D+G+A  L   D  +  +       +MAPE   +   
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPE-VIKQSA 177

Query: 870 ITDKCDVYGFGVLVLEVVTGKRPLS 894
              K D++  G+  +E+  G+ P S
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 75.3 bits (185), Expect = 9e-15
 Identities = 56/193 (29%), Positives = 99/193 (51%), Gaps = 6/193 (3%)

Query: 697 ELGRGGFGAVYRTVL-RDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V  +    VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E      ++      +    + ++ +L + N IH +
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129

Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D Y   +  +  + + APE +    K + K D
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSD 187

Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 188 VWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 75.5 bits (186), Expect = 9e-15
 Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 35/212 (16%)

Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG-Y 755
           LG G  G+V +  L++   + A+K +T       Q+   RE++     + P +V   G +
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68

Query: 756 YWTQSLQLLI-YEFVSGGSLHKHLHEGSGGNFLSWNERFN------VIQGTAKSLAHLHQ 808
               S  + I  E+  GGSL     +           R        + +   K L++LH 
Sbjct: 69  LDESSSSIGIAMEYCEGGSL-----DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFAC 865
             IIH +IK SN+L+   G+ K+ D+G++  L       ++S   +  G   YMAPE   
Sbjct: 124 RKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-------VNSLAGTFTGTSFYMAPE--- 173

Query: 866 RTVKITDK-----CDVYGFGVLVLEVVTGKRP 892
              +I  K      DV+  G+ +LEV   + P
Sbjct: 174 ---RIQGKPYSITSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 75.4 bits (185), Expect = 9e-15
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 20/209 (9%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQED----FEREVKKLGKVRHPNLVTL 752
           LG+GGFG V    +++ G+  A KKL    L K   +     E+E+  L KV  P +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHL-HEGSGGNFLSWNERFNVIQGTAK---SLAHLHQ 808
              + +++   L+   ++GG L  H+ + G  G  +       VI  +A+    + HLH 
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEME-----RVIHYSAQITCGILHLHS 113

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTV 868
            +I++ ++K  NVL+D  G  ++ D GLA  L   D   ++ +  +  GYMAPE      
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK--DGKTITQRAGTN-GYMAPEILKEEP 170

Query: 869 KITDKCDVYGFGVLVLEVVTGKRPLSTWK 897
                 D +  G  + E+V G+ P    K
Sbjct: 171 YSY-PVDWFAMGCSIYEMVAGRTPFKDHK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 61/209 (29%), Positives = 110/209 (52%), Gaps = 26/209 (12%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQED-----FEREVKKLGKVRHPNLV 750
           ++G G +G VY+    + G+ VA+KK+ +    +S+E+       RE+  L +++HPN+V
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRL----ESEEEGVPSTAIREISLLKELQHPNIV 62

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFL------SWNERFNVIQGTAKSLA 804
            L+     +S   LI+EF+S   L K+L     G ++      S+   + ++QG    + 
Sbjct: 63  CLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSY--LYQILQG----IL 115

Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
             H   ++H ++K  N+LID  G  K+ D+GLAR   +  R V + ++ + L Y APE  
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-VYTHEVVT-LWYRAPEVL 173

Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
             + + +   D++  G +  E+ T K+PL
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 63/213 (29%), Positives = 89/213 (41%), Gaps = 36/213 (16%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG+G +G VY    L     +AIK++        Q   E E+     ++H N+V   G  
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE-EIALHSYLKHRNIVQYLGSD 74

Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKS----LAHLHQSNII 812
                  +  E V GGSL   L    G   L  NE    I    K     L +LH + I+
Sbjct: 75  SENGFFKIFMEQVPGGSLSALLRSKWGP--LKDNE--QTIIFYTKQILEGLKYLHDNQIV 130

Query: 813 HYNIKSSNVLIDG-SGEPKVGDYG----LARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
           H +IK  NVL++  SG  K+ D+G    LA + P       +      L YMAPE     
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC------TETFTGTLQYMAPE----- 179

Query: 868 VKITDK--------CDVYGFGVLVLEVVTGKRP 892
             + DK         D++  G  ++E+ TGK P
Sbjct: 180 --VIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 52/193 (26%), Positives = 90/193 (46%), Gaps = 8/193 (4%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           LG+G FG V++  L+D  PVA+K        + +  F  E + L +  HPN+V L G   
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIK 817
            +    ++ E V GG     L +           +F +    A  +A+L   N IH ++ 
Sbjct: 63  QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL--DAAAGMAYLESKNCIHRDLA 120

Query: 818 SSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK--IQSALGYMAPEFACRTVKITDKCD 875
           + N L+  +   K+ D+G++R     D  + SS    Q  + + APE A    + + + D
Sbjct: 121 ARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPE-ALNYGRYSSESD 176

Query: 876 VYGFGVLVLEVVT 888
           V+ +G+L+ E  +
Sbjct: 177 VWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 21/216 (9%)

Query: 697 ELGRGGFGAVYRTVL-----RDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           ELG   FG +Y+  L        + VAIK L   +  +   +F++E   + ++ HPN+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHL--------------HEGSGGNFLSWNERFNVIQ 797
           L G    +    +++E+++ G LH+ L               +G+  + L   +  ++  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 798 GTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG 857
             A  + +L     +H ++ + N+LI      K+ D GL+R +   D Y +  K    + 
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR 191

Query: 858 YMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           +M PE A    K +   D++ FGV++ E+ + G +P
Sbjct: 192 WMPPE-AIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 66/235 (28%), Positives = 110/235 (46%), Gaps = 43/235 (18%)

Query: 674 KLVMFSGDPDFSTGTHALLNKDCELGRGGFGAV-YRTVLRDGRPVAIKKLTVSSLVKSQ- 731
           +LV+  GDP       + L+   ++G G  G V   T    GR VA+KK+    L K Q 
Sbjct: 9   QLVVDPGDP------RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM---DLRKQQR 59

Query: 732 -EDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSL-----HKHLHEGSGGN 785
            E    EV  +   +HPN+V +   Y       ++ EF+ GG+L     H  ++E     
Sbjct: 60  RELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE----- 114

Query: 786 FLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYG----LARLLP 841
                +   V     K+L+ LH   +IH +IKS ++L+   G  K+ D+G    +++ +P
Sbjct: 115 ----EQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170

Query: 842 MLDRYVLSSKIQSALG---YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
                    + +S +G   +MAPE   R    T+  D++  G++V+E+V G+ P 
Sbjct: 171 ---------RRKSLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 57/230 (24%), Positives = 109/230 (47%), Gaps = 32/230 (13%)

Query: 697 ELGRGGFGAVYR------TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG G FG V+       +  +D   VA+K L   +L  +++DF+RE + L  ++H ++V
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIV 70

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHE--------------GSGGNFLSWNERFNVI 796
              G        ++++E++  G L+K L                 + G  L  ++  ++ 
Sbjct: 71  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE-LGLSQMLHIA 129

Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL 856
              A  + +L   + +H ++ + N L+  +   K+GD+G++R +   D Y +       +
Sbjct: 130 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVT 905
            +M PE +    K T + DV+ FGV++ E+ T GK+P        WF ++
Sbjct: 190 RWMPPE-SIMYRKFTTESDVWSFGVILWEIFTYGKQP--------WFQLS 230

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 54/215 (25%), Positives = 102/215 (47%), Gaps = 21/215 (9%)

Query: 697 ELGRGGFGAVYRTVLRDGRP------VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG G FG V+     +  P      VA+K L  +S   +++DF+RE + L  ++H ++V
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIV 70

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLH------------EGSGGNFLSWNERFNVIQG 798
              G        L+++E++  G L++ L             E      L+  +   +   
Sbjct: 71  RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130

Query: 799 TAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGY 858
            A  + +L   + +H ++ + N L+      K+GD+G++R +   D Y +  +    + +
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 190

Query: 859 MAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           M PE +    K T + D++ FGV++ E+ T GK+P
Sbjct: 191 MPPE-SILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 15/206 (7%)

Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG+GGFG V    +R  G+  A KKL    L K +  E    E + L KV    +V+L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGN--FLSWNERF---NVIQGTAKSLAHLHQS 809
            + T++   L+   ++GG L  H++     N  F      F    +I G    L HLHQ 
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG----LEHLHQR 116

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            II+ ++K  NVL+D  G  ++ D GLA  + + D    +       G+MAPE   +  +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPEL-LQGEE 173

Query: 870 ITDKCDVYGFGVLVLEVVTGKRPLST 895
                D +  GV + E++  + P   
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPFRA 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 16/202 (7%)

Query: 696 CELGRGGFGAVYRTVLRDGRP-VAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTL 752
             +G G FG V+    R      A+K + +  ++  K ++    E + L +V HP ++ L
Sbjct: 7   KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
                 Q    ++ E+V GG L  +L   + G F +    F   +    +L +LH   I+
Sbjct: 67  FWTEHDQRFLYMLMEYVPGGELFSYLR--NSGRFSNSTGLFYASE-IVCALEYLHSKEIV 123

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR-YVLSSKIQSALGYMAPEFACRTVKIT 871
           + ++K  N+L+D  G  K+ D+G A+ L   DR + L    +    Y+APE      K  
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKL--RDRTWTLCGTPE----YLAPEVIQS--KGH 175

Query: 872 DKC-DVYGFGVLVLEVVTGKRP 892
           +K  D +  G+L+ E++ G  P
Sbjct: 176 NKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 74.5 bits (183), Expect = 3e-14
 Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 17/203 (8%)

Query: 698 LGRGGFGAVY--RTVLRD--GRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTL 752
           LG+G FG V+  R +     G+  A+K L  ++L V+ +   + E   L +V HP +V L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
              + T+    LI +F+ GG L   L +     F   + +F + +  A +L HLH   II
Sbjct: 64  HYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAE-LALALDHLHSLGII 120

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVK 869
           + ++K  N+L+D  G  K+ D+GL++    +D      K  S  G   YMAPE   R   
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSK--ESIDH---EKKAYSFCGTVEYMAPEVVNRRGH 175

Query: 870 ITDKCDVYGFGVLVLEVVTGKRP 892
            T   D + FGVL+ E++TG  P
Sbjct: 176 -TQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 57/207 (27%), Positives = 107/207 (51%), Gaps = 19/207 (9%)

Query: 698 LGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQ-----EDFEREVKKLGKVRHPNL 749
           LG G F + Y+   RD   G  +A+K++T      S+     E   +E++ + ++ HP++
Sbjct: 8   LGTGAFSSCYQA--RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHE-GSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           + + G     S   L  E+++GGS+   L + G+    +  N    +++G    L++LH+
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRG----LSYLHE 121

Query: 809 SNIIHYNIKSSNVLIDGSGEP-KVGDYGLA-RLLPMLDRY-VLSSKIQSALGYMAPEFAC 865
           + IIH ++K +N+LID +G+  ++ D+G A RL            ++   + +MAPE   
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE-VL 180

Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRP 892
           R  +    CDV+  G +++E+ T K P
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 76.4 bits (188), Expect = 4e-14
 Identities = 45/123 (36%), Positives = 70/123 (56%), Gaps = 13/123 (10%)

Query: 56  WSEDDDTPC-----NWFGVKC---SPRSNRVIE-LTLNGLSLTGRIGRGLLQLQFLRKLS 106
           W+ D   PC      W G  C   S +    I+ L L+   L G I   + +L+ L+ ++
Sbjct: 392 WNGD---PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSIN 448

Query: 107 LSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIP 166
           LS N++ G+I P+L  + +L V+DLS NS +GSIP E   Q  SLR+++L  N  SG++P
Sbjct: 449 LSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP-ESLGQLTSLRILNLNGNSLSGRVP 507

Query: 167 SSL 169
           ++L
Sbjct: 508 AAL 510

Length = 623

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 74.6 bits (183), Expect = 4e-14
 Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 22/210 (10%)

Query: 698 LGRGGFGAVYRTVLRD------GRPVAIKKLTVSSLV---KSQEDFEREVKKLGKVRH-P 747
           LG G +G V+  ++R       G+  A+K L  ++LV   K+ E    E   L  VR  P
Sbjct: 8   LGTGAYGKVF--LVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 748 NLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH 807
            LVTL   + T++   LI ++VSGG +  HL++    NF     RF   +    +L HLH
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGE-IILALEHLH 122

Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR--LLPMLDR-YVLSSKIQSALGYMAPEFA 864
           +  I++ +IK  N+L+D  G   + D+GL++  L    +R Y     I+    YMAPE  
Sbjct: 123 KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIE----YMAPEII 178

Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
                     D +  G+L+ E++TG  P +
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFT 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 73.0 bits (179), Expect = 4e-14
 Identities = 53/203 (26%), Positives = 102/203 (50%), Gaps = 20/203 (9%)

Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQED-FEREVKKLGKVRHPNLVTLEGY 755
           +GRG FG V+    + D + V IK++ V  + K +    + E + L  + HPN++    Y
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII---EY 64

Query: 756 Y--WTQSLQLLI-YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           Y  + +   L+I  E+  GG+L +++ +    + L  +   +       +L H+H   I+
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLDEDTILHFFVQILLALHHVHTKLIL 123

Query: 813 HYNIKSSNVLIDGSGEP-KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTV 868
           H ++K+ N+L+D      K+GD+G++++L         SK  + +G   Y++PE  C   
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKIL------SSKSKAYTVVGTPCYISPEL-CEGK 176

Query: 869 KITDKCDVYGFGVLVLEVVTGKR 891
               K D++  G ++ E+ + KR
Sbjct: 177 PYNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 73.5 bits (180), Expect = 4e-14
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 25/212 (11%)

Query: 698 LGRGGFGAVYRTVLRDGRPVA-------IKKLTVSSLVKSQEDFEREVKKLGKVRH-PNL 749
           LG G +G V+      G           +KK T+    K+ E    E + L  +R  P L
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN------VIQGTAKSL 803
           VTL   + T +   LI ++++GG L  HL         S  ERF              +L
Sbjct: 68  VTLHYAFQTDTKLHLILDYINGGELFTHL---------SQRERFKEQEVQIYSGEIVLAL 118

Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
            HLH+  II+ +IK  N+L+D +G   + D+GL++     D    +      + YMAP+ 
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-HEDEVERAYSFCGTIEYMAPDI 177

Query: 864 ACRTVKITDKC-DVYGFGVLVLEVVTGKRPLS 894
                   DK  D +  GVL+ E++TG  P +
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 73.1 bits (179), Expect = 5e-14
 Identities = 61/240 (25%), Positives = 102/240 (42%), Gaps = 22/240 (9%)

Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE--REVKKLGKVRHPNLVTLEG 754
           LG+GGFG V    +R  G+  A KKL    + K + +     E + L KV    +V+L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            Y T+    L+   ++GG L  H++      F      F   +     L  L +  I++ 
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE-LCCGLEDLQRERIVYR 126

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+L+D  G  ++ D GLA  +P  +   +  ++   +GYMAPE      K T   
Sbjct: 127 DLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPE-VINNEKYTFSP 182

Query: 875 DVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVSMRSCKGSSRQRRRF 934
           D +G G L+ E++ G+ P    K              ++ +   V  R  +       +F
Sbjct: 183 DWWGLGCLIYEMIQGQSPFRKRK--------------ERVKREEVDRRVKEDQEEYSEKF 228

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 72.7 bits (178), Expect = 6e-14
 Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 24/216 (11%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQED------FEREVKKLGKVRHPNLV 750
           LGRG FG VY     D GR +A+K++       SQE        E E++ L  +RH  +V
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDP--DSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 751 TLEGYYW--TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAKSLAHL 806
              G      +    +  E++ GGS+   L +  G    +   R+   ++QG    +++L
Sbjct: 68  QYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQG----VSYL 122

Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEF 863
           H + I+H +IK +N+L D +G  K+GD+G ++ +  +   +  + I+S  G   +M+PE 
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI--CMSGTGIKSVTGTPYWMSPE- 179

Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM 899
                    K DV+     V+E++T K P + ++ M
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM 215

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 73.1 bits (179), Expect = 7e-14
 Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 28/218 (12%)

Query: 698 LGRGGFGAVYR-TVLR-DGRP----VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           LG G FG V + T  R  GR     VA+K L  ++      D   E   L +V HP+++ 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHE---------GSGGNFLSW-----NER----- 792
           L G        LLI E+   GSL   L E         GS GN  S      +ER     
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 793 --FNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS 850
              +     ++ + +L +  ++H ++ + NVL+    + K+ D+GL+R +   D YV  S
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187

Query: 851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           K +  + +MA E     +  T + DV+ FGVL+ E+VT
Sbjct: 188 KGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 72.1 bits (177), Expect = 8e-14
 Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 26/206 (12%)

Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQE----DFEREVKKLGKVRHPNLVT 751
            + +G FG+VY    R  G   AIK L  S ++   +      ER +  + +   P +  
Sbjct: 3   PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIM-MIQGESPYVAK 61

Query: 752 LEGYYWTQSLQ--LLIYEFVSGG---SLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHL 806
           L  YY  QS     L+ E+++GG   SL K L    GG    W +++  I      +  L
Sbjct: 62  L--YYSFQSKDYLYLVMEYLNGGDCASLIKTL----GGLPEDWAKQY--IAEVVLGVEDL 113

Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           HQ  IIH +IK  N+LID +G  K+ D+GL+R        + + K      Y+APE    
Sbjct: 114 HQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPE-TIL 166

Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRP 892
            V      D +  G ++ E + G  P
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 74.5 bits (183), Expect = 1e-13
 Identities = 31/85 (36%), Positives = 53/85 (62%)

Query: 378 EGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIG 437
           +G+ G   +  S    LQ ++LS N   G  P ++G+++ L++L+LS NS  G IP ++G
Sbjct: 428 QGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG 487

Query: 438 DLKALNVLDLSENWLNGSIPPEIGG 462
            L +L +L+L+ N L+G +P  +GG
Sbjct: 488 QLTSLRILNLNGNSLSGRVPAALGG 512

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 74.5 bits (183), Expect = 1e-13
 Identities = 36/89 (40%), Positives = 54/89 (60%)

Query: 202 LDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNL 261
           L L +  L G IP  +  L++L+ INLS N   G+IP  +GS + L  +D S NSF+G++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 262 PETMQKLSLCNFMNLRKNLFSGEVPKWIG 290
           PE++ +L+    +NL  N  SG VP  +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 72.6 bits (179), Expect = 1e-13
 Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 43/221 (19%)

Query: 692 LNKDCELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFE----REVKKLGKVRH 746
           LN+  E   G +G VYR    + G  VA+KKL +    K +E F     RE+  L K++H
Sbjct: 10  LNRIEE---GTYGVVYRARDKKTGEIVALKKLKME---KEKEGFPITSLREINILLKLQH 63

Query: 747 PNLVTLEGYYWTQSLQLLIYEFVSGGSLH-------------KHLHEGSGGNFLSWNERF 793
           PN+VT++             E V G +L              K L E     FL  +E  
Sbjct: 64  PNIVTVK-------------EVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQ-SEVK 109

Query: 794 NVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKI 852
            ++      +AHLH + I+H ++K+SN+L++  G  K+ D+GLAR     L  Y   +++
Sbjct: 110 CLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY---TQL 166

Query: 853 QSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
              L Y APE      + +   D++  G +  E++T K+PL
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 55/236 (23%), Positives = 104/236 (44%), Gaps = 33/236 (13%)

Query: 698 LGRGGFG-AVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG A+    +   +  A+K++ +     + ED  +E   L K++HPN+V  +  +
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67

Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNF-----LSWNERFNVIQGTAKSLAHLHQSNI 811
                  ++ E+  GG L + +    G  F     L W  +  +       + H+H+  +
Sbjct: 68  EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEKRV 121

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H +IKS N+ +  +G+ K+GD+G ARLL     Y  +        Y  P      +   
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT---YVGTPYYVPPEIWENMPYN 178

Query: 872 DKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVSMRSCKGS 927
           +K D++  G ++ E+ T K P                  ++   W+N+ ++ C+GS
Sbjct: 179 NKSDIWSLGCILYELCTLKHP------------------FQANSWKNLILKVCQGS 216

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 26/215 (12%)

Query: 697 ELGRGGFGAVYRTV---LRDGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ++G+G FG V++     L    P   VA+K L   +    Q DF+RE   + +  HPN+V
Sbjct: 12  DIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGS-----------------GGNF--LSWNE 791
            L G         L++E+++ G L++ L   S                 G N   LS  E
Sbjct: 72  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 792 RFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK 851
           +  + +  A  +A+L +   +H ++ + N L+  +   K+ D+GL+R +   D Y  S  
Sbjct: 132 QLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEN 191

Query: 852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEV 886
               + +M PE +    + T + DV+ +GV++ E+
Sbjct: 192 DAIPIRWMPPE-SIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 29/214 (13%)

Query: 697 ELGRGGFGAVYRTVLR--DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLE 753
            +G+G FG V + V R  DG+ +  K++   ++  K ++    EV  L +++HPN+V   
Sbjct: 7   TIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV--- 62

Query: 754 GYYW----TQSLQLLIY-EFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAKSLAHL 806
            YY       +  L I  E+  GG L + L +          E F   ++     +L   
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEEFIWRILTQLLLALYEC 121

Query: 807 H-----QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---Y 858
           H      + ++H ++K +N+ +D +   K+GD+GLA++L        SS  ++ +G   Y
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH-----DSSFAKTYVGTPYY 176

Query: 859 MAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
           M+PE     +   +K D++  G L+ E+     P
Sbjct: 177 MSPEQ-LNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 72.3 bits (177), Expect = 2e-13
 Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 18/209 (8%)

Query: 694 KDCELGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPN 748
           K   LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P+
Sbjct: 11  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 70

Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGS----GGNFLSWNERFNVIQGTAKSLA 804
           +  L G   T ++QL I + +  G L  ++ E          L+W      +Q  AK + 
Sbjct: 71  VCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW-----CVQ-IAKGMN 123

Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
           +L +  ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E  
Sbjct: 124 YLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183

Query: 865 CRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
              +  T + DV+ +GV V E++T G +P
Sbjct: 184 LHRI-YTHQSDVWSYGVTVWELMTFGSKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 25/210 (11%)

Query: 698 LGRGGFGAVY---RTVLRDGRPVAIKKLTVSSL----VKSQEDFEREVKKLGKVRHPNLV 750
           + +G +G V+   +    D    AIK +  + +       Q   ER++  L + + P +V
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDI--LSQAQSPYVV 56

Query: 751 TLEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
            L  YY  Q  +   L+ E++ GG L   L   + G+      R  + +    +L +LH 
Sbjct: 57  KL--YYSFQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDVARIYIAE-IVLALEYLHS 111

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLA------RLLPMLDRYVLSSKIQSALGYMAPE 862
           + IIH ++K  N+LID +G  K+ D+GL+      R + + D      +I     Y+APE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171

Query: 863 FACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
                   +   D +  G ++ E + G  P
Sbjct: 172 VILGQ-GHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 63/209 (30%), Positives = 93/209 (44%), Gaps = 26/209 (12%)

Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKSQED-----FEREVKKLGKVRHPNLVT 751
           LG+G FG V    L+      AIK L    +V   +D      ER V  L    HP L  
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALK-KDVVLEDDDVECTMVERRVLALAW-EHPFLTH 60

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF---NVIQGTAKSLAHLHQ 808
           L   + T+     + E+++GG L  H+   S G F     RF    +I G    L  LH+
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQ--SSGRFDEARARFYAAEIICG----LQFLHK 114

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFAC 865
             II+ ++K  NVL+D  G  K+ D+G+ +            K  +  G   Y+APE   
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKE-----NMNGEGKASTFCGTPDYIAPEI-L 168

Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
           +  K  +  D + FGVL+ E++ G+ P  
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQSPFH 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 29/219 (13%)

Query: 698 LGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFE---REVKKLGKVRHPN 748
           LG+G F  +Y+ VLR         P     + +  L     D          + ++ H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           LV L G        + + E+V  G L   LH       L W  + +V +  A +L +L  
Sbjct: 63  LVKLYGVCVRDENIM-VEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119

Query: 809 SNIIHYNIKSSNVLI-----DGSGEP--KVGDYGLARLLPMLDRYVLSSKIQSALGYMAP 861
             ++H N+   N+L+     +    P  K+ D G+     +L R     +I     ++AP
Sbjct: 120 KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERIP----WIAP 173

Query: 862 EFACR--TVKITDKCDVYGFGVLVLEVVT-GKRPLSTWK 897
           E   R     +T   D + FG  +LE+ + G+ PLST  
Sbjct: 174 EC-IRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 71.1 bits (174), Expect = 3e-13
 Identities = 56/201 (27%), Positives = 101/201 (50%), Gaps = 17/201 (8%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           ++G+G  G VY  + +  G+ VAIK++ +    K +E    E+  + + +HPN+V     
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK-KELIINEILVMRENKHPNIVNYLDS 84

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           Y       ++ E+++GGSL   + E      +   +   V +   ++L  LH + +IH +
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQVIHRD 140

Query: 816 IKSSNVLIDGSGEPKVGDYGL-ARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKIT 871
           IKS N+L+   G  K+ D+G  A++ P        SK  + +G   +MAPE   R     
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPE------QSKRSTMVGTPYWMAPEVVTRK-AYG 193

Query: 872 DKCDVYGFGVLVLEVVTGKRP 892
            K D++  G++ +E+V G+ P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 70.5 bits (172), Expect = 3e-13
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 23/211 (10%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGY 755
           +G G +G VY+   ++ G+  AIK + V+     +E+ ++E+  L K   H N+ T  G 
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 756 YWTQSL-----QL-LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
           +  ++      QL L+ EF   GS+   L + + GN L       + +   + L+HLHQ 
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE-FAC 865
            +IH +IK  NVL+  + E K+ D+G++     LDR V   +  + +G   +MAPE  AC
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTV--GRRNTFIGTPYWMAPEVIAC 185

Query: 866 RT---VKITDKCDVYGFGVLVLEVVTGKRPL 893
                     K D++  G+  +E+  G  PL
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 71.3 bits (175), Expect = 4e-13
 Identities = 54/227 (23%), Positives = 95/227 (41%), Gaps = 33/227 (14%)

Query: 694 KDCELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFE-------------REVK 739
           K   LG G +G V +      G+ VAIKK+ +  +                     RE+K
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 740 KLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGT 799
            + +++H N++ L   Y       L+ + ++   L K +        L+ ++   ++   
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKI---RLTESQVKCILLQI 128

Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR-------------LLPMLDRY 846
              L  LH+   +H ++  +N+ I+  G  K+ D+GLAR                M  R 
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
            ++SK+ + L Y APE      K     D++  G +  E++TGK PL
Sbjct: 189 EMTSKVVT-LWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK-PL 233

Length = 335

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 70.3 bits (172), Expect = 4e-13
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 15/208 (7%)

Query: 698 LGRGGFGAVYRTVL----RDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           LG G FG + R  L    +   PVAI  L      K +  F  E   LG+  H N+V LE
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHL--HEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           G     +  +++ E++S G+L   L  HEG     L   +   ++ G A  + +L +   
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFLRKHEGQ----LVAGQLMGMLPGLASGMKYLSEMGY 128

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H  + +  VL++     K+  +   +       Y   S     L + APE A +    +
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL-WAAPE-AIQYHHFS 186

Query: 872 DKCDVYGFGVLVLEVVT-GKRPLSTWKM 898
              DV+ FG+++ EV++ G+RP   W M
Sbjct: 187 SASDVWSFGIVMWEVMSYGERPY--WDM 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 70.6 bits (173), Expect = 4e-13
 Identities = 53/200 (26%), Positives = 104/200 (52%), Gaps = 9/200 (4%)

Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +  VY+   R  G  VA+K++ + +   +     RE+  + +++H N+V L   
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
             T++  +L++E++    L K++        L  N   +      K +A  H++ ++H +
Sbjct: 67  IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRD 125

Query: 816 IKSSNVLIDGSGEPKVGDYGLARL--LPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
           +K  N+LI+  GE K+ D+GLAR   +P+      S+++ + L Y AP+    +   +  
Sbjct: 126 LKPQNLLINKRGELKLADFGLARAFGIPV---NTFSNEVVT-LWYRAPDVLLGSRTYSTS 181

Query: 874 CDVYGFGVLVLEVVTGKRPL 893
            D++  G ++ E++TG RPL
Sbjct: 182 IDIWSVGCIMAEMITG-RPL 200

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 17/210 (8%)

Query: 697 ELGRGGFGAVYRTVLRDGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           ELG G FG V + V +  +    VAIK L   +    +++  RE + + ++ +P +V + 
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
           G    ++L +L+ E  SGG L+K L      + ++ +    ++   +  + +L   N +H
Sbjct: 62  GVCEAEAL-MLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118

Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA----LGYMAPEFACRTV- 868
            ++ + NVL+      K+ D+GL++ L   D Y    K +SA    L + APE  C    
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYY---KARSAGKWPLKWYAPE--CINFR 173

Query: 869 KITDKCDVYGFGVLVLEVVT-GKRPLSTWK 897
           K + + DV+ +G+ + E  + G++P    K
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 70.2 bits (172), Expect = 5e-13
 Identities = 55/208 (26%), Positives = 86/208 (41%), Gaps = 15/208 (7%)

Query: 698 LGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           LGRG FG V+    +          V +K L  +     Q +F RE+    K+ H N+V 
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNF------LSWNERFNVIQGTAKSLAH 805
           L G         +I E+   G L + L      +       LS  ++  +    A  + H
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 806 LHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFAC 865
           L  +  +H ++ + N L+    E KV    L++       Y         L ++APE A 
Sbjct: 133 LSNARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNALIPLRWLAPE-AV 190

Query: 866 RTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           +    + K DV+ FGVL+ EV T G+ P
Sbjct: 191 QEDDFSTKSDVWSFGVLMWEVFTQGELP 218

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 70.8 bits (173), Expect = 5e-13
 Identities = 55/199 (27%), Positives = 103/199 (51%), Gaps = 9/199 (4%)

Query: 697 ELGRGGFGAVY--RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           +LG G +  VY  R+ L D   VA+K++ +     +     REV  L  ++H N+VTL  
Sbjct: 13  KLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
              T+    L++E++    L ++L +   GN ++ +     +    + L + H+  ++H 
Sbjct: 72  IIHTEKSLTLVFEYLDK-DLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LI+  GE K+ D+GLAR   +  +   S+++ + L Y  P+    +   + + 
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTK-TYSNEVVT-LWYRPPDILLGSTDYSTQI 186

Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++G G +  E+ TG RPL
Sbjct: 187 DMWGVGCIFYEMSTG-RPL 204

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 70.2 bits (172), Expect = 5e-13
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 16/201 (7%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKL---TVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           ++G G +G VY+      G  VA+KK+   T +  V S     RE+  L ++ HPN+V L
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI--REISLLKELNHPNIVKL 64

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNF---LSWNERFNVIQGTAKSLAHLHQS 809
                T++   L++EF+    L K +           L  +  F ++QG    LA  H  
Sbjct: 65  LDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQG----LAFCHSH 119

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE       
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKY 177

Query: 870 ITDKCDVYGFGVLVLEVVTGK 890
            +   D++  G +  E+VT +
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 70.6 bits (173), Expect = 5e-13
 Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 27/214 (12%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFE----REVKKLGKVRHPNLVT 751
           ++G G +G VY+   +D G  VA+KK+    L   +E F     RE+K L ++ H N+V 
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKV---RLDNEKEGFPITAIREIKILRQLNHRNIVN 70

Query: 752 LEGYYWTQSLQL----------LIYEFVSGGSLHKHLHEGSGGNFLSWNERFN--VIQGT 799
           L+     +   L          L++E++    L   L  G     + ++E      ++  
Sbjct: 71  LKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQL 125

Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYM 859
            + L + H+ N +H +IK SN+L++  G+ K+ D+GLARL    +    ++K+ + L Y 
Sbjct: 126 LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT-LWYR 184

Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
            PE      +     DV+  G ++ E+ T K+P+
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 70.4 bits (172), Expect = 5e-13
 Identities = 68/240 (28%), Positives = 115/240 (47%), Gaps = 30/240 (12%)

Query: 672 SGKLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKS 730
           SGK ++F   PD S  T  ++     +G+G +G V++ +  ++G   A+K L    +   
Sbjct: 4   SGKTIIFDSFPDPSD-TWEIIET---IGKGTYGKVFKVLNKKNGSKAAVKIL--DPIHDI 57

Query: 731 QEDFEREVKKLGKVR-HPNLVTLEGYYWTQSL----QL-LIYEFVSGGSLHKHLHEGSGG 784
            E+ E E   L  +  HPN+V   G Y+ + +    QL L+ E  +GGS+   L +G   
Sbjct: 58  DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-TDLVKG--- 113

Query: 785 NFLSWNERFN------VIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR 838
            FL   ER        ++      L HLH +  IH ++K +N+L+   G  K+ D+G++ 
Sbjct: 114 -FLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172

Query: 839 LLPMLDRYVLSSKIQSALGYMAPE-FACRT---VKITDKCDVYGFGVLVLEVVTGKRPLS 894
            L    R   ++ + +   +MAPE  AC          +CDV+  G+  +E+  G  PL+
Sbjct: 173 QLTS-TRLRRNTSVGTPF-WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 72.2 bits (177), Expect = 6e-13
 Identities = 39/103 (37%), Positives = 60/103 (58%), Gaps = 1/103 (0%)

Query: 445 LDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPI 504
           L L    L G IP +I     L+ + L  N + G IP S+ + +SL  L LS N+  G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 505 PIAIAKLTNLQNVDLSFNSLTGGLPKQL-VNLVHLSSFNISHN 546
           P ++ +LT+L+ ++L+ NSL+G +P  L   L+H +SFN + N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525

Length = 623

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 70.5 bits (172), Expect = 6e-13
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 17/201 (8%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           ++G+G  G V+    +  G+ VAIK++ +    K +E    E+  + ++++PN+V     
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK-KELIINEILVMKELKNPNIVNFLDS 84

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           +       ++ E+++GGSL   + E      +   +   V +   ++L  LH + +IH +
Sbjct: 85  FLVGDELFVVMEYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQVIHRD 140

Query: 816 IKSSNVLIDGSGEPKVGDYGL-ARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKIT 871
           IKS NVL+   G  K+ D+G  A++ P        SK  + +G   +MAPE   R     
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPE------QSKRSTMVGTPYWMAPEVVTRKA-YG 193

Query: 872 DKCDVYGFGVLVLEVVTGKRP 892
            K D++  G++ +E+V G+ P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 69.4 bits (170), Expect = 7e-13
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 28/207 (13%)

Query: 698 LGRGGFGAVYRTVLRDGRP----VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +G+G FG VY   L D        A+K L   + ++  E F +E   +    HPN+++L 
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 754 GYYW-TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQG-------TAKSLAH 805
           G    ++   L++  ++  G L          NF+        ++         AK + +
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLR---------NFIRSETHNPTVKDLIGFGLQVAKGMEY 113

Query: 806 LHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR--YVLSSKIQSAL--GYMAP 861
           L     +H ++ + N ++D S   KV D+GLAR   + D+  Y + +   + L   +MA 
Sbjct: 114 LASKKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSVHNHTGAKLPVKWMAL 171

Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT 888
           E + +T K T K DV+ FGVL+ E++T
Sbjct: 172 E-SLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 69.7 bits (170), Expect = 7e-13
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 21/216 (9%)

Query: 697 ELGRGGFGAVYRTVLRDGRP------VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG   FG VY+  L    P      VAIK L   +    +E+F+ E     +++HPN+V
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHL-----HEGSGG--------NFLSWNERFNVIQ 797
            L G    +    +I+ + S   LH+ L     H   G         + L   +  +++ 
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 798 GTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG 857
             A  +  L   +++H ++ + NVL+      K+ D GL R +   D Y L       + 
Sbjct: 132 QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR 191

Query: 858 YMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           +M+PE A    K +   D++ +GV++ EV + G +P
Sbjct: 192 WMSPE-AIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 69.7 bits (170), Expect = 7e-13
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 25/207 (12%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ--EDF---EREVKKLGKVRHPNLVTL 752
           +G G +G VY+      R V   +L    ++K +  EDF   ++E+  +   +H N+V  
Sbjct: 17  IGSGTYGDVYK-----ARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY 71

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
            G Y  +    +  EF  GGSL    H       LS ++   V + T + L +LH    +
Sbjct: 72  FGSYLRRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYYLHSKGKM 128

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGL-ARLLPMLDRYVLSSKIQSALG---YMAPEFAC--R 866
           H +IK +N+L+  +G  K+ D+G+ A++   +      +K +S +G   +MAPE A   R
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATI------AKRKSFIGTPYWMAPEVAAVER 182

Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPL 893
                  CD++  G+  +E+   + P+
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 69.7 bits (170), Expect = 8e-13
 Identities = 61/229 (26%), Positives = 112/229 (48%), Gaps = 33/229 (14%)

Query: 674 KLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKS 730
           ++V+  GDP       +LL    ++G G  G V   + R+   GR VA+K + +    + 
Sbjct: 11  RMVVDQGDP------RSLLENYIKIGEGSTGIV--CIAREKHSGRQVAVKMMDLRKQQRR 62

Query: 731 QEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWN 790
           +  F  EV  +   +H N+V +   Y       ++ EF+ GG+L   + +      L+  
Sbjct: 63  ELLFN-EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR----LNEE 117

Query: 791 ERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYG----LARLLPMLDRY 846
           +   V +   ++L +LH   +IH +IKS ++L+   G  K+ D+G    +++ +P     
Sbjct: 118 QIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP----- 172

Query: 847 VLSSKIQSALG---YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
               K +S +G   +MAPE   RT   T+  D++  G++V+E+V G+ P
Sbjct: 173 ----KRKSLVGTPYWMAPEVISRTPYGTE-VDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 70.2 bits (172), Expect = 9e-13
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 18/201 (8%)

Query: 698 LGRGGFGAV--YRTVLRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +G G FG V   R  L  G+ VAIKK+    S+ V ++  + RE+K L  +RH N+++L 
Sbjct: 18  VGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENIISLS 75

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
             + +    +     + G  LH+ L              + +++G    L ++H + ++H
Sbjct: 76  DIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRG----LKYVHSAGVVH 131

Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
            ++K SN+LI+ + + K+ D+GLAR+  P +  YV      S   Y APE      K   
Sbjct: 132 RDLKPSNILINENCDLKICDFGLARIQDPQMTGYV------STRYYRAPEIMLTWQKYDV 185

Query: 873 KCDVYGFGVLVLEVVTGKRPL 893
           + D++  G +  E++ GK PL
Sbjct: 186 EVDIWSAGCIFAEMLEGK-PL 205

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 23/211 (10%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGY 755
           +G G +G VY+   ++ G+  AIK + V+     +E+ + E+  L K   H N+ T  G 
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 756 YWTQSL-----QL-LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
           +  +S      QL L+ EF   GS+   L + + GN L  +    + +   + LAHLH  
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE-FAC 865
            +IH +IK  NVL+  + E K+ D+G++     LDR V   +  + +G   +MAPE  AC
Sbjct: 141 KVIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTV--GRRNTFIGTPYWMAPEVIAC 195

Query: 866 RT---VKITDKCDVYGFGVLVLEVVTGKRPL 893
                     + D++  G+  +E+  G  PL
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 16/210 (7%)

Query: 697 ELGRGGFGAVYRTVLRDG---RPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           E+G G FG V    +  G     V +K+L VS+ V+ Q  F  E +    ++H NL+   
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLA----HLHQS 809
           G     +  LL+ EF   G L  +L        ++ +     +Q  A  +A    HLH++
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPT--TLQRMACEIALGLLHLHKN 119

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA----- 864
           N IH ++   N L+      K+GDYGL+      D YV   ++   L ++APE       
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179

Query: 865 -CRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
               V  T + +V+  GV + E+   G +P
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 69.4 bits (169), Expect = 1e-12
 Identities = 55/201 (27%), Positives = 101/201 (50%), Gaps = 17/201 (8%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           ++G+G  G VY  + +  G+ VAIK++ +    K +E    E+  + + ++PN+V     
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDS 84

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           Y       ++ E+++GGSL   + E      +   +   V +   ++L  LH + +IH +
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQVIHRD 140

Query: 816 IKSSNVLIDGSGEPKVGDYGL-ARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKIT 871
           IKS N+L+   G  K+ D+G  A++ P        SK  + +G   +MAPE   R     
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPE------QSKRSTMVGTPYWMAPEVVTRKA-YG 193

Query: 872 DKCDVYGFGVLVLEVVTGKRP 892
            K D++  G++ +E+V G+ P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 71.0 bits (174), Expect = 2e-12
 Identities = 31/79 (39%), Positives = 48/79 (60%)

Query: 259 GNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQR 318
           G +P  + KL     +NL  N   G +P  +G + SLE LDLS N F+G++P S+G L  
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 319 LKVLNFSANRLTGSLPDSM 337
           L++LN + N L+G +P ++
Sbjct: 492 LRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 26/213 (12%)

Query: 698 LGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGY 755
           +G+G +G VY+ T  +DG   A+K L   S V   E+ E E   L  +  HPN+V   G 
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDV--DEEIEAEYNILQSLPNHPNVVKFYGM 87

Query: 756 YWTQSL----QL-LIYEFVSGGSLHKHLHEGSGGNFLSWNERFN------VIQGTAKSLA 804
           ++        QL L+ E  +GGS+   L +G     L   +R +      ++ G    L 
Sbjct: 88  FYKADKLVGGQLWLVLELCNGGSV-TELVKG----LLICGQRLDEAMISYILYGALLGLQ 142

Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE-F 863
           HLH + IIH ++K +N+L+   G  K+ D+G++  L    R   ++ + +   +MAPE  
Sbjct: 143 HLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS-TRLRRNTSVGTPF-WMAPEVI 200

Query: 864 ACRT---VKITDKCDVYGFGVLVLEVVTGKRPL 893
           AC          +CDV+  G+  +E+  G  PL
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 68.8 bits (168), Expect = 2e-12
 Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 19/203 (9%)

Query: 698 LGRGGFGAVYRTVLRDG-RPVAIKKLTVSSLV-KSQEDF---EREVKKLGKVRHPNLVTL 752
           +G+G FG V +   RD  R  A+K +  + +V +S+      ER V  L +V  P +V L
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTV--LAQVNCPFIVPL 58

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           +  + +     L+  F++GG L  HL     G F     RF   +    +L +LH+ N+I
Sbjct: 59  KFSFQSPEKLYLVLAFINGGELFHHLQRE--GRFDLSRARFYTAE-LLCALENLHKFNVI 115

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVK 869
           + ++K  N+L+D  G   + D+GL + L M D      K  +  G   Y+APE       
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCK-LNMKD----DDKTNTFCGTPEYLAPELLL-GHG 169

Query: 870 ITDKCDVYGFGVLVLEVVTGKRP 892
            T   D +  GVL+ E++TG  P
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 27/226 (11%)

Query: 674 KLVMFSGDPDFSTGTHALLNKDCELGRGGFGAV-YRTVLRDGRPVAIKKLTVSSLVKSQE 732
           ++V+  GDP         L+   ++G G  G V   TV   G+ VA+KK+ +    + + 
Sbjct: 10  QMVVDPGDP------RTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRREL 63

Query: 733 DFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSL-----HKHLHEGSGGNFL 787
            F  EV  +   +H N+V +   Y       ++ EF+ GG+L     H  ++E       
Sbjct: 64  LFN-EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------- 115

Query: 788 SWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV 847
              +   V     K+L+ LH   +IH +IKS ++L+   G  K+ D+G       + + V
Sbjct: 116 --EQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC---AQVSKEV 170

Query: 848 LSSKIQSALGY-MAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
              K      Y MAPE   R +    + D++  G++V+E+V G+ P
Sbjct: 171 PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 68.6 bits (168), Expect = 3e-12
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 28/209 (13%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQE----DFEREVKKLGKVRHPNLVT 751
           ++G+GG+G V+    +D G  VA+K++  S L K  E      ER++  L   +   LV 
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDI--LTTTKSEWLVK 65

Query: 752 LEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNE-RFNVIQGTAKSLAHLHQ 808
           L   Y  Q  +   L  E+V GG     L   +    LS +  RF + +    ++  LH+
Sbjct: 66  L--LYAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFE-AVDALHE 119

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFAC 865
              IH ++K  N LID SG  K+ D+GL++         + +   S +G   YMAPE   
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSK--------GIVTYANSVVGSPDYMAPE-VL 170

Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
           R        D +  G ++ E + G  P S
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 68.2 bits (166), Expect = 3e-12
 Identities = 51/198 (25%), Positives = 99/198 (50%), Gaps = 11/198 (5%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           ++G+G  G VY  + +  G+ VAI+++ +    K +E    E+  + + ++PN+V     
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDS 85

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           Y       ++ E+++GGSL   + E      +   +   V +   ++L  LH + +IH +
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQVIHRD 141

Query: 816 IKSSNVLIDGSGEPKVGDYGL-ARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           IKS N+L+   G  K+ D+G  A++ P   +    S +     +MAPE   R      K 
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKA-YGPKV 197

Query: 875 DVYGFGVLVLEVVTGKRP 892
           D++  G++ +E++ G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 68.5 bits (167), Expect = 3e-12
 Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 12/201 (5%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDF-----EREVKKLGKVRHPNLVTL 752
           +GRG +  V    L+    +   K+    LV   ED      E+ V +     HP LV L
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVGL 61

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
              + T+S    + E+V+GG L  H+           + RF   +  + +L +LH+  II
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAE-ISLALNYLHERGII 118

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           + ++K  NVL+D  G  K+ DYG+ +    L     +S       Y+APE   R      
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEI-LRGEDYGF 175

Query: 873 KCDVYGFGVLVLEVVTGKRPL 893
             D +  GVL+ E++ G+ P 
Sbjct: 176 SVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 67.8 bits (165), Expect = 4e-12
 Identities = 54/200 (27%), Positives = 102/200 (51%), Gaps = 18/200 (9%)

Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +  VY+   + +G+ VA+K + +     +     RE   L  ++H N+V L   
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71

Query: 756 YWTQSLQLLIYEFVSGG---SLHKH---LHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
             T+    L++E+V       + KH   LH  +   FL     F +++G    L+++HQ 
Sbjct: 72  IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFL-----FQLLRG----LSYIHQR 122

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            I+H ++K  N+LI  +GE K+ D+GLAR    +  +  S+++ + L Y  P+    + +
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVT-LWYRPPDVLLGSTE 180

Query: 870 ITDKCDVYGFGVLVLEVVTG 889
            +   D++G G + +E++ G
Sbjct: 181 YSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 69.5 bits (170), Expect = 5e-12
 Identities = 42/127 (33%), Positives = 64/127 (50%), Gaps = 2/127 (1%)

Query: 462 GAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSF 521
           G + +  L L+   L G IP  I     L S+ LS N++ G IP ++  +T+L+ +DLS+
Sbjct: 416 GKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSY 475

Query: 522 NSLTGGLPKQLVNLVHLSSFNISHNHLQGELPA--GGFFNTISPSSVLGNPSLCGSAVNK 579
           NS  G +P+ L  L  L   N++ N L G +PA  GG     +  +   N  LCG    +
Sbjct: 476 NSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLR 535

Query: 580 SCPAVLP 586
           +C   L 
Sbjct: 536 ACGPHLS 542

Length = 623

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 68.1 bits (166), Expect = 5e-12
 Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 25/206 (12%)

Query: 698 LGRGGFGAVYRTVLRDGR--PVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLE 753
           LG G FG V     ++    PVAIK+   S ++K ++      E K L  + HP  V L 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKS------LAHLH 807
           G +  +S   L+ EFV GG             FL  N+RF    G   +        +L 
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFF---------TFLRRNKRFPNDVGCFYAAQIVLIFEYLQ 148

Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
             NI++ ++K  N+L+D  G  K+ D+G A+++     Y L    +    Y+APE     
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-RTYTLCGTPE----YIAPEILL-N 202

Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
           V      D +  G+ + E++ G  P 
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 67.7 bits (165), Expect = 5e-12
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 36/225 (16%)

Query: 697 ELGRGGFGAVYRTV---------------LRDGRP--VAIKKLTVSSLVKSQEDFEREVK 739
           +LG G FG V+                  +R GRP  VA+K L   +   ++ DF +EVK
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 740 KLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSL-----HKHLHEGSG----------- 783
            L +++ PN++ L G    +    +I E++  G L       HL +              
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 784 GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML 843
              +S++   +V    A  + +L   N +H ++ + N L+  +   K+ D+G++R L   
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAG 191

Query: 844 DRYVLSSKIQSALGYMAPEFACRTV-KITDKCDVYGFGVLVLEVV 887
           D Y +  +    + +MA E  C  + K T   DV+ FGV + E++
Sbjct: 192 DYYRIQGRAVLPIRWMAWE--CILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 67.8 bits (165), Expect = 5e-12
 Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 34/218 (15%)

Query: 696 CELGRGGFGAVYRTVLRDG---RPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           C++GRG +G VY+   +DG   R  A+K++  + +  S     RE+  L +++HPN+++L
Sbjct: 7   CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA---CREIALLRELKHPNVISL 63

Query: 753 EGYYWTQSLQ--LLIYEFVSGGSLH-KHLHEGSGGNFLSWNERFNVIQGTAKSLA----- 804
           +  + + + +   L++++      H    H  S  N     +   + +G  KSL      
Sbjct: 64  QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN----KKPVQLPRGMVKSLLYQILD 119

Query: 805 ---HLHQSNIIHYNIKSSNVLIDGSGEP----KVGDYGLARLL-----PMLDRYVLSSKI 852
              +LH + ++H ++K +N+L+ G G      K+ D G ARL      P+ D       +
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL----DPV 175

Query: 853 QSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGK 890
                Y APE        T   D++  G +  E++T +
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 67.4 bits (165), Expect = 6e-12
 Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 14/201 (6%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDF-----EREVKKLGKVRHPNLVT 751
           LG+G FG V    L+      A+K L    ++   +D      E+ V  L   +HP L  
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLK-KDVILQDDDVECTMTEKRVLALAG-KHPFLTQ 60

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L   + T+     + E+V+GG L  H+     G F     RF   +     L  LH+  I
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAE-IVLGLQFLHERGI 117

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           I+ ++K  NVL+D  G  K+ D+G+ +   +L   V +S       Y+APE         
Sbjct: 118 IYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGG-VTTSTFCGTPDYIAPEI-LSYQPYG 174

Query: 872 DKCDVYGFGVLVLEVVTGKRP 892
              D +  GVL+ E++ G+ P
Sbjct: 175 PAVDWWALGVLLYEMLAGQSP 195

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 66.2 bits (161), Expect = 7e-12
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 10/193 (5%)

Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
            +GRG FG V+   LR D  PVA+K    +     +  F +E + L +  HPN+V L G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    ++ E V GG     L   + G  L   E   +++  A  + +L   + IH +
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLR--TEGPRLKVKELIQMVENAAAGMEYLESKHCIHRD 119

Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK---IQSALGYMAPEFACRTVKITD 872
           + + N L+      K+ D+G++R     +  V +S     Q  + + APE A    + + 
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPE-ALNYGRYSS 175

Query: 873 KCDVYGFGVLVLE 885
           + DV+ FG+L+ E
Sbjct: 176 ESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 67.0 bits (164), Expect = 7e-12
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 26/216 (12%)

Query: 698 LGRGGFGAVY--------RTVLRDGRP---------VAIKKLTVSSLVKSQEDFEREVKK 740
           LG G FG V+            +             VA+K L   +   ++EDF +EVK 
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 741 LGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHL--HEG------SGGNFLSWNER 792
           L ++  PN+  L G         +I E++  G L++ L  H             LS++  
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132

Query: 793 FNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI 852
             +    A  + +L   N +H ++ + N L+  +   K+ D+G++R L   D Y +  + 
Sbjct: 133 LYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRA 192

Query: 853 QSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
              + +MA E      K T K DV+ FGV + E++T
Sbjct: 193 PLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 67.0 bits (164), Expect = 8e-12
 Identities = 65/219 (29%), Positives = 100/219 (45%), Gaps = 48/219 (21%)

Query: 698 LGRGGFGAVYRTVLRD---GRPVAIKK---------LTVSSLVKSQEDFEREVKKLGKVR 745
           +G G +G VYR   RD   G  VA+KK         + +SSL        RE+  L  +R
Sbjct: 15  IGEGTYGIVYRA--RDTTSGEIVALKKVRMDNERDGIPISSL--------REITLLLNLR 64

Query: 746 HPNLVTLEGYYWTQSLQ--LLIYEFVSG--GSLHKHLHEGSGGNFLSWNERFNVIQGTAK 801
           HPN+V L+     + L    L+ E+      SL  ++         S ++   ++    +
Sbjct: 65  HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMP-----TPFSESQVKCLMLQLLR 119

Query: 802 SLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-----PMLDRYVLSSKIQSAL 856
            L +LH++ IIH ++K SN+L+   G  K+ D+GLAR       PM  + V        L
Sbjct: 120 GLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-------TL 172

Query: 857 GYMAPE--FACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
            Y APE    C T   T   D++  G ++ E++  K PL
Sbjct: 173 WYRAPELLLGCTTY--TTAIDMWAVGCILAELLAHK-PL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 66.3 bits (162), Expect = 8e-12
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 10/200 (5%)

Query: 698 LGRGGFGAVYRTVLRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +G G FG VY+ V          VA+K     +    +E F +E   + +  HP++V L 
Sbjct: 14  IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
           G   T++   ++ E    G L  +L        L            + +LA+L     +H
Sbjct: 74  GVI-TENPVWIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKRFVH 130

Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            +I + NVL+      K+GD+GL+R L   + Y  +SK +  + +MAPE +    + T  
Sbjct: 131 RDIAARNVLVSSPDCVKLGDFGLSRYLED-ESYYKASKGKLPIKWMAPE-SINFRRFTSA 188

Query: 874 CDVYGFGVLVLEVVT-GKRP 892
            DV+ FGV + E++  G +P
Sbjct: 189 SDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 66.2 bits (161), Expect = 8e-12
 Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 20/214 (9%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVS----SLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG+G FG VY     D GR +A K++          K     E E++ L  ++H  +V  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 753 EGYYWTQSLQLL--IYEFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAKSLAHLHQ 808
            G    ++ + L    E++ GGS+   L +  G    S   ++   +++G    +++LH 
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEG----MSYLHS 124

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFAC 865
           + I+H +IK +N+L D +G  K+GD+G ++ L  +   +  + I+S  G   +M+PE   
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI--CMSGTGIRSVTGTPYWMSPE-VI 181

Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM 899
                  K DV+  G  V+E++T K P + ++ M
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM 215

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 66.6 bits (162), Expect = 9e-12
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 27/226 (11%)

Query: 674 KLVMFSGDPDFSTGTHALLNKDCELGRGGFGAV-YRTVLRDGRPVAIKKLTVSSLVKSQE 732
           +LV+  GDP         L+   ++G G  G V   T    G+ VA+KK+ +    + + 
Sbjct: 12  QLVVSPGDP------REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL 65

Query: 733 DFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSL-----HKHLHEGSGGNFL 787
            F  EV  +    H N+V +   Y       ++ EF+ GG+L     H  ++E       
Sbjct: 66  LFN-EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------- 117

Query: 788 SWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV 847
              +   V     ++L++LH   +IH +IKS ++L+   G  K+ D+G       + + V
Sbjct: 118 --EQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFC---AQVSKEV 172

Query: 848 LSSKIQSALGY-MAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
              K      Y MAPE   R    T+  D++  G++V+E++ G+ P
Sbjct: 173 PKRKSLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 54/202 (26%), Positives = 106/202 (52%), Gaps = 15/202 (7%)

Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +  V++   +     VA+K++ +     +     REV  L  ++H N+VTL   
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNE----RFNVIQGTAKSLAHLHQSNI 811
             T+    L++E++    L ++L   + GN +S +      F +++G    L++ H+  I
Sbjct: 72  IHTERCLTLVFEYLDS-DLKQYLD--NCGNLMSMHNVKIFMFQLLRG----LSYCHKRKI 124

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H ++K  N+LI+  GE K+ D+GLAR   +  +   S+++ + L Y  P+    + + +
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TYSNEVVT-LWYRPPDVLLGSTEYS 182

Query: 872 DKCDVYGFGVLVLEVVTGKRPL 893
              D++G G ++ E+ TG RP+
Sbjct: 183 TPIDMWGVGCILYEMATG-RPM 203

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 53/221 (23%)

Query: 698 LGRGGFGAVY-------------------RTVLRDGRPVAIKKLTVSSLVKSQEDFEREV 738
           +GRGGFG VY                   R  ++ G  +A+ +  + SLV + +      
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD------ 55

Query: 739 KKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF---NV 795
                   P +V +   + T      I + ++GG LH HL +   G F     RF    +
Sbjct: 56  -------CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEI 106

Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
           I G    L H+H   +++ ++K +N+L+D  G  ++ D GLA      D    S K   A
Sbjct: 107 ILG----LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-----CD---FSKKKPHA 154

Query: 856 L----GYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
                GYMAPE   + V      D +  G ++ +++ G  P
Sbjct: 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 53/199 (26%), Positives = 104/199 (52%), Gaps = 9/199 (4%)

Query: 697 ELGRGGFGAVY--RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           +LG G +  V+  R+ L +   VA+K++ +     +     REV  L  ++H N+VTL  
Sbjct: 13  KLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
              T     L++E++    L +++ +   GN +S +     +    + LA+ H+  ++H 
Sbjct: 72  IVHTDKSLTLVFEYLDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LI+  GE K+ D+GLAR   +  +   S+++ + L Y  P+    + + + + 
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPTK-TYSNEVVT-LWYRPPDVLLGSSEYSTQI 186

Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++G G +  E+ +G RPL
Sbjct: 187 DMWGVGCIFFEMASG-RPL 204

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 66.4 bits (162), Expect = 2e-11
 Identities = 58/200 (29%), Positives = 89/200 (44%), Gaps = 12/200 (6%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDF-----EREVKKLGKVRHPNLVTL 752
           +GRG +  V    L+  R +   K+    LV   ED      E+ V +     HP LV L
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS-NHPFLVGL 61

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
              + T+S    + EFVSGG L  H+           + RF   +  + +L  LH+  II
Sbjct: 62  HSCFQTESRLFFVIEFVSGGDLMFHMQRQR--KLPEEHARFYSAE-ISLALNFLHERGII 118

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           + ++K  NVL+D  G  K+ DYG+ +    +     +S       Y+APE   R      
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEI-LRGEDYGF 175

Query: 873 KCDVYGFGVLVLEVVTGKRP 892
             D +  GVL+ E++ G+ P
Sbjct: 176 SVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 66.1 bits (161), Expect = 2e-11
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 33/218 (15%)

Query: 698 LGRGGFGAVYRTV---LRDGRP-----VAIKKLTVSSLVKSQEDF--EREVKKLGKVRHP 747
           LG G FG V R     +   RP     VA+K L  ++  K   D   E E+ KL   +H 
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG-KHK 78

Query: 748 NLVTLEGYYWTQSLQLLIYEFVSGGSLHKHL-----------------HEGSGGNFLSWN 790
           N++ L G    +    +I E+ + G+L + L                  E      LS+ 
Sbjct: 79  NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ----LSFK 134

Query: 791 ERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS 850
           +  +     A+ + +L     IH ++ + NVL+      K+ D+GLAR +  +D Y  +S
Sbjct: 135 DLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194

Query: 851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
             +  + +MAPE     V  T + DV+ FG+L+ E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 66.2 bits (161), Expect = 2e-11
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 12/201 (5%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDF-----EREVKKLGKVRHPNLVTL 752
           +GRG +  V    L+    +   K+    LV   ED      E+ V +     +P LV L
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASS-NPFLVGL 61

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
              + T S   L+ E+V+GG L  H+           + RF   +    +L  LH+  II
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHMQRQR--KLPEEHARFYAAE-ICIALNFLHERGII 118

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           + ++K  NVL+D  G  K+ DYG+ +    L     +S       Y+APE   R  +   
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEI-LRGEEYGF 175

Query: 873 KCDVYGFGVLVLEVVTGKRPL 893
             D +  GVL+ E++ G+ P 
Sbjct: 176 SVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 65.8 bits (161), Expect = 2e-11
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 15/205 (7%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT-VSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +G G +G V   +  R G+ VAIKK+     +    +   RE+K L   +H N++ +   
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72

Query: 756 YWT-QSLQLLIYEFV---SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
                +    +Y  V       LH  +H  S       + R+ + Q   + L ++H +N+
Sbjct: 73  LRPPGADFKDVY-VVMDLMESDLHHIIH--SDQPLTEEHIRYFLYQ-LLRGLKYIHSANV 128

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAPEFACRTV 868
           IH ++K SN+L++   E ++GD+G+AR L   P   +Y ++  + +   Y APE      
Sbjct: 129 IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV-ATRWYRAPELLLSLP 187

Query: 869 KITDKCDVYGFGVLVLEVVTGKRPL 893
           + T   D++  G +  E++ G+R L
Sbjct: 188 EYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 65.5 bits (159), Expect = 2e-11
 Identities = 53/218 (24%), Positives = 99/218 (45%), Gaps = 34/218 (15%)

Query: 696 CELGRGGFGAVYRTVLRDG---RPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           C++GRG +G VY+   +DG   +  A+K++  + +  S     RE+  L +++HPN++ L
Sbjct: 7   CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA---CREIALLRELKHPNVIAL 63

Query: 753 EGYYWTQSLQ--LLIYEFVSGGSLH-KHLHEGSGGNFLSWNERFNVIQGTAKSLA----- 804
           +  + + S +   L++++      H    H  S  N     +   + +   KSL      
Sbjct: 64  QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN----KKPMQLPRSMVKSLLYQILD 119

Query: 805 ---HLHQSNIIHYNIKSSNVLIDGSGEP----KVGDYGLARLL-----PMLDRYVLSSKI 852
              +LH + ++H ++K +N+L+ G G      K+ D G ARL      P+ D       +
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL----DPV 175

Query: 853 QSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGK 890
                Y APE        T   D++  G +  E++T +
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 54/199 (27%), Positives = 104/199 (52%), Gaps = 14/199 (7%)

Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE----REVKKLGKVRHPNLVT 751
           +LG G +  VY+ + R +G+ VA+K +++    K++E       RE   L  ++H N+V 
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISM----KTEEGVPFTAIREASLLKGLKHANIVL 67

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L     T+     ++E++    L +++ +  GG    +N R  + Q   + LA++H  +I
Sbjct: 68  LHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGG-LHPYNVRLFMFQ-LLRGLAYIHGQHI 124

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H ++K  N+LI   GE K+ D+GLAR   +  +   SS++ + L Y  P+        +
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-TYSSEVVT-LWYRPPDVLLGATDYS 182

Query: 872 DKCDVYGFGVLVLEVVTGK 890
              D++G G + +E++ G+
Sbjct: 183 SALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 23/206 (11%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ--EDF---EREVKKLGKVRHPNLVTL 752
           +G G +G VY+      R +   +L    ++K +  +DF   ++E+  + + +H N+V  
Sbjct: 17  VGSGTYGDVYK-----ARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY 71

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
            G Y ++    +  E+  GGSL    H       LS  +   V + T + LA+LH    +
Sbjct: 72  FGSYLSREKLWICMEYCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLAYLHSKGKM 128

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFAC--RT 867
           H +IK +N+L+  +G+ K+ D+G+A  +         +K +S +G   +MAPE A   + 
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKIT-----ATIAKRKSFIGTPYWMAPEVAAVEKN 183

Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
                 CD++  G+  +E+   + P+
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 65.8 bits (160), Expect = 3e-11
 Identities = 70/218 (32%), Positives = 107/218 (49%), Gaps = 9/218 (4%)

Query: 96  LLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVIS 155
           LL L  L  L L+ N L  +IS  L +L NL  +DL  N+++  IP        +L+ + 
Sbjct: 89  LLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELD 146

Query: 156 LAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPK 215
           L+ N+    +PS L     L  ++LS N  S  LP  +  LS L  LDLS N +  ++P 
Sbjct: 147 LSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPP 203

Query: 216 GVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMN 275
            +E L  L  ++LS N     +   + +   L  ++ S N    +LPE++  LS    ++
Sbjct: 204 EIELLSALEELDLSNN-SIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLD 261

Query: 276 LRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISI 313
           L  N  S  +   +G L +L  LDLSGN  S A+P+  
Sbjct: 262 LSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLIA 297

Length = 394

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 64.5 bits (157), Expect = 4e-11
 Identities = 55/206 (26%), Positives = 100/206 (48%), Gaps = 17/206 (8%)

Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           ELG+G +G+VY+ + R  G  +A+K++ +            E+  L K   P +V   G 
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHL-HQSNIIHY 814
           ++ +    +  E++  GSL K    G     +  +    +     K L  L  + NIIH 
Sbjct: 68  FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHR 127

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE-----FACR 866
           ++K +NVL++G+G+ K+ D+G++  L       ++S  ++ +G   YMAPE        +
Sbjct: 128 DVKPTNVLVNGNGQVKLCDFGVSGNL-------VASLAKTNIGCQSYMAPERIKSGGPNQ 180

Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRP 892
               T + DV+  G+ +LE+  G+ P
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 16/206 (7%)

Query: 697 ELGRGGFGAVY----RTVLRDGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNL 749
           ELG+G FG VY    + V++D  P   VAIK +  ++ ++ + +F  E   + +    ++
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKD-EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71

Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLH------EGSGGNFLSWNERFNVIQG-TAKS 802
           V L G        L+I E ++ G L  +L       E +        ++   + G  A  
Sbjct: 72  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           +A+L+ +  +H ++ + N ++      K+GD+G+ R +   D Y    K    + +M+PE
Sbjct: 132 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 191

Query: 863 FACRTVKITDKCDVYGFGVLVLEVVT 888
            + +    T   DV+ FGV++ E+ T
Sbjct: 192 -SLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 64.4 bits (157), Expect = 6e-11
 Identities = 52/170 (30%), Positives = 83/170 (48%), Gaps = 11/170 (6%)

Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQED----FEREVKKLGKVRHPNLVTL 752
           +G+G FG V     + DG+  A+K L   +++K +E      ER V  L  V+HP LV L
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVL-LKNVKHPFLVGL 61

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
              + T      + ++V+GG L  HL      +F     RF   +  A +L +LH  NII
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHLQRER--SFPEPRARFYAAE-IASALGYLHSLNII 118

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           + ++K  N+L+D  G   + D+GL +    ++    +S       Y+APE
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 64.3 bits (156), Expect = 6e-11
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 18/204 (8%)

Query: 698 LGRGGFGAVYRTVL-RDGRPVAIKKLTVSSLVKSQED----FEREVKKLGKVRHPNLVTL 752
           +G+G FG V       DG+  A+K L    ++  +E      ER V  L  V+HP LV L
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVL-LKNVKHPFLVGL 61

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
              + T      + +FV+GG L  HL      +F     RF   +  A +L +LH  NI+
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRER--SFPEPRARFYAAE-IASALGYLHSINIV 118

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVK 869
           + ++K  N+L+D  G   + D+GL +     +    S    +  G   Y+APE   R   
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK-----EGIAQSDTTTTFCGTPEYLAPE-VIRKQP 172

Query: 870 ITDKCDVYGFGVLVLEVVTGKRPL 893
             +  D +  G ++ E++ G  P 
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 63.5 bits (154), Expect = 7e-11
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 18/213 (8%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVS----SLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG+G FG VY     D GR +A+K++          K     E E++ L  + H  +V  
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 753 EGYYW-TQSLQLLIY-EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
            G         L I+ E + GGS+   L        L+ N      +   + +++LH + 
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA---LTENVTRKYTRQILEGVSYLHSNM 126

Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS-SKIQSALG---YMAPEFACR 866
           I+H +IK +N+L D  G  K+GD+G ++ L  +    LS + ++S  G   +M+PE    
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQTI---CLSGTGMKSVTGTPYWMSPE-VIS 182

Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM 899
                 K D++  G  V+E++T K P + ++ M
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM 215

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 64.0 bits (156), Expect = 7e-11
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 13/200 (6%)

Query: 698 LGRGGFGAVYR-TVLRDGRP-----VAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LG G FG V   T     +      VA+K L  ++    +E    E+K +  +  H N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
            L G        L+I E+   G L   L      +FL+  +  +     AK +A L   N
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN 161

Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE--FACRTV 868
            IH ++ + NVL+      K+ D+GLAR +     YV+    +  + +MAPE  F C   
Sbjct: 162 CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC--- 218

Query: 869 KITDKCDVYGFGVLVLEVVT 888
             T + DV+ +G+L+ E+ +
Sbjct: 219 VYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 65.6 bits (160), Expect = 8e-11
 Identities = 32/98 (32%), Positives = 57/98 (58%)

Query: 274 MNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSL 333
           + L      G +P  I +L  L++++LSGN   G +P S+G++  L+VL+ S N   GS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 334 PDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSF 371
           P+S+    +L  L+ + NS++G +P  +    L++ SF
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF 520

Length = 623

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 8e-11
 Identities = 55/188 (29%), Positives = 85/188 (45%), Gaps = 39/188 (20%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVS--------SLVKSQEDFEREV---KKLGKV 744
           E+G G +G VY+   L  GR VA+KK+ V         S +       RE+   K+L   
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTL-------REIALLKQLESF 58

Query: 745 RHPNLVTL----EGYYWTQSLQL-LIYEFVSGGSLHKHL--HEGSGGNFLSWNERFNVIQ 797
            HPN+V L     G    + L+L L++E V    L  +L      G   L      ++++
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPG---LPPETIKDLMR 114

Query: 798 GTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQS--- 854
              + +  LH   I+H ++K  N+L+   G+ K+ D+GLAR+      Y     + S   
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI------YSFEMALTSVVV 168

Query: 855 ALGYMAPE 862
            L Y APE
Sbjct: 169 TLWYRAPE 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 63.9 bits (155), Expect = 9e-11
 Identities = 53/213 (24%), Positives = 98/213 (46%), Gaps = 23/213 (10%)

Query: 698 LGRGGFGAVY--------RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V         +   ++   VA+K L   +  K   D   E++ +  + +H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHE----GSGGNF---------LSWNERFNV 795
           ++ L G         +I E+ S G+L ++L      G   ++         +++ +  + 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+  +   K+ D+GLAR +  +D Y  ++  +  
Sbjct: 143 TYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLP 202

Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     V  T + DV+ FGVL+ E+ T
Sbjct: 203 VKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 63.9 bits (155), Expect = 9e-11
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 22/206 (10%)

Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQED----FEREVKKLGKVRHPNLVTL 752
           +G+G FG V     + + +  A+K L   +++K +E+     ER V  L  V+HP LV L
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVL-LKNVKHPFLVGL 61

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
              + T      + ++++GG L  HL       FL    RF   +  A +L +LH  NI+
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAE-IASALGYLHSLNIV 118

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFAC-----RT 867
           + ++K  N+L+D  G   + D+GL +    ++    +S       Y+APE        RT
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT 176

Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
           V      D +  G ++ E++ G  P 
Sbjct: 177 V------DWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 63.8 bits (155), Expect = 9e-11
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 12/201 (5%)

Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQED----FEREVKKLGKVRHPNLVTL 752
           +G+G FG V     + DG   A+K L   +++K +E      ER V  L  ++HP LV L
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVL-LKNLKHPFLVGL 61

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
              + T      + ++V+GG L  HL       FL    RF   +  A ++ +LH  NII
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQRER--CFLEPRARFYAAE-VASAIGYLHSLNII 118

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           + ++K  N+L+D  G   + D+GL +    ++    +S       Y+APE   R      
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPE-VLRKEPYDR 175

Query: 873 KCDVYGFGVLVLEVVTGKRPL 893
             D +  G ++ E++ G  P 
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 65.2 bits (159), Expect = 1e-10
 Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 1/95 (1%)

Query: 163 GKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKN 222
           G IP+ +S    L +INLS N     +P  +  +++L  LDLS N   G IP+ +  L +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 223 LRVINLSKNMFSGSIPDGIGSCSLLRTI-DFSENS 256
           LR++NL+ N  SG +P  +G   L R   +F++N+
Sbjct: 492 LRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNA 526

Length = 623

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 63.4 bits (154), Expect = 1e-10
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 13/207 (6%)

Query: 691 LLNKDCELGRGGFGAVYRTVL-----RDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR 745
            L +  +LG G FG V            G  VA+K L   S      D ++E++ L  + 
Sbjct: 5   FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64

Query: 746 HPNLVTLEGYY---WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKS 802
           H N+V  +G         ++L I EF+  GSL ++L      N ++  ++        K 
Sbjct: 65  HENIVKYKGICTEDGGNGIKL-IMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKG 121

Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAP 861
           + +L     +H ++ + NVL++   + K+GD+GL + +    + Y +   + S + + AP
Sbjct: 122 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181

Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT 888
           E   ++ K     DV+ FGV + E++T
Sbjct: 182 ECLIQS-KFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 63.8 bits (155), Expect = 1e-10
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 32/211 (15%)

Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-----REVKKLGKVRHPNLVT 751
           LG+G FG V    L+  G   A+K L    +V   +D E     + V  L    +P L  
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALK-KDVVLIDDDVECTMVEKRVLALA-WENPFLTH 60

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKS------LAH 805
           L   + T+     + EF++GG L  H+ +           RF++ + T  +      L  
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG---------RFDLYRATFYAAEIVCGLQF 111

Query: 806 LHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE 862
           LH   II+ ++K  NV++D  G  K+ D+G+ +     +     ++  +  G   Y+APE
Sbjct: 112 LHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCK-----ENVFGDNRASTFCGTPDYIAPE 166

Query: 863 FACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
              + +K T   D + FGVL+ E++ G+ P 
Sbjct: 167 I-LQGLKYTFSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 65.3 bits (159), Expect = 1e-10
 Identities = 54/191 (28%), Positives = 91/191 (47%), Gaps = 19/191 (9%)

Query: 714 GRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTL--EGYYWTQSLQLLIYEFV 769
           G  VAIK L   +  +  +   F RE     ++ HPN+V L   G      L   ++E+V
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61

Query: 770 SGGSLHKHL-HEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG- 827
            G +L + L  +G+    L   E   ++     +LA  H   I+H ++K  N+++  +G 
Sbjct: 62  PGRTLREVLAADGA----LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117

Query: 828 EP--KVGDYGLARLLP-----MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFG 880
            P  KV D+G+  LLP      +     ++++     Y APE   R   +T   D+Y +G
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNSDLYAWG 176

Query: 881 VLVLEVVTGKR 891
           ++ LE +TG+R
Sbjct: 177 LIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 57/226 (25%), Positives = 92/226 (40%), Gaps = 53/226 (23%)

Query: 698 LGRGGFGAVY-------------------RTVLRDGRPVAIKKLTVSSLVKSQEDFEREV 738
           +GRGGFG VY                   R  ++ G  +A+ +  + SLV + +      
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD------ 55

Query: 739 KKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF---NV 795
                   P +V +   + T      I + ++GG LH HL +   G F     RF    +
Sbjct: 56  -------CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEI 106

Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
           I G    L H+H   +++ ++K +N+L+D  G  ++ D GLA      D    S K   A
Sbjct: 107 ILG----LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-----CD---FSKKKPHA 154

Query: 856 L----GYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWK 897
                GYMAPE   +        D +  G ++ +++ G  P    K
Sbjct: 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 21/201 (10%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           +G+G FG V     R G  VA+K +   +  ++   F  E   + ++RH NLV L G   
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69

Query: 758 TQSLQLLIY-EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
            +   L I  E+++ GSL  +L    G + L  +          +++ +L  +N +H ++
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDL 128

Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA----LGYMAPEFACRTVKITD 872
            + NVL+      KV D+GL +          +S  Q      + + APE A R  K + 
Sbjct: 129 AARNVLVSEDNVAKVSDFGLTK---------EASSTQDTGKLPVKWTAPE-ALREKKFST 178

Query: 873 KCDVYGFGVLVLEVVT-GKRP 892
           K DV+ FG+L+ E+ + G+ P
Sbjct: 179 KSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 17/205 (8%)

Query: 697 ELGRGGFGAVYRTVL---RDGRPVAIKKLTVSSLVKSQED-FEREVKKLGKVRHPNLVTL 752
           ELG G FG V + +    +  + VA+K L   +   + +D   RE   + ++ +P +V +
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
            G    +S  +L+ E    G L+K L +       +  E   ++   +  + +L ++N +
Sbjct: 62  IGICEAESW-MLVMELAELGPLNKFLQKNKHVTEKNITE---LVHQVSMGMKYLEETNFV 117

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQS----ALGYMAPEFACRTV 868
           H ++ + NVL+      K+ D+GL++ L   + Y    K ++     + + APE      
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYY---KAKTHGKWPVKWYAPE-CMNYY 173

Query: 869 KITDKCDVYGFGVLVLEVVT-GKRP 892
           K + K DV+ FGVL+ E  + G++P
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 41/218 (18%)

Query: 694 KDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-----REVKKLGKVRHP 747
           K  +LG G +  VY+   +  G+ VA+K++ +       E+       RE   L  ++H 
Sbjct: 9   KLDKLGEGSYATVYKGRSKLTGQLVALKEIRLE-----HEEGAPFTAIREASLLKDLKHA 63

Query: 748 NLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHE--GSGGNFLSWNE----RFNVIQGTAK 801
           N+VTL     T+    L++E++        L +     G  LS +      F +++G   
Sbjct: 64  NIVTLHDIIHTKKTLTLVFEYL-----DTDLKQYMDDCGGGLSMHNVRLFLFQLLRG--- 115

Query: 802 SLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL--LPMLDRYVLSSKIQS----A 855
            LA+ HQ  ++H ++K  N+LI   GE K+ D+GLAR   +P        SK  S     
Sbjct: 116 -LAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--------SKTYSNEVVT 166

Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           L Y  P+    + + +   D++G G +  E+ TG RPL
Sbjct: 167 LWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG-RPL 203

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 45/217 (20%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFE-------REVKKLGKVRHPNL 749
           +G G +G VY+      G  VA+KK+ +       ED E       RE+  L ++ HPN+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLE-----TED-EGVPSTAIREISLLKELNHPNI 60

Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHL-HEGSGGN-------FLSWNERFNVIQGTAK 801
           V L     +++   L++EF+    L K++      G        +L     + ++QG   
Sbjct: 61  VRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYL-----YQLLQG--- 111

Query: 802 SLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL--LPMLDRY---VLSSKIQSAL 856
            +A+ H   ++H ++K  N+LID  G  K+ D+GLAR   +P +  Y   V++      L
Sbjct: 112 -IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP-VRTYTHEVVT------L 163

Query: 857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
            Y APE    + + +   D++  G +  E+V  +RPL
Sbjct: 164 WYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 62.4 bits (151), Expect = 2e-10
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 21/208 (10%)

Query: 698 LGRGGFGAVYRTVLR-DGRPV--AIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLE 753
           +G G FG V +  ++ DG  +  AIK++   +      DF  E++ L K+  HPN++ L 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLH-------------EGSGGNFLSWNERFNVIQGTA 800
           G    +    L  E+   G+L   L                S  + LS  +  +     A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 801 KSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMA 860
           + + +L Q   IH ++ + N+L+  +   K+ D+GL+R     + YV  +  +  + +MA
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMA 179

Query: 861 PEFACRTVKITDKCDVYGFGVLVLEVVT 888
            E    +V  T   DV+ +GVL+ E+V+
Sbjct: 180 IESLNYSV-YTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 51/202 (25%), Positives = 100/202 (49%), Gaps = 14/202 (6%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G  G+V +   +  G  +A K + + +    ++   RE++ + + R P +V+  G 
Sbjct: 12  DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH-QSNIIHY 814
           +  ++   +  EF+  GSL +   +G     +       +     + L +L+    I+H 
Sbjct: 72  FLNENNICMCMEFMDCGSLDRIYKKGGP---IPVEILGKIAVAVVEGLTYLYNVHRIMHR 128

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLL--PMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           +IK SN+L++  G+ K+ D+G++  L   + D +V +S       YM+PE   +  K T 
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTST------YMSPE-RIQGGKYTV 181

Query: 873 KCDVYGFGVLVLEVVTGKRPLS 894
           K DV+  G+ ++E+  GK P +
Sbjct: 182 KSDVWSLGISIIELALGKFPFA 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 16/200 (8%)

Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     +  G   AIK L    ++  K  +   +E   L ++ HP +V +  
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +  ++    + EFV GG L  HL     G F +   +F   +    +  +LH  +II+ 
Sbjct: 86  SFQDENRVYFLLEFVVGGELFTHLR--KAGRFPNDVAKFYHAE-LVLAFEYLHSKDIIYR 142

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDR-YVLSSKIQSALGYMAPEFACRTVKITDK 873
           ++K  N+L+D  G  KV D+G A+ +P  DR + L    +    Y+APE      K   K
Sbjct: 143 DLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFTLCGTPE----YLAPEVI--QSKGHGK 194

Query: 874 C-DVYGFGVLVLEVVTGKRP 892
             D +  GVL+ E + G  P
Sbjct: 195 AVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 2e-10
 Identities = 51/193 (26%), Positives = 82/193 (42%), Gaps = 45/193 (23%)

Query: 699 GRGGFGAVYRTVL---RDGRPVAIKKLTVSSLVKSQEDFE----REVKKLGKVRHPNLVT 751
           GRG +G VY+      +DG+  AIKK       +          RE+  L +++H N+V+
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKF--KGDKEQYTGISQSACREIALLRELKHENVVS 66

Query: 752 LEGYY---WTQSLQLLI-Y-EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSL--- 803
           L   +     +S+ LL  Y E      +  H             +R ++     KSL   
Sbjct: 67  LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQ----------AKRVSIPPSMVKSLLWQ 116

Query: 804 -----AHLHQSNIIHYNIKSSNVLIDGSGEP----KVGDYGLAR-----LLPMLDRYVLS 849
                 +LH + ++H ++K +N+L+ G G      K+GD GLAR     L P+ D     
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD----L 172

Query: 850 SKIQSALGYMAPE 862
             +   + Y APE
Sbjct: 173 DPVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 25/223 (11%)

Query: 698 LGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQEDFER--EVKKLGKVRHPNLVTL 752
           LG+G FG V   ++R+   GR  A+K L    ++   E      E + L   RHP L  L
Sbjct: 3   LGKGTFGKV--ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           +  + T      + E+ +GG L  HL       F     RF   +    +L +LH  +++
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAE-IVSALEYLHSRDVV 117

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVK 869
           + +IK  N+++D  G  K+ D+GL +     +     + +++  G   Y+APE     ++
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAPE----VLE 168

Query: 870 ITD---KCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE 909
             D     D +G GV++ E++ G+ P         F +  +EE
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 211

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.7 bits (155), Expect = 3e-10
 Identities = 29/74 (39%), Positives = 48/74 (64%)

Query: 189 LPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLR 248
           +P  I  L  L++++LS N + G IP  + S+ +L V++LS N F+GSIP+ +G  + LR
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493

Query: 249 TIDFSENSFSGNLP 262
            ++ + NS SG +P
Sbjct: 494 ILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 62.6 bits (152), Expect = 3e-10
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 20/205 (9%)

Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQED------FEREVKKLGKVRHPNLV 750
           LG+G FG V    L+  GR  A+K L    ++  Q+D       E+ +  L +  HP L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVIL--QDDDVECTMTEKRILSLAR-NHPFLT 59

Query: 751 TLEGYYWTQSLQLLIY--EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
            L  Y   Q+   L +  EFV+GG L  H+ +     F     RF   + T+ +L  LH 
Sbjct: 60  QL--YCCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEITS-ALMFLHD 114

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTV 868
             II+ ++K  NVL+D  G  K+ D+G+ +    +     +S       Y+APE   + +
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEI-LQEM 171

Query: 869 KITDKCDVYGFGVLVLEVVTGKRPL 893
                 D +  GVL+ E++ G  P 
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 61.8 bits (150), Expect = 3e-10
 Identities = 55/206 (26%), Positives = 100/206 (48%), Gaps = 33/206 (16%)

Query: 698 LGRGGFGAVYRT-VLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G  G VY+   L   R +A+K + +   V+ Q+    E++ L K   P ++   G +
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 757 WTQSLQLLIYEFVSGGSL--HKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           + ++   +  EF+ GGSL  ++ + E   G       R  V     K L +L    I+H 
Sbjct: 69  FVENRISICTEFMDGGSLDVYRKIPEHVLG-------RIAV--AVVKGLTYLWSLKILHR 119

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKIT 871
           ++K SN+L++  G+ K+ D+G++  L       ++S  ++ +G   YMAPE      +I+
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVSTQL-------VNSIAKTYVGTNAYMAPE------RIS 166

Query: 872 DK-----CDVYGFGVLVLEVVTGKRP 892
            +      DV+  G+  +E+  G+ P
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 62.4 bits (151), Expect = 3e-10
 Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 19/220 (8%)

Query: 698 LGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQEDFER--EVKKLGKVRHPNLVTL 752
           LG+G FG V   ++R+   G+  A+K L    ++   E      E + L   RHP L +L
Sbjct: 3   LGKGTFGKV--ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           +  + T+     + E+V+GG L  HL       F     RF   +    +L +LH   I+
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRER--VFSEDRTRFYGAE-IVSALDYLHSGKIV 117

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVK 869
           + ++K  N+++D  G  K+ D+GL +     +    ++ +++  G   Y+APE       
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK-----EGITDAATMKTFCGTPEYLAPE-VLEDND 171

Query: 870 ITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE 909
                D +G GV++ E++ G+ P         F +  +E+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED 211

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 25/216 (11%)

Query: 697 ELGRGGFGAVY-------------RTVLRDGRP--VAIKKLTVSSLVKSQEDFEREVKKL 741
           +LG G FG V+                  DG+P  VA+K L       ++ DF +E+K +
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 742 GKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHE-------GSGGNF--LSWNER 792
            ++++PN++ L G   +     +I E++  G L++ L +           N   +S    
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 793 FNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI 852
             +    A  + +L   N +H ++ + N L+      K+ D+G++R L   D Y +  + 
Sbjct: 132 LYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRA 191

Query: 853 QSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
              + +MA E +    K T   DV+ FGV + E+ T
Sbjct: 192 VLPIRWMAWE-SILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 62.1 bits (151), Expect = 3e-10
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 33/210 (15%)

Query: 698 LGRGGFGAVYRTVL----RDGRPVAIKKLTVSSLVKSQEDFER--EVKKLGKVRHPNLVT 751
           LG+G FG V   +L      G+  A+K L    ++   E      E + L   RHP L  
Sbjct: 3   LGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHL-HEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           L+  + T      + E+ +GG L  HL  E     F     RF   +    +L +LH  +
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAE-IVSALGYLHSCD 115

Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFA--- 864
           +++ ++K  N+++D  G  K+ D+GL +     +     + +++  G   Y+APE     
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAPEVLEDN 170

Query: 865 --CRTVKITDKCDVYGFGVLVLEVVTGKRP 892
              R V      D +G GV++ E++ G+ P
Sbjct: 171 DYGRAV------DWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 62.3 bits (151), Expect = 4e-10
 Identities = 80/314 (25%), Positives = 128/314 (40%), Gaps = 48/314 (15%)

Query: 244 CSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGN 303
                T+    +S S  L   +   S  + ++  +NL           L  L +LDL+ N
Sbjct: 53  NLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENL---------LNLLPLPSLDLNLN 103

Query: 304 KFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFS 363
           +        +  L  L  L+   N +T   P       NL  LD S N +   LP  + +
Sbjct: 104 RLRSN-ISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRN 161

Query: 364 -SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLN 422
              L  +  + N + +          S+  +L  LDLS N+ S + P  I  LS L+ L+
Sbjct: 162 LPNLKNLDLSFNDLSD-----LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELD 215

Query: 423 LSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPT 482
           LS NS++  +  ++ +LK L+ L+LS N L                           +P 
Sbjct: 216 LSNNSII-ELLSSLSNLKNLSGLELSNNKLE-------------------------DLPE 249

Query: 483 SIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFN 542
           SI N S+L +L LS N ++     ++  LTNL+ +DLS NSL+  LP     L+ L    
Sbjct: 250 SIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLI--ALLLLLLEL 305

Query: 543 ISHNHLQGELPAGG 556
           + +  L  +     
Sbjct: 306 LLNLLLTLKALELK 319

Length = 394

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 61.7 bits (150), Expect = 4e-10
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 41/216 (18%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFE-------REVKKLGKVRHPN 748
           ++G G +G V++   R+    VA+K+      V+  +D E       RE+  L +++H N
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKR------VRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSG-------GNFLSWNERFNVIQGTAK 801
           +V L     +     L++E+     L K+    +G        +F+     F +++G   
Sbjct: 61  IVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFM-----FQLLKG--- 111

Query: 802 SLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA----LG 857
            LA  H  N++H ++K  N+LI+ +GE K+ D+GLAR       + +  +  SA    L 
Sbjct: 112 -LAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR------AFGIPVRCYSAEVVTLW 164

Query: 858 YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           Y  P+        +   D++  G +  E+    RPL
Sbjct: 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 52/209 (24%), Positives = 96/209 (45%), Gaps = 23/209 (11%)

Query: 701 GGFGAVYRTVLRDGRPVAIKKLTVSSLVK--SQEDFER---EVKKLGKVRHPNL-----V 750
           G FG ++  +L D +P   +++ V ++    S+        E   L  + H N+     V
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLH---EGSGGNFLSWNERFNVIQGT--AKSLAH 805
            +E          ++Y +++ G+L   L     G   N  + + +  V      A  +++
Sbjct: 77  CIEDG----EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132

Query: 806 LHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR-LLPMLDRYVLSSKIQSALGYMAPEFA 864
           LH+  +IH +I + N +ID   + K+ D  L+R L PM D + L       + +MA E +
Sbjct: 133 LHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPM-DYHCLGDNENRPVKWMALE-S 190

Query: 865 CRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
               + +   DV+ FGVL+ E++T G+ P
Sbjct: 191 LVNKEYSSASDVWSFGVLLWELMTLGQTP 219

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 61.8 bits (151), Expect = 5e-10
 Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 37/161 (22%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKL--TVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           +G G +G V   V  R GR VAIKK+      L+ ++    RE+K L  +RH N++ L  
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHENIIGL-- 64

Query: 755 YYWTQSLQLLIYEFVSGGS------------LHKHLHEGSGGNFLSWNERF-----NVIQ 797
                 L +L        +            LHK +        L+ ++        +++
Sbjct: 65  ------LDILRPPSPEDFNDVYIVTELMETDLHKVIKSP---QPLT-DDHIQYFLYQILR 114

Query: 798 GTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR 838
           G    L +LH +N+IH ++K SN+L++ + + K+ D+GLAR
Sbjct: 115 G----LKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 61.3 bits (149), Expect = 5e-10
 Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 27/220 (12%)

Query: 692 LNKDCELGRGGFGAVYRTVLRDGRP------VAIKKLTVSSLVKSQEDF--EREV-KKLG 742
           L     LG G FG V +              VA+K L   +  K   D   E E+ K +G
Sbjct: 14  LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 73

Query: 743 KVRHPNLVTLEGYYWTQSLQL-LIYEFVSGGSLHKHLHEGSG-GNFLSWNERFNVIQG-- 798
           K  H N++ L G   TQ   L ++ E+ + G+L   L      G + S ++     +   
Sbjct: 74  K--HKNIINLLGVC-TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130

Query: 799 ----------TAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL 848
                      A+ +  L     IH ++ + NVL+      K+ D+GLAR +  +D Y  
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190

Query: 849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           ++  +  + +MAPE     V  T + DV+ FGVL+ E+ T
Sbjct: 191 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 55.0 bits (133), Expect = 5e-10
 Identities = 20/42 (47%), Positives = 26/42 (61%), Gaps = 1/42 (2%)

Query: 32 LNDDVLGLIVFKADIQ-DPNGKLSSWSEDDDTPCNWFGVKCS 72
          LNDD   L+ FK+ +  DP+G LSSW+     PC+W GV C 
Sbjct: 1  LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 16/210 (7%)

Query: 698 LGRGGFGAVYRTVLR--DGRP--VAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTL 752
           LG G FG+V    L   DG    VA+K + +     S+ E+F  E   +    HPN++ L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 753 EGYYWTQSLQ------LLIYEFVSGGSLHKHL---HEGSGGNFLSWNERFNVIQGTAKSL 803
            G  +  S        ++I  F+  G LH  L     G     L        +   A  +
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
            +L   N IH ++ + N ++       V D+GL++ +   D Y      +  + ++A E 
Sbjct: 127 EYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES 186

Query: 864 ACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
               V  T K DV+ FGV + E+ T G+ P
Sbjct: 187 LADRV-YTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 61.1 bits (148), Expect = 5e-10
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 14/205 (6%)

Query: 697 ELGRGGFGAVYRTVLRD---GRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG+G FG VY    RD   G     VA+K +  S+ ++ + +F  E   +      ++V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLH------EGSGGNFL-SWNERFNVIQGTAKSL 803
            L G        L++ E ++ G L  +L       E + G    +  E   +    A  +
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
           A+L+    +H ++ + N ++      K+GD+G+ R +   D Y    K    + +MAPE 
Sbjct: 133 AYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE- 191

Query: 864 ACRTVKITDKCDVYGFGVLVLEVVT 888
           + +    T   D++ FGV++ E+ +
Sbjct: 192 SLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 61.2 bits (148), Expect = 6e-10
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 27/211 (12%)

Query: 698 LGRGGFGAVYRTVLR-DGRPV--AIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLE 753
           +G G FG V R +++ DG  +  AIK L   +      DF  E++ L K+  HPN++ L 
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLA--------- 804
           G    +    +  E+   G+L   L +      L  +  F    GTA +L          
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKS---RVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 805 -------HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG 857
                  +L +   IH ++ + NVL+  +   K+ D+GL+R     + YV  +  +  + 
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLPVR 183

Query: 858 YMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           +MA E    +V  T K DV+ FGVL+ E+V+
Sbjct: 184 WMAIESLNYSV-YTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 60.9 bits (148), Expect = 6e-10
 Identities = 67/233 (28%), Positives = 106/233 (45%), Gaps = 53/233 (22%)

Query: 696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLG----KVRHPNLV 750
            ELGRG +G V +      G  +A+K++  +  V SQE  +R +  L      V  P  V
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRAT--VNSQEQ-KRLLMDLDISMRSVDCPYTV 63

Query: 751 TL------EGYYWTQSLQLLIYEFVSGGSL---HKHLHEGS---GGNFLSWNERFNVIQG 798
           T       EG  W       I   V   SL   +K +++       + L       +   
Sbjct: 64  TFYGALFREGDVW-------ICMEVMDTSLDKFYKKVYDKGLTIPEDILG-----KIAVS 111

Query: 799 TAKSLAHLH-QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS-SKIQSAL 856
             K+L +LH + ++IH ++K SNVLI+ +G+ K+ D+G++  L      V S +K   A 
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL------VDSVAKTIDA- 164

Query: 857 G---YMAPEFACRTVKITD------KCDVYGFGVLVLEVVTGKRPLSTWKMMW 900
           G   YMAPE   R     +      K DV+  G+ ++E+ TG+ P  +WK  +
Sbjct: 165 GCKPYMAPE---RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF 214

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 61.2 bits (148), Expect = 6e-10
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 21/208 (10%)

Query: 698 LGRGGFGAVYRTVLR-DG--RPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLE 753
           +G G FG V +  ++ DG     AIK++   +      DF  E++ L K+  HPN++ L 
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEG-------------SGGNFLSWNERFNVIQGTA 800
           G    +    L  E+   G+L   L +              S  + LS  +  +     A
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 801 KSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMA 860
           + + +L Q   IH ++ + N+L+  +   K+ D+GL+R     + YV  +  +  + +MA
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMA 191

Query: 861 PEFACRTVKITDKCDVYGFGVLVLEVVT 888
            E    +V  T+  DV+ +GVL+ E+V+
Sbjct: 192 IESLNYSVYTTNS-DVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 61.2 bits (148), Expect = 6e-10
 Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 23/213 (10%)

Query: 698 LGRGGFGAVYRTV---LRDGRP-----VAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V       L   +P     VA+K L   +  K   D   E++ +  + +H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH-------------EGSGGNFLSWNERFNV 795
           ++ L G         +I E+ S G+L ++L                     LS+ +  + 
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+      K+ D+GLAR +  +D Y  ++  +  
Sbjct: 146 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205

Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE A      T + DV+ FGVL+ E+ T
Sbjct: 206 VKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 61.2 bits (148), Expect = 8e-10
 Identities = 50/205 (24%), Positives = 97/205 (47%), Gaps = 20/205 (9%)

Query: 696 CELGRGGFGAVYRTVLRDGRPVAIKKLT---VSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
            ELG G  G V +   +    +  +KL    +   +++Q    RE++ L +   P +V  
Sbjct: 11  SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPYIVGF 68

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN-I 811
            G +++     +  E + GGSL + L E      +       V     + LA+L + + I
Sbjct: 69  YGAFYSDGEISICMEHMDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLAYLREKHQI 125

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTV 868
           +H ++K SN+L++  GE K+ D+G++  L       + S   S +G   YM+PE   +  
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQL-------IDSMANSFVGTRSYMSPE-RLQGT 177

Query: 869 KITDKCDVYGFGVLVLEVVTGKRPL 893
             + + D++  G+ ++E+  G+ P+
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 60.4 bits (146), Expect = 9e-10
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 15/209 (7%)

Query: 698 LGRGGFGAVYRTVLRDGR---PVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLE 753
           LG G FG+V    L        VA+K + ++   +S+ EDF  E   + +  HPN++ L 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 754 GYYWTQSLQ------LLIYEFVSGGSLHKHLHEGSGGN---FLSWNERFNVIQGTAKSLA 804
           G              ++I  F+  G LH  L     G+   +L        +   A  + 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
           +L   + IH ++ + N +++ +    V D+GL++ +   D Y      +  + ++A E  
Sbjct: 127 YLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESL 186

Query: 865 CRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
              V  T K DV+ FGV + E+ T G+ P
Sbjct: 187 ADRV-YTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 60.7 bits (147), Expect = 1e-09
 Identities = 50/200 (25%), Positives = 93/200 (46%), Gaps = 13/200 (6%)

Query: 696 CELGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
            ++G G +G+V   +  R G  VAIKKL+    S + ++  + RE+  L  ++H N++ L
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHENVIGL 79

Query: 753 EGYYWTQSLQLLIYEF-VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
              + +        +F +    +   L +  G        ++ V Q     L ++H + I
Sbjct: 80  LDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQ-MLCGLKYIHSAGI 138

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPEFACRTVKI 870
           IH ++K  N+ ++   E K+ D+GLAR     +  YV++        Y APE     +  
Sbjct: 139 IHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR------WYRAPEVILNWMHY 192

Query: 871 TDKCDVYGFGVLVLEVVTGK 890
               D++  G ++ E++TGK
Sbjct: 193 NQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 26/215 (12%)

Query: 698 LGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTL 752
           LG+G FG+V    L+      + VA+K L       S  E+F RE   + +  HPN++ L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 753 EGYYWTQSLQ------LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGT------- 799
            G       +      ++I  F+  G LH  L     G      E F +   T       
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGE-----EPFTLPLQTLVRFMID 121

Query: 800 -AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGY 858
            A  + +L   N IH ++ + N +++ +    V D+GL++ +   D Y      +  + +
Sbjct: 122 IASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181

Query: 859 MAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           +A E     V  T   DV+ FGV + E++T G+ P
Sbjct: 182 LALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 60.4 bits (146), Expect = 2e-09
 Identities = 64/233 (27%), Positives = 96/233 (41%), Gaps = 38/233 (16%)

Query: 91  RIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGS 150
            +   L  L  L+ L LS N+L+  +   L+ L NL  +DLSGN +S             
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS------------- 199

Query: 151 LRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLE 210
                         +P  + L S L  ++LS+N     L   +  L  L  L+LS+N LE
Sbjct: 200 -------------DLPPEIELLSALEELDLSNNS-IIELLSSLSNLKNLSGLELSNNKLE 245

Query: 211 GEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSL 270
            ++P+ + +L NL  ++LS N    S    +GS + LR +D S NS S  LP        
Sbjct: 246 -DLPESIGNLSNLETLDLSNNQ--ISSISSLGSLTNLRELDLSGNSLSNALPLIAL---- 298

Query: 271 CNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLN 323
              + L   L    +         L ++ L+ N  S     S   L  L+ LN
Sbjct: 299 ---LLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILESLN 348

Length = 394

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 59.9 bits (145), Expect = 2e-09
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 16/202 (7%)

Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKSQED------FEREVKKLGKVRHPNLV 750
           LG+G FG V    L+    V AIK L    ++  Q+D       E+ +  L   +HP L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL--QDDDVDCTMTEKRILALAA-KHPFLT 59

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
            L   + T+     + E+V+GG L   +       F     RF   + T  +L  LH+  
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTL-ALMFLHRHG 116

Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKI 870
           +I+ ++K  N+L+D  G  K+ D+G+ +    +   V ++       Y+APE   + ++ 
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEI-LQELEY 173

Query: 871 TDKCDVYGFGVLVLEVVTGKRP 892
               D +  GVL+ E++ G+ P
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 23/213 (10%)

Query: 698 LGRGGFGAVYRTVL------RDGRP--VAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V           +  +P  VA+K L   +  K   D   E++ +  + +H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHE----GSGGNF---------LSWNERFNV 795
           ++ L G         ++ E+ S G+L ++L      G   +F         L++ +  + 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+      K+ D+GLAR +  +D Y  ++  +  
Sbjct: 140 AYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLP 199

Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     V  T + DV+ FGVL+ E+ T
Sbjct: 200 VKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 60.6 bits (147), Expect = 3e-09
 Identities = 38/117 (32%), Positives = 58/117 (49%), Gaps = 25/117 (21%)

Query: 101 FLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNR 160
           F+  L L +  L G I  +++KL++L+ I+LSGNS+ G+IP        SL V+ L+ N 
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSL-GSITSLEVLDLSYNS 477

Query: 161 FSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGV 217
           F+G IP SL                          L++LR L+L+ N L G +P  +
Sbjct: 478 FNGSIPESLGQ------------------------LTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 60.0 bits (145), Expect = 3e-09
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 28/207 (13%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY  +  D    VAIKK+      K+     RE+  +  + H N++ L+ YY
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN-----RELLIMKNLNHINIIFLKDYY 128

Query: 757 WTQSLQL--------LIYEFVSGGSLHKHLHEGSGGN-----FLSWNERFNVIQGTAKSL 803
           +T+  +         ++ EF+   ++HK++   +  N     FL     + +     ++L
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQL----CRAL 183

Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEP-KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           A++H   I H ++K  N+LID +    K+ D+G A+ L    R V  S I S   Y APE
Sbjct: 184 AYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV--SYICSRF-YRAPE 240

Query: 863 FACRTVKITDKCDVYGFGVLVLEVVTG 889
                   T   D++  G ++ E++ G
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 59.3 bits (144), Expect = 3e-09
 Identities = 47/172 (27%), Positives = 83/172 (48%), Gaps = 36/172 (20%)

Query: 687 GTHALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE----REVKKL 741
             +  L K   +G+G FG V++   +   + VA+KK+ +      +E F     RE+K L
Sbjct: 12  SKYEKLAK---IGQGTFGEVFKARHKKTKQIVALKKVLME---NEKEGFPITALREIKIL 65

Query: 742 GKVRHPNLVTLEGYYWTQSLQ--------LLIYEFVSGGSLHKHLHEGSGGNFLSW-NER 792
             ++H N+V L     T++           L++EF          H+ +G   LS  N +
Sbjct: 66  QLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE--------HDLAG--LLSNKNVK 115

Query: 793 FN------VIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR 838
           F       V++     L ++H++ I+H ++K++N+LI   G  K+ D+GLAR
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 58.8 bits (142), Expect = 5e-09
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 26/206 (12%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKL--TVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           ++G G +G V   +  R G  VAIKKL     S + ++  + RE++ L  ++H N++ L 
Sbjct: 22  QVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMKHENVIGLL 80

Query: 754 GYYWTQSLQL-------LIYEFVSGGSLHKHL-HEGSGGNFLSWNERFNVIQGTAKSLAH 805
             + T  L L       L+  F+ G  L K + HE    + +    +F V Q   K L +
Sbjct: 81  DVF-TPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRI----QFLVYQ-MLKGLKY 133

Query: 806 LHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFA 864
           +H + IIH ++K  N+ ++   E K+ D+GLAR     +  YV++        Y APE  
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR------WYRAPEVI 187

Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGK 890
              +  T   D++  G ++ E++TGK
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 58.4 bits (141), Expect = 5e-09
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 32/211 (15%)

Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-----REVKKLGKVRHPNLVT 751
           LG+G FG V+   L+   +  AIK L    +V   +D E     + V  L    HP L  
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALK-KDVVLMDDDVECTMVEKRVLSLA-WEHPFLTH 60

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKS------LAH 805
           L   + T+     + E+++GG L  H+             +F++ + T  +      L  
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSC---------HKFDLPRATFYAAEIICGLQF 111

Query: 806 LHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE 862
           LH   I++ ++K  N+L+D  G  K+ D+G+ +     +  +  +K  +  G   Y+APE
Sbjct: 112 LHSKGIVYRDLKLDNILLDTDGHIKIADFGMCK-----ENMLGDAKTCTFCGTPDYIAPE 166

Query: 863 FACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
                 K     D + FGVL+ E++ G+ P 
Sbjct: 167 ILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 58.0 bits (140), Expect = 6e-09
 Identities = 48/204 (23%), Positives = 83/204 (40%), Gaps = 18/204 (8%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVA---IKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           E+G G FG V  + +     VA   +K+L  ++  K Q +F ++      ++HPN++   
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHL-----HEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           G        LL++E+   G L  +L     H  +    L       +  G    + H+H+
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG----VTHMHK 117

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR-- 866
            N +H ++   N  +      KVGDYG+       D           L ++APE      
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177

Query: 867 ----TVKITDKCDVYGFGVLVLEV 886
               T + T   +V+  GV + E+
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 59.8 bits (145), Expect = 6e-09
 Identities = 64/232 (27%), Positives = 103/232 (44%), Gaps = 48/232 (20%)

Query: 698 LGRGGFGAVYRTVLRD---GRPVAIKK----LTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           +G+GG G VY  +  D    R VA+KK    L+ + L+K +  F RE K    + HP +V
Sbjct: 10  IGKGGMGEVY--LAYDPVCSRRVALKKIREDLSENPLLKKR--FLREAKIAADLIHPGIV 65

Query: 751 TL-------EGYYWTQ------SLQLLIYEFVSGGSLHKHLHEG-SGGNFLSWNERFNVI 796
            +       +  Y+T       +L+ L+       SL K L E  S G FLS    F+ I
Sbjct: 66  PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSI---FHKI 122

Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS------ 850
             T   + ++H   ++H ++K  N+L+   GE  + D+G A    + +  +L        
Sbjct: 123 CAT---IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179

Query: 851 ----------KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
                     KI     YMAPE     V  ++  D+Y  GV++ +++T   P
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERL-LGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 7e-09
 Identities = 64/254 (25%), Positives = 106/254 (41%), Gaps = 67/254 (26%)

Query: 698 LGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKS-QEDF---EREVKKLGKVRHPNLV 750
           +GRG FG V+  ++RD   G+  A+K L  S ++K  Q      ER++  L     P +V
Sbjct: 9   IGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDI--LADADSPWIV 64

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVI-QGTAK-------- 801
            L   +  +    L+ E++ GG            + ++   R +V  + TA+        
Sbjct: 65  KLYYSFQDEEHLYLVMEYMPGG------------DLMNLLIRKDVFPEETARFYIAELVL 112

Query: 802 SLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLA-----------------RLLPMLD 844
           +L  +H+   IH +IK  N+LID  G  K+ D+GL                   LL   +
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172

Query: 845 RYVLSSKIQ-------SALG---YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
             V     +       S +G   Y+APE    T     +CD +  GV++ E++ G  P  
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFY 231

Query: 895 ------TW-KMMWW 901
                 T+ K++ W
Sbjct: 232 SDTLQETYNKIINW 245

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 58.2 bits (141), Expect = 9e-09
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 42/218 (19%)

Query: 695 DCELGRGGFGAVYR-TVLRDGRPVAIKKL--TVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           D  +G G FG V+  T  RDG+ VA+KK+     +LV  +  F RE+K L   +H N+++
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLS 63

Query: 752 L-------------EGYYWTQSLQLLIYEFVSGGSLHK------HLHEGSGGNFLSWNER 792
                         E Y  T+ +Q           LHK       L       FL     
Sbjct: 64  ALDILQPPHIDPFEEIYVVTELMQ---------SDLHKIIVSPQPLSSDHVKVFL----- 109

Query: 793 FNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI 852
           + +++G    L +LH + I+H +IK  N+L++ +   K+ D+GLAR+    +   ++ ++
Sbjct: 110 YQILRG----LKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEV 165

Query: 853 QSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGK 890
            +   Y APE    +   T   D++  G +  E++  +
Sbjct: 166 VTQY-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 44/180 (24%), Positives = 88/180 (48%), Gaps = 9/180 (5%)

Query: 717 VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHK 776
           VA+K L   +   ++ DF +E+K + +++ PN++ L     T     +I E++  G L++
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 777 HL--HE------GSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGE 828
            L  HE       +    +S++    +    A  + +L   N +H ++ + N L+  +  
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT 168

Query: 829 PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
            K+ D+G++R L   D Y +  +    + +M+ E +    K T   DV+ FGV + E++T
Sbjct: 169 IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWE-SILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 14/202 (6%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFE------REVKKLGKVRHPNLVT 751
           LG+G FG V     +    +   K+    +V   +D E      R +   GK   P L  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK--PPFLTQ 65

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L   + T      + E+V+GG L   + +   G F   +  F   +  A  L  LH   I
Sbjct: 66  LHSCFQTMDRLYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAE-IAIGLFFLHSKGI 122

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           I+ ++K  NV++D  G  K+ D+G+ +   M D  V +        Y+APE         
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDG-VTTKTFCGTPDYIAPEI-IAYQPYG 179

Query: 872 DKCDVYGFGVLVLEVVTGKRPL 893
              D + FGVL+ E++ G+ P 
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 57/214 (26%), Positives = 103/214 (48%), Gaps = 36/214 (16%)

Query: 697 ELGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQEDFE-------REVKKLGKVRH 746
           ++G G +G VY+   RD      +A+KK+ +      QED E       RE+  L +++H
Sbjct: 9   KIGEGTYGVVYKA--RDRVTNETIALKKIRLE-----QED-EGVPSTAIREISLLKEMQH 60

Query: 747 PNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNER------FNVIQGTA 800
            N+V L+    ++    L++E++    L KH+   S  +F + N R      + +++G  
Sbjct: 61  GNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMD--SSPDF-AKNPRLIKTYLYQILRG-- 114

Query: 801 KSLAHLHQSNIIHYNIKSSNVLIDGSGEP-KVGDYGLARLLPMLDRYVLSSKIQSALGYM 859
             +A+ H   ++H ++K  N+LID      K+ D+GLAR   +  R      +   L Y 
Sbjct: 115 --IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYR 170

Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           APE    +   +   D++  G +  E+V  ++PL
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203

Length = 294

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 56.6 bits (137), Expect = 2e-08
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 31/213 (14%)

Query: 697 ELGRGGFG---AVYRTVLRDGRPVAIKKLT-VSSLVKSQEDFEREVKKLGKVR-HPNLVT 751
           ELG+G +G   +       +   VAIKK+T V S     +   RE+K L   R H N+  
Sbjct: 7   ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66

Query: 752 L---EGYYWTQSLQLLIYEFVSGGSLHKHLHEG---SGGNFLSWNERFNVIQGTAKSLAH 805
           L   +  +     +L +YE +    LH+ +  G   +  +F S+      I      L +
Sbjct: 67  LYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSF------IYQILCGLKY 120

Query: 806 LHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL--------PMLDRYVLSSKIQSALG 857
           +H +N++H ++K  N+L++   E K+ D+GLAR            +  YV +        
Sbjct: 121 IHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR------W 174

Query: 858 YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGK 890
           Y APE        T   DV+  G ++ E++  K
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 24/211 (11%)

Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKK---LTVSSLVKSQEDFEREVKKLGKVRHPN 748
             K  ELG G  G V + + R    +  +K   L +   +++Q    RE+K L +   P 
Sbjct: 3   FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQ--IIRELKVLHECNSPY 60

Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGS--GGNFLSWNERFNVIQGTAKSLAHL 806
           +V   G +++     +  E + GGSL + L +      N L       +     + L +L
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYL 115

Query: 807 HQS-NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE 862
            +   I+H ++K SN+L++  GE K+ D+G++  L       + S   S +G   YM+PE
Sbjct: 116 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-------IDSMANSFVGTRSYMSPE 168

Query: 863 FACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
               T   T + D++  G+ ++E+  G+ P+
Sbjct: 169 RLQGT-HYTVQSDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 55.7 bits (135), Expect = 3e-08
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 47/215 (21%)

Query: 696 CELGRGGFGAVYRT-VLRDGRPVAIKKL--TVSSLVKSQEDFEREVKKLGKVR-HPNLVT 751
            ++G G F  V +    + G+  AIK +     SL   Q +  RE++ L ++  HPN++ 
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL--EQVNNLREIQALRRLSPHPNILR 62

Query: 752 LEGYYW---TQSLQLL-------IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAK 801
           L    +   T  L L+       +YE + G    + L E    +++     + ++    K
Sbjct: 63  LIEVLFDRKTGRLALVFELMDMNLYELIKG--RKRPLPEKRVKSYM-----YQLL----K 111

Query: 802 SLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGY 858
           SL H+H++ I H +IK  N+LI      K+ D+G  R +   P    Y+      S   Y
Sbjct: 112 SLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYI------STRWY 164

Query: 859 MAPEFACRTVKITD-----KCDVYGFGVLVLEVVT 888
            APE  C    +TD     K D++  G +  E+++
Sbjct: 165 RAPE--CL---LTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 55.9 bits (135), Expect = 3e-08
 Identities = 42/192 (21%), Positives = 84/192 (43%), Gaps = 24/192 (12%)

Query: 713 DGRPVAIKKLTVSS--LVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQL----LIY 766
           + + V I+             +  E E+K L ++   N++ + G+       L    LI 
Sbjct: 42  NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101

Query: 767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS-NIIHYNIKSSNVLIDG 825
           E+ + G L + L +      LS+  + ++     K L +L++  N  + N+ S + L+  
Sbjct: 102 EYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE 158

Query: 826 SGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE-----FACRTVKITDKCDVYGFG 880
           + + K+  +GL ++L          K  + + Y + +     F+    + T K D+Y  G
Sbjct: 159 NYKLKIICHGLEKILS-----SPPFKNVNFMVYFSYKMLNDIFS----EYTIKDDIYSLG 209

Query: 881 VLVLEVVTGKRP 892
           V++ E+ TGK P
Sbjct: 210 VVLWEIFTGKIP 221

Length = 283

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 55.7 bits (135), Expect = 4e-08
 Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 30/214 (14%)

Query: 696 CELGRGGFGAVYRTVLRD-GRPVAIKKL--TVSSLVKSQEDFEREVKKLGKVR-HPNLVT 751
            +LG+G +G V++ + R     VA+KK+     +   +Q  F RE+  L ++  HPN+V 
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNIVK 71

Query: 752 LEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFL-SWNERFNVIQGTAKSLAHLHQ 808
           L      ++ +   L++E+     +   LH     N L   ++R+ + Q   K+L ++H 
Sbjct: 72  LLNVIKAENDKDIYLVFEY-----METDLHAVIRANILEDVHKRYIMYQ-LLKALKYIHS 125

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---------PMLDRYVLSSKIQSALGYM 859
            N+IH ++K SN+L++     K+ D+GLAR L         P+L  YV      +   Y 
Sbjct: 126 GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV------ATRWYR 179

Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           APE    + + T   D++  G ++ E++ GK PL
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEMLLGK-PL 212

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 4e-08
 Identities = 47/150 (31%), Positives = 75/150 (50%), Gaps = 22/150 (14%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQE----DFEREVKKLGKVRHPNLVTL 752
           +GRG FG V     +D G   A+KKL  S +++ ++      ER++  L +  +P +V L
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDI--LAEADNPWVVKL 66

Query: 753 EGYYWTQSLQ-----LLIYEFVSGGSLHKHLHEGSGGNFLSWNE-RFNVIQGTAKSLAHL 806
             YY   S Q      LI E++ GG +   L +    +  +  E RF  I  T  ++  +
Sbjct: 67  --YY---SFQDENYLYLIMEYLPGGDMMTLLMKK---DTFTEEETRF-YIAETILAIDSI 117

Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGL 836
           H+   IH +IK  N+L+D  G  K+ D+GL
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 57/225 (25%), Positives = 107/225 (47%), Gaps = 36/225 (16%)

Query: 698 LGRGGFGAVYRTVLRDG--RPVAIKKLTVSSLV---------KSQEDFEREVKKLGK-VR 745
           LG G FG VY+   ++     +A+K++ V +           KS  D   EV  + + +R
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 746 HPNLVTLEGYY--WTQSLQL-LIYEFVSGGSLHKH---LHEGSGGNFLSWNER-FNVIQG 798
           HPN+V    YY  + ++ +L ++ + + G  L +H   L E     F    ER +N+   
Sbjct: 68  HPNIVR---YYKTFLENDRLYIVMDLIEGAPLGEHFNSLKE-KKQRFTE--ERIWNIFVQ 121

Query: 799 TAKSLAHLH-QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG 857
              +L +LH +  I+H ++  +N+++    +  + D+GLA+      +    SK+ S +G
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK------QKQPESKLTSVVG 175

Query: 858 ---YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM 899
              Y  PE   +     +K DV+ FG ++ ++ T + P  +  M+
Sbjct: 176 TILYSCPEIV-KNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 56.4 bits (136), Expect = 5e-08
 Identities = 36/136 (26%), Positives = 54/136 (39%), Gaps = 32/136 (23%)

Query: 280 LFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMAN 339
            F     KW      ++ L L      G +P  I  L+ L+ +N S N + G++P S+ +
Sbjct: 410 QFDSTKGKWF-----IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGS 464

Query: 340 CMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDL 399
             +L  LD S NS NG +P+                           S     SL+ L+L
Sbjct: 465 ITSLEVLDLSYNSFNGSIPE---------------------------SLGQLTSLRILNL 497

Query: 400 SHNEFSGETPATIGAL 415
           + N  SG  PA +G  
Sbjct: 498 NGNSLSGRVPAALGGR 513

Length = 623

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 55.6 bits (134), Expect = 5e-08
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 12/204 (5%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT-VSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +G+G +G V   +    G  VAIKK+  V   V       RE+K L  +RHP++V ++  
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGN--FLSWNERFNVIQGTAKSLAHLHQSNIIH 813
               S +     +V    +   LH+    N      + +F + Q   ++L ++H +N+ H
Sbjct: 68  MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQ-LLRALKYIHTANVFH 126

Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR---YVLSSKIQSALGYMAPEF-ACRTVK 869
            ++K  N+L +   + K+ D+GLAR     +     +  +   +   Y APE       K
Sbjct: 127 RDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 184

Query: 870 ITDKCDVYGFGVLVLEVVTGKRPL 893
            T   D++  G +  EV+TGK PL
Sbjct: 185 YTPAIDIWSIGCIFAEVLTGK-PL 207

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 56.4 bits (136), Expect = 5e-08
 Identities = 58/229 (25%), Positives = 98/229 (42%), Gaps = 58/229 (25%)

Query: 698 LGRGGFGAV-YRTVLRDGRPVAIKKLTVS-----------------------SLVKSQED 733
           LG G  G V     + DG P A+K + +                        S+VK  ED
Sbjct: 40  LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99

Query: 734 FEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGN--FLSWNE 791
           F    KK    R+P  V          +  L+ ++ + G L + +   +  N  F     
Sbjct: 100 F---AKK--DPRNPENV---------LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEA 145

Query: 792 RFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK 851
               IQ    ++ H+H  ++IH +IKS+N+L+  +G  K+GD+G +++         ++ 
Sbjct: 146 GLLFIQ-VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM--------YAAT 196

Query: 852 IQSALG--------YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
           +   +G        Y+APE   R    + K D++  GVL+ E++T KRP
Sbjct: 197 VSDDVGRTFCGTPYYVAPEI-WRRKPYSKKADMFSLGVLLYELLTLKRP 244

Length = 496

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 54.6 bits (131), Expect = 7e-08
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 30/214 (14%)

Query: 697 ELGRGGFGAVY--RTVLRDGRPVAIKKLTVSSLVKSQEDFE----REV---KKLGKVRHP 747
           E+G G +G V+  R +   GR VA+K++ V +    +E       REV   + L    HP
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAVLRHLETFEHP 64

Query: 748 NLVTLEGYYWT-----QSLQLLIYEFVSGG---SLHKHLHEGSGGNFLSWNERFNVIQGT 799
           N+V L           ++   L++E V       L K    G     +  +  F +++G 
Sbjct: 65  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-DMMFQLLRG- 122

Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYM 859
              L  LH   ++H ++K  N+L+  SG+ K+ D+GLAR+       +  + +   L Y 
Sbjct: 123 ---LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYR 176

Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           APE   ++   T   D++  G +  E+   ++PL
Sbjct: 177 APEVLLQSSYAT-PVDLWSVGCIFAEMFR-RKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 9e-08
 Identities = 49/227 (21%), Positives = 91/227 (40%), Gaps = 34/227 (14%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVK----SQEDFEREVKKLGKVRHPNLVT 751
            LG+G  G V+   L+  G+  A+K L    ++K     +   E+E+  L  + HP L T
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI--LATLDHPFLPT 65

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L   + T++   L+ ++  GG L + L    G        RF   +    +L +LH   I
Sbjct: 66  LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-ALEYLHLLGI 124

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLL-----PMLDRYVLSSKIQSALGYMAPEFACR 866
           ++ ++K  N+L+  SG   + D+ L++       P+       S+  S     +  F+  
Sbjct: 125 VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEE 184

Query: 867 TVKITDKC---------------------DVYGFGVLVLEVVTGKRP 892
               ++                       D +  G+L+ E++ G  P
Sbjct: 185 PSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 52/200 (26%), Positives = 87/200 (43%), Gaps = 10/200 (5%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFE---REVKKLGKVRHPNLVT-LE 753
           LG+G FG V     +    +   K+    +V   +D E    E + L     P  +T L 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
             + T      + E+V+GG L  H+ +   G F      F   +  +  L  LH+  II+
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAE-ISVGLFFLHRRGIIY 124

Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            ++K  NV++D  G  K+ D+G+ +   M+D  V +        Y+APE           
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCK-EHMVDG-VTTRTFCGTPDYIAPEIIAYQ-PYGKS 181

Query: 874 CDVYGFGVLVLEVVTGKRPL 893
            D + +GVL+ E++ G+ P 
Sbjct: 182 VDWWAYGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 16/219 (7%)

Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFER--EVKKLGKVRHPNLVTLEG 754
           LG+G FG V     +  GR  A+K L    +V   E      E + L   RHP L  L+ 
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH-QSNIIH 813
            + T      + E+ +GG L  HL       F     RF   +    +L +LH + N+++
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAE-IVSALDYLHSEKNVVY 119

Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKI 870
            ++K  N+++D  G  K+ D+GL +     +     + +++  G   Y+APE        
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKTFCGTPEYLAPE-VLEDNDY 173

Query: 871 TDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE 909
               D +G GV++ E++ G+ P         F +  +EE
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 212

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 54.6 bits (132), Expect = 1e-07
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 26/205 (12%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLVTL-E 753
           +G G +G V        GR VAIKKL+    S + ++  + RE++ L  + H N++ L +
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHENVIGLLD 81

Query: 754 GYYWTQSLQ-----LLIYEFVSGGSLHKHLHEGSGGNFLSWNE-RFNVIQGTAKSLAHLH 807
            +    SL+      L+   + G  L+  +        LS +  +F V Q   + L ++H
Sbjct: 82  VFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQK----LSDDHIQFLVYQ-ILRGLKYIH 135

Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL--PMLDRYVLSSKIQSALGYMAPEFAC 865
            + IIH ++K SN+ ++   E K+ D+GLAR     M   YV +        Y APE   
Sbjct: 136 SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTG-YVATR------WYRAPEIML 188

Query: 866 RTVKITDKCDVYGFGVLVLEVVTGK 890
             +      D++  G ++ E++TGK
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 53/204 (25%), Positives = 101/204 (49%), Gaps = 24/204 (11%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNE------RFNVIQGTAKSLAHLH 807
            +   +SL+    EF +   L  HL      N +   +      +F + Q   + L ++H
Sbjct: 84  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH 137

Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP-MLDRYVLSSKIQSALGYMAPEFACR 866
            ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE    
Sbjct: 138 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLN 191

Query: 867 TVKITDKCDVYGFGVLVLEVVTGK 890
            +      D++  G ++ E++TG+
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 63/220 (28%), Positives = 94/220 (42%), Gaps = 41/220 (18%)

Query: 698 LGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQED---FEREVKKLGKVRHPNLVT 751
           +GRG FG V   V+R+   G   A+K +  S L+ +QE    FE E   L     P    
Sbjct: 9   VGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLL-AQETVSFFEEERDILSISNSP---- 61

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF------NVIQ----GTAK 801
                W   LQ   Y F    +L+  +    GG+ LS   R+      ++ Q        
Sbjct: 62  -----WIPQLQ---YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVL 113

Query: 802 SLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAP 861
           ++  +HQ   +H +IK  NVLID +G  K+ D+G A  L   ++ V S        Y+AP
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA-NKMVNSKLPVGTPDYIAP 172

Query: 862 EFACRTVKITD-------KCDVYGFGVLVLEVVTGKRPLS 894
           E    T    D       +CD +  GV+  E++ G+ P  
Sbjct: 173 EVL--TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 19/161 (11%)

Query: 745 RHPNLVTLEGYYWTQSLQLLIYEFVSGGS----LHKHLHEGSGGNFLSWNERFNVIQGTA 800
           RHPN++T    + T S   +I  F++ GS    L  +  EG     +      N++ G  
Sbjct: 57  RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG-----NILFGAL 111

Query: 801 KSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR-------YVLSSKIQ 853
           + L +LHQ+  IH NIK+S++LI  SG+  V   GL+ L  ++         Y       
Sbjct: 112 RGLNYLHQNGYIHRNIKASHILI--SGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST 169

Query: 854 SALGYMAPEFACRTVKITD-KCDVYGFGVLVLEVVTGKRPL 893
           S L +++PE   + +   + K D+Y  G+   E+ TG+ P 
Sbjct: 170 SVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 53.0 bits (127), Expect = 3e-07
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 29/213 (13%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFE----REV---KKLGKVRHPN 748
           E+G G +G VY+      G  VA+K + V +   +++       REV   K+L    HPN
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQT---NEDGLPLSTVREVALLKRLEAFDHPN 63

Query: 749 LVTLEGYYWT-----QSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSL 803
           +V L     T     ++   L++E V    L  +L +      L      ++++   + L
Sbjct: 64  IVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPG-LPAETIKDLMRQFLRGL 121

Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP---MLDRYVLSSKIQSALGYMA 860
             LH + I+H ++K  N+L+   G+ K+ D+GLAR+      L   V++      L Y A
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVT------LWYRA 175

Query: 861 PEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           PE   ++   T   D++  G +  E+   ++PL
Sbjct: 176 PEVLLQSTYAT-PVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 52.6 bits (126), Expect = 3e-07
 Identities = 51/196 (26%), Positives = 92/196 (46%), Gaps = 12/196 (6%)

Query: 698 LGRGGFGAVY----RTVLRDGRPVAIKKLTVSSLVKSQEDFE--REVKKLGKVRHPNLVT 751
           LG+G FG VY    +  + + R   +K++ V  L    E  +  +E + L K+ HP +V 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGEL-NPNETVQANQEAQLLSKLDHPAIVK 66

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHE-GSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
               +  +    +I E+  G  L   L E    G  LS N+           + ++HQ  
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126

Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKI 870
           I+H ++K+ N+ +  +   K+GD+G++RLL  +    L++       YM+PE A +    
Sbjct: 127 ILHRDLKAKNIFLK-NNLLKIGDFGVSRLL--MGSCDLATTFTGTPYYMSPE-ALKHQGY 182

Query: 871 TDKCDVYGFGVLVLEV 886
             K D++  G ++ E+
Sbjct: 183 DSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 52/208 (25%), Positives = 101/208 (48%), Gaps = 22/208 (10%)

Query: 694 KDCELGRGGFGAVYRTVLRDGRPVAIKKLT---VSSLVKSQEDFEREVKKLGKVRHPNLV 750
           K  ELG G  G V++   +    +  +KL    +   +++Q    RE++ L +   P +V
Sbjct: 9   KISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPYIV 66

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHE-GSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
              G +++     +  E + GGSL + L + G     +       VI+G    L +L + 
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTYLREK 122

Query: 810 N-IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFAC 865
           + I+H ++K SN+L++  GE K+ D+G++  L       + S   S +G   YM+PE   
Sbjct: 123 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-------IDSMANSFVGTRSYMSPE-RL 174

Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           +    + + D++  G+ ++E+  G+ P+
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 52.9 bits (127), Expect = 4e-07
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 32/210 (15%)

Query: 698 LGRGGFGAVYRTVLRDGRPV----AIKKLTVSSLVKSQED------FEREVKKLGKVRHP 747
           LG+G FG V   +L + +      AIK L    ++  Q+D       E+ V  L   + P
Sbjct: 8   LGKGSFGKV---MLAERKGTDELYAIKILKKDVII--QDDDVECTMVEKRVLALPG-KPP 61

Query: 748 NLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH 807
            L  L   + T      + E+V+GG L  H+ +   G F   +  F   +  A  L  LH
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAE-IAIGLFFLH 118

Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFAC-- 865
              II+ ++K  NV++D  G  K+ D+G+ +          +        Y+APE     
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQ 176

Query: 866 ---RTVKITDKCDVYGFGVLVLEVVTGKRP 892
              ++V      D + FGVL+ E++ G+ P
Sbjct: 177 PYGKSV------DWWAFGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 52.2 bits (125), Expect = 4e-07
 Identities = 50/213 (23%), Positives = 95/213 (44%), Gaps = 24/213 (11%)

Query: 698 LGRGGFGAVYRTVLR---DGRPVAIKKLTVSSLVKSQ----EDFEREVKKLGKVRHPNLV 750
           LG+G F  +++ + R   D   +   ++ +  L KS     E F      + ++ H +LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
              G        +++ E+V  GSL  +L +      +SW  +  V +  A +L  L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120

Query: 811 IIHYNIKSSNVLI-----DGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           + H N+ + NVL+       +G P   K+ D G++  + +L + +L  +I     ++ PE
Sbjct: 121 LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERIP----WVPPE 174

Query: 863 FACRTVKITDKCDVYGFGVLVLEVVTG-KRPLS 894
                  ++   D + FG  + E+ +G  +PLS
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|215633 PLN03210, PLN03210, Resistant to P

 Score = 53.7 bits (129), Expect = 5e-07
 Identities = 90/317 (28%), Positives = 139/317 (43%), Gaps = 40/317 (12%)

Query: 222 NLRVINLSKNMFSGS----IPDGIGSCSLLRTIDF--SEN-------SFSGNLPETMQKL 268
           N R  NL K    GS    + DG+ S + LR ID   S+N       S + NL    + L
Sbjct: 607 NFRPENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNL----ETL 662

Query: 269 SLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANR 328
            L +  +L       E+P  I  L  LE LD+S  +    +P  I NL+ L  LN S   
Sbjct: 663 KLSDCSSLV------ELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCS 715

Query: 329 LTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKI-----REGMNGP 383
              S PD   N   +  LD  + ++  + P  +    L+++   E K      R     P
Sbjct: 716 RLKSFPDISTN---ISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWERVQPLTP 771

Query: 384 FASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALN 443
             +  S   SL  L LS      E P++I  L  L+ L +     +  +P  I +L++L 
Sbjct: 772 LMTMLS--PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLE 828

Query: 444 VLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGP 503
            LDLS      + P +I  + ++ +L L R  +  ++P  IE  S+L  L ++  N    
Sbjct: 829 SLDLSGCSRLRTFP-DI--STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQR 884

Query: 504 IPIAIAKLTNLQNVDLS 520
           + + I+KL +L+ VD S
Sbjct: 885 VSLNISKLKHLETVDFS 901

syringae 6; Provisional. Length = 1153

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.2 bits (125), Expect = 8e-07
 Identities = 49/151 (32%), Positives = 75/151 (49%), Gaps = 22/151 (14%)

Query: 698 LGRGGFGAVYRTV--LRDGRPVAIKKLTVSSLVKSQE----DFEREVKKLGKVRHPNLVT 751
           +G+G FG V R V     G+  A+K L  S + K  +      ER+V  L +   P +V+
Sbjct: 9   IGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDV--LAESDSPWVVS 65

Query: 752 LEGYYWTQSLQLL--IYEFVSGGSLHKHLHEGSGGNFLSWNE---RFNVIQGTAKSLAHL 806
           L  YY  Q  Q L  I EF+ GG L   L       + +++E   RF + +    ++  +
Sbjct: 66  L--YYSFQDAQYLYLIMEFLPGGDLMTMLI-----KYDTFSEDVTRFYMAE-CVLAIEAV 117

Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLA 837
           H+   IH +IK  N+LID  G  K+ D+GL+
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 51.6 bits (123), Expect = 9e-07
 Identities = 52/200 (26%), Positives = 97/200 (48%), Gaps = 16/200 (8%)

Query: 698 LGRGGFGAV---YRTVLRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-T 751
           +G G +G+V   Y T LR  + VA+KKL+    SL+ ++  + RE++ L  ++H N++  
Sbjct: 23  VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVIGL 79

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L+ +    S++     ++    +   L+       LS      +I    + L ++H + I
Sbjct: 80  LDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGI 139

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKI 870
           IH ++K SNV ++   E ++ D+GLAR     +  YV +        Y APE     +  
Sbjct: 140 IHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR------WYRAPEIMLNWMHY 193

Query: 871 TDKCDVYGFGVLVLEVVTGK 890
               D++  G ++ E++ GK
Sbjct: 194 NQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 51.1 bits (122), Expect = 1e-06
 Identities = 48/183 (26%), Positives = 76/183 (41%), Gaps = 9/183 (4%)

Query: 91  RIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGS 150
            + + L  L  L  L LS N ++  + P +  L  L  +DLS NS+   +         +
Sbjct: 177 DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLK-N 233

Query: 151 LRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLE 210
           L  + L+ N+    +P S+   S L T++LS+N+ SS   LG   L+ LR LDLS N L 
Sbjct: 234 LSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISSLG--SLTNLRELDLSGNSLS 290

Query: 211 GEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSL 270
             +P     L  L ++              +   S+L   +   N  + +        SL
Sbjct: 291 NALPLIALLLLLLELLLNLLLT---LKALELKLNSILLNNNILSNGETSSPEALSILESL 347

Query: 271 CNF 273
            N 
Sbjct: 348 NNL 350

Length = 394

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 51.6 bits (124), Expect = 1e-06
 Identities = 55/280 (19%), Positives = 104/280 (37%), Gaps = 62/280 (22%)

Query: 197 SALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENS 256
            +L+ L LS N   G IP+G++SL                   G+     L+ +D S+N+
Sbjct: 51  PSLKELCLSLNET-GRIPRGLQSL-----------------LQGLTKGCGLQELDLSDNA 92

Query: 257 FSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFS-GAVPISIGN 315
              +    ++ L   +                     SL+ L L+ N      + +    
Sbjct: 93  LGPDGCGVLESLLRSS---------------------SLQELKLNNNGLGDRGLRLLAKG 131

Query: 316 LQ----RLKVLNFSANRLTGSLPDSMANCM----NLVALDFSQNSMNGDLPQWIF----- 362
           L+     L+ L    NRL G+  +++A  +    +L  L+ + N +     + +      
Sbjct: 132 LKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKA 191

Query: 363 SSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGE-----TPATIGALSG 417
           +  L  +    N + +      A + +S +SL+ L+L  N  +         A +     
Sbjct: 192 NCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNIS 251

Query: 418 LQLLNLSRNSL--VGPIPVA--IGDLKALNVLDLSENWLN 453
           L  L+LS N +   G   +A  + + ++L  LDL  N   
Sbjct: 252 LLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 52.2 bits (125), Expect = 1e-06
 Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 18/149 (12%)

Query: 700 RGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK----SQEDFEREVKKLGKVRHPNLVTLEG 754
           RG FG VY    + + +  A+K +  + ++      Q   ER+   L K   P +V L  
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK--SPFIVHL-- 69

Query: 755 YYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNV--IQGTAKSLAHLHQSN 810
           YY  QS     L+ E++ GG +   LH      +  ++E   V  I   A +L +LH+  
Sbjct: 70  YYSLQSANNVYLVMEYLIGGDVKSLLHI-----YGYFDEEMAVKYISEVALALDYLHRHG 124

Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARL 839
           IIH ++K  N+LI   G  K+ D+GL+++
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 51.2 bits (123), Expect = 1e-06
 Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 52/222 (23%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFER---EVKKLGKVRHPNLVTL- 752
           +GRG +G V      +    VAIKK  +++   ++ D +R   E+K L  + H N++ + 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKK--IANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70

Query: 753 -----------EGYYWTQSLQLLIYEFVSGGSLHK------HLHEGSGGNFLSWNERFNV 795
                         Y       ++YE +    LH+       L +     FL     + +
Sbjct: 71  DIMPPPHREAFNDVY-------IVYELMDT-DLHQIIRSSQTLSDDHCQYFL-----YQL 117

Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL----LPMLDRYVLSSK 851
           ++G    L ++H +N++H ++K SN+L++ + + K+ D+GLAR        +  YV++  
Sbjct: 118 LRG----LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRW 173

Query: 852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
                 Y APE      + T   DV+  G +  E++  K PL
Sbjct: 174 ------YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK-PL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.0 bits (122), Expect = 2e-06
 Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 6/96 (6%)

Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYM 859
           A+ +  L   N IH ++ + NVL+      K+ D+GLAR +     YV+    +  + +M
Sbjct: 222 AQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWM 281

Query: 860 APE--FACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           APE  F C     T + DV+ +G+L+ E+ + GK P
Sbjct: 282 APESIFDC---VYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 65/279 (23%), Positives = 110/279 (39%), Gaps = 64/279 (22%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG-- 754
           +GRG FG V     +D G   A+K L  + ++        E +++G +R    + +E   
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMKILRKADML--------EKEQVGHIRAERDILVEADS 60

Query: 755 -------YYWTQSLQL-LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHL 806
                  Y +   L L LI EF+ GG +   L +    + L+  E    I  T  ++  +
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSI 117

Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL---------- 856
           HQ   IH +IK  N+L+D  G  K+ D+GL   L    R      +  +L          
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177

Query: 857 -----------------------GYMAPEFACRTVKITDKCDVYGFGVLVLEVVTG---- 889
                                   Y+APE   +T      CD +  GV++ E++ G    
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 890 --KRPLSTWK--MMWWFSVTWLEEHWKKAEWRNVSMRSC 924
             + P  T+K  M W  ++ +  E     + +++ +R C
Sbjct: 237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFC 275

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 45.2 bits (108), Expect = 2e-06
 Identities = 23/60 (38%), Positives = 33/60 (55%)

Query: 465 SLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSL 524
           +LK L L  N L      + +   +L  L LS NNLT   P A + L +L+++DLS N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 42/159 (26%), Positives = 76/159 (47%), Gaps = 16/159 (10%)

Query: 743 KVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKS 802
           +V H ++V L G        +++ EFV  G L   +H  S  + L+   +F V +  A +
Sbjct: 60  QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASA 117

Query: 803 LAHLHQSNIIHYNIKSSNVL-----IDGSGEP--KVGDYGLARLLPMLDRYVLSSKIQSA 855
           L++L   +++H N+ + N+L     IDG   P  K+ D G+   + +L R     +I   
Sbjct: 118 LSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--ITVLSRQECVERIP-- 173

Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVV-TGKRPL 893
             ++APE    +  ++   D + FG  + E+   G+ PL
Sbjct: 174 --WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 50.2 bits (120), Expect = 3e-06
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 39/218 (17%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G  G V+  V  D  + VA+KK+ ++   +S +   RE+K + ++ H N+V      
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-PQSVKHALREIKIIRRLDHDNIVK----- 66

Query: 757 WTQSLQLLIYE--FVSGGSLHKHLHEGSGGNFLSWNERF------NVI-QGTAKS----- 802
                   +YE    SG  L + +   +  N +   + +      NV+ QG         
Sbjct: 67  --------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL 118

Query: 803 --------LAHLHQSNIIHYNIKSSNVLIDGSGEP-KVGDYGLARLL-PMLDRYVLSSKI 852
                   L ++H +N++H ++K +NV I+      K+GD+GLAR++ P        S+ 
Sbjct: 119 FMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178

Query: 853 QSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGK 890
                Y +P         T   D++  G +  E++TGK
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 25/105 (23%)

Query: 801 KSLAHLHQS-NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS-SKIQSA--L 856
           K+L +L +   +IH ++K SN+L+D SG  K+ D+G++       R V S +K +SA   
Sbjct: 125 KALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGIS------GRLVDSKAKTRSAGCA 178

Query: 857 GYMAPEFACRTVKITDK---------CDVYGFGVLVLEVVTGKRP 892
            YMAPE      +I             DV+  G+ ++E+ TG+ P
Sbjct: 179 AYMAPE------RIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 30/206 (14%)

Query: 698 LGRGGFG---AVYRTVLRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           +G G  G   A + TVL  G  VA+KKL+    +   ++  + RE+  L  V H N+++L
Sbjct: 29  IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISL 85

Query: 753 EGYYWTQ-SLQ-----LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHL 806
              +  Q SL+      L+ E +   +L + +H       +S+   + ++ G    + HL
Sbjct: 86  LNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSY-LLYQMLCG----IKHL 139

Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP---MLDRYVLSSKIQSALGYMAPEF 863
           H + IIH ++K SN+++      K+ D+GLAR      M+  YV++        Y APE 
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY------YRAPEV 193

Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTG 889
               +   +  D++  G ++ E+V G
Sbjct: 194 IL-GMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 49.3 bits (117), Expect = 6e-06
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 34/215 (15%)

Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKSQEDF----EREVKKLGKVRHPNLVTL 752
           +GRG FG V    L++   V A+K L    ++K  E      ER+V   G  +       
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ------- 61

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN--VIQGTAK--------S 802
               W  +L    Y F    +L+  +    GG+ L+   +F   + +  A+        +
Sbjct: 62  ----WITTLH---YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIA 114

Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           +  +HQ + +H +IK  N+L+D +G  ++ D+G    L M D  V SS       Y++PE
Sbjct: 115 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAVGTPDYISPE 173

Query: 863 FACRTV----KITDKCDVYGFGVLVLEVVTGKRPL 893
                     K   +CD +  GV + E++ G+ P 
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 48.8 bits (117), Expect = 8e-06
 Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 43/218 (19%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFE---------REVKKLGKVRHP 747
           +G G +G V        G  VAIKK+           FE         RE+K L + +H 
Sbjct: 13  IGEGAYGMVCSATHKPTGVKVAIKKI---------SPFEHQTFCQRTLREIKILRRFKHE 63

Query: 748 NLVTLEGYYWTQSLQ-----LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKS 802
           N++ +       S +      ++ E +    L+K +        LS +     +    + 
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQH----LSNDHIQYFLYQILRG 118

Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL-LP------MLDRYVLSSKIQSA 855
           L ++H +N++H ++K SN+L++ + + K+ D+GLAR+  P       L  YV +      
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR----- 173

Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
             Y APE    +   T   D++  G ++ E+++  RPL
Sbjct: 174 -WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 43.3 bits (103), Expect = 1e-05
 Identities = 27/61 (44%), Positives = 35/61 (57%), Gaps = 3/61 (4%)

Query: 102 LRKLSLSSNNLTGSISPN-LAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNR 160
           L+ L LS+N LT  I       L NL+V+DLSGN+L+ SI  E F    SLR + L+ N 
Sbjct: 2   LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59

Query: 161 F 161
            
Sbjct: 60  L 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 43.3 bits (103), Expect = 1e-05
 Identities = 25/60 (41%), Positives = 33/60 (55%)

Query: 489 SLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHL 548
           +L SL LS N LT     A   L NL+ +DLS N+LT   P+    L  L S ++S N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.9 bits (102), Expect = 1e-05
 Identities = 21/59 (35%), Positives = 34/59 (57%)

Query: 294 SLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNS 352
           +L++LDLS N+ +     +   L  LKVL+ S N LT   P++ +   +L +LD S N+
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Length = 60

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 48.5 bits (115), Expect = 1e-05
 Identities = 62/256 (24%), Positives = 102/256 (39%), Gaps = 48/256 (18%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +GRG FG V     +D G   A+K L  + +++ ++      ++   V       ++ +Y
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68

Query: 757 WTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
             Q  +   LI EF+ GG +   L +    + LS       I  T  ++  +HQ   IH 
Sbjct: 69  SFQDKRNLYLIMEFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLGFIHR 125

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV-----------------LSSKIQ---- 853
           +IK  N+L+D  G  K+ D+GL   L    R                   ++SK +    
Sbjct: 126 DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETW 185

Query: 854 ---------SALG---YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWW 901
                    S +G   Y+APE   +T      CD +  GV++ E++ G  P         
Sbjct: 186 KKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFC------- 237

Query: 902 FSVTWLEEHWKKAEWR 917
            S T  E + K   W+
Sbjct: 238 -SETPQETYRKVMNWK 252

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.9 bits (114), Expect = 1e-05
 Identities = 41/147 (27%), Positives = 76/147 (51%), Gaps = 16/147 (10%)

Query: 701 GGFGAVYRTVLRDGRP-VAIKKLTVSSLV---KSQEDF-EREVKKLGKVRHPNLVTLEGY 755
           G +GAVY    ++ R   A+KK+   +L+   + Q+ F ER++  L    +P +V++   
Sbjct: 12  GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDI--LTFAENPFVVSMFCS 69

Query: 756 YWTQSLQLLIYEFVSGG---SLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           + T+    ++ E+V GG   +L K++     G       R    + T  +L +LH   I+
Sbjct: 70  FETKRHLCMVMEYVEGGDCATLLKNI-----GALPVDMARMYFAE-TVLALEYLHNYGIV 123

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARL 839
           H ++K  N+LI   G  K+ D+GL+++
Sbjct: 124 HRDLKPDNLLITSMGHIKLTDFGLSKI 150

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 47.9 bits (114), Expect = 1e-05
 Identities = 48/220 (21%), Positives = 94/220 (42%), Gaps = 41/220 (18%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQED-----FEREVKKLGKVRH-PNLV 750
           +G G +G VY+      G+ VA+KK    + ++  E+       RE+  L  +     +V
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKK----TRLEMDEEGIPPTALREISLLQMLSESIYIV 64

Query: 751 TLEGYYWTQS-----LQLLIYEFVS----------GGSLHKHLHEGSGGNFLSWNERFNV 795
            L      +         L++E++           G    + L   +  +F+     + +
Sbjct: 65  RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFM-----YQL 119

Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEP-KVGDYGLARLLPM-LDRYVLSSKIQ 853
           ++G    +AH H+  ++H ++K  N+L+D      K+ D GL R   + +  Y  + +I 
Sbjct: 120 LKG----VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIV 173

Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           + L Y APE    +   +   D++  G +  E+   K+PL
Sbjct: 174 T-LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPL 211

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 47.4 bits (113), Expect = 2e-05
 Identities = 56/224 (25%), Positives = 86/224 (38%), Gaps = 49/224 (21%)

Query: 96  LLQLQFLRKLSLSSNNLTGSISPNLAK-----LQNLRVIDLSGNSLSGSIPDEFFKQCGS 150
           LL+   L++L L++N L       LAK        L  + L  N L G           S
Sbjct: 104 LLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEG----------AS 153

Query: 151 LRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSP----LPLGIWGLSALRTLDLSD 206
              ++ A           L     L  +NL++N         L  G+     L  LDL++
Sbjct: 154 CEALAKA-----------LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNN 202

Query: 207 NLLEGE----IPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLP 262
           N L  E    + + + SLK+L V+NL  N           + +       +    S N  
Sbjct: 203 NGLTDEGASALAETLASLKSLEVLNLGDN-----------NLTDAGAAALASALLSPN-- 249

Query: 263 ETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFS 306
            ++  LSL    N   +  + ++ + + E ESL  LDL GNKF 
Sbjct: 250 ISLLTLSLSC--NDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 47.9 bits (114), Expect = 2e-05
 Identities = 25/103 (24%), Positives = 52/103 (50%), Gaps = 8/103 (7%)

Query: 787 LSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML--D 844
           L  ++   + +   + L +LH   IIH ++K+ N+ I+   +  +GD G A+  P++   
Sbjct: 154 LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPA 212

Query: 845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVV 887
              L+  +++     APE   R  K   K D++  G+++ E++
Sbjct: 213 FLGLAGTVETN----APEVLARD-KYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 48.1 bits (114), Expect = 2e-05
 Identities = 35/132 (26%), Positives = 66/132 (50%), Gaps = 2/132 (1%)

Query: 763 LLIYEFVSGGSLHKHLHEGSGGNF-LSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNV 821
           LLI E+ SGG L+K + +    +      E   +      +L  +H   ++H ++KS+N+
Sbjct: 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANI 200

Query: 822 LIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGV 881
            +  +G  K+GD+G ++         ++S       Y+APE   R  + + K D++  GV
Sbjct: 201 FLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGV 259

Query: 882 LVLEVVTGKRPL 893
           ++ E++T  RP 
Sbjct: 260 ILYELLTLHRPF 271

Length = 478

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 54/215 (25%), Positives = 87/215 (40%), Gaps = 34/215 (15%)

Query: 698 LGRGGFGAVYRTVLRDG-RPVAIKKLTVSSLVKSQEDF----EREVKKLGKVRHPNLVTL 752
           +GRG FG V    ++   R  A+K L    ++K  E      ER V   G  +       
Sbjct: 9   IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ------- 61

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN----------VIQGTAKS 802
               W  +L    Y F     L+  +    GG+ L+   +F            I     +
Sbjct: 62  ----WITTLH---YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA 114

Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           +  +HQ + +H +IK  NVL+D +G  ++ D+G + L    D  V SS       Y++PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPE 173

Query: 863 FACRTV----KITDKCDVYGFGVLVLEVVTGKRPL 893
                     K   +CD +  GV + E++ G+ P 
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 47.1 bits (112), Expect = 3e-05
 Identities = 64/269 (23%), Positives = 102/269 (37%), Gaps = 64/269 (23%)

Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKSQE----DFEREVKKLGKVRHPNLVTL 752
           +G G FG V      D   + A+K L  + ++   +      ER++  L +  +  +V L
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDI--LAEADNEWVVKL 66

Query: 753 EGYYWTQSLQLL--IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
             YY  Q    L  + +++ GG +   L     G F     RF + + T  ++  +H+  
Sbjct: 67  --YYSFQDKDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTC-AIESVHKMG 121

Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGL---------------------------------- 836
            IH +IK  N+LID  G  K+ D+GL                                  
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181

Query: 837 -ARLLPMLDRYV---LSSKIQSALG---YMAPEFACRTVKITDKCDVYGFGVLVLEVVTG 889
             RL P+  R           S +G   Y+APE   RT   T  CD +  GV++ E++ G
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEMLVG 240

Query: 890 KRPLSTWKMMWWFSVTWLEEHWKKAEWRN 918
           + P        + + T  E   K   W  
Sbjct: 241 QPP--------FLADTPAETQLKVINWET 261

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|215633 PLN03210, PLN03210, Resistant to P

 Score = 46.8 bits (111), Expect = 5e-05
 Identities = 64/209 (30%), Positives = 92/209 (44%), Gaps = 15/209 (7%)

Query: 151 LRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLS--DNL 208
           LR I L  ++   +IP  LS+ + L T+ LS       LP  I  L+ L  LD+S  +NL
Sbjct: 636 LRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENL 694

Query: 209 LEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLP-ETMQK 267
               +P G+ +LK+L  +NLS      S PD   + S L   + +   F  NL  E + +
Sbjct: 695 --EILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIEEFPSNLRLENLDE 751

Query: 268 LSLCNFMNL----RKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLN 323
           L LC   +     R    +   P       SL  L LS       +P SI NL +L+ L 
Sbjct: 752 LILCEMKSEKLWERVQPLT---PLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLE 808

Query: 324 FSANRLTGSLPDSMANCMNLVALDFSQNS 352
                   +LP  + N  +L +LD S  S
Sbjct: 809 IENCINLETLPTGI-NLESLESLDLSGCS 836

syringae 6; Provisional. Length = 1153

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 46.0 bits (109), Expect = 6e-05
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 6/96 (6%)

Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYM 859
           AK ++ L   N IH ++ + N+L+      K+ D+GLAR +     YV+    +  + +M
Sbjct: 224 AKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWM 283

Query: 860 APE--FACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           APE  F C     T + DV+ +G+L+ E+ + G  P
Sbjct: 284 APESIFNC---VYTFESDVWSYGILLWEIFSLGSSP 316

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.0 bits (97), Expect = 7e-05
 Identities = 27/85 (31%), Positives = 38/85 (44%), Gaps = 25/85 (29%)

Query: 125 NLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNR 184
           NL+ +DLS N L+  IPD  FK   +L+V+ L+ N  +   P +                
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAF--------------- 44

Query: 185 FSSPLPLGIWGLSALRTLDLSDNLL 209
                     GL +LR+LDLS N L
Sbjct: 45  ---------SGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 45.6 bits (108), Expect = 7e-05
 Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 1/89 (1%)

Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYM 859
           A+ +  L     IH ++ + N+L+  +   K+ D+GLAR +     YV     +  L +M
Sbjct: 183 ARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242

Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVT 888
           APE     V  T + DV+ FGVL+ E+ +
Sbjct: 243 APESIFDKV-YTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 45.4 bits (107), Expect = 9e-05
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 2/94 (2%)

Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYM 859
           A+ +  L     IH ++ + N+L+  +   K+ D+GLAR +     YV     +  L +M
Sbjct: 184 ARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243

Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           APE     V  T + DV+ FGVL+ E+ + G  P
Sbjct: 244 APESIFDKV-YTTQSDVWSFGVLLWEIFSLGASP 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 45.4 bits (107), Expect = 9e-05
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 2/94 (2%)

Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYM 859
           AK +  L     IH ++ + N+L+  +   K+ D+GLAR +     YV     +  L +M
Sbjct: 189 AKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 248

Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           APE     V  T + DV+ FGVL+ E+ + G  P
Sbjct: 249 APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.6 bits (96), Expect = 1e-04
 Identities = 22/58 (37%), Positives = 31/58 (53%)

Query: 393 SLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSEN 450
           +L+ LDLS+N  +         L  L++L+LS N+L    P A   L +L  LDLS N
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 48/211 (22%), Positives = 74/211 (35%), Gaps = 69/211 (32%)

Query: 764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAH------------LHQSNI 811
           L Y F    +L+  +    GG+ +S   R  +     + LA             +H+   
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFP---EDLARFYIAELTCAVESVHKMGF 122

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLA---------------------------------- 837
           IH +IK  N+LID  G  K+ D+GL                                   
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 838 -----RLLPMLDRYV------LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEV 886
                RL P+  R        L+  +     Y+APE   RT   T  CD +  GV++ E+
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEM 241

Query: 887 VTGKRPLSTWKMMWWFSVTWLEEHWKKAEWR 917
           + G+ P        + + T LE   K   W+
Sbjct: 242 LVGQPP--------FLAQTPLETQMKVINWQ 264

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 5/145 (3%)

Query: 698 LGRGGFGAVYRTVLRDGRP-VAIKKLTVSSLVKS-QEDFEREVKKLGKVRHPNLVTLEGY 755
           +G G +G V +   ++ +  VAIKK   S   +  +E   RE+K L  ++  N+V L+  
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           +  +    L++E+V    L   L E           R  + Q   K++   H+++I+H +
Sbjct: 69  FRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQ-LIKAIHWCHKNDIVHRD 125

Query: 816 IKSSNVLIDGSGEPKVGDYGLARLL 840
           IK  N+LI  +   K+ D+G AR L
Sbjct: 126 IKPENLLISHNDVLKLCDFGFARNL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 44.1 bits (105), Expect = 2e-04
 Identities = 51/158 (32%), Positives = 70/158 (44%), Gaps = 31/158 (19%)

Query: 746 HPNLVTLEGYYWTQSL--QLLIYEFVSGGSLHKHLH-EGSGGNFLSWNERFNVIQGTAKS 802
           +PN + L  YY   +L   +LI +++  G L   L  EG     LS  E   +I+   ++
Sbjct: 68  NPNFIKL--YYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK----LSEAEVKKIIRQLVEA 121

Query: 803 LAHLHQSNIIHYNIKSSNVLIDGS-GEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAP 861
           L  LH+ NIIH +IK  NVL D +     + DYGL +           S     L Y +P
Sbjct: 122 LNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK------IIGTPSCYDGTLDYFSP 175

Query: 862 EFACRTVKITDKCDVYGF-------GVLVLEVVTGKRP 892
           E      KI  K   Y         GVL  E++TGK P
Sbjct: 176 E------KI--KGHNYDVSFDWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 44.3 bits (105), Expect = 2e-04
 Identities = 48/218 (22%), Positives = 93/218 (42%), Gaps = 27/218 (12%)

Query: 695 DCELGRGGFGAVYRTVLR---DGRPVAIKKLTVSSLVKSQEDFER---EVKKLGKVRHPN 748
              +G+     +   + +       VA+KK+ + S   S+ED +    E+    +++HPN
Sbjct: 3   LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS--CSKEDLKLLQQEIITSRQLQHPN 60

Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGS----LHKHLHEGSGGNFLSWNERFNVIQGTAKSLA 804
           ++     +   S   ++   ++ GS    L  H  EG     L       +++    +L 
Sbjct: 61  ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-----LPELAIAFILKDVLNALD 115

Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD-----RYVLSSKIQSA--LG 857
           ++H    IH ++K+S++L+ G G  KV   GL   + M+      R V      S   L 
Sbjct: 116 YIHSKGFIHRSVKASHILLSGDG--KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173

Query: 858 YMAPEFACRTVK-ITDKCDVYGFGVLVLEVVTGKRPLS 894
           +++PE   + ++   +K D+Y  G+   E+  G  P  
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 43.5 bits (103), Expect = 3e-04
 Identities = 50/189 (26%), Positives = 75/189 (39%), Gaps = 43/189 (22%)

Query: 80  ELTLNGLSLTGRIGR----GLLQLQF-LRKLSLSSNNLTGSISPNLAKL----QNLRVID 130
           EL LN   L  R  R    GL  L   L KL L  N L G+    LAK     ++L+ ++
Sbjct: 112 ELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELN 171

Query: 131 LSGNSLSGS-IPD--EFFKQCGSLRVISLAKNRF----SGKIPSSLSLCSTLATINLSSN 183
           L+ N +  + I    E  K   +L V+ L  N      +  +  +L+   +L  +NL  N
Sbjct: 172 LANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDN 231

Query: 184 RFSSPLPLGIWGLSA-----------LRTLDLSDNLLEGEIPKGVESL-------KNLRV 225
                  L   G +A           L TL LS N +  +   G + L       ++L  
Sbjct: 232 ------NLTDAGAAALASALLSPNISLLTLSLSCNDITDD---GAKDLAEVLAEKESLLE 282

Query: 226 INLSKNMFS 234
           ++L  N F 
Sbjct: 283 LDLRGNKFG 291

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 43.8 bits (103), Expect = 3e-04
 Identities = 28/89 (31%), Positives = 43/89 (48%), Gaps = 1/89 (1%)

Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYM 859
           A  +  L   N +H ++ + NVLI      K+ D+GLAR +     Y+        L +M
Sbjct: 249 ANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWM 308

Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVT 888
           APE     +  T   DV+ FG+L+ E+ T
Sbjct: 309 APESIFNNL-YTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 43.8 bits (103), Expect = 3e-04
 Identities = 47/195 (24%), Positives = 87/195 (44%), Gaps = 24/195 (12%)

Query: 714 GRPVAIKKLTVSSLVKSQEDF---EREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS 770
           G  V ++++ + +       F   E  V KL    HPN+V     +   +   ++  F++
Sbjct: 25  GEYVTVRRINLEACTNEMVTFLQGELHVSKL--FNHPNIVPYRATFIADNELWVVTSFMA 82

Query: 771 GGS----LHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS 826
            GS    +  H  +G     +++     ++QG  K+L ++H    +H ++K+S++LI   
Sbjct: 83  YGSAKDLICTHFMDGMSELAIAY-----ILQGVLKALDYIHHMGYVHRSVKASHILISVD 137

Query: 827 GEPKVGDYGLARLLPMLD-----RYVLSSKIQSA--LGYMAPEFACRTVKITD-KCDVYG 878
           G  KV   GL   L M++     R V      S   L +++PE   + ++  D K D+Y 
Sbjct: 138 G--KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 195

Query: 879 FGVLVLEVVTGKRPL 893
            G+   E+  G  P 
Sbjct: 196 VGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 43.6 bits (103), Expect = 3e-04
 Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 38/216 (17%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDF----EREVKKLGKVRHPNLVTL 752
           +GRG FG V    +++ G+  A+K L    ++K  E      ER+V   G  R       
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR------- 61

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAK--------S 802
               W  +L    Y F    +L+  +    GG+ L+   +F   + +  A+        +
Sbjct: 62  ----WITNLH---YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLA 114

Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYG-LARLLPMLDRYVLSSKIQSALGYMAP 861
           +  +HQ   +H +IK  NVL+D +G  ++ D+G   RLL   D  V S+       Y++P
Sbjct: 115 IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA--DGTVQSNVAVGTPDYISP 172

Query: 862 EFACRTV-----KITDKCDVYGFGVLVLEVVTGKRP 892
           E   + +     +   +CD +  GV + E++ G+ P
Sbjct: 173 EI-LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 42.9 bits (101), Expect = 4e-04
 Identities = 35/149 (23%), Positives = 66/149 (44%), Gaps = 19/149 (12%)

Query: 747 PNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAK----S 802
           PN+V L  Y  ++    L+ +   GG L  H+       FL  N     ++  A     +
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-----SKFL--NIPEECVKRWAAEMVVA 97

Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYG-LARLLPMLDRYVLSSKIQSALGYMAP 861
           L  LH+  I+  ++  +N+L+D  G  ++  +   + +    D   + +       Y AP
Sbjct: 98  LDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAP 151

Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVTGK 890
           E    + + T+ CD +  G ++ E++TGK
Sbjct: 152 EVGGIS-EETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 43.5 bits (102), Expect = 4e-04
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 41/217 (18%)

Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKSQED--FEREVKKLGKVRHPNLVTLEG 754
           +GRG FG V     +  + V A+K L+   ++K  +   F  E   +     P +V L  
Sbjct: 51  IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAK--------SLAHL 806
            +       ++ E++ GG L          N +S    ++V +  AK        +L  +
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLV---------NLMS---NYDVPEKWAKFYTAEVVLALDAI 158

Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEF 863
           H   +IH ++K  N+L+D  G  K+ D+G       +D   +  +  +A+G   Y++PE 
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCM---KMDETGM-VRCDTAVGTPDYISPE- 213

Query: 864 ACRTVKITD-------KCDVYGFGVLVLEVVTGKRPL 893
               +K          +CD +  GV + E++ G  P 
Sbjct: 214 ---VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 42.7 bits (100), Expect = 6e-04
 Identities = 26/91 (28%), Positives = 46/91 (50%), Gaps = 10/91 (10%)

Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP---MLDRYVLSSKIQSALGYM 859
           + HLH + IIH ++K SN+++      K+ D+GLAR      M+  YV++        Y 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY------YR 192

Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTGK 890
           APE     +   +  D++  G ++ E++ G 
Sbjct: 193 APEVIL-GMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 42.8 bits (101), Expect = 6e-04
 Identities = 50/178 (28%), Positives = 81/178 (45%), Gaps = 27/178 (15%)

Query: 698 LGRGGFGAV---YRTVLRDGRPVAIKKLTVS-SLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +G G  G V   Y TV   G+ VAIKKL+     V   +   RE+  +  V H N++ L 
Sbjct: 24  IGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81

Query: 754 GYYWTQ-SLQ-----LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH 807
             +  Q SL+      L+ E +   +L + +        +S+     ++      + HLH
Sbjct: 82  NVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSY-----LLYQMLCGIKHLH 135

Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP---MLDRYVLSSKIQSALGYMAPE 862
            + IIH ++K SN+++      K+ D+GLAR      M+  YV++        Y APE
Sbjct: 136 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY------YRAPE 187

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

 Score = 42.6 bits (100), Expect = 6e-04
 Identities = 56/231 (24%), Positives = 89/231 (38%), Gaps = 39/231 (16%)

Query: 103 RKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGS---LRVISLAK- 158
           +KL L +      +   L  +  L  +DLSGN++     +E      +   LRV++ +  
Sbjct: 9   KKLKLETKEDVKGVVEELEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDA 68

Query: 159 --NRFSGKIPSSLSL-------CSTLATINLSSNRFSS--PLPLG--IWGLSALRTLDLS 205
              R   ++ S+L +       C  L  ++LS N F S  P  LG  I   + L  L L+
Sbjct: 69  FTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLN 128

Query: 206 DNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETM 265
           +N L G I  G           + K +F  +          L  +    N    N  + +
Sbjct: 129 NNGL-GPIAGG----------RIGKALFHLAYNKKAADKPKLEVVICGRNRLE-NGSKEL 176

Query: 266 QKLSLCNFMNLR--KNLFSGEVPKWIGEL--------ESLETLDLSGNKFS 306
               L +  NL+  K   +G  P+ +  L         SLE LDL  N F+
Sbjct: 177 SAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFT 227

Length = 388

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 42.2 bits (99), Expect = 7e-04
 Identities = 42/161 (26%), Positives = 74/161 (45%), Gaps = 16/161 (9%)

Query: 741 LGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTA 800
           + +V H +L  + G     S  +++ EFV  G L   L +  G   ++W  +  V Q  A
Sbjct: 70  MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLA 127

Query: 801 KSLAHLHQSNIIHYNIKSSNVLIDGSG-----EP--KVGDYGLARLLPMLDRYVLSSKIQ 853
            +L++L   N++H N+ + N+L+   G      P  K+ D G++     L R     +I 
Sbjct: 128 SALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREERVERIP 185

Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVV-TGKRPL 893
               ++APE       ++   D + FG  +LE+   G+ PL
Sbjct: 186 ----WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPL 222

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 42.7 bits (100), Expect = 8e-04
 Identities = 29/113 (25%), Positives = 52/113 (46%), Gaps = 1/113 (0%)

Query: 776 KHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYG 835
           K+L    G   L+  +  +     A+ +  L   N +H ++ + NVL+      K+ D+G
Sbjct: 223 KNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFG 282

Query: 836 LARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           LAR +     YV        + +MAPE     +  T   DV+ +G+L+ E+ +
Sbjct: 283 LARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.5 bits (88), Expect = 0.001
 Identities = 23/60 (38%), Positives = 35/60 (58%), Gaps = 2/60 (3%)

Query: 199 LRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSF 257
           L++LDLS+N L   IP G  + L NL+V++LS N  +   P+       LR++D S N+ 
Sbjct: 2   LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 42.0 bits (98), Expect = 0.001
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 34/209 (16%)

Query: 698 LGRGGFG---AVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKL---GKVRHPNLVT 751
           +G G  G   A Y  VL   R VAIKKL  S   ++Q   +R  ++L     V H N+++
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80

Query: 752 LEGYYWTQ-SLQ-----LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-VIQGTAKSLA 804
           L   +  Q SL+      L+ E +          E         +ER + ++      + 
Sbjct: 81  LLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIK 133

Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP---MLDRYVLSSKIQSALGYMAP 861
           HLH + IIH ++K SN+++      K+ D+GLAR      M+  YV++        Y AP
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY------YRAP 187

Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVTGK 890
           E     +   +  D++  G ++ E+V  K
Sbjct: 188 EVIL-GMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 41.9 bits (98), Expect = 0.001
 Identities = 35/160 (21%), Positives = 72/160 (45%), Gaps = 12/160 (7%)

Query: 737 EVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVI 796
           E   L  + HP+++ L+G +       LI        L+ +L   +    ++  +   + 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYL---AAKRNIAICDILAIE 188

Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM---LDRYVLSSKIQ 853
           +   +++ +LH++ IIH +IK+ N+ I+  G+  +GD+G A   P+    ++Y       
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYY---GWA 244

Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
             +   APE   R        D++  G+++ E+ T    L
Sbjct: 245 GTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 41.8 bits (98), Expect = 0.001
 Identities = 38/178 (21%), Positives = 80/178 (44%), Gaps = 14/178 (7%)

Query: 720 KKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL-EGYYWTQSLQLLIYEFVSGGSLHKHL 778
           KK+ V ++   +    RE+  L  + H  ++ L   Y W  ++ +++ ++     L  ++
Sbjct: 120 KKVIVKAVTGGK-TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC--DLFTYV 176

Query: 779 HEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR 838
            + SG   L   +   + +   ++LA+LH   IIH ++K+ N+ +D      +GD+G A 
Sbjct: 177 -DRSGP--LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA- 232

Query: 839 LLPMLDRYVLSSKIQSALGYM---APEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
               LD +  + +     G +   +PE          K D++  G+++ E+      L
Sbjct: 233 --CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCA-KTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 50/209 (23%), Positives = 83/209 (39%), Gaps = 25/209 (11%)

Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKSQED--FEREVKKLGKVRHPNLVTLEG 754
           +GRG FG V     +  R V A+K L+   ++K  +   F  E   +     P +V L  
Sbjct: 51  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLS-------WNERFNVIQGTAKSLAHLH 807
            +       ++ E++ GG L          N +S       W  RF   +    +L  +H
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLV---------NLMSNYDVPEKW-ARFYTAE-VVLALDAIH 159

Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
               IH ++K  N+L+D SG  K+ D+G    +   +  V          Y++PE     
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-EGMVRCDTAVGTPDYISPEVLKSQ 218

Query: 868 VK---ITDKCDVYGFGVLVLEVVTGKRPL 893
                   +CD +  GV + E++ G  P 
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.8 bits (86), Expect = 0.002
 Identities = 17/55 (30%), Positives = 25/55 (45%)

Query: 275 NLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRL 329
           +L  N  +         L +L+ LDLSGN  +   P +   L  L+ L+ S N L
Sbjct: 6   DLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 41.7 bits (98), Expect = 0.002
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 35/213 (16%)

Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVK-SQEDF---EREVKKLGKVRHPNLVTL 752
           +GRG FG V     +  + V A+K L+   ++K S   F   ER++     + H N    
Sbjct: 51  IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI-----MAHAN---- 101

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAK--------SLA 804
               W   L    Y F     L+  +    GG+ ++    +++ +  A+        +L 
Sbjct: 102 --SEWIVQLH---YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALD 156

Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPEF 863
            +H    IH ++K  N+L+D SG  K+ D+G    + M  +  V          Y++PE 
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC--MKMDANGMVRCDTAVGTPDYISPE- 213

Query: 864 ACRTVKITD----KCDVYGFGVLVLEVVTGKRP 892
             ++         +CD +  GV + E++ G  P
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 36.3 bits (85), Expect = 0.002
 Identities = 16/36 (44%), Positives = 23/36 (63%), Gaps = 2/36 (5%)

Query: 102 LRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLS 137
           L  L LS+N +T  + P L+ L NL  +DLSGN ++
Sbjct: 3   LETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKIT 36

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	936
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.98
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.98
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.98
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.98
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.98
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.98
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.98
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.98
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.98
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.98
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.98
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.98
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.98
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.98
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.98
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.98
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.98
PLN00009	294	cyclin-dependent kinase A; Provisional	99.98
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.98
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.98
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.98
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.98
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.97
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.95
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.95
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.95
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.89
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
PLN00181	793	protein SPA1-RELATED; Provisional	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.86
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.86
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.86
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.84
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.82
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.81
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.8
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.79
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.77
PRK10345	210	hypothetical protein; Provisional	99.77
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.76
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.76
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.74
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.74
smart00090	237	RIO RIO-like kinase.	99.72
PRK14879	211	serine/threonine protein kinase; Provisional	99.72
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.7
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.67
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.66
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.66
PLN03150	623	hypothetical protein; Provisional	99.63
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.62
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.6
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.6
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.55
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.52
PLN03150	623	hypothetical protein; Provisional	99.51
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.49
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.46
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.43
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.36
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.35
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.3
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.28
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.27
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.26
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.24
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.24
KOG1243	690	consensus Protein kinase [General function predict	99.2
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.19
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.18
KOG3087	229	consensus Serine/threonine protein kinase [General	99.18
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.14
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.13
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.13
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.11
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.11
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.11
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.11
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.1
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.07
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.02
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.96
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.95
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.95
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.93
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.89
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.87
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.86
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.82
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.79
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.74
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.71
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.66
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.66
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.66
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.57
PRK09902	216	hypothetical protein; Provisional	98.56
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.55
COG4248	637	Uncharacterized protein with protein kinase and he	98.48

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=6.2e-107  Score=1023.67  Aligned_cols=858  Identities=31%  Similarity=0.525  Sum_probs=602.9

Q ss_pred             HHHHHHHHHHHHhhhhcccCCCCChhHHHHHHHHHHhccCCCCCCCCCCCCCCCCccceeEEecCCCCceEEeccCCCCC
Q 002321            9 ASVFSLLTFLVLAPALTRSLNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSL   88 (936)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aLl~~k~~~~d~~~~l~sW~~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l   88 (936)
                      +..|++++++++....+.    ..++|++||++||+++.||.+.+.+|+..++ ||.|.||+|+.. ++|+.|+|+++++
T Consensus         8 ~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~-~c~w~gv~c~~~-~~v~~L~L~~~~i   81 (968)
T PLN00113          8 HCPYLIFMLFFLFLNFSM----LHAEELELLLSFKSSINDPLKYLSNWNSSAD-VCLWQGITCNNS-SRVVSIDLSGKNI   81 (968)
T ss_pred             CCChHHHHHHHHHHHccC----CCHHHHHHHHHHHHhCCCCcccCCCCCCCCC-CCcCcceecCCC-CcEEEEEecCCCc
Confidence            344555555555443232    1358999999999999999888999987655 999999999864 7999999999999


Q ss_pred             CcccccccccCccccEEeccCCcccCcCCCchh-hcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCC
Q 002321           89 TGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLA-KLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPS  167 (936)
Q Consensus        89 ~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~-~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~  167 (936)
                      +|.+++.+..+++|+.|+|++|++++.+|..+. ++++|++|+|++|+++|.+|.   ..+++|++|+|++|.+++.+|.
T Consensus        82 ~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~---~~l~~L~~L~Ls~n~~~~~~p~  158 (968)
T PLN00113         82 SGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR---GSIPNLETLDLSNNMLSGEIPN  158 (968)
T ss_pred             cccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc---cccCCCCEEECcCCcccccCCh
Confidence            999999999999999999999999988888765 899999999999998877774   3466777777777777766777


Q ss_pred             CccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCc
Q 002321          168 SLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLL  247 (936)
Q Consensus       168 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L  247 (936)
                      .++.+++|++|+|++|.+.+..|..+.++++|++|+|++|.+++.+|..++++++|++|+|++|++++.+|..++.+++|
T Consensus       159 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L  238 (968)
T PLN00113        159 DIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSL  238 (968)
T ss_pred             HHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCC
Confidence            77777777777777777776677777777777777777777776667667777777777777777766666666666777


Q ss_pred             ceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCC
Q 002321          248 RTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSAN  327 (936)
Q Consensus       248 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N  327 (936)
                      ++|++++|.+++.+|..+.++++|+.|+|++|.+++.+|..+..+++|++|+|++|++.+.+|..+.++++|+.|++++|
T Consensus       239 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n  318 (968)
T PLN00113        239 NHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSN  318 (968)
T ss_pred             CEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCC
Confidence            77777777666666666666666666666666666666666666666666666666666666666666666666666666


Q ss_pred             cccccCChhhhccCCCCEEEccCCcCccCCChhhhc-cCCccccccccccccCC--------------------CCCCCC
Q 002321          328 RLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFS-SGLNKVSFAENKIREGM--------------------NGPFAS  386 (936)
Q Consensus       328 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~l~~n~l~~~~--------------------~~~~~~  386 (936)
                      .+++..|..+..+++|+.|++++|.+.+.+|..+.. ..++.|++.+|.+....                    .+.+|.
T Consensus       319 ~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~  398 (968)
T PLN00113        319 NFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPK  398 (968)
T ss_pred             ccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCH
Confidence            666556666666666666666666665555543322 34444444444443111                    012333


Q ss_pred             CCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccC-----------------------cccCC
Q 002321          387 SGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGD-----------------------LKALN  443 (936)
Q Consensus       387 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----------------------l~~L~  443 (936)
                      .+..+++|+.|++++|++++..|..+..++.|+.|+|++|++++.+|..+..                       .++|+
T Consensus       399 ~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~  478 (968)
T PLN00113        399 SLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLE  478 (968)
T ss_pred             HHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccce
Confidence            3344555555555555555555555555555555555555444444433322                       35677


Q ss_pred             eeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCc
Q 002321          444 VLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNS  523 (936)
Q Consensus       444 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  523 (936)
                      .|+|++|++++.+|..+..+++|+.|+|++|++++.+|..+.++++|++|+|++|++++.+|..+..+++|+.|||++|+
T Consensus       479 ~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  558 (968)
T PLN00113        479 NLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ  558 (968)
T ss_pred             EEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCc
Confidence            77777788878888888889999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCcccccccccCeeecCCCcccccCCCCCccCcCCCccccCCCCCCCCCCCC---CCCCCCCCCcccCCCCCCCCC
Q 002321          524 LTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNK---SCPAVLPKPIVLNPNSSSDST  600 (936)
Q Consensus       524 l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~gn~~~c~~~~~~---~~~~~~~~p~~~~p~s~s~~~  600 (936)
                      ++|.+|..+..+++|+.|++++|++.|.+|..++|.++...++.||+.+||.+...   +|..                 
T Consensus       559 l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~-----------------  621 (968)
T PLN00113        559 LSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKR-----------------  621 (968)
T ss_pred             ccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcc-----------------
Confidence            99999999999999999999999999999999999999999999999999865321   1110                 


Q ss_pred             CCCCCCCCCCcchhhHHHHHHHHHHHHHHHHHHHHHHhhheeecccccccccccccccCCCCCCCCCCCCCCCceeeccC
Q 002321          601 TSSVAPNPRHKRIILSISAIIAIGAAAVIVIGVIAITVLNLRVRSSTSRSAAALTLSAGDDFSRSPTTDANSGKLVMFSG  680 (936)
Q Consensus       601 t~s~~~~~~~~~~~~~~~~~i~~~~~~~~~~~i~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  680 (936)
                      .   ..  .....     .+++.++++++++++++++++++|+|+........  ...+. .           ....+..
T Consensus       622 ~---~~--~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~-----------~~~~~~~  677 (968)
T PLN00113        622 V---RK--TPSWW-----FYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVE--NEDGT-W-----------ELQFFDS  677 (968)
T ss_pred             c---cc--cceee-----eehhHHHHHHHHHHHHHHHHHHHHhhhcccccccc--ccccc-c-----------ccccccc
Confidence            0   00  00111     11111111122222222222222222211110000  00000 0           0000000


Q ss_pred             C--CCcc-ccccccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEE
Q 002321          681 D--PDFS-TGTHALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY  756 (936)
Q Consensus       681 ~--~~~~-~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  756 (936)
                      .  ..+. ......+...+.||+|+||.||+|+.. +++.||||+++....     ...+|++.+++++|||||++++++
T Consensus       678 ~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~  752 (968)
T PLN00113        678 KVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLC  752 (968)
T ss_pred             ccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEE
Confidence            0  0000 001123456678999999999999974 689999999854321     123568899999999999999999


Q ss_pred             EeCCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCCCCEEEcCCCCeEEee
Q 002321          757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH---QSNIIHYNIKSSNVLIDGSGEPKVGD  833 (936)
Q Consensus       757 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~D  833 (936)
                      .+....++||||+++|+|.++++.      ++|.++.+++.|+++|++|||   +.+|+||||||+||+++.++..++. 
T Consensus       753 ~~~~~~~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-  825 (968)
T PLN00113        753 RSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-  825 (968)
T ss_pred             EcCCCCEEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-
Confidence            999999999999999999999964      789999999999999999999   6699999999999999999988876 


Q ss_pred             ccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHH----
Q 002321          834 YGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE----  909 (936)
Q Consensus       834 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~----  909 (936)
                      ||.+.....      .....+++.|+|||++ ....++.++|||||||++|||++|+.||+...........|...    
T Consensus       826 ~~~~~~~~~------~~~~~~t~~y~aPE~~-~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  898 (968)
T PLN00113        826 LSLPGLLCT------DTKCFISSAYVAPETR-ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD  898 (968)
T ss_pred             ecccccccc------CCCccccccccCcccc-cCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc
Confidence            665543211      1223577899999988 45578999999999999999999999996432211111111110    


Q ss_pred             ---------H---------hhhccccceeecccccccccccccC
Q 002321          910 ---------H---------WKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       910 ---------~---------~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                               .         ....++.+++.+||..||.+||+++
T Consensus       899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~  942 (968)
T PLN00113        899 CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAN  942 (968)
T ss_pred             cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHH
Confidence                     0         0112345677899999999999874

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.8e-56  Score=562.96  Aligned_cols=471  Identities=33%  Similarity=0.538  Sum_probs=403.8

Q ss_pred             ccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccc
Q 002321          100 QFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATIN  179 (936)
Q Consensus       100 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  179 (936)
                      ..++.|+|++|++++.++..|..+++|++|+|++|+++|.+|.++|..+++|++|+|++|++++.+|.  +.+++|++|+
T Consensus        69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~  146 (968)
T PLN00113         69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD  146 (968)
T ss_pred             CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence            46899999999999999999999999999999999999999999999999999999999999988886  4689999999


Q ss_pred             cccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCC
Q 002321          180 LSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSG  259 (936)
Q Consensus       180 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~  259 (936)
                      |++|.+++..|..++++++|++|+|++|.+.+.+|..+.++++|++|+|++|++++.+|..++.+++|++|+|++|++++
T Consensus       147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~  226 (968)
T PLN00113        147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSG  226 (968)
T ss_pred             CcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhc
Q 002321          260 NLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMAN  339 (936)
Q Consensus       260 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~  339 (936)
                      .+|..+.++++|+.|+|++|.+++.+|..++++++|++|+|++|++.+.+|..+.++++|++|+|++|.+++.+|..+.+
T Consensus       227 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~  306 (968)
T PLN00113        227 EIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ  306 (968)
T ss_pred             cCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCEEEccCCcCccCCChhhhc-cCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCC------------
Q 002321          340 CMNLVALDFSQNSMNGDLPQWIFS-SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSG------------  406 (936)
Q Consensus       340 l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~------------  406 (936)
                      +++|+.|++++|.+.+.+|..+.. ..++.|++.+|.+..    .+|..++.+++|+.|+|++|++++            
T Consensus       307 l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~----~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L  382 (968)
T PLN00113        307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSG----EIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNL  382 (968)
T ss_pred             CCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcC----cCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCC
Confidence            999999999999999988876544 679999999998863    234444455555555555555544            


Q ss_pred             ------------CChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcC----------
Q 002321          407 ------------ETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAY----------  464 (936)
Q Consensus       407 ------------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~----------  464 (936)
                                  ..|..+..+++|+.|+|++|++++.+|..|..+++|+.|+|++|.+++.+|..+..++          
T Consensus       383 ~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n  462 (968)
T PLN00113        383 FKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARN  462 (968)
T ss_pred             CEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCc
Confidence                        4455555566677777777777766777777777777777777777766555444333          


Q ss_pred             -------------CCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcc
Q 002321          465 -------------SLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQ  531 (936)
Q Consensus       465 -------------~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  531 (936)
                                   +|+.|+|++|++++.+|..+.++++|+.|+|++|++++.+|..+..+++|++|+|++|+++|.+|..
T Consensus       463 ~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  542 (968)
T PLN00113        463 KFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPAS  542 (968)
T ss_pred             eeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChh
Confidence                         4555666666666777777888888888888888888888888888899999999999999888988


Q ss_pred             cccccccCeeecCCCcccccCCCC-CccCcCCCccccCCCCCCCCC
Q 002321          532 LVNLVHLSSFNISHNHLQGELPAG-GFFNTISPSSVLGNPSLCGSA  576 (936)
Q Consensus       532 l~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~gn~~~c~~~  576 (936)
                      +..+++|+.|+|++|+++|.+|.. ..+..+....+.+|+..+..|
T Consensus       543 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p  588 (968)
T PLN00113        543 FSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP  588 (968)
T ss_pred             HhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence            999999999999999999888863 345556677777887665444

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-45  Score=374.70  Aligned_cols=240  Identities=25%  Similarity=0.380  Sum_probs=202.7

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ...|+..++||+|+||+||+|+++ ++..||||.+..... .+..+.+..|+.+|+.++|||||++++++++++.+++||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            345677778999999999999977 589999999976653 344677899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC------CCeEEeeccCcccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS------GEPKVGDYGLARLL  840 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~------~~~kl~Dfg~a~~~  840 (936)
                      |||.||||.+|+++.+.   +++..+..++.|+|.||++||+++||||||||.|||++..      -.+||+|||+|+..
T Consensus        89 EyC~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             EeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            99999999999998764   9999999999999999999999999999999999999765      46899999999987


Q ss_pred             CCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH-------HHHHHHhhh
Q 002321          841 PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV-------TWLEEHWKK  913 (936)
Q Consensus       841 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~-------~~~~~~~~~  913 (936)
                      ..   .......+|++-|||||++. ...|+.|+|+||+|+++|+|++|+.||+.....+....       ....+....
T Consensus       166 ~~---~~~a~tlcGSplYMAPEV~~-~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s  241 (429)
T KOG0595|consen  166 QP---GSMAETLCGSPLYMAPEVIM-SQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELS  241 (429)
T ss_pred             Cc---hhHHHHhhCCccccCHHHHH-hccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhcc
Confidence            63   23445678999999999995 44799999999999999999999999997765443321       112345555


Q ss_pred             ccccceeecccccccccccccC
Q 002321          914 AEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       914 ~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ++..+++...+..+|.+|-.|.
T Consensus       242 ~~~~~Ll~~ll~~~~~~~~~~~  263 (429)
T KOG0595|consen  242 NPLRELLISLLQRNPKDRISFE  263 (429)
T ss_pred             CchhhhhhHHHhcCccccCchH
Confidence            6666788888888888876653

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-44  Score=386.27  Aligned_cols=241  Identities=28%  Similarity=0.437  Sum_probs=202.6

Q ss_pred             ccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccc-hHHHHHHHHHHHHcCCCCCcceeeeEEEeCC-eeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLVTLEGYYWTQS-LQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~  769 (936)
                      +...+.||+|+||+||+|.++....||||++....... ..++|.+|+.++.+++|||||+++|+|.+.. ..++||||+
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            34555699999999999999844449999997654332 2578999999999999999999999999877 789999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCCCCEEEcCCC-CeEEeeccCccccCCCcccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN-IIHYNIKSSNVLIDGSG-EPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~-ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      ++|+|.++++.. ....+++..+++++.|||+||+|||+.+ ||||||||+|||++.++ ++||+|||+++......  .
T Consensus       123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~  199 (362)
T KOG0192|consen  123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T  199 (362)
T ss_pred             CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence            999999999874 2334999999999999999999999999 99999999999999998 99999999998654321  2


Q ss_pred             ccccccCcccccCcccccC-cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH------HHhhhcccccee
Q 002321          848 LSSKIQSALGYMAPEFACR-TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE------EHWKKAEWRNVS  920 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~  920 (936)
                      ......||+.|||||++.+ ...|+.|+||||||+++|||+||+.||.+.............      +...++.|.+++
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~  279 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLM  279 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHH
Confidence            3344789999999999954 467999999999999999999999999998873333221111      233668899999


Q ss_pred             ecccccccccccccC
Q 002321          921 MRSCKGSSRQRRRFQ  935 (936)
Q Consensus       921 ~~~l~~~p~~Rp~f~  935 (936)
                      .+||..||.+||+|+
T Consensus       280 ~~CW~~dp~~RP~f~  294 (362)
T KOG0192|consen  280 ERCWLVDPSRRPSFL  294 (362)
T ss_pred             HHhCCCCCCcCCCHH
Confidence            999999999999995

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=388.10  Aligned_cols=242  Identities=29%  Similarity=0.386  Sum_probs=209.5

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ...+...++||+|.||+||.|.++....||||.++....  ..++|.+|+++|++++|++||+++++|..++.++|||||
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m--~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~  282 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM--SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY  282 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc--ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence            344567788999999999999998777999999987643  357889999999999999999999999998899999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      |+.|+|.++++... +..+...+.+.++.|||+||+||+++++|||||.++||||+++..+||+|||+|+.+. .+++..
T Consensus       283 m~~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~-d~~Y~~  360 (468)
T KOG0197|consen  283 MPKGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG-DDEYTA  360 (468)
T ss_pred             cccCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC-CCceee
Confidence            99999999999733 3458899999999999999999999999999999999999999999999999999543 345555


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHH-----HHHHHHHHhhhccccceeec
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWF-----SVTWLEEHWKKAEWRNVSMR  922 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~  922 (936)
                      ......+..|.|||.+. ...++.|||||||||++|||+| |+.||.........     ..+...|.-++.+.+++|..
T Consensus       361 ~~~~kfPIkWtAPEa~~-~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~  439 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALN-YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKS  439 (468)
T ss_pred             cCCCCCCceecCHHHHh-hCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHH
Confidence            56666778899999995 4469999999999999999999 99999887653222     22334467788999999999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      ||+.+|.+||+|+
T Consensus       440 CW~~~P~~RPtF~  452 (468)
T KOG0197|consen  440 CWHEDPEDRPTFE  452 (468)
T ss_pred             HhhCCcccCCCHH
Confidence            9999999999996

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4e-44  Score=366.41  Aligned_cols=238  Identities=23%  Similarity=0.338  Sum_probs=202.9

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC-eeEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS-LQLLIY  766 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~  766 (936)
                      ...++....||+|..|+|||++++ +++.+|+|++.........+++.+|++++++.+||+||++||.|..+. .+.++|
T Consensus        78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m  157 (364)
T KOG0581|consen   78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM  157 (364)
T ss_pred             HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence            345677889999999999999987 588999999965555556789999999999999999999999999998 599999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ-SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      |||++|+|+++++..++   +++....+|+.++++||.|||+ ++||||||||+|||++..|.+||||||.++.+-..  
T Consensus       158 EYMDgGSLd~~~k~~g~---i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  158 EYMDGGSLDDILKRVGR---IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             hhcCCCCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            99999999999987644   9999999999999999999995 99999999999999999999999999999876432  


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccc---hhHHHHHHH---HHH-----Hhhhc
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWK---MMWWFSVTW---LEE-----HWKKA  914 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~---~~~~~~~~~---~~~-----~~~~~  914 (936)
                        ......||..|||||.+ .+..|+.++||||||+.++|+.+|+.||....   +.+...+..   .++     ...++
T Consensus       233 --~a~tfvGT~~YMsPERi-~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~  309 (364)
T KOG0581|consen  233 --IANTFVGTSAYMSPERI-SGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSP  309 (364)
T ss_pred             --hcccccccccccChhhh-cCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCH
Confidence              44667899999999999 45589999999999999999999999998751   122221111   111     23456


Q ss_pred             cccceeeccccccccccccc
Q 002321          915 EWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       915 ~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      ++++++..||.+||.+||+-
T Consensus       310 ef~~FV~~CL~Kdp~~R~s~  329 (364)
T KOG0581|consen  310 EFRSFVSCCLRKDPSERPSA  329 (364)
T ss_pred             HHHHHHHHHhcCCcccCCCH
Confidence            79999999999999999974

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-43  Score=382.28  Aligned_cols=239  Identities=22%  Similarity=0.335  Sum_probs=212.2

Q ss_pred             ccccCCCcccccCceEEEEEEe-CCCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVL-RDGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|...+.||+|+|+.||+++. ..|+.||+|++......  ...+.+.+|+++-++++|||||+++++|++...+|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688899999999999999998 67999999999765443  34678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      |+|+.++|..++++.+   .+++.++..+++||+.||.|||+++|+|||||..|++++++.++||+|||+|..+...+  
T Consensus        98 ELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~--  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG--  172 (592)
T ss_pred             EecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc--
Confidence            9999999999998543   39999999999999999999999999999999999999999999999999998875432  


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH----HHHHHHHHhhhccccceeec
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF----SVTWLEEHWKKAEWRNVSMR  922 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  922 (936)
                      +.....+|||.|.|||++. ...++..+||||+|||+|.|+.|++||++......+    ..++..|...+.+.+++|..
T Consensus       173 Erk~TlCGTPNYIAPEVl~-k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~  251 (592)
T KOG0575|consen  173 ERKKTLCGTPNYIAPEVLN-KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRK  251 (592)
T ss_pred             cccceecCCCcccChhHhc-cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHH
Confidence            3456789999999999995 557899999999999999999999999998654333    33455577888999999999


Q ss_pred             cccccccccccc
Q 002321          923 SCKGSSRQRRRF  934 (936)
Q Consensus       923 ~l~~~p~~Rp~f  934 (936)
                      ++..||.+||+-
T Consensus       252 lL~~~P~~Rpsl  263 (592)
T KOG0575|consen  252 LLRPNPSERPSL  263 (592)
T ss_pred             HhcCCcccCCCH
Confidence            999999999984

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.8e-43  Score=397.25  Aligned_cols=247  Identities=24%  Similarity=0.372  Sum_probs=214.3

Q ss_pred             ccccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCe
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSL  761 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  761 (936)
                      +...+...++||+|+||+||+|+..      +...||||.++.......+.+|+||+++++.++|||||+++|+|..++.
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            3444567788999999999999843      3567999999988777778999999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeE
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSG-----------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPK  830 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~k  830 (936)
                      .+||+|||..|||.+||+....           ...++..+.+.||.|||.||+||-++.+|||||..+|+||.++..||
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEE
Confidence            9999999999999999975421           12388999999999999999999999999999999999999999999


Q ss_pred             EeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHH-----
Q 002321          831 VGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSV-----  904 (936)
Q Consensus       831 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~-----  904 (936)
                      |+|||+++.+-..+++.......-+.+|||||.+..+ .|+.+||||||||++||+++ |+-||.+....++-..     
T Consensus       644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~  722 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ  722 (774)
T ss_pred             ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC
Confidence            9999999988777777766666678899999999666 68999999999999999999 9999988765433311     


Q ss_pred             HHHHHHhhhccccceeecccccccccccccC
Q 002321          905 TWLEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+.-|+-++.+.+++|.+||+..|.+||+|.
T Consensus       723 lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~  753 (774)
T KOG1026|consen  723 LLSCPENCPTEVYSLMLECWNENPKRRPSFK  753 (774)
T ss_pred             cccCCCCCCHHHHHHHHHHhhcCcccCCCHH
Confidence            1233566778999999999999999999994

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-43  Score=364.08  Aligned_cols=240  Identities=22%  Similarity=0.326  Sum_probs=197.6

Q ss_pred             ccccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc------hHHHHHHHHHHHHcCCCCCcceeeeEEEeCC
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK------SQEDFEREVKKLGKVRHPNLVTLEGYYWTQS  760 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  760 (936)
                      ....|...+.+|+|+||.|-+|..+ +|+.||||++.......      ....+++|+++|+++.|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4556778889999999999999966 69999999996543322      2345689999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC---CCeEEeeccCc
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS---GEPKVGDYGLA  837 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a  837 (936)
                      ..||||||++||+|.+.+-.++.   +.+..-..+++|++.|+.|||++||+||||||+|||+..+   ..+||+|||+|
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence            99999999999999999877654   6677778899999999999999999999999999999765   67999999999


Q ss_pred             cccCCCccccccccccCcccccCcccccCcc--cCCchhhHHHHHHHHHHHHcCCCCCCccch-----hHHHH--HHHHH
Q 002321          838 RLLPMLDRYVLSSKIQSALGYMAPEFACRTV--KITDKCDVYGFGVLVLEVVTGKRPLSTWKM-----MWWFS--VTWLE  908 (936)
Q Consensus       838 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~-----~~~~~--~~~~~  908 (936)
                      +..+..   ......+|||.|.|||++.+..  .+..++|+||+||++|-+++|.+||.+.-.     +++..  ..+.+
T Consensus       327 K~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p  403 (475)
T KOG0615|consen  327 KVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP  403 (475)
T ss_pred             hccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC
Confidence            987532   3345678999999999985332  244589999999999999999999977532     22222  22233


Q ss_pred             HHh--hhccccceeecccccccccccc
Q 002321          909 EHW--KKAEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       909 ~~~--~~~~~~~~~~~~l~~~p~~Rp~  933 (936)
                      +.|  .+++..++|.+++..||.+||+
T Consensus       404 ~~w~~Iseea~dlI~~mL~VdP~~R~s  430 (475)
T KOG0615|consen  404 LQWDRISEEALDLINWMLVVDPENRPS  430 (475)
T ss_pred             hhhhhhhHHHHHHHHHhhEeCcccCcC
Confidence            444  4478889999999999999997

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-44  Score=350.79  Aligned_cols=243  Identities=23%  Similarity=0.376  Sum_probs=203.6

Q ss_pred             ccccccCCCcccccCceEEEEEEe-CCCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEE-EeCC-eeE
Q 002321          688 THALLNKDCELGRGGFGAVYRTVL-RDGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYY-WTQS-LQL  763 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~-~~~  763 (936)
                      +...|++.++||+|+||+|||+.. .+|..||.|.+.....+ +..+++..|+.+|++++|||||+++++. .++. ..+
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            456688889999999999999984 47999999999755444 3457789999999999999999999944 3333 378


Q ss_pred             EEEEecCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHh--CC--cccCCCCCCCEEEcCCCCeEEeeccCcc
Q 002321          764 LIYEFVSGGSLHKHLHEGS-GGNFLSWNERFNVIQGTAKSLAHLHQ--SN--IIHYNIKSSNVLIDGSGEPKVGDYGLAR  838 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~--~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  838 (936)
                      +||||+.+|||...++.-+ ..+.+++..+++++.|+++||.++|.  ..  |+||||||.||+++++|.+|++|||+++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence            9999999999999887543 23469999999999999999999999  55  9999999999999999999999999999


Q ss_pred             ccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH----HHHH--HHHHhh
Q 002321          839 LLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF----SVTW--LEEHWK  912 (936)
Q Consensus       839 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~----~~~~--~~~~~~  912 (936)
                      .+...  ........|||.||+||.+. ...|++++||||+||++|||+.-++||.+..-....    ..++  .+....
T Consensus       177 ~l~s~--~tfA~S~VGTPyYMSPE~i~-~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~Y  253 (375)
T KOG0591|consen  177 FLSSK--TTFAHSLVGTPYYMSPERIH-ESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHY  253 (375)
T ss_pred             Hhcch--hHHHHhhcCCCcccCHHHHh-cCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHh
Confidence            87643  33456688999999999994 557999999999999999999999999987542222    2222  334667


Q ss_pred             hccccceeecccccccccccc
Q 002321          913 KAEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       913 ~~~~~~~~~~~l~~~p~~Rp~  933 (936)
                      +..+.+++..|+..||.+||+
T Consensus       254 S~~l~~li~~ci~vd~~~RP~  274 (375)
T KOG0591|consen  254 STDLRELINMCIAVDPEQRPD  274 (375)
T ss_pred             hhHHHHHHHHHccCCcccCCC
Confidence            788899999999999999997

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-43  Score=357.13  Aligned_cols=238  Identities=25%  Similarity=0.355  Sum_probs=205.0

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccch--HHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  765 (936)
                      -..|+..+.||+|+||+||.++.+ +++.+|+|++++....+.  .+...+|..++.+++||.||+++..|++.+..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            345788899999999999999976 489999999987766543  67789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      +||+.||.|..++.+.+.   +++..+.-++.+|+.||.|||++||||||+||+|||+|++|+++|+|||+++..-..  
T Consensus       104 ld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~--  178 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD--  178 (357)
T ss_pred             EeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC--
Confidence            999999999999987654   899988889999999999999999999999999999999999999999999854322  


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHH-HH----HHHHHhhhcccccee
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS-VT----WLEEHWKKAEWRNVS  920 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~-~~----~~~~~~~~~~~~~~~  920 (936)
                      .......+||+.|||||++.+. .|+.++|.||+|+++|||++|.+||...+...... ..    ..++.+.+.+.++++
T Consensus       179 ~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll  257 (357)
T KOG0598|consen  179 GDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLL  257 (357)
T ss_pred             CCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHH
Confidence            2233457999999999999554 79999999999999999999999999987533332 21    223444667899999


Q ss_pred             eccccccccccc
Q 002321          921 MRSCKGSSRQRR  932 (936)
Q Consensus       921 ~~~l~~~p~~Rp  932 (936)
                      .+.++.||++|-
T Consensus       258 ~~LL~rdp~~RL  269 (357)
T KOG0598|consen  258 KKLLKRDPRQRL  269 (357)
T ss_pred             HHHhccCHHHhc
Confidence            999999999984

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.4e-42  Score=341.96  Aligned_cols=239  Identities=23%  Similarity=0.306  Sum_probs=196.5

Q ss_pred             cccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCccch-HHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKS-QEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      .|+...++|+|+||.||||+.++ |+.||||++.....+.. .+-..||++++++++|+|+|.++++|......++|+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            46777889999999999999874 99999999976654433 45678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      ++..-|+++- +...+  ++.....+++.|+++|+.|+|+++++||||||+|||++.+|.+||||||+|+.+..+.+  .
T Consensus        83 ~dhTvL~eLe-~~p~G--~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd--~  157 (396)
T KOG0593|consen   83 CDHTVLHELE-RYPNG--VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD--N  157 (396)
T ss_pred             cchHHHHHHH-hccCC--CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc--h
Confidence            9876555543 33322  88899999999999999999999999999999999999999999999999998864332  2


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH-HH---------------------
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV-TW---------------------  906 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~-~~---------------------  906 (936)
                      .+....|.+|+|||.+.+...|+..+||||+||++.||++|++-|.+..+..+... +.                     
T Consensus       158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G  237 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG  237 (396)
T ss_pred             hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence            35567789999999999989999999999999999999999999988766433211 00                     


Q ss_pred             -----------HHHHh--hhccccceeeccccccccccccc
Q 002321          907 -----------LEEHW--KKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       907 -----------~~~~~--~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                 .+..+  ..+..-+++..|++.||++|+++
T Consensus       238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc  278 (396)
T KOG0593|consen  238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSC  278 (396)
T ss_pred             eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccH
Confidence                       00011  11235677789999999999875

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=6e-46  Score=378.21  Aligned_cols=450  Identities=27%  Similarity=0.408  Sum_probs=285.2

Q ss_pred             EEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccC
Q 002321           79 IELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAK  158 (936)
Q Consensus        79 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~  158 (936)
                      ..+.+++|+++ .+.+.+.+|..|..|++++|+++ ..|++++.+..++.|+.++|+++ .+|.++ ..+.+|+.|+.++
T Consensus        48 ~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i-~s~~~l~~l~~s~  123 (565)
T KOG0472|consen   48 QKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQI-GSLISLVKLDCSS  123 (565)
T ss_pred             hhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHH-hhhhhhhhhhccc
Confidence            34445555554 33344555555556666666555 45555555555666666666555 455443 4455555555555


Q ss_pred             ccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCC
Q 002321          159 NRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIP  238 (936)
Q Consensus       159 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  238 (936)
                      |.+. .+|++++.+..|+.|+..+|+++. .|..+..+.+|..|++.+|+++...|..+. ++.|++|++.+|-++ .+|
T Consensus       124 n~~~-el~~~i~~~~~l~dl~~~~N~i~s-lp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP  199 (565)
T KOG0472|consen  124 NELK-ELPDSIGRLLDLEDLDATNNQISS-LPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLP  199 (565)
T ss_pred             ccee-ecCchHHHHhhhhhhhcccccccc-CchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCC
Confidence            5555 345555555555555555555553 444555555555555555555533333332 555555555555554 445


Q ss_pred             cccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccc-cCCccceecccCceeccccCccccccc
Q 002321          239 DGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIG-ELESLETLDLSGNKFSGAVPISIGNLQ  317 (936)
Q Consensus       239 ~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~l~~l~  317 (936)
                      ..++.+.+|..|||.+|+|. ..| .|..++.|..++++.|++. .+|.+.+ .++++.+|||.+|++. ..|+.+.-++
T Consensus       200 ~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLr  275 (565)
T KOG0472|consen  200 PELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLR  275 (565)
T ss_pred             hhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhh
Confidence            55555555555555555554 233 4555555555555555555 3333333 5555555555555555 4555555555


Q ss_pred             ccceEEccCCcccccCChhhhccCCCCEEEccCCcCcc-------------------------------------CCChh
Q 002321          318 RLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNG-------------------------------------DLPQW  360 (936)
Q Consensus       318 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-------------------------------------~~p~~  360 (936)
                      +|.+||+++|.|+ ..|.+++++ .|+.|-+.+|++..                                     +.|.+
T Consensus       276 sL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~  353 (565)
T KOG0472|consen  276 SLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSE  353 (565)
T ss_pred             hhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCC
Confidence            5555555555555 344455555 55555555555531                                     11222


Q ss_pred             hhc-----cCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCC-eeeccCccccCCCCc
Q 002321          361 IFS-----SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQ-LLNLSRNSLVGPIPV  434 (936)
Q Consensus       361 ~~~-----~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~  434 (936)
                      .|.     -..+.|++.+-.++.++...|-..  .-.-....+++.|++. ++|..+..+..+. .+.+++|.+. .+|.
T Consensus       354 ~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~--~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~  429 (565)
T KOG0472|consen  354 SFPDIYAIITTKILDVSDKQLTLVPDEVFEAA--KSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPL  429 (565)
T ss_pred             cccchhhhhhhhhhcccccccccCCHHHHHHh--hhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchH
Confidence            221     233445555555555444433221  1112556777777775 6666666666554 4455555554 7888


Q ss_pred             cccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCc
Q 002321          435 AIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNL  514 (936)
Q Consensus       435 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  514 (936)
                      .+..+++|..|+|++|.+. .+|..++.+..|+.|++|.|+|. .+|..+..+..|+.+-.++|++....|..+.+|.+|
T Consensus       430 ~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL  507 (565)
T KOG0472|consen  430 ELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNL  507 (565)
T ss_pred             HHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhc
Confidence            8999999999999999998 68999999999999999999998 899999999999999999999997777779999999


Q ss_pred             cEEEcCCCcccCCCCcccccccccCeeecCCCccc
Q 002321          515 QNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQ  549 (936)
Q Consensus       515 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~  549 (936)
                      ..|||.+|.|. .+|+.++++++|++|+++||+|+
T Consensus       508 ~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  508 TTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             ceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            99999999998 89999999999999999999999

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=367.97  Aligned_cols=395  Identities=26%  Similarity=0.266  Sum_probs=222.2

Q ss_pred             CCccceeEEecCCCCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccc
Q 002321           62 TPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIP  141 (936)
Q Consensus        62 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~  141 (936)
                      |+|.=.=..|+.  .++..++  ...+.|.+|+      +-+.|++++|+|+.+.+..|.++++|++++|.+|.++ .||
T Consensus        50 c~c~~~lldcs~--~~lea~~--~~~l~g~lp~------~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP  118 (873)
T KOG4194|consen   50 CPCNTRLLDCSD--RELEAID--KSRLKGFLPS------QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIP  118 (873)
T ss_pred             CCCCceeeecCc--ccccccc--ccccCCcCcc------ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcc
Confidence            345544455654  2333322  2234444442      3455677777776666666666666666666666666 555


Q ss_pred             hhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCC
Q 002321          142 DEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLK  221 (936)
Q Consensus       142 ~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  221 (936)
                      .. -....+|+.|+|.+|.|+..-..+++.++.|+.||||.|.|+.+....|..-.++++|+|++|.|+......|.++.
T Consensus       119 ~f-~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~ln  197 (873)
T KOG4194|consen  119 RF-GHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLN  197 (873)
T ss_pred             cc-cccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccc
Confidence            32 12333455555555555555455555555555555555555554444444444555555555555544444455555


Q ss_pred             CcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceeccc
Q 002321          222 NLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLS  301 (936)
Q Consensus       222 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  301 (936)
                      +|..|.|++|+++...+..|.++++|+.|+|..|+|                        .-.---.|..+++|+.|.|.
T Consensus       198 sL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~i------------------------rive~ltFqgL~Sl~nlklq  253 (873)
T KOG4194|consen  198 SLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRI------------------------RIVEGLTFQGLPSLQNLKLQ  253 (873)
T ss_pred             hheeeecccCcccccCHHHhhhcchhhhhhccccce------------------------eeehhhhhcCchhhhhhhhh
Confidence            555555555555544444444455555555444444                        42223345556666666666


Q ss_pred             CceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCC
Q 002321          302 GNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMN  381 (936)
Q Consensus       302 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~  381 (936)
                      .|.|.......|..+.++++|+|..|+++..-..++.+++.|+.|+||+|.|...-+..                     
T Consensus       254 rN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~---------------------  312 (873)
T KOG4194|consen  254 RNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDS---------------------  312 (873)
T ss_pred             hcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecch---------------------
Confidence            66666555566666666666666666666555556666666666666666654221110                     


Q ss_pred             CCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCC---
Q 002321          382 GPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPP---  458 (936)
Q Consensus       382 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~---  458 (936)
                            ..-.++|++|+|++|+|+...++.|..+..|++|+|++|+++..-...|..+++|+.|||++|.|+..+.+   
T Consensus       313 ------WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~  386 (873)
T KOG4194|consen  313 ------WSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAV  386 (873)
T ss_pred             ------hhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchh
Confidence                  11235667777777777766667777777777777777777655555666677777777777776654433   


Q ss_pred             CCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcC
Q 002321          459 EIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLS  520 (936)
Q Consensus       459 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  520 (936)
                      .|.++++|+.|+|.+|+|..+...+|.++++|+.|||.+|.|..+-|.+|..| .|++|-+.
T Consensus       387 ~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~n  447 (873)
T KOG4194|consen  387 AFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMN  447 (873)
T ss_pred             hhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhc
Confidence            35556666666666666654334455566666666666666655555555555 55555443

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.7e-41  Score=352.63  Aligned_cols=214  Identities=24%  Similarity=0.339  Sum_probs=185.2

Q ss_pred             ccccccccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeC--
Q 002321          684 FSTGTHALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ--  759 (936)
Q Consensus       684 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  759 (936)
                      |.......|++.++||+|+||.||+|++. +|+.||+|+++.+... .......|||.+|++++||||+++.+...+.  
T Consensus       111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~  190 (560)
T KOG0600|consen  111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS  190 (560)
T ss_pred             ccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence            44445667899999999999999999965 6999999999876643 3456788999999999999999999999876  


Q ss_pred             CeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          760 SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       760 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      +.+|||+|||++ ||.-++....  -.+++.++..+++|++.||+|+|++||+|||||.+|||+|.+|.+||+|||+|++
T Consensus       191 ~siYlVFeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~  267 (560)
T KOG0600|consen  191 GSIYLVFEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARF  267 (560)
T ss_pred             ceEEEEEecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceee
Confidence            689999999974 8888876543  2399999999999999999999999999999999999999999999999999997


Q ss_pred             cCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHH
Q 002321          840 LPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWW  901 (936)
Q Consensus       840 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~  901 (936)
                      +..... ...+...-|.+|+|||.+.+...|+.++|+||.|||+.||+.|++.|++..+..+
T Consensus       268 y~~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ  328 (560)
T KOG0600|consen  268 YTPSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ  328 (560)
T ss_pred             ccCCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH
Confidence            754332 2245566789999999999999999999999999999999999999999876433

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-41  Score=331.95  Aligned_cols=233  Identities=24%  Similarity=0.328  Sum_probs=207.3

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||.|+||.|..++.+ +|..+|+|++......  +..+....|.++++.+.||.++++++.+.+.+..+|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            45677889999999999999976 5889999999766544  34567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||++||.|..++++.++   +++..+.-++.||+.|++|||+.+|++||+||+|||+|.+|.+||+|||+|+.+...   
T Consensus       124 eyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r---  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR---  197 (355)
T ss_pred             eccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence            99999999999998765   999999999999999999999999999999999999999999999999999976432   


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH----HHHHHHHHhhhccccceeec
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF----SVTWLEEHWKKAEWRNVSMR  922 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  922 (936)
                        ....+|||.|+|||++ ..+.|..++|.|||||++|||+.|.+||.+...+..+    .....+|.+-+...++++..
T Consensus       198 --T~TlCGTPeYLAPEii-~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~  274 (355)
T KOG0616|consen  198 --TWTLCGTPEYLAPEII-QSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK  274 (355)
T ss_pred             --EEEecCCccccChHHh-hcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence              3567899999999999 5678999999999999999999999999998875444    33445577788899999999


Q ss_pred             ccccccccc
Q 002321          923 SCKGSSRQR  931 (936)
Q Consensus       923 ~l~~~p~~R  931 (936)
                      .+.+|-++|
T Consensus       275 LL~vD~t~R  283 (355)
T KOG0616|consen  275 LLQVDLTKR  283 (355)
T ss_pred             HHhhhhHhh
Confidence            999998887

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-42  Score=364.72  Aligned_cols=367  Identities=28%  Similarity=0.283  Sum_probs=290.9

Q ss_pred             CCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEE
Q 002321           75 SNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVI  154 (936)
Q Consensus        75 ~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L  154 (936)
                      +..+..||+++|.+...-+..|.++++|+++++..|.++ .||...+...+|+.|+|.+|.|+ .+..+.+..++.|+.|
T Consensus        77 p~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~-sv~se~L~~l~alrsl  154 (873)
T KOG4194|consen   77 PSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLIS-SVTSEELSALPALRSL  154 (873)
T ss_pred             ccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccc-cccHHHHHhHhhhhhh
Confidence            356789999999999877888999999999999999999 67777777788999999999999 8899999999999999


Q ss_pred             EccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeeccccccc
Q 002321          155 SLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFS  234 (936)
Q Consensus       155 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  234 (936)
                      ||+.|.|+.+.-.+|..-.++++|+|++|+|+......|.++.+|..|.|+.|+|+...+..|.+|++|+.|+|..|+|.
T Consensus       155 DLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~ir  234 (873)
T KOG4194|consen  155 DLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIR  234 (873)
T ss_pred             hhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhcccccee
Confidence            99999999888888999999999999999999999999999999999999999999888889999999999999999998


Q ss_pred             ccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccc
Q 002321          235 GSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIG  314 (936)
Q Consensus       235 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~  314 (936)
                      -.---.|.++.+|+.|.|..|.+.......|..+.++++|+|+.|+++..-..|+.+++.|+.|+||+|.|....++.+.
T Consensus       235 ive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Ws  314 (873)
T KOG4194|consen  235 IVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWS  314 (873)
T ss_pred             eehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhh
Confidence            44356788999999999999999988888888999999999999999888888888999999999999999888888888


Q ss_pred             cccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcc
Q 002321          315 NLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESL  394 (936)
Q Consensus       315 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L  394 (936)
                      -.++|+.|+|++|+|+...+.+|..+..|+.|.|++|.+.. +.                      .+.|    ..+++|
T Consensus       315 ftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~-l~----------------------e~af----~~lssL  367 (873)
T KOG4194|consen  315 FTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDH-LA----------------------EGAF----VGLSSL  367 (873)
T ss_pred             hcccceeEeccccccccCChhHHHHHHHhhhhcccccchHH-HH----------------------hhHH----HHhhhh
Confidence            88899999999999988888888888777777777777651 11                      1111    234556


Q ss_pred             cEEeccCcccCCCCh---hhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEe
Q 002321          395 QFLDLSHNEFSGETP---ATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRL  471 (936)
Q Consensus       395 ~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  471 (936)
                      ++|||++|.|+..+.   ..|.++++|+.|.|.+|++..+...+|.++.+|+.|||.+|.|-.+-|+.|..+ .|++|.+
T Consensus       368 ~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~  446 (873)
T KOG4194|consen  368 HKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVM  446 (873)
T ss_pred             hhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhh
Confidence            666666666554332   234445555555555555554333444455555555555554444444444444 4444433

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-40  Score=360.77  Aligned_cols=208  Identities=42%  Similarity=0.726  Sum_probs=178.1

Q ss_pred             CccccccccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC-e
Q 002321          683 DFSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS-L  761 (936)
Q Consensus       683 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~  761 (936)
                      ++..+|. .|.....||+|+||.||+|...+|+.||||++....... ..+|.+|+.++.+++|||+|+++|||.+.+ .
T Consensus        69 el~~AT~-~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~  146 (361)
T KOG1187|consen   69 ELRKATN-NFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEH  146 (361)
T ss_pred             HHHHHHh-CCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCce
Confidence            4444443 357778999999999999999989999999886654332 566999999999999999999999999988 5


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCCEEEcCCCCeEEeeccCcc
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS---NIIHYNIKSSNVLIDGSGEPKVGDYGLAR  838 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  838 (936)
                      .++|+|||++|+|.++++..... .++|..|++||.++|+||+|||..   .|+|||||++|||+|+++.+||+|||+|+
T Consensus       147 ~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~  225 (361)
T KOG1187|consen  147 RLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK  225 (361)
T ss_pred             EEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence            99999999999999999986544 689999999999999999999985   49999999999999999999999999997


Q ss_pred             ccCCCccccccccc-cCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCcc
Q 002321          839 LLPMLDRYVLSSKI-QSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTW  896 (936)
Q Consensus       839 ~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~  896 (936)
                      ..+..  ....... .||.+|+|||+... ...+.|+|||||||++.|+++|+.|.+..
T Consensus       226 ~~~~~--~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~  281 (361)
T KOG1187|consen  226 LGPEG--DTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQS  281 (361)
T ss_pred             cCCcc--ccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCC
Confidence            65431  1111112 79999999999944 57899999999999999999999988864

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-41  Score=354.93  Aligned_cols=245  Identities=25%  Similarity=0.334  Sum_probs=214.1

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      +..+...++||+|-||+|..|....+..||||+++..+......+|.+|+++|.+++||||++++|+|..++.+++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            34456677899999999999999878999999999888777789999999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      |++|+|.+++.++.... .....-.+|+.||+.||+||.+.++||||+.++|+|+|+++++||+|||+++.+-..+.+..
T Consensus       617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence            99999999998874322 45556678999999999999999999999999999999999999999999997777777777


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc--CCCCCCccchhHHHHH--H----------HHHHHhhhc
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT--GKRPLSTWKMMWWFSV--T----------WLEEHWKKA  914 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~--g~~Pf~~~~~~~~~~~--~----------~~~~~~~~~  914 (936)
                      .....-+.+|||||.+..+ .++.++|||+||+++||+++  .+.||....++.+..-  .          ...|..+++
T Consensus       696 qgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~  774 (807)
T KOG1094|consen  696 QGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQ  774 (807)
T ss_pred             ecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcH
Confidence            7777778899999988655 68999999999999999887  8899988776544321  1          122566778


Q ss_pred             cccceeecccccccccccccC
Q 002321          915 EWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       915 ~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+.+++.+||..|..+||+|+
T Consensus       775 ~lyelml~Cw~~es~~RPsFe  795 (807)
T KOG1094|consen  775 GLYELMLRCWRRESEQRPSFE  795 (807)
T ss_pred             HHHHHHHHHhchhhhcCCCHH
Confidence            899999999999999999996

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-41  Score=356.15  Aligned_cols=244  Identities=20%  Similarity=0.302  Sum_probs=207.6

Q ss_pred             ccccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccch--HHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeE
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKS--QEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  763 (936)
                      +-..|..++.||+|+|++||+|+.+ ++++||||++.+.-..++  .+.+.+|-.+|.+| .||.|++++..|.|+...|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            3445788889999999999999966 589999999965544322  46678999999999 8999999999999999999


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      .|+||+++|+|.+++++.+.   +++.-...++.+|+.|++|||++|||||||||+|||+|++|++||+|||.|+.++..
T Consensus       151 FvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             EEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            99999999999999998754   898889999999999999999999999999999999999999999999999887532


Q ss_pred             cc---------ccc--cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH----HHHHHH
Q 002321          844 DR---------YVL--SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF----SVTWLE  908 (936)
Q Consensus       844 ~~---------~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~----~~~~~~  908 (936)
                      ..         ...  .....||..|.+||++ .....++.+|+|+|||++|+|+.|.+||....+...+    ..++..
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL-~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~f  306 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELL-NDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEF  306 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHh-cCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccC
Confidence            11         111  1447799999999999 5557899999999999999999999999998774333    344444


Q ss_pred             HHhhhccccceeecccccccccccccC
Q 002321          909 EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 ~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +.--++..++++.+.+..||.+|.+-|
T Consensus       307 p~~fp~~a~dLv~KLLv~dp~~Rlt~~  333 (604)
T KOG0592|consen  307 PEGFPEDARDLIKKLLVRDPSDRLTSQ  333 (604)
T ss_pred             CCCCCHHHHHHHHHHHccCccccccHH
Confidence            555668899999999999999998743

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.2e-40  Score=318.93  Aligned_cols=208  Identities=26%  Similarity=0.366  Sum_probs=182.7

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccch-HHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKS-QEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      .|...+++|+|.||.||+|++. +|+.||||+++.....+. .....||++.++.++|+||+.++++|...+...+|+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            3677789999999999999965 699999999987654433 35678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      |+ .+|+..++...  ..++..++..++.++++|++|||++.|+||||||.|+|++++|.+||+|||+|+.+........
T Consensus        83 m~-tdLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~  159 (318)
T KOG0659|consen   83 MP-TDLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT  159 (318)
T ss_pred             cc-ccHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence            95 79999998654  3588999999999999999999999999999999999999999999999999998876554333


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHH
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS  903 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~  903 (936)
                      .  ..-|.+|+|||.+.+.+.|+..+||||.||++.||+-|.+-|.+..+.++..
T Consensus       160 ~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~  212 (318)
T KOG0659|consen  160 H--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLS  212 (318)
T ss_pred             c--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHH
Confidence            2  3678899999999999999999999999999999999998888877654443

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=6e-44  Score=363.68  Aligned_cols=427  Identities=29%  Similarity=0.424  Sum_probs=371.4

Q ss_pred             ceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEc
Q 002321           77 RVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISL  156 (936)
Q Consensus        77 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L  156 (936)
                      -.+.+++.++.++ ++|++++.+..++.|+.++|++. .+|+++..+.+|+.|+.++|.+. .+|+++ +.+..|..|+.
T Consensus        69 ~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i-~~~~~l~dl~~  144 (565)
T KOG0472|consen   69 CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSI-GRLLDLEDLDA  144 (565)
T ss_pred             ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchH-HHHhhhhhhhc
Confidence            4677888888887 89999999999999999999998 78999999999999999999998 778765 67889999999


Q ss_pred             cCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeeccccccccc
Q 002321          157 AKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGS  236 (936)
Q Consensus       157 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  236 (936)
                      .+|+|+ ..|+.+..+.+|..|++.+|+++...|..+. ++.|++||..+|.++ .+|..++.+.+|+-|+|.+|+|. .
T Consensus       145 ~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~  220 (565)
T KOG0472|consen  145 TNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-F  220 (565)
T ss_pred             cccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-c
Confidence            999999 5788899999999999999999976666555 999999999999999 78999999999999999999998 6


Q ss_pred             CCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccc
Q 002321          237 IPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNL  316 (936)
Q Consensus       237 ~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l  316 (936)
                      .| .|.+++.|++|+++.|+|+-...+...++.++..|||+.|++. ..|+.++-+.+|++||+|+|.|+ ..|.+++++
T Consensus       221 lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl  297 (565)
T KOG0472|consen  221 LP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL  297 (565)
T ss_pred             CC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc
Confidence            67 8999999999999999998544455569999999999999999 78999999999999999999999 678889999


Q ss_pred             cccceEEccCCccccc--------------------------------------CChhh---hccCCCCEEEccCCcCcc
Q 002321          317 QRLKVLNFSANRLTGS--------------------------------------LPDSM---ANCMNLVALDFSQNSMNG  355 (936)
Q Consensus       317 ~~L~~L~L~~N~l~~~--------------------------------------~~~~~---~~l~~L~~L~Ls~N~l~~  355 (936)
                       +|+.|-+.+|.+..+                                      .+..|   ....+.+.|++++-+++ 
T Consensus       298 -hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-  375 (565)
T KOG0472|consen  298 -HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-  375 (565)
T ss_pred             -eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-
Confidence             999999999988521                                      00011   12345788999999988 


Q ss_pred             CCChhhhc----cCCccccccccccccCCCCCCCCCCCCCCccc-EEeccCcccCCCChhhhcccccCCeeeccCccccC
Q 002321          356 DLPQWIFS----SGLNKVSFAENKIREGMNGPFASSGSSFESLQ-FLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVG  430 (936)
Q Consensus       356 ~~p~~~~~----~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  430 (936)
                      .+|...|.    ..+..++++.|++.+.+.+     +..+..+. .+++++|.+ +.+|..++.+++|..|+|++|-+. 
T Consensus       376 ~VPdEVfea~~~~~Vt~VnfskNqL~elPk~-----L~~lkelvT~l~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-  448 (565)
T KOG0472|consen  376 LVPDEVFEAAKSEIVTSVNFSKNQLCELPKR-----LVELKELVTDLVLSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-  448 (565)
T ss_pred             cCCHHHHHHhhhcceEEEecccchHhhhhhh-----hHHHHHHHHHHHhhcCcc-ccchHHHHhhhcceeeecccchhh-
Confidence            77877665    3478899999999886543     33344444 455666666 589999999999999999999998 


Q ss_pred             CCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccc
Q 002321          431 PIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAK  510 (936)
Q Consensus       431 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~  510 (936)
                      .+|..++.+..|+.||+|.|++. .+|..+..+..|+.+-.++|++....|+.+.+|.+|..|||.+|.+. .+|..+++
T Consensus       449 ~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~Lgn  526 (565)
T KOG0472|consen  449 DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGN  526 (565)
T ss_pred             hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhcc
Confidence            68999999999999999999998 78988888888888888999999666777999999999999999999 79999999


Q ss_pred             cCCccEEEcCCCccc
Q 002321          511 LTNLQNVDLSFNSLT  525 (936)
Q Consensus       511 l~~L~~L~Ls~N~l~  525 (936)
                      |++|++|+|++|++.
T Consensus       527 mtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  527 MTNLRHLELDGNPFR  541 (565)
T ss_pred             ccceeEEEecCCccC
Confidence            999999999999997

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-41  Score=389.41  Aligned_cols=246  Identities=26%  Similarity=0.392  Sum_probs=214.4

Q ss_pred             cccccCCCcccccCceEEEEEEeCC--Cc----EEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCee
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRD--GR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQ  762 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  762 (936)
                      ....+..+.||+|+||.||+|...+  |.    .||||.+++........+|.+|..+|+.++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3445677889999999999999663  43    49999998877777789999999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCcc
Q 002321          763 LLIYEFVSGGSLHKHLHEGSG----GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR  838 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  838 (936)
                      ++++|||++|||..|+++.+.    ...++..+.+.++.|||+|++||+++++|||||.++|+|+++...+||+|||+|+
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr  850 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLAR  850 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhH
Confidence            999999999999999998632    2358999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHH-----HHHHHHHHhh
Q 002321          839 LLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWF-----SVTWLEEHWK  912 (936)
Q Consensus       839 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~-----~~~~~~~~~~  912 (936)
                      .+...+.+.......-+..|||||.+.. ..++.|+|||||||++||++| |..||...+..++.     ..+..+|.++
T Consensus       851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~C  929 (1025)
T KOG1095|consen  851 DIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYC  929 (1025)
T ss_pred             hhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCC
Confidence            7766566555544455678999999955 579999999999999999999 99999887764333     3355668889


Q ss_pred             hccccceeecccccccccccccC
Q 002321          913 KAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       913 ~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +.+.+++|..||+.+|++||+|.
T Consensus       930 P~~ly~lM~~CW~~~pe~RP~F~  952 (1025)
T KOG1095|consen  930 PEKLYQLMLQCWKHDPEDRPSFR  952 (1025)
T ss_pred             ChHHHHHHHHHccCChhhCccHH
Confidence            99999999999999999999995

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=337.52  Aligned_cols=243  Identities=24%  Similarity=0.326  Sum_probs=206.8

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..++||.|.-++||+|+.. .++.||||++..+....+.+.+++|+..|+.++||||++++..|..+...|+||.|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            35788889999999999999954 58999999998877766778999999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCC-Ccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYV  847 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~-~~~~~  847 (936)
                      |.+|++.+.++..-... +.+..+..|.+++++||.|||++|.+|||||+.|||++.+|.+||+|||.+..+-. ..+..
T Consensus       106 Ma~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~  184 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQV  184 (516)
T ss_pred             hcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceee
Confidence            99999999998754433 89999999999999999999999999999999999999999999999998765432 22222


Q ss_pred             cc-ccccCcccccCccc-ccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH--------------HHHHHHh
Q 002321          848 LS-SKIQSALGYMAPEF-ACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV--------------TWLEEHW  911 (936)
Q Consensus       848 ~~-~~~~~~~~y~aPE~-~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~--------------~~~~~~~  911 (936)
                      .. ....|++.|||||+ ......|+.|+||||||++..||.+|..||.+..++.....              ...+...
T Consensus       185 ~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~  264 (516)
T KOG0582|consen  185 TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKK  264 (516)
T ss_pred             EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhh
Confidence            22 45679999999999 44555699999999999999999999999999876554322              1122233


Q ss_pred             hhccccceeecccccccccccc
Q 002321          912 KKAEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       912 ~~~~~~~~~~~~l~~~p~~Rp~  933 (936)
                      .+..+++++..|+..||.+||+
T Consensus       265 ~~ksf~e~i~~CL~kDP~kRpt  286 (516)
T KOG0582|consen  265 FSKSFREMIALCLVKDPSKRPT  286 (516)
T ss_pred             hcHHHHHHHHHHhhcCcccCCC
Confidence            3457899999999999999997

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.2e-40  Score=350.22  Aligned_cols=241  Identities=25%  Similarity=0.328  Sum_probs=202.6

Q ss_pred             ccccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      ....|+..+.||+|+||+||.|+.+ +|+.+|+|++++..+.  .+.+.++.|-.+|...++|.||+++..|.+.+..|+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4456788899999999999999977 5999999999877654  235778899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCC--
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM--  842 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~--  842 (936)
                      ||||++|||+..+|.+.+.   +++..+..++.+++.|++.+|+.|++||||||+|+|||..|++||+|||++.-+..  
T Consensus       219 iMEylPGGD~mTLL~~~~~---L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKDT---LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             EEEecCCccHHHHHHhcCc---CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence            9999999999999987654   99999999999999999999999999999999999999999999999999853311  


Q ss_pred             --------------------Cccc-----------------------cccccccCcccccCcccccCcccCCchhhHHHH
Q 002321          843 --------------------LDRY-----------------------VLSSKIQSALGYMAPEFACRTVKITDKCDVYGF  879 (936)
Q Consensus       843 --------------------~~~~-----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSl  879 (936)
                                          .+..                       .......|||.|||||++.+ ..|+..+|.||+
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWSL  374 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWSL  374 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHHH
Confidence                                0000                       01123678999999999954 469999999999


Q ss_pred             HHHHHHHHcCCCCCCccchhHHH--HHHH------HHHHhhhccccceeecccccccccccc
Q 002321          880 GVLVLEVVTGKRPLSTWKMMWWF--SVTW------LEEHWKKAEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       880 G~~l~el~~g~~Pf~~~~~~~~~--~~~~------~~~~~~~~~~~~~~~~~l~~~p~~Rp~  933 (936)
                      |||+|||+.|.+||...++...+  .+.|      ..+.....+.+|+|.|+|. ||.+|-.
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence            99999999999999998875443  2233      2344455788999999888 9998854

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=347.35  Aligned_cols=237  Identities=24%  Similarity=0.349  Sum_probs=200.2

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-CCCcceeeeEEEeCC-eeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQS-LQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lv~  766 (936)
                      ..|...++||.|+||.||+|+.. +|+.||||+++..-...++-.-.||+..|++++ ||||+++.+++.+.+ ..++||
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf   89 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF   89 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence            45777889999999999999955 689999999976654433444579999999998 999999999999988 889999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      |||+ .+|+++++..  .+.+++..+..|+.||++||+|+|.+|+.|||+||+|||+..+..+||+|||+||.+..... 
T Consensus        90 E~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP-  165 (538)
T KOG0661|consen   90 EFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP-  165 (538)
T ss_pred             Hhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC-
Confidence            9995 7999999875  45699999999999999999999999999999999999999999999999999998754333 


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH-----------HHHH-------
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV-----------TWLE-------  908 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~-----------~~~~-------  908 (936)
                        .+....|.+|+|||++.+...|+.+.||||+|||++|+.+-++-|.+..+.++-..           .|.+       
T Consensus       166 --YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~  243 (538)
T KOG0661|consen  166 --YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA  243 (538)
T ss_pred             --cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence              35567899999999999999999999999999999999999999988755322200           1111       


Q ss_pred             -----------------HHhhhccccceeecccccccccccc
Q 002321          909 -----------------EHWKKAEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       909 -----------------~~~~~~~~~~~~~~~l~~~p~~Rp~  933 (936)
                                       +. +..+..+++.+||.-||.+||+
T Consensus       244 mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpT  284 (538)
T KOG0661|consen  244 MNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPT  284 (538)
T ss_pred             hccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCcc
Confidence                             11 3455677888999999999997

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-40  Score=353.54  Aligned_cols=243  Identities=27%  Similarity=0.368  Sum_probs=199.0

Q ss_pred             ccccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ....+...+.||+|.||+||+|+|..  .||||++...... +..+.|+.|+..+++-||.||+-+.|||..+.. .||+
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT  466 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT  466 (678)
T ss_pred             CHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence            34455677889999999999999973  6999999876654 346889999999999999999999999988776 9999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      .+|+|.+|+.+++....  .++..+.+.|++|||+||.|||.++|+|||+|..||+++++++|||+|||++..-......
T Consensus       467 qwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~  544 (678)
T KOG0193|consen  467 QWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE  544 (678)
T ss_pred             hhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence            99999999999987553  3888999999999999999999999999999999999999999999999999754332222


Q ss_pred             cccccccCcccccCccccc--CcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH---H-----HHHHHH-Hhhhcc
Q 002321          847 VLSSKIQSALGYMAPEFAC--RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF---S-----VTWLEE-HWKKAE  915 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~---~-----~~~~~~-~~~~~~  915 (936)
                      .......+..-|||||++.  ...+|++.+||||||+|+|||++|..||.......+.   .     -+.... .-+.++
T Consensus       545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~  624 (678)
T KOG0193|consen  545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKA  624 (678)
T ss_pred             cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHH
Confidence            2223345667799999884  3456999999999999999999999999854332211   1     111222 234468


Q ss_pred             ccceeecccccccccccccC
Q 002321          916 WRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++++..||+.++.+||.|.
T Consensus       625 mk~Ll~~C~~~~~~eRP~F~  644 (678)
T KOG0193|consen  625 MKRLLSDCWKFDREERPLFP  644 (678)
T ss_pred             HHHHHHHHHhcCcccCccHH
Confidence            99999999999999999983

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-40  Score=344.63  Aligned_cols=241  Identities=27%  Similarity=0.396  Sum_probs=197.1

Q ss_pred             ccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC--eeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS--LQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~  768 (936)
                      +...+.||+|+||.||++...+ |+..|||.+....... .+.+.+|+++|++++|||||+++|......  ..+++|||
T Consensus        19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            5677889999999999999764 8999999986653222 567899999999999999999999854444  68899999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCCeEEeeccCccccCC-Cccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG-SGEPKVGDYGLARLLPM-LDRY  846 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~-~~~~  846 (936)
                      +++|+|.+++.+.+.  .+++..+.++++||++||+|||++|||||||||+|||++. ++.+||+|||+++.... ....
T Consensus        98 ~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~  175 (313)
T KOG0198|consen   98 APGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS  175 (313)
T ss_pred             cCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence            999999999998764  3999999999999999999999999999999999999999 79999999999986653 1222


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCcc-chhH-HHHHH-----HHHHHhhhccccce
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTW-KMMW-WFSVT-----WLEEHWKKAEWRNV  919 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~-~~~~-~~~~~-----~~~~~~~~~~~~~~  919 (936)
                      .......||+.|||||++..+.....++||||+||++.||+||+.||... +... .....     ..-+...+.+.+++
T Consensus       176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~F  255 (313)
T KOG0198|consen  176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDF  255 (313)
T ss_pred             cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHH
Confidence            33445789999999999965433446999999999999999999999873 3221 11111     11134455788999


Q ss_pred             eecccccccccccccC
Q 002321          920 SMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       920 ~~~~l~~~p~~Rp~f~  935 (936)
                      +.+|+..||.+||+.+
T Consensus       256 l~~C~~~~p~~Rpta~  271 (313)
T KOG0198|consen  256 LRKCFKRDPEKRPTAE  271 (313)
T ss_pred             HHHHhhcCcccCcCHH
Confidence            9999999999999853

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=357.67  Aligned_cols=241  Identities=24%  Similarity=0.378  Sum_probs=205.4

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc----cchHHHHHHHHHHHHcCC-CCCcceeeeEEEeCCee
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL----VKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQSLQ  762 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  762 (936)
                      ...|...+.||+|+||+|+.|... +++.||||++.....    ....+.+.+|+.++++++ ||||+++++++......
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~   95 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI   95 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence            345788889999999999999865 689999997765311    123466779999999998 99999999999999999


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-CCeEEeeccCccccC
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS-GEPKVGDYGLARLLP  841 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~  841 (936)
                      ++||||+.||+|.+++...++   +.+.++.++++|++.|++|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus        96 ~ivmEy~~gGdL~~~i~~~g~---l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   96 YIVMEYCSGGDLFDYIVNKGR---LKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             EEEEEecCCccHHHHHHHcCC---CChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            999999999999999988433   8889999999999999999999999999999999999999 999999999998763


Q ss_pred             CCccccccccccCcccccCcccccCcc-cCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH----HHHHHHHHhh-hcc
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTV-KITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF----SVTWLEEHWK-KAE  915 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~----~~~~~~~~~~-~~~  915 (936)
                        .........+|++.|+|||++.+.. +.+.++||||+||++|.|++|+.||++.+....+    ..++..+.+. +.+
T Consensus       173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~  250 (370)
T KOG0583|consen  173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE  250 (370)
T ss_pred             --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence              2333456678999999999996655 4568999999999999999999999997653322    3344446666 888


Q ss_pred             ccceeeccccccccccccc
Q 002321          916 WRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f  934 (936)
                      .++++.+|+..||.+|++.
T Consensus       251 ~~~Li~~mL~~~P~~R~t~  269 (370)
T KOG0583|consen  251 ARSLIEKMLVPDPSTRITL  269 (370)
T ss_pred             HHHHHHHHcCCCcccCCCH
Confidence            8999999999999999874

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-41  Score=367.58  Aligned_cols=241  Identities=24%  Similarity=0.368  Sum_probs=204.9

Q ss_pred             ccCCCcccccCceEEEEEEeCC----CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      +.+++.||.|.||+||+|+++-    ...||||.++.....+.+.+|..|+.||.+++||||+++.|++......+||.|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            4567789999999999999772    357999999988888888999999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc-cc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD-RY  846 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~  846 (936)
                      ||++|+|+.||+.+.++  +++.+..-+.++||.||+||.+.++|||||.++||||+.+-.+|++|||++|.+.+.. ..
T Consensus       711 yMENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~  788 (996)
T KOG0196|consen  711 YMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA  788 (996)
T ss_pred             hhhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence            99999999999987744  9999999999999999999999999999999999999999999999999999875433 22


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHH-----HHHHHHHHhhhcccccee
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWF-----SVTWLEEHWKKAEWRNVS  920 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~~  920 (936)
                      .......-+.+|.|||.+ ..+.++.++||||+|++|||.++ |+.||.+.....+-     ..+..+|--++..++.+|
T Consensus       789 ytt~GGKIPiRWTAPEAI-a~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLM  867 (996)
T KOG0196|consen  789 YTTLGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLM  867 (996)
T ss_pred             ccccCCccceeecChhHh-hhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHH
Confidence            222333346789999988 56679999999999999999998 99999665432221     111122233557799999


Q ss_pred             ecccccccccccccC
Q 002321          921 MRSCKGSSRQRRRFQ  935 (936)
Q Consensus       921 ~~~l~~~p~~Rp~f~  935 (936)
                      ..||++|=++||+|+
T Consensus       868 ldCWqkdR~~RP~F~  882 (996)
T KOG0196|consen  868 LDCWQKDRNRRPKFA  882 (996)
T ss_pred             HHHHHHHhhcCCCHH
Confidence            999999999999995

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.6e-40  Score=348.35  Aligned_cols=235  Identities=23%  Similarity=0.349  Sum_probs=199.4

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      |...+.||+|+||.||||+.+ +.+.||+|.+.+.... ++.+.+.+|++++++++||||+.++++|+.....|+|.||+
T Consensus         4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a   83 (808)
T KOG0597|consen    4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA   83 (808)
T ss_pred             hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence            455678999999999999966 5789999998655433 45678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      .| +|..++.....   ++++.+..++.|++.||.|||+.+|.|||+||+|||++++|++|+||||+|+.+..  .....
T Consensus        84 ~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~vl  157 (808)
T KOG0597|consen   84 VG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSVL  157 (808)
T ss_pred             hh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Cceee
Confidence            75 99999987655   99999999999999999999999999999999999999999999999999998754  34456


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceeecccc
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSMRSCK  925 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~  925 (936)
                      +.+.|||.|||||+. .+.+|+..+|+||+||++|||++|++||....-........    .++.-.+..+.+++.-.+.
T Consensus       158 tsikGtPlYmAPElv-~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~  236 (808)
T KOG0597|consen  158 TSIKGTPLYMAPELV-EEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLI  236 (808)
T ss_pred             eeccCcccccCHHHH-cCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhh
Confidence            778899999999998 46689999999999999999999999997755432221111    1122344667888888999


Q ss_pred             cccccccc
Q 002321          926 GSSRQRRR  933 (936)
Q Consensus       926 ~~p~~Rp~  933 (936)
                      +||.+|-+
T Consensus       237 kdP~~Rlt  244 (808)
T KOG0597|consen  237 KDPAQRLT  244 (808)
T ss_pred             cChhhccc
Confidence            99999865

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-40  Score=314.10  Aligned_cols=244  Identities=26%  Similarity=0.349  Sum_probs=211.0

Q ss_pred             ccccccccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccch--HHHHHHHHHHHHcCCCCCcceeeeEEEeCC
Q 002321          684 FSTGTHALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEGYYWTQS  760 (936)
Q Consensus       684 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  760 (936)
                      ..+.+-+.++.++.||+|-||.||.|+.+ ++-.||+|++........  .+++.||+++-+.++||||+++|+++.+..
T Consensus        16 ~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~   95 (281)
T KOG0580|consen   16 TKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK   95 (281)
T ss_pred             ccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence            34445667899999999999999999966 578899999976654322  578999999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCcccc
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL  840 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  840 (936)
                      ..|+++||.+.|.+...++.... ..+++.....++.|+|.|+.|+|.++|+||||||+|+|++.+|.+|++|||-+...
T Consensus        96 riyLilEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen   96 RIYLILEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             eeEEEEEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            99999999999999999986543 33888899999999999999999999999999999999999999999999999765


Q ss_pred             CCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchh----HHHHHHHHHHHhhhccc
Q 002321          841 PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM----WWFSVTWLEEHWKKAEW  916 (936)
Q Consensus       841 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~----~~~~~~~~~~~~~~~~~  916 (936)
                      +.    ......+||..|.+||+. .+..++..+|+|++|++.||++.|.+||......    .+..++...|...+...
T Consensus       175 p~----~kR~tlcgt~dyl~pEmv-~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a  249 (281)
T KOG0580|consen  175 PS----NKRKTLCGTLDYLPPEMV-EGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGA  249 (281)
T ss_pred             CC----CCceeeecccccCCHhhc-CCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhH
Confidence            42    234567899999999999 6778899999999999999999999999887642    22244555567777889


Q ss_pred             cceeecccccccccccc
Q 002321          917 RNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       917 ~~~~~~~l~~~p~~Rp~  933 (936)
                      +|+|.+|+..+|.+|+.
T Consensus       250 ~dlI~~ll~~~p~~r~~  266 (281)
T KOG0580|consen  250 ADLISRLLVKNPIERLA  266 (281)
T ss_pred             HHHHHHHhccCcccccc
Confidence            99999999999999975

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-39  Score=346.32  Aligned_cols=236  Identities=22%  Similarity=0.335  Sum_probs=203.5

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..++||+|+.|.||.|+.. +++.||||++...... ..+-+..|+.+|+..+|+|||.+++.+...+..|+||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            45677788999999999999854 6889999999655432 345678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      |+||+|.+.+....    +++.++..|++++++||+|||.+||+|||||..|||++.+|.+||+|||++..+....  ..
T Consensus       352 m~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~--~K  425 (550)
T KOG0578|consen  352 MEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ--SK  425 (550)
T ss_pred             cCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc--Cc
Confidence            99999999987654    8999999999999999999999999999999999999999999999999998765322  24


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH-H------HHHHHhhhccccceee
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV-T------WLEEHWKKAEWRNVSM  921 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~-~------~~~~~~~~~~~~~~~~  921 (936)
                      .....|||.|||||++ ..+.|++++||||||++++||+-|++||-..+....... .      ...+.-.+..+++++.
T Consensus       426 R~TmVGTPYWMAPEVv-trk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~  504 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVV-TRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLD  504 (550)
T ss_pred             cccccCCCCccchhhh-hhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHH
Confidence            5678899999999999 566899999999999999999999999987666322211 1      1224556688999999


Q ss_pred             cccccccccccc
Q 002321          922 RSCKGSSRQRRR  933 (936)
Q Consensus       922 ~~l~~~p~~Rp~  933 (936)
                      +|+..|+.+|++
T Consensus       505 ~cL~~dv~~Ras  516 (550)
T KOG0578|consen  505 RCLVVDVEQRAS  516 (550)
T ss_pred             HHhhcchhcCCC
Confidence            999999999986

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=343.82  Aligned_cols=228  Identities=27%  Similarity=0.400  Sum_probs=196.8

Q ss_pred             ccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      +...+-+|.|+.|.||+|+++ ++.||||+++.-        -+.+|+-|++++|+||+.+.|+|....-++||||||..
T Consensus       126 IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~  196 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ  196 (904)
T ss_pred             hhhhhhhccCcccceeeeecc-CceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence            345567999999999999997 789999987422        24678899999999999999999999889999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      |.|+.+++....   ++....+.|..+||.||.|||.+.|+|||||.-||||..+..+||+|||.++....   ......
T Consensus       197 GqL~~VLka~~~---itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~---~STkMS  270 (904)
T KOG4721|consen  197 GQLYEVLKAGRP---ITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD---KSTKMS  270 (904)
T ss_pred             ccHHHHHhccCc---cCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh---hhhhhh
Confidence            999999987554   88899999999999999999999999999999999999999999999999986643   234456


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HH-----HHHHHHhhhccccceeecccc
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SV-----TWLEEHWKKAEWRNVSMRSCK  925 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~~~l~  925 (936)
                      ..||..|||||++ ...+.++|+||||||||+|||+||+.||.+.+.+.+. .+     -...|.-++.-++-++..||+
T Consensus       271 FaGTVaWMAPEvI-rnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~  349 (904)
T KOG4721|consen  271 FAGTVAWMAPEVI-RNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWN  349 (904)
T ss_pred             hhhhHhhhCHHHh-hcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHh
Confidence            7899999999999 5668999999999999999999999999998764332 22     222345566778888999999


Q ss_pred             cccccccccC
Q 002321          926 GSSRQRRRFQ  935 (936)
Q Consensus       926 ~~p~~Rp~f~  935 (936)
                      ..|+.||+|+
T Consensus       350 sKpRNRPSFr  359 (904)
T KOG4721|consen  350 SKPRNRPSFR  359 (904)
T ss_pred             cCCCCCccHH
Confidence            9999999996

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.1e-39  Score=327.15  Aligned_cols=236  Identities=20%  Similarity=0.318  Sum_probs=204.4

Q ss_pred             cccCCCcccccCceEEEEEEe-CCCcEEEEEEeeccCccch--HHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVL-RDGRPVAIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      .|+..+.||+|+||.|-+|+. ..|+.||||.++.......  .-.++||+++|+.++||||+.++.+|+..+.+.+|||
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME  133 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME  133 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence            467888999999999999996 4799999999987766543  3457899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |..+|.|++|+.+.+.   +++.++.++++||..|+.|+|.+++||||+|.+|||+|.++.+||+|||++..+...   .
T Consensus       134 YaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~---k  207 (668)
T KOG0611|consen  134 YASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK---K  207 (668)
T ss_pred             ecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc---c
Confidence            9999999999988665   999999999999999999999999999999999999999999999999999877532   2


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchh----HHHHHHHHHHHhhhccccceeecc
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM----WWFSVTWLEEHWKKAEWRNVSMRS  923 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  923 (936)
                      .-+..+|+|-|.+||++.+..+-++.+|-||+||++|.++.|..||++.+-.    ++..+.+.+ .-.+.+...+|.++
T Consensus       208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE-P~~PSdA~gLIRwm  286 (668)
T KOG0611|consen  208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE-PETPSDASGLIRWM  286 (668)
T ss_pred             HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC-CCCCchHHHHHHHH
Confidence            3456789999999999966666678999999999999999999999998752    222333333 33456778999999


Q ss_pred             cccccccccc
Q 002321          924 CKGSSRQRRR  933 (936)
Q Consensus       924 l~~~p~~Rp~  933 (936)
                      ++++|.+|.+
T Consensus       287 LmVNP~RRAT  296 (668)
T KOG0611|consen  287 LMVNPERRAT  296 (668)
T ss_pred             HhcCcccchh
Confidence            9999998875

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-38  Score=329.09  Aligned_cols=245  Identities=23%  Similarity=0.282  Sum_probs=196.4

Q ss_pred             ccccccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc-------------hHHHHHHHHHHHHcCCCCCcce
Q 002321          686 TGTHALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK-------------SQEDFEREVKKLGKVRHPNLVT  751 (936)
Q Consensus       686 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~niv~  751 (936)
                      ..+-+.|+..++||+|.||.|-+|+.. +++.||||++.+.....             ..+.+.+|+.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            445677899999999999999999965 68999999995432211             1357899999999999999999


Q ss_pred             eeeEEEeC--CeeEEEEEecCCCChhhhhhccCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCC
Q 002321          752 LEGYYWTQ--SLQLLIYEFVSGGSLHKHLHEGSGGNF-LSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGE  828 (936)
Q Consensus       752 l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~-~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~  828 (936)
                      ++++..+.  +..|||+|||..|.+...-.    ... +++.++++++++++.||+|||.+||+||||||+|+|++++|+
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence            99999764  57899999999887754322    223 899999999999999999999999999999999999999999


Q ss_pred             eEEeeccCccccCCC---ccccccccccCcccccCcccccCc---ccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH
Q 002321          829 PKVGDYGLARLLPML---DRYVLSSKIQSALGYMAPEFACRT---VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF  902 (936)
Q Consensus       829 ~kl~Dfg~a~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~  902 (936)
                      +||+|||.+......   +....-....|||.|+|||...++   ...+.+.||||+||++|.|+.|+.||-+......+
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~  328 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF  328 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence            999999998765322   111222347899999999988663   34567999999999999999999999886654444


Q ss_pred             HHHHHH----HHh--hhccccceeeccccccccccccc
Q 002321          903 SVTWLE----EHW--KKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       903 ~~~~~~----~~~--~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      ......    |..  ..+..+++|.+++.+||.+|-+.
T Consensus       329 ~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l  366 (576)
T KOG0585|consen  329 DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITL  366 (576)
T ss_pred             HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeeh
Confidence            332222    122  34678999999999999999654

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-39  Score=349.78  Aligned_cols=242  Identities=27%  Similarity=0.401  Sum_probs=199.7

Q ss_pred             ccccccCCCcccccCceEEEEEEeCC--C---cEEEEEEeecc--CccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLRD--G---RPVAIKKLTVS--SLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS  760 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~~--~---~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  760 (936)
                      .+......++||+|+||+||+|+++.  +   ..||||..+.+  .......++.+|+++|++++|||||++||++.++.
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~  234 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE  234 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            34445666899999999999999763  2   23899998753  23345788999999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCcccc
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL  840 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  840 (936)
                      ..++|||+|+||+|.+++++.+.  .++..++.+++.+.|+||+|||+++++||||.++|+|++.++.+||+|||+++.-
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            99999999999999999998764  4999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCccccccc-cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHH------HHHHHhh
Q 002321          841 PMLDRYVLSS-KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVT------WLEEHWK  912 (936)
Q Consensus       841 ~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~------~~~~~~~  912 (936)
                      .   .+.... ...-+.+|+|||.+..+ -|++++|||||||++||+++ |..||.+..........      ...+.-.
T Consensus       313 ~---~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~  388 (474)
T KOG0194|consen  313 S---QYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKT  388 (474)
T ss_pred             c---ceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCC
Confidence            2   122111 22356789999999544 89999999999999999999 89999988764333211      1223345


Q ss_pred             hccccceeecccccccccccccC
Q 002321          913 KAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       913 ~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +.....++.+||..+|.+||+|+
T Consensus       389 p~~~~~~~~~c~~~~p~~R~tm~  411 (474)
T KOG0194|consen  389 PKELAKVMKQCWKKDPEDRPTMS  411 (474)
T ss_pred             HHHHHHHHHHhccCChhhccCHH
Confidence            56677788899999999999985

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.7e-38  Score=348.58  Aligned_cols=246  Identities=24%  Similarity=0.330  Sum_probs=194.8

Q ss_pred             cccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeC-C
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQ-S  760 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  760 (936)
                      ...|+..++||+|+||.||+|.+.      +++.||||+++........+.+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            345778889999999999999742      35689999997554344456789999999999 899999999988764 4


Q ss_pred             eeEEEEEecCCCChhhhhhccCC---------------------------------------------------------
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSG---------------------------------------------------------  783 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  783 (936)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            57899999999999999875321                                                         


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccccccCcccccCc
Q 002321          784 --GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAP  861 (936)
Q Consensus       784 --~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  861 (936)
                        ...+++.++.+++.|+++||+|||++||+||||||+||+++.++.+||+|||+++...............+++.|+||
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  245 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP  245 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence              123778889999999999999999999999999999999999999999999999865433222233334456789999


Q ss_pred             ccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH------HHHhhhccccceeeccccccccccccc
Q 002321          862 EFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL------EEHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       862 E~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      |++. ...++.++|||||||++|||++ |..||..............      .+...+..+++++.+||..||.+||++
T Consensus       246 E~~~-~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  324 (338)
T cd05102         246 ESIF-DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTF  324 (338)
T ss_pred             HHhh-cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence            9884 4568999999999999999997 9999987543221111111      122334568899999999999999987


Q ss_pred             C
Q 002321          935 Q  935 (936)
Q Consensus       935 ~  935 (936)
                      +
T Consensus       325 ~  325 (338)
T cd05102         325 S  325 (338)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=336.91  Aligned_cols=238  Identities=25%  Similarity=0.366  Sum_probs=206.1

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|...+.||+|+||.||+|.+. .++.||+|++..+......+++++|+.++.+++++||.++|+.+..+...+++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            34566688999999999999965 58899999998888777789999999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +.||++.+.++....   +.+.++..|+++++.|+.|||.++.+|||||+.||++..+|.+|++|||.+........  .
T Consensus        93 ~~gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--r  167 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--R  167 (467)
T ss_pred             hcCcchhhhhccCCC---CccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh--c
Confidence            999999999987542   57888888999999999999999999999999999999999999999999987654332  2


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH--HHHH---hhhccccceeecc
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW--LEEH---WKKAEWRNVSMRS  923 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~--~~~~---~~~~~~~~~~~~~  923 (936)
                      .....||+.|||||++. ...|+.|+||||||++.+||.+|.+|+.+.+++.+.....  .+|.   ..+..+++++..|
T Consensus       168 r~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~C  246 (467)
T KOG0201|consen  168 RKTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEAC  246 (467)
T ss_pred             cccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHH
Confidence            36678999999999995 6689999999999999999999999999988864442211  1121   2335689999999


Q ss_pred             cccccccccc
Q 002321          924 CKGSSRQRRR  933 (936)
Q Consensus       924 l~~~p~~Rp~  933 (936)
                      +.+||+.||+
T Consensus       247 L~k~P~~Rps  256 (467)
T KOG0201|consen  247 LDKNPEFRPS  256 (467)
T ss_pred             hhcCcccCcC
Confidence            9999999997

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-38  Score=345.72  Aligned_cols=238  Identities=25%  Similarity=0.333  Sum_probs=205.2

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  764 (936)
                      ...+...+.||+|+||+|+.+..+ +++.+|||++++....  ++.+..+.|.+++.-. +||.+++++.+|...++.+.
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            344567788999999999999977 5889999999887654  3467788999998877 59999999999999999999


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ||||+.||++..+.+...    +++..+.-++..++.||.|||++||+|||||.+|||+|.+|++||+|||+++.--  .
T Consensus       447 vmey~~Ggdm~~~~~~~~----F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m--~  520 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHIHTDV----FSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM--G  520 (694)
T ss_pred             EEEecCCCcEEEEEeccc----ccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC--C
Confidence            999999999555544332    8999999999999999999999999999999999999999999999999998542  1


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH----HHHHHHhhhcccccee
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV----TWLEEHWKKAEWRNVS  920 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~  920 (936)
                      .....+..+|||.|||||++ .+..|+.++|.|||||++|||+.|+.||.+.+++..+..    +..+|.|.+.+..+++
T Consensus       521 ~g~~TsTfCGTpey~aPEil-~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il  599 (694)
T KOG0694|consen  521 QGDRTSTFCGTPEFLAPEVL-TEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIM  599 (694)
T ss_pred             CCCccccccCChhhcChhhh-ccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHH
Confidence            22355678999999999999 455899999999999999999999999998887666633    3455788889999999


Q ss_pred             ecccccccccccc
Q 002321          921 MRSCKGSSRQRRR  933 (936)
Q Consensus       921 ~~~l~~~p~~Rp~  933 (936)
                      .+.+.++|.+|-.
T Consensus       600 ~~ll~k~p~kRLG  612 (694)
T KOG0694|consen  600 RRLLRKNPEKRLG  612 (694)
T ss_pred             HHHhccCcccccC
Confidence            9999999999864

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=337.52  Aligned_cols=240  Identities=24%  Similarity=0.332  Sum_probs=206.4

Q ss_pred             cccCCCcccccCceEEEEEEeCC---C--cEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRD---G--RPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  765 (936)
                      .+...+.||+|-||.||+|...+   |  -.||||..+.....+..+.|..|+.+|+.++||||++++|+|.+. ..|+|
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv  468 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV  468 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence            34556679999999999999653   3  368999998877777788999999999999999999999999765 56999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      ||.++-|.|..|++.++..  ++......++.||+.||+|||+..+|||||..+||||....-+|++|||+++.+.....
T Consensus       469 mEL~~~GELr~yLq~nk~s--L~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y  546 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNKDS--LPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY  546 (974)
T ss_pred             EecccchhHHHHHHhcccc--chHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence            9999999999999876543  88889999999999999999999999999999999999999999999999999876555


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhH-----HHHHHHHHHHhhhccccce
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMW-----WFSVTWLEEHWKKAEWRNV  919 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~  919 (936)
                      +.. +...-+..|||||.+ ..+.++.++|||-|||++||+++ |..||.+-+...     ....+...|.-+++.++.+
T Consensus       547 Yka-S~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYsl  624 (974)
T KOG4257|consen  547 YKA-SRGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSL  624 (974)
T ss_pred             hhc-cccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHH
Confidence            443 355556789999988 77789999999999999999998 999998865422     2233344467788999999


Q ss_pred             eecccccccccccccC
Q 002321          920 SMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       920 ~~~~l~~~p~~Rp~f~  935 (936)
                      +.+||++||.+||||.
T Consensus       625 mskcWayeP~kRPrft  640 (974)
T KOG4257|consen  625 MSKCWAYEPSKRPRFT  640 (974)
T ss_pred             HHHHhccCcccCCcHH
Confidence            9999999999999994

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-38  Score=341.72  Aligned_cols=239  Identities=23%  Similarity=0.289  Sum_probs=208.9

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccC-cc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSS-LV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..++.++.||+|+-|.|-.|++. +|+.+|||++.... .. .....+++|+.+|+-++||||+++|+++++....|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            44677889999999999999975 69999999996542 21 22567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++|.|.+++.+.+.   +++.++.++++||+.|+.|+|..+|+|||+||+|+|+|..+.+||+|||+|..-....  
T Consensus        92 Eyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk--  166 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK--  166 (786)
T ss_pred             EecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc--
Confidence            99999999999987665   9999999999999999999999999999999999999999999999999997543221  


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch----hHHHHHHHHHHHhhhccccceeec
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM----MWWFSVTWLEEHWKKAEWRNVSMR  922 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  922 (936)
                       .-..-+|+|.|.|||++.+..+.+.++||||.|||+|.|++|+.||++..-    ..+..+.|..|.+.+.+..+++.+
T Consensus       167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~  245 (786)
T KOG0588|consen  167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRR  245 (786)
T ss_pred             -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHH
Confidence             223457999999999998888888999999999999999999999997654    345566777788889999999999


Q ss_pred             cccccccccccc
Q 002321          923 SCKGSSRQRRRF  934 (936)
Q Consensus       923 ~l~~~p~~Rp~f  934 (936)
                      |+.+||..|-+.
T Consensus       246 ml~VDp~~RiT~  257 (786)
T KOG0588|consen  246 MLDVDPSTRITT  257 (786)
T ss_pred             HhccCccccccH
Confidence            999999998654

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.2e-37  Score=309.58  Aligned_cols=208  Identities=24%  Similarity=0.314  Sum_probs=180.6

Q ss_pred             ccccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccch-HHHHHHHHHHHHcCCCCCcceeeeEEEeC--CeeE
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKS-QEDFEREVKKLGKVRHPNLVTLEGYYWTQ--SLQL  763 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  763 (936)
                      +-..|+....|++|+||.||+|+++ +++.||+|+++.+..... .-...||+.++.+.+|||||.+..++...  +.+|
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            4456788889999999999999976 689999999986653222 34578999999999999999999988754  5689


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      +|||||+ -||..++..-+  +.+...+...++.|+++|++|||...|+|||+|++|+|+...|.+||+|||+||.++.+
T Consensus       154 ~VMe~~E-hDLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  154 IVMEYVE-HDLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             eeHHHHH-hhHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            9999996 59999998754  34888999999999999999999999999999999999999999999999999988654


Q ss_pred             ccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhH
Q 002321          844 DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMW  900 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~  900 (936)
                      -  ...+...-|.+|+|||.+.+.+.|+.+.||||+|||+.||+++++-|.+.....
T Consensus       231 ~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d  285 (419)
T KOG0663|consen  231 L--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID  285 (419)
T ss_pred             c--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH
Confidence            2  234556678999999999999999999999999999999999999998876543

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.1e-37  Score=340.49  Aligned_cols=235  Identities=23%  Similarity=0.330  Sum_probs=197.1

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||.||+|+++ +++.||||+++.....  ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            34677788999999999999976 5889999999654321  23467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++|+|.+++.....   +++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++......  
T Consensus        98 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--  172 (329)
T PTZ00263         98 EFVVGGELFTHLRKAGR---FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--  172 (329)
T ss_pred             cCCCCChHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence            99999999999986543   7888899999999999999999999999999999999999999999999998654321  


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH----HHHHHHhhhccccceeec
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV----TWLEEHWKKAEWRNVSMR  922 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  922 (936)
                         ....|++.|+|||++. ...++.++||||+||++|||++|+.||...........    ....+.+.+.++++++.+
T Consensus       173 ---~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  248 (329)
T PTZ00263        173 ---FTLCGTPEYLAPEVIQ-SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG  248 (329)
T ss_pred             ---ceecCChhhcCHHHHc-CCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHH
Confidence               2346889999999984 55679999999999999999999999987665322211    111234456778899999


Q ss_pred             ccccccccccc
Q 002321          923 SCKGSSRQRRR  933 (936)
Q Consensus       923 ~l~~~p~~Rp~  933 (936)
                      ||..||.+|++
T Consensus       249 ~L~~dP~~R~~  259 (329)
T PTZ00263        249 LLQTDHTKRLG  259 (329)
T ss_pred             HhhcCHHHcCC
Confidence            99999999986

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=9.7e-37  Score=333.43  Aligned_cols=245  Identities=23%  Similarity=0.321  Sum_probs=195.1

Q ss_pred             ccccCCCcccccCceEEEEEEeCC-----------------CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCccee
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRD-----------------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL  752 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  752 (936)
                      ..|...++||+|+||.||+|.+++                 +..||+|.+..........++.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            346677889999999999998542                 336999998765444446779999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCChhhhhhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 002321          753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSG----------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI  816 (936)
Q Consensus       753 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dl  816 (936)
                      ++++.+....++||||+++|+|.+++.....                ...+++....+++.|++.||+|||+.||+||||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dl  164 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL  164 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCc
Confidence            9999998999999999999999998865321                123678889999999999999999999999999


Q ss_pred             CCCCEEEcCCCCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc--CCCCCC
Q 002321          817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT--GKRPLS  894 (936)
Q Consensus       817 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~--g~~Pf~  894 (936)
                      ||+||+++.++.+||+|||+++.....+.........++..|+|||++. ...++.++|||||||++|||++  +..||.
T Consensus       165 kp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~~~~~p~~  243 (304)
T cd05096         165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPYG  243 (304)
T ss_pred             chhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHh-cCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence            9999999999999999999998664433333333445577899999884 4468999999999999999987  667887


Q ss_pred             ccchhHHHH-H-HHH----------HHHhhhccccceeecccccccccccccC
Q 002321          895 TWKMMWWFS-V-TWL----------EEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       895 ~~~~~~~~~-~-~~~----------~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ......... . ...          .+...++.+.+++.+||..||.+||+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~  296 (304)
T cd05096         244 ELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFS  296 (304)
T ss_pred             cCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHH
Confidence            654432211 1 100          0122346788999999999999999974

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=317.85  Aligned_cols=191  Identities=29%  Similarity=0.430  Sum_probs=163.0

Q ss_pred             ccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcC--CCCCcceeeeEEEeCC----eeEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV--RHPNLVTLEGYYWTQS----LQLLI  765 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~~lv  765 (936)
                      ++..+.||+|.||.||||.+. ++.||||++...    ..+.|+.|-++++-.  +|+||++++++-....    ..++|
T Consensus       212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc-CceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            355668999999999999997 699999999643    456788887776655  8999999999976554    77999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh---------CCcccCCCCCCCEEEcCCCCeEEeeccC
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ---------SNIIHYNIKSSNVLIDGSGEPKVGDYGL  836 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---------~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  836 (936)
                      +||.+.|+|.+|++.+-    ++|....+|+..+++||+|||+         .+|+|||||.+||||.+|+++.|+|||+
T Consensus       287 t~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            99999999999998765    9999999999999999999995         3599999999999999999999999999


Q ss_pred             ccccCCCccccccccccCcccccCcccccCcccCC-----chhhHHHHHHHHHHHHcCCC
Q 002321          837 ARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT-----DKCDVYGFGVLVLEVVTGKR  891 (936)
Q Consensus       837 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-----~~~DvwSlG~~l~el~~g~~  891 (936)
                      |..+.............||.+|||||++.+...+.     .+.||||+|.|+|||+++-.
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~  422 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT  422 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence            98886544444444578999999999996665555     36899999999999998643

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.1e-37  Score=313.32  Aligned_cols=206  Identities=26%  Similarity=0.373  Sum_probs=177.7

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCC-cceeeeEEEeCC------e
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPN-LVTLEGYYWTQS------L  761 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------~  761 (936)
                      .|+..++||+|+||+||+|+.+ +|+.||+|+++..... .......||+.++++++|+| |+++++++....      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            4566778999999999999966 6899999999766542 23456789999999999999 999999998776      7


Q ss_pred             eEEEEEecCCCChhhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCcccc
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGG-NFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL  840 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  840 (936)
                      .++|+||++ -+|.+++...... ..++...+..+++|+++||+|||+++|+||||||+||||+++|.+||+|||+|+..
T Consensus        92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~  170 (323)
T KOG0594|consen   92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAF  170 (323)
T ss_pred             EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHh
Confidence            789999995 7999999876532 33777889999999999999999999999999999999999999999999999976


Q ss_pred             CCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchh
Q 002321          841 PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM  899 (936)
Q Consensus       841 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~  899 (936)
                      .-+..  ..+....|.+|+|||++.+...|+...||||+||+++||++++.-|.+..+.
T Consensus       171 ~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~  227 (323)
T KOG0594|consen  171 SIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI  227 (323)
T ss_pred             cCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH
Confidence            53332  2355677889999999999989999999999999999999999999887653

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-37  Score=333.77  Aligned_cols=233  Identities=21%  Similarity=0.299  Sum_probs=194.8

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      |+..+.||+|+||.||+|+.. +++.||||++......  +..+.+.+|+.++++++||||+++++++.+....++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   82 (291)
T cd05612           3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY   82 (291)
T ss_pred             ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence            566788999999999999976 5899999998654321  2346688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++|+|.+++.....   +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.....     
T Consensus        83 ~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----  154 (291)
T cd05612          83 VPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----  154 (291)
T ss_pred             CCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-----
Confidence            999999999976543   889999999999999999999999999999999999999999999999999765321     


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceeeccc
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSMRSC  924 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l  924 (936)
                      .....|++.|+|||++ .+..++.++||||+||++|||++|+.||...+.........    ..+...+..+++++.+||
T Consensus       155 ~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l  233 (291)
T cd05612         155 TWTLCGTPEYLAPEVI-QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLL  233 (291)
T ss_pred             cccccCChhhcCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHc
Confidence            1234688999999988 45568999999999999999999999998876533221111    112233567889999999


Q ss_pred             ccccccccc
Q 002321          925 KGSSRQRRR  933 (936)
Q Consensus       925 ~~~p~~Rp~  933 (936)
                      ..||.+||+
T Consensus       234 ~~dp~~R~~  242 (291)
T cd05612         234 VVDRTRRLG  242 (291)
T ss_pred             CCCHHHccC
Confidence            999999995

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=332.05  Aligned_cols=243  Identities=25%  Similarity=0.360  Sum_probs=211.2

Q ss_pred             ccccccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      .+..+....+||-|.||+||.|.|+. .-.||||.++.+.+  ..++|..|+.+|+.++|||+|+++|+|.....+|||+
T Consensus       265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM--eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT  342 (1157)
T KOG4278|consen  265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT  342 (1157)
T ss_pred             cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch--hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence            44455677889999999999999984 67899999986654  4789999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      |||.+|+|.+|+++..+. .++....+.++.||..||+||..++++|||+.++|+||.++..+|++|||+++.+.. +.+
T Consensus       343 EfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg-DTY  420 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG-DTY  420 (1157)
T ss_pred             ecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC-Cce
Confidence            999999999999987653 377778889999999999999999999999999999999999999999999998854 444


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHH-----HHHHHHHHhhhcccccee
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWF-----SVTWLEEHWKKAEWRNVS  920 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~~  920 (936)
                      ........++.|.|||-+.. ..++.|+|||+|||++||+.| |..||.+.+...++     .+++..|+-++++.+++|
T Consensus       421 TAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLM  499 (1157)
T KOG4278|consen  421 TAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELM  499 (1157)
T ss_pred             ecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHH
Confidence            44455556778999998844 468999999999999999998 99999998876555     334444677889999999


Q ss_pred             ecccccccccccccC
Q 002321          921 MRSCKGSSRQRRRFQ  935 (936)
Q Consensus       921 ~~~l~~~p~~Rp~f~  935 (936)
                      ..||+-+|.+||+|.
T Consensus       500 raCW~WsPsDRPsFa  514 (1157)
T KOG4278|consen  500 RACWNWSPSDRPSFA  514 (1157)
T ss_pred             HHHhcCCcccCccHH
Confidence            999999999999994

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7e-37  Score=337.00  Aligned_cols=232  Identities=22%  Similarity=0.300  Sum_probs=191.6

Q ss_pred             CcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCC
Q 002321          696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGG  772 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  772 (936)
                      +.||+|+||.||+|+.+ +|+.||||+++.....  .....+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999975 6899999999754321  23456788999999999999999999999999999999999999


Q ss_pred             ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccccc
Q 002321          773 SLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI  852 (936)
Q Consensus       773 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  852 (936)
                      +|.+++....   .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++......  ......
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~  155 (323)
T cd05571          81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTF  155 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccce
Confidence            9999987644   38899999999999999999999999999999999999999999999999987532111  122345


Q ss_pred             cCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceeeccccccc
Q 002321          853 QSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSMRSCKGSS  928 (936)
Q Consensus       853 ~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~~p  928 (936)
                      .|++.|+|||++ .+..++.++||||+||++|||++|+.||...+.........    ..+...+..+++++.+||..||
T Consensus       156 ~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP  234 (323)
T cd05571         156 CGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP  234 (323)
T ss_pred             ecCccccChhhh-cCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence            689999999998 45578999999999999999999999998765533222111    1122345678899999999999


Q ss_pred             ccccc
Q 002321          929 RQRRR  933 (936)
Q Consensus       929 ~~Rp~  933 (936)
                      .+||+
T Consensus       235 ~~R~~  239 (323)
T cd05571         235 KQRLG  239 (323)
T ss_pred             HHcCC
Confidence            99994

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-37  Score=339.54  Aligned_cols=246  Identities=25%  Similarity=0.349  Sum_probs=208.3

Q ss_pred             ccccccccCCCcccccCceEEEEEEeC-CC----cEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC
Q 002321          686 TGTHALLNKDCELGRGGFGAVYRTVLR-DG----RPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS  760 (936)
Q Consensus       686 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  760 (936)
                      ...+....++++||.|+||+||+|.|- +|    -+||+|++......+...++.+|+.+|.+++|||+++++++|....
T Consensus       692 I~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~  771 (1177)
T KOG1025|consen  692 ILKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST  771 (1177)
T ss_pred             echhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch
Confidence            334555678889999999999999975 33    4799999977766677789999999999999999999999998765


Q ss_pred             eeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCcccc
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL  840 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  840 (936)
                       ..+|++||+.|.|.++++..+.  .+-....+.|..|||+||.|||++++|||||.++||||.+...+||.|||+|+..
T Consensus       772 -~qlvtq~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll  848 (1177)
T KOG1025|consen  772 -LQLVTQLMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLL  848 (1177)
T ss_pred             -HHHHHHhcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence             7899999999999999998653  3788889999999999999999999999999999999999999999999999987


Q ss_pred             CCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHH-----HHHHHHhhhc
Q 002321          841 PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSV-----TWLEEHWKKA  914 (936)
Q Consensus       841 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~-----~~~~~~~~~~  914 (936)
                      ...+.........-.+.|||-|.+ ....|+.++|||||||++||++| |..||+.....++...     +..+|.....
T Consensus       849 ~~d~~ey~~~~gK~pikwmale~i-~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCti  927 (1177)
T KOG1025|consen  849 APDEKEYSAPGGKVPIKWMALESI-RIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTI  927 (1177)
T ss_pred             CcccccccccccccCcHHHHHHHh-hccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccH
Confidence            655544444444556679999988 45579999999999999999999 9999998876554432     2233555667


Q ss_pred             cccceeecccccccccccccC
Q 002321          915 EWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       915 ~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +..-++.+||+.|+..||.|+
T Consensus       928 DVy~~mvkCwmid~~~rp~fk  948 (1177)
T KOG1025|consen  928 DVYMVMVKCWMIDADSRPTFK  948 (1177)
T ss_pred             HHHHHHHHHhccCcccCccHH
Confidence            788889999999999999995

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.3e-36  Score=341.24  Aligned_cols=246  Identities=25%  Similarity=0.347  Sum_probs=196.8

Q ss_pred             cccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCe
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSL  761 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  761 (936)
                      ...|+..+.||+|+||.||+|++.      ++..||||+++........+.+.+|+++++.+ +||||+++++++.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            345788899999999999999742      35689999997654444567789999999999 89999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhccCC----------------------------------------------------------
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSG----------------------------------------------------------  783 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------  783 (936)
                      .++||||+++|+|.++++....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999999865321                                                          


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          784 --------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       784 --------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                                    ...+++..+.+++.|+++||+|||+++|+||||||+||+++.++.+||+|||+++...........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  273 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK  273 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence                          113788889999999999999999999999999999999999999999999999866433322222


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHH--HHH----HHHHHhhhccccceeec
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWF--SVT----WLEEHWKKAEWRNVSMR  922 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~--~~~----~~~~~~~~~~~~~~~~~  922 (936)
                      ....++..|+|||... ...++.++|||||||++|||++ |..||.........  ...    ...+...+.++++++.+
T Consensus       274 ~~~~~~~~y~aPE~~~-~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  352 (375)
T cd05104         274 GNARLPVKWMAPESIF-NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKS  352 (375)
T ss_pred             CCCCCCcceeChhHhc-CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHH
Confidence            2334556799999884 4578999999999999999998 89999765432111  110    11123345678899999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      ||..||.+||+++
T Consensus       353 cl~~dP~~RPs~~  365 (375)
T cd05104         353 CWDADPLKRPTFK  365 (375)
T ss_pred             HccCChhHCcCHH
Confidence            9999999999974

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=7.1e-39  Score=341.71  Aligned_cols=362  Identities=29%  Similarity=0.409  Sum_probs=210.4

Q ss_pred             eEEeccCCCCCCc-ccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEc
Q 002321           78 VIELTLNGLSLTG-RIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISL  156 (936)
Q Consensus        78 v~~l~l~~~~l~g-~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L  156 (936)
                      |..+|+++|+++| ..|..+.++++++.|.|...++. .+|+.++.|.+|++|.+++|++.                   
T Consensus         9 VrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-------------------   68 (1255)
T KOG0444|consen    9 VRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-------------------   68 (1255)
T ss_pred             eecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-------------------
Confidence            5556666666663 55656666666666666666665 45666666666666666666654                   


Q ss_pred             cCccCCCCCCCCccccccccccccccccccCC-CCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccc
Q 002321          157 AKNRFSGKIPSSLSLCSTLATINLSSNRFSSP-LPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSG  235 (936)
Q Consensus       157 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  235 (936)
                             .+-+.+..++.|+.+.+.+|++... +|..+..+..|+.||||+|++. +.|..+..-+++-+|+|++|+|..
T Consensus        69 -------~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Iet  140 (1255)
T KOG0444|consen   69 -------SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIET  140 (1255)
T ss_pred             -------hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCcccc
Confidence                   2334455566666666666666432 4556666777777777777776 667777766777777777777764


Q ss_pred             cCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceec-cccCcccc
Q 002321          236 SIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFS-GAVPISIG  314 (936)
Q Consensus       236 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~l~  314 (936)
                      ++...|.+++.|-+||||+|++. .+|+.+..+..|+.|.|++|.+....-..+..+++|++|.+++.+-+ .-+|.++.
T Consensus       141 IPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld  219 (1255)
T KOG0444|consen  141 IPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLD  219 (1255)
T ss_pred             CCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchh
Confidence            43344556677777777777766 34455555555555555555544322223334445555555554322 23444444


Q ss_pred             cccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcc
Q 002321          315 NLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESL  394 (936)
Q Consensus       315 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L  394 (936)
                      .+.+|..++|+.|.+. ..|+.+-++.+|+.|+||+|+|                                         
T Consensus       220 ~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~i-----------------------------------------  257 (1255)
T KOG0444|consen  220 DLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKI-----------------------------------------  257 (1255)
T ss_pred             hhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCce-----------------------------------------
Confidence            4555555555555544 4444444444444444444444                                         


Q ss_pred             cEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccc-cCCCCCCCcCCCcEEEecC
Q 002321          395 QFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNG-SIPPEIGGAYSLKELRLER  473 (936)
Q Consensus       395 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~  473 (936)
                                + .+....+...+|+.|+||+|+++ .+|+++..+++|+.|++.+|+++- -+|..++++.+|+.+..++
T Consensus       258 ----------t-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aan  325 (1255)
T KOG0444|consen  258 ----------T-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAAN  325 (1255)
T ss_pred             ----------e-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhc
Confidence                      3 22233334445555555555555 455555555555555555555541 2566666666666666666


Q ss_pred             CccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcc
Q 002321          474 NFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSL  524 (936)
Q Consensus       474 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  524 (936)
                      |++. .+|+.++.|..|+.|.|+.|+|. .+|+++.-|+.|+.|||..|.=
T Consensus       326 N~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpn  374 (1255)
T KOG0444|consen  326 NKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPN  374 (1255)
T ss_pred             cccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcC
Confidence            6665 66777777777777777777766 5666776677777777776653

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=333.83  Aligned_cols=231  Identities=22%  Similarity=0.308  Sum_probs=191.2

Q ss_pred             ccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCCCh
Q 002321          698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSL  774 (936)
Q Consensus       698 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  774 (936)
                      ||+|+||.||+|+.. +++.||+|+++....  ......+.+|+.++++++||||+++++++.+....++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999976 478999999865322  22346678999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccccccC
Q 002321          775 HKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQS  854 (936)
Q Consensus       775 ~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  854 (936)
                      .+++.+...   +++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++......  .......|
T Consensus        81 ~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g  155 (312)
T cd05585          81 FHHLQREGR---FDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCG  155 (312)
T ss_pred             HHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccC
Confidence            999976443   8899999999999999999999999999999999999999999999999997542211  12234568


Q ss_pred             cccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH----HHHhhhccccceeeccccccccc
Q 002321          855 ALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL----EEHWKKAEWRNVSMRSCKGSSRQ  930 (936)
Q Consensus       855 ~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~~p~~  930 (936)
                      ++.|+|||++. +..++.++||||+||++|||++|+.||..............    .+...+..+++++.+||..||.+
T Consensus       156 t~~y~aPE~~~-~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~  234 (312)
T cd05585         156 TPEYLAPELLL-GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTR  234 (312)
T ss_pred             CcccCCHHHHc-CCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHH
Confidence            99999999884 55789999999999999999999999987655432221111    12234467889999999999999


Q ss_pred             cccc
Q 002321          931 RRRF  934 (936)
Q Consensus       931 Rp~f  934 (936)
                      ||++
T Consensus       235 R~~~  238 (312)
T cd05585         235 RLGY  238 (312)
T ss_pred             cCCC
Confidence            9875

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.4e-36  Score=326.80  Aligned_cols=238  Identities=24%  Similarity=0.316  Sum_probs=192.9

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      |+..+.||+|+||+||+|... +|+.||||++......  .....+.+|+.++++++|++|+++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            355678999999999999965 6899999998654322  2234678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++|+|.+++..... ..+++..+..++.|++.|++|||+++|+||||||+||++++++.+||+|||+++......   .
T Consensus        82 ~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~  157 (285)
T cd05631          82 MNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---T  157 (285)
T ss_pred             cCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC---e
Confidence            999999988765332 248899999999999999999999999999999999999999999999999998653222   1


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHH-HHHH-HH------HHHhhhcccccee
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWW-FSVT-WL------EEHWKKAEWRNVS  920 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~-~~~~-~~------~~~~~~~~~~~~~  920 (936)
                      .....+++.|+|||++. +..++.++||||+||++|||++|+.||...+.... .... ..      .+...+..+.+++
T Consensus       158 ~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  236 (285)
T cd05631         158 VRGRVGTVGYMAPEVIN-NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC  236 (285)
T ss_pred             ecCCCCCCCccCHhhhc-CCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence            23346889999999984 55789999999999999999999999987543211 1110 00      1112345778899


Q ss_pred             eccccccccccccc
Q 002321          921 MRSCKGSSRQRRRF  934 (936)
Q Consensus       921 ~~~l~~~p~~Rp~f  934 (936)
                      .+||..||.+||++
T Consensus       237 ~~~l~~~P~~R~~~  250 (285)
T cd05631         237 RMLLTKNPKERLGC  250 (285)
T ss_pred             HHHhhcCHHHhcCC
Confidence            99999999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.1e-37  Score=316.29  Aligned_cols=234  Identities=23%  Similarity=0.284  Sum_probs=184.1

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC-----eeE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS-----LQL  763 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  763 (936)
                      ..|+..+.+|.|+||.||+|+.. +++.||||++-.+..     .-.+|+++|+.++|||||++.-+|....     ...
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            34667788999999999999976 478999999854322     2357999999999999999998886532     235


Q ss_pred             EEEEecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-CCeEEeeccCccccC
Q 002321          764 LIYEFVSGGSLHKHLHEG-SGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS-GEPKVGDYGLARLLP  841 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~  841 (936)
                      +|||||+ -+|.++++.. .....++...+.-++.|+++|+.|||+.||+||||||.|+|+|.+ |.+||||||.|+.+.
T Consensus        99 lVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen   99 LVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence            8999997 5899888742 112237777788899999999999999999999999999999986 999999999999875


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH-----------------
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV-----------------  904 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~-----------------  904 (936)
                      ..+.   ......+..|+|||.+.+..+|+.+.||||.|||+.||+-|++-|.+.+...+...                 
T Consensus       178 ~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn  254 (364)
T KOG0658|consen  178 KGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN  254 (364)
T ss_pred             cCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence            4332   24455677899999999999999999999999999999999999988653221110                 


Q ss_pred             ----HHHHH------------Hhhhccccceeeccccccccccc
Q 002321          905 ----TWLEE------------HWKKAEWRNVSMRSCKGSSRQRR  932 (936)
Q Consensus       905 ----~~~~~------------~~~~~~~~~~~~~~l~~~p~~Rp  932 (936)
                          ....+            ...++++-+++.+++.++|.+|-
T Consensus       255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~  298 (364)
T KOG0658|consen  255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRL  298 (364)
T ss_pred             cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcC
Confidence                00111            11235566777899999999885

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.1e-37  Score=342.42  Aligned_cols=247  Identities=25%  Similarity=0.341  Sum_probs=197.7

Q ss_pred             ccccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCC
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQS  760 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  760 (936)
                      ....|+..+.||+|+||.||+|++.      ++..||||+++........+.+.+|+++++.+ +|+||+++++++...+
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            3456788899999999999999853      24579999997654444567788999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhccCC---------------------------------------------------------
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSG---------------------------------------------------------  783 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  783 (936)
                      ..++||||+++|+|.++++....                                                         
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            99999999999999998864311                                                         


Q ss_pred             ----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccccc
Q 002321          784 ----------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQ  853 (936)
Q Consensus       784 ----------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  853 (936)
                                ...+++.++.+++.|++.||+|||++||+||||||+||++++++.+||+|||+++...............
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~  275 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR  275 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence                      1237788899999999999999999999999999999999999999999999997654332222222334


Q ss_pred             CcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHH-HH-----HHHHHHhhhccccceeeccccc
Q 002321          854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWF-SV-----TWLEEHWKKAEWRNVSMRSCKG  926 (936)
Q Consensus       854 ~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~~~l~~  926 (936)
                      ++..|||||++. ...++.++||||+||++|||++ |+.||......... ..     ....+.+.+.++++++.+||..
T Consensus       276 ~~~~y~aPE~~~-~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  354 (374)
T cd05106         276 LPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNL  354 (374)
T ss_pred             CccceeCHHHhc-CCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCC
Confidence            556799999884 4578999999999999999997 99999775432211 11     1111233457789999999999


Q ss_pred             ccccccccC
Q 002321          927 SSRQRRRFQ  935 (936)
Q Consensus       927 ~p~~Rp~f~  935 (936)
                      ||.+||+++
T Consensus       355 dp~~RPs~~  363 (374)
T cd05106         355 EPTERPTFS  363 (374)
T ss_pred             ChhhCcCHH
Confidence            999999974

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.7e-36  Score=325.45  Aligned_cols=231  Identities=19%  Similarity=0.236  Sum_probs=190.2

Q ss_pred             CcccccCceEEEEEEeCCCcEEEEEEeeccCccc--hHHHHHHHHHHHHcCCCCCcceeeeEEEe----CCeeEEEEEec
Q 002321          696 CELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVK--SQEDFEREVKKLGKVRHPNLVTLEGYYWT----QSLQLLIYEFV  769 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  769 (936)
                      ..||+|++|.||+|++ +|+.||||+++......  ..+.+.+|+.++++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6799999999999998 58999999996543221  14678899999999999999999999877    34678999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS-NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      ++|+|.+++.+..   .+++....+++.|++.|++|||+. +++||||||+||++++++.+||+|||+++......    
T Consensus       105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----  177 (283)
T PHA02988        105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----  177 (283)
T ss_pred             CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----
Confidence            9999999998654   388999999999999999999984 99999999999999999999999999998653221    


Q ss_pred             cccccCcccccCcccccCc-ccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH------HHHHhhhccccceee
Q 002321          849 SSKIQSALGYMAPEFACRT-VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW------LEEHWKKAEWRNVSM  921 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~~~~  921 (936)
                       ....++..|+|||++.+. ..++.++|||||||++|||++|+.||...+.........      ..+...+..+++++.
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~  256 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVE  256 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHH
Confidence             234567889999988432 468999999999999999999999998776533322110      011134567899999


Q ss_pred             cccccccccccccC
Q 002321          922 RSCKGSSRQRRRFQ  935 (936)
Q Consensus       922 ~~l~~~p~~Rp~f~  935 (936)
                      +||..||.+||+|+
T Consensus       257 ~cl~~dp~~Rps~~  270 (283)
T PHA02988        257 ACTSHDSIKRPNIK  270 (283)
T ss_pred             HHhcCCcccCcCHH
Confidence            99999999999985

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.8e-37  Score=326.02  Aligned_cols=239  Identities=33%  Similarity=0.511  Sum_probs=189.9

Q ss_pred             CCcccccCceEEEEEEeC-----CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          695 DCELGRGGFGAVYRTVLR-----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       695 ~~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .+.||+|+||.||+|.++     .+..|+||+++........+.+.+|++.+++++||||++++|++...+..++||||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            457999999999999987     257899999966544445788999999999999999999999999888899999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++|+|.++++... ...+++..+.+|+.|+++||+|||+++++|+||+++||+++.++.+||+|||+++...........
T Consensus        84 ~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~  162 (259)
T PF07714_consen   84 PGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKND  162 (259)
T ss_dssp             TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEES
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999998862 233899999999999999999999999999999999999999999999999999876333333333


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHH-H----HHHHhhhccccceeecc
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVT-W----LEEHWKKAEWRNVSMRS  923 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~  923 (936)
                      ........|+|||.+. ...++.++||||||+++||+++ |+.||.+.+........ .    ..+...+..+.+++.+|
T Consensus       163 ~~~~~~~~~~aPE~~~-~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C  241 (259)
T PF07714_consen  163 SSQQLPLRYLAPEVLK-DGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQC  241 (259)
T ss_dssp             TTSESGGGGS-HHHHH-HSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHHH
T ss_pred             cccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHHHH
Confidence            4445667899999884 4458999999999999999999 78999887554322111 0    01222356689999999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..||.+||+|+
T Consensus       242 ~~~~p~~RPs~~  253 (259)
T PF07714_consen  242 WSHDPEKRPSFQ  253 (259)
T ss_dssp             T-SSGGGS--HH
T ss_pred             cCCChhhCcCHH
Confidence            999999999985

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=335.99  Aligned_cols=242  Identities=24%  Similarity=0.372  Sum_probs=206.9

Q ss_pred             cccCCCcccccCceEEEEEEeCC--C--cEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRD--G--RPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      .+...++||+|+||.|++|.|..  |  ..||||.++.........+|.+|+.+|.+++|+|++++||++.+ ....|||
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            34556789999999999999873  3  47999999887766678899999999999999999999999988 5668999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      |.++.|+|.+.+++. ....+-......++.|||.||.||.++++||||+..+|+++-....+||+|||+.+.++..+..
T Consensus       190 ELaplGSLldrLrka-~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRKA-KKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             hhcccchHHHHHhhc-cccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            999999999999983 3445888889999999999999999999999999999999999999999999999988766554


Q ss_pred             c-ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHH-HH----HHHHHHhhhccccce
Q 002321          847 V-LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWF-SV----TWLEEHWKKAEWRNV  919 (936)
Q Consensus       847 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~-~~----~~~~~~~~~~~~~~~  919 (936)
                      + ......-...|+|||.+ ....++.++|||+|||++|||++ |+.||.+.....+. .+    +...+..++++++++
T Consensus       269 Yvm~p~rkvPfAWCaPEsL-rh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~i  347 (1039)
T KOG0199|consen  269 YVMAPQRKVPFAWCAPESL-RHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQI  347 (1039)
T ss_pred             eEecCCCcCcccccCHhHh-ccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHH
Confidence            4 33333445679999998 67789999999999999999999 99999987664333 11    222367788999999


Q ss_pred             eecccccccccccccC
Q 002321          920 SMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       920 ~~~~l~~~p~~Rp~f~  935 (936)
                      +.+||+.+|++||+|.
T Consensus       348 mk~cWah~paDRptFs  363 (1039)
T KOG0199|consen  348 MKNCWAHNPADRPTFS  363 (1039)
T ss_pred             HHHhccCCccccccHH
Confidence            9999999999999995

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=7.4e-39  Score=341.57  Aligned_cols=368  Identities=26%  Similarity=0.374  Sum_probs=283.9

Q ss_pred             cEEEccCccccc-ccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecC
Q 002321          127 RVIDLSGNSLSG-SIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLS  205 (936)
Q Consensus       127 ~~L~Ls~N~l~~-~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  205 (936)
                      +-.|+++|.++| .+|.++ .++++++.|.|...++. .+|..++.+.+|++|.+++|++.. +-..++.|+.|+.+++.
T Consensus        10 rGvDfsgNDFsg~~FP~~v-~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~-vhGELs~Lp~LRsv~~R   86 (1255)
T KOG0444|consen   10 RGVDFSGNDFSGDRFPHDV-EQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLIS-VHGELSDLPRLRSVIVR   86 (1255)
T ss_pred             ecccccCCcCCCCcCchhH-HHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHh-hhhhhccchhhHHHhhh
Confidence            334444444442 233222 44444445555444444 478888999999999999999985 55678899999999999


Q ss_pred             CCCCC-CCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCC
Q 002321          206 DNLLE-GEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGE  284 (936)
Q Consensus       206 ~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~  284 (936)
                      +|++. .-+|+.+..|..|..|+|++|+++ ..|..+..-+++-.|+||+|+|..+.-..|-+++.|-+|+|++|++. .
T Consensus        87 ~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~  164 (1255)
T KOG0444|consen   87 DNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-M  164 (1255)
T ss_pred             ccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-h
Confidence            99986 346777888899999999999998 77888888888888888888888555455666666667777777666 4


Q ss_pred             CCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhcc
Q 002321          285 VPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSS  364 (936)
Q Consensus       285 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~  364 (936)
                      +|..+..+.+|++|+|++|.+.-..-..+..+++|++|.+++.+=+                                  
T Consensus       165 LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRT----------------------------------  210 (1255)
T KOG0444|consen  165 LPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRT----------------------------------  210 (1255)
T ss_pred             cCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccch----------------------------------
Confidence            5555666666666666666654332233334444455554443322                                  


Q ss_pred             CCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCe
Q 002321          365 GLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNV  444 (936)
Q Consensus       365 ~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  444 (936)
                                      -..+|.++..+.+|..+|||.|++. ..|+++-.+.+|+.|+||+|+|+ .+....+...+|++
T Consensus       211 ----------------l~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEt  272 (1255)
T KOG0444|consen  211 ----------------LDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLET  272 (1255)
T ss_pred             ----------------hhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhh
Confidence                            0124555566778888888888887 89999999999999999999998 56667788899999


Q ss_pred             eecCCccccccCCCCCCCcCCCcEEEecCCccCC-cCccccccccccccccccCccccCCCcccccccCCccEEEcCCCc
Q 002321          445 LDLSENWLNGSIPPEIGGAYSLKELRLERNFLAG-KIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNS  523 (936)
Q Consensus       445 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  523 (936)
                      |+||.|+++ .+|+.++++++|+.|++.+|+++- -+|..++++.+|+.+..++|+|. .+|+.++.+..|+.|.|+.|+
T Consensus       273 LNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~Nr  350 (1255)
T KOG0444|consen  273 LNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNR  350 (1255)
T ss_pred             hccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccc
Confidence            999999998 799999999999999999999883 58999999999999999999998 899999999999999999999


Q ss_pred             ccCCCCcccccccccCeeecCCCcccccCCC
Q 002321          524 LTGGLPKQLVNLVHLSSFNISHNHLQGELPA  554 (936)
Q Consensus       524 l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~  554 (936)
                      |- .+|+.+.-|+.|+.|||..|+=---+|.
T Consensus       351 Li-TLPeaIHlL~~l~vLDlreNpnLVMPPK  380 (1255)
T KOG0444|consen  351 LI-TLPEAIHLLPDLKVLDLRENPNLVMPPK  380 (1255)
T ss_pred             ee-echhhhhhcCCcceeeccCCcCccCCCC
Confidence            98 7999999999999999999975544443

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-36  Score=313.19  Aligned_cols=243  Identities=21%  Similarity=0.254  Sum_probs=199.0

Q ss_pred             cccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCccc--hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVK--SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      .++..+.||.|.-|+||.++.++ +..+|+|++.+.....  ...+.+.|.+||+.++||.++.+|+.++.+...++|||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            35677789999999999999884 5899999997765542  34678889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC----
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML----  843 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~----  843 (936)
                      ||+||+|...++++.. +.+++..+.-++.+++.||+|||..|||+|||||+||||.++|++.|+||.++......    
T Consensus       158 yCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~  236 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV  236 (459)
T ss_pred             cCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence            9999999999887664 45888888899999999999999999999999999999999999999999987543110    


Q ss_pred             -----------------------------cc---------------------ccccccccCcccccCcccccCcccCCch
Q 002321          844 -----------------------------DR---------------------YVLSSKIQSALGYMAPEFACRTVKITDK  873 (936)
Q Consensus       844 -----------------------------~~---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~  873 (936)
                                                   ..                     ...+....||-+|.|||++. +..++.+
T Consensus       237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~-G~GHgsA  315 (459)
T KOG0610|consen  237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR-GEGHGSA  315 (459)
T ss_pred             ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee-cCCCCch
Confidence                                         00                     01122345778899999995 4467999


Q ss_pred             hhHHHHHHHHHHHHcCCCCCCccchhHHH-HHHHHHHH-----hhhccccceeecccccccccccccC
Q 002321          874 CDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVTWLEEH-----WKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       874 ~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +|.|+|||++|||+.|..||.+....... .+-..+..     ..+...+|+|.+.+.+||.+|-.+.
T Consensus       316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~  383 (459)
T KOG0610|consen  316 VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSK  383 (459)
T ss_pred             hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccc
Confidence            99999999999999999999988764333 22221222     2335689999999999999997653

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-36  Score=310.95  Aligned_cols=233  Identities=23%  Similarity=0.330  Sum_probs=181.4

Q ss_pred             cccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcC--CCCCcceeeeEEEeCC----eeEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV--RHPNLVTLEGYYWTQS----LQLL  764 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~~l  764 (936)
                      .+...+.||+|.||+||+|.|+ |+.||||++..    .+++.+.||.++++..  +|+||+.+++.-..+.    +.|+
T Consensus       212 qI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL  286 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL  286 (513)
T ss_pred             eeEEEEEecCccccceeecccc-CCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence            3466678999999999999998 99999999953    3467788888887766  9999999998865332    5689


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCcccCCCCCCCEEEcCCCCeEEeeccC
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ--------SNIIHYNIKSSNVLIDGSGEPKVGDYGL  836 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~--------~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  836 (936)
                      |.+|.+.|+|+||+.+..    ++....++++..+|.||+|||.        ..|.|||||.+||||.++|.+.|+|+|+
T Consensus       287 vTdYHe~GSL~DyL~r~t----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL  362 (513)
T KOG2052|consen  287 VTDYHEHGSLYDYLNRNT----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  362 (513)
T ss_pred             eeecccCCcHHHHHhhcc----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence            999999999999998854    8999999999999999999994        3599999999999999999999999999


Q ss_pred             ccccCCCcc--ccccccccCcccccCcccccCccc---C--CchhhHHHHHHHHHHHHcC----------CCCCCccchh
Q 002321          837 ARLLPMLDR--YVLSSKIQSALGYMAPEFACRTVK---I--TDKCDVYGFGVLVLEVVTG----------KRPLSTWKMM  899 (936)
Q Consensus       837 a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~---~--~~~~DvwSlG~~l~el~~g----------~~Pf~~~~~~  899 (936)
                      |........  ........||.+|||||++.....   +  -..+||||||.|+||+..+          +.||.+..+.
T Consensus       363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~  442 (513)
T KOG2052|consen  363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS  442 (513)
T ss_pred             eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence            977654321  234556789999999999844322   1  1369999999999998852          4788775432


Q ss_pred             HHHHHHH------------HHHHhhh----ccccceeeccccccccccc
Q 002321          900 WWFSVTW------------LEEHWKK----AEWRNVSMRSCKGSSRQRR  932 (936)
Q Consensus       900 ~~~~~~~------------~~~~~~~----~~~~~~~~~~l~~~p~~Rp  932 (936)
                      .....+.            .+..|.+    ..+..+|..||..+|+-|-
T Consensus       443 DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRl  491 (513)
T KOG2052|consen  443 DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARL  491 (513)
T ss_pred             CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhh
Confidence            2221111            1123322    3355667889999998774

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.7e-36  Score=332.09  Aligned_cols=232  Identities=23%  Similarity=0.299  Sum_probs=190.6

Q ss_pred             CcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCC
Q 002321          696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGG  772 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  772 (936)
                      +.||+|+||.||+++.. +|+.||+|+++....  ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            36999999999999975 589999999975432  123456778999999999999999999999999999999999999


Q ss_pred             ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccccc
Q 002321          773 SLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI  852 (936)
Q Consensus       773 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  852 (936)
                      +|.+++....   .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......  ......
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~  155 (323)
T cd05595          81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTF  155 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cccccc
Confidence            9999887654   38899999999999999999999999999999999999999999999999987532111  122345


Q ss_pred             cCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH----HHHhhhccccceeeccccccc
Q 002321          853 QSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL----EEHWKKAEWRNVSMRSCKGSS  928 (936)
Q Consensus       853 ~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~~p  928 (936)
                      .|++.|+|||++. ...++.++||||+||++|||++|+.||...+..........    .+...++.+++++.+||..||
T Consensus       156 ~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP  234 (323)
T cd05595         156 CGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP  234 (323)
T ss_pred             cCCcCcCCccccc-CCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence            6889999999984 45789999999999999999999999987665432221111    122335678899999999999


Q ss_pred             ccccc
Q 002321          929 RQRRR  933 (936)
Q Consensus       929 ~~Rp~  933 (936)
                      .+|+.
T Consensus       235 ~~R~~  239 (323)
T cd05595         235 KQRLG  239 (323)
T ss_pred             HHhCC
Confidence            99983

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5e-36  Score=324.87  Aligned_cols=240  Identities=22%  Similarity=0.304  Sum_probs=193.4

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .|+..++||+|+||.||+|+.+ +++.||+|+++..........+.+|++++++++||||+++++++.+....++||||+
T Consensus         6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   85 (288)
T cd07871           6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL   85 (288)
T ss_pred             cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence            4677789999999999999976 588999999975543334567789999999999999999999999988999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      + |+|.+++....  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......  ...
T Consensus        86 ~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~~~  160 (288)
T cd07871          86 D-SDLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--KTY  160 (288)
T ss_pred             C-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--ccc
Confidence            6 59998886543  237889999999999999999999999999999999999999999999999997543221  112


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH-----------------------
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW-----------------------  906 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~-----------------------  906 (936)
                      ....+++.|+|||++.+...++.++||||+||++|||++|+.||...+.........                       
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY  240 (288)
T ss_pred             cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence            334578899999988666678999999999999999999999997755322110000                       


Q ss_pred             HHH-----------HhhhccccceeecccccccccccccC
Q 002321          907 LEE-----------HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       907 ~~~-----------~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..+           ...+.+..+++.+|+..||.+||+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~  280 (288)
T cd07871         241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAE  280 (288)
T ss_pred             ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHH
Confidence            000           01234567899999999999999853

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=303.27  Aligned_cols=237  Identities=24%  Similarity=0.402  Sum_probs=196.1

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ..|+..++||+|.|+.||++... +|+.+|+|++...... .+.+++.+|+++.+.++||||+++.+.....+..++|+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            45677778999999999999865 6899999988554332 346789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCCeEEeeccCccccCCCc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG---SGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~~  844 (936)
                      +|+|++|..-+-..   ..+++..+...++||+.||.|+|.++|||||+||+|+++-.   ...+|++|||+|..+.   
T Consensus        91 ~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~---  164 (355)
T KOG0033|consen   91 LVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN---  164 (355)
T ss_pred             cccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC---
Confidence            99999997544332   23788889999999999999999999999999999999943   3479999999998776   


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH------HHHHHHh--hhccc
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV------TWLEEHW--KKAEW  916 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~------~~~~~~~--~~~~~  916 (936)
                      .........|||+|||||++. ..+|+..+|||+-||++|-++.|..||.+.+....+..      .+..+.|  ..++.
T Consensus       165 ~g~~~~G~~GtP~fmaPEvvr-kdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A  243 (355)
T KOG0033|consen  165 DGEAWHGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA  243 (355)
T ss_pred             CccccccccCCCcccCHHHhh-cCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence            233445678999999999994 44799999999999999999999999999776544422      1222334  33678


Q ss_pred             cceeecccccccccccc
Q 002321          917 RNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       917 ~~~~~~~l~~~p~~Rp~  933 (936)
                      ++++.||+..||++|=+
T Consensus       244 k~LvrrML~~dP~kRIt  260 (355)
T KOG0033|consen  244 KSLIRRMLTVNPKKRIT  260 (355)
T ss_pred             HHHHHHHhccChhhhcc
Confidence            89999999999999853

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=6.9e-36  Score=326.41  Aligned_cols=240  Identities=22%  Similarity=0.315  Sum_probs=192.4

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..++||+|+||.||+|+.. +++.||||+++..........+.+|+.++++++||||+++++++.+....++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            45677889999999999999976 68899999987554333445678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      ++ +++.+++....  ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++......  ..
T Consensus        85 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  159 (303)
T cd07869          85 VH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--HT  159 (303)
T ss_pred             CC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--cc
Confidence            95 68888776543  237888999999999999999999999999999999999999999999999987543221  12


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHH--HHHH-------------------
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS--VTWL-------------------  907 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~--~~~~-------------------  907 (936)
                      .....+++.|+|||++.+...++.++||||+||++|||++|+.||...+......  ....                   
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd07869         160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK  239 (303)
T ss_pred             CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence            2334578899999988666678999999999999999999999998754321110  0000                   


Q ss_pred             ------------HHHh----hhccccceeeccccccccccccc
Q 002321          908 ------------EEHW----KKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       908 ------------~~~~----~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                  ...+    ..+..++++.+|+..||++||+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~  282 (303)
T cd07869         240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSA  282 (303)
T ss_pred             cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCH
Confidence                        0000    11345689999999999999974

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=309.66  Aligned_cols=238  Identities=22%  Similarity=0.318  Sum_probs=193.2

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeecc-CccchHHHHHHHHHHHHcCCCCCcceeeeEEEe-----CCeeEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVS-SLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWT-----QSLQLL  764 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~l  764 (936)
                      |...+.||+|+||.|.+|+.+ +|+.||||++... ......++..||+++++.++|+||+.+.+++..     -..+|+
T Consensus        24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYi  103 (359)
T KOG0660|consen   24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYL  103 (359)
T ss_pred             ecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEE
Confidence            344678999999999999976 6899999998622 222346778899999999999999999999865     246799


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      |+|+| +.+|...++.+..   ++.....-++.|+++|++|+|+.+|+|||+||.|++++.+..+||+|||+|+......
T Consensus       104 V~elM-etDL~~iik~~~~---L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  104 VFELM-ETDLHQIIKSQQD---LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF  179 (359)
T ss_pred             ehhHH-hhHHHHHHHcCcc---ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence            99999 6899999987653   8889999999999999999999999999999999999999999999999999875432


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH--------------------
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV--------------------  904 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~--------------------  904 (936)
                      ....-+....|.+|+|||+......|+.+.||||.|||++||++|++-|.+.+...+...                    
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence            223334566789999999998888999999999999999999999999988654222111                    


Q ss_pred             --HHHHH-------------Hhhhccccceeecccccccccccc
Q 002321          905 --TWLEE-------------HWKKAEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       905 --~~~~~-------------~~~~~~~~~~~~~~l~~~p~~Rp~  933 (936)
                        .+...             ..+++...+++.+++.-||.+|.+
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit  303 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT  303 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC
Confidence              11110             122345667778999999999975

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=8.1e-36  Score=332.85  Aligned_cols=238  Identities=24%  Similarity=0.346  Sum_probs=190.6

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ...|+..++||+|+||.||+|++. +++.||||++...........+.+|++++++++|+||+++++++.+.+..++|||
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            345677789999999999999976 5899999999655444445778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+++|+|.+..       ...+..+..++.|++.||+|||+.+|+||||||+|||+++++.+||+|||+++.+....  .
T Consensus       153 ~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~  223 (353)
T PLN00034        153 FMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--D  223 (353)
T ss_pred             cCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--c
Confidence            99999986532       25667788899999999999999999999999999999999999999999998654221  1


Q ss_pred             ccccccCcccccCcccccC----cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH-HH-------HHHhhhcc
Q 002321          848 LSSKIQSALGYMAPEFACR----TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT-WL-------EEHWKKAE  915 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~-~~-------~~~~~~~~  915 (936)
                      ......|+..|+|||++..    +...+.++|||||||++|||++|+.||............ ..       .+...+.+
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE  303 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHH
Confidence            1234568899999998732    223456899999999999999999999754332111110 00       01223467


Q ss_pred             ccceeecccccccccccccC
Q 002321          916 WRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++++.+||..||.+||+++
T Consensus       304 l~~li~~~l~~~P~~Rpt~~  323 (353)
T PLN00034        304 FRHFISCCLQREPAKRWSAM  323 (353)
T ss_pred             HHHHHHHHccCChhhCcCHH
Confidence            89999999999999999863

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.8e-36  Score=334.91  Aligned_cols=235  Identities=23%  Similarity=0.325  Sum_probs=195.2

Q ss_pred             cccccCCCcccccCceEEEEEEeCC--CcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRD--GRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      ...|+..+.||+|+||.||+|+.+.  +..||+|++.....  ....+.+.+|+++++.++||||+++++++.+....++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3456777889999999999998653  36899999864332  2234678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ||||+++|+|.+++.+...   +++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++..... 
T Consensus       109 v~Ey~~~g~L~~~i~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNKR---FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence            9999999999999986543   889999999999999999999999999999999999999999999999999865321 


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH----HHHHHhhhcccccee
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT----WLEEHWKKAEWRNVS  920 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~  920 (936)
                          .....||+.|+|||++. +..++.++||||+||++|||++|+.||...+........    ...+...++..++++
T Consensus       185 ----~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  259 (340)
T PTZ00426        185 ----TYTLCGTPEYIAPEILL-NVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLM  259 (340)
T ss_pred             ----cceecCChhhcCHHHHh-CCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence                12356889999999984 456789999999999999999999999887653222111    111334456788999


Q ss_pred             eccccccccccc
Q 002321          921 MRSCKGSSRQRR  932 (936)
Q Consensus       921 ~~~l~~~p~~Rp  932 (936)
                      .+|+..||.+|+
T Consensus       260 ~~~l~~dp~~R~  271 (340)
T PTZ00426        260 KKLLSHDLTKRY  271 (340)
T ss_pred             HHHcccCHHHcC
Confidence            999999999996

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.6e-36  Score=329.80  Aligned_cols=243  Identities=24%  Similarity=0.323  Sum_probs=194.9

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCc----EEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  763 (936)
                      ...|+..+.||+|+||.||+|++. +++    .||||+++........+++.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            445788889999999999999864 333    48999987554444567889999999999999999999999765 467


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      +|+||+++|+|.++++...  ..+++..+.+++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          85 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            9999999999999998653  23788899999999999999999999999999999999999999999999999876533


Q ss_pred             ccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhcccc
Q 002321          844 DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWR  917 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~  917 (936)
                      ...........+..|+|||.+. ...++.++|||||||++|||++ |+.||.+...........     ..+......+.
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY  241 (316)
T ss_pred             CcceeccCCccceeecChHHhc-cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence            3222222233456799999884 4578999999999999999998 999998765433221111     11223346788


Q ss_pred             ceeecccccccccccccC
Q 002321          918 NVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++.+||..+|.+||+|+
T Consensus       242 ~li~~cl~~~p~~Rps~~  259 (316)
T cd05108         242 MIMVKCWMIDADSRPKFR  259 (316)
T ss_pred             HHHHHHccCChhhCcCHH
Confidence            899999999999999974

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=8.5e-36  Score=329.55  Aligned_cols=201  Identities=23%  Similarity=0.370  Sum_probs=174.0

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..+.||+|+||.||+++.. ++..||+|++.........+.+.+|++++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            45677788999999999999976 58899999987654334457799999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS-NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      +++|+|.+++.....   +++..+.+++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++......    
T Consensus        85 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----  157 (331)
T cd06649          85 MDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----  157 (331)
T ss_pred             CCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc----
Confidence            999999999976543   88999999999999999999986 6999999999999999999999999998755321    


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM  898 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~  898 (936)
                      ......+++.|+|||++. +..++.++||||+||++|||++|+.||...+.
T Consensus       158 ~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~p~~~~~~  207 (331)
T cd06649         158 MANSFVGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA  207 (331)
T ss_pred             ccccCCCCcCcCCHhHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            123446888999999984 55789999999999999999999999976543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-36  Score=326.60  Aligned_cols=240  Identities=21%  Similarity=0.356  Sum_probs=207.3

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc-hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCe-eEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSL-QLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  766 (936)
                      ..|+..+.||+|+||.++.++.+ +++.||+|++....... .++....|+.++++++|||||.+.+.|..++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            34678889999999999998866 58899999997665443 34578899999999999999999999999888 89999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      +|++||++.+.+.+.+ +..++++.+.+|+.|++.|+.|||+++|+|||||+.||+++.++.+||+|||+|+......  
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--  160 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch--
Confidence            9999999999998866 4569999999999999999999999999999999999999999999999999999876433  


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH-----HHHHhhhccccceee
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSM  921 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~  921 (936)
                      .......||+.||+||++ .+.+|..|+||||+||++|||++-+++|+..++........     .-+.....+++.++.
T Consensus       161 ~~a~tvvGTp~YmcPEil-~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~  239 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEIL-SDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVK  239 (426)
T ss_pred             hhhheecCCCcccCHHHh-CCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHH
Confidence            244567899999999988 67799999999999999999999999999998843332111     124455678899999


Q ss_pred             cccccccccccc
Q 002321          922 RSCKGSSRQRRR  933 (936)
Q Consensus       922 ~~l~~~p~~Rp~  933 (936)
                      .|+..+|..||+
T Consensus       240 ~~l~~~P~~RPs  251 (426)
T KOG0589|consen  240 SMLRKNPEHRPS  251 (426)
T ss_pred             HHhhcCCccCCC
Confidence            999999999996

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3e-36  Score=332.32  Aligned_cols=232  Identities=22%  Similarity=0.287  Sum_probs=190.9

Q ss_pred             CcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCC
Q 002321          696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGG  772 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  772 (936)
                      +.||+|+||.||+++.. +++.||||++......  .....+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            36899999999999976 5899999999754322  23467889999999999999999999999999999999999999


Q ss_pred             ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccccc
Q 002321          773 SLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI  852 (936)
Q Consensus       773 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  852 (936)
                      +|.+++....   .+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.....  .......
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~  155 (328)
T cd05593          81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKTF  155 (328)
T ss_pred             CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccccc
Confidence            9999887644   3899999999999999999999999999999999999999999999999998753211  1122345


Q ss_pred             cCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceeeccccccc
Q 002321          853 QSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSMRSCKGSS  928 (936)
Q Consensus       853 ~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~~p  928 (936)
                      .|++.|+|||++. ...++.++||||+||++|||++|+.||...+.........    ..+...+...++++.+||..||
T Consensus       156 ~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP  234 (328)
T cd05593         156 CGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDP  234 (328)
T ss_pred             cCCcCccChhhhc-CCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCH
Confidence            6899999999984 4568999999999999999999999998765533221111    1122234678899999999999


Q ss_pred             ccccc
Q 002321          929 RQRRR  933 (936)
Q Consensus       929 ~~Rp~  933 (936)
                      .+|++
T Consensus       235 ~~R~~  239 (328)
T cd05593         235 NKRLG  239 (328)
T ss_pred             HHcCC
Confidence            99974

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.7e-36  Score=331.64  Aligned_cols=233  Identities=24%  Similarity=0.329  Sum_probs=191.9

Q ss_pred             CcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      +.||+|+||.||+|+.+ +++.||||+++....  ....+.+.+|.+++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999976 588999999865422  22345677888888877 699999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      |+|.+++.+...   +++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 g~L~~~i~~~~~---l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~  155 (320)
T cd05590          81 GDLMFHIQKSRR---FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTST  155 (320)
T ss_pred             chHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Ccccc
Confidence            999998876543   8899999999999999999999999999999999999999999999999987532211  12234


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceeecccccc
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSMRSCKGS  927 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~~  927 (936)
                      ..|++.|+|||++ ....++.++||||+||++|||++|+.||...+.........    ..+.+.+...++++.+|+..|
T Consensus       156 ~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~d  234 (320)
T cd05590         156 FCGTPDYIAPEIL-QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKN  234 (320)
T ss_pred             cccCccccCHHHH-cCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccC
Confidence            5689999999988 45578999999999999999999999998876543322111    123345667889999999999


Q ss_pred             ccccccc
Q 002321          928 SRQRRRF  934 (936)
Q Consensus       928 p~~Rp~f  934 (936)
                      |.+||+.
T Consensus       235 P~~R~~~  241 (320)
T cd05590         235 PTMRLGS  241 (320)
T ss_pred             HHHCCCC
Confidence            9999974

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6.2e-36  Score=328.19  Aligned_cols=233  Identities=24%  Similarity=0.318  Sum_probs=189.2

Q ss_pred             CcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      +.||+|+||.||+|+.. +++.||||+++....  ....+....|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999976 478999999975432  12334556677777654 899999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      |+|.+++.....   +++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 g~L~~~~~~~~~---~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~  155 (316)
T cd05592          81 GDLMFHIQSSGR---FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAST  155 (316)
T ss_pred             CcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccccc
Confidence            999999876443   8899999999999999999999999999999999999999999999999997543222  22334


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceeecccccc
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSMRSCKGS  927 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~~  927 (936)
                      ..|++.|+|||++. +..++.++||||+||++|||++|+.||...+.........    ..+...+.+..+++.+||..|
T Consensus       156 ~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~  234 (316)
T cd05592         156 FCGTPDYIAPEILK-GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERD  234 (316)
T ss_pred             ccCCccccCHHHHc-CCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCC
Confidence            56899999999884 4568999999999999999999999998776533321111    112334566789999999999


Q ss_pred             ccccccc
Q 002321          928 SRQRRRF  934 (936)
Q Consensus       928 p~~Rp~f  934 (936)
                      |.+||+.
T Consensus       235 P~~R~~~  241 (316)
T cd05592         235 PTKRLGV  241 (316)
T ss_pred             HHHcCCC
Confidence            9999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-36  Score=332.44  Aligned_cols=235  Identities=23%  Similarity=0.338  Sum_probs=194.8

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      |+..+.||+|+||.||+|++. +++.||||+++.....  .....+.+|+.++.+++||||+++++++.+....++||||
T Consensus         3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   82 (333)
T cd05600           3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY   82 (333)
T ss_pred             cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence            566788999999999999987 4889999999754322  2346688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++|+|.+++....   .+++.++..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++....     .
T Consensus        83 ~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~  154 (333)
T cd05600          83 VPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----Y  154 (333)
T ss_pred             CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----c
Confidence            99999999997644   388999999999999999999999999999999999999999999999999976532     2


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHH-H-HH----HHHHhh------hccc
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS-V-TW----LEEHWK------KAEW  916 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~-~-~~----~~~~~~------~~~~  916 (936)
                      .....|++.|+|||++. +..++.++||||+||++|||++|+.||...+...... . .+    ..+.+.      +.++
T Consensus       155 ~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~  233 (333)
T cd05600         155 ANSVVGSPDYMAPEVLR-GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEA  233 (333)
T ss_pred             cCCcccCccccChhHhc-CCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHH
Confidence            23456889999999984 4478999999999999999999999998765533221 1 11    111111      4567


Q ss_pred             cceeecccccccccccccC
Q 002321          917 RNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       917 ~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+++.+|+..+|.+||+++
T Consensus       234 ~~li~~~l~~~~~rr~s~~  252 (333)
T cd05600         234 WDLITKLINDPSRRFGSLE  252 (333)
T ss_pred             HHHHHHHhhChhhhcCCHH
Confidence            8899999998888888753

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6e-37  Score=297.37  Aligned_cols=239  Identities=23%  Similarity=0.398  Sum_probs=199.3

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc-------hHHHHHHHHHHHHcC-CCCCcceeeeEEEeC
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK-------SQEDFEREVKKLGKV-RHPNLVTLEGYYWTQ  759 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  759 (936)
                      .+.|+..+.+|.|..++|-++.++ +|+++|+|++...+...       -.++-.+|+.+++++ .||+|+++.++++.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            345677788999999999998866 58899999986533221       134567899999999 699999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          760 SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       760 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      ...++|+|.|+.|.|.|++...-.   +++.+..+|++|+..|++|||.+.|||||+||+|||+|++..+||+|||+|..
T Consensus        96 sF~FlVFdl~prGELFDyLts~Vt---lSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~  172 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKVT---LSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQ  172 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhhee---ecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeec
Confidence            999999999999999999987543   89999999999999999999999999999999999999999999999999988


Q ss_pred             cCCCccccccccccCcccccCccccc-----CcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH------HHHH
Q 002321          840 LPMLDRYVLSSKIQSALGYMAPEFAC-----RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV------TWLE  908 (936)
Q Consensus       840 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~------~~~~  908 (936)
                      ++..+.   -...+|||+|.|||.+.     +...|+..+|+||.||++|.++.|.+||...+++-....      ++--
T Consensus       173 l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s  249 (411)
T KOG0599|consen  173 LEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS  249 (411)
T ss_pred             cCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC
Confidence            765443   35688999999999772     345588899999999999999999999988776433322      2223


Q ss_pred             HHhhh--ccccceeecccccccccccc
Q 002321          909 EHWKK--AEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       909 ~~~~~--~~~~~~~~~~l~~~p~~Rp~  933 (936)
                      |.|++  .+.+++|.+|+.+||.+|-+
T Consensus       250 peWadis~~~KdLIsrlLqVdp~~Rit  276 (411)
T KOG0599|consen  250 PEWADISATVKDLISRLLQVDPTKRIT  276 (411)
T ss_pred             cchhhccccHHHHHHHHHeeCchhccc
Confidence            45544  66778889999999999854

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.8e-36  Score=328.23  Aligned_cols=233  Identities=24%  Similarity=0.354  Sum_probs=190.3

Q ss_pred             CcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      +.||+|+||+||+|+.. +++.||||+++....  .........|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999976 478999999975422  22345567788888765 899999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      |+|.+++....   .+++.++..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~  155 (316)
T cd05619          81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCT  155 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cceee
Confidence            99999987643   38889999999999999999999999999999999999999999999999987532211  12234


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HHHH---HHHHhhhccccceeecccccc
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVTW---LEEHWKKAEWRNVSMRSCKGS  927 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~~---~~~~~~~~~~~~~~~~~l~~~  927 (936)
                      ..|++.|+|||++. +..++.++||||+||++|||++|+.||...+..... ....   ..+.+.+.++++++.+||..|
T Consensus       156 ~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~  234 (316)
T cd05619         156 FCGTPDYIAPEILL-GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVRE  234 (316)
T ss_pred             ecCCccccCHHHHc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccC
Confidence            56889999999884 456899999999999999999999999877653322 1111   113345567889999999999


Q ss_pred             ccccccc
Q 002321          928 SRQRRRF  934 (936)
Q Consensus       928 p~~Rp~f  934 (936)
                      |.+||+.
T Consensus       235 P~~R~~~  241 (316)
T cd05619         235 PERRLGV  241 (316)
T ss_pred             HhhcCCC
Confidence            9999876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=8.4e-36  Score=327.16  Aligned_cols=233  Identities=24%  Similarity=0.341  Sum_probs=190.6

Q ss_pred             CcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      +.||+|+||.||+|+.+ +|+.||||+++....  .........|.+++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999976 588999999975432  22345667788888765 899999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      |+|.+++.....   +++.++..++.|+++||+|||++||+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 g~L~~~i~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~  155 (316)
T cd05620          81 GDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAST  155 (316)
T ss_pred             CcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cceec
Confidence            999999876433   8899999999999999999999999999999999999999999999999987432111  12234


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceeecccccc
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSMRSCKGS  927 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~~  927 (936)
                      ..|++.|+|||++. ...++.++||||+||++|||++|+.||...+.........    ..+.+.+.++++++.+||..|
T Consensus       156 ~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  234 (316)
T cd05620         156 FCGTPDYIAPEILQ-GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERD  234 (316)
T ss_pred             cCCCcCccCHHHHc-CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCC
Confidence            56899999999984 4578999999999999999999999998766533221111    113345567889999999999


Q ss_pred             ccccccc
Q 002321          928 SRQRRRF  934 (936)
Q Consensus       928 p~~Rp~f  934 (936)
                      |.+|++.
T Consensus       235 P~~R~~~  241 (316)
T cd05620         235 PTRRLGV  241 (316)
T ss_pred             HHHcCCC
Confidence            9999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=6.3e-36  Score=320.25  Aligned_cols=242  Identities=21%  Similarity=0.304  Sum_probs=194.2

Q ss_pred             ccccCCCcccccCceEEEEEEeC----CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  765 (936)
                      ..|+..+.||+|+||.||+|.++    .+..||+|+++..........+.+|+.++++++||||+++++++..+...++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            34677788999999999999864    35689999997664444457789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      |||+++|+|.+++....  ..+++.++++++.|++.|++|||+++++||||||+||+++.++.++++|||.+...... .
T Consensus        85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~-~  161 (266)
T cd05064          85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE-A  161 (266)
T ss_pred             EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc-c
Confidence            99999999999997643  23889999999999999999999999999999999999999999999999987653211 1


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHH-H----HHHHHhhhccccce
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSV-T----WLEEHWKKAEWRNV  919 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~-~----~~~~~~~~~~~~~~  919 (936)
                      ........++..|+|||.+. ...++.++||||+||++||+++ |+.||........... .    ...+...+..+.++
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  240 (266)
T cd05064         162 IYTTMSGKSPVLWAAPEAIQ-YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQL  240 (266)
T ss_pred             hhcccCCCCceeecCHHHHh-hCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence            11111233456799999884 4578999999999999999875 9999987654322111 0    01112234678889


Q ss_pred             eecccccccccccccC
Q 002321          920 SMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       920 ~~~~l~~~p~~Rp~f~  935 (936)
                      +.+||..+|.+||+++
T Consensus       241 i~~c~~~~p~~RP~~~  256 (266)
T cd05064         241 MLDCWQKERGERPRFS  256 (266)
T ss_pred             HHHHcCCCchhCCCHH
Confidence            9999999999999974

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.7e-36  Score=331.08  Aligned_cols=233  Identities=22%  Similarity=0.329  Sum_probs=191.3

Q ss_pred             CcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      +.||+|+||.||+|+.. +++.||||+++....  ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999976 478999999965432  22345677889998876 799999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      |+|..++.....   +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~  155 (321)
T cd05591          81 GDLMFQIQRSRK---FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTT  155 (321)
T ss_pred             CcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC--ccccc
Confidence            999998876543   8899999999999999999999999999999999999999999999999987542211  12234


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH----HHHHHhhhccccceeecccccc
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT----WLEEHWKKAEWRNVSMRSCKGS  927 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~  927 (936)
                      ..|++.|+|||++ ....++.++||||+||++|||++|+.||...+........    ...+.+.+.++.+++.+|+..|
T Consensus       156 ~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~d  234 (321)
T cd05591         156 FCGTPDYIAPEIL-QELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKN  234 (321)
T ss_pred             cccCccccCHHHH-cCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccC
Confidence            5688999999988 4557899999999999999999999999877654322111    1123345677889999999999


Q ss_pred             ccccccc
Q 002321          928 SRQRRRF  934 (936)
Q Consensus       928 p~~Rp~f  934 (936)
                      |.+|+.+
T Consensus       235 p~~R~~~  241 (321)
T cd05591         235 PNKRLGC  241 (321)
T ss_pred             HHHcCCC
Confidence            9999954

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.8e-36  Score=328.98  Aligned_cols=235  Identities=25%  Similarity=0.326  Sum_probs=189.7

Q ss_pred             cCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHH---HcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          693 NKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKL---GKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       693 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      +..+.||+|+||.||+|... +++.||||+++....  ....+.+.+|++++   ++++||||+++++++.+....++||
T Consensus         2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~   81 (324)
T cd05589           2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM   81 (324)
T ss_pred             eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence            45678999999999999976 589999999975432  12245667776665   5668999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++|+|..+++..    .+++..+..++.|++.||+|||+.||+||||||+||++++++.+||+|||+++......  
T Consensus        82 E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--  155 (324)
T cd05589          82 EYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG--  155 (324)
T ss_pred             cCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC--
Confidence            999999999888653    38999999999999999999999999999999999999999999999999987532211  


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH-H---HHHHhhhccccceeec
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT-W---LEEHWKKAEWRNVSMR  922 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~-~---~~~~~~~~~~~~~~~~  922 (936)
                      .......|++.|+|||.+. +..++.++||||+||++|||++|+.||...+........ .   ..+...+..+.+++.+
T Consensus       156 ~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  234 (324)
T cd05589         156 DRTSTFCGTPEFLAPEVLT-ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRR  234 (324)
T ss_pred             CcccccccCccccCHhHhc-CCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            1223456889999999884 457899999999999999999999999876654322111 1   1122345667889999


Q ss_pred             cccccccccccc
Q 002321          923 SCKGSSRQRRRF  934 (936)
Q Consensus       923 ~l~~~p~~Rp~f  934 (936)
                      ||..||.+||+.
T Consensus       235 ~L~~dP~~R~~~  246 (324)
T cd05589         235 LLRRNPERRLGS  246 (324)
T ss_pred             HhhcCHhHcCCC
Confidence            999999999964

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.2e-35  Score=333.99  Aligned_cols=246  Identities=23%  Similarity=0.294  Sum_probs=195.6

Q ss_pred             cccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-CCCcceeeeEEEeCCe
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQSL  761 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  761 (936)
                      ...|...+.||+|+||.||+|+..      .+..||||+++........+.+.+|+++++++. ||||+++++++.+...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            445677889999999999999853      134799999976544445678999999999996 9999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhccCC----------------------------------------------------------
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSG----------------------------------------------------------  783 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------  783 (936)
                      .++||||+++|+|.++++....                                                          
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999998865311                                                          


Q ss_pred             -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCC
Q 002321          784 -----------------------------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGE  828 (936)
Q Consensus       784 -----------------------------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~  828 (936)
                                                         ...+++.++.+++.|+++|++|||+.+|+||||||+||+++.++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~  275 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKI  275 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCE
Confidence                                               123778888999999999999999999999999999999999999


Q ss_pred             eEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHH--HH
Q 002321          829 PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFS--VT  905 (936)
Q Consensus       829 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~--~~  905 (936)
                      +||+|||+++...............+++.|+|||.+. +..++.++|||||||++|||++ |..||..........  ..
T Consensus       276 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~  354 (400)
T cd05105         276 VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF-DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIK  354 (400)
T ss_pred             EEEEeCCcceeccccccccccCCcCCCcceEChhhhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHh
Confidence            9999999998654322222233344667899999884 4568999999999999999997 999997653321111  00


Q ss_pred             ----HHHHHhhhccccceeecccccccccccccC
Q 002321          906 ----WLEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       906 ----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                          ...+...+..+.+++.+||..||.+||+|.
T Consensus       355 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  388 (400)
T cd05105         355 SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFL  388 (400)
T ss_pred             cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHH
Confidence                011122345688999999999999999974

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.8e-35  Score=319.06  Aligned_cols=235  Identities=25%  Similarity=0.304  Sum_probs=189.7

Q ss_pred             ccccCceEEEEEEeC-CCcEEEEEEeeccCccc--hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCCCh
Q 002321          698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK--SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSL  774 (936)
Q Consensus       698 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  774 (936)
                      ||+|+||+||++... +++.||||++.......  ..+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999976 68899999986543222  235678899999999999999999999999999999999999999


Q ss_pred             hhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccccc
Q 002321          775 HKHLHEGS-GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQ  853 (936)
Q Consensus       775 ~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  853 (936)
                      .+++.... ....+++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+|||++........  ......
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~  158 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYA  158 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cccccC
Confidence            98875422 223589999999999999999999999999999999999999999999999999976543221  123346


Q ss_pred             CcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHH--HHHH-HHH-----HHhhhccccceeecccc
Q 002321          854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWW--FSVT-WLE-----EHWKKAEWRNVSMRSCK  925 (936)
Q Consensus       854 ~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~--~~~~-~~~-----~~~~~~~~~~~~~~~l~  925 (936)
                      +++.|+|||.+. +..++.++||||+||++|||++|+.||...+....  .... ...     +...+...++++.+||.
T Consensus       159 g~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  237 (280)
T cd05608         159 GTPGFMAPELLQ-GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA  237 (280)
T ss_pred             CCcCccCHHHhc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence            788999999984 45788999999999999999999999986543111  1010 000     12234668899999999


Q ss_pred             cccccccccC
Q 002321          926 GSSRQRRRFQ  935 (936)
Q Consensus       926 ~~p~~Rp~f~  935 (936)
                      .||.+||+|+
T Consensus       238 ~~P~~R~~~~  247 (280)
T cd05608         238 KDPEKRLGFR  247 (280)
T ss_pred             CCHHHhcCCC
Confidence            9999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.3e-36  Score=328.04  Aligned_cols=232  Identities=26%  Similarity=0.381  Sum_probs=189.2

Q ss_pred             CcccccCceEEEEEEeC----CCcEEEEEEeeccCcc---chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          696 CELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLV---KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      +.||+|+||.||+++..    +++.||||+++.....   .....+.+|+.++++++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            57999999999999853    5789999999754322   2235678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++|+|.+++....   .+.+..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++......  ..
T Consensus        82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  156 (323)
T cd05584          82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TV  156 (323)
T ss_pred             CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--Cc
Confidence            99999999987644   37888888999999999999999999999999999999999999999999987532211  12


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceeeccc
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSMRSC  924 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l  924 (936)
                      .....|++.|+|||++. ...++.++||||+||++|||++|+.||...+.........    ..+...+..+++++.+||
T Consensus       157 ~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  235 (323)
T cd05584         157 THTFCGTIEYMAPEILM-RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLL  235 (323)
T ss_pred             ccccCCCccccChhhcc-CCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHc
Confidence            23356889999999984 4567899999999999999999999998766532221110    112233466789999999


Q ss_pred             ccccccccc
Q 002321          925 KGSSRQRRR  933 (936)
Q Consensus       925 ~~~p~~Rp~  933 (936)
                      ..||.+||.
T Consensus       236 ~~~p~~R~~  244 (323)
T cd05584         236 KRNPSSRLG  244 (323)
T ss_pred             ccCHhHcCC
Confidence            999999983

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.5e-35  Score=320.66  Aligned_cols=244  Identities=25%  Similarity=0.385  Sum_probs=198.9

Q ss_pred             cccCCCcccccCceEEEEEEeCC------CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRD------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      .|+..+.||+|+||.||+|....      ...||+|+++.........++.+|++++++++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   85 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM   85 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence            46778899999999999998653      257999998765444456778999999999999999999999998888999


Q ss_pred             EEEecCCCChhhhhhccCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEE
Q 002321          765 IYEFVSGGSLHKHLHEGSGG-------------NFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKV  831 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~-------------~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl  831 (936)
                      +|||+++|+|.+++......             ..+++.++..++.|++.|++|||+++++||||||+||++++++.+||
T Consensus        86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L  165 (283)
T cd05048          86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKI  165 (283)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEE
Confidence            99999999999999764221             34788999999999999999999999999999999999999999999


Q ss_pred             eeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH----
Q 002321          832 GDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW----  906 (936)
Q Consensus       832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~----  906 (936)
                      +|||+++.....+.........+++.|+|||.+. ...++.++||||+||++|||++ |..||...........-.    
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~  244 (283)
T cd05048         166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAIL-YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL  244 (283)
T ss_pred             CCCcceeeccccccccccCCCcccccccCHHHhc-cCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence            9999997654333333334445677899999884 4468999999999999999998 999998765432221110    


Q ss_pred             -HHHHhhhccccceeecccccccccccccC
Q 002321          907 -LEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       907 -~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                       ..+...++.+.+++.+||..||++||+++
T Consensus       245 ~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~  274 (283)
T cd05048         245 LPCPEDCPARVYALMIECWNEIPARRPRFK  274 (283)
T ss_pred             CCCcccCCHHHHHHHHHHccCChhhCcCHH
Confidence             11233457888999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-37  Score=294.08  Aligned_cols=245  Identities=23%  Similarity=0.319  Sum_probs=197.8

Q ss_pred             cccccCCCcccccCceEEEEEE-eCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC-----ee
Q 002321          689 HALLNKDCELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS-----LQ  762 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  762 (936)
                      ...|...+++|+|+|+.||.++ ..+++.||+|++.... .++.+..++|++..++++||||++++++...+.     ..
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            4567888999999999999998 4578999999997665 456788999999999999999999999875443     47


Q ss_pred             EEEEEecCCCChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          763 LLIYEFVSGGSLHKHLHEGSG-GNFLSWNERFNVIQGTAKSLAHLHQSN--IIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      |++++|+..|+|.+.+...+. +.++++.+.++|+.++++||++||+..  ++||||||.||++.+++.+++.|||.++.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence            999999999999999876543 447999999999999999999999987  99999999999999999999999999876


Q ss_pred             cCCCc-------cccccccccCcccccCccccc--CcccCCchhhHHHHHHHHHHHHcCCCCCCccch------hHHH--
Q 002321          840 LPMLD-------RYVLSSKIQSALGYMAPEFAC--RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM------MWWF--  902 (936)
Q Consensus       840 ~~~~~-------~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~------~~~~--  902 (936)
                      .+-.-       +.........|..|+|||.+.  .+...++++|||||||++|+|+.|..||+..-.      ..+.  
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~  258 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNA  258 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecc
Confidence            53210       011122345677899999872  233467899999999999999999999976422      1111  


Q ss_pred             HHHHHHHHhhhccccceeeccccccccccccc
Q 002321          903 SVTWLEEHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      ...+......++.+.+++..|+..||.+||+-
T Consensus       259 q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i  290 (302)
T KOG2345|consen  259 QISIPNSSRYSEALHQLIKSMLQVDPNQRPTI  290 (302)
T ss_pred             ccccCCCCCccHHHHHHHHHHhcCCcccCCCH
Confidence            12222234466788999999999999999973

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=315.26  Aligned_cols=241  Identities=23%  Similarity=0.316  Sum_probs=207.6

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc-hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ...|+.++.||+|.|+.|-.|++- +|++||||++.+...+. ....+.+|++.|+-++|||||++|++...+...|+|+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            356888899999999999999854 79999999997665543 3567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE-cCCCCeEEeeccCccccCCCcc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLI-DGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll-~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      |.-++|+|++|+.+...+  +.+..+.+++.||+.|+.|+|+..+||||+||+|+.+ .+-|-+|+.|||++..+.....
T Consensus        97 ELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k  174 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK  174 (864)
T ss_pred             EecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence            999999999999887654  8999999999999999999999999999999999876 6689999999999987654433


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHH----HHHHHHHhhhccccceee
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS----VTWLEEHWKKAEWRNVSM  921 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  921 (936)
                         -...+|+..|-|||++.+..+..+++||||+|||+|.+++|+.||+...+.+...    ..+.-|...+.+-+++|.
T Consensus       175 ---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~  251 (864)
T KOG4717|consen  175 ---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQ  251 (864)
T ss_pred             ---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHH
Confidence               2446788999999999888877899999999999999999999999877643332    233346667778899999


Q ss_pred             ccccccccccccc
Q 002321          922 RSCKGSSRQRRRF  934 (936)
Q Consensus       922 ~~l~~~p~~Rp~f  934 (936)
                      +|+..||.+|.+.
T Consensus       252 sMLvRdPkkRAsl  264 (864)
T KOG4717|consen  252 SMLVRDPKKRASL  264 (864)
T ss_pred             HHHhcCchhhccH
Confidence            9999999999864

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=305.82  Aligned_cols=238  Identities=24%  Similarity=0.403  Sum_probs=204.6

Q ss_pred             ccccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      .+.+|+...++|+|+||.||+|.++ +|+.||||.+.++.   +.+++..|+.++++++.++||++||.+......|+||
T Consensus        31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM  107 (502)
T KOG0574|consen   31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM  107 (502)
T ss_pred             hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence            4556788889999999999999977 59999999997663   4688999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      |||-.|+..+.++-..  +.+++.++..+++..++||+|||...-+|||||+.|||++.+|.+|++|||.|..+.  +..
T Consensus       108 EYCGAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--DTM  183 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT--DTM  183 (502)
T ss_pred             hhcCCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhh--hhH
Confidence            9999999999987644  349999999999999999999999999999999999999999999999999997553  333


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH-------HHHHHhhhccccce
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT-------WLEEHWKKAEWRNV  919 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~-------~~~~~~~~~~~~~~  919 (936)
                      .....+.|||.|||||++ ....|..++||||+|++..||.-|++||.+.+++..-.+.       +.+|+.-+.++-++
T Consensus       184 AKRNTVIGTPFWMAPEVI-~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DF  262 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVI-EEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDF  262 (502)
T ss_pred             HhhCccccCcccccHHHH-HHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHH
Confidence            445667899999999999 5667899999999999999999999999998875433221       12233334578899


Q ss_pred             eecccccccccccc
Q 002321          920 SMRSCKGSSRQRRR  933 (936)
Q Consensus       920 ~~~~l~~~p~~Rp~  933 (936)
                      +..|+.+.|.+|.+
T Consensus       263 i~~CLiK~PE~R~T  276 (502)
T KOG0574|consen  263 IRSCLIKKPEERKT  276 (502)
T ss_pred             HHHHhcCCHHHHHH
Confidence            99999999999864

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.5e-35  Score=318.92  Aligned_cols=244  Identities=23%  Similarity=0.341  Sum_probs=195.7

Q ss_pred             cccCCCcccccCceEEEEEEeC-----CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  765 (936)
                      .++..++||+|+||.||+|+..     ++..||+|.++..........+.+|++++++++||||+++++++......++|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   85 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML   85 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence            3566778999999999999852     46789999997544444457789999999999999999999999998899999


Q ss_pred             EEecCCCChhhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEE
Q 002321          766 YEFVSGGSLHKHLHEGSG--------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKV  831 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl  831 (936)
                      |||+++++|.+++.....              ...+++.+...++.|++.||+|||+++++||||||+||++++++.+||
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl  165 (283)
T cd05090          86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKI  165 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEe
Confidence            999999999999863321              124788899999999999999999999999999999999999999999


Q ss_pred             eeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHH-HHH---
Q 002321          832 GDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFS-VTW---  906 (936)
Q Consensus       832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~-~~~---  906 (936)
                      +|||+++...............++..|+|||.+. ...++.++||||+||++|||++ |..||.......... ...   
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  244 (283)
T cd05090         166 SDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM-YGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL  244 (283)
T ss_pred             ccccccccccCCcceecccCCCccceecChHHhc-cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence            9999998664333222233344567799999884 4468999999999999999998 999997755432211 110   


Q ss_pred             -HHHHhhhccccceeecccccccccccccC
Q 002321          907 -LEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       907 -~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                       ..+...+..+.+++.+||..||.+||+|+
T Consensus       245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~  274 (283)
T cd05090         245 LPCSEDCPPRMYSLMTECWQEGPSRRPRFK  274 (283)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCcCHH
Confidence             01122356788999999999999999974

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.8e-35  Score=325.36  Aligned_cols=200  Identities=24%  Similarity=0.387  Sum_probs=172.8

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..++||+|+||.||+|++. ++..+|+|++...........+.+|++++++++|+||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            45778889999999999999977 58889999886553333456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS-NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      +++|+|.+++.....   +++.....++.|++.|++|||+. +++||||||+||+++.++.+||+|||++......    
T Consensus        85 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----  157 (333)
T cd06650          85 MDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----  157 (333)
T ss_pred             CCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----
Confidence            999999999976443   78889999999999999999985 7999999999999999999999999998754321    


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccc
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWK  897 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~  897 (936)
                      ......++..|+|||.+ .+..++.++||||+||++|||++|+.||....
T Consensus       158 ~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~  206 (333)
T cd06650         158 MANSFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD  206 (333)
T ss_pred             ccccCCCCccccCHHHh-cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence            12334678899999988 45568999999999999999999999997654

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.5e-35  Score=319.61  Aligned_cols=239  Identities=20%  Similarity=0.228  Sum_probs=190.9

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      |+..+.||+|+||.||+|+.+ +++.||||+++..... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07848           3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV   82 (287)
T ss_pred             ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence            567788999999999999986 5789999999754332 23567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      +++.+..+....   ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus        83 ~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~  158 (287)
T cd07848          83 EKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANY  158 (287)
T ss_pred             CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-ccc
Confidence            987776554332   2388999999999999999999999999999999999999999999999999986543221 112


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HHHHH---------H-----------
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVTWL---------E-----------  908 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~~~---------~-----------  908 (936)
                      ....+++.|+|||++. +..++.++||||+||++|||++|+.||......... .....         +           
T Consensus       159 ~~~~~~~~y~aPE~~~-~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         159 TEYVATRWYRSPELLL-GAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             cccccccccCCcHHHc-CCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence            2346788999999884 446899999999999999999999999875432111 00000         0           


Q ss_pred             ---------------HHhhhccccceeecccccccccccccC
Q 002321          909 ---------------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 ---------------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                                     ....+..+.+++.+|+..||.+||+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~  279 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTE  279 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHH
Confidence                           001234578899999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=9.1e-36  Score=328.86  Aligned_cols=233  Identities=24%  Similarity=0.304  Sum_probs=188.0

Q ss_pred             CcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      +.||+|+||.||+|+.. +++.||||+++.....  ...+.+.+|..++.++ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36899999999999976 5889999999754322  2345688999999998 799999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      |+|.+++.+..   .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~  155 (329)
T cd05588          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTST  155 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Ccccc
Confidence            99999887643   38999999999999999999999999999999999999999999999999987432111  12234


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhH-------HHHHH-HHH-----HHhhhccccc
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMW-------WFSVT-WLE-----EHWKKAEWRN  918 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~-------~~~~~-~~~-----~~~~~~~~~~  918 (936)
                      ..|++.|+|||++. +..++.++||||+||++|||++|+.||+......       ..... ..+     +...+.++.+
T Consensus       156 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  234 (329)
T cd05588         156 FCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASS  234 (329)
T ss_pred             ccCCccccCHHHHc-CCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            56899999999984 4578999999999999999999999996422110       00000 001     1233455778


Q ss_pred             eeeccccccccccccc
Q 002321          919 VSMRSCKGSSRQRRRF  934 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f  934 (936)
                      ++.+||..||.+|++.
T Consensus       235 li~~~L~~dP~~R~~~  250 (329)
T cd05588         235 VLKGFLNKDPKERLGC  250 (329)
T ss_pred             HHHHHhccCHHHcCCC
Confidence            9999999999999974

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=8.5e-36  Score=328.82  Aligned_cols=231  Identities=24%  Similarity=0.322  Sum_probs=189.9

Q ss_pred             CcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCC
Q 002321          696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGG  772 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  772 (936)
                      +.||+|+||.||+++.. +|+.||+|+++.....  .....+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            36899999999999965 6899999999754322  23456788999999999999999999999999999999999999


Q ss_pred             ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccc
Q 002321          773 SLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ-SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       773 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      +|.+++....   .+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~  155 (325)
T cd05594          81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKT  155 (325)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--ccccc
Confidence            9999887644   38999999999999999999997 799999999999999999999999999987532211  11233


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH----HHhhhccccceeecccccc
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE----EHWKKAEWRNVSMRSCKGS  927 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~~  927 (936)
                      ..|++.|+|||++ .+..++.++||||+||++|||++|+.||...+...........    +...+.++++++.+||..|
T Consensus       156 ~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~d  234 (325)
T cd05594         156 FCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKD  234 (325)
T ss_pred             ccCCcccCCHHHH-ccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence            5688999999998 4557899999999999999999999999876654332221111    2224567889999999999


Q ss_pred             ccccc
Q 002321          928 SRQRR  932 (936)
Q Consensus       928 p~~Rp  932 (936)
                      |.+|+
T Consensus       235 P~~R~  239 (325)
T cd05594         235 PKQRL  239 (325)
T ss_pred             HHHhC
Confidence            99997

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.9e-35  Score=325.81  Aligned_cols=237  Identities=22%  Similarity=0.264  Sum_probs=191.6

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCC-CCcceeeeEEEeCCeeEEEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRH-PNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  767 (936)
                      |+..+.||+|+||.||+|+.. +++.||||+++....  ....+.+..|.+++..++| ++|+++++++.+.+..++|||
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME   81 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence            456678999999999999976 478999999965422  2335667889999999976 568889999998899999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+++|+|.+++.....   +++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......  .
T Consensus        82 ~~~~g~L~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~  156 (324)
T cd05587          82 YVNGGDLMYHIQQVGK---FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--K  156 (324)
T ss_pred             CCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC--C
Confidence            9999999999876543   8899999999999999999999999999999999999999999999999986432111  1


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceeecc
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSMRS  923 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  923 (936)
                      ......|++.|+|||++. +..++.++||||+||++|||++|+.||...+.........    ..+...+.++.+++.+|
T Consensus       157 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  235 (324)
T cd05587         157 TTRTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGL  235 (324)
T ss_pred             ceeeecCCccccChhhhc-CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            223456889999999984 4568999999999999999999999998766533221111    01223446677899999


Q ss_pred             ccccccccccc
Q 002321          924 CKGSSRQRRRF  934 (936)
Q Consensus       924 l~~~p~~Rp~f  934 (936)
                      |..||.+|++.
T Consensus       236 l~~~P~~R~~~  246 (324)
T cd05587         236 LTKHPAKRLGC  246 (324)
T ss_pred             hhcCHHHcCCC
Confidence            99999999864

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.5e-35  Score=312.76  Aligned_cols=239  Identities=28%  Similarity=0.372  Sum_probs=194.4

Q ss_pred             cccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      .|+..+.||+|+||.||+|+++++..+|+|.+....  ...+.+.+|++++++++||||+++++++......++||||++
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            356667899999999999999888899999886443  235678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                      +|+|.++++....  .+++..+..++.|++.||+|||+.+++||||||+||+++.++.+|++|||.++....... ....
T Consensus        83 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~~  159 (256)
T cd05114          83 NGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSS  159 (256)
T ss_pred             CCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-eccC
Confidence            9999999875432  388999999999999999999999999999999999999999999999999976533221 1122


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHH-HHHH----HHHHhhhccccceeeccc
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWF-SVTW----LEEHWKKAEWRNVSMRSC  924 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~l  924 (936)
                      ...++..|+|||.+ ....++.++||||+|+++|||++ |+.||...+..... ....    ..+...+..+.+++.+||
T Consensus       160 ~~~~~~~y~aPE~~-~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~  238 (256)
T cd05114         160 GAKFPVKWSPPEVF-NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCW  238 (256)
T ss_pred             CCCCchhhCChhhc-ccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence            23345679999988 44568899999999999999999 99999776542221 1110    012223456788999999


Q ss_pred             ccccccccccC
Q 002321          925 KGSSRQRRRFQ  935 (936)
Q Consensus       925 ~~~p~~Rp~f~  935 (936)
                      ..+|.+||+++
T Consensus       239 ~~~p~~Rps~~  249 (256)
T cd05114         239 HEKPEGRPTFA  249 (256)
T ss_pred             cCCcccCcCHH
Confidence            99999999974

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.8e-35  Score=340.29  Aligned_cols=242  Identities=19%  Similarity=0.210  Sum_probs=197.0

Q ss_pred             cccCCCcccccCceEEEEEEeC-C-CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-D-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      .|...+.||+|+||.||+|... + ++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            3677788999999999999865 3 5788888764432 23345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          769 VSGGSLHKHLHEGS-GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       769 ~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      +++|+|.++++... ....+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.........
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~  226 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD  226 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence            99999999886432 22348899999999999999999999999999999999999999999999999998764332222


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-----HHHhhhccccceeec
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-----EEHWKKAEWRNVSMR  922 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~  922 (936)
                      ......||+.|+|||++ ....++.++||||+||++|||++|+.||...+..........     .+...+..+++++.+
T Consensus       227 ~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  305 (478)
T PTZ00267        227 VASSFCGTPYYLAPELW-ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDP  305 (478)
T ss_pred             cccccCCCccccCHhHh-CCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHHH
Confidence            33455689999999988 455789999999999999999999999987655332211110     112234678999999


Q ss_pred             cccccccccccc
Q 002321          923 SCKGSSRQRRRF  934 (936)
Q Consensus       923 ~l~~~p~~Rp~f  934 (936)
                      ||..||.+||++
T Consensus       306 ~L~~dP~~Rps~  317 (478)
T PTZ00267        306 LLSKNPALRPTT  317 (478)
T ss_pred             HhccChhhCcCH
Confidence            999999999986

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2e-35  Score=325.63  Aligned_cols=237  Identities=22%  Similarity=0.273  Sum_probs=192.7

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      |+..+.||+|+||.||+|+.. +++.||||+++.....  ...+....|..++..+ +|++|+++++++.+.+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME   81 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence            456678999999999999976 4789999998754321  2234567788888877 58999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+++|+|.+++.....   +++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......  .
T Consensus        82 ~~~~g~L~~~~~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--~  156 (323)
T cd05616          82 YVNGGDLMYQIQQVGR---FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--V  156 (323)
T ss_pred             CCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC--C
Confidence            9999999998876443   8899999999999999999999999999999999999999999999999987542211  1


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceeecc
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSMRS  923 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  923 (936)
                      ......|++.|+|||++. ...++.++||||+||++|||++|+.||...+.........    ..+...+.++.+++.+|
T Consensus       157 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  235 (323)
T cd05616         157 TTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL  235 (323)
T ss_pred             ccccCCCChhhcCHHHhc-CCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHH
Confidence            223456889999999984 5578999999999999999999999998776543221111    11223456788899999


Q ss_pred             ccccccccccc
Q 002321          924 CKGSSRQRRRF  934 (936)
Q Consensus       924 l~~~p~~Rp~f  934 (936)
                      +..||.+|++.
T Consensus       236 l~~~p~~R~~~  246 (323)
T cd05616         236 MTKHPGKRLGC  246 (323)
T ss_pred             cccCHHhcCCC
Confidence            99999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2e-35  Score=327.08  Aligned_cols=238  Identities=26%  Similarity=0.346  Sum_probs=191.4

Q ss_pred             ccCCCcccccCceEEEEEEeC----CCcEEEEEEeeccCc---cchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSL---VKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  763 (936)
                      |+..++||+|+||.||+++..    +++.||+|+++....   ....+.+.+|+.+++++ +|++|+++++++......+
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            456678999999999998853    578999999865322   12345678899999999 5899999999999999999


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      +||||+++|+|.+++.....   +++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        82 lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~  158 (332)
T cd05614          82 LILDYVSGGEMFTHLYQRDN---FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence            99999999999999876443   889999999999999999999999999999999999999999999999999765322


Q ss_pred             ccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchh---HHHHHHHHH-----HHhhhcc
Q 002321          844 DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM---WWFSVTWLE-----EHWKKAE  915 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~---~~~~~~~~~-----~~~~~~~  915 (936)
                      .. .......|++.|+|||++.+...++.++||||+||++|||++|+.||......   .........     +...+..
T Consensus       159 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T cd05614         159 EK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPE  237 (332)
T ss_pred             CC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence            21 12234568999999999865556788999999999999999999999754321   111111111     1123456


Q ss_pred             ccceeecccccccccccc
Q 002321          916 WRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~  933 (936)
                      +++++.+||..||.+||+
T Consensus       238 ~~~li~~~l~~dp~~R~~  255 (332)
T cd05614         238 AQDLLHKLLRKDPKKRLG  255 (332)
T ss_pred             HHHHHHHHcCCCHHHcCC
Confidence            789999999999999994

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.4e-35  Score=330.15  Aligned_cols=235  Identities=24%  Similarity=0.321  Sum_probs=187.2

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      |+..+.||+|+||+||+|+.. +++.||||+++.....  .....+.+|+.++.+++|++|+++++++.+....++||||
T Consensus         3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~   82 (363)
T cd05628           3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF   82 (363)
T ss_pred             ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence            567788999999999999876 5889999999654321  2345688899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc--
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY--  846 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--  846 (936)
                      +++|+|.+++.+..   .+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++........  
T Consensus        83 ~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~  159 (363)
T cd05628          83 LPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF  159 (363)
T ss_pred             CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence            99999999997654   3899999999999999999999999999999999999999999999999998754321100  


Q ss_pred             -------------------------------cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCc
Q 002321          847 -------------------------------VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLST  895 (936)
Q Consensus       847 -------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~  895 (936)
                                                     .......||+.|+|||++. +..++.++||||+||++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc-CCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                                           0012346899999999984 45789999999999999999999999987


Q ss_pred             cchhHHHHHHH--------HHHHhhhccccceeecccccccccc
Q 002321          896 WKMMWWFSVTW--------LEEHWKKAEWRNVSMRSCKGSSRQR  931 (936)
Q Consensus       896 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~~p~~R  931 (936)
                      ...........        .+....++++++++.++|. +|.+|
T Consensus       239 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r  281 (363)
T cd05628         239 ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHR  281 (363)
T ss_pred             CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-Chhhc
Confidence            65533221111        0011234677888877553 45544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.8e-35  Score=318.04  Aligned_cols=244  Identities=24%  Similarity=0.358  Sum_probs=198.6

Q ss_pred             cccCCCcccccCceEEEEEEeCC------CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRD------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      .|...+.||+|+||.||+|+..+      ++.||||+++.....+..+.+.+|++++++++|+||+++++++......++
T Consensus         6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   85 (280)
T cd05049           6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIM   85 (280)
T ss_pred             HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEE
Confidence            35667889999999999998643      478999999765444456789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEee
Q 002321          765 IYEFVSGGSLHKHLHEGSG-----------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGD  833 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D  833 (936)
                      ||||+++++|.++++....           ...+++.++..++.|++.|++|||+++++||||||+||+++.++.+||+|
T Consensus        86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d  165 (280)
T cd05049          86 VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGD  165 (280)
T ss_pred             EEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECC
Confidence            9999999999999975431           23478899999999999999999999999999999999999999999999


Q ss_pred             ccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----H
Q 002321          834 YGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----L  907 (936)
Q Consensus       834 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~  907 (936)
                      ||+++...............+++.|+|||++. ...++.++||||+||++|||++ |+.||...+.........     .
T Consensus       166 ~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~  244 (280)
T cd05049         166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQ  244 (280)
T ss_pred             cccceecccCcceecCCCCcccceecChhhhc-cCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            99997654333222233444567899999884 4568999999999999999998 999997655432221111     1


Q ss_pred             HHHhhhccccceeecccccccccccccC
Q 002321          908 EEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       908 ~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+...+..+++++.+||..||.+||+++
T Consensus       245 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~  272 (280)
T cd05049         245 RPRTCPSEVYDIMLGCWKRDPQQRINIK  272 (280)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence            1223456789999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.8e-35  Score=340.08  Aligned_cols=245  Identities=20%  Similarity=0.280  Sum_probs=197.8

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCC-------
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS-------  760 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  760 (936)
                      ..|...+.||+|+||+||+|+.. +|+.||||++...... .....+.+|+.++..++|+|++++++.+....       
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            45677889999999999999865 6899999999765432 33467889999999999999999988765332       


Q ss_pred             -eeEEEEEecCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCcc
Q 002321          761 -LQLLIYEFVSGGSLHKHLHEGS-GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR  838 (936)
Q Consensus       761 -~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  838 (936)
                       ..++||||+++|+|.++++... ....+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~  191 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK  191 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence             3579999999999999987532 23458899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-----HHHhhh
Q 002321          839 LLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-----EEHWKK  913 (936)
Q Consensus       839 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-----~~~~~~  913 (936)
                      ...............|++.|+|||++. ...++.++||||+||++|||++|+.||...+..........     .+...+
T Consensus       192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~-~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  270 (496)
T PTZ00283        192 MYAATVSDDVGRTFCGTPYYVAPEIWR-RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSIS  270 (496)
T ss_pred             eccccccccccccccCCcceeCHHHhC-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Confidence            654322222234456899999999984 55789999999999999999999999987765433221110     122344


Q ss_pred             ccccceeecccccccccccccC
Q 002321          914 AEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       914 ~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++.+++.+||..||.+||+++
T Consensus       271 ~~l~~li~~~L~~dP~~RPs~~  292 (496)
T PTZ00283        271 PEMQEIVTALLSSDPKRRPSSS  292 (496)
T ss_pred             HHHHHHHHHHcccChhhCcCHH
Confidence            6788999999999999999863

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.4e-35  Score=313.28  Aligned_cols=237  Identities=23%  Similarity=0.318  Sum_probs=189.4

Q ss_pred             CcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCCCh
Q 002321          696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSL  774 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  774 (936)
                      ++||+|+||.||+|+.. +++.||+|.+......+....+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999975 68999999886543334457799999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccccccC
Q 002321          775 HKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQS  854 (936)
Q Consensus       775 ~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  854 (936)
                      .+++....  ..+++.++..++.|++.||+|||+++++||||||+||+++.++.+||+|||++.................
T Consensus        81 ~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          81 LTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence            99987543  2388999999999999999999999999999999999999999999999999875432111111111223


Q ss_pred             cccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHH-H----HHHHhhhccccceeeccccccc
Q 002321          855 ALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVT-W----LEEHWKKAEWRNVSMRSCKGSS  928 (936)
Q Consensus       855 ~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~l~~~p  928 (936)
                      +..|+|||.+. ...++.++||||+||++|||++ |..||............ .    ..+...+..+.+++.+||..+|
T Consensus       159 ~~~y~aPE~~~-~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  237 (252)
T cd05084         159 PVKWTAPEALN-YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP  237 (252)
T ss_pred             ceeecCchhhc-CCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence            45699999884 4468899999999999999998 99999765442211110 0    0112234567889999999999


Q ss_pred             ccccccC
Q 002321          929 RQRRRFQ  935 (936)
Q Consensus       929 ~~Rp~f~  935 (936)
                      .+||+++
T Consensus       238 ~~Rps~~  244 (252)
T cd05084         238 GQRPSFS  244 (252)
T ss_pred             hhCcCHH
Confidence            9999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5.5e-35  Score=313.66  Aligned_cols=239  Identities=26%  Similarity=0.319  Sum_probs=187.6

Q ss_pred             CcccccCceEEEEEEeCC---CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCC
Q 002321          696 CELGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGG  772 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  772 (936)
                      +.||+|+||.||+|++.+   +..+|+|+++..........+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            369999999999998653   46799999876544444567889999999999999999999999888899999999999


Q ss_pred             ChhhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          773 SLHKHLHEGSG--GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       773 ~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                      +|.++++....  ....++..+.+++.|++.|++|||+++++||||||+||+++.++.+|++|||.++............
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~  160 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD  160 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence            99999975432  1235677788899999999999999999999999999999999999999999997544333222233


Q ss_pred             cccCcccccCcccccCc------ccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHHH-------HH---hhh
Q 002321          851 KIQSALGYMAPEFACRT------VKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWLE-------EH---WKK  913 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~------~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~~-------~~---~~~  913 (936)
                      ...++..|+|||++...      ..++.++||||+||++|||++ |+.||...+...........       +.   ..+
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (269)
T cd05087         161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLS  240 (269)
T ss_pred             CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCC
Confidence            44567789999987422      135789999999999999996 99999876554332211111       11   123


Q ss_pred             ccccceeecccccccccccccC
Q 002321          914 AEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       914 ~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..+++++.+|| .+|.+||+++
T Consensus       241 ~~~~~l~~~c~-~~P~~Rpt~~  261 (269)
T cd05087         241 DRWYEVMQFCW-LQPEQRPSAE  261 (269)
T ss_pred             hHHHHHHHHHh-cCcccCCCHH
Confidence            55778888887 6899999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-36  Score=338.86  Aligned_cols=241  Identities=20%  Similarity=0.293  Sum_probs=200.5

Q ss_pred             cccCCCcccccCceEEEEEEeCCC-cEEEEEEeeccCccchHHHHHHHHHHHHcCC-CCCcceeeeE-EEe------CCe
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRDG-RPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGY-YWT------QSL  761 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~~~  761 (936)
                      .+++.+.|.+|+|+.||.|.+..+ .+||+|++-.. .......+.+|+.+|+.+. |+|||.+++. ...      ...
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            357788999999999999998865 99999999766 4456788999999999996 9999999993 321      135


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN--IIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      +++.||||+||.|.+++......+ +++.++++|+.|+++|+++||...  |+|||||.+|||++.+|..||||||.|..
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt  195 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT  195 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence            679999999999999998654333 999999999999999999999875  99999999999999999999999999854


Q ss_pred             cCCCc-c------ccccccccCcccccCcccc--cCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHHH
Q 002321          840 LPMLD-R------YVLSSKIQSALGYMAPEFA--CRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEH  910 (936)
Q Consensus       840 ~~~~~-~------~~~~~~~~~~~~y~aPE~~--~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~  910 (936)
                      .-... .      .........|+.|+|||++  .++...++|+|||||||++|-|+....||++.....+..+.+..|.
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~~P~  275 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYSFPP  275 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccccCCC
Confidence            32111 1      0111224468899999976  3556789999999999999999999999999977777766666665


Q ss_pred             h--hhccccceeecccccccccccc
Q 002321          911 W--KKAEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       911 ~--~~~~~~~~~~~~l~~~p~~Rp~  933 (936)
                      +  ....++++|..||+.||.+||+
T Consensus       276 ~p~ys~~l~~LI~~mL~~nP~~RPn  300 (738)
T KOG1989|consen  276 FPNYSDRLKDLIRTMLQPNPDERPN  300 (738)
T ss_pred             CccHHHHHHHHHHHHhccCcccCCC
Confidence            4  6689999999999999999996

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.1e-35  Score=323.09  Aligned_cols=233  Identities=24%  Similarity=0.332  Sum_probs=191.1

Q ss_pred             CcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      +.||+|+||+||+|+.+ +++.||||+++....  ......+.+|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999976 478999999975432  22345677899999888 799999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      |+|.+++.+...   +++.++..++.|++.||+|||+.+|+||||||+||++++++.+||+|||+++......  .....
T Consensus        81 ~~L~~~~~~~~~---l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~  155 (318)
T cd05570          81 GDLMFHIQRSGR---FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTST  155 (318)
T ss_pred             CCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccccc
Confidence            999998876543   8999999999999999999999999999999999999999999999999986432111  11223


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceeecccccc
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSMRSCKGS  927 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~~  927 (936)
                      ..+++.|+|||++. +..++.++||||+||++|||++|+.||...+.........    ..+...+..+.+++.+||..|
T Consensus       156 ~~g~~~y~aPE~~~-~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~d  234 (318)
T cd05570         156 FCGTPDYIAPEILS-YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKN  234 (318)
T ss_pred             eecCccccCHHHhc-CCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCC
Confidence            45788999999984 4578999999999999999999999998766543322111    112234567889999999999


Q ss_pred             ccccccc
Q 002321          928 SRQRRRF  934 (936)
Q Consensus       928 p~~Rp~f  934 (936)
                      |.+||+.
T Consensus       235 P~~R~s~  241 (318)
T cd05570         235 PEKRLGC  241 (318)
T ss_pred             HHHcCCC
Confidence            9999985

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.9e-36  Score=328.14  Aligned_cols=232  Identities=26%  Similarity=0.353  Sum_probs=191.3

Q ss_pred             CcccccCceEEEEEEe----CCCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          696 CELGRGGFGAVYRTVL----RDGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      +.||+|+||.||+++.    .+|+.||+|+++..... .....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            4699999999999875    25789999999754322 234567789999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                      +|+|.+++.+..   .+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~  156 (318)
T cd05582          82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAY  156 (318)
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Ccee
Confidence            999999987643   38999999999999999999999999999999999999999999999999987643221  1223


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceeeccccc
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSMRSCKG  926 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~  926 (936)
                      ...|++.|+|||.+. ...++.++||||+||++|||++|+.||...+.........    ..+...+..+++++.+||..
T Consensus       157 ~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~  235 (318)
T cd05582         157 SFCGTVEYMAPEVVN-RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKR  235 (318)
T ss_pred             cccCChhhcCHHHHc-CCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhc
Confidence            456889999999884 4567899999999999999999999998766532221111    01223456788999999999


Q ss_pred             ccccccc
Q 002321          927 SSRQRRR  933 (936)
Q Consensus       927 ~p~~Rp~  933 (936)
                      ||.+||+
T Consensus       236 ~P~~R~~  242 (318)
T cd05582         236 NPANRLG  242 (318)
T ss_pred             CHhHcCC
Confidence            9999997

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-35  Score=319.24  Aligned_cols=238  Identities=25%  Similarity=0.316  Sum_probs=192.8

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      |+..+.||+|+||+||++... +++.||||++......  .....+.+|++++++++|+||+++++++..++..++||||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            456678999999999999975 5899999998654322  1234577899999999999999999999998999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++|+|.+++..... ..+++..+..++.|++.|++|||+.+++||||||+||++++++.++|+|||+++......   .
T Consensus        82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~  157 (285)
T cd05605          82 MNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---T  157 (285)
T ss_pred             cCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC---c
Confidence            999999988865432 348999999999999999999999999999999999999999999999999998654222   1


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HH-HHHH------HHhhhcccccee
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SV-TWLE------EHWKKAEWRNVS  920 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~-~~~~------~~~~~~~~~~~~  920 (936)
                      .....+++.|+|||.+. ...++.++||||+||++|||++|+.||...+..... .. ....      +...+..+++++
T Consensus       158 ~~~~~~~~~y~aPE~~~-~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05605         158 IRGRVGTVGYMAPEVVK-NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC  236 (285)
T ss_pred             cccccCCCCccCcHHhc-CCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence            12346788999999984 456899999999999999999999999876542111 11 1011      112346678899


Q ss_pred             eccccccccccccc
Q 002321          921 MRSCKGSSRQRRRF  934 (936)
Q Consensus       921 ~~~l~~~p~~Rp~f  934 (936)
                      .+||..||.+||++
T Consensus       237 ~~~l~~~P~~R~~~  250 (285)
T cd05605         237 RQLLTKDPGFRLGC  250 (285)
T ss_pred             HHHccCCHHHhcCC
Confidence            99999999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.8e-35  Score=324.77  Aligned_cols=233  Identities=23%  Similarity=0.303  Sum_probs=187.2

Q ss_pred             CcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      +.||+|+||.||+|+.. +++.||+|+++....  ....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36999999999999976 578999999975432  22345678899998877 899999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      |+|..++.....   +++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~~L~~~~~~~~~---l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~  155 (329)
T cd05618          81 GDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTST  155 (329)
T ss_pred             CCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Ccccc
Confidence            999988876443   8999999999999999999999999999999999999999999999999987532211  12234


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch---------hHHHHHHH----HHHHhhhccccc
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM---------MWWFSVTW----LEEHWKKAEWRN  918 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~---------~~~~~~~~----~~~~~~~~~~~~  918 (936)
                      ..|++.|+|||++. +..++.++||||+||++|||++|+.||.....         ........    ..+...+..+++
T Consensus       156 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  234 (329)
T cd05618         156 FCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS  234 (329)
T ss_pred             ccCCccccCHHHHc-CCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence            56889999999984 55789999999999999999999999963211         00110000    012223456678


Q ss_pred             eeeccccccccccccc
Q 002321          919 VSMRSCKGSSRQRRRF  934 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f  934 (936)
                      ++.+||..||.+||+.
T Consensus       235 ll~~~L~~dP~~R~~~  250 (329)
T cd05618         235 VLKSFLNKDPKERLGC  250 (329)
T ss_pred             HHHHHhcCCHHHcCCC
Confidence            9999999999999974

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.2e-35  Score=325.18  Aligned_cols=233  Identities=23%  Similarity=0.302  Sum_probs=187.6

Q ss_pred             CcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHH-HHHcCCCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVK-KLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      +.||+|+||+||+|+.. +|+.||||++......  .....+.+|.. +++.++||||+++++++.+....++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999976 6899999999654321  22344555554 56789999999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      |+|.+++....   .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~  155 (323)
T cd05575          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTST  155 (323)
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Ccccc
Confidence            99999987644   38899999999999999999999999999999999999999999999999987532211  12234


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH----HHhhhccccceeecccccc
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE----EHWKKAEWRNVSMRSCKGS  927 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~~  927 (936)
                      ..|++.|+|||++. +..++.++||||+||++|||++|+.||...+...........    +...++.+.+++.+|+..|
T Consensus       156 ~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~  234 (323)
T cd05575         156 FCGTPEYLAPEVLR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKD  234 (323)
T ss_pred             ccCChhhcChhhhc-CCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence            56889999999884 557899999999999999999999999876653322111111    1123567889999999999


Q ss_pred             ccccccc
Q 002321          928 SRQRRRF  934 (936)
Q Consensus       928 p~~Rp~f  934 (936)
                      |.+||+-
T Consensus       235 p~~R~~~  241 (323)
T cd05575         235 RTKRLGA  241 (323)
T ss_pred             HHhCCCC
Confidence            9999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-36  Score=334.47  Aligned_cols=237  Identities=25%  Similarity=0.382  Sum_probs=191.5

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      |+..+.||+|+||+||+|+.. +++.||||+++.....  .....+.+|+.+++.++||||+++++++.++...++||||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (364)
T cd05599           3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY   82 (364)
T ss_pred             ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence            566788999999999999976 5899999999754321  2345678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc--
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY--  846 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--  846 (936)
                      +++|+|.+++....   .+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.+......  
T Consensus        83 ~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          83 LPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             CCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence            99999999997644   3899999999999999999999999999999999999999999999999998754321100  


Q ss_pred             ----------------------------------cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCC
Q 002321          847 ----------------------------------VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP  892 (936)
Q Consensus       847 ----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~P  892 (936)
                                                        .......||+.|+|||++. ...++.++||||+||++|||++|..|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~G~~P  238 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVIMYEMLVGYPP  238 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc-CCCCCCeeeeecchhHHHHhhcCCCC
Confidence                                              0011245899999999884 55689999999999999999999999


Q ss_pred             CCccchhHHHHH--HHHH------HHhhhccccceeecccccccccccc
Q 002321          893 LSTWKMMWWFSV--TWLE------EHWKKAEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       893 f~~~~~~~~~~~--~~~~------~~~~~~~~~~~~~~~l~~~p~~Rp~  933 (936)
                      |...+.......  .+.+      ....++..++++.+|+. +|.+|++
T Consensus       239 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~  286 (364)
T cd05599         239 FCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLG  286 (364)
T ss_pred             CCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCC
Confidence            987765332211  1100      01124567888888885 9999987

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-35  Score=313.84  Aligned_cols=242  Identities=26%  Similarity=0.377  Sum_probs=197.3

Q ss_pred             cccCCCcccccCceEEEEEEeCC----CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      .|+..+.||+|+||.||+|++..    ...||||+++.........++.+|+.++++++|+||+++++++...+..++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   84 (266)
T cd05033           5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT   84 (266)
T ss_pred             HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence            46778899999999999999752    45899999876554455678899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++++|.+++.....  .+++.++.+++.|++.|++|||+++|+||||||+||++++++.++++|||+++........
T Consensus        85 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd05033          85 EYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT  162 (266)
T ss_pred             EcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence            99999999999976442  4899999999999999999999999999999999999999999999999999876422222


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHH-HH----HHHHhhhcccccee
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSV-TW----LEEHWKKAEWRNVS  920 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~-~~----~~~~~~~~~~~~~~  920 (936)
                      .......++..|+|||.. ....++.++||||+|+++|||++ |..||........... ..    ..+...+..+.+++
T Consensus       163 ~~~~~~~~~~~y~~Pe~~-~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  241 (266)
T cd05033         163 YTTKGGKIPIRWTAPEAI-AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLM  241 (266)
T ss_pred             eeccCCCCCccccChhhh-ccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            222233446689999988 44568999999999999999998 9999976654322211 10    11122346788999


Q ss_pred             ecccccccccccccC
Q 002321          921 MRSCKGSSRQRRRFQ  935 (936)
Q Consensus       921 ~~~l~~~p~~Rp~f~  935 (936)
                      .+||..+|.+||+++
T Consensus       242 ~~cl~~~p~~Rp~~~  256 (266)
T cd05033         242 LDCWQKDRNERPTFS  256 (266)
T ss_pred             HHHcCCCcccCcCHH
Confidence            999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=322.20  Aligned_cols=237  Identities=26%  Similarity=0.396  Sum_probs=201.9

Q ss_pred             cccccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCccc--hHHHHHHHHHHHHcCC-CCCcceeeeEEEeCCeeEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVK--SQEDFEREVKKLGKVR-HPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  764 (936)
                      ...|+..++||+|.||.||+++.+. |+.+|+|++.......  ..+.+.+|+++|+++. |||||.+++++++....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            4457777899999999999999875 9999999997665432  3478999999999998 9999999999999999999


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC----CCeEEeeccCcccc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS----GEPKVGDYGLARLL  840 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~~~  840 (936)
                      |||+++||.|.+.+...   . +++..+..+++|++.|++|||+.||+|||+||+|+|+...    +.+|++|||++...
T Consensus       114 vmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            99999999999999876   2 8999999999999999999999999999999999999643    47999999999987


Q ss_pred             CCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHH----H--HHHHHHh--h
Q 002321          841 PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS----V--TWLEEHW--K  912 (936)
Q Consensus       841 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~----~--~~~~~~~--~  912 (936)
                      ..   .......+||+.|+|||++ ....|+..+||||+||++|.|++|..||..........    .  .+..+.|  .
T Consensus       190 ~~---~~~~~~~~Gtp~y~APEvl-~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~i  265 (382)
T KOG0032|consen  190 KP---GERLHTIVGTPEYVAPEVL-GGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDI  265 (382)
T ss_pred             cC---CceEeeecCCccccCchhh-cCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcccc
Confidence            54   3344668899999999999 55689999999999999999999999999887533331    1  1122333  2


Q ss_pred             hccccceeecccccccccccc
Q 002321          913 KAEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       913 ~~~~~~~~~~~l~~~p~~Rp~  933 (936)
                      +..+++++.+++..||.+|++
T Consensus       266 s~~akd~i~~ll~~dp~~R~t  286 (382)
T KOG0032|consen  266 SESAKDFIRKLLEFDPRKRLT  286 (382)
T ss_pred             CHHHHHHHHHhcccCcccCCC
Confidence            367888899999999988876

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=6.3e-35  Score=314.67  Aligned_cols=245  Identities=21%  Similarity=0.281  Sum_probs=195.2

Q ss_pred             ccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  763 (936)
                      ..|+..++||+|+||.||+|.+.      ++..||||++..........++.+|+.+++.++|+||+++++++.+....+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~   85 (277)
T cd05062           6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   85 (277)
T ss_pred             HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence            44677889999999999998753      256799999865443344567889999999999999999999999888999


Q ss_pred             EEEEecCCCChhhhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccC
Q 002321          764 LIYEFVSGGSLHKHLHEGSG-------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGL  836 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  836 (936)
                      +||||+++|+|.++++....       ....++..+..++.|++.|++|||+.+++||||||+||++++++.++++|||+
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~  165 (277)
T cd05062          86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM  165 (277)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCC
Confidence            99999999999999875322       12367888999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH-----HHH
Q 002321          837 ARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL-----EEH  910 (936)
Q Consensus       837 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~-----~~~  910 (936)
                      ++...............+++.|+|||.+. ...++.++|||||||++|||++ |..||..............     .+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (277)
T cd05062         166 TRDIYETDYYRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPD  244 (277)
T ss_pred             ccccCCcceeecCCCCccCHhhcChhHhh-cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence            97654433322222334567899999884 4568999999999999999999 7899977654322211110     012


Q ss_pred             hhhccccceeecccccccccccccC
Q 002321          911 WKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       911 ~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..+..+.+++.+||..||.+||+++
T Consensus       245 ~~~~~~~~li~~~l~~~p~~Rps~~  269 (277)
T cd05062         245 NCPDMLFELMRMCWQYNPKMRPSFL  269 (277)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHH
Confidence            2335678899999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.9e-35  Score=331.68  Aligned_cols=239  Identities=21%  Similarity=0.266  Sum_probs=187.6

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      |+..+.||+|+||+||+|+.. +++.||||++......  ...+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~   82 (381)
T cd05626           3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (381)
T ss_pred             ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence            566788999999999999876 5889999999654322  2346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc---
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR---  845 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---  845 (936)
                      +++|+|.+++.+...   +++..+..++.|++.||+|||+.||+||||||+|||++.++++||+|||+++.......   
T Consensus        83 ~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~  159 (381)
T cd05626          83 IPGGDMMSLLIRMEV---FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY  159 (381)
T ss_pred             CCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence            999999999876543   88888999999999999999999999999999999999999999999999754311000   


Q ss_pred             ------------------------------------------ccccccccCcccccCcccccCcccCCchhhHHHHHHHH
Q 002321          846 ------------------------------------------YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLV  883 (936)
Q Consensus       846 ------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l  883 (936)
                                                                ........||+.|+|||++. ...++.++||||+||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DiwSlG~il  238 (381)
T cd05626         160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVIL  238 (381)
T ss_pred             ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc-CCCCCCccceeehhhHH
Confidence                                                      00012346899999999984 45689999999999999


Q ss_pred             HHHHcCCCCCCccchhHHHHH--HHHH----HH--hhhccccceeeccc--cccccccccc
Q 002321          884 LEVVTGKRPLSTWKMMWWFSV--TWLE----EH--WKKAEWRNVSMRSC--KGSSRQRRRF  934 (936)
Q Consensus       884 ~el~~g~~Pf~~~~~~~~~~~--~~~~----~~--~~~~~~~~~~~~~l--~~~p~~Rp~f  934 (936)
                      |||++|+.||...+.......  .+..    +.  ..+.+..+++.++|  ..+|.+|++.
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~  299 (381)
T cd05626         239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA  299 (381)
T ss_pred             HHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence            999999999987665322211  1110    11  13456778887744  3444446653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.2e-35  Score=333.07  Aligned_cols=237  Identities=20%  Similarity=0.276  Sum_probs=188.6

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      |+..++||+|+||+||+|+.. +++.||||++.....  ......+.+|+.++++++|+||+++++++.+....++||||
T Consensus         3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~   82 (382)
T cd05625           3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY   82 (382)
T ss_pred             cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence            567788999999999999976 588999999865432  12346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc---
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR---  845 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---  845 (936)
                      +++|+|.+++.+..   .+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.......   
T Consensus        83 ~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~  159 (382)
T cd05625          83 IPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (382)
T ss_pred             CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence            99999999987643   378888999999999999999999999999999999999999999999999753210000   


Q ss_pred             ------------------------------------------ccccccccCcccccCcccccCcccCCchhhHHHHHHHH
Q 002321          846 ------------------------------------------YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLV  883 (936)
Q Consensus       846 ------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l  883 (936)
                                                                ........||+.|+|||++. +..++.++||||+||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DiwSlGvil  238 (382)
T cd05625         160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVIL  238 (382)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc-CCCCCCeeeEEechHHH
Confidence                                                      00012246889999999884 55789999999999999


Q ss_pred             HHHHcCCCCCCccchhHHHHHHH--H----HH--Hhhhccccceeecccccccccccc
Q 002321          884 LEVVTGKRPLSTWKMMWWFSVTW--L----EE--HWKKAEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       884 ~el~~g~~Pf~~~~~~~~~~~~~--~----~~--~~~~~~~~~~~~~~l~~~p~~Rp~  933 (936)
                      |||++|+.||...+.........  .    .+  ...+.+..+++.++|. +|.+|++
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~  295 (382)
T cd05625         239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLG  295 (382)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHcc-CHhHcCC
Confidence            99999999998765532221110  0    01  1234566777878764 9999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3e-35  Score=324.00  Aligned_cols=233  Identities=23%  Similarity=0.309  Sum_probs=186.7

Q ss_pred             CcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHH-HHHcCCCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVK-KLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      +.||+|+||.||+|+.. +++.||+|++......  .....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999976 5889999998654322  22344555554 57889999999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      |+|..++....   .+++.++..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~  155 (321)
T cd05603          81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTST  155 (321)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Ccccc
Confidence            99998887543   37888899999999999999999999999999999999999999999999987532211  12234


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH----HHhhhccccceeecccccc
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE----EHWKKAEWRNVSMRSCKGS  927 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~~  927 (936)
                      ..+++.|+|||.+. ...++.++||||+||++|||++|+.||...+...........    +......+.+++.+|+..|
T Consensus       156 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~  234 (321)
T cd05603         156 FCGTPEYLAPEVLR-KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKD  234 (321)
T ss_pred             ccCCcccCCHHHhc-CCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCC
Confidence            56889999999884 556899999999999999999999999887653332211111    1123345778999999999


Q ss_pred             ccccccc
Q 002321          928 SRQRRRF  934 (936)
Q Consensus       928 p~~Rp~f  934 (936)
                      |.+|++.
T Consensus       235 p~~R~~~  241 (321)
T cd05603         235 QRRRLGA  241 (321)
T ss_pred             HhhcCCC
Confidence            9999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6.4e-36  Score=330.82  Aligned_cols=240  Identities=22%  Similarity=0.297  Sum_probs=194.7

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      |+..+.||+|+||+||+|+.. +|+.||||+++....  ....+.+.+|+.+++.++|+||+++++++.+....++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (330)
T cd05601           3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY   82 (330)
T ss_pred             ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence            566778999999999999976 589999999975432  22346688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++|+|.+++.+..  ..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++......... .
T Consensus        83 ~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~  159 (330)
T cd05601          83 QPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-N  159 (330)
T ss_pred             CCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-e
Confidence            99999999997652  23899999999999999999999999999999999999999999999999999866432221 2


Q ss_pred             cccccCcccccCcccccC-----cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH--------HHHhhhcc
Q 002321          849 SSKIQSALGYMAPEFACR-----TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL--------EEHWKKAE  915 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~--------~~~~~~~~  915 (936)
                      .....+++.|+|||++..     ...++.++||||+||++|||++|+.||..............        .....+..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD  239 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence            233468899999998742     34578899999999999999999999987655332211100        01123456


Q ss_pred             ccceeecccccccccccccC
Q 002321          916 WRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +.+++.+|+. +|.+||+++
T Consensus       240 ~~~li~~ll~-~p~~R~t~~  258 (330)
T cd05601         240 FLDLIQSLLC-GQKERLGYE  258 (330)
T ss_pred             HHHHHHHHcc-ChhhCCCHH
Confidence            7888888887 999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.3e-35  Score=324.74  Aligned_cols=237  Identities=22%  Similarity=0.271  Sum_probs=191.6

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCC-CCCcceeeeEEEeCCeeEEEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      |+..+.||+|+||+||+|+.+ +|+.||||+++....  ....+.+..|.++++.+. |++|+++++++.+.+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            355678999999999999976 588999999875422  223456778999998885 5778889999999899999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+++|+|.+++.....   +++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......  .
T Consensus        82 y~~~g~L~~~i~~~~~---l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~--~  156 (323)
T cd05615          82 YVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--V  156 (323)
T ss_pred             CCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC--c
Confidence            9999999999876543   8999999999999999999999999999999999999999999999999987542211  1


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceeecc
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSMRS  923 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  923 (936)
                      ......|++.|+|||++. ...++.++||||+||++|||++|+.||.............    ..+...+.+..+++.+|
T Consensus       157 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  235 (323)
T cd05615         157 TTRTFCGTPDYIAPEIIA-YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGL  235 (323)
T ss_pred             cccCccCCccccCHHHHc-CCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence            223456889999999884 5578999999999999999999999998876532221111    11223446678899999


Q ss_pred             ccccccccccc
Q 002321          924 CKGSSRQRRRF  934 (936)
Q Consensus       924 l~~~p~~Rp~f  934 (936)
                      |..+|.+|++.
T Consensus       236 l~~~p~~R~~~  246 (323)
T cd05615         236 MTKHPSKRLGC  246 (323)
T ss_pred             cccCHhhCCCC
Confidence            99999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.3e-35  Score=323.23  Aligned_cols=233  Identities=21%  Similarity=0.281  Sum_probs=186.0

Q ss_pred             CcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHH-HHHHcCCCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREV-KKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      +.||+|+||.||+|+.. +++.||+|++......  .....+.+|. .+++.++|+||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999976 5788999998654321  1223444444 456788999999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      |+|.+++.....   +.+..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~~L~~~~~~~~~---~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~~  155 (325)
T cd05602          81 GELFYHLQRERC---FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTST  155 (325)
T ss_pred             CcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCccc
Confidence            999999876443   7788888899999999999999999999999999999999999999999987532211  12234


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH----HHhhhccccceeecccccc
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE----EHWKKAEWRNVSMRSCKGS  927 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~~  927 (936)
                      ..|++.|+|||++. +..++.++||||+||++|||++|+.||...+...........    +.-.+..+++++.+|+..|
T Consensus       156 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~  234 (325)
T cd05602         156 FCGTPEYLAPEVLH-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKD  234 (325)
T ss_pred             ccCCccccCHHHHc-CCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccC
Confidence            56899999999884 557899999999999999999999999876654322111111    1123466788999999999


Q ss_pred             ccccccc
Q 002321          928 SRQRRRF  934 (936)
Q Consensus       928 p~~Rp~f  934 (936)
                      |.+|++.
T Consensus       235 p~~R~~~  241 (325)
T cd05602         235 RTKRLGA  241 (325)
T ss_pred             HHHCCCC
Confidence            9999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.2e-35  Score=324.23  Aligned_cols=234  Identities=22%  Similarity=0.296  Sum_probs=187.6

Q ss_pred             CcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHH-HHHcCCCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVK-KLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      +.||+|+||+||+|+.. +|+.||||++......  .....+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            36999999999999976 6899999998654221  22345555655 46778999999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      |+|..++....   .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.....  ......
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~  155 (325)
T cd05604          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTTT  155 (325)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCccc
Confidence            99998887644   3899999999999999999999999999999999999999999999999998753211  112234


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH----HHhhhccccceeecccccc
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE----EHWKKAEWRNVSMRSCKGS  927 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~~  927 (936)
                      ..|++.|+|||++. +..++.++||||+||++|||++|+.||...+...........    ....+..+.+++.+|+..+
T Consensus       156 ~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~  234 (325)
T cd05604         156 FCGTPEYLAPEVIR-KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKD  234 (325)
T ss_pred             ccCChhhCCHHHHc-CCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccC
Confidence            56889999999984 456889999999999999999999999877654332211111    1123355678899999999


Q ss_pred             cccccccC
Q 002321          928 SRQRRRFQ  935 (936)
Q Consensus       928 p~~Rp~f~  935 (936)
                      |.+||+.+
T Consensus       235 p~~R~~~~  242 (325)
T cd05604         235 RQRRLGAK  242 (325)
T ss_pred             HHhcCCCC
Confidence            99999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.4e-35  Score=322.36  Aligned_cols=234  Identities=23%  Similarity=0.312  Sum_probs=188.9

Q ss_pred             CcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      +.||+|+||+||+|+.. +++.||||+++.....  ...+.+.+|+.++.++ +||+|+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999976 5789999999754322  2345688999999988 699999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      |+|.+++.....   +++..+..++.|++.|++|||++||+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~~L~~~~~~~~~---l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  155 (327)
T cd05617          81 GDLMFHMQRQRK---LPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTST  155 (327)
T ss_pred             CcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cceec
Confidence            999998876433   8999999999999999999999999999999999999999999999999987532211  12234


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch-------hHHHHHHHH----HHHhhhcccccee
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM-------MWWFSVTWL----EEHWKKAEWRNVS  920 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~-------~~~~~~~~~----~~~~~~~~~~~~~  920 (936)
                      ..|++.|+|||++. +..++.++||||+||++|||++|+.||.....       .........    .+...+....+++
T Consensus       156 ~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li  234 (327)
T cd05617         156 FCGTPNYIAPEILR-GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVL  234 (327)
T ss_pred             ccCCcccCCHHHHC-CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            56899999999984 55789999999999999999999999964321       111111110    1122345678899


Q ss_pred             ecccccccccccccC
Q 002321          921 MRSCKGSSRQRRRFQ  935 (936)
Q Consensus       921 ~~~l~~~p~~Rp~f~  935 (936)
                      .+||..||.+|++.+
T Consensus       235 ~~~L~~dP~~R~~~~  249 (327)
T cd05617         235 KGFLNKDPKERLGCQ  249 (327)
T ss_pred             HHHhccCHHHcCCCC
Confidence            999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=331.64  Aligned_cols=237  Identities=23%  Similarity=0.307  Sum_probs=195.0

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      |+..+.||+|+||+||+|+.. +++.||||+++.....  .....+.+|++++..++|+||+++++++.+....++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (350)
T cd05573           3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY   82 (350)
T ss_pred             ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence            566778999999999999976 6899999999754322  3356788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc----
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD----  844 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~----  844 (936)
                      +++++|.+++.+..   .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......    
T Consensus        83 ~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          83 MPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence            99999999998753   38999999999999999999999999999999999999999999999999997654322    


Q ss_pred             -----------------------cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHH
Q 002321          845 -----------------------RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWW  901 (936)
Q Consensus       845 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~  901 (936)
                                             .........|++.|+|||++. ...++.++||||+||++|||++|+.||...+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~  238 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR-GTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET  238 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHc-CCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence                                   011223456889999999984 44789999999999999999999999988764322


Q ss_pred             HHHHH------HHHHh--hhccccceeecccccccccccc
Q 002321          902 FSVTW------LEEHW--KKAEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       902 ~~~~~------~~~~~--~~~~~~~~~~~~l~~~p~~Rp~  933 (936)
                      .....      ..+..  .++.+.+++.+|+. ||.+||+
T Consensus       239 ~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~  277 (350)
T cd05573         239 YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLG  277 (350)
T ss_pred             HHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCC
Confidence            21111      01111  25677889999997 9999998

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-35  Score=331.89  Aligned_cols=236  Identities=22%  Similarity=0.334  Sum_probs=188.1

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      |+..++||+|+||+||+|+.. +++.||||++.....  ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus         3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~   82 (377)
T cd05629           3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF   82 (377)
T ss_pred             ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence            566788999999999999875 689999999865432  12346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc--
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY--  846 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--  846 (936)
                      +++|+|.+++....   .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.+......  
T Consensus        83 ~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          83 LPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            99999999987643   3888899999999999999999999999999999999999999999999999643210000  


Q ss_pred             -------------------------------------------cccccccCcccccCcccccCcccCCchhhHHHHHHHH
Q 002321          847 -------------------------------------------VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLV  883 (936)
Q Consensus       847 -------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l  883 (936)
                                                                 .......||+.|+|||++. ...++.++||||+||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil  238 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL-QQGYGQECDWWSLGAIM  238 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc-cCCCCCceeeEecchhh
Confidence                                                       0001245899999999884 55789999999999999


Q ss_pred             HHHHcCCCCCCccchhHHHHH--HHHH----HH--hhhccccceeeccccccccccc
Q 002321          884 LEVVTGKRPLSTWKMMWWFSV--TWLE----EH--WKKAEWRNVSMRSCKGSSRQRR  932 (936)
Q Consensus       884 ~el~~g~~Pf~~~~~~~~~~~--~~~~----~~--~~~~~~~~~~~~~l~~~p~~Rp  932 (936)
                      |||++|+.||...........  .+..    +.  ..+.+.++++.+|+. +|.+|+
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~  294 (377)
T cd05629         239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRL  294 (377)
T ss_pred             hhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcC
Confidence            999999999987665332211  1100    11  123567788889887 888774

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.2e-35  Score=316.45  Aligned_cols=243  Identities=24%  Similarity=0.318  Sum_probs=194.1

Q ss_pred             ccCCCcccccCceEEEEEEeCC------CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLRD------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  765 (936)
                      |+..++||+|+||.||+|+..+      +..||||+++........+.+.+|+.++++++||||+++++++......+++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            5667789999999999998642      4789999997554333356788999999999999999999999998899999


Q ss_pred             EEecCCCChhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEe
Q 002321          766 YEFVSGGSLHKHLHEGS-------------GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVG  832 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~  832 (936)
                      +||+++++|.+++....             ....+++..+.+++.|++.||+|+|++||+||||||+||++++++.+||+
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~  166 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKIS  166 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEec
Confidence            99999999999985321             11247888899999999999999999999999999999999999999999


Q ss_pred             eccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHHH---
Q 002321          833 DYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWLE---  908 (936)
Q Consensus       833 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~~---  908 (936)
                      |||+++...............+++.|+|||.+. ...++.++||||+||++|||++ |..||...............   
T Consensus       167 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~  245 (283)
T cd05091         167 DLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL  245 (283)
T ss_pred             ccccccccccchheeeccCccCCccccCHHHHh-cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            999988654333222223344567899999884 4468999999999999999998 88899776553222111100   


Q ss_pred             --HHhhhccccceeecccccccccccccC
Q 002321          909 --EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 --~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                        +.-.+..+.+++.+||+.+|.+||+|+
T Consensus       246 ~~~~~~~~~~~~li~~cl~~~p~~RP~~~  274 (283)
T cd05091         246 PCPDDCPAWVYTLMLECWNEFPSRRPRFK  274 (283)
T ss_pred             CCCCCCCHHHHHHHHHHhCCCcccCCCHH
Confidence              122445688999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.2e-34  Score=325.54  Aligned_cols=246  Identities=25%  Similarity=0.309  Sum_probs=195.7

Q ss_pred             cccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-CCCcceeeeEEEeCCe
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQSL  761 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  761 (936)
                      ...+...++||+|+||.||+|+++      .++.||||+++........+.+.+|++++.++. ||||+++++++...+.
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            345677889999999999999864      246899999976544444567889999999997 9999999999999889


Q ss_pred             eEEEEEecCCCChhhhhhccCC----------------------------------------------------------
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSG----------------------------------------------------------  783 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------  783 (936)
                      .++||||+++|+|.+++++...                                                          
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            9999999999999999975421                                                          


Q ss_pred             -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC
Q 002321          784 -------------------------------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS  826 (936)
Q Consensus       784 -------------------------------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~  826 (936)
                                                           ...+++....+++.|++.||+|||+.+++||||||+||+++++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~  275 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEG  275 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCC
Confidence                                                 1236777889999999999999999999999999999999999


Q ss_pred             CCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHH
Q 002321          827 GEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVT  905 (936)
Q Consensus       827 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~  905 (936)
                      +.+||+|||+++...............++..|+|||.+. ...++.++||||+||++|||++ |..||............
T Consensus       276 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~  354 (401)
T cd05107         276 KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF-NNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNA  354 (401)
T ss_pred             CEEEEEecCcceecccccccccCCCcCCCCceeChHHhc-CCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHH
Confidence            999999999997653222222222344677899999884 4468999999999999999998 89999765432221110


Q ss_pred             H------HHHHhhhccccceeecccccccccccccC
Q 002321          906 W------LEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       906 ~------~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .      ..+...+.++.+++.+||..+|.+||+|+
T Consensus       355 ~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~  390 (401)
T cd05107         355 IKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFS  390 (401)
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHH
Confidence            0      01223456788999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.1e-35  Score=322.82  Aligned_cols=245  Identities=24%  Similarity=0.337  Sum_probs=192.9

Q ss_pred             ccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeC-Ce
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQ-SL  761 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~  761 (936)
                      ..|+..+.||+|+||.||+|...      +++.||+|+++........+.+.+|+.++.++ +|+||+++++++... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            35788899999999999999743      25789999987544334456788999999999 899999999988654 56


Q ss_pred             eEEEEEecCCCChhhhhhccCC----------------------------------------------------------
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSG----------------------------------------------------------  783 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------------  783 (936)
                      .+++|||+++++|.+++.....                                                          
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            7899999999999999864321                                                          


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccccccCcccccCccc
Q 002321          784 GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF  863 (936)
Q Consensus       784 ~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~  863 (936)
                      ...+++..+.+++.|++.||+|||+++|+||||||+||+++.++.++|+|||+++.+.............++..|+|||+
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~  246 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES  246 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence            12478999999999999999999999999999999999999999999999999987643332223334455678999998


Q ss_pred             ccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHH------HHHHHhhhccccceeecccccccccccccC
Q 002321          864 ACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVT------WLEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       864 ~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +. ...++.++||||+||++|||++ |..||.+..........      ...+.....++.+++.+||..+|.+||++.
T Consensus       247 ~~-~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~  324 (337)
T cd05054         247 IF-DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFS  324 (337)
T ss_pred             hc-CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence            84 4578999999999999999998 99999764332111110      011122345678899999999999999863

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.7e-34  Score=311.02  Aligned_cols=232  Identities=25%  Similarity=0.313  Sum_probs=187.4

Q ss_pred             ccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCCCh
Q 002321          698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSL  774 (936)
Q Consensus       698 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  774 (936)
                      ||+|+||.||+++.+ +|+.||+|++......  .....+..|++++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999976 5899999998643322  1234556799999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccccccC
Q 002321          775 HKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQS  854 (936)
Q Consensus       775 ~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  854 (936)
                      .+++..... ..+++..+..++.|++.|++|||+.||+||||||+||+++.++.++|+|||++.......   ......+
T Consensus        81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~  156 (277)
T cd05607          81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAG  156 (277)
T ss_pred             HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeeccCC
Confidence            988865432 238889999999999999999999999999999999999999999999999997654322   1233467


Q ss_pred             cccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhH--HHHHH-HHH------HHhhhccccceeecccc
Q 002321          855 ALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMW--WFSVT-WLE------EHWKKAEWRNVSMRSCK  925 (936)
Q Consensus       855 ~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~--~~~~~-~~~------~~~~~~~~~~~~~~~l~  925 (936)
                      +..|+|||++.+ ..++.++||||+||++|||++|+.||.......  ..... ...      ....+.+.++++.+||.
T Consensus       157 ~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  235 (277)
T cd05607         157 TNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLA  235 (277)
T ss_pred             CCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhc
Confidence            889999998854 458999999999999999999999997643211  11000 000      01234668999999999


Q ss_pred             ccccccccc
Q 002321          926 GSSRQRRRF  934 (936)
Q Consensus       926 ~~p~~Rp~f  934 (936)
                      .||.+||+.
T Consensus       236 ~~P~~R~~~  244 (277)
T cd05607         236 KKPEDRLGS  244 (277)
T ss_pred             cCHhhCCCC
Confidence            999999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.1e-34  Score=341.89  Aligned_cols=242  Identities=20%  Similarity=0.254  Sum_probs=192.4

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      .|+..++||+|+||.||+|+.. +|+.||||+++.....  ...+++.+|++++++++||||+++++++.+.+..++|||
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME   82 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP   82 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence            3567788999999999999976 5899999998654222  235678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          768 FVSGGSLHKHLHEGSG--------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~--------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      |++||+|.+++.....        ....++..+.+++.|+++||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus        83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~  162 (932)
T PRK13184         83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIF  162 (932)
T ss_pred             cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCccee
Confidence            9999999998864211        12356778899999999999999999999999999999999999999999999986


Q ss_pred             cCCCcc----------------ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHH
Q 002321          840 LPMLDR----------------YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS  903 (936)
Q Consensus       840 ~~~~~~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~  903 (936)
                      ......                ........||+.|+|||.+. +..++.++||||+||++|||++|+.||...+......
T Consensus       163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~-g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~  241 (932)
T PRK13184        163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL-GVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY  241 (932)
T ss_pred             cccccccccccccccccccccccccCCCCCCCCCCCCHHHhc-CCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh
Confidence            521110                01112346899999999884 5568999999999999999999999998754422211


Q ss_pred             HHHH-H------HHhhhccccceeecccccccccccc
Q 002321          904 VTWL-E------EHWKKAEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       904 ~~~~-~------~~~~~~~~~~~~~~~l~~~p~~Rp~  933 (936)
                      .... .      ....+..+.+++.+|+..||.+||+
T Consensus       242 ~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~s  278 (932)
T PRK13184        242 RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYS  278 (932)
T ss_pred             hhhccChhhccccccCCHHHHHHHHHHccCChhhCcC
Confidence            1110 0      0123355788999999999999975

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.6e-34  Score=316.71  Aligned_cols=239  Identities=21%  Similarity=0.310  Sum_probs=192.3

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .|...++||+|+||.||+|+.+ +++.||+|+++..........+.+|++++++++||||+++++++..++..++||||+
T Consensus         7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   86 (309)
T cd07872           7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL   86 (309)
T ss_pred             ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence            4677788999999999999976 578899999976544444556789999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      + +++.+++....  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.......  ..
T Consensus        87 ~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~  161 (309)
T cd07872          87 D-KDLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TY  161 (309)
T ss_pred             C-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--cc
Confidence            6 58888876543  2378889999999999999999999999999999999999999999999999975432211  12


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH-----------------------H
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT-----------------------W  906 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~-----------------------~  906 (936)
                      ....+++.|+|||.+.+...++.++||||+||++|||++|+.||...+........                       +
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY  241 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence            23456788999998866667899999999999999999999999876542111000                       0


Q ss_pred             HHHH-----------hhhccccceeeccccccccccccc
Q 002321          907 LEEH-----------WKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       907 ~~~~-----------~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      ..+.           ..++..++++.+|+..||.+||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~  280 (309)
T cd07872         242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISA  280 (309)
T ss_pred             hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCH
Confidence            0000           123456789999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8.1e-35  Score=313.96  Aligned_cols=242  Identities=23%  Similarity=0.298  Sum_probs=190.0

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCc----EEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      ..|+..+.||+|+||+||+|++. +++    .||+|++..........++..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            35677788999999999999975 344    4778887543333334678889999999999999999998854 45678


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ++||+++|+|.+++....  ..+++..+..++.|++.||+|||+++++||||||+||++++++.+||+|||.++......
T Consensus        86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD  163 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence            999999999999997643  238999999999999999999999999999999999999999999999999998664333


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccc
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRN  918 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~  918 (936)
                      .........++..|+|||.+. ...++.++|||||||++||+++ |+.||.+.+.........     ..+........+
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESIL-FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYM  242 (279)
T ss_pred             cccccCCCCCcccccCHHHhc-cCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHH
Confidence            222233445667899999884 4468999999999999999998 999998765532221110     001122345567


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..||.+||+++
T Consensus       243 li~~c~~~~p~~Rps~~  259 (279)
T cd05111         243 VMVKCWMIDENVRPTFK  259 (279)
T ss_pred             HHHHHcCCCcccCcCHH
Confidence            88899999999999974

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.2e-34  Score=311.05  Aligned_cols=239  Identities=24%  Similarity=0.294  Sum_probs=183.8

Q ss_pred             CcccccCceEEEEEEeCC---CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCC
Q 002321          696 CELGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGG  772 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  772 (936)
                      ++||+|+||+||+|+..+   ...+|+|.+...........+.+|+..++.++|+||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999997543   35788888765444444567889999999999999999999999999999999999999


Q ss_pred             ChhhhhhccCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          773 SLHKHLHEGSGG--NFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       773 ~L~~~l~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                      +|.+++......  ...++....+++.|++.|++|||+++|+||||||+||++++++.+||+|||+++............
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~  160 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD  160 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence            999999765421  235677888999999999999999999999999999999999999999999987543322222223


Q ss_pred             cccCcccccCcccccC------cccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHHH----------HHhhh
Q 002321          851 KIQSALGYMAPEFACR------TVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWLE----------EHWKK  913 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~------~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~~----------~~~~~  913 (936)
                      ...++..|+|||+...      ...++.++||||+||++|||++ |..||...............          +...+
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (269)
T cd05042         161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYS  240 (269)
T ss_pred             CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCC
Confidence            3445677999998632      3356889999999999999999 88999776543221111000          11223


Q ss_pred             ccccceeecccccccccccccC
Q 002321          914 AEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       914 ~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..+++++..|| .||.+||+++
T Consensus       241 ~~~~~~~~~~~-~dp~~Rpt~~  261 (269)
T cd05042         241 DRWYEVMQFCW-LDPETRPTAE  261 (269)
T ss_pred             HHHHHHHHHHh-cCcccccCHH
Confidence            44566666666 6999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-34  Score=308.44  Aligned_cols=239  Identities=27%  Similarity=0.360  Sum_probs=194.5

Q ss_pred             cccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      .++..+.||+|+||.||+|.++++..+|+|++.....  ....+.+|++++++++|+||+++++++...+..++||||++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            3567788999999999999988778899999864332  34578899999999999999999999999899999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                      +++|.+++.....  .+++..+.+++.|++.|++|||+.+++||||||+||+++.++.+||+|||.++....... ....
T Consensus        83 ~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~~  159 (256)
T cd05059          83 NGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSSQ  159 (256)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-cccC
Confidence            9999999976432  489999999999999999999999999999999999999999999999999976542211 1112


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceeeccc
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSMRSC  924 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l  924 (936)
                      ...++..|+|||.+. ...++.++||||+|+++|||++ |+.||...+.........     ..+...+..+.+++.+||
T Consensus       160 ~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  238 (256)
T cd05059         160 GTKFPVKWAPPEVFD-YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCW  238 (256)
T ss_pred             CCCCCccccCHHHhc-cCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHh
Confidence            223345799999884 4568899999999999999999 899998765432221110     112234577999999999


Q ss_pred             ccccccccccC
Q 002321          925 KGSSRQRRRFQ  935 (936)
Q Consensus       925 ~~~p~~Rp~f~  935 (936)
                      ..+|.+||+++
T Consensus       239 ~~~p~~Rpt~~  249 (256)
T cd05059         239 HEKPEDRPAFK  249 (256)
T ss_pred             cCChhhCcCHH
Confidence            99999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.1e-34  Score=322.38  Aligned_cols=239  Identities=22%  Similarity=0.326  Sum_probs=187.1

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC-----eeEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS-----LQLL  764 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l  764 (936)
                      |+..+.||+|+||.||+|+.. +++.||||++..... ......+.+|++++++++||||+++++++....     ..++
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            456678999999999999976 589999999864321 223456889999999999999999999886432     4789


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ||||+ +++|.+++.....   +++..+..++.|+++||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        82 v~e~~-~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          82 VFELM-ESDLHQVIKANDD---LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT  157 (338)
T ss_pred             EEecC-CCCHHHHHHhccc---CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence            99999 4789998876443   8999999999999999999999999999999999999999999999999997543211


Q ss_pred             c-ccccccccCcccccCcccccCc-ccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH------------------
Q 002321          845 R-YVLSSKIQSALGYMAPEFACRT-VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV------------------  904 (936)
Q Consensus       845 ~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~------------------  904 (936)
                      . ........+++.|+|||++.+. ..++.++||||+||++|||++|+.||...+.......                  
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  237 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN  237 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            1 1122345688999999987432 4688999999999999999999999977543211100                  


Q ss_pred             ----HHHH-----------HH--hhhccccceeeccccccccccccc
Q 002321          905 ----TWLE-----------EH--WKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       905 ----~~~~-----------~~--~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                          ....           ..  -.++.+.+++.+||..||.+||+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~  284 (338)
T cd07859         238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTA  284 (338)
T ss_pred             hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCH
Confidence                0000           00  122445789999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.1e-34  Score=309.84  Aligned_cols=241  Identities=25%  Similarity=0.324  Sum_probs=196.1

Q ss_pred             ccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      ..|+..++||+|+||.||+|...++..||+|.+....  ...+.+.+|+.++++++|+||+++++++.+....+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            4567788999999999999998888899999986532  23577899999999999999999999999988999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++++|.++++.... ..+++..+..++.|++.|++|||+.+++||||||+||+++.++.++|+|||.++........ ..
T Consensus        84 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~  161 (261)
T cd05072          84 AKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AR  161 (261)
T ss_pred             CCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCcee-cc
Confidence            99999999976432 34888899999999999999999999999999999999999999999999999876432211 12


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH---HH--HHhhhccccceeecc
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW---LE--EHWKKAEWRNVSMRS  923 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~---~~--~~~~~~~~~~~~~~~  923 (936)
                      ....++..|+|||... ...++.++||||+||++|||++ |+.||.............   ..  ....+....+++.+|
T Consensus       162 ~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (261)
T cd05072         162 EGAKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTC  240 (261)
T ss_pred             CCCccceecCCHHHhc-cCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence            2233566799999884 4568899999999999999998 999997765432221100   00  112345788899999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..+|.+||+++
T Consensus       241 l~~~p~~Rp~~~  252 (261)
T cd05072         241 WKEKAEERPTFD  252 (261)
T ss_pred             ccCCcccCcCHH
Confidence            999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2e-35  Score=330.72  Aligned_cols=237  Identities=24%  Similarity=0.323  Sum_probs=191.4

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      |+..+.||+|+||.||+|+.. +++.||||+++....  ......+.+|+.++.+++|++|+++++++.+....++||||
T Consensus         3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~   82 (360)
T cd05627           3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF   82 (360)
T ss_pred             ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence            566778999999999999976 589999999964322  22346788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc---
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR---  845 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---  845 (936)
                      +++|+|.+++.+...   +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.......   
T Consensus        83 ~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          83 LPGGDMMTLLMKKDT---LSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             CCCccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence            999999999976443   88999999999999999999999999999999999999999999999999875432110   


Q ss_pred             ------------------------------ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCc
Q 002321          846 ------------------------------YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLST  895 (936)
Q Consensus       846 ------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~  895 (936)
                                                    ........||+.|+|||++. +..++.++||||+||++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc-CCCCCCcceeccccceeeecccCCCCCCC
Confidence                                          00112346899999999984 55789999999999999999999999987


Q ss_pred             cchhHHHHHHH--------HHHHhhhccccceeecccccccccccc
Q 002321          896 WKMMWWFSVTW--------LEEHWKKAEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       896 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~~p~~Rp~  933 (936)
                      ...........        .+....+.+.++++.++|. ||.+|++
T Consensus       239 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~  283 (360)
T cd05627         239 ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIG  283 (360)
T ss_pred             CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCC
Confidence            76543321111        0011234677888888775 9999985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.6e-34  Score=307.60  Aligned_cols=235  Identities=24%  Similarity=0.337  Sum_probs=187.2

Q ss_pred             cccccCceEEEEEEeC---CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCCC
Q 002321          697 ELGRGGFGAVYRTVLR---DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGS  773 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  773 (936)
                      +||+|+||.||+|+++   .+..||+|+++........+.+.+|+.++++++|+||+++++++.. ...++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999864   3557999998765433445779999999999999999999998854 46789999999999


Q ss_pred             hhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc-ccccc
Q 002321          774 LHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV-LSSKI  852 (936)
Q Consensus       774 L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~  852 (936)
                      |.+++....  ..+++..+.+++.|++.|++|||++|++||||||+||+++.++.+||+|||+++......... .....
T Consensus        81 L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          81 LNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence            999987533  248999999999999999999999999999999999999999999999999997654322211 11222


Q ss_pred             cCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHH-H----HHHHhhhccccceeeccccc
Q 002321          853 QSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVT-W----LEEHWKKAEWRNVSMRSCKG  926 (936)
Q Consensus       853 ~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~l~~  926 (936)
                      .++..|+|||... ...++.++|||||||++||+++ |..||............ .    ..+...+.++.+++.+||..
T Consensus       159 ~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~  237 (257)
T cd05115         159 KWPLKWYAPECIN-FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY  237 (257)
T ss_pred             CCCcccCCHHHHc-cCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            3356799999874 4468899999999999999996 99999876553322111 0    01122356788999999999


Q ss_pred             ccccccccC
Q 002321          927 SSRQRRRFQ  935 (936)
Q Consensus       927 ~p~~Rp~f~  935 (936)
                      ||.+||+|.
T Consensus       238 ~~~~Rp~~~  246 (257)
T cd05115         238 KWEDRPNFA  246 (257)
T ss_pred             ChhhCcCHH
Confidence            999999974

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-37  Score=295.84  Aligned_cols=256  Identities=23%  Similarity=0.309  Sum_probs=206.1

Q ss_pred             eeccCCCCccccccccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceee
Q 002321          676 VMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLE  753 (936)
Q Consensus       676 ~~~~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  753 (936)
                      ....++....+.+...++...+||.|+||+|+|-.++ .|+..|||+++.....++++++..|.....+- +.||||++|
T Consensus        50 l~~p~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfy  129 (361)
T KOG1006|consen   50 LKLPDDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFY  129 (361)
T ss_pred             eecCCcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence            3444555666667777788889999999999998876 59999999998887777888999999886665 789999999


Q ss_pred             eEEEeCCeeEEEEEecCCCChhhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCCeE
Q 002321          754 GYYWTQSLQLLIYEFVSGGSLHKHLHEG--SGGNFLSWNERFNVIQGTAKSLAHLHQ-SNIIHYNIKSSNVLIDGSGEPK  830 (936)
Q Consensus       754 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~k  830 (936)
                      |.+..++..|+.||.| ..+++.+.+.-  .....+++...-+|....++||.||-. ..|+|||+||+|||+|..|.+|
T Consensus       130 Ga~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vK  208 (361)
T KOG1006|consen  130 GALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVK  208 (361)
T ss_pred             hhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEe
Confidence            9999999999999999 46887655431  112238888888899999999999986 5899999999999999999999


Q ss_pred             EeeccCccccCCCccccccccccCcccccCcccccCccc-CCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-
Q 002321          831 VGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK-ITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-  908 (936)
Q Consensus       831 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-  908 (936)
                      +||||++..+   ....+.+...|...|||||.+..... |+.++||||+|+++||+.||+.||..++....+..+-.. 
T Consensus       209 LCDFGIcGqL---v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g  285 (361)
T KOG1006|consen  209 LCDFGICGQL---VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG  285 (361)
T ss_pred             eecccchHhH---HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC
Confidence            9999998654   23445566778888999998854433 889999999999999999999999999874333222211 


Q ss_pred             -H---------HhhhccccceeecccccccccccccC
Q 002321          909 -E---------HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 -~---------~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                       +         ...+.++..++.-|+.+|-..||.|.
T Consensus       286 dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~  322 (361)
T KOG1006|consen  286 DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYD  322 (361)
T ss_pred             CCCeecCcccccccCHHHHHHHHHHhhcccccCcchh
Confidence             1         11234678888999999999999984

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-34  Score=308.61  Aligned_cols=240  Identities=27%  Similarity=0.380  Sum_probs=195.7

Q ss_pred             cccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      .++..+.||+|+||.||+|...+++.||||.++....  ..+++.+|++++++++|+||+++++++......++||||++
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05068           7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK   84 (261)
T ss_pred             heeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence            4567788999999999999987788999999865432  35678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                      +++|.+++.... ...+++..+..++.|++.|+.|||+.|++||||||+||++++++.+||+|||+++....... ....
T Consensus        85 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~  162 (261)
T cd05068          85 YGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-EARE  162 (261)
T ss_pred             CCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-cccC
Confidence            999999997654 33489999999999999999999999999999999999999999999999999987642211 1111


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHH-HHH----HHHHhhhccccceeeccc
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFS-VTW----LEEHWKKAEWRNVSMRSC  924 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~l  924 (936)
                      ....+..|+|||.+ ....++.++||||+|+++|||++ |+.||.......... ...    ..+...+..+.+++.+||
T Consensus       163 ~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  241 (261)
T cd05068         163 GAKFPIKWTAPEAA-LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCW  241 (261)
T ss_pred             CCcCceeccCcccc-ccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHh
Confidence            12234579999988 44568999999999999999999 999998765432221 110    011223577889999999


Q ss_pred             ccccccccccC
Q 002321          925 KGSSRQRRRFQ  935 (936)
Q Consensus       925 ~~~p~~Rp~f~  935 (936)
                      ..+|.+||+++
T Consensus       242 ~~~P~~Rp~~~  252 (261)
T cd05068         242 KEDPDDRPTFE  252 (261)
T ss_pred             hcCcccCCCHH
Confidence            99999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-37  Score=343.98  Aligned_cols=440  Identities=27%  Similarity=0.322  Sum_probs=304.0

Q ss_pred             ceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEc
Q 002321           77 RVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISL  156 (936)
Q Consensus        77 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L  156 (936)
                      .++.|+++.|-+-...-+.+..--.|+.|+|++|++. ..|..+..+++|+.|+++.|.|. .+| .....+.+|++|.|
T Consensus        22 ~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp-~s~~~~~~l~~lnL   98 (1081)
T KOG0618|consen   22 ALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVP-SSCSNMRNLQYLNL   98 (1081)
T ss_pred             HHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCc-hhhhhhhcchhhee
Confidence            3777777777654332333444555899999999887 67888999999999999999988 667 34577889999999


Q ss_pred             cCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeeccccccccc
Q 002321          157 AKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGS  236 (936)
Q Consensus       157 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  236 (936)
                      .+|++. ..|.++..+.+|++|+++.|++. .+|..+..++.++.+..++|.....    ++.. .++.++|..|.+.+.
T Consensus        99 ~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----lg~~-~ik~~~l~~n~l~~~  171 (1081)
T KOG0618|consen   99 KNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR----LGQT-SIKKLDLRLNVLGGS  171 (1081)
T ss_pred             ccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh----hccc-cchhhhhhhhhcccc
Confidence            999888 68888999999999999999987 4788888889999999999932212    2222 288888899988888


Q ss_pred             CCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccc
Q 002321          237 IPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNL  316 (936)
Q Consensus       237 ~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l  316 (936)
                      ++..+..+..  .|||.+|.+.   --.+..+.+|+.+....|++....    -..++|+.|+.++|.++...+. + --
T Consensus       172 ~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~-p-~p  240 (1081)
T KOG0618|consen  172 FLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDVH-P-VP  240 (1081)
T ss_pred             hhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeeccc-c-cc
Confidence            8888877776  7999999886   234667788888888888877321    2447889999999988833332 2 23


Q ss_pred             cccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhc-cCCccccccccccccCCCCCCCCCCCCCCccc
Q 002321          317 QRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFS-SGLNKVSFAENKIREGMNGPFASSGSSFESLQ  395 (936)
Q Consensus       317 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~  395 (936)
                      .+|+++++++|+++ .+|+++..+.+|+.++..+|.+. .+|..++. ..++.+....|.+..     +|..+..+++|+
T Consensus       241 ~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~y-----ip~~le~~~sL~  313 (1081)
T KOG0618|consen  241 LNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEY-----IPPFLEGLKSLR  313 (1081)
T ss_pred             ccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhh-----CCCcccccceee
Confidence            58999999999998 46699999999999999999995 66665554 678888888888865     455566788999


Q ss_pred             EEeccCcccCCCChhhhccc-------------------------ccCCeeeccCccccCCCCccccCcccCCeeecCCc
Q 002321          396 FLDLSHNEFSGETPATIGAL-------------------------SGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSEN  450 (936)
Q Consensus       396 ~L~Ls~N~l~~~~~~~~~~l-------------------------~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  450 (936)
                      +|||..|+|...++..+..+                         +.|+.|+|.+|.+++..-..+.+.+.|+.|+|++|
T Consensus       314 tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyN  393 (1081)
T KOG0618|consen  314 TLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYN  393 (1081)
T ss_pred             eeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccc
Confidence            99999999974444333222                         23455555555555444445555555555555555


Q ss_pred             cccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCc
Q 002321          451 WLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPK  530 (936)
Q Consensus       451 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  530 (936)
                      +|.......+.++..|++|+||+|+++ .+|+.+.+++.|++|...+|++. ..| .+.++++|+.+|+|.|+|+...-.
T Consensus       394 rL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~  470 (1081)
T KOG0618|consen  394 RLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLP  470 (1081)
T ss_pred             ccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhh
Confidence            555322233455555555555555555 45555555555555555555555 344 555555555555555555432222


Q ss_pred             ccccccccCeeecCCCc
Q 002321          531 QLVNLVHLSSFNISHNH  547 (936)
Q Consensus       531 ~l~~l~~L~~L~ls~N~  547 (936)
                      +....++|++|||+||.
T Consensus       471 ~~~p~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  471 EALPSPNLKYLDLSGNT  487 (1081)
T ss_pred             hhCCCcccceeeccCCc
Confidence            22222555555555554

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.2e-35  Score=331.23  Aligned_cols=238  Identities=21%  Similarity=0.303  Sum_probs=188.7

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      .|+..++||+|+||.||+|+.. +++.||||++.....  ......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            3667789999999999999976 589999999864322  1234668899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc---
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD---  844 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---  844 (936)
                      |+++|+|.+++.+..   .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+|..+....   
T Consensus        82 ~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          82 YIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence            999999999997644   37888889999999999999999999999999999999999999999999975321000   


Q ss_pred             --------------------------------------cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHH
Q 002321          845 --------------------------------------RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEV  886 (936)
Q Consensus       845 --------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el  886 (936)
                                                            .........||+.|+|||++ ....++.++||||+||++|||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL-LRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHH-cCCCCCcceeeeeccceeeeh
Confidence                                                  00001134689999999998 455789999999999999999


Q ss_pred             HcCCCCCCccchhHHHH-H-HHHH----H--Hhhhccccceeecccccccccccc
Q 002321          887 VTGKRPLSTWKMMWWFS-V-TWLE----E--HWKKAEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       887 ~~g~~Pf~~~~~~~~~~-~-~~~~----~--~~~~~~~~~~~~~~l~~~p~~Rp~  933 (936)
                      ++|+.||.......... . .+..    +  ...+....+++.+++ .+|.+|++
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~  291 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLG  291 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence            99999998876532221 1 1100    0  112355677787865 59999983

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.3e-34  Score=308.61  Aligned_cols=242  Identities=22%  Similarity=0.373  Sum_probs=195.5

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      .|+..++||+|+||.||+|+.. +++.||||.++....  .+....+.+|++++++++||||+++++++.+.+..++|+|
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence            3567788999999999999965 689999998864322  2334678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          768 FVSGGSLHKHLHEGSG-GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      |+++|+|.+++..... ...+++..+.+++.|+++|++|||+++++|+||||+||+++.++.++|+|||++.......  
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~--  160 (267)
T cd08228          83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--  160 (267)
T ss_pred             ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh--
Confidence            9999999988864322 2347889999999999999999999999999999999999999999999999988654322  


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH--------HHhhhccccc
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE--------EHWKKAEWRN  918 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~  918 (936)
                      .......+++.|+|||... ...++.++||||+|+++|||++|+.||...............        ....+..+++
T Consensus       161 ~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd08228         161 TAAHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE  239 (267)
T ss_pred             HHHhcCCCCccccChhhhc-cCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence            1122345778899999884 446789999999999999999999999765432111111111        1233467899


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..+|.+||+|.
T Consensus       240 li~~cl~~~p~~Rp~~~  256 (267)
T cd08228         240 LVSMCIYPDPDQRPDIG  256 (267)
T ss_pred             HHHHHCCCCcccCcCHH
Confidence            99999999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.6e-34  Score=312.18  Aligned_cols=238  Identities=21%  Similarity=0.302  Sum_probs=185.6

Q ss_pred             cccCCCcccccCceEEEEEEeC--CCcEEEEEEeeccCccc-hHHHHHHHHHHHHcC---CCCCcceeeeEEEe-----C
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR--DGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKV---RHPNLVTLEGYYWT-----Q  759 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~  759 (936)
                      .|+..++||+|+||.||+|+..  +++.||||+++...... ....+.+|+.+++++   +||||+++++++..     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            3667788999999999999864  46889999986543322 234566788777766   69999999999853     3


Q ss_pred             CeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          760 SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       760 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      ...++||||++ ++|.+++..... ..+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  159 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence            45789999995 699998876432 2388999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH-----------HHH
Q 002321          840 LPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT-----------WLE  908 (936)
Q Consensus       840 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~-----------~~~  908 (936)
                      ....   .......+++.|+|||.+. ...++.++||||+||++|||++|+.||............           +..
T Consensus       160 ~~~~---~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         160 YSFQ---MALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             ccCC---cccccccccccccChHHHh-CCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence            5422   2233456888999999884 456889999999999999999999999876542221100           000


Q ss_pred             ------H--------------Hhhhccccceeeccccccccccccc
Q 002321          909 ------E--------------HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       909 ------~--------------~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                            .              ...++..++++.+|+..||.+||+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~  281 (290)
T cd07862         236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA  281 (290)
T ss_pred             hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCH
Confidence                  0              0122445788999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.2e-34  Score=309.58  Aligned_cols=242  Identities=21%  Similarity=0.294  Sum_probs=188.8

Q ss_pred             cCCCcccccCceEEEEEEeCCC---cEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeC------Cee
Q 002321          693 NKDCELGRGGFGAVYRTVLRDG---RPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ------SLQ  762 (936)
Q Consensus       693 ~~~~~iG~G~~g~Vy~~~~~~~---~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  762 (936)
                      ...+.||+|+||.||+|++.++   ..||+|.++.... ....+.+.+|++++++++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            4567899999999999997643   2699998865432 23356788999999999999999999987532      245


Q ss_pred             EEEEEecCCCChhhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          763 LLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      +++|||+++|+|.+++....   ....+++.....++.|++.|++|||+++|+||||||+||++++++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  161 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK  161 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence            89999999999998874322   223488999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH-----HHHhhh
Q 002321          840 LPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL-----EEHWKK  913 (936)
Q Consensus       840 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~-----~~~~~~  913 (936)
                      +.............+++.|+|||.. ....++.++||||+||++|||++ |+.||...+..........     .+.-..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (272)
T cd05075         162 IYNGDYYRQGRIAKMPVKWIAIESL-ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCL  240 (272)
T ss_pred             cCcccceecCCcccCCcccCCHHHc-cCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            6433322222233456789999988 45578999999999999999999 8999977654322211110     011233


Q ss_pred             ccccceeecccccccccccccC
Q 002321          914 AEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       914 ~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..+.+++.+||..||.+||+++
T Consensus       241 ~~~~~li~~~l~~~p~~Rps~~  262 (272)
T cd05075         241 DGLYSLMSSCWLLNPKDRPSFE  262 (272)
T ss_pred             HHHHHHHHHHcCCCcccCcCHH
Confidence            5688899999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.5e-34  Score=325.15  Aligned_cols=238  Identities=21%  Similarity=0.252  Sum_probs=190.0

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC-----eeEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS-----LQLL  764 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l  764 (936)
                      |+..++||+|+||.||+|+.. +++.||||++..... ....+++.+|+++++.++|+||+++++++....     ..++
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   81 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV   81 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence            467788999999999999975 689999999854321 223467889999999999999999999998766     7899


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ||||+. ++|.+++....   .+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++......
T Consensus        82 v~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          82 VTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE  157 (372)
T ss_pred             Eeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence            999995 68888776543   38999999999999999999999999999999999999999999999999997653222


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH-------------------
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT-------------------  905 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~-------------------  905 (936)
                      . .......+++.|+|||.+.+...++.++||||+||++|||++|+.||...+........                   
T Consensus       158 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  236 (372)
T cd07853         158 S-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA  236 (372)
T ss_pred             c-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence            1 12233456888999999866666899999999999999999999999876543221100                   


Q ss_pred             --HHH---------------HHhhhccccceeeccccccccccccc
Q 002321          906 --WLE---------------EHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       906 --~~~---------------~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                        ...               ....+++..+++.+|+..||.+||+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~  282 (372)
T cd07853         237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISA  282 (372)
T ss_pred             HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCH
Confidence              000               00113456788999999999999985

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.4e-34  Score=330.50  Aligned_cols=236  Identities=22%  Similarity=0.266  Sum_probs=184.1

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeC--------C
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ--------S  760 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~  760 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||||++...     .....+|+.++++++||||+++++++...        .
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            45778889999999999999975 5889999988533     22345799999999999999999887532        2


Q ss_pred             eeEEEEEecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-CeEEeeccCcc
Q 002321          761 LQLLIYEFVSGGSLHKHLHEG-SGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG-EPKVGDYGLAR  838 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~  838 (936)
                      ..++||||++ +++.+++... .....+++..+..++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+|+
T Consensus       141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~  219 (440)
T PTZ00036        141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK  219 (440)
T ss_pred             EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence            3568999996 5777766532 1223488999999999999999999999999999999999999765 79999999998


Q ss_pred             ccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HH-------------
Q 002321          839 LLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SV-------------  904 (936)
Q Consensus       839 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~-------------  904 (936)
                      .+....   ......+++.|+|||++.+...++.++||||+||++|||++|..||.+....... ..             
T Consensus       220 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~  296 (440)
T PTZ00036        220 NLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK  296 (440)
T ss_pred             hccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            654322   1223457889999998866667899999999999999999999999876432111 00             


Q ss_pred             -------------------HHHHHHhhhccccceeeccccccccccccc
Q 002321          905 -------------------TWLEEHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       905 -------------------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                         ....+...+.++.+++.+||..||.+||+-
T Consensus       297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta  345 (440)
T PTZ00036        297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNP  345 (440)
T ss_pred             HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCH
Confidence                               000011234567899999999999999874

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-35  Score=324.92  Aligned_cols=232  Identities=25%  Similarity=0.337  Sum_probs=186.3

Q ss_pred             ccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcC---CCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKV---RHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       698 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      ||+|+||+||+|+.. +++.||||++......  ........|..++.+.   +||+|+++++++.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999976 5899999998643222  1223445666676655   699999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      |+|.+++.+...   +++..+..++.|+++||+|||+++|+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 g~L~~~l~~~~~---~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~  155 (330)
T cd05586          81 GELFWHLQKEGR---FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNT  155 (330)
T ss_pred             ChHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCccC
Confidence            999998876443   8999999999999999999999999999999999999999999999999987532211  12234


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH-----HHHHhhhccccceeeccccc
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSMRSCKG  926 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~  926 (936)
                      ..|++.|+|||++.+...++.++||||+||++|||++|+.||...+.........     .+....+..+++++.+||..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~  235 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNR  235 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCC
Confidence            5689999999988666568999999999999999999999998765433221111     01122356778899999999


Q ss_pred             cccccccc
Q 002321          927 SSRQRRRF  934 (936)
Q Consensus       927 ~p~~Rp~f  934 (936)
                      ||.+||..
T Consensus       236 ~P~~R~~~  243 (330)
T cd05586         236 NPQHRLGA  243 (330)
T ss_pred             CHHHCCCC
Confidence            99999854

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.9e-34  Score=306.91  Aligned_cols=239  Identities=28%  Similarity=0.361  Sum_probs=193.9

Q ss_pred             cccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      .|+..+.||+|+||.||+|++.++..||||.++....  ..+++.+|+.++++++||||+++++++......++||||++
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            3566678999999999999987777899999864432  35678999999999999999999999998888999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                      +|+|.+++.....  .+++.++++++.|++.|++|||+.+++|+||||+||+++.++.+||+|||.++....... ....
T Consensus        83 ~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~  159 (256)
T cd05113          83 NGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSV  159 (256)
T ss_pred             CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eecC
Confidence            9999999876432  489999999999999999999999999999999999999999999999999876543221 1122


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHH-HHHH----HHHhhhccccceeeccc
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFS-VTWL----EEHWKKAEWRNVSMRSC  924 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~l  924 (936)
                      ...++..|+|||... ...++.++|||||||++|||++ |+.||.......... ....    .+...+..+++++.+||
T Consensus       160 ~~~~~~~y~~pe~~~-~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  238 (256)
T cd05113         160 GSKFPVRWSPPEVLL-YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCW  238 (256)
T ss_pred             CCccChhhCCHHHHh-cCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence            233556799999884 4468899999999999999998 999997655422111 1100    11223467889999999


Q ss_pred             ccccccccccC
Q 002321          925 KGSSRQRRRFQ  935 (936)
Q Consensus       925 ~~~p~~Rp~f~  935 (936)
                      ..+|.+||+++
T Consensus       239 ~~~p~~Rp~~~  249 (256)
T cd05113         239 HEKAEERPTFQ  249 (256)
T ss_pred             CCCcccCCCHH
Confidence            99999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.5e-34  Score=312.10  Aligned_cols=242  Identities=25%  Similarity=0.344  Sum_probs=192.0

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCc----EEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      ..++..++||+|+||+||+|++. +++    .||+|+++.........++.+|+.+++.+.|+||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence            44677789999999999999864 344    48999987655445567889999999999999999999999754 4678


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ++||+++|+|.++++...  ..+++.++..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++......
T Consensus        86 ~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~  163 (279)
T cd05109          86 VTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE  163 (279)
T ss_pred             EEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence            999999999999997643  238999999999999999999999999999999999999999999999999998764322


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccc
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRN  918 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~  918 (936)
                      .........+++.|+|||... ...++.++|||||||++|||++ |..||.............     ..+...+..+.+
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (279)
T cd05109         164 TEYHADGGKVPIKWMALESIL-HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYM  242 (279)
T ss_pred             ceeecCCCccchhhCCHHHhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHH
Confidence            221122233456799999884 4468999999999999999998 999998765432221100     011223355678


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..||.+||++.
T Consensus       243 li~~~l~~dp~~Rp~~~  259 (279)
T cd05109         243 IMVKCWMIDSECRPRFR  259 (279)
T ss_pred             HHHHHcCCChhhCcCHH
Confidence            99999999999999874

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.5e-34  Score=306.26  Aligned_cols=234  Identities=22%  Similarity=0.344  Sum_probs=187.7

Q ss_pred             cccccCceEEEEEEeC---CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCC
Q 002321          697 ELGRGGFGAVYRTVLR---DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGG  772 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  772 (936)
                      +||+|+||.||+|.++   ++..||+|+++..... ...+++.+|+.++++++|+||+++++++.. ...++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            6999999999999753   4789999998654332 235678999999999999999999998864 4568999999999


Q ss_pred             ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc-cccc
Q 002321          773 SLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV-LSSK  851 (936)
Q Consensus       773 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~  851 (936)
                      +|.+++....   .+++..+.+++.|++.|++|||++|++||||||.||++++++.+||+|||+++......... ....
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence            9999997543   38899999999999999999999999999999999999999999999999998664332211 1122


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHH-HH----HHHHhhhccccceeecccc
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSV-TW----LEEHWKKAEWRNVSMRSCK  925 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~l~  925 (936)
                      ..++..|+|||.+ ....++.++|||||||++|||++ |+.||........... ..    ..+...+.++.+++.+||.
T Consensus       158 ~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~  236 (257)
T cd05116         158 GKWPVKWYAPECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWT  236 (257)
T ss_pred             CCCCccccCHhHh-ccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhc
Confidence            2345689999988 44568889999999999999998 9999987654322211 10    1122345678899999999


Q ss_pred             cccccccccC
Q 002321          926 GSSRQRRRFQ  935 (936)
Q Consensus       926 ~~p~~Rp~f~  935 (936)
                      .||.+||+|+
T Consensus       237 ~~p~~Rp~~~  246 (257)
T cd05116         237 YGVDERPGFA  246 (257)
T ss_pred             cCchhCcCHH
Confidence            9999999985

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.5e-34  Score=311.69  Aligned_cols=243  Identities=23%  Similarity=0.346  Sum_probs=195.0

Q ss_pred             cccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      .|...+.||+|+||.||++...      ++..+|+|.+.... ....+.+.+|+.++++++|+||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            4567788999999999999842      34568999886543 2345678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhccCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeec
Q 002321          765 IYEFVSGGSLHKHLHEGSG----------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDY  834 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df  834 (936)
                      ||||+++++|.+++.....          ...+++..+..++.|++.||+|||++|++||||||+||++++++.+||+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~df  164 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDF  164 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccC
Confidence            9999999999999875431          124899999999999999999999999999999999999999999999999


Q ss_pred             cCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HH
Q 002321          835 GLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LE  908 (936)
Q Consensus       835 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~  908 (936)
                      |+++...............++..|+|||.+ ....++.++|||||||++|||++ |..||.............     ..
T Consensus       165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~  243 (288)
T cd05093         165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESI-MYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR  243 (288)
T ss_pred             CccccccCCceeecCCCCCccccccCHHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence            999865433322233334456789999988 44578999999999999999998 999997765432211100     00


Q ss_pred             HHhhhccccceeecccccccccccccC
Q 002321          909 EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 ~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +...+..+.+++.+||..||.+||+++
T Consensus       244 ~~~~~~~l~~li~~~l~~~p~~Rpt~~  270 (288)
T cd05093         244 PRTCPKEVYDLMLGCWQREPHMRLNIK  270 (288)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHH
Confidence            112345788999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2e-34  Score=311.30  Aligned_cols=245  Identities=21%  Similarity=0.235  Sum_probs=197.3

Q ss_pred             ccccCCCcccccCceEEEEEEeCC-----CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEe-CCeeE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRD-----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWT-QSLQL  763 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~  763 (936)
                      ..|...+.||+|+||.||+|.+.+     +..||+|++.........+.+.+|+.++++++|+||+++++++.. +...+
T Consensus         6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   85 (280)
T cd05043           6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF   85 (280)
T ss_pred             hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence            345667889999999999999765     688999998755444456778999999999999999999999876 46778


Q ss_pred             EEEEecCCCChhhhhhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCcc
Q 002321          764 LIYEFVSGGSLHKHLHEGSGG-----NFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR  838 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  838 (936)
                      +++||+++|+|.+++......     ..+++.++..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++
T Consensus        86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~  165 (280)
T cd05043          86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR  165 (280)
T ss_pred             EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcc
Confidence            999999999999998764322     458999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH-----HHHhh
Q 002321          839 LLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL-----EEHWK  912 (936)
Q Consensus       839 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~-----~~~~~  912 (936)
                      .+...+.........++..|+|||.+. ...++.++||||+||++||+++ |+.||...+..........     .+...
T Consensus       166 ~~~~~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  244 (280)
T cd05043         166 DLFPMDYHCLGDNENRPVKWMALESLV-NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINC  244 (280)
T ss_pred             cccCCceEEeCCCCCcchhccCHHHHh-cCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCcC
Confidence            654333222222344566799999884 4568999999999999999999 9999987655332211100     01123


Q ss_pred             hccccceeecccccccccccccC
Q 002321          913 KAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       913 ~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+.+++.+||..||.+||+++
T Consensus       245 ~~~~~~li~~~l~~~p~~Rps~~  267 (280)
T cd05043         245 PDELFAVMACCWALDPEERPSFS  267 (280)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHH
Confidence            46788999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.7e-34  Score=308.68  Aligned_cols=239  Identities=24%  Similarity=0.341  Sum_probs=193.9

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      ++..++||+|+||.||+|.++ .++.||+|+++...  ...+++.+|++++++++|+||+++++++......++||||++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             eEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            566678999999999999976 48899999986442  335678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                      +++|.+++..... ..+++..+..++.|++.||+|||+++++||||||+||++++++.+||+|||.+........ ....
T Consensus        86 ~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~~~~  163 (263)
T cd05052          86 YGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHA  163 (263)
T ss_pred             CCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-eccC
Confidence            9999999876432 3488999999999999999999999999999999999999999999999999976543221 1112


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceeeccc
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSMRSC  924 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l  924 (936)
                      ....+..|+|||.+ ....++.++|||||||++|||++ |..||...+.........     ..+.-.+..+.+++.+||
T Consensus       164 ~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  242 (263)
T cd05052         164 GAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACW  242 (263)
T ss_pred             CCCCccccCCHHHh-ccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence            22335679999988 45568899999999999999998 999998765533221111     011123357888999999


Q ss_pred             ccccccccccC
Q 002321          925 KGSSRQRRRFQ  935 (936)
Q Consensus       925 ~~~p~~Rp~f~  935 (936)
                      ..||.+||+++
T Consensus       243 ~~~p~~Rp~~~  253 (263)
T cd05052         243 QWNPSDRPSFA  253 (263)
T ss_pred             cCCcccCCCHH
Confidence            99999999974

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-34  Score=311.66  Aligned_cols=245  Identities=21%  Similarity=0.274  Sum_probs=197.6

Q ss_pred             ccccCCCcccccCceEEEEEEeCC------CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRD------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  763 (936)
                      ..|+..+.||+|+||.||+|....      +..||+|.+...........+.+|+.+++.++|+||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            345677889999999999998652      36899999865544444567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccC
Q 002321          764 LIYEFVSGGSLHKHLHEGSG-------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGL  836 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  836 (936)
                      +||||+++|+|.+++.....       ...+++..+..++.|++.|++|||+.+++||||||+||+++.++.+||+|||+
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~  165 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGM  165 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCccc
Confidence            99999999999999875322       12378889999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHH
Q 002321          837 ARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEH  910 (936)
Q Consensus       837 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~  910 (936)
                      ++.+...+.........++..|+|||... ...++.++|||||||++||+++ |+.||...+.........     ..+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (277)
T cd05032         166 TRDIYETDYYRKGGKGLLPVRWMAPESLK-DGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPE  244 (277)
T ss_pred             chhhccCcccccCCCCCccccccCHHHHh-cCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCCC
Confidence            98664433222223344567899999884 4468999999999999999998 999997765432221111     1122


Q ss_pred             hhhccccceeecccccccccccccC
Q 002321          911 WKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       911 ~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..+..+.+++.+||..+|.+||+++
T Consensus       245 ~~~~~~~~li~~~l~~~p~~Rpt~~  269 (277)
T cd05032         245 NCPDKLLELMRMCWQYNPKMRPTFL  269 (277)
T ss_pred             CCCHHHHHHHHHHcCCChhhCCCHH
Confidence            2346788999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.3e-34  Score=312.47  Aligned_cols=243  Identities=27%  Similarity=0.345  Sum_probs=194.8

Q ss_pred             ccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  765 (936)
                      |+..+.||+|+||.||+|+..      ....+|+|.+.........+.+.+|+.++++++||||+++++.+...+..++|
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI   81 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence            456678999999999999853      23578999887554444457789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc
Q 002321          766 YEFVSGGSLHKHLHEGSG---------------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLID  824 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~  824 (936)
                      |||+++|+|.+++.....                     ...+++..++.++.|++.|++|||+.+++||||||+||+++
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~  161 (290)
T cd05045          82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA  161 (290)
T ss_pred             EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEc
Confidence            999999999999864321                     12478899999999999999999999999999999999999


Q ss_pred             CCCCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHH
Q 002321          825 GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFS  903 (936)
Q Consensus       825 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~  903 (936)
                      +++.+||+|||+++...............++..|+|||.. ....++.++||||||+++|||++ |..||..........
T Consensus       162 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~  240 (290)
T cd05045         162 EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL-FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN  240 (290)
T ss_pred             CCCcEEeccccccccccCccchhcccCCCCCccccCHHHH-ccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            9999999999999765433322222334456689999987 44568999999999999999998 999998765543322


Q ss_pred             HHH-----HHHHhhhccccceeecccccccccccccC
Q 002321          904 VTW-----LEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       904 ~~~-----~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ...     ..+...+.++.+++.+||..+|.+||+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~  277 (290)
T cd05045         241 LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFA  277 (290)
T ss_pred             HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence            111     01222345788999999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.2e-34  Score=306.35  Aligned_cols=240  Identities=22%  Similarity=0.357  Sum_probs=196.7

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      |+..++||+|+||.||+++.. +++.||+|.++........+.+.+|+.++++++|+||+++++++.++...++||||++
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD   81 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence            456678999999999999976 5889999998755444456788899999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                      +|++.+++.... ...+++....+++.|++.|+.|||+++++|+||||+||++++++.++++|||.++.......  ...
T Consensus        82 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~  158 (255)
T cd08219          82 GGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YAC  158 (255)
T ss_pred             CCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--ccc
Confidence            999999887543 23478899999999999999999999999999999999999999999999999976543221  123


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH-----HHHHhhhccccceeecccc
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSMRSCK  925 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~  925 (936)
                      ...+++.|+|||+. ....++.++||||+|+++|+|++|+.||...+.........     ..+...+..+++++.+||.
T Consensus       159 ~~~~~~~~~aPE~~-~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  237 (255)
T cd08219         159 TYVGTPYYVPPEIW-ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFK  237 (255)
T ss_pred             cccCCccccCHHHH-ccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHh
Confidence            34578889999988 45568999999999999999999999998765432211100     0012234567889999999


Q ss_pred             cccccccccC
Q 002321          926 GSSRQRRRFQ  935 (936)
Q Consensus       926 ~~p~~Rp~f~  935 (936)
                      .||.+||++.
T Consensus       238 ~~P~~Rp~~~  247 (255)
T cd08219         238 RNPRSRPSAT  247 (255)
T ss_pred             CCcccCCCHH
Confidence            9999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.7e-34  Score=311.47  Aligned_cols=245  Identities=20%  Similarity=0.271  Sum_probs=194.8

Q ss_pred             ccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  763 (936)
                      ..|+..++||+|+||.||+|..+      .+..||+|.+...........+.+|+.++++++|+||+++++++.+....+
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL   85 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            45677889999999999999754      245899999865543344567889999999999999999999999888999


Q ss_pred             EEEEecCCCChhhhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccC
Q 002321          764 LIYEFVSGGSLHKHLHEGSG-------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGL  836 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  836 (936)
                      +||||+++|+|.++++....       ....++..+..++.|++.|+.|||+++|+||||||+||++++++.++++|||+
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~  165 (288)
T cd05061          86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM  165 (288)
T ss_pred             EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCc
Confidence            99999999999999975321       12356778889999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHH
Q 002321          837 ARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEH  910 (936)
Q Consensus       837 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~  910 (936)
                      ++...............++..|+|||... ...++.++||||+||++|||++ |+.||.............     ..+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~-~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (288)
T cd05061         166 TRDIYETDYYRKGGKGLLPVRWMAPESLK-DGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD  244 (288)
T ss_pred             cccccccccccccCCCcccccccCHHHhc-cCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            98654333222222333466799999884 4468999999999999999998 889997765443222111     0112


Q ss_pred             hhhccccceeecccccccccccccC
Q 002321          911 WKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       911 ~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..+..+++++.+||..||.+||+++
T Consensus       245 ~~~~~~~~li~~~l~~~p~~Rps~~  269 (288)
T cd05061         245 NCPERVTDLMRMCWQFNPKMRPTFL  269 (288)
T ss_pred             CCCHHHHHHHHHHcCCChhHCcCHH
Confidence            2346789999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=9.9e-35  Score=325.29  Aligned_cols=239  Identities=18%  Similarity=0.239  Sum_probs=192.0

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||+|+++.....  ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM  122 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence            35677788999999999999976 5889999998643221  22355788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++|+|.+++....    +++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus       123 Ey~~gg~L~~~l~~~~----l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~-~  197 (370)
T cd05596         123 EYMPGGDLVNLMSNYD----IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-M  197 (370)
T ss_pred             cCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC-c
Confidence            9999999999987543    7888888999999999999999999999999999999999999999999997653221 1


Q ss_pred             cccccccCcccccCcccccCc---ccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH------HHH--hhhcc
Q 002321          847 VLSSKIQSALGYMAPEFACRT---VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL------EEH--WKKAE  915 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~------~~~--~~~~~  915 (936)
                      .......|++.|+|||++...   ..++.++||||+||++|||++|+.||...+..........      .+.  ..+..
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  277 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQ  277 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHH
Confidence            122345689999999987433   2478899999999999999999999988765322211110      011  23467


Q ss_pred             ccceeeccccccccc--ccc
Q 002321          916 WRNVSMRSCKGSSRQ--RRR  933 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~--Rp~  933 (936)
                      +++++.+|+..+|.+  |++
T Consensus       278 ~~~li~~~L~~~p~r~~R~s  297 (370)
T cd05596         278 AKDLICAFLTDREVRLGRNG  297 (370)
T ss_pred             HHHHHHHHccChhhccCCCC
Confidence            788899999988866  665

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.7e-34  Score=303.72  Aligned_cols=235  Identities=24%  Similarity=0.327  Sum_probs=191.0

Q ss_pred             cccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCCChhh
Q 002321          697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHK  776 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  776 (936)
                      .||+|+||.||+|...+++.||+|++...........+.+|++++++++||||+++++++......++||||+++++|.+
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   81 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS   81 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence            68999999999999888899999998655433445678899999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccccccCcc
Q 002321          777 HLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL  856 (936)
Q Consensus       777 ~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~  856 (936)
                      ++....  ..+++..+..++.|++.|+.|+|++|++||||||+||+++.++.+|++|||++....... ........++.
T Consensus        82 ~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~  158 (250)
T cd05085          82 FLRKKK--DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQIPI  158 (250)
T ss_pred             HHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCCcc
Confidence            987543  237899999999999999999999999999999999999999999999999987543211 11112223456


Q ss_pred             cccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceeeccccccccc
Q 002321          857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSMRSCKGSSRQ  930 (936)
Q Consensus       857 ~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~p~~  930 (936)
                      .|+|||+. ....++.++||||+|+++||+++ |..||.............     ..+...+..+.+++.+||..+|.+
T Consensus       159 ~y~aPE~~-~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  237 (250)
T cd05085         159 KWTAPEAL-NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPEN  237 (250)
T ss_pred             cccCHHHh-ccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCccc
Confidence            79999988 44568899999999999999998 999997664432211110     001223477889999999999999


Q ss_pred             ccccC
Q 002321          931 RRRFQ  935 (936)
Q Consensus       931 Rp~f~  935 (936)
                      ||+++
T Consensus       238 Rp~~~  242 (250)
T cd05085         238 RPKFS  242 (250)
T ss_pred             CCCHH
Confidence            99874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-34  Score=321.97  Aligned_cols=193  Identities=20%  Similarity=0.275  Sum_probs=165.3

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..++||+|+||.||+|.+. +++.||+|+..       ...+.+|++++++++||||+++++++......++|+|+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            45788889999999999999976 58899999653       34568999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      + +++|.+++.....   +++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+|+...... ...
T Consensus       165 ~-~~~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~  239 (391)
T PHA03212        165 Y-KTDLYCYLAAKRN---IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANK  239 (391)
T ss_pred             C-CCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-ccc
Confidence            9 4789888866433   8899999999999999999999999999999999999999999999999997532211 112


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCc
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLST  895 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~  895 (936)
                      .....||+.|+|||++. ...++.++||||+||++|||++|+.||..
T Consensus       240 ~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        240 YYGWAGTIATNAPELLA-RDPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             cccccCccCCCChhhhc-CCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            23456899999999884 45789999999999999999999988754

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-36  Score=317.36  Aligned_cols=236  Identities=27%  Similarity=0.391  Sum_probs=196.5

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  765 (936)
                      ...|...++||.|+||.||-|++. +.+.||||++...+..  +.-.++..|++++.+++|||++.+.|+|......|+|
T Consensus        25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV  104 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV  104 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence            456777889999999999999965 6789999999654432  3346789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      |||| -|+-.|++.-.++  ++.+.++..|+.+.+.||+|||+.+.+|||||+.|||+++.|.||++|||.|....    
T Consensus       105 MEYC-lGSAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~----  177 (948)
T KOG0577|consen  105 MEYC-LGSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA----  177 (948)
T ss_pred             HHHH-hccHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC----
Confidence            9999 5788888866543  38899999999999999999999999999999999999999999999999997653    


Q ss_pred             ccccccccCcccccCcccc--cCcccCCchhhHHHHHHHHHHHHcCCCCCCccch-hHHHHHH-HHHHHhhhc----ccc
Q 002321          846 YVLSSKIQSALGYMAPEFA--CRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM-MWWFSVT-WLEEHWKKA----EWR  917 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~--~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~-~~~~~~~-~~~~~~~~~----~~~  917 (936)
                        ......|||.|||||++  +....|+-++||||+|++..|+.-+++|+..... ...+-.. ...|...+.    .|+
T Consensus       178 --PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~  255 (948)
T KOG0577|consen  178 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFR  255 (948)
T ss_pred             --chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHH
Confidence              23567899999999987  3556799999999999999999999999765543 3333232 223333333    456


Q ss_pred             ceeecccccccccccc
Q 002321          918 NVSMRSCKGSSRQRRR  933 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~  933 (936)
                      .++..|+.+=|.+||+
T Consensus       256 ~Fvd~CLqKipqeRpt  271 (948)
T KOG0577|consen  256 NFVDSCLQKIPQERPT  271 (948)
T ss_pred             HHHHHHHhhCcccCCc
Confidence            7888999999999997

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.4e-34  Score=312.25  Aligned_cols=245  Identities=24%  Similarity=0.318  Sum_probs=197.4

Q ss_pred             ccccCCCcccccCceEEEEEEeCC-----------------CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCccee
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRD-----------------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL  752 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  752 (936)
                      ..|+..++||+|+||.||+|+..+                 +..||+|++.........+.+.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            346778899999999999988642                 246899998765544556789999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCChhhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc
Q 002321          753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSG--------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLID  824 (936)
Q Consensus       753 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~  824 (936)
                      ++++......++||||+++++|.+++.+...        ...+++..+..++.|++.||+|||+.+++||||||+||+++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~  164 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG  164 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeec
Confidence            9999998999999999999999999976541        12488999999999999999999999999999999999999


Q ss_pred             CCCCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc--CCCCCCccchhHHH
Q 002321          825 GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT--GKRPLSTWKMMWWF  902 (936)
Q Consensus       825 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~--g~~Pf~~~~~~~~~  902 (936)
                      .++.++|+|||+++.....+.........++..|+|||... ...++.++|||||||++|||++  |..||.........
T Consensus       165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~  243 (296)
T cd05051         165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVL-LGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI  243 (296)
T ss_pred             CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhh-cCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHH
Confidence            99999999999997654333333333445677899999884 4468999999999999999998  78888765543222


Q ss_pred             HHHHHH------------HHhhhccccceeecccccccccccccC
Q 002321          903 SVTWLE------------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       903 ~~~~~~------------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ......            +...+.++.+++.+||..||.+||+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~  288 (296)
T cd05051         244 ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFR  288 (296)
T ss_pred             HHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHH
Confidence            111100            112235789999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.7e-34  Score=306.94  Aligned_cols=241  Identities=27%  Similarity=0.378  Sum_probs=198.4

Q ss_pred             ccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      ..|+..++||+|+||.||+|...+++.+|+|++..... .....+.+|+.++++++|+||+++++++.+....++||||+
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            45677889999999999999998899999999865432 23567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++++|.++++.... ..+++.++.+++.|++.|++|||++|++||||||+||++++++.+||+|||.+.......  ...
T Consensus        85 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~--~~~  161 (261)
T cd05148          85 EKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--YLS  161 (261)
T ss_pred             ccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc--ccc
Confidence            99999999986542 348999999999999999999999999999999999999999999999999997654321  112


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH-----HHHhhhccccceeecc
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL-----EEHWKKAEWRNVSMRS  923 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  923 (936)
                      ....++..|+|||... ...++.++||||+|+++|+|++ |+.||..............     .+...++.+.+++.+|
T Consensus       162 ~~~~~~~~~~~PE~~~-~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  240 (261)
T cd05148         162 SDKKIPYKWTAPEAAS-HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLEC  240 (261)
T ss_pred             cCCCCceEecCHHHHc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHH
Confidence            2334567899999884 4578899999999999999998 8999977654322211111     1123346788999999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..||.+||+++
T Consensus       241 l~~~p~~Rpt~~  252 (261)
T cd05148         241 WAAEPEDRPSFK  252 (261)
T ss_pred             cCCCchhCcCHH
Confidence            999999999974

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.2e-34  Score=314.41  Aligned_cols=242  Identities=24%  Similarity=0.351  Sum_probs=191.0

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCc--EEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGR--PVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  765 (936)
                      +.|+..+.||+|+||.||+|.++ ++.  .+|+|.++........+.+.+|+.++.++ +|+||+++++++...+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            45677788999999999999975 344  46777775433333456788999999999 899999999999999999999


Q ss_pred             EEecCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEe
Q 002321          766 YEFVSGGSLHKHLHEGSG-------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVG  832 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~  832 (936)
                      |||+++|+|.+++++...             ...+++.++..++.|++.|++|||++|++||||||+||++++++.+||+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~  166 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA  166 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeC
Confidence            999999999999975431             1247899999999999999999999999999999999999999999999


Q ss_pred             eccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH----
Q 002321          833 DYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL----  907 (936)
Q Consensus       833 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~----  907 (936)
                      |||+++....   .........+..|+|||.. ....++.++||||+||++|||++ |..||...+..........    
T Consensus       167 dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~  242 (303)
T cd05088         167 DFGLSRGQEV---YVKKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL  242 (303)
T ss_pred             ccccCcccch---hhhcccCCCcccccCHHHH-hccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcC
Confidence            9999864321   1111222335679999988 44568899999999999999998 9999976654332221110    


Q ss_pred             -HHHhhhccccceeecccccccccccccC
Q 002321          908 -EEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       908 -~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                       .+...+..+.+++.+||..+|.+||+++
T Consensus       243 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~  271 (303)
T cd05088         243 EKPLNCDDEVYDLMRQCWREKPYERPSFA  271 (303)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence             0111345678899999999999999864

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.9e-34  Score=312.07  Aligned_cols=245  Identities=25%  Similarity=0.344  Sum_probs=196.9

Q ss_pred             cccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCe
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSL  761 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  761 (936)
                      ...|...+.||+|+||.||+|...      ++..||||+++........+.+.+|+++++++ +|+||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            345678889999999999999742      35589999987554444456789999999999 79999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .++||||+++|+|.++++.... ..+++.++.+++.|++.|++|||+++++|+||||+||+++.++.++++|||+++...
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~  192 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIM  192 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence            9999999999999999975432 338999999999999999999999999999999999999999999999999998654


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH------HHHHhhhc
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW------LEEHWKKA  914 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~------~~~~~~~~  914 (936)
                      ............++..|+|||.+. ...++.++||||+||++|||++ |..||.............      ..+...+.
T Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (302)
T cd05055         193 NDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPA  271 (302)
T ss_pred             CCCceeecCCCCcccccCCHhhhc-cCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCH
Confidence            332222222334567899999884 4468999999999999999998 999997755422111100      01123346


Q ss_pred             cccceeecccccccccccccC
Q 002321          915 EWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       915 ~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+.+++.+||..+|.+||+++
T Consensus       272 ~~~~li~~cl~~~p~~Rpt~~  292 (302)
T cd05055         272 EIYDIMKTCWDADPLKRPTFK  292 (302)
T ss_pred             HHHHHHHHHcCCCchhCcCHH
Confidence            788999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.2e-34  Score=313.26  Aligned_cols=245  Identities=24%  Similarity=0.333  Sum_probs=197.3

Q ss_pred             ccccCCCcccccCceEEEEEEeCC------CcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCee
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRD------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQ  762 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  762 (936)
                      ..|+..+.||+|+||.||++....      ...||+|++......+...++.+|+.++.++ +|+||+++++++...+..
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   91 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL   91 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence            446777899999999999998642      3689999987554444456788999999999 899999999999999999


Q ss_pred             EEEEEecCCCChhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCe
Q 002321          763 LLIYEFVSGGSLHKHLHEGS-------------GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEP  829 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~  829 (936)
                      +++|||+++|+|.++++...             ....+++..+.+++.|++.|++|||+.+|+||||||+||+++.++.+
T Consensus        92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~  171 (293)
T cd05053          92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVM  171 (293)
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeE
Confidence            99999999999999986531             22358899999999999999999999999999999999999999999


Q ss_pred             EEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHHH
Q 002321          830 KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWLE  908 (936)
Q Consensus       830 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~~  908 (936)
                      ||+|||.++.+.............++..|+|||.. ....++.++|||||||++|||++ |..||...............
T Consensus       172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  250 (293)
T cd05053         172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG  250 (293)
T ss_pred             EeCccccccccccccceeccCCCCCCccccCHHHh-ccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999876543322222333345679999987 44568899999999999999998 99999876654333221111


Q ss_pred             -----HHhhhccccceeecccccccccccccC
Q 002321          909 -----EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 -----~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                           +......+.+++.+||..||.+||+.+
T Consensus       251 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  282 (293)
T cd05053         251 YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFK  282 (293)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcccCcccCcCHH
Confidence                 122346788899999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.4e-34  Score=313.32  Aligned_cols=247  Identities=23%  Similarity=0.326  Sum_probs=197.4

Q ss_pred             ccccccCCCcccccCceEEEEEEeC--------CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEe
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLR--------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWT  758 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  758 (936)
                      ....|+..+.||+|+||.||+|+..        ++..||+|.++........+++.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3455678889999999999999742        24579999986543344467789999999999 89999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC
Q 002321          759 QSLQLLIYEFVSGGSLHKHLHEGSG-------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG  825 (936)
Q Consensus       759 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~  825 (936)
                      ....++||||+++|+|.+++.....             ...+++.++.+++.|++.||+|||++|++||||||+||+++.
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~  172 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTE  172 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcC
Confidence            9999999999999999999976421             124788899999999999999999999999999999999999


Q ss_pred             CCCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHH
Q 002321          826 SGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSV  904 (936)
Q Consensus       826 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~  904 (936)
                      ++.+||+|||.++...............+++.|+|||++. +..++.++||||+|+++|||++ |..||...........
T Consensus       173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~  251 (304)
T cd05101         173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL  251 (304)
T ss_pred             CCcEEECCCccceecccccccccccCCCCCceeeCchhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence            9999999999998764433322223334567799999884 4568999999999999999998 8899977654332221


Q ss_pred             HHHH-----HHhhhccccceeecccccccccccccC
Q 002321          905 TWLE-----EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       905 ~~~~-----~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ....     +.-.+..+++++.+||..+|.+||+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~  287 (304)
T cd05101         252 LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFK  287 (304)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHH
Confidence            1100     112346788899999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-34  Score=307.74  Aligned_cols=242  Identities=22%  Similarity=0.308  Sum_probs=192.4

Q ss_pred             cCCCcccccCceEEEEEEeCC----CcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCe------
Q 002321          693 NKDCELGRGGFGAVYRTVLRD----GRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSL------  761 (936)
Q Consensus       693 ~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  761 (936)
                      ...+.||+|+||.||+|+...    +..||||+++..... ...+.+.+|+..++.++|+||+++++++.....      
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            456789999999999998652    367999998754332 234678999999999999999999999866543      


Q ss_pred             eEEEEEecCCCChhhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCcc
Q 002321          762 QLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR  838 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  838 (936)
                      .+++|||+++|+|.+++....   ....+++.....++.|++.||+|||+.+++||||||+||++++++.+||+|||+++
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  161 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK  161 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCcccee
Confidence            689999999999999885432   22358999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhh
Q 002321          839 LLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWK  912 (936)
Q Consensus       839 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~  912 (936)
                      ................+..|+|||.. ....++.++||||+||++|||++ |..||.+.+.........     ..+...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  240 (273)
T cd05035         162 KIYSGDYYRQGRIAKMPVKWIAIESL-ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDC  240 (273)
T ss_pred             eccccccccccccccCCccccCHhhc-ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCC
Confidence            76443333223333456679999988 45578999999999999999999 999997765433221111     012224


Q ss_pred             hccccceeecccccccccccccC
Q 002321          913 KAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       913 ~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +.++.+++.+||..||.+||+++
T Consensus       241 ~~~~~~li~~~l~~~p~~Rp~~~  263 (273)
T cd05035         241 LDELYDLMYSCWRADPKDRPTFT  263 (273)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHH
Confidence            46788999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.1e-34  Score=310.36  Aligned_cols=238  Identities=26%  Similarity=0.317  Sum_probs=188.7

Q ss_pred             cCCCcccccCceEEEEEEe-----CCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeC--CeeEEE
Q 002321          693 NKDCELGRGGFGAVYRTVL-----RDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ--SLQLLI  765 (936)
Q Consensus       693 ~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  765 (936)
                      +..+.||+|+||+||++..     .+++.||+|.++........+.+.+|++++++++||||+++++++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            6678899999999988653     257899999987654333467788999999999999999999998653  357899


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      |||+++++|.+++....    +++.+++.++.|+++|++|||+++|+||||||+||++++++.++|+|||+++.......
T Consensus        87 ~e~~~~~~l~~~~~~~~----l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  162 (283)
T cd05080          87 MEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  162 (283)
T ss_pred             ecCCCCCCHHHHHHHcC----CCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence            99999999999997643    89999999999999999999999999999999999999999999999999986643222


Q ss_pred             cc-ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH----------HHHHHH------
Q 002321          846 YV-LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF----------SVTWLE------  908 (936)
Q Consensus       846 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~----------~~~~~~------  908 (936)
                      .. ......++..|+|||... ...++.++||||||+++|||++|..||.........          .....+      
T Consensus       163 ~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T cd05080         163 YYRVREDGDSPVFWYAVECLK-ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM  241 (283)
T ss_pred             hhccCCCCCCCceeeCHhHhc-ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCC
Confidence            11 112233556799999884 456889999999999999999999998654321100          000000      


Q ss_pred             ----HHhhhccccceeecccccccccccccC
Q 002321          909 ----EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 ----~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                          +...+.++.+++.+||..+|.+||+++
T Consensus       242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~  272 (283)
T cd05080         242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFR  272 (283)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccChhhCCCHH
Confidence                111245788899999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.3e-34  Score=309.00  Aligned_cols=245  Identities=24%  Similarity=0.350  Sum_probs=193.8

Q ss_pred             ccccCCCcccccCceEEEEEEeCC------CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRD------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  763 (936)
                      ..|...+.||+|+||.||+|.+.+      +..||+|.+...........+.+|+.++++++|+||+++++++.+....+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            345677889999999999999753      56899998865544444567899999999999999999999999888889


Q ss_pred             EEEEecCCCChhhhhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---CeEEeeccC
Q 002321          764 LIYEFVSGGSLHKHLHEGSG----GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG---EPKVGDYGL  836 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~  836 (936)
                      +||||+++++|.+++.....    ...+++.++.+++.||+.|++|||+++++||||||+||+++.++   .+|++|||+
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~  165 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM  165 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcc
Confidence            99999999999999976532    12488999999999999999999999999999999999998765   599999999


Q ss_pred             ccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHH
Q 002321          837 ARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEH  910 (936)
Q Consensus       837 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~  910 (936)
                      ++................+..|+|||++. ...++.++|||||||++|||++ |..||...+.........     ..+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  244 (277)
T cd05036         166 ARDIYRASYYRKGGRAMLPIKWMPPEAFL-DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPK  244 (277)
T ss_pred             ccccCCccceecCCCCCccHhhCCHHHHh-cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence            98663222211122223356799999984 4468999999999999999997 999998765432221110     0112


Q ss_pred             hhhccccceeecccccccccccccC
Q 002321          911 WKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       911 ~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..+.++.+++.+||..+|.+||+++
T Consensus       245 ~~~~~~~~~i~~cl~~~p~~Rps~~  269 (277)
T cd05036         245 GCPGPVYRIMTDCWQHTPEDRPNFA  269 (277)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHH
Confidence            2345678899999999999999874

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.1e-34  Score=311.45  Aligned_cols=241  Identities=24%  Similarity=0.349  Sum_probs=190.9

Q ss_pred             cccCCCcccccCceEEEEEEeCC-C--cEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRD-G--RPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      .|+..+.||+|+||.||+|..++ +  ..+|+|.++........+.+.+|+.+++++ +||||+++++++......++||
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~   82 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI   82 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence            35677889999999999998763 3  357888886443334456789999999999 7999999999999988899999


Q ss_pred             EecCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEee
Q 002321          767 EFVSGGSLHKHLHEGSG-------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGD  833 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D  833 (936)
                      ||+++|+|.+++++...             ...+++..+.+++.|++.|++|||++|++||||||+||++++++.+||+|
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~d  162 (297)
T cd05089          83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIAD  162 (297)
T ss_pred             EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECC
Confidence            99999999999976431             12488899999999999999999999999999999999999999999999


Q ss_pred             ccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----H
Q 002321          834 YGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----L  907 (936)
Q Consensus       834 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~  907 (936)
                      ||++.....   .........+..|+|||.. ....++.++|||||||++|||++ |..||.............     .
T Consensus       163 fg~~~~~~~---~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~  238 (297)
T cd05089         163 FGLSRGEEV---YVKKTMGRLPVRWMAIESL-NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME  238 (297)
T ss_pred             cCCCccccc---eeccCCCCcCccccCchhh-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence            999864321   1111122234569999988 44568999999999999999997 999998765533221110     0


Q ss_pred             HHHhhhccccceeecccccccccccccC
Q 002321          908 EEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       908 ~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+...+..+.+++.+||..+|.+||+++
T Consensus       239 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~  266 (297)
T cd05089         239 KPRNCDDEVYELMRQCWRDRPYERPPFA  266 (297)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence            1122346688999999999999999874

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4e-34  Score=305.42  Aligned_cols=231  Identities=22%  Similarity=0.276  Sum_probs=183.6

Q ss_pred             CcccccCceEEEEEEeCC-------------CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCee
Q 002321          696 CELGRGGFGAVYRTVLRD-------------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQ  762 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  762 (936)
                      +.||+|+||.||+|+..+             ...||+|.+.... ......+.+|+.+++.++||||+++++++..+...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            358999999999998542             2358889875432 23345788899999999999999999999998889


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCC-------eEEeecc
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGE-------PKVGDYG  835 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~-------~kl~Dfg  835 (936)
                      ++||||+++|+|..++....  ..+++..+.+++.|+++|++|||+++|+||||||+||+++.++.       ++++|||
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            99999999999999887543  23889999999999999999999999999999999999987664       8999999


Q ss_pred             CccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHH-cCCCCCCccchhHHHHHHHHH---HHh
Q 002321          836 LARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVV-TGKRPLSTWKMMWWFSVTWLE---EHW  911 (936)
Q Consensus       836 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~-~g~~Pf~~~~~~~~~~~~~~~---~~~  911 (936)
                      .+......      ....++..|+|||.+.....++.++|||||||++|||+ .|..||...............   ...
T Consensus       158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  231 (262)
T cd05077         158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTP  231 (262)
T ss_pred             CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCCC
Confidence            98654321      22346778999998865667899999999999999998 589998765543222111000   111


Q ss_pred             hhccccceeecccccccccccccC
Q 002321          912 KKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       912 ~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ....+++++.+||..||.+||+|+
T Consensus       232 ~~~~~~~li~~cl~~dp~~Rp~~~  255 (262)
T cd05077         232 SCKELADLMTHCMNYDPNQRPFFR  255 (262)
T ss_pred             ChHHHHHHHHHHcCCChhhCcCHH
Confidence            235678999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.8e-34  Score=310.60  Aligned_cols=239  Identities=25%  Similarity=0.298  Sum_probs=192.5

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc--hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK--SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      |+..+.||+|+||.||+|... +++.||||.+.......  ....+.+|+.++++++|++++++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            455678999999999999976 58899999986543322  234577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++++|.+++..... ..+++.++..++.|++.|++|||+.+|+||||||+||+++.++.++|+|||++........   
T Consensus        82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---  157 (285)
T cd05630          82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---  157 (285)
T ss_pred             cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---
Confidence            999999998865332 2388999999999999999999999999999999999999999999999999876532221   


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHH----HHH----HHHHHHhhhcccccee
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWW----FSV----TWLEEHWKKAEWRNVS  920 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~----~~~----~~~~~~~~~~~~~~~~  920 (936)
                      .....++..|+|||.+. ...++.++||||+||++|||++|+.||........    ...    ....+...+...++++
T Consensus       158 ~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05630         158 IKGRVGTVGYMAPEVVK-NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC  236 (285)
T ss_pred             ccCCCCCccccChHHHc-CCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence            12346888999999984 45689999999999999999999999986532111    000    0011122345678999


Q ss_pred             ecccccccccccccC
Q 002321          921 MRSCKGSSRQRRRFQ  935 (936)
Q Consensus       921 ~~~l~~~p~~Rp~f~  935 (936)
                      .+||..||.+||+++
T Consensus       237 ~~~l~~~p~~R~s~~  251 (285)
T cd05630         237 KMLLCKDPKERLGCQ  251 (285)
T ss_pred             HHHhhcCHHHccCCC
Confidence            999999999999853

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.4e-34  Score=318.26  Aligned_cols=246  Identities=27%  Similarity=0.355  Sum_probs=193.1

Q ss_pred             cccccCCCcccccCceEEEEEEe------CCCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeC-C
Q 002321          689 HALLNKDCELGRGGFGAVYRTVL------RDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQ-S  760 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  760 (936)
                      ...|+..+.||+|+||.||+|.+      .+++.||||+++..........+.+|+.++.++ +|+||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            34578889999999999999974      247899999997654444456788999999999 689999999988654 4


Q ss_pred             eeEEEEEecCCCChhhhhhccCC---------------------------------------------------------
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSG---------------------------------------------------------  783 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  783 (936)
                      ..++||||+++|+|.++++....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            57899999999999999865321                                                         


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccccccCcc
Q 002321          784 -------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL  856 (936)
Q Consensus       784 -------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~  856 (936)
                             ...+++.++.+++.|++.|++|||+++|+||||||+||+++.++.+||+|||+++...............++.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  245 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence                   1236788889999999999999999999999999999999999999999999997653322222223334566


Q ss_pred             cccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH------HHHHhhhccccceeecccccccc
Q 002321          857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW------LEEHWKKAEWRNVSMRSCKGSSR  929 (936)
Q Consensus       857 ~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~p~  929 (936)
                      .|+|||... ...++.++||||+|+++|||++ |..||.............      ..+.+.++.+.+++.+||+.||.
T Consensus       246 ~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~  324 (343)
T cd05103         246 KWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS  324 (343)
T ss_pred             ceECcHHhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            799999884 4568999999999999999997 999997754321111111      11233456778899999999999


Q ss_pred             cccccC
Q 002321          930 QRRRFQ  935 (936)
Q Consensus       930 ~Rp~f~  935 (936)
                      +||++.
T Consensus       325 ~Rps~~  330 (343)
T cd05103         325 QRPTFS  330 (343)
T ss_pred             hCcCHH
Confidence            999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.6e-34  Score=304.87  Aligned_cols=240  Identities=27%  Similarity=0.370  Sum_probs=193.1

Q ss_pred             ccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      ..|+..++||+|+||.||+|...++..||+|.+.....  ..+.+.+|+.++++++|++++++++++. ....+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            34677889999999999999988888999999865432  3567899999999999999999999885 45678999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++++|.++++.... ..+++.++.+++.|++.|++|||+.+++||||||+||++++++.++|+|||.+......... ..
T Consensus        83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~  160 (260)
T cd05070          83 SKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-AR  160 (260)
T ss_pred             CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-cc
Confidence            99999999976432 33789999999999999999999999999999999999999999999999999765432211 11


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceeecc
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSMRS  923 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  923 (936)
                      ....++..|+|||.. ....++.++||||||+++|||++ |+.||.+.+.........     ..+...+..+.+++.+|
T Consensus       161 ~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  239 (260)
T cd05070         161 QGAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQC  239 (260)
T ss_pred             cCCCCCccccChHHH-hcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHH
Confidence            222345679999987 44568899999999999999999 999997755432221110     01122346788999999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..+|.+||+++
T Consensus       240 l~~~p~~Rpt~~  251 (260)
T cd05070         240 WKKDPEERPTFE  251 (260)
T ss_pred             cccCcccCcCHH
Confidence            999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.5e-34  Score=308.77  Aligned_cols=241  Identities=23%  Similarity=0.302  Sum_probs=192.6

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      |+..+.||+|+||.||+|+.+ +++.||||+++..... ...+.+.+|+.++++++||||+++++++.++...++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL   81 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence            456678999999999999976 5899999998654322 22467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      + +++.+++........+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||++.......  ...
T Consensus        82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~  158 (285)
T cd07861          82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--RVY  158 (285)
T ss_pred             C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc--ccc
Confidence            7 6898888765444558999999999999999999999999999999999999999999999999997553221  112


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH-------------------HHHH-
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT-------------------WLEE-  909 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~-------------------~~~~-  909 (936)
                      ....+++.|+|||.+.+...++.++||||+||++|||++|+.||............                   ...+ 
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT  238 (285)
T ss_pred             cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence            23356788999998866556789999999999999999999999865432111000                   0000 


Q ss_pred             -------------HhhhccccceeecccccccccccccC
Q 002321          910 -------------HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       910 -------------~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                                   ...+++..+++.+||..||.+||+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~  277 (285)
T cd07861         239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAK  277 (285)
T ss_pred             ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHH
Confidence                         01234556899999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.5e-34  Score=310.70  Aligned_cols=245  Identities=24%  Similarity=0.322  Sum_probs=196.0

Q ss_pred             ccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  763 (936)
                      ..|+..++||+|+||.||+|...      ++..||+|++..........++.+|+.++++++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~   84 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC   84 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence            45677889999999999999863      467899999875544444577999999999999999999999999988899


Q ss_pred             EEEEecCCCChhhhhhccCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc
Q 002321          764 LIYEFVSGGSLHKHLHEGSG-------------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLID  824 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~-------------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~  824 (936)
                      +||||+++|+|.+++.....                   ...+++.+++.++.|++.||+|||+++++||||||+||+++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~  164 (288)
T cd05050          85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG  164 (288)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEec
Confidence            99999999999999974321                   12377888999999999999999999999999999999999


Q ss_pred             CCCCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHH
Q 002321          825 GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFS  903 (936)
Q Consensus       825 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~  903 (936)
                      .++.++|+|||.++.+..............+..|+|||... ...++.++|||||||++|||++ |..||..........
T Consensus       165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~  243 (288)
T cd05050         165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY  243 (288)
T ss_pred             CCCceEECccccceecccCccccccCCCccChhhcCHHHHh-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999987654332222222333456799999884 4568999999999999999997 888997654432221


Q ss_pred             HHHH-----HHHhhhccccceeecccccccccccccC
Q 002321          904 VTWL-----EEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       904 ~~~~-----~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ....     .+...+.++.+++.+||..||.+||++.
T Consensus       244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  280 (288)
T cd05050         244 YVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFA  280 (288)
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence            1100     0122346789999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.5e-34  Score=307.13  Aligned_cols=242  Identities=21%  Similarity=0.310  Sum_probs=194.6

Q ss_pred             ccccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ....|+..++||+|+||.||+|+.. +++.||+|++..... .....+++|+.++++++||||+++++++......++||
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            3456788899999999999999975 688999999864422 33456889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++++|.++++...   .+++..+..++.|++.|++|||+.+|+|||+||+||+++.++.++|+|||+++......  
T Consensus        86 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--  160 (267)
T cd06646          86 EYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--  160 (267)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc--
Confidence            9999999999987543   38899999999999999999999999999999999999999999999999997653211  


Q ss_pred             cccccccCcccccCccccc--CcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-H---HHHHHH-----Hhhhcc
Q 002321          847 VLSSKIQSALGYMAPEFAC--RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-S---VTWLEE-----HWKKAE  915 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~---~~~~~~-----~~~~~~  915 (936)
                      .......++..|+|||.+.  ....++.++||||+||++|||++|+.||...+..... .   ..+..+     ...+..
T Consensus       161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06646         161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST  240 (267)
T ss_pred             cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence            1122345778899999873  2334678999999999999999999999665432111 0   000001     112356


Q ss_pred             ccceeecccccccccccccC
Q 002321          916 WRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +.+++.+||..+|.+||+++
T Consensus       241 ~~~li~~~l~~~P~~Rp~~~  260 (267)
T cd06646         241 FHNFVKISLTKNPKKRPTAE  260 (267)
T ss_pred             HHHHHHHHhhCChhhCcCHH
Confidence            78899999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6.7e-34  Score=302.87  Aligned_cols=240  Identities=25%  Similarity=0.385  Sum_probs=196.9

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      |+..+.||+|+||.||+|+.. +++.||+|.+..... ....+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA   81 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence            455678999999999999976 589999999865432 244677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++++|.++++... ...+++..+++++.|++.|++|||+.|++|+||||+||++++++.++|+|||+++.......  ..
T Consensus        82 ~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--~~  158 (256)
T cd08529          82 ENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FA  158 (256)
T ss_pred             CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc--hh
Confidence            9999999998653 23488999999999999999999999999999999999999999999999999886643221  12


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-----HHHhhhccccceeeccc
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-----EEHWKKAEWRNVSMRSC  924 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l  924 (936)
                      ....+++.|+|||+.. ...++.++|||||||++|||++|+.||...+..........     .+...+..+.+++.+||
T Consensus       159 ~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  237 (256)
T cd08529         159 NTIVGTPYYLSPELCE-DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCL  237 (256)
T ss_pred             hccccCccccCHHHhc-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHc
Confidence            3345778899999884 44688999999999999999999999987664322111000     01133467899999999


Q ss_pred             ccccccccccC
Q 002321          925 KGSSRQRRRFQ  935 (936)
Q Consensus       925 ~~~p~~Rp~f~  935 (936)
                      ..+|.+||++.
T Consensus       238 ~~~p~~Rp~~~  248 (256)
T cd08529         238 TKDYRQRPDTF  248 (256)
T ss_pred             cCCcccCcCHH
Confidence            99999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.7e-34  Score=308.74  Aligned_cols=230  Identities=22%  Similarity=0.245  Sum_probs=182.1

Q ss_pred             cccccCceEEEEEEeCC-------------------------CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcce
Q 002321          697 ELGRGGFGAVYRTVLRD-------------------------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT  751 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  751 (936)
                      +||+|+||.||+|+...                         ...||+|++.... .....++.+|+.++++++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence            69999999999997521                         1358899885432 223456888999999999999999


Q ss_pred             eeeEEEeCCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC----
Q 002321          752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG----  827 (936)
Q Consensus       752 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~----  827 (936)
                      +++++.+....++||||+++|+|..++.+..  ..+++..+.+++.|+++||+|||+++|+||||||+||++++.+    
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999987533  2388999999999999999999999999999999999998654    


Q ss_pred             ---CeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHH-cCCCCCCccchhHHHH
Q 002321          828 ---EPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVV-TGKRPLSTWKMMWWFS  903 (936)
Q Consensus       828 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~-~g~~Pf~~~~~~~~~~  903 (936)
                         .+|++|||.+......      ....++..|+|||.+.+...++.++|||||||++|||+ +|+.||..........
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  232 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER  232 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence               3899999988643211      12345677999998865567899999999999999995 6999997765432211


Q ss_pred             HH---HHHHHhhhccccceeecccccccccccccC
Q 002321          904 VT---WLEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       904 ~~---~~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..   ...+......+.+++.+||..+|.+||+|+
T Consensus       233 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~  267 (274)
T cd05076         233 FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFR  267 (274)
T ss_pred             HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHH
Confidence            11   111122235689999999999999999984

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-34  Score=309.60  Aligned_cols=245  Identities=23%  Similarity=0.313  Sum_probs=193.2

Q ss_pred             ccccCCCcccccCceEEEEEEeCC---------------CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeee
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRD---------------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG  754 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  754 (936)
                      ..|+..++||+|+||.||+|+...               ...||||+++..........+.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            356778899999999999987542               23589999875533344567999999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCChhhhhhccCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC
Q 002321          755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSG---------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG  825 (936)
Q Consensus       755 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~  825 (936)
                      ++......++||||+++++|.+++.....         ...+++..+.+++.|++.|++|||+.+++||||||+||+++.
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~  164 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN  164 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC
Confidence            99999999999999999999999865321         123688899999999999999999999999999999999999


Q ss_pred             CCCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc--CCCCCCccchhHHH-
Q 002321          826 SGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT--GKRPLSTWKMMWWF-  902 (936)
Q Consensus       826 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~--g~~Pf~~~~~~~~~-  902 (936)
                      ++.+||+|||+++...............++..|+|||... ...++.++|||||||++|||++  |..||......... 
T Consensus       165 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~  243 (295)
T cd05097         165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE  243 (295)
T ss_pred             CCcEEecccccccccccCcceeccCcCcCceeecChhhhc-cCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHH
Confidence            9999999999997654332222223334567899999884 4468999999999999999998  67888775543221 


Q ss_pred             HH-HHHH----------HHhhhccccceeecccccccccccccC
Q 002321          903 SV-TWLE----------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       903 ~~-~~~~----------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .. ....          +...++.+.+++.+||..||.+||++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~  287 (295)
T cd05097         244 NTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFN  287 (295)
T ss_pred             HHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence            11 1111          112235678999999999999999874

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-34  Score=303.79  Aligned_cols=238  Identities=26%  Similarity=0.385  Sum_probs=197.7

Q ss_pred             CcccccCceEEEEEEeCC----CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          696 CELGRGGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      +.||+|+||.||+|+...    +..||+|++.........+.+.+|++++++++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            369999999999999764    7899999997655444467899999999999999999999999998999999999999


Q ss_pred             CChhhhhhccCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          772 GSLHKHLHEGSG------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       772 g~L~~~l~~~~~------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      ++|.+++.....      ...+++.++++++.|++.|++|||+++++||||||+||++++++.+||+|||.++.......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  160 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY  160 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence            999999987521      24589999999999999999999999999999999999999999999999999987654332


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccce
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNV  919 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~  919 (936)
                      ........++..|+|||.+... .++.++||||+||++|||++ |+.||...+.........     ..+...+..+.++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (262)
T cd00192         161 YRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYEL  239 (262)
T ss_pred             cccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHH
Confidence            2333445577889999988444 68999999999999999999 699998875532221111     1123345778899


Q ss_pred             eeccccccccccccc
Q 002321          920 SMRSCKGSSRQRRRF  934 (936)
Q Consensus       920 ~~~~l~~~p~~Rp~f  934 (936)
                      +.+||..+|.+||+.
T Consensus       240 i~~~l~~~p~~Rps~  254 (262)
T cd00192         240 MLSCWQLDPEDRPTF  254 (262)
T ss_pred             HHHHccCCcccCcCH
Confidence            999999999999985

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.4e-34  Score=312.02  Aligned_cols=245  Identities=22%  Similarity=0.321  Sum_probs=193.6

Q ss_pred             ccccCCCcccccCceEEEEEEeC-----------------CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCccee
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-----------------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL  752 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  752 (936)
                      ..|+..+.||+|+||.||++...                 ++..||+|++..........++.+|++++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            34677889999999999998643                 2346899998755444446789999999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCChhhhhhccCCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc
Q 002321          753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGG--------NFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLID  824 (936)
Q Consensus       753 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~  824 (936)
                      ++++...+..++||||+++|+|.+++......        ..+++.++.+++.|++.|++|||+.+++||||||+||+++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~  164 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG  164 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEc
Confidence            99999999999999999999999998764321        2377889999999999999999999999999999999999


Q ss_pred             CCCCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc--CCCCCCccchhHHH
Q 002321          825 GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT--GKRPLSTWKMMWWF  902 (936)
Q Consensus       825 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~--g~~Pf~~~~~~~~~  902 (936)
                      .++.++++|||+++.+..............+..|+|||.... ..++.++||||+||++|||++  |..||.........
T Consensus       165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~  243 (296)
T cd05095         165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI  243 (296)
T ss_pred             CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH
Confidence            999999999999976543222222222334567999998744 468999999999999999998  78899765543221


Q ss_pred             H--HHHH----------HHHhhhccccceeecccccccccccccC
Q 002321          903 S--VTWL----------EEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       903 ~--~~~~----------~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .  ..+.          .+...+..+.+++.+||..||.+||+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~  288 (296)
T cd05095         244 ENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQ  288 (296)
T ss_pred             HHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence            1  1111          0122346778999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-34  Score=303.47  Aligned_cols=240  Identities=23%  Similarity=0.351  Sum_probs=194.7

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc----chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV----KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      |+..+.||+|++|.||+|... +++.||+|++......    ...+.+.+|++++++++||||+++++++.+....++|+
T Consensus         4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   83 (263)
T cd06625           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM   83 (263)
T ss_pred             ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence            567789999999999999865 5899999998644322    12356889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++++|.+++....   .+++..+.+++.|++.|++|||+.+++||||||+||++++++.++|+|||+++........
T Consensus        84 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          84 EYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            9999999999987643   3788899999999999999999999999999999999999999999999999765332111


Q ss_pred             cc-cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HHHH-----HHHHhhhccccce
Q 002321          847 VL-SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVTW-----LEEHWKKAEWRNV  919 (936)
Q Consensus       847 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~~-----~~~~~~~~~~~~~  919 (936)
                      .. .....++..|+|||...+ ..++.++||||+|+++|||++|+.||...+..... ....     ..+...+..+.++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF  239 (263)
T ss_pred             cccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHH
Confidence            11 123456778999999854 46889999999999999999999999776543221 1110     0112345678899


Q ss_pred             eecccccccccccccC
Q 002321          920 SMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       920 ~~~~l~~~p~~Rp~f~  935 (936)
                      +.+||..+|.+||++.
T Consensus       240 i~~~l~~~p~~Rpt~~  255 (263)
T cd06625         240 LRRTFVENAKKRPSAE  255 (263)
T ss_pred             HHHHhhcCcccCCCHH
Confidence            9999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-34  Score=307.90  Aligned_cols=242  Identities=26%  Similarity=0.328  Sum_probs=194.7

Q ss_pred             ccccCCCcccccCceEEEEEEeCC-Cc----EEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRD-GR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      ..|+..+.||+|+||.||+|.+++ |+    .||+|............++.+|+.++++++|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            456777899999999999999653 33    6899988766544455788999999999999999999999987 67899


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ||||+++|+|.+++.....  .+++..+..++.|++.|++|||+++++||||||+||+++.++.+||+|||.++......
T Consensus        86 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~  163 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE  163 (279)
T ss_pred             EEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence            9999999999999976532  38999999999999999999999999999999999999999999999999998765332


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccc
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRN  918 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~  918 (936)
                      .........++..|+|||.. ....++.++|+||+||++||+++ |+.||.............     ..+...+..+.+
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (279)
T cd05057         164 KEYHAEGGKVPIKWMALESI-LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYM  242 (279)
T ss_pred             cceecCCCcccccccCHHHh-hcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence            22222222335679999988 44568899999999999999998 999998876543221111     011223456778


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..||.+||+++
T Consensus       243 ~~~~~l~~~p~~Rp~~~  259 (279)
T cd05057         243 VLVKCWMIDAESRPTFK  259 (279)
T ss_pred             HHHHHcCCChhhCCCHH
Confidence            89999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5e-34  Score=312.36  Aligned_cols=245  Identities=25%  Similarity=0.322  Sum_probs=194.6

Q ss_pred             ccccCCCcccccCceEEEEEEeC--------CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCC
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR--------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQS  760 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  760 (936)
                      ..|...++||+|+||.||+|+..        ++..||+|.++.........++.+|+.+++.+ +|+||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            35678889999999999999853        23579999997554334456788999999999 7999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSG-------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG  827 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~  827 (936)
                      ..++||||+++|+|.+++.....             ...+++.++.+++.|++.||+|||+.|++||||||+||+++.++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~  177 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  177 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC
Confidence            99999999999999999976432             12488999999999999999999999999999999999999999


Q ss_pred             CeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH
Q 002321          828 EPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW  906 (936)
Q Consensus       828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~  906 (936)
                      .+||+|||.++...............++..|+|||... +..++.++||||+||++|||++ |..||.............
T Consensus       178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~  256 (307)
T cd05098         178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK  256 (307)
T ss_pred             cEEECCCcccccccccchhhccccCCCccceeChHHhc-cCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence            99999999997654322211122223446799999884 4568999999999999999998 899997655433221110


Q ss_pred             -----HHHHhhhccccceeecccccccccccccC
Q 002321          907 -----LEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       907 -----~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                           ..+...+..+.+++.+||..+|.+||+++
T Consensus       257 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  290 (307)
T cd05098         257 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK  290 (307)
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHH
Confidence                 11122346788899999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3e-34  Score=321.24  Aligned_cols=237  Identities=19%  Similarity=0.238  Sum_probs=189.6

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||+|++......  ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            45677889999999999999976 5889999998643221  22455788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++|+|.++++...    +++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++...... .
T Consensus       123 Ey~~gg~L~~~~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~-~  197 (371)
T cd05622         123 EYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-M  197 (371)
T ss_pred             cCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-c
Confidence            9999999999987543    7888889999999999999999999999999999999999999999999998654221 1


Q ss_pred             cccccccCcccccCcccccCc---ccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH------HH--Hhhhcc
Q 002321          847 VLSSKIQSALGYMAPEFACRT---VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL------EE--HWKKAE  915 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~------~~--~~~~~~  915 (936)
                      .......||+.|+|||++...   ..++.++||||+||++|||++|+.||...+..........      .+  .-.+..
T Consensus       198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  277 (371)
T cd05622         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE  277 (371)
T ss_pred             ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHH
Confidence            122345689999999988433   2378899999999999999999999988765433221110      01  123456


Q ss_pred             ccceeeccccccccccc
Q 002321          916 WRNVSMRSCKGSSRQRR  932 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp  932 (936)
                      .++++.+|+. +|.+|+
T Consensus       278 ~~~li~~~L~-~~~~r~  293 (371)
T cd05622         278 AKNLICAFLT-DREVRL  293 (371)
T ss_pred             HHHHHHHHcC-Chhhhc
Confidence            7788888887 665554

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.6e-34  Score=323.15  Aligned_cols=236  Identities=19%  Similarity=0.255  Sum_probs=186.9

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||+|++......  ...+.+.+|+.+++.++||||+++++++.++...++||
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM  122 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            34677788999999999999976 5789999998643221  23456789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++|+|.+++....    +++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||++........ 
T Consensus       123 Ey~~gg~L~~~l~~~~----~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~-  197 (370)
T cd05621         123 EYMPGGDLVNLMSNYD----VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-  197 (370)
T ss_pred             cCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc-
Confidence            9999999999987542    78889999999999999999999999999999999999999999999999986542221 


Q ss_pred             cccccccCcccccCcccccCc---ccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH--------HHHhhhcc
Q 002321          847 VLSSKIQSALGYMAPEFACRT---VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL--------EEHWKKAE  915 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~--------~~~~~~~~  915 (936)
                      .......||+.|+|||++...   ..++.++||||+||++|||++|+.||..............        +....+..
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~  277 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH  277 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence            122345689999999988533   2378899999999999999999999987665322211110        00112455


Q ss_pred             ccceeecccccccccc
Q 002321          916 WRNVSMRSCKGSSRQR  931 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~R  931 (936)
                      .++++.+|+. ++.+|
T Consensus       278 ~~~li~~~L~-~~~~r  292 (370)
T cd05621         278 AKNLICAFLT-DREVR  292 (370)
T ss_pred             HHHHHHHHcc-Cchhc
Confidence            6777888886 44443

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=5.7e-34  Score=304.16  Aligned_cols=238  Identities=29%  Similarity=0.459  Sum_probs=194.9

Q ss_pred             ccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCccchH-HHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      |+..+.||+|+||+||+++... ++.||+|++......... ....+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            3556789999999999999874 678999999776544332 23466999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++++|.+++.....   +++.++..++.|+++||+|||+.+++|+||||+||++++++.++|+|||.+....  ......
T Consensus        81 ~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~~  155 (260)
T PF00069_consen   81 PGGSLQDYLQKNKP---LSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNENF  155 (260)
T ss_dssp             TTEBHHHHHHHHSS---BBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSEB
T ss_pred             cccccccccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccc
Confidence            99999999984332   8999999999999999999999999999999999999999999999999997541  222234


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccc---hhHHHH-HH--HHHHHh-h----hccccc
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWK---MMWWFS-VT--WLEEHW-K----KAEWRN  918 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~---~~~~~~-~~--~~~~~~-~----~~~~~~  918 (936)
                      ....++..|+|||+......++.++||||+|+++|+|++|..||....   ...... ..  ...... .    .+.+.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD  235 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence            456678899999998536678999999999999999999999999872   211111 11  111111 1    268999


Q ss_pred             eeeccccccccccccc
Q 002321          919 VSMRSCKGSSRQRRRF  934 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f  934 (936)
                      ++.+||..||.+||+.
T Consensus       236 li~~~l~~~p~~R~~~  251 (260)
T PF00069_consen  236 LIKKMLSKDPEQRPSA  251 (260)
T ss_dssp             HHHHHSSSSGGGSTTH
T ss_pred             HHHHHccCChhHCcCH
Confidence            9999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.3e-34  Score=313.13  Aligned_cols=245  Identities=25%  Similarity=0.333  Sum_probs=194.4

Q ss_pred             ccccCCCcccccCceEEEEEEeC--------CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCC
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR--------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQS  760 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  760 (936)
                      ..|...++||+|+||.||+|+..        ....||+|+++.........++.+|+++++++ +||||+++++++.+.+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            45677889999999999999742        24579999987554444466788999999999 6999999999999988


Q ss_pred             eeEEEEEecCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSG-------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG  827 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~  827 (936)
                      ..++||||+++|+|.+++.....             ...+++.+..+++.|++.||+|||++|++||||||+||+++.++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~  171 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN  171 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC
Confidence            89999999999999999976421             13488999999999999999999999999999999999999999


Q ss_pred             CeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH
Q 002321          828 EPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW  906 (936)
Q Consensus       828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~  906 (936)
                      .+||+|||.++...............++..|+|||.+. ...++.++||||+||++|||++ |..||.............
T Consensus       172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~  250 (314)
T cd05099         172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF-DRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR  250 (314)
T ss_pred             cEEEccccccccccccccccccccCCCCccccCHHHHc-cCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99999999998664322222222223445799999884 4578999999999999999999 899997765433222111


Q ss_pred             HH-----HHhhhccccceeecccccccccccccC
Q 002321          907 LE-----EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       907 ~~-----~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..     +...+.++.+++.+||..+|.+||+++
T Consensus       251 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~  284 (314)
T cd05099         251 EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFK  284 (314)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence            11     111234678899999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6e-34  Score=309.29  Aligned_cols=242  Identities=24%  Similarity=0.379  Sum_probs=194.2

Q ss_pred             ccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  765 (936)
                      |...+.||+|+||.||+|+..      ++..+|+|.++.... ...+.+.+|++++++++|+||+++++++......++|
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (291)
T cd05094           7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV   85 (291)
T ss_pred             eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence            456678999999999999843      355789998864432 3346789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEe
Q 002321          766 YEFVSGGSLHKHLHEGSG-------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVG  832 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~  832 (936)
                      |||+++++|.+++.....             ...+++..+++++.|++.|++|||+++++||||||+||+++.++.++|+
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~  165 (291)
T cd05094          86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIG  165 (291)
T ss_pred             EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEEC
Confidence            999999999999975431             1237899999999999999999999999999999999999999999999


Q ss_pred             eccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH----
Q 002321          833 DYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL----  907 (936)
Q Consensus       833 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~----  907 (936)
                      |||++................++..|+|||.+. ...++.++||||+||++|||++ |+.||..............    
T Consensus       166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~  244 (291)
T cd05094         166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL  244 (291)
T ss_pred             CCCcccccCCCceeecCCCCCcceeecChHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCC
Confidence            999997654433333333445677899999884 4568899999999999999998 9999976554322211110    


Q ss_pred             -HHHhhhccccceeecccccccccccccC
Q 002321          908 -EEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       908 -~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                       .+...+..+.+++.+||..||.+||+++
T Consensus       245 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~  273 (291)
T cd05094         245 ERPRVCPKEVYDIMLGCWQREPQQRLNIK  273 (291)
T ss_pred             CCCccCCHHHHHHHHHHcccChhhCcCHH
Confidence             0122345688899999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=6.3e-34  Score=307.24  Aligned_cols=242  Identities=24%  Similarity=0.370  Sum_probs=193.5

Q ss_pred             ccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  765 (936)
                      +...++||+|+||.||++...      ++..+|+|.++... ....+.+.+|++++++++|+||+++++++.+....+++
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (280)
T cd05092           7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV   85 (280)
T ss_pred             ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence            466778999999999999742      35689999876443 23456899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEee
Q 002321          766 YEFVSGGSLHKHLHEGSG------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGD  833 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D  833 (936)
                      |||+++++|.++++....            ...+++..+..++.|++.|++|||+.+++||||||+||++++++.+||+|
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~d  165 (280)
T cd05092          86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGD  165 (280)
T ss_pred             EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECC
Confidence            999999999999876432            12478899999999999999999999999999999999999999999999


Q ss_pred             ccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHH-HHHH----H
Q 002321          834 YGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWF-SVTW----L  907 (936)
Q Consensus       834 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~-~~~~----~  907 (936)
                      ||+++...............+++.|+|||... ...++.++|||||||++|||++ |..||......... ....    .
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  244 (280)
T cd05092         166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELE  244 (280)
T ss_pred             CCceeEcCCCceeecCCCccccccccCHHHhc-cCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCC
Confidence            99997654333222223334567899999884 4468999999999999999998 99999765543222 1111    1


Q ss_pred             HHHhhhccccceeecccccccccccccC
Q 002321          908 EEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       908 ~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+...+....+++.+||..||.+||+++
T Consensus       245 ~~~~~~~~~~~li~~cl~~~P~~Rp~~~  272 (280)
T cd05092         245 RPRTCPPEVYAIMQGCWQREPQQRMVIK  272 (280)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence            1123446678999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=317.13  Aligned_cols=203  Identities=33%  Similarity=0.531  Sum_probs=179.1

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC------eeE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS------LQL  763 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  763 (936)
                      .+...+.||+|+||.||+|+.+ +|+.||||.+......+..+..-+|++++++++|+|||+++++-++..      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3455678999999999999955 699999999988877778899999999999999999999999876543      458


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE--cCCC--CeEEeeccCccc
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLI--DGSG--EPKVGDYGLARL  839 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll--~~~~--~~kl~Dfg~a~~  839 (936)
                      +|||||.+|||...+.+..+..-+++.+.+.+..+++.||.|||+.||+||||||.||++  .++|  ..||+|||.|+.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are  173 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE  173 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence            999999999999999987766679999999999999999999999999999999999998  3334  579999999997


Q ss_pred             cCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCcc
Q 002321          840 LPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTW  896 (936)
Q Consensus       840 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~  896 (936)
                      +++..   ......||..|.+||+....+.|+..+|.|||||++|++.||..||...
T Consensus       174 l~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  174 LDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             CCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            75433   5677899999999999965678999999999999999999999999553

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=8.4e-34  Score=303.07  Aligned_cols=239  Identities=26%  Similarity=0.361  Sum_probs=191.9

Q ss_pred             cccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      .|+..++||+|+||.||+|++.++..||+|+++....  ..+.+.+|++++++++|+||+++++++.. ...++||||++
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (262)
T cd05071           7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   83 (262)
T ss_pred             HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence            4677889999999999999987777899999865322  34678999999999999999999998754 55789999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                      +|+|.+++.+.. ...+++..+..++.|++.||+|+|+.+++||||||+||++++++.++|+|||.++....... ....
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~~~  161 (262)
T cd05071          84 KGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQ  161 (262)
T ss_pred             CCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc-cccc
Confidence            999999997643 23478999999999999999999999999999999999999999999999999976643322 1122


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceeeccc
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSMRSC  924 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l  924 (936)
                      ...++..|+|||.. ....++.++||||+||++|||++ |..||.............     ..+...+..+.+++.+||
T Consensus       162 ~~~~~~~y~~PE~~-~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  240 (262)
T cd05071         162 GAKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW  240 (262)
T ss_pred             CCcccceecCHhHh-ccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHHc
Confidence            33456679999987 44568999999999999999999 888997664432211100     001223466888999999


Q ss_pred             ccccccccccC
Q 002321          925 KGSSRQRRRFQ  935 (936)
Q Consensus       925 ~~~p~~Rp~f~  935 (936)
                      ..||++||++.
T Consensus       241 ~~~p~~Rp~~~  251 (262)
T cd05071         241 RKEPEERPTFE  251 (262)
T ss_pred             cCCcccCCCHH
Confidence            99999999874

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-34  Score=303.21  Aligned_cols=235  Identities=24%  Similarity=0.350  Sum_probs=188.6

Q ss_pred             CcccccCceEEEEEEeCC----CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          696 CELGRGGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      ++||+|+||.||+|++..    +..||+|.+.........+++.+|++++++++|+||+++++++.. ...++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            469999999999998642    268999999766544456789999999999999999999998764 457899999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc-cc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL-SS  850 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~-~~  850 (936)
                      |+|.+++....   .+++..+..++.|++.|++|||..+++||||||+||+++.++.+||+|||.++.......... ..
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~  156 (257)
T cd05060          80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT  156 (257)
T ss_pred             CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence            99999998654   389999999999999999999999999999999999999999999999999986643332211 11


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHH-H----HHHHhhhccccceeeccc
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVT-W----LEEHWKKAEWRNVSMRSC  924 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~l  924 (936)
                      ...++..|+|||.. ....++.++|||||||++|||++ |..||...+........ .    ..+...+..+++++.+||
T Consensus       157 ~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  235 (257)
T cd05060         157 AGRWPLKWYAPECI-NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCW  235 (257)
T ss_pred             CccccccccCHHHh-cCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHh
Confidence            22234579999988 45568999999999999999998 99999876543221110 0    112223456789999999


Q ss_pred             ccccccccccC
Q 002321          925 KGSSRQRRRFQ  935 (936)
Q Consensus       925 ~~~p~~Rp~f~  935 (936)
                      ..+|.+||+++
T Consensus       236 ~~~p~~Rp~~~  246 (257)
T cd05060         236 KYRPEDRPTFS  246 (257)
T ss_pred             cCChhhCcCHH
Confidence            99999999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=338.74  Aligned_cols=442  Identities=26%  Similarity=0.337  Sum_probs=343.8

Q ss_pred             eEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEcc
Q 002321           78 VIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLA  157 (936)
Q Consensus        78 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~  157 (936)
                      ..+||++++.+. ..|..+..+.+|+.|+++.|.|. ..|.+..++.+|++|.|.+|.+. ..|.+ +..+++|++|+++
T Consensus        47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~-~~~lknl~~LdlS  122 (1081)
T KOG0618|consen   47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPAS-ISELKNLQYLDLS  122 (1081)
T ss_pred             eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchh-HHhhhcccccccc
Confidence            778888887664 78888999999999999999998 67899999999999999999998 66755 6899999999999


Q ss_pred             CccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCc-------------------c
Q 002321          158 KNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGV-------------------E  218 (936)
Q Consensus       158 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-------------------~  218 (936)
                      +|++. .+|..+..++.++.+..++|.-....+.    . .++.++|..|.+.+.++..+                   .
T Consensus       123 ~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~----~-~ik~~~l~~n~l~~~~~~~i~~l~~~ldLr~N~~~~~dls  196 (1081)
T KOG0618|consen  123 FNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQ----T-SIKKLDLRLNVLGGSFLIDIYNLTHQLDLRYNEMEVLDLS  196 (1081)
T ss_pred             hhccC-CCchhHHhhhHHHHHhhhcchhhhhhcc----c-cchhhhhhhhhcccchhcchhhhheeeecccchhhhhhhh
Confidence            99998 6787777777777777777721111111    1 14444444444444444433                   3


Q ss_pred             CCCCcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCcccee
Q 002321          219 SLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETL  298 (936)
Q Consensus       219 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  298 (936)
                      .+.+|+.|+...|+++..    --..++|+.|+.++|.++...+  -..-.+|+++++++|++++ +|+|++.+.+|+.|
T Consensus       197 ~~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~--~p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l  269 (1081)
T KOG0618|consen  197 NLANLEVLHCERNQLSEL----EISGPSLTALYADHNPLTTLDV--HPVPLNLQYLDISHNNLSN-LPEWIGACANLEAL  269 (1081)
T ss_pred             hccchhhhhhhhcccceE----EecCcchheeeeccCcceeecc--ccccccceeeecchhhhhc-chHHHHhcccceEe
Confidence            444555555555555421    1233567777777777762221  1223579999999999995 56999999999999


Q ss_pred             cccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhcc---CCccccccccc
Q 002321          299 DLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSS---GLNKVSFAENK  375 (936)
Q Consensus       299 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~---~l~~l~l~~n~  375 (936)
                      +..+|+|. .+|..+...++|+.|.+..|.+. -+|.....++.|++|+|..|+|. ..|..++..   .++.+..+.|+
T Consensus       270 ~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~  346 (1081)
T KOG0618|consen  270 NANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNK  346 (1081)
T ss_pred             cccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhcc
Confidence            99999996 88888999999999999999998 67888888999999999999997 666655542   24455555566


Q ss_pred             cccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCcccccc
Q 002321          376 IREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGS  455 (936)
Q Consensus       376 l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  455 (936)
                      +...+.    ..-..++.|+.|.+.+|.+++..-..+.++..|+.|+|++|++.......+.++..|+.|+||+|+++ .
T Consensus       347 l~~lp~----~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~  421 (1081)
T KOG0618|consen  347 LSTLPS----YEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-T  421 (1081)
T ss_pred             cccccc----ccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-h
Confidence            654441    12235678999999999999988889999999999999999999666678899999999999999999 6


Q ss_pred             CCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcccccc
Q 002321          456 IPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNL  535 (936)
Q Consensus       456 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l  535 (936)
                      +|..+..+..|+.|...+|+|. ..| ++..++.|+.+|++.|+|+...-..-..-++|++|||++|.-.-..-..|..+
T Consensus       422 Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l  499 (1081)
T KOG0618|consen  422 LPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVL  499 (1081)
T ss_pred             hhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHh
Confidence            8999999999999999999998 788 89999999999999999985433332333899999999998543445677788


Q ss_pred             cccCeeecCCC
Q 002321          536 VHLSSFNISHN  546 (936)
Q Consensus       536 ~~L~~L~ls~N  546 (936)
                      .++..+++.-|
T Consensus       500 ~~l~~~~i~~~  510 (1081)
T KOG0618|consen  500 KSLSQMDITLN  510 (1081)
T ss_pred             hhhhheecccC
Confidence            88888888776

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7.9e-34  Score=302.52  Aligned_cols=237  Identities=26%  Similarity=0.389  Sum_probs=192.3

Q ss_pred             CcccccCceEEEEEEeCC--C--cEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          696 CELGRGGFGAVYRTVLRD--G--RPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      +.||+|++|.||+|.+.+  +  ..||||.+.........+.+.+|++++++++|+||+++++++.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999999753  2  36999999766544456789999999999999999999999988 888999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc-cccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY-VLSS  850 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~  850 (936)
                      ++|.+++..... ..+++...+.++.|++.||+|||+++++|+||||+||+++.++.+||+|||+++........ ....
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  158 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE  158 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence            999999987543 34899999999999999999999999999999999999999999999999999876542221 1222


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHH-HHHHH-----HHHhhhccccceeecc
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWF-SVTWL-----EEHWKKAEWRNVSMRS  923 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~-~~~~~-----~~~~~~~~~~~~~~~~  923 (936)
                      ...++..|+|||.+ ....++.++||||+||++|||++ |+.||......... .....     .+...+..+.+++.+|
T Consensus       159 ~~~~~~~y~~pE~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  237 (257)
T cd05040         159 HLKVPFAWCAPESL-RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQC  237 (257)
T ss_pred             CCCCCceecCHHHh-cccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHH
Confidence            34466789999988 45568999999999999999998 99999765443221 11100     1112346788899999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..+|.+||+++
T Consensus       238 l~~~p~~Rps~~  249 (257)
T cd05040         238 WAHNPADRPTFA  249 (257)
T ss_pred             CCCCcccCCCHH
Confidence            999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-35  Score=316.39  Aligned_cols=234  Identities=26%  Similarity=0.357  Sum_probs=193.9

Q ss_pred             cccccCceEEEEEEeCC-CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCCChh
Q 002321          697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLH  775 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  775 (936)
                      .+|+|+||+||-|++.+ ...+|||.+.... .+..+.+..|+..-++++|.|||+++|.+..++..-|+||.++||+|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            59999999999999774 5689999986543 344567889999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc-CCCCeEEeeccCccccCCCccccccccccC
Q 002321          776 KHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQS  854 (936)
Q Consensus       776 ~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  854 (936)
                      ++++..-+.-.-.+...--+.+||++||.|||+..|||||||..|+||+ -.|.+||+|||.++......  .......|
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TETFTG  738 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTETFTG  738 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC--cccccccc
Confidence            9998754332236777888999999999999999999999999999996 58999999999998763222  22345678


Q ss_pred             cccccCccccc-CcccCCchhhHHHHHHHHHHHHcCCCCCCccch--hHHHHHHHHH-----HHhhhccccceeeccccc
Q 002321          855 ALGYMAPEFAC-RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM--MWWFSVTWLE-----EHWKKAEWRNVSMRSCKG  926 (936)
Q Consensus       855 ~~~y~aPE~~~-~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~--~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~  926 (936)
                      |..|||||++- +.+.|+.++|||||||++.||.||++||.....  ...+.+.+++     |.-.+.+.+.+|.+|...
T Consensus       739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFep  818 (1226)
T KOG4279|consen  739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEP  818 (1226)
T ss_pred             chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCC
Confidence            99999999984 445699999999999999999999999987643  3334444433     344457789999999999


Q ss_pred             ccccccc
Q 002321          927 SSRQRRR  933 (936)
Q Consensus       927 ~p~~Rp~  933 (936)
                      ||.+||+
T Consensus       819 d~~~R~s  825 (1226)
T KOG4279|consen  819 DPCDRPS  825 (1226)
T ss_pred             CcccCcc
Confidence            9999997

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.2e-33  Score=303.05  Aligned_cols=238  Identities=21%  Similarity=0.277  Sum_probs=181.9

Q ss_pred             cccccCceEEEEEEeCCC---cEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCCC
Q 002321          697 ELGRGGFGAVYRTVLRDG---RPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGS  773 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  773 (936)
                      +||+|+||.||+|+..++   ..+++|.++........+.+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            699999999999986543   35667766554433456789999999999999999999999999889999999999999


Q ss_pred             hhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccccc
Q 002321          774 LHKHLHEGSG-GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI  852 (936)
Q Consensus       774 L~~~l~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  852 (936)
                      |.+++++... ....++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||++...............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  161 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDK  161 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCC
Confidence            9999976432 223667778899999999999999999999999999999999999999999998643222211222344


Q ss_pred             cCcccccCcccccC------cccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHHH-------H---Hhhhcc
Q 002321          853 QSALGYMAPEFACR------TVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWLE-------E---HWKKAE  915 (936)
Q Consensus       853 ~~~~~y~aPE~~~~------~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~~-------~---~~~~~~  915 (936)
                      .++..|+|||+...      ...++.++|||||||++|||++ |..||...+...........       +   ...++.
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (268)
T cd05086         162 CVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSER  241 (268)
T ss_pred             cCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHH
Confidence            56788999998732      1235789999999999999997 67788766553222211111       1   112355


Q ss_pred             ccceeecccccccccccccC
Q 002321          916 WRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++++.+|| .+|.+||+++
T Consensus       242 ~~~l~~~c~-~~P~~Rp~~~  260 (268)
T cd05086         242 WYEVLQFCW-LSPEKRATAE  260 (268)
T ss_pred             HHHHHHHHh-hCcccCCCHH
Confidence            677777777 7899999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=9.2e-34  Score=306.64  Aligned_cols=237  Identities=25%  Similarity=0.314  Sum_probs=191.5

Q ss_pred             cCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc--hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          693 NKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK--SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       693 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      +..+.||+|+||+||+|.+. +++.||+|.+.......  ....+.+|++++++++|++|+++.+++..++..++||||+
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05632           3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM   82 (285)
T ss_pred             eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEec
Confidence            44567999999999999976 58899999986543322  2345788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++++|.+++..... ..+++..+..++.|++.||+|||+++|+||||||+||++++++.++|+|||++.......   ..
T Consensus        83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~  158 (285)
T cd05632          83 NGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SI  158 (285)
T ss_pred             cCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC---cc
Confidence            99999988865432 248999999999999999999999999999999999999999999999999997653221   11


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHH-HHHH-HHH------HHhhhccccceee
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWW-FSVT-WLE------EHWKKAEWRNVSM  921 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~-~~~~-~~~------~~~~~~~~~~~~~  921 (936)
                      ....++..|+|||.+. ...++.++|+||+||++|||++|+.||........ .... ...      +...+....+++.
T Consensus       159 ~~~~g~~~~~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (285)
T cd05632         159 RGRVGTVGYMAPEVLN-NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK  237 (285)
T ss_pred             cCCCCCcCccChHHhc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence            2346789999999984 45689999999999999999999999987654211 1110 000      1113355788899


Q ss_pred             ccccccccccccc
Q 002321          922 RSCKGSSRQRRRF  934 (936)
Q Consensus       922 ~~l~~~p~~Rp~f  934 (936)
                      +||..||.+||++
T Consensus       238 ~~l~~~P~~R~~~  250 (285)
T cd05632         238 MLLTKDPKQRLGC  250 (285)
T ss_pred             HHccCCHhHcCCC
Confidence            9999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.9e-34  Score=305.57  Aligned_cols=232  Identities=21%  Similarity=0.297  Sum_probs=188.7

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      |+..+.||+|+||.||+|+.. +++.||+|++..........++.+|++++++++||||+++++++......++||||++
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   82 (279)
T cd06619           3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD   82 (279)
T ss_pred             chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence            466678999999999999865 6889999998655434445678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                      ++++..+.       .+++..+..++.|++.|++|||+.||+|+||||+||+++.++.++|+|||++......    ...
T Consensus        83 ~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~  151 (279)
T cd06619          83 GGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAK  151 (279)
T ss_pred             CCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----ccc
Confidence            99997652       2678888999999999999999999999999999999999999999999999765322    123


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhH-----HHHHHH-H---H----HHhhhcccc
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMW-----WFSVTW-L---E----EHWKKAEWR  917 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~-----~~~~~~-~---~----~~~~~~~~~  917 (936)
                      ...++..|+|||.+. ...++.++||||+||++|+|++|+.||.......     ...... .   .    ....+.+++
T Consensus       152 ~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (279)
T cd06619         152 TYVGTNAYMAPERIS-GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV  230 (279)
T ss_pred             CCCCChhhcCceeec-CCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence            346788999999884 4568999999999999999999999997533210     010000 0   0    011335678


Q ss_pred             ceeecccccccccccccC
Q 002321          918 NVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++.+||..+|.+||+++
T Consensus       231 ~li~~~l~~~P~~Rp~~~  248 (279)
T cd06619         231 HFITQCMRKQPKERPAPE  248 (279)
T ss_pred             HHHHHHhhCChhhCCCHH
Confidence            999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6e-34  Score=313.47  Aligned_cols=198  Identities=22%  Similarity=0.403  Sum_probs=161.8

Q ss_pred             CCcccccCceEEEEEEeC---CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEe--CCeeEEEEEec
Q 002321          695 DCELGRGGFGAVYRTVLR---DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWT--QSLQLLIYEFV  769 (936)
Q Consensus       695 ~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~  769 (936)
                      .++||+|+||+||+|+..   +++.||+|.+.....   ...+.+|++++++++||||+++++++..  +...++||||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            468999999999999965   467899999865432   3457889999999999999999999864  45678999999


Q ss_pred             CCCChhhhhhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE----cCCCCeEEeeccCccc
Q 002321          770 SGGSLHKHLHEGS------GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLI----DGSGEPKVGDYGLARL  839 (936)
Q Consensus       770 ~~g~L~~~l~~~~------~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~a~~  839 (936)
                      + +++.+++....      ....+++..+..++.|++.||+|||++||+||||||+|||+    +..+.+||+|||+++.
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            5 68888775322      12248889999999999999999999999999999999999    4567999999999986


Q ss_pred             cCCCcc-ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCcc
Q 002321          840 LPMLDR-YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTW  896 (936)
Q Consensus       840 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~  896 (936)
                      ...... ........+|+.|+|||++.+...++.++||||+||++|||++|+.||...
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            643221 112234567889999999866667899999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.6e-34  Score=303.20  Aligned_cols=240  Identities=27%  Similarity=0.366  Sum_probs=193.6

Q ss_pred             ccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      ..|+..++||+|+||.||+|..++++.||+|++.....  ..+++.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            34677789999999999999988899999999865432  3567899999999999999999999874 45679999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++++|.+++..... ..+++.++..++.|++.|++|||+.|++||||||+||+++.++.++++|||++........ ...
T Consensus        83 ~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~  160 (260)
T cd05067          83 ENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAR  160 (260)
T ss_pred             CCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-ccc
Confidence            99999999876442 3488999999999999999999999999999999999999999999999999976542221 112


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHH-HHHH----HHHHhhhccccceeecc
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWF-SVTW----LEEHWKKAEWRNVSMRS  923 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~  923 (936)
                      ....++..|+|||.. ....++.++||||+|+++||+++ |+.||...+..... ....    ..+...+.++.+++.+|
T Consensus       161 ~~~~~~~~y~~pe~~-~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  239 (260)
T cd05067         161 EGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLC  239 (260)
T ss_pred             cCCcccccccCHHHh-ccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence            233456789999988 44568899999999999999999 99999766542221 1100    00122335799999999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..+|.+||+++
T Consensus       240 l~~~p~~Rp~~~  251 (260)
T cd05067         240 WKEKPEERPTFE  251 (260)
T ss_pred             ccCChhhCCCHH
Confidence            999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=8.3e-34  Score=308.67  Aligned_cols=237  Identities=22%  Similarity=0.343  Sum_probs=193.7

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .|+..+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus        21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            4667778999999999999965 588999999865443 33567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++++|.+++....    +++.++..++.|++.|++|||+.||+||||||+||+++.++.+||+|||++.......  ...
T Consensus       100 ~~~~L~~~~~~~~----~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~  173 (296)
T cd06654         100 AGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKR  173 (296)
T ss_pred             CCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc--ccc
Confidence            9999999986532    7889999999999999999999999999999999999999999999999987543221  112


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-------HHhhhccccceeec
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-------EHWKKAEWRNVSMR  922 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~  922 (936)
                      ....+++.|+|||... ...++.++|||||||++|+|++|+.||...+...........       +......+.+++.+
T Consensus       174 ~~~~~~~~y~aPE~~~-~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  252 (296)
T cd06654         174 STMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR  252 (296)
T ss_pred             CcccCCccccCHHHHc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHH
Confidence            3346788899999884 456789999999999999999999999876543221111100       11123557888999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      ||..||.+||++.
T Consensus       253 ~l~~~p~~Rpt~~  265 (296)
T cd06654         253 CLDMDVEKRGSAK  265 (296)
T ss_pred             HCcCCcccCcCHH
Confidence            9999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=6.1e-34  Score=305.41  Aligned_cols=242  Identities=26%  Similarity=0.397  Sum_probs=192.6

Q ss_pred             cccCCCcccccCceEEEEEEeC-CC---cEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DG---RPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      .|+..+.||+|+||.||+|+.. ++   ..+|+|+++........+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT   85 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence            4566788999999999999975 23   3799999865543444677899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++++|.+++....  ..+++.++..++.|++.|++|||+.+++||||||+||+++.++.+|++|||++.........
T Consensus        86 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  163 (268)
T cd05063          86 EYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG  163 (268)
T ss_pred             EcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence            9999999999987643  23899999999999999999999999999999999999999999999999999765432211


Q ss_pred             cc-cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccce
Q 002321          847 VL-SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNV  919 (936)
Q Consensus       847 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~  919 (936)
                      .. ......+..|+|||++. ...++.++||||+||++|||++ |+.||.............     ..+.-.+..+.++
T Consensus       164 ~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l  242 (268)
T cd05063         164 TYTTSGGKIPIRWTAPEAIA-YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQL  242 (268)
T ss_pred             ceeccCCCcCceecCHHHhh-cCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence            11 11122345799999884 4568999999999999999997 999997655432221110     0011234567899


Q ss_pred             eecccccccccccccC
Q 002321          920 SMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       920 ~~~~l~~~p~~Rp~f~  935 (936)
                      +.+||+.+|.+||+++
T Consensus       243 i~~c~~~~p~~Rp~~~  258 (268)
T cd05063         243 MLQCWQQDRARRPRFV  258 (268)
T ss_pred             HHHHcCCCcccCcCHH
Confidence            9999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.3e-33  Score=308.22  Aligned_cols=240  Identities=21%  Similarity=0.315  Sum_probs=192.6

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..++||+|+||.||+|+.+ +++.||+|.++..........+.+|+.++++++|+||+++++++......++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            34677788999999999999976 58899999987554444456678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      ++ ++|.+++.....  .+++..+..++.|+++||+|||+.+|+|+||||+||+++.++.+||+|||++........  .
T Consensus        86 ~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~  160 (301)
T cd07873          86 LD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--T  160 (301)
T ss_pred             cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--c
Confidence            96 689888875432  378899999999999999999999999999999999999999999999999975432211  1


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH--H---------HH----------
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV--T---------WL----------  907 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~--~---------~~----------  907 (936)
                      .....+++.|+|||.+.+...++.++||||+||++|||++|+.||...+.......  .         |.          
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (301)
T cd07873         161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS  240 (301)
T ss_pred             ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence            12334678899999886666688999999999999999999999987654211100  0         00          


Q ss_pred             --HH-----------Hhhhccccceeeccccccccccccc
Q 002321          908 --EE-----------HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       908 --~~-----------~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                        .+           ...++..++++.+|+..||.+||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~  280 (301)
T cd07873         241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISA  280 (301)
T ss_pred             cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCH
Confidence              00           0123455789999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-35  Score=301.73  Aligned_cols=242  Identities=24%  Similarity=0.295  Sum_probs=200.9

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc--hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK--SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  765 (936)
                      .+.+..-+.||+|+||+||-++.+ +|+.||.|++......+  .+.-...|-.+++++..+.||.+-..++..+..++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            345567788999999999999876 59999999885443322  234567899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      +..|.||||.-++...+. .-+++.+++-++.+|+.||++||.++||+||+||+|||+|+.|+++|+|.|+|..++....
T Consensus       264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~  342 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP  342 (591)
T ss_pred             EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence            999999999998876654 3499999999999999999999999999999999999999999999999999998865443


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch----hHHHHHHHHH----HHhhhcccc
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM----MWWFSVTWLE----EHWKKAEWR  917 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~----~~~~~~~~~~----~~~~~~~~~  917 (936)
                         .....||.+|||||++... .|+...|.||+||++|||+.|+.||...+.    +.++......    +.--+++.+
T Consensus       343 ---~~~rvGT~GYMAPEvl~ne-~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eak  418 (591)
T KOG0986|consen  343 ---IRGRVGTVGYMAPEVLQNE-VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAK  418 (591)
T ss_pred             ---cccccCcccccCHHHHcCC-cccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHH
Confidence               2344899999999999655 599999999999999999999999987654    2233222222    222346778


Q ss_pred             ceeecccccccccccccC
Q 002321          918 NVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f~  935 (936)
                      ++....+..||.+|-.++
T Consensus       419 slc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  419 SLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHHHHHccCHHHhccCC
Confidence            888889999999998775

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.9e-34  Score=305.67  Aligned_cols=241  Identities=25%  Similarity=0.388  Sum_probs=191.4

Q ss_pred             ccCCCcccccCceEEEEEEeCC-C---cEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLRD-G---RPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ++..+.||+|+||.||+|+... +   ..||||.++.........++.+|+.++++++||||+++++++.+....++|||
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   85 (269)
T cd05065           6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE   85 (269)
T ss_pred             eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence            5667889999999999999753 3   36999998755434456789999999999999999999999999899999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+++++|.+++.....  .+++.++..++.|++.|++|||++|++||||||+||+++.++.+|++|||.+..........
T Consensus        86 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~  163 (269)
T cd05065          86 FMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP  163 (269)
T ss_pred             cCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcccc
Confidence            9999999999876432  38899999999999999999999999999999999999999999999999987654322111


Q ss_pred             c-ccccc--CcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHH-H----HHHHhhhccccc
Q 002321          848 L-SSKIQ--SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVT-W----LEEHWKKAEWRN  918 (936)
Q Consensus       848 ~-~~~~~--~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~-~----~~~~~~~~~~~~  918 (936)
                      . .....  .+..|+|||.+ ....++.++||||+||++|||++ |..||...+........ .    ..+.-.+..+.+
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (269)
T cd05065         164 TYTSSLGGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQ  242 (269)
T ss_pred             ccccccCCCcceeecCHhHh-ccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHH
Confidence            1 11111  23579999988 45578999999999999999987 99999776543221110 0    001112346788


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..+|.+||+++
T Consensus       243 li~~~l~~~p~~Rp~~~  259 (269)
T cd05065         243 LMLDCWQKDRNARPKFG  259 (269)
T ss_pred             HHHHHcCCChhhCcCHH
Confidence            89999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=286.50  Aligned_cols=239  Identities=24%  Similarity=0.289  Sum_probs=203.0

Q ss_pred             ccccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccch--HHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      +-+.++..+.+|+|.||.|-.++.+ +++.+|+|+++++.....  ...-..|-++++..+||.+..+-..+...++.+.
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            4556788889999999999999966 689999999987765432  3455689999999999999999989999999999


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ||||+.||.|.-++.+.+   .+++....-+-..|+.||.|||+++||.||+|.+|.|+|++|++||+|||+++.--  .
T Consensus       246 VMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~  320 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--K  320 (516)
T ss_pred             EEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc--c
Confidence            999999999999887644   38888888889999999999999999999999999999999999999999997431  2


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhcccccee
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVS  920 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~  920 (936)
                      ........+|||.|.|||++ ...+|+.++|.|.+||++|||++|+.||...+....+....    .+|.-.+++.+.++
T Consensus       321 ~g~t~kTFCGTPEYLAPEVl-eDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLL  399 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVL-EDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLL  399 (516)
T ss_pred             ccceeccccCChhhcCchhh-ccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHH
Confidence            22334567899999999999 66799999999999999999999999999887755554333    33455567788888


Q ss_pred             eccccccccccc
Q 002321          921 MRSCKGSSRQRR  932 (936)
Q Consensus       921 ~~~l~~~p~~Rp  932 (936)
                      .-.+.+||++|-
T Consensus       400 sGLL~kdP~kRL  411 (516)
T KOG0690|consen  400 SGLLKKDPKKRL  411 (516)
T ss_pred             HHHhhcChHhhc
Confidence            899999999984

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.2e-34  Score=308.20  Aligned_cols=239  Identities=24%  Similarity=0.362  Sum_probs=194.7

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..+.||+|+||.||+|.+. +++.||+|.++........+.+.+|++++++++||||+++++++..+...++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            34566678999999999999865 57899999987554444557889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++++|.+++...    .+++..+..++.|+++|+.|||+++++|+||+|+||++++++.++++|||++.......  ..
T Consensus        84 ~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06642          84 LGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             cCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hh
Confidence            9999999988653    37889999999999999999999999999999999999999999999999997654321  11


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH--HHH---Hhhhccccceeecc
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW--LEE---HWKKAEWRNVSMRS  923 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~--~~~---~~~~~~~~~~~~~~  923 (936)
                      .....++..|+|||.. ....++.++||||+||++|||++|+.||.............  ..+   ...+..+.+++.+|
T Consensus       158 ~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  236 (277)
T cd06642         158 RNTFVGTPFWMAPEVI-KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEAC  236 (277)
T ss_pred             hhcccCcccccCHHHh-CcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHH
Confidence            2234567889999988 45578899999999999999999999997654432111100  000   11235678899999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..+|.+||+++
T Consensus       237 l~~~p~~Rp~~~  248 (277)
T cd06642         237 LNKDPRFRPTAK  248 (277)
T ss_pred             ccCCcccCcCHH
Confidence            999999999864

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.2e-33  Score=309.43  Aligned_cols=236  Identities=22%  Similarity=0.343  Sum_probs=192.1

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      |+..++||+|+||.||+++.. ++..||+|.+..........++.+|++++++++||||+++++++.+++..++||||++
T Consensus         3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~   82 (308)
T cd06615           3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD   82 (308)
T ss_pred             ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence            567788999999999999976 5788999988654333345678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ-SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      +++|.+++++..   .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......    ..
T Consensus        83 ~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~  155 (308)
T cd06615          83 GGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MA  155 (308)
T ss_pred             CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc----cc
Confidence            999999997653   38899999999999999999997 58999999999999999999999999998754321    12


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH------------------------
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT------------------------  905 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~------------------------  905 (936)
                      ....++..|+|||.. .+..++.++||||+||++|||++|+.||...+........                        
T Consensus       156 ~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (308)
T cd06615         156 NSFVGTRSYMSPERL-QGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP  234 (308)
T ss_pred             ccCCCCcCccChhHh-cCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence            334678889999987 4556889999999999999999999999654432111000                        


Q ss_pred             -------HHHH-----------HhhhccccceeecccccccccccccC
Q 002321          906 -------WLEE-----------HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       906 -------~~~~-----------~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                             ....           ...+..+++++.+||..+|.+||+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~  282 (308)
T cd06615         235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLK  282 (308)
T ss_pred             chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHH
Confidence                   0000           01234588999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-34  Score=304.64  Aligned_cols=235  Identities=24%  Similarity=0.363  Sum_probs=185.9

Q ss_pred             cccccCceEEEEEEeCC-Cc--EEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEEEecCCC
Q 002321          697 ELGRGGFGAVYRTVLRD-GR--PVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIYEFVSGG  772 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  772 (936)
                      .||+|+||.||+|++++ +.  .+|+|.++........+.+.+|++++.++ +||||+++++++...+..++||||+++|
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            58999999999999764 43  57888886443334456789999999999 7999999999999998999999999999


Q ss_pred             ChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          773 SLHKHLHEGSG-------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       773 ~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      +|.++++....             ...+++.++.+++.|++.|++|||+.|++||||||+||++++++.+|++|||++..
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~  161 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG  161 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccc
Confidence            99999975431             12478999999999999999999999999999999999999999999999999863


Q ss_pred             cCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhh
Q 002321          840 LPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKK  913 (936)
Q Consensus       840 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~  913 (936)
                      ...   .........+..|+|||++ ....++.++|||||||++|||++ |..||...+.........     ..+...+
T Consensus       162 ~~~---~~~~~~~~~~~~y~apE~~-~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  237 (270)
T cd05047         162 QEV---YVKKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD  237 (270)
T ss_pred             cch---hhhccCCCCccccCChHHH-ccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCC
Confidence            221   1111122335679999988 45568999999999999999997 999997654432221110     0011123


Q ss_pred             ccccceeecccccccccccccC
Q 002321          914 AEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       914 ~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..+.+++.+||..+|.+||+++
T Consensus       238 ~~~~~li~~~l~~~p~~Rps~~  259 (270)
T cd05047         238 DEVYDLMRQCWREKPYERPSFA  259 (270)
T ss_pred             HHHHHHHHHHcccChhhCCCHH
Confidence            5678899999999999999874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.2e-33  Score=303.00  Aligned_cols=241  Identities=24%  Similarity=0.401  Sum_probs=195.5

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      |+..+.||+|+||.||+|... +++.||||.+......  ...+++.+|+++++.++|+||+++++++.+++..+++|||
T Consensus         4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   83 (267)
T cd08229           4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL   83 (267)
T ss_pred             hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence            566778999999999999964 7899999988653322  2346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          769 VSGGSLHKHLHEGSG-GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      +++++|.+++..... ...+++..+++++.|+++|++|||++|++|+||||+||+++.++.++++|||++........  
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--  161 (267)
T cd08229          84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--  161 (267)
T ss_pred             cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc--
Confidence            999999998874322 23489999999999999999999999999999999999999999999999999876543221  


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH--------HHhhhccccce
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE--------EHWKKAEWRNV  919 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~~  919 (936)
                      ......++..|+|||... ...++.++||||+|+++|||++|..||...............        +...+..++++
T Consensus       162 ~~~~~~~~~~~~ape~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  240 (267)
T cd08229         162 AAHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL  240 (267)
T ss_pred             ccccccCCcCccCHHHhc-CCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHH
Confidence            112345778899999884 456889999999999999999999999765442212111111        12244678999


Q ss_pred             eecccccccccccccC
Q 002321          920 SMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       920 ~~~~l~~~p~~Rp~f~  935 (936)
                      +.+||..||.+||+++
T Consensus       241 i~~~l~~~p~~Rpt~~  256 (267)
T cd08229         241 VNMCINPDPEKRPDIT  256 (267)
T ss_pred             HHHhcCCCcccCCCHH
Confidence            9999999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2e-33  Score=301.24  Aligned_cols=242  Identities=23%  Similarity=0.395  Sum_probs=196.9

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      .|+..+.||+|+||.||+|... +|+.||+|.++....  ....+.+.+|++++++++|++++++++++.+.+..++|||
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   82 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence            3667788999999999999987 789999998864322  2235778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          768 FVSGGSLHKHLHEGSG-GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      |+++|+|.+++..... ...+++.++..++.|+++|++|||+.|++||||||+||+++.++.++++|||+++....... 
T Consensus        83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~-  161 (267)
T cd08224          83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-  161 (267)
T ss_pred             cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc-
Confidence            9999999998865322 33488999999999999999999999999999999999999999999999999876532211 


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH--------HHHhhhccccc
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL--------EEHWKKAEWRN  918 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~  918 (936)
                       ......++..|+|||.+. +..++.++||||+||++|+|++|+.||..............        +....+..+++
T Consensus       162 -~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd08224         162 -AAHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRD  239 (267)
T ss_pred             -ccceecCCccccCHHHhc-cCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHH
Confidence             122345778899999884 55688999999999999999999999976543222111111        11134457899


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..+|.+||++.
T Consensus       240 ~i~~cl~~~p~~Rp~~~  256 (267)
T cd08224         240 LVSRCINPDPEKRPDIS  256 (267)
T ss_pred             HHHHHcCCCcccCCCHH
Confidence            99999999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5.5e-34  Score=305.99  Aligned_cols=238  Identities=28%  Similarity=0.420  Sum_probs=191.1

Q ss_pred             cccccCceEEEEEEeCC-------CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          697 ELGRGGFGAVYRTVLRD-------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .||+|+||.||+|+..+       ++.||||.+...........+.+|+.++++++||||+++++++...+..++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            68999999999998653       25799998865443345677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-----CeEEeeccCcccc
Q 002321          770 SGGSLHKHLHEGS----GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG-----EPKVGDYGLARLL  840 (936)
Q Consensus       770 ~~g~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~-----~~kl~Dfg~a~~~  840 (936)
                      ++++|.+++....    ....+++.++..++.|++.|++|||+.+++|+||||+||+++.++     .++++|||+++..
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~  161 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI  161 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccccc
Confidence            9999999997532    123478899999999999999999999999999999999999887     8999999999765


Q ss_pred             CCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHH-----HHHHHHhhhc
Q 002321          841 PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSV-----TWLEEHWKKA  914 (936)
Q Consensus       841 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~-----~~~~~~~~~~  914 (936)
                      ..............+..|+|||.+. ...++.++|||||||++|||++ |+.||...........     ....+...+.
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (269)
T cd05044         162 YKSDYYRKEGEGLLPVRWMAPESLL-DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPD  240 (269)
T ss_pred             ccccccccCcccCCCccccCHHHHc-cCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccchH
Confidence            4333222223334567899999884 4468999999999999999998 9999976654322211     0111223446


Q ss_pred             cccceeecccccccccccccC
Q 002321          915 EWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       915 ~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+.+++.+||..+|.+||+++
T Consensus       241 ~~~~li~~~l~~~p~~Rp~~~  261 (269)
T cd05044         241 KIYQLMTNCWAQDPSERPTFD  261 (269)
T ss_pred             HHHHHHHHHcCCCcccCCCHH
Confidence            788999999999999999874

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.6e-33  Score=300.56  Aligned_cols=238  Identities=27%  Similarity=0.384  Sum_probs=190.5

Q ss_pred             ccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      |+..++||+|+||.||+|.+.++..||+|++....  ...+.+.+|++++++++|+|++++++++. ....++||||+++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~   84 (260)
T cd05069           8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK   84 (260)
T ss_pred             eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence            56677899999999999998877789999886443  23467889999999999999999998875 4567899999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      ++|.++++... ...+++..+..++.|++.|++|||+.|++|+||||+||++++++.++|+|||.++....... .....
T Consensus        85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~  162 (260)
T cd05069          85 GSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TARQG  162 (260)
T ss_pred             CCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cccCC
Confidence            99999997643 23478999999999999999999999999999999999999999999999999976543221 11122


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHH-HHH----HHHhhhccccceeecccc
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSV-TWL----EEHWKKAEWRNVSMRSCK  925 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~l~  925 (936)
                      ..++..|+|||.. ....++.++||||+||++|||++ |+.||........... ...    .+...+..+++++.+||.
T Consensus       163 ~~~~~~y~~Pe~~-~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  241 (260)
T cd05069         163 AKFPIKWTAPEAA-LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWK  241 (260)
T ss_pred             CccchhhCCHHHh-ccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcc
Confidence            3456679999988 44568999999999999999999 9999987554321111 000    011234568899999999


Q ss_pred             cccccccccC
Q 002321          926 GSSRQRRRFQ  935 (936)
Q Consensus       926 ~~p~~Rp~f~  935 (936)
                      .||.+||+++
T Consensus       242 ~~p~~Rp~~~  251 (260)
T cd05069         242 KDPDERPTFE  251 (260)
T ss_pred             CCcccCcCHH
Confidence            9999999864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.4e-33  Score=315.65  Aligned_cols=199  Identities=24%  Similarity=0.295  Sum_probs=165.4

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC------e
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS------L  761 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  761 (936)
                      ..|+..+.||+|+||.||+|+.. +|+.||||++..... ......+.+|+.+++.++||||+++++++....      .
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  100 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD  100 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence            45777889999999999999975 589999999865422 233567889999999999999999999986543      4


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .++||||++ +++.+.+..     .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus       101 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876         101 VYLVMELMD-ANLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             eEEEEeCCC-cCHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence            689999996 466666543     27888899999999999999999999999999999999999999999999997543


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM  898 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~  898 (936)
                      ..   .......+++.|+|||++. +..++.++||||+||++|||++|+.||...+.
T Consensus       175 ~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~  227 (359)
T cd07876         175 TN---FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGELVKGSVIFQGTDH  227 (359)
T ss_pred             cC---ccCCCCcccCCCCCchhcc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence            21   1223456788999999984 55789999999999999999999999987653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.3e-33  Score=304.39  Aligned_cols=238  Identities=23%  Similarity=0.351  Sum_probs=195.9

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .|+..++||+|+||.||+|++. +++.||+|+++..........+.+|+.++++++|+||+++++++.+....++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4567778999999999999976 588999999876544445678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++|+|.+++....    +++.+...++.|++.|++|||+.+++|+||+|+||+++.++.++++|||++.......  ...
T Consensus        85 ~~~~L~~~i~~~~----l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~  158 (277)
T cd06640          85 GGGSALDLLRAGP----FDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR  158 (277)
T ss_pred             CCCcHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--ccc
Confidence            9999999987532    7888999999999999999999999999999999999999999999999997654322  122


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH-H----HHHHhhhccccceeeccc
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT-W----LEEHWKKAEWRNVSMRSC  924 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~l  924 (936)
                      ....++..|+|||... +..++.++|+|||||++|||++|+.||............ .    ..+...+.++.+++.+||
T Consensus       159 ~~~~~~~~y~apE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  237 (277)
T cd06640         159 NTFVGTPFWMAPEVIQ-QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL  237 (277)
T ss_pred             ccccCcccccCHhHhc-cCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence            3345677899999884 446899999999999999999999999865543221110 0    001123456789999999


Q ss_pred             ccccccccccC
Q 002321          925 KGSSRQRRRFQ  935 (936)
Q Consensus       925 ~~~p~~Rp~f~  935 (936)
                      ..+|.+||+++
T Consensus       238 ~~~p~~Rp~~~  248 (277)
T cd06640         238 NKDPSFRPTAK  248 (277)
T ss_pred             ccCcccCcCHH
Confidence            99999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-33  Score=317.11  Aligned_cols=197  Identities=20%  Similarity=0.260  Sum_probs=168.2

Q ss_pred             ccccCCCcccccCceEEEEEEeC---CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR---DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||.||+|...   .++.||||.+...      ....+|++++++++||||+++++++......++||
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            45788889999999999999754   3578999987533      33568999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      |++. ++|.+++....   .+++.++..++.|++.||+|||++||+||||||+|||++.++.++|+|||+++........
T Consensus       166 e~~~-~~l~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~  241 (392)
T PHA03207        166 PKYK-CDLFTYVDRSG---PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT  241 (392)
T ss_pred             hhcC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence            9995 78888885432   3899999999999999999999999999999999999999999999999999766543333


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccc
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWK  897 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~  897 (936)
                      .......||+.|+|||++. ...++.++||||+||++|||++|+.||....
T Consensus       242 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~el~~g~~pf~~~~  291 (392)
T PHA03207        242 PQCYGWSGTLETNSPELLA-LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ  291 (392)
T ss_pred             ccccccccccCccCHhHhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            3334466899999999884 4568999999999999999999999997643

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-33  Score=300.63  Aligned_cols=241  Identities=27%  Similarity=0.382  Sum_probs=196.1

Q ss_pred             ccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      ..|...+.||+|+||.||+|...+++.||||.+....  ...+++.+|+.++++++|+||+++++++......++||||+
T Consensus         6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            4467778999999999999998888899999986543  23567899999999999999999999999888899999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++++|.+++.... ...+++.++..++.|++.|++|||+.+++|+||||+||+++.++.+|++|||.++...... ....
T Consensus        84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~  161 (261)
T cd05034          84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YTAR  161 (261)
T ss_pred             CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh-hhhh
Confidence            9999999997643 2348999999999999999999999999999999999999999999999999987654311 1111


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceeecc
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSMRS  923 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  923 (936)
                      .....+..|+|||... +..++.++||||+||++||+++ |+.||.............     ..+...+.++.+++.+|
T Consensus       162 ~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  240 (261)
T cd05034         162 EGAKFPIKWTAPEAAN-YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQC  240 (261)
T ss_pred             hccCCCccccCHHHhc-cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence            2223456799999884 4568999999999999999998 999997655432221110     01122346789999999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      +..+|.+||+++
T Consensus       241 l~~~p~~Rp~~~  252 (261)
T cd05034         241 WDKDPEERPTFE  252 (261)
T ss_pred             cccCcccCCCHH
Confidence            999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-33  Score=298.83  Aligned_cols=240  Identities=24%  Similarity=0.352  Sum_probs=195.4

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .|+..+.||+|+||.||+|... +++.+|+|++..... ...+.+.+|++++++++||||+++++++.+....+++|||+
T Consensus         4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            4567788999999999999975 578899999875432 24578899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++++|.+++....  ..+++.++..++.|++.|++|||+.+++|+||||+||+++.++.+||+|||.+.......  ...
T Consensus        83 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~  158 (262)
T cd06613          83 GGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AKR  158 (262)
T ss_pred             CCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hcc
Confidence            9999999987642  238899999999999999999999999999999999999999999999999987654221  112


Q ss_pred             ccccCcccccCcccccCc--ccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HHHHH--------HHHhhhccccc
Q 002321          850 SKIQSALGYMAPEFACRT--VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVTWL--------EEHWKKAEWRN  918 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~--~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~~~--------~~~~~~~~~~~  918 (936)
                      ....++..|+|||.....  ..++.++||||+||++|||++|+.||...+..... .....        .+...+..+.+
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (262)
T cd06613         159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHD  238 (262)
T ss_pred             ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHH
Confidence            334577789999988432  26788999999999999999999999876543221 11111        01122356889


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..+|.+||+++
T Consensus       239 li~~~l~~~p~~Rpt~~  255 (262)
T cd06613         239 FIKKCLTKDPKKRPTAT  255 (262)
T ss_pred             HHHHHcCCChhhCCCHH
Confidence            99999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-33  Score=299.42  Aligned_cols=237  Identities=23%  Similarity=0.322  Sum_probs=192.4

Q ss_pred             CcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCCChh
Q 002321          696 CELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLH  775 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  775 (936)
                      ++||+|+||.||+|.+.+++.||+|+++........+.+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46999999999999987799999999876544445678999999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccccccCc
Q 002321          776 KHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA  855 (936)
Q Consensus       776 ~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~  855 (936)
                      +++.....  .+++.....++.|++.|++|||+++++||||||+||+++.++.+||+|||.+.................+
T Consensus        81 ~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (251)
T cd05041          81 TFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP  158 (251)
T ss_pred             HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence            99876432  3788999999999999999999999999999999999999999999999999765322111111222335


Q ss_pred             ccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceeecccccccc
Q 002321          856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSMRSCKGSSR  929 (936)
Q Consensus       856 ~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~p~  929 (936)
                      ..|+|||.+. ...++.++||||+||++|||++ |..||.............     ..+...+..+.+++.+||..+|.
T Consensus       159 ~~y~~PE~~~-~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  237 (251)
T cd05041         159 IKWTAPEALN-YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPE  237 (251)
T ss_pred             eccCChHhhc-cCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChh
Confidence            6799999884 4468999999999999999999 899997765432221110     01123346789999999999999


Q ss_pred             cccccC
Q 002321          930 QRRRFQ  935 (936)
Q Consensus       930 ~Rp~f~  935 (936)
                      +||+.+
T Consensus       238 ~Rp~~~  243 (251)
T cd05041         238 NRPSFS  243 (251)
T ss_pred             hCcCHH
Confidence            999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=280.95  Aligned_cols=240  Identities=22%  Similarity=0.317  Sum_probs=195.9

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      +.++....||.|+-|.|++++.+ +|..+|||.+......++.+++.+.+.++..- +.|+||+.+|||..+...++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            34456667999999999999987 48999999998887777778888899887766 48999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ-SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      .| ..-.+.++++...  ++++..+-++...+.+||.||.+ ++|+|||+||+|||+|+.|.+|+||||++.++-   +.
T Consensus       172 lM-s~C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv---dS  245 (391)
T KOG0983|consen  172 LM-STCAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV---DS  245 (391)
T ss_pred             HH-HHHHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee---cc
Confidence            99 4566677766443  38888888999999999999986 589999999999999999999999999997653   23


Q ss_pred             cccccccCcccccCcccccC--cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH--HHHH-Hh-----hhccc
Q 002321          847 VLSSKIQSALGYMAPEFACR--TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT--WLEE-HW-----KKAEW  916 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~--~~~~-~~-----~~~~~  916 (936)
                      .+.+...|.+.|||||.+..  ...|+.++||||||+.++|+.||+.||...+++......  ..+| ..     -++.+
T Consensus       246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F  325 (391)
T KOG0983|consen  246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDF  325 (391)
T ss_pred             cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHH
Confidence            34556678899999998832  235888999999999999999999999997764332111  1111 11     33678


Q ss_pred             cceeecccccccccccccC
Q 002321          917 RNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       917 ~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+++..|+.+|+.+||.|.
T Consensus       326 ~~fv~~CL~kd~r~RP~Y~  344 (391)
T KOG0983|consen  326 QSFVKDCLTKDHRKRPKYN  344 (391)
T ss_pred             HHHHHHHhhcCcccCcchH
Confidence            8999999999999999874

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.5e-33  Score=303.15  Aligned_cols=241  Identities=24%  Similarity=0.341  Sum_probs=193.3

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeC------Ce
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQ------SL  761 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~~  761 (936)
                      ..|+..+.||+|+||.||+|... +++.||+|++....  .....+.+|+.+++++ +|+||+++++++...      ..
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            44677788999999999999976 58899999986543  3356788999999999 799999999998753      45


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .++||||+++++|.+++.... ...+++..+..++.|++.|++|||+++|+|+||||+||++++++.++|+|||+++...
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~  162 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  162 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence            789999999999999987643 2348899999999999999999999999999999999999999999999999997653


Q ss_pred             CCccccccccccCcccccCcccccC----cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH------HHh
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACR----TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE------EHW  911 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~------~~~  911 (936)
                      ...  .......++..|+|||++..    ...++.++||||+||++|||++|+.||...+...........      ...
T Consensus       163 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  240 (272)
T cd06637         163 RTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK  240 (272)
T ss_pred             ccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCC
Confidence            211  12334567888999998742    235788999999999999999999999766543222211111      011


Q ss_pred             hhccccceeecccccccccccccC
Q 002321          912 KKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       912 ~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+..+++++.+||..+|.+||+++
T Consensus       241 ~~~~~~~li~~~l~~~p~~Rpt~~  264 (272)
T cd06637         241 WSKKFQSFIESCLVKNHSQRPTTE  264 (272)
T ss_pred             cCHHHHHHHHHHcCCChhhCCCHH
Confidence            235788999999999999999863

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-34  Score=304.13  Aligned_cols=247  Identities=19%  Similarity=0.267  Sum_probs=199.3

Q ss_pred             ccccccccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCC-CCCcceeeeEEEeCCe
Q 002321          684 FSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQSL  761 (936)
Q Consensus       684 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  761 (936)
                      +.......|++.++||.|+.+.||++...+.+.||+|++.....+ .....|..|+..|.+++ |.+|+++++|-..++.
T Consensus       355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~  434 (677)
T KOG0596|consen  355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY  434 (677)
T ss_pred             eEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence            333445578999999999999999999888889999988554433 34578999999999994 9999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .||||||- ..||..++++..... ..| .+..+..|++.|+.+.|++||||.||||.|+|+- .|.+||+|||+|..+.
T Consensus       435 lYmvmE~G-d~DL~kiL~k~~~~~-~~~-~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  435 LYMVMECG-DIDLNKILKKKKSID-PDW-FLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ  510 (677)
T ss_pred             EEEEeecc-cccHHHHHHhccCCC-chH-HHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence            99999998 579999998765432 223 5667889999999999999999999999999987 5899999999999887


Q ss_pred             CCccccccccccCcccccCcccccCccc----------CCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH-----
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVK----------ITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW-----  906 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~----------~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~-----  906 (936)
                      ............||+.||+||.+.....          .+.++||||+|||+|+|+.|+.||......+...-..     
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~  590 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNH  590 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCc
Confidence            7666667778889999999997732211          4578999999999999999999998876433322222     


Q ss_pred             --HHHHhhh-ccccceeeccccccccccccc
Q 002321          907 --LEEHWKK-AEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       907 --~~~~~~~-~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                        .++.... .++-+++..|+..||.+||+.
T Consensus       591 ~Iefp~~~~~~~li~~mK~CL~rdPkkR~si  621 (677)
T KOG0596|consen  591 EIEFPDIPENDELIDVMKCCLARDPKKRWSI  621 (677)
T ss_pred             cccccCCCCchHHHHHHHHHHhcCcccCCCc
Confidence              1222222 226788899999999999984

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.4e-33  Score=302.42  Aligned_cols=242  Identities=24%  Similarity=0.368  Sum_probs=193.2

Q ss_pred             cccCCCcccccCceEEEEEEeC-C---CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-D---GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      .|+..+.||+|+||.||+|++. +   +..||+|.++........+.+.+|+.++++++||||+++++++..++..++||
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (267)
T cd05066           5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT   84 (267)
T ss_pred             HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence            3566788999999999999864 2   34799999875544445678899999999999999999999999989999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++++|.+++....  ..+++.++.+++.|++.|++|||+++++||||||+||+++.++.++++|||+++........
T Consensus        85 e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd05066          85 EYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  162 (267)
T ss_pred             EcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence            9999999999997643  23789999999999999999999999999999999999999999999999999866432221


Q ss_pred             cc-cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH---HH--HHhhhccccce
Q 002321          847 VL-SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW---LE--EHWKKAEWRNV  919 (936)
Q Consensus       847 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~---~~--~~~~~~~~~~~  919 (936)
                      .. ......+..|+|||.+. ...++.++|+||+||++||+++ |+.||...+.........   ..  +...+..+.++
T Consensus       163 ~~~~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (267)
T cd05066         163 AYTTRGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQL  241 (267)
T ss_pred             eeecCCCccceeecCHhHhc-cCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHH
Confidence            11 11222346799999884 4568999999999999999887 999998765432211100   00  11123567889


Q ss_pred             eecccccccccccccC
Q 002321          920 SMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       920 ~~~~l~~~p~~Rp~f~  935 (936)
                      +.+||..+|.+||+++
T Consensus       242 i~~~l~~~p~~Rp~~~  257 (267)
T cd05066         242 MLDCWQKDRNERPKFE  257 (267)
T ss_pred             HHHHcccCchhCCCHH
Confidence            9999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.5e-33  Score=303.05  Aligned_cols=241  Identities=23%  Similarity=0.321  Sum_probs=194.9

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..++||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+++++.++|+||+++++++..+...++||||
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            34677788999999999999976 47788999885443 23456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++++|..++....  ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.+|++|||++.......  ..
T Consensus        84 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~  159 (282)
T cd06643          84 CAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR  159 (282)
T ss_pred             cCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence            99999998876532  248999999999999999999999999999999999999999999999999987543211  12


Q ss_pred             cccccCcccccCccccc----CcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-------HHHhhhcccc
Q 002321          849 SSKIQSALGYMAPEFAC----RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-------EEHWKKAEWR  917 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~  917 (936)
                      .....+++.|+|||++.    ....++.++||||+||++|||++|+.||...+..........       .+...+.+++
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK  239 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHH
Confidence            23446788999999873    234577899999999999999999999987654322211100       1112345789


Q ss_pred             ceeecccccccccccccC
Q 002321          918 NVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++.+||..||.+||++.
T Consensus       240 ~li~~~l~~~p~~Rp~~~  257 (282)
T cd06643         240 DFLKKCLEKNVDARWTTT  257 (282)
T ss_pred             HHHHHHccCChhhCcCHH
Confidence            999999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-33  Score=304.52  Aligned_cols=239  Identities=26%  Similarity=0.386  Sum_probs=197.1

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCC---CCCcceeeeEEEeCCeeEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR---HPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  766 (936)
                      .|+..+.||+|+||.||+|++. +++.||+|.++........+++.+|+.++++++   |||++++++++.+....++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            3566788999999999999975 689999999876544445677889999999996   999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++++|.++++..    .+++.....++.|++.|++|||+.|++|+||+|+||+++.++.++++|||.+.......  
T Consensus        82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--  155 (277)
T cd06917          82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--  155 (277)
T ss_pred             ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--
Confidence            999999999998653    38899999999999999999999999999999999999999999999999998764332  


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH-HH-HHHH----hhhcccccee
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV-TW-LEEH----WKKAEWRNVS  920 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~-~~-~~~~----~~~~~~~~~~  920 (936)
                      .......++..|+|||.+..+..++.++||||+||++|+|++|+.||...+....... .. ..+.    -.+..+.+++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (277)
T cd06917         156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFV  235 (277)
T ss_pred             cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHH
Confidence            1223345788899999886666678999999999999999999999987654322211 00 0111    1345788899


Q ss_pred             ecccccccccccccC
Q 002321          921 MRSCKGSSRQRRRFQ  935 (936)
Q Consensus       921 ~~~l~~~p~~Rp~f~  935 (936)
                      .+||..||.+||+++
T Consensus       236 ~~~l~~~p~~R~~~~  250 (277)
T cd06917         236 AACLDEEPKERLSAE  250 (277)
T ss_pred             HHHcCCCcccCcCHH
Confidence            999999999999863

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.3e-33  Score=302.83  Aligned_cols=239  Identities=23%  Similarity=0.288  Sum_probs=192.9

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      |+..+.||+|+||.||+|+.+ +++.||+|++...... ...+.+.+|+.++++++|+|++++++++......++||||+
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~   82 (286)
T cd07847           3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC   82 (286)
T ss_pred             eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence            566778999999999999987 5899999998654322 23456789999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      +++.+..+.....   .+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++........  ..
T Consensus        83 ~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~  157 (286)
T cd07847          83 DHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DY  157 (286)
T ss_pred             CccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--cc
Confidence            9988888765433   289999999999999999999999999999999999999999999999999987643321  12


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HHHH-H--------------------
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVTW-L--------------------  907 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~~-~--------------------  907 (936)
                      ....++..|+|||.+.+...++.++||||+||++|||++|+.||.+.+..... .... .                    
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07847         158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL  237 (286)
T ss_pred             cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence            23346778999998865566889999999999999999999999875542111 0000 0                    


Q ss_pred             -----------HH--HhhhccccceeecccccccccccccC
Q 002321          908 -----------EE--HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       908 -----------~~--~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                                 +.  .-.+..+.+++.+||..+|.+||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~  278 (286)
T cd07847         238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCE  278 (286)
T ss_pred             cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHH
Confidence                       00  01235577899999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.2e-33  Score=305.23  Aligned_cols=236  Identities=22%  Similarity=0.356  Sum_probs=194.4

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      |+..+.||.|+||.||+|... +++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++......++|+||++
T Consensus        21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   99 (296)
T cd06655          21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA   99 (296)
T ss_pred             EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence            566778999999999999864 689999999865432 335678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                      +++|.+++....    +++.++..++.|++.|++|||+.|++||||||+||+++.++.+||+|||++........  ...
T Consensus       100 ~~~L~~~~~~~~----l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~  173 (296)
T cd06655         100 GGSLTDVVTETC----MDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRS  173 (296)
T ss_pred             CCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCC
Confidence            999999886532    89999999999999999999999999999999999999999999999999876533221  123


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-------HHHhhhccccceeecc
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-------EEHWKKAEWRNVSMRS  923 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~  923 (936)
                      ...++..|+|||.+ ....++.++||||+||++|+|++|+.||...+..........       .+.-.++.+.+++.+|
T Consensus       174 ~~~~~~~y~aPE~~-~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  252 (296)
T cd06655         174 TMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC  252 (296)
T ss_pred             CcCCCccccCcchh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHH
Confidence            34577889999988 455688999999999999999999999988765322211110       0112235678889999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..||.+||+++
T Consensus       253 l~~dp~~Rpt~~  264 (296)
T cd06655         253 LEMDVEKRGSAK  264 (296)
T ss_pred             hhcChhhCCCHH
Confidence            999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.4e-33  Score=308.24  Aligned_cols=242  Identities=25%  Similarity=0.355  Sum_probs=190.3

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCc----EEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      ..++..+.||+|+||.||+|++. +|+    .||+|.+..........++.+|+.++++++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            44567788999999999999865 343    57889886554334455788999999999999999999998754 4578


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ++||+++|+|.+++....  ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++......
T Consensus        86 v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~  163 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE  163 (303)
T ss_pred             eehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcc
Confidence            999999999999987643  237889999999999999999999999999999999999999999999999998664322


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccc
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRN  918 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~  918 (936)
                      .........++..|+|||.+ .+..++.++|||||||++|||++ |..||.............     ..+......+.+
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (303)
T cd05110         164 KEYNADGGKMPIKWMALECI-HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYM  242 (303)
T ss_pred             cccccCCCccccccCCHHHh-ccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence            22222233456689999988 45568999999999999999997 999997754322221110     001223456788


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..+|++||+++
T Consensus       243 li~~c~~~~p~~Rp~~~  259 (303)
T cd05110         243 VMVKCWMIDADSRPKFK  259 (303)
T ss_pred             HHHHHcCCChhhCcCHH
Confidence            89999999999999874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.5e-33  Score=300.16  Aligned_cols=239  Identities=24%  Similarity=0.326  Sum_probs=193.8

Q ss_pred             ccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCcc-----chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV-----KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      |...+.||+|+||+||+|...+++.+|||.++.....     +....+.+|++++++++|+||+++++++.+....++||
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM   81 (265)
T ss_pred             ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence            4567789999999999999888999999998643221     22356889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc--
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD--  844 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~--  844 (936)
                      ||+++++|.+++.+...   +++..+..++.|++.|++|||+.+++|+||||+||++++++.++|+|||.+.......  
T Consensus        82 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          82 EFVPGGSISSILNRFGP---LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             ecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            99999999999976432   7889999999999999999999999999999999999999999999999987653211  


Q ss_pred             --cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-------HHHhhhcc
Q 002321          845 --RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-------EEHWKKAE  915 (936)
Q Consensus       845 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-------~~~~~~~~  915 (936)
                        .........++..|+|||... ...++.++||||+||++|||++|+.||...+..........       .+...+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVIN-ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA  237 (265)
T ss_pred             ccccccccccCCCccccChhhhc-CCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHH
Confidence              111223345788899999884 45678999999999999999999999987554322111000       11123356


Q ss_pred             ccceeeccccccccccccc
Q 002321          916 WRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f  934 (936)
                      +.+++.+||..+|.+||++
T Consensus       238 ~~~~i~~~l~~~p~~Rp~~  256 (265)
T cd06631         238 AIDFVTSCLTRDQHERPSA  256 (265)
T ss_pred             HHHHHHHHhcCCcccCCCH
Confidence            7889999999999999986

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.6e-33  Score=312.10  Aligned_cols=245  Identities=24%  Similarity=0.322  Sum_probs=194.6

Q ss_pred             ccccCCCcccccCceEEEEEEeCC--------CcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCC
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRD--------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQS  760 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  760 (936)
                      ..|+..+.||+|+||.||+|+...        +..||+|.++........+++.+|+++++++ +|+||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            346788899999999999997531        2368999887544444567899999999999 7999999999999988


Q ss_pred             eeEEEEEecCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSG-------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG  827 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~  827 (936)
                      ..+++|||+++|+|.+++.+...             ...+++.++.+++.|++.||+|||++|++||||||+||+++.++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~  171 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN  171 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC
Confidence            99999999999999999875321             22478899999999999999999999999999999999999999


Q ss_pred             CeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH
Q 002321          828 EPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW  906 (936)
Q Consensus       828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~  906 (936)
                      .+||+|||+++...............++..|+|||+.. ...++.++||||+||++|||++ |..||.............
T Consensus       172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  250 (334)
T cd05100         172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK  250 (334)
T ss_pred             cEEECCcccceecccccccccccCCCcCceEcCHHHhc-cCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            99999999998664332222222233456799999884 4568899999999999999998 899997765433322111


Q ss_pred             HH-----HHhhhccccceeecccccccccccccC
Q 002321          907 LE-----EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       907 ~~-----~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..     +...+.++.+++.+||..+|.+||+++
T Consensus       251 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~  284 (334)
T cd05100         251 EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFK  284 (334)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHH
Confidence            10     112235678899999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.8e-33  Score=299.60  Aligned_cols=234  Identities=23%  Similarity=0.322  Sum_probs=189.8

Q ss_pred             cccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEE-eCCeeEEEEEec
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW-TQSLQLLIYEFV  769 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~  769 (936)
                      .|+..+.||+|+||.||+|... |+.||+|.++..   ...+.+.+|+.++++++|+|++++++++. .....++||||+
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            4567788999999999999875 888999998643   23567899999999999999999999765 445679999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++++|.++++.... ..+++..+.+++.|++.|++|||++|++||||||+||+++.++.+|++|||+++......     
T Consensus        83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----  156 (256)
T cd05082          83 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----  156 (256)
T ss_pred             CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC-----
Confidence            99999999876443 348899999999999999999999999999999999999999999999999987543221     


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH-----HHHhhhccccceeecc
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL-----EEHWKKAEWRNVSMRS  923 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  923 (936)
                      .....+..|+|||+. ....++.++||||+||++|||++ |+.||..............     .+...+..+++++.+|
T Consensus       157 ~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (256)
T cd05082         157 DTGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQC  235 (256)
T ss_pred             CCCccceeecCHHHH-ccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence            223345679999988 45568899999999999999997 9999987654322211000     0122346789999999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..+|.+||+++
T Consensus       236 l~~~p~~Rpt~~  247 (256)
T cd05082         236 WHLDAATRPSFL  247 (256)
T ss_pred             hcCChhhCcCHH
Confidence            999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2e-33  Score=301.21  Aligned_cols=244  Identities=23%  Similarity=0.325  Sum_probs=199.3

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      |+..+.||.|+||+||+|... ++..+|+|++.........+.+.+|+++++.++|+||+++++.+......++||||++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   82 (267)
T cd06610           3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS   82 (267)
T ss_pred             ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence            567788999999999999965 5789999998755444456789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc--c
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV--L  848 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~--~  848 (936)
                      +++|.++++.......+++.....++.|++.|++|||+.|++||||||+||++++++.++|+|||++..........  .
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~  162 (267)
T cd06610          83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV  162 (267)
T ss_pred             CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccc
Confidence            99999999765433458999999999999999999999999999999999999999999999999987664332221  2


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH--HHHH--------hhhccccc
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW--LEEH--------WKKAEWRN  918 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~--~~~~--------~~~~~~~~  918 (936)
                      .....++..|+|||.+.....++.++|+||+||++|||++|+.||.............  ..+.        -.+..+.+
T Consensus       163 ~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06610         163 RKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRK  242 (267)
T ss_pred             cccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHH
Confidence            2334578889999988555578999999999999999999999998765432221110  0000        11245688


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..||.+||+++
T Consensus       243 li~~~l~~~p~~Rp~~~  259 (267)
T cd06610         243 MISLCLQKDPSKRPTAE  259 (267)
T ss_pred             HHHHHcCCChhhCcCHH
Confidence            99999999999999863

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-33  Score=301.94  Aligned_cols=237  Identities=23%  Similarity=0.351  Sum_probs=196.5

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      |+..+.||.|+||.||+|+.. +++.||+|++...........+.+|+++++.++|+||+++++++.+....++|+||++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   82 (274)
T cd06609           3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG   82 (274)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence            566778999999999999976 5889999999765444455778999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                      +++|.+++...    .+++..+..++.|++.|+.|||+.+++||||+|+||++++++.++++|||+++......  ....
T Consensus        83 ~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~  156 (274)
T cd06609          83 GGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRN  156 (274)
T ss_pred             CCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cccc
Confidence            99999998764    38999999999999999999999999999999999999999999999999998765322  1223


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH--HH---Hh-hhccccceeeccc
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL--EE---HW-KKAEWRNVSMRSC  924 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~--~~---~~-~~~~~~~~~~~~l  924 (936)
                      ...+++.|+|||... +..++.++||||+||++|||++|+.||...+..........  .+   .. .+..+.+++.+||
T Consensus       157 ~~~~~~~y~~PE~~~-~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l  235 (274)
T cd06609         157 TFVGTPFWMAPEVIK-QSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL  235 (274)
T ss_pred             cccCCccccChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHh
Confidence            345777899999984 44589999999999999999999999987654322111000  01   11 3456889999999


Q ss_pred             ccccccccccC
Q 002321          925 KGSSRQRRRFQ  935 (936)
Q Consensus       925 ~~~p~~Rp~f~  935 (936)
                      ..||.+||+.+
T Consensus       236 ~~~p~~Rpt~~  246 (274)
T cd06609         236 NKDPKERPSAK  246 (274)
T ss_pred             hCChhhCcCHH
Confidence            99999999853

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.1e-33  Score=310.15  Aligned_cols=202  Identities=18%  Similarity=0.266  Sum_probs=165.7

Q ss_pred             CCccccc--CceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          695 DCELGRG--GFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       695 ~~~iG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      .++||+|  +|++||+++.+ +|+.||||+++..... ...+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            4679999  77899999875 6899999999655332 234567889999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc----
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY----  846 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~----  846 (936)
                      +|+|.+++..... ..+++..+.+++.|++.||+|||+++|+||||||+||+++.++.++++||+.+.........    
T Consensus        83 ~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~  161 (327)
T cd08227          83 YGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV  161 (327)
T ss_pred             CCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence            9999999865432 23889999999999999999999999999999999999999999999999865433211110    


Q ss_pred             -cccccccCcccccCcccccCc-ccCCchhhHHHHHHHHHHHHcCCCCCCccc
Q 002321          847 -VLSSKIQSALGYMAPEFACRT-VKITDKCDVYGFGVLVLEVVTGKRPLSTWK  897 (936)
Q Consensus       847 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~  897 (936)
                       .......++..|+|||++.+. ..++.++||||+||++|||++|+.||....
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  214 (327)
T cd08227         162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP  214 (327)
T ss_pred             ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence             011223456679999998543 358899999999999999999999997643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-33  Score=304.44  Aligned_cols=241  Identities=23%  Similarity=0.358  Sum_probs=195.0

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .|+..+.||+|+||.||+|... +++.||+|.++..........+.+|+.++++++|+||+++++++......++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            3567788999999999999986 689999999875433334567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ-SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      ++++|.+++........+++..+.+++.|++.|+.|||+ .+++||||||+||+++.++.++|+|||++.......    
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----  157 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL----  157 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc----
Confidence            999999998765333358999999999999999999996 599999999999999999999999999987553211    


Q ss_pred             cccccCcccccCcccccCcc-----cCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHH-HHHH-H------HHhhhcc
Q 002321          849 SSKIQSALGYMAPEFACRTV-----KITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS-VTWL-E------EHWKKAE  915 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~-~~~~-~------~~~~~~~  915 (936)
                      .....+++.|+|||.+.+..     .++.++||||+||++|||++|+.||.......... .... .      +...+..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD  237 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence            12234677899999874322     35789999999999999999999997654432221 1110 0      1113467


Q ss_pred             ccceeecccccccccccccC
Q 002321          916 WRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++++.+||..+|.+||+++
T Consensus       238 ~~~li~~~l~~~p~~Rp~~~  257 (286)
T cd06622         238 AQDFVAKCLNKIPNRRPTYA  257 (286)
T ss_pred             HHHHHHHHcccCcccCCCHH
Confidence            88999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.3e-34  Score=302.85  Aligned_cols=231  Identities=21%  Similarity=0.283  Sum_probs=184.2

Q ss_pred             CcccccCceEEEEEEeCC--------CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          696 CELGRGGFGAVYRTVLRD--------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      +.||+|+||.||+|..+.        ..+||+|.+.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            369999999999998642        2348888875332 2334678889999999999999999999999888999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCC--------eEEeeccCccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGE--------PKVGDYGLARL  839 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~--------~kl~Dfg~a~~  839 (936)
                      |+++|+|.++++....  .+++..+.+++.|++.|++|||+++|+||||||+||+++.++.        ++++|||.+..
T Consensus        80 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          80 YVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             cCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999999976543  3789999999999999999999999999999999999987765        69999998865


Q ss_pred             cCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcC-CCCCCccchhHHHHHHHHH---HHhhhcc
Q 002321          840 LPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTG-KRPLSTWKMMWWFSVTWLE---EHWKKAE  915 (936)
Q Consensus       840 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g-~~Pf~~~~~~~~~~~~~~~---~~~~~~~  915 (936)
                      ...      .....++..|+|||++.+...++.++||||+||++|||++| ..||...+...........   +.....+
T Consensus       158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (258)
T cd05078         158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTE  231 (258)
T ss_pred             cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHH
Confidence            432      12345677899999986655688999999999999999998 5676665543222111111   1122256


Q ss_pred             ccceeecccccccccccccC
Q 002321          916 WRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +.+++.+||..||.+||+++
T Consensus       232 ~~~li~~~l~~~p~~Rps~~  251 (258)
T cd05078         232 LANLINQCMDYEPDFRPSFR  251 (258)
T ss_pred             HHHHHHHHhccChhhCCCHH
Confidence            88999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.8e-33  Score=332.80  Aligned_cols=243  Identities=17%  Similarity=0.291  Sum_probs=192.0

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeC--CeeEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ--SLQLLI  765 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  765 (936)
                      ..|+..++||+|+||+||+|++. ++..||+|++...... .....+.+|+.++++++||||+++++++.+.  ...++|
T Consensus        13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV   92 (1021)
T PTZ00266         13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL   92 (1021)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence            35677889999999999999976 4778999998654333 3356789999999999999999999988653  567999


Q ss_pred             EEecCCCChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhC-------CcccCCCCCCCEEEcC------------
Q 002321          766 YEFVSGGSLHKHLHEGSG-GNFLSWNERFNVIQGTAKSLAHLHQS-------NIIHYNIKSSNVLIDG------------  825 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~-------~ivH~Dlkp~NIll~~------------  825 (936)
                      |||+++|+|.+++..... ...+++..++.|+.||+.||+|||+.       +||||||||+|||++.            
T Consensus        93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~  172 (1021)
T PTZ00266         93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA  172 (1021)
T ss_pred             EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence            999999999999875321 23489999999999999999999984       4999999999999964            


Q ss_pred             -----CCCeEEeeccCccccCCCccccccccccCcccccCcccccCc-ccCCchhhHHHHHHHHHHHHcCCCCCCccchh
Q 002321          826 -----SGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT-VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM  899 (936)
Q Consensus       826 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~  899 (936)
                           .+.+||+|||++..+....   ......+++.|+|||++... ..++.++|||||||++|||++|+.||...+..
T Consensus       173 ~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~  249 (1021)
T PTZ00266        173 NNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF  249 (1021)
T ss_pred             cccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence                 3358999999997653221   22345689999999987533 45789999999999999999999999876543


Q ss_pred             HHHHHHHHH-H----HhhhccccceeecccccccccccccC
Q 002321          900 WWFSVTWLE-E----HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       900 ~~~~~~~~~-~----~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ......... +    ...+..+.++|.+||..+|.+||++.
T Consensus       250 ~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~  290 (1021)
T PTZ00266        250 SQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSAL  290 (1021)
T ss_pred             HHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHH
Confidence            222111111 1    12346788999999999999999863

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.9e-33  Score=298.00  Aligned_cols=238  Identities=23%  Similarity=0.391  Sum_probs=196.6

Q ss_pred             ccccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      +.|+..+.||+|+||.||+|+..+ ++.||+|.++...   ..+++.+|++++++++|+||+++++++.+....++++||
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            457788899999999999999875 7899999986542   267899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++++|.+++....  ..+++..+..++.|++.|++|||+.+++||||+|+||+++.++.++|+|||++........  .
T Consensus        80 ~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~  155 (256)
T cd06612          80 CGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--K  155 (256)
T ss_pred             CCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--c
Confidence            99999999986533  3489999999999999999999999999999999999999999999999999986643221  2


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH-------HHHHhhhccccceee
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW-------LEEHWKKAEWRNVSM  921 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~  921 (936)
                      .....++..|+|||.+ .+..++.++||||+|+++|+|++|+.||.............       ..+...+..+.+++.
T Consensus       156 ~~~~~~~~~y~~PE~~-~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd06612         156 RNTVIGTPFWMAPEVI-QEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK  234 (256)
T ss_pred             cccccCCccccCHHHH-hcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence            2334467889999988 44578999999999999999999999998765422111100       011223356888999


Q ss_pred             cccccccccccccC
Q 002321          922 RSCKGSSRQRRRFQ  935 (936)
Q Consensus       922 ~~l~~~p~~Rp~f~  935 (936)
                      +||..||.+||+++
T Consensus       235 ~~l~~~P~~Rps~~  248 (256)
T cd06612         235 KCLVKDPEERPSAI  248 (256)
T ss_pred             HHHhcChhhCcCHH
Confidence            99999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=311.18  Aligned_cols=236  Identities=20%  Similarity=0.266  Sum_probs=186.0

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      |+..+.||+|+||+||+++.. +++.||||++......  ...+.+.+|+.++..++|+||+++++++.+....++||||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (331)
T cd05597           3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY   82 (331)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence            566788999999999999976 5889999998643221  2345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++|+|.+++.+..  ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++........ ..
T Consensus        83 ~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~  159 (331)
T cd05597          83 YVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQ  159 (331)
T ss_pred             CCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-cc
Confidence            99999999997532  2388999999999999999999999999999999999999999999999999876533221 11


Q ss_pred             cccccCcccccCcccccC----cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-------HH--Hhhhcc
Q 002321          849 SSKIQSALGYMAPEFACR----TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-------EE--HWKKAE  915 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-------~~--~~~~~~  915 (936)
                      .....|++.|+|||++..    ...++.++||||+||++|||++|+.||..............       ++  ...+..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  239 (331)
T cd05597         160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE  239 (331)
T ss_pred             ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence            223458999999998842    23578899999999999999999999987654322211110       00  113456


Q ss_pred             ccceeecccccccccc
Q 002321          916 WRNVSMRSCKGSSRQR  931 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~R  931 (936)
                      .++++.+|+.. |.+|
T Consensus       240 ~~~li~~ll~~-~~~r  254 (331)
T cd05597         240 AKDLIRRLICS-PETR  254 (331)
T ss_pred             HHHHHHHHccC-cccc
Confidence            77888887754 4444

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2e-33  Score=299.20  Aligned_cols=238  Identities=28%  Similarity=0.406  Sum_probs=193.6

Q ss_pred             ccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      ++..+.||+|+||.||+|.+.+++.+|+|+++....  ....+.+|++++++++|||++++++++......++||||+++
T Consensus         6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd05112           6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH   83 (256)
T ss_pred             eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence            456678999999999999987788999999865432  346789999999999999999999999998999999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      ++|.+++.....  .+++..+..++.|++.|++|||+.+++||||||+||+++.++.++|+|||.++...... ......
T Consensus        84 ~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~  160 (256)
T cd05112          84 GCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTG  160 (256)
T ss_pred             CcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc-ccccCC
Confidence            999999875432  37889999999999999999999999999999999999999999999999987653221 111122


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHH-----HHHHHHhhhccccceeecccc
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSV-----TWLEEHWKKAEWRNVSMRSCK  925 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~  925 (936)
                      ...+..|+|||... ...++.++||||+|+++|||++ |+.||...........     ....+...++.+.+++.+||.
T Consensus       161 ~~~~~~~~aPe~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~  239 (256)
T cd05112         161 TKFPVKWSSPEVFS-FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWK  239 (256)
T ss_pred             CccchhhcCHhHhc-cCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcc
Confidence            33456899999884 4568899999999999999998 9999987654322211     011123345678899999999


Q ss_pred             cccccccccC
Q 002321          926 GSSRQRRRFQ  935 (936)
Q Consensus       926 ~~p~~Rp~f~  935 (936)
                      .+|.+||+++
T Consensus       240 ~~p~~Rp~~~  249 (256)
T cd05112         240 ERPEDRPSFS  249 (256)
T ss_pred             cChhhCCCHH
Confidence            9999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-33  Score=298.11  Aligned_cols=235  Identities=24%  Similarity=0.348  Sum_probs=194.4

Q ss_pred             cccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      .|+..+.||.|+||.||+|... |+.||||.++....  ..+++.+|+.++++++|+||+++++++.+....++||||++
T Consensus         7 ~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           7 ELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            4577788999999999999875 88999999975533  46778999999999999999999999998889999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                      +++|.++++.... ..+++..+..++.|++.|+.|||+++++||||||+||+++.++.+||+|||.++......     .
T Consensus        84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~  157 (256)
T cd05039          84 KGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-----D  157 (256)
T ss_pred             CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-----c
Confidence            9999999976542 248999999999999999999999999999999999999999999999999998653211     1


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceeeccc
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSMRSC  924 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l  924 (936)
                      ....+..|+|||... ...++.++||||+|+++|||++ |+.||.............     ..+...++.+.+++.+||
T Consensus       158 ~~~~~~~~~ape~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  236 (256)
T cd05039         158 SGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCW  236 (256)
T ss_pred             cCCCcccccCchhhc-CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHh
Confidence            223456799999884 4468899999999999999997 999998765433221110     111223467889999999


Q ss_pred             ccccccccccC
Q 002321          925 KGSSRQRRRFQ  935 (936)
Q Consensus       925 ~~~p~~Rp~f~  935 (936)
                      ..+|.+||++.
T Consensus       237 ~~~p~~Rp~~~  247 (256)
T cd05039         237 ELDPAKRPTFK  247 (256)
T ss_pred             ccChhhCcCHH
Confidence            99999999863

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.1e-33  Score=301.14  Aligned_cols=240  Identities=22%  Similarity=0.329  Sum_probs=193.4

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..++||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            35677788999999999999875 588999999865432 2345678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++++|.+++....   .+++.+...++.|++.|++|||+.|++|+||||+||+++.++.++|+|||++......  ...
T Consensus        88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~  162 (267)
T cd06645          88 CGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAK  162 (267)
T ss_pred             cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--ccc
Confidence            99999999987644   3899999999999999999999999999999999999999999999999998755321  122


Q ss_pred             cccccCcccccCccccc--CcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HHH---HHHHH-----hhhcccc
Q 002321          849 SSKIQSALGYMAPEFAC--RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVT---WLEEH-----WKKAEWR  917 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~---~~~~~-----~~~~~~~  917 (936)
                      .....++..|+|||++.  ....++.++||||+||++|||++|+.||......... ...   ..++.     ..+..++
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH  242 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence            23456788999999863  2335788999999999999999999999765442211 110   00011     1124577


Q ss_pred             ceeecccccccccccccC
Q 002321          918 NVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++.+||..+|.+||+++
T Consensus       243 ~li~~~l~~~P~~R~~~~  260 (267)
T cd06645         243 HFVKMALTKNPKKRPTAE  260 (267)
T ss_pred             HHHHHHccCCchhCcCHH
Confidence            899999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.4e-33  Score=303.08  Aligned_cols=237  Identities=22%  Similarity=0.288  Sum_probs=183.9

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc-hHHHHHHHHHHHHcC---CCCCcceeeeEEEeC-----Ce
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKV---RHPNLVTLEGYYWTQ-----SL  761 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~~  761 (936)
                      |+..++||+|+||+||+|+.. +++.||+|.++...... ....+.+|+.+++++   +||||+++++++...     ..
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            566778999999999999976 58899999986543222 234566777777665   799999999998642     45


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .++||||++ +++.+++..... ..+++.++..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus        82 ~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          82 VTLVFEHVD-QDLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             EEEEEcccc-cCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            789999996 589888876432 338999999999999999999999999999999999999999999999999997653


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH------HH------
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL------EE------  909 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~------~~------  909 (936)
                      ...   ......++..|+|||++. ...++.++||||+||++|||++|+.||..............      ..      
T Consensus       160 ~~~---~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         160 CQM---ALTPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             Ccc---cCCCccccccccCchHhh-CCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            221   123345788899999884 44689999999999999999999999976544221110000      00      


Q ss_pred             -------------------Hhhhccccceeeccccccccccccc
Q 002321          910 -------------------HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       910 -------------------~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                         ...++.+++++.+|+..||.+||+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  279 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISA  279 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCH
Confidence                               0123446788999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.7e-33  Score=298.26  Aligned_cols=236  Identities=25%  Similarity=0.346  Sum_probs=182.8

Q ss_pred             CcccccCceEEEEEEeCC----CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEE-eCCeeEEEEEecC
Q 002321          696 CELGRGGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW-TQSLQLLIYEFVS  770 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  770 (936)
                      +.||+|+||.||+|.+.+    +..||+|++.........+.+.+|+.+++.++||||+++++++. .+...++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            368999999999998642    45799998854333344577889999999999999999999876 4556789999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc--cc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY--VL  848 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--~~  848 (936)
                      +|+|.+++.+...  ..++..+..++.|++.|++|||+.+++||||||+||+++.++.+||+|||+++........  ..
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence            9999999976432  2677788899999999999999999999999999999999999999999999755321111  11


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceeec
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSMR  922 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  922 (936)
                      .....++..|+|||... ...++.++|||||||++|||++ |..||...+.........     ..+...+..+.+++.+
T Consensus       159 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  237 (262)
T cd05058         159 HTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS  237 (262)
T ss_pred             cccCcCCccccChhHhc-cCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence            12234566899999884 4578999999999999999999 466676554432221111     0112234568899999


Q ss_pred             cccccccccccc
Q 002321          923 SCKGSSRQRRRF  934 (936)
Q Consensus       923 ~l~~~p~~Rp~f  934 (936)
                      ||..+|.+||++
T Consensus       238 cl~~~p~~Rp~~  249 (262)
T cd05058         238 CWHPKPEMRPTF  249 (262)
T ss_pred             HcCCChhhCCCH
Confidence            999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-33  Score=303.12  Aligned_cols=240  Identities=23%  Similarity=0.330  Sum_probs=195.3

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .|+..+.||+|+||.||+|+.. ++..||+|+++... ....+.+.+|+.++++++|+||+++++++..+...++||||+
T Consensus         6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            4677788999999999999975 58899999986542 234567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++++|.+++.+...  .+++..+.+++.|++.|+.|||+.+|+|+||||+||+++.++.++|+|||.+.......  ...
T Consensus        85 ~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~  160 (280)
T cd06611          85 DGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--QKR  160 (280)
T ss_pred             CCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--ccc
Confidence            99999999876432  38999999999999999999999999999999999999999999999999986543211  122


Q ss_pred             ccccCcccccCccccc----CcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HHHHH------HHHhhhccccc
Q 002321          850 SKIQSALGYMAPEFAC----RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVTWL------EEHWKKAEWRN  918 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~----~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~~~------~~~~~~~~~~~  918 (936)
                      ....+++.|+|||.+.    ....++.++||||+|+++|||++|+.||...+..... .....      .+...+..+.+
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (280)
T cd06611         161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFND  240 (280)
T ss_pred             ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHH
Confidence            3345788899999873    2334678999999999999999999999876543221 11110      01123457889


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..+|.+||++.
T Consensus       241 li~~~l~~~p~~Rps~~  257 (280)
T cd06611         241 FLKSCLVKDPDDRPTAA  257 (280)
T ss_pred             HHHHHhccChhhCcCHH
Confidence            99999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.1e-33  Score=302.93  Aligned_cols=241  Identities=22%  Similarity=0.303  Sum_probs=193.7

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|+||+++++++..+...++||||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            45678889999999999999976 48899999986543 23456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      ++++++..++.+...  .+++..+..++.|++.|++|||+.+++||||||+||+++.++.+||+|||++......  ...
T Consensus        91 ~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~  166 (292)
T cd06644          91 CPGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQR  166 (292)
T ss_pred             CCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc--ccc
Confidence            999999888765332  3899999999999999999999999999999999999999999999999998654221  111


Q ss_pred             cccccCcccccCcccccC----cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH--HH-----HHhhhcccc
Q 002321          849 SSKIQSALGYMAPEFACR----TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW--LE-----EHWKKAEWR  917 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~--~~-----~~~~~~~~~  917 (936)
                      .....+++.|+|||.+..    ...++.++||||+||++|||++|+.||...+.........  ..     +...+.++.
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR  246 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHH
Confidence            233457788999998742    3346789999999999999999999998765432221110  00     111224678


Q ss_pred             ceeecccccccccccccC
Q 002321          918 NVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++.+||..||.+||++.
T Consensus       247 ~li~~~l~~~p~~Rp~~~  264 (292)
T cd06644         247 DFLKTALDKHPETRPSAA  264 (292)
T ss_pred             HHHHHHhcCCcccCcCHH
Confidence            899999999999999863

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.6e-34  Score=309.59  Aligned_cols=240  Identities=21%  Similarity=0.316  Sum_probs=205.4

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccch-HHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKS-QEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ..|...+.||+|.|++|..|++. ++..||||.+........ ...+.+|+++|+.++|||||+++.+.+.+...|+|||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e  135 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME  135 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence            35677889999999999999976 599999999977665433 3558899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+.+|.+.+++.+.++   +.+..+..++.|+.+|++|||++.|||||||++|||++.+..+||+|||++..+.   ...
T Consensus       136 ya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~~~  209 (596)
T KOG0586|consen  136 YASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---YGL  209 (596)
T ss_pred             eccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec---ccc
Confidence            9999999999998776   6668888999999999999999999999999999999999999999999998774   333


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchh----HHHHHHHHHHHhhhccccceeecc
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM----WWFSVTWLEEHWKKAEWRNVSMRS  923 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  923 (936)
                      .-...+|++.|.|||++.+..+.++.+|+||+|+++|.|+.|..||++..-.    ......+-=+.+...+-+++++++
T Consensus       210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~  289 (596)
T KOG0586|consen  210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKF  289 (596)
T ss_pred             cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHHh
Confidence            4466789999999999988778889999999999999999999999975431    111222222455667788899999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      +..+|.+|+..+
T Consensus       290 lvl~Pskr~~~d  301 (596)
T KOG0586|consen  290 LVLNPSKRGPCD  301 (596)
T ss_pred             hccCccccCCHH
Confidence            999999998754

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.2e-33  Score=305.48  Aligned_cols=238  Identities=22%  Similarity=0.348  Sum_probs=194.9

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            34677788999999999999964 689999999865433 3356788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++++|.+++.+..    +++.++..++.|++.|+.|||+.+++||||||+||+++.++.++|+|||.+........  .
T Consensus        98 ~~~~~L~~~~~~~~----~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~  171 (297)
T cd06656          98 LAGGSLTDVVTETC----MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  171 (297)
T ss_pred             cCCCCHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--C
Confidence            99999999986532    78899999999999999999999999999999999999999999999999876532221  1


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH-------HHHHhhhccccceee
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW-------LEEHWKKAEWRNVSM  921 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~  921 (936)
                      .....+++.|+|||... ...++.++||||+||++|+|++|+.||...+.........       ..+...+..+++++.
T Consensus       172 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  250 (297)
T cd06656         172 RSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN  250 (297)
T ss_pred             cCcccCCccccCHHHHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence            23345778899999884 4568899999999999999999999997765422110000       011223355788999


Q ss_pred             cccccccccccccC
Q 002321          922 RSCKGSSRQRRRFQ  935 (936)
Q Consensus       922 ~~l~~~p~~Rp~f~  935 (936)
                      +||..+|.+||++.
T Consensus       251 ~~l~~~p~~Rps~~  264 (297)
T cd06656         251 RCLEMDVDRRGSAK  264 (297)
T ss_pred             HHccCChhhCcCHH
Confidence            99999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.5e-33  Score=307.49  Aligned_cols=198  Identities=21%  Similarity=0.390  Sum_probs=161.0

Q ss_pred             CCcccccCceEEEEEEeC---CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEe--CCeeEEEEEec
Q 002321          695 DCELGRGGFGAVYRTVLR---DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWT--QSLQLLIYEFV  769 (936)
Q Consensus       695 ~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~  769 (936)
                      .++||+|+||+||+|+.+   ++..||+|.+....   ....+.+|++++++++||||+++++++..  +...++||||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            357999999999999965   35789999986543   23467899999999999999999999854  45678999999


Q ss_pred             CCCChhhhhhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE----cCCCCeEEeeccCccc
Q 002321          770 SGGSLHKHLHEGS------GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLI----DGSGEPKVGDYGLARL  839 (936)
Q Consensus       770 ~~g~L~~~l~~~~------~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~a~~  839 (936)
                      + +++.+++....      ....+++..+.+++.|++.||+|||+.+|+||||||+||++    +.++.+||+|||+++.
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            5 57877765321      12247889999999999999999999999999999999999    5667999999999986


Q ss_pred             cCCCcc-ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCcc
Q 002321          840 LPMLDR-YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTW  896 (936)
Q Consensus       840 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~  896 (936)
                      ...... ........+++.|+|||++.+...++.++||||+||++|||++|+.||...
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            643221 112233467889999998866566899999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.6e-33  Score=297.55  Aligned_cols=239  Identities=23%  Similarity=0.323  Sum_probs=189.5

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc----cchHHHHHHHHHHHHcCCCCCcceeeeEEEe--CCeeEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL----VKSQEDFEREVKKLGKVRHPNLVTLEGYYWT--QSLQLL  764 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  764 (936)
                      |+..+.||+|+||.||+|... +++.||+|++.....    .+....+.+|+.++++++||||+++++++.+  ....++
T Consensus         4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   83 (266)
T cd06651           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI   83 (266)
T ss_pred             ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence            567788999999999999975 588999998864322    1234568899999999999999999999875  356789


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ++||+++++|.+++.....   +++.....++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++......
T Consensus        84 ~~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          84 FMEYMPGGSVKDQLKAYGA---LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            9999999999999976443   7889999999999999999999999999999999999999999999999997653211


Q ss_pred             c-ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH------HHHHhhhcccc
Q 002321          845 R-YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW------LEEHWKKAEWR  917 (936)
Q Consensus       845 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~  917 (936)
                      . ........++..|+|||.+. +..++.++||||+||++|||++|+.||...+.........      ..+....+.++
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVIS-GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHAR  239 (266)
T ss_pred             ccCCccccCCccccccCHHHhC-CCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHH
Confidence            1 11112345778899999884 4568899999999999999999999998765432221110      00223345566


Q ss_pred             ceeecccccccccccccC
Q 002321          918 NVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++ +||..+|.+||+++
T Consensus       240 ~li-~~~~~~p~~Rp~~~  256 (266)
T cd06651         240 DFL-GCIFVEARHRPSAE  256 (266)
T ss_pred             HHH-HHhcCChhhCcCHH
Confidence            776 79999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.9e-33  Score=298.51  Aligned_cols=229  Identities=24%  Similarity=0.309  Sum_probs=183.6

Q ss_pred             CcccccCceEEEEEEeCCCc-----------EEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          696 CELGRGGFGAVYRTVLRDGR-----------PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      +.||+|+||.||+|.+.+..           .|++|.+......  ...+.+|+.++++++|+||+++++++.. ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            36999999999999986432           5788877544322  6788999999999999999999999988 77799


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-------CeEEeeccCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG-------EPKVGDYGLA  837 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~-------~~kl~Dfg~a  837 (936)
                      ||||+++|+|.+++.....  .+++..+..++.|++.||+|||+++|+||||||+||+++.++       .+|++|||++
T Consensus        78 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            9999999999999986542  488999999999999999999999999999999999999888       7999999999


Q ss_pred             cccCCCccccccccccCcccccCcccccCc-ccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHHH---HHhh
Q 002321          838 RLLPMLDRYVLSSKIQSALGYMAPEFACRT-VKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWLE---EHWK  912 (936)
Q Consensus       838 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~~---~~~~  912 (936)
                      .....      .....++..|+|||.+... ..++.++||||+||++|||++ |..||...+...........   +...
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  229 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPD  229 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCCC
Confidence            76532      1223455679999988544 368899999999999999999 68888776532211110000   1112


Q ss_pred             hccccceeecccccccccccccC
Q 002321          913 KAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       913 ~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ...+.+++.+||..+|.+||+++
T Consensus       230 ~~~~~~li~~~l~~~p~~Rpt~~  252 (259)
T cd05037         230 CAELANLINQCWTYDPTKRPSFR  252 (259)
T ss_pred             chHHHHHHHHHhccChhhCCCHH
Confidence            25778999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-33  Score=304.47  Aligned_cols=242  Identities=25%  Similarity=0.344  Sum_probs=190.4

Q ss_pred             cccCCCcccccCceEEEEEEeC-----CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeC--CeeE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ--SLQL  763 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  763 (936)
                      .|+..++||+|+||.||.|+..     ++..||+|.++........+.+.+|++++++++|+||+++++++.+.  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            4677889999999999999842     47899999987654444567899999999999999999999998775  5678


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      +||||+++++|.+++.+...  .+++.++..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++.....
T Consensus        85 lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  162 (284)
T ss_pred             EEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence            99999999999999875432  3899999999999999999999999999999999999999999999999999866432


Q ss_pred             ccc-cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhH-------------HHHHHHHH-
Q 002321          844 DRY-VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMW-------------WFSVTWLE-  908 (936)
Q Consensus       844 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~-------------~~~~~~~~-  908 (936)
                      ... .......++..|+|||+.. +..++.++||||+||++|||++++.|+.......             ........ 
T Consensus       163 ~~~~~~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         163 KEYYTVKDDLDSPVFWYAPECLI-QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             ccceeecCCCCCCccccCHHHhc-cCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            221 1122344566799999884 4468899999999999999999877653321100             00000000 


Q ss_pred             ------HHhhhccccceeecccccccccccccC
Q 002321          909 ------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 ------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                            +.-.+.++.+++.+||..+|.+||+++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~  274 (284)
T cd05079         242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQ  274 (284)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCCcccCcCHH
Confidence                  111235678999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.3e-33  Score=312.08  Aligned_cols=234  Identities=22%  Similarity=0.272  Sum_probs=185.9

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      |+..+.||+|+||+||+++.. +++.||+|++.....  ......+.+|+.++..++|++|+++++++.+.+..++||||
T Consensus         3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey   82 (331)
T cd05624           3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY   82 (331)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence            566778999999999999976 578999999864322  12245578899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++|+|.+++.+..  ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++....... ..
T Consensus        83 ~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~  159 (331)
T cd05624          83 YVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQ  159 (331)
T ss_pred             CCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-ee
Confidence            99999999997632  2388899999999999999999999999999999999999999999999999976543221 12


Q ss_pred             cccccCcccccCcccccCc----ccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-------HHHh--hhcc
Q 002321          849 SSKIQSALGYMAPEFACRT----VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-------EEHW--KKAE  915 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-------~~~~--~~~~  915 (936)
                      .....|++.|+|||++...    ..++.++||||+||++|||++|+.||...+..........       +..+  .+..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~  239 (331)
T cd05624         160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE  239 (331)
T ss_pred             eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence            2235689999999987431    3578899999999999999999999987654322211110       0111  2456


Q ss_pred             ccceeeccccccc
Q 002321          916 WRNVSMRSCKGSS  928 (936)
Q Consensus       916 ~~~~~~~~l~~~p  928 (936)
                      +++++.+|+..++
T Consensus       240 ~~~li~~ll~~~~  252 (331)
T cd05624         240 AKDLIQRLICSRE  252 (331)
T ss_pred             HHHHHHHHccCch
Confidence            7888888887655

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=6e-33  Score=300.52  Aligned_cols=240  Identities=21%  Similarity=0.283  Sum_probs=195.0

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      |+..+.||+|++|.||+|+.. +|+.||||+++........+.+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD   81 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence            566788999999999999986 5889999999765544445678889999999999999999999999999999999997


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                       +++.+++........+++..+.+++.|++.||+|||+.+++||||||+||++++++.++++|||.++......  ....
T Consensus        82 -~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--~~~~  158 (284)
T cd07836          82 -KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--NTFS  158 (284)
T ss_pred             -ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--cccc
Confidence             5898888765444458999999999999999999999999999999999999999999999999997553221  1122


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-----------------------
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-----------------------  907 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-----------------------  907 (936)
                      ...++..|+|||.+.+...++.++||||+||++|||++|+.||...+..........                       
T Consensus       159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07836         159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF  238 (284)
T ss_pred             cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence            344677899999886655678999999999999999999999987653221111000                       


Q ss_pred             ----------HHHhhhccccceeeccccccccccccc
Q 002321          908 ----------EEHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       908 ----------~~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                .....+...++++.+|+..||.+||++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~  275 (284)
T cd07836         239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISA  275 (284)
T ss_pred             cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCH
Confidence                      001234667789999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.2e-33  Score=302.99  Aligned_cols=239  Identities=25%  Similarity=0.309  Sum_probs=192.4

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc-hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      |+..++||+|+||.||+|.++ +++.||+|++....... ..+.+.+|++++++++||||+++++++.+....++||||+
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   82 (286)
T cd07846           3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV   82 (286)
T ss_pred             eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence            566788999999999999986 48999999986543322 3467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      +++++.++......   +++.++..++.|+++|++|||+.+++||||+|+||++++++.++|+|||++........  ..
T Consensus        83 ~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~  157 (286)
T cd07846          83 DHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VY  157 (286)
T ss_pred             CccHHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--cc
Confidence            99999887765332   89999999999999999999999999999999999999999999999999876543221  12


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HHHH--------HHH-----------
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVTW--------LEE-----------  909 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~~--------~~~-----------  909 (936)
                      ....++..|+|||+..+...++.++||||+||++|||++|+.||...+..... ....        ..+           
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07846         158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM  237 (286)
T ss_pred             CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence            23456788999998865556788999999999999999999999765532111 0000        000           


Q ss_pred             ---------------HhhhccccceeecccccccccccccC
Q 002321          910 ---------------HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       910 ---------------~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                                     ...+..+.+++.+||..+|.+||+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~  278 (286)
T cd07846         238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSS  278 (286)
T ss_pred             ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHH
Confidence                           01234578899999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.7e-33  Score=313.07  Aligned_cols=199  Identities=23%  Similarity=0.282  Sum_probs=165.3

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeC------Ce
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ------SL  761 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  761 (936)
                      ..|+..+.||+|+||.||+|... .++.||||++...... .....+.+|+.+++.++||||+++++++...      ..
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   96 (355)
T cd07874          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD   96 (355)
T ss_pred             hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence            35677789999999999999865 5889999998654322 2346778999999999999999999988643      24


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .++||||++ +++.+.+..     .+++..+..++.|+++||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus        97 ~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          97 VYLVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             eEEEhhhhc-ccHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence            689999996 467666643     27888899999999999999999999999999999999999999999999997653


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM  898 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~  898 (936)
                      ..   .......+++.|+|||++ .+..++.++||||+||++|||++|+.||...+.
T Consensus       171 ~~---~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  223 (355)
T cd07874         171 TS---FMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY  223 (355)
T ss_pred             Cc---cccCCccccCCccCHHHH-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            21   122335678899999988 455789999999999999999999999987653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.9e-33  Score=310.30  Aligned_cols=235  Identities=20%  Similarity=0.236  Sum_probs=186.0

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeC------Ce
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ------SL  761 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  761 (936)
                      ..|+..+.||+|+||.||+|... +++.||||++...... ...+.+.+|++++++++|+||+++++++...      ..
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            34677789999999999999965 5789999998653221 2345677899999999999999999987543      34


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .++++|++ +++|.+++...    .+++..+..++.|++.||+|||++||+||||||+||++++++.+||+|||+++...
T Consensus        95 ~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  169 (343)
T cd07878          95 VYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD  169 (343)
T ss_pred             EEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence            58999998 78998887643    28999999999999999999999999999999999999999999999999998653


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH----------------
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT----------------  905 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~----------------  905 (936)
                      ..     .....+++.|+|||++.+...++.++||||+||++|||++|+.||...+........                
T Consensus       170 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07878         170 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS  244 (343)
T ss_pred             CC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            21     123457889999999866567899999999999999999999999765432111000                


Q ss_pred             ------HHH--H-----------Hhhhccccceeeccccccccccccc
Q 002321          906 ------WLE--E-----------HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       906 ------~~~--~-----------~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                            +..  +           ....+.+.+++.+|+..||.+||+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~  292 (343)
T cd07878         245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISA  292 (343)
T ss_pred             hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCH
Confidence                  000  0           0012235688899999999999974

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.3e-33  Score=299.61  Aligned_cols=239  Identities=24%  Similarity=0.362  Sum_probs=195.8

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..+.||+|+||.||+|... +++.||||++.........+.+.+|+.++++++||||+++++++.++...++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            45677788999999999999865 58899999986554444557789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++++|.+++...    .+++..+..++.|++.|++|||+.+++|+||||+||+++.++.++++|||++.......  ..
T Consensus        84 ~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06641          84 LGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hh
Confidence            9999999998753    28899999999999999999999999999999999999999999999999987654321  11


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH-HH-H---HHhhhccccceeecc
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT-WL-E---EHWKKAEWRNVSMRS  923 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~-~~-~---~~~~~~~~~~~~~~~  923 (936)
                      .....++..|+|||... ...++.++|+||+||++|+|++|..||............ .. .   +...+..+.+++.+|
T Consensus       158 ~~~~~~~~~y~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  236 (277)
T cd06641         158 RNTFVGTPFWMAPEVIK-QSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC  236 (277)
T ss_pred             hccccCCccccChhhhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence            22345778899999884 456788999999999999999999999765543221111 00 0   112345688899999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..+|.+||++.
T Consensus       237 l~~~p~~Rp~~~  248 (277)
T cd06641         237 LNKEPSFRPTAK  248 (277)
T ss_pred             ccCChhhCcCHH
Confidence            999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.7e-33  Score=311.29  Aligned_cols=236  Identities=20%  Similarity=0.248  Sum_probs=186.1

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      |+..++||+|+||+||+++.+ +++.||+|++......  .....+.+|+.++..++|++|+++++++.+....++||||
T Consensus         3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey   82 (332)
T cd05623           3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY   82 (332)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence            566778999999999999976 4788999998543221  2234578899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++|+|.+++++...  .+++..+..++.|++.|++|||+++|+||||||+||+++.++.+||+|||++....... ...
T Consensus        83 ~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-~~~  159 (332)
T cd05623          83 YVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQ  159 (332)
T ss_pred             cCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC-cce
Confidence            999999999976322  38888999999999999999999999999999999999999999999999987543211 112


Q ss_pred             cccccCcccccCcccccC----cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH------HH---Hhhhcc
Q 002321          849 SSKIQSALGYMAPEFACR----TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL------EE---HWKKAE  915 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~------~~---~~~~~~  915 (936)
                      .....|++.|+|||++..    ...++.++||||+||++|||++|+.||...+..........      .+   ...+..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~  239 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED  239 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence            233568999999998742    34578899999999999999999999987665332211110      00   113456


Q ss_pred             ccceeeccccccccc
Q 002321          916 WRNVSMRSCKGSSRQ  930 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~  930 (936)
                      .++++.+|+..++.+
T Consensus       240 ~~~li~~ll~~~~~r  254 (332)
T cd05623         240 AKDLIRRLICSREHR  254 (332)
T ss_pred             HHHHHHHHccChhhh
Confidence            788888887655433

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.5e-33  Score=297.27  Aligned_cols=240  Identities=25%  Similarity=0.373  Sum_probs=192.1

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc--------hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCee
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK--------SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQ  762 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  762 (936)
                      |.....||+|+||.||+|... +++.||+|.+.......        ..+.+.+|+.++++++||||+++++++......
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            345568999999999999875 57899999886543221        125688999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCC
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM  842 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  842 (936)
                      ++||||+++++|.+++....   .+++..+..++.|++.|++|||+.+++||||+|+||+++.++.++|+|||.++....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA  158 (267)
T ss_pred             EEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence            99999999999999997653   278889999999999999999999999999999999999999999999999986642


Q ss_pred             Ccc----ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HHH-HHH---HHhhh
Q 002321          843 LDR----YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVT-WLE---EHWKK  913 (936)
Q Consensus       843 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~-~~~---~~~~~  913 (936)
                      ...    ........++..|+|||... ...++.++||||+||++|+|++|+.||...+..... ... ...   +.-.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVK-QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNIS  237 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhc-cCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccC
Confidence            111    11112345778899999884 446788999999999999999999999876543211 110 000   11234


Q ss_pred             ccccceeecccccccccccccC
Q 002321          914 AEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       914 ~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..+.+++.+||..||.+||++.
T Consensus       238 ~~~~~li~~~l~~~p~~Rp~~~  259 (267)
T cd06628         238 SEAIDFLEKTFEIDHNKRPTAA  259 (267)
T ss_pred             HHHHHHHHHHccCCchhCcCHH
Confidence            6678899999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.9e-33  Score=299.14  Aligned_cols=241  Identities=22%  Similarity=0.313  Sum_probs=192.3

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc---------chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCe
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV---------KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSL  761 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  761 (936)
                      |...+.||+|+||.||+|... +|+.||||.++.....         ...+.+.+|+.++++++|+|++++++++.....
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   82 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY   82 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence            456678999999999999865 5899999988543211         112467889999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .++||||+++++|.+++++..   .+++..+..++.|++.|+.|||+.+++||||+|+||+++.++.++++|||+++...
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  159 (272)
T cd06629          83 LSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD  159 (272)
T ss_pred             eEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence            999999999999999997753   38888999999999999999999999999999999999999999999999997654


Q ss_pred             CCccccccccccCcccccCcccccCcc-cCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HHHHH--H----HH---
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTV-KITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVTWL--E----EH---  910 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~~~--~----~~---  910 (936)
                      ............++..|+|||...... .++.++||||+|+++||+++|..||...+..... .....  .    +.   
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM  239 (272)
T ss_pred             ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccc
Confidence            322222223445788899999875443 4788999999999999999999999765442211 11000  0    00   


Q ss_pred             hhhccccceeecccccccccccccC
Q 002321          911 WKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       911 ~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..+..+++++.+||..||.+||+++
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rps~~  264 (272)
T cd06629         240 NLSPVALDFLNACFTINPDNRPTAR  264 (272)
T ss_pred             cCCHHHHHHHHHHhcCChhhCCCHH
Confidence            1245788899999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.9e-33  Score=316.76  Aligned_cols=193  Identities=21%  Similarity=0.230  Sum_probs=163.5

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      -|...+.||+|+||.||+|++. .++.||||...       ...+.+|++++++++|+||+++++++...+..++|||++
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            3666778999999999999976 47899999642       234578999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                       .++|.+++....  ..+++.++..++.|+++||+|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus       243 -~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  319 (461)
T PHA03211        243 -RSDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH  319 (461)
T ss_pred             -CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence             478988886543  24899999999999999999999999999999999999999999999999999865432222222


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCC
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS  894 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~  894 (936)
                      ....||+.|+|||++. +..++.++|||||||++|||++|..|+.
T Consensus       320 ~~~~GT~~Y~APE~~~-~~~~~~~sDvwSlGviL~El~~g~~~lf  363 (461)
T PHA03211        320 YGIAGTVDTNAPEVLA-GDPYTPSVDIWSAGLVIFEAAVHTASLF  363 (461)
T ss_pred             cccCCCcCCcCHHHHc-CCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence            3456899999999984 4568999999999999999999876653

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-34  Score=283.50  Aligned_cols=234  Identities=21%  Similarity=0.356  Sum_probs=185.8

Q ss_pred             CcccccCceEEEEEE-eCCCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEEEecCCCC
Q 002321          696 CELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIYEFVSGGS  773 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~  773 (936)
                      +.||+|+|+.|--++ +.+|.+||||++.+. ....+.++.||++++.+. .|+||+++++||+++...|+|||-|.||+
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            469999999998887 567999999999655 345678899999999999 59999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---CeEEeeccCccccCCCcc-----
Q 002321          774 LHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG---EPKVGDYGLARLLPMLDR-----  845 (936)
Q Consensus       774 L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~~~-----  845 (936)
                      |..++++...   +++.++.+++++|+.||.+||.+||.|||+||+|||-....   -+|||||.++.-+.....     
T Consensus       163 lLshI~~~~~---F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas  239 (463)
T KOG0607|consen  163 LLSHIQKRKH---FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS  239 (463)
T ss_pred             HHHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence            9999988654   99999999999999999999999999999999999986654   589999998864422111     


Q ss_pred             ccccccccCcccccCccccc----CcccCCchhhHHHHHHHHHHHHcCCCCCCcc-------ch------------hHHH
Q 002321          846 YVLSSKIQSALGYMAPEFAC----RTVKITDKCDVYGFGVLVLEVVTGKRPLSTW-------KM------------MWWF  902 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~-------~~------------~~~~  902 (936)
                      ...-....|+..|||||+..    ....|+.++|.||+|||+|-|++|.+||.+.       +.            +.++
T Consensus       240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ  319 (463)
T KOG0607|consen  240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ  319 (463)
T ss_pred             CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence            11112345777899999752    3345889999999999999999999999762       11            1111


Q ss_pred             --HHHHHHHHhh--hccccceeecccccccccccc
Q 002321          903 --SVTWLEEHWK--KAEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       903 --~~~~~~~~~~--~~~~~~~~~~~l~~~p~~Rp~  933 (936)
                        ..+|.+..|.  +.+.++++...+..|+.+|-+
T Consensus       320 EGkYeFPdkdWahIS~eakdlisnLlvrda~~rls  354 (463)
T KOG0607|consen  320 EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLS  354 (463)
T ss_pred             ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhh
Confidence              1222333443  356677778888888888743

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.8e-33  Score=295.02  Aligned_cols=237  Identities=25%  Similarity=0.359  Sum_probs=193.5

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc----chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV----KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      |+..+.||+|+||.||+|... +++.||+|.+......    +..+.+.+|+.++++++|+||+++++++.+....++|+
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            456678999999999999976 6899999998654321    23467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++++|.+++.+..   .+++..+..++.|++.|++|||+.|++|+||+|+||+++.++.+||+|||.+.......  
T Consensus        82 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--  156 (258)
T cd06632          82 ELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--  156 (258)
T ss_pred             EecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence            9999999999997653   37899999999999999999999999999999999999999999999999987653322  


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HHHH-----HHHHhhhcccccee
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVTW-----LEEHWKKAEWRNVS  920 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~~-----~~~~~~~~~~~~~~  920 (936)
                       ......++..|+|||.......++.++|+||+||++|+|++|+.||......... ....     ..+...+..+.+++
T Consensus       157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  235 (258)
T cd06632         157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI  235 (258)
T ss_pred             -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHH
Confidence             2234557888999998844333789999999999999999999999776532211 1111     00112345678889


Q ss_pred             eccccccccccccc
Q 002321          921 MRSCKGSSRQRRRF  934 (936)
Q Consensus       921 ~~~l~~~p~~Rp~f  934 (936)
                      .+||..+|.+||++
T Consensus       236 ~~~l~~~p~~Rp~~  249 (258)
T cd06632         236 LKCLQRDPSLRPTA  249 (258)
T ss_pred             HHHhhcCcccCcCH
Confidence            99999999999986

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.8e-33  Score=301.11  Aligned_cols=240  Identities=25%  Similarity=0.348  Sum_probs=188.8

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHH-HHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKK-LGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      |+..+.||+|+||.||+|+.. +|+.||+|+++.........++..|+.. ++..+||||+++++++..+...++||||+
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~   82 (283)
T cd06617           3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM   82 (283)
T ss_pred             ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence            566678999999999999976 5899999998765433444566667665 56668999999999999999999999999


Q ss_pred             CCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          770 SGGSLHKHLHEGS-GGNFLSWNERFNVIQGTAKSLAHLHQS-NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       770 ~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      + |+|.+++.... ....+++..+..++.|++.|++|||++ +++||||||+||+++.++.+||+|||.++.....   .
T Consensus        83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---~  158 (283)
T cd06617          83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---V  158 (283)
T ss_pred             c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc---c
Confidence            6 78888776432 234589999999999999999999997 9999999999999999999999999999765321   1


Q ss_pred             ccccccCcccccCcccccCc---ccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-------HHhhhcccc
Q 002321          848 LSSKIQSALGYMAPEFACRT---VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-------EHWKKAEWR  917 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~  917 (936)
                      ......++..|+|||.+.+.   ..++.++|+||+||++|||++|+.||...............       ....++++.
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  238 (283)
T cd06617         159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQ  238 (283)
T ss_pred             ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHH
Confidence            12234567889999987432   34688999999999999999999999764432111111111       112346788


Q ss_pred             ceeecccccccccccccC
Q 002321          918 NVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++.+||..+|.+||+++
T Consensus       239 ~li~~~l~~~p~~Rp~~~  256 (283)
T cd06617         239 DFVNKCLKKNYKERPNYP  256 (283)
T ss_pred             HHHHHHccCChhhCcCHH
Confidence            999999999999999874

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=6e-33  Score=311.27  Aligned_cols=199  Identities=22%  Similarity=0.278  Sum_probs=165.9

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeC------Ce
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ------SL  761 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  761 (936)
                      ..|+..+.||+|+||.||+|... .++.||||++..... ......+.+|+.+++.++||||+++++++...      ..
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~  103 (364)
T cd07875          24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  103 (364)
T ss_pred             cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence            45677889999999999999975 588999999865432 23356788999999999999999999987543      35


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .++||||++ +++.+.+..     .+++..+..++.|+++||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus       104 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         104 VYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             EEEEEeCCC-CCHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence            689999996 577777643     27888899999999999999999999999999999999999999999999997653


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM  898 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~  898 (936)
                      ..   .......+++.|+|||++. +..++.++||||+||++|||++|+.||...+.
T Consensus       178 ~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  230 (364)
T cd07875         178 TS---FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH  230 (364)
T ss_pred             CC---CcccCCcccCCcCCHHHHh-CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH
Confidence            21   1223346788999999984 55789999999999999999999999987654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.9e-33  Score=301.98  Aligned_cols=239  Identities=22%  Similarity=0.283  Sum_probs=188.5

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      |+..+.||+|+||.||+|+.. +|+.||+|+++..... .....+.+|++++++++|+||+++++++.+....++|+||+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            456678999999999999976 5899999998654322 22356788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      + +++.+++....  ..+++..+..++.|+++||+|||+++++||||||+||+++.++.+||+|||+++.......  ..
T Consensus        82 ~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~  156 (284)
T cd07839          82 D-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--CY  156 (284)
T ss_pred             C-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--Cc
Confidence            6 68888776532  2389999999999999999999999999999999999999999999999999976533221  11


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HHH-----------H-----------
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVT-----------W-----------  906 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~-----------~-----------  906 (936)
                      ....+++.|+|||.+.+...++.++||||+||++|||++|+.||......... ...           +           
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP  236 (284)
T ss_pred             CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence            23456788999998866566789999999999999999999886443221110 000           0           


Q ss_pred             ----------HH-HHhhhccccceeecccccccccccccC
Q 002321          907 ----------LE-EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       907 ----------~~-~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                                .+ ....++++++++.+||..||.+||+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~  276 (284)
T cd07839         237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAE  276 (284)
T ss_pred             cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHH
Confidence                      00 001235667899999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7.1e-33  Score=295.65  Aligned_cols=238  Identities=28%  Similarity=0.387  Sum_probs=192.5

Q ss_pred             ccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      ..++..++||+|+||.||+|...++..+|+|++....  ...+.+.+|++++++++|+||+++++++.. ...+++|||+
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            3467778999999999999998778889999886442  235678899999999999999999999877 6779999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++++|.+++.+.. ...+++.++..++.|++.|++|||+.|++|+||||+||+++.++.+||+|||.+........ ...
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~  160 (260)
T cd05073          83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAR  160 (260)
T ss_pred             CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-ccc
Confidence            9999999997643 23478889999999999999999999999999999999999999999999999976543221 112


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHHH-------HHhhhccccceee
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWLE-------EHWKKAEWRNVSM  921 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~  921 (936)
                      ....++..|+|||++. ...++.++||||+||++|++++ |+.||...+......  ...       +...+..+.+++.
T Consensus       161 ~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~  237 (260)
T cd05073         161 EGAKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR--ALERGYRMPRPENCPEELYNIMM  237 (260)
T ss_pred             cCCcccccccCHhHhc-cCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHhCCCCCCCcccCCHHHHHHHH
Confidence            2233456799999884 4568899999999999999998 999998765432211  111       1123356788999


Q ss_pred             cccccccccccccC
Q 002321          922 RSCKGSSRQRRRFQ  935 (936)
Q Consensus       922 ~~l~~~p~~Rp~f~  935 (936)
                      +||..+|.+||++.
T Consensus       238 ~~l~~~p~~Rp~~~  251 (260)
T cd05073         238 RCWKNRPEERPTFE  251 (260)
T ss_pred             HHcccCcccCcCHH
Confidence            99999999999863

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=9.8e-33  Score=293.90  Aligned_cols=239  Identities=21%  Similarity=0.315  Sum_probs=195.7

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      |+..+.||+|+||.||.++.. +++.+|+|++..... .....++.+|++++++++|+||+++++++.+....+++|||+
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~   81 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA   81 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence            566778999999999998865 588999999865432 234567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++++|.+++.+.. ...+++.++..++.|++.|++|||+.+++|+||+|+||++++++.+||+|||.+........  ..
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~  158 (256)
T cd08221          82 NGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MA  158 (256)
T ss_pred             CCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cc
Confidence            9999999997653 23488999999999999999999999999999999999999999999999999976543221  22


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH-----HHHHhhhccccceeeccc
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSMRSC  924 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l  924 (936)
                      ....+++.|+|||... +..++.++||||+|+++|||++|+.||.............     ..+...+.++.+++.+||
T Consensus       159 ~~~~~~~~y~ape~~~-~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  237 (256)
T cd08221         159 ETVVGTPYYMSPELCQ-GVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLL  237 (256)
T ss_pred             cccCCCccccCHhhcC-CCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHc
Confidence            3455788999999884 4457889999999999999999999997754422211100     001223567899999999


Q ss_pred             cccccccccc
Q 002321          925 KGSSRQRRRF  934 (936)
Q Consensus       925 ~~~p~~Rp~f  934 (936)
                      ..+|.+||++
T Consensus       238 ~~~p~~R~s~  247 (256)
T cd08221         238 QQDPEKRPTA  247 (256)
T ss_pred             ccCcccCCCH
Confidence            9999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.4e-33  Score=299.08  Aligned_cols=239  Identities=24%  Similarity=0.301  Sum_probs=191.2

Q ss_pred             cccCCCcccccCceEEEEEEeCC----CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      .+...++||+|+||.||+|.+.+    ...||||...........+.+.+|+.++++++|+||+++++++.+ ...++||
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~   85 (270)
T cd05056           7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVM   85 (270)
T ss_pred             hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEE
Confidence            35667789999999999998653    247899988655434456789999999999999999999999875 4568999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++|+|.+++.....  .+++..+..++.|++.|++|||+.+++||||||+||+++.++.+|++|||+++........
T Consensus        86 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  163 (270)
T cd05056          86 ELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY  163 (270)
T ss_pred             EcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccce
Confidence            99999999999976432  3899999999999999999999999999999999999999999999999999765432211


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHH-----HHHHHhhhcccccee
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVT-----WLEEHWKKAEWRNVS  920 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~-----~~~~~~~~~~~~~~~  920 (936)
                       ......++..|+|||.+ ....++.++||||+|+++||+++ |..||............     ...+...+..+.+++
T Consensus       164 -~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  241 (270)
T cd05056         164 -KASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM  241 (270)
T ss_pred             -ecCCCCccccccChhhh-ccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHH
Confidence             12223345679999987 45578999999999999999996 99999776543222110     001123346789999


Q ss_pred             eccccccccccccc
Q 002321          921 MRSCKGSSRQRRRF  934 (936)
Q Consensus       921 ~~~l~~~p~~Rp~f  934 (936)
                      .+||..+|.+||+.
T Consensus       242 ~~~l~~~P~~Rpt~  255 (270)
T cd05056         242 TKCWAYDPSKRPRF  255 (270)
T ss_pred             HHHcCCChhhCcCH
Confidence            99999999999985

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=307.43  Aligned_cols=240  Identities=23%  Similarity=0.332  Sum_probs=198.5

Q ss_pred             cccccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ...+++..+||.|+||.||+|..++ +-..|.|++...+ .+..+++.-|+.||+.++||+||++++.|+..+..||..|
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE  109 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE  109 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence            3456777889999999999999775 4445677764433 3456889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      ||.||-.+..+-+-.+  .+++.++.-+++|++.||.|||+..|+|||+|+.|||++-+|.++++|||.+....  ....
T Consensus       110 FC~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~q  185 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQ  185 (1187)
T ss_pred             ecCCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch--hHHh
Confidence            9999999988876543  49999999999999999999999999999999999999999999999999985432  2233


Q ss_pred             ccccccCcccccCccccc----CcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH-HHHH------HHhhhccc
Q 002321          848 LSSKIQSALGYMAPEFAC----RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV-TWLE------EHWKKAEW  916 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~-~~~~------~~~~~~~~  916 (936)
                      ......|||+|||||+..    ...+|+.++||||||+++.||..+.+|-+...++.+... ...+      |..-...+
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F  265 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF  265 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence            445678999999999763    345789999999999999999999999999888766522 2211      22223467


Q ss_pred             cceeecccccccccccc
Q 002321          917 RNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       917 ~~~~~~~l~~~p~~Rp~  933 (936)
                      +|++.+|+.++|..||.
T Consensus       266 ~DfLk~cL~Knp~~Rp~  282 (1187)
T KOG0579|consen  266 SDFLKRCLVKNPRNRPP  282 (1187)
T ss_pred             HHHHHHHHhcCCccCCC
Confidence            89999999999999986

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=9.2e-33  Score=294.32  Aligned_cols=240  Identities=25%  Similarity=0.354  Sum_probs=193.3

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEe-CCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWT-QSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~  768 (936)
                      |+..+.||+|++|.||+++.+ +++.||+|++...... ...+.+.+|++++++++|+|++++++.+.. +...++||||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            566778999999999999976 4789999998654332 335678899999999999999999988764 4467899999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++++|.+++..... ..+++.++.+++.|++.|++|||+.|++||||||+||+++.++.++|+|||++.......  ..
T Consensus        82 ~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~  158 (257)
T cd08223          82 CEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--DM  158 (257)
T ss_pred             cCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC--Cc
Confidence            999999999976432 348999999999999999999999999999999999999999999999999997654322  12


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH-----HHHHhhhccccceeecc
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSMRS  923 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  923 (936)
                      .....+++.|+|||... ...++.++||||+||++|||++|+.||...+.........     ..+...+..+.+++.+|
T Consensus       159 ~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  237 (257)
T cd08223         159 ASTLIGTPYYMSPELFS-NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATM  237 (257)
T ss_pred             cccccCCcCccChhHhc-CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHH
Confidence            23445788899999884 4568899999999999999999999998765432211100     01122346688999999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..+|.+||+++
T Consensus       238 l~~~p~~Rp~~~  249 (257)
T cd08223         238 LSKRPEKRPSVK  249 (257)
T ss_pred             hccCcccCCCHH
Confidence            999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.1e-32  Score=301.52  Aligned_cols=239  Identities=21%  Similarity=0.265  Sum_probs=191.7

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      |+..+.||+|+||.||++... +++.||+|.+......  ...+.+.+|+++++.++||||+++++.+..+...++||||
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (305)
T cd05609           3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY   82 (305)
T ss_pred             ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence            566678999999999999976 4789999998655321  2345788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc---
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR---  845 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~---  845 (936)
                      +++++|.+++....   .+++..+..++.|++.|++|||+.+++||||||+||+++.++.+|++|||+++.......   
T Consensus        83 ~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          83 VEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            99999999997643   388999999999999999999999999999999999999999999999999864211000   


Q ss_pred             ----------ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH----H--
Q 002321          846 ----------YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE----E--  909 (936)
Q Consensus       846 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~----~--  909 (936)
                                ........++..|+|||.+. ...++.++|+||+||++|||++|+.||...+...........    +  
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEG  238 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhcc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCc
Confidence                      00111234677899999884 446899999999999999999999999866543222211110    0  


Q ss_pred             -Hhhhccccceeeccccccccccccc
Q 002321          910 -HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       910 -~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                       ...+..+++++.+||..||.+||++
T Consensus       239 ~~~~~~~~~~li~~~l~~~P~~R~~~  264 (305)
T cd05609         239 DEALPADAQDLISRLLRQNPLERLGT  264 (305)
T ss_pred             cccCCHHHHHHHHHHhccChhhccCc
Confidence             1234568999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.9e-33  Score=300.49  Aligned_cols=241  Identities=26%  Similarity=0.378  Sum_probs=187.5

Q ss_pred             cccCCCcccccCceEEEEEEeC-----CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeC--CeeE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ--SLQL  763 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  763 (936)
                      .++..+.||+|+||.||+|..+     +++.||+|+++... ....+.+.+|++++++++||||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            3566778999999999999743     47899999986543 23356789999999999999999999987543  4578


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      +||||+++|+|.+++.+...  .+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||+++.....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  161 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD  161 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence            99999999999999975432  3889999999999999999999999999999999999999999999999999876432


Q ss_pred             cccc-ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHH--------------HHHHH
Q 002321          844 DRYV-LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS--------------VTWLE  908 (936)
Q Consensus       844 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~--------------~~~~~  908 (936)
                      .... ......++..|+|||... +..++.++||||+||++|||++|..|+..........              .....
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhc-cCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            2211 112223344699999884 4568999999999999999999987765433211110              00000


Q ss_pred             -------HHhhhccccceeecccccccccccccC
Q 002321          909 -------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 -------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                             +...+.++.+++.+||..+|.+||+++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~  274 (284)
T cd05081         241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFS  274 (284)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence                   011235688999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.3e-32  Score=299.04  Aligned_cols=240  Identities=20%  Similarity=0.277  Sum_probs=189.0

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|...++||+|+||.||+|... +++.||+|+++..........+.+|+.++++++|+||+++++++...+..++||||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            34667788999999999999865 58899999986554333345678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      ++ +++.+++....  ..+.+..+..++.|++.||+|||+.+|+|+||||+||+++.++.+||+|||+++.......  .
T Consensus        85 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~  159 (291)
T cd07870          85 MH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--T  159 (291)
T ss_pred             cc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--C
Confidence            95 77777765432  2377888889999999999999999999999999999999999999999999975432221  1


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH--------------------H
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL--------------------E  908 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~--------------------~  908 (936)
                      .....+++.|+|||.+.+...++.++||||+||++|||++|+.||+.............                    .
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07870         160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK  239 (291)
T ss_pred             CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence            22334678899999886555678899999999999999999999976543211100000                    0


Q ss_pred             HH-----------------hhhccccceeeccccccccccccc
Q 002321          909 EH-----------------WKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       909 ~~-----------------~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      +.                 .......+++.+|+..||.+||+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~  282 (291)
T cd07870         240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA  282 (291)
T ss_pred             chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCH
Confidence            00                 012356688999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.4e-33  Score=297.59  Aligned_cols=237  Identities=24%  Similarity=0.343  Sum_probs=195.1

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      |+..+.||+|+||.||+|..+ +++.||+|++.........+++.+|++++++++||||+++++++......++++||++
T Consensus         3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (265)
T cd06605           3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD   82 (265)
T ss_pred             chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence            466678999999999999987 5889999998766544556788999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ-SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      +++|.+++....  ..+++....+++.|++.|++|||+ .+++|+||||+||++++++.++|+|||.+........    
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----  156 (265)
T cd06605          83 GGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----  156 (265)
T ss_pred             CCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----
Confidence            999999997653  348899999999999999999999 9999999999999999999999999999875532111    


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch---hHHHHHH-HHH-------HHhhhccccc
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM---MWWFSVT-WLE-------EHWKKAEWRN  918 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~---~~~~~~~-~~~-------~~~~~~~~~~  918 (936)
                      ....++..|+|||... +..++.++||||+|+++|+|++|+.||...+.   ......+ ...       ....+..+.+
T Consensus       157 ~~~~~~~~y~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd06605         157 KTFVGTSSYMAPERIQ-GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD  235 (265)
T ss_pred             hcccCChhccCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence            1156778899999884 45789999999999999999999999976531   1111111 101       1113456899


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..||.+||+++
T Consensus       236 li~~~l~~~p~~Rpt~~  252 (265)
T cd06605         236 FVNLCLIKDPRERPSYK  252 (265)
T ss_pred             HHHHHcCCCchhCcCHH
Confidence            99999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.9e-33  Score=302.63  Aligned_cols=237  Identities=22%  Similarity=0.330  Sum_probs=192.5

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .++....||+|+||.||++... ++..||||++.... ....+.+.+|+.+++.++|+||+++++.+...+..++||||+
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            3455567999999999999875 58899999986433 233567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++++|.+++....    +++.++..++.|++.|++|||+++++||||||+||++++++.++|+|||++.......  ...
T Consensus       102 ~~~~L~~~~~~~~----l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~  175 (292)
T cd06658         102 EGGALTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKR  175 (292)
T ss_pred             CCCcHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccC
Confidence            9999999886432    7889999999999999999999999999999999999999999999999987543211  112


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH--HHH-----Hhhhccccceeec
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW--LEE-----HWKKAEWRNVSMR  922 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~--~~~-----~~~~~~~~~~~~~  922 (936)
                      ....++..|+|||.. ....++.++||||+|+++|||++|+.||...+.........  .++     ...+..+.+++.+
T Consensus       176 ~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  254 (292)
T cd06658         176 KSLVGTPYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL  254 (292)
T ss_pred             ceeecCccccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence            234578889999988 45568899999999999999999999998765533221110  011     1234567888999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      ||..||.+||+++
T Consensus       255 ~l~~~P~~Rpt~~  267 (292)
T cd06658         255 MLVREPSQRATAQ  267 (292)
T ss_pred             HccCChhHCcCHH
Confidence            9999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.5e-33  Score=298.66  Aligned_cols=243  Identities=24%  Similarity=0.324  Sum_probs=193.5

Q ss_pred             cccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      .|+..+.||+|+||.||+|+.+      +.+.||+|.+.........+.+.+|++++++++|+||+++++++.+....++
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   85 (275)
T cd05046           6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYM   85 (275)
T ss_pred             hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceE
Confidence            4567788999999999999964      2467999988654333345779999999999999999999999998888999


Q ss_pred             EEEecCCCChhhhhhccCCCC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCcc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGN------FLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR  838 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~------~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  838 (936)
                      ||||+++|+|.+++.......      .+++..+..++.|++.||+|||+.+|+||||||+||+++.++.++++|||++.
T Consensus        86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~  165 (275)
T cd05046          86 ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK  165 (275)
T ss_pred             EEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccccccc
Confidence            999999999999997654221      48999999999999999999999999999999999999999999999999986


Q ss_pred             ccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHH------HHHHHh
Q 002321          839 LLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVT------WLEEHW  911 (936)
Q Consensus       839 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~------~~~~~~  911 (936)
                      ...... ........++..|+|||... ...++.++||||+|+++|+|++ |..||............      +..+..
T Consensus       166 ~~~~~~-~~~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  243 (275)
T cd05046         166 DVYNSE-YYKLRNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEG  243 (275)
T ss_pred             ccCccc-ccccCCceeEEeecChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCC
Confidence            543221 11222334566799999884 4467889999999999999999 88999765443222111      111122


Q ss_pred             hhccccceeecccccccccccccC
Q 002321          912 KKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       912 ~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+..+.+++.+||..+|.+||+.+
T Consensus       244 ~~~~l~~~i~~~l~~~p~~Rp~~~  267 (275)
T cd05046         244 CPSRLYKLMTRCWAVNPKDRPSFS  267 (275)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHH
Confidence            346788999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.1e-32  Score=295.72  Aligned_cols=239  Identities=24%  Similarity=0.311  Sum_probs=189.6

Q ss_pred             CCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCC
Q 002321          694 KDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGG  772 (936)
Q Consensus       694 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  772 (936)
                      ....||+|+||.||+|++. +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++..++..++|+||++++
T Consensus        12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   90 (268)
T cd06624          12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG   90 (268)
T ss_pred             ceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence            3457999999999999965 57889999886543 234567899999999999999999999999999999999999999


Q ss_pred             ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCCeEEeeccCccccCCCcccccccc
Q 002321          773 SLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG-SGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       773 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      +|.+++.........++..+..++.|++.|++|||+++|+||||||+||+++. ++.++|+|||.+........  ....
T Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~  168 (268)
T cd06624          91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTET  168 (268)
T ss_pred             CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--cccc
Confidence            99999976432211377888899999999999999999999999999999986 67999999999876532211  1223


Q ss_pred             ccCcccccCcccccCc-ccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH--HHHH-----HHHHhhhccccceeecc
Q 002321          852 IQSALGYMAPEFACRT-VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF--SVTW-----LEEHWKKAEWRNVSMRS  923 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~-~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~--~~~~-----~~~~~~~~~~~~~~~~~  923 (936)
                      ..+++.|+|||.+... ..++.++||||+|+++|+|++|+.||...+.....  ....     ..+....+++++++.+|
T Consensus       169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  248 (268)
T cd06624         169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRC  248 (268)
T ss_pred             CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHH
Confidence            4578889999987433 34788999999999999999999999765432111  1110     01223446778899999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..+|.+||+++
T Consensus       249 l~~~p~~Rpt~~  260 (268)
T cd06624         249 FEPDPDKRASAH  260 (268)
T ss_pred             cCCCchhCCCHH
Confidence            999999999874

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6.2e-33  Score=301.16  Aligned_cols=233  Identities=24%  Similarity=0.331  Sum_probs=194.2

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      |+..+.||+|+||.||++... +++.||+|++......  +..+.+.+|++++++++||||+++++++.+....++||||
T Consensus         3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (290)
T cd05580           3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY   82 (290)
T ss_pred             eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence            556678999999999999976 5899999998654322  2356788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++++|.+++....   .+++..+..++.|++.||+|||+.|++||||+|+||+++.++.+||+|||+++.....     
T Consensus        83 ~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----  154 (290)
T cd05580          83 VPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----  154 (290)
T ss_pred             CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----
Confidence            99999999997754   3889999999999999999999999999999999999999999999999999865432     


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH----HHHHHHhhhccccceeeccc
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV----TWLEEHWKKAEWRNVSMRSC  924 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l  924 (936)
                      .....+++.|+|||.+. ...++.++||||+|+++|+|++|+.||...+.......    ....+...+..+++++.+||
T Consensus       155 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  233 (290)
T cd05580         155 TYTLCGTPEYLAPEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLL  233 (290)
T ss_pred             CCCCCCCccccChhhhc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHc
Confidence            23345788999999884 44678899999999999999999999987664322211    11112233577889999999


Q ss_pred             ccccccccc
Q 002321          925 KGSSRQRRR  933 (936)
Q Consensus       925 ~~~p~~Rp~  933 (936)
                      ..||.+|+.
T Consensus       234 ~~~p~~R~~  242 (290)
T cd05580         234 QVDLTKRLG  242 (290)
T ss_pred             cCCHHHccC
Confidence            999999984

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=9.5e-33  Score=294.31  Aligned_cols=240  Identities=27%  Similarity=0.391  Sum_probs=195.6

Q ss_pred             cCCCcccccCceEEEEEEeCC-----CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          693 NKDCELGRGGFGAVYRTVLRD-----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       693 ~~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      +..+.||+|+||.||+|++.+     +..||+|+++........+.+.+|++++++++|+||+++++++.+.+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            455789999999999999764     388999999765444356789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+++++|.+++...... .+++.++..++.|++.|++|||+.+++||||||+||+++.++.++++|||+++.........
T Consensus        82 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  160 (258)
T smart00219       82 YMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK  160 (258)
T ss_pred             ccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence            99999999998764422 17999999999999999999999999999999999999999999999999998765432222


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceee
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSM  921 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~  921 (936)
                      . ....+++.|+|||.. ....++.++||||+|+++|||++ |..||...+.........     ..+...+..+.+++.
T Consensus       161 ~-~~~~~~~~y~~Pe~~-~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  238 (258)
T smart00219      161 K-KGGKLPIRWMAPESL-KDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLML  238 (258)
T ss_pred             c-ccCCCcccccChHHh-ccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHH
Confidence            1 123367789999988 55578999999999999999998 889987654432221111     112224567888999


Q ss_pred             cccccccccccccC
Q 002321          922 RSCKGSSRQRRRFQ  935 (936)
Q Consensus       922 ~~l~~~p~~Rp~f~  935 (936)
                      +||..||.+||+++
T Consensus       239 ~~l~~~p~~Rpt~~  252 (258)
T smart00219      239 QCWAEDPEDRPTFS  252 (258)
T ss_pred             HHCcCChhhCcCHH
Confidence            99999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=299.45  Aligned_cols=203  Identities=26%  Similarity=0.397  Sum_probs=170.7

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..+.||+|+||.||+|+.+ +++.||||.+...........+.+|+.++++++|+||+++++++.+....++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            34667788999999999999976 58999999986544333345577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      ++ ++|.+++.....  .+++.....++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++.......  .
T Consensus        85 ~~-~~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~  159 (291)
T cd07844          85 LD-TDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--T  159 (291)
T ss_pred             CC-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--c
Confidence            97 599998876432  488999999999999999999999999999999999999999999999999875432111  1


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccc
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWK  897 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~  897 (936)
                      .....++..|+|||...+...++.++||||+||++|||++|+.||....
T Consensus       160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  208 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST  208 (291)
T ss_pred             ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence            1223457789999988665668899999999999999999999997654

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=6.1e-33  Score=299.11  Aligned_cols=233  Identities=25%  Similarity=0.280  Sum_probs=188.2

Q ss_pred             ccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCCCh
Q 002321          698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSL  774 (936)
Q Consensus       698 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  774 (936)
                      ||+|+||+||+|... +|+.||+|++......  .....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999865 5899999998654322  2244567899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccccccC
Q 002321          775 HKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQS  854 (936)
Q Consensus       775 ~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  854 (936)
                      .+++.+... ..+++.++..++.|++.|+.|||+.|++||||+|+||++++++.++|+|||.+.....   ........+
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~  156 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAG  156 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccC
Confidence            999876543 3489999999999999999999999999999999999999999999999999876532   111223456


Q ss_pred             cccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchh----HHHHH----HHHHHHhhhccccceeeccccc
Q 002321          855 ALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM----WWFSV----TWLEEHWKKAEWRNVSMRSCKG  926 (936)
Q Consensus       855 ~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~----~~~~~----~~~~~~~~~~~~~~~~~~~l~~  926 (936)
                      +..|+|||...+ ..++.++||||+||++|+|++|+.||...+..    .....    ....+.-.++.+.+++.+||..
T Consensus       157 ~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (277)
T cd05577         157 TPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK  235 (277)
T ss_pred             CCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccC
Confidence            778999998854 45889999999999999999999999765431    00000    0001112346788999999999


Q ss_pred             ccccccccC
Q 002321          927 SSRQRRRFQ  935 (936)
Q Consensus       927 ~p~~Rp~f~  935 (936)
                      ||.+||+|+
T Consensus       236 ~p~~R~~~~  244 (277)
T cd05577         236 DPEKRLGCR  244 (277)
T ss_pred             ChhHccCCC
Confidence            999999774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=335.16  Aligned_cols=239  Identities=27%  Similarity=0.337  Sum_probs=197.6

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      .+....+||.|.||.||-|..- +|+-.|||.++..... +..+.+.+|+.++..++|||+|+++|+-.+++..+|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            3556678999999999999854 5899999998654433 3356788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc--c
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR--Y  846 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~  846 (936)
                      |++|+|.+.+..++.   .++.....+..|++.|++|||+.|||||||||.||+++.+|.+|++|||.|+.+....+  .
T Consensus      1316 C~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred             hccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence            999999999987543   66666777889999999999999999999999999999999999999999988754321  1


Q ss_pred             cccccccCcccccCcccccCcc--cCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH--HH----HHHHhhhccccc
Q 002321          847 VLSSKIQSALGYMAPEFACRTV--KITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV--TW----LEEHWKKAEWRN  918 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~--~~----~~~~~~~~~~~~  918 (936)
                      ..-....||+-|||||++.+.+  ....++||||+|||..||+||+.||+..+.+|.-..  ..    .-|.-.++.-++
T Consensus      1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~d 1472 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRD 1472 (1509)
T ss_pred             HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHH
Confidence            2234577999999999996543  356799999999999999999999999887544321  11    012336678899


Q ss_pred             eeeccccccccccc
Q 002321          919 VSMRSCKGSSRQRR  932 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp  932 (936)
                      ++.+|+..||++|=
T Consensus      1473 Fle~Cl~~dP~~Rw 1486 (1509)
T KOG4645|consen 1473 FLEHCLEQDPKMRW 1486 (1509)
T ss_pred             HHHHHHhcCchhhh
Confidence            99999999999983

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.5e-32  Score=297.79  Aligned_cols=239  Identities=24%  Similarity=0.307  Sum_probs=193.9

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      |+..+.||+|+||.||+|++. +|+.||||++..... ....+.+.+|+.++++++|+||+++++++..+...++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   81 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM   81 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence            456678999999999999975 689999999976543 233567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                       +++|.+++....  ..+++.++..++.|+++||+|||+.+++|+||||+||+++.++.++++|||.+........ ...
T Consensus        82 -~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~  157 (286)
T cd07832          82 -PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLY  157 (286)
T ss_pred             -CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Ccc
Confidence             999999987543  3489999999999999999999999999999999999999999999999999986643221 112


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH-----------H-----------
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW-----------L-----------  907 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~-----------~-----------  907 (936)
                      ....++..|+|||.+.+...++.++||||+||++|||++|..||.............           .           
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI  237 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence            234578889999988666667899999999999999999988887654322111000           0           


Q ss_pred             ----------HH--Hhhhccccceeeccccccccccccc
Q 002321          908 ----------EE--HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       908 ----------~~--~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                ..  .-.+..+.+++.+|+..+|.+||+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~  276 (286)
T cd07832         238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA  276 (286)
T ss_pred             cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCH
Confidence                      00  0123566788999999999999985

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-32  Score=302.10  Aligned_cols=240  Identities=23%  Similarity=0.285  Sum_probs=195.1

Q ss_pred             ccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCccc--hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVK--SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      |+..+.||+|+||.||+|...+ ++.||+|.+.......  ..+.+.+|+++++.++|+||+++++++.+....++||||
T Consensus         3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   82 (316)
T cd05574           3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY   82 (316)
T ss_pred             eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence            5667789999999999999764 8999999997654432  456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc-
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV-  847 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-  847 (936)
                      +++++|.+++.... ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......... 
T Consensus        83 ~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  161 (316)
T cd05574          83 CPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS  161 (316)
T ss_pred             cCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence            99999999987543 2348999999999999999999999999999999999999999999999999987543211100 


Q ss_pred             --------------------------ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHH
Q 002321          848 --------------------------LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWW  901 (936)
Q Consensus       848 --------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~  901 (936)
                                                ......++..|+|||+.. +..++.++||||+|+++|+|++|+.||...+....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS-GDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc-CCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence                                      111235678899999984 45679999999999999999999999987654322


Q ss_pred             HHHHHH----HHH--hhhccccceeecccccccccccc
Q 002321          902 FSVTWL----EEH--WKKAEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       902 ~~~~~~----~~~--~~~~~~~~~~~~~l~~~p~~Rp~  933 (936)
                      ......    .+.  ..+..+++++.+||..||.+||+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s  278 (316)
T cd05574         241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLG  278 (316)
T ss_pred             HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCC
Confidence            211110    011  13567899999999999999998

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.1e-33  Score=299.76  Aligned_cols=238  Identities=22%  Similarity=0.296  Sum_probs=193.9

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..+.||+|+||+||++... +++.||+|++.........+.+.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            34677789999999999999976 58899999987554444567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ-SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      +++++|.+++.+.+   .+++.....++.+++.|+.|||+ .+++||||||+||+++.++.++|+|||++......    
T Consensus        85 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~----  157 (284)
T cd06620          85 MDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----  157 (284)
T ss_pred             CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh----
Confidence            99999999987643   38899999999999999999997 58999999999999999999999999998654221    


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhH------HHHHHHHH-------H----H
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMW------WFSVTWLE-------E----H  910 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~------~~~~~~~~-------~----~  910 (936)
                      ......++..|+|||.+.+ ..++.++||||+||++|++++|+.||.......      ........       +    .
T Consensus       158 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd06620         158 IADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS  236 (284)
T ss_pred             ccCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCch
Confidence            1123467889999998844 478899999999999999999999998654310      00000000       0    1


Q ss_pred             hhhccccceeecccccccccccccC
Q 002321          911 WKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       911 ~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..+..+.+++.+||..||.+||+++
T Consensus       237 ~~~~~~~~li~~~l~~dp~~Rpt~~  261 (284)
T cd06620         237 DFPEDLRDFVDACLLKDPTERPTPQ  261 (284)
T ss_pred             hcCHHHHHHHHHHhcCCcccCcCHH
Confidence            1334678899999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8.6e-33  Score=319.69  Aligned_cols=197  Identities=22%  Similarity=0.276  Sum_probs=160.6

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCC------CCcceeeeEEEeC-Ce
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH------PNLVTLEGYYWTQ-SL  761 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~-~~  761 (936)
                      ..|+..++||+|+||+||+|.+. .++.||||+++...  ....+...|++++++++|      .+++++++++... ..
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~  206 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH  206 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence            45777889999999999999975 57889999986431  223456677877777754      4588888888754 56


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCC-------------
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ-SNIIHYNIKSSNVLIDGSG-------------  827 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~ivH~Dlkp~NIll~~~~-------------  827 (936)
                      .++|||++ +++|.+++.+..   .+++..+..|+.|++.||+|||+ .||+||||||+|||++.++             
T Consensus       207 ~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~  282 (467)
T PTZ00284        207 MCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP  282 (467)
T ss_pred             EEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence            78999998 788998887643   38999999999999999999998 5999999999999998765             


Q ss_pred             ---CeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch
Q 002321          828 ---EPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM  898 (936)
Q Consensus       828 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~  898 (936)
                         .+||+|||.+....     .......+|+.|+|||++. +..++.++|||||||++|||++|+.||...+.
T Consensus       283 ~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~~  350 (467)
T PTZ00284        283 DPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVL-GLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN  350 (467)
T ss_pred             CCceEEECCCCccccCc-----cccccccCCccccCcHHhh-cCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence               49999999875422     1223467899999999984 45789999999999999999999999987654

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.3e-32  Score=297.89  Aligned_cols=240  Identities=22%  Similarity=0.291  Sum_probs=190.5

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      |+..+.||+|+||.||+|+.. +++.||||+++..... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   81 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence            456678999999999999976 5899999998654322 22457889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      . ++|.+++..... ..+++..+..++.|++.|++|||+.+++||||+|+||+++.++.+|++|||++........  ..
T Consensus        82 ~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~  157 (284)
T cd07860          82 H-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TY  157 (284)
T ss_pred             c-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--cc
Confidence            5 689888876432 3488999999999999999999999999999999999999999999999999876532211  12


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH--HH--------------------H
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV--TW--------------------L  907 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~--~~--------------------~  907 (936)
                      ....+++.|+|||.+.+...++.++||||+||++|||++|+.||...++......  +.                    .
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07860         158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS  237 (284)
T ss_pred             ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence            2334577899999886555578899999999999999999999976544211100  00                    0


Q ss_pred             HH-----------HhhhccccceeecccccccccccccC
Q 002321          908 EE-----------HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       908 ~~-----------~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+           ...+...++++.+||..||.+||+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~  276 (284)
T cd07860         238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAK  276 (284)
T ss_pred             cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHH
Confidence            00           01224556789999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.3e-32  Score=299.96  Aligned_cols=238  Identities=25%  Similarity=0.299  Sum_probs=191.3

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc----chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV----KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      |+..+.||+|+||.||+|... +++.||||+++.....    .....+.+|++++++++|+||+++++++.+....++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            455678999999999999976 5899999999765432    12355778999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+ +|+|.+++....  ..+++..+.+++.|+++||+|||+.|++|+||||+||+++.++.++|+|||+++....... 
T Consensus        82 e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-  157 (298)
T cd07841          82 EFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-  157 (298)
T ss_pred             ccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc-
Confidence            999 899999997654  2489999999999999999999999999999999999999999999999999986643221 


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH------HH-----------
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL------EE-----------  909 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~------~~-----------  909 (936)
                       ......+++.|+|||.+.+...++.++||||+||++|||++|..||..............      +.           
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (298)
T cd07841         158 -KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY  236 (298)
T ss_pred             -cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence             112234567899999885556788999999999999999999888876554321111000      00           


Q ss_pred             ---------------Hhhhccccceeeccccccccccccc
Q 002321          910 ---------------HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       910 ---------------~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                     ...+..+.+++.+||..||.+||++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~  276 (298)
T cd07841         237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITA  276 (298)
T ss_pred             ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCH
Confidence                           0112455678999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.2e-33  Score=279.43  Aligned_cols=206  Identities=22%  Similarity=0.350  Sum_probs=172.6

Q ss_pred             ccccCCCcccccCceEEEEEEeCC-----CcEEEEEEeeccCccch-HHHHHHHHHHHHcCCCCCcceeeeEEEe-CCee
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRD-----GRPVAIKKLTVSSLVKS-QEDFEREVKKLGKVRHPNLVTLEGYYWT-QSLQ  762 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  762 (936)
                      ..|+...+||+|+||.||+|+-.+     .+.+|+|+++.+..... ....-||+.+++.++||||+.+..++.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            457788899999999999996432     34799999976643222 3456789999999999999999999876 7788


Q ss_pred             EEEEEecCCCChhhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC----CCeEEeeccC
Q 002321          763 LLIYEFVSGGSLHKHLHEGS--GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS----GEPKVGDYGL  836 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~  836 (936)
                      ++++||.+. +|...++..+  ..+.++......|+.||+.|+.|||+.-|+|||+||.||||..+    |.+||+|||+
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence            999999974 8988886543  33468888899999999999999999999999999999999887    8999999999


Q ss_pred             ccccCCCcc-ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCcc
Q 002321          837 ARLLPMLDR-YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTW  896 (936)
Q Consensus       837 a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~  896 (936)
                      |+.+..+-. ......+.-|.+|+|||.+.+.++|+.+.||||.||++.||++-++-|.+.
T Consensus       183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            998865432 224455667899999999999999999999999999999999988777553

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8.9e-33  Score=299.48  Aligned_cols=242  Identities=22%  Similarity=0.369  Sum_probs=190.7

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEE-----eCCee
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYW-----TQSLQ  762 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~~~~~  762 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||+|++....  .....+.+|+.+++++ +|+||+++++++.     .+...
T Consensus        18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   95 (286)
T cd06638          18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL   95 (286)
T ss_pred             cceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence            34677889999999999999875 57899999875432  2346688899999999 7999999999884     34567


Q ss_pred             EEEEEecCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          763 LLIYEFVSGGSLHKHLHEGS-GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      ++||||+++++|.+++.... ....+++..+..++.|+++|+.|||+.+++||||||+||+++.++.+|++|||+++...
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  175 (286)
T cd06638          96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  175 (286)
T ss_pred             EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence            99999999999999876421 22348889999999999999999999999999999999999999999999999987653


Q ss_pred             CCccccccccccCcccccCcccccC----cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HHHHH------HHH
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACR----TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVTWL------EEH  910 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~~~------~~~  910 (936)
                      ...  .......+++.|+|||++..    ...++.++||||+||++|||++|+.||...+..... .....      .+.
T Consensus       176 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (286)
T cd06638         176 STR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPE  253 (286)
T ss_pred             cCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCC
Confidence            221  12233457889999998732    234788999999999999999999999876542211 11000      011


Q ss_pred             hhhccccceeecccccccccccccC
Q 002321          911 WKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       911 ~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .....+.+++.+||..||.+||+++
T Consensus       254 ~~~~~~~~li~~~l~~~p~~Rps~~  278 (286)
T cd06638         254 LWSNEFNDFIRKCLTKDYEKRPTVS  278 (286)
T ss_pred             CcCHHHHHHHHHHccCCcccCCCHH
Confidence            2235688999999999999999974

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.9e-32  Score=295.22  Aligned_cols=230  Identities=22%  Similarity=0.322  Sum_probs=181.5

Q ss_pred             cccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHH---cCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLG---KVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      .||+|+||.||++... +++.||+|.+......  .....+.+|..+++   ..+|++|+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            3899999999999975 5889999998654322  11233444544433   3479999999999998889999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                      +|+|.+++....   .+++..+..++.|++.|++|||+.+++||||||+||++++++.++++|||++.......    ..
T Consensus        81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~  153 (279)
T cd05633          81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PH  153 (279)
T ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----cc
Confidence            999999987644   38999999999999999999999999999999999999999999999999987543221    12


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-------HHHhhhccccceeecc
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-------EEHWKKAEWRNVSMRS  923 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~  923 (936)
                      ...++..|+|||....+..++.++||||+||++|||++|+.||..............       .+...+.++++++.+|
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  233 (279)
T cd05633         154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGL  233 (279)
T ss_pred             CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHH
Confidence            345788999999875555688999999999999999999999976533211111111       1122346778999999


Q ss_pred             cccccccccc
Q 002321          924 CKGSSRQRRR  933 (936)
Q Consensus       924 l~~~p~~Rp~  933 (936)
                      |..||.+||+
T Consensus       234 l~~~p~~R~~  243 (279)
T cd05633         234 LQRDVSKRLG  243 (279)
T ss_pred             hcCCHHHhcC
Confidence            9999999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.9e-32  Score=293.06  Aligned_cols=241  Identities=27%  Similarity=0.380  Sum_probs=195.6

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      |+..+.||+|+||.||+|... +++.||+|.++..... ...+.+.+|+.++++++|+||+++++++......++|+||+
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC   81 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence            556688999999999999965 6889999998765432 35678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc-
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL-  848 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~-  848 (936)
                      ++++|.+++....   .+++..+.+++.|+++|++|||+.+++|+||+|+||++++++.+||+|||.+........... 
T Consensus        82 ~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          82 SGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             CCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence            9999999997643   378889999999999999999999999999999999999999999999999987643322111 


Q ss_pred             -cccccCcccccCcccccCcc--cCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH------HHhh--hcccc
Q 002321          849 -SSKIQSALGYMAPEFACRTV--KITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE------EHWK--KAEWR  917 (936)
Q Consensus       849 -~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~------~~~~--~~~~~  917 (936)
                       .....++..|+|||.+....  .++.++||||+|+++||+++|+.||...+...........      +.+.  +..+.
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK  238 (264)
T ss_pred             cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHH
Confidence             11345678899999884432  3788999999999999999999999766432222111110      1122  46678


Q ss_pred             ceeecccccccccccccC
Q 002321          918 NVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++.+||..+|.+||++.
T Consensus       239 ~li~~~l~~~p~~R~~~~  256 (264)
T cd06626         239 DFLDRCLESDPKKRPTAS  256 (264)
T ss_pred             HHHHHHccCCcccCCCHH
Confidence            999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=6.6e-33  Score=301.63  Aligned_cols=236  Identities=22%  Similarity=0.326  Sum_probs=191.4

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      ++...+||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            344557999999999999975 689999999865432 335678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                      +++|.+++...    .+++..+..++.|++.|++|||+.+++||||||+||+++.++.+||+|||++.......  ....
T Consensus       102 ~~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~  175 (297)
T cd06659         102 GGALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRK  175 (297)
T ss_pred             CCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccc
Confidence            99999987653    28899999999999999999999999999999999999999999999999987553221  1123


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HHHHHH------HHhhhccccceeecc
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVTWLE------EHWKKAEWRNVSMRS  923 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~~~~------~~~~~~~~~~~~~~~  923 (936)
                      ...++..|+|||++. ...++.++||||+||++|||++|+.||...+..... ......      ....+..+.+++.+|
T Consensus       176 ~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~  254 (297)
T cd06659         176 SLVGTPYWMAPEVIS-RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM  254 (297)
T ss_pred             ceecCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence            355788999999884 456899999999999999999999999866542211 111000      111234578899999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..+|.+||++.
T Consensus       255 l~~~P~~Rps~~  266 (297)
T cd06659         255 LTREPQERATAQ  266 (297)
T ss_pred             hcCCcccCcCHH
Confidence            999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.2e-32  Score=293.13  Aligned_cols=240  Identities=24%  Similarity=0.408  Sum_probs=195.2

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      |+..+.||+|+||.||+++.. +|+.||+|++..... ....+++.+|++++++++|+||+++++++...+..++||||+
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC   81 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence            566778999999999999965 588999999865432 233567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++++|.+++..... ..+++.+..+++.|++.|++|||+.+++|+||+|+||+++.++.++++|||.+........  ..
T Consensus        82 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~  158 (256)
T cd08218          82 EGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LA  158 (256)
T ss_pred             CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--hh
Confidence            99999999876432 2378899999999999999999999999999999999999999999999999976543221  12


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-----HHHhhhccccceeeccc
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-----EEHWKKAEWRNVSMRSC  924 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l  924 (936)
                      ....+++.|+|||... +..++.++||||+||++|+|++|+.||...+..........     .+...+..+++++.+||
T Consensus       159 ~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  237 (256)
T cd08218         159 RTCIGTPYYLSPEICE-NRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLF  237 (256)
T ss_pred             hhccCCccccCHHHhC-CCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHh
Confidence            2345778899999884 44678899999999999999999999987654322211100     11223456889999999


Q ss_pred             ccccccccccC
Q 002321          925 KGSSRQRRRFQ  935 (936)
Q Consensus       925 ~~~p~~Rp~f~  935 (936)
                      ..+|.+||+++
T Consensus       238 ~~~p~~Rp~~~  248 (256)
T cd08218         238 KRNPRDRPSVN  248 (256)
T ss_pred             hCChhhCcCHH
Confidence            99999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-33  Score=253.47  Aligned_cols=204  Identities=23%  Similarity=0.343  Sum_probs=176.6

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccch-HHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKS-QEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      .|++.++||+|.||+||+|+.+ +++.||+|+++....++. .....||+-+++.++|.|||+++++...+....+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            3566788999999999999966 588999999987665544 46788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      | ..+|..+...-.+  .++......++.|+++|+.++|++++.|||+||.|.+++.+|++|++|||+|+.++-+-  ..
T Consensus        83 c-dqdlkkyfdslng--~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv--rc  157 (292)
T KOG0662|consen   83 C-DQDLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RC  157 (292)
T ss_pred             h-hHHHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--Ee
Confidence            9 4688888765433  38888899999999999999999999999999999999999999999999999775432  23


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchh
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMM  899 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~  899 (936)
                      .+...-|.+|++|.++.+.+-|+...|+||.||++.|+.. |++-|.+.+..
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd  209 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD  209 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH
Confidence            3455678899999999999999999999999999999997 77778877654

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=299.12  Aligned_cols=240  Identities=23%  Similarity=0.258  Sum_probs=193.0

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      |+..++||+|+||.||+|... +++.||||+++..... ...+.+.+|++++++++|+||+++++++..++..++||||+
T Consensus         3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   82 (288)
T cd07833           3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV   82 (288)
T ss_pred             eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence            566778999999999999976 5889999998654322 23577899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      +++.+..+.....   .+++.++..++.|++.|++|||+.+++|+||+|+||++++++.+||+|||.+........ ...
T Consensus        83 ~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~  158 (288)
T cd07833          83 ERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL  158 (288)
T ss_pred             CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence            9877766655432   288999999999999999999999999999999999999999999999999987644322 122


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HH------------------------
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SV------------------------  904 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~------------------------  904 (936)
                      ....++..|+|||++.+...++.++||||+|+++|+|++|+.||......... ..                        
T Consensus       159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07833         159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV  238 (288)
T ss_pred             cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence            33456788999999865547889999999999999999999999765331110 00                        


Q ss_pred             -----------HHHHHHhhhccccceeecccccccccccccC
Q 002321          905 -----------TWLEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       905 -----------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                                 ....+...+.++++++.+||..+|.+||+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  280 (288)
T cd07833         239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCD  280 (288)
T ss_pred             ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHH
Confidence                       0001112256688999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.4e-32  Score=292.32  Aligned_cols=234  Identities=24%  Similarity=0.374  Sum_probs=188.3

Q ss_pred             ccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      ..|+..+.||+|+||.||++.. +++.||+|.++...   ..+.+.+|+.++++++|||++++++++.... .++||||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECC
Confidence            3467788999999999999975 57889999986432   3467889999999999999999999987654 68999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++++|.+++..... ..+++..+..++.|++.|+.|||+.|++||||||+||+++.++.+||+|||.++.....     .
T Consensus        81 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~  154 (254)
T cd05083          81 SKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----V  154 (254)
T ss_pred             CCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-----C
Confidence            99999999976432 34889999999999999999999999999999999999999999999999998754321     1


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceeecc
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSMRS  923 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  923 (936)
                      .....+..|+|||.+ ....++.++||||+||++|||++ |+.||...+.........     ..+...+..+.+++.+|
T Consensus       155 ~~~~~~~~y~~pe~~-~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  233 (254)
T cd05083         155 DNSKLPVKWTAPEAL-KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSC  233 (254)
T ss_pred             CCCCCCceecCHHHh-ccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHH
Confidence            122335679999988 44578999999999999999997 999998765532211100     00111235677899999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..+|.+||+++
T Consensus       234 l~~~p~~Rp~~~  245 (254)
T cd05083         234 WETEPKKRPSFH  245 (254)
T ss_pred             cCCChhhCcCHH
Confidence            999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=286.52  Aligned_cols=243  Identities=23%  Similarity=0.288  Sum_probs=209.2

Q ss_pred             ccCCCcccccCceEEEEEEeCC------CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEe-CCeeEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLRD------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWT-QSLQLL  764 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l  764 (936)
                      ++....+-+|.||.||.|.|++      .+.|-||.++.....-+...+..|.-.+..+.|||+.++.+++.+ ....++
T Consensus       286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V  365 (563)
T KOG1024|consen  286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFV  365 (563)
T ss_pred             eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceE
Confidence            4455568899999999997763      456788888776665566788899999999999999999999865 456788


Q ss_pred             EEEecCCCChhhhhh-----ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          765 IYEFVSGGSLHKHLH-----EGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       765 v~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      ++.++..|+|..++.     +....+.++..+...++.|++.|++|||.+|+||.||.++|+++|+.-.+||+|=.++|.
T Consensus       366 ~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRD  445 (563)
T KOG1024|consen  366 LYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRD  445 (563)
T ss_pred             EEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccc
Confidence            999999999999998     334445688889999999999999999999999999999999999999999999999998


Q ss_pred             cCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHH-----HHHHHHHHhhh
Q 002321          840 LPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWF-----SVTWLEEHWKK  913 (936)
Q Consensus       840 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~-----~~~~~~~~~~~  913 (936)
                      ....++........++..||+||.+ ....|+.++|||||||++|||+| |+.||...|+.+..     ..+.-+|.-++
T Consensus       446 LFP~DYhcLGDnEnRPvkWMslEal-~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCP  524 (563)
T KOG1024|consen  446 LFPGDYHCLGDNENRPVKWMSLEAL-QNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCP  524 (563)
T ss_pred             cCcccccccCCCCCCcccccCHHHH-hhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCCCCc
Confidence            8877887778888889999999988 56689999999999999999999 99999998875443     33444566678


Q ss_pred             ccccceeecccccccccccccC
Q 002321          914 AEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       914 ~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .++..+|.=||..+|++||+|+
T Consensus       525 DeLf~vMacCWallpeeRPsf~  546 (563)
T KOG1024|consen  525 DELFTVMACCWALLPEERPSFS  546 (563)
T ss_pred             HHHHHHHHHHHhcCcccCCCHH
Confidence            8899999999999999999996

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.7e-32  Score=295.18  Aligned_cols=242  Identities=22%  Similarity=0.314  Sum_probs=189.1

Q ss_pred             cCCCcccccCceEEEEEEeC----CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCC------e
Q 002321          693 NKDCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS------L  761 (936)
Q Consensus       693 ~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  761 (936)
                      ...+.||+|+||.||+|.+.    +++.||||+++..... ...+++.+|++++++++||||+++++++....      .
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   81 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI   81 (273)
T ss_pred             cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence            45678999999999999864    3688999998654322 33567889999999999999999999886532      2


Q ss_pred             eEEEEEecCCCChhhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCcc
Q 002321          762 QLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR  838 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  838 (936)
                      .++++||+++|+|.+++....   ....+++.....++.|++.|++|||+.+|+||||||+||+++.++.+|++|||.++
T Consensus        82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~  161 (273)
T cd05074          82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK  161 (273)
T ss_pred             eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccc
Confidence            368899999999998875322   11247888999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhh
Q 002321          839 LLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWK  912 (936)
Q Consensus       839 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~  912 (936)
                      ...............+++.|++||.. ....++.++||||+||++|||++ |+.||...+.........     ..+...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~pe~~-~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  240 (273)
T cd05074         162 KIYSGDYYRQGCASKLPVKWLALESL-ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDC  240 (273)
T ss_pred             cccCCcceecCCCccCchhhcCHhHH-hcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence            65433222222233455679999988 45567899999999999999999 899997765532221111     011223


Q ss_pred             hccccceeecccccccccccccC
Q 002321          913 KAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       913 ~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +..+.+++.+||..+|.+||+++
T Consensus       241 ~~~~~~l~~~~l~~~p~~Rps~~  263 (273)
T cd05074         241 LEDVYELMCQCWSPEPKCRPSFQ  263 (273)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHH
Confidence            46789999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.4e-32  Score=297.17  Aligned_cols=241  Identities=23%  Similarity=0.329  Sum_probs=191.4

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEe------CCe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWT------QSL  761 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~  761 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||+|++....  ....++..|+.+++++ +|+||+++++++..      ...
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   93 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ   93 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence            35677788999999999999975 58899999985442  2346788999999999 79999999999853      356


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .+++|||+++|+|.+++..... ..+++..+..++.|++.|++|||+.+++|+||||+||+++.++.++|+|||++....
T Consensus        94 ~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~  172 (282)
T cd06636          94 LWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  172 (282)
T ss_pred             EEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence            7999999999999999876432 337888889999999999999999999999999999999999999999999987553


Q ss_pred             CCccccccccccCcccccCcccccC----cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHH-HHHH-H----HHh
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACR----TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS-VTWL-E----EHW  911 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~-~~~~-~----~~~  911 (936)
                      ...  .......++..|+|||.+..    ...++.++||||+||++|||++|+.||.......... .... +    ...
T Consensus       173 ~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  250 (282)
T cd06636         173 RTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKK  250 (282)
T ss_pred             ccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccc
Confidence            211  12233457888999998742    3357889999999999999999999997765432221 1111 0    112


Q ss_pred             hhccccceeecccccccccccccC
Q 002321          912 KKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       912 ~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+..+.+++.+||..||.+||+++
T Consensus       251 ~~~~~~~li~~cl~~~p~~Rp~~~  274 (282)
T cd06636         251 WSKKFIDFIEGCLVKNYLSRPSTE  274 (282)
T ss_pred             cCHHHHHHHHHHhCCChhhCcCHH
Confidence            345788999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.3e-32  Score=292.66  Aligned_cols=239  Identities=23%  Similarity=0.312  Sum_probs=187.4

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc----cchHHHHHHHHHHHHcCCCCCcceeeeEEEeC--CeeEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL----VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ--SLQLL  764 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  764 (936)
                      |+..+.||+|+||.||+|+.. +++.||||++.....    ....+.+.+|++++++++||||+++++++.+.  ...++
T Consensus         4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (265)
T cd06652           4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI   83 (265)
T ss_pred             ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence            566778999999999999976 489999998853221    12346788999999999999999999998764  46789


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ||||+++++|.+++.....   +++..+.+++.|++.||+|||+.+++|+||||+||+++.++.++|+|||.++......
T Consensus        84 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          84 FMEHMPGGSIKDQLKSYGA---LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEecCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            9999999999999876432   7888899999999999999999999999999999999999999999999987653211


Q ss_pred             c-ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH------HHHhhhcccc
Q 002321          845 R-YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL------EEHWKKAEWR  917 (936)
Q Consensus       845 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~  917 (936)
                      . ........++..|+|||... ...++.++|||||||++|||++|+.||...+..........      .+........
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVIS-GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCR  239 (265)
T ss_pred             ccccccccCCCCccccChhhhc-CCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHH
Confidence            1 11122345778899999884 45688999999999999999999999987644322211110      0112234567


Q ss_pred             ceeecccccccccccccC
Q 002321          918 NVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++.+||. +|.+||+++
T Consensus       240 ~~i~~~l~-~p~~Rp~~~  256 (265)
T cd06652         240 DFLKRIFV-EAKLRPSAD  256 (265)
T ss_pred             HHHHHHhc-ChhhCCCHH
Confidence            78888884 999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.1e-32  Score=291.36  Aligned_cols=239  Identities=20%  Similarity=0.360  Sum_probs=194.2

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      |+..+.||+|+||.||+|... +++.+|||++...... .....+.+|++++++++||||+++++.+......++||||+
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA   81 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence            456678999999999999975 5889999998765432 34577899999999999999999999999889999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-CeEEeeccCccccCCCccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG-EPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      ++++|.+++.... ...+++..+.+++.|+++|++|||+++++|+||||+||+++.++ .+|++|||.+.......   .
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---~  157 (256)
T cd08220          82 PGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---K  157 (256)
T ss_pred             CCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---c
Confidence            9999999997643 23488999999999999999999999999999999999998654 68999999998664322   1


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-----HHhhhccccceeecc
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-----EHWKKAEWRNVSMRS  923 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~  923 (936)
                      .....++..|+|||... ...++.++||||+|+++|+|++|+.||...+...........     +...+..+++++.+|
T Consensus       158 ~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  236 (256)
T cd08220         158 AYTVVGTPCYISPELCE-GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSM  236 (256)
T ss_pred             ccccccCCcccCchhcc-CCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHH
Confidence            22345778899999884 446788999999999999999999999876543222111100     112346688999999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..+|.+||+++
T Consensus       237 l~~~p~~Rpt~~  248 (256)
T cd08220         237 LNLDPSKRPQLS  248 (256)
T ss_pred             ccCChhhCCCHH
Confidence            999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-33  Score=304.62  Aligned_cols=232  Identities=27%  Similarity=0.396  Sum_probs=189.6

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeec---cCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCe--eEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTV---SSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSL--QLLI  765 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv  765 (936)
                      .....+||+|+|-+||||.+. +|..||--.++.   ....+..++|..|+.+|+.++|+||+++|+++.+...  +.+|
T Consensus        42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            455668999999999999976 477787444432   2233445789999999999999999999999987654  7789


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCCCCEEEcC-CCCeEEeeccCccccCC
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS--NIIHYNIKSSNVLIDG-SGEPKVGDYGLARLLPM  842 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~--~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~  842 (936)
                      +|.+..|+|..|+++.++   +..+...+|++||++||.|||++  .|+|||||..||+|+. .|.|||+|.|+|+....
T Consensus       122 TEL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             eecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            999999999999998776   88899999999999999999986  6999999999999976 58999999999987643


Q ss_pred             CccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch-hHHHHH--HHHH----HHhhhcc
Q 002321          843 LDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM-MWWFSV--TWLE----EHWKKAE  915 (936)
Q Consensus       843 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~-~~~~~~--~~~~----~~~~~~~  915 (936)
                      .    ....+.|||.|||||+..  ..|.+.+||||||+++.||+|+..||..... ..++..  .-.+    .....++
T Consensus       199 s----~aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPe  272 (632)
T KOG0584|consen  199 S----HAKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPE  272 (632)
T ss_pred             c----ccceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHH
Confidence            2    223478999999999883  4699999999999999999999999977543 333311  1111    2334578


Q ss_pred             ccceeecccccccccccc
Q 002321          916 WRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~  933 (936)
                      .+++|.+|+.. ..+|++
T Consensus       273 vr~fIekCl~~-~~~R~s  289 (632)
T KOG0584|consen  273 VREFIEKCLAT-KSERLS  289 (632)
T ss_pred             HHHHHHHHhcC-chhccC
Confidence            99999999999 888886

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.1e-32  Score=303.03  Aligned_cols=190  Identities=19%  Similarity=0.269  Sum_probs=160.1

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||+|+....       ....|+.++++++|+||+++++++......++||||
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  138 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH  138 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence            34778889999999999999976 4678999975322       235699999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      + .++|.+++....  ..+++.++.+++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++.....   ..
T Consensus       139 ~-~~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~  212 (357)
T PHA03209        139 Y-SSDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PA  212 (357)
T ss_pred             c-CCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC---cc
Confidence            9 578988886543  24899999999999999999999999999999999999999999999999999753211   11


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCC
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL  893 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf  893 (936)
                      .....|++.|+|||++. ...++.++||||+||++|||+++..|+
T Consensus       213 ~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        213 FLGLAGTVETNAPEVLA-RDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccccccccccCCeecC-CCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            23356889999999984 446899999999999999999855444

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.3e-33  Score=295.73  Aligned_cols=236  Identities=25%  Similarity=0.300  Sum_probs=195.5

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      |+..+.||+|+||.||+|+.. +++.||+|++......  ...+.+.+|++++++++||||+++++++.+....++|+||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            456678999999999999976 5899999999654322  3457889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++++|.+++....   .+++.++..++.|+++|++|||+.+++|+||+|+||++++++.++|+|||.+.......   .
T Consensus        82 ~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~  155 (258)
T cd05578          82 LLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---L  155 (258)
T ss_pred             CCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---c
Confidence            99999999997652   38899999999999999999999999999999999999999999999999987654322   2


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchh---HHHHH----HHHHHHhhhccccceee
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM---WWFSV----TWLEEHWKKAEWRNVSM  921 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~---~~~~~----~~~~~~~~~~~~~~~~~  921 (936)
                      .....++..|+|||... ...++.++|+||+|+++|+|++|+.||......   .....    ....+...+..+.+++.
T Consensus       156 ~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (258)
T cd05578         156 TTSTSGTPGYMAPEVLC-RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAIN  234 (258)
T ss_pred             ccccCCChhhcCHHHHc-ccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHH
Confidence            23345777899999884 445899999999999999999999999876631   11110    01112224467889999


Q ss_pred             ccccccccccccc
Q 002321          922 RSCKGSSRQRRRF  934 (936)
Q Consensus       922 ~~l~~~p~~Rp~f  934 (936)
                      +||..||.+||++
T Consensus       235 ~~l~~~p~~R~~~  247 (258)
T cd05578         235 KLLERDPQKRLGD  247 (258)
T ss_pred             HHccCChhHcCCc
Confidence            9999999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.6e-32  Score=292.85  Aligned_cols=239  Identities=23%  Similarity=0.390  Sum_probs=192.2

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-----chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-----KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  765 (936)
                      |+..+.||+|+||.||+|+.. +++.||+|++......     +..+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v   81 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF   81 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence            456678999999999999864 6899999998643321     1246789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-CeEEeeccCccccCCCc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG-EPKVGDYGLARLLPMLD  844 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~  844 (936)
                      |||+++++|.+++.+..   .+++..+.+++.|++.|++|||++|++|+||||+||+++.++ .+||+|||.+.......
T Consensus        82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~  158 (268)
T cd06630          82 VEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG  158 (268)
T ss_pred             EeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence            99999999999997643   388999999999999999999999999999999999998876 59999999987664321


Q ss_pred             c--ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH---------HHHHhhh
Q 002321          845 R--YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW---------LEEHWKK  913 (936)
Q Consensus       845 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~---------~~~~~~~  913 (936)
                      .  ........++..|+|||... ...++.++||||+|+++|+|++|+.||.............         ..+...+
T Consensus       159 ~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06630         159 TGAGEFQGQLLGTIAFMAPEVLR-GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS  237 (268)
T ss_pred             ccCCccccccccccceeCHhHhc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence            1  11122345778899999884 4568899999999999999999999997654321111110         0112234


Q ss_pred             ccccceeeccccccccccccc
Q 002321          914 AEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       914 ~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      +++.+++.+|+..+|.+||+.
T Consensus       238 ~~~~~~i~~~l~~~p~~R~~~  258 (268)
T cd06630         238 PGLRDVTLRCLELQPEDRPPS  258 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCH
Confidence            677889999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-32  Score=294.32  Aligned_cols=239  Identities=22%  Similarity=0.269  Sum_probs=191.1

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc-hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      |+..++||+|++|.||+|... +|+.||+|++....... ..+.+.+|++++++++|+|++++++++.+....+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            356678999999999999975 69999999986553322 2456889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      + ++|.+++..... ..+++..+..++.|+++||+|||+++++||||+|+||+++.++.++|+|||.++.......  ..
T Consensus        81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~  156 (283)
T cd07835          81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TY  156 (283)
T ss_pred             C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--cc
Confidence            5 789998876542 3489999999999999999999999999999999999999999999999999975532211  11


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH--HH--------------H------
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV--TW--------------L------  907 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~--~~--------------~------  907 (936)
                      ....++..|+|||++.+...++.++||||+|+++|||++|+.||...+.......  +.              .      
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT  236 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence            2234577899999886655678999999999999999999999987654221110  00              0      


Q ss_pred             H-----------HHhhhccccceeeccccccccccccc
Q 002321          908 E-----------EHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       908 ~-----------~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      .           ....+..+.+++.+||..||.+||+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~  274 (283)
T cd07835         237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA  274 (283)
T ss_pred             cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCH
Confidence            0           01112456788999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.5e-32  Score=296.27  Aligned_cols=240  Identities=20%  Similarity=0.254  Sum_probs=188.9

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCC-CCCcceeeeEEEeCCe-----eE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQSL-----QL  763 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----~~  763 (936)
                      |+..+.||+|+||.||+|.+. +++.||||+++..... .....+.+|+.++++++ |+||+++++++.....     .+
T Consensus         3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~   82 (295)
T cd07837           3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY   82 (295)
T ss_pred             ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence            566778999999999999976 5899999998654322 22457888999999995 6999999999987655     79


Q ss_pred             EEEEecCCCChhhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCCeEEeeccCcccc
Q 002321          764 LIYEFVSGGSLHKHLHEGSG--GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG-SGEPKVGDYGLARLL  840 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~  840 (936)
                      +||||+++ ++.+++.....  ...+++..+..++.|+++||+|||+++++||||||+||+++. ++.+||+|||+++..
T Consensus        83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~  161 (295)
T cd07837          83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF  161 (295)
T ss_pred             EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceec
Confidence            99999975 89888865432  235899999999999999999999999999999999999998 899999999998765


Q ss_pred             CCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-------------
Q 002321          841 PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-------------  907 (936)
Q Consensus       841 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-------------  907 (936)
                      .....  ......+++.|+|||.+.+...++.++||||+|+++|||++|..||...+..........             
T Consensus       162 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T cd07837         162 SIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV  239 (295)
T ss_pred             CCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence            32211  112234577899999886666689999999999999999999999977544321110000             


Q ss_pred             -----------------H--HHhhhccccceeeccccccccccccc
Q 002321          908 -----------------E--EHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       908 -----------------~--~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                       .  ....++++.+++.+||..||.+||++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~  285 (295)
T cd07837         240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA  285 (295)
T ss_pred             hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCH
Confidence                             0  01134667889999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.3e-32  Score=298.47  Aligned_cols=240  Identities=23%  Similarity=0.313  Sum_probs=187.8

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-CCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      ++..++||+|+||.||+++.. +++.||+|++...........+.+|+.++.++. |+||+++++++......+++|||+
T Consensus         6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~   85 (288)
T cd06616           6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM   85 (288)
T ss_pred             hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence            455678999999999999976 589999999875544445677899999999996 999999999999988899999998


Q ss_pred             CCCChhhhhhc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          770 SGGSLHKHLHE--GSGGNFLSWNERFNVIQGTAKSLAHLHQS-NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       770 ~~g~L~~~l~~--~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      . +++.++...  ......+++.....++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++......  
T Consensus        86 ~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--  162 (288)
T cd06616          86 D-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI--  162 (288)
T ss_pred             c-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC--
Confidence            5 566554321  11123489999999999999999999974 99999999999999999999999999997653221  


Q ss_pred             cccccccCcccccCcccccCc--ccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH---HHHh-------hhc
Q 002321          847 VLSSKIQSALGYMAPEFACRT--VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL---EEHW-------KKA  914 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~---~~~~-------~~~  914 (936)
                       ......+++.|+|||.+...  ..++.++||||+||++|||++|+.||...........+..   ++..       .+.
T Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd06616         163 -AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSP  241 (288)
T ss_pred             -ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCH
Confidence             12234577889999988544  3688999999999999999999999987652111111110   0111       234


Q ss_pred             cccceeecccccccccccccC
Q 002321          915 EWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       915 ~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+++.+||..||.+||+++
T Consensus       242 ~l~~li~~~l~~~p~~Rpt~~  262 (288)
T cd06616         242 SFVNFINLCLIKDESKRPKYK  262 (288)
T ss_pred             HHHHHHHHHccCChhhCcCHH
Confidence            578899999999999999874

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.9e-32  Score=295.49  Aligned_cols=239  Identities=23%  Similarity=0.271  Sum_probs=191.7

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc-hHHHHHHHHHHHHcCCCCCcceeeeEEEeC--CeeEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLVTLEGYYWTQ--SLQLLIY  766 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  766 (936)
                      .|+..+.||+|+||.||+|+.+ +++.||+|.++...... ....+.+|+.++++++||||+++++++...  ...++||
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~   85 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM   85 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence            4677789999999999999987 58899999997543322 234577899999999999999999999877  7889999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||++ ++|.+++.....  .+++..+.+++.|++.||+|||+.+++|+||||+||+++.++.+||+|||.+.......  
T Consensus        86 e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--  160 (293)
T cd07843          86 EYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL--  160 (293)
T ss_pred             hhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc--
Confidence            9996 599988876432  48999999999999999999999999999999999999999999999999998664322  


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-------------------
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-------------------  907 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-------------------  907 (936)
                      .......+++.|+|||.+.+...++.++||||+|+++|||++|+.||..............                   
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence            1122345677899999886655678999999999999999999999987654322111000                   


Q ss_pred             -------------HHHh----hhccccceeeccccccccccccc
Q 002321          908 -------------EEHW----KKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       908 -------------~~~~----~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                   ...+    .++..++++.+||..||.+||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~  284 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA  284 (293)
T ss_pred             cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCH
Confidence                         0000    24456788999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.6e-32  Score=289.80  Aligned_cols=229  Identities=23%  Similarity=0.316  Sum_probs=190.4

Q ss_pred             ccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCCCh
Q 002321          698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSL  774 (936)
Q Consensus       698 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  774 (936)
                      ||+|+||.||+|+.. +++.||+|++......  ...+.+.+|+.++++++|+||+++++++.+....++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999976 4889999999654322  3356789999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccccccC
Q 002321          775 HKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQS  854 (936)
Q Consensus       775 ~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  854 (936)
                      .+++.+...   +++..+..++.|++.|++|||+.+++|+||+|+||+++.++.++|+|||.++......   ......+
T Consensus        81 ~~~l~~~~~---l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~  154 (262)
T cd05572          81 WTILRDRGL---FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCG  154 (262)
T ss_pred             HHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccC
Confidence            999976543   8899999999999999999999999999999999999999999999999998664322   1223457


Q ss_pred             cccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccc--hhHHHHHH------HHHHHhhhccccceeeccccc
Q 002321          855 ALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWK--MMWWFSVT------WLEEHWKKAEWRNVSMRSCKG  926 (936)
Q Consensus       855 ~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~--~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~  926 (936)
                      +..|+|||.+. ...++.++|+||+|+++|+|++|..||...+  ........      ...+...+..+.+++.+||..
T Consensus       155 ~~~~~~PE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  233 (262)
T cd05572         155 TPEYVAPEIIL-NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR  233 (262)
T ss_pred             CcCccChhHhc-CCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccC
Confidence            78899999874 4568899999999999999999999998776  22111110      011222357889999999999


Q ss_pred             ccccccc
Q 002321          927 SSRQRRR  933 (936)
Q Consensus       927 ~p~~Rp~  933 (936)
                      +|.+||+
T Consensus       234 ~p~~R~~  240 (262)
T cd05572         234 NPEERLG  240 (262)
T ss_pred             ChhhCcC
Confidence            9999998

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=3.8e-32  Score=292.60  Aligned_cols=242  Identities=24%  Similarity=0.364  Sum_probs=192.8

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCC------e
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQS------L  761 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------~  761 (936)
                      +.|+..+.||+|+||.||+|+.+ +++.||+|++.....  ..+.+.+|+.+++++ +|+||+++++++....      .
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            45778889999999999999986 578999999865432  356789999999999 7999999999997644      4


Q ss_pred             eEEEEEecCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCcccc
Q 002321          762 QLLIYEFVSGGSLHKHLHEGS-GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL  840 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  840 (936)
                      .++||||+++++|.+++.... ....+++..+..++.|++.|++|||+.+++|+||+|+||++++++.+||+|||.+...
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~  163 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL  163 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence            799999999999999886532 1234899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCccccccccccCcccccCcccccC----cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHH-HHHHH------HHH
Q 002321          841 PMLDRYVLSSKIQSALGYMAPEFACR----TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWW-FSVTW------LEE  909 (936)
Q Consensus       841 ~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~-~~~~~------~~~  909 (936)
                      ....  .......++..|+|||.+..    ...++.++||||+||++|+|++|+.||...+.... .....      ..+
T Consensus       164 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  241 (275)
T cd06608         164 DSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSP  241 (275)
T ss_pred             ccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCch
Confidence            4222  12233457888999998732    23467899999999999999999999976543211 11100      001


Q ss_pred             HhhhccccceeecccccccccccccC
Q 002321          910 HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       910 ~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ....+.+++++.+||..||.+||+.+
T Consensus       242 ~~~~~~~~~li~~~l~~dp~~Rpt~~  267 (275)
T cd06608         242 ENWSKKFNDFISECLIKNYEQRPFME  267 (275)
T ss_pred             hhcCHHHHHHHHHHhhcChhhCcCHH
Confidence            11335788999999999999999863

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.98  E-value=5.3e-32  Score=292.88  Aligned_cols=237  Identities=23%  Similarity=0.338  Sum_probs=192.4

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .+...+.||+|++|.||+|... +++.||+|++..... ...+.+.+|+.++++++|+||+++++++...+..++|+||+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~   98 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL   98 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence            3455678999999999999965 688999998864322 23456889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++++|.+++...    .+++.++..++.|++.|++|||+.|++||||+|+||+++.++.++++|||.+.......  ...
T Consensus        99 ~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~  172 (285)
T cd06648          99 EGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRR  172 (285)
T ss_pred             CCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--ccc
Confidence            999999998762    28889999999999999999999999999999999999999999999999887543211  112


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHH-HHHHH-HH-----hhhccccceeec
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS-VTWLE-EH-----WKKAEWRNVSMR  922 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~-~~~~~-~~-----~~~~~~~~~~~~  922 (936)
                      ....+++.|+|||... ...++.++||||+||++|||++|+.||...+...... ..... +.     ..+..+.+++.+
T Consensus       173 ~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (285)
T cd06648         173 KSLVGTPYWMAPEVIS-RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDR  251 (285)
T ss_pred             ccccCCccccCHHHhc-CCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHH
Confidence            2345788899999884 4468899999999999999999999997765432221 11111 01     134578899999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      ||..+|.+||++.
T Consensus       252 ~l~~~p~~Rpt~~  264 (285)
T cd06648         252 MLVRDPAQRATAA  264 (285)
T ss_pred             HcccChhhCcCHH
Confidence            9999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.98  E-value=5.3e-32  Score=292.76  Aligned_cols=236  Identities=21%  Similarity=0.220  Sum_probs=186.7

Q ss_pred             cCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-CCCcceeeeEEEeC--CeeEEEEEe
Q 002321          693 NKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQ--SLQLLIYEF  768 (936)
Q Consensus       693 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~  768 (936)
                      +..++||+|+||.||+|+.. +++.||+|+++............+|+.++.++. |+|++++++++.+.  +..++||||
T Consensus         2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~   81 (282)
T cd07831           2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL   81 (282)
T ss_pred             ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence            45567999999999999965 588999999865433333344567999999995 99999999999987  888999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      ++ |++.+.+....  ..+++.++..++.|++.||+|||+.+++||||||+||+++. +.+||+|||.++.......   
T Consensus        82 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~---  154 (282)
T cd07831          82 MD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP---  154 (282)
T ss_pred             CC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC---
Confidence            96 68888876533  24899999999999999999999999999999999999999 9999999999976543221   


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH-------------HH--------
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT-------------WL--------  907 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~-------------~~--------  907 (936)
                      .....++..|+|||.......++.++||||+||++|||++|..||...+........             ..        
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07831         155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY  234 (282)
T ss_pred             cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence            122346788999997755556789999999999999999999999775432111000             00        


Q ss_pred             ------------HHHhhhccccceeecccccccccccccC
Q 002321          908 ------------EEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       908 ------------~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                                  .....+..+.+++.+||..+|.+||+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~  274 (282)
T cd07831         235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAK  274 (282)
T ss_pred             cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHH
Confidence                        0012246778899999999999999864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.98  E-value=2.9e-32  Score=302.33  Aligned_cols=240  Identities=19%  Similarity=0.264  Sum_probs=188.8

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC-----eeEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS-----LQLL  764 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l  764 (936)
                      .|+..++||+|+||.||+|+.. +|+.||||+++..........+.+|+.++++++|+||+++++++....     ..++
T Consensus         6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   85 (336)
T cd07849           6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI   85 (336)
T ss_pred             ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence            4677788999999999999865 689999999865433344567889999999999999999999876543     4689


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      |+||++ +++.+++...    .+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++......
T Consensus        86 v~e~~~-~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          86 VQELME-TDLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             Eehhcc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence            999995 5888877643    38999999999999999999999999999999999999999999999999997654322


Q ss_pred             cc-cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHH--------------------
Q 002321          845 RY-VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS--------------------  903 (936)
Q Consensus       845 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~--------------------  903 (936)
                      .. .......+++.|+|||.+.+...++.++||||+||++|+|++|+.||.+.+......                    
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL  240 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence            11 111234578889999987555668999999999999999999999997654321100                    


Q ss_pred             --HHHHH-------------HHhhhccccceeecccccccccccccC
Q 002321          904 --VTWLE-------------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       904 --~~~~~-------------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                        ..+..             ....+.+..+++.+||..||.+||+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~  287 (336)
T cd07849         241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVE  287 (336)
T ss_pred             hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHH
Confidence              00000             001235577899999999999999863

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.98  E-value=6.3e-32  Score=295.79  Aligned_cols=236  Identities=28%  Similarity=0.375  Sum_probs=190.6

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      .|+..++||+|+||.||+|+.. +++.||+|++......  ...+++.+|+++++.++||||+++++++.+....++|||
T Consensus        16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   95 (307)
T cd06607          16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME   95 (307)
T ss_pred             hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence            3677788999999999999976 5899999998643322  234678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |++ |++.+++....  ..+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++......    
T Consensus        96 ~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~----  168 (307)
T cd06607          96 YCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----  168 (307)
T ss_pred             hhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence            996 67777765432  23899999999999999999999999999999999999999999999999998754321    


Q ss_pred             ccccccCcccccCccccc--CcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HHHHH-----HHHhhhccccce
Q 002321          848 LSSKIQSALGYMAPEFAC--RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVTWL-----EEHWKKAEWRNV  919 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~~~-----~~~~~~~~~~~~  919 (936)
                        ....+++.|+|||++.  ....++.++||||+|+++|||++|+.||...+..... .....     .+...++.++++
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  246 (307)
T cd06607         169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNF  246 (307)
T ss_pred             --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHH
Confidence              2335677899999874  2345788999999999999999999999876543221 11110     011134568899


Q ss_pred             eecccccccccccccC
Q 002321          920 SMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       920 ~~~~l~~~p~~Rp~f~  935 (936)
                      +.+||..+|.+||+++
T Consensus       247 i~~~l~~~p~~Rp~~~  262 (307)
T cd06607         247 VDSCLQKIPQDRPSSE  262 (307)
T ss_pred             HHHHhcCChhhCcCHH
Confidence            9999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.98  E-value=9.5e-33  Score=298.92  Aligned_cols=242  Identities=26%  Similarity=0.348  Sum_probs=192.0

Q ss_pred             cccCCCcccccCceEEEEEEeC-----CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEe--CCeeE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWT--QSLQL  763 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  763 (936)
                      .++..+.||+|+||.||+|++.     +++.||||+++........+.+.+|++++++++|+||+++++++..  ....+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            3566678999999999999854     3689999999765443346789999999999999999999999887  55779


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      +||||+++++|.+++.....  .+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+......
T Consensus        85 lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED  162 (284)
T ss_pred             EEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence            99999999999999976542  3899999999999999999999999999999999999999999999999999876522


Q ss_pred             ccc-cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-------------HHHHHH-
Q 002321          844 DRY-VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-------------SVTWLE-  908 (936)
Q Consensus       844 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-------------~~~~~~-  908 (936)
                      ... ........+..|+|||... ...++.++||||+|+++|||++|+.||.........             ...... 
T Consensus       163 ~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05038         163 KDYYYVKEPGESPIFWYAPECLR-TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE  241 (284)
T ss_pred             CcceeccCCCCCcccccCcHHHc-cCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence            221 1122233455699999884 446889999999999999999999998764321100             011111 


Q ss_pred             ------HHhhhccccceeecccccccccccccC
Q 002321          909 ------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 ------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                            +...+.++.+++.+||..+|.+||+++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~  274 (284)
T cd05038         242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFA  274 (284)
T ss_pred             CCcCCCCccCCHHHHHHHHHHhccChhhCCCHH
Confidence                  112235678999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.98  E-value=5e-32  Score=293.56  Aligned_cols=238  Identities=23%  Similarity=0.295  Sum_probs=189.6

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeC--CeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ--SLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~  768 (936)
                      |+..+.||.|++|.||+|... +++.||+|++..........++.+|++++++++||||+++++++.+.  ...++||||
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   82 (287)
T cd06621           3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY   82 (287)
T ss_pred             eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence            456678999999999999985 58899999987554444567799999999999999999999998653  467999999


Q ss_pred             cCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          769 VSGGSLHKHLHEGS-GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       769 ~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      +++++|.+++.... ....+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.......   
T Consensus        83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---  159 (287)
T cd06621          83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL---  159 (287)
T ss_pred             cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc---
Confidence            99999998876422 23347889999999999999999999999999999999999999999999999987543211   


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch---hHHHHHHHHH----HHh---------
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM---MWWFSVTWLE----EHW---------  911 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~---~~~~~~~~~~----~~~---------  911 (936)
                       .....++..|+|||.+ ....++.++||||+||++|+|++|+.||...+.   .......+..    +..         
T Consensus       160 -~~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd06621         160 -AGTFTGTSFYMAPERI-QGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK  237 (287)
T ss_pred             -cccccCCccccCHHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCc
Confidence             1234467789999988 455688999999999999999999999987632   1111111111    000         


Q ss_pred             hhccccceeeccccccccccccc
Q 002321          912 KKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       912 ~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      .++.+++++.+||..+|.+||++
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rpt~  260 (287)
T cd06621         238 WSEEFKDFIKQCLEKDPTRRPTP  260 (287)
T ss_pred             hHHHHHHHHHHHcCCCcccCCCH
Confidence            12457899999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=2e-32  Score=321.71  Aligned_cols=242  Identities=25%  Similarity=0.333  Sum_probs=203.0

Q ss_pred             cCCCcccccCceEEEEEEeC----C----CcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeE
Q 002321          693 NKDCELGRGGFGAVYRTVLR----D----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       693 ~~~~~iG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  763 (936)
                      ...+.+|+|+||.|++|...    .    ...||||..+......+.+.+..|+++|+.+ +|+||+.++|+|..++..+
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~  378 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY  378 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence            55568999999999999843    1    4579999998877777788999999999999 6999999999999999999


Q ss_pred             EEEEecCCCChhhhhhccC-------C----C--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeE
Q 002321          764 LIYEFVSGGSLHKHLHEGS-------G----G--NFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPK  830 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~-------~----~--~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~k  830 (936)
                      +|+||++.|+|.++++..+       .    .  ..++..+.+.++.|||.|++||++.++||||+.++|||++++..+|
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~k  458 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIK  458 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEE
Confidence            9999999999999998766       0    0  1388899999999999999999999999999999999999999999


Q ss_pred             EeeccCccccCCCccccccccc-cCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccch-hHHH-----
Q 002321          831 VGDYGLARLLPMLDRYVLSSKI-QSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKM-MWWF-----  902 (936)
Q Consensus       831 l~Dfg~a~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~-~~~~-----  902 (936)
                      |+|||+|+.....+.+...... .-+..|||||.+.. ..|+.++|||||||++||+++ |..||.+... ....     
T Consensus       459 IaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~  537 (609)
T KOG0200|consen  459 IADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKE  537 (609)
T ss_pred             EccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhc
Confidence            9999999976555544433222 13456999999954 689999999999999999999 9999987442 1111     


Q ss_pred             HHHHHHHHhhhccccceeecccccccccccccC
Q 002321          903 SVTWLEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..+...|..+.++++++|..||+.+|.+||+|.
T Consensus       538 G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~  570 (609)
T KOG0200|consen  538 GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFS  570 (609)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHH
Confidence            122344777889999999999999999999994

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.98  E-value=1.9e-32  Score=300.65  Aligned_cols=199  Identities=23%  Similarity=0.297  Sum_probs=171.6

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-C-----CCcceeeeEEEeCCeeE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-H-----PNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~  763 (936)
                      .|++.+.||+|+||.|.+|.+. +++.||||+++...  ....+...|+.+|..++ |     -|+|++++++..+.+.+
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            5788899999999999999976 59999999997553  33456678999999996 4     48999999999999999


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC--CeEEeeccCccccC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG--EPKVGDYGLARLLP  841 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~  841 (936)
                      ||+|.+ .-+|+++++.+.... ++...+..++.||+.||.+||+.+|||+||||+|||+...+  .+||+|||.|....
T Consensus       265 iVfELL-~~NLYellK~n~f~G-lsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~  342 (586)
T KOG0667|consen  265 IVFELL-STNLYELLKNNKFRG-LSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES  342 (586)
T ss_pred             eeehhh-hhhHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence            999999 579999999887654 89999999999999999999999999999999999997544  79999999998754


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchh
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM  899 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~  899 (936)
                      ..-.     ....+..|+|||++.+. +|+.+.||||||||++||++|.+-|.+....
T Consensus       343 q~vy-----tYiQSRfYRAPEVILGl-pY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~  394 (586)
T KOG0667|consen  343 QRVY-----TYIQSRFYRAPEVILGL-PYDTAIDMWSLGCILAELFTGEPLFPGDNEY  394 (586)
T ss_pred             Ccce-----eeeeccccccchhhccC-CCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence            3221     34456679999999654 7999999999999999999999999887653

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.98  E-value=5.1e-32  Score=296.87  Aligned_cols=240  Identities=23%  Similarity=0.286  Sum_probs=190.3

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc-hHHHHHHHHHHHHcCCCCCcceeeeEEEeC--CeeEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLVTLEGYYWTQ--SLQLLI  765 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  765 (936)
                      ..|+..+.||+|+||.||+|+.. +|+.||+|+++...... ....+.+|+.++++++|+||+++++++.+.  +..++|
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV   86 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence            34677888999999999999976 58999999986543222 234567899999999999999999998765  467999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      |||++ ++|.+++....  ..+++.++..++.|++.|++|||+.|++||||||+||+++.++.+||+|||.+........
T Consensus        87 ~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~  163 (309)
T cd07845          87 MEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK  163 (309)
T ss_pred             EecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence            99996 58888887543  3489999999999999999999999999999999999999999999999999986643221


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH------------------
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL------------------  907 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~------------------  907 (936)
                        ......++..|+|||.+.+...++.++||||+||++|||++|+.||...+..........                  
T Consensus       164 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07845         164 --PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL  241 (309)
T ss_pred             --CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence              112233467799999886666789999999999999999999999987654322110000                  


Q ss_pred             ----------------HHHhhhccccceeeccccccccccccc
Q 002321          908 ----------------EEHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       908 ----------------~~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                      ...+.++.+.+++.+|+..||.+||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~  284 (309)
T cd07845         242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATA  284 (309)
T ss_pred             cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCH
Confidence                            001124556789999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.98  E-value=6e-32  Score=289.24  Aligned_cols=238  Identities=24%  Similarity=0.371  Sum_probs=196.5

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      |+..+.||+|++|.||+|+.. +++.||||++.........+.+.+|++.+.+++|+|++++++++......++||||++
T Consensus         3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (264)
T cd06623           3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD   82 (264)
T ss_pred             ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence            566788999999999999987 4899999998766443446789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ-SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      +++|.+++....   .+++..+..++.|+++|++|||+ .+++||||+|+||+++.++.++|+|||.+.........  .
T Consensus        83 ~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~  157 (264)
T cd06623          83 GGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--C  157 (264)
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--c
Confidence            999999997653   38999999999999999999999 99999999999999999999999999999866432221  1


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch-hHHHHHHHHH----H---Hh-hhcccccee
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM-MWWFSVTWLE----E---HW-KKAEWRNVS  920 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~-~~~~~~~~~~----~---~~-~~~~~~~~~  920 (936)
                      ....++..|+|||.. ....++.++||||||+++|+|++|+.||...+. ..........    +   .. .+..+.+++
T Consensus       158 ~~~~~~~~y~~pE~~-~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  236 (264)
T cd06623         158 NTFVGTVTYMSPERI-QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI  236 (264)
T ss_pred             cceeecccccCHhhh-CCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence            234567889999988 445788999999999999999999999987752 1111111111    0   11 345688899


Q ss_pred             ecccccccccccccC
Q 002321          921 MRSCKGSSRQRRRFQ  935 (936)
Q Consensus       921 ~~~l~~~p~~Rp~f~  935 (936)
                      .+||..+|.+||+++
T Consensus       237 ~~~l~~~p~~R~~~~  251 (264)
T cd06623         237 SACLQKDPKKRPSAA  251 (264)
T ss_pred             HHHccCChhhCCCHH
Confidence            999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.98  E-value=2.5e-32  Score=296.56  Aligned_cols=238  Identities=23%  Similarity=0.348  Sum_probs=193.7

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++......++|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            34677788999999999999865 57899999985432 23356788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++++|.+++.+..    +++.++..++.|++.|++|||++|++|+||||+||+++.++.++|+|||++........  .
T Consensus        98 ~~~~~L~~~~~~~~----l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~  171 (293)
T cd06647          98 LAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  171 (293)
T ss_pred             CCCCcHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--c
Confidence            99999999987543    78889999999999999999999999999999999999999999999998875543221  2


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH--HHH-----HHhhhccccceee
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT--WLE-----EHWKKAEWRNVSM  921 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~--~~~-----~~~~~~~~~~~~~  921 (936)
                      .....+++.|+|||... ...++.++||||+||++|++++|+.||...+........  ...     +...+..+++++.
T Consensus       172 ~~~~~~~~~y~~PE~~~-~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (293)
T cd06647         172 RSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  250 (293)
T ss_pred             cccccCChhhcCchhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHH
Confidence            23345778899999884 446789999999999999999999999876542211100  001     1112356889999


Q ss_pred             cccccccccccccC
Q 002321          922 RSCKGSSRQRRRFQ  935 (936)
Q Consensus       922 ~~l~~~p~~Rp~f~  935 (936)
                      +||..+|.+||+|.
T Consensus       251 ~~l~~~p~~Rp~~~  264 (293)
T cd06647         251 RCLEMDVEKRGSAK  264 (293)
T ss_pred             HHccCChhhCcCHH
Confidence            99999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.98  E-value=4.8e-32  Score=290.86  Aligned_cols=240  Identities=20%  Similarity=0.329  Sum_probs=191.7

Q ss_pred             ccCCCcccccCceEEEEEEeCC--CcEEEEEEeeccCc---------cchHHHHHHHHHHHHc-CCCCCcceeeeEEEeC
Q 002321          692 LNKDCELGRGGFGAVYRTVLRD--GRPVAIKKLTVSSL---------VKSQEDFEREVKKLGK-VRHPNLVTLEGYYWTQ  759 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~  759 (936)
                      |+..+.||+|+||.||+|....  ++.+|||.+.....         .....++.+|+.++.+ ++|+||+++++++.+.
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            4567789999999999999764  68899998854321         1223557788888875 7999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCCeEEeeccCc
Q 002321          760 SLQLLIYEFVSGGSLHKHLHEG-SGGNFLSWNERFNVIQGTAKSLAHLHQ-SNIIHYNIKSSNVLIDGSGEPKVGDYGLA  837 (936)
Q Consensus       760 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  837 (936)
                      +..++||||+++++|.+++... .....+++..+++++.|++.|+.|||+ .+++|+||||+||+++.++.+||+|||.+
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~  161 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA  161 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccce
Confidence            9999999999999999887542 122348899999999999999999996 78999999999999999999999999999


Q ss_pred             cccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH------HHHh
Q 002321          838 RLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL------EEHW  911 (936)
Q Consensus       838 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~------~~~~  911 (936)
                      .......   ......++..|+|||... ...++.++||||+|+++|||++|+.||...+..........      .+..
T Consensus       162 ~~~~~~~---~~~~~~~~~~~~~Pe~~~-~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd08528         162 KQKQPES---KLTSVVGTILYSCPEIVK-NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM  237 (269)
T ss_pred             eeccccc---ccccccCcccCcChhhhc-CCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCccc
Confidence            7654322   223456788899999985 45689999999999999999999999987655322211100      0112


Q ss_pred             hhccccceeecccccccccccccC
Q 002321          912 KKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       912 ~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+..+.+++.+||..||.+||++.
T Consensus       238 ~~~~l~~li~~cl~~~p~~Rp~~~  261 (269)
T cd08528         238 YSEDVTDVITSCLTPDAEARPDII  261 (269)
T ss_pred             CCHHHHHHHHHHCCCCCccCCCHH
Confidence            346788999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.98  E-value=3.3e-32  Score=254.50  Aligned_cols=213  Identities=22%  Similarity=0.323  Sum_probs=177.0

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      .+.+.....||+|+||.|-+.++. +|...|||+++..-.....++..+|+.+..+. ..|.+|++||...+....|+.|
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            344566778999999999887765 69999999998776666678889999987666 7999999999999999999999


Q ss_pred             EecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          767 EFVSGGSLHKHLHEG-SGGNFLSWNERFNVIQGTAKSLAHLHQS-NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       767 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      |.| ..+|+.+.++- ..+..+++...-+|+..+..||.|||++ .++|||+||+|||++.+|.+|+||||++-.+.   
T Consensus       125 E~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~---  200 (282)
T KOG0984|consen  125 ELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV---  200 (282)
T ss_pred             HHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh---
Confidence            999 47888766542 2334589999999999999999999986 89999999999999999999999999997653   


Q ss_pred             cccccccccCcccccCcccccC---cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH
Q 002321          845 RYVLSSKIQSALGYMAPEFACR---TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT  905 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~  905 (936)
                      +....+...|...|||||.+..   ...|+.++||||+|+++.||.+++.||+.+........+
T Consensus       201 dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkq  264 (282)
T KOG0984|consen  201 DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQ  264 (282)
T ss_pred             hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHH
Confidence            2334445567888999998732   336889999999999999999999999998775444333

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.98  E-value=6.4e-32  Score=293.49  Aligned_cols=242  Identities=23%  Similarity=0.348  Sum_probs=189.6

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeC-----Cee
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQ-----SLQ  762 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----~~~  762 (936)
                      ..|+..+.||+|+||.||+|... +++.+|+|++....  .....+.+|+.+++++ +|||++++++++...     ...
T Consensus        22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            34677778999999999999975 58899999985432  2346678899999999 899999999998754     357


Q ss_pred             EEEEEecCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          763 LLIYEFVSGGSLHKHLHEGS-GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      ++||||+++++|.++++... ....+++..+..++.|++.|++|||+.+++||||||+||+++.++.+||+|||.++...
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~  179 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  179 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence            89999999999999886422 22348899999999999999999999999999999999999999999999999987654


Q ss_pred             CCccccccccccCcccccCcccccCcc----cCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HHHHH-H-----HH
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTV----KITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVTWL-E-----EH  910 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~~~-~-----~~  910 (936)
                      ....  ......++..|+|||.+....    .++.++||||+||++|||++|+.||...+..... ..... .     +.
T Consensus       180 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  257 (291)
T cd06639         180 STRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE  257 (291)
T ss_pred             cccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCccc
Confidence            3221  122345778899999874332    3678999999999999999999999876542111 11000 0     01


Q ss_pred             hhhccccceeecccccccccccccC
Q 002321          911 WKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       911 ~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      -....+.+++.+||+.+|.+||+++
T Consensus       258 ~~~~~l~~li~~~l~~~p~~Rps~~  282 (291)
T cd06639         258 KWCRSFNHFISQCLIKDFEARPSVT  282 (291)
T ss_pred             ccCHHHHHHHHHHhhcChhhCcCHH
Confidence            1223577899999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.98  E-value=2.6e-32  Score=292.18  Aligned_cols=233  Identities=21%  Similarity=0.281  Sum_probs=191.1

Q ss_pred             ccccCceEEEEEEeCC-CcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCCCh
Q 002321          698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSL  774 (936)
Q Consensus       698 iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  774 (936)
                      ||+|+||.||+++..+ |+.||+|++......  ...+.+.+|++++++++|+||+++++.+......+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999874 899999998654332  3456788999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc------ccc
Q 002321          775 HKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR------YVL  848 (936)
Q Consensus       775 ~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~------~~~  848 (936)
                      .+++.+..   .+++..+.+++.|++.||+|||+.+++||||+|+||++++++.++|+|||++........      ...
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  157 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE  157 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence            99997644   389999999999999999999999999999999999999999999999999875432211      112


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH----HHHHHhh--hccccceeec
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT----WLEEHWK--KAEWRNVSMR  922 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~----~~~~~~~--~~~~~~~~~~  922 (936)
                      .....++..|+|||.... ..++.++||||+|+++||+++|+.||...+........    ...+...  +..+.+++.+
T Consensus       158 ~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  236 (265)
T cd05579         158 DKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISK  236 (265)
T ss_pred             ccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHH
Confidence            233456778999998844 45788999999999999999999999876653322111    0011111  5678999999


Q ss_pred             cccccccccccc
Q 002321          923 SCKGSSRQRRRF  934 (936)
Q Consensus       923 ~l~~~p~~Rp~f  934 (936)
                      ||..+|.+||++
T Consensus       237 ~l~~~p~~Rpt~  248 (265)
T cd05579         237 LLVPDPEKRLGA  248 (265)
T ss_pred             HhcCCHhhcCCC
Confidence            999999999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.98  E-value=7.5e-32  Score=290.54  Aligned_cols=230  Identities=23%  Similarity=0.317  Sum_probs=182.1

Q ss_pred             cccccCceEEEEEEeC-CCcEEEEEEeeccCccc--hHHHHHHHH---HHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK--SQEDFEREV---KKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      .||+|+||.||+|... +++.||+|.+.......  ....+..|.   +.++...||+|+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            3899999999999865 58899999986543221  122233443   34455679999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                      +|+|.+++....   .+++.++..++.|+++|++|||+.+++||||||+||+++.++.+||+|||++.......    ..
T Consensus        81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~  153 (278)
T cd05606          81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PH  153 (278)
T ss_pred             CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----Cc
Confidence            999999887543   38999999999999999999999999999999999999999999999999987553221    12


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch---hHHHHHHHH----HHHhhhccccceeecc
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM---MWWFSVTWL----EEHWKKAEWRNVSMRS  923 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~---~~~~~~~~~----~~~~~~~~~~~~~~~~  923 (936)
                      ...++..|+|||...++..++.++||||+||++|||++|+.||.....   .........    .+...+.++.+++.+|
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  233 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL  233 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHH
Confidence            345788999999986555688999999999999999999999987633   211111110    0112346788999999


Q ss_pred             cccccccccc
Q 002321          924 CKGSSRQRRR  933 (936)
Q Consensus       924 l~~~p~~Rp~  933 (936)
                      +..+|.+||.
T Consensus       234 l~~~p~~R~~  243 (278)
T cd05606         234 LQRDVNRRLG  243 (278)
T ss_pred             hhcCHHhccC
Confidence            9999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.98  E-value=9.3e-32  Score=292.67  Aligned_cols=240  Identities=20%  Similarity=0.249  Sum_probs=188.1

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      .|+..++||+|++|.||+|+.. +|+.||+|++...... ...+.+.+|++++++++|+||+++++++.+....++||||
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY   82 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence            3567778999999999999976 6889999998654332 2246688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCCeEEeeccCccccCCCcccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG-SGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      ++ +++.+++..... ...++..+..++.|++.||+|||+++++||||+|+||+++. ++.+||+|||++.......  .
T Consensus        83 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~--~  158 (294)
T PLN00009         83 LD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV--R  158 (294)
T ss_pred             cc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc--c
Confidence            95 688887765432 23678888899999999999999999999999999999985 5579999999997653221  1


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH--------------------
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL--------------------  907 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~--------------------  907 (936)
                      ......+++.|+|||.+.+...++.++||||+||++|+|++|+.||...+........+.                    
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK  238 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence            112334678899999885555688999999999999999999999976544211110000                    


Q ss_pred             --HH-----------Hhhhccccceeeccccccccccccc
Q 002321          908 --EE-----------HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       908 --~~-----------~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                        .+           ...++.+.+++.+|+..+|.+||+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~  278 (294)
T PLN00009        239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITA  278 (294)
T ss_pred             hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCH
Confidence              00           0123456678999999999999975

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.98  E-value=4.3e-32  Score=289.14  Aligned_cols=240  Identities=25%  Similarity=0.409  Sum_probs=192.9

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      |+..+.||+|+||.||+|..+ +|..||+|.+...... ...+.+.+|+.++++++|+||+++++++......++|+||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   81 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC   81 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence            455678999999999999976 4889999998654322 23567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-CeEEeeccCccccCCCccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG-EPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      ++++|.+++.+... ..+++..+..++.|+++|++|||+.+++|+||||+||++++++ .+|++|||.+........  .
T Consensus        82 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~  158 (257)
T cd08225          82 DGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--L  158 (257)
T ss_pred             CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--c
Confidence            99999999876432 2478999999999999999999999999999999999999886 469999999976543221  1


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-----HHhhhccccceeecc
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-----EHWKKAEWRNVSMRS  923 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~  923 (936)
                      .....+++.|+|||... ...++.++||||+|+++|||++|..||...+...........     ..-.+..+.+++.+|
T Consensus       159 ~~~~~~~~~~~ape~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  237 (257)
T cd08225         159 AYTCVGTPYYLSPEICQ-NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQL  237 (257)
T ss_pred             ccccCCCccccCHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHH
Confidence            22345788899999884 446889999999999999999999999765543222111100     011235688899999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..+|.+||+++
T Consensus       238 l~~~p~~Rpt~~  249 (257)
T cd08225         238 FKVSPRDRPSIT  249 (257)
T ss_pred             hccChhhCcCHH
Confidence            999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.98  E-value=2.2e-33  Score=276.64  Aligned_cols=227  Identities=22%  Similarity=0.298  Sum_probs=185.8

Q ss_pred             CcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEe----CCeeEEEEEec
Q 002321          696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWT----QSLQLLIYEFV  769 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~e~~  769 (936)
                      ++||-|-.|.|-.+..+ +++++|+|++..      ....++|++.--.. .|||||.++++++.    .....+|||.|
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~D------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m  141 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLD------SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM  141 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhc------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence            47999999999999876 689999999842      35567888875444 69999999999864    34557899999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCCeEEeeccCccccCCCccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG---SGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      +||.|...+...+. ..++++++..|++||+.|+.|||+.+|.||||||+|+|...   +..+||+|||+|+.-..   .
T Consensus       142 eGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~---~  217 (400)
T KOG0604|consen  142 EGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE---P  217 (400)
T ss_pred             cchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC---C
Confidence            99999999987553 45999999999999999999999999999999999999964   45799999999986432   2


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch--------hHHH--HHHHHHHHhh--hc
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM--------MWWF--SVTWLEEHWK--KA  914 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~--------~~~~--~~~~~~~~~~--~~  914 (936)
                      ..-...+.||.|.|||++ +...|+..+|+||+||++|-|++|.+||...+-        ..+.  ...|..++|.  ++
T Consensus       218 ~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe  296 (400)
T KOG0604|consen  218 GDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSE  296 (400)
T ss_pred             ccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHH
Confidence            223446779999999999 666799999999999999999999999977532        1111  3344456664  48


Q ss_pred             cccceeecccccccccccc
Q 002321          915 EWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       915 ~~~~~~~~~l~~~p~~Rp~  933 (936)
                      ..+++|+..++.+|.+|-+
T Consensus       297 ~aKdlIR~LLkt~PteRlT  315 (400)
T KOG0604|consen  297 AAKDLIRKLLKTEPTERLT  315 (400)
T ss_pred             HHHHHHHHHhcCCchhhee
Confidence            8899999999999999976

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.98  E-value=9.2e-32  Score=291.46  Aligned_cols=238  Identities=23%  Similarity=0.355  Sum_probs=196.4

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .|+..+.||+|+||.||+|.++ +++.||+|++.....  ..+.+.+|++++++++|+|++++++++......++|+||+
T Consensus        20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   97 (286)
T cd06614          20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYM   97 (286)
T ss_pred             cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEecc
Confidence            4566778999999999999987 688999999965433  4677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++++|.+++....  ..+++.++..++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+........  ..
T Consensus        98 ~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~  173 (286)
T cd06614          98 DGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KR  173 (286)
T ss_pred             CCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hh
Confidence            9999999998754  2489999999999999999999999999999999999999999999999999865532211  12


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH-------HHHHhhhccccceeec
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW-------LEEHWKKAEWRNVSMR  922 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~  922 (936)
                      ....++..|+|||.+. ...++.++||||+||++|+|++|+.||...+.........       ..+...+..+++++.+
T Consensus       174 ~~~~~~~~y~~PE~~~-~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  252 (286)
T cd06614         174 NSVVGTPYWMAPEVIK-RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNK  252 (286)
T ss_pred             ccccCCcccCCHhHhc-CCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHH
Confidence            2344677899999884 4568999999999999999999999998765532221110       0011134568899999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      ||..+|.+||++.
T Consensus       253 ~l~~~p~~Rpt~~  265 (286)
T cd06614         253 CLVKDPEKRPSAE  265 (286)
T ss_pred             HhccChhhCcCHH
Confidence            9999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.98  E-value=5.8e-32  Score=297.67  Aligned_cols=205  Identities=22%  Similarity=0.351  Sum_probs=168.3

Q ss_pred             ccCCCcccccCceEEEEEEeCC---CcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeC--CeeEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLRD---GRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ--SLQLL  764 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  764 (936)
                      |+..++||+|+||.||+|+...   ++.||+|.+.....  ....+.+.+|+.++++++||||+++++++.+.  ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            4556789999999999999754   78999999976321  22246678899999999999999999999988  78899


Q ss_pred             EEEecCCCChhhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC----CCCeEEeeccCcc
Q 002321          765 IYEFVSGGSLHKHLHEGSG--GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG----SGEPKVGDYGLAR  838 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~----~~~~kl~Dfg~a~  838 (936)
                      ||||++ +++.+++.....  ...+++..+..++.|++.|++|||+.+|+||||||+||+++.    ++.+||+|||+++
T Consensus        82 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~  160 (316)
T cd07842          82 LFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR  160 (316)
T ss_pred             EEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence            999996 577776653322  225889999999999999999999999999999999999999    9999999999998


Q ss_pred             ccCCCcc-ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccc
Q 002321          839 LLPMLDR-YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWK  897 (936)
Q Consensus       839 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~  897 (936)
                      ....... ........++..|+|||...+...++.++||||+||++|||++|+.||...+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            6543222 1122334567889999988666668899999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=1.4e-31  Score=285.30  Aligned_cols=240  Identities=26%  Similarity=0.361  Sum_probs=197.7

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeC--CeeEEEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ--SLQLLIYE  767 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  767 (936)
                      |...+.||+|++|.||+|+.. +++.|++|++..... ....+.+.+|+.++++++|+||+++++++.+.  ...++|+|
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   81 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE   81 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence            455678999999999999987 689999999865543 23467889999999999999999999999988  88899999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+++++|.+++....   .+++..+..++.|+++|++|||+.+++|+||+|+||+++.++.++|+|||.+..........
T Consensus        82 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          82 YVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             ecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence            999999999998654   48999999999999999999999999999999999999999999999999998765433211


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-------HHHhhhcccccee
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-------EEHWKKAEWRNVS  920 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~~~~  920 (936)
                      ......++..|+|||... ....+.++||||+|+++|+|++|..||...+..........       .+...+..+.+++
T Consensus       159 ~~~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i  237 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIR-GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL  237 (260)
T ss_pred             cccCCCCCccccCHhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence            233456778899999884 44589999999999999999999999988762111111111       1122357799999


Q ss_pred             ecccccccccccccC
Q 002321          921 MRSCKGSSRQRRRFQ  935 (936)
Q Consensus       921 ~~~l~~~p~~Rp~f~  935 (936)
                      .+|+..+|.+||+.+
T Consensus       238 ~~~l~~~p~~Rp~~~  252 (260)
T cd06606         238 RKCLRRDPKKRPTAD  252 (260)
T ss_pred             HHhCcCChhhCCCHH
Confidence            999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-31  Score=284.73  Aligned_cols=229  Identities=23%  Similarity=0.283  Sum_probs=183.9

Q ss_pred             CcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHH-HcCCCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKL-GKVRHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      +.||+|+||.||+|+.. +++.||||+++.....  .....+..|..++ ...+|+|++++++++...+..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46999999999999975 5889999998654321  1223344555444 455899999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      ++|.+++....   .+++..+.+++.|++.||.|||+.+++||||+|+||++++++.++|+|||+++....      ...
T Consensus        82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~  152 (260)
T cd05611          82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKK  152 (260)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------ccc
Confidence            99999997644   388999999999999999999999999999999999999999999999999875432      223


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH-HHHH-------HHhhhccccceeecc
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV-TWLE-------EHWKKAEWRNVSMRS  923 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~-~~~~-------~~~~~~~~~~~~~~~  923 (936)
                      ..++..|+|||...+. .++.++||||+|+++|||++|..||...+....... ....       ....++.+.+++.+|
T Consensus       153 ~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  231 (260)
T cd05611         153 FVGTPDYLAPETILGV-GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL  231 (260)
T ss_pred             CCCCcCccChhhhcCC-CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHH
Confidence            4577889999988544 588999999999999999999999987655332211 1100       112457789999999


Q ss_pred             ccccccccccc
Q 002321          924 CKGSSRQRRRF  934 (936)
Q Consensus       924 l~~~p~~Rp~f  934 (936)
                      |..+|.+||+.
T Consensus       232 l~~~p~~R~~~  242 (260)
T cd05611         232 LCMDPAKRLGA  242 (260)
T ss_pred             ccCCHHHccCC
Confidence            99999999964

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.97  E-value=1.4e-31  Score=286.51  Aligned_cols=241  Identities=20%  Similarity=0.349  Sum_probs=192.5

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEe--CCeeEEEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWT--QSLQLLIYE  767 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  767 (936)
                      |+..+.||.|+||.||+|... +++.||+|++...... ...+.+.+|++++++++|+||+++++++..  ....+++||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e   81 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME   81 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence            456678999999999999865 5789999998654332 335678899999999999999999998764  346789999


Q ss_pred             ecCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          768 FVSGGSLHKHLHEGS-GGNFLSWNERFNVIQGTAKSLAHLH-----QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~~LH-----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      |+++++|.+++.... ....+++.+++.++.|++.|++|||     +.+++|+||||+||+++.++.+|++|||++....
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~  161 (265)
T cd08217          82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG  161 (265)
T ss_pred             hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence            999999999987542 1235899999999999999999999     8899999999999999999999999999998764


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-----HHHhhhccc
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-----EEHWKKAEW  916 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~  916 (936)
                      ....  ......+++.|+|||.+. ...++.++||||+|+++|+|++|+.||...+..........     .+...+..+
T Consensus       162 ~~~~--~~~~~~~~~~~~~pE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (265)
T cd08217         162 HDSS--FAKTYVGTPYYMSPEQLN-HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSEL  238 (265)
T ss_pred             CCcc--cccccccCCCccChhhhc-CCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHH
Confidence            3221  122345788899999984 44688999999999999999999999987653221111000     011223567


Q ss_pred             cceeecccccccccccccC
Q 002321          917 RNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       917 ~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+++.+|+..+|.+||+++
T Consensus       239 ~~l~~~~l~~~p~~Rp~~~  257 (265)
T cd08217         239 NEVIKSMLNVDPDKRPSTE  257 (265)
T ss_pred             HHHHHHHccCCcccCCCHH
Confidence            8899999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.97  E-value=1.2e-31  Score=297.60  Aligned_cols=241  Identities=22%  Similarity=0.302  Sum_probs=189.9

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccC-ccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeC--CeeEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSS-LVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQ--SLQLL  764 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~l  764 (936)
                      ..|+..+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.+++++ +|+||+++++++...  ...++
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            34677788999999999999976 58899999885422 123345677899999999 999999999998653  36799


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ||||++ ++|.+++...    .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus        87 v~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~  161 (337)
T cd07852          87 VFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE  161 (337)
T ss_pred             Eecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence            999996 6999888764    37888999999999999999999999999999999999999999999999998664332


Q ss_pred             cc---cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH-H--------------
Q 002321          845 RY---VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT-W--------------  906 (936)
Q Consensus       845 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~-~--------------  906 (936)
                      ..   .......++..|+|||.+.+...++.++||||+|+++|||++|+.||............ .              
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07852         162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK  241 (337)
T ss_pred             ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence            21   12223457888999998766666889999999999999999999999765432211000 0              


Q ss_pred             ---HH---------------H--HhhhccccceeecccccccccccccC
Q 002321          907 ---LE---------------E--HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       907 ---~~---------------~--~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                         ..               .  .-.+..+.+++.+||..||.+||+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~  290 (337)
T cd07852         242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAE  290 (337)
T ss_pred             hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHH
Confidence               00               0  00235577899999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1.4e-31  Score=289.62  Aligned_cols=239  Identities=25%  Similarity=0.352  Sum_probs=191.6

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-CCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      |+..+.||+|+||+||+|+.. +++.||||++.............+|+..+++++ |+|++++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            355678999999999999986 478999999865433233345567999999998 999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                       +|++.+++.... ...+++.++..++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||.+........   .
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  155 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---Y  155 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---c
Confidence             889999887654 23489999999999999999999999999999999999999999999999999976543221   1


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH-----------H------------
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT-----------W------------  906 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~-----------~------------  906 (936)
                      ....++..|+|||++.....++.++|+||||+++|||++|+.||............           +            
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07830         156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF  235 (283)
T ss_pred             CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence            23456778999998866666889999999999999999999999765432111000           0            


Q ss_pred             ---------HH--HHhhhccccceeecccccccccccccC
Q 002321          907 ---------LE--EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       907 ---------~~--~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                               ..  .......+.+++.+||..||.+||+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~  275 (283)
T cd07830         236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTAS  275 (283)
T ss_pred             cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHH
Confidence                     00  011236688999999999999999853

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=2.2e-31  Score=282.59  Aligned_cols=236  Identities=28%  Similarity=0.434  Sum_probs=195.4

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      |+..+.||+|++|.||++... +++.|++|++..... ...+.+.+|++++++++|++++++++++......++++||++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            456678999999999999986 688999999965543 356789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                      +++|.+++....  ..+++..+..++.|++.|++|||+.+++||||+|+||++++++.++|+|||.+........   ..
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~  155 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RN  155 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---cc
Confidence            999999987653  2389999999999999999999999999999999999999999999999999976643321   23


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HHHHH-H-----HHhhhccccceeecc
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVTWL-E-----EHWKKAEWRNVSMRS  923 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~~~-~-----~~~~~~~~~~~~~~~  923 (936)
                      ...++..|+|||... ...++.++||||+|+++|+|++|+.||...+..... ..... .     ....+..+.+++.+|
T Consensus       156 ~~~~~~~~~~PE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  234 (253)
T cd05122         156 TMVGTPYWMAPEVIN-GKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKC  234 (253)
T ss_pred             ceecCCcccCHHHHc-CCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHH
Confidence            455778899999884 445789999999999999999999999877432211 11100 0     111145678999999


Q ss_pred             ccccccccccc
Q 002321          924 CKGSSRQRRRF  934 (936)
Q Consensus       924 l~~~p~~Rp~f  934 (936)
                      |..||.+||+.
T Consensus       235 l~~~p~~R~t~  245 (253)
T cd05122         235 LQKNPEKRPTA  245 (253)
T ss_pred             ccCChhhCCCH
Confidence            99999999985

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=1.3e-31  Score=291.11  Aligned_cols=241  Identities=16%  Similarity=0.157  Sum_probs=175.9

Q ss_pred             ccccCCCcccccCceEEEEEEeCC----CcEEEEEEeeccCccchH----------HHHHHHHHHHHcCCCCCcceeeeE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQ----------EDFEREVKKLGKVRHPNLVTLEGY  755 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~----------~~~~~E~~~l~~l~h~niv~l~~~  755 (936)
                      ..|...+.||+|+||.||+|...+    +..+|+|+..........          .....+...+..++|+++++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            457788899999999999999764    345666654322211100          112233445667789999999998


Q ss_pred             EEeCC----eeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEE
Q 002321          756 YWTQS----LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKV  831 (936)
Q Consensus       756 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl  831 (936)
                      +....    ..++++|++ ..++.+.+....   ..++..+..++.|++.|++|||+++|+||||||+|||++.++.++|
T Consensus        92 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKL-VENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             eeEecCCceEEEEEEehh-ccCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence            76543    346788877 356666665432   2567888899999999999999999999999999999999999999


Q ss_pred             eeccCccccCCCccc-----cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhH----HH
Q 002321          832 GDYGLARLLPMLDRY-----VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMW----WF  902 (936)
Q Consensus       832 ~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~----~~  902 (936)
                      +|||+|+.+......     .......||+.|+|||.. .+..++.++||||+||++|||++|+.||.......    ..
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~-~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~  246 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAH-NGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA  246 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHh-CCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence            999999866322111     112234689999999988 45578999999999999999999999998763211    11


Q ss_pred             HHHHH--------HHHhhhccccceeecccccccccccccC
Q 002321          903 SVTWL--------EEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       903 ~~~~~--------~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..++.        .....+..+.+++..||..+|.+||+|+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~  287 (294)
T PHA02882        247 KCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYD  287 (294)
T ss_pred             HHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHH
Confidence            11111        1123346788999999999999999985

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.97  E-value=1.8e-31  Score=291.78  Aligned_cols=242  Identities=22%  Similarity=0.285  Sum_probs=189.7

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC-------
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS-------  760 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  760 (936)
                      ..|+..+.||+|+||.||+|+.+ +|+.||||+++.... ......+.+|++++++++||||+++++++.+..       
T Consensus         7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~   86 (302)
T cd07864           7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK   86 (302)
T ss_pred             hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence            34677889999999999999986 588999999965432 223456788999999999999999999987654       


Q ss_pred             ---eeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCc
Q 002321          761 ---LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLA  837 (936)
Q Consensus       761 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  837 (936)
                         ..++|+||+++ ++.+.+....  ..+++..+..++.|++.||+|||+.+|+||||||+||++++++.+||+|||.+
T Consensus        87 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~  163 (302)
T cd07864          87 DKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA  163 (302)
T ss_pred             cCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence               67999999975 7777766532  24899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH-HH----------
Q 002321          838 RLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV-TW----------  906 (936)
Q Consensus       838 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~-~~----------  906 (936)
                      ........ .......++..|+|||.+.+...++.++||||+||++|||++|+.||........... ..          
T Consensus       164 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (302)
T cd07864         164 RLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW  242 (302)
T ss_pred             ccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            76643221 1112233566799999885555678999999999999999999999976543211100 00          


Q ss_pred             -----------------------HHHHhhhccccceeecccccccccccccC
Q 002321          907 -----------------------LEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       907 -----------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                                             ......+.+..+++.+||..||.+||++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~  294 (302)
T cd07864         243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAE  294 (302)
T ss_pred             ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHH
Confidence                                   00011346678889999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=1.4e-31  Score=293.86  Aligned_cols=241  Identities=22%  Similarity=0.273  Sum_probs=186.3

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc-hHHHHHHHHHHHHcCCCCCcceeeeEEEeCC--------
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLVTLEGYYWTQS--------  760 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  760 (936)
                      .|+..++||+|+||.||+|+.. +++.||||++....... ....+.+|++++++++||||+++++++....        
T Consensus        13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   92 (310)
T cd07865          13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG   92 (310)
T ss_pred             heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence            4677788999999999999976 58999999986543222 2345678999999999999999999987654        


Q ss_pred             eeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCcccc
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL  840 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  840 (936)
                      ..++||||+. +++.+++....  ..+++.++..++.|++.||+|||+++++|+||||+||+++.++.+||+|||++...
T Consensus        93 ~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  169 (310)
T cd07865          93 SFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF  169 (310)
T ss_pred             eEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence            3489999995 58888776543  23899999999999999999999999999999999999999999999999999765


Q ss_pred             CCCccc--cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHH-HHH-----------
Q 002321          841 PMLDRY--VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS-VTW-----------  906 (936)
Q Consensus       841 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~-~~~-----------  906 (936)
                      ......  .......++..|+|||.+.+...++.++||||+|+++|||++|+.||...+...... ...           
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (310)
T cd07865         170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP  249 (310)
T ss_pred             cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            432211  111233467789999988655567889999999999999999999997654321110 000           


Q ss_pred             --------------------HH----HHhhhccccceeeccccccccccccc
Q 002321          907 --------------------LE----EHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       907 --------------------~~----~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                          ..    .........+++.+||..||.+||+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~  301 (310)
T cd07865         250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDA  301 (310)
T ss_pred             cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCH
Confidence                                00    00112344578999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=1.3e-31  Score=294.52  Aligned_cols=237  Identities=14%  Similarity=0.180  Sum_probs=182.7

Q ss_pred             cccccCceEEEEEEeCCCcEEEEEEeeccC-ccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCCChh
Q 002321          697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSS-LVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLH  775 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  775 (936)
                      .+|.|+++.||+++. +++.||||++.... .....+.+.+|++++++++|+||+++++++.+....+++|||+++|++.
T Consensus         9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   87 (314)
T cd08216           9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE   87 (314)
T ss_pred             hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence            344455555555544 58999999997652 2344678999999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc-----ccccc
Q 002321          776 KHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR-----YVLSS  850 (936)
Q Consensus       776 ~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~  850 (936)
                      +++..... ..+++.....++.|+++||+|||+++|+||||||+||+++.++.+|++|||.+........     .....
T Consensus        88 ~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~  166 (314)
T cd08216          88 DLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK  166 (314)
T ss_pred             HHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence            99986432 2388889999999999999999999999999999999999999999999998865532211     11122


Q ss_pred             cccCcccccCcccccCc-ccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH------------------------
Q 002321          851 KIQSALGYMAPEFACRT-VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT------------------------  905 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~------------------------  905 (936)
                      ...++..|+|||++... ..++.++||||+||++|||++|+.||............                        
T Consensus       167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
T cd08216         167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQS  246 (314)
T ss_pred             cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcc
Confidence            34466789999988443 35788999999999999999999999865432111000                        


Q ss_pred             --------------HHHHHhhhccccceeecccccccccccccC
Q 002321          906 --------------WLEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       906 --------------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                                    .......+..+.+++.+||..||.+||+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~  290 (314)
T cd08216         247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSAS  290 (314)
T ss_pred             cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHH
Confidence                          000111224567899999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.97  E-value=2.3e-31  Score=288.46  Aligned_cols=239  Identities=23%  Similarity=0.323  Sum_probs=190.7

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccC-ccchHHHHHHHHHHHHcCCCCCcceeeeEEEeC--CeeEEEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSS-LVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ--SLQLLIYE  767 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  767 (936)
                      |+..++||+|+||.||+|+.. +++.||+|+++... .......+.+|++++++++|+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            345678999999999999977 48899999997653 223346788999999999999999999999887  78999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |++ ++|.+++....  ..+++.++..++.|++.|++|||+.+++|+||||+||++++++.+||+|||.+........ .
T Consensus        81 ~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~  156 (287)
T cd07840          81 YMD-HDLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-A  156 (287)
T ss_pred             ccc-ccHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-c
Confidence            996 58988886542  2489999999999999999999999999999999999999999999999999986643321 1


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH---------------------
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW---------------------  906 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~---------------------  906 (936)
                      ......++..|+|||.+.+...++.++||||||+++|||++|+.||.............                     
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE  236 (287)
T ss_pred             cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence            12233456789999987555568899999999999999999999998765421111000                     


Q ss_pred             --------------HHHHhhhccccceeeccccccccccccc
Q 002321          907 --------------LEEHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       907 --------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                    ......+....+++.+||..+|.+||+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~  278 (287)
T cd07840         237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA  278 (287)
T ss_pred             hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCH
Confidence                          0001114556778999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=1.8e-31  Score=290.68  Aligned_cols=241  Identities=23%  Similarity=0.337  Sum_probs=189.0

Q ss_pred             cccccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ...|+..+.||+|+||.||+|++.+ ++.||||+++.........++.+|+.++.+. +|+||+++++++.+....++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3456778899999999999999875 8999999997654444456677788777777 4999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ-SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      ||++ +++.++......  .+++..+..++.|+++|++|||+ .+|+||||+|+||++++++.+||+|||++..+.....
T Consensus        94 e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          94 ELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             eccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence            9984 577777655332  48899999999999999999997 5999999999999999999999999999876533221


Q ss_pred             ccccccccCcccccCcccccCc---ccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH---HH-----hhhc
Q 002321          846 YVLSSKIQSALGYMAPEFACRT---VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE---EH-----WKKA  914 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~---~~-----~~~~  914 (936)
                         .....++..|+|||.+...   ..++.++||||+|+++|||++|+.||...............   +.     -.+.
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (296)
T cd06618         171 ---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSP  247 (296)
T ss_pred             ---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCH
Confidence               1233467789999988433   23788999999999999999999999764332111111111   01     1234


Q ss_pred             cccceeecccccccccccccC
Q 002321          915 EWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       915 ~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+++.+||..||.+||+++
T Consensus       248 ~l~~li~~~l~~~p~~Rp~~~  268 (296)
T cd06618         248 DFCSFVDLCLTKDHRKRPKYR  268 (296)
T ss_pred             HHHHHHHHHccCChhhCCCHH
Confidence            578999999999999999874

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.97  E-value=1.8e-31  Score=289.52  Aligned_cols=234  Identities=22%  Similarity=0.328  Sum_probs=190.2

Q ss_pred             cCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          693 NKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       693 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      +...+||+|+||.||++... +++.||||++.... ......+.+|+.++++++|+||+++++++...+..++||||+++
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  101 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  101 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence            34457999999999999875 68999999885432 23456788999999999999999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      ++|.+++...    .+++.....++.|++.|++|||+.|++||||||+||++++++.++|+|||.+.......  .....
T Consensus       102 ~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~  175 (292)
T cd06657         102 GALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKS  175 (292)
T ss_pred             CcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccc
Confidence            9999987543    27889999999999999999999999999999999999999999999999987553221  12233


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHH-HHH-HHHH-----hhhccccceeeccc
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS-VTW-LEEH-----WKKAEWRNVSMRSC  924 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~-~~~-~~~~-----~~~~~~~~~~~~~l  924 (936)
                      ..+++.|+|||.. ....++.++|+||+|+++|||++|+.||.......... ... .++.     ..+..+.+++.+||
T Consensus       176 ~~~~~~y~~pE~~-~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  254 (292)
T cd06657         176 LVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLL  254 (292)
T ss_pred             cccCccccCHHHh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHH
Confidence            5578889999987 44567899999999999999999999998765432211 111 1111     12456778899999


Q ss_pred             cccccccccc
Q 002321          925 KGSSRQRRRF  934 (936)
Q Consensus       925 ~~~p~~Rp~f  934 (936)
                      ..+|.+||+.
T Consensus       255 ~~~P~~R~~~  264 (292)
T cd06657         255 VRDPAQRATA  264 (292)
T ss_pred             hCCcccCcCH
Confidence            9999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=1.2e-31  Score=296.18  Aligned_cols=201  Identities=26%  Similarity=0.325  Sum_probs=163.6

Q ss_pred             Cccccc--CceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          696 CELGRG--GFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       696 ~~iG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      .+||+|  +||+||+|++. +|+.||||++...... +..+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  99999999975 6899999998654322 3346789999999999999999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc-----
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY-----  846 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-----  846 (936)
                      +++.+++..... ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.++++||+.+.........     
T Consensus        84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence            999999876532 23888999999999999999999999999999999999999999999999865433211110     


Q ss_pred             cccccccCcccccCcccccCc-ccCCchhhHHHHHHHHHHHHcCCCCCCccc
Q 002321          847 VLSSKIQSALGYMAPEFACRT-VKITDKCDVYGFGVLVLEVVTGKRPLSTWK  897 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~  897 (936)
                      .......++..|+|||++.+. ..++.++||||+||++|||++|+.||....
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  214 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML  214 (328)
T ss_pred             cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence            011112345569999998543 347899999999999999999999997654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=6.1e-33  Score=291.32  Aligned_cols=234  Identities=24%  Similarity=0.377  Sum_probs=189.9

Q ss_pred             CCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          694 KDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       694 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      .++.+|.|-||+||-|+++ +|+.||||++.+..+. +.+..++.|++|++.++||.||.+...|+..+.+++|||-+ .
T Consensus       568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~  646 (888)
T KOG4236|consen  568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-H  646 (888)
T ss_pred             hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-c
Confidence            4568999999999999976 6999999999765554 44678899999999999999999999999999999999999 5


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC---CCeEEeeccCccccCCCccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS---GEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      |+..+.+-....+ .+++....-++.||+.||.|||.++|||+|+||+|||+...   ..+||||||+|+.+++   ...
T Consensus       647 GDMLEMILSsEkg-RL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ksF  722 (888)
T KOG4236|consen  647 GDMLEMILSSEKG-RLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KSF  722 (888)
T ss_pred             chHHHHHHHhhcc-cchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch---hhh
Confidence            6666666544333 38888888899999999999999999999999999999653   4799999999999864   334


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchh--HHHHHHHHHH--Hh--hhccccceeec
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM--WWFSVTWLEE--HW--KKAEWRNVSMR  922 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~--~~~~~~~~~~--~~--~~~~~~~~~~~  922 (936)
                      .....|||.|.|||++ ..+.|...-||||.||++|-=++|..||...++.  +++...+.+|  .|  .+....|+|..
T Consensus       723 RrsVVGTPAYLaPEVL-rnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~  801 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVL-RNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINN  801 (888)
T ss_pred             hhhhcCCccccCHHHH-hhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence            5678899999999999 5667899999999999999999999999877653  3333333221  22  22445566677


Q ss_pred             ccccccccccc
Q 002321          923 SCKGSSRQRRR  933 (936)
Q Consensus       923 ~l~~~p~~Rp~  933 (936)
                      .+++..++|.+
T Consensus       802 LLqVkm~kRys  812 (888)
T KOG4236|consen  802 LLQVKMRKRYS  812 (888)
T ss_pred             HHHHHHHHhcc
Confidence            88888866654

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=2.5e-31  Score=292.18  Aligned_cols=237  Identities=28%  Similarity=0.388  Sum_probs=190.1

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||.||+|+.. ++..||+|++......  +....+.+|++++++++|+|++++++++.+....++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            34677788999999999999975 5889999998644222  23457889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||++ |++.+.+....  ..+++.++..++.|++.|+.|||+.+++||||+|+||+++.++.++|+|||++......   
T Consensus       105 e~~~-g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         105 EYCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             eCCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence            9996 57877765432  23899999999999999999999999999999999999999999999999998754321   


Q ss_pred             cccccccCcccccCccccc--CcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HHHHHH-----HHhhhccccc
Q 002321          847 VLSSKIQSALGYMAPEFAC--RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVTWLE-----EHWKKAEWRN  918 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~~~~-----~~~~~~~~~~  918 (936)
                         ....+++.|+|||.+.  ....++.++||||+||++|||++|+.||...+..... ......     ....++.+++
T Consensus       179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  255 (317)
T cd06635         179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN  255 (317)
T ss_pred             ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHH
Confidence               2345778899999873  2345788999999999999999999999776542211 111100     1122345789


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..+|.+||+++
T Consensus       256 li~~~l~~~p~~Rpt~~  272 (317)
T cd06635         256 FVDSCLQKIPQDRPTSE  272 (317)
T ss_pred             HHHHHccCCcccCcCHH
Confidence            99999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.4e-31  Score=283.35  Aligned_cols=238  Identities=23%  Similarity=0.330  Sum_probs=187.9

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccC----ccchHHHHHHHHHHHHcCCCCCcceeeeEEEeC--CeeEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSS----LVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ--SLQLL  764 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  764 (936)
                      |+..+.||+|+||.||+|+.. +++.||+|++....    .......+.+|++++++++|+||+++++++.+.  ...++
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (264)
T cd06653           4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI   83 (264)
T ss_pred             eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence            567789999999999999975 58999999875321    123346788999999999999999999998764  45789


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      |+||+++++|.+++.....   +++....+++.|++.|++|||+.+++|+||||+||+++.++.++|+|||+++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          84 FVEYMPGGSIKDQLKAYGA---LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEeCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence            9999999999999876432   7888999999999999999999999999999999999999999999999997653211


Q ss_pred             c-ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH------HHhhhcccc
Q 002321          845 R-YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE------EHWKKAEWR  917 (936)
Q Consensus       845 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~  917 (936)
                      . ........++..|+|||... +..++.++||||+||++|||++|+.||...............      +....+...
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~  239 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVIS-GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACR  239 (264)
T ss_pred             ccCccccccCCcccccCHhhhc-CCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHH
Confidence            1 11112345788899999884 446789999999999999999999999876543222111110      122335678


Q ss_pred             ceeeccccccccccccc
Q 002321          918 NVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f  934 (936)
                      +++.+||. +|..||+.
T Consensus       240 ~~i~~~l~-~~~~r~~~  255 (264)
T cd06653         240 DFLKQIFV-EEKRRPTA  255 (264)
T ss_pred             HHHHHHhc-CcccCccH
Confidence            88889998 57888874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=3.5e-31  Score=283.47  Aligned_cols=220  Identities=24%  Similarity=0.247  Sum_probs=176.2

Q ss_pred             ccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEEEecCCCChh
Q 002321          698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIYEFVSGGSLH  775 (936)
Q Consensus       698 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  775 (936)
                      ||+|+||.||+++.+ +++.+|+|++.......      .|+.....+ +|+||+++++++...+..++||||+++++|.
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~   97 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLF   97 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHH
Confidence            599999999999965 58889999986542211      122222222 7999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-CeEEeeccCccccCCCccccccccccC
Q 002321          776 KHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG-EPKVGDYGLARLLPMLDRYVLSSKIQS  854 (936)
Q Consensus       776 ~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~  854 (936)
                      +++....   .+++.++..++.|+++|++|||+.+++||||||+||+++.++ .++|+|||+++.....      ....+
T Consensus        98 ~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~~  168 (267)
T PHA03390         98 DLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYDG  168 (267)
T ss_pred             HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccCCC
Confidence            9997654   389999999999999999999999999999999999999998 9999999998765321      22357


Q ss_pred             cccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HH----HHhhhccccceeeccccc
Q 002321          855 ALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LE----EHWKKAEWRNVSMRSCKG  926 (936)
Q Consensus       855 ~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~----~~~~~~~~~~~~~~~l~~  926 (936)
                      +..|+|||++. ...++.++||||+||++|||++|+.||............+    .+    +...++.+.+++.+||..
T Consensus       169 ~~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  247 (267)
T PHA03390        169 TLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKY  247 (267)
T ss_pred             CCcccChhhhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhcc
Confidence            78899999984 4568899999999999999999999998654322111111    00    112456788899999999


Q ss_pred             ccccccc
Q 002321          927 SSRQRRR  933 (936)
Q Consensus       927 ~p~~Rp~  933 (936)
                      +|.+||.
T Consensus       248 ~p~~R~~  254 (267)
T PHA03390        248 NINYRLT  254 (267)
T ss_pred             ChhhCCc
Confidence            9999994

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=3.2e-31  Score=293.99  Aligned_cols=237  Identities=22%  Similarity=0.273  Sum_probs=187.8

Q ss_pred             CCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccch-------------HHHHHHHHHHHHcCCCCCcceeeeEEEeC
Q 002321          694 KDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKS-------------QEDFEREVKKLGKVRHPNLVTLEGYYWTQ  759 (936)
Q Consensus       694 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-------------~~~~~~E~~~l~~l~h~niv~l~~~~~~~  759 (936)
                      ..+.||+|+||+||+|+.. +++.||||+++.......             ...+.+|++++++++|+||+++++++...
T Consensus        13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   92 (335)
T PTZ00024         13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG   92 (335)
T ss_pred             hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence            4567999999999999976 689999999865432210             12577899999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          760 SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       760 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      ...++||||++ |+|.+++....   .+++.....++.|++.||+|||+.|++||||||+||+++.++.++++|||+++.
T Consensus        93 ~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~  168 (335)
T PTZ00024         93 DFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARR  168 (335)
T ss_pred             CcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceee
Confidence            99999999996 68999886543   388999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCc------------cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH
Q 002321          840 LPMLD------------RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL  907 (936)
Q Consensus       840 ~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~  907 (936)
                      .....            .........+++.|+|||.+.+...++.++||||+||++|||++|+.||...+..........
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~  248 (335)
T PTZ00024        169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE  248 (335)
T ss_pred             cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            54110            011112234577899999886555678999999999999999999999987664322111000


Q ss_pred             -----------H---------------------HHhhhccccceeeccccccccccccc
Q 002321          908 -----------E---------------------EHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       908 -----------~---------------------~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                 .                     ....+.+..+++.+||..+|.+||+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~  307 (335)
T PTZ00024        249 LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA  307 (335)
T ss_pred             HhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCH
Confidence                       0                     01123556789999999999999975

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=3.1e-31  Score=287.91  Aligned_cols=238  Identities=24%  Similarity=0.307  Sum_probs=187.8

Q ss_pred             ccCCCcccccCceEEEEEEeC----CCcEEEEEEeeccCc---cchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSL---VKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  763 (936)
                      |+..+.||+|+||.||+|+..    +|+.||+|+++....   ....+.+.+|+++++++ +|+||+++++++..+...+
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            456678999999999999863    688999999865332   12346788999999999 5899999999999888899


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      +||||+++++|.+++....   .+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++.....
T Consensus        82 lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  158 (290)
T cd05613          82 LILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence            9999999999999987643   3788899999999999999999999999999999999999999999999999765322


Q ss_pred             ccccccccccCcccccCcccccCc-ccCCchhhHHHHHHHHHHHHcCCCCCCccchh--HHHHHHHH------HHHhhhc
Q 002321          844 DRYVLSSKIQSALGYMAPEFACRT-VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM--WWFSVTWL------EEHWKKA  914 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~--~~~~~~~~------~~~~~~~  914 (936)
                      . ........++..|+|||..... ..++.++||||+|+++|+|++|+.||......  ........      .+...+.
T Consensus       159 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (290)
T cd05613         159 E-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA  237 (290)
T ss_pred             c-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCH
Confidence            1 1112234578889999988533 24678999999999999999999999643221  01111100      0111335


Q ss_pred             cccceeecccccccccccc
Q 002321          915 EWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       915 ~~~~~~~~~l~~~p~~Rp~  933 (936)
                      .+.+++.+||..||.+||+
T Consensus       238 ~~~~ll~~~l~~~p~~R~~  256 (290)
T cd05613         238 LAKDIIQRLLMKDPKKRLG  256 (290)
T ss_pred             HHHHHHHHHhcCCHHHhcC
Confidence            5788999999999999974

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=2.9e-31  Score=287.12  Aligned_cols=239  Identities=21%  Similarity=0.263  Sum_probs=192.9

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      |+..+.||+|++|.||+|+.. +++.+|+|+++..... .....+.+|++++++++|+||+++++++.++...++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            345678999999999999975 6889999998655432 23567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      + +++.+++....  ..+++.++..++.|++.|++|||+.+++|+||||+||+++.++.++|+|||.+.......  ...
T Consensus        81 ~-~~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~  155 (283)
T cd05118          81 D-TDLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPY  155 (283)
T ss_pred             C-CCHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccc
Confidence            6 58888887643  238999999999999999999999999999999999999999999999999997664332  112


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH----------------------
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL----------------------  907 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~----------------------  907 (936)
                      ....++..|+|||...+...++.++||||+|+++|+|++|+.||...+..........                      
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF  235 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence            2345677899999885554789999999999999999999999976554221100000                      


Q ss_pred             ------------HHHhhhccccceeecccccccccccccC
Q 002321          908 ------------EEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       908 ------------~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                                  ...-.+.++++++.+||..||.+||+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~  275 (283)
T cd05118         236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAE  275 (283)
T ss_pred             hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHH
Confidence                        0011346788999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=3e-31  Score=290.40  Aligned_cols=238  Identities=29%  Similarity=0.406  Sum_probs=190.3

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  765 (936)
                      +..|+..+.||+|+||.||+|+.. +++.||+|.+.....  .....++.+|+++++.++|+|++++++++......++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            344667788999999999999976 578999999864322  22345688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      |||+. |++.+.+....  ..+++.++..++.|++.|++|||+.+++||||||+||+++.++.++++|||++......  
T Consensus        94 ~e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          94 MEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EEccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            99996 68877775432  23789999999999999999999999999999999999999999999999998754321  


Q ss_pred             ccccccccCcccccCccccc--CcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HHHH-----HHHHhhhcccc
Q 002321          846 YVLSSKIQSALGYMAPEFAC--RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVTW-----LEEHWKKAEWR  917 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~~-----~~~~~~~~~~~  917 (936)
                          ....+++.|+|||.+.  ....++.++||||+||++|||++|..||...+..... ....     ......+..++
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR  244 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHH
Confidence                2345678899999874  2345788999999999999999999999776543211 1110     01112345688


Q ss_pred             ceeecccccccccccccC
Q 002321          918 NVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++.+||..+|.+||+++
T Consensus       245 ~li~~cl~~~P~~Rp~~~  262 (308)
T cd06634         245 NFVDSCLQKIPQDRPTSE  262 (308)
T ss_pred             HHHHHHhhCCcccCCCHH
Confidence            999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=1.8e-31  Score=295.75  Aligned_cols=241  Identities=19%  Similarity=0.293  Sum_probs=189.7

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEe----CCeeE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWT----QSLQL  763 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  763 (936)
                      ..|+..+.||+|+||.||+|+.. +|+.||+|++..... ....+.+.+|+.++++++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            34667788999999999999976 589999999865432 2335677889999999999999999998753    34678


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      +||||+. ++|.+++.....   +++..+..++.|++.||+|||+.+++||||||+||++++++.+||+|||++......
T Consensus        85 lv~e~~~-~~l~~~~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  160 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQP---LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS  160 (334)
T ss_pred             EEEehhh-hhHHHHhccCCC---CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence            9999995 689988865433   899999999999999999999999999999999999999999999999999765332


Q ss_pred             ccc--cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH-----------------
Q 002321          844 DRY--VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV-----------------  904 (936)
Q Consensus       844 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~-----------------  904 (936)
                      ...  .......++..|+|||.+.....++.++||||+||++|||++|+.||...+.......                 
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~  240 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG  240 (334)
T ss_pred             CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence            211  1112345778899999875555689999999999999999999999977543211100                 


Q ss_pred             ----H-HHH--H-----------Hhhhccccceeeccccccccccccc
Q 002321          905 ----T-WLE--E-----------HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       905 ----~-~~~--~-----------~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                          . ...  +           .-.+.++.+++.+||..||.+||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~  288 (334)
T cd07855         241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITV  288 (334)
T ss_pred             hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCH
Confidence                0 000  0           0124667889999999999999985

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.6e-33  Score=290.56  Aligned_cols=237  Identities=22%  Similarity=0.309  Sum_probs=202.4

Q ss_pred             ccCCCcccccCceEEEEEEeCCC-cEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLRDG-RPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ++....||-|+||.|-.+..... ..+|+|++++....  +..+.+..|-.+|.+.+.|.||++|-.|.++...|+.||-
T Consensus       422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa  501 (732)
T KOG0614|consen  422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA  501 (732)
T ss_pred             hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence            45566799999999999887643 34899998766554  3456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      |-||.++..++..+.   ++.....-++..++.|++|||++|||+||+||+|+++|.+|-+||.|||+|+.+....   .
T Consensus       502 ClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~---K  575 (732)
T KOG0614|consen  502 CLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR---K  575 (732)
T ss_pred             hcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC---c
Confidence            999999999987654   7888888889999999999999999999999999999999999999999999886443   3


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH------HHHHHHhhhccccceeec
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV------TWLEEHWKKAEWRNVSMR  922 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~  922 (936)
                      ....+|||.|.|||++. .+.++.++|.||+|+++|||++|.+||...+++..+..      .+..|........++|.+
T Consensus       576 TwTFcGTpEYVAPEIIL-nKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~  654 (732)
T KOG0614|consen  576 TWTFCGTPEYVAPEIIL-NKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKK  654 (732)
T ss_pred             eeeecCCcccccchhhh-ccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHH
Confidence            45678999999999985 44679999999999999999999999999998765532      223355566777889999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      .|..+|.+|-.+|
T Consensus       655 LCr~~P~ERLG~~  667 (732)
T KOG0614|consen  655 LCRDNPTERLGYQ  667 (732)
T ss_pred             HHhcCcHhhhccc
Confidence            9999999998765

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=9.8e-32  Score=290.30  Aligned_cols=239  Identities=19%  Similarity=0.240  Sum_probs=196.4

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCC-CCCcceeeeEEEeCCeeEEEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      |...+.||+|+||.||+|+.+ +++.||+|++.....  ....+.+.+|+.++++++ |+||+++++++.+.+..++|||
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd05581           3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE   82 (280)
T ss_pred             ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence            566778999999999999976 689999999865332  223467889999999998 9999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc--
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR--  845 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--  845 (936)
                      |+++++|.+++.+..   .+++..+..++.|++.|++|||+.|++|+||+|+||+++.++.++++|||++........  
T Consensus        83 ~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          83 YAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence            999999999998754   389999999999999999999999999999999999999999999999999976543221  


Q ss_pred             ----------------ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH---
Q 002321          846 ----------------YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW---  906 (936)
Q Consensus       846 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~---  906 (936)
                                      ........++..|+|||... ...++.++||||+|++++++++|+.||...+.........   
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  238 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN-EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE  238 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhC-CCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC
Confidence                            12223345678899999884 4468899999999999999999999998876533221111   


Q ss_pred             -HHHHhhhccccceeeccccccccccccc
Q 002321          907 -LEEHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       907 -~~~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                       ..+...++.+.+++.+||..+|.+||++
T Consensus       239 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~  267 (280)
T cd05581         239 YSFPPNFPPDAKDLIEKLLVLDPQDRLGV  267 (280)
T ss_pred             CCCCCccCHHHHHHHHHHhcCCHhhCCCc
Confidence             1112224678899999999999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=2.2e-31  Score=283.42  Aligned_cols=238  Identities=22%  Similarity=0.360  Sum_probs=195.4

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      |+..++||+|+||.||+++.. +++.+|+|++...... ....++.+|++++++++|+||+++++++.+....++||||+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA   81 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence            456678999999999999865 6889999998754332 33567789999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          770 SGGSLHKHLHEGSG-GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       770 ~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      ++++|.+++.+... ...+++..+..++.|++.|++|||+.|++|+||+|+||+++.++.+|++|||++......    .
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~----~  157 (256)
T cd08530          82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----M  157 (256)
T ss_pred             CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC----C
Confidence            99999999876322 234889999999999999999999999999999999999999999999999999776432    1


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH------HHhhhccccceeec
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE------EHWKKAEWRNVSMR  922 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~  922 (936)
                      .....+++.|+|||.. ....++.++|+||+|+++|||++|+.||...+....... ...      +...+.++++++.+
T Consensus       158 ~~~~~~~~~~~~Pe~~-~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~  235 (256)
T cd08530         158 AKTQIGTPHYMAPEVW-KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK-VQRGKYPPIPPIYSQDLQNFIRS  235 (256)
T ss_pred             cccccCCccccCHHHH-CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HhcCCCCCCchhhCHHHHHHHHH
Confidence            2234577889999988 455688899999999999999999999988765322211 111      11234668899999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      ||..+|.+||+++
T Consensus       236 ~l~~~p~~Rp~~~  248 (256)
T cd08530         236 MLQVKPKLRPNCD  248 (256)
T ss_pred             HcCCCcccCCCHH
Confidence            9999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=8.4e-31  Score=287.39  Aligned_cols=237  Identities=26%  Similarity=0.373  Sum_probs=189.3

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..+...++||+|+||+||+|+.. +++.||+|++......  ...+.+.+|++++++++|+|++++++++.+....++||
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  100 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM  100 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence            44566678999999999999975 5889999998654322  23456889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+. |++.+++....  ..+++.++..++.|++.|++|||+.|++|+||||+||+++.++.+||+|||++.....    
T Consensus       101 e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----  173 (313)
T cd06633         101 EYCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----  173 (313)
T ss_pred             ecCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence            9995 67877776433  2388999999999999999999999999999999999999999999999999864321    


Q ss_pred             cccccccCcccccCccccc--CcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HHHHHH-H----Hhhhccccc
Q 002321          847 VLSSKIQSALGYMAPEFAC--RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVTWLE-E----HWKKAEWRN  918 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~~~~-~----~~~~~~~~~  918 (936)
                        .....++..|+|||++.  ....++.++||||+||++|||++|..||...+..... ...... +    ...+..+++
T Consensus       174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  251 (313)
T cd06633         174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRG  251 (313)
T ss_pred             --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHH
Confidence              12345778899999873  2345788999999999999999999999776542211 111111 1    112245889


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..+|.+||++.
T Consensus       252 li~~~l~~~P~~Rp~~~  268 (313)
T cd06633         252 FVDYCLQKIPQERPASA  268 (313)
T ss_pred             HHHHHccCChhhCcCHH
Confidence            99999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=4.9e-32  Score=312.19  Aligned_cols=238  Identities=26%  Similarity=0.374  Sum_probs=181.8

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeC---------
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ---------  759 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  759 (936)
                      ..|+..+.||+|+||.||+++.+ ||+.||||++...........+.+|+..+++++|||||+++..+.+.         
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            45677788999999999999977 89999999997765445567889999999999999999987652100         


Q ss_pred             --------------------------------------------------------------------------------
Q 002321          760 --------------------------------------------------------------------------------  759 (936)
Q Consensus       760 --------------------------------------------------------------------------------  759 (936)
                                                                                                      
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             ------------------------------CeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 002321          760 ------------------------------SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS  809 (936)
Q Consensus       760 ------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~  809 (936)
                                                    ...||=||||+...+.++++++....  .....++++++|+.||+|+|+.
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~~  716 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHDQ  716 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHhC
Confidence                                          01356788998888888887765321  4677899999999999999999


Q ss_pred             CcccCCCCCCCEEEcCCCCeEEeeccCccccC----------------CCccccccccccCcccccCcccccCcc--cCC
Q 002321          810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP----------------MLDRYVLSSKIQSALGYMAPEFACRTV--KIT  871 (936)
Q Consensus       810 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~----------------~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~  871 (936)
                      |||||||||.||++|+++.|||+|||+|....                ........+...||.-|+|||++.+..  .|+
T Consensus       717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence            99999999999999999999999999998721                011111334566888899999986555  599


Q ss_pred             chhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-----HH---h--hhccccceeecccccccccccc
Q 002321          872 DKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-----EH---W--KKAEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       872 ~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-----~~---~--~~~~~~~~~~~~l~~~p~~Rp~  933 (936)
                      .|+||||+|||++||+.   ||.+ .|+.........     ..   +  ..+.-+.+|.+++..||++||+
T Consensus       797 ~KiDmYSLGIVlFEM~y---PF~T-sMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPt  864 (1351)
T KOG1035|consen  797 SKIDMYSLGIVLFEMLY---PFGT-SMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPT  864 (1351)
T ss_pred             chhhhHHHHHHHHHHhc---cCCc-hHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCC
Confidence            99999999999999996   4544 233222222111     01   1  1123356778899999999997

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=3.6e-31  Score=306.97  Aligned_cols=201  Identities=16%  Similarity=0.264  Sum_probs=155.7

Q ss_pred             ccccCCCcccccCceEEEEEEeCC--CcEEEEEEe--------------ec--cCccchHHHHHHHHHHHHcCCCCCcce
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRD--GRPVAIKKL--------------TV--SSLVKSQEDFEREVKKLGKVRHPNLVT  751 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~vavK~~--------------~~--~~~~~~~~~~~~E~~~l~~l~h~niv~  751 (936)
                      ..|+..++||+|+||+||+|..+.  +..+++|.+              ..  .........+++|+.++++++|+||++
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            457888899999999999987642  222222211              00  001122456889999999999999999


Q ss_pred             eeeEEEeCCeeEEEEEecCCCChhhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCe
Q 002321          752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSG--GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEP  829 (936)
Q Consensus       752 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~  829 (936)
                      +++++...+..++|+|++ ++++.+++.....  .......++.+++.|++.||+|||++||+||||||+|||++.++.+
T Consensus       228 l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~v  306 (501)
T PHA03210        228 IEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKI  306 (501)
T ss_pred             EeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE
Confidence            999999999999999999 4678777654321  1123456677899999999999999999999999999999999999


Q ss_pred             EEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCC
Q 002321          830 KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL  893 (936)
Q Consensus       830 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf  893 (936)
                      ||+|||+++.+..... .......|+..|+|||++. +..++.++||||+||++|||++|..|+
T Consensus       307 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        307 VLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILA-GDGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             EEEeCCCceecCcccc-cccccccCCcCCCCchhhc-CCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            9999999987643221 1223456899999999984 456899999999999999999987543

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=2.6e-31  Score=294.70  Aligned_cols=239  Identities=20%  Similarity=0.258  Sum_probs=188.1

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccC-ccchHHHHHHHHHHHHcCCCCCcceeeeEEEeC-----CeeE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSS-LVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ-----SLQL  763 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  763 (936)
                      .|...+.||+|+||.||+|+.. +++.||||++.... .......+.+|+.+++.++|+||+++++++...     ...+
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   85 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY   85 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence            3566778999999999999965 58999999986432 222345677899999999999999999988654     2469


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      +|+||+. ++|.+++....   .+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||+++.....
T Consensus        86 lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          86 IVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             EEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            9999995 78988887543   3899999999999999999999999999999999999999999999999999865432


Q ss_pred             ccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHH--------------------
Q 002321          844 DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS--------------------  903 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~--------------------  903 (936)
                      ..  ......++..|+|||.+.....++.++||||+||++|+|++|+.||...+......                    
T Consensus       162 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07858         162 GD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE  239 (337)
T ss_pred             cc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence            21  12234567789999987554568899999999999999999999997653211000                    


Q ss_pred             --HHHH-----------H--HHhhhccccceeecccccccccccccC
Q 002321          904 --VTWL-----------E--EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       904 --~~~~-----------~--~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                        ..+.           .  ..-.++++.+++.+||..+|.+||+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~  286 (337)
T cd07858         240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVE  286 (337)
T ss_pred             hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHH
Confidence              0000           0  011345567899999999999999863

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=3.9e-31  Score=295.30  Aligned_cols=199  Identities=23%  Similarity=0.302  Sum_probs=165.6

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccC-ccchHHHHHHHHHHHHcCCCCCcceeeeEEEeC------Ce
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSS-LVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ------SL  761 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  761 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||||++.... .......+.+|+.++++++|+||+++++++...      ..
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            45677789999999999999975 68999999986432 223345678899999999999999999988643      24


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .++||||++ ++|.+.+...     +++.++..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++...
T Consensus        96 ~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850          96 VYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             EEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence            689999995 6888877542     7888899999999999999999999999999999999999999999999998654


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM  898 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~  898 (936)
                      ...   ......++..|+|||.+. +..++.++||||+||++|+|++|+.||...+.
T Consensus       170 ~~~---~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~  222 (353)
T cd07850         170 TSF---MMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH  222 (353)
T ss_pred             CCC---CCCCCcccccccCHHHHh-CCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH
Confidence            321   122345678899999884 55789999999999999999999999976553

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=9.7e-31  Score=278.09  Aligned_cols=237  Identities=24%  Similarity=0.346  Sum_probs=194.9

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      |+..+.||+|++|.||+|+.. +++.||+|.+...... ...+.+.+|++++++++|+|++++++++.+....++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA   81 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence            456678999999999999876 5789999999765432 34567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++++|.+++....   .+++..+..++.|++.|+.|||+.|++||||||+||+++.++.++|+|||.+.........  .
T Consensus        82 ~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~  156 (254)
T cd06627          82 ENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--D  156 (254)
T ss_pred             CCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--c
Confidence            9999999987653   3899999999999999999999999999999999999999999999999999876433221  2


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HHH-HH---HHHhhhccccceeeccc
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVT-WL---EEHWKKAEWRNVSMRSC  924 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~-~~---~~~~~~~~~~~~~~~~l  924 (936)
                      ....++..|+|||.... ..++.++||||+|+++|+|++|+.||...+..... ... ..   .+...+..+++++.+||
T Consensus       157 ~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  235 (254)
T cd06627         157 ASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCF  235 (254)
T ss_pred             cccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHH
Confidence            33457888999998844 45789999999999999999999999876542111 110 00   01223467889999999


Q ss_pred             cccccccccc
Q 002321          925 KGSSRQRRRF  934 (936)
Q Consensus       925 ~~~p~~Rp~f  934 (936)
                      ..+|.+||+.
T Consensus       236 ~~~p~~R~~~  245 (254)
T cd06627         236 QKDPNLRPTA  245 (254)
T ss_pred             hCChhhCcCH
Confidence            9999999974

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=6.8e-33  Score=266.33  Aligned_cols=206  Identities=26%  Similarity=0.379  Sum_probs=170.3

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEe--------C
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWT--------Q  759 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  759 (936)
                      ..|+...+||+|.||+||+|+.+ +|++||+|++..+... .......+|++++..++|+|++.+++.|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34677788999999999999966 4788999987543322 224567899999999999999999998853        2


Q ss_pred             CeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          760 SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       760 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      ...++||++|+ .+|.-++....  ..++..++.+++.++..||.|+|...|+|||+||.|+|++.+|.+||+|||+|+.
T Consensus        97 ~t~ylVf~~ce-hDLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen   97 ATFYLVFDFCE-HDLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             ceeeeeHHHhh-hhHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence            35799999996 58888776532  2388999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCcccccc--ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch
Q 002321          840 LPMLDRYVLS--SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM  898 (936)
Q Consensus       840 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~  898 (936)
                      +...+.....  +...-|.+|++||.+.+.++|+++.|||+.||++.||++|.+-|++...
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte  234 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE  234 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH
Confidence            6543332222  2233488999999999999999999999999999999999998887543

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=6.2e-31  Score=280.15  Aligned_cols=241  Identities=23%  Similarity=0.386  Sum_probs=197.6

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      |+..+.||+|+||.||++... +++.||+|++...... ...+.+.+|++++++++|+|++++++.+......++|+||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~   81 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA   81 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence            456678999999999999976 5889999999765432 44577899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          770 SGGSLHKHLHEGS-GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       770 ~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      ++++|.+++.... ....+++.++..++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+.......  ..
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~  159 (258)
T cd08215          82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DL  159 (258)
T ss_pred             CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--ce
Confidence            9999999997642 12458999999999999999999999999999999999999999999999999997654332  12


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-----HHHhhhccccceeecc
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-----EEHWKKAEWRNVSMRS  923 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  923 (936)
                      .....+++.|+|||... ...++.++||||+|+++|+|++|+.||...+..........     .+...+..+.+++.+|
T Consensus       160 ~~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (258)
T cd08215         160 AKTVVGTPYYLSPELCQ-NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSL  238 (258)
T ss_pred             ecceeeeecccChhHhc-cCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence            23346778899999874 44688999999999999999999999987764322221110     0112346778899999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..+|.+||++.
T Consensus       239 l~~~p~~Rp~~~  250 (258)
T cd08215         239 LQKDPEERPSIA  250 (258)
T ss_pred             cCCChhhCcCHH
Confidence            999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=6.3e-31  Score=278.88  Aligned_cols=231  Identities=26%  Similarity=0.345  Sum_probs=191.8

Q ss_pred             ccccCceEEEEEEeC-CCcEEEEEEeeccCccc--hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCCCh
Q 002321          698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK--SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSL  774 (936)
Q Consensus       698 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  774 (936)
                      ||+|+||.||+++.. +++.||+|++.......  ..+.+.+|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999976 48999999986654322  356789999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccccccC
Q 002321          775 HKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQS  854 (936)
Q Consensus       775 ~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  854 (936)
                      .+++....   .+++..+..++.|++.|+.|+|+.+++|+||+|+||+++.++.++|+|||.+.......  .......+
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~  155 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCG  155 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcC
Confidence            99997654   38999999999999999999999999999999999999999999999999997654321  12234557


Q ss_pred             cccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH-H---HHHHHhhhccccceeeccccccccc
Q 002321          855 ALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV-T---WLEEHWKKAEWRNVSMRSCKGSSRQ  930 (936)
Q Consensus       855 ~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~l~~~p~~  930 (936)
                      +..|+|||... ....+.++|+||+|+++||+++|+.||...+....... .   +..+...+..+.+++.+||..||.+
T Consensus       156 ~~~~~~Pe~~~-~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~  234 (250)
T cd05123         156 TPEYLAPEVLL-GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTK  234 (250)
T ss_pred             CccccChHHhC-CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhh
Confidence            77899999884 44578899999999999999999999987764322211 1   1112233567899999999999999


Q ss_pred             cccc
Q 002321          931 RRRF  934 (936)
Q Consensus       931 Rp~f  934 (936)
                      ||++
T Consensus       235 R~~~  238 (250)
T cd05123         235 RLGS  238 (250)
T ss_pred             CCCc
Confidence            9987

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=7.5e-31  Score=284.63  Aligned_cols=240  Identities=28%  Similarity=0.337  Sum_probs=188.7

Q ss_pred             ccCCCcccccCceEEEEEEeC----CCcEEEEEEeeccCc---cchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSL---VKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  763 (936)
                      |+..+.||+|+||.||+++..    +++.||||+++....   ....+.+.+|++++.++ +|+||+++++.+......+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            455678999999999999853    478899999864322   12345688999999999 5999999999999888999


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      +||||+++|+|.+++....   .+++..+..++.|+++||+|||+.+++||||||+||+++.++.++++|||+++.....
T Consensus        82 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  158 (288)
T cd05583          82 LILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence            9999999999999987643   3888999999999999999999999999999999999999999999999998765432


Q ss_pred             ccccccccccCcccccCcccccCcc-cCCchhhHHHHHHHHHHHHcCCCCCCccchhH--HH-HHHHH-----HHHhhhc
Q 002321          844 DRYVLSSKIQSALGYMAPEFACRTV-KITDKCDVYGFGVLVLEVVTGKRPLSTWKMMW--WF-SVTWL-----EEHWKKA  914 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~--~~-~~~~~-----~~~~~~~  914 (936)
                      .. .......++..|+|||...+.. ..+.++||||+|+++|||++|..||...+...  .. .....     .+...+.
T Consensus       159 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd05583         159 EE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSA  237 (288)
T ss_pred             cc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCH
Confidence            21 1122345788899999874432 36789999999999999999999996432210  00 00000     0112345


Q ss_pred             cccceeecccccccccccccC
Q 002321          915 EWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       915 ~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..++++.+||..||.+||+++
T Consensus       238 ~l~~li~~~l~~~p~~R~t~~  258 (288)
T cd05583         238 EARDFIQKLLEKDPKKRLGAN  258 (288)
T ss_pred             HHHHHHHHHhcCCHhhccCcc
Confidence            678899999999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=7.8e-31  Score=288.00  Aligned_cols=242  Identities=24%  Similarity=0.275  Sum_probs=187.1

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc-hHHHHHHHHHHHHcCCCCCcceeeeEEEeCC-------
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLVTLEGYYWTQS-------  760 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  760 (936)
                      ..|+..++||+|+||.||+|+.. +++.||||++....... ....+.+|++++++++|+||+++++++.+..       
T Consensus         8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   87 (311)
T cd07866           8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR   87 (311)
T ss_pred             ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence            45677788999999999999976 58999999986543222 2346788999999999999999999875433       


Q ss_pred             -eeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          761 -LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       761 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                       ..++||||++ +++...+....  ..+++.++..++.|+++||+|||++|++||||||+||++++++.++|+|||+++.
T Consensus        88 ~~~~lv~~~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  164 (311)
T cd07866          88 GSVYMVTPYMD-HDLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP  164 (311)
T ss_pred             ceEEEEEecCC-cCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence             4589999996 57777665432  2489999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCccc---------cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH---
Q 002321          840 LPMLDRY---------VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL---  907 (936)
Q Consensus       840 ~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~---  907 (936)
                      .......         .......+++.|+|||...+...++.++||||+||++|||++|+.||.+..........+.   
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~  244 (311)
T cd07866         165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG  244 (311)
T ss_pred             ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            5322211         1112234577899999876665688999999999999999999999987654322111000   


Q ss_pred             -----------------------------HH--Hhhhccccceeeccccccccccccc
Q 002321          908 -----------------------------EE--HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       908 -----------------------------~~--~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                                   .+  .-..+.+.+++.+|+..||.+||+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~  302 (311)
T cd07866         245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA  302 (311)
T ss_pred             CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCH
Confidence                                         00  0112456789999999999999974

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-30  Score=282.59  Aligned_cols=238  Identities=21%  Similarity=0.275  Sum_probs=186.2

Q ss_pred             ccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCccc-hHHHHHHHHHHHHcC---CCCCcceeeeEEEeCCe-----
Q 002321          692 LNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVK-SQEDFEREVKKLGKV---RHPNLVTLEGYYWTQSL-----  761 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  761 (936)
                      |+..+.||+|+||.||+|+.+. ++.||+|+++...... ....+.+|+.+++++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            3456789999999999999874 8999999997543322 234566788777666   59999999999988776     


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .+++|||++ +++.+++..... ..+++..+..++.|+++||+|||+.+++|+||+|+||+++.++.+||+|||.+....
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence            899999996 589888876432 248999999999999999999999999999999999999999999999999997654


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-------------
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-------------  908 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-------------  908 (936)
                      ....   .....++..|+|||.+. ...++.++||||+||++|||++|+.||...............             
T Consensus       159 ~~~~---~~~~~~~~~~~~PE~~~-~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07838         159 FEMA---LTSVVVTLWYRAPEVLL-QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV  234 (287)
T ss_pred             CCcc---cccccccccccChHHhc-cCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence            3221   12334677899999884 446889999999999999999999999876542211100000             


Q ss_pred             ------------------HHhhhccccceeecccccccccccccC
Q 002321          909 ------------------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 ------------------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                                        ..-....+.+++.+||..||.+||+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~  279 (287)
T cd07838         235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAF  279 (287)
T ss_pred             ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHH
Confidence                              001235567889999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=274.29  Aligned_cols=237  Identities=23%  Similarity=0.276  Sum_probs=193.5

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      .+.....||+|+||.|-.|.-+ +.+.+|||+++.....  .+.+--..|-++|+-- +-|.++++..++..-++.|.||
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM  429 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM  429 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence            4566778999999999999876 4678999999876543  2234456778888777 5789999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+.||+|-.+++.-++   +.+..++-+|.+||-||-+||++||+.||+|..|||+|.+|++||+|||+++.--  -..
T Consensus       430 EyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni--~~~  504 (683)
T KOG0696|consen  430 EYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--FDG  504 (683)
T ss_pred             EEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc--cCC
Confidence            99999999998887554   7888899999999999999999999999999999999999999999999997421  122


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH----HHhhhccccceeec
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE----EHWKKAEWRNVSMR  922 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~  922 (936)
                      ......+|||.|+|||++... +|+..+|.||+||++|||+.|++||++.++...+......    |...+.+.-++...
T Consensus       505 ~TTkTFCGTPdYiAPEIi~Yq-PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg  583 (683)
T KOG0696|consen  505 VTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKG  583 (683)
T ss_pred             cceeeecCCCcccccceEEec-ccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHH
Confidence            234567899999999999655 7899999999999999999999999999887666554433    23333455566667


Q ss_pred             ccccccccccc
Q 002321          923 SCKGSSRQRRR  933 (936)
Q Consensus       923 ~l~~~p~~Rp~  933 (936)
                      .+.+.|.+|-.
T Consensus       584 ~ltK~P~kRLG  594 (683)
T KOG0696|consen  584 LLTKHPGKRLG  594 (683)
T ss_pred             HhhcCCccccC
Confidence            78888888753

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.1e-30  Score=290.12  Aligned_cols=234  Identities=23%  Similarity=0.257  Sum_probs=185.9

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC------ee
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS------LQ  762 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~  762 (936)
                      .|+..+.||+|+||.||+|... +++.||||++..... ....+.+.+|++++++++|+||+++++++....      ..
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07880          16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF   95 (343)
T ss_pred             ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence            4667788999999999999865 689999999854322 223456889999999999999999999987543      35


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCC
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM  842 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  842 (936)
                      ++||||+ +++|.+++...    .+++..+..++.|++.|++|||+.||+||||||+||+++.++.++++|||+++....
T Consensus        96 ~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880          96 YLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             EEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence            8999999 78998887643    388999999999999999999999999999999999999999999999999976532


Q ss_pred             CccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH------------------
Q 002321          843 LDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV------------------  904 (936)
Q Consensus       843 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~------------------  904 (936)
                      .     .....+++.|+|||.+.+...++.++|+||+||++|++++|+.||...+.......                  
T Consensus       171 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07880         171 E-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS  245 (343)
T ss_pred             C-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence            1     12335678899999885545688999999999999999999999986543211100                  


Q ss_pred             ----HHHH-------------HHhhhccccceeeccccccccccccc
Q 002321          905 ----TWLE-------------EHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       905 ----~~~~-------------~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                          .+..             ....+....+++.+|+..||.+||+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~  292 (343)
T cd07880         246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITA  292 (343)
T ss_pred             hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCH
Confidence                0000             01123446788999999999999975

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=6.6e-31  Score=291.91  Aligned_cols=239  Identities=21%  Similarity=0.234  Sum_probs=185.7

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeC---------
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ---------  759 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  759 (936)
                      ..|+..+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++...         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            34677788999999999999976 588999999865543 3456788999999999999999999876543         


Q ss_pred             -----CeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCCeEEee
Q 002321          760 -----SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG-SGEPKVGD  833 (936)
Q Consensus       760 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~D  833 (936)
                           ...++||||++ ++|.+++...    .+++..+..++.|++.|++|||+.|++||||||+||+++. ++.+|++|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence                 34689999996 6898887643    2889999999999999999999999999999999999974 56789999


Q ss_pred             ccCccccCCCccc-cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH------
Q 002321          834 YGLARLLPMLDRY-VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW------  906 (936)
Q Consensus       834 fg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~------  906 (936)
                      ||.++........ .......++..|+|||.+.....++.++||||+||++|||++|+.||.............      
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999765321111 111223467789999987565678899999999999999999999997654322111000      


Q ss_pred             -----------HH-----------------HHhhhccccceeeccccccccccccc
Q 002321          907 -----------LE-----------------EHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       907 -----------~~-----------------~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                 ..                 ....+.++.+++.+||..||.+||+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  294 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA  294 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCH
Confidence                       00                 00123456788999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=7e-31  Score=290.83  Aligned_cols=240  Identities=23%  Similarity=0.275  Sum_probs=192.0

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC-----eeEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS-----LQLL  764 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l  764 (936)
                      |+..+.||+|+||.||+|+.. +++.||||++..... ....+.+.+|+.++++++|+||+++++++....     ..++
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l   81 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI   81 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence            466778999999999999976 489999999865432 234567899999999999999999999998765     7799


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ||||++ ++|.+++....   .+++..+..++.|++.||+|||+.||+||||||.||+++.++.++|+|||++.......
T Consensus        82 v~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~  157 (330)
T cd07834          82 VTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE  157 (330)
T ss_pred             Eecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence            999996 58988887643   48999999999999999999999999999999999999999999999999998764332


Q ss_pred             cc-cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH----------------
Q 002321          845 RY-VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL----------------  907 (936)
Q Consensus       845 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~----------------  907 (936)
                      .. .......+++.|+|||.+.+...++.++||||+|+++|+|++|+.||..............                
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE  237 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence            10 1123345678899999985554789999999999999999999999977654221110000                


Q ss_pred             ------H-------------HHhhhccccceeecccccccccccccC
Q 002321          908 ------E-------------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       908 ------~-------------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                            .             ..-.+..+.+++.+||..+|.+||+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~  284 (330)
T cd07834         238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITAD  284 (330)
T ss_pred             chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHH
Confidence                  0             001235567899999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=4e-31  Score=277.66  Aligned_cols=218  Identities=20%  Similarity=0.247  Sum_probs=176.5

Q ss_pred             cCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCCChhhhhh
Q 002321          701 GGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH  779 (936)
Q Consensus       701 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~  779 (936)
                      |.||.||++++. +++.||+|+++...      ...+|...+....||||+++++++.+....++||||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            899999999976 58899999986542      23445555666679999999999999999999999999999999987


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccccccCccccc
Q 002321          780 EGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYM  859 (936)
Q Consensus       780 ~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~  859 (936)
                      +...   +++..+.+++.|++.||+|||+++++||||||+||+++.++.++++|||.+......     .....++..|+
T Consensus        78 ~~~~---l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~  149 (237)
T cd05576          78 KFLN---IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYC  149 (237)
T ss_pred             HhcC---CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcccc
Confidence            6543   899999999999999999999999999999999999999999999999988654321     12233456799


Q ss_pred             CcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHHHhhhccccceeecccccccccccc
Q 002321          860 APEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       860 aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~  933 (936)
                      |||.. ....++.++||||+|+++|||++|+.||............+..+.+.+..+++++.+|+..||.+|++
T Consensus       150 aPE~~-~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~  222 (237)
T cd05576         150 APEVG-GISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLG  222 (237)
T ss_pred             CCccc-CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccCCHHHhcC
Confidence            99987 44567899999999999999999999886543221111111123445677889999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.2e-30  Score=289.84  Aligned_cols=233  Identities=20%  Similarity=0.257  Sum_probs=183.5

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC------ee
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS------LQ  762 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~  762 (936)
                      .|...+.||+|+||.||+|+.. +|+.||||+++.... ......+.+|++++++++|+||+++++++....      ..
T Consensus        16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   95 (342)
T cd07879          16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF   95 (342)
T ss_pred             ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence            4566788999999999999965 689999999865322 222456889999999999999999999987542      45


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCC
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM  842 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  842 (936)
                      ++|+||+. .++.++..     ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++....
T Consensus        96 ~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~  169 (342)
T cd07879          96 YLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA  169 (342)
T ss_pred             EEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence            89999995 47766542     1288899999999999999999999999999999999999999999999999875432


Q ss_pred             CccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH-----------------
Q 002321          843 LDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT-----------------  905 (936)
Q Consensus       843 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~-----------------  905 (936)
                      .     .....++..|+|||.+.+...++.++||||+||++|||++|+.||...+........                 
T Consensus       170 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (342)
T cd07879         170 E-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED  244 (342)
T ss_pred             C-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence            1     123356778999998865556889999999999999999999999876532211100                 


Q ss_pred             -----HHH-------H------Hhhhccccceeeccccccccccccc
Q 002321          906 -----WLE-------E------HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       906 -----~~~-------~------~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                           +..       .      .-.+..+.+++.+||..||.+||+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~  291 (342)
T cd07879         245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTA  291 (342)
T ss_pred             cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCH
Confidence                 000       0      0123456789999999999999985

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=290.48  Aligned_cols=230  Identities=21%  Similarity=0.297  Sum_probs=188.0

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEEEe
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      .|+....+|.|+|+.|-.+... +++..+||++...     ..+..+|+.++... .||||+++.+.+.+....|+|||.
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~  397 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL  397 (612)
T ss_pred             hhccccccCCCCccceeeeeccccccchhheecccc-----ccccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence            4566667999999999988865 5889999999654     23345677676666 799999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE-cCCCCeEEeeccCccccCCCcccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLI-DGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll-~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      +.|+-+.+.+.....   .. .++..|+.+|+.|+.|||++|+||||+||+|||+ +..|+++|+|||.++.....    
T Consensus       398 l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----  469 (612)
T KOG0603|consen  398 LDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----  469 (612)
T ss_pred             ccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence            999988887766542   33 7788899999999999999999999999999999 68999999999999865432    


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH---HHhhhccccceeeccc
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE---EHWKKAEWRNVSMRSC  924 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l  924 (936)
                       ....+-|..|.|||+.. ...|++++|+||||+++|+|++|+.||........-..+...   ....+...++++..++
T Consensus       470 -~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~LL  547 (612)
T KOG0603|consen  470 -CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQLL  547 (612)
T ss_pred             -hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHHHhc
Confidence             23345577899999995 668999999999999999999999999876443111111112   2677889999999999


Q ss_pred             ccccccccccC
Q 002321          925 KGSSRQRRRFQ  935 (936)
Q Consensus       925 ~~~p~~Rp~f~  935 (936)
                      +.||++|++.+
T Consensus       548 ~~dP~~Rl~~~  558 (612)
T KOG0603|consen  548 QVDPALRLGAD  558 (612)
T ss_pred             cCChhhCcChh
Confidence            99999999753

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.2e-30  Score=287.97  Aligned_cols=234  Identities=20%  Similarity=0.262  Sum_probs=184.1

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeC------Cee
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ------SLQ  762 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  762 (936)
                      .|+..+.||+|+||.||+|... +++.||+|+++.... ....+.+.+|+.++++++|+||+++++++...      ...
T Consensus        18 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   97 (345)
T cd07877          18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV   97 (345)
T ss_pred             ceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccE
Confidence            4667788999999999999864 689999999865322 22346678899999999999999999988643      235


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCC
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM  842 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  842 (936)
                      +++++++ +++|.+++...    .+++..+..++.|+++|++|||+.+|+||||||+||++++++.+||+|||+++....
T Consensus        98 ~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~  172 (345)
T cd07877          98 YLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  172 (345)
T ss_pred             EEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence            7888887 78998887643    288999999999999999999999999999999999999999999999999875432


Q ss_pred             CccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH------------------
Q 002321          843 LDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV------------------  904 (936)
Q Consensus       843 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~------------------  904 (936)
                      .     .....++..|+|||...+...++.++||||+||++|||++|+.||...+.......                  
T Consensus       173 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (345)
T cd07877         173 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  247 (345)
T ss_pred             c-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence            1     12345678899999875545688999999999999999999999976543211100                  


Q ss_pred             ----HHHH--H-----------Hhhhccccceeeccccccccccccc
Q 002321          905 ----TWLE--E-----------HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       905 ----~~~~--~-----------~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                          .+..  +           ...+..+.+++.+|+..||.+||+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~  294 (345)
T cd07877         248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA  294 (345)
T ss_pred             HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCH
Confidence                0000  0           0123457789999999999999874

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=3.7e-30  Score=283.87  Aligned_cols=235  Identities=23%  Similarity=0.290  Sum_probs=187.1

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEe-CCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWT-QSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  766 (936)
                      +.|+..+.||+|+||.||+|... +++.||||++..... ....+.+.+|++++++++||||+++++++.. ....++|+
T Consensus        10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~   89 (328)
T cd07856          10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT   89 (328)
T ss_pred             cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence            44677889999999999999866 689999998854322 2235678899999999999999999999875 45678999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+ +++|.++++...    +++..+..++.|++.|++|||+.+|+||||+|+||+++.++.++|+|||.++.....   
T Consensus        90 e~~-~~~L~~~~~~~~----~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---  161 (328)
T cd07856          90 ELL-GTDLHRLLTSRP----LEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---  161 (328)
T ss_pred             ehh-ccCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC---
Confidence            999 678988886432    778888899999999999999999999999999999999999999999998754321   


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHH----------------------H
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS----------------------V  904 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~----------------------~  904 (936)
                        .....++..|+|||.+.+...++.++||||+||++|||++|+.||..........                      .
T Consensus       162 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd07856         162 --MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL  239 (328)
T ss_pred             --cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence              1223467789999987555678999999999999999999999997654321110                      0


Q ss_pred             HHHH-----------H--Hhhhccccceeeccccccccccccc
Q 002321          905 TWLE-----------E--HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       905 ~~~~-----------~--~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      ....           .  ...+..+++++.+||..+|.+||+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~  282 (328)
T cd07856         240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISA  282 (328)
T ss_pred             HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCH
Confidence            0000           0  0123568899999999999999975

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=305.64  Aligned_cols=239  Identities=22%  Similarity=0.247  Sum_probs=193.1

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc--hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK--SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  765 (936)
                      ...|++.+.||+|+||+|..++.+ +++.||+|++....+.+  ...-|..|-.+|..-+.+-|+++.-.|.+..+.|+|
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV  153 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV  153 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence            345788899999999999999976 58899999997644332  235688899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      ||||+||||-.++.+..   .+++.-+.-++..|+-||..+|+.|+|||||||.|||+|..|++||+|||.+-.+.. +.
T Consensus       154 MdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~-dG  229 (1317)
T KOG0612|consen  154 MDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA-DG  229 (1317)
T ss_pred             EecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC-CC
Confidence            99999999999998765   388888888999999999999999999999999999999999999999999877653 33


Q ss_pred             ccccccccCcccccCcccccC---c-ccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH--------HHhhh
Q 002321          846 YVLSSKIQSALGYMAPEFACR---T-VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE--------EHWKK  913 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~---~-~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~--------~~~~~  913 (936)
                      ...+....|||.|.+||++..   + ..|+..+|.||+||++|||+.|..||....-...++.....        ..-.+
T Consensus       230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VS  309 (1317)
T KOG0612|consen  230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVS  309 (1317)
T ss_pred             cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccC
Confidence            455667789999999998732   2 46899999999999999999999999887654433222211        12244


Q ss_pred             ccccceeeccccccccccc
Q 002321          914 AEWRNVSMRSCKGSSRQRR  932 (936)
Q Consensus       914 ~~~~~~~~~~l~~~p~~Rp  932 (936)
                      ++.+++|.+. -.+|..|-
T Consensus       310 eeakdLI~~l-l~~~e~RL  327 (1317)
T KOG0612|consen  310 EEAKDLIEAL-LCDREVRL  327 (1317)
T ss_pred             HHHHHHHHHH-hcChhhhc
Confidence            5666766543 33444443

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=2.5e-30  Score=286.34  Aligned_cols=239  Identities=22%  Similarity=0.219  Sum_probs=184.7

Q ss_pred             ccCCCcccccCceEEEEEEeC-C--CcEEEEEEeeccCcc-chHHHHHHHHHHHHcC-CCCCcceeeeEEEeC----Cee
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-D--GRPVAIKKLTVSSLV-KSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQ----SLQ  762 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~~  762 (936)
                      |+..+.||+|+||.||+++.. +  +..||+|+++..... ...+.+.+|+++++++ +|+||+++++++...    ...
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            345668999999999999976 3  678999998643221 2346678899999999 599999999876432    346


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCC
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM  842 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  842 (936)
                      ++++||+. ++|.+++....   .+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||.++....
T Consensus        82 ~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~  157 (332)
T cd07857          82 YLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSE  157 (332)
T ss_pred             EEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence            78899985 78998886543   389999999999999999999999999999999999999999999999999976543


Q ss_pred             Cccc--cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH----------------
Q 002321          843 LDRY--VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV----------------  904 (936)
Q Consensus       843 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~----------------  904 (936)
                      ....  .......++..|+|||...+...++.++||||+||++|+|++|+.||...+.......                
T Consensus       158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T cd07857         158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI  237 (332)
T ss_pred             ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            2211  1122346788899999875555689999999999999999999999987543211100                


Q ss_pred             ------HH-----------HHH--Hhhhccccceeeccccccccccccc
Q 002321          905 ------TW-----------LEE--HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       905 ------~~-----------~~~--~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                            .+           ...  ...+..+.+++.+||..||.+||+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~  286 (332)
T cd07857         238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV  286 (332)
T ss_pred             hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCH
Confidence                  00           000  0123567889999999999999985

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=8.8e-31  Score=279.55  Aligned_cols=240  Identities=20%  Similarity=0.276  Sum_probs=187.4

Q ss_pred             ccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCc----cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSL----VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      |...++||+|+||.||++++.. +..+++|+++....    ......+.+|+.++++++||||+++++++.+....++||
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            4566789999999999998763 45566666543221    123446778999999999999999999999888899999


Q ss_pred             EecCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          767 EFVSGGSLHKHLHEGS-GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      ||+++++|.+++.+.. ....+++.++..++.|++.|++|||+.|++|+||||+||+++. +.++++|||.++.......
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~  160 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD  160 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCcc
Confidence            9999999999886522 2235899999999999999999999999999999999999975 6799999999876533221


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH-----HHHHhhhcccccee
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVS  920 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~  920 (936)
                        ......+++.|+|||.. ....++.++|+||+|+++|+|++|..||.............     ..+...+.++.+++
T Consensus       161 --~~~~~~~~~~~~~pe~~-~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (260)
T cd08222         161 --LATTFTGTPYYMSPEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIM  237 (260)
T ss_pred             --cccCCCCCcCccCHHHH-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHH
Confidence              22334577889999987 44567889999999999999999999997654422211110     00122346788999


Q ss_pred             ecccccccccccccC
Q 002321          921 MRSCKGSSRQRRRFQ  935 (936)
Q Consensus       921 ~~~l~~~p~~Rp~f~  935 (936)
                      .+||..+|.+||++.
T Consensus       238 ~~~l~~~p~~Rp~~~  252 (260)
T cd08222         238 QSMLNKDPSLRPSAA  252 (260)
T ss_pred             HHHhcCChhhCcCHH
Confidence            999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=2e-30  Score=280.34  Aligned_cols=238  Identities=25%  Similarity=0.342  Sum_probs=190.8

Q ss_pred             cCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          693 NKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       693 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      +..+.||+|+||.||+|+.. +++.||+|++..... ....+.+.+|+.++++++|+|++++++++.+.+..++||||++
T Consensus         2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (282)
T cd07829           2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD   81 (282)
T ss_pred             eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence            45567999999999999976 489999999976532 2234677889999999999999999999999999999999997


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                       ++|.+++....  ..+++..+.+++.|++.|++|||+.+|+||||+|+||++++++.++|+|||.++.......  ...
T Consensus        82 -~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~  156 (282)
T cd07829          82 -MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYT  156 (282)
T ss_pred             -cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccC
Confidence             69999998753  2389999999999999999999999999999999999999999999999999976543221  112


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHH-H-H---------H-----------HH
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS-V-T---------W-----------LE  908 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~-~-~---------~-----------~~  908 (936)
                      ....+..|+|||.+.....++.++||||+||++|||++|+.||.......... . .         |           ..
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07829         157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF  236 (282)
T ss_pred             ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence            23456679999988655578999999999999999999999997754321110 0 0         0           00


Q ss_pred             ---------HH--hhhccccceeecccccccccccccC
Q 002321          909 ---------EH--WKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 ---------~~--~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                               ..  -.+..+.+++.+||..||.+||+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~  274 (282)
T cd07829         237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAK  274 (282)
T ss_pred             cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHH
Confidence                     00  0135678899999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1e-30  Score=290.44  Aligned_cols=235  Identities=22%  Similarity=0.264  Sum_probs=188.4

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCe------e
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSL------Q  762 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~  762 (936)
                      .|+..+.||+|+||.||+|+.. +++.||||++..... ....+.+.+|+.++++++|+|++++.+++.....      .
T Consensus        16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07851          16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV   95 (343)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence            3667788999999999999976 578999999864322 2234667889999999999999999998866554      7


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCC
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM  842 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  842 (936)
                      ++|+||+ +++|.+++...    .+++..+.+++.|+++|++|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus        96 ~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (343)
T cd07851          96 YLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD  170 (343)
T ss_pred             EEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence            9999999 67999988753    389999999999999999999999999999999999999999999999999976532


Q ss_pred             CccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH-----------------
Q 002321          843 LDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT-----------------  905 (936)
Q Consensus       843 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~-----------------  905 (936)
                      .     .....++..|+|||...+...++.++||||+||++|||++|+.||............                 
T Consensus       171 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (343)
T cd07851         171 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS  245 (343)
T ss_pred             c-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence            2     123356778999998755456789999999999999999999999765542211100                 


Q ss_pred             -----HH-----------HH--HhhhccccceeecccccccccccccC
Q 002321          906 -----WL-----------EE--HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       906 -----~~-----------~~--~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                           +.           .+  .-.++.+.+++.+||..||.+||+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~  293 (343)
T cd07851         246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAA  293 (343)
T ss_pred             hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHH
Confidence                 00           00  01246678899999999999999864

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=275.70  Aligned_cols=239  Identities=25%  Similarity=0.351  Sum_probs=189.8

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccch------HHHHHHHHHHHHcCCCCCcceeeeEEE-eCCe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKS------QEDFEREVKKLGKVRHPNLVTLEGYYW-TQSL  761 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~  761 (936)
                      ..|-....||+|+|++||+|.+- ..+.||||+-.....-++      .+...||.++-+.++||.||++|+|+. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            34555678999999999999854 578999998754332221      245678999999999999999999997 5567


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCCCCEEEc---CCCCeEEeeccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS--NIIHYNIKSSNVLID---GSGEPKVGDYGL  836 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~--~ivH~Dlkp~NIll~---~~~~~kl~Dfg~  836 (936)
                      ++-|+|||+|.+|+-|++..+-   +++.++..|+.||+.||.||.+.  .|+|-|+||.|||+-   .-|.+||+|||+
T Consensus       543 FCTVLEYceGNDLDFYLKQhkl---mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKL---MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhh---hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            7899999999999999987654   99999999999999999999974  799999999999994   457899999999


Q ss_pred             ccccCCCcc-----ccccccccCcccccCcccccCc---ccCCchhhHHHHHHHHHHHHcCCCCCCccch-hHHH-----
Q 002321          837 ARLLPMLDR-----YVLSSKIQSALGYMAPEFACRT---VKITDKCDVYGFGVLVLEVVTGKRPLSTWKM-MWWF-----  902 (936)
Q Consensus       837 a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~-~~~~-----  902 (936)
                      ++.+....+     ....+...||.+|.+||.+.-+   ...+.|+||||+||++|.++.|+.||..... ..+.     
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI  699 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI  699 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence            998864332     2345567799999999987533   3467899999999999999999999976432 1111     


Q ss_pred             ----HHHHHHHHhhhccccceeecccccccccc
Q 002321          903 ----SVTWLEEHWKKAEWRNVSMRSCKGSSRQR  931 (936)
Q Consensus       903 ----~~~~~~~~~~~~~~~~~~~~~l~~~p~~R  931 (936)
                          .+.|......+.+.+++|.||+.+...+|
T Consensus       700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR  732 (775)
T KOG1151|consen  700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDR  732 (775)
T ss_pred             hcceeccCCCCCccCHHHHHHHHHHHHhhhhhh
Confidence                22333334455778999999999877665

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-31  Score=259.84  Aligned_cols=205  Identities=24%  Similarity=0.328  Sum_probs=170.9

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeecc-CccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC-----eeEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVS-SLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS-----LQLL  764 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l  764 (936)
                      ++.++.||.|+||.||.+++. +|+.||.|++..- ......+++.+|++++..++|.|++..++...-..     .+|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            467789999999999999865 7999999998432 11234578899999999999999999988876432     4578


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ++|.| ..+|...+-...   .++.....-+..||++||+|||+.+|.||||||.|.|++.+..+||||||+|+..+. +
T Consensus       135 ~TELm-QSDLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~-d  209 (449)
T KOG0664|consen  135 LTELM-QSDLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ-R  209 (449)
T ss_pred             HHHHH-HhhhhheeccCC---CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch-h
Confidence            88999 478888876543   388888888999999999999999999999999999999999999999999986543 3


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHH
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWW  901 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~  901 (936)
                      +....+...-|..|+|||++++.++|+.+.||||.||++.|++.++.-|+...+...
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQ  266 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQ  266 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHH
Confidence            333334455678899999999999999999999999999999999999988766433

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=1.1e-29  Score=303.53  Aligned_cols=145  Identities=25%  Similarity=0.388  Sum_probs=129.5

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      .|...++||+|+||.||+|.+. +++.||||+++.....  .....+.+|+.+++.++|+||+++++++......++|||
T Consensus         5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE   84 (669)
T cd05610           5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME   84 (669)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence            4566788999999999999977 5899999999654322  224678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCcc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR  838 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  838 (936)
                      |+++++|.+++....   .+++..+++++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++
T Consensus        85 y~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          85 YLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999997643   37889999999999999999999999999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.6e-30  Score=277.16  Aligned_cols=204  Identities=23%  Similarity=0.348  Sum_probs=169.3

Q ss_pred             cccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      .|.+.+.||-|+||+|..+...| ...||.|.+++....  .....++.|-.||+.-+.+-||++|-.|.+.+..|.|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            35667789999999999988554 678999998654332  224567889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC------
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP------  841 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~------  841 (936)
                      |++||++-.+|-+.+   .+.+..+.-++.++..|+++.|..|++||||||.|||||.+|++||+|||++.-+.      
T Consensus       710 YIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk  786 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  786 (1034)
T ss_pred             ccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence            999999999887644   27777777888999999999999999999999999999999999999999985431      


Q ss_pred             ---CCc-------------------------------cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHH
Q 002321          842 ---MLD-------------------------------RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVV  887 (936)
Q Consensus       842 ---~~~-------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~  887 (936)
                         ..+                               .........||+.|+|||++. ...|+.-+|.||.|||+|||+
T Consensus       787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~-r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA-RTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc-ccCccccchhhHhhHHHHHHh
Confidence               100                               001112356889999999995 446899999999999999999


Q ss_pred             cCCCCCCccch
Q 002321          888 TGKRPLSTWKM  898 (936)
Q Consensus       888 ~g~~Pf~~~~~  898 (936)
                      .|+.||.+...
T Consensus       866 ~g~~pf~~~tp  876 (1034)
T KOG0608|consen  866 VGQPPFLADTP  876 (1034)
T ss_pred             hCCCCccCCCC
Confidence            99999987654

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=6.1e-30  Score=261.71  Aligned_cols=214  Identities=26%  Similarity=0.321  Sum_probs=177.0

Q ss_pred             CCCCCceeeccCCCCccccccccccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCccchHHHHHHHHHHHHcCC-C
Q 002321          669 DANSGKLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-H  746 (936)
Q Consensus       669 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h  746 (936)
                      +...|+.+...|+..     ...|+....+|+|+||.|-++.++. +..||||+++.-  .+..+...-|++++.++. +
T Consensus        73 dD~dGH~v~~~gD~l-----~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~  145 (415)
T KOG0671|consen   73 DDKDGHYVYQVGDIL-----TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINES  145 (415)
T ss_pred             CCCCceEEEEecccc-----ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhc
Confidence            556676666655442     4557888899999999999998764 789999998533  344567788999999993 2


Q ss_pred             -C----CcceeeeEEEeCCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 002321          747 -P----NLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNV  821 (936)
Q Consensus       747 -~----niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NI  821 (936)
                       |    -+|++.+|+...+..++|+|.+ |-++.+++..+... .++...+..++.|+++++++||+.+++|.|+||+||
T Consensus       146 DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~-~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENI  223 (415)
T KOG0671|consen  146 DPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYI-PFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENI  223 (415)
T ss_pred             CCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCcc-ccchHHHHHHHHHHHHHHHHHHhcceeecCCChheE
Confidence             3    3888999999999999999999 77999999987653 388999999999999999999999999999999999


Q ss_pred             EEcC--------------------CCCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHH
Q 002321          822 LIDG--------------------SGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGV  881 (936)
Q Consensus       822 ll~~--------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~  881 (936)
                      |+..                    +..+|++|||.|+....     ....+..|..|+|||++. +..++.++||||+||
T Consensus       224 Lfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViL-gLGwS~pCDvWSiGC  297 (415)
T KOG0671|consen  224 LFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVIL-GLGWSQPCDVWSIGC  297 (415)
T ss_pred             EEeccceEEEeccCCccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchhee-ccCcCCccCceeeee
Confidence            9832                    23589999999986432     225667888999999995 557899999999999


Q ss_pred             HHHHHHcCCCCCCccc
Q 002321          882 LVLEVVTGKRPLSTWK  897 (936)
Q Consensus       882 ~l~el~~g~~Pf~~~~  897 (936)
                      |++|+++|..-|++-+
T Consensus       298 IL~ElytG~~LFqtHe  313 (415)
T KOG0671|consen  298 ILVELYTGETLFQTHE  313 (415)
T ss_pred             EEEEeeccceecccCC
Confidence            9999999999998865

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1e-29  Score=253.31  Aligned_cols=239  Identities=23%  Similarity=0.287  Sum_probs=192.7

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  765 (936)
                      +.++..+.||+|+|++|..++++ +.+.||+|+++++-..  ++.+-++.|-.+..+- +||.+|.+..++....+.+.|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            44677889999999999999966 5788999999765433  3356678888888777 799999999999999999999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      .||++||+|--++++.++   ++++.+.-+...|.-||.|||++||+.||+|..|+|+|..|++|++|+|+++.--.  .
T Consensus       330 ieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~--~  404 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG--P  404 (593)
T ss_pred             EEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC--C
Confidence            999999999877776554   99999999999999999999999999999999999999999999999999975322  2


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchh--HHHHHHHH-----HH-----Hhhh
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM--WWFSVTWL-----EE-----HWKK  913 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~--~~~~~~~~-----~~-----~~~~  913 (936)
                      ....+..+|||.|.|||++ .+.+|+..+|.|++||+++||+.|+.||+--.+.  .....++.     +.     ...+
T Consensus       405 gd~tstfcgtpnyiapeil-rgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsls  483 (593)
T KOG0695|consen  405 GDTTSTFCGTPNYIAPEIL-RGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLS  483 (593)
T ss_pred             CcccccccCCCcccchhhh-cccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceee
Confidence            2344668899999999998 5668999999999999999999999999764431  11122222     21     1122


Q ss_pred             ccccceeeccccccccccccc
Q 002321          914 AEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       914 ~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      -+...++...+++||++|-.+
T Consensus       484 vkas~vlkgflnkdp~erlgc  504 (593)
T KOG0695|consen  484 VKASHVLKGFLNKDPKERLGC  504 (593)
T ss_pred             hhhHHHHHHhhcCCcHHhcCC
Confidence            334455667899999998765

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-29  Score=282.31  Aligned_cols=239  Identities=24%  Similarity=0.354  Sum_probs=196.2

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEe-----CCeeE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWT-----QSLQL  763 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~~~~~  763 (936)
                      .++..+.||+|.+|.||+++.+ +++.+|||+.....  +..++++.|.++++.. +|||++.++|++.-     +++.|
T Consensus        20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW   97 (953)
T KOG0587|consen   20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW   97 (953)
T ss_pred             ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence            3567778999999999999955 68889999886553  3357788899999888 69999999999863     46889


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      +|||||.+|+.-|+++.-. +..+.|..+..|++.+++|+.+||...++|||||-.|||++.++.+|++|||.+..+.. 
T Consensus        98 LVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds-  175 (953)
T KOG0587|consen   98 LVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS-  175 (953)
T ss_pred             EEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec-
Confidence            9999999999999998766 55699999999999999999999999999999999999999999999999999876543 


Q ss_pred             ccccccccccCcccccCcccccC----cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH-HHH------HHhh
Q 002321          844 DRYVLSSKIQSALGYMAPEFACR----TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT-WLE------EHWK  912 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~-~~~------~~~~  912 (936)
                       .........|||.|||||++.-    ...|+.++|+||+|++..||--|.+|+.+..++...... ..+      +.-=
T Consensus       176 -T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kW  254 (953)
T KOG0587|consen  176 -TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKW  254 (953)
T ss_pred             -ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhH
Confidence             2233455679999999998832    234677899999999999999999999888775333111 111      1222


Q ss_pred             hccccceeeccccccccccccc
Q 002321          913 KAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       913 ~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      .+++.++|..|+.+|-.+||..
T Consensus       255 s~~FndFIs~cL~Kd~e~RP~~  276 (953)
T KOG0587|consen  255 SKKFNDFISTCLVKDYEQRPST  276 (953)
T ss_pred             HHHHHHHHHHHHhhccccCcch
Confidence            3678999999999999999964

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=1e-28  Score=260.28  Aligned_cols=227  Identities=29%  Similarity=0.412  Sum_probs=187.2

Q ss_pred             CceEEEEEEeCC-CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCCChhhhhhc
Q 002321          702 GFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHE  780 (936)
Q Consensus       702 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  780 (936)
                      +||.||+|+..+ ++.+|+|++.........+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999874 8999999997654433367899999999999999999999999998999999999999999999876


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccccccCcccccC
Q 002321          781 GSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMA  860 (936)
Q Consensus       781 ~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~a  860 (936)
                      ...   +++..+..++.++++++.|||+.+++|+||+|+||+++.++.++++|||.+.......   ......++..|++
T Consensus        81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~  154 (244)
T smart00220       81 RGR---LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMA  154 (244)
T ss_pred             ccC---CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCC
Confidence            443   7889999999999999999999999999999999999999999999999998664322   2234557778999


Q ss_pred             cccccCcccCCchhhHHHHHHHHHHHHcCCCCCCcc-chhHHHHHHHHHH-----Hh--hhccccceeeccccccccccc
Q 002321          861 PEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTW-KMMWWFSVTWLEE-----HW--KKAEWRNVSMRSCKGSSRQRR  932 (936)
Q Consensus       861 PE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~-~~~~~~~~~~~~~-----~~--~~~~~~~~~~~~l~~~p~~Rp  932 (936)
                      ||... ...++.++||||+|+++|++++|..||... +............     ..  .+.++.+++.+||..+|.+||
T Consensus       155 pE~~~-~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp  233 (244)
T smart00220      155 PEVLL-GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL  233 (244)
T ss_pred             HHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhcc
Confidence            99884 456788999999999999999999999873 3322221111110     00  446778999999999999999


Q ss_pred             ccC
Q 002321          933 RFQ  935 (936)
Q Consensus       933 ~f~  935 (936)
                      +++
T Consensus       234 ~~~  236 (244)
T smart00220      234 TAE  236 (244)
T ss_pred             CHH
Confidence            874

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-29  Score=269.36  Aligned_cols=197  Identities=21%  Similarity=0.333  Sum_probs=170.7

Q ss_pred             ccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCccc-------hHHHHHHHHHHHHcCC---CCCcceeeeEEEeCC
Q 002321          692 LNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVK-------SQEDFEREVKKLGKVR---HPNLVTLEGYYWTQS  760 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~  760 (936)
                      |...+++|+|+||.|+.|.++. ...|+||.++++..-.       ....+-.|++||+.++   |+||++++++|++++
T Consensus       563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd  642 (772)
T KOG1152|consen  563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD  642 (772)
T ss_pred             ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence            6777889999999999999874 6789999986654321       1234567999999997   999999999999999


Q ss_pred             eeEEEEEec-CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          761 LQLLIYEFV-SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       761 ~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      ..|++||-. ++-+|.+++.....   +++.++..|++|++.|+++||+.||||||||-+|+.++.+|-+||+|||.|..
T Consensus       643 ~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~  719 (772)
T KOG1152|consen  643 YYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY  719 (772)
T ss_pred             eeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence            999999976 45688899987665   99999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCc
Q 002321          840 LPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLST  895 (936)
Q Consensus       840 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~  895 (936)
                      .....    -....||.+|.|||++.+.++.+...|||++|+++|.++..+.||..
T Consensus       720 ~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  720 TKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            64332    24467999999999997777788899999999999999999999863

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.95  E-value=4.5e-29  Score=277.95  Aligned_cols=237  Identities=24%  Similarity=0.309  Sum_probs=184.6

Q ss_pred             ccccCCCcccccCceE-EEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEEE
Q 002321          690 ALLNKDCELGRGGFGA-VYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ..+...+.+|.|+-|+ ||+|... |+.||||++-.+    ..+-.+||+..++.- +|||||++++.-.++...|+..|
T Consensus       509 ~~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE  583 (903)
T KOG1027|consen  509 LFFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE  583 (903)
T ss_pred             eeeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence            3455566789999986 7999985 899999998433    345678999999888 69999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---C--CCeEEeeccCccccC
Q 002321          768 FVSGGSLHKHLHEGSGGN-FLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG---S--GEPKVGDYGLARLLP  841 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~-~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~---~--~~~kl~Dfg~a~~~~  841 (936)
                      .| ..+|.+++....... .......+.+..|++.||++||+.+||||||||.||||+.   +  ..++|+|||+++...
T Consensus       584 LC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  584 LC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             Hh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            99 579999998741111 1122456778899999999999999999999999999976   3  479999999999875


Q ss_pred             CCcc-ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHH------HHHHHHhhh
Q 002321          842 MLDR-YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSV------TWLEEHWKK  913 (936)
Q Consensus       842 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~------~~~~~~~~~  913 (936)
                      .... ........||-+|+|||.+... .-+.++||||+||++|+.++ |.+||.+.-..+....      ...++....
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~-~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~  741 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLRED-RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDC  741 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhcc-ccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchH
Confidence            4332 2234556789999999999544 45779999999999999999 4999988654322211      112222211


Q ss_pred             ccccceeeccccccccccccc
Q 002321          914 AEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       914 ~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                       +.+++|.+|++.||..||+-
T Consensus       742 -eA~dLI~~ml~~dP~~RPsa  761 (903)
T KOG1027|consen  742 -EAKDLISRMLNPDPQLRPSA  761 (903)
T ss_pred             -HHHHHHHHhcCCCcccCCCH
Confidence             77899999999999999973

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.95  E-value=2.9e-28  Score=283.70  Aligned_cols=240  Identities=18%  Similarity=0.192  Sum_probs=159.2

Q ss_pred             cccccCCCcccccCceEEEEEEeC-C----CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeE------EE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-D----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY------YW  757 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~  757 (936)
                      ...|+..++||+|+||.||+|++. +    +..||||++.....   .+....|  .+.+..+.++..++..      ..
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            445778889999999999999976 3    68999998754321   1111111  1112222222222211      23


Q ss_pred             eCCeeEEEEEecCCCChhhhhhccCCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 002321          758 TQSLQLLIYEFVSGGSLHKHLHEGSGGN-----------------FLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSN  820 (936)
Q Consensus       758 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-----------------~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~N  820 (936)
                      .....++||||+++++|.+++.......                 ......+..++.|++.||+|||+++|+||||||+|
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N  285 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN  285 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence            4567899999999999999987543110                 01233456799999999999999999999999999


Q ss_pred             EEEcC-CCCeEEeeccCccccCCCccccccccccCcccccCcccccCcc---------------------cCCchhhHHH
Q 002321          821 VLIDG-SGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTV---------------------KITDKCDVYG  878 (936)
Q Consensus       821 Ill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~DvwS  878 (936)
                      ||++. ++.+||+|||+|+.+..... .......+++.|+|||.+....                     .++.++||||
T Consensus       286 ILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        286 IIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             EEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            99986 58999999999986543222 2223456788999999652221                     2345679999


Q ss_pred             HHHHHHHHHcCCCCCCccchhHHH--------HHHHHH---HHh-------------hhccccceeeccccccccccccc
Q 002321          879 FGVLVLEVVTGKRPLSTWKMMWWF--------SVTWLE---EHW-------------KKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       879 lG~~l~el~~g~~Pf~~~~~~~~~--------~~~~~~---~~~-------------~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      +||++|||+++..|++........        ...|..   +..             ......+++.+|+..||.+||+.
T Consensus       365 lGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta  444 (566)
T PLN03225        365 AGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA  444 (566)
T ss_pred             HHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence            999999999988776543211100        001100   000             01112379999999999999985

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.95  E-value=1.4e-27  Score=270.40  Aligned_cols=244  Identities=21%  Similarity=0.249  Sum_probs=170.4

Q ss_pred             cccccCCCcccccCceEEEEEEe-----------------CCCcEEEEEEeeccCccc-------------hHHHHHHHH
Q 002321          689 HALLNKDCELGRGGFGAVYRTVL-----------------RDGRPVAIKKLTVSSLVK-------------SQEDFEREV  738 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~-------------~~~~~~~E~  738 (936)
                      .+.|+..++||+|+||.||+|..                 .+++.||||++.......             ..+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            45678889999999999999964                 235689999986432110             112344577


Q ss_pred             HHHHcCCCCCc-----ceeeeEEEe--------CCeeEEEEEecCCCChhhhhhccCC---------------------C
Q 002321          739 KKLGKVRHPNL-----VTLEGYYWT--------QSLQLLIYEFVSGGSLHKHLHEGSG---------------------G  784 (936)
Q Consensus       739 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~  784 (936)
                      .++.+++|.++     ++++++|..        .+..++||||+++++|.++++....                     .
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            88888876654     677777753        3457999999999999999874311                     0


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccccccCcccccCcccc
Q 002321          785 NFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA  864 (936)
Q Consensus       785 ~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  864 (936)
                      ...++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++....... ........++.|+|||.+
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPEEL  382 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChhhh
Confidence            1246778889999999999999999999999999999999999999999999975532211 111223347889999987


Q ss_pred             cCccc---------------------CCchhhHHHHHHHHHHHHcCCC-CCCccchhHHH-------HHHHH--------
Q 002321          865 CRTVK---------------------ITDKCDVYGFGVLVLEVVTGKR-PLSTWKMMWWF-------SVTWL--------  907 (936)
Q Consensus       865 ~~~~~---------------------~~~~~DvwSlG~~l~el~~g~~-Pf~~~~~~~~~-------~~~~~--------  907 (936)
                      .....                     ...+.||||+||++|||++|.. ||.........       ...|.        
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~  462 (507)
T PLN03224        383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD  462 (507)
T ss_pred             cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence            43211                     1134799999999999999985 77653221100       00110        


Q ss_pred             --HHHhhhccccceeeccccccc---ccccc
Q 002321          908 --EEHWKKAEWRNVSMRSCKGSS---RQRRR  933 (936)
Q Consensus       908 --~~~~~~~~~~~~~~~~l~~~p---~~Rp~  933 (936)
                        .....++..++++.+++..+|   .+|++
T Consensus       463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlS  493 (507)
T PLN03224        463 FSLLDRNKEAGWDLACKLITKRDQANRGRLS  493 (507)
T ss_pred             cccccccChHHHHHHHHHhccCCCCcccCCC
Confidence              011123556778889998766   45665

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-29  Score=258.76  Aligned_cols=291  Identities=21%  Similarity=0.206  Sum_probs=205.1

Q ss_pred             CceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccC-cccccccchhhhhcCCCCcEE
Q 002321           76 NRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSG-NSLSGSIPDEFFKQCGSLRVI  154 (936)
Q Consensus        76 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~-N~l~~~i~~~~f~~l~~L~~L  154 (936)
                      ...++|+|..|.++...+.+|..++.|++||||+|+|+.+-|++|.+|.+|..|-+-+ |+|+ .+|...|++|..|+.|
T Consensus        67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrL  145 (498)
T KOG4237|consen   67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRL  145 (498)
T ss_pred             CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHH
Confidence            4566777777777644444577777777777777777777777777777665554444 7776 6777777777777777


Q ss_pred             EccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCC------------CCCCccCccCCCC
Q 002321          155 SLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLL------------EGEIPKGVESLKN  222 (936)
Q Consensus       155 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l------------~~~~~~~~~~l~~  222 (936)
                      .+.-|++.-+..+.|..+++|..|.|.+|.+..+-...|.++..++.+.+..|.+            .-..|..++...-
T Consensus       146 llNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc  225 (498)
T KOG4237|consen  146 LLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARC  225 (498)
T ss_pred             hcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhccccee
Confidence            7777777766666677777777777777777755445677777777777777662            1223344445555


Q ss_pred             cceeecccccccccCCcccccc-cCcceeeccccccCCCCc-hhhhccccccEEeccCccccCCCCcccccCCccceecc
Q 002321          223 LRVINLSKNMFSGSIPDGIGSC-SLLRTIDFSENSFSGNLP-ETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDL  300 (936)
Q Consensus       223 L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  300 (936)
                      ..-..+.++++..+-+..|... ..+..=-.+.....+..| ..|..|++|+.|+|++|+++++-+.+|..+..+++|+|
T Consensus       226 ~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L  305 (498)
T KOG4237|consen  226 VSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYL  305 (498)
T ss_pred             cchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhc
Confidence            5555566666654444333321 122111112222223333 45899999999999999999999999999999999999


Q ss_pred             cCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCc
Q 002321          301 SGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLN  367 (936)
Q Consensus       301 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~  367 (936)
                      ..|+|.......|.++..|+.|+|.+|+|+...|..|..+..|..|.|-.|.+...---..+..+++
T Consensus       306 ~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr  372 (498)
T KOG4237|consen  306 TRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLR  372 (498)
T ss_pred             CcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHh
Confidence            9999997777889999999999999999999999999999999999999999987655444444443

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=5.8e-28  Score=229.34  Aligned_cols=199  Identities=22%  Similarity=0.321  Sum_probs=168.2

Q ss_pred             ccccccccCCCcccccCceEEEEEEe-CCCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-CCCcceeeeEEEeCC--e
Q 002321          686 TGTHALLNKDCELGRGGFGAVYRTVL-RDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQS--L  761 (936)
Q Consensus       686 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~  761 (936)
                      .+....|+..+++|+|-|++||.|.. .++++++||+++.-    ..+.+.||+.++..++ ||||++++++..++.  .
T Consensus        34 wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   34 WGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            34556788899999999999999984 46889999999643    3577899999999997 999999999998764  4


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-CCeEEeeccCcccc
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS-GEPKVGDYGLARLL  840 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~  840 (936)
                      ..+|+||+.+.+...+...      ++..++..++.++++||.|+|+.||.|||+||+|+++|.. -.++++|+|+|.++
T Consensus       110 paLiFE~v~n~Dfk~ly~t------l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLYPT------LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             chhHhhhhccccHHHHhhh------hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhc
Confidence            5699999999887776544      6777788899999999999999999999999999999864 57999999999988


Q ss_pred             CCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccc
Q 002321          841 PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWK  897 (936)
Q Consensus       841 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~  897 (936)
                      ....++..   ...+..|.-||.+..-..|+..-|+|||||++++|+..+.||-...
T Consensus       184 Hp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~  237 (338)
T KOG0668|consen  184 HPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH  237 (338)
T ss_pred             CCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence            65554432   3345568999999877789999999999999999999999996654

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-28  Score=251.09  Aligned_cols=384  Identities=21%  Similarity=0.249  Sum_probs=235.6

Q ss_pred             cccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccC-ccCCCCCCCCccccccccccc
Q 002321          101 FLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAK-NRFSGKIPSSLSLCSTLATIN  179 (936)
Q Consensus       101 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~  179 (936)
                      .-.+++|..|+|+.+.+.+|..+++|+.||||+|+|+ .|.+++|.++++|..|-+-+ |+|+....+.|+++..|+.|.
T Consensus        68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is-~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl  146 (498)
T KOG4237|consen   68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNIS-FIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL  146 (498)
T ss_pred             cceEEEeccCCcccCChhhccchhhhceecccccchh-hcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence            4567899999999888889999999999999999998 78889999999988777666 999987778899999999999


Q ss_pred             cccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeeccccccc------------ccCCcccccccCc
Q 002321          180 LSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFS------------GSIPDGIGSCSLL  247 (936)
Q Consensus       180 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~------------~~~p~~l~~l~~L  247 (936)
                      +.-|++..+...+|..+++|..|.|.+|.+..+--..|..+..++.+++..|.+.            ...|..++...-.
T Consensus       147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~  226 (498)
T KOG4237|consen  147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCV  226 (498)
T ss_pred             cChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceec
Confidence            9999999988899999999999999999998444448889999999999988842            1223333333333


Q ss_pred             ceeeccccccCCCCchhhhcc-cccc-EEeccCccccCCCC-cccccCCccceecccCceeccccCcccccccccceEEc
Q 002321          248 RTIDFSENSFSGNLPETMQKL-SLCN-FMNLRKNLFSGEVP-KWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNF  324 (936)
Q Consensus       248 ~~L~Ls~N~l~~~~~~~l~~l-~~L~-~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L  324 (936)
                      .-..|.++++....+..|..- ..+. .+....+ ..+..| ..|..+++|+.|+|++|+|+++-+.+|.++.+++.|.|
T Consensus       227 ~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~-~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L  305 (498)
T KOG4237|consen  227 SPYRLYYKRINQEDARKFLCSLESLPSRLSSEDF-PDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYL  305 (498)
T ss_pred             chHHHHHHHhcccchhhhhhhHHhHHHhhccccC-cCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhc
Confidence            334444444433333222211 1111 1111111 111222 23445555555555555555555555555555555555


Q ss_pred             cCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCccc
Q 002321          325 SANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEF  404 (936)
Q Consensus       325 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l  404 (936)
                      ..|+|...-...|.++..|+.|+|.+|+|+                                                  
T Consensus       306 ~~N~l~~v~~~~f~~ls~L~tL~L~~N~it--------------------------------------------------  335 (498)
T KOG4237|consen  306 TRNKLEFVSSGMFQGLSGLKTLSLYDNQIT--------------------------------------------------  335 (498)
T ss_pred             CcchHHHHHHHhhhccccceeeeecCCeeE--------------------------------------------------
Confidence            555554444444444555555555544444                                                  


Q ss_pred             CCCChhhhcccccCCeeeccCccc------------------cCCCCccccCcccCCeeecCCccccc---cCCCCCC--
Q 002321          405 SGETPATIGALSGLQLLNLSRNSL------------------VGPIPVAIGDLKALNVLDLSENWLNG---SIPPEIG--  461 (936)
Q Consensus       405 ~~~~~~~~~~l~~L~~L~L~~N~l------------------~~~~~~~~~~l~~L~~L~Ls~N~l~~---~~p~~~~--  461 (936)
                       ...|.+|..+..|.+|+|-.|.+                  .|..|-  +.-..++.++++++.+..   ..|++.+  
T Consensus       336 -~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~C--q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~  412 (498)
T KOG4237|consen  336 -TVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRC--QSPGFVRQIPISDVAFGDFRCGGPEELGCL  412 (498)
T ss_pred             -EEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCC--CCCchhccccchhccccccccCCccccCCC
Confidence             44444444444444444433332                  111111  112234555555554432   1222222  


Q ss_pred             -------CcCCCc-EEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcccc
Q 002321          462 -------GAYSLK-ELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLV  533 (936)
Q Consensus       462 -------~l~~L~-~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~  533 (936)
                             .++-+. ....|++.++ .+|..+.  ..-.+|++.+|.++ .+|..  .+..| .+||++|+|...---.|.
T Consensus       413 ~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~  485 (498)
T KOG4237|consen  413 TSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFS  485 (498)
T ss_pred             CCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhccccc
Confidence                   122233 2334444444 5555444  35567888888888 56666  56677 888888888755556788


Q ss_pred             cccccCeeecCCC
Q 002321          534 NLVHLSSFNISHN  546 (936)
Q Consensus       534 ~l~~L~~L~ls~N  546 (936)
                      ++++|.+|-||+|
T Consensus       486 n~tql~tlilsyn  498 (498)
T KOG4237|consen  486 NMTQLSTLILSYN  498 (498)
T ss_pred             chhhhheeEEecC
Confidence            8888888888876

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=7.5e-26  Score=235.52  Aligned_cols=200  Identities=31%  Similarity=0.491  Sum_probs=170.2

Q ss_pred             cCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          693 NKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       693 ~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      ...+.||+|++|.||++...+ ++.+|+|.+.........+.+.+|++.+++++|+|++++++++......++++||+++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   81 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG   81 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence            455689999999999999875 8999999997654332567889999999999999999999999988899999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      ++|.+++......  +++.....++.+++.++.|||+.+++|+|++|.||+++.++.++|+|||.+......... ....
T Consensus        82 ~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~~  158 (225)
T smart00221       82 GDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLKT  158 (225)
T ss_pred             CCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cccc
Confidence            9999998765432  788899999999999999999999999999999999999999999999999876433210 1223


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCc
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLST  895 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~  895 (936)
                      ..++..|++||.......++.++|||++|++++||++|+.||..
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            45667799999874445677899999999999999999999966

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.93  E-value=1.6e-25  Score=230.26  Aligned_cols=206  Identities=32%  Similarity=0.536  Sum_probs=176.8

Q ss_pred             ccccCceEEEEEEeCC-CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCCChhh
Q 002321          698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHK  776 (936)
Q Consensus       698 iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  776 (936)
                      ||+|.+|.||+++..+ ++.++||++.........+.+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999864 899999999765433235779999999999999999999999999889999999999999999


Q ss_pred             hhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCCeEEeeccCccccCCCccccccccccCc
Q 002321          777 HLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG-SGEPKVGDYGLARLLPMLDRYVLSSKIQSA  855 (936)
Q Consensus       777 ~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~  855 (936)
                      ++....  ..+++..+..++.+++++++|||+.+++|+||+|.||+++. ++.++|+|||.+........  ......+.
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~  156 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT  156 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence            987652  23889999999999999999999999999999999999999 89999999999976543221  12334567


Q ss_pred             ccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHHHhhhccccceeeccccccccccccc
Q 002321          856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       856 ~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      ..|++||.......++.+.|+|++|++++++                           ..+.+++.+|+..+|.+||+.
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------~~~~~~l~~~l~~~p~~R~~~  208 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------PELKDLIRKMLQKDPEKRPSA  208 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------HHHHHHHHHHhhCCcccCcCH
Confidence            7799999884433678899999999999999                           577888999999999999975

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=2.3e-27  Score=257.35  Aligned_cols=238  Identities=23%  Similarity=0.360  Sum_probs=196.8

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ...|+....+|.|+||.||||++. +++..|||+++.+.. ....-.+.|+-+++..+||||+.+++.+..++..|++||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            345677788999999999999965 689999999976543 345667899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+.+|+|.+..+...   ++++.++..+++..++|++|||+.|=+|||||-.||++++.|.+|++|||.+..+..  ...
T Consensus        93 ycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti~  167 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIA  167 (829)
T ss_pred             ecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh--hhh
Confidence            999999999877644   389999999999999999999999999999999999999999999999999876542  223


Q ss_pred             ccccccCcccccCccccc--CcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHHHhhh----------cc
Q 002321          848 LSSKIQSALGYMAPEFAC--RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKK----------AE  915 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~----------~~  915 (936)
                      ......||+.|||||+..  ....|...+|||+.|+...|+---++|-.+..++.....- .+..+.+          +.
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm-TkS~~qpp~lkDk~kws~~  246 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM-TKSGFQPPTLKDKTKWSEF  246 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh-hccCCCCCcccCCccchHH
Confidence            345677999999999762  3345889999999999999999999987777665444221 1222222          33


Q ss_pred             ccceeecccccccccccc
Q 002321          916 WRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~  933 (936)
                      +.++++-++.++|++||+
T Consensus       247 fh~fvK~altknpKkRpt  264 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPT  264 (829)
T ss_pred             HHHHHHHHhcCCCccCCC
Confidence            566778899999999996

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=2.9e-26  Score=229.26  Aligned_cols=201  Identities=23%  Similarity=0.295  Sum_probs=163.2

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC------ee
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS------LQ  762 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~  762 (936)
                      .|.....+|.|+- .|..|-+. .+++||+|++..+-. ....++..+|..++..++|+||++++.++.-+.      ..
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            4556667888887 55555543 588999999854411 223567889999999999999999999986543      45


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCC
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM  842 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  842 (936)
                      |+|||+| ..+|...+...     ++-.....+..|+++|++|||+.||+|||+||+||++..++++||.|||+|+....
T Consensus        97 y~v~e~m-~~nl~~vi~~e-----lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen   97 YLVMELM-DANLCQVILME-----LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT  170 (369)
T ss_pred             HHHHHhh-hhHHHHHHHHh-----cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence            8999999 57898888732     66678889999999999999999999999999999999999999999999986432


Q ss_pred             CccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH
Q 002321          843 LDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF  902 (936)
Q Consensus       843 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~  902 (936)
                      .   ..-+....+..|.|||++.+.. +.+.+||||+||++.||++|+.-|.+.+....+
T Consensus       171 ~---~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~  226 (369)
T KOG0665|consen  171 D---FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQW  226 (369)
T ss_pred             c---cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHH
Confidence            1   2345566788899999997665 899999999999999999999999877654333

>PLN03210 Resistant to P

Probab=99.93  E-value=1.7e-24  Score=273.65  Aligned_cols=347  Identities=24%  Similarity=0.296  Sum_probs=197.2

Q ss_pred             cchhhhhcCCCCcEEEccCccC------CCCCCCCccccc-cccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCC
Q 002321          140 IPDEFFKQCGSLRVISLAKNRF------SGKIPSSLSLCS-TLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGE  212 (936)
Q Consensus       140 i~~~~f~~l~~L~~L~L~~N~l------~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  212 (936)
                      +...+|.++++|+.|.+.++..      ...+|..|..++ +|+.|++.+|.++. +|..| .+.+|++|+|++|++. .
T Consensus       549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~-lP~~f-~~~~L~~L~L~~s~l~-~  625 (1153)
T PLN03210        549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRC-MPSNF-RPENLVKLQMQGSKLE-K  625 (1153)
T ss_pred             ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCC-CCCcC-CccCCcEEECcCcccc-c
Confidence            5667788888888888876542      334566666654 58888888888764 56655 5678888888888887 5


Q ss_pred             CccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccC
Q 002321          213 IPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGEL  292 (936)
Q Consensus       213 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l  292 (936)
                      +|..+..+++|+.|+|++|.....+|+ +..+++|++|+|++|.....+|..+.++++|+.|++++|..-..+|..+ ++
T Consensus       626 L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l  703 (1153)
T PLN03210        626 LWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NL  703 (1153)
T ss_pred             cccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CC
Confidence            677777888888888887754445664 6778888888888876666777777777788888887765444555544 67


Q ss_pred             CccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCcccccc
Q 002321          293 ESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFA  372 (936)
Q Consensus       293 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~  372 (936)
                      ++|+.|++++|.....+|..   ..+|+.|++++|.++ .+|..+ .+++|+.|++.++.... +...            
T Consensus       704 ~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~-l~~~------------  765 (1153)
T PLN03210        704 KSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEK-LWER------------  765 (1153)
T ss_pred             CCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhh-cccc------------
Confidence            77777777777554444432   346677777777765 345443 45666666665543210 0000            


Q ss_pred             ccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccc
Q 002321          373 ENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWL  452 (936)
Q Consensus       373 ~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  452 (936)
                         +.    ...+......++|+.|+|++|...+.+|..++++++|+.|+|++|...+.+|..+ .+++|+.|+|++|..
T Consensus       766 ---~~----~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~  837 (1153)
T PLN03210        766 ---VQ----PLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSR  837 (1153)
T ss_pred             ---cc----ccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCc
Confidence               00    0000000112345555555555444555555555555555555543333344333 344555555555433


Q ss_pred             cccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccC-ccccCCCcccccccCCccEEEcCCC
Q 002321          453 NGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSK-NNLTGPIPIAIAKLTNLQNVDLSFN  522 (936)
Q Consensus       453 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N  522 (936)
                      ...+|..   ..+|+.|+|++|.++ .+|.++..+++|+.|+|++ |++. .+|..+..+++|+.|++++|
T Consensus       838 L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C  903 (1153)
T PLN03210        838 LRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC  903 (1153)
T ss_pred             ccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence            2223321   134444444444444 3444444444444444444 2222 23333444444444444443

syringae 6; Provisional

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.7e-26  Score=223.58  Aligned_cols=200  Identities=22%  Similarity=0.386  Sum_probs=158.5

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEE-EeCCeeEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYY-WTQSLQLLI  765 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~-~~~~~~~lv  765 (936)
                      .+.|.+.+.+|+|.||.+-.++++ +.+.+|+|.+..+.  ...++|.+|.-.--.+ .|.||+.-|++. +..+..+.+
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            456788899999999999999988 47789999886553  3468899998775555 589999877764 556777889


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE-cCC-CCeEEeeccCccccCCC
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLI-DGS-GEPKVGDYGLARLLPML  843 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll-~~~-~~~kl~Dfg~a~~~~~~  843 (936)
                      +||++.|+|.+-+...+    +-+..-.+++.|++.|+.|||++.+||||||.+|||| +.+ -.+|+||||..+..+..
T Consensus       101 qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t  176 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT  176 (378)
T ss_pred             eccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence            99999999998776644    7778888999999999999999999999999999998 333 38999999999865432


Q ss_pred             ccccccccccCcccccCcccccCc----ccCCchhhHHHHHHHHHHHHcCCCCCCccchh
Q 002321          844 DRYVLSSKIQSALGYMAPEFACRT----VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM  899 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~  899 (936)
                      -.     ....+..|.+||....-    ....+.+|+|.||+++|.+++|+.||+....+
T Consensus       177 V~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~  231 (378)
T KOG1345|consen  177 VK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM  231 (378)
T ss_pred             eh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc
Confidence            21     12234458899865221    12456799999999999999999999865433

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=3.6e-25  Score=232.58  Aligned_cols=131  Identities=24%  Similarity=0.305  Sum_probs=111.5

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-----C---CCcceeeeEEEeC-
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-----H---PNLVTLEGYYWTQ-  759 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~~-  759 (936)
                      ..|-..++||+|.|++||.|.+. ..+.||+|+.+...  ...+....||++|++++     |   ..||+++++|... 
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            56778889999999999999865 57899999997553  34567789999999994     3   4699999999764 


Q ss_pred             ---CeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEc
Q 002321          760 ---SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS-NIIHYNIKSSNVLID  824 (936)
Q Consensus       760 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~ivH~Dlkp~NIll~  824 (936)
                         .+++||+|++ |.+|..++....... ++.....+|++||+.||.|||.+ ||+|.||||+|||+.
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrG-lpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRG-LPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCC-CcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence               4779999999 889999998765433 89999999999999999999976 899999999999984

>PLN03210 Resistant to P

Probab=99.92  E-value=3e-24  Score=271.39  Aligned_cols=339  Identities=24%  Similarity=0.298  Sum_probs=221.9

Q ss_pred             CCCccccccccccccccccc------cCCCCCCCCCCC-CCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCC
Q 002321          166 PSSLSLCSTLATINLSSNRF------SSPLPLGIWGLS-ALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIP  238 (936)
Q Consensus       166 p~~~~~l~~L~~L~L~~N~l------~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  238 (936)
                      +..|.++++|+.|.+..+..      ...+|..|..++ +|+.|++.+|.++ .+|..| ...+|++|+|.+|++. .++
T Consensus       551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~  627 (1153)
T PLN03210        551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLW  627 (1153)
T ss_pred             HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccc
Confidence            34466677777777755432      223455555543 4677777776666 455555 3466777777777666 455


Q ss_pred             cccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccc
Q 002321          239 DGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQR  318 (936)
Q Consensus       239 ~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~  318 (936)
                      ..+..+++|++|+|++|.....+|. +..+++|+.|+|++|..-..+|..+..+++|+.|++++|..-+.+|..+ ++++
T Consensus       628 ~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~s  705 (1153)
T PLN03210        628 DGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKS  705 (1153)
T ss_pred             cccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCC
Confidence            5666666777777766554334443 5556666666666655445566666666666666666654333444433 5566


Q ss_pred             cceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEe
Q 002321          319 LKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLD  398 (936)
Q Consensus       319 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~  398 (936)
                      |+.|++++|.....+|..   ..+|+.|++++|.+. .+|.                           .+ .+++|++|+
T Consensus       706 L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~---------------------------~~-~l~~L~~L~  753 (1153)
T PLN03210        706 LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPS---------------------------NL-RLENLDELI  753 (1153)
T ss_pred             CCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccc---------------------------cc-ccccccccc
Confidence            666666665443333322   235556666665553 2222                           11 356677777


Q ss_pred             ccCccc-------CCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEe
Q 002321          399 LSHNEF-------SGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRL  471 (936)
Q Consensus       399 Ls~N~l-------~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  471 (936)
                      +.++..       ....+..+...++|+.|+|++|...+.+|..++++++|+.|+|++|...+.+|..+ .+++|+.|+|
T Consensus       754 l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~L  832 (1153)
T PLN03210        754 LCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDL  832 (1153)
T ss_pred             ccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEEC
Confidence            766332       12222333445789999999998877889999999999999999886555677766 6889999999


Q ss_pred             cCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCC-CcccCCCCcccccccccCeeecCCCc
Q 002321          472 ERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSF-NSLTGGLPKQLVNLVHLSSFNISHNH  547 (936)
Q Consensus       472 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~ls~N~  547 (936)
                      ++|.....+|..   .++|+.|+|++|.++ .+|.++..+++|++|+|++ |+|+ .+|..+..+++|+.++++++.
T Consensus       833 s~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        833 SGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             CCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence            998655455553   367889999999998 6788899999999999998 4555 688888889999999998874

syringae 6; Provisional

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=1.1e-24  Score=226.59  Aligned_cols=200  Identities=24%  Similarity=0.363  Sum_probs=168.9

Q ss_pred             cccccCCCcccccCceEEEEEEeC----CCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-CCCcceeeeEEEeCCeeE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  763 (936)
                      ...|...++||+|+|++||++++.    ..+.||+|.+...+.   ..++..|++++..+. +.||+++.+++..++...
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            345677889999999999999854    367899999866543   467899999999994 999999999999999999


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCCeEEeeccCccccCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG-SGEPKVGDYGLARLLPM  842 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~  842 (936)
                      +|+||++...-.++...      ++..++..+++.+..||+++|..|||||||||.|++.+. .+.-.|.|||+|...+.
T Consensus       112 ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~  185 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG  185 (418)
T ss_pred             EEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence            99999999999988876      677889999999999999999999999999999999975 57889999999972210


Q ss_pred             C------------------------------------------ccccccccccCcccccCcccccCcccCCchhhHHHHH
Q 002321          843 L------------------------------------------DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFG  880 (936)
Q Consensus       843 ~------------------------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG  880 (936)
                      .                                          ..........||++|+|||++.....-++++||||.|
T Consensus       186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G  265 (418)
T KOG1167|consen  186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG  265 (418)
T ss_pred             hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence            0                                          0001112345899999999998888889999999999


Q ss_pred             HHHHHHHcCCCCCCccc
Q 002321          881 VLVLEVVTGKRPLSTWK  897 (936)
Q Consensus       881 ~~l~el~~g~~Pf~~~~  897 (936)
                      |++..+++++.||-...
T Consensus       266 VI~Lslls~~~PFf~a~  282 (418)
T KOG1167|consen  266 VILLSLLSRRYPFFKAK  282 (418)
T ss_pred             ceeehhhccccccccCc
Confidence            99999999999996654

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.90  E-value=1.7e-24  Score=228.34  Aligned_cols=200  Identities=21%  Similarity=0.229  Sum_probs=166.8

Q ss_pred             ccccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCccchHHHHHHHHHHHHcCC------CCCcceeeeEEEeCCee
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR------HPNLVTLEGYYWTQSLQ  762 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~~~  762 (936)
                      ..|......|+|-|++|.+|.+.. |..||||++......  .+.=.+|+++|+++.      --|+++++-.|....+.
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M--~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL  509 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM--HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL  509 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH--hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence            345666678999999999999764 789999999755332  355578999999995      35899999999999999


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-CCeEEeeccCccccC
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS-GEPKVGDYGLARLLP  841 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~  841 (936)
                      +||+|-+ .-+|.+++++.+..--+.......++.|+.-||..|-.-||+|.||||.||||++. ..+||||||.|..+.
T Consensus       510 ClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~  588 (752)
T KOG0670|consen  510 CLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFAS  588 (752)
T ss_pred             EEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccc
Confidence            9999998 57999999987766568888899999999999999999999999999999999875 478999999997764


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccc
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWK  897 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~  897 (936)
                      ..+    .+...-+..|.|||++. +.+|+...|+||+||++||++||+.-|.+..
T Consensus       589 ene----itPYLVSRFYRaPEIiL-G~~yd~~iD~WSvgctLYElYtGkIlFpG~T  639 (752)
T KOG0670|consen  589 ENE----ITPYLVSRFYRAPEIIL-GLPYDYPIDTWSVGCTLYELYTGKILFPGRT  639 (752)
T ss_pred             ccc----ccHHHHHHhccCcceee-cCcccCCccceeeceeeEEeeccceecCCCC
Confidence            322    12223344599999995 5578999999999999999999999998754

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=2.7e-23  Score=243.04  Aligned_cols=123  Identities=32%  Similarity=0.372  Sum_probs=68.6

Q ss_pred             cccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEec
Q 002321          393 SLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLE  472 (936)
Q Consensus       393 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  472 (936)
                      +|+.|+|++|+|++ +|..   .++|+.|++++|+|+. +|..   ..+|+.|+|++|+|++ +|..   ..+|+.|+++
T Consensus       343 ~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS  410 (788)
T PRK15387        343 GLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVS  410 (788)
T ss_pred             ccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---ccCCCEEEcc
Confidence            45666666666653 2322   2345556666666653 3432   2356666666666663 4432   2356666666


Q ss_pred             CCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCccc
Q 002321          473 RNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQL  532 (936)
Q Consensus       473 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l  532 (936)
                      +|+|+ .+|...   .+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++..|..+
T Consensus       411 ~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L  465 (788)
T PRK15387        411 GNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL  465 (788)
T ss_pred             CCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence            66666 344432   34556666666666 456666666666666666666665555544

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.89  E-value=5.7e-23  Score=242.30  Aligned_cols=344  Identities=20%  Similarity=0.315  Sum_probs=176.4

Q ss_pred             hhcccCCCC---ChhHHHHHHHHHHhccCCC---CCCCCCCCCCCCCcccee----------------EEecCCCCceEE
Q 002321           23 ALTRSLNPS---LNDDVLGLIVFKADIQDPN---GKLSSWSEDDDTPCNWFG----------------VKCSPRSNRVIE   80 (936)
Q Consensus        23 ~~~~~~~~~---~~~~~~aLl~~k~~~~d~~---~~l~sW~~~~~~~c~w~g----------------v~c~~~~~~v~~   80 (936)
                      |....|+|.   .++|.++++++.+.+..|.   +.-..|++.++ .|.=..                |.|..  +.|+.
T Consensus        49 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~-fc~~~~~~~~~l~~~~~~~~~tv~~~~--~~vt~  125 (754)
T PRK15370         49 CIAYLCHPPETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQ-YCILSENSQEILSIVFNTEGYTVEGGG--KSVTY  125 (754)
T ss_pred             HHHHHhCCCCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCc-ccccCCcchhhheeeecCCceEEecCC--Ccccc
Confidence            555667764   4679999999999998772   23344998877 884322                66754  56666


Q ss_pred             eccCCCCCCccccc--ccccCccccEEeccCCcccCcC---CCchh-----hcCCCcEEEccCcccccccchhhhhcCCC
Q 002321           81 LTLNGLSLTGRIGR--GLLQLQFLRKLSLSSNNLTGSI---SPNLA-----KLQNLRVIDLSGNSLSGSIPDEFFKQCGS  150 (936)
Q Consensus        81 l~l~~~~l~g~~~~--~l~~l~~L~~L~L~~n~l~~~~---~~~l~-----~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~  150 (936)
                      +..-|.........  ...+....-. +-..+.-.+..   ..++.     -..+...|+|++++++ .+|..+   .++
T Consensus       126 l~~~g~~~~~~~~~~~~~~~~~~~w~-~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~I---p~~  200 (754)
T PRK15370        126 TRVTESEQASSASGSKDAVNYELIWS-EWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACI---PEQ  200 (754)
T ss_pred             cccccccccccCCCCCChhhHHHHHH-HHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCccc---ccC
Confidence            65544322111100  0000000000 00000000000   00010     0123455555555555 344332   134


Q ss_pred             CcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeeccc
Q 002321          151 LRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSK  230 (936)
Q Consensus       151 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  230 (936)
                      |+.|+|++|+|+. +|..+.  ++|++|+|++|+|+. +|..+.  .+|+.|+|++|+++ .+|..+.  ++|+.|+|++
T Consensus       201 L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~  271 (754)
T PRK15370        201 ITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFH  271 (754)
T ss_pred             CcEEEecCCCCCc-CChhhc--cCCCEEECCCCcccc-CChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcC
Confidence            5555555555552 333332  355555555555553 333321  24555666666555 4444433  3556666666


Q ss_pred             ccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccC
Q 002321          231 NMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVP  310 (936)
Q Consensus       231 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  310 (936)
                      |+|+ .+|..+.  ++|+.|+|++|+|++ +|..+.  +.|+.|++++|.++. +|..+.  ++|+.|++++|.+++ +|
T Consensus       272 N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP  341 (754)
T PRK15370        272 NKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LP  341 (754)
T ss_pred             CccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CC
Confidence            6655 3444332  356666666666653 232221  245566666666663 333222  467777777777764 45


Q ss_pred             cccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCC
Q 002321          311 ISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSS  390 (936)
Q Consensus       311 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~  390 (936)
                      ..+.  ++|+.|++++|+|+ .+|..+.  ++|+.|+|++|++. .+|..+.                            
T Consensus       342 ~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~----------------------------  387 (754)
T PRK15370        342 ASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP----------------------------  387 (754)
T ss_pred             hhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH----------------------------
Confidence            4443  57777888887777 4555442  57778888888776 3343221                            


Q ss_pred             CCcccEEeccCcccCCCChh----hhcccccCCeeeccCcccc
Q 002321          391 FESLQFLDLSHNEFSGETPA----TIGALSGLQLLNLSRNSLV  429 (936)
Q Consensus       391 l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~  429 (936)
                       ..|+.|++++|+|+ .+|.    .+..++.+..|+|.+|.++
T Consensus       388 -~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        388 -AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             -HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence             24666666666665 3333    3334466677777777765

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=8.5e-23  Score=238.86  Aligned_cols=263  Identities=27%  Similarity=0.347  Sum_probs=191.2

Q ss_pred             CCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEec
Q 002321          197 SALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNL  276 (936)
Q Consensus       197 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L  276 (936)
                      .+-..|+|++|.|+ .+|..+.  ++|+.|++.+|+|+. +|..   +++|++|+|++|+|+.. |.             
T Consensus       201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~LtsL-P~-------------  259 (788)
T PRK15387        201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLTSL-PV-------------  259 (788)
T ss_pred             CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccCcc-cC-------------
Confidence            44667888888888 5777665  478888888888883 4542   46677777777776632 21             


Q ss_pred             cCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccC
Q 002321          277 RKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGD  356 (936)
Q Consensus       277 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  356 (936)
                                 .   .++|+.|+|++|+|+ .+|..   ..+|+.|++++|+++. +|.   ..++|+.|+|++|++.+ 
T Consensus       260 -----------l---p~sL~~L~Ls~N~L~-~Lp~l---p~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~-  316 (788)
T PRK15387        260 -----------L---PPGLLELSIFSNPLT-HLPAL---PSGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLAS-  316 (788)
T ss_pred             -----------c---ccccceeeccCCchh-hhhhc---hhhcCEEECcCCcccc-ccc---cccccceeECCCCcccc-
Confidence                       1   235566666666665 33332   2456677777777763 443   23567788888877762 


Q ss_pred             CChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccc
Q 002321          357 LPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAI  436 (936)
Q Consensus       357 ~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  436 (936)
                      +|.                        +      ..+|+.|++++|+|++ +|..   ..+|++|+|++|+|++ +|.. 
T Consensus       317 Lp~------------------------l------p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l-  360 (788)
T PRK15387        317 LPA------------------------L------PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL-  360 (788)
T ss_pred             CCC------------------------C------cccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCC-
Confidence            221                        1      1357788889999874 4432   2579999999999995 5543 


Q ss_pred             cCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccE
Q 002321          437 GDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQN  516 (936)
Q Consensus       437 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  516 (936)
                        ..+|+.|++++|+|++ +|..   ..+|+.|+|++|+|+ .+|..   .++|+.|++++|+|++ +|...   .+|+.
T Consensus       361 --p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~  426 (788)
T PRK15387        361 --PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLTS-LPMLP---SGLLS  426 (788)
T ss_pred             --Ccccceehhhcccccc-Cccc---ccccceEEecCCccc-CCCCc---ccCCCEEEccCCcCCC-CCcch---hhhhh
Confidence              3578889999999985 6654   357999999999999 46654   3689999999999995 67543   46889


Q ss_pred             EEcCCCcccCCCCcccccccccCeeecCCCcccccCCC
Q 002321          517 VDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPA  554 (936)
Q Consensus       517 L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~  554 (936)
                      |+|++|+|+ .+|..+.++++|+.|+|++|+|+|.+|.
T Consensus       427 L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~  463 (788)
T PRK15387        427 LSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  463 (788)
T ss_pred             hhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence            999999998 7999999999999999999999998775

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.89  E-value=7.4e-24  Score=260.29  Aligned_cols=189  Identities=16%  Similarity=0.125  Sum_probs=132.9

Q ss_pred             cCCC-CCcceeeeEE-------EeCCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 002321          743 KVRH-PNLVTLEGYY-------WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY  814 (936)
Q Consensus       743 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~  814 (936)
                      .++| +||+++++++       ......+.++||+ +++|.+++....  ..+++.++..++.||++||+|||++||+||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~gIvHr  104 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQGIVVH  104 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            3445 5777888876       2233567788988 679999997532  348999999999999999999999999999


Q ss_pred             CCCCCCEEEcCC-------------------CCeEEeeccCccccCCCcc--------------ccccccccCcccccCc
Q 002321          815 NIKSSNVLIDGS-------------------GEPKVGDYGLARLLPMLDR--------------YVLSSKIQSALGYMAP  861 (936)
Q Consensus       815 Dlkp~NIll~~~-------------------~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~~~~~y~aP  861 (936)
                      ||||+|||++..                   +.+|++|||+++.......              ........+|+.||||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            999999999654                   4556666666653211000              0001113478889999


Q ss_pred             ccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHH-HHHHHHHHHh--hhccccceeecccccccccccccC
Q 002321          862 EFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWW-FSVTWLEEHW--KKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       862 E~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      |++. +..++.++|||||||++|||++|..|+........ ......++.+  ...+..+++.+||..+|.+||+++
T Consensus       185 E~~~-~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~  260 (793)
T PLN00181        185 EEDN-GSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMS  260 (793)
T ss_pred             hhhc-cCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChH
Confidence            9985 44689999999999999999999999865432111 1111111111  223445677889999999999864

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=1.1e-22  Score=220.85  Aligned_cols=161  Identities=22%  Similarity=0.248  Sum_probs=124.2

Q ss_pred             ccccCCCcccccCceEEEEEEeC--CCcEEEEEEeeccC----ccchHHHHHHHHHHHHcCCCCCcce-eeeEEEeCCee
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR--DGRPVAIKKLTVSS----LVKSQEDFEREVKKLGKVRHPNLVT-LEGYYWTQSLQ  762 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~  762 (936)
                      ..|+..+.||+|+||+||+|+++  +++.||||+.....    .....+.+.+|++++++++|+|+++ ++++    +..
T Consensus        18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~   93 (365)
T PRK09188         18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKD   93 (365)
T ss_pred             CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCc
Confidence            45788889999999999999875  47778999875321    1123567899999999999999985 4432    456


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC-CCCCEEEcCCCCeEEeeccCccccC
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI-KSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dl-kp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      ++||||++|++|... ..      ..   ...++.|+++||+|||++||+|||| ||+|||++.++.+||+|||+|+.+.
T Consensus        94 ~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~  163 (365)
T PRK09188         94 GLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR  163 (365)
T ss_pred             EEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence            999999999999732 11      11   1467889999999999999999999 9999999999999999999998764


Q ss_pred             CCccccc------cccccCcccccCcccc
Q 002321          842 MLDRYVL------SSKIQSALGYMAPEFA  864 (936)
Q Consensus       842 ~~~~~~~------~~~~~~~~~y~aPE~~  864 (936)
                      .......      -....+++.|+|||.+
T Consensus       164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~  192 (365)
T PRK09188        164 RRGALYRIAAYEDLRHLLKHKRTYAPDAL  192 (365)
T ss_pred             cCcchhhhhhhhhhhhhhccCccCCcccC
Confidence            3221111      1245567789999977

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=2e-22  Score=193.49  Aligned_cols=202  Identities=18%  Similarity=0.273  Sum_probs=166.5

Q ss_pred             ccccCCCcccccCceEEEEEE-eCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCC-CCcceeeeEEEeCCeeEEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH-PNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ..|...++||.|+||.+|.|. ..+|+.||||+-+...   ....+..|.++...+++ ..|..+..|..+.....+|||
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            346778899999999999998 4579999999865432   23567889999999976 678888888888888899999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC---CCeEEeeccCccccCCCc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS---GEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~~  844 (936)
                      .. |.+|.++..-..+  .++..+.+..+-|++.-++|+|.++++||||||+|+|..-+   ..+.++|||+|+.+-+..
T Consensus        92 LL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~  168 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR  168 (341)
T ss_pred             cc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence            99 8999998876543  28889999999999999999999999999999999998643   468999999998764332


Q ss_pred             c-----ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch
Q 002321          845 R-----YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM  898 (936)
Q Consensus       845 ~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~  898 (936)
                      .     +.......||.+|.+-... -+.+.+.+.|+-|+|.++.++--|..||++...
T Consensus       169 t~~HIpyre~r~ltGTaRYASinAh-~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  169 TRQHIPYREDRNLTGTARYASINAH-LGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             ccccCccccCCccceeeeehhhhhh-hhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence            2     2334456788899886644 344567889999999999999999999999765

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=2.3e-23  Score=202.80  Aligned_cols=234  Identities=20%  Similarity=0.273  Sum_probs=180.6

Q ss_pred             cCCCcccccCceEEEEEEeCCCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          693 NKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       693 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      ....+|.+...|+.|+|+|+ |..+++|++...... +..++|..|.-.++.+.||||+++++.|.......++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            44457889999999999997 667788888655433 2346799999999999999999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN--IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      |+|+..+++... -..+..++.+++.++|+|++|||+..  |.---+..+.+++|++.+.+|+- +-+++.      ...
T Consensus       272 gslynvlhe~t~-vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarism-ad~kfs------fqe  343 (448)
T KOG0195|consen  272 GSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISM-ADTKFS------FQE  343 (448)
T ss_pred             hHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheec-ccceee------eec
Confidence            999999998653 34778899999999999999999863  44456889999999999888761 111110      011


Q ss_pred             ccccCcccccCcccccCcccC--CchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH------HHhhhccccceee
Q 002321          850 SKIQSALGYMAPEFACRTVKI--TDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE------EHWKKAEWRNVSM  921 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~--~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~  921 (936)
                      ....-.|.||+||.+....+.  -.++|+|||++++||+.|++.||.+...++.....-.+      |.-.+..+..++.
T Consensus       344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~  423 (448)
T KOG0195|consen  344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMN  423 (448)
T ss_pred             cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHH
Confidence            122335679999988544332  24799999999999999999999999887655333333      2223345667788


Q ss_pred             cccccccccccccC
Q 002321          922 RSCKGSSRQRRRFQ  935 (936)
Q Consensus       922 ~~l~~~p~~Rp~f~  935 (936)
                      .|++-||.+||.|+
T Consensus       424 icmnedpgkrpkfd  437 (448)
T KOG0195|consen  424 ICMNEDPGKRPKFD  437 (448)
T ss_pred             HHhcCCCCcCCCcc
Confidence            99999999999997

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.86  E-value=5.1e-22  Score=198.16  Aligned_cols=145  Identities=21%  Similarity=0.216  Sum_probs=114.2

Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      |+|.++++...  ..+++.+++.++.|+++||+|||+++      ||+||+++.++.+|+  ||.++.....       .
T Consensus         1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~   63 (176)
T smart00750        1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------Q   63 (176)
T ss_pred             CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-------c
Confidence            68999997533  24999999999999999999999998      999999999999999  9998765321       1


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-------------HHhhh-cccc
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-------------EHWKK-AEWR  917 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-------------~~~~~-~~~~  917 (936)
                      ..+++.|||||++. +..++.++||||+||++|||++|+.||...............             ..+.. .+++
T Consensus        64 ~~g~~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  142 (176)
T smart00750       64 SRVDPYFMAPEVIQ-GQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFA  142 (176)
T ss_pred             CCCcccccChHHhc-CCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHH
Confidence            25788999999984 557899999999999999999999999765432111111100             11111 1689


Q ss_pred             ceeeccccccccccccc
Q 002321          918 NVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f  934 (936)
                      +++.+||..+|.+||++
T Consensus       143 ~~i~~cl~~~p~~Rp~~  159 (176)
T smart00750      143 DFMRVCASRLPQRREAA  159 (176)
T ss_pred             HHHHHHHhcccccccCH
Confidence            99999999999999986

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=3.7e-21  Score=210.63  Aligned_cols=204  Identities=21%  Similarity=0.271  Sum_probs=165.8

Q ss_pred             cccCCCcccccCceEEEEEEeCCC--cEEEEEEeeccCccchHHHHHHHHHHHHcCCC----CCcceeeeEE-EeCCeeE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRDG--RPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH----PNLVTLEGYY-WTQSLQL  763 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~  763 (936)
                      .|...++||+|+||.||.|...+.  ..+|+|........... .+..|..++..+..    +++..+++.. ......+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            578888999999999999997653  47899987654333222 67889999888863    6899999988 4777889


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-----CCeEEeeccCcc
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS-----GEPKVGDYGLAR  838 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~-----~~~kl~Dfg~a~  838 (936)
                      +||+.+ |.+|.++.+... .+.++.....+|+.|++.+|+++|+.|++||||||.|+++...     ..+.+.|||+++
T Consensus        98 iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             EEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            999999 899999886655 4559999999999999999999999999999999999999865     369999999998


Q ss_pred             ccC--CCc----ccc-c-cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch
Q 002321          839 LLP--MLD----RYV-L-SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM  898 (936)
Q Consensus       839 ~~~--~~~----~~~-~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~  898 (936)
                      ...  ...    ... . .....||.+|++++.- .+.+.+.+.|+||++.++.|+..|..||...++
T Consensus       176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H-~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~  242 (322)
T KOG1164|consen  176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVH-LGIEQGRRDDLESLFYMLLELLKGSLPWEALEM  242 (322)
T ss_pred             cccccCCCCcccccCCCCccCCCCccccccHHHh-CCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence            332  111    111 1 2335599999999976 566889999999999999999999999977654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=2.9e-21  Score=194.01  Aligned_cols=201  Identities=18%  Similarity=0.256  Sum_probs=170.3

Q ss_pred             cccCCCcccccCceEEEEEE-eCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-CCCcceeeeEEEeCCeeEEEEEe
Q 002321          691 LLNKDCELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      -|.++++||+|+||+++.|+ +-+++.||||.-...+   ...++..|.+.++.+. .+.|..++-+........+|+|.
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            36889999999999999998 3479999999765443   2466888999999995 69999998888888888899999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-----CeEEeeccCccccCCC
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG-----EPKVGDYGLARLLPML  843 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~-----~~kl~Dfg~a~~~~~~  843 (936)
                      + |.+|.|+..-.++  .++......+|.|++.-++|+|++.+|.|||||+|+||...+     .+.++|||+|+.+.++
T Consensus       106 L-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp  182 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP  182 (449)
T ss_pred             h-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence            9 8999998876543  399999999999999999999999999999999999997654     5899999999987654


Q ss_pred             cc-----ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch
Q 002321          844 DR-----YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM  898 (936)
Q Consensus       844 ~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~  898 (936)
                      +.     +...-...||.+||+-..-. +++-+.+.|+-|+|-++++.+-|..||++.+.
T Consensus       183 ~TkqHIPYrE~KSLsGTARYMSINTHl-GrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  183 KTKQHIPYREHKSLSGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             cccccCccccccccccceeeeEeeccc-cchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            32     34455677999999988764 45678899999999999999999999998653

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.85  E-value=2.7e-21  Score=228.13  Aligned_cols=290  Identities=25%  Similarity=0.393  Sum_probs=141.9

Q ss_pred             ceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEc
Q 002321           77 RVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISL  156 (936)
Q Consensus        77 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L  156 (936)
                      ..+.|++++++++ .+|..+.  +.|+.|+|++|+|+ .+|..+.  ++|++|+|++|+|+ .+|..++   .+|+.|+|
T Consensus       179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~---~~L~~L~L  248 (754)
T PRK15370        179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP---DTIQEMEL  248 (754)
T ss_pred             CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh---ccccEEEC
Confidence            4455666666555 3444332  35666666666665 2344332  35666666666665 4554332   24555555


Q ss_pred             cCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeeccccccccc
Q 002321          157 AKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGS  236 (936)
Q Consensus       157 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  236 (936)
                      ++|+|+ .+|..+.  ++|+.|+|++|+|+. +|..+.  ++|+.|+|++|+|++ +|..+.  ++|+.|++++|+++. 
T Consensus       249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-  318 (754)
T PRK15370        249 SINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-  318 (754)
T ss_pred             cCCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-
Confidence            555555 3344332  345555555555553 333332  245555555555542 333222  244445555555442 


Q ss_pred             CCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccc
Q 002321          237 IPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNL  316 (936)
Q Consensus       237 ~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l  316 (936)
                      +|..+.  +                        +|+.|++++|.+++ +|..+.  ++|+.|+|++|+|+ .+|..+.  
T Consensus       319 LP~~l~--~------------------------sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--  366 (754)
T PRK15370        319 LPETLP--P------------------------GLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--  366 (754)
T ss_pred             CCcccc--c------------------------cceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--
Confidence            222221  3                        44445555555543 333332  45666666666665 3444332  


Q ss_pred             cccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccE
Q 002321          317 QRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQF  396 (936)
Q Consensus       317 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~  396 (936)
                      ++|+.|+|++|+|+ .+|..+.  ..|+.|++++|++. .+|..+                       +.....++++..
T Consensus       367 ~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl-----------------------~~~~~~~~~l~~  419 (754)
T PRK15370        367 PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESL-----------------------PHFRGEGPQPTR  419 (754)
T ss_pred             CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhH-----------------------HHHhhcCCCccE
Confidence            46677777777776 3444443  24666777777765 334321                       111223456777


Q ss_pred             EeccCcccCCCChhhhcccccCCeeeccCccccC-CCCccccCcccCCeeecCCccc
Q 002321          397 LDLSHNEFSGETPATIGALSGLQLLNLSRNSLVG-PIPVAIGDLKALNVLDLSENWL  452 (936)
Q Consensus       397 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l  452 (936)
                      |+|.+|.++.      ..+.+|+.| ++.+.+.| .++...+.+.+++....-.+.+
T Consensus       420 L~L~~Npls~------~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~~~~~l~~a~  469 (754)
T PRK15370        420 IIVEYNPFSE------RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVRVTRPLHQAV  469 (754)
T ss_pred             EEeeCCCccH------HHHHHHHHh-hhcccccCCcccccccccccccccchHHHHH
Confidence            7777777752      233444444 33444433 2333444444554433333333

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.84  E-value=7.7e-21  Score=190.14  Aligned_cols=140  Identities=18%  Similarity=0.207  Sum_probs=109.4

Q ss_pred             CCcccccCceEEEEEEeCCCcEEEEEEeeccCccc-h------------------------HHHHHHHHHHHHcCCCCCc
Q 002321          695 DCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVK-S------------------------QEDFEREVKKLGKVRHPNL  749 (936)
Q Consensus       695 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~------------------------~~~~~~E~~~l~~l~h~ni  749 (936)
                      .+.||+|+||.||+|...+|+.||||+++...... .                        .....+|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            35799999999999998889999999997542110 0                        1123459999999988877


Q ss_pred             ceeeeEEEeCCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCCCEEEcCCCC
Q 002321          750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHL-HQSNIIHYNIKSSNVLIDGSGE  828 (936)
Q Consensus       750 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~L-H~~~ivH~Dlkp~NIll~~~~~  828 (936)
                      .....+...  ..++||||++++++........   .++..+..+++.|++.+|+|+ |+.||+||||||+||+++ ++.
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~---~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~  155 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDA---PLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK  155 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence            544433222  2389999998877765433222   388899999999999999999 699999999999999998 588


Q ss_pred             eEEeeccCcccc
Q 002321          829 PKVGDYGLARLL  840 (936)
Q Consensus       829 ~kl~Dfg~a~~~  840 (936)
                      ++|+|||+|...
T Consensus       156 v~LiDFG~a~~~  167 (190)
T cd05147         156 LYIIDVSQSVEH  167 (190)
T ss_pred             EEEEEccccccC
Confidence            999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=4e-20  Score=205.10  Aligned_cols=240  Identities=30%  Similarity=0.405  Sum_probs=188.1

Q ss_pred             ccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccc--hHHHHHHHHHHHHcCCCC-CcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVK--SQEDFEREVKKLGKVRHP-NLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  768 (936)
                      |...+.||.|+||.||++...  ..+|+|.+.......  ....+.+|+.+++.+.|+ +++++.+++......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            345567999999999999987  789999997665444  367899999999999988 799999999877778999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-CeEEeeccCccccCCCccc-
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG-EPKVGDYGLARLLPMLDRY-  846 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~-  846 (936)
                      +.++++.+++........+.......++.|++.+++|+|+.+++|||+||+||+++..+ .++++|||.++........ 
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~  159 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS  159 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence            99999997776543112388899999999999999999999999999999999999998 7999999999855433222 


Q ss_pred             ---cccccccCcccccCcccccCc--ccCCchhhHHHHHHHHHHHHcCCCCCCccchh--HHHHHHHHHHHh--------
Q 002321          847 ---VLSSKIQSALGYMAPEFACRT--VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM--WWFSVTWLEEHW--------  911 (936)
Q Consensus       847 ---~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~--~~~~~~~~~~~~--------  911 (936)
                         .......++..|+|||.....  ..++...|+||+|++++++++|..||......  ............        
T Consensus       160 ~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (384)
T COG0515         160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL  239 (384)
T ss_pred             cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccccc
Confidence               134567789999999988553  57889999999999999999999998777631  111111111111        


Q ss_pred             hh-------ccccceeecccccccccccc
Q 002321          912 KK-------AEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       912 ~~-------~~~~~~~~~~l~~~p~~Rp~  933 (936)
                      ..       ....+++.+++..+|.+|..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~r~~  268 (384)
T COG0515         240 SPSNPELISKAASDLLKKLLAKDPKNRLS  268 (384)
T ss_pred             CccccchhhHHHHHHHHHHHhcCchhcCC
Confidence            11       24567777888888877754

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=5.9e-20  Score=180.38  Aligned_cols=188  Identities=18%  Similarity=0.159  Sum_probs=140.2

Q ss_pred             CCCcccccCceEEEEEEeCCCcEEEEEEeeccCccc---hHHHHHHHHHHHHcCC-CCCcceeeeEEEeCCeeEEEEEec
Q 002321          694 KDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVK---SQEDFEREVKKLGKVR-HPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       694 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      ....|++|+||+||.+.. ++.+++.+.+.......   ....+.+|+++++++. |+++++++++    ...+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            456799999999997765 68888888775443211   1235789999999995 5889999886    3458999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC-CCCCEEEcCCCCeEEeeccCccccCCCccc--
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI-KSSNVLIDGSGEPKVGDYGLARLLPMLDRY--  846 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dl-kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--  846 (936)
                      +|.+|.+....          ....++.|++++++++|+.||+|||| ||.|||++.++.++|+|||+|.........  
T Consensus        81 ~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         81 AGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             cCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            99988654321          11357789999999999999999999 799999999999999999999865432210  


Q ss_pred             --c-------ccccccCcccccCcccccCcccCC-chhhHHHHHHHHHHHHcCCCCCCcc
Q 002321          847 --V-------LSSKIQSALGYMAPEFACRTVKIT-DKCDVYGFGVLVLEVVTGKRPLSTW  896 (936)
Q Consensus       847 --~-------~~~~~~~~~~y~aPE~~~~~~~~~-~~~DvwSlG~~l~el~~g~~Pf~~~  896 (936)
                        .       .......++.|++|+...--...+ .+.+.++.|+-+|.++||..|+...
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence              0       011223567788888553222334 5678899999999999999887553

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=1.3e-19  Score=182.20  Aligned_cols=140  Identities=21%  Similarity=0.273  Sum_probs=111.5

Q ss_pred             CCcccccCceEEEEEEeCCCcEEEEEEeeccCccc-h------------------------HHHHHHHHHHHHcCCCCCc
Q 002321          695 DCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVK-S------------------------QEDFEREVKKLGKVRHPNL  749 (936)
Q Consensus       695 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~------------------------~~~~~~E~~~l~~l~h~ni  749 (936)
                      .+.||+|+||.||+|+..+|+.||||+++...... .                        ...+.+|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            35799999999999998789999999997542110 0                        1234689999999999988


Q ss_pred             ceeeeEEEeCCeeEEEEEecCCCChhhh-hhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCC
Q 002321          750 VTLEGYYWTQSLQLLIYEFVSGGSLHKH-LHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ-SNIIHYNIKSSNVLIDGSG  827 (936)
Q Consensus       750 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~ivH~Dlkp~NIll~~~~  827 (936)
                      .....+....  .++||||++|+++... +...    .++..+..+++.|++.++.++|+ .||+||||||+||+++ ++
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~----~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~  154 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKDV----PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG  154 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhhc----cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence            6554444332  4899999988755433 3322    26788899999999999999999 9999999999999999 89


Q ss_pred             CeEEeeccCccccC
Q 002321          828 EPKVGDYGLARLLP  841 (936)
Q Consensus       828 ~~kl~Dfg~a~~~~  841 (936)
                      .++|+|||+++...
T Consensus       155 ~~~liDFG~a~~~~  168 (190)
T cd05145         155 KPYIIDVSQAVELD  168 (190)
T ss_pred             CEEEEEcccceecC
Confidence            99999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=3.5e-21  Score=223.21  Aligned_cols=237  Identities=20%  Similarity=0.166  Sum_probs=179.9

Q ss_pred             cCCCcccccCceEEEEEEeC-CCcEEEEEEeec----cCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          693 NKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTV----SSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       693 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~----~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ...+.+|.|++|.|+.+... ..+..+.|.++.    .... .....+..|+.+-..+.|+|++.....+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34567999999988877754 344455554431    1111 11233667888888999999998888877766666669


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++ +|..++.....   +...++..+++|++.|+.|+|+.||.|||+|++|++++.+|.+||+|||.+.....+.+.
T Consensus       401 E~~~~-Dlf~~~~~~~~---~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGK---LTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             hcccH-HHHHHHhcccc---cchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            99998 99999987633   888889999999999999999999999999999999999999999999999876554443


Q ss_pred             --cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-------------HHHHHHHHh
Q 002321          847 --VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-------------SVTWLEEHW  911 (936)
Q Consensus       847 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-------------~~~~~~~~~  911 (936)
                        .......|+..|+|||+..+...-....||||.|++++.|.+|+.||.........             ...+.-...
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSL  556 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHh
Confidence              45566778889999999955544556799999999999999999999776543221             001111223


Q ss_pred             hhccccceeecccccccccccc
Q 002321          912 KKAEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       912 ~~~~~~~~~~~~l~~~p~~Rp~  933 (936)
                      .+..-+.++.++++.||.+|-+
T Consensus       557 lp~~~~~~~~~~l~~~P~~R~t  578 (601)
T KOG0590|consen  557 LPRETRIIIYRMLQLDPTKRIT  578 (601)
T ss_pred             chhhHHHHHHHHccCChhheec
Confidence            3455678888999999999854

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.82  E-value=3.9e-21  Score=220.05  Aligned_cols=236  Identities=21%  Similarity=0.269  Sum_probs=180.2

Q ss_pred             cccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHH---HHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFE---REVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      .+...+.+|.+.|=+|.+|++++|. |+||++-.....-..+.+.   +|++ ...++|||++++.-+...+...|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            3566678999999999999998887 9999996554333333333   4444 556699999999888878888899999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCcccc--CCCc-
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL--PMLD-  844 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~--~~~~-  844 (936)
                      |+ .-+|+|.+....   ++...+...|+.|++.|+.-+|..||+|||||.+|||++.-..+.|+||.--+..  +... 
T Consensus       102 yv-khnLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  102 YV-KHNLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             HH-hhhhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence            99 468999887643   4888899999999999999999999999999999999999999999999765432  1111 


Q ss_pred             -cc--cccccccCcccccCcccccCcc---------c-CCchhhHHHHHHHHHHHHc-CCCCCCccchhH-----HHHHH
Q 002321          845 -RY--VLSSKIQSALGYMAPEFACRTV---------K-ITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMW-----WFSVT  905 (936)
Q Consensus       845 -~~--~~~~~~~~~~~y~aPE~~~~~~---------~-~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~-----~~~~~  905 (936)
                       ++  ...+. .+-..|.|||.+..+.         . .+++.||||+||+++|+++ |++||.-..-..     .+..+
T Consensus       178 adf~fFFDTS-rRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e  256 (1431)
T KOG1240|consen  178 ADFTFFFDTS-RRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPE  256 (1431)
T ss_pred             ccceEEEecC-CceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHH
Confidence             11  01111 1122499999885422         1 5678999999999999999 788886543322     23344


Q ss_pred             HHHHHhhhccccceeecccccccccccc
Q 002321          906 WLEEHWKKAEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~l~~~p~~Rp~  933 (936)
                      +.-+...+...++++..|.+.||.+|-+
T Consensus       257 ~~Le~Ied~~~Rnlil~Mi~rdPs~RlS  284 (1431)
T KOG1240|consen  257 QLLEKIEDVSLRNLILSMIQRDPSKRLS  284 (1431)
T ss_pred             HHHHhCcCccHHHHHHHHHccCchhccC
Confidence            5556777789999999999999999965

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.81  E-value=3.4e-20  Score=186.70  Aligned_cols=171  Identities=15%  Similarity=0.138  Sum_probs=130.1

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccch--HH------HHHHHHHHHHcCCCCCcceeeeEEEeC-
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKS--QE------DFEREVKKLGKVRHPNLVTLEGYYWTQ-  759 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~------~~~~E~~~l~~l~h~niv~l~~~~~~~-  759 (936)
                      ...|...+.+|.|+||.||.+.. ++..+|||.+........  ..      .+++|++.+.+++|++|..+.+++... 
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            34567778899999999999766 577899999965432221  12      268999999999999999999886643 


Q ss_pred             -------CeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEe
Q 002321          760 -------SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVG  832 (936)
Q Consensus       760 -------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~  832 (936)
                             ...++||||++|.+|.++..       .+.    ....+++.++..+|+.|++|||+||.||+++.+| ++++
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li  176 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII  176 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence                   24689999999999988732       222    2456899999999999999999999999999988 9999


Q ss_pred             eccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHH
Q 002321          833 DYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVV  887 (936)
Q Consensus       833 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~  887 (936)
                      |||..+......               |-+.+.....+..++|+||+|+++....
T Consensus       177 Dfg~~~~~~e~~---------------a~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        177 DLSGKRCTAQRK---------------AKDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             ECCCcccccchh---------------hHHHHHHHhHhcccccccceeEeehHHH
Confidence            999886542111               0111223335668999999999876543

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.80  E-value=3.1e-21  Score=175.73  Aligned_cols=179  Identities=31%  Similarity=0.449  Sum_probs=160.9

Q ss_pred             CCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcE
Q 002321          389 SSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKE  468 (936)
Q Consensus       389 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  468 (936)
                      -++.+++.|.||+|+++ .+|..+..+.+|+.|++++|+++ .+|..++.+++|+.|+++-|++. ..|..|+.++.|+.
T Consensus        30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev  106 (264)
T KOG0617|consen   30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV  106 (264)
T ss_pred             cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence            35678889999999998 77778999999999999999998 78999999999999999999998 79999999999999


Q ss_pred             EEecCCccCC-cCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCc
Q 002321          469 LRLERNFLAG-KIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNH  547 (936)
Q Consensus       469 L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~  547 (936)
                      |||..|++.. .+|..|..|..|+-|+|++|.+. .+|..++++++|+.|.+.+|.+- .+|.+++.|++|++|++.+|+
T Consensus       107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr  184 (264)
T KOG0617|consen  107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR  184 (264)
T ss_pred             hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence            9999999985 68999999999999999999998 88999999999999999999998 899999999999999999999


Q ss_pred             ccccCCCCCccCcCCC---ccccCCCCC
Q 002321          548 LQGELPAGGFFNTISP---SSVLGNPSL  572 (936)
Q Consensus       548 l~~~~p~~~~~~~~~~---~~~~gn~~~  572 (936)
                      ++-..|+.+.+.....   ...+.|||.
T Consensus       185 l~vlppel~~l~l~~~k~v~r~E~NPwv  212 (264)
T KOG0617|consen  185 LTVLPPELANLDLVGNKQVMRMEENPWV  212 (264)
T ss_pred             eeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence            9988887666654432   334577774

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.79  E-value=5.6e-21  Score=209.41  Aligned_cols=223  Identities=26%  Similarity=0.303  Sum_probs=179.4

Q ss_pred             ccccCceEEEEEEe----CCCcEEEEEEeeccCccch-HHHHHHHHHHHHcCC-CCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          698 LGRGGFGAVYRTVL----RDGRPVAIKKLTVSSLVKS-QEDFEREVKKLGKVR-HPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       698 iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      +|+|+||.|+.+..    ..|.-+|.|+.+....... ......|..++...+ ||.++++...++.+...+++++|..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            69999999997652    2377889998865543321 224566888889997 99999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK  851 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  851 (936)
                      |++...+.....   +++.....+...++-|++++|+.+|+|||+|++||+++.+|++++.|||+++..-..+      .
T Consensus        82 g~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~  152 (612)
T KOG0603|consen   82 GDLFTRLSKEVM---FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------I  152 (612)
T ss_pred             chhhhccccCCc---hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh------h
Confidence            999888776543   6667777788889999999999999999999999999999999999999998643211      2


Q ss_pred             ccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHHHhhhccccceeecccccccccc
Q 002321          852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVSMRSCKGSSRQR  931 (936)
Q Consensus       852 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~R  931 (936)
                      .+|+..|||||++.   ....++|.||+|++++||++|..||....+..+.......|.......++++.++...+|..|
T Consensus       153 ~cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nr  229 (612)
T KOG0603|consen  153 ACGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGGDTMKRILKAELEMPRELSAEARSLFRQLFKRNPENR  229 (612)
T ss_pred             cccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCchHHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHH
Confidence            28899999999984   357889999999999999999999999555555554555566666777777777777777665


Q ss_pred             c
Q 002321          932 R  932 (936)
Q Consensus       932 p  932 (936)
                      -
T Consensus       230 L  230 (612)
T KOG0603|consen  230 L  230 (612)
T ss_pred             h
Confidence            3

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=7.3e-20  Score=189.84  Aligned_cols=234  Identities=17%  Similarity=0.224  Sum_probs=150.2

Q ss_pred             ccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCC----------CCcceeeeEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRH----------PNLVTLEGYYWT  758 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~~  758 (936)
                      +...+.||.|+++.||.+++.+ |+++|||++......  ...+++++|.-....+.+          -.++..++....
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            3566789999999999999874 899999998655422  345777777766666432          233333333321


Q ss_pred             C------------C-----eeEEEEEecCCCChhhhhhc---cCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 002321          759 Q------------S-----LQLLIYEFVSGGSLHKHLHE---GSGG-NFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIK  817 (936)
Q Consensus       759 ~------------~-----~~~lv~e~~~~g~L~~~l~~---~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlk  817 (936)
                      .            .     ..+++|+-+ .+||.+++..   .... .......+..+..|+++.+++||+.|+||+|||
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~  172 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK  172 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence            1            1     125678877 5788877542   2211 123445566777899999999999999999999


Q ss_pred             CCCEEEcCCCCeEEeeccCccccCCCccccccccccCcccccCcccccC-------cccCCchhhHHHHHHHHHHHHcCC
Q 002321          818 SSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR-------TVKITDKCDVYGFGVLVLEVVTGK  890 (936)
Q Consensus       818 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwSlG~~l~el~~g~  890 (936)
                      |+|++++++|.++|+||+.....+.  ... .  ...+..|.+||....       ...++.+.|.|++|+++|.|++|+
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~--~~~-~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGT--RYR-C--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTE--EEE-G--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCc--eee-c--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            9999999999999999988765432  111 1  234467999996632       235788999999999999999999


Q ss_pred             CCCCccchhHHHHHHHHHHHhhhccccceeecccccccccc
Q 002321          891 RPLSTWKMMWWFSVTWLEEHWKKAEWRNVSMRSCKGSSRQR  931 (936)
Q Consensus       891 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~R  931 (936)
                      .||............+..=.-.++.++.+|..++..+|.+|
T Consensus       248 lPf~~~~~~~~~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  248 LPFGLSSPEADPEWDFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -STCCCGGGSTSGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCCccccccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence            99986644221111111111334678889999999999887

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.77  E-value=1.6e-20  Score=206.80  Aligned_cols=283  Identities=20%  Similarity=0.240  Sum_probs=148.8

Q ss_pred             eeeccccccc-ccCCcccccccCcceeeccccccCCC----CchhhhccccccEEeccCccccCCCCcccccCCccceec
Q 002321          225 VINLSKNMFS-GSIPDGIGSCSLLRTIDFSENSFSGN----LPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLD  299 (936)
Q Consensus       225 ~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  299 (936)
                      .|+|..+.++ ......+..+.+|++|+++++.++..    ++..+...+.++.++++++.+.+. +..+          
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~-~~~~----------   70 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRI-PRGL----------   70 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCc-chHH----------
Confidence            4566666665 23334455566666777766666432    222333344455555554444310 0000          


Q ss_pred             ccCceeccccCcccccccccceEEccCCcccccCChhhhccCC---CCEEEccCCcCccCCChhhhccCCcccccccccc
Q 002321          300 LSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMN---LVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKI  376 (936)
Q Consensus       300 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l  376 (936)
                             ..++..+..+++|+.|++++|.+.+..+..+..+..   |+.|++++|++.+.....+               
T Consensus        71 -------~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l---------------  128 (319)
T cd00116          71 -------QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLL---------------  128 (319)
T ss_pred             -------HHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHH---------------
Confidence                   112223444555555666555555444444444443   6666666665542111110               


Q ss_pred             ccCCCCCCCCCCCCC-CcccEEeccCcccCCC----ChhhhcccccCCeeeccCccccCC----CCccccCcccCCeeec
Q 002321          377 REGMNGPFASSGSSF-ESLQFLDLSHNEFSGE----TPATIGALSGLQLLNLSRNSLVGP----IPVAIGDLKALNVLDL  447 (936)
Q Consensus       377 ~~~~~~~~~~~~~~l-~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L  447 (936)
                              ...+..+ ++|++|++++|.+++.    ....+..+++|++|+|++|.+++.    ++..+..+++|++|+|
T Consensus       129 --------~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L  200 (319)
T cd00116         129 --------AKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDL  200 (319)
T ss_pred             --------HHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEec
Confidence                    0001122 4566666666666532    223344455666666666666531    2233444456777777


Q ss_pred             CCcccccc----CCCCCCCcCCCcEEEecCCccCCcCcccccc-----ccccccccccCccccC----CCcccccccCCc
Q 002321          448 SENWLNGS----IPPEIGGAYSLKELRLERNFLAGKIPTSIEN-----CSSLVSLILSKNNLTG----PIPIAIAKLTNL  514 (936)
Q Consensus       448 s~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~-----l~~L~~L~L~~N~l~~----~~p~~~~~l~~L  514 (936)
                      ++|.+++.    ++..+..+++|+.|++++|.+++.....+..     .+.|+.|++++|.++.    .+...+..+++|
T Consensus       201 ~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L  280 (319)
T cd00116         201 NNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESL  280 (319)
T ss_pred             cCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCc
Confidence            77766532    2334555667777777777776533333322     2677777777777752    233455566778


Q ss_pred             cEEEcCCCcccCC----CCcccccc-cccCeeecCCCcc
Q 002321          515 QNVDLSFNSLTGG----LPKQLVNL-VHLSSFNISHNHL  548 (936)
Q Consensus       515 ~~L~Ls~N~l~~~----~p~~l~~l-~~L~~L~ls~N~l  548 (936)
                      +++|+++|.++..    +...+... +.|+++++.+|++
T Consensus       281 ~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         281 LELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             cEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            8888888887743    34444444 6777777777764

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PRK10345 hypothetical protein; Provisional

Probab=99.77  E-value=3e-18  Score=172.64  Aligned_cols=137  Identities=18%  Similarity=0.187  Sum_probs=106.3

Q ss_pred             ccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcC-----CCCCcceeeeEEEeCC---e-e
Q 002321          692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-----RHPNLVTLEGYYWTQS---L-Q  762 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~  762 (936)
                      +...+.||+|+||.||.  +.+....+||++..... ...+.+.+|+++++++     +||||++++|+++++.   . .
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            35567899999999996  43333347998865432 2457799999999999     5799999999998863   3 3


Q ss_pred             EEEEEe--cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCcccCCCCCCCEEEcCC----CCeEEeecc
Q 002321          763 LLIYEF--VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSL-AHLHQSNIIHYNIKSSNVLIDGS----GEPKVGDYG  835 (936)
Q Consensus       763 ~lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al-~~LH~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg  835 (936)
                      .+|+||  +++|+|.+++.+..    +++.  ..++.|++.++ +|||+++|+||||||+||+++..    +.++|+||+
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEEecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            378999  55799999997632    4544  35677888777 99999999999999999999743    379999944


Q ss_pred             Cc
Q 002321          836 LA  837 (936)
Q Consensus       836 ~a  837 (936)
                      .+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            44

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.76  E-value=2.2e-20  Score=205.71  Aligned_cols=203  Identities=25%  Similarity=0.322  Sum_probs=114.2

Q ss_pred             EeccCCCCCCc-ccccccccCccccEEeccCCcccCc----CCCchhhcCCCcEEEccCccccc-----ccchhhhhcCC
Q 002321           80 ELTLNGLSLTG-RIGRGLLQLQFLRKLSLSSNNLTGS----ISPNLAKLQNLRVIDLSGNSLSG-----SIPDEFFKQCG  149 (936)
Q Consensus        80 ~l~l~~~~l~g-~~~~~l~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~-----~i~~~~f~~l~  149 (936)
                      .|+|.++++++ .....+..++.|++|+++++.+++.    ++..+...++|++|+++++.+.+     ......|..++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            35666666663 3344456677788888888777542    44455666778888888777652     01123455677


Q ss_pred             CCcEEEccCccCCCCCCCCcccccc---ccccccccccccCC----CCCCCCCC-CCCCEEecCCCCCCCC----CccCc
Q 002321          150 SLRVISLAKNRFSGKIPSSLSLCST---LATINLSSNRFSSP----LPLGIWGL-SALRTLDLSDNLLEGE----IPKGV  217 (936)
Q Consensus       150 ~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~----~~~~~~~l-~~L~~L~L~~N~l~~~----~~~~~  217 (936)
                      +|++|+|++|.+.+..+..+..+.+   |++|++++|++++.    +...+..+ ++|+.|+|++|.+++.    ++..+
T Consensus        82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~  161 (319)
T cd00116          82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL  161 (319)
T ss_pred             ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence            7777777777776555555555544   77777777766531    12233444 6667777777766632    22234


Q ss_pred             cCCCCcceeeccccccccc----CCcccccccCcceeeccccccCCCCc----hhhhccccccEEeccCcccc
Q 002321          218 ESLKNLRVINLSKNMFSGS----IPDGIGSCSLLRTIDFSENSFSGNLP----ETMQKLSLCNFMNLRKNLFS  282 (936)
Q Consensus       218 ~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~----~~l~~l~~L~~L~L~~N~l~  282 (936)
                      ..+++|++|++++|.+++.    ++..+..+++|++|+|++|.+++...    ..+..+++|+.|++++|.++
T Consensus       162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~  234 (319)
T cd00116         162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLT  234 (319)
T ss_pred             HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCc
Confidence            4455666666666666532    12223344566666666666553222    22333344444444444444

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.76  E-value=2.1e-20  Score=170.32  Aligned_cols=158  Identities=32%  Similarity=0.585  Sum_probs=102.7

Q ss_pred             ccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCcccccc
Q 002321           95 GLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCST  174 (936)
Q Consensus        95 ~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  174 (936)
                      .+.++++++.|.||+|+++ .+|+.++.|.+|++|++++|+|. .+|..+ +.+++|+.|+++-|++. ..|..|+.++.
T Consensus        28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~i-ssl~klr~lnvgmnrl~-~lprgfgs~p~  103 (264)
T KOG0617|consen   28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSI-SSLPKLRILNVGMNRLN-ILPRGFGSFPA  103 (264)
T ss_pred             cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhh-hhchhhhheecchhhhh-cCccccCCCch
Confidence            4677888888899999998 67888899999999999999887 555443 55666666666666655 45556666666


Q ss_pred             ccccccccccccC-CCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeecc
Q 002321          175 LATINLSSNRFSS-PLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFS  253 (936)
Q Consensus       175 L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls  253 (936)
                      |+.|||.+|++.. ..|..|..+..|+-|+|++|.++ .+|..+++|++|+.|.+..|.+- .+|..++.+++|++|+++
T Consensus       104 levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiq  181 (264)
T KOG0617|consen  104 LEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQ  181 (264)
T ss_pred             hhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcc
Confidence            6666666665542 34555555555555555555555 55555555555555555555555 455555555555555555


Q ss_pred             ccccC
Q 002321          254 ENSFS  258 (936)
Q Consensus       254 ~N~l~  258 (936)
                      +|+++
T Consensus       182 gnrl~  186 (264)
T KOG0617|consen  182 GNRLT  186 (264)
T ss_pred             cceee
Confidence            55555

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=1.8e-18  Score=203.64  Aligned_cols=227  Identities=19%  Similarity=0.231  Sum_probs=168.9

Q ss_pred             ccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCC---CCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR---HPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|.+.++||+|+||+||+|...+|+.||+|+-+....-+    |.--.+++.|++   -+.|.++.......+..++|+
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~  773 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS  773 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence            3467778899999999999998889999999987665432    111233344444   345666666666667779999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-------CCCeEEeeccCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG-------SGEPKVGDYGLARL  839 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~-------~~~~kl~Dfg~a~~  839 (936)
                      ||.+.|+|.+++...   +.++|...+.++.|+++-+++||..+||||||||+|.|+..       ...++|+|||.+..
T Consensus       774 ey~~~Gtlld~~N~~---~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD  850 (974)
T KOG1166|consen  774 EYSPYGTLLDLINTN---KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID  850 (974)
T ss_pred             eccccccHHHhhccC---CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence            999999999999843   34999999999999999999999999999999999999942       34699999999976


Q ss_pred             cCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHHHhhhccccce
Q 002321          840 LPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNV  919 (936)
Q Consensus       840 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  919 (936)
                      +.-......-....+|-.+-.+|+. .++.++...|.|.++-+++-|+.|++-=...+..|.. -..+...|...-|.++
T Consensus       851 m~lfp~~~~F~~~~~td~f~C~EM~-~grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g~~~~~-~~~~~Ry~~~~~W~~~  928 (974)
T KOG1166|consen  851 MKLFPDGTKFKAVWHTDLFDCIEMR-EGRPWTYQIDYFGLAATVHVMLFGKYMEVKNGSSWMV-KTNFPRYWKRDMWNKF  928 (974)
T ss_pred             eeEcCCCcEEeeeeccccchhHHHh-cCCCCchhhhhHHHHHHHHHHHHHHHHHhcCCcceec-cccchhhhhHHHHHHH
Confidence            6433333333455677789999988 6779999999999999999999997532111111111 1113445566667777


Q ss_pred             eecccc
Q 002321          920 SMRSCK  925 (936)
Q Consensus       920 ~~~~l~  925 (936)
                      +.+.|+
T Consensus       929 F~~lLN  934 (974)
T KOG1166|consen  929 FDLLLN  934 (974)
T ss_pred             HHHHhC
Confidence            777776

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.74  E-value=1.6e-18  Score=178.12  Aligned_cols=185  Identities=21%  Similarity=0.272  Sum_probs=135.4

Q ss_pred             CCCCcceeeeEEEeC---------------------------CeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHH
Q 002321          745 RHPNLVTLEGYYWTQ---------------------------SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ  797 (936)
Q Consensus       745 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~  797 (936)
                      +|||||++.++|.+.                           ...|+||..++ .+|..++....    .+...+.-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence            599999998887432                           23588998884 68999887654    55666777899


Q ss_pred             HHHHHHHHHHhCCcccCCCCCCCEEEc--CCC--CeEEeeccCccccCC----CccccccccccCcccccCcccccCccc
Q 002321          798 GTAKSLAHLHQSNIIHYNIKSSNVLID--GSG--EPKVGDYGLARLLPM----LDRYVLSSKIQSALGYMAPEFACRTVK  869 (936)
Q Consensus       798 ~i~~al~~LH~~~ivH~Dlkp~NIll~--~~~--~~kl~Dfg~a~~~~~----~~~~~~~~~~~~~~~y~aPE~~~~~~~  869 (936)
                      |+++|+.|||++||.|||+|..|||+.  +|+  .+.|+|||++-....    .....-.....|.-.-||||+.. ..+
T Consensus       349 QlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t-a~P  427 (598)
T KOG4158|consen  349 QLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT-AVP  427 (598)
T ss_pred             HHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh-cCC
Confidence            999999999999999999999999984  333  578899999743221    01111112334555689999872 211


Q ss_pred             ------CCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH------HHhhhccccceeecccccccccccccC
Q 002321          870 ------ITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       870 ------~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                            --.|+|.|+.|-+.||+++...||.....+......+-+      +.-.+...++++...++.||.+|++=+
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence                  114899999999999999999999987665544444333      233446678888889999999998743

>smart00090 RIO RIO-like kinase

Probab=99.72  E-value=3.1e-17  Score=169.81  Aligned_cols=143  Identities=17%  Similarity=0.237  Sum_probs=110.4

Q ss_pred             cccCCCcccccCceEEEEEE--eCCCcEEEEEEeeccCccc-----------------------hHHHHHHHHHHHHcCC
Q 002321          691 LLNKDCELGRGGFGAVYRTV--LRDGRPVAIKKLTVSSLVK-----------------------SQEDFEREVKKLGKVR  745 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~  745 (936)
                      .|+..+.||+|+||.||+|.  ..+|+.||||+++......                       ....+.+|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            45677889999999999998  4579999999987542110                       0123678999999997


Q ss_pred             CCC--cceeeeEEEeCCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCCCCEE
Q 002321          746 HPN--LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN-IIHYNIKSSNVL  822 (936)
Q Consensus       746 h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~-ivH~Dlkp~NIl  822 (936)
                      +..  +.+++++    ...++||||++++++........   .....+...++.|++.++++||+.| ++||||||+||+
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl  181 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL  181 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence            533  3444433    23489999999888876543222   2555667889999999999999999 999999999999


Q ss_pred             EcCCCCeEEeeccCccccC
Q 002321          823 IDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       823 l~~~~~~kl~Dfg~a~~~~  841 (936)
                      ++ ++.++++|||.+....
T Consensus       182 i~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      182 VH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EE-CCCEEEEEChhhhccC
Confidence            99 8899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=6.8e-17  Score=166.30  Aligned_cols=135  Identities=20%  Similarity=0.357  Sum_probs=114.8

Q ss_pred             CcccccCceEEEEEEeCCCcEEEEEEeeccCccc-------hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          696 CELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVK-------SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      +.||+|++|.||+|.+ +|..|+||+........       ....+.+|++++..++|+++.....++.+....++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4699999999999988 57889999865432211       124678899999999999998887787777788999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      ++|++|.+++....      . ++..++.+++.++.++|+.+++|||++|.||+++ ++.++++|||.++.
T Consensus        81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999886532      2 7788999999999999999999999999999999 88999999999875

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.70  E-value=1.1e-16  Score=162.56  Aligned_cols=136  Identities=18%  Similarity=0.206  Sum_probs=107.9

Q ss_pred             ccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCcc---------------------chHHHHHHHHHHHHcCCCCC--
Q 002321          692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV---------------------KSQEDFEREVKKLGKVRHPN--  748 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~E~~~l~~l~h~n--  748 (936)
                      +...+.||+|+||.||+|...+|+.||||+++.....                     .......+|+.++..+.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            5566789999999999999888999999987643210                     01123678999999998774  


Q ss_pred             cceeeeEEEeCCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCC
Q 002321          749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGE  828 (936)
Q Consensus       749 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~  828 (936)
                      +.+.++    ....++||||++|++|.+....         ....+++.+++.++.++|+.|++||||||+||++++++.
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~  163 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK  163 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence            444443    2345899999999998765321         234578899999999999999999999999999999999


Q ss_pred             eEEeeccCcccc
Q 002321          829 PKVGDYGLARLL  840 (936)
Q Consensus       829 ~kl~Dfg~a~~~  840 (936)
                      ++|+|||++...
T Consensus       164 ~~liDfg~~~~~  175 (198)
T cd05144         164 IYIIDWPQMVST  175 (198)
T ss_pred             EEEEECCccccC
Confidence            999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=1.1e-16  Score=162.95  Aligned_cols=131  Identities=20%  Similarity=0.355  Sum_probs=108.0

Q ss_pred             cccccCceEEEEEEeCCCcEEEEEEeeccCcc-------chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV-------KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .||+|+||.||+|.+ ++..|++|+.......       ....++.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999986 4789999986443211       11356788999999999887666555666666779999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      +|++|.+++....    .      .++.+++.++.++|+.|++|||++|.||+++ ++.++++|||+++.
T Consensus        80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999998875422    1      7889999999999999999999999999999 89999999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.67  E-value=6.5e-17  Score=178.49  Aligned_cols=193  Identities=27%  Similarity=0.345  Sum_probs=147.7

Q ss_pred             HHcCCCCCcceeeeEEEeCCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-ccCCCCCC
Q 002321          741 LGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI-IHYNIKSS  819 (936)
Q Consensus       741 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i-vH~Dlkp~  819 (936)
                      |+.+.|.|+.+++|.+.++.....|.+|+..|+|.|.+....  ..+++.....++++++.||+|+|...| +|+-++..
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence            357899999999999999999999999999999999998733  238888999999999999999998766 99999999


Q ss_pred             CEEEcCCCCeEEeeccCccccCCCccccccccccCcccccCcccccCc--cc----CCchhhHHHHHHHHHHHHcCCCCC
Q 002321          820 NVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT--VK----ITDKCDVYGFGVLVLEVVTGKRPL  893 (936)
Q Consensus       820 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~----~~~~~DvwSlG~~l~el~~g~~Pf  893 (936)
                      |+++|....+|++|||+....................-|.|||.+...  ..    .+.+.||||+|++++|+++...||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            999999999999999998766431111222222233459999988542  11    467899999999999999999999


Q ss_pred             Cccchh-----HHHHHHH-----HHHH-----hhhccccceeecccccccccccccC
Q 002321          894 STWKMM-----WWFSVTW-----LEEH-----WKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       894 ~~~~~~-----~~~~~~~-----~~~~-----~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +.....     .+..+..     .-|.     -..++...++.+||.-+|.+||+++
T Consensus       159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~  215 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIE  215 (484)
T ss_pred             ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHH
Confidence            884331     1111111     0000     1112456677899999999999975

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.66  E-value=4.9e-16  Score=181.98  Aligned_cols=135  Identities=19%  Similarity=0.297  Sum_probs=110.6

Q ss_pred             cCCCcccccCceEEEEEEeCCCcEEEEEEeeccCc-c------chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEE
Q 002321          693 NKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSL-V------KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       693 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  765 (936)
                      ...+.||+|+||+||+|.+.. ..+++|+...... .      ...+++.+|++++++++|++++....++.+....++|
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv  414 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV  414 (535)
T ss_pred             CccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence            456789999999999998764 4455554322111 1      1135688999999999999999888888777778999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCcccc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL  840 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  840 (936)
                      |||+++++|.+++.           ....++.|+++++.|||+.+++|||+||+||++ .++.++|+|||+++..
T Consensus       415 ~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        415 MEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            99999999998875           245789999999999999999999999999999 6789999999999753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.66  E-value=2.5e-17  Score=189.34  Aligned_cols=202  Identities=23%  Similarity=0.305  Sum_probs=144.0

Q ss_pred             cccccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ...|+..+.|..|+||.||.++++. .+.+|+|+=+.. .      +.|-  ++.....|.+|                 
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-l------ilRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-L------ILRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc-h------hhhc--cccccCCccee-----------------
Confidence            3446777889999999999998774 567888543211 1      1111  22222333333                 


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC----
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML----  843 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~----  843 (936)
                          ||-...++..+.   ++        .+++.|++|+|+.||||||+||.|.+|+.-|++|+.|||+.+.....    
T Consensus       136 ----gDc~tllk~~g~---lP--------vdmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 ----GDCATLLKNIGP---LP--------VDMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             ----chhhhhcccCCC---Cc--------chhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence                444444543222   22        12378999999999999999999999999999999999998764211    


Q ss_pred             ---------ccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH------HHHHHH
Q 002321          844 ---------DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF------SVTWLE  908 (936)
Q Consensus       844 ---------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~------~~~~~~  908 (936)
                               .........++|+.|.|||++... .|+..+|.|++|+++||.+.|..||.+...+..+      .+.|.+
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq-gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE  279 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE  279 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhh-ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence                     111223346899999999999544 6899999999999999999999999998765555      334444


Q ss_pred             HHh-hhccccceeeccccccccccc
Q 002321          909 EHW-KKAEWRNVSMRSCKGSSRQRR  932 (936)
Q Consensus       909 ~~~-~~~~~~~~~~~~l~~~p~~Rp  932 (936)
                      +.+ ...+.++++.+.+..+|.+|-
T Consensus       280 ~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  280 EDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             cCcCCCHHHHHHHHHHHHhChHhhc
Confidence            433 236778888999999998874

>PLN03150 hypothetical protein; Provisional

Probab=99.63  E-value=9.3e-16  Score=181.25  Aligned_cols=149  Identities=32%  Similarity=0.530  Sum_probs=110.0

Q ss_pred             CChhHHHHHHHHHHhccCCCCCCCCCCCCCCCC----ccceeEEecCC--C--CceEEeccCCCCCCcccccccccCccc
Q 002321           31 SLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTP----CNWFGVKCSPR--S--NRVIELTLNGLSLTGRIGRGLLQLQFL  102 (936)
Q Consensus        31 ~~~~~~~aLl~~k~~~~d~~~~l~sW~~~~~~~----c~w~gv~c~~~--~--~~v~~l~l~~~~l~g~~~~~l~~l~~L  102 (936)
                      ..+.|.+||++||+++.++..  .+|.++ + |    |.|.||.|+..  .  .+|+.|+|+++++.|.+|+.++++++|
T Consensus       369 t~~~~~~aL~~~k~~~~~~~~--~~W~g~-~-C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L  444 (623)
T PLN03150        369 TLLEEVSALQTLKSSLGLPLR--FGWNGD-P-CVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHL  444 (623)
T ss_pred             cCchHHHHHHHHHHhcCCccc--CCCCCC-C-CCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCC
Confidence            345799999999999987642  489753 3 3    27999999632  2  258888888888888888888888888


Q ss_pred             cEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCcccc-ccccccccc
Q 002321          103 RKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLC-STLATINLS  181 (936)
Q Consensus       103 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~  181 (936)
                      +.|+|++|+|+|.+|..++.+++|+.|||++|+++|.+|.. +..+++|++|+|++|++++.+|..++.. .++..+++.
T Consensus       445 ~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~-l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~  523 (623)
T PLN03150        445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES-LGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFT  523 (623)
T ss_pred             CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchH-HhcCCCCCEEECcCCcccccCChHHhhccccCceEEec
Confidence            88888888888888888888888888888888888776643 4667777777777777777666665432 233444444


Q ss_pred             ccc
Q 002321          182 SNR  184 (936)
Q Consensus       182 ~N~  184 (936)
                      +|.
T Consensus       524 ~N~  526 (623)
T PLN03150        524 DNA  526 (623)
T ss_pred             CCc
Confidence            443

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.62  E-value=5.6e-17  Score=174.86  Aligned_cols=170  Identities=18%  Similarity=0.236  Sum_probs=135.4

Q ss_pred             eeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCcccc
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL  840 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  840 (936)
                      ..++.|++++-.+|.+++.+......-++.....++.|++.|++|   ++.+|+|+||.||++..+..+||.|||+....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            468999999999999999876666667888899999999999999   99999999999999999999999999998766


Q ss_pred             CCCc----cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccch-hHHHHHHHHHHHhhh-
Q 002321          841 PMLD----RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKM-MWWFSVTWLEEHWKK-  913 (936)
Q Consensus       841 ~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~-~~~~~~~~~~~~~~~-  913 (936)
                      ....    .....+...||..||+||.+ .+..|+.++||||||++++|+++ =..+|..... ..+....+.+..+.. 
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi-~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~~~~d~  485 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQI-RGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIPPEFLQDY  485 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHH-hhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChHHhhcC
Confidence            5433    23345567799999999999 45589999999999999999998 4455544333 233333343333333 


Q ss_pred             ccccceeeccccccccccccc
Q 002321          914 AEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       914 ~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      +.-++++.+++...|.+||.+
T Consensus       486 p~e~~ll~~lls~~p~~RP~~  506 (516)
T KOG1033|consen  486 PEEYTLLQQLLSPSPEERPSA  506 (516)
T ss_pred             cHHHHHHHHhcCCCcccCchH
Confidence            455688899999999999943

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.60  E-value=5.5e-15  Score=148.90  Aligned_cols=136  Identities=20%  Similarity=0.307  Sum_probs=98.7

Q ss_pred             CCcccccCceEEEEEEeCCCcEEEEEEeeccCccc-hHH----------------------HHHHHHHHHHcCCCCC--c
Q 002321          695 DCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVK-SQE----------------------DFEREVKKLGKVRHPN--L  749 (936)
Q Consensus       695 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~----------------------~~~~E~~~l~~l~h~n--i  749 (936)
                      .+.||+|+||.||+|...+|+.||||+++...... ...                      ....|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            35799999999999998889999999986532211 111                      1145666666665433  4


Q ss_pred             ceeeeEEEeCCeeEEEEEecCCCChhhh-hhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCC
Q 002321          750 VTLEGYYWTQSLQLLIYEFVSGGSLHKH-LHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ-SNIIHYNIKSSNVLIDGSG  827 (936)
Q Consensus       750 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~ivH~Dlkp~NIll~~~~  827 (936)
                      .+.+++    ...++||||++++.+... +....    .. .+..+++.+++.++.++|. .+|+||||||+||+++ ++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~  151 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG  151 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence            444433    235899999998554321 11111    11 5677899999999999999 9999999999999999 99


Q ss_pred             CeEEeeccCcccc
Q 002321          828 EPKVGDYGLARLL  840 (936)
Q Consensus       828 ~~kl~Dfg~a~~~  840 (936)
                      .++++|||.+...
T Consensus       152 ~~~liDfg~a~~~  164 (187)
T cd05119         152 KVYIIDVPQAVEI  164 (187)
T ss_pred             cEEEEECcccccc
Confidence            9999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.60  E-value=9.1e-15  Score=151.82  Aligned_cols=138  Identities=18%  Similarity=0.223  Sum_probs=107.7

Q ss_pred             cCCCccc-ccCceEEEEEEeCCCcEEEEEEeeccCc------------cchHHHHHHHHHHHHcCCCCCc--ceeeeEEE
Q 002321          693 NKDCELG-RGGFGAVYRTVLRDGRPVAIKKLTVSSL------------VKSQEDFEREVKKLGKVRHPNL--VTLEGYYW  757 (936)
Q Consensus       693 ~~~~~iG-~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~  757 (936)
                      .....|| .|+.|+||.++.. +..+|||++.....            ......+.+|++++.+++|++|  ++.+++..
T Consensus        34 ~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~  112 (239)
T PRK01723         34 QQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV  112 (239)
T ss_pred             hcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence            3456788 8999999999875 78899998854321            0123568899999999998775  66777654


Q ss_pred             eCC----eeEEEEEecCC-CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEe
Q 002321          758 TQS----LQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVG  832 (936)
Q Consensus       758 ~~~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~  832 (936)
                      ...    ..++||||++| .+|.+++....    ++..    .+.+++.++.+||+.||+||||||.|||++.++.++|+
T Consensus       113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~----l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        113 VRHGLFYRADILIERIEGARDLVALLQEAP----LSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             eecCcceeeeEEEEecCCCCCHHHHHhcCC----CCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEE
Confidence            322    22599999997 68988876532    4443    35789999999999999999999999999999999999


Q ss_pred             eccCccc
Q 002321          833 DYGLARL  839 (936)
Q Consensus       833 Dfg~a~~  839 (936)
                      |||.++.
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9998864

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.55  E-value=3e-14  Score=138.10  Aligned_cols=131  Identities=22%  Similarity=0.204  Sum_probs=111.0

Q ss_pred             CCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCC--CCcceeeeEEEeCCeeEEEEEecCCC
Q 002321          695 DCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH--PNLVTLEGYYWTQSLQLLIYEFVSGG  772 (936)
Q Consensus       695 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  772 (936)
                      .+.||+|.++.||+++.. +..++||.......   ...+.+|+.+++.++|  ..+++++++...++..+++|||++++
T Consensus         3 ~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             ceecccccccceEEEEec-CCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            457999999999999986 47899999865432   4678899999999976  58999988888778889999999887


Q ss_pred             ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          773 SLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS---NIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       773 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      .+..+          +......++.+++++++++|..   +++|+|++|+||++++.+.+++.|||.++.
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77654          3455667889999999999985   799999999999999999999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.52  E-value=1.5e-15  Score=176.47  Aligned_cols=242  Identities=21%  Similarity=0.253  Sum_probs=183.9

Q ss_pred             ccccCCCcccccCceEEEEEEeCC--CcEEEEEEeeccC-ccchHHHHHHHHHHHHcCC-CCCcceeeeEEEeCCeeEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRD--GRPVAIKKLTVSS-LVKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  765 (936)
                      ..|...+.||+|+|+.|-......  ...+|+|.+.... .....+....|..+-+.+. |+|++++++........+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            345666679999999998877542  4567777765543 2233455666888888886 99999999999999999999


Q ss_pred             EEecCCCChhhhh-hccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCCEEEcCCC-CeEEeeccCccccCC
Q 002321          766 YEFVSGGSLHKHL-HEGSGGNFLSWNERFNVIQGTAKSLAHLH-QSNIIHYNIKSSNVLIDGSG-EPKVGDYGLARLLPM  842 (936)
Q Consensus       766 ~e~~~~g~L~~~l-~~~~~~~~~~~~~~~~i~~~i~~al~~LH-~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~  842 (936)
                      ++|.+++++.+.+ +....  ..+......++.|+..++.|+| ..+++|+|+||+|.+++..+ ..+++|||+|..+..
T Consensus       100 ~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            9999999999888 43321  2556667788999999999999 99999999999999999999 999999999987766


Q ss_pred             -CccccccccccC-cccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHHH--hhh-----
Q 002321          843 -LDRYVLSSKIQS-ALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEH--WKK-----  913 (936)
Q Consensus       843 -~~~~~~~~~~~~-~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~--~~~-----  913 (936)
                       ...........| ++.|+|||...+.....+..|+||.|+++..+++|..|+............|.+..  +..     
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS  257 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence             444555556677 99999999986655678899999999999999999999988776544433333321  112     


Q ss_pred             --ccccceeecccccccccccc
Q 002321          914 --AEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       914 --~~~~~~~~~~l~~~p~~Rp~  933 (936)
                        ....++..+++..+|..|.+
T Consensus       258 ~~~~~~~~l~k~l~~~~~~r~s  279 (601)
T KOG0590|consen  258 ISDQAHDLLHKILKENPSNRLS  279 (601)
T ss_pred             CChhhhhcccccccCCchhccc
Confidence              22333444555566666654

>PLN03150 hypothetical protein; Provisional

Probab=99.51  E-value=1.2e-14  Score=172.00  Aligned_cols=117  Identities=33%  Similarity=0.552  Sum_probs=99.2

Q ss_pred             CCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecC
Q 002321          465 SLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNIS  544 (936)
Q Consensus       465 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls  544 (936)
                      .++.|+|++|.++|.+|..++++++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+.++++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            47888999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCC--CccCcCCCccccCCCCCCCCCCCCCC
Q 002321          545 HNHLQGELPAG--GFFNTISPSSVLGNPSLCGSAVNKSC  581 (936)
Q Consensus       545 ~N~l~~~~p~~--~~~~~~~~~~~~gn~~~c~~~~~~~~  581 (936)
                      +|+++|.+|..  ..+.......+.+|+.+|+.|....|
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C  537 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC  537 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCCCCCC
Confidence            99999998863  22233445678899999997765556

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.49  E-value=2.1e-15  Score=162.44  Aligned_cols=177  Identities=33%  Similarity=0.536  Sum_probs=139.8

Q ss_pred             EEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeeccccc
Q 002321          153 VISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNM  232 (936)
Q Consensus       153 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  232 (936)
                      ..||+.|++. .+|..+..+..|+.|.|..|.|. .+|..+.++..|++|||+.|+++ ..|..+..|+ |+.|-+++|+
T Consensus        79 ~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNk  154 (722)
T KOG0532|consen   79 FADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNK  154 (722)
T ss_pred             hhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCc
Confidence            3444444444 46666777788888888888887 47778888888888888888888 6777777775 8888888888


Q ss_pred             ccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcc
Q 002321          233 FSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPIS  312 (936)
Q Consensus       233 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  312 (936)
                      ++ .+|..++.+..|..||.+.|.+. .+|..+..+..|+.|+++.|++. .+|..++.| .|..||+|.|+++ .+|..
T Consensus       155 l~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~  229 (722)
T KOG0532|consen  155 LT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVD  229 (722)
T ss_pred             cc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchh
Confidence            88 77888888888888888888887 66778888888888888888887 566666755 4788999999998 78888


Q ss_pred             cccccccceEEccCCcccccCChhhhc
Q 002321          313 IGNLQRLKVLNFSANRLTGSLPDSMAN  339 (936)
Q Consensus       313 l~~l~~L~~L~L~~N~l~~~~~~~~~~  339 (936)
                      |.+|+.|++|-|.+|.+. ..|..++.
T Consensus       230 fr~m~~Lq~l~LenNPLq-SPPAqIC~  255 (722)
T KOG0532|consen  230 FRKMRHLQVLQLENNPLQ-SPPAQICE  255 (722)
T ss_pred             hhhhhhheeeeeccCCCC-CChHHHHh
Confidence            999999999999999988 45655543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.46  E-value=2.7e-13  Score=153.15  Aligned_cols=141  Identities=23%  Similarity=0.344  Sum_probs=101.9

Q ss_pred             CcccccCceEEEEEEeCCCcEEEEEEeeccCccc---------------------------------------hHHHHHH
Q 002321          696 CELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVK---------------------------------------SQEDFER  736 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------------------------------------~~~~~~~  736 (936)
                      +.||.|++|.||+|++++|+.||||+.+......                                       .+-++.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            5699999999999999999999999986432100                                       0013556


Q ss_pred             HHHHHHcCC----CCCcceeeeEEE-eCCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 002321          737 EVKKLGKVR----HPNLVTLEGYYW-TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAK-SLAHLHQSN  810 (936)
Q Consensus       737 E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~-al~~LH~~~  810 (936)
                      |++.+.+++    |.+-+.+-.++. .....++||||++|+++.++......+  .   .+.+++.+++. .+..+|..|
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhCC
Confidence            666666662    333333333332 234568999999999998876532211  2   23456666666 478899999


Q ss_pred             cccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       811 ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      ++|+|+||.||++++++.++++|||++..++
T Consensus       278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            9999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.43  E-value=7.6e-15  Score=158.16  Aligned_cols=149  Identities=34%  Similarity=0.497  Sum_probs=79.2

Q ss_pred             cccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEec
Q 002321          393 SLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLE  472 (936)
Q Consensus       393 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  472 (936)
                      .|+.+.|.+|.|. .+|..++++..|++|+|+.|+++ ..|..+..++ |+.|-+++|+++ .+|+.++.+..|..||.+
T Consensus        99 ~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s  174 (722)
T KOG0532|consen   99 SLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVS  174 (722)
T ss_pred             HHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhh
Confidence            3444444444443 44555555555555555555554 3444444433 555555555554 455555555555555555


Q ss_pred             CCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCccc
Q 002321          473 RNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQ  549 (936)
Q Consensus       473 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~  549 (936)
                      .|.+. .+|..++.+.+|+.|+++.|++. .+|..++.| .|..||+|.|+++ .+|-.|.++.+|++|-|.+|+|+
T Consensus       175 ~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  175 KNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             hhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence            55555 45555555555555555555555 344444433 3555555555555 55555555555555555555555

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.36  E-value=1.2e-12  Score=148.31  Aligned_cols=37  Identities=30%  Similarity=0.223  Sum_probs=17.7

Q ss_pred             cccccccccCccccCCCcccccccCCccEEEcCCCccc
Q 002321          488 SSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLT  525 (936)
Q Consensus       488 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  525 (936)
                      ..+...++..+... ..+..+.....+..++...+...
T Consensus       322 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  358 (394)
T COG4886         322 SILLNNNILSNGET-SSPEALSILESLNNLWTLDNALD  358 (394)
T ss_pred             cccccccccccccc-ccchhhcccccccCceecccccc
Confidence            33334444444444 34444555555555555555544

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.35  E-value=1.8e-12  Score=147.04  Aligned_cols=176  Identities=38%  Similarity=0.560  Sum_probs=86.4

Q ss_pred             ccccEEeccCccccCCCCcccccCC-ccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEE
Q 002321          269 SLCNFMNLRKNLFSGEVPKWIGELE-SLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALD  347 (936)
Q Consensus       269 ~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  347 (936)
                      +.+..|++.+|.++ .++.....+. +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|.....+++|+.|+
T Consensus       116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~  192 (394)
T COG4886         116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD  192 (394)
T ss_pred             cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence            34444444444444 3333344442 5666666666665 34344555666666666666665 3444333455555555


Q ss_pred             ccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCcc
Q 002321          348 FSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNS  427 (936)
Q Consensus       348 Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  427 (936)
                      +++|++. .+|...                           .....|++|++++|.+. ..+..+..+.++..|.+.+|+
T Consensus       193 ls~N~i~-~l~~~~---------------------------~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~  243 (394)
T COG4886         193 LSGNKIS-DLPPEI---------------------------ELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNK  243 (394)
T ss_pred             ccCCccc-cCchhh---------------------------hhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCce
Confidence            5555554 222211                           11223555555555322 334444555555555555555


Q ss_pred             ccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCc
Q 002321          428 LVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGK  479 (936)
Q Consensus       428 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  479 (936)
                      +. .++..++.+.+|+.|++++|.++. ++. ++.+.+++.|++++|.+...
T Consensus       244 ~~-~~~~~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~  292 (394)
T COG4886         244 LE-DLPESIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNA  292 (394)
T ss_pred             ee-eccchhccccccceeccccccccc-ccc-ccccCccCEEeccCcccccc
Confidence            54 224445555555555555555552 222 55555555555555555533

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.30  E-value=2.9e-12  Score=146.04  Aligned_cols=145  Identities=17%  Similarity=0.280  Sum_probs=94.9

Q ss_pred             ccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCcc---------------------------------chH------
Q 002321          692 LNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLV---------------------------------KSQ------  731 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---------------------------------~~~------  731 (936)
                      |+. +.||.|++|.||+|++++ |+.||||+.++....                                 +..      
T Consensus       122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E  200 (537)
T PRK04750        122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE  200 (537)
T ss_pred             cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence            344 579999999999999987 999999999643110                                 001      


Q ss_pred             HHHHHHHHHHHcCC----CCCcceeeeEEEe-CCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHH-HHHH
Q 002321          732 EDFEREVKKLGKVR----HPNLVTLEGYYWT-QSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAK-SLAH  805 (936)
Q Consensus       732 ~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~-al~~  805 (936)
                      -++.+|+..+.+++    +...+.+-.++.+ ....++||||++|+.+.++-.-...+  .+..   .++...+. -+..
T Consensus       201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~~---~la~~~v~~~~~Q  275 (537)
T PRK04750        201 LDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDMK---LLAERGVEVFFTQ  275 (537)
T ss_pred             hCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCHH---HHHHHHHHHHHHH
Confidence            12455665555553    4444444444433 34568999999999998743211111  1211   12222221 1233


Q ss_pred             HHhCCcccCCCCCCCEEEcCCC----CeEEeeccCccccCC
Q 002321          806 LHQSNIIHYNIKSSNVLIDGSG----EPKVGDYGLARLLPM  842 (936)
Q Consensus       806 LH~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg~a~~~~~  842 (936)
                      +...|++|+|+||.||+++.+|    .+++.|||++..++.
T Consensus       276 if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            4468999999999999999988    999999999987653

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.28  E-value=1.5e-11  Score=121.63  Aligned_cols=126  Identities=21%  Similarity=0.245  Sum_probs=95.4

Q ss_pred             CcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcc-eeeeEEEeCCeeEEEEEecCCCCh
Q 002321          696 CELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV-TLEGYYWTQSLQLLIYEFVSGGSL  774 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L  774 (936)
                      +.++.|.++.||+++.. ++.|++|.......  ....+.+|+.+++.+.+.+++ +++.+.  ....++||||++|.++
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            46889999999999875 78899998754421  123567899999998655544 444443  3345899999999877


Q ss_pred             hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----ccCCCCCCCEEEcCCCCeEEeeccCcc
Q 002321          775 HKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI-----IHYNIKSSNVLIDGSGEPKVGDYGLAR  838 (936)
Q Consensus       775 ~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i-----vH~Dlkp~NIll~~~~~~kl~Dfg~a~  838 (936)
                      .+.    .    ..   ...++.+++++++.||+.++     +|+|++|.||+++ ++.++++|||.+.
T Consensus        79 ~~~----~----~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTE----D----FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc----c----cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            643    0    11   12456789999999999875     9999999999999 6789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.27  E-value=6.2e-11  Score=117.19  Aligned_cols=136  Identities=15%  Similarity=0.152  Sum_probs=99.3

Q ss_pred             CcccccCceEEEEEEeCC-------CcEEEEEEeeccCcc---------------------chHHH----HHHHHHHHHc
Q 002321          696 CELGRGGFGAVYRTVLRD-------GRPVAIKKLTVSSLV---------------------KSQED----FEREVKKLGK  743 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~---------------------~~~~~----~~~E~~~l~~  743 (936)
                      ..||.|--+.||.|...+       +..+|||+++.....                     ...+.    .++|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            358999999999998653       479999998642110                     01122    3489999999


Q ss_pred             CCC--CCcceeeeEEEeCCeeEEEEEecCCCChhh-hhhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCC
Q 002321          744 VRH--PNLVTLEGYYWTQSLQLLIYEFVSGGSLHK-HLHEGSGGNFLSWNERFNVIQGTAKSLAHL-HQSNIIHYNIKSS  819 (936)
Q Consensus       744 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~i~~~i~~al~~L-H~~~ivH~Dlkp~  819 (936)
                      +..  -++.+++++    ...++||||+.++.+.. .++..    .++..+...+..+++.++.++ |..|+||||+++.
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~  154 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY  154 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence            953  566677664    34589999997644422 22221    144556677889999999999 8999999999999


Q ss_pred             CEEEcCCCCeEEeeccCcccc
Q 002321          820 NVLIDGSGEPKVGDYGLARLL  840 (936)
Q Consensus       820 NIll~~~~~~kl~Dfg~a~~~  840 (936)
                      ||+++ ++.+.++|||-+...
T Consensus       155 NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         155 NMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HEEEE-CCcEEEEECCCceeC
Confidence            99997 578999999988754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.26  E-value=7.6e-13  Score=131.78  Aligned_cols=132  Identities=26%  Similarity=0.275  Sum_probs=88.5

Q ss_pred             cccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCcccccccccccccc
Q 002321          415 LSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLI  494 (936)
Q Consensus       415 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~  494 (936)
                      +..|+++|||+|.|+ .+.....-++.++.|++|+|.|.. + ..+..+++|+.||||+|.++ .+..+-.++.++++|.
T Consensus       283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~  358 (490)
T KOG1259|consen  283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK  358 (490)
T ss_pred             Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence            344555555555555 344455555666666666666652 2 22566667777777777776 5556666777788888


Q ss_pred             ccCccccCCCcccccccCCccEEEcCCCcccCCC-CcccccccccCeeecCCCcccccC
Q 002321          495 LSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGL-PKQLVNLVHLSSFNISHNHLQGEL  552 (936)
Q Consensus       495 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~ls~N~l~~~~  552 (936)
                      |+.|.+..  -..+++|-+|.+||+++|+|+..- -..+++|+-|+++.|.+|++.+.+
T Consensus       359 La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  359 LAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             hhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence            88887762  345777888888888888887322 257788888899999999988643

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.24  E-value=7.9e-11  Score=111.43  Aligned_cols=131  Identities=23%  Similarity=0.396  Sum_probs=102.9

Q ss_pred             cccccCceEEEEEEeCCCcEEEEEEeeccCc-----cc--hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSL-----VK--SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .+++|+-+.+|.+.+. |.++++|.-..+..     +.  ..++..+|++++.+++--.|.-.+-+..+.....++|||+
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            5789999999999875 55567775432221     11  1356778999999998766666566666777778999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      +|..|.+.+...          ...++..+-.-+.-||..||+|+|+.++||.+..++ +.++|||++..
T Consensus        82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc----------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999988888764          245778888889999999999999999999998665 99999999974

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.24  E-value=4.3e-12  Score=140.47  Aligned_cols=241  Identities=22%  Similarity=0.286  Sum_probs=176.0

Q ss_pred             cccCCCcccc--cCceEEEEEEe--C-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCC-CCCcceeeeEEEeCCeeE
Q 002321          691 LLNKDCELGR--GGFGAVYRTVL--R-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       691 ~~~~~~~iG~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  763 (936)
                      .+.....+|.  |.+|.||.+.-  + ++..+|+|+-+..-. ......-.+|+..-++++ |++.++.+..+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3455667899  99999999886  3 688999998433221 112233456777777774 999999999999999999


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCcccCCCCCCCEEEcCC-CCeEEeeccCcc
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAK----SLAHLHQSNIIHYNIKSSNVLIDGS-GEPKVGDYGLAR  838 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~----al~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~  838 (936)
                      +-+|++ +.++.++.+...  ..++....+.+..+..+    |+.++|+.+++|-|+||.||+...+ ...+++|||+..
T Consensus       195 iqtE~~-~~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~  271 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS  271 (524)
T ss_pred             eeeccc-cchhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence            999999 578888876533  23777788888888888    9999999999999999999999999 889999999998


Q ss_pred             ccCCCccc---cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH--HHHHHHHHhh-
Q 002321          839 LLPMLDRY---VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF--SVTWLEEHWK-  912 (936)
Q Consensus       839 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~--~~~~~~~~~~-  912 (936)
                      .+....-.   ...-...+...|++||.. .+ -++.++|+||+|.++.+...|..++.......+.  .-.+.+.+++ 
T Consensus       272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~  349 (524)
T KOG0601|consen  272 KISDGNFSSVFKVSKRPEGDCIYAAKELL-NG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE  349 (524)
T ss_pred             EccCCccccceeeeecCCCCceEeChhhh-cc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence            87654321   111222566679999988 33 5789999999999999999988777665322111  1111233333 


Q ss_pred             --hccccceeecccccccccccccCC
Q 002321          913 --KAEWRNVSMRSCKGSSRQRRRFQL  936 (936)
Q Consensus       913 --~~~~~~~~~~~l~~~p~~Rp~f~~  936 (936)
                        ....+..+..++.-+|..|+++|+
T Consensus       350 ~~s~~l~~~~~~~~d~~~~~~~~~q~  375 (524)
T KOG0601|consen  350 GGSSSLRSVTSQMLDEDPRLRLTAQI  375 (524)
T ss_pred             CcchhhhhHHHHhcCcchhhhhHHHH
Confidence              233444666777778888887764

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.20  E-value=1.3e-10  Score=129.66  Aligned_cols=165  Identities=25%  Similarity=0.314  Sum_probs=128.3

Q ss_pred             eCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCCChhhhhhccCCCCCCCHH
Q 002321          711 LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWN  790 (936)
Q Consensus       711 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~  790 (936)
                      ..++.+|.|..++.... ...+...+.++.++.+|||||+++++.++..+..|+|+|.+.  .|..++++      +...
T Consensus        34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~  104 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKE  104 (690)
T ss_pred             eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHH
Confidence            34688999998876654 334567788999999999999999999999999999999984  77778876      3456


Q ss_pred             HHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccccccCcccccCcccccCccc
Q 002321          791 ERFNVIQGTAKSLAHLHQ-SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK  869 (936)
Q Consensus       791 ~~~~i~~~i~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  869 (936)
                      .....+.||++||.+||. .+++|++|.-.-|+|++.|+.||++|..+...+....  .......-..|..|+.....  
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s--  180 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS--  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc--
Confidence            677788999999999985 5799999999999999999999999998865433221  01111112236777755211  


Q ss_pred             CCchhhHHHHHHHHHHHHcC
Q 002321          870 ITDKCDVYGFGVLVLEVVTG  889 (936)
Q Consensus       870 ~~~~~DvwSlG~~l~el~~g  889 (936)
                       +-..|.|-|||+++|++.|
T Consensus       181 -~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 -EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             -ccchhhhhHHHHHHHHhCc
Confidence             1357999999999999999

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.19  E-value=3e-12  Score=127.64  Aligned_cols=208  Identities=25%  Similarity=0.274  Sum_probs=145.8

Q ss_pred             cCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCC
Q 002321          309 VPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSG  388 (936)
Q Consensus       309 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~  388 (936)
                      .|-.+.-+.+|+.+.++++.-. .+-+....-+.|+++.+.+..++ ..|...-...+......+-..   ..|+....+
T Consensus       206 l~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~-~~~~l~pe~~~~D~~~~E~~t---~~G~~~~~~  280 (490)
T KOG1259|consen  206 LSFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQ-DVPSLLPETILADPSGSEPST---SNGSALVSA  280 (490)
T ss_pred             cccchHHhhhhheeeeeccchh-heeceeecCchhheeeeeccccc-ccccccchhhhcCccCCCCCc---cCCceEEec
Confidence            3444555677888887776543 22222334467888887766654 333222111111111111111   123333344


Q ss_pred             CCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcE
Q 002321          389 SSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKE  468 (936)
Q Consensus       389 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  468 (936)
                      ...+.|++||||+|.|+ .+.+...-++.++.|++|+|.|...  ..+..+.+|+.||||+|.++ .+..+-.++.+++.
T Consensus       281 dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKt  356 (490)
T KOG1259|consen  281 DTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKT  356 (490)
T ss_pred             chHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEee
Confidence            45678999999999997 6777788889999999999999833  34888999999999999998 35555567889999


Q ss_pred             EEecCCccCCcCccccccccccccccccCccccCCC-cccccccCCccEEEcCCCcccCC
Q 002321          469 LRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPI-PIAIAKLTNLQNVDLSFNSLTGG  527 (936)
Q Consensus       469 L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~  527 (936)
                      |.|++|.|.  .-..++++-+|..||+++|++.... -..+++||-|+.|.|.+|+|.+.
T Consensus       357 L~La~N~iE--~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  357 LKLAQNKIE--TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS  414 (490)
T ss_pred             eehhhhhHh--hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence            999999985  3456888999999999999997432 45689999999999999999854

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.18  E-value=3.5e-12  Score=144.69  Aligned_cols=242  Identities=27%  Similarity=0.316  Sum_probs=145.1

Q ss_pred             ccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccC
Q 002321          271 CNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQ  350 (936)
Q Consensus       271 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  350 (936)
                      ++.++++.|.+.. +-..+..+.+|+.|++.+|+|... ...+..+++|++|++++|+|+...  .+..+..|+.|++++
T Consensus        74 l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~  149 (414)
T KOG0531|consen   74 LKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSG  149 (414)
T ss_pred             HHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccchhhheecc
Confidence            3333444444442 223345566677777777777632 222556677777777777776432  344555566677777


Q ss_pred             CcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCCh-hhhcccccCCeeeccCcccc
Q 002321          351 NSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETP-ATIGALSGLQLLNLSRNSLV  429 (936)
Q Consensus       351 N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  429 (936)
                      |.|.. +.                            .+..+..|+.+++++|.+....+ . ...+.+|+.+++.+|.+.
T Consensus       150 N~i~~-~~----------------------------~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~  199 (414)
T KOG0531|consen  150 NLISD-IS----------------------------GLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR  199 (414)
T ss_pred             Ccchh-cc----------------------------CCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh
Confidence            66651 11                            11225677888888888865544 2 466777788888888876


Q ss_pred             CCCCccccCcccCCeeecCCccccccCCCCCCCcCC--CcEEEecCCccCCcCccccccccccccccccCccccCCCccc
Q 002321          430 GPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYS--LKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIA  507 (936)
Q Consensus       430 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~  507 (936)
                        ....+..+..+..+++..|.++..-+  +..+..  |+.+++++|.+. .++..+..+..+..|++.+|++...  ..
T Consensus       200 --~i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~  272 (414)
T KOG0531|consen  200 --EIEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EG  272 (414)
T ss_pred             --cccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--cc
Confidence              23444555566666778887764322  222333  778888888876 4546677777788888888877632  23


Q ss_pred             ccccCCccEEEcCCCcccCC---CCcc-cccccccCeeecCCCcccccCC
Q 002321          508 IAKLTNLQNVDLSFNSLTGG---LPKQ-LVNLVHLSSFNISHNHLQGELP  553 (936)
Q Consensus       508 ~~~l~~L~~L~Ls~N~l~~~---~p~~-l~~l~~L~~L~ls~N~l~~~~p  553 (936)
                      +.....+..+++..|++...   .... ....+.+..+.+.+|+.....+
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
T KOG0531|consen  273 LERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS  322 (414)
T ss_pred             ccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence            44556677777777776522   1121 4556667777777776665443

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.18  E-value=3e-10  Score=106.69  Aligned_cols=143  Identities=18%  Similarity=0.277  Sum_probs=108.5

Q ss_pred             CCcccccCceEEEEEEeCCCcEEEEEEeeccCccc-------hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          695 DCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVK-------SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       695 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ...|-+|+-+.|+++.+. |+..+||.-.......       ..++..+|++.+.+++--.|.-..-++.+.....++||
T Consensus        12 l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             ceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            456889999999999986 8888888653332211       24678899999999976666555556666666789999


Q ss_pred             ecCC-CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---CeEEeeccCccc
Q 002321          768 FVSG-GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG---EPKVGDYGLARL  839 (936)
Q Consensus       768 ~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~  839 (936)
                      |++| .++.+++.........+ ......+++|-+.+.-||..+|+|||+..+||++..++   .+.++|||++..
T Consensus        91 ~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             eccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            9976 47888887654433222 22367889999999999999999999999999997665   468999999864

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.14  E-value=5.6e-11  Score=120.49  Aligned_cols=197  Identities=22%  Similarity=0.240  Sum_probs=136.6

Q ss_pred             HHHHHcCCCCCcceeeeEEEeCC-----eeEEEEEecCCCChhhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHh--C
Q 002321          738 VKKLGKVRHPNLVTLEGYYWTQS-----LQLLIYEFVSGGSLHKHLHEGSGG-NFLSWNERFNVIQGTAKSLAHLHQ--S  809 (936)
Q Consensus       738 ~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~--~  809 (936)
                      +.-+-++.|-|+|++..|+.+..     +...+.|||..|++..++++.++. ..+......+|+.||..||.|||+  .
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            33456667999999999986543     457789999999999999875433 347777888999999999999997  4


Q ss_pred             CcccCCCCCCCEEEcCCCCeEEee--ccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHH
Q 002321          810 NIIHYNIKSSNVLIDGSGEPKVGD--YGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVV  887 (936)
Q Consensus       810 ~ivH~Dlkp~NIll~~~~~~kl~D--fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~  887 (936)
                      .|+|+.+..+-|++..+|-+|+.-  +......-............+-++|.|||.- .....+.++|||+||....||.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg-~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG-TTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC-cccccccchhhhhhhHHHHHHH
Confidence            799999999999999999998852  1111110011112223334466789999976 3334577899999999999999


Q ss_pred             cCCCCCCc-c-chhHHHHHHHHHHHhhhccccceeecccccccccccccC
Q 002321          888 TGKRPLST-W-KMMWWFSVTWLEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       888 ~g~~Pf~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .|+.--.. . +.+-.......--......=++.+.+|+..+|..||+-+
T Consensus       277 ilEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar  326 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDAR  326 (458)
T ss_pred             HheeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchh
Confidence            88753111 1 111111111111122334457889999999999999743

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.13  E-value=1.2e-12  Score=134.01  Aligned_cols=134  Identities=21%  Similarity=0.243  Sum_probs=88.9

Q ss_pred             ccCCeeeccCccccCC----CCccccCcccCCeeecCCcccccc----CCCCCCCcCCCcEEEecCCccCC----cCccc
Q 002321          416 SGLQLLNLSRNSLVGP----IPVAIGDLKALNVLDLSENWLNGS----IPPEIGGAYSLKELRLERNFLAG----KIPTS  483 (936)
Q Consensus       416 ~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~  483 (936)
                      +.|+.+..++|++...    +...|...+.|+.+.++.|.|...    +-..+..+++|+.|||..|-++.    .+...
T Consensus       157 ~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~Laka  236 (382)
T KOG1909|consen  157 PKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKA  236 (382)
T ss_pred             cceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHH
Confidence            4566666666666421    223455556677777777766421    12335667777788888777763    34566


Q ss_pred             cccccccccccccCccccCCCcccc-----cccCCccEEEcCCCcccC----CCCcccccccccCeeecCCCccc
Q 002321          484 IENCSSLVSLILSKNNLTGPIPIAI-----AKLTNLQNVDLSFNSLTG----GLPKQLVNLVHLSSFNISHNHLQ  549 (936)
Q Consensus       484 l~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~ls~N~l~  549 (936)
                      +..+++|+.|+++++.+...-...|     ...++|++|.|.+|.++.    .+-..+...+.|..|+|++|++.
T Consensus       237 L~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  237 LSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             hcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            6778888888888888875433333     236789999999998872    23345566788999999999883

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.13  E-value=1.6e-11  Score=118.81  Aligned_cols=126  Identities=29%  Similarity=0.357  Sum_probs=34.4

Q ss_pred             ccCccccEEeccCCcccCcCCCchh-hcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccc
Q 002321           97 LQLQFLRKLSLSSNNLTGSISPNLA-KLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTL  175 (936)
Q Consensus        97 ~~l~~L~~L~L~~n~l~~~~~~~l~-~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  175 (936)
                      .+...+++|+|++|+|+.+  +.++ .+.+|+.|||++|+|+ .++  .+..+++|++|+|++|+|              
T Consensus        16 ~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~-~l~--~l~~L~~L~~L~L~~N~I--------------   76 (175)
T PF14580_consen   16 NNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQIT-KLE--GLPGLPRLKTLDLSNNRI--------------   76 (175)
T ss_dssp             ----------------------S--TT-TT--EEE-TTS--S---T--T----TT--EEE--SS----------------
T ss_pred             ccccccccccccccccccc--cchhhhhcCCCEEECCCCCCc-ccc--CccChhhhhhcccCCCCC--------------
Confidence            3444556666666666532  2343 3556666666666665 332  134444444444444444              


Q ss_pred             cccccccccccCCCCCCC-CCCCCCCEEecCCCCCCCCCc-cCccCCCCcceeecccccccccCCc----ccccccCcce
Q 002321          176 ATINLSSNRFSSPLPLGI-WGLSALRTLDLSDNLLEGEIP-KGVESLKNLRVINLSKNMFSGSIPD----GIGSCSLLRT  249 (936)
Q Consensus       176 ~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~  249 (936)
                                +.+.+ .+ ..+++|++|+|++|+|...-. ..+..+++|++|+|.+|.++.. +.    .+..+++|+.
T Consensus        77 ----------~~i~~-~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~  144 (175)
T PF14580_consen   77 ----------SSISE-GLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKV  144 (175)
T ss_dssp             -----------S-CH-HHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SE
T ss_pred             ----------Ccccc-chHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhhe
Confidence                      43211 12 234455555555555542111 2345566677777777766632 22    2456777777


Q ss_pred             eecc
Q 002321          250 IDFS  253 (936)
Q Consensus       250 L~Ls  253 (936)
                      ||-.
T Consensus       145 LD~~  148 (175)
T PF14580_consen  145 LDGQ  148 (175)
T ss_dssp             ETTE
T ss_pred             eCCE
Confidence            7643

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.11  E-value=4.5e-10  Score=116.55  Aligned_cols=140  Identities=24%  Similarity=0.286  Sum_probs=106.4

Q ss_pred             CcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCC--CCcceeeeEEEeC---CeeEEEEEecC
Q 002321          696 CELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH--PNLVTLEGYYWTQ---SLQLLIYEFVS  770 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e~~~  770 (936)
                      +.|+.|.++.||+++..+|+.+++|.............+.+|+++++.+++  ..+.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            468999999999999876789999997554322234678999999999975  3456777776553   25689999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ------------------------------------------  808 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~------------------------------------------  808 (936)
                      |.++.+.+..    ..++..+...++.++++++.+||+                                          
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9888775532    125666667777777777777773                                          


Q ss_pred             --------------CCcccCCCCCCCEEEcC--CCCeEEeeccCccc
Q 002321          809 --------------SNIIHYNIKSSNVLIDG--SGEPKVGDYGLARL  839 (936)
Q Consensus       809 --------------~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~  839 (936)
                                    ..++|+|+++.||+++.  ++.+.++||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          23589999999999998  66789999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.11  E-value=5.1e-11  Score=115.38  Aligned_cols=125  Identities=27%  Similarity=0.323  Sum_probs=44.5

Q ss_pred             ccccCCeeeccCccccCCCCcccc-CcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCcccc-ccccccc
Q 002321          414 ALSGLQLLNLSRNSLVGPIPVAIG-DLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSI-ENCSSLV  491 (936)
Q Consensus       414 ~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~  491 (936)
                      +..++++|+|++|+|+. + +.++ .+.+|+.|||++|.|+. + +.+..++.|++|++++|+|+ .+++.+ ..+++|+
T Consensus        17 n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l-~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~   91 (175)
T PF14580_consen   17 NPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-L-EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQ   91 (175)
T ss_dssp             ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS----S-CHHHHHH-TT--
T ss_pred             ccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-c-cCccChhhhhhcccCCCCCC-ccccchHHhCCcCC
Confidence            33456777777777763 2 2444 46677777777777774 2 34667778888888888887 344444 3578888


Q ss_pred             cccccCccccCCC-cccccccCCccEEEcCCCcccCCC---CcccccccccCeeec
Q 002321          492 SLILSKNNLTGPI-PIAIAKLTNLQNVDLSFNSLTGGL---PKQLVNLVHLSSFNI  543 (936)
Q Consensus       492 ~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~---p~~l~~l~~L~~L~l  543 (936)
                      +|+|++|+|...- -..+..+++|++|+|.+|+++..-   ..-+..+|+|+.||-
T Consensus        92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen   92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred             EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence            8888888886422 245667788888888888886331   124456777777763

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.11  E-value=1.1e-11  Score=140.64  Aligned_cols=218  Identities=28%  Similarity=0.367  Sum_probs=105.4

Q ss_pred             ccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccc
Q 002321          100 QFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATIN  179 (936)
Q Consensus       100 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  179 (936)
                      +.++.++..++.+.+.--. ...+..++.+++..|.|. .+ ......+++|+.|++.+|+|.. +...+..+++|++|+
T Consensus        49 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~-~~-~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~  124 (414)
T KOG0531|consen   49 SDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIA-KI-LNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLD  124 (414)
T ss_pred             chhhhhcchhccccchhhh-HHHhHhHHhhccchhhhh-hh-hcccccccceeeeeccccchhh-cccchhhhhcchhee
Confidence            3455555555544422111 145666666667777765 21 1223455666666666666652 222245556666666


Q ss_pred             cccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCC
Q 002321          180 LSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSG  259 (936)
Q Consensus       180 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~  259 (936)
                      |++|+|+.+.  .+..++.|+.|++++|.|+..  ..+..+++|+.+++++|+++...+.....+.+++.+++..|.+. 
T Consensus       125 ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~-  199 (414)
T KOG0531|consen  125 LSFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIR-  199 (414)
T ss_pred             cccccccccc--chhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchh-
Confidence            6666665432  234444555555555555521  23344555555555555555332200244445555555555443 


Q ss_pred             CCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCccccccc--ccceEEccCCcccccCChhh
Q 002321          260 NLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQ--RLKVLNFSANRLTGSLPDSM  337 (936)
Q Consensus       260 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~--~L~~L~L~~N~l~~~~~~~~  337 (936)
                                             ..  ..+..+..+..+++..|.++...+.  ..+.  +|+.+++++|++. ..+..+
T Consensus       200 -----------------------~i--~~~~~~~~l~~~~l~~n~i~~~~~l--~~~~~~~L~~l~l~~n~i~-~~~~~~  251 (414)
T KOG0531|consen  200 -----------------------EI--EGLDLLKKLVLLSLLDNKISKLEGL--NELVMLHLRELYLSGNRIS-RSPEGL  251 (414)
T ss_pred             -----------------------cc--cchHHHHHHHHhhcccccceeccCc--ccchhHHHHHHhcccCccc-cccccc
Confidence                                   11  1222333344445555555422211  1111  2556666666655 222444


Q ss_pred             hccCCCCEEEccCCcCc
Q 002321          338 ANCMNLVALDFSQNSMN  354 (936)
Q Consensus       338 ~~l~~L~~L~Ls~N~l~  354 (936)
                      ..+..+..|++.+|++.
T Consensus       252 ~~~~~l~~l~~~~n~~~  268 (414)
T KOG0531|consen  252 ENLKNLPVLDLSSNRIS  268 (414)
T ss_pred             cccccccccchhhcccc
Confidence            45556666666666554

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.11  E-value=5.8e-12  Score=129.08  Aligned_cols=90  Identities=23%  Similarity=0.358  Sum_probs=53.3

Q ss_pred             hhccccccEEeccCccccCC----CCcccccCCccceecccCceeccccCccc-----ccccccceEEccCCccccc---
Q 002321          265 MQKLSLCNFMNLRKNLFSGE----VPKWIGELESLETLDLSGNKFSGAVPISI-----GNLQRLKVLNFSANRLTGS---  332 (936)
Q Consensus       265 l~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~l-----~~l~~L~~L~L~~N~l~~~---  332 (936)
                      |..+++|+.|||+.|-|+..    +...++.+++|++|+++++.+......++     ...++|++|.|.+|.|+..   
T Consensus       209 l~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~  288 (382)
T KOG1909|consen  209 LEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAAL  288 (382)
T ss_pred             HHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHH
Confidence            44444555555555544421    23445566777777777777764433322     2356788888888877632   


Q ss_pred             -CChhhhccCCCCEEEccCCcCc
Q 002321          333 -LPDSMANCMNLVALDFSQNSMN  354 (936)
Q Consensus       333 -~~~~~~~l~~L~~L~Ls~N~l~  354 (936)
                       +-..+...+.|..|+|++|.+.
T Consensus       289 ~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  289 ALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             HHHHHHhcchhhHHhcCCccccc
Confidence             2334455677888888888873

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.10  E-value=9.7e-12  Score=130.77  Aligned_cols=209  Identities=24%  Similarity=0.255  Sum_probs=107.5

Q ss_pred             hcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCC--CCCCccccccccccccccccccCCCCCCCC-CCCC
Q 002321          122 KLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGK--IPSSLSLCSTLATINLSSNRFSSPLPLGIW-GLSA  198 (936)
Q Consensus       122 ~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~  198 (936)
                      ++.+|+...|.+..+......+....+++++.|||+.|-+..-  +-.-...+++|+.|+|+.|++......... .++.
T Consensus       119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~  198 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH  198 (505)
T ss_pred             hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence            4667777777777765221124456677777777777766531  222334567777777777776643322221 3556


Q ss_pred             CCEEecCCCCCCCC-CccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCC-chhhhccccccEEec
Q 002321          199 LRTLDLSDNLLEGE-IPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNL-PETMQKLSLCNFMNL  276 (936)
Q Consensus       199 L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-~~~l~~l~~L~~L~L  276 (936)
                      |+.|.|+.+.|+-. +...+..+|+|+.|+|..|...........-+..|+.|||++|++-... -...           
T Consensus       199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~-----------  267 (505)
T KOG3207|consen  199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKV-----------  267 (505)
T ss_pred             hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccccccccccc-----------
Confidence            66666666666521 1122344566666666666422232333444556666666666654211 1223           


Q ss_pred             cCccccCCCCcccccCCccceecccCceecccc-Ccc-----cccccccceEEccCCccccc-CChhhhccCCCCEEEcc
Q 002321          277 RKNLFSGEVPKWIGELESLETLDLSGNKFSGAV-PIS-----IGNLQRLKVLNFSANRLTGS-LPDSMANCMNLVALDFS  349 (936)
Q Consensus       277 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~-----l~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls  349 (936)
                                   +.++.|+.|+++.+.+...- |+.     ...+++|++|++..|++..- .-..+..+.+|+.|...
T Consensus       268 -------------~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~  334 (505)
T KOG3207|consen  268 -------------GTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRIT  334 (505)
T ss_pred             -------------ccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcc
Confidence                         34444444444444443211 111     23455666666666666421 11233445566666666


Q ss_pred             CCcCc
Q 002321          350 QNSMN  354 (936)
Q Consensus       350 ~N~l~  354 (936)
                      .|.++
T Consensus       335 ~n~ln  339 (505)
T KOG3207|consen  335 LNYLN  339 (505)
T ss_pred             ccccc
Confidence            66665

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.07  E-value=1.6e-11  Score=129.08  Aligned_cols=160  Identities=27%  Similarity=0.271  Sum_probs=90.0

Q ss_pred             CCCCCCEEecCCCCCCCCCc--cCccCCCCcceeecccccccccCCcc-cccccCcceeeccccccCCCC-chhhhcccc
Q 002321          195 GLSALRTLDLSDNLLEGEIP--KGVESLKNLRVINLSKNMFSGSIPDG-IGSCSLLRTIDFSENSFSGNL-PETMQKLSL  270 (936)
Q Consensus       195 ~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~-~~~l~~l~~  270 (936)
                      .+++++.|||++|-+....+  .....|++|+.|+|+.|++....... -..++.|+.|.|+.|.|+-.. ...+...++
T Consensus       144 ~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPs  223 (505)
T KOG3207|consen  144 ILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPS  223 (505)
T ss_pred             hCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCc
Confidence            34444444444444432111  12234455555555555543211111 113455555666655554211 112234455


Q ss_pred             ccEEeccCccccCCCCcccccCCccceecccCceecccc-CcccccccccceEEccCCccccc-CChh-----hhccCCC
Q 002321          271 CNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAV-PISIGNLQRLKVLNFSANRLTGS-LPDS-----MANCMNL  343 (936)
Q Consensus       271 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~~~-~~~~-----~~~l~~L  343 (936)
                      |..|+|..|.....-.....-+..|++|||++|++-... -...+.++.|..|+++.+.++.. .|+.     ....++|
T Consensus       224 l~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL  303 (505)
T KOG3207|consen  224 LEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKL  303 (505)
T ss_pred             HHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccc
Confidence            666666666422222333445678999999999886332 13567899999999999998864 2333     3567899


Q ss_pred             CEEEccCCcCc
Q 002321          344 VALDFSQNSMN  354 (936)
Q Consensus       344 ~~L~Ls~N~l~  354 (936)
                      +.|+++.|++.
T Consensus       304 ~~L~i~~N~I~  314 (505)
T KOG3207|consen  304 EYLNISENNIR  314 (505)
T ss_pred             eeeecccCccc
Confidence            99999999985

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.02  E-value=7.4e-11  Score=130.78  Aligned_cols=194  Identities=20%  Similarity=0.219  Sum_probs=147.7

Q ss_pred             ccccCCCcccccCceEEEEEEeC--CCcEEEEEEeeccCccchH-HHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR--DGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  765 (936)
                      ..+.....||.|.|+.||+...+  ++..|++|........... ..-..|+.+...+ -|.+++..+..+......++=
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            34566678999999999998855  5788999988654333222 2235677777777 488899888887777777888


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-CCeEEeeccCccccCCCc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS-GEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~  844 (936)
                      -||+++++......-.   ..+++..++++..|++.++.++|+..++|+|+||+||++..+ +..++.|||++..+..  
T Consensus       345 ~e~~~~~s~~l~~~~~---~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~--  419 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSVTS---QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF--  419 (524)
T ss_pred             hhhhcCcchhhhhHHH---HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce--
Confidence            9999999988766322   237888899999999999999999999999999999999886 8899999999864211  


Q ss_pred             cccccccccCccccc-CcccccCcccCCchhhHHHHHHHHHHHHcCCC
Q 002321          845 RYVLSSKIQSALGYM-APEFACRTVKITDKCDVYGFGVLVLEVVTGKR  891 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~-aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~  891 (936)
                        .. ......-+++ .+|.+.....+..+.|++|||.-+.|..+|..
T Consensus       420 --~~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~  464 (524)
T KOG0601|consen  420 --SS-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP  464 (524)
T ss_pred             --ec-ccccccccccccchhhccccccccccccccccccccccccCcc
Confidence              01 1111222344 36666677788899999999999999998863

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.96  E-value=5.9e-10  Score=134.67  Aligned_cols=133  Identities=32%  Similarity=0.402  Sum_probs=105.3

Q ss_pred             cccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcc--cccccchhhhhcCCCCcEEEccCccCCCCCCCCccccc
Q 002321           96 LLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNS--LSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCS  173 (936)
Q Consensus        96 l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~--l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~  173 (936)
                      ..+....++..+-+|++. .++.... .++|++|-+..|.  +. .++.++|..++.|++|||++|.=-+.+|.+++.+-
T Consensus       519 ~~~~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li  595 (889)
T KOG4658|consen  519 VKSWNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELV  595 (889)
T ss_pred             ccchhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhh
Confidence            445577888888888886 3333332 3479999999986  54 78888999999999999999877678899999999


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeeccccc
Q 002321          174 TLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNM  232 (936)
Q Consensus       174 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  232 (936)
                      +|++|+|++..++ .+|..+.+|.+|.+|++.++.-...+|.....|++|++|.+..-.
T Consensus       596 ~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  596 HLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             hhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence            9999999999888 578888888888888888887655566666678888888877654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.95  E-value=1.5e-08  Score=106.31  Aligned_cols=134  Identities=16%  Similarity=0.073  Sum_probs=97.4

Q ss_pred             eEEEEEEeCCCcEEEEEEeeccCccch----------HHHHHHHHHHHHcCCCCC--cceeeeEEEe-----CCeeEEEE
Q 002321          704 GAVYRTVLRDGRPVAIKKLTVSSLVKS----------QEDFEREVKKLGKVRHPN--LVTLEGYYWT-----QSLQLLIY  766 (936)
Q Consensus       704 g~Vy~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~E~~~l~~l~h~n--iv~l~~~~~~-----~~~~~lv~  766 (936)
                      ..|+++.+ +|+.|.||........+.          ...+.+|.+.+.++...+  +++++++.+.     ....++|+
T Consensus        36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            44667766 478899998754332111          124789999998885433  3444556543     23468999


Q ss_pred             EecCCC-ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-------CCCeEEeeccCcc
Q 002321          767 EFVSGG-SLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG-------SGEPKVGDYGLAR  838 (936)
Q Consensus       767 e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~-------~~~~kl~Dfg~a~  838 (936)
                      |++++. +|.+++..... ...+......++.+++..+.-||..||+|+|++++|||++.       ++.+.++||+.++
T Consensus       115 e~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        115 EDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             eeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            999876 78888753211 22456677789999999999999999999999999999975       4689999999875


Q ss_pred             c
Q 002321          839 L  839 (936)
Q Consensus       839 ~  839 (936)
                      .
T Consensus       194 ~  194 (268)
T PRK15123        194 I  194 (268)
T ss_pred             c
Confidence            3

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.95  E-value=6.4e-10  Score=80.83  Aligned_cols=40  Identities=45%  Similarity=1.025  Sum_probs=31.1

Q ss_pred             hhHHHHHHHHHHhcc-CCCCCCCCCCCCC-CCCccceeEEec
Q 002321           33 NDDVLGLIVFKADIQ-DPNGKLSSWSEDD-DTPCNWFGVKCS   72 (936)
Q Consensus        33 ~~~~~aLl~~k~~~~-d~~~~l~sW~~~~-~~~c~w~gv~c~   72 (936)
                      ++|++||++||+++. ||.+.+.+|+.+. .+||+|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence            579999999999999 5778999999873 359999999996

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.93  E-value=1e-08  Score=101.18  Aligned_cols=126  Identities=21%  Similarity=0.327  Sum_probs=84.0

Q ss_pred             EEEEEEeCCCcEEEEEEeeccCcc-------------------------chHHHHHHHHHHHHcCCCC--CcceeeeEEE
Q 002321          705 AVYRTVLRDGRPVAIKKLTVSSLV-------------------------KSQEDFEREVKKLGKVRHP--NLVTLEGYYW  757 (936)
Q Consensus       705 ~Vy~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  757 (936)
                      .||.|...+|..+|||+++.....                         ......++|.+.|.++...  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            489999888999999998642110                         0124577899999999766  566666543 


Q ss_pred             eCCeeEEEEEecC--CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCcccCCCCCCCEEEcCCCCeEEeec
Q 002321          758 TQSLQLLIYEFVS--GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAH-LHQSNIIHYNIKSSNVLIDGSGEPKVGDY  834 (936)
Q Consensus       758 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~-LH~~~ivH~Dlkp~NIll~~~~~~kl~Df  834 (936)
                         ...+||||++  |..+..+....     ++......++.+++..+.. +|..||+|||+.+.||+++++ .+.++||
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf  150 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF  150 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence               3379999998  55554433321     1123455677788886555 579999999999999999987 9999999


Q ss_pred             cCcccc
Q 002321          835 GLARLL  840 (936)
Q Consensus       835 g~a~~~  840 (936)
                      |.+...
T Consensus       151 ~qav~~  156 (188)
T PF01163_consen  151 GQAVDS  156 (188)
T ss_dssp             TTEEET
T ss_pred             Ccceec
Confidence            988643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.89  E-value=3e-10  Score=132.01  Aligned_cols=238  Identities=20%  Similarity=0.217  Sum_probs=162.5

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      .+...+-+-.|+++.++.++-. .|...+.|+.......  .+.+...++-.+.-..++|.++....-+......+++++
T Consensus       805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~  884 (1205)
T KOG0606|consen  805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGH  884 (1205)
T ss_pred             cceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhH
Confidence            3445556788999999987744 3545555554322111  112333344444444456777765555555667799999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC----
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML----  843 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~----  843 (936)
                      |+.++++...++....   .+...+......+..+.+|||...+.|+|++|.|++...+|+.+++|||....+...    
T Consensus       885 ~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~  961 (1205)
T KOG0606|consen  885 YLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT  961 (1205)
T ss_pred             HhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence            9999999999887652   344444455667889999999999999999999999999999999999854333110    


Q ss_pred             -------------------------ccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch
Q 002321          844 -------------------------DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM  898 (936)
Q Consensus       844 -------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~  898 (936)
                                               +.........+|+.|.+||... +......+|.|+.|++++|.++|..||.....
T Consensus       962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~l-g~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen  962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILL-GRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred             CcccccccCccccccccccccccccchhhccccccCCCcccCCcccc-cccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence                                     0112234466889999999885 44678899999999999999999999998877


Q ss_pred             hHHHHHHH-HH------HHhhhccccceeeccccccccccc
Q 002321          899 MWWFSVTW-LE------EHWKKAEWRNVSMRSCKGSSRQRR  932 (936)
Q Consensus       899 ~~~~~~~~-~~------~~~~~~~~~~~~~~~l~~~p~~Rp  932 (936)
                      ..++.-.. ..      +.....+..+.+.+.+..+|.+|-
T Consensus      1041 q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~ 1081 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRL 1081 (1205)
T ss_pred             hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhcc
Confidence            65552111 00      122234556666777777777763

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.87  E-value=1.6e-09  Score=86.21  Aligned_cols=60  Identities=38%  Similarity=0.566  Sum_probs=37.9

Q ss_pred             cccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccC
Q 002321          101 FLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRF  161 (936)
Q Consensus       101 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l  161 (936)
                      +|++|++++|+|+.+.+..|.++++|++|++++|+|+ .++++.|.++++|++|++++|+|
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~-~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLT-SIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSES-EEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccC-ccCHHHHcCCCCCCEEeCcCCcC
Confidence            5666666666666555556666666666666666665 55666666666666666666654

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.86  E-value=1.1e-09  Score=87.16  Aligned_cols=61  Identities=31%  Similarity=0.512  Sum_probs=36.5

Q ss_pred             CCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccc
Q 002321          124 QNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRF  185 (936)
Q Consensus       124 ~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  185 (936)
                      ++|++|+|++|+|+ .+|.++|.++++|++|++++|+|+...|..|..+++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            45666777777666 56666666666666666666666555555555555555555555543

...

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.82  E-value=4.4e-09  Score=127.27  Aligned_cols=129  Identities=27%  Similarity=0.371  Sum_probs=65.0

Q ss_pred             CCCCEEecCCCCCCCCCccCccCCCCcceeeccccc--ccccCCcccccccCcceeeccccccCCCCchhhhccccccEE
Q 002321          197 SALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNM--FSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFM  274 (936)
Q Consensus       197 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~--l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L  274 (936)
                      ...+...+-+|.+. .++.... .++|+.|-+..|.  +....+..|..++.|.+|||++|.=-+.+|..++.|-+|++|
T Consensus       523 ~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL  600 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL  600 (889)
T ss_pred             hheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence            34455555555544 2222222 2345555555553  332333334455555555555554444555555555555555


Q ss_pred             eccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCc
Q 002321          275 NLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANR  328 (936)
Q Consensus       275 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~  328 (936)
                      +|++..++ .+|..+.+++.|.+|++..+.-...+|.....|++|++|.+..-.
T Consensus       601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence            55555555 455555555555556555554433444444555666666555543

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.79  E-value=4.3e-08  Score=98.80  Aligned_cols=156  Identities=19%  Similarity=0.236  Sum_probs=109.5

Q ss_pred             CCCceeeccCCCCcccc----ccccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCc-------------------
Q 002321          671 NSGKLVMFSGDPDFSTG----THALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSL-------------------  727 (936)
Q Consensus       671 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------  727 (936)
                      ..|..+.+.|..-+...    .......+.+||.|--+.||.|...+|.++|||.-+....                   
T Consensus        68 y~Gy~lT~~GyD~LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~s  147 (304)
T COG0478          68 YEGYQLTFSGYDALALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGS  147 (304)
T ss_pred             ceeEEEEecchhHHHHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcc
Confidence            33445555555432221    1123456678999999999999999999999997542111                   


Q ss_pred             --cchHHHHHHHHHHHHcCCCC--CcceeeeEEEeCCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHH
Q 002321          728 --VKSQEDFEREVKKLGKVRHP--NLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSL  803 (936)
Q Consensus       728 --~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al  803 (936)
                        .......++|.++|.++...  .|.+.+++-    ...+||||++|-.|...--        +....-.++..|++-+
T Consensus       148 Wl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~n----RHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~  215 (304)
T COG0478         148 WLYVSRLAAEREFEALQRLYPEGVKVPKPIAWN----RHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEV  215 (304)
T ss_pred             hhhhHHHHHHHHHHHHHHhhhcCCCCCCccccc----cceeeeehcccceeecccC--------cccCHHHHHHHHHHHH
Confidence              01134578999999999655  777777664    4479999999866654321        2223344556666666


Q ss_pred             HHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCcc
Q 002321          804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR  838 (936)
Q Consensus       804 ~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  838 (936)
                      .-.-..|+||||+.+-||+++++|.+.++||--+.
T Consensus       216 ~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         216 RKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             HHHHHcCccccCCchheEEEecCCCEEEEeCcccc
Confidence            66668999999999999999999999999996554

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.74  E-value=4.3e-10  Score=124.98  Aligned_cols=127  Identities=31%  Similarity=0.294  Sum_probs=98.4

Q ss_pred             CcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCC-CCCCcCCCcEEE
Q 002321          392 ESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPP-EIGGAYSLKELR  470 (936)
Q Consensus       392 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~  470 (936)
                      ..|...+.++|.+. .....+.-++.|+.|+|++|+++..  +.+..++.|++|||++|.+.. +|. ...++. |+.|.
T Consensus       164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~-vp~l~~~gc~-L~~L~  238 (1096)
T KOG1859|consen  164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRH-VPQLSMVGCK-LQLLN  238 (1096)
T ss_pred             hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhcc-ccccchhhhh-heeee
Confidence            46788889999997 6667788889999999999999854  388889999999999999984 443 233343 89999


Q ss_pred             ecCCccCCcCccccccccccccccccCccccCCC-cccccccCCccEEEcCCCccc
Q 002321          471 LERNFLAGKIPTSIENCSSLVSLILSKNNLTGPI-PIAIAKLTNLQNVDLSFNSLT  525 (936)
Q Consensus       471 Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~  525 (936)
                      |++|.++.  -..+.+|.+|+.|||++|-|.+.- -.-++.|..|+.|+|.+|.+-
T Consensus       239 lrnN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  239 LRNNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             ecccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            99998873  245778888888999998887532 233566778888888888885

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.71  E-value=6e-10  Score=98.92  Aligned_cols=113  Identities=22%  Similarity=0.219  Sum_probs=84.9

Q ss_pred             ccCCeeecCCccccccCCCCC-CCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEE
Q 002321          440 KALNVLDLSENWLNGSIPPEI-GGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVD  518 (936)
Q Consensus       440 ~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  518 (936)
                      ..|+..+|++|.+.. .|+.| ...+.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|-+||
T Consensus        53 ~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld  129 (177)
T KOG4579|consen   53 YELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD  129 (177)
T ss_pred             ceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence            344555666666664 34333 33457788888888888 78888999999999999999998 6788888899999999


Q ss_pred             cCCCcccCCCCcccccccccCeeecCCCcccccCCCCC
Q 002321          519 LSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGG  556 (936)
Q Consensus       519 Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~  556 (936)
                      ..+|.+. .+|-.+..-+.....++.++++.+..|.+.
T Consensus       130 s~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~kl  166 (177)
T KOG4579|consen  130 SPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKL  166 (177)
T ss_pred             CCCCccc-cCcHHHhccccHHHHHhcCCcccccCcccc
Confidence            9999887 677655555555666778888888777643

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.66  E-value=1e-07  Score=108.34  Aligned_cols=142  Identities=20%  Similarity=0.321  Sum_probs=97.0

Q ss_pred             CcccccCceEEEEEEeCCCcEEEEEEeeccCccc---------------------------------------hHHHHHH
Q 002321          696 CELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVK---------------------------------------SQEDFER  736 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------------------------------------~~~~~~~  736 (936)
                      +.|+.++-|.||+|++++|+.||||+.++.-...                                       .+-++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            4689999999999999999999999975421100                                       0113566


Q ss_pred             HHHHHHcCC-----CCCcceeeeEEEeCCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 002321          737 EVKKLGKVR-----HPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKS-LAHLHQSN  810 (936)
Q Consensus       737 E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~a-l~~LH~~~  810 (936)
                      |+.-+.+++     .+++.-..-|++......++|||++|..+.+...-...+  .+.   ..++..++++ +..+-..|
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d~---k~ia~~~~~~f~~q~~~dg  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--IDR---KELAELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--CCH---HHHHHHHHHHHHHHHHhcC
Confidence            777776663     344332222333345668999999999998874322211  342   2344444433 33444589


Q ss_pred             cccCCCCCCCEEEcCCCCeEEeeccCccccCC
Q 002321          811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM  842 (936)
Q Consensus       811 ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  842 (936)
                      ++|+|.+|.||+++.+|.+.+.|||+...++.
T Consensus       286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            99999999999999999999999999977653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.66  E-value=2.4e-07  Score=94.31  Aligned_cols=106  Identities=24%  Similarity=0.303  Sum_probs=84.4

Q ss_pred             HHHHHHHHHHHHcCCC--CCcceeeeEEEeCC----eeEEEEEecCCC-ChhhhhhccCCCCCCCHHHHHHHHHHHHHHH
Q 002321          731 QEDFEREVKKLGKVRH--PNLVTLEGYYWTQS----LQLLIYEFVSGG-SLHKHLHEGSGGNFLSWNERFNVIQGTAKSL  803 (936)
Q Consensus       731 ~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al  803 (936)
                      .....+|.+.+.++..  =.+.+.+++.+...    ..++|+|++++. +|.+++.....   .+......++.++++.+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence            4567889998888853  34556667766532    347999999874 78988876332   45566778999999999


Q ss_pred             HHHHhCCcccCCCCCCCEEEcCCC---CeEEeeccCccc
Q 002321          804 AHLHQSNIIHYNIKSSNVLIDGSG---EPKVGDYGLARL  839 (936)
Q Consensus       804 ~~LH~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~  839 (936)
                      +-||+.||+|+|+++.|||++.++   .+.++||+-++.
T Consensus       132 ~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999999999999999999887   899999997764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.66  E-value=9e-10  Score=122.48  Aligned_cols=178  Identities=29%  Similarity=0.371  Sum_probs=123.0

Q ss_pred             ccccccCccccEEeccCCcccCcCCCchhhc-CCCcEEEccCcccccccchhhhhc----------CCCCcEEEccCccC
Q 002321           93 GRGLLQLQFLRKLSLSSNNLTGSISPNLAKL-QNLRVIDLSGNSLSGSIPDEFFKQ----------CGSLRVISLAKNRF  161 (936)
Q Consensus        93 ~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l-~~L~~L~Ls~N~l~~~i~~~~f~~----------l~~L~~L~L~~N~l  161 (936)
                      |-.|..+..|++|-|+++.|..  ...+..+ .+|+.|--+ |.+. . -.++|..          ...|...+.++|.+
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~-A-l~~v~ascggd~~ns~~Wn~L~~a~fsyN~L  176 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLD-A-LRHVFASCGGDISNSPVWNKLATASFSYNRL  176 (1096)
T ss_pred             CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHH-H-HHHHHHHhccccccchhhhhHhhhhcchhhH
Confidence            4467888889999998888864  1223332 345555433 3332 1 1122221          23578888899998


Q ss_pred             CCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCcc-CccCCCCcceeecccccccccCCcc
Q 002321          162 SGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPK-GVESLKNLRVINLSKNMFSGSIPDG  240 (936)
Q Consensus       162 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~  240 (936)
                      . ....++.-++.|+.|+|++|+++...  .+..+++|++|||++|.+. .+|. ...++. |+.|.|++|.++..  ..
T Consensus       177 ~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~tL--~g  249 (1096)
T KOG1859|consen  177 V-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTTL--RG  249 (1096)
T ss_pred             H-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHhh--hh
Confidence            7 56667888999999999999998643  7888999999999999998 4443 334444 99999999998743  45


Q ss_pred             cccccCcceeeccccccCCCC-chhhhccccccEEeccCcccc
Q 002321          241 IGSCSLLRTIDFSENSFSGNL-PETMQKLSLCNFMNLRKNLFS  282 (936)
Q Consensus       241 l~~l~~L~~L~Ls~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~  282 (936)
                      +.++.+|+.|||++|-|.+.- -..+..|..|+.|+|.+|.+-
T Consensus       250 ie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  250 IENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             HHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            778899999999999887432 233455666677777777654

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.57  E-value=5.7e-07  Score=97.70  Aligned_cols=166  Identities=17%  Similarity=0.252  Sum_probs=122.5

Q ss_pred             eEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEE----eCCeeEEEEEecCC-CChhhh
Q 002321          704 GAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW----TQSLQLLIYEFVSG-GSLHKH  777 (936)
Q Consensus       704 g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-g~L~~~  777 (936)
                      .+.||+... ||..|++|++...... .......-+++++++.|.|||++.+++.    .+...++|++|+++ ++|.++
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~-~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQ-STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             ceeEeeeeccCCceeeeeeecccccc-CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            467888854 7999999998332211 1112234578899999999999999886    34567899999986 566664


Q ss_pred             hhccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          778 LHEGS------------GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       778 l~~~~------------~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      -....            .+...++...|.++.|+..||.++|+.|+..+-+.+++|+++.+.+++|+..|+...+.... 
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-  447 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-  447 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC-
Confidence            43221            11237789999999999999999999999999999999999999999998777765443211 


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCC
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGK  890 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~  890 (936)
                                   .  |.+    .--.+-|.=.+|.++..|.+|.
T Consensus       448 -------------~--~~l----e~~Qq~D~~~lG~ll~aLAt~~  473 (655)
T KOG3741|consen  448 -------------T--EPL----ESQQQNDLRDLGLLLLALATGT  473 (655)
T ss_pred             -------------C--cch----hHHhhhhHHHHHHHHHHHhhcc
Confidence                         0  112    1123678889999999999984

>PRK09902 hypothetical protein; Provisional

Probab=98.56  E-value=1.7e-06  Score=85.80  Aligned_cols=139  Identities=17%  Similarity=0.152  Sum_probs=102.6

Q ss_pred             ccccCceEEEEEEeCCCcEEEEEEeeccC--c---cchHHHHHHHHHHHHcCCC--CCcceeeeEEE-eC----CeeEEE
Q 002321          698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSS--L---VKSQEDFEREVKKLGKVRH--PNLVTLEGYYW-TQ----SLQLLI  765 (936)
Q Consensus       698 iG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~---~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~-~~----~~~~lv  765 (936)
                      -|+|+.+-|++.... |+.+-+|+-...-  .   .-....|.+|+..+.++..  -.+.+++ ++. ..    -..++|
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            477889999997765 5678888763110  0   2246789999999999953  3355555 332 21    235799


Q ss_pred             EEecCC-CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCC--eEEeeccCccc
Q 002321          766 YEFVSG-GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGE--PKVGDYGLARL  839 (936)
Q Consensus       766 ~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~  839 (936)
                      +|-+++ -+|.+++..... ...+...+..+..++++++.-||+.|+.|+|+.++||+++.+|.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997753 688888765432 23577778899999999999999999999999999999987776  99999986653

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.55  E-value=2.1e-08  Score=100.72  Aligned_cols=204  Identities=20%  Similarity=0.195  Sum_probs=108.1

Q ss_pred             cccCccccEEeccCCcccCcC-CCchh-hcCCCcEEEccCccccccc-chhhhhcCCCCcEEEccCccCCCCCCCCcccc
Q 002321           96 LLQLQFLRKLSLSSNNLTGSI-SPNLA-KLQNLRVIDLSGNSLSGSI-PDEFFKQCGSLRVISLAKNRFSGKIPSSLSLC  172 (936)
Q Consensus        96 l~~l~~L~~L~L~~n~l~~~~-~~~l~-~l~~L~~L~Ls~N~l~~~i-~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l  172 (936)
                      ++.+..++-|.+.++.|..+- ...|+ ..++++.|||.+|.|+.-- -..++.++|.|++|+|+.|++...|...-..+
T Consensus        41 v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~  120 (418)
T KOG2982|consen   41 VSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPL  120 (418)
T ss_pred             eccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccc
Confidence            444445556666666665331 12232 3567777777777777421 12345677777777777777764443322456


Q ss_pred             ccccccccccccccCC-CCCCCCCCCCCCEEecCCCCCC----------CCCcc--CccCCCCcceeecccccccccCCc
Q 002321          173 STLATINLSSNRFSSP-LPLGIWGLSALRTLDLSDNLLE----------GEIPK--GVESLKNLRVINLSKNMFSGSIPD  239 (936)
Q Consensus       173 ~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~----------~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~  239 (936)
                      .+|+.|-|.+..+.=. ....+..++.++.|.+|.|.+.          ..-|.  .+..++.+..+.++.|++...   
T Consensus       121 ~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~---  197 (418)
T KOG2982|consen  121 KNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRI---  197 (418)
T ss_pred             cceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhh---
Confidence            6777777776665421 1233456666777777776332          11110  122233444444444555432   


Q ss_pred             ccccccCcceeeccccccCCCC-chhhhccccccEEeccCccccCCC-CcccccCCccceecccCceec
Q 002321          240 GIGSCSLLRTIDFSENSFSGNL-PETMQKLSLCNFMNLRKNLFSGEV-PKWIGELESLETLDLSGNKFS  306 (936)
Q Consensus       240 ~l~~l~~L~~L~Ls~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~  306 (936)
                          ++++..+-+..|.+.... -..+..++.+..|+|+.|++..-- -+++..+++|..|.+++|.+.
T Consensus       198 ----Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~  262 (418)
T KOG2982|consen  198 ----FPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS  262 (418)
T ss_pred             ----cccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence                345666667777665322 123444455556666666665321 234455566666666666554

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.48  E-value=1.9e-06  Score=91.19  Aligned_cols=196  Identities=17%  Similarity=0.206  Sum_probs=127.2

Q ss_pred             ccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEE------E-eCCeeE
Q 002321          692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYY------W-TQSLQL  763 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~------~-~~~~~~  763 (936)
                      +...+.+|+|+-+.+|-.-.- + .-+.|++...-..    .-...+..|... .||-+-.=+.|=      - .+....
T Consensus        13 i~~gr~LgqGgea~ly~l~e~-~-d~VAKIYh~Pppa----~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG   86 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEV-R-DQVAKIYHAPPPA----AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG   86 (637)
T ss_pred             cCCCccccCCccceeeecchh-h-chhheeecCCCch----HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence            456678999999999964321 1 2345776433221    112234444444 565433311121      1 122356


Q ss_pred             EEEEecCCC-Chhhhhhc---cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          764 LIYEFVSGG-SLHKHLHE---GSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       764 lv~e~~~~g-~L~~~l~~---~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      +.|..+.+- ....++..   ...-....|...+++++.++.|.+.||..|.+-||+.++|+||.+++.+.+.|=..-..
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee
Confidence            777777653 22222221   12223478999999999999999999999999999999999999999999997443221


Q ss_pred             cCCCccccccccccCcccccCccccc----CcccCCchhhHHHHHHHHHHHHcC-CCCCCcc
Q 002321          840 LPMLDRYVLSSKIQSALGYMAPEFAC----RTVKITDKCDVYGFGVLVLEVVTG-KRPLSTW  896 (936)
Q Consensus       840 ~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwSlG~~l~el~~g-~~Pf~~~  896 (936)
                      -   ..........+...|.+||.-.    .+.+-+...|.|.+|+++++++.| ++||.+.
T Consensus       167 ~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         167 N---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             c---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            1   1222334456788899999542    123346679999999999999986 9999874

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	936
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		4e-49
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		5e-49
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-32
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-32
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-30
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-29
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-29
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-29
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-28
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-28
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		7e-24
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		5e-19
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-21
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-21
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-19
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-18
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-17
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-17
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		9e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-16
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-16
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-16
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-16
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-16
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-16
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		9e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-15
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-15
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		8e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		9e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-14
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-14
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-14
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-14
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-14
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		9e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		9e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		9e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		9e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		9e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		9e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-13
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-13
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-13
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-13
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-13
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-13
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-13
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		9e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-12
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-12
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-12
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-12
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-12
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-12
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-12
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-12
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-12
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-12
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-12
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-12
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-12
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-12
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-12
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		9e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-12
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-11
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-11
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-11
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-11
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-11
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-11
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		7e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		7e-11
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		8e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-11
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		9e-11
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-10
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-10
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-10
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-10
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-10
3soa_A	444	Full-Length Human Camkii Length = 444		3e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-10
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		6e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		7e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		9e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		9e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-09
3b2d_A	603	Crystal Structure Of Human Rp105MD-1 Complex Length		5e-09
3b2d_A	603	Crystal Structure Of Human Rp105MD-1 Complex Length		1e-04
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		6e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		6e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		7e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		7e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		7e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		7e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		8e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		8e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		9e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-08
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-08
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-08
3rg1_A	612	Crystal Structure Of The Rp105MD-1 Complex Length =		7e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		7e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		7e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		7e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		8e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		8e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		8e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		8e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		9e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		9e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		9e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		9e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		9e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		9e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		9e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		9e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-07
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-07
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-07
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-07
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-07
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-07
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-07
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-07
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-07
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-07
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-07
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-07
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-07
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-07
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-07
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		7e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		7e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		8e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		9e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-06
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-06
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-06
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-06
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-06
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-06
3rfs_A	272	Design Of A Binding Scaffold Based On Variable Lymp		4e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-06
3j0a_A	844	Homology Model Of Human Toll-Like Receptor 5 Fitted		7e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		7e-06
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		8e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		8e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		8e-06
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		9e-06
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-05
3cig_A	697	Crystal Structure Of Mouse Tlr3 Ectodomain Length =		1e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-05
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-05
3fxi_A	605	Crystal Structure Of The Human Tlr4-Human Md-2-E.Co		6e-05
3gni_B	389	Structure Of Strad And Mo25 Length = 389		6e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		7e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-05
1p8t_A	285	Crystal Structure Of Nogo-66 Receptor Length = 285		8e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-05
1ozn_A	285	1.5a Crystal Structure Of The Nogo Receptor Ligand		8e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		9e-05
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		9e-05
3t6q_A	606	Crystal Structure Of Mouse Rp105MD-1 Complex Length		9e-05
2id5_A	477	Crystal Structure Of The Lingo-1 Ectodomain Length		1e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-04
4g8a_A	635	Crystal Structure Of Human Tlr4 Polymorphic Variant		1e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-04
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-04
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-04
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
2z66_A	306	Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A		2e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-04
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-04
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-04
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-04
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-04
2o6s_A	208	Structural Diversity Of The Hagfish Variable Lympho		4e-04
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		6e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		7e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-04
4fcg_A	328	Structure Of The Leucine-Rich Repeat Domain Of The		7e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		8e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		8e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		8e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		9e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  178 bits (451), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 148/483 (30%), Positives = 228/483 (47%), Gaps = 44/483 (9%)
Query: 110 NNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSL 169
           N+  G++ P       L  + LS N+ SG +P +   +   L+V+ L+ N FSG++P SL
Sbjct: 301 NHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESL 360
Query: 170 S-LCSTLATINLSSNRFSSP-LP-LGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVI 226
           + L ++L T++LSSN FS P LP L     + L+ L L +N   G+IP  + +   L  +
Sbjct: 361 TNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSL 420
Query: 227 NLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVP 286
           +LS N  SG+IP  +GS S LR +    N   G +P+ +  +     + L  N  +GE+P
Sbjct: 421 HLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIP 480
Query: 287 KWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVAL 346
             +    +L  + LS N+ +G +P  IG L+ L +L  S N  +G++P  + +C +L+ L
Sbjct: 481 SGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWL 540
Query: 347 DFSQNSMNGDLPQWIF-SSGLNKVSFAENK-----IREGMNGPFASSGSSFESLQFLDLS 400
           D + N  NG +P  +F  SG    +F   K       +GM      +G+  E        
Sbjct: 541 DLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLE-------- 592
Query: 401 HNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEI 460
              F G     +  LS     N++     G       +  ++  LD+S N L+G IP EI
Sbjct: 593 ---FQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEI 649
Query: 461 GGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLS 520
           G    L  L L  N ++G IP  + +   L  L LS N L G IP A++ LT L  +DL 
Sbjct: 650 GSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDL- 708
Query: 521 FNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKS 580
                                  S+N+L G +P  G F T  P+  L NP LCG  + + 
Sbjct: 709 -----------------------SNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRC 745
Query: 581 CPA 583
            P+
Sbjct: 746 DPS 748

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  178 bits (451), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 148/483 (30%), Positives = 228/483 (47%), Gaps = 44/483 (9%)
Query: 110 NNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSL 169
           N+  G++ P       L  + LS N+ SG +P +   +   L+V+ L+ N FSG++P SL
Sbjct: 304 NHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESL 363
Query: 170 S-LCSTLATINLSSNRFSSP-LP-LGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVI 226
           + L ++L T++LSSN FS P LP L     + L+ L L +N   G+IP  + +   L  +
Sbjct: 364 TNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSL 423
Query: 227 NLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVP 286
           +LS N  SG+IP  +GS S LR +    N   G +P+ +  +     + L  N  +GE+P
Sbjct: 424 HLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIP 483
Query: 287 KWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVAL 346
             +    +L  + LS N+ +G +P  IG L+ L +L  S N  +G++P  + +C +L+ L
Sbjct: 484 SGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWL 543
Query: 347 DFSQNSMNGDLPQWIF-SSGLNKVSFAENK-----IREGMNGPFASSGSSFESLQFLDLS 400
           D + N  NG +P  +F  SG    +F   K       +GM      +G+  E        
Sbjct: 544 DLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLE-------- 595
Query: 401 HNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEI 460
              F G     +  LS     N++     G       +  ++  LD+S N L+G IP EI
Sbjct: 596 ---FQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEI 652
Query: 461 GGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLS 520
           G    L  L L  N ++G IP  + +   L  L LS N L G IP A++ LT L  +DL 
Sbjct: 653 GSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDL- 711
Query: 521 FNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKS 580
                                  S+N+L G +P  G F T  P+  L NP LCG  + + 
Sbjct: 712 -----------------------SNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRC 748
Query: 581 CPA 583
            P+
Sbjct: 749 DPS 751

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  136 bits (342), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 75/205 (36%), Positives = 124/205 (60%), Gaps = 6/205 (2%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           LGRGGFG VY+  L DG  VA+K+L        +  F+ EV+ +    H NL+ L G+  
Sbjct: 38  LGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97
Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGN-FLSWNERFNVIQGTAKSLAHLHQS---NIIH 813
           T + +LL+Y +++ GS+   L E       L W +R  +  G+A+ LA+LH      IIH
Sbjct: 98  TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIH 157
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            ++K++N+L+D   E  VGD+GLA+L+   D +V  + ++  +G++APE+   T K ++K
Sbjct: 158 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VRGXIGHIAPEYLS-TGKSSEK 215
Query: 874 CDVYGFGVLVLEVVTGKRPLSTWKM 898
            DV+G+GV++LE++TG+R     ++
Sbjct: 216 TDVFGYGVMLLELITGQRAFDLARL 240

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  136 bits (342), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 75/205 (36%), Positives = 124/205 (60%), Gaps = 6/205 (2%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           LGRGGFG VY+  L DG  VA+K+L        +  F+ EV+ +    H NL+ L G+  
Sbjct: 46  LGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCM 105
Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGN-FLSWNERFNVIQGTAKSLAHLHQS---NIIH 813
           T + +LL+Y +++ GS+   L E       L W +R  +  G+A+ LA+LH      IIH
Sbjct: 106 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIH 165
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            ++K++N+L+D   E  VGD+GLA+L+   D +V  + ++  +G++APE+   T K ++K
Sbjct: 166 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VRGTIGHIAPEYLS-TGKSSEK 223
Query: 874 CDVYGFGVLVLEVVTGKRPLSTWKM 898
            DV+G+GV++LE++TG+R     ++
Sbjct: 224 TDVFGYGVMLLELITGQRAFDLARL 248

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  129 bits (324), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 75/196 (38%), Positives = 115/196 (58%), Gaps = 6/196 (3%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQE---DFEREVKKLGKVRHPNLVTLE 753
           ++G GGFG VY+  + +   VA+KKL     + ++E    F++E+K + K +H NLV L 
Sbjct: 38  KMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
           G+        L+Y ++  GSL   L    G   LSW+ R  + QG A  +  LH+++ IH
Sbjct: 97  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 156
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            +IKS+N+L+D +   K+ D+GLAR      + V+ S+I     YMAPE A R  +IT K
Sbjct: 157 RDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPE-ALRG-EITPK 214
Query: 874 CDVYGFGVLVLEVVTG 889
            D+Y FGV++LE++TG
Sbjct: 215 SDIYSFGVVLLEIITG 230

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  127 bits (320), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 74/197 (37%), Positives = 123/197 (62%), Gaps = 9/197 (4%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           +G G FG VY+ VLRDG  VA+K+ T  S  +  E+FE E++ L   RHP+LV+L G+  
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCD 105
Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNF----LSWNERFNVIQGTAKSLAHLHQSNIIH 813
            ++  +LIY+++  G+L +HL+   G +     +SW +R  +  G A+ L +LH   IIH
Sbjct: 106 ERNEMILIYKYMENGNLKRHLY---GSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIH 162
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            ++KS N+L+D +  PK+ D+G+++    LD+  L   ++  LGY+ PE+  +  ++T+K
Sbjct: 163 RDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKG-RLTEK 221
Query: 874 CDVYGFGVLVLEVVTGK 890
            DVY FGV++ EV+  +
Sbjct: 222 SDVYSFGVVLFEVLCAR 238

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  127 bits (319), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 74/196 (37%), Positives = 114/196 (58%), Gaps = 6/196 (3%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQE---DFEREVKKLGKVRHPNLVTLE 753
           ++G GGFG VY+  + +   VA+KKL     + ++E    F++E+K + K +H NLV L 
Sbjct: 38  KMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
           G+        L+Y ++  GSL   L    G   LSW+ R  + QG A  +  LH+++ IH
Sbjct: 97  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 156
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            +IKS+N+L+D +   K+ D+GLAR      + V+  +I     YMAPE A R  +IT K
Sbjct: 157 RDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPE-ALRG-EITPK 214
Query: 874 CDVYGFGVLVLEVVTG 889
            D+Y FGV++LE++TG
Sbjct: 215 SDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  127 bits (319), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 74/196 (37%), Positives = 114/196 (58%), Gaps = 6/196 (3%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQE---DFEREVKKLGKVRHPNLVTLE 753
           ++G GGFG VY+  + +   VA+KKL     + ++E    F++E+K + K +H NLV L 
Sbjct: 32  KMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 90
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
           G+        L+Y ++  GSL   L    G   LSW+ R  + QG A  +  LH+++ IH
Sbjct: 91  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 150
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            +IKS+N+L+D +   K+ D+GLAR      + V+  +I     YMAPE A R  +IT K
Sbjct: 151 RDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPE-ALRG-EITPK 208
Query: 874 CDVYGFGVLVLEVVTG 889
            D+Y FGV++LE++TG
Sbjct: 209 SDIYSFGVVLLEIITG 224

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  124 bits (311), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 73/197 (37%), Positives = 122/197 (61%), Gaps = 9/197 (4%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           +G G FG VY+ VLRDG  VA+K+ T  S  +  E+FE E++ L   RHP+LV+L G+  
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCD 105
Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNF----LSWNERFNVIQGTAKSLAHLHQSNIIH 813
            ++  +LIY+++  G+L +HL+   G +     +SW +R  +  G A+ L +LH   IIH
Sbjct: 106 ERNEMILIYKYMENGNLKRHLY---GSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIH 162
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            ++KS N+L+D +  PK+ D+G+++    L +  L   ++  LGY+ PE+  +  ++T+K
Sbjct: 163 RDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKG-RLTEK 221
Query: 874 CDVYGFGVLVLEVVTGK 890
            DVY FGV++ EV+  +
Sbjct: 222 SDVYSFGVVLFEVLCAR 238

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  123 bits (308), Expect = 6e-28,   Method: Composition-based stats.
 Identities = 74/194 (38%), Positives = 109/194 (56%), Gaps = 6/194 (3%)
Query: 699 GRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQE---DFEREVKKLGKVRHPNLVTLEGY 755
           G GGFG VY+  + +   VA+KKL     + ++E    F++E+K   K +H NLV L G+
Sbjct: 31  GEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGF 89
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
                   L+Y +   GSL   L    G   LSW+ R  + QG A  +  LH+++ IH +
Sbjct: 90  SSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIHRD 149
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           IKS+N+L+D +   K+ D+GLAR      + V  S+I     Y APE A R  +IT K D
Sbjct: 150 IKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPE-ALRG-EITPKSD 207
Query: 876 VYGFGVLVLEVVTG 889
           +Y FGV++LE++TG
Sbjct: 208 IYSFGVVLLEIITG 221

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score =  109 bits (273), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 99/307 (32%), Positives = 147/307 (47%), Gaps = 15/307 (4%)
Query: 35  DVLGLIVFKADIQDPNGKLSSWSEDDDTPCN--WFGVKCSP--RSNRVIELTLNGLSXXX 90
           D   L+  K D+ +P   LSSW    D  CN  W GV C    ++ RV  L L+GL+   
Sbjct: 7   DKQALLQIKKDLGNPT-TLSSWLPTTDC-CNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 91  XXXXXXXXXXXXXXXXXXX---NNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQ 147
                                 NNL G I P +AKL  L  + ++  ++SG+IPD F  Q
Sbjct: 65  PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD-FLSQ 123
Query: 148 CGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRT-LDLSD 206
             +L  +  + N  SG +P S+S    L  I    NR S  +P      S L T + +S 
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183
Query: 207 NLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQ 266
           N L G+IP    +L NL  ++LS+NM  G      GS    + I  ++NS + +L +   
Sbjct: 184 NRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGL 242
Query: 267 KLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSA 326
             +L N ++LR N   G +P+ + +L+ L +L++S N   G +P   GNLQR  V  ++ 
Sbjct: 243 SKNL-NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYAN 300
Query: 327 NR-LTGS 332
           N+ L GS
Sbjct: 301 NKCLCGS 307

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 88/302 (29%), Positives = 130/302 (43%), Gaps = 42/302 (13%)
Query: 288 WIGELESLET-------LDLSGNKFSGAVPI--SIGNLQRLKVLNFSA-NRLTGSLPDSM 337
           W+G L   +T       LDLSG       PI  S+ NL  L  L     N L G +P ++
Sbjct: 38  WLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAI 97
Query: 338 ANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFL 397
           A    L  L  +  +++G +P ++                           S  ++L  L
Sbjct: 98  AKLTQLHYLYITHTNVSGAIPDFL---------------------------SQIKTLVTL 130
Query: 398 DLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDL-KALNVLDLSENWLNGSI 456
           D S+N  SG  P +I +L  L  +    N + G IP + G   K    + +S N L G I
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190
Query: 457 PPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPI-PIAIAKLTNLQ 515
           PP      +L  + L RN L G       +  +   + L+KN+L   +  + ++K  NL 
Sbjct: 191 PPTFAN-LNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSK--NLN 247
Query: 516 NVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGS 575
            +DL  N + G LP+ L  L  L S N+S N+L GE+P GG       S+   N  LCGS
Sbjct: 248 GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307
Query: 576 AV 577
            +
Sbjct: 308 PL 309

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  102 bits (254), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/208 (37%), Positives = 111/208 (53%), Gaps = 15/208 (7%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLV 750
           LN   ++G G FG V+R     G  VA+K L       +   +F REV  + ++RHPN+V
Sbjct: 39  LNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 751 TLEGYYWTQSLQL-LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
              G   TQ   L ++ E++S GSL++ LH+      L    R ++    AK + +LH  
Sbjct: 98  LFMGAV-TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 810 N--IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFA 864
           N  I+H N+KS N+L+D     KV D+GL+RL        LSSK  SA G   +MAPE  
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST---FLSSK--SAAGTPEWMAPE-V 210
Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRP 892
            R     +K DVY FGV++ E+ T ++P
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 107/205 (52%), Gaps = 9/205 (4%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLV 750
           LN   ++G G FG V+R     G  VA+K L       +   +F REV  + ++RHPN+V
Sbjct: 39  LNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 751 TLEGYYWTQSLQL-LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
              G   TQ   L ++ E++S GSL++ LH+      L    R ++    AK + +LH  
Sbjct: 98  LFMGAV-TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 810 N--IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
           N  I+H ++KS N+L+D     KV D+GL+RL      ++ S        +MAPE   R 
Sbjct: 157 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPE-VLRD 213
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRP 892
               +K DVY FGV++ E+ T ++P
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQP 238

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 114/225 (50%), Gaps = 17/225 (7%)
Query: 684 FSTGTH-ALLNKDCELGRGGFGAVYRTVLRDGR-----PVAIKKLTVSSLVKSQEDFERE 737
           F+T  H + + +   +G G FG VY+ +L+        PVAIK L      K + DF  E
Sbjct: 37  FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 96
Query: 738 VKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ 797
              +G+  H N++ LEG        ++I E++  G+L K L E  G    S  +   +++
Sbjct: 97  AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLR 154
Query: 798 GTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQS 854
           G A  + +L   N +H ++ + N+L++ +   KV D+GL+R+L   P         KI  
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI-- 212
Query: 855 ALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKM 898
            + + APE A    K T   DV+ FG+++ EV+T G+RP   W++
Sbjct: 213 PIRWTAPE-AISYRKFTSASDVWSFGIVMWEVMTYGERPY--WEL 254

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 93.2 bits (230), Expect = 7e-19,   Method: Composition-based stats.
 Identities = 73/235 (31%), Positives = 111/235 (47%), Gaps = 31/235 (13%)
Query: 681 DPD-----FSTGTHALLNKDCELGRGGFGAVY--RTVLRDGRPVAIKKLTVSSLVKSQ-- 731
           DPD     F      L +   E+G G FGAVY  R V R+   VAIKK++ S    ++  
Sbjct: 1   DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKW 59
Query: 732 EDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGS-----LHKHLHEGSGGNF 786
           +D  +EV+ L K+RHPN +   G Y  +    L+ E+  G +     +HK          
Sbjct: 60  QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-------- 111
Query: 787 LSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY 846
           L   E   V  G  + LA+LH  N+IH ++K+ N+L+   G  K+GD+G A ++   + +
Sbjct: 112 LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF 171
Query: 847 VLSSKIQSALGYMAPE--FACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM 899
           V +        +MAPE   A    +   K DV+  G+  +E+   K PL     M
Sbjct: 172 VGTPY------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+        VA+K L V++    Q + F+ EV  L K RH N++   GY 
Sbjct: 20  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
            T+    ++ ++  G SL+ HLH  +        +  ++ + TA+ + +LH  +IIH ++
Sbjct: 78  -TKPQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDL 134
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD---- 872
           KS+N+ +      K+GD+GLA +           ++  ++ +MAPE     +++ D    
Sbjct: 135 KSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE----VIRMQDSNPY 190
Query: 873 --KCDVYGFGVLVLEVVTGKRPLS 894
             + DVY FG+++ E++TG+ P S
Sbjct: 191 SFQSDVYAFGIVLYELMTGQLPYS 214

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 110/229 (48%), Gaps = 31/229 (13%)
Query: 681 DPD-----FSTGTHALLNKDCELGRGGFGAVY--RTVLRDGRPVAIKKLTVSSLVKSQ-- 731
           DPD     F      L +   E+G G FGAVY  R V R+   VAIKK++ S    ++  
Sbjct: 40  DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKW 98
Query: 732 EDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGS-----LHKHLHEGSGGNF 786
           +D  +EV+ L K+RHPN +   G Y  +    L+ E+  G +     +HK          
Sbjct: 99  QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--------KP 150
Query: 787 LSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY 846
           L   E   V  G  + LA+LH  N+IH ++K+ N+L+   G  K+GD+G A ++   + +
Sbjct: 151 LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF 210
Query: 847 VLSSKIQSALGYMAPE--FACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           V +        +MAPE   A    +   K DV+  G+  +E+   K PL
Sbjct: 211 VGTPY------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+        VA+K L V++    Q + F+ EV  L K RH N++   GY 
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
            T+    ++ ++  G SL+ HLH  +        +  ++ + TA+ + +LH  +IIH ++
Sbjct: 90  -TKPQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDL 146
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD---- 872
           KS+N+ +      K+GD+GLA             ++  ++ +MAPE     +++ D    
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE----VIRMQDSNPY 202
Query: 873 --KCDVYGFGVLVLEVVTGKRPLS 894
             + DVY FG+++ E++TG+ P S
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYS 226

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 107/207 (51%), Gaps = 22/207 (10%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+        VA+K L V      Q + F  EV  L K RH N++   GY 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              +L  ++ ++  G SL+KHLH           +  ++ + TA+ + +LH  NIIH ++
Sbjct: 102 TKDNL-AIVTQWCEGSSLYKHLHVQETK--FQMFQLIDIARQTAQGMDYLHAKNIIHRDM 158
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKITD- 872
           KS+N+ +      K+GD+GLA    +  R+  S +++   G   +MAPE     +++ D 
Sbjct: 159 KSNNIFLHEGLTVKIGDFGLA---TVKSRWSGSQQVEQPTGSVLWMAPE----VIRMQDN 211
Query: 873 -----KCDVYGFGVLVLEVVTGKRPLS 894
                + DVY +G+++ E++TG+ P S
Sbjct: 212 NPFSFQSDVYSYGIVLYELMTGELPYS 238

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+        VA+K L V++    Q + F+ EV  L K RH N++   GY 
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
               L  ++ ++  G SL+ HLH  +        +  ++ + TA+ + +LH  +IIH ++
Sbjct: 90  TAPQL-AIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDL 146
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD---- 872
           KS+N+ +      K+GD+GLA             ++  ++ +MAPE     +++ D    
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE----VIRMQDSNPY 202
Query: 873 --KCDVYGFGVLVLEVVTGKRPLS 894
             + DVY FG+++ E++TG+ P S
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYS 226

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 108/231 (46%), Gaps = 15/231 (6%)
Query: 682 PDFSTGTHALLNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKK 740
           P   T T         LG GGFG V R + +D G  VAIK+       K++E +  E++ 
Sbjct: 6   PSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQI 65
Query: 741 LGKVRHPNLVTLEGY------YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN 794
           + K+ HPN+V+               L LL  E+  GG L K+L++      L       
Sbjct: 66  MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSK 851
           ++   + +L +LH++ IIH ++K  N+++    +    K+ D G A+    LD+  L ++
Sbjct: 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTE 182
Query: 852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP-LSTWKMMWW 901
               L Y+APE      K T   D + FG L  E +TG RP L  W+ + W
Sbjct: 183 FVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW 232

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 16/205 (7%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGY 755
            +G G FG VY+        VA+K L V++    Q + F+ EV  L K RH N++   GY
Sbjct: 20  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
             T+    ++ ++  G SL+ HLH           +  ++ + TA+ + +LH  +IIH +
Sbjct: 78  S-TKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKSIIHRD 134
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK-- 873
           +KS+N+ +      K+GD+GLA +           ++  ++ +MAPE     +++ DK  
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE----VIRMQDKNP 190
Query: 874 ----CDVYGFGVLVLEVVTGKRPLS 894
                DVY FG+++ E++TG+ P S
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQLPYS 215

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 108/231 (46%), Gaps = 15/231 (6%)
Query: 682 PDFSTGTHALLNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKK 740
           P   T T         LG GGFG V R + +D G  VAIK+       K++E +  E++ 
Sbjct: 7   PSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQI 66
Query: 741 LGKVRHPNLVTLEGY------YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN 794
           + K+ HPN+V+               L LL  E+  GG L K+L++      L       
Sbjct: 67  MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 126
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSK 851
           ++   + +L +LH++ IIH ++K  N+++    +    K+ D G A+    LD+  L ++
Sbjct: 127 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTE 183
Query: 852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP-LSTWKMMWW 901
               L Y+APE      K T   D + FG L  E +TG RP L  W+ + W
Sbjct: 184 FVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW 233

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 16/205 (7%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGY 755
            +G G FG VY+        VA+K L V++    Q + F+ EV  L K RH N++   GY
Sbjct: 15  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
             T+    ++ ++  G SL+ HLH           +  ++ + TA+ + +LH  +IIH +
Sbjct: 73  S-TKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKSIIHRD 129
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK-- 873
           +KS+N+ +      K+GD+GLA +           ++  ++ +MAPE     +++ DK  
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE----VIRMQDKNP 185
Query: 874 ----CDVYGFGVLVLEVVTGKRPLS 894
                DVY FG+++ E++TG+ P S
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYS 210

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 16/205 (7%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGY 755
            +G G FG VY+        VA+K L V++    Q + F+ EV  L K RH N++   GY
Sbjct: 17  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
             T+    ++ ++  G SL+ HLH           +  ++ + TA+ + +LH  +IIH +
Sbjct: 75  S-TKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKSIIHRD 131
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK-- 873
           +KS+N+ +      K+GD+GLA +           ++  ++ +MAPE     +++ DK  
Sbjct: 132 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE----VIRMQDKNP 187
Query: 874 ----CDVYGFGVLVLEVVTGKRPLS 894
                DVY FG+++ E++TG+ P S
Sbjct: 188 YSFQSDVYAFGIVLYELMTGQLPYS 212

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 16/205 (7%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGY 755
            +G G FG VY+        VA+K L V++    Q + F+ EV  L K RH N++   GY
Sbjct: 20  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
             T+    ++ ++  G SL+ HLH           +  ++ + TA+ + +LH  +IIH +
Sbjct: 78  S-TKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKSIIHRD 134
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK-- 873
           +KS+N+ +      K+GD+GLA +           ++  ++ +MAPE     +++ DK  
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE----VIRMQDKNP 190
Query: 874 ----CDVYGFGVLVLEVVTGKRPLS 894
                DVY FG+++ E++TG+ P S
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQLPYS 215

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 16/205 (7%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGY 755
            +G G FG VY+        VA+K L V++    Q + F+ EV  L K RH N++   GY
Sbjct: 42  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
             T+    ++ ++  G SL+ HLH           +  ++ + TA+ + +LH  +IIH +
Sbjct: 100 S-TKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKSIIHRD 156
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK-- 873
           +KS+N+ +      K+GD+GLA +           ++  ++ +MAPE     +++ DK  
Sbjct: 157 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE----VIRMQDKNP 212
Query: 874 ----CDVYGFGVLVLEVVTGKRPLS 894
                DVY FG+++ E++TG+ P S
Sbjct: 213 YSFQSDVYAFGIVLYELMTGQLPYS 237

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 16/205 (7%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGY 755
            +G G FG VY+        VA+K L V++    Q + F+ EV  L K RH N++   GY
Sbjct: 15  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
                L + + ++  G SL+ HLH           +  ++ + TA+ + +LH  +IIH +
Sbjct: 73  STAPQLAI-VTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKSIIHRD 129
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK-- 873
           +KS+N+ +      K+GD+GLA +           ++  ++ +MAPE     +++ DK  
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE----VIRMQDKNP 185
Query: 874 ----CDVYGFGVLVLEVVTGKRPLS 894
                DVY FG+++ E++TG+ P S
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYS 210

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 16/205 (7%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGY 755
            +G G FG VY+        VA+K L V++    Q + F+ EV  L K RH N++   GY
Sbjct: 43  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
             T+    ++ ++  G SL+ HLH           +  ++ + TA+ + +LH  +IIH +
Sbjct: 101 S-TKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKSIIHRD 157
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK-- 873
           +KS+N+ +      K+GD+GLA +           ++  ++ +MAPE     +++ DK  
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE----VIRMQDKNP 213
Query: 874 ----CDVYGFGVLVLEVVTGKRPLS 894
                DVY FG+++ E++TG+ P S
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQLPYS 238

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 697 ELGRGGFG-AVYRTVLRDGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEG 754
           ++G G FG A+      DGR   IK++ +S +  K +E+  REV  L  ++HPN+V    
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +       ++ ++  GG L K ++    G     ++  +       +L H+H   I+H 
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRIN-AQKGVLFQEDQILDWFVQICLALKHVHDRKILHR 149
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG------YMAPEFACRTV 868
           +IKS N+ +   G  ++GD+G+AR        VL+S ++ A        Y++PE  C   
Sbjct: 150 DIKSQNIFLTKDGTVQLGDFGIAR--------VLNSTVELARACIGTPYYLSPEI-CENK 200
Query: 869 KITDKCDVYGFGVLVLEVVTGKRPLSTWKM 898
              +K D++  G ++ E+ T K       M
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEAGSM 230

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 16/205 (7%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGY 755
            +G G FG VY+        VA+K L V++    Q + F+ EV  L K RH N++   GY
Sbjct: 15  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
             T+    ++ ++  G SL+ HLH           +  ++ + TA+ + +LH  +IIH +
Sbjct: 73  S-TKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKSIIHRD 129
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK-- 873
           +KS+N+ +      K+GD+GLA             ++  ++ +MAPE     +++ DK  
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE----VIRMQDKNP 185
Query: 874 ----CDVYGFGVLVLEVVTGKRPLS 894
                DVY FG+++ E++TG+ P S
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYS 210

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 16/205 (7%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGY 755
            +G G FG VY+        VA+K L V++    Q + F+ EV  L K RH N++   GY
Sbjct: 35  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
             T+    ++ ++  G SL+ HLH           +  ++ + TA+ + +LH  +IIH +
Sbjct: 93  S-TKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKSIIHRD 149
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK-- 873
           +KS+N+ +      K+GD+GLA             ++  ++ +MAPE     +++ DK  
Sbjct: 150 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE----VIRMQDKNP 205
Query: 874 ----CDVYGFGVLVLEVVTGKRPLS 894
                DVY FG+++ E++TG+ P S
Sbjct: 206 YSFQSDVYAFGIVLYELMTGQLPYS 230

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 16/205 (7%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGY 755
            +G G FG VY+        VA+K L V++    Q + F+ EV  L K RH N++   GY
Sbjct: 43  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
             T+    ++ ++  G SL+ HLH           +  ++ + TA+ + +LH  +IIH +
Sbjct: 101 S-TKPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKSIIHRD 157
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK-- 873
           +KS+N+ +      K+GD+GLA             ++  ++ +MAPE     +++ DK  
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE----VIRMQDKNP 213
Query: 874 ----CDVYGFGVLVLEVVTGKRPLS 894
                DVY FG+++ E++TG+ P S
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQLPYS 238

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Composition-based stats.
 Identities = 70/229 (30%), Positives = 112/229 (48%), Gaps = 27/229 (11%)
Query: 698 LGRGGFGAVYRTVLR-DGR---PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +G G FG V    L+  G+   PVAIK L V    K + DF  E   +G+  HPN++ LE
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLAHLH 807
           G        +++ E++  GSL   L +  G        +F VIQ      G +  + +L 
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDG--------QFTVIQLVGMLRGISAGMKYLS 141
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAPEFA 864
               +H ++ + N+LI+ +   KV D+GL+R+L   P         KI   + + APE A
Sbjct: 142 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTAPE-A 198
Query: 865 CRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWLEEHWK 912
               K T   DV+ +G+++ EVV+ G+RP   W+M     +  +EE ++
Sbjct: 199 IAFRKFTSASDVWSYGIVMWEVVSYGERPY--WEMTNQDVIKAVEEGYR 245

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 112/232 (48%), Gaps = 31/232 (13%)
Query: 698 LGRGGFGAVYRTVLR-DGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +G G FG V    L+  G+    VAIK L      K + DF  E   +G+  HPN++ LE
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLAHLH 807
           G     +  ++I EF+  GSL   L +  G        +F VIQ      G A  + +L 
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLA 152
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG------YMAP 861
             N +H ++ + N+L++ +   KV D+GL+R    L+         SALG      + AP
Sbjct: 153 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF---LEDDTSDPTYTSALGGKIPIRWTAP 209
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWLEEHWK 912
           E A +  K T   DV+ +G+++ EV++ G+RP   W M     +  +E+ ++
Sbjct: 210 E-AIQYRKFTSASDVWSYGIVMWEVMSYGERPY--WDMTNQDVINAIEQDYR 258

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 102/197 (51%), Gaps = 7/197 (3%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           E+G G FG V+     +   VAIK  T+     S+EDF  E + + K+ HP LV L G  
Sbjct: 14  EIGSGQFGLVHLGYWLNKDKVAIK--TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             Q+   L++EF+  G L  +L    G    +      +     + +A+L ++++IH ++
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEASVIHRDL 129
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
            + N L+  +   KV D+G+ R + + D+Y  S+  +  + + +PE    + + + K DV
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDV 187
Query: 877 YGFGVLVLEVVT-GKRP 892
           + FGVL+ EV + GK P
Sbjct: 188 WSFGVLMWEVFSEGKIP 204

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 61/200 (30%), Positives = 106/200 (53%), Gaps = 6/200 (3%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           L  + +LG+G FG V+         VAIK L   ++  S E F +E + + K+RH  LV 
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQ 77
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L      + + ++I E++S GSL   L +G  G +L   +  ++    A  +A++ + N 
Sbjct: 78  LYAVVSEEPIYIVI-EYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H +++++N+L+  +   KV D+GLARL+   + Y      +  + + APE A    + T
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG-RFT 193
Query: 872 DKCDVYGFGVLVLEVVTGKR 891
            K DV+ FG+L+ E+ T  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 133
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R  LS      L Y+ PE     +   +K 
Sbjct: 134 DIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----GTLDYLPPEMIEGRMH-DEKV 188
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 189 DLWSLGVLCYEFLVGKPPF 207

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    ++ + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKKVIHR 132
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R  L       L Y+ PE     +   +K 
Sbjct: 133 DIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDYLPPEMIEGRMH-DEKV 187
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 188 DLWSLGVLCYEFLVGKPPF 206

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G ++K L + S             I   A +L++ H   +IH 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 137
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R  L       L Y+ PE     +   +K 
Sbjct: 138 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-DEKV 192
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 193 DLWSLGVLCYEFLVGKPPF 211

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G ++K L + S             I   A +L++ H   +IH 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 137
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R  L       L Y+ PE     +   +K 
Sbjct: 138 DIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL----XGTLDYLPPEMIEGRMH-DEKV 192
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 193 DLWSLGVLCYEFLVGKPPF 211

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 60/200 (30%), Positives = 105/200 (52%), Gaps = 6/200 (3%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           L  + +LG+G FG V+         VAIK L   ++  S E F +E + + K+RH  LV 
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKIRHEKLVQ 77
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L      + +  ++ E++S GSL   L +G  G +L   +  ++    A  +A++ + N 
Sbjct: 78  LYAVVSEEPI-YIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H +++++N+L+  +   KV D+GLARL+   + Y      +  + + APE A    + T
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG-RFT 193
Query: 872 DKCDVYGFGVLVLEVVTGKR 891
            K DV+ FG+L+ E+ T  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 60/200 (30%), Positives = 105/200 (52%), Gaps = 6/200 (3%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           L  + +LG+G FG V+         VAIK L   ++  S E F +E + + K+RH  LV 
Sbjct: 13  LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQ 70
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L      + +  ++ E++S GSL   L +G  G +L   +  ++    A  +A++ + N 
Sbjct: 71  LYAVVSEEPI-YIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVERMNY 128
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H +++++N+L+  +   KV D+GLARL+   + Y      +  + + APE A    + T
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG-RFT 186
Query: 872 DKCDVYGFGVLVLEVVTGKR 891
            K DV+ FG+L+ E+ T  R
Sbjct: 187 IKSDVWSFGILLTELTTKGR 206

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 59/197 (29%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           E+G G FG V+     +   VAIK  T+     S+EDF  E + + K+ HP LV L G  
Sbjct: 12  EIGSGQFGLVHLGYWLNKDKVAIK--TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             Q+   L++EF+  G L  +L    G    +      +     + +A+L ++ +IH ++
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
            + N L+  +   KV D+G+ R + + D+Y  S+  +  + + +PE    + + + K DV
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDV 185
Query: 877 YGFGVLVLEVVT-GKRP 892
           + FGVL+ EV + GK P
Sbjct: 186 WSFGVLMWEVFSEGKIP 202

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 59/197 (29%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           E+G G FG V+     +   VAIK  T+     S+EDF  E + + K+ HP LV L G  
Sbjct: 17  EIGSGQFGLVHLGYWLNKDKVAIK--TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             Q+   L++EF+  G L  +L    G    +      +     + +A+L ++ +IH ++
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEACVIHRDL 132
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
            + N L+  +   KV D+G+ R + + D+Y  S+  +  + + +PE    + + + K DV
Sbjct: 133 AARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDV 190
Query: 877 YGFGVLVLEVVT-GKRP 892
           + FGVL+ EV + GK P
Sbjct: 191 WSFGVLMWEVFSEGKIP 207

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 59/197 (29%), Positives = 101/197 (51%), Gaps = 7/197 (3%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           E+G G FG V+     +   VAIK  T+     S+EDF  E + + K+ HP LV L G  
Sbjct: 14  EIGSGQFGLVHLGYWLNKDKVAIK--TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             Q+   L++EF+  G L  +L    G    +      +     + +A+L ++ +IH ++
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEACVIHRDL 129
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
            + N L+  +   KV D+G+ R + + D+Y  S+  +  + + +PE    + + + K DV
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDV 187
Query: 877 YGFGVLVLEVVT-GKRP 892
           + FGVL+ EV + GK P
Sbjct: 188 WSFGVLMWEVFSEGKIP 204

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 136
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R  L       L Y+ PE     +   +K 
Sbjct: 137 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-DEKV 191
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 192 DLWSLGVLCYEFLVGKPPF 210

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 75  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 131
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R  L       L Y+ PE     +   +K 
Sbjct: 132 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-DEKV 186
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 187 DLWSLGVLCYEFLVGKPPF 205

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 135
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R  L       L Y+ PE     +   +K 
Sbjct: 136 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-DEKV 190
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 191 DLWSLGVLCYEFLVGKPPF 209

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 105/218 (48%), Gaps = 31/218 (14%)
Query: 698 LGRGGFGAVYRTVLR-DGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +G G FG V    L+  G+    VAIK L      K + DF  E   +G+  HPN++ LE
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLAHLH 807
           G     +  ++I EF+  GSL   L +  G        +F VIQ      G A  + +L 
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLA 126
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG------YMAP 861
             N +H  + + N+L++ +   KV D+GL+R    L+         SALG      + AP
Sbjct: 127 DMNYVHRALAARNILVNSNLVCKVSDFGLSRF---LEDDTSDPTYTSALGGKIPIRWTAP 183
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKM 898
           E A +  K T   DV+ +G+++ EV++ G+RP   W M
Sbjct: 184 E-AIQYRKFTSASDVWSYGIVMWEVMSYGERPY--WDM 218

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 132
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R  L       L Y+ PE     +   +K 
Sbjct: 133 DIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDYLPPEMIEGRMH-DEKV 187
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 188 DLWSLGVLCYEFLVGKPPF 206

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 135
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R  L       L Y+ PE     +   +K 
Sbjct: 136 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-DEKV 190
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 191 DLWSLGVLCYEFLVGKPPF 209

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 137
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R  L       L Y+ PE     +   +K 
Sbjct: 138 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-DEKV 192
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 193 DLWSLGVLCYEFLVGKPPF 211

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 132
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R  L       L Y+ PE     +   +K 
Sbjct: 133 DIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGRMH-DEKV 187
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 188 DLWSLGVLCYEFLVGKPPF 206

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 135
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R  L       L Y+ PE     +   +K 
Sbjct: 136 DIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGRMH-DEKV 190
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 191 DLWSLGVLCYEFLVGKPPF 209

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 102/197 (51%), Gaps = 7/197 (3%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           E+G G FG V+     +   VAIK +   S+  S++DF  E + + K+ HP LV L G  
Sbjct: 34  EIGSGQFGLVHLGYWLNKDKVAIKTIKEGSM--SEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             Q+   L++EF+  G L  +L    G    +      +     + +A+L ++ +IH ++
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEACVIHRDL 149
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
            + N L+  +   KV D+G+ R + + D+Y  S+  +  + + +PE    + + + K DV
Sbjct: 150 AARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDV 207
Query: 877 YGFGVLVLEVVT-GKRP 892
           + FGVL+ EV + GK P
Sbjct: 208 WSFGVLMWEVFSEGKIP 224

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 132
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R  L       L Y+ PE     +   +K 
Sbjct: 133 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-DEKV 187
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 188 DLWSLGVLCYEFLVGKPPF 206

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 60/200 (30%), Positives = 105/200 (52%), Gaps = 6/200 (3%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           L  + +LG+G FG V+         VAIK L   ++  S E F +E + + K+RH  LV 
Sbjct: 9   LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQ 66
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L      + +  ++ E++S GSL   L +G  G +L   +  ++    A  +A++ + N 
Sbjct: 67  LYAVVSEEPI-YIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 124
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H +++++N+L+  +   KV D+GLARL+   + Y      +  + + APE A    + T
Sbjct: 125 VHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG-RFT 182
Query: 872 DKCDVYGFGVLVLEVVTGKR 891
            K DV+ FG+L+ E+ T  R
Sbjct: 183 IKSDVWSFGILLTELTTKGR 202

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 135
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R  L       L Y+ PE     +   +K 
Sbjct: 136 DIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDYLPPEMIEGRMH-DEKV 190
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 191 DLWSLGVLCYEFLVGKPPF 209

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 60/200 (30%), Positives = 105/200 (52%), Gaps = 6/200 (3%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           L  + +LG+G FG V+         VAIK L   ++  S E F +E + + K+RH  LV 
Sbjct: 11  LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQ 68
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L      + +  ++ E++S GSL   L +G  G +L   +  ++    A  +A++ + N 
Sbjct: 69  LYAVVSEEPI-YIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 126
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H +++++N+L+  +   KV D+GLARL+   + Y      +  + + APE A    + T
Sbjct: 127 VHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG-RFT 184
Query: 872 DKCDVYGFGVLVLEVVTGKR 891
            K DV+ FG+L+ E+ T  R
Sbjct: 185 IKSDVWSFGILLTELTTKGR 204

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 60/200 (30%), Positives = 105/200 (52%), Gaps = 6/200 (3%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           L  + +LG+G FG V+         VAIK L   ++  S E F +E + + K+RH  LV 
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQ 77
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L      + +  ++ E++S GSL   L +G  G +L   +  ++    A  +A++ + N 
Sbjct: 78  LYAVVSEEPI-YIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H +++++N+L+  +   KV D+GLARL+   + Y      +  + + APE A    + T
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG-RFT 193
Query: 872 DKCDVYGFGVLVLEVVTGKR 891
            K DV+ FG+L+ E+ T  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 105/200 (52%), Gaps = 6/200 (3%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           L  + +LG+G FG V+         VAIK L   ++  S E F +E + + K+RH  LV 
Sbjct: 269 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQ 326
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L      + +  ++ E++S GSL   L +G  G +L   +  ++    A  +A++ + N 
Sbjct: 327 LYAVVSEEPI-YIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H +++++N+L+  +   KV D+GLARL+   + Y      +  + + APE A    + T
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG-RFT 442
Query: 872 DKCDVYGFGVLVLEVVTGKR 891
            K DV+ FG+L+ E+ T  R
Sbjct: 443 IKSDVWSFGILLTELTTKGR 462

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 134
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R  L       L Y+ PE     +   +K 
Sbjct: 135 DIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGRMH-DEKV 189
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 190 DLWSLGVLCYEFLVGKPPF 208

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 132
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R  L       L Y+ PE     +   +K 
Sbjct: 133 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLC----GTLDYLPPEMIEGRMH-DEKV 187
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 188 DLWSLGVLCYEFLVGKPPF 206

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 132
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R    +++   L Y+ PE     +   +K 
Sbjct: 133 DIKPENLLLGSAGELKIADFGWSVHAPSSRR----TELCGTLDYLPPEMIEGRMH-DEKV 187
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 188 DLWSLGVLCYEFLVGKPPF 206

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 105/200 (52%), Gaps = 6/200 (3%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           L  + +LG+G FG V+         VAIK L   ++  S E F +E + + K+RH  LV 
Sbjct: 186 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQ 243
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L      + +  ++ E++S GSL   L +G  G +L   +  ++    A  +A++ + N 
Sbjct: 244 LYAVVSEEPI-YIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H +++++N+L+  +   KV D+GLARL+   + Y      +  + + APE A    + T
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG-RFT 359
Query: 872 DKCDVYGFGVLVLEVVTGKR 891
            K DV+ FG+L+ E+ T  R
Sbjct: 360 IKSDVWSFGILLTELTTKGR 379

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 105/200 (52%), Gaps = 6/200 (3%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           L  + +LG+G FG V+         VAIK L   ++  S E F +E + + K+RH  LV 
Sbjct: 186 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQ 243
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L      + +  ++ E++S GSL   L +G  G +L   +  ++    A  +A++ + N 
Sbjct: 244 LYAVVSEEPI-YIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H +++++N+L+  +   KV D+GLARL+   + Y      +  + + APE A    + T
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG-RFT 359
Query: 872 DKCDVYGFGVLVLEVVTGKR 891
            K DV+ FG+L+ E+ T  R
Sbjct: 360 IKSDVWSFGILLTELTTKGR 379

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 93  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 149
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R  L       L Y+ PE     +   +K 
Sbjct: 150 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-DEKV 204
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 205 DLWSLGVLCYEFLVGKPPF 223

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 60/200 (30%), Positives = 105/200 (52%), Gaps = 6/200 (3%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           L  + +LG+G FG V+         VAIK L   ++  S E F +E + + K+RH  LV 
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQ 77
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L      + +  ++ E++S GSL   L +G  G +L   +  ++    A  +A++ + N 
Sbjct: 78  LYAVVSEEPI-YIVCEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H +++++N+L+  +   KV D+GLARL+   + Y      +  + + APE A    + T
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG-RFT 193
Query: 872 DKCDVYGFGVLVLEVVTGKR 891
            K DV+ FG+L+ E+ T  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 137
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R  L       L Y+ PE         +K 
Sbjct: 138 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPE-XIEGRXHDEKV 192
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 193 DLWSLGVLCYEFLVGKPPF 211

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 133
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R  L       L Y+ PE     +   +K 
Sbjct: 134 DIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC----GTLDYLPPEMIEGRMH-DEKV 188
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 189 DLWSLGVLCYEFLVGKPPF 207

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 132
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R    + +   L Y+ PE     +   +K 
Sbjct: 133 DIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMH-DEKV 187
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 188 DLWSLGVLCYEFLVGKPPF 206

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 132
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R    + +   L Y+ PE     +   +K 
Sbjct: 133 DIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMH-DEKV 187
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 188 DLWSLGVLCYEFLVGKPPF 206

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 129
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R  L       L Y+ PE     +   +K 
Sbjct: 130 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-DEKV 184
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 185 DLWSLGVLCYEFLVGKPPF 203

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 137
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R    + +   L Y+ PE     +   +K 
Sbjct: 138 DIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMH-DEKV 192
Query: 875 DVYGFGVLVLEVVTGKRPLST 895
           D++  GVL  E + GK P   
Sbjct: 193 DLWSLGVLCYEFLVGKPPFEA 213

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 133
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R    + +   L Y+ PE     +   +K 
Sbjct: 134 DIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMH-DEKV 188
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 189 DLWSLGVLCYEFLVGKPPF 207

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 19/227 (8%)
Query: 682 PDFSTGTHALLNKDCELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLV--KSQEDFEREV 738
           PD    T A    + ++GRG F  VYR   L DG PVA+KK+ +  L+  K++ D  +E+
Sbjct: 24  PDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEI 83
Query: 739 KKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHL-HEGSGGNFLSWNERFNVIQ 797
             L ++ HPN++     +   +   ++ E    G L + + H       +     +    
Sbjct: 84  DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143
Query: 798 GTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG 857
               +L H+H   ++H +IK +NV I  +G  K+GD GL R          SSK  +A  
Sbjct: 144 QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--------FSSKTTAAHS 195
Query: 858 ------YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM 898
                 YM+PE          K D++  G L+ E+   + P    KM
Sbjct: 196 LVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 241

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 105/200 (52%), Gaps = 6/200 (3%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           L  + +LG+G FG V+         VAIK L   ++  S E F +E + + K+RH  LV 
Sbjct: 186 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQ 243
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L      + +  ++ E++S GSL   L +G  G +L   +  ++    A  +A++ + N 
Sbjct: 244 LYAVVSEEPI-YIVGEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H +++++N+L+  +   KV D+GLARL+   + Y      +  + + APE A    + T
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG-RFT 359
Query: 872 DKCDVYGFGVLVLEVVTGKR 891
            K DV+ FG+L+ E+ T  R
Sbjct: 360 IKSDVWSFGILLTELTTKGR 379

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 158
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R  L       L Y+ PE     +   +K 
Sbjct: 159 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-DEKV 213
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 214 DLWSLGVLCYEFLVGKPPF 232

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Composition-based stats.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    R  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN------VIQGTAKSLAHLHQ 808
           Y+   +   LI E+   G++++ L + S         RF+       I   A +L++ H 
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLS---------RFDEQRTATYITELANALSYCHS 130
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTV 868
             +IH +IK  N+L+  +GE K+ D+G +   P   R  L       L Y+ PE     +
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRM 186
Query: 869 KITDKCDVYGFGVLVLEVVTGKRPL 893
              +K D++  GVL  E + G  P 
Sbjct: 187 H-DEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Composition-based stats.
 Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 135
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R      +   L Y+ PE     +   +K 
Sbjct: 136 DIKPENLLLGSAGELKIADFGWSVHAPSSRR----DDLCGTLDYLPPEMIEGRMH-DEKV 190
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 191 DLWSLGVLCYEFLVGKPPF 209

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Composition-based stats.
 Identities = 60/200 (30%), Positives = 104/200 (52%), Gaps = 6/200 (3%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           L  + +LG+G FG V+         VAIK L   ++  S E F +E + + K+RH  LV 
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQ 77
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L      + +  ++ E++S GSL   L +G  G +L   +  ++    A  +A++ + N 
Sbjct: 78  LYAVVSEEPI-YIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H ++ ++N+L+  +   KV D+GLARL+   + Y      +  + + APE A    + T
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG-RFT 193
Query: 872 DKCDVYGFGVLVLEVVTGKR 891
            K DV+ FG+L+ E+ T  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 98/195 (50%), Gaps = 6/195 (3%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEGY 755
           ++G G +G VY+     GR VA+K++ + +  +       RE+  L ++ HPN+V+L   
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
             ++    L++EF+    L K L E   G  L  ++    +    + +AH HQ  I+H +
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVLDENKTG--LQDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           +K  N+LI+  G  K+ D+GLAR   +  R      +   L Y AP+    + K +   D
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGSKKYSTSVD 202
Query: 876 VYGFGVLVLEVVTGK 890
           ++  G +  E++TGK
Sbjct: 203 IWSIGCIFAEMITGK 217

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Composition-based stats.
 Identities = 59/200 (29%), Positives = 105/200 (52%), Gaps = 6/200 (3%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           L  + +LG+G FG V+         VAIK L   ++  S E F +E + + K+RH  LV 
Sbjct: 17  LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQ 74
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L      + +  ++ E+++ GSL   L +G  G +L   +  ++    A  +A++ + N 
Sbjct: 75  LYAVVSEEPI-YIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIASGMAYVERMNY 132
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H +++++N+L+  +   KV D+GLARL+   + Y      +  + + APE A    + T
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG-RFT 190
Query: 872 DKCDVYGFGVLVLEVVTGKR 891
            K DV+ FG+L+ E+ T  R
Sbjct: 191 IKSDVWSFGILLTELTTKGR 210

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 98/195 (50%), Gaps = 6/195 (3%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEGY 755
           ++G G +G VY+     GR VA+K++ + +  +       RE+  L ++ HPN+V+L   
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
             ++    L++EF+    L K L E   G  L  ++    +    + +AH HQ  I+H +
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVLDENKTG--LQDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           +K  N+LI+  G  K+ D+GLAR   +  R      +   L Y AP+    + K +   D
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGSKKYSTSVD 202
Query: 876 VYGFGVLVLEVVTGK 890
           ++  G +  E++TGK
Sbjct: 203 IWSIGCIFAEMITGK 217

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 61/194 (31%), Positives = 98/194 (50%), Gaps = 6/194 (3%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           LG G FG V+         VA+K L   S+  S + F  E   + +++H  LV L     
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVV- 73
Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIK 817
           TQ    +I E++  GSL   L   SG   L+ N+  ++    A+ +A + + N IH N++
Sbjct: 74  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNYIHRNLR 132
Query: 818 SSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVY 877
           ++N+L+  +   K+ D+GLARL+   + Y      +  + + APE A      T K DV+
Sbjct: 133 AANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPE-AINYGTFTIKSDVW 190
Query: 878 GFGVLVLEVVTGKR 891
            FG+L+ E+VT  R
Sbjct: 191 SFGILLTEIVTHGR 204

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 7/197 (3%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           E+G G FG V+     +   VAIK  T+     S+EDF  E + + K+ HP LV L G  
Sbjct: 15  EIGSGQFGLVHLGYWLNKDKVAIK--TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             Q+   L+ EF+  G L  +L    G    +      +     + +A+L ++ +IH ++
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEACVIHRDL 130
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
            + N L+  +   KV D+G+ R + + D+Y  S+  +  + + +PE    + + + K DV
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDV 188
Query: 877 YGFGVLVLEVVT-GKRP 892
           + FGVL+ EV + GK P
Sbjct: 189 WSFGVLMWEVFSEGKIP 205

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 23/205 (11%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    R  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN------VIQGTAKSLAHLHQ 808
           Y+   +   LI E+   G++++ L + S         RF+       I   A +L++ H 
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLS---------RFDEQRTATYITELANALSYCHS 130
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTV 868
             +IH +IK  N+L+  +GE K+ D+G +   P   R  L       L Y+ PE     +
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC----GTLDYLPPEMIEGRM 186
Query: 869 KITDKCDVYGFGVLVLEVVTGKRPL 893
              +K D++  GVL  E + G  P 
Sbjct: 187 H-DEKVDLWSLGVLCYEFLVGMPPF 210

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 135
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ ++G +   P   R  L       L Y+ PE     +   +K 
Sbjct: 136 DIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-DEKV 190
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 191 DLWSLGVLCYEFLVGKPPF 209

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 59/200 (29%), Positives = 105/200 (52%), Gaps = 6/200 (3%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           L  + +LG+G FG V+         VAIK L   ++  S E F +E + + K+RH  LV 
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQ 77
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L      + + +++ E++S G L   L +G  G +L   +  ++    A  +A++ + N 
Sbjct: 78  LYAVVSEEPIYIVM-EYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H +++++N+L+  +   KV D+GLARL+   + Y      +  + + APE A    + T
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG-RFT 193
Query: 872 DKCDVYGFGVLVLEVVTGKR 891
            K DV+ FG+L+ E+ T  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 60/200 (30%), Positives = 105/200 (52%), Gaps = 6/200 (3%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           L  + +LG+G FG V+         VAIK L   ++  S E F +E + + K+RH  LV 
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQ 77
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L      + + ++I E++S GSL   L +G  G +L   +  ++    A  +A++ + N 
Sbjct: 78  LYAVVSEEPIYIVI-EYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H +++++N+L+  +   KV D+GLARL+   +        +  + + APE A    + T
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIED-NEXTARQGAKFPIKWTAPEAALYG-RFT 193
Query: 872 DKCDVYGFGVLVLEVVTGKR 891
            K DV+ FG+L+ E+ T  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           LG+G FG   +   R+   V + K  +    ++Q  F +EVK +  + HPN++   G  +
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIK 817
                  I E++ GG+L   +   S  +   W++R +  +  A  +A+LH  NIIH ++ 
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIK--SMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLN 135
Query: 818 SSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQS-----------ALG---YMAPEF 863
           S N L+  +    V D+GLARL  M+D       ++S            +G   +MAPE 
Sbjct: 136 SHNCLVRENKNVVVADFGLARL--MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 864 ACRTVKITDKCDVYGFGVLVLEVV 887
                   +K DV+ FG+++ E++
Sbjct: 194 -INGRSYDEKVDVFSFGIVLCEII 216

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 134
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ ++G +   P   R  L       L Y+ PE     +   +K 
Sbjct: 135 DIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH-DEKV 189
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 190 DLWSLGVLCYEFLVGKPPF 208

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 59/200 (29%), Positives = 104/200 (52%), Gaps = 6/200 (3%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           L  + +LG+G FG V+         VAIK L   ++  S E F +E + + K+RH  LV 
Sbjct: 20  LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQ 77
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L      + +  ++ E++S G L   L +G  G +L   +  ++    A  +A++ + N 
Sbjct: 78  LYAVVSEEPI-YIVTEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H +++++N+L+  +   KV D+GLARL+   + Y      +  + + APE A    + T
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYG-RFT 193
Query: 872 DKCDVYGFGVLVLEVVTGKR 891
            K DV+ FG+L+ E+ T  R
Sbjct: 194 IKSDVWSFGILLTELTTKGR 213

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L + S             I   A +L++ H   +IH 
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHR 158
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  +GE K+ D+G +   P   R      +   L Y+ PE     +   +K 
Sbjct: 159 DIKPENLLLGSAGELKIADFGWSVHAPSSRR----DDLCGTLDYLPPEMIEGRMH-DEKV 213
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  GVL  E + GK P 
Sbjct: 214 DLWSLGVLCYEFLVGKPPF 232

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           LG G FG V+     +   VA+K L   ++  S + F  E   +  ++H  LV L     
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIK 817
            +    +I E+++ GSL   L    GG  L   +  +     A+ +A++ + N IH +++
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNYIHRDLR 137
Query: 818 SSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE---FACRTVKITDKC 874
           ++NVL+  S   K+ D+GLAR++   + Y      +  + + APE   F C T+    K 
Sbjct: 138 AANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAINFGCFTI----KS 192
Query: 875 DVYGFGVLVLEVVT-GKRP 892
           DV+ FG+L+ E+VT GK P
Sbjct: 193 DVWSFGILLYEIVTYGKIP 211

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 60/200 (30%), Positives = 101/200 (50%), Gaps = 12/200 (6%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +LG G FG V+     +   VA+K L   ++  S + F  E   +  ++H  LV L    
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             +    +I EF++ GSL   L    GG  L   +  +     A+ +A++ + N IH ++
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNYIHRDL 135
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE---FACRTVKITDK 873
           +++NVL+  S   K+ D+GLAR++   + Y      +  + + APE   F C T+    K
Sbjct: 136 RAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAINFGCFTI----K 190
Query: 874 CDVYGFGVLVLEVVT-GKRP 892
            +V+ FG+L+ E+VT GK P
Sbjct: 191 SNVWSFGILLYEIVTYGKIP 210

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 59/200 (29%), Positives = 104/200 (52%), Gaps = 6/200 (3%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           L  + +LG+G FG V+         VAIK L   ++  S E F +E + + K+RH  LV 
Sbjct: 10  LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQ 67
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L      + + + + E++S GSL   L +G  G +L   +  ++    A  +A++ + N 
Sbjct: 68  LYAVVSEEPIXI-VTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVERMNY 125
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H +++++N+L+  +   KV D+GLARL+   +        +  + + APE A    + T
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLARLIED-NEXTARQGAKFPIKWTAPEAALYG-RFT 183
Query: 872 DKCDVYGFGVLVLEVVTGKR 891
            K DV+ FG+L+ E+ T  R
Sbjct: 184 IKSDVWSFGILLTELTTKGR 203

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 104/200 (52%), Gaps = 6/200 (3%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           L  + +LG+G FG V+         VAIK L   ++  S E F +E + + K+RH  LV 
Sbjct: 187 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNM--SPEAFLQEAQVMKKLRHEKLVQ 244
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L      + +  ++ E++S GSL   L +G  G +L   +  ++    A  +A++ + N 
Sbjct: 245 LYAVVSEEPI-YIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 302
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H +++++N+L+  +   KV D+GL RL+   + Y      +  + + APE A    + T
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGRLIED-NEYTARQGAKFPIKWTAPEAALYG-RFT 360
Query: 872 DKCDVYGFGVLVLEVVTGKR 891
            K DV+ FG+L+ E+ T  R
Sbjct: 361 IKSDVWSFGILLTELTTKGR 380

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 58/200 (29%), Positives = 105/200 (52%), Gaps = 6/200 (3%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           L  + +LG+G FG V+         VAIK L   ++  S E F +E + + K+RH  LV 
Sbjct: 17  LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQ 74
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L      + +  ++ E+++ GSL   L +G  G +L   +  ++    A  +A++ + N 
Sbjct: 75  LYAVVSEEPI-YIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIASGMAYVERMNY 132
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H +++++N+L+  +   KV D+GLARL+   + +      +  + + APE A    + T
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIED-NEWTARQGAKFPIKWTAPEAALYG-RFT 190
Query: 872 DKCDVYGFGVLVLEVVTGKR 891
            K DV+ FG+L+ E+ T  R
Sbjct: 191 IKSDVWSFGILLTELTTKGR 210

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           +GRG FG V +   R  + VAIK++   S  K+   F  E+++L +V HPN+V L G   
Sbjct: 17  VGRGAFGVVCKAKWR-AKDVAIKQIESESERKA---FIVELRQLSRVNHPNIVKLYGA-- 70
Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN---IIHY 814
             +   L+ E+  GGSL+  LH      + +     +     ++ +A+LH      +IH 
Sbjct: 71  CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 130
Query: 815 NIKSSNVLIDGSGEP-KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
           ++K  N+L+   G   K+ D+G A      D     +  + +  +MAPE        ++K
Sbjct: 131 DLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVF-EGSNYSEK 184
Query: 874 CDVYGFGVLVLEVVTGKRPLS-----TWKMMW 900
           CDV+ +G+++ EV+T ++P        +++MW
Sbjct: 185 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMW 216

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT-LEGY 755
           ELG G FG VY+   ++   +A  K+  +   +  ED+  E+  L    HPN+V  L+ +
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           Y+  +L +LI EF +GG++   + E      L+ ++   V + T  +L +LH + IIH +
Sbjct: 104 YYENNLWILI-EFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDNKIIHRD 160
Query: 816 IKSSNVLIDGSGEPKVGDYGLA----RLLPMLDRYVLSSKIQSALGYMAPEFA-CRTVK- 869
           +K+ N+L    G+ K+ D+G++    R +   D ++ +        +MAPE   C T K 
Sbjct: 161 LKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPY------WMAPEVVMCETSKD 214
Query: 870 --ITDKCDVYGFGVLVLEVVTGKRP 892
                K DV+  G+ ++E+   + P
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT-LEGY 755
           ELG G FG VY+   ++   +A  K+  +   +  ED+  E+  L    HPN+V  L+ +
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           Y+  +L +LI EF +GG++   + E      L+ ++   V + T  +L +LH + IIH +
Sbjct: 104 YYENNLWILI-EFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDNKIIHRD 160
Query: 816 IKSSNVLIDGSGEPKVGDYGLA----RLLPMLDRYVLSSKIQSALGYMAPEFA-CRTVK- 869
           +K+ N+L    G+ K+ D+G++    R +   D ++ +        +MAPE   C T K 
Sbjct: 161 LKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPY------WMAPEVVMCETSKD 214
Query: 870 --ITDKCDVYGFGVLVLEVVTGKRP 892
                K DV+  G+ ++E+   + P
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT-LEGY 755
           ELG G FG VY+   ++   +A  K+  +   +  ED+  E+  L    HPN+V  L+ +
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           Y+  +L +LI EF +GG++   + E      L+ ++   V + T  +L +LH + IIH +
Sbjct: 104 YYENNLWILI-EFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDNKIIHRD 160
Query: 816 IKSSNVLIDGSGEPKVGDYGLA----RLLPMLDRYVLSSKIQSALGYMAPEFA-CRTVK- 869
           +K+ N+L    G+ K+ D+G++    R +   D ++ +        +MAPE   C T K 
Sbjct: 161 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPY------WMAPEVVMCETSKD 214
Query: 870 --ITDKCDVYGFGVLVLEVVTGKRP 892
                K DV+  G+ ++E+   + P
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 60/194 (30%), Positives = 98/194 (50%), Gaps = 6/194 (3%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           LG G FG V+         VA+K L   S+  S + F  E   + +++H  LV L     
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVV- 83
Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIK 817
           TQ    +I E++  GSL   L   SG   L+ N+  ++    A+ +A + + N IH +++
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNYIHRDLR 142
Query: 818 SSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVY 877
           ++N+L+  +   K+ D+GLARL+   + Y      +  + + APE A      T K DV+
Sbjct: 143 AANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPE-AINYGTFTIKSDVW 200
Query: 878 GFGVLVLEVVTGKR 891
            FG+L+ E+VT  R
Sbjct: 201 SFGILLTEIVTHGR 214

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 60/194 (30%), Positives = 98/194 (50%), Gaps = 6/194 (3%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           LG G FG V+         VA+K L   S+  S + F  E   + +++H  LV L     
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVV- 87
Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIK 817
           TQ    +I E++  GSL   L   SG   L+ N+  ++    A+ +A + + N IH +++
Sbjct: 88  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNYIHRDLR 146
Query: 818 SSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVY 877
           ++N+L+  +   K+ D+GLARL+   + Y      +  + + APE A      T K DV+
Sbjct: 147 AANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPE-AINYGTFTIKSDVW 204
Query: 878 GFGVLVLEVVTGKR 891
            FG+L+ E+VT  R
Sbjct: 205 SFGILLTEIVTHGR 218

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 60/194 (30%), Positives = 98/194 (50%), Gaps = 6/194 (3%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           LG G FG V+         VA+K L   S+  S + F  E   + +++H  LV L     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIK 817
           TQ    +I E++  GSL   L   SG   L+ N+  ++    A+ +A + + N IH +++
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136
Query: 818 SSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVY 877
           ++N+L+  +   K+ D+GLARL+   + Y      +  + + APE A      T K DV+
Sbjct: 137 AANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPE-AINYGTFTIKSDVW 194
Query: 878 GFGVLVLEVVTGKR 891
            FG+L+ E+VT  R
Sbjct: 195 SFGILLTEIVTHGR 208

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 60/194 (30%), Positives = 98/194 (50%), Gaps = 6/194 (3%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           LG G FG V+         VA+K L   S+  S + F  E   + +++H  LV L     
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVV- 72
Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIK 817
           TQ    +I E++  GSL   L   SG   L+ N+  ++    A+ +A + + N IH +++
Sbjct: 73  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNYIHRDLR 131
Query: 818 SSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVY 877
           ++N+L+  +   K+ D+GLARL+   + Y      +  + + APE A      T K DV+
Sbjct: 132 AANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPE-AINYGTFTIKSDVW 189
Query: 878 GFGVLVLEVVTGKR 891
            FG+L+ E+VT  R
Sbjct: 190 SFGILLTEIVTHGR 203

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 60/194 (30%), Positives = 98/194 (50%), Gaps = 6/194 (3%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           LG G FG V+         VA+K L   S+  S + F  E   + +++H  LV L     
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVV- 82
Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIK 817
           TQ    +I E++  GSL   L   SG   L+ N+  ++    A+ +A + + N IH +++
Sbjct: 83  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNYIHRDLR 141
Query: 818 SSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVY 877
           ++N+L+  +   K+ D+GLARL+   + Y      +  + + APE A      T K DV+
Sbjct: 142 AANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPE-AINYGTFTIKSDVW 199
Query: 878 GFGVLVLEVVTGKR 891
            FG+L+ E+VT  R
Sbjct: 200 SFGILLTEIVTHGR 213

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 716 PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLH 775
           PVAIK L      + + DF  E   +G+  HPN++ LEG      L +++ E++  GSL 
Sbjct: 79  PVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD 138
Query: 776 KHL--HEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGD 833
             L  H+G      +  +   +++G    + +L     +H ++ + NVL+D +   KV D
Sbjct: 139 TFLRTHDGQ----FTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSD 194
Query: 834 YGLARLL---PMLDRYVLSSKIQSALGYMAPE-FACRTVKITDKCDVYGFGVLVLEVVT- 888
           +GL+R+L   P         KI   + + APE  A RT   +   DV+ FGV++ EV+  
Sbjct: 195 FGLSRVLEDDPDAAXTTTGGKI--PIRWTAPEAIAFRT--FSSASDVWSFGVVMWEVLAY 250
Query: 889 GKRPLSTWKMMWWFSVTWLEEHWK 912
           G+RP   W M     ++ +EE ++
Sbjct: 251 GERPY--WNMTNRDVISSVEEGYR 272

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 63/206 (30%), Positives = 109/206 (52%), Gaps = 24/206 (11%)
Query: 697 ELGRGGFGAVYRT---VLRD--GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG+G FG+V       L+D  G  VA+KKL  S+  +   DFERE++ L  ++H N+V 
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVK 76
Query: 752 LEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN---VIQGTA---KSL 803
            +G  ++   +   LI E++  GSL  +L +          ER +   ++Q T+   K +
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--------KERIDHIKLLQYTSQICKGM 128
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPE 862
            +L     IH N+ + N+L++     K+GD+GL ++LP   + Y +    +S + + APE
Sbjct: 129 EYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE 188
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVT 888
               + K +   DV+ FGV++ E+ T
Sbjct: 189 SLTES-KFSVASDVWSFGVVLYELFT 213

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 716 PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLH 775
           PVAIK L      + + DF  E   +G+  HPN++ LEG      L +++ E++  GSL 
Sbjct: 79  PVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD 138
Query: 776 KHL--HEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGD 833
             L  H+G      +  +   +++G    + +L     +H ++ + NVL+D +   KV D
Sbjct: 139 TFLRTHDGQ----FTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSD 194
Query: 834 YGLARLL---PMLDRYVLSSKIQSALGYMAPE-FACRTVKITDKCDVYGFGVLVLEVVT- 888
           +GL+R+L   P         KI   + + APE  A RT   +   DV+ FGV++ EV+  
Sbjct: 195 FGLSRVLEDDPDAAYTTTGGKI--PIRWTAPEAIAFRT--FSSASDVWSFGVVMWEVLAY 250
Query: 889 GKRPLSTWKMMWWFSVTWLEEHWK 912
           G+RP   W M     ++ +EE ++
Sbjct: 251 GERPY--WNMTNRDVISSVEEGYR 272

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 12/210 (5%)
Query: 689 HALLNKDC--ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH 746
           H L + D   ELG G FG V+R   R        K  ++     +E   +E++ +  +RH
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH 213
Query: 747 PNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHL 806
           P LV L   +   +  ++IYEF+SGG L + +      N +S +E    ++   K L H+
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV--ADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 807 HQSNIIHYNIKSSNVLI--DGSGEPKVGDYGL-ARLLPMLDRYVLSSKIQSALGYMAPEF 863
           H++N +H ++K  N++     S E K+ D+GL A L P     V +   +    + APE 
Sbjct: 272 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE----FAAPEV 327
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           A     +    D++  GVL   +++G  P 
Sbjct: 328 A-EGKPVGYYTDMWSVGVLSYILLSGLSPF 356

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 695 DCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           D  +G G FG V    L+        VAIK L V    K + DF  E   +G+  HPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLA 804
            LEG        +++ E++  GSL   L +         + +F VIQ      G A  + 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--------DAQFTVIQLVGMLRGIASGMK 161
Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAP 861
           +L     +H ++ + N+LI+ +   KV D+GLAR+L   P         KI   + + +P
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKI--PIRWTSP 219
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKM 898
           E A    K T   DV+ +G+++ EV++ G+RP   W+M
Sbjct: 220 E-AIAYRKFTSASDVWSYGIVLWEVMSYGERPY--WEM 254

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Composition-based stats.
 Identities = 59/197 (29%), Positives = 98/197 (49%), Gaps = 7/197 (3%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           ELG G FG V     +    VA+K +   S+  S+++F +E + + K+ HP LV   G  
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             +    ++ E++S G L  +L   S G  L  ++   +     + +A L     IH ++
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLR--SHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDL 130
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
            + N L+D     KV D+G+ R + + D+YV S   +  + + APE      K + K DV
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWSAPE-VFHYFKYSSKSDV 188
Query: 877 YGFGVLVLEVVT-GKRP 892
           + FG+L+ EV + GK P
Sbjct: 189 WAFGILMWEVFSLGKMP 205

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           +GRG FG V +   R  + VAIK++   S  K+   F  E+++L +V HPN+V L G   
Sbjct: 16  VGRGAFGVVCKAKWR-AKDVAIKQIESESERKA---FIVELRQLSRVNHPNIVKLYGACL 71
Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN---IIHY 814
                 L+ E+  GGSL+  LH      + +     +     ++ +A+LH      +IH 
Sbjct: 72  NPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 815 NIKSSNVLIDGSGEP-KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
           ++K  N+L+   G   K+ D+G A      D     +  + +  +MAPE        ++K
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPE-VFEGSNYSEK 183
Query: 874 CDVYGFGVLVLEVVTGKRPLS-----TWKMMW 900
           CDV+ +G+++ EV+T ++P        +++MW
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMW 215

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 12/210 (5%)
Query: 689 HALLNKDC--ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH 746
           H L + D   ELG G FG V+R   R        K  ++     +E   +E++ +  +RH
Sbjct: 48  HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH 107
Query: 747 PNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHL 806
           P LV L   +   +  ++IYEF+SGG L + +      N +S +E    ++   K L H+
Sbjct: 108 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV--ADEHNKMSEDEAVEYMRQVCKGLCHM 165
Query: 807 HQSNIIHYNIKSSNVLI--DGSGEPKVGDYGL-ARLLPMLDRYVLSSKIQSALGYMAPEF 863
           H++N +H ++K  N++     S E K+ D+GL A L P     V +   + A    APE 
Sbjct: 166 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFA----APEV 221
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           A     +    D++  GVL   +++G  P 
Sbjct: 222 A-EGKPVGYYTDMWSVGVLSYILLSGLSPF 250

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 28/212 (13%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTV---SSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           +G GGFG VYR     G  VA+K         + ++ E+  +E K    ++HPN++ L G
Sbjct: 15  IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN---I 811
               +    L+ EF  GG L++ L     G  +  +   N     A+ + +LH      I
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 812 IHYNIKSSNVLIDGSGEP--------KVGDYGLARLLPMLDRYVLSSKIQSALGY--MAP 861
           IH ++KSSN+LI    E         K+ D+GLAR       +  ++K+ +A  Y  MAP
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAR------EWHRTTKMSAAGAYAWMAP 183
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           E   R    +   DV+ +GVL+ E++TG+ P 
Sbjct: 184 E-VIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Composition-based stats.
 Identities = 67/229 (29%), Positives = 109/229 (47%), Gaps = 27/229 (11%)
Query: 698 LGRGGFGAVYRTVLR-DGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +G G FG V    L+  G+    VAIK L      K + DF  E   +G+  HPN++ LE
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLAHLH 807
           G        ++I E++  GSL   L +  G        RF VIQ      G    + +L 
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDG--------RFTVIQLVGMLRGIGSGMKYLS 133
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAPEFA 864
             + +H ++ + N+L++ +   KV D+G++R+L   P         KI   + + APE A
Sbjct: 134 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIRWTAPE-A 190
Query: 865 CRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWLEEHWK 912
               K T   DV+ +G+++ EV++ G+RP   W M     +  +EE ++
Sbjct: 191 IAYRKFTSASDVWSYGIVMWEVMSYGERPY--WDMSNQDVIKAIEEGYR 237

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Composition-based stats.
 Identities = 67/229 (29%), Positives = 109/229 (47%), Gaps = 27/229 (11%)
Query: 698 LGRGGFGAVYRTVLR-DGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +G G FG V    L+  G+    VAIK L      K + DF  E   +G+  HPN++ LE
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLAHLH 807
           G        ++I E++  GSL   L +  G        RF VIQ      G    + +L 
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFLRKNDG--------RFTVIQLVGMLRGIGSGMKYLS 148
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAPEFA 864
             + +H ++ + N+L++ +   KV D+G++R+L   P         KI   + + APE A
Sbjct: 149 DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIRWTAPE-A 205
Query: 865 CRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWLEEHWK 912
               K T   DV+ +G+++ EV++ G+RP   W M     +  +EE ++
Sbjct: 206 IAYRKFTSASDVWSYGIVMWEVMSYGERPY--WDMSNQDVIKAIEEGYR 252

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Composition-based stats.
 Identities = 67/229 (29%), Positives = 109/229 (47%), Gaps = 27/229 (11%)
Query: 698 LGRGGFGAVYRTVLR-DGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +G G FG V    L+  G+    VAIK L      K + DF  E   +G+  HPN++ LE
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLAHLH 807
           G        ++I E++  GSL   L +  G        RF VIQ      G    + +L 
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRKNDG--------RFTVIQLVGMLRGIGSGMKYLS 127
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAPEFA 864
             + +H ++ + N+L++ +   KV D+G++R+L   P         KI   + + APE A
Sbjct: 128 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIRWTAPE-A 184
Query: 865 CRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWLEEHWK 912
               K T   DV+ +G+++ EV++ G+RP   W M     +  +EE ++
Sbjct: 185 IAYRKFTSASDVWSYGIVMWEVMSYGERPY--WDMSNQDVIKAIEEGYR 231

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 695 DCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           D  +G G FG V    L+        VAIK L V    K + DF  E   +G+  HPN++
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLA 804
            LEG        +++ E++  GSL   L +         + +F VIQ      G A  + 
Sbjct: 98  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--------DAQFTVIQLVGMLRGIASGMK 149
Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAP 861
           +L     +H ++ + N+LI+ +   KV D+GL+R+L   P         KI   + + +P
Sbjct: 150 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSP 207
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKM 898
           E A    K T   DV+ +G+++ EV++ G+RP   W+M
Sbjct: 208 E-AIAYRKFTSASDVWSYGIVLWEVMSYGERPY--WEM 242

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 695 DCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           D  +G G FG V    L+        VAIK L V    K + DF  E   +G+  HPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLA 804
            LEG        +++ E++  GSL   L +         + +F VIQ      G A  + 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--------DAQFTVIQLVGMLRGIASGMK 161
Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAP 861
           +L     +H ++ + N+LI+ +   KV D+GL+R+L   P         KI   + + +P
Sbjct: 162 YLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSP 219
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKM 898
           E A    K T   DV+ +G+++ EV++ G+RP   W+M
Sbjct: 220 E-AIAYRKFTSASDVWSYGIVLWEVMSYGERPY--WEM 254

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 698 LGRGGFGAVY---RTVLRDGRPV----AIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           LG+G FG V+   +    D R +     +KK T+    + +   ER++  L +V HP +V
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI--LVEVNHPFIV 90
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
            L   + T+    LI +F+ GG L   L +     F   + +F + +  A +L HLH   
Sbjct: 91  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAE-LALALDHLHSLG 147
Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKI 870
           II+ ++K  N+L+D  G  K+ D+GL++    +D    +      + YMAPE   R    
Sbjct: 148 IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGH- 204
Query: 871 TDKCDVYGFGVLVLEVVTGKRPL 893
           T   D + FGVL+ E++TG  P 
Sbjct: 205 TQSADWWSFGVLMFEMLTGTLPF 227

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 698 LGRGGFGAVY---RTVLRDGRPV----AIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           LG+G FG V+   +    D R +     +KK T+    + +   ER++  L +V HP +V
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI--LVEVNHPFIV 89
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
            L   + T+    LI +F+ GG L   L +     F   + +F + +  A +L HLH   
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAE-LALALDHLHSLG 146
Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKI 870
           II+ ++K  N+L+D  G  K+ D+GL++    +D    +      + YMAPE   R    
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGH- 203
Query: 871 TDKCDVYGFGVLVLEVVTGKRPL 893
           T   D + FGVL+ E++TG  P 
Sbjct: 204 TQSADWWSFGVLMFEMLTGTLPF 226

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 695 DCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           D  +G G FG V    L+        VAIK L V    K + DF  E   +G+  HPN++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLA 804
            LEG        +++ E++  GSL   L +         + +F VIQ      G A  + 
Sbjct: 81  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--------DAQFTVIQLVGMLRGIASGMK 132
Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAP 861
           +L     +H ++ + N+LI+ +   KV D+GL+R+L   P         KI   + + +P
Sbjct: 133 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSP 190
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKM 898
           E A    K T   DV+ +G+++ EV++ G+RP   W+M
Sbjct: 191 E-AIAYRKFTSASDVWSYGIVLWEVMSYGERPY--WEM 225

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 109/205 (53%), Gaps = 14/205 (6%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG V++ V + +G     PV IK +   S  +S +     +  +G + H ++V L
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHL--HEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
            G     SLQL + +++  GSL  H+  H G+ G  L  N    +    AK + +L +  
Sbjct: 99  LGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI----AKGMYYLEEHG 153
Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKI 870
           ++H N+ + NVL+    + +V D+G+A LLP  D+ +L S+ ++ + +MA E +    K 
Sbjct: 154 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE-SIHFGKY 212
Query: 871 TDKCDVYGFGVLVLEVVT-GKRPLS 894
           T + DV+ +GV V E++T G  P +
Sbjct: 213 THQSDVWSYGVTVWELMTFGAEPYA 237

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 695 DCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           D  +G G FG V    L+        VAIK L V    K + DF  E   +G+  HPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLA 804
            LEG        +++ E++  GSL   L +         + +F VIQ      G A  + 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--------DAQFTVIQLVGMLRGIASGMK 161
Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAP 861
           +L     +H ++ + N+LI+ +   KV D+GL+R+L   P         KI   + + +P
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSP 219
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKM 898
           E A    K T   DV+ +G+++ EV++ G+RP   W+M
Sbjct: 220 E-AIAYRKFTSASDVWSYGIVLWEVMSYGERPY--WEM 254

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK L  ++  K+  +F  E   +  + HP+LV L
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   + ++QL + + +  G L +++HE     G   L      N     AK + +L + 
Sbjct: 83  LGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLL-----LNWCVQIAKGMMYLEER 136
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLARLL   ++   +   +  + +MA E      K
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE-CIHYRK 195
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV + E++T G +P
Sbjct: 196 FTHQSDVWSYGVTIWELMTFGGKP 219

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 6/194 (3%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           LG G FG V+         VAIK L   ++  S E F  E + + K++H  LV L     
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTM--SPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIK 817
            + +  ++ E+++ GSL   L +G G   L      ++    A  +A++ + N IH +++
Sbjct: 75  EEPI-YIVTEYMNKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERMNYIHRDLR 132
Query: 818 SSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVY 877
           S+N+L+      K+ D+GLARL+   +        +  + + APE A    + T K DV+
Sbjct: 133 SANILVGNGLICKIADFGLARLIED-NEXTARQGAKFPIKWTAPEAALYG-RFTIKSDVW 190
Query: 878 GFGVLVLEVVTGKR 891
            FG+L+ E+VT  R
Sbjct: 191 SFGILLTELVTKGR 204

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK L  ++  K+  +F  E   +  + HP+LV L
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   + ++QL + + +  G L +++HE     G   L      N     AK + +L + 
Sbjct: 106 LGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLL-----LNWCVQIAKGMMYLEER 159
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLARLL   ++   +   +  + +MA E      K
Sbjct: 160 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE-CIHYRK 218
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV + E++T G +P
Sbjct: 219 FTHQSDVWSYGVTIWELMTFGGKP 242

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 695 DCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           D  +G G FG V    L+        VAIK L V    K + DF  E   +G+  HPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLA 804
            LEG        +++ E++  GSL   L +         + +F VIQ      G A  + 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--------DAQFTVIQLVGMLRGIASGMK 161
Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAP 861
           +L     +H ++ + N+LI+ +   KV D+GL+R+L   P         KI   + + +P
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSP 219
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKM 898
           E A    K T   DV+ +G+++ EV++ G+RP   W+M
Sbjct: 220 E-AIAYRKFTSASDVWSYGIVLWEVMSYGERPY--WEM 254

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 695 DCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           D  +G G FG V    L+        VAIK L V    K + DF  E   +G+  HPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLA 804
            LEG        +++ E++  GSL   L +         + +F VIQ      G A  + 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--------DAQFTVIQLVGMLRGIASGMK 161
Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAP 861
           +L     +H ++ + N+LI+ +   KV D+GL+R+L   P         KI   + + +P
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSP 219
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKM 898
           E A    K T   DV+ +G+++ EV++ G+RP   W+M
Sbjct: 220 E-AIAYRKFTSASDVWSYGIVLWEVMSYGERPY--WEM 254

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 102/199 (51%), Gaps = 9/199 (4%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G+VY+ + ++ G+ VAIK++ V S +   ++  +E+  + +   P++V   G 
Sbjct: 36  KLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL---QEIIKEISIMQQCDSPHVVKYYGS 92
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           Y+  +   ++ E+   GS+   +        L+ +E   ++Q T K L +LH    IH +
Sbjct: 93  YFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRD 150
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           IK+ N+L++  G  K+ D+G+A  L   D     + +     +MAPE   + +      D
Sbjct: 151 IKAGNILLNTEGHAKLADFGVAGQL--TDXMAKRNXVIGTPFWMAPE-VIQEIGYNCVAD 207
Query: 876 VYGFGVLVLEVVTGKRPLS 894
           ++  G+  +E+  GK P +
Sbjct: 208 IWSLGITAIEMAEGKPPYA 226

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 695 DCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           D  +G G FG V    L+        VAIK L V    K + DF  E   +G+  HPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLA 804
            LEG        +++ E++  GSL   L +         + +F VIQ      G A  + 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--------DAQFTVIQLVGMLRGIASGMK 161
Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAP 861
           +L     +H ++ + N+LI+ +   KV D+GL+R+L   P         KI   + + +P
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSP 219
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKM 898
           E A    K T   DV+ +G+++ EV++ G+RP   W+M
Sbjct: 220 E-AIAYRKFTSASDVWSYGIVLWEVMSYGERPY--WEM 254

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 695 DCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           D  +G G FG V    L+        VAIK L V    K + DF  E   +G+  HPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLA 804
            LEG        +++ E++  GSL   L +         + +F VIQ      G A  + 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--------DAQFTVIQLVGMLRGIASGMK 161
Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAP 861
           +L     +H ++ + N+LI+ +   KV D+GL R+L   P         KI   + + +P
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI--PIRWTSP 219
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKM 898
           E A    K T   DV+ +G+++ EV++ G+RP   W+M
Sbjct: 220 E-AIAYRKFTSASDVWSYGIVLWEVMSYGERPY--WEM 254

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 695 DCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           D  +G G FG V    L+        VAIK L V    K + DF  E   +G+  HPN++
Sbjct: 48  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 107
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLA 804
            LEG        +++ E++  GSL   L +         + +F VIQ      G A  + 
Sbjct: 108 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--------DAQFTVIQLVGMLRGIASGMK 159
Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAP 861
           +L     +H ++ + N+LI+ +   KV D+GL+R+L   P         KI   + + +P
Sbjct: 160 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSP 217
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKM 898
           E A    K T   DV+ +G+++ EV++ G+RP   W+M
Sbjct: 218 E-AIAYRKFTSASDVWSYGIVLWEVMSYGERPY--WEM 252

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 109/205 (53%), Gaps = 14/205 (6%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG V++ V + +G     PV IK +   S  +S +     +  +G + H ++V L
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHL--HEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
            G     SLQL + +++  GSL  H+  H G+ G  L  N    +    AK + +L +  
Sbjct: 81  LGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI----AKGMYYLEEHG 135
Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKI 870
           ++H N+ + NVL+    + +V D+G+A LLP  D+ +L S+ ++ + +MA E +    K 
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE-SIHFGKY 194
Query: 871 TDKCDVYGFGVLVLEVVT-GKRPLS 894
           T + DV+ +GV V E++T G  P +
Sbjct: 195 THQSDVWSYGVTVWELMTFGAEPYA 219

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 11/201 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  S L K   +    RE++    +RHPN++ +  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+  +    L+ EF   G L+K L +   G F         ++  A +L + H+  +IH 
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKH--GRF-DEQRSATFMEELADALHYCHERKVIHR 138
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+   GE K+ D+G +   P L R  +       L Y+ PE         +K 
Sbjct: 139 DIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIEGKTH-DEKV 193
Query: 875 DVYGFGVLVLEVVTGKRPLST 895
           D++  GVL  E + G  P  +
Sbjct: 194 DLWCAGVLCYEFLVGMPPFDS 214

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 11/201 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +  + + A+K L  S L K   +    RE++    +RHPN++ +  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+  +    L+ EF   G L+K L +   G F         ++  A +L + H+  +IH 
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKH--GRF-DEQRSATFMEELADALHYCHERKVIHR 139
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+   GE K+ D+G +   P L R  +       L Y+ PE         +K 
Sbjct: 140 DIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIEGKTH-DEKV 194
Query: 875 DVYGFGVLVLEVVTGKRPLST 895
           D++  GVL  E + G  P  +
Sbjct: 195 DLWCAGVLCYEFLVGMPPFDS 215

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 100/193 (51%), Gaps = 6/193 (3%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +     +    +   Q  + ++ +L + N IH N
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKNFIHRN 343
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D Y   +  +  + + APE +    K + K D
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSD 401
Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 402 VWAFGVLLWEIAT 414

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 698 LGRGGFGAVY---RTVLRDGRPV----AIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           LG+G FG V+   +    D R +     +KK T+    + +   ER++  L +V HP +V
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI--LVEVNHPFIV 89
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
            L   + T+    LI +F+ GG L   L       F   + +F + +  A +L HLH   
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLAE-LALALDHLHSLG 146
Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKI 870
           II+ ++K  N+L+D  G  K+ D+GL++    +D    +      + YMAPE   R    
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGH- 203
Query: 871 TDKCDVYGFGVLVLEVVTGKRPLS 894
           T   D + FGVL+ E++TG  P  
Sbjct: 204 TQSADWWSFGVLMFEMLTGTLPFQ 227

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 10/201 (4%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + DG     PVAIK L  ++  K+ ++   E   +  V  P +  L
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
            G   T ++QL + + +  G L  H+ E  G   L   +  N     AK +++L    ++
Sbjct: 85  LGICLTSTVQL-VTQLMPYGCLLDHVRENRGR--LGSQDLLNWCMQIAKGMSYLEDVRLV 141
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           H ++ + NVL+      K+ D+GLARLL + +    +   +  + +MA E   R  + T 
Sbjct: 142 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRR-RFTH 200
Query: 873 KCDVYGFGVLVLEVVT-GKRP 892
           + DV+ +GV V E++T G +P
Sbjct: 201 QSDVWSYGVTVWELMTFGAKP 221

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 64/207 (30%), Positives = 110/207 (53%), Gaps = 26/207 (12%)
Query: 697 ELGRGGFGAVYRT---VLRD--GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG+G FG+V       L+D  G  VA+KKL  S+  +   DFERE++ L  ++H N+V 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVK 78
Query: 752 LEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN---VIQGTA---KSL 803
            +G  ++   +   LI EF+  GSL ++L +          ER +   ++Q T+   K +
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKH--------KERIDHIKLLQYTSQICKGM 130
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI--QSALGYMAP 861
            +L     IH ++ + N+L++     K+GD+GL ++LP  D+     K   +S + + AP
Sbjct: 131 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAP 189
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT 888
           E    + K +   DV+ FGV++ E+ T
Sbjct: 190 ESLTES-KFSVASDVWSFGVVLYELFT 215

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 27/215 (12%)
Query: 698 LGRGGFGAVYRTVLR-DGR---PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +G G FG V    L+  G+    VAIK L V    K + DF  E   +G+  HPN+V LE
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLAHLH 807
           G        +++ EF+  G+L   L +  G        +F VIQ      G A  + +L 
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFLRKHDG--------QFTVIQLVGMLRGIAAGMRYLA 162
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS---KIQSALGYMAPEFA 864
               +H ++ + N+L++ +   KV D+GL+R++      V ++   KI   + + APE A
Sbjct: 163 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKI--PVRWTAPE-A 219
Query: 865 CRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKM 898
            +  K T   DV+ +G+++ EV++ G+RP   W M
Sbjct: 220 IQYRKFTSASDVWSYGIVMWEVMSYGERPY--WDM 252

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 4/196 (2%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V   V R     VA+K + +   V   E+ ++E+     + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              ++Q L  E+ SGG L   +    G         F+ +      + +LH   I H +I
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHGIGITHRDI 131
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           K  N+L+D     K+ D+GLA +    +R  L +K+   L Y+APE   R     +  DV
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 877 YGFGVLVLEVVTGKRP 892
           +  G+++  ++ G+ P
Sbjct: 192 WSCGIVLTAMLAGELP 207

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 4/196 (2%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V   V R     VA+K + +   V   E+ ++E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              ++Q L  E+ SGG L   +    G         F+ +      + +LH   I H +I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHGIGITHRDI 130
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           K  N+L+D     K+ D+GLA +    +R  L +K+   L Y+APE   R     +  DV
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 190
Query: 877 YGFGVLVLEVVTGKRP 892
           +  G+++  ++ G+ P
Sbjct: 191 WSCGIVLTAMLAGELP 206

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 112/221 (50%), Gaps = 26/221 (11%)
Query: 692 LNKDCELGRGGFGAVYR-TVLRDGRPVAIKKLTV------SSLVKSQEDFEREVKKLGKV 744
           +  + ++G+GGFG V++  +++D   VAIK L +      + +++  ++F+REV  +  +
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 745 RHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLA 804
            HPN+V L G     +   ++ EFV  G L+  L + +  + + W+ +  ++   A  + 
Sbjct: 81  NHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIE 136
Query: 805 HLHQSN--IIHYNIKSSNVLIDGSGE-----PKVGDYGLARLLPMLDRYVLS-SKIQSAL 856
           ++   N  I+H +++S N+ +    E      KV D+GL++      + V S S +    
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ------QSVHSVSGLLGNF 190
Query: 857 GYMAPE-FACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTW 896
            +MAPE         T+K D Y F +++  ++TG+ P   +
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 6/194 (3%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           LG G FG V+         VA+K L   S+  S + F  E   + +++H  LV L     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIK 817
           TQ    +I E++  GSL   L   SG   L+ N+  ++    A+ +A + + N IH +++
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136
Query: 818 SSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVY 877
           ++N+L+  +   K+ D+GLARL+   +        +  + + APE A      T K DV+
Sbjct: 137 AANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTAPE-AINYGTFTIKSDVW 194
Query: 878 GFGVLVLEVVTGKR 891
            FG+L+ E+VT  R
Sbjct: 195 SFGILLTEIVTHGR 208

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 6/194 (3%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           LG G FG V+         VA+K L   S+  S + F  E   + +++H  LV L     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIK 817
           TQ    +I E++  GSL   L   SG   L+ N+  ++    A+ +A + + N IH +++
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136
Query: 818 SSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVY 877
           ++N+L+  +   K+ D+GLARL+   +        +  + + APE A      T K DV+
Sbjct: 137 AANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTAPE-AINYGTFTIKSDVW 194
Query: 878 GFGVLVLEVVTGKR 891
            FG+L+ E+VT  R
Sbjct: 195 SFGILLTEIVTHGR 208

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 6/194 (3%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           LG G FG V+         VA+K L   S+  S + F  E   + +++H  LV L     
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVV- 86
Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIK 817
           TQ    +I E++  GSL   L   SG   L+ N+  ++    A+ +A + + N IH +++
Sbjct: 87  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNYIHRDLR 145
Query: 818 SSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVY 877
           ++N+L+  +   K+ D+GLARL+   +        +  + + APE A      T K DV+
Sbjct: 146 AANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTAPE-AINYGTFTIKSDVW 203
Query: 878 GFGVLVLEVVTGKR 891
            FG+L+ E+VT  R
Sbjct: 204 SFGILLTEIVTHGR 217

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 6/194 (3%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           LG G FG V+         VA+K L   S+  S + F  E   + +++H  LV L     
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVV- 85
Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIK 817
           TQ    +I E++  GSL   L   SG   L+ N+  ++    A+ +A + + N IH +++
Sbjct: 86  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNYIHRDLR 144
Query: 818 SSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVY 877
           ++N+L+  +   K+ D+GLARL+   +        +  + + APE A      T K DV+
Sbjct: 145 AANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTAPE-AINYGTFTIKSDVW 202
Query: 878 GFGVLVLEVVTGKR 891
            FG+L+ E+VT  R
Sbjct: 203 SFGILLTEIVTHGR 216

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 6/194 (3%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           LG G FG V+         VA+K L   S+  S + F  E   + +++H  LV L     
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVV- 83
Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIK 817
           TQ    +I E++  GSL   L   SG   L+ N+  ++    A+ +A + + N IH +++
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNYIHRDLR 142
Query: 818 SSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVY 877
           ++N+L+  +   K+ D+GLARL+   +        +  + + APE A      T K DV+
Sbjct: 143 AANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTAPE-AINYGTFTIKSDVW 200
Query: 878 GFGVLVLEVVTGKR 891
            FG+L+ E+VT  R
Sbjct: 201 SFGILLTEIVTHGR 214

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 6/194 (3%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           LG G FG V+         VA+K L   S+  S + F  E   + +++H  LV L     
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVV- 78
Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIK 817
           TQ    +I E++  GSL   L   SG   L+ N+  ++    A+ +A + + N IH +++
Sbjct: 79  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNYIHRDLR 137
Query: 818 SSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVY 877
           ++N+L+  +   K+ D+GLARL+   +        +  + + APE A      T K DV+
Sbjct: 138 AANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTAPE-AINYGTFTIKSDVW 195
Query: 878 GFGVLVLEVVTGKR 891
            FG+L+ E+VT  R
Sbjct: 196 SFGILLTEIVTHGR 209

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 6/194 (3%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           LG G FG V+         VA+K L   S+  S + F  E   + +++H  LV L     
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVV- 79
Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIK 817
           TQ    +I E++  GSL   L   SG   L+ N+  ++    A+ +A + + N IH +++
Sbjct: 80  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNYIHRDLR 138
Query: 818 SSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVY 877
           ++N+L+  +   K+ D+GLARL+   +        +  + + APE A      T K DV+
Sbjct: 139 AANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTAPE-AINYGTFTIKSDVW 196
Query: 878 GFGVLVLEVVTGKR 891
            FG+L+ E+VT  R
Sbjct: 197 SFGILLTEIVTHGR 210

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 56/213 (26%), Positives = 105/213 (49%), Gaps = 19/213 (8%)
Query: 697 ELGRGGFGAVYRTVLRDGRP------VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG G FG V+     +  P      VA+K L  +S   +++DF RE + L  ++H ++V
Sbjct: 20  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIV 78
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLH----------EGSGGNFLSWNERFNVIQGTA 800
              G        ++++E++  G L+K L           EG+    L+ ++  ++ Q  A
Sbjct: 79  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIA 138
Query: 801 KSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMA 860
             + +L   + +H ++ + N L+  +   K+GD+G++R +   D Y +       + +M 
Sbjct: 139 AGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 198
Query: 861 PEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           PE +    K T + DV+  GV++ E+ T GK+P
Sbjct: 199 PE-SIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 6/193 (3%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +     +    +   Q  + ++ +L + N IH +
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKNFIHRD 136
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D Y   +  +  + + APE      K + K D
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSD 194
Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 195 VWAFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 6/193 (3%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +     +    +   Q  + ++ +L + N IH +
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKNFIHRD 136
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D Y   +  +  + + APE      K + K D
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSD 194
Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 195 VWAFGVLLWEIAT 207

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 6/193 (3%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +     +    +   Q  + ++ +L + N IH +
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKNFIHRD 136
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D Y   +  +  + + APE      K + K D
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSD 194
Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 195 VWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 6/193 (3%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +     +    +   Q  + ++ +L + N IH +
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKNFIHRD 136
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D Y   +  +  + + APE      K + K D
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSD 194
Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 195 VWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 6/193 (3%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +     +    +   Q  + ++ +L + N IH +
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKNFIHRD 141
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D Y   +  +  + + APE      K + K D
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSD 199
Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 200 VWAFGVLLWEIAT 212

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 7/197 (3%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +LG G FG V+         VA+K +   S+  S E F  E   +  ++H  LV L    
Sbjct: 22  KLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVV 79
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
            T+    +I EF++ GSL   L    G       +  +     A+ +A + Q N IH ++
Sbjct: 80  -TKEPIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           +++N+L+  S   K+ D+GLAR++   + Y      +  + + APE A      T K DV
Sbjct: 138 RAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAPE-AINFGSFTIKSDV 195
Query: 877 YGFGVLVLEVVT-GKRP 892
           + FG+L++E+VT G+ P
Sbjct: 196 WSFGILLMEIVTYGRIP 212

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 100/193 (51%), Gaps = 6/193 (3%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 266 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +     +    +   Q  + ++ +L + N IH N
Sbjct: 324 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ-ISSAMEYLEKKNFIHRN 382
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D Y   +  +  + + APE +    K + K D
Sbjct: 383 LAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSD 440
Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 441 VWAFGVLLWEIAT 453

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 17/206 (8%)
Query: 698 LGRGGFGAVYR----TVLRDGRPVAIKKLTVSSLVKSQED-----FEREVKKLGKVRHPN 748
           LG+GG+G V++    T    G+  A+K L  + +V++ +D      ER +  L +V+HP 
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI--LEEVKHPF 82
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           +V L   + T     LI E++SGG L   L     G F+     F + +  + +L HLHQ
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAE-ISMALGHLHQ 139
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTV 868
             II+ ++K  N++++  G  K+ D+GL +    +    ++      + YMAPE   R+ 
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTIEYMAPEILMRSG 197
Query: 869 KITDKCDVYGFGVLVLEVVTGKRPLS 894
                 D +  G L+ +++TG  P +
Sbjct: 198 H-NRAVDWWSLGALMYDMLTGAPPFT 222

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 695 DCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           D  +G G FG V    L+        VAIK L V    K + DF  E   +G+  HPN++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLA 804
            LEG        +++ E +  GSL   L +         + +F VIQ      G A  + 
Sbjct: 81  RLEGVVTKSKPVMIVTEXMENGSLDSFLRKH--------DAQFTVIQLVGMLRGIASGMK 132
Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAP 861
           +L     +H ++ + N+LI+ +   KV D+GL+R+L   P         KI   + + +P
Sbjct: 133 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSP 190
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKM 898
           E A    K T   DV+ +G+++ EV++ G+RP   W+M
Sbjct: 191 E-AIAYRKFTSASDVWSYGIVLWEVMSYGERPY--WEM 225

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 17/206 (8%)
Query: 698 LGRGGFGAVYR----TVLRDGRPVAIKKLTVSSLVKSQED-----FEREVKKLGKVRHPN 748
           LG+GG+G V++    T    G+  A+K L  + +V++ +D      ER +  L +V+HP 
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI--LEEVKHPF 82
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           +V L   + T     LI E++SGG L   L     G F+     F + +  + +L HLHQ
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAE-ISMALGHLHQ 139
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTV 868
             II+ ++K  N++++  G  K+ D+GL +    +    ++      + YMAPE   R+ 
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPEILMRSG 197
Query: 869 KITDKCDVYGFGVLVLEVVTGKRPLS 894
                 D +  G L+ +++TG  P +
Sbjct: 198 H-NRAVDWWSLGALMYDMLTGAPPFT 222

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 695 DCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           D  +G G FG V    L+        VAIK L V    K + DF  E   +G+  HPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLA 804
            LEG        +++ E +  GSL   L +         + +F VIQ      G A  + 
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKH--------DAQFTVIQLVGMLRGIASGMK 161
Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAP 861
           +L     +H ++ + N+LI+ +   KV D+GL+R+L   P         KI   + + +P
Sbjct: 162 YLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSP 219
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKM 898
           E A    K T   DV+ +G+++ EV++ G+RP   W+M
Sbjct: 220 E-AIAYRKFTSASDVWSYGIVLWEVMSYGERPY--WEM 254

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 6/193 (3%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +     +    +   Q  + ++ +L + N IH +
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ-ISSAMEYLEKKNFIHRD 141
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D Y   +  +  + + APE      K + K D
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSD 199
Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 200 VWAFGVLLWEIAT 212

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 6/200 (3%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           L  + +LG G FG V+         VA+K +   S+  S E F  E   +  ++H  LV 
Sbjct: 190 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVK 247
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L     T+    +I EF++ GSL   L    G       +  +     A+ +A + Q N 
Sbjct: 248 LHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIEQRNY 305
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           IH +++++N+L+  S   K+ D+GLAR++   + Y      +  + + APE A      T
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAPE-AINFGSFT 363
Query: 872 DKCDVYGFGVLVLEVVTGKR 891
            K DV+ FG+L++E+VT  R
Sbjct: 364 IKSDVWSFGILLMEIVTYGR 383

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 6/193 (3%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +     +    +   Q  + ++ +L + N IH +
Sbjct: 79  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ-ISSAMEYLEKKNFIHRD 137
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D Y   +  +  + + APE      K + K D
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYN-KFSIKSD 195
Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 196 VWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 6/193 (3%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +     +    +   Q  + ++ +L + N IH +
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ-ISSAMEYLEKKNFIHRD 138
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D Y   +  +  + + APE      K + K D
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYN-KFSIKSD 196
Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 197 VWAFGVLLWEIAT 209

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 6/193 (3%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +     +    +   Q  + ++ +L + N IH +
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ-ISSAMEYLEKKNFIHRD 141
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D Y   +  +  + + APE      K + K D
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSD 199
Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 200 VWAFGVLLWEIAT 212

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 6/193 (3%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 33  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +     +    +   Q  + ++ +L + N IH +
Sbjct: 91  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ-ISSAMEYLEKKNFIHRD 149
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D Y   +  +  + + APE      K + K D
Sbjct: 150 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSD 207
Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 208 VWAFGVLLWEIAT 220

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 6/193 (3%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +     +    +   Q  + ++ +L + N IH +
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ-ISSAMEYLEKKNFIHRD 141
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D Y   +  +  + + APE      K + K D
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSD 199
Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 200 VWAFGVLLWEIAT 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 6/193 (3%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +     +    +   Q  + ++ +L + N IH +
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ-ISSAMEYLEKKNFIHRD 136
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D Y   +  +  + + APE      K + K D
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSD 194
Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 195 VWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 6/193 (3%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +     +    +   Q  + ++ +L + N IH +
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ-ISSAMEYLEKKNFIHRD 140
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D Y   +  +  + + APE      K + K D
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSD 198
Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 199 VWAFGVLLWEIAT 211

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 6/193 (3%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +     +    +   Q  + ++ +L + N IH +
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ-ISSAMEYLEKKNFIHRD 136
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D Y   +  +  + + APE      K + K D
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSD 194
Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 195 VWAFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 6/193 (3%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +     +    +   Q  + ++ +L + N IH +
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ-ISSAMEYLEKKNFIHRD 138
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D Y   +  +  + + APE      K + K D
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSD 196
Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 197 VWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 6/193 (3%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +     +    +   Q  + ++ +L + N IH +
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ-ISSAMEYLEKKNFIHRD 138
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D Y   +  +  + + APE      K + K D
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSD 196
Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 197 VWAFGVLLWEIAT 209

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQE---DFEREVKKLGKVRHPNLV--- 750
           LG GG   V+    LRD R VA+K L  + L +       F RE +    + HP +V   
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 751 -TLEGYYWTQSLQLLIYEFVSGGSLHKHLH-EGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
            T E       L  ++ E+V G +L   +H EG     ++      VI    ++L   HQ
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQ 134
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL-SSKIQSALGYMAPEFACRT 867
           + IIH ++K +N+LI  +   KV D+G+AR +      V  ++ +     Y++PE A R 
Sbjct: 135 NGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQA-RG 193
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPLS 894
             +  + DVY  G ++ EV+TG+ P +
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 61/206 (29%), Positives = 108/206 (52%), Gaps = 24/206 (11%)
Query: 697 ELGRGGFGAVYRT---VLRD--GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG+G FG+V       L+D  G  VA+KKL  S+  +   DFERE++ L  ++H N+V 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVK 75
Query: 752 LEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN---VIQGTA---KSL 803
            +G  ++   +   LI E++  GSL  +L +          ER +   ++Q T+   K +
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--------KERIDHIKLLQYTSQICKGM 127
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV-LSSKIQSALGYMAPE 862
            +L     IH ++ + N+L++     K+GD+GL ++LP    +  +    +S + + APE
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVT 888
               + K +   DV+ FGV++ E+ T
Sbjct: 188 SLTES-KFSVASDVWSFGVVLYELFT 212

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 4/196 (2%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V   V R     VA+K + +   V   E+ ++E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              ++Q L  E+ SGG L   +    G         F+ +      + +LH   I H +I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHGIGITHRDI 130
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           K  N+L+D     K+ D+GLA +    +R  L +K+   L Y+APE   R     +  DV
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDV 190
Query: 877 YGFGVLVLEVVTGKRP 892
           +  G+++  ++ G+ P
Sbjct: 191 WSCGIVLTAMLAGELP 206

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 4/196 (2%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V   V R     VA+K + +   V   E+ ++E+     + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              ++Q L  E+ SGG L   +    G         F+ +      + +LH   I H +I
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHGIGITHRDI 131
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           K  N+L+D     K+ D+GLA +    +R  L +K+   L Y+APE   R     +  DV
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDV 191
Query: 877 YGFGVLVLEVVTGKRP 892
           +  G+++  ++ G+ P
Sbjct: 192 WSCGIVLTAMLAGELP 207

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 698 LGRGGFGAVY--RTVLR--DGRPVAIKKLTVSSLV---KSQEDFEREVKKLGKVRHPNLV 750
           LG+G FG V+  R V R   G   A+K L  ++L    + +   ER++  L  V HP +V
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDI--LADVNHPFVV 93
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
            L   + T+    LI +F+ GG L   L +     F   + +F + +  A  L HLH   
Sbjct: 94  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAE-LALGLDHLHSLG 150
Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKI 870
           II+ ++K  N+L+D  G  K+ D+GL++    +D    +      + YMAPE   R    
Sbjct: 151 IIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAYSFCGTVEYMAPEVVNRQGH- 207
Query: 871 TDKCDVYGFGVLVLEVVTGKRPLS 894
           +   D + +GVL+ E++TG  P  
Sbjct: 208 SHSADWWSYGVLMFEMLTGSLPFQ 231

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 29/217 (13%)
Query: 698 LGRGGFGAVYRTVLRD-GRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +G G FG V R  L+  G+    VAIK L      + + +F  E   +G+  HPN++ LE
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLAHLH 807
           G        +++ EF+  G+L   L    G        +F VIQ      G A  + +L 
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFLRLNDG--------QFTVIQLVGMLRGIASGMRYLA 135
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-----LDRYVLSSKIQSALGYMAPE 862
           + + +H ++ + N+L++ +   KV D+GL+R L        +   L  KI   + + APE
Sbjct: 136 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI--PIRWTAPE 193
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKM 898
            A    K T   D + +G+++ EV++ G+RP   W M
Sbjct: 194 -AIAFRKFTSASDAWSYGIVMWEVMSFGERPY--WDM 227

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 56/229 (24%), Positives = 107/229 (46%), Gaps = 30/229 (13%)
Query: 697 ELGRGGFGAVYR------TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG G FG V+       +  +D   VA+K L   +L  +++DF+RE + L  ++H ++V
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA-ARKDFQREAELLTNLQHEHIV 80
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHL-------------HEGSGGNFLSWNERFNVIQ 797
              G        ++++E++  G L+K L                     L  ++  ++  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 798 GTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG 857
             A  + +L   + +H ++ + N L+  +   K+GD+G++R +   D Y +       + 
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 200
Query: 858 YMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVT 905
           +M PE +    K T + DV+ FGV++ E+ T GK+P        WF ++
Sbjct: 201 WMPPE-SIMYRKFTTESDVWSFGVILWEIFTYGKQP--------WFQLS 240

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 698 LGRGGFGAVYRTVLRD-GRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +G G FG V R  L+  G+    VAIK L      + + +F  E   +G+  HPN++ LE
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLAHLH 807
           G        +++ EF+  G+L   L    G        +F VIQ      G A  + +L 
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLRLNDG--------QFTVIQLVGMLRGIASGMRYLA 133
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD---RYVLSSKIQSALGYMAPEFA 864
           + + +H ++ + N+L++ +   KV D+GL+R L        Y  S   +  + + APE A
Sbjct: 134 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPE-A 192
Query: 865 CRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKM 898
               K T   D + +G+++ EV++ G+RP   W M
Sbjct: 193 IAFRKFTSASDAWSYGIVMWEVMSFGERPY--WDM 225

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 695 DCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           D  +G G FG V    L+        VAIK L V    K + DF  E   +G+  HPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSLA 804
            LEG        +++ E +  GSL   L +         + +F VIQ      G A  + 
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKH--------DAQFTVIQLVGMLRGIASGMK 161
Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAP 861
           +L     +H ++ + N+LI+ +   KV D+GL+R+L   P         KI   + + +P
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTSP 219
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKM 898
           E A    K T   DV+ +G+++ EV++ G+RP   W+M
Sbjct: 220 E-AIAYRKFTSASDVWSYGIVLWEVMSYGERPY--WEM 254

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQE---DFEREVKKLGKVRHPNLV--- 750
           LG GG   V+    LRD R VA+K L  + L +       F RE +    + HP +V   
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 751 -TLEGYYWTQSLQLLIYEFVSGGSLHKHLH-EGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
            T E       L  ++ E+V G +L   +H EG     ++      VI    ++L   HQ
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQ 134
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL-SSKIQSALGYMAPEFACRT 867
           + IIH ++K +N++I  +   KV D+G+AR +      V  ++ +     Y++PE A R 
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA-RG 193
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPLS 894
             +  + DVY  G ++ EV+TG+ P +
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 7/197 (3%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           ELG G FG V     R    VAIK +   S+  S+++F  E K +  + H  LV L G  
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             Q    +I E+++ G L  +L E    +     +   + +   +++ +L     +H ++
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 131
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
            + N L++  G  KV D+GL+R + + D Y  S   +  + +  PE    + K + K D+
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSRGSKFPVRWSPPEVLMYS-KFSSKSDI 189
Query: 877 YGFGVLVLEVVT-GKRP 892
           + FGVL+ E+ + GK P
Sbjct: 190 WAFGVLMWEIYSLGKMP 206

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQE---DFEREVKKLGKVRHPNLV--- 750
           LG GG   V+    LRD R VA+K L  + L +       F RE +    + HP +V   
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 751 -TLEGYYWTQSLQLLIYEFVSGGSLHKHLH-EGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
            T E       L  ++ E+V G +L   +H EG     ++      VI    ++L   HQ
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQ 134
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL-SSKIQSALGYMAPEFACRT 867
           + IIH ++K +N++I  +   KV D+G+AR +      V  ++ +     Y++PE A R 
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA-RG 193
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPLS 894
             +  + DVY  G ++ EV+TG+ P +
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 14/204 (6%)
Query: 697 ELGRGGFGAVY---RTVLRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVT 751
           +LG GG   VY    T+L     VAIK + +    K +  + FEREV    ++ H N+V+
Sbjct: 18  KLGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           +           L+ E++ G +L +++ E  G   LS +   N        + H H   I
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGP--LSVDTAINFTNQILDGIKHAHDMRI 132
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H +IK  N+LID +   K+ D+G+A+ L        ++ +   + Y +PE A    + T
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGTVQYFSPEQA--KGEAT 189
Query: 872 DKC-DVYGFGVLVLEVVTGKRPLS 894
           D+C D+Y  G+++ E++ G+ P +
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFN 213

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 697 ELGRGGFGAVYRTVLR--DGRPVAIK----KLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           +LG G FG V R       G+ V++     K  V S  ++ +DF REV  +  + H NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
            L G   T  +++ + E    GSL   L +  G   L    R+ V    A+ + +L    
Sbjct: 79  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKR 135
Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPEFACRTVK 869
            IH ++ + N+L+      K+GD+GL R LP   D YV+    +    + APE + +T  
Sbjct: 136 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE-SLKTRT 194
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            +   D + FGV + E+ T G+ P
Sbjct: 195 FSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 697 ELGRGGFGAVYRTVLR--DGRPVAIK----KLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           +LG G FG V R       G+ V++     K  V S  ++ +DF REV  +  + H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
            L G   T  +++ + E    GSL   L +  G   L    R+ V    A+ + +L    
Sbjct: 75  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKR 131
Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML-DRYVLSSKIQSALGYMAPEFACRTVK 869
            IH ++ + N+L+      K+GD+GL R LP   D YV+    +    + APE + +T  
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE-SLKTRT 190
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            +   D + FGV + E+ T G+ P
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 7/197 (3%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           ELG G FG V     R    VAIK +   S+  S+++F  E K +  + H  LV L G  
Sbjct: 22  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             Q    +I E+++ G L  +L E    +     +   + +   +++ +L     +H ++
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 137
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
            + N L++  G  KV D+GL+R + + D Y  S   +  + +  PE    + K + K D+
Sbjct: 138 AARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDI 195
Query: 877 YGFGVLVLEVVT-GKRP 892
           + FGVL+ E+ + GK P
Sbjct: 196 WAFGVLMWEIYSLGKMP 212

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 7/197 (3%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           ELG G FG V     R    VAIK +   S+  S+++F  E K +  + H  LV L G  
Sbjct: 15  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             Q    +I E+++ G L  +L E    +     +   + +   +++ +L     +H ++
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 130
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
            + N L++  G  KV D+GL+R + + D Y  S   +  + +  PE    + K + K D+
Sbjct: 131 AARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDI 188
Query: 877 YGFGVLVLEVVT-GKRP 892
           + FGVL+ E+ + GK P
Sbjct: 189 WAFGVLMWEIYSLGKMP 205

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 7/197 (3%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           ELG G FG V     R    VAIK +   S+  S+++F  E K +  + H  LV L G  
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             Q    +I E+++ G L  +L E    +     +   + +   +++ +L     +H ++
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 131
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
            + N L++  G  KV D+GL+R + + D Y  S   +  + +  PE    + K + K D+
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDI 189
Query: 877 YGFGVLVLEVVT-GKRP 892
           + FGVL+ E+ + GK P
Sbjct: 190 WAFGVLMWEIYSLGKMP 206

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 7/197 (3%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           ELG G FG V     R    VAIK +   S+  S+++F  E K +  + H  LV L G  
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             Q    +I E+++ G L  +L E    +     +   + +   +++ +L     +H ++
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 146
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
            + N L++  G  KV D+GL+R + + D Y  S   +  + +  PE    + K + K D+
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDI 204
Query: 877 YGFGVLVLEVVT-GKRP 892
           + FGVL+ E+ + GK P
Sbjct: 205 WAFGVLMWEIYSLGKMP 221

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 7/197 (3%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           ELG G FG V     R    VAIK +   S+  S+++F  E K +  + H  LV L G  
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             Q    +I E+++ G L  +L E    +     +   + +   +++ +L     +H ++
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 126
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
            + N L++  G  KV D+GL+R + + D Y  S   +  + +  PE    + K + K D+
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDI 184
Query: 877 YGFGVLVLEVVT-GKRP 892
           + FGVL+ E+ + GK P
Sbjct: 185 WAFGVLMWEIYSLGKMP 201

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 26/207 (12%)
Query: 697 ELGRGGFGAVYRT---VLRD--GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG+G FG+V       L+D  G  VA+KKL  S+  +   DFERE++ L  ++H N+V 
Sbjct: 15  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVK 73
Query: 752 LEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN---VIQGTA---KSL 803
            +G  ++   +   LI E++  GSL  +L +          ER +   ++Q T+   K +
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--------KERIDHIKLLQYTSQICKGM 125
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI--QSALGYMAP 861
            +L     IH ++ + N+L++     K+GD+GL ++LP  D+     K   +S + + AP
Sbjct: 126 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAP 184
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT 888
           E    + K +   DV+ FGV++ E+ T
Sbjct: 185 ESLTES-KFSVASDVWSFGVVLYELFT 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 26/207 (12%)
Query: 697 ELGRGGFGAVYRT---VLRD--GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG+G FG+V       L+D  G  VA+KKL  S+  +   DFERE++ L  ++H N+V 
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVK 79
Query: 752 LEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN---VIQGTA---KSL 803
            +G  ++   +   LI E++  GSL  +L +          ER +   ++Q T+   K +
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--------KERIDHIKLLQYTSQICKGM 131
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI--QSALGYMAP 861
            +L     IH ++ + N+L++     K+GD+GL ++LP  D+     K   +S + + AP
Sbjct: 132 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAP 190
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT 888
           E    + K +   DV+ FGV++ E+ T
Sbjct: 191 ESLTES-KFSVASDVWSFGVVLYELFT 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 26/207 (12%)
Query: 697 ELGRGGFGAVYRT---VLRD--GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG+G FG+V       L+D  G  VA+KKL  S+  +   DFERE++ L  ++H N+V 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVK 75
Query: 752 LEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN---VIQGTA---KSL 803
            +G  ++   +   LI E++  GSL  +L +          ER +   ++Q T+   K +
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--------KERIDHIKLLQYTSQICKGM 127
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI--QSALGYMAP 861
            +L     IH ++ + N+L++     K+GD+GL ++LP  D+     K   +S + + AP
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAP 186
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT 888
           E    + K +   DV+ FGV++ E+ T
Sbjct: 187 ESLTES-KFSVASDVWSFGVVLYELFT 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 26/207 (12%)
Query: 697 ELGRGGFGAVYRT---VLRD--GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG+G FG+V       L+D  G  VA+KKL  S+  +   DFERE++ L  ++H N+V 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVK 93
Query: 752 LEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN---VIQGTA---KSL 803
            +G  ++   +   LI E++  GSL  +L +          ER +   ++Q T+   K +
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--------KERIDHIKLLQYTSQICKGM 145
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI--QSALGYMAP 861
            +L     IH ++ + N+L++     K+GD+GL ++LP  D+     K   +S + + AP
Sbjct: 146 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAP 204
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT 888
           E    + K +   DV+ FGV++ E+ T
Sbjct: 205 ESLTES-KFSVASDVWSFGVVLYELFT 230

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 26/207 (12%)
Query: 697 ELGRGGFGAVYRT---VLRD--GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG+G FG+V       L+D  G  VA+KKL  S+  +   DFERE++ L  ++H N+V 
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVK 74
Query: 752 LEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN---VIQGTA---KSL 803
            +G  ++   +   LI E++  GSL  +L +          ER +   ++Q T+   K +
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--------KERIDHIKLLQYTSQICKGM 126
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI--QSALGYMAP 861
            +L     IH ++ + N+L++     K+GD+GL ++LP  D+     K   +S + + AP
Sbjct: 127 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAP 185
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT 888
           E    + K +   DV+ FGV++ E+ T
Sbjct: 186 ESLTES-KFSVASDVWSFGVVLYELFT 211

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 26/207 (12%)
Query: 697 ELGRGGFGAVYRT---VLRD--GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG+G FG+V       L+D  G  VA+KKL  S+  +   DFERE++ L  ++H N+V 
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVK 81
Query: 752 LEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN---VIQGTA---KSL 803
            +G  ++   +   LI E++  GSL  +L +          ER +   ++Q T+   K +
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--------KERIDHIKLLQYTSQICKGM 133
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI--QSALGYMAP 861
            +L     IH ++ + N+L++     K+GD+GL ++LP  D+     K   +S + + AP
Sbjct: 134 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAP 192
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT 888
           E    + K +   DV+ FGV++ E+ T
Sbjct: 193 ESLTES-KFSVASDVWSFGVVLYELFT 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 26/207 (12%)
Query: 697 ELGRGGFGAVYRT---VLRD--GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG+G FG+V       L+D  G  VA+KKL  S+  +   DFERE++ L  ++H N+V 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVK 75
Query: 752 LEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN---VIQGTA---KSL 803
            +G  ++   +   LI E++  GSL  +L +          ER +   ++Q T+   K +
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--------KERIDHIKLLQYTSQICKGM 127
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI--QSALGYMAP 861
            +L     IH ++ + N+L++     K+GD+GL ++LP  D+     K   +S + + AP
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAP 186
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT 888
           E    + K +   DV+ FGV++ E+ T
Sbjct: 187 ESLTES-KFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 26/207 (12%)
Query: 697 ELGRGGFGAVYRT---VLRD--GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG+G FG+V       L+D  G  VA+KKL  S+  +   DFERE++ L  ++H N+V 
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVK 80
Query: 752 LEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN---VIQGTA---KSL 803
            +G  ++   +   LI E++  GSL  +L +          ER +   ++Q T+   K +
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--------KERIDHIKLLQYTSQICKGM 132
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI--QSALGYMAP 861
            +L     IH ++ + N+L++     K+GD+GL ++LP  D+     K   +S + + AP
Sbjct: 133 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAP 191
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT 888
           E    + K +   DV+ FGV++ E+ T
Sbjct: 192 ESLTES-KFSVASDVWSFGVVLYELFT 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 26/207 (12%)
Query: 697 ELGRGGFGAVYRT---VLRD--GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG+G FG+V       L+D  G  VA+KKL  S+  +   DFERE++ L  ++H N+V 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVK 78
Query: 752 LEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN---VIQGTA---KSL 803
            +G  ++   +   LI E++  GSL  +L +          ER +   ++Q T+   K +
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--------KERIDHIKLLQYTSQICKGM 130
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI--QSALGYMAP 861
            +L     IH ++ + N+L++     K+GD+GL ++LP  D+     K   +S + + AP
Sbjct: 131 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAP 189
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT 888
           E    + K +   DV+ FGV++ E+ T
Sbjct: 190 ESLTES-KFSVASDVWSFGVVLYELFT 215

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 4/196 (2%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V   V R     VA+K + +   V   E+ ++E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              ++Q L  E+ SGG L   +    G         F+ +      + +LH   I H +I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHGIGITHRDI 130
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           K  N+L+D     K+ D+GLA +    +R  L +K+   L Y+APE   R     +  DV
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 190
Query: 877 YGFGVLVLEVVTGKRP 892
           +  G+++  ++ G+ P
Sbjct: 191 WSCGIVLTAMLAGELP 206

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 26/207 (12%)
Query: 697 ELGRGGFGAVYRT---VLRD--GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG+G FG+V       L+D  G  VA+KKL  S+  +   DFERE++ L  ++H N+V 
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVK 82
Query: 752 LEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN---VIQGTA---KSL 803
            +G  ++   +   LI E++  GSL  +L +          ER +   ++Q T+   K +
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--------KERIDHIKLLQYTSQICKGM 134
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI--QSALGYMAP 861
            +L     IH ++ + N+L++     K+GD+GL ++LP  D+     K   +S + + AP
Sbjct: 135 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAP 193
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT 888
           E    + K +   DV+ FGV++ E+ T
Sbjct: 194 ESLTES-KFSVASDVWSFGVVLYELFT 219

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 697 ELGRGGFGAVYRTVLR--DGRPVAIK----KLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           +LG G FG V R       G+ V++     K  V S  ++ +DF REV  +  + H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
            L G   T  +++ + E    GSL   L +  G   L    R+ V    A+ + +L    
Sbjct: 75  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKR 131
Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML-DRYVLSSKIQSALGYMAPEFACRTVK 869
            IH ++ + N+L+      K+GD+GL R LP   D YV+    +    + APE + +T  
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE-SLKTRT 190
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            +   D + FGV + E+ T G+ P
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 26/207 (12%)
Query: 697 ELGRGGFGAVYRTV---LRD--GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG+G FG+V       L+D  G  VA+KKL  S+  +   DFERE++ L  ++H N+V 
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVK 106
Query: 752 LEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSL 803
            +G  ++   +   LI E++  GSL  +L +          ER + I+         K +
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--------ERIDHIKLLQYTSQICKGM 158
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI--QSALGYMAP 861
            +L     IH ++ + N+L++     K+GD+GL ++LP  D+     K   +S + + AP
Sbjct: 159 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAP 217
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT 888
           E    + K +   DV+ FGV++ E+ T
Sbjct: 218 ESLTES-KFSVASDVWSFGVVLYELFT 243

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 4/196 (2%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V   V R     VA+K + +   V   E+ ++E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              ++Q L  E+ SGG L   +    G         F+ +      + +LH   I H +I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHGIGITHRDI 130
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           K  N+L+D     K+ D+GLA +    +R  L +K+   L Y+APE   R     +  DV
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDV 190
Query: 877 YGFGVLVLEVVTGKRP 892
           +  G+++  ++ G+ P
Sbjct: 191 WSCGIVLTAMLAGELP 206

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 4/196 (2%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V   V R     VA+K + +   V   E+ ++E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              ++Q L  E+ SGG L   +    G         F+ +      + +LH   I H +I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHGIGITHRDI 130
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           K  N+L+D     K+ D+GLA +    +R  L +K+   L Y+APE   R     +  DV
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDV 190
Query: 877 YGFGVLVLEVVTGKRP 892
           +  G+++  ++ G+ P
Sbjct: 191 WSCGIVLTAMLAGELP 206

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 4/196 (2%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V   V R     VA+K + +   V   E+ ++E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              ++Q L  E+ SGG L   +    G         F+ +      + +LH   I H +I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHGIGITHRDI 130
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           K  N+L+D     K+ D+GLA +    +R  L +K+   L Y+APE   R     +  DV
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDV 190
Query: 877 YGFGVLVLEVVTGKRP 892
           +  G+++  ++ G+ P
Sbjct: 191 WSCGIVLTAMLAGELP 206

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 56/193 (29%), Positives = 99/193 (51%), Gaps = 6/193 (3%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +     +    +   Q  + ++ +L + N IH +
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKNFIHRD 134
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D +   +  +  + + APE      K + K D
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTG-DTFTAHAGAKFPIKWTAPESLAYN-KFSIKSD 192
Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 193 VWAFGVLLWEIAT 205

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           ELG G FG VY+   ++   +A  K+  +   +  ED+  E++ L    HP +V L G Y
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
           +      ++ EF  GG++   + E   G  L+  +   V +   ++L  LH   IIH ++
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSKRIIHRDL 135
Query: 817 KSSNVLIDGSGEPKVGDYGL-ARLLPMLDRYVLSSKIQSALG---YMAPEFA-CRTVKIT 871
           K+ NVL+   G+ ++ D+G+ A+ L  L       K  S +G   +MAPE   C T+K T
Sbjct: 136 KAGNVLMTLEGDIRLADFGVSAKNLKTL------QKRDSFIGTPYWMAPEVVMCETMKDT 189
Query: 872 D---KCDVYGFGVLVLEVVTGKRP 892
               K D++  G+ ++E+   + P
Sbjct: 190 PYDYKADIWSLGITLIEMAQIEPP 213

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           ELG G FG VY+   ++   +A  K+  +   +  ED+  E++ L    HP +V L G Y
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
           +      ++ EF  GG++   + E   G  L+  +   V +   ++L  LH   IIH ++
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSKRIIHRDL 143
Query: 817 KSSNVLIDGSGEPKVGDYGL-ARLLPMLDRYVLSSKIQSALG---YMAPEFA-CRTVKIT 871
           K+ NVL+   G+ ++ D+G+ A+ L  L       K  S +G   +MAPE   C T+K T
Sbjct: 144 KAGNVLMTLEGDIRLADFGVSAKNLKTL------QKRDSFIGTPYWMAPEVVMCETMKDT 197
Query: 872 D---KCDVYGFGVLVLEVVTGKRP 892
               K D++  G+ ++E+   + P
Sbjct: 198 PYDYKADIWSLGITLIEMAQIEPP 221

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 26/207 (12%)
Query: 697 ELGRGGFGAVYRT---VLRD--GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG+G FG+V       L+D  G  VA+KKL  S+  +   DFERE++ L  ++H N+V 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVK 78
Query: 752 LEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN---VIQGTA---KSL 803
            +G  ++   +   LI E++  GSL  +L   +        ER +   ++Q T+   K +
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHA--------ERIDHIKLLQYTSQICKGM 130
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI--QSALGYMAP 861
            +L     IH ++ + N+L++     K+GD+GL ++LP  D+     K   +S + + AP
Sbjct: 131 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAP 189
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT 888
           E    + K +   DV+ FGV++ E+ T
Sbjct: 190 ESLTES-KFSVASDVWSFGVVLYELFT 215

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 697 ELGRGGFGAVYRTVLR--DGRPVAIK----KLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           +LG G FG V R       G+ V++     K  V S  ++ +DF REV  +  + H NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
            L G   T  +++ + E    GSL   L +  G   L    R+ V    A+ + +L    
Sbjct: 79  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKR 135
Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML-DRYVLSSKIQSALGYMAPEFACRTVK 869
            IH ++ + N+L+      K+GD+GL R LP   D YV+    +    + APE + +T  
Sbjct: 136 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE-SLKTRT 194
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            +   D + FGV + E+ T G+ P
Sbjct: 195 FSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 697 ELGRGGFGAVYRTVLR--DGRPVAIK----KLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           +LG G FG V R       G+ V++     K  V S  ++ +DF REV  +  + H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
            L G   T  +++ + E    GSL   L +  G   L    R+ V    A+ + +L    
Sbjct: 85  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKR 141
Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML-DRYVLSSKIQSALGYMAPEFACRTVK 869
            IH ++ + N+L+      K+GD+GL R LP   D YV+    +    + APE + +T  
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE-SLKTRT 200
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            +   D + FGV + E+ T G+ P
Sbjct: 201 FSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 4/196 (2%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V   V R     VA+K + +   V   E+ ++E+     + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              ++Q L  E+ SGG L   +    G         F+ +      + +LH   I H +I
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHGIGITHRDI 131
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           K  N+L+D     K+ D+GLA +    +R  L +K+   L Y+APE   R     +  DV
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 877 YGFGVLVLEVVTGKRP 892
           +  G+++  ++ G+ P
Sbjct: 192 WSCGIVLTAMLAGELP 207

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 14/231 (6%)
Query: 665 SPTTDANSGKLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTV-LRDGRPVAIKKLT 723
           S   D  +  L   S DP+       L  K  ++G+G FG V++ +  R  + VAIK + 
Sbjct: 8   SSGVDLGTENLYFQSMDPE------ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID 61
Query: 724 VSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSG 783
           +       ED ++E+  L +   P +    G Y   +   +I E++ GGS    L  G  
Sbjct: 62  LEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP- 120
Query: 784 GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML 843
              L   +   +++   K L +LH    IH +IK++NVL+   GE K+ D+G+A  L   
Sbjct: 121 ---LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-- 175
Query: 844 DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
           D  +  +       +MAPE   +      K D++  G+  +E+  G+ P S
Sbjct: 176 DTQIKRNTFVGTPFWMAPE-VIKQSAYDSKADIWSLGITAIELARGEPPHS 225

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 26/207 (12%)
Query: 697 ELGRGGFGAVYRTV---LRD--GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG+G FG+V       L+D  G  VA+KKL  S+  +   DFERE++ L  ++H N+V 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVK 93
Query: 752 LEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ------GTAKSL 803
            +G  ++   +   LI E++  GSL  +L +          ER + I+         K +
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--------ERIDHIKLLQYTSQICKGM 145
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI--QSALGYMAP 861
            +L     IH ++ + N+L++     K+GD+GL ++LP  D+     K   +S + + AP
Sbjct: 146 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAP 204
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT 888
           E    + K +   DV+ FGV++ E+ T
Sbjct: 205 ESLTES-KFSVASDVWSFGVVLYELFT 230

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 111/221 (50%), Gaps = 26/221 (11%)
Query: 692 LNKDCELGRGGFGAVYR-TVLRDGRPVAIKKLTV------SSLVKSQEDFEREVKKLGKV 744
           +  + ++G+GGFG V++  +++D   VAIK L +      + +++  ++F+REV  +  +
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 745 RHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLA 804
            HPN+V L G     +   ++ EFV  G L+  L + +  + + W+ +  ++   A  + 
Sbjct: 81  NHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIE 136
Query: 805 HLHQSN--IIHYNIKSSNVLIDGSGE-----PKVGDYGLARLLPMLDRYVLS-SKIQSAL 856
           ++   N  I+H +++S N+ +    E      KV D+G ++      + V S S +    
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ------QSVHSVSGLLGNF 190
Query: 857 GYMAPE-FACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTW 896
            +MAPE         T+K D Y F +++  ++TG+ P   +
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 57/193 (29%), Positives = 98/193 (50%), Gaps = 6/193 (3%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G FG VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 18  KLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +     +    +   Q  + ++ +L + N IH +
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKNFIHRD 134
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D     +  +  + + APE      K + K D
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYN-KFSIKSD 192
Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 193 VWAFGVLLWEIAT 205

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 116/259 (44%), Gaps = 27/259 (10%)
Query: 659 GDDFSRSPTTDANSGKLVMFSGDPDF--STGTHALLNKDC----ELGRGGFGAVYRTVLR 712
           G   S SPT    SG       +P +      H +  +D     ELG G FG V+     
Sbjct: 4   GSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECH 63
Query: 713 DGRP------VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY 766
           +  P      VA+K L  +S   +++DF+RE + L  ++H ++V   G        L+++
Sbjct: 64  NLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVF 122
Query: 767 EFVSGGSLHKHLH-EGSGGNFLSWNER-----------FNVIQGTAKSLAHLHQSNIIHY 814
           E++  G L++ L   G     L+  E              V    A  + +L   + +H 
Sbjct: 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHR 182
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++ + N L+      K+GD+G++R +   D Y +  +    + +M PE +    K T + 
Sbjct: 183 DLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE-SILYRKFTTES 241
Query: 875 DVYGFGVLVLEVVT-GKRP 892
           DV+ FGV++ E+ T GK+P
Sbjct: 242 DVWSFGVVLWEIFTYGKQP 260

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           ELG G FG V     R    VAIK +   S+  S+++F  E K +  + H  LV L G  
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             Q    +I E+++ G L  +L E    +     +   + +   +++ +L     +H ++
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 146
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG------YMAPEFACRTVKI 870
            + N L++  G  KV D+GL+R       YVL  +  S++G      +  PE    + K 
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSR-------YVLDDEETSSVGSKFPVRWSPPEVLMYS-KF 198
Query: 871 TDKCDVYGFGVLVLEVVT-GKRP 892
           + K D++ FGVL+ E+ + GK P
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMP 221

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 111/221 (50%), Gaps = 26/221 (11%)
Query: 692 LNKDCELGRGGFGAVYR-TVLRDGRPVAIKKLTV------SSLVKSQEDFEREVKKLGKV 744
           +  + ++G+GGFG V++  +++D   VAIK L +      + +++  ++F+REV  +  +
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 745 RHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLA 804
            HPN+V L G     +   ++ EFV  G L+  L + +  + + W+ +  ++   A  + 
Sbjct: 81  NHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIE 136
Query: 805 HLHQSN--IIHYNIKSSNVLIDGSGE-----PKVGDYGLARLLPMLDRYVLS-SKIQSAL 856
           ++   N  I+H +++S N+ +    E      KV D+ L++      + V S S +    
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ------QSVHSVSGLLGNF 190
Query: 857 GYMAPE-FACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTW 896
            +MAPE         T+K D Y F +++  ++TG+ P   +
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 92/196 (46%), Gaps = 9/196 (4%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEGY 755
           +G G +G V +   +D GR VAIKK   S   K  +    RE+K L ++RH NLV L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNF-LSWNERFNVIQGTAKSLAHLHQSNIIHY 814
              +    L++EFV    L       +G ++ +     F +I G    +   H  NIIH 
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIING----IGFCHSHNIIHR 148
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +IK  N+L+  SG  K+ D+G AR L      V   ++ +   Y APE     VK     
Sbjct: 149 DIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYDDEVATRW-YRAPELLVGDVKYGKAV 206
Query: 875 DVYGFGVLVLEVVTGK 890
           DV+  G LV E+  G+
Sbjct: 207 DVWAIGCLVTEMFMGE 222

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 4/196 (2%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V   V R     VA+K + +   V   E+ ++E+     + H N+V   G+ 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              ++Q L  E+ SGG L   +    G         F+ +      + +LH   I H +I
Sbjct: 73  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHGIGITHRDI 129
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           K  N+L+D     K+ D+GLA +    +R  L +K+   L Y+APE   R     +  DV
Sbjct: 130 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 189
Query: 877 YGFGVLVLEVVTGKRP 892
           +  G+++  ++ G+ P
Sbjct: 190 WSCGIVLTAMLAGELP 205

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 4/196 (2%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V   V R     VA+K + +   V   E+ ++E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              ++Q L  E+ SGG L   +    G         F+ +      + +LH   I H +I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHGIGITHRDI 130
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           K  N+L+D     K+ D+GLA +    +R  L +K+   L Y+APE   R     +  DV
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 190
Query: 877 YGFGVLVLEVVTGKRP 892
           +  G+++  ++ G+ P
Sbjct: 191 WSCGIVLTAMLAGELP 206

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 4/196 (2%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V   V R     VA+K + +   V   E+ ++E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              ++Q L  E+ SGG L   +    G         F+ +      + +LH   I H +I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHGIGITHRDI 130
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           K  N+L+D     K+ D+GLA +    +R  L +K+   L Y+APE   R     +  DV
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 190
Query: 877 YGFGVLVLEVVTGKRP 892
           +  G+++  ++ G+ P
Sbjct: 191 WSCGIVLTAMLAGELP 206

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 4/196 (2%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V   V R     VA+K + +   V   E+ ++E+     + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              ++Q L  E+ SGG L   +    G         F+ +      + +LH   I H +I
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHGIGITHRDI 131
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           K  N+L+D     K+ D+GLA +    +R  L +K+   L Y+APE   R     +  DV
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 877 YGFGVLVLEVVTGKRP 892
           +  G+++  ++ G+ P
Sbjct: 192 WSCGIVLTAMLAGELP 207

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 4/196 (2%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V   V R     VA+K + +   V   E+ ++E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              ++Q L  E+ SGG L   +    G         F+ +      + +LH   I H +I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHGIGITHRDI 130
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           K  N+L+D     K+ D+GLA +    +R  L +K+   L Y+APE   R     +  DV
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 190
Query: 877 YGFGVLVLEVVTGKRP 892
           +  G+++  ++ G+ P
Sbjct: 191 WSCGIVLTAMLAGELP 206

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 4/196 (2%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V   V R     VA+K + +   V   E+ ++E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              ++Q L  E+ SGG L   +    G         F+ +      + +LH   I H +I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHGIGITHRDI 130
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           K  N+L+D     K+ D+GLA +    +R  L +K+   L Y+APE   R     +  DV
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 190
Query: 877 YGFGVLVLEVVTGKRP 892
           +  G+++  ++ G+ P
Sbjct: 191 WSCGIVLTAMLAGELP 206

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 4/196 (2%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V   V R     VA+K + +   V   E+ ++E+     + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              ++Q L  E+ SGG L   +    G         F+ +      + +LH   I H +I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHGIGITHRDI 130
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           K  N+L+D     K+ D+GLA +    +R  L +K+   L Y+APE   R     +  DV
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 190
Query: 877 YGFGVLVLEVVTGKRP 892
           +  G+++  ++ G+ P
Sbjct: 191 WSCGIVLTAMLAGELP 206

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 4/196 (2%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V   V R     VA+K + +   V   E+ ++E+     + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              ++Q L  E+ SGG L   +    G         F+ +      + +LH   I H +I
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHGIGITHRDI 131
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           K  N+L+D     K+ D+GLA +    +R  L +K+   L Y+APE   R     +  DV
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 877 YGFGVLVLEVVTGKRP 892
           +  G+++  ++ G+ P
Sbjct: 192 WSCGIVLTAMLAGELP 207

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +  VY+ + +  G  VA+K++ + S   +     RE+  + +++H N+V L   
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGN-----------FLSWNERFNVIQGTAKSLA 804
             T++   L++EF+    L K++   + GN           +  W     ++QG    LA
Sbjct: 72  IHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQ----LLQG----LA 122
Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
             H++ I+H ++K  N+LI+  G+ K+GD+GLAR    +     SS++ + L Y AP+  
Sbjct: 123 FCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTFSSEVVT-LWYRAPDVL 180
Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGK 890
             +   +   D++  G ++ E++TGK
Sbjct: 181 MGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 691 LLNKDCELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNL 749
           L  K  ++G+G FG V++ +  R  + VAIK + +       ED ++E+  L +   P +
Sbjct: 8   LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
               G Y   +   +I E++ GGS    L  G     L   +   +++   K L +LH  
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSE 123
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
             IH +IK++NVL+   GE K+ D+G+A  L   D  +  +       +MAPE   +   
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPE-VIKQSA 180
Query: 870 ITDKCDVYGFGVLVLEVVTGKRPLS 894
              K D++  G+  +E+  G+ P S
Sbjct: 181 YDSKADIWSLGITAIELARGEPPHS 205

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 691 LLNKDCELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNL 749
           L  K  ++G+G FG V++ +  R  + VAIK + +       ED ++E+  L +   P +
Sbjct: 8   LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
               G Y   +   +I E++ GGS    L  G     L   +   +++   K L +LH  
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSE 123
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
             IH +IK++NVL+   GE K+ D+G+A  L   D  +  +       +MAPE   +   
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPE-VIKQSA 180
Query: 870 ITDKCDVYGFGVLVLEVVTGKRPLS 894
              K D++  G+  +E+  G+ P S
Sbjct: 181 YDSKADIWSLGITAIELARGEPPHS 205

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 4/196 (2%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V   V R     VA+K + +   V   E+ ++E+     + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              ++Q L  E+ SGG L   +    G         F+ +      + +LH   I H +I
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHGIGITHRDI 131
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           K  N+L+D     K+ D+GLA +    +R  L +K+   L Y+APE   R     +  DV
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 877 YGFGVLVLEVVTGKRP 892
           +  G+++  ++ G+ P
Sbjct: 192 WSCGIVLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 4/196 (2%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V   V R     VA+K + +   V   E+ ++E+     + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              ++Q L  E+ SGG L   +    G         F+ +      + +LH   I H +I
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHGIGITHRDI 131
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           K  N+L+D     K+ D+GLA +    +R  L +K+   L Y+APE   R     +  DV
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 877 YGFGVLVLEVVTGKRP 892
           +  G+++  ++ G+ P
Sbjct: 192 WSCGIVLTAMLAGELP 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 4/196 (2%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V   V R     VA+K + +   V   E+ ++E+     + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              ++Q L  E+ SGG L   +    G         F+ +      + +LH   I H +I
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHGIGITHRDI 131
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           K  N+L+D     K+ D+GLA +    +R  L +K+   L Y+APE   R     +  DV
Sbjct: 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191
Query: 877 YGFGVLVLEVVTGKRP 892
           +  G+++  ++ G+ P
Sbjct: 192 WSCGIVLTAMLAGELP 207

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDF---EREVKKLGKVRHPNLVTL 752
           ELG+G F  V R V +  G   A K +    L  S  DF   ERE +   K++HPN+V L
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRL 93
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
                 +S   L+++ V+GG L + +       F S  +  + IQ   +S+A+ H + I+
Sbjct: 94  HDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESIAYCHSNGIV 150
Query: 813 HYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           H N+K  N+L+    +    K+ D+GLA  + + D            GY++PE   +   
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG-FAGTPGYLSPE-VLKKDP 206
Query: 870 ITDKCDVYGFGVLVLEVVTGKRPL 893
            +   D++  GV++  ++ G  P 
Sbjct: 207 YSKPVDIWACGVILYILLVGYPPF 230

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 9/212 (4%)
Query: 691 LLNKDCELGRGGFGAVYRTVLRDGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHP 747
           LL  D ELG G FG+V + V R  +    VAIK L   +     E+  RE + + ++ +P
Sbjct: 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 396
Query: 748 NLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH 807
            +V L G    ++L +L+ E   GG LHK L        +  +    ++   +  + +L 
Sbjct: 397 YIVRLIGVCQAEAL-MLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLE 453
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS-SKIQSALGYMAPEFACR 866
           + N +H N+ + NVL+      K+ D+GL++ L   D Y  + S  +  L + APE    
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CIN 512
Query: 867 TVKITDKCDVYGFGVLVLEVVT-GKRPLSTWK 897
             K + + DV+ +GV + E ++ G++P    K
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 117/236 (49%), Gaps = 15/236 (6%)
Query: 696 CE-LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKS----QEDFEREVKKLGKVRHPNL 749
           CE +G+G F  V R + R+ G+  A+K + V+    S     ED +RE      ++HP++
Sbjct: 29  CEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAKSLAHLH 807
           V L   Y +  +  +++EF+ G  L   + + +   F+ ++E    + ++   ++L + H
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFV-YSEAVASHYMRQILEALRYCH 147
Query: 808 QSNIIHYNIKSSNVLI---DGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
            +NIIH ++K  NVL+   + S   K+GD+G+A  + + +  +++        +MAPE  
Sbjct: 148 DNNIIHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVS 920
            R        DV+G GV++  +++G  P    K   +  +   +      +W ++S
Sbjct: 206 KRE-PYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHIS 260

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 691 LLNKDCELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNL 749
           L  K  ++G+G FG V++ +  R  + VAIK + +       ED ++E+  L +   P +
Sbjct: 23  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
               G Y   +   +I E++ GGS    L  G     L   +   +++   K L +LH  
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSE 138
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
             IH +IK++NVL+   GE K+ D+G+A  L   D  +  +       +MAPE   +   
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPE-VIKQSA 195
Query: 870 ITDKCDVYGFGVLVLEVVTGKRPLS 894
              K D++  G+  +E+  G+ P S
Sbjct: 196 YDSKADIWSLGITAIELARGEPPHS 220

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 12/203 (5%)
Query: 698 LGRGGFGAVYRT-VLRDGRPVAIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G F  VYR   +  G  VAIK +   ++ K+   +  + EVK   +++HP+++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   L+ E    G ++++L         S NE  + +      + +LH   I+H 
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKP--FSENEARHFMHQIITGMLYLHSHGILHR 136
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLL--PMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           ++  SN+L+  +   K+ D+GLA  L  P    Y L         Y++PE A R+    +
Sbjct: 137 DLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC----GTPNYISPEIATRSAHGLE 192
Query: 873 KCDVYGFGVLVLEVVTGKRPLST 895
             DV+  G +   ++ G+ P  T
Sbjct: 193 S-DVWSLGCMFYTLLIGRPPFDT 214

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 56/193 (29%), Positives = 98/193 (50%), Gaps = 6/193 (3%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +     +    +   Q  + ++ +L + N IH +
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEKKNFIHRD 134
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D     +  +  + + APE      K + K D
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYN-KFSIKSD 192
Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 193 VWAFGVLLWEIAT 205

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 57/194 (29%), Positives = 99/194 (51%), Gaps = 8/194 (4%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 39  KLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    ++ E++  G+L  +L E +     +    +   Q  + ++ +L + N IH +
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQ-ISSAMEYLEKKNFIHRD 155
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE-FACRTVKITDKC 874
           + + N L+  +   KV D+GL+RL+   D Y   +  +  + + APE  A  T  I  K 
Sbjct: 156 LAARNCLVGENHVVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNTFSI--KS 212
Query: 875 DVYGFGVLVLEVVT 888
           DV+ FGVL+ E+ T
Sbjct: 213 DVWAFGVLLWEIAT 226

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 56/193 (29%), Positives = 98/193 (50%), Gaps = 6/193 (3%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +     +    +   Q  + ++ +L + N IH +
Sbjct: 79  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ-ISSAMEYLEKKNFIHRD 137
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D     +  +  + + APE      K + K D
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYN-KFSIKSD 195
Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 196 VWAFGVLLWEIAT 208

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 9/212 (4%)
Query: 691 LLNKDCELGRGGFGAVYRTVLRDGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHP 747
           LL  D ELG G FG+V + V R  +    VAIK L   +     E+  RE + + ++ +P
Sbjct: 11  LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 70
Query: 748 NLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH 807
            +V L G    ++L +L+ E   GG LHK L        +  +    ++   +  + +L 
Sbjct: 71  YIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLE 127
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS-SKIQSALGYMAPEFACR 866
           + N +H ++ + NVL+      K+ D+GL++ L   D Y  + S  +  L + APE    
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CIN 186
Query: 867 TVKITDKCDVYGFGVLVLEVVT-GKRPLSTWK 897
             K + + DV+ +GV + E ++ G++P    K
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 21/215 (9%)
Query: 697 ELGRGGFGAVYRTVLRDGRP------VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG G FG V+     +  P      VA+K L  +S   +++DF+RE + L  ++H ++V
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIV 83
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLH-EGSGGNFLSWNER-----------FNVIQG 798
              G        L+++E++  G L++ L   G     L+  E              V   
Sbjct: 84  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 143
Query: 799 TAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGY 858
            A  + +L   + +H ++ + N L+      K+GD+G++R +   D Y +  +    + +
Sbjct: 144 VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 203
Query: 859 MAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           M PE +    K T + DV+ FGV++ E+ T GK+P
Sbjct: 204 MPPE-SILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 21/215 (9%)
Query: 697 ELGRGGFGAVYRTVLRDGRP------VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG G FG V+     +  P      VA+K L  +S   +++DF+RE + L  ++H ++V
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIV 77
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLH-EGSGGNFLSWNER-----------FNVIQG 798
              G        L+++E++  G L++ L   G     L+  E              V   
Sbjct: 78  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 137
Query: 799 TAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGY 858
            A  + +L   + +H ++ + N L+      K+GD+G++R +   D Y +  +    + +
Sbjct: 138 VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 197
Query: 859 MAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           M PE +    K T + DV+ FGV++ E+ T GK+P
Sbjct: 198 MPPE-SILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 56/193 (29%), Positives = 98/193 (50%), Gaps = 6/193 (3%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +     +    +   Q  + ++ +L + N IH +
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ-ISSAMEYLEKKNFIHRD 141
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D     +  +  + + APE      K + K D
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYN-KFSIKSD 199
Query: 876 VYGFGVLVLEVVT 888
           V+ FGVL+ E+ T
Sbjct: 200 VWAFGVLLWEIAT 212

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 58/194 (29%), Positives = 96/194 (49%), Gaps = 6/194 (3%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           LG G  G V+         VA+K L   S+  S + F  E   + +++H  LV L     
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIK 817
           TQ    +I E++  GSL   L   SG   L+ N+  ++    A+ +A + + N IH +++
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136
Query: 818 SSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVY 877
           ++N+L+  +   K+ D+GLARL+   +        +  + + APE A      T K DV+
Sbjct: 137 AANILVSDTLSCKIADFGLARLIEDAEXTAREGA-KFPIKWTAPE-AINYGTFTIKSDVW 194
Query: 878 GFGVLVLEVVTGKR 891
            FG+L+ E+VT  R
Sbjct: 195 SFGILLTEIVTHGR 208

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 697 ELGRGGFGAVYRTVLRDG---RPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           ++G G FG     ++RD      VA+K +   + +   E+ +RE+     +RHPN+V  +
Sbjct: 27  DIGSGNFGVA--RLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFK 82
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
               T +   +I E+ SGG L++ +   + G F     RF   Q     +++ H   I H
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERI--CNAGRFSEDEARF-FFQQLLSGVSYCHSMQICH 139
Query: 814 YNIKSSNVLIDGSGEP--KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTV 868
            ++K  N L+DGS  P  K+ D+G ++        VL S+ +S +G   Y+APE   R  
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLRQE 193
Query: 869 KITDKCDVYGFGVLVLEVVTGKRPLS 894
                 DV+  GV +  ++ G  P  
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGAYPFE 219

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDF---EREVKKLGKVRHPNLVTL 752
           ELG+G F  V R V +  G   A K +    L  S  DF   ERE +   K++HPN+V L
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRL 70
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
                 +S   L+++ V+GG L + +       F S  +  + IQ   +S+A+ H + I+
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESIAYCHSNGIV 127
Query: 813 HYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           H N+K  N+L+    +    K+ D+GLA  + + D            GY++PE   +   
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG-FAGTPGYLSPE-VLKKDP 183
Query: 870 ITDKCDVYGFGVLVLEVVTGKRPL 893
            +   D++  GV++  ++ G  P 
Sbjct: 184 YSKPVDIWACGVILYILLVGYPPF 207

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDF---EREVKKLGKVRHPNLVTL 752
           ELG+G F  V R V +  G   A K +    L  S  DF   ERE +   K++HPN+V L
Sbjct: 12  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRL 69
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
                 +S   L+++ V+GG L + +       F S  +  + IQ   +S+A+ H + I+
Sbjct: 70  HDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESIAYCHSNGIV 126
Query: 813 HYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           H N+K  N+L+    +    K+ D+GLA  + + D            GY++PE   +   
Sbjct: 127 HRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG-FAGTPGYLSPE-VLKKDP 182
Query: 870 ITDKCDVYGFGVLVLEVVTGKRPL 893
            +   D++  GV++  ++ G  P 
Sbjct: 183 YSKPVDIWACGVILYILLVGYPPF 206

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDF---EREVKKLGKVRHPNLVTL 752
           ELG+G F  V R V +  G   A K +    L  S  DF   ERE +   K++HPN+V L
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRL 70
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
                 +S   L+++ V+GG L + +       F S  +  + IQ   +S+A+ H + I+
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQILESIAYCHSNGIV 127
Query: 813 HYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           H N+K  N+L+    +    K+ D+GLA  + + D            GY++PE   +   
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG-FAGTPGYLSPE-VLKKDP 183
Query: 870 ITDKCDVYGFGVLVLEVVTGKRPL 893
            +   D++  GV++  ++ G  P 
Sbjct: 184 YSKPVDIWACGVILYILLVGYPPF 207

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 697 ELGRGGFGAVYRTVLR--DGRPVAIK----KLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           +LG G FG V R       G+ V++     K  V S  ++ +DF REV  +  + H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
            L G   T  +++ + E    GSL   L +  G   L    R+ V    A+ + +L    
Sbjct: 75  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKR 131
Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY-VLSSKIQSALGYMAPEFACRTVK 869
            IH ++ + N+L+      K+GD+GL R LP  D + V+    +    + APE + +T  
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE-SLKTRT 190
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            +   D + FGV + E+ T G+ P
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 697 ELGRGGFGAVYRTVLR--DGRPVAIK----KLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           +LG G FG V R       G+ V++     K  V S  ++ +DF REV  +  + H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
            L G   T  +++ + E    GSL   L +  G   L    R+ V    A+ + +L    
Sbjct: 85  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKR 141
Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY-VLSSKIQSALGYMAPEFACRTVK 869
            IH ++ + N+L+      K+GD+GL R LP  D + V+    +    + APE + +T  
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE-SLKTRT 200
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            +   D + FGV + E+ T G+ P
Sbjct: 201 FSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-------AIKKLTVSSLVKSQEDFEREVKKLGKVRH-PNL 749
           LG G +G V+      G           +KK T+    K+ E    E + L  +R  P L
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN------VIQGTAKSL 803
           VTL   + T++   LI ++++GG L  HL         S  ERF        +     +L
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHL---------SQRERFTEHEVQIYVGEIVLAL 172
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
            HLH+  II+ +IK  N+L+D +G   + D+GL++   + D    +      + YMAP+ 
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCGTIEYMAPDI 231
Query: 864 ACRTVKITDKC-DVYGFGVLVLEVVTGKRPLST 895
                   DK  D +  GVL+ E++TG  P + 
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 90/196 (45%), Gaps = 4/196 (2%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G  G V   V R     VA+K + +   V   E+ ++E+     + H N+V   G+ 
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              ++Q L  E+ SGG L   +    G         F+ +      + +LH   I H +I
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHGIGITHRDI 130
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           K  N+L+D     K+ D+GLA +    +R  L +K+   L Y+APE   R     +  DV
Sbjct: 131 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 190
Query: 877 YGFGVLVLEVVTGKRP 892
           +  G+++  ++ G+ P
Sbjct: 191 WSCGIVLTAMLAGELP 206

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQE---DFEREVKKLGKVRHPNLV--- 750
           LG GG   V+    LR  R VA+K L  + L +       F RE +    + HP +V   
Sbjct: 37  LGFGGMSEVHLARDLRLHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVAVY 95
Query: 751 -TLEGYYWTQSLQLLIYEFVSGGSLHKHLH-EGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
            T E       L  ++ E+V G +L   +H EG     ++      VI    ++L   HQ
Sbjct: 96  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQ 151
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL-SSKIQSALGYMAPEFACRT 867
           + IIH ++K +N++I  +   KV D+G+AR +      V  ++ +     Y++PE A R 
Sbjct: 152 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA-RG 210
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPLS 894
             +  + DVY  G ++ EV+TG+ P +
Sbjct: 211 DSVDARSDVYSLGCVLYEVLTGEPPFT 237

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 697 ELGRGGFGAV---YRTVLRD--GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG+G FG+V       L D  G  VA+K+L  S     Q DF+RE++ L  +    +V 
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVK 76
Query: 752 LEGYYW---TQSLQLLIYEFVSGGSL----HKHLHEGSGGNFLSWNERFNVIQGTAKSLA 804
             G  +    QSL+L++ E++  G L     +H         L ++ +        K + 
Sbjct: 77  YRGVSYGPGRQSLRLVM-EYLPSGCLRDFLQRHRARLDASRLLLYSSQI------CKGME 129
Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPEF 863
           +L     +H ++ + N+L++     K+ D+GLA+LLP+  D YV+    QS + + APE 
Sbjct: 130 YLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 189
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVT 888
               +  + + DV+ FGV++ E+ T
Sbjct: 190 LSDNI-FSRQSDVWSFGVVLYELFT 213

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 697 ELGRGGFGAV---YRTVLRD--GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG+G FG+V       L D  G  VA+K+L  S     Q DF+RE++ L  +    +V 
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVK 75
Query: 752 LEGYYW---TQSLQLLIYEFVSGGSL----HKHLHEGSGGNFLSWNERFNVIQGTAKSLA 804
             G  +    QSL+L++ E++  G L     +H         L ++ +        K + 
Sbjct: 76  YRGVSYGPGRQSLRLVM-EYLPSGCLRDFLQRHRARLDASRLLLYSSQI------CKGME 128
Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPEF 863
           +L     +H ++ + N+L++     K+ D+GLA+LLP+  D YV+    QS + + APE 
Sbjct: 129 YLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 188
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVT 888
               +  + + DV+ FGV++ E+ T
Sbjct: 189 LSDNI-FSRQSDVWSFGVVLYELFT 212

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQE---DFEREVKKLGKVRHPNLV--- 750
           LG GG   V+    LR  R VA+K L  + L +       F RE +    + HP +V   
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 751 -TLEGYYWTQSLQLLIYEFVSGGSLHKHLH-EGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
            T E       L  ++ E+V G +L   +H EG     ++      VI    ++L   HQ
Sbjct: 79  ATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQ 134
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL-SSKIQSALGYMAPEFACRT 867
           + IIH ++K +N++I  +   KV D+G+AR +      V  ++ +     Y++PE A R 
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA-RG 193
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPLS 894
             +  + DVY  G ++ EV+TG+ P +
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQE---DFEREVKKLGKVRHPNLV--- 750
           LG GG   V+    LR  R VA+K L  + L +       F RE +    + HP +V   
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 751 -TLEGYYWTQSLQLLIYEFVSGGSLHKHLH-EGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
            T E       L  ++ E+V G +L   +H EG     ++      VI    ++L   HQ
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQ 134
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL-SSKIQSALGYMAPEFACRT 867
           + IIH ++K +N++I  +   KV D+G+AR +      V  ++ +     Y++PE A R 
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA-RG 193
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPLS 894
             +  + DVY  G ++ EV+TG+ P +
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 697 ELGRGGFGAV---YRTVLRD--GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG+G FG+V       L D  G  VA+K+L  S     Q DF+RE++ L  +    +V 
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVK 88
Query: 752 LEGYYW---TQSLQLLIYEFVSGGSL----HKHLHEGSGGNFLSWNERFNVIQGTAKSLA 804
             G  +    QSL+L++ E++  G L     +H         L ++ +        K + 
Sbjct: 89  YRGVSYGPGRQSLRLVM-EYLPSGCLRDFLQRHRARLDASRLLLYSSQI------CKGME 141
Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPEF 863
           +L     +H ++ + N+L++     K+ D+GLA+LLP+  D YV+    QS + + APE 
Sbjct: 142 YLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVT 888
               +  + + DV+ FGV++ E+ T
Sbjct: 202 LSDNI-FSRQSDVWSFGVVLYELFT 225

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVA---IKKLTVSSLVK--SQEDFEREVKKLGKVRHPNLV 750
           ELG G F  V +   +  G+  A   IKK  +SS  +  S+E+ EREV  L ++RHPN++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           TL   +  ++  +LI E VSGG L   L E      L+ +E    ++     + +LH   
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGVHYLHSKR 128
Query: 811 IIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           I H+++K  N+++     P    K+ D+G+A  +   + +     I     ++APE    
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIV-N 184
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPL 893
              +  + D++  GV+   +++G  P 
Sbjct: 185 YEPLGLEADMWSIGVITYILLSGASPF 211

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 698 LGRGGFGAVY--RTVLRDGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEG 754
           +G+G F  V   R VL  GR VA+K +  + L   S +   REV+ +  + HPN+V L  
Sbjct: 23  IGKGNFAKVKLARHVL-TGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
              T+    L+ E+ SGG +  +L   + G       R    Q    ++ + HQ  I+H 
Sbjct: 82  VIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFRQ-IVSAVQYCHQKYIVHR 138
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKIT 871
           ++K+ N+L+DG    K+ D+G +      + + + +K+ +  G   Y APE         
Sbjct: 139 DLKAENLLLDGDMNIKIADFGFS------NEFTVGNKLDTFCGSPPYAAPELFQGKKYDG 192
Query: 872 DKCDVYGFGVLVLEVVTGKRPLS 894
            + DV+  GV++  +V+G  P  
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVA---IKKLTVSSLVK--SQEDFEREVKKLGKVRHPNLV 750
           ELG G F  V +   +  G+  A   IKK  +SS  +  S+E+ EREV  L ++RHPN++
Sbjct: 19  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           TL   +  ++  +LI E VSGG L   L E      L+ +E    ++     + +LH   
Sbjct: 79  TLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGVHYLHSKR 135
Query: 811 IIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           I H+++K  N+++     P    K+ D+G+A  +   + +     I     ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIV-N 191
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPL 893
              +  + D++  GV+   +++G  P 
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 15/222 (6%)
Query: 676 VMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTVLR-----DGRPVAIKKLTVSSLVKS 730
           V+F G  D +      L K  +LG G FG V            G  VA+K L   +  + 
Sbjct: 17  VLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH 76
Query: 731 QEDFEREVKKLGKVRHPNLVTLEGYYW---TQSLQLLIYEFVSGGSLHKHLHEGSGGNFL 787
           +  +++E+  L  + H +++  +G        SLQL++ E+V  GSL  +L   S G   
Sbjct: 77  RSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVM-EYVPLGSLRDYLPRHSIG--- 132
Query: 788 SWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRY 846
              +     Q   + +A+LH  + IH ++ + NVL+D     K+GD+GLA+ +P   + Y
Sbjct: 133 -LAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXY 191
Query: 847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
            +     S + + APE   +  K     DV+ FGV + E++T
Sbjct: 192 RVREDGDSPVFWYAPE-CLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           ELG G FG V+R V +    V + K   +     +   + E+  + ++ HP L+ L   +
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             +   +LI EF+SGG L   +   +    +S  E  N ++   + L H+H+ +I+H +I
Sbjct: 118 EDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDI 175
Query: 817 KSSNVLID--GSGEPKVGDYGLA-RLLPMLDRYVLSSKIQSALG-YMAPEFACRTVKITD 872
           K  N++ +   +   K+ D+GLA +L P  D  V   K+ +A   + APE   R   +  
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNP--DEIV---KVTTATAEFAAPEIVDRE-PVGF 229
Query: 873 KCDVYGFGVLVLEVVTGKRPLS 894
             D++  GVL   +++G  P +
Sbjct: 230 YTDMWAIGVLGYVLLSGLSPFA 251

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 697 ELGRGGFGAVYRTVLRDGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           ++G G FG     ++RD +    VA+K +      K  E+ +RE+     +RHPN+V  +
Sbjct: 26  DIGAGNFGVA--RLMRDKQANELVAVKYIERGE--KIDENVKREIINHRSLRHPNIVRFK 81
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
               T +   ++ E+ SGG L + +   + G F     RF   Q     +++ H   + H
Sbjct: 82  EVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARF-FFQQLISGVSYAHAMQVAH 138
Query: 814 YNIKSSNVLIDGSGEP--KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTV 868
            ++K  N L+DGS  P  K+ D+G ++        VL S+ +SA+G   Y+APE   +  
Sbjct: 139 RDLKLENTLLDGSPAPRLKIADFGYSKA------SVLHSQPKSAVGTPAYIAPEVLLKKE 192
Query: 869 KITDKCDVYGFGVLVLEVVTGKRPLS 894
                 DV+  GV +  ++ G  P  
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           L  + +LG G FG V+         VA+K +   S+  S E F  E   +  ++H  LV 
Sbjct: 184 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVK 241
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L     T+    +I EF++ GSL   L    G       +  +     A+ +A + Q N 
Sbjct: 242 LHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIEQRNY 299
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           IH +++++N+L+  S   K+ D+GLAR+             +  + + APE A      T
Sbjct: 300 IHRDLRAANILVSASLVCKIADFGLARV-----------GAKFPIKWTAPE-AINFGSFT 347
Query: 872 DKCDVYGFGVLVLEVVTGKR 891
            K DV+ FG+L++E+VT  R
Sbjct: 348 IKSDVWSFGILLMEIVTYGR 367

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 66/228 (28%), Positives = 111/228 (48%), Gaps = 25/228 (10%)
Query: 679 SGDPDFSTGTHALLNKDCELGR----GGFGAVYRTVLRDGRP---VAIKKLTVSSLVKS- 730
           SG PD  T  H  ++ D E+GR    G FG VY  + R+ +    VA+K L  S + K  
Sbjct: 10  SGTPDILT-RHFTID-DFEIGRPLGKGKFGNVY--LAREKKSHFIVALKVLFKSQIEKEG 65
Query: 731 -QEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW 789
            +    RE++    + HPN++ L  Y++ +    LI E+   G L+K L +       ++
Sbjct: 66  VEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSC-----TF 120
Query: 790 NER--FNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV 847
           +E+    +++  A +L + H   +IH +IK  N+L+   GE K+ D+G +   P L R  
Sbjct: 121 DEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKT 180
Query: 848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLST 895
           +       L Y+ PE     +   +K D++  GVL  E++ G  P  +
Sbjct: 181 MC----GTLDYLPPEMIEGRMH-NEKVDLWCIGVLCYELLVGNPPFES 223

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 680 GDPDFSTGTHALLNKDCELGRGGFGAVY--RTVLRDGRPVAIKKLTVSSL-VKSQEDFER 736
            D     G + LL     +G+G F  V   R +L  GR VAIK +  + L   S +   R
Sbjct: 8   ADEQPHIGNYRLLKT---IGKGNFAKVKLARHIL-TGREVAIKIIDKTQLNPTSLQKLFR 63
Query: 737 EVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVI 796
           EV+ +  + HPN+V L     T+    LI E+ SGG +  +L        +   E  +  
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL---VAHGRMKEKEARSKF 120
Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL 856
           +    ++ + HQ  I+H ++K+ N+L+D     K+ D+G +      + + +  K+ +  
Sbjct: 121 RQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS------NEFTVGGKLDAFC 174
Query: 857 G---YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
           G   Y APE          + DV+  GV++  +V+G  P  
Sbjct: 175 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 110/228 (48%), Gaps = 22/228 (9%)
Query: 682 PDFSTGTHALLNKDCE--LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE--- 735
           PD++         D +  +GRG    V R V R  G   A+K + V++   S E  E   
Sbjct: 84  PDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVR 143
Query: 736 ----REVKKLGKVR-HPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWN 790
               RE   L +V  HP+++TL   Y + S   L+++ +  G L  +L E      LS  
Sbjct: 144 EATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA---LSEK 200
Query: 791 ERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS 850
           E  ++++   ++++ LH +NI+H ++K  N+L+D + + ++ D+G +  L   ++     
Sbjct: 201 ETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL---R 257
Query: 851 KIQSALGYMAPEFACRTVKIT-----DKCDVYGFGVLVLEVVTGKRPL 893
           ++    GY+APE    ++  T      + D++  GV++  ++ G  P 
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 46/192 (23%), Positives = 93/192 (48%), Gaps = 10/192 (5%)
Query: 717 VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGS--- 773
           VAIK++ +     S ++  +E++ + +  HPN+V+    +  +    L+ + +SGGS   
Sbjct: 38  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 97
Query: 774 LHKHL---HEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPK 830
           + KH+    E   G  L  +    +++   + L +LH++  IH ++K+ N+L+   G  +
Sbjct: 98  IIKHIVAKGEHKSG-VLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQ 156
Query: 831 VGDYGLARLLPM---LDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVV 887
           + D+G++  L     + R  +         +MAPE   +      K D++ FG+  +E+ 
Sbjct: 157 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 216
Query: 888 TGKRPLSTWKMM 899
           TG  P   +  M
Sbjct: 217 TGAAPYHKYPPM 228

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 46/192 (23%), Positives = 93/192 (48%), Gaps = 10/192 (5%)
Query: 717 VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGS--- 773
           VAIK++ +     S ++  +E++ + +  HPN+V+    +  +    L+ + +SGGS   
Sbjct: 43  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 102
Query: 774 LHKHL---HEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPK 830
           + KH+    E   G  L  +    +++   + L +LH++  IH ++K+ N+L+   G  +
Sbjct: 103 IIKHIVAKGEHKSG-VLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQ 161
Query: 831 VGDYGLARLLPM---LDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVV 887
           + D+G++  L     + R  +         +MAPE   +      K D++ FG+  +E+ 
Sbjct: 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221
Query: 888 TGKRPLSTWKMM 899
           TG  P   +  M
Sbjct: 222 TGAAPYHKYPPM 233

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 16/203 (7%)
Query: 698 LGRGGFGAVY--RTVLRDGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEG 754
           +G+G F  V   R +L  GR VAIK +  + L   S +   REV+ +  + HPN+V L  
Sbjct: 20  IGKGNFAKVKLARHIL-TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 78
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
              T+    LI E+ SGG +  +L        +   E  +  +    ++ + HQ  I+H 
Sbjct: 79  VIETEKTLYLIMEYASGGEVFDYL---VAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHR 135
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKIT 871
           ++K+ N+L+D     K+ D+G +      + + +  K+ +  G   Y APE         
Sbjct: 136 DLKAENLLLDADMNIKIADFGFS------NEFTVGGKLDTFCGSPPYAAPELFQGKKYDG 189
Query: 872 DKCDVYGFGVLVLEVVTGKRPLS 894
            + DV+  GV++  +V+G  P  
Sbjct: 190 PEVDVWSLGVILYTLVSGSLPFD 212

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 21/223 (9%)
Query: 674 KLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKS 730
           ++V+  GDP        LL+   ++G G  G V   + R+   GR VA+K + +    + 
Sbjct: 35  RMVVDQGDPRL------LLDSYVKIGEGSTGIV--CLAREKHSGRQVAVKMMDLRKQQRR 86
Query: 731 QEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWN 790
           +  F  EV  +   +H N+V +   Y       ++ EF+ GG+L   + +      L+  
Sbjct: 87  ELLFN-EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR----LNEE 141
Query: 791 ERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS 850
           +   V +   ++LA+LH   +IH +IKS ++L+   G  K+ D+G       + + V   
Sbjct: 142 QIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFC---AQISKDVPKR 198
Query: 851 KIQSALGY-MAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
           K      Y MAPE   R++  T+  D++  G++V+E+V G+ P
Sbjct: 199 KXLVGTPYWMAPEVISRSLYATE-VDIWSLGIMVIEMVDGEPP 240

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 697 ELGRGGFGAVYR-----TVLRDGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLV 750
           ELG G F  V +     T L+       K+ T SS    S+ED EREV  L +++HPN++
Sbjct: 18  ELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           TL   Y  ++  +LI E V+GG L   L E      L+  E    ++     + +LH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 811 IIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           I H+++K  N+++     P    K+ D+GLA  +   + +     I     ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIV-N 190
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPL 893
              +  + D++  GV+   +++G  P 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V+    R +GR  A+K L    +V  K  E    E   L  V HP ++ + G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +       +I +++ GG L   L +     F +   +F   +    +L +LH  +II+ 
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAE-VCLALEYLHSKDIIYR 130
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+L+D +G  K+ D+G A+ +P      ++  +     Y+APE    T       
Sbjct: 131 DLKPENILLDKNGHIKITDFGFAKYVP-----DVTYXLCGTPDYIAPE-VVSTKPYNKSI 184
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D + FG+L+ E++ G  P 
Sbjct: 185 DWWSFGILIYEMLAGYTPF 203

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 100/218 (45%), Gaps = 19/218 (8%)
Query: 683 DFSTGTHALLNKDCELGRGGFGAVY--RTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVK 739
           D   G + LL     +G+G F  V   R +L  G+ VA+K +  + L  S  +   REV+
Sbjct: 3   DLHIGNYRLLKT---IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQKLFREVR 58
Query: 740 KLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGT 799
            +  + HPN+V L     T+    L+ E+ SGG +  +L       ++   E     +  
Sbjct: 59  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL---VAHGWMKEKEARAKFRQI 115
Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG-- 857
             ++ + HQ  I+H ++K+ N+L+D     K+ D+G +      + +   +K+ +  G  
Sbjct: 116 VSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDTFCGSP 169
Query: 858 -YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
            Y APE          + DV+  GV++  +V+G  P  
Sbjct: 170 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 697 ELGRGGFGAVYR-----TVLRDGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLV 750
           ELG G F  V +     T L+       K+ T SS    S+ED EREV  L +++HPN++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           TL   Y  ++  +LI E V+GG L   L E      L+  E    ++     + +LH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 811 IIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           I H+++K  N+++     P    K+ D+GLA  +   + +     I     ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPAFVAPEI-VN 190
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPL 893
              +  + D++  GV+   +++G  P 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 697 ELGRGGFGAVYR-----TVLRDGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLV 750
           ELG G F  V +     T L+       K+ T SS    S+ED EREV  L +++HPN++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           TL   Y  ++  +LI E V+GG L   L E      L+  E    ++     + +LH   
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHSLQ 133
Query: 811 IIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           I H+++K  N+++     P    K+ D+GLA  +   + +     I     ++APE    
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIV-N 189
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPL 893
              +  + D++  GV+   +++G  P 
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 697 ELGRGGFGAVYR-----TVLRDGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLV 750
           ELG G F  V +     T L+       K+ T SS    S+ED EREV  L +++HPN++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           TL   Y  ++  +LI E V+GG L   L E      L+  E    ++     + +LH   
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHSLQ 133
Query: 811 IIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           I H+++K  N+++     P    K+ D+GLA  +   + +     I     ++APE    
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIV-N 189
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPL 893
              +  + D++  GV+   +++G  P 
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 697 ELGRGGFGAVYR-----TVLRDGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLV 750
           ELG G F  V +     T L+       K+ T SS    S+ED EREV  L +++HPN++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           TL   Y  ++  +LI E V+GG L   L E      L+  E    ++     + +LH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 811 IIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           I H+++K  N+++     P    K+ D+GLA  +   + +     I     ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIV-N 190
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPL 893
              +  + D++  GV+   +++G  P 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 697 ELGRGGFGAVYR-----TVLRDGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLV 750
           ELG G F  V +     T L+       K+ T SS    S+ED EREV  L +++HPN++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           TL   Y  ++  +LI E V+GG L   L E      L+  E    ++     + +LH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 811 IIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           I H+++K  N+++     P    K+ D+GLA  +   + +     I     ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIV-N 190
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPL 893
              +  + D++  GV+   +++G  P 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 697 ELGRGGFGAVYR-----TVLRDGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLV 750
           ELG G F  V +     T L+       K+ T SS    S+ED EREV  L +++HPN++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           TL   Y  ++  +LI E V+GG L   L E      L+  E    ++     + +LH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 811 IIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           I H+++K  N+++     P    K+ D+GLA  +   + +     I     ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIV-N 190
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPL 893
              +  + D++  GV+   +++G  P 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 697 ELGRGGFGAVYR-----TVLRDGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLV 750
           ELG G F  V +     T L+       K+ T SS    S+ED EREV  L +++HPN++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           TL   Y  ++  +LI E V+GG L   L E      L+  E    ++     + +LH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 811 IIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           I H+++K  N+++     P    K+ D+GLA  +   + +     I     ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIV-N 190
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPL 893
              +  + D++  GV+   +++G  P 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 697 ELGRGGFGAVYR-----TVLRDGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLV 750
           ELG G F  V +     T L+       K+ T SS    S+ED EREV  L +++HPN++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           TL   Y  ++  +LI E V+GG L   L E      L+  E    ++     + +LH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 811 IIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           I H+++K  N+++     P    K+ D+GLA  +   + +     I     ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIV-N 190
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPL 893
              +  + D++  GV+   +++G  P 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIK-----KLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG G F  V +   +  G+  A K     +L  S    S+E+ EREV  L ++RHPN++
Sbjct: 33  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNII 92
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           TL   +  ++  +LI E VSGG L   L E      L+ +E    ++     + +LH   
Sbjct: 93  TLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGVHYLHSKR 149
Query: 811 IIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           I H+++K  N+++     P    K+ D+G+A  +   + +     I     ++APE    
Sbjct: 150 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIV-N 205
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPL 893
              +  + D++  GV+   +++G  P 
Sbjct: 206 YEPLGLEADMWSIGVITYILLSGASPF 232

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 19/226 (8%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G FG V+    R  G    IK +         E  E E++ L  + HPN++ +   
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSG-GNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           +       ++ E   GG L + +      G  LS      +++    +LA+ H  +++H 
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHK 148
Query: 815 NIKSSNVLIDGSG--EP-KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           ++K  N+L   +    P K+ D+GLA L    +    S+       YMAPE   R V  T
Sbjct: 149 DLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFKRDV--T 203
Query: 872 DKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWR 917
            KCD++  GV++  ++TG  P         F+ T LEE  +KA ++
Sbjct: 204 FKCDIWSAGVVMYFLLTGCLP---------FTGTSLEEVQQKATYK 240

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 8/203 (3%)
Query: 691 LLNKDCELGRGGFGAVYRTVL-RDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNL 749
           L  K   +G+G FG V++ +  R  + VAIK + +       ED ++E+  L +     +
Sbjct: 24  LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYV 83
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
               G Y   S   +I E++ GGS    L  G    F    +   +++   K L +LH  
Sbjct: 84  TKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEF----QIATMLKEILKGLDYLHSE 139
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
             IH +IK++NVL+   G+ K+ D+G+A  L   D  +  +       +MAPE   ++  
Sbjct: 140 KKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIQQSA- 196
Query: 870 ITDKCDVYGFGVLVLEVVTGKRP 892
              K D++  G+  +E+  G+ P
Sbjct: 197 YDSKADIWSLGITAIELAKGEPP 219

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 695 DCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           + ELGRG    VYR   +   +P A+K L  +     ++    E+  L ++ HPN++ L+
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
             + T +   L+ E V+GG L   + E     + S  +  + ++   +++A+LH++ I+H
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENGIVH 171
Query: 814 YNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++K  N+L   +  P    K+ D+GL+++   ++  VL   +    GY APE   R   
Sbjct: 172 RDLKPENLLY-ATPAPDAPLKIADFGLSKI---VEHQVLMKTVCGTPGYCAPEI-LRGCA 226
Query: 870 ITDKCDVYGFGVLVLEVVTGKRPL 893
              + D++  G++   ++ G  P 
Sbjct: 227 YGPEVDMWSVGIITYILLCGFEPF 250

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           ++G+G  G VY  + +  G+ VAI+++ +    K +E    E+  + + ++PN+V     
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDS 86
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           Y       ++ E+++GGSL   + E      +   +   V +   ++L  LH + +IH N
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQVIHRN 142
Query: 816 IKSSNVLIDGSGEPKVGDYGL-ARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKIT 871
           IKS N+L+   G  K+ D+G  A++ P        SK  + +G   +MAPE   R     
Sbjct: 143 IKSDNILLGMDGSVKLTDFGFCAQITPE------QSKRSTMVGTPYWMAPEVVTRKA-YG 195
Query: 872 DKCDVYGFGVLVLEVVTGKRP 892
            K D++  G++ +E++ G+ P
Sbjct: 196 PKVDIWSLGIMAIEMIEGEPP 216

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 698 LGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGY 755
           +G G +G VY+   ++ G+  AIK + V+     +E+ ++E+  L K   H N+ T  G 
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 756 YWTQSL-----QL-LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
           +  ++      QL L+ EF   GS+   L + + GN L       + +   + L+HLHQ 
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 148
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE-FAC 865
            +IH +IK  NVL+  + E K+ D+G++     LDR V   +  + +G   +MAPE  AC
Sbjct: 149 KVIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTV--GRRNTFIGTPYWMAPEVIAC 203
Query: 866 RT---VKITDKCDVYGFGVLVLEVVTGKRPL 893
                     K D++  G+  +E+  G  PL
Sbjct: 204 DENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 697 ELGRGGFGAVYR-----TVLRDGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLV 750
           ELG G F  V +     T L+       K+ T SS    S+ED EREV  L +++HPN++
Sbjct: 18  ELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           TL   Y  ++  +LI E V+GG L   L E      L+  E    ++     + +LH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 811 IIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           I H+++K  N+++     P    K+ D+GLA  +   + +     I     ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIV-N 190
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPL 893
              +  + D++  GV+   +++G  P 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 697 ELGRGGFGAVYR-----TVLRDGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLV 750
           ELG G F  V +     T L+       K+ T SS    S+ED EREV  L +++HPN++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           TL   Y  ++  +LI E V+GG L   L E      L+  E    ++     + +LH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 811 IIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           I H+++K  N+++     P    K+ D+GLA  +   + +     I     ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEI-VN 190
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPL 893
              +  + D++  GV+   +++G  P 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 697 ELGRGGFGAVYR-----TVLRDGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLV 750
           ELG G F  V +     T L+       K+ T SS    S+ED EREV  L +++HPN++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           TL   Y  ++  +LI E V+GG L   L E      L+  E    ++     + +LH   
Sbjct: 78  TLHEVYENKTDVILIGELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 811 IIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           I H+++K  N+++     P    K+ D+GLA  +   + +     I     ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIV-N 190
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPL 893
              +  + D++  GV+   +++G  P 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 97/219 (44%), Gaps = 28/219 (12%)
Query: 697 ELGRGGFGAVYRTVLRDGRP------VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ++G G FG V++       P      VA+K L   +    Q DF+RE   + +  +PN+V
Sbjct: 54  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---------------------GGNFLSW 789
            L G         L++E+++ G L++ L   S                     G   LS 
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 790 NERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS 849
            E+  + +  A  +A+L +   +H ++ + N L+  +   K+ D+GL+R +   D Y   
Sbjct: 174 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAD 233
Query: 850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
                 + +M PE +    + T + DV+ +GV++ E+ +
Sbjct: 234 GNDAIPIRWMPPE-SIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 679 SGDPDFSTGTHALLNKDCELGRGGFGAVY--RTVLRDGRPVAIKKLTVSSLVKSQ-EDFE 735
           S D     G + LL     +G+G F  V   R +L  G+ VA+K +  + L  S  +   
Sbjct: 6   SADEQPHIGNYRLLKT---IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQKLF 61
Query: 736 REVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNV 795
           REV+ +  + HPN+V L     T+    L+ E+ SGG +  +L   + G       R   
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKF 119
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
            Q    ++ + HQ  I+H ++K+ N+L+D     K+ D+G +      + +   +K+ + 
Sbjct: 120 RQ-IVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDTF 172
Query: 856 LG---YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
            G   Y APE          + DV+  GV++  +V+G  P  
Sbjct: 173 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 679 SGDPDFSTGTHALLNKDCELGRGGFGAVY--RTVLRDGRPVAIKKLTVSSLVKSQ-EDFE 735
           S D     G + LL     +G+G F  V   R +L  G+ VA+K +  + L  S  +   
Sbjct: 6   SADEQPHIGNYRLLKT---IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQKLF 61
Query: 736 REVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNV 795
           REV+ +  + HPN+V L     T+    L+ E+ SGG +  +L   + G       R   
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKF 119
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
            Q    ++ + HQ  I+H ++K+ N+L+D     K+ D+G +      + +   +K+ + 
Sbjct: 120 RQ-IVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDTF 172
Query: 856 LG---YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
            G   Y APE          + DV+  GV++  +V+G  P  
Sbjct: 173 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 8/205 (3%)
Query: 691 LLNKDCELGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKSQEDFEREVKKLGKVRHPNL 749
           L  K   +G+G FG VY+ +    + V AIK + +       ED ++E+  L +   P +
Sbjct: 20  LFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 79
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
               G Y   +   +I E++ GGS    L  G     L       +++   K L +LH  
Sbjct: 80  TRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLHSE 135
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
             IH +IK++NVL+   G+ K+ D+G+A  L   D  +  +       +MAPE   +   
Sbjct: 136 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPE-VIKQSA 192
Query: 870 ITDKCDVYGFGVLVLEVVTGKRPLS 894
              K D++  G+  +E+  G+ P S
Sbjct: 193 YDFKADIWSLGITAIELAKGEPPNS 217

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 87  LGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 140
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E     + 
Sbjct: 141 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 199
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 200 YTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Composition-based stats.
 Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 692 LNKDCELGRGGFGAVY-----RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH 746
           L K  +LG G FG V       T    G  VA+K L      + +  +++E+  L  + H
Sbjct: 16  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYH 75
Query: 747 PNLVTLEGYYWTQ---SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSL 803
            +++  +G    Q   SLQL++ E+V  GSL  +L   S G      +     Q   + +
Sbjct: 76  EHIIKYKGCCEDQGEKSLQLVM-EYVPLGSLRDYLPRHSIG----LAQLLLFAQQICEGM 130
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPE 862
           A+LH  + IH N+ + NVL+D     K+GD+GLA+ +P   + Y +     S + + APE
Sbjct: 131 AYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 190
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVT 888
              +  K     DV+ FGV + E++T
Sbjct: 191 -CLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 697 ELGRGGFGAVYRTVLRDGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           ++G G FG     ++RD +    VA+K +      K  E+ +RE+     +RHPN+V  +
Sbjct: 25  DIGSGNFGVA--RLMRDKQSNELVAVKYIERGE--KIDENVKREIINHRSLRHPNIVRFK 80
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
               T +   ++ E+ SGG L + +   + G F     RF   Q     +++ H   + H
Sbjct: 81  EVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARF-FFQQLISGVSYCHAMQVCH 137
Query: 814 YNIKSSNVLIDGSGEP--KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTV 868
            ++K  N L+DGS  P  K+ D+G ++        VL S+ +S +G   Y+APE   +  
Sbjct: 138 RDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLKKE 191
Query: 869 KITDKCDVYGFGVLVLEVVTGKRPLS 894
                 DV+  GV +  ++ G  P  
Sbjct: 192 YDGKVADVWSCGVTLYVMLVGAYPFE 217

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 679 SGDPDFSTGTHALLNKDCELGRGGFGAVY--RTVLRDGRPVAIKKLTVSSLVKSQ-EDFE 735
           S D     G + LL     +G+G F  V   R +L  G+ VA+K +  + L  S  +   
Sbjct: 6   SADEQPHIGNYRLLKT---IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQKLF 61
Query: 736 REVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNV 795
           REV+ +  + HPN+V L     T+    L+ E+ SGG +  +L   + G       R   
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKF 119
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
            Q    ++ + HQ  I+H ++K+ N+L+D     K+ D+G +      + +   +K+ + 
Sbjct: 120 RQ-IVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDAF 172
Query: 856 LG---YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
            G   Y APE          + DV+  GV++  +V+G  P  
Sbjct: 173 CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 84  LGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 137
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E     + 
Sbjct: 138 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 196
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 197 YTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 697 ELGRGGFGAVYR-----TVLRDGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLV 750
           ELG G F  V +     T L+       K+ T SS    S+ED EREV  L +++HPN++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           TL   Y  ++  +LI E V+GG L   L E      L+  E    ++     + +LH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 811 IIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           I H+++K  N+++     P    K+ D+GLA  +   + +     I     ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEI-VN 190
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPL 893
              +  + D++  GV+   +++G  P 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 697 ELGRGGFGAVYR-----TVLRDGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLV 750
           ELG G F  V +     T L+       K+ T SS    S+ED EREV  L +++HPN++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           TL   Y  ++  +LI E V+GG L   L E      L+  E    ++     + +LH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHSLQ 134
Query: 811 IIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           I H+++K  N+++     P    K+ D+GLA  +   + +     I     ++APE    
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNY 191
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPL 893
              +  + D++  GV+   +++G  P 
Sbjct: 192 E-PLGLEADMWSIGVITYILLSGASPF 217

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 86  LGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 139
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E     + 
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 198
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 199 YTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 85  LGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 138
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E     + 
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 197
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 198 YTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 697 ELGRGGFGAVYR--TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           +LG G +  VY+  + L D   VA+K++ +     +     REV  L  ++H N+VTL  
Sbjct: 9   KLGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
              T+    L++E++    L ++L +   GN ++ +     +    + LA+ H+  ++H 
Sbjct: 68  IIHTEKSLTLVFEYLDK-DLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQKVLHR 124
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LI+  GE K+ D+GLAR   +  +   +  +   L Y  P+    +   + + 
Sbjct: 125 DLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGSTDYSTQI 182
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++G G +  E+ TG RPL
Sbjct: 183 DMWGVGCIFYEMATG-RPL 200

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 84  LGICLTSTVQL-IMQLMPFGXLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 137
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E     + 
Sbjct: 138 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 196
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 197 YTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 83  LGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 136
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E     + 
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 195
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 692 LNKDCELGRGGFGAVY-----RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH 746
           L K  +LG G FG V       T    G  VA+K L      + +  +++E+  L  + H
Sbjct: 16  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYH 75
Query: 747 PNLVTLEGYYWTQ---SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSL 803
            +++  +G    Q   SLQL++ E+V  GSL  +L   S G      +     Q   + +
Sbjct: 76  EHIIKYKGCCEDQGEKSLQLVM-EYVPLGSLRDYLPRHSIG----LAQLLLFAQQICEGM 130
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPE 862
           A+LH  + IH N+ + NVL+D     K+GD+GLA+ +P   + Y +     S + + APE
Sbjct: 131 AYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 190
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVT 888
              +  K     DV+ FGV + E++T
Sbjct: 191 -CLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDF-----EREVKKLGKVRHPNLVTL 752
           +GRG +  V    L+    +   K+    LV   ED      E+ V +     HP LV L
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVGL 86
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
              + T+S    + E+V+GG L  H+           + RF   +  + +L +LH+  II
Sbjct: 87  HSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAE-ISLALNYLHERGII 143
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLAR--LLPMLDRYVLSSKIQSALGYMAPEFACRTVKI 870
           + ++K  NVL+D  G  K+ DYG+ +  L P       +S       Y+APE   R    
Sbjct: 144 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG----DTTSXFCGTPNYIAPEI-LRGEDY 198
Query: 871 TDKCDVYGFGVLVLEVVTGKRPLS 894
               D +  GVL+ E++ G+ P  
Sbjct: 199 GFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 93  LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 146
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E     + 
Sbjct: 147 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 205
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 206 YTHQSDVWSYGVTVWELMTFGSKP 229

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 86  LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 139
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E     + 
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 198
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 199 YTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 86  LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 139
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E     + 
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 198
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 199 YTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 85  LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 138
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E     + 
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 197
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 198 YTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 89  LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 142
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E     + 
Sbjct: 143 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 201
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 202 YTHQSDVWSYGVTVWELMTFGSKP 225

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 24/218 (11%)
Query: 680 GDPDFSTGTHALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-RE 737
           G P+F         K  ++G G +G VY+   +  G  VA+KK+ + +  +       RE
Sbjct: 4   GSPEFMEN----FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE 59
Query: 738 VKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW-------N 790
           +  L ++ HPN+V L     T++   L++EF     LH+ L +    + L+        +
Sbjct: 60  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKS 114
Query: 791 ERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS 850
             F ++QG    LA  H   ++H ++K  N+LI+  G  K+ D+GLAR   +  R     
Sbjct: 115 YLFQLLQG----LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 170
Query: 851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
            +   L Y APE        +   D++  G +  E+VT
Sbjct: 171 VV--TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 83  LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 136
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E     + 
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 195
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 86  LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 139
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E     + 
Sbjct: 140 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 198
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 199 YTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDF-----EREVKKLGKVRHPNLVTL 752
           +GRG +  V    L+    +   K+    LV   ED      E+ V +     HP LV L
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVGL 75
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
              + T+S    + E+V+GG L  H+           + RF   +  + +L +LH+  II
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAE-ISLALNYLHERGII 132
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLAR--LLPMLDRYVLSSKIQSALGYMAPEFACRTVKI 870
           + ++K  NVL+D  G  K+ DYG+ +  L P       +S       Y+APE   R    
Sbjct: 133 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG----DTTSXFCGTPNYIAPEI-LRGEDY 187
Query: 871 TDKCDVYGFGVLVLEVVTGKRPLS 894
               D +  GVL+ E++ G+ P  
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEG 754
           ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+V L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW-------NERFNVIQGTAKSLAHLH 807
              T++   L++EF     LH+ L +    + L+        +  F ++QG    LA  H
Sbjct: 70  VIHTENKLYLVFEF-----LHQDLKDFMDASALTGIPLPLIKSYLFQLLQG----LAFCH 120
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
              ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE     
Sbjct: 121 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGC 178
Query: 868 VKITDKCDVYGFGVLVLEVVT 888
              +   D++  G +  E+VT
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT 199

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 90  LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 143
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E     + 
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 202
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 203 YTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDF-----EREVKKLGKVRHPNLVTL 752
           +GRG +  V    L+    +   K+    LV   ED      E+ V +     HP LV L
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVGL 71
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
              + T+S    + E+V+GG L  H+           + RF   +  + +L +LH+  II
Sbjct: 72  HSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAE-ISLALNYLHERGII 128
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLAR--LLPMLDRYVLSSKIQSALGYMAPEFACRTVKI 870
           + ++K  NVL+D  G  K+ DYG+ +  L P       +S       Y+APE   R    
Sbjct: 129 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG----DTTSXFCGTPNYIAPEI-LRGEDY 183
Query: 871 TDKCDVYGFGVLVLEVVTGKRPLS 894
               D +  GVL+ E++ G+ P  
Sbjct: 184 GFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNL 749
             K  ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLS-------WNERFNVIQGTAKS 802
           V L     T++   L++EF     LH+ L +    + L+        +  F ++QG    
Sbjct: 68  VKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG---- 118
Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           LA  H   ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE
Sbjct: 119 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVTGK 890
                   +   D++  G +  E+VT +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNL 749
             K  ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLS-------WNERFNVIQGTAKS 802
           V L     T++   L++EF     LH+ L +    + L+        +  F ++QG    
Sbjct: 67  VKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG---- 117
Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           LA  H   ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE
Sbjct: 118 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 175
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVTGK 890
                   +   D++  G +  E+VT +
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 24/218 (11%)
Query: 680 GDPDFSTGTHALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-RE 737
           G P+F         K  ++G G +G VY+   +  G  VA+KK+ + +  +       RE
Sbjct: 4   GSPEFMEN----FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE 59
Query: 738 VKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW-------N 790
           +  L ++ HPN+V L     T++   L++EF     LH+ L +    + L+        +
Sbjct: 60  ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKS 114
Query: 791 ERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS 850
             F ++QG    LA  H   ++H ++K  N+LI+  G  K+ D+GLAR   +  R     
Sbjct: 115 YLFQLLQG----LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 170
Query: 851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
            +   L Y APE        +   D++  G +  E+VT
Sbjct: 171 VV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 83  LGICLTSTVQL-ITQLMPFGXLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 136
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E     + 
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 195
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNL 749
             K  ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLS-------WNERFNVIQGTAKS 802
           V L     T++   L++EF     LH+ L +    + L+        +  F ++QG    
Sbjct: 66  VKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG---- 116
Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           LA  H   ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE
Sbjct: 117 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 174
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVTGK 890
                   +   D++  G +  E+VT +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNL 749
             K  ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLS-------WNERFNVIQGTAKS 802
           V L     T++   L++EF     LH+ L +    + L+        +  F ++QG    
Sbjct: 68  VKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG---- 118
Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           LA  H   ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE
Sbjct: 119 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVTGK 890
                   +   D++  G +  E+VT +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEG 754
           ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+V L  
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW-------NERFNVIQGTAKSLAHLH 807
              T++   L++EF     LH+ L +    + L+        +  F ++QG    LA  H
Sbjct: 71  VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LAFCH 121
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
              ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE     
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGC 179
Query: 868 VKITDKCDVYGFGVLVLEVVT 888
              +   D++  G +  E+VT
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVT 200

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 108 LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 161
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E     + 
Sbjct: 162 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 220
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 221 YTHQSDVWSYGVTVWELMTFGSKP 244

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 19/222 (8%)
Query: 679 SGDPDFSTGTHALLNKDCELGRGGFGAVY--RTVLRDGRPVAIKKLTVSSLVKSQ-EDFE 735
           S D     G + LL     +G+G F  V   R +L  G+ VA++ +  + L  S  +   
Sbjct: 6   SADEQPHIGNYRLLKT---IGKGNFAKVKLARHIL-TGKEVAVRIIDKTQLNSSSLQKLF 61
Query: 736 REVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNV 795
           REV+ +  + HPN+V L     T+    L+ E+ SGG +  +L   + G       R   
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKF 119
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
            Q    ++ + HQ  I+H ++K+ N+L+D     K+ D+G +      + +   +K+ + 
Sbjct: 120 RQ-IVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDTF 172
Query: 856 LG---YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
            G   Y APE          + DV+  GV++  +V+G  P  
Sbjct: 173 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 77  LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 130
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E     + 
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 189
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKP 213

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 83  LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 136
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E     + 
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 195
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNL 749
             K  ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLS-------WNERFNVIQGTAKS 802
           V L     T++   L++EF     LH+ L +    + L+        +  F ++QG    
Sbjct: 69  VKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG---- 119
Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           LA  H   ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE
Sbjct: 120 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 177
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVTGK 890
                   +   D++  G +  E+VT +
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEG 754
           ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+V L  
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW-------NERFNVIQGTAKSLAHLH 807
              T++   L++EF     LH+ L +    + L+        +  F ++QG    LA  H
Sbjct: 69  VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LAFCH 119
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
              ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE     
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGC 177
Query: 868 VKITDKCDVYGFGVLVLEVVT 888
              +   D++  G +  E+VT
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVT 198

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNL 749
             K  ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLS-------WNERFNVIQGTAKS 802
           V L     T++   L++EF     LH+ L +    + L+        +  F ++QG    
Sbjct: 65  VKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG---- 115
Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           LA  H   ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVTGK 890
                   +   D++  G +  E+VT +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEG 754
           ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+V L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW-------NERFNVIQGTAKSLAHLH 807
              T++   L++EF     LH+ L +    + L+        +  F ++QG    LA  H
Sbjct: 70  VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LAFCH 120
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
              ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE     
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGX 178
Query: 868 VKITDKCDVYGFGVLVLEVVT 888
              +   D++  G +  E+VT
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT 199

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEG 754
           ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+V L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW-------NERFNVIQGTAKSLAHLH 807
              T++   L++EF     LH+ L +    + L+        +  F ++QG    LA  H
Sbjct: 70  VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LAFCH 120
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
              ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE     
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGC 178
Query: 868 VKITDKCDVYGFGVLVLEVVT 888
              +   D++  G +  E+VT
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT 199

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEG 754
           ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+V L  
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW-------NERFNVIQGTAKSLAHLH 807
              T++   L++EF     LH+ L +    + L+        +  F ++QG    LA  H
Sbjct: 69  VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LAFCH 119
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
              ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE     
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGC 177
Query: 868 VKITDKCDVYGFGVLVLEVVT 888
              +   D++  G +  E+VT
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVT 198

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEG 754
           ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+V L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW-------NERFNVIQGTAKSLAHLH 807
              T++   L++EF     LH+ L +    + L+        +  F ++QG    LA  H
Sbjct: 70  VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LAFCH 120
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
              ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE     
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGC 178
Query: 868 VKITDKCDVYGFGVLVLEVVT 888
              +   D++  G +  E+VT
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEG 754
           ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+V L  
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW-------NERFNVIQGTAKSLAHLH 807
              T++   L++EF     LH+ L +    + L+        +  F ++QG    LA  H
Sbjct: 71  VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LAFCH 121
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
              ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE     
Sbjct: 122 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGC 179
Query: 868 VKITDKCDVYGFGVLVLEVVT 888
              +   D++  G +  E+VT
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVT 200

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEG 754
           ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+V L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW-------NERFNVIQGTAKSLAHLH 807
              T++   L++EF     LH+ L +    + L+        +  F ++QG    LA  H
Sbjct: 70  VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LAFCH 120
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
              ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE     
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGC 178
Query: 868 VKITDKCDVYGFGVLVLEVVT 888
              +   D++  G +  E+VT
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 12/204 (5%)
Query: 692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNL 749
             K  ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNF---LSWNERFNVIQGTAKSLAHL 806
           V L     T++   L++EF+S   L K +   +       L  +  F ++QG    LA  
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQG----LAFC 122
Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           H   ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE    
Sbjct: 123 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 180
Query: 867 TVKITDKCDVYGFGVLVLEVVTGK 890
               +   D++  G +  E+VT +
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEG 754
           ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+V L  
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW-------NERFNVIQGTAKSLAHLH 807
              T++   L++EF     LH+ L +    + L+        +  F ++QG    LA  H
Sbjct: 74  VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LAFCH 124
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
              ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE     
Sbjct: 125 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGC 182
Query: 868 VKITDKCDVYGFGVLVLEVVT 888
              +   D++  G +  E+VT
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVT 203

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 12/204 (5%)
Query: 692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNL 749
             K  ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNF---LSWNERFNVIQGTAKSLAHL 806
           V L     T++   L++EF+S   L K +   +       L  +  F ++QG    LA  
Sbjct: 66  VKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQG----LAFC 120
Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           H   ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE    
Sbjct: 121 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLG 178
Query: 867 TVKITDKCDVYGFGVLVLEVVTGK 890
               +   D++  G +  E+VT +
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEG 754
           ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+V L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW-------NERFNVIQGTAKSLAHLH 807
              T++   L++EF     LH+ L +    + L+        +  F ++QG    LA  H
Sbjct: 70  VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LAFCH 120
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
              ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE     
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGC 178
Query: 868 VKITDKCDVYGFGVLVLEVVT 888
              +   D++  G +  E+VT
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT 199

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 51/198 (25%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           ++G+G  G VY  + +  G+ VAI+++ +    K +E    E+  + + ++PN+V     
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDS 85
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           Y       ++ E+++GGSL   + E      +   +   V +   ++L  LH + +IH +
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 816 IKSSNVLIDGSGEPKVGDYGL-ARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           IKS N+L+   G  K+ D+G  A++ P   +    S++     +MAPE   R      K 
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSEMVGTPYWMAPEVVTRKA-YGPKV 197
Query: 875 DVYGFGVLVLEVVTGKRP 892
           D++  G++ +E++ G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEG 754
           ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+V L  
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW-------NERFNVIQGTAKSLAHLH 807
              T++   L++EF     LH+ L +    + L+        +  F ++QG    LA  H
Sbjct: 69  VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LAFCH 119
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
              ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE     
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGC 177
Query: 868 VKITDKCDVYGFGVLVLEVVT 888
              +   D++  G +  E+VT
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVT 198

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEG 754
           ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+V L  
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW-------NERFNVIQGTAKSLAHLH 807
              T++   L++EF     LH+ L +    + L+        +  F ++QG    LA  H
Sbjct: 69  VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LAFCH 119
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
              ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE     
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGC 177
Query: 868 VKITDKCDVYGFGVLVLEVVT 888
              +   D++  G +  E+VT
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVT 198

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEG 754
           ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+V L  
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW-------NERFNVIQGTAKSLAHLH 807
              T++   L++EF     LH+ L +    + L+        +  F ++QG    LA  H
Sbjct: 72  VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LAFCH 122
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
              ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE     
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGC 180
Query: 868 VKITDKCDVYGFGVLVLEVVT 888
              +   D++  G +  E+VT
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVT 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEG 754
           ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+V L  
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW-------NERFNVIQGTAKSLAHLH 807
              T++   L++EF     LH+ L +    + L+        +  F ++QG    LA  H
Sbjct: 72  VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LAFCH 122
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
              ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE     
Sbjct: 123 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGC 180
Query: 868 VKITDKCDVYGFGVLVLEVVT 888
              +   D++  G +  E+VT
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVT 201

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEG 754
           ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+V L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW-------NERFNVIQGTAKSLAHLH 807
              T++   L++EF     LH+ L +    + L+        +  F ++QG    LA  H
Sbjct: 70  VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LAFCH 120
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
              ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE     
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGC 178
Query: 868 VKITDKCDVYGFGVLVLEVVT 888
              +   D++  G +  E+VT
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT 199

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 53/201 (26%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           ++G+G  G VY  + +  G+ VAI+++ +    K +E    E+  + + ++PN+V     
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDS 85
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           Y       ++ E+++GGSL   + E      +   +   V +   ++L  LH + +IH +
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 816 IKSSNVLIDGSGEPKVGDYGL-ARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKIT 871
           IKS N+L+   G  K+ D+G  A++ P        SK  + +G   +MAPE   R     
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPE------QSKRSTMVGTPYWMAPEVVTRKA-YG 194
Query: 872 DKCDVYGFGVLVLEVVTGKRP 892
            K D++  G++ +E++ G+ P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP 215

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEG 754
           ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+V L  
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW-------NERFNVIQGTAKSLAHLH 807
              T++   L++EF     LH+ L +    + L+        +  F ++QG    LA  H
Sbjct: 71  VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LAFCH 121
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
              ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE     
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGC 179
Query: 868 VKITDKCDVYGFGVLVLEVVT 888
              +   D++  G +  E+VT
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVT 200

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDF-----EREVKKLGKVRHPNLVTL 752
           +GRG +  V    L+    +   ++    LV   ED      E+ V +     HP LV L
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVGL 118
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
              + T+S    + E+V+GG L  H+           + RF   +  + +L +LH+  II
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAE-ISLALNYLHERGII 175
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLAR--LLPMLDRYVLSSKIQSALGYMAPEFACRTVKI 870
           + ++K  NVL+D  G  K+ DYG+ +  L P       +S       Y+APE   R    
Sbjct: 176 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG----DTTSTFCGTPNYIAPEI-LRGEDY 230
Query: 871 TDKCDVYGFGVLVLEVVTGKRPLS 894
               D +  GVL+ E++ G+ P  
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 19/222 (8%)
Query: 679 SGDPDFSTGTHALLNKDCELGRGGFGAVY--RTVLRDGRPVAIKKLTVSSLVKSQ-EDFE 735
           S D     G + LL     +G+G F  V   R +L  G+ VA++ +  + L  S  +   
Sbjct: 6   SADEQPHIGNYRLLKT---IGKGNFAKVKLARHIL-TGKEVAVRIIDKTQLNSSSLQKLF 61
Query: 736 REVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNV 795
           REV+ +  + HPN+V L     T+    L+ E+ SGG +  +L   + G       R   
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKF 119
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
            Q    ++ + HQ  I+H ++K+ N+L+D     K+ D+G +      + +   +K+   
Sbjct: 120 RQ-IVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDEF 172
Query: 856 LG---YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
            G   Y APE          + DV+  GV++  +V+G  P  
Sbjct: 173 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 19/222 (8%)
Query: 679 SGDPDFSTGTHALLNKDCELGRGGFGAVY--RTVLRDGRPVAIKKLTVSSLVKSQ-EDFE 735
           S D     G + LL     +G+G F  V   R +L  G+ VA+K +  + L  S  +   
Sbjct: 6   SADEQPHIGNYRLLKT---IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQKLF 61
Query: 736 REVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNV 795
           REV+    + HPN+V L     T+    L+ E+ SGG +  +L             +F  
Sbjct: 62  REVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQ 121
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
           I     ++ + HQ  I+H ++K+ N+L+D     K+ D+G +      + +   +K+ + 
Sbjct: 122 I---VSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFS------NEFTFGNKLDAF 172
Query: 856 LG---YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
            G   Y APE          + DV+  GV++  +V+G  P  
Sbjct: 173 CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLE 753
           C LG+G FG V +   R   +  A+K +  +S   K      REV+ L K+ HPN++ L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
                 S   ++ E  +GG L   + +       S ++   +I+     + ++H+ NI+H
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 814 YNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRT 867
            ++K  N+L++   +    K+ D+GL+           ++K++  +G   Y+APE    T
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQ------NTKMKDRIGTAYYIAPEVLRGT 198
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
               +KCDV+  GV++  +++G  P 
Sbjct: 199 Y--DEKCDVWSAGVILYILLSGTPPF 222

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 66/225 (29%), Positives = 99/225 (44%), Gaps = 42/225 (18%)
Query: 691 LLNKDCELGRGGFGAVYRTVLRDGR-PVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPN 748
            L  D E+GRG F  VY+ +  +    VA  +L    L KS+ + F+ E + L  ++HPN
Sbjct: 27  FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPN 86
Query: 749 LVTLEGYY--WTQSLQ-----LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ---- 797
           +V    +Y  W  +++     +L+ E  + G+L  +L            +RF V +    
Sbjct: 87  IVR---FYDSWESTVKGKKCIVLVTELXTSGTLKTYL------------KRFKVXKIKVL 131
Query: 798 -----GTAKSLAHLHQSN--IIHYNIKSSNVLIDG-SGEPKVGDYGLARLLPMLDRYVLS 849
                   K L  LH     IIH ++K  N+ I G +G  K+GD GLA     L R   +
Sbjct: 132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA----TLKRASFA 187
Query: 850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
             +     + APE      K  +  DVY FG   LE  T + P S
Sbjct: 188 KAVIGTPEFXAPEX--YEEKYDESVDVYAFGXCXLEXATSEYPYS 230

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNL 749
             K  ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLS-------WNERFNVIQGTAKS 802
           V L     T++   L++EF     LH+ L      + L+        +  F ++QG    
Sbjct: 68  VKLLDVIHTENKLYLVFEF-----LHQDLKTFMDASALTGIPLPLIKSYLFQLLQG---- 118
Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           LA  H   ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE
Sbjct: 119 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVTGK 890
                   +   D++  G +  E+VT +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFE----REVKKLGKVRHPNLVTL 752
           ++G G +G VY+     G   A+KK+    L K  E       RE+  L +++H N+V L
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKI---RLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
                T+   +L++E +    L K L    GG   S   +  ++Q     +A+ H   ++
Sbjct: 66  YDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKSFLLQ-LLNGIAYCHDRRVL 122
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           H ++K  N+LI+  GE K+ D+GLAR   +  R      +   L Y AP+    + K + 
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLMGSKKYST 180
Query: 873 KCDVYGFGVLVLEVVTG 889
             D++  G +  E+V G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFE----REVKKLGKVRHPNLVTL 752
           ++G G +G VY+     G   A+KK+    L K  E       RE+  L +++H N+V L
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKI---RLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
                T+   +L++E +    L K L    GG   S   +  ++Q     +A+ H   ++
Sbjct: 66  YDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKSFLLQ-LLNGIAYCHDRRVL 122
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           H ++K  N+LI+  GE K+ D+GLAR   +  R      +   L Y AP+    + K + 
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLMGSKKYST 180
Query: 873 KCDVYGFGVLVLEVVTG 889
             D++  G +  E+V G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 115/236 (48%), Gaps = 15/236 (6%)
Query: 696 CE-LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKS----QEDFEREVKKLGKVRHPNL 749
           CE +G+G F  V R + R+ G+  A+K + V+    S     ED +RE      ++HP++
Sbjct: 31  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 90
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAKSLAHLH 807
           V L   Y +  +  +++EF+ G  L   + + +   F+ ++E    + ++   ++L + H
Sbjct: 91  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFV-YSEAVASHYMRQILEALRYCH 149
Query: 808 QSNIIHYNIKSSNVLI---DGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
            +NIIH ++K   VL+   + S   K+G +G+A  + + +  +++        +MAPE  
Sbjct: 150 DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVGTPHFMAPEVV 207
Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVS 920
            R        DV+G GV++  +++G  P    K   +  +   +      +W ++S
Sbjct: 208 KRE-PYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHIS 262

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 51/198 (25%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           ++G+G  G VY  + +  G+ VAI+++ +    K +E    E+  + + ++PN+V     
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDS 85
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           Y       ++ E+++GGSL   + E      +   +   V +   ++L  LH + +IH +
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 816 IKSSNVLIDGSGEPKVGDYGL-ARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           IKS N+L+   G  K+ D+G  A++ P   +    S +     +MAPE   R      K 
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAPEVVTRKA-YGPKV 197
Query: 875 DVYGFGVLVLEVVTGKRP 892
           D++  G++ +E++ G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFE----REVKKLGKVRHPNLVTL 752
           ++G G +G VY+     G   A+KK+    L K  E       RE+  L +++H N+V L
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKI---RLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
                T+   +L++E +    L K L    GG   S   +  ++Q     +A+ H   ++
Sbjct: 66  YDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKSFLLQ-LLNGIAYCHDRRVL 122
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           H ++K  N+LI+  GE K+ D+GLAR   +  R      +   L Y AP+    + K + 
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLMGSKKYST 180
Query: 873 KCDVYGFGVLVLEVVTG 889
             D++  G +  E+V G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 51/198 (25%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           ++G+G  G VY  + +  G+ VAI+++ +    K +E    E+  + + ++PN+V     
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDS 86
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           Y       ++ E+++GGSL   + E      +   +   V +   ++L  LH + +IH +
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQVIHRD 142
Query: 816 IKSSNVLIDGSGEPKVGDYGL-ARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           IKS N+L+   G  K+ D+G  A++ P   +    S +     +MAPE   R      K 
Sbjct: 143 IKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAPEVVTRKA-YGPKV 198
Query: 875 DVYGFGVLVLEVVTGKRP 892
           D++  G++ +E++ G+ P
Sbjct: 199 DIWSLGIMAIEMIEGEPP 216

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 698 LGRGGFGAVYRTVL----RDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVT 751
           LG G FG VY   +     D  P+ +   T+  +   Q+  DF  E   + K+ H N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEG----SGGNFLSWNERFNVIQGTAKSLAHLH 807
             G       + ++ E ++GG L   L E     S  + L+  +  +V +  A    +L 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 808 QSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
           +++ IH +I + N L+   G     K+GD+G+AR +     Y         + +M PE  
Sbjct: 159 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 218
Query: 865 CRTVKITDKCDVYGFGVLVLEVVT 888
              +  T K D + FGVL+ E+ +
Sbjct: 219 MEGI-FTSKTDTWSFGVLLWEIFS 241

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 698 LGRGGFGAVYRTVL----RDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVT 751
           LG G FG VY   +     D  P+ +   T+  +   Q+  DF  E   + K+ H N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEG----SGGNFLSWNERFNVIQGTAKSLAHLH 807
             G       + ++ E ++GG L   L E     S  + L+  +  +V +  A    +L 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 808 QSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
           +++ IH +I + N L+   G     K+GD+G+AR +     Y         + +M PE  
Sbjct: 173 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 232
Query: 865 CRTVKITDKCDVYGFGVLVLEVVT 888
              +  T K D + FGVL+ E+ +
Sbjct: 233 MEGI-FTSKTDTWSFGVLLWEIFS 255

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 11/200 (5%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G F  V      R  + VAIK +   +L   +   E E+  L K++HPN+V L+  Y
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
            +     LI + VSGG L   + E     F +  +   +I     ++ +LH   I+H ++
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLGIVHRDL 142
Query: 817 KSSNVL---IDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
           K  N+L   +D   +  + D+GL++   M D   + S      GY+APE   +    +  
Sbjct: 143 KPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQK-PYSKA 198
Query: 874 CDVYGFGVLVLEVVTGKRPL 893
            D +  GV+   ++ G  P 
Sbjct: 199 VDCWSIGVIAYILLCGYPPF 218

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 21/216 (9%)
Query: 697 ELGRGGFGAVYRTVLRDGRP------VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG   FG VY+  L    P      VAIK L   +    +E+F  E     +++HPN+V
Sbjct: 33  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 92
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHL-----HEGSGG--------NFLSWNERFNVIQ 797
            L G         +I+ + S G LH+ L     H   G         + L   +  +++ 
Sbjct: 93  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 152
Query: 798 GTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG 857
             A  + +L   +++H ++ + NVL+      K+ D GL R +   D Y L       + 
Sbjct: 153 QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR 212
Query: 858 YMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           +MAPE A    K +   D++ +GV++ EV + G +P
Sbjct: 213 WMAPE-AIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 21/216 (9%)
Query: 697 ELGRGGFGAVYRTVLRDGRP------VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG   FG VY+  L    P      VAIK L   +    +E+F  E     +++HPN+V
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHL-----HEGSGG--------NFLSWNERFNVIQ 797
            L G         +I+ + S G LH+ L     H   G         + L   +  +++ 
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 798 GTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG 857
             A  + +L   +++H ++ + NVL+      K+ D GL R +   D Y L       + 
Sbjct: 136 QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR 195
Query: 858 YMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           +MAPE A    K +   D++ +GV++ EV + G +P
Sbjct: 196 WMAPE-AIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 674 KLVMFSGDPDFSTGTHALLNKDCELGRGGFGAV-YRTVLRDGRPVAIKKLTVSSLVKSQE 732
           +LV+  GDP       + L+   ++G G  G V   TV   G+ VA+KK+ +    + + 
Sbjct: 141 QLVVDPGDP------RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL 194
Query: 733 DFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSL-----HKHLHEGSGGNFL 787
            F  EV  +   +H N+V +   Y       ++ EF+ GG+L     H  ++E       
Sbjct: 195 LFN-EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------- 246
Query: 788 SWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV 847
              +   V     ++L+ LH   +IH +IKS ++L+   G  K+ D+G       + + V
Sbjct: 247 --EQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCA---QVSKEV 301
Query: 848 LSSKIQSALGY-MAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
              K      Y MAPE   R +    + D++  G++V+E+V G+ P
Sbjct: 302 PRRKXLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 698 LGRGGFGAVYRTVL----RDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVT 751
           LG G FG VY   +     D  P+ +   T+  +   Q+  DF  E   + K  H N+V 
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEG----SGGNFLSWNERFNVIQGTAKSLAHLH 807
             G       + ++ E ++GG L   L E     S  + L+  +  +V +  A    +L 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 808 QSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
           +++ IH +I + N L+   G     K+GD+G+AR +     Y         + +M PE  
Sbjct: 150 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 209
Query: 865 CRTVKITDKCDVYGFGVLVLEVVT 888
              +  T K D + FGVL+ E+ +
Sbjct: 210 MEGI-FTSKTDTWSFGVLLWEIFS 232

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 698 LGRGGFGAVYRTVL----RDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVT 751
           LG G FG VY   +     D  P+ +   T+  +   Q+  DF  E   + K  H N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEG----SGGNFLSWNERFNVIQGTAKSLAHLH 807
             G       + ++ E ++GG L   L E     S  + L+  +  +V +  A    +L 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 808 QSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
           +++ IH +I + N L+   G     K+GD+G+AR +     Y         + +M PE  
Sbjct: 158 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 217
Query: 865 CRTVKITDKCDVYGFGVLVLEVVT 888
              +  T K D + FGVL+ E+ +
Sbjct: 218 MEGI-FTSKTDTWSFGVLLWEIFS 240

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 698 LGRGGFGAVYRTVL----RDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVT 751
           LG G FG VY   +     D  P+ +   T+  +   Q+  DF  E   + K  H N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEG----SGGNFLSWNERFNVIQGTAKSLAHLH 807
             G       + ++ E ++GG L   L E     S  + L+  +  +V +  A    +L 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 808 QSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
           +++ IH +I + N L+   G     K+GD+G+AR +     Y         + +M PE  
Sbjct: 158 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 217
Query: 865 CRTVKITDKCDVYGFGVLVLEVVT 888
              +  T K D + FGVL+ E+ +
Sbjct: 218 MEGI-FTSKTDTWSFGVLLWEIFS 240

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 697 ELGRGGFGAVYRTVLRDGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           ++G G FG     ++RD +    VA+K +     + +  + +RE+     +RHPN+V  +
Sbjct: 26  DIGSGNFGVA--RLMRDKQSNELVAVKYIERGEKIAA--NVKREIINHRSLRHPNIVRFK 81
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
               T +   ++ E+ SGG L + +   + G F     RF   Q     +++ H   + H
Sbjct: 82  EVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARF-FFQQLISGVSYCHAMQVCH 138
Query: 814 YNIKSSNVLIDGSGEP--KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTV 868
            ++K  N L+DGS  P  K+ D+G ++        VL S+ +S +G   Y+APE   +  
Sbjct: 139 RDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLKKE 192
Query: 869 KITDKCDVYGFGVLVLEVVTGKRPLS 894
                 DV+  GV +  ++ G  P  
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 115/236 (48%), Gaps = 15/236 (6%)
Query: 696 CE-LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKS----QEDFEREVKKLGKVRHPNL 749
           CE +G+G F  V R + R+ G+  A+K + V+    S     ED +RE      ++HP++
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAKSLAHLH 807
           V L   Y +  +  +++EF+ G  L   + + +   F+ ++E    + ++   ++L + H
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFV-YSEAVASHYMRQILEALRYCH 147
Query: 808 QSNIIHYNIKSSNVLI---DGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
            +NIIH ++K   VL+   + S   K+G +G+A  + + +  +++        +MAPE  
Sbjct: 148 DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVS 920
            R        DV+G GV++  +++G  P    K   +  +   +      +W ++S
Sbjct: 206 KRE-PYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHIS 260

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 698 LGRGGFGAVYRTVL----RDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVT 751
           LG G FG VY   +     D  P+ +   T+  +   Q+  DF  E   + K  H N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEG----SGGNFLSWNERFNVIQGTAKSLAHLH 807
             G       + ++ E ++GG L   L E     S  + L+  +  +V +  A    +L 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 808 QSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
           +++ IH +I + N L+   G     K+GD+G+AR +     Y         + +M PE  
Sbjct: 173 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 232
Query: 865 CRTVKITDKCDVYGFGVLVLEVVT 888
              +  T K D + FGVL+ E+ +
Sbjct: 233 MEGI-FTSKTDTWSFGVLLWEIFS 255

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 698 LGRGGFGAVYRTVL----RDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVT 751
           LG G FG VY   +     D  P+ +   T+  +   Q+  DF  E   + K  H N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEG----SGGNFLSWNERFNVIQGTAKSLAHLH 807
             G       + ++ E ++GG L   L E     S  + L+  +  +V +  A    +L 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 808 QSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
           +++ IH +I + N L+   G     K+GD+G+AR +     Y         + +M PE  
Sbjct: 159 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 218
Query: 865 CRTVKITDKCDVYGFGVLVLEVVT 888
              +  T K D + FGVL+ E+ +
Sbjct: 219 MEGI-FTSKTDTWSFGVLLWEIFS 241

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEG 754
           ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+V L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW-------NERFNVIQGTAKSLAHLH 807
              T++   L++EF     LH+ L +    + L+        +  F ++QG    L+  H
Sbjct: 70  VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LSFCH 120
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
              ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE     
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGC 178
Query: 868 VKITDKCDVYGFGVLVLEVVT 888
              +   D++  G +  E+VT
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT 199

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 698 LGRGGFGAVYRTVL----RDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVT 751
           LG G FG VY   +     D  P+ +   T+  +   Q+  DF  E   + K  H N+V 
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEG----SGGNFLSWNERFNVIQGTAKSLAHLH 807
             G       + ++ E ++GG L   L E     S  + L+  +  +V +  A    +L 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 808 QSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
           +++ IH +I + N L+   G     K+GD+G+AR +     Y         + +M PE  
Sbjct: 175 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 234
Query: 865 CRTVKITDKCDVYGFGVLVLEVVT 888
              +  T K D + FGVL+ E+ +
Sbjct: 235 MEGI-FTSKTDTWSFGVLLWEIFS 257

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 11/202 (5%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEG 754
           ELG+G F  V R V +   +  A K +    L  +  +  ERE +    ++HPN+V L  
Sbjct: 38  ELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 97
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
               +    L+++ V+GG L + +       + S  +  + I    +S+ H+HQ +I+H 
Sbjct: 98  SISEEGFHYLVFDLVTGGELFEDI---VAREYYSEADASHCIHQILESVNHIHQHDIVHR 154
Query: 815 NIKSSNVLIDGS---GEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           ++K  N+L+         K+ D+GLA  + +              GY++PE   R     
Sbjct: 155 DLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAWFGFAGTPGYLSPE-VLRKDPYG 211
Query: 872 DKCDVYGFGVLVLEVVTGKRPL 893
              D++  GV++  ++ G  P 
Sbjct: 212 KPVDIWACGVILYILLVGYPPF 233

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 698 LGRGGFGAVYRTVL----RDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVT 751
           LG G FG VY   +     D  P+ +   T+  +   Q+  DF  E   + K  H N+V 
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEG----SGGNFLSWNERFNVIQGTAKSLAHLH 807
             G       + ++ E ++GG L   L E     S  + L+  +  +V +  A    +L 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 808 QSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
           +++ IH +I + N L+   G     K+GD+G+AR +     Y         + +M PE  
Sbjct: 165 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 224
Query: 865 CRTVKITDKCDVYGFGVLVLEVVT 888
              +  T K D + FGVL+ E+ +
Sbjct: 225 MEGI-FTSKTDTWSFGVLLWEIFS 247

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     A+ + +L   
Sbjct: 80  LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAEGMNYLEDR 133
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E     + 
Sbjct: 134 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 192
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 193 YTHQSDVWSYGVTVWELMTFGSKP 216

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 91/179 (50%), Gaps = 11/179 (6%)
Query: 721 KLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH 779
           +  V  + KS+ D   E++ L +  +HPN++TL+  Y       L+ E + GG L   L 
Sbjct: 54  EYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL---LD 110
Query: 780 EGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVL-IDGSGEP---KVGDYG 835
           +     F S  E   V+    K++ +LH   ++H ++K SN+L +D SG P   ++ D+G
Sbjct: 111 KILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFG 170
Query: 836 LARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
            A+ L   +  +L +   +A  ++APE   R     + CD++  G+L+  ++ G  P +
Sbjct: 171 FAKQL-RAENGLLMTPCYTA-NFVAPEVLKRQ-GYDEGCDIWSLGILLYTMLAGYTPFA 226

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 674 KLVMFSGDPDFSTGTHALLNKDCELGRGGFGAV-YRTVLRDGRPVAIKKLTVSSLVKSQE 732
           +LV+  GDP       + L+   ++G G  G V   TV   G+ VA+KK+ +    + + 
Sbjct: 64  QLVVDPGDP------RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL 117
Query: 733 DFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSL-----HKHLHEGSGGNFL 787
            F  EV  +   +H N+V +   Y       ++ EF+ GG+L     H  ++E       
Sbjct: 118 LFN-EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------- 169
Query: 788 SWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV 847
              +   V     ++L+ LH   +IH +IKS ++L+   G  K+ D+G       + + V
Sbjct: 170 --EQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC---AQVSKEV 224
Query: 848 LSSKIQSALGY-MAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
              K      Y MAPE   R +    + D++  G++V+E+V G+ P
Sbjct: 225 PRRKXLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 87  LGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 140
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+G A+LL   ++   +   +  + +MA E     + 
Sbjct: 141 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 199
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 200 YTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           L  G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 90  LGICLTSTVQL-IMQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 143
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E     + 
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 202
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 203 YTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL++ + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 85  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 138
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+G A+LL   ++   +   +  + +MA E     + 
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 197
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 198 YTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 698 LGRGGFGAVY--------RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V         +   ++   VA+K L   +  K   D   E++ +  + +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH--EGSGGNF-----------LSWNERFNV 795
           ++TL G         +I E+ S G+L ++L      G  +           +++ +  + 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+  +   K+ D+GLAR +  +D Y  ++  +  
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     V  T + DV+ FGVL+ E+ T
Sbjct: 223 VKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL++ + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 85  LGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 138
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+G A+LL   ++   +   +  + +MA E     + 
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 197
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 198 YTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNL 749
             K  ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW----NERFNVIQGTAKSLAH 805
           V L     T++   L++EF+S     K   + S    +      +  F ++QG    LA 
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMDL--KDFMDASALTGIPLPLIKSYLFQLLQG----LAF 121
Query: 806 LHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFAC 865
            H   ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE   
Sbjct: 122 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 179
Query: 866 RTVKITDKCDVYGFGVLVLEVVTGK 890
                +   D++  G +  E+VT +
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYY 756
           +G G +    R V +        +  V  + KS+ D   E++ L +  +HPN++TL+  Y
Sbjct: 35  IGVGSYSECKRCVHK----ATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKDVY 90
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
                  L+ E + GG L   L +     F S  E   V+    K++ +LH   ++H ++
Sbjct: 91  DDGKHVYLVTELMRGGEL---LDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDL 147
Query: 817 KSSNVL-IDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           K SN+L +D SG P   ++ D+G A+ L   +  +++    +   ++APE   R     +
Sbjct: 148 KPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTA--NFVAPEVLKRQ-GYDE 204
Query: 873 KCDVYGFGVLVLEVVTGKRPLS 894
            CD++  G+L+  ++ G  P +
Sbjct: 205 GCDIWSLGILLYTMLAGYTPFA 226

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 698 LGRGGFGAVYRTVL----RDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVT 751
           LG G FG VY   +     D  P+ +   T+  +   Q+  DF  E   + K  H N+V 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEG----SGGNFLSWNERFNVIQGTAKSLAHLH 807
             G       + ++ E ++GG L   L E     S  + L+  +  +V +  A    +L 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 808 QSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
           +++ IH +I + N L+   G     K+GD+G+AR +     Y         + +M PE  
Sbjct: 199 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAF 258
Query: 865 CRTVKITDKCDVYGFGVLVLEVVT 888
              +  T K D + FGVL+ E+ +
Sbjct: 259 MEGI-FTSKTDTWSFGVLLWEIFS 281

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 698 LGRGGFGAVYRTVL----RDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVT 751
           LG G FG VY   +     D  P+ +   T+  +   Q+  DF  E   + K  H N+V 
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEG----SGGNFLSWNERFNVIQGTAKSLAHLH 807
             G       + ++ E ++GG L   L E     S  + L+  +  +V +  A    +L 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 808 QSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
           +++ IH +I + N L+   G     K+GD+G+AR +     Y         + +M PE  
Sbjct: 176 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAF 235
Query: 865 CRTVKITDKCDVYGFGVLVLEVVT 888
              +  T K D + FGVL+ E+ +
Sbjct: 236 MEGI-FTSKTDTWSFGVLLWEIFS 258

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNL 749
             K  ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW----NERFNVIQGTAKSLAH 805
           V L     T++   L++EF+S     K   + S    +      +  F ++QG    LA 
Sbjct: 67  VKLLDVIHTENKLYLVFEFLSMDL--KDFMDASALTGIPLPLIKSYLFQLLQG----LAF 120
Query: 806 LHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFAC 865
            H   ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE   
Sbjct: 121 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 178
Query: 866 RTVKITDKCDVYGFGVLVLEVVTGK 890
                +   D++  G +  E+VT +
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 674 KLVMFSGDPDFSTGTHALLNKDCELGRGGFGAV-YRTVLRDGRPVAIKKLTVSSLVKSQE 732
           +LV+  GDP       + L+   ++G G  G V   TV   G+ VA+KK+ +    + + 
Sbjct: 14  QLVVDPGDP------RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL 67
Query: 733 DFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSL-----HKHLHEGSGGNFL 787
            F  EV  +   +H N+V +   Y       ++ EF+ GG+L     H  ++E       
Sbjct: 68  LFN-EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------- 119
Query: 788 SWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV 847
              +   V     ++L+ LH   +IH +IKS ++L+   G  K+ D+G       + + V
Sbjct: 120 --EQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC---AQVSKEV 174
Query: 848 LSSKIQSALGY-MAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
              K      Y MAPE   R +    + D++  G++V+E+V G+ P
Sbjct: 175 PRRKXLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 674 KLVMFSGDPDFSTGTHALLNKDCELGRGGFGAV-YRTVLRDGRPVAIKKLTVSSLVKSQE 732
           +LV+  GDP       + L+   ++G G  G V   TV   G+ VA+KK+ +    + + 
Sbjct: 19  QLVVDPGDP------RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL 72
Query: 733 DFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSL-----HKHLHEGSGGNFL 787
            F  EV  +   +H N+V +   Y       ++ EF+ GG+L     H  ++E       
Sbjct: 73  LFN-EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------- 124
Query: 788 SWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV 847
              +   V     ++L+ LH   +IH +IKS ++L+   G  K+ D+G       + + V
Sbjct: 125 --EQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC---AQVSKEV 179
Query: 848 LSSKIQSALGY-MAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
              K      Y MAPE   R +    + D++  G++V+E+V G+ P
Sbjct: 180 PRRKXLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           L  G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 83  LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 136
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E     + 
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 195
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           L  G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 90  LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 143
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E     + 
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 202
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 203 YTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 674 KLVMFSGDPDFSTGTHALLNKDCELGRGGFGAV-YRTVLRDGRPVAIKKLTVSSLVKSQE 732
           +LV+  GDP       + L+   ++G G  G V   TV   G+ VA+KK+ +    + + 
Sbjct: 10  QLVVDPGDP------RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL 63
Query: 733 DFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSL-----HKHLHEGSGGNFL 787
            F  EV  +   +H N+V +   Y       ++ EF+ GG+L     H  ++E       
Sbjct: 64  LFN-EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------- 115
Query: 788 SWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV 847
              +   V     ++L+ LH   +IH +IKS ++L+   G  K+ D+G       + + V
Sbjct: 116 --EQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC---AQVSKEV 170
Query: 848 LSSKIQSALGY-MAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
              K      Y MAPE   R +    + D++  G++V+E+V G+ P
Sbjct: 171 PRRKXLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 90/179 (50%), Gaps = 11/179 (6%)
Query: 721 KLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH 779
           +  V  + KS+ D   E++ L +  +HPN++TL+  Y       ++ E + GG L   L 
Sbjct: 49  EFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL---LD 105
Query: 780 EGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVL-IDGSGEP---KVGDYG 835
           +     F S  E   V+    K++ +LH   ++H ++K SN+L +D SG P   ++ D+G
Sbjct: 106 KILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFG 165
Query: 836 LARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
            A+ L   +  +++    +   ++APE   R       CD++  GVL+  ++TG  P +
Sbjct: 166 FAKQLRAENGLLMTPCYTA--NFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFA 221

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 85  LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 138
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+G A+LL   ++   +   +  + +MA E     + 
Sbjct: 139 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 197
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 198 YTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQED------FEREVKKLGKVRHPNL 749
           ++G G +G V++   RD G+ VAIKK      ++S++D        RE++ L +++HPNL
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKF-----LESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHK--HLHEGSGGNFLSWNERFNVIQGTAKSLAHLH 807
           V L   +  +    L++E+     LH+      G   + +      ++   T +++   H
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVK-----SITWQTLQAVNFCH 119
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
           + N IH ++K  N+LI      K+ D+G ARLL     Y    ++ +   Y +PE     
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY-YDDEVATRW-YRSPELLVGD 177
Query: 868 VKITDKCDVYGFGVLVLEVVTG 889
            +     DV+  G +  E+++G
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSG 199

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G F  V+    R  G+  A+K +  S   +     E E+  L K++H N+VTLE  Y
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS-LENEIAVLKKIKHENIVTLEDIY 75
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
            + +   L+ + VSGG L   + E   G +   +    VIQ    ++ +LH++ I+H ++
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILE--RGVYTEKDASL-VIQQVLSAVKYLHENGIVHRDL 132
Query: 817 KSSNVLI---DGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
           K  N+L    + + +  + D+GL++   M    ++S+   +  GY+APE   +    +  
Sbjct: 133 KPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTACGTP-GYVAPEVLAQK-PYSKA 187
Query: 874 CDVYGFGVLVLEVVTGKRPL 893
            D +  GV+   ++ G  P 
Sbjct: 188 VDCWSIGVITYILLCGYPPF 207

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 674 KLVMFSGDPDFSTGTHALLNKDCELGRGGFGAV-YRTVLRDGRPVAIKKLTVSSLVKSQE 732
           +LV+  GDP       + L+   ++G G  G V   TV   G+ VA+KK+ +    + + 
Sbjct: 21  QLVVDPGDP------RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL 74
Query: 733 DFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSL-----HKHLHEGSGGNFL 787
            F  EV  +   +H N+V +   Y       ++ EF+ GG+L     H  ++E       
Sbjct: 75  LFN-EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------- 126
Query: 788 SWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV 847
              +   V     ++L+ LH   +IH +IKS ++L+   G  K+ D+G       + + V
Sbjct: 127 --EQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC---AQVSKEV 181
Query: 848 LSSKIQSALGY-MAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
              K      Y MAPE   R +    + D++  G++V+E+V G+ P
Sbjct: 182 PRRKXLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 83  LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 136
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+G A+LL   ++   +   +  + +MA E     + 
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 195
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAI +L  ++  K+ ++   E   +  V +P++  L
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 117 LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 170
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E     + 
Sbjct: 171 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 229
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 230 YTHQSDVWSYGVTVWELMTFGSKP 253

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 698 LGRGGFGAVYRTVL----RDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVT 751
           LG G FG VY   +     D  P+ +   T+  +   Q+  DF  E   + K  H N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEG----SGGNFLSWNERFNVIQGTAKSLAHLH 807
             G       + ++ E ++GG L   L E     S  + L+  +  +V +  A    +L 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 808 QSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
           +++ IH +I + N L+   G     K+GD+G+AR +     Y         + +M PE  
Sbjct: 173 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 232
Query: 865 CRTVKITDKCDVYGFGVLVLEVVT 888
              +  T K D + FGVL+ E+ +
Sbjct: 233 MEGI-FTSKTDTWSFGVLLWEIFS 255

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG VY+ + + +G     PVAIK+L  ++  K+ ++   E   +  V +P++  L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQS 809
            G   T ++QL I + +  G L  ++ E     G  +L      N     AK + +L   
Sbjct: 90  LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR 143
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            ++H ++ + NVL+      K+ D+G A+LL   ++   +   +  + +MA E     + 
Sbjct: 144 RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI- 202
Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T + DV+ +GV V E++T G +P
Sbjct: 203 YTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 697 ELGRGGFGAVYRTVLRDGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           ++G G FG     ++RD +    VA+K +      K  E+ +RE+     +RHPN+V  +
Sbjct: 26  DIGSGNFGVA--RLMRDKQSNELVAVKYIERGE--KIDENVKREIINHRSLRHPNIVRFK 81
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
               T +   ++ E+ SGG L + +   + G F     RF   Q     +++ H   + H
Sbjct: 82  EVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARF-FFQQLISGVSYCHAMQVCH 138
Query: 814 YNIKSSNVLIDGSGEP--KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTV 868
            ++K  N L+DGS  P  K+  +G ++        VL S+ +S +G   Y+APE   +  
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLKKE 192
Query: 869 KITDKCDVYGFGVLVLEVVTGKRPLS 894
                 DV+  GV +  ++ G  P  
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 697 ELGRGGFGAVYRTVLRDGR-PVAIKKLTVSSLVKSQ------------EDFEREVKKLGK 743
           +LG G +G V     ++G    AIK +  S   K +            E+   E+  L  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 744 VRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSL 803
           + HPN++ L   +  +    L+ EF  GG L + +      +     +  N+++     +
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---INRHKFDECDAANIMKQILSGI 159
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSG---EPKVGDYGLARLLPMLDRYVLSSKIQSALGYMA 860
            +LH+ NI+H +IK  N+L++        K+ D+GL+        Y L  ++ +A  Y+A
Sbjct: 160 CYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK--DYKLRDRLGTAY-YIA 216
Query: 861 PEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           PE   +  K  +KCDV+  GV++  ++ G  P 
Sbjct: 217 PEVLKK--KYNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEG 754
           ++G G +G VY+   +  G  VA+ K+ + +  +       RE+  L ++ HPN+V L  
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW-------NERFNVIQGTAKSLAHLH 807
              T++   L++EF     LH+ L +    + L+        +  F ++QG    LA  H
Sbjct: 70  VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LAFCH 120
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
              ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE     
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGC 178
Query: 868 VKITDKCDVYGFGVLVLEVVT 888
              +   D++  G +  E+VT
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEG 754
           ++G G +G VY+   +  G  VA+ K+ + +  +       RE+  L ++ HPN+V L  
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW-------NERFNVIQGTAKSLAHLH 807
              T++   L++EF     LH+ L +    + L+        +  F ++QG    LA  H
Sbjct: 69  VIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQG----LAFCH 119
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
              ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE     
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGC 177
Query: 868 VKITDKCDVYGFGVLVLEVVT 888
              +   D++  G +  E+VT
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVT 198

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 698 LGRGGFGAVYRTVL----RDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVT 751
           LG G FG VY   +     D  P+ +   T+  +   Q+  DF  E   + K  H N+V 
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEG----SGGNFLSWNERFNVIQGTAKSLAHLH 807
             G       + ++ E ++GG L   L E     S  + L+  +  +V +  A    +L 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 808 QSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
           +++ IH +I + N L+   G     K+GD+G+AR +     Y         + +M PE  
Sbjct: 185 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 244
Query: 865 CRTVKITDKCDVYGFGVLVLEVVT 888
              +  T K D + FGVL+ E+ +
Sbjct: 245 MEGI-FTSKTDTWSFGVLLWEIFS 267

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/242 (23%), Positives = 108/242 (44%), Gaps = 21/242 (8%)
Query: 694 KDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTL 752
           KD  LG G F    + V +        K+    +   + + ++E+  L     HPN+V L
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKL 71
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
              +  Q    L+ E ++GG L + + +       S  E   +++    +++H+H   ++
Sbjct: 72  HEVFHDQLHTFLVMELLNGGELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDVGVV 128
Query: 813 HYNIKSSNVLIDGSG---EPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           H ++K  N+L        E K+ D+G ARL P  D   L +   + L Y APE   +   
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPCFT-LHYAAPELLNQN-G 185
Query: 870 ITDKCDVYGFGVLVLEVVTGKRPLSTW-KMMWWFSVTWLEEHWKKAE-------WRNVSM 921
             + CD++  GV++  +++G+ P  +  + +   S   + +  KK +       W+NVS 
Sbjct: 186 YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ 245
Query: 922 RS 923
            +
Sbjct: 246 EA 247

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLEG 754
           +G+G FG V      D + + A+K +     V+  E  +  +E++ +  + HP LV L  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +  +    ++ + + GG L  HL +    +F     +  + +    +L +L    IIH 
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICE-LVMALDYLQNQRIIHR 139
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE-FACRT-VKITD 872
           ++K  N+L+D  G   + D+ +A +LP   R    + +     YMAPE F+ R     + 
Sbjct: 140 DMKPDNILLDEHGHVHITDFNIAAMLP---RETQITTMAGTKPYMAPEMFSSRKGAGYSF 196
Query: 873 KCDVYGFGVLVLEVVTGKRP 892
             D +  GV   E++ G+RP
Sbjct: 197 AVDWWSLGVTAYELLRGRRP 216

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 54/206 (26%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 696 CELGRGGFGAVYRTVLR-DGRPVAIKKLT-VSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           C LG+G FG V +   R   +  A+K +   S+  K      REV+ L K+ HPN++ L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
                 S   ++ E  +GG L   + +       S ++   +I+     + ++H+ NI+H
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 814 YNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRT 867
            ++K  N+L++   +    K+ D+GL+           ++K++  +G   Y+APE    T
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQ------NTKMKDRIGTAYYIAPEVLRGT 198
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
               +KCDV+  GV++  +++G  P 
Sbjct: 199 YD--EKCDVWSAGVILYILLSGTPPF 222

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 54/206 (26%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 696 CELGRGGFGAVYRTVLR-DGRPVAIKKLT-VSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           C LG+G FG V +   R   +  A+K +   S+  K      REV+ L K+ HPN++ L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
                 S   ++ E  +GG L   + +       S ++   +I+     + ++H+ NI+H
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 814 YNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRT 867
            ++K  N+L++   +    K+ D+GL+           ++K++  +G   Y+APE    T
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQ------NTKMKDRIGTAYYIAPEVLRGT 198
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
               +KCDV+  GV++  +++G  P 
Sbjct: 199 YD--EKCDVWSAGVILYILLSGTPPF 222

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 98/200 (49%), Gaps = 10/200 (5%)
Query: 698 LGRGGFGAV-YRTVLRDGRPVAIKKLTVSSLVKSQEDF--EREVKKLGKVRHPNLVTLEG 754
           LG G FG V   T  +  + VA+K ++   L KS      ERE+  L  +RHP+++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
              T +  +++ E+ +GG L  ++ E      ++ +E     Q    ++ + H+  I+H 
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYIVEKKR---MTEDEGRRFFQQIICAIEYCHRHKIVHR 132
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+L+D +   K+ D+GL+ +  M D   L +   S   Y APE     +    + 
Sbjct: 133 DLKPENLLLDDNLNVKIADFGLSNI--MTDGNFLKTSCGSP-NYAAPEVINGKLYAGPEV 189
Query: 875 DVYGFGVLVLEVVTGKRPLS 894
           DV+  G+++  ++ G+ P  
Sbjct: 190 DVWSCGIVLYVMLVGRLPFD 209

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 698 LGRGGFGAVYRTV---LRDGRP-----VAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V       L   +P     VA+K L   +  K   D   E++ +  + +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH--EGSGGNF-----------LSWNERFNV 795
           ++ L G         +I E+ S G+L ++L   E  G  +           LS  +  + 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+      K+ D+GLAR +  +D Y  ++  +  
Sbjct: 156 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 215
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     +  T + DV+ FGVL+ E+ T
Sbjct: 216 VKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 247

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 97/227 (42%), Gaps = 18/227 (7%)
Query: 685 STGTHALLNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGK 743
           ST  H  L  D  LG+G    V+R   +  G   AIK     S ++  +   RE + L K
Sbjct: 5   STSNHLWLLSDI-LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63
Query: 744 VRHPNLVTLEGYY--WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAK 801
           + H N+V L       T   ++LI EF   GSL+  L E S    L  +E   V++    
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 802 SLAHLHQSNIIHYNIKSSNVLI----DGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG 857
            + HL ++ I+H NIK  N++     DG    K+ D+G AR L   +++V     +    
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEE--- 180
Query: 858 YMAPEFACRTVKITDKCDVYG-------FGVLVLEVVTGKRPLSTWK 897
           Y+ P+   R V   D    YG        GV      TG  P   ++
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 12/206 (5%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V     +  G  VAIKK+             RE+K L   +H N++T+    
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              S +     ++    +   LH       LS +     I  T +++  LH SN+IH ++
Sbjct: 79  RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDL 138
Query: 817 KSSNVLIDGSGEPKVGDYGLARLL---------PMLDRYVLSSKIQSALGYMAPEFACRT 867
           K SN+LI+ + + KV D+GLAR++         P   +  ++  + +   Y APE    +
Sbjct: 139 KPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATR-WYRAPEVMLTS 197
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
            K +   DV+  G ++ E+   +RP+
Sbjct: 198 AKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 104/208 (50%), Gaps = 26/208 (12%)
Query: 698 LGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQEDFE---REVKKLGKVRHPNLVT 751
           LG+G FG V   + +D   G+  A+K ++    VK + D E   REV+ L ++ HPN++ 
Sbjct: 34  LGKGSFGEV--ILCKDKITGQECAVKVIS-KRQVKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L  ++  +    L+ E  +GG L     E       S  +   +I+     + ++H++ I
Sbjct: 91  LYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDAARIIRQVLSGITYMHKNKI 147
Query: 812 IHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFAC 865
           +H ++K  N+L++   +    ++ D+GL+        +  S K++  +G   Y+APE   
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLST------HFEASKKMKDKIGTAYYIAPEVLH 201
Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRPL 893
            T    +KCDV+  GV++  +++G  P 
Sbjct: 202 GTY--DEKCDVWSTGVILYILLSGCPPF 227

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG+G +G VY    L +   +AIK++       SQ     E+     ++H N+V   G +
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-LHEEIALHKHLKHKNIVQYLGSF 88
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNER---FNVIQGTAKSLAHLHQSNIIH 813
                  +  E V GGSL   L    G   L  NE+   F   Q   + L +LH + I+H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGP--LKDNEQTIGFYTKQ-ILEGLKYLHDNQIVH 145
Query: 814 YNIKSSNVLIDG-SGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
            +IK  NVLI+  SG  K+ D+G ++ L  ++    +      L YMAPE   +  +   
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYG 203
Query: 873 K-CDVYGFGVLVLEVVTGKRPL 893
           K  D++  G  ++E+ TGK P 
Sbjct: 204 KAADIWSLGCTIIEMATGKPPF 225

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG+G +G VY    L +   +AIK++       SQ     E+     ++H N+V   G +
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-LHEEIALHKHLKHKNIVQYLGSF 74
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNER---FNVIQGTAKSLAHLHQSNIIH 813
                  +  E V GGSL   L    G   L  NE+   F   Q   + L +LH + I+H
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGP--LKDNEQTIGFYTKQ-ILEGLKYLHDNQIVH 131
Query: 814 YNIKSSNVLIDG-SGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
            +IK  NVLI+  SG  K+ D+G ++ L  ++    +      L YMAPE   +  +   
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYG 189
Query: 873 K-CDVYGFGVLVLEVVTGKRPL 893
           K  D++  G  ++E+ TGK P 
Sbjct: 190 KAADIWSLGCTIIEMATGKPPF 211

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 698 LGRGGFGAVYRTVLRDGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           LG G F  V   +  D R    VAIK +   +L   +   E E+  L K++HPN+V L+ 
Sbjct: 26  LGTGAFSEV--ILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            Y +     LI + VSGG L   + E     F +  +   +I     ++ +LH   I+H 
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLGIVHR 140
Query: 815 NIKSSNVL---IDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           ++K  N+L   +D   +  + D+GL++   M D   + S      GY+APE   +    +
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQK-PYS 196
Query: 872 DKCDVYGFGVLVLEVVTGKRPL 893
              D +  GV+   ++ G  P 
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPF 218

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 106/224 (47%), Gaps = 8/224 (3%)
Query: 673 GKLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTV--LRDGRPVAIKKLTVSSLVKS 730
           G++ M  G P F  G      +   +G G +G V      +R  R VAIKK++       
Sbjct: 29  GEVEMVKGQP-FDVGPR--YTQLQYIGEGAYGMVSSAYDHVRKTR-VAIKKISPFEHQTY 84
Query: 731 QEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWN 790
            +   RE++ L + RH N++ +       +L+ +   ++    +   L++      LS +
Sbjct: 85  CQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSND 144
Query: 791 ERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLS 849
                +    + L ++H +N++H ++K SN+LI+ + + K+ D+GLAR+  P  D     
Sbjct: 145 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFL 204
Query: 850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           ++  +   Y APE    +   T   D++  G ++ E+++  RP+
Sbjct: 205 TEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGY 755
           ++G G +    R + +        +  V  + KS+ D   E++ L +  +HPN++TL+  
Sbjct: 29  DIGVGSYSVCKRCIHK----ATNXEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDV 84
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           Y       ++ E   GG L   L +     F S  E   V+    K++ +LH   ++H +
Sbjct: 85  YDDGKYVYVVTELXKGGEL---LDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRD 141
Query: 816 IKSSNVL-IDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +K SN+L +D SG P   ++ D+G A+ L   +  +L +   +A  ++APE   R     
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLXTPCYTA-NFVAPEVLERQ-GYD 198
Query: 872 DKCDVYGFGVLVLEVVTGKRPLS 894
             CD++  GVL+   +TG  P +
Sbjct: 199 AACDIWSLGVLLYTXLTGYTPFA 221

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 698 LGRGGFGAVYRTVLRDGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           LG G F  V   +  D R    VAIK +   +L   +   E E+  L K++HPN+V L+ 
Sbjct: 26  LGTGAFSEV--ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            Y +     LI + VSGG L   + E     F +  +   +I     ++ +LH   I+H 
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLGIVHR 140
Query: 815 NIKSSNVL---IDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           ++K  N+L   +D   +  + D+GL++   M D   + S      GY+APE   +    +
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQK-PYS 196
Query: 872 DKCDVYGFGVLVLEVVTGKRPL 893
              D +  GV+   ++ G  P 
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPF 218

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVK----SQEDFEREVKKLGKVRHPNLVTL 752
           +LGRG FG V+R V       + KK  ++  VK     Q   ++E+  L   RH N++ L
Sbjct: 12  DLGRGEFGIVHRCV-----ETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNER--FNVIQGTAKSLAHLHQSN 810
              + +    ++I+EF+SG  + + ++  +       NER   + +    ++L  LH  N
Sbjct: 67  HESFESMEELVMIFEFISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHSHN 122
Query: 811 IIHYNIKSSNVLIDG--SGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTV 868
           I H++I+  N++     S   K+ ++G AR L   D + L   + +A  Y APE     V
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDV 179
Query: 869 KITDKCDVYGFGVLVLEVVTGKRPL 893
            ++   D++  G LV  +++G  P 
Sbjct: 180 -VSTATDMWSLGTLVYVLLSGINPF 203

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 698 LGRGGFGAVYRTVL--RDGRPV--AIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +GRG FG VY   L   DG+ +  A+K L   + +     F  E   +    HPN+++L 
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 754 GYYW-TQSLQLLIYEFVSGGSLHKHL----HEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           G    ++   L++  ++  G L   +    H  +  + + +  +       AK + +L  
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYLAS 169
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL--GYMAPEFACR 866
              +H ++ + N ++D     KV D+GLAR +   + Y + +K  + L   +MA E + +
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-SLQ 228
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRP 892
           T K T K DV+ FGVL+ E++T   P
Sbjct: 229 TQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 698 LGRGGFGAVYRTVL----RDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVT 751
           LG G FG VY   +     D  P+ +   T+  +   Q+  DF  E   + K  H N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEG----SGGNFLSWNERFNVIQGTAKSLAHLH 807
             G       + ++ E ++GG L   L E     S  + L+  +  +V +  A    +L 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 808 QSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
           +++ IH +I + N L+   G     K+GD+G+A+ +     Y         + +M PE  
Sbjct: 159 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAF 218
Query: 865 CRTVKITDKCDVYGFGVLVLEVVT 888
              +  T K D + FGVL+ E+ +
Sbjct: 219 MEGI-FTSKTDTWSFGVLLWEIFS 241

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 698 LGRGGFGAV---YRTVLRDGRPVAIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTL 752
           LG G FG V   Y T    G+ VA+K +    L KS  Q   ERE+  L  +RHP+++ L
Sbjct: 21  LGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 78
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
                ++   +++ E+ +G  L  ++ +      +S  E     Q    ++ + H+  I+
Sbjct: 79  YDVIKSKDEIIMVIEY-AGNELFDYIVQRDK---MSEQEARRFFQQIISAVEYCHRHKIV 134
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           H ++K  N+L+D     K+ D+GL+ +  M D   L +   S   Y APE     +    
Sbjct: 135 HRDLKPENLLLDEHLNVKIADFGLSNI--MTDGNFLKTSCGSP-NYAAPEVISGKLYAGP 191
Query: 873 KCDVYGFGVLVLEVVTGKRPLS 894
           + DV+  GV++  ++  + P  
Sbjct: 192 EVDVWSCGVILYVMLCRRLPFD 213

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 698 LGRGGFGAVYRTVL--RDGRPV--AIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +GRG FG VY   L   DG+ +  A+K L   + +     F  E   +    HPN+++L 
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 754 GYYW-TQSLQLLIYEFVSGGSLHKHL----HEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           G    ++   L++  ++  G L   +    H  +  + + +  +       AK + +L  
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYLAS 170
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL--GYMAPEFACR 866
              +H ++ + N ++D     KV D+GLAR +   + Y + +K  + L   +MA E + +
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-SLQ 229
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRP 892
           T K T K DV+ FGVL+ E++T   P
Sbjct: 230 TQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 697 ELGRGGFGAV----YRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG+G FG+V    Y  +  + G  VA+K+L  S     Q DF+RE++ L  +    +V 
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVK 72
Query: 752 LEGY-YWTQSLQL-LIYEFVSGGSL----HKHLHEGSGGNFLSWNERFNVIQGTAKSLAH 805
             G  Y     +L L+ E++  G L     +H         L ++ +        K + +
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI------CKGMEY 126
Query: 806 LHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPEFA 864
           L     +H ++ + N+L++     K+ D+GLA+LLP+  D  V+    QS + + APE  
Sbjct: 127 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESL 186
Query: 865 CRTVKITDKCDVYGFGVLVLEVVT 888
              +  + + DV+ FGV++ E+ T
Sbjct: 187 SDNI-FSRQSDVWSFGVVLYELFT 209

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 698 LGRGGFGAVYRTVLRDGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           LG G F  V   +  D R    VAIK +   +L   +   E E+  L K++HPN+V L+ 
Sbjct: 26  LGTGAFSEV--ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            Y +     LI + VSGG L   + E     F +  +   +I     ++ +LH   I+H 
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLGIVHR 140
Query: 815 NIKSSNVL---IDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           ++K  N+L   +D   +  + D+GL++   M D   + S      GY+APE   +    +
Sbjct: 141 DLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQK-PYS 196
Query: 872 DKCDVYGFGVLVLEVVTGKRPL 893
              D +  GV+   ++ G  P 
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPF 218

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 12/206 (5%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V     +  G  VAIKK+             RE+K L   +H N++T+    
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              S +     ++    +   LH       LS +     I  T +++  LH SN+IH ++
Sbjct: 79  RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDL 138
Query: 817 KSSNVLIDGSGEPKVGDYGLARLL---------PMLDRYVLSSKIQSALGYMAPEFACRT 867
           K SN+LI+ + + KV D+GLAR++         P   +  ++  + +   Y APE    +
Sbjct: 139 KPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATR-WYRAPEVMLTS 197
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
            K +   DV+  G ++ E+   +RP+
Sbjct: 198 AKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/209 (26%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 698 LGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQEDFE---REVKKLGKVRHPNLVT 751
           LG+G FG V   + +D   G+  A+K ++    VK + D E   REV+ L ++ HPN++ 
Sbjct: 40  LGKGSFGEV--ILCKDKITGQECAVKVIS-KRQVKQKTDKESLLREVQLLKQLDHPNIMK 96
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L  ++  +    L+ E  +GG L     E       S  +   +I+     + ++H++ I
Sbjct: 97  LYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDAARIIRQVLSGITYMHKNKI 153
Query: 812 IHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFAC 865
           +H ++K  N+L++   +    ++ D+GL+        +  S K++  +G   Y+APE   
Sbjct: 154 VHRDLKPENLLLESKSKDANIRIIDFGLS------THFEASKKMKDKIGTAYYIAPEVLH 207
Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
            T    +KCDV+  GV++  +++G  P +
Sbjct: 208 GTYD--EKCDVWSTGVILYILLSGCPPFN 234

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 692 LNKDCELGRGGFGAVY-----RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH 746
           L K  +LG G FG V       T    G  VA+K L      + +  ++RE++ L  + H
Sbjct: 10  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYH 69
Query: 747 PNLVTLEGYYWTQ---SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSL 803
            ++V  +G    Q   S+QL++ E+V  GSL  +L     G      +     Q   + +
Sbjct: 70  EHIVKYKGCCEDQGEKSVQLVM-EYVPLGSLRDYLPRHCVG----LAQLLLFAQQICEGM 124
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPE 862
           A+LH  + IH  + + NVL+D     K+GD+GLA+ +P   + Y +     S + + APE
Sbjct: 125 AYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 184
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVT 888
              +  K     DV+ FGV + E++T
Sbjct: 185 -CLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 692 LNKDCELGRGGFGAVY-----RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH 746
           L K  +LG G FG V       T    G  VA+K L      + +  ++RE++ L  + H
Sbjct: 11  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYH 70
Query: 747 PNLVTLEGYYWTQ---SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSL 803
            ++V  +G    Q   S+QL++ E+V  GSL  +L     G      +     Q   + +
Sbjct: 71  EHIVKYKGCCEDQGEKSVQLVM-EYVPLGSLRDYLPRHCVG----LAQLLLFAQQICEGM 125
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPE 862
           A+LH  + IH  + + NVL+D     K+GD+GLA+ +P   + Y +     S + + APE
Sbjct: 126 AYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 185
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVT 888
              +  K     DV+ FGV + E++T
Sbjct: 186 -CLKECKFYYASDVWSFGVTLYELLT 210

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 8/203 (3%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE--REVKKLGKVRHPNLVTLEG 754
           LG+GGFG V    +R  G+  A KKL    + K + +     E + L KV    +V+L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            Y T+    L+   ++GG L  H++      F      F   +     L  LH+  I++ 
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLHRERIVYR 310
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+L+D  G  ++ D GLA  +P  +   +  ++   +GYMAPE   +  + T   
Sbjct: 311 DLKPENILLDDHGHIRISDLGLAVHVP--EGQTIKGRV-GTVGYMAPEVV-KNERYTFSP 366
Query: 875 DVYGFGVLVLEVVTGKRPLSTWK 897
           D +  G L+ E++ G+ P    K
Sbjct: 367 DWWALGCLLYEMIAGQSPFQQRK 389

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 8/203 (3%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE--REVKKLGKVRHPNLVTLEG 754
           LG+GGFG V    +R  G+  A KKL    + K + +     E + L KV    +V+L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            Y T+    L+   ++GG L  H++      F      F   +     L  LH+  I++ 
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLHRERIVYR 310
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+L+D  G  ++ D GLA  +P  +   +  ++   +GYMAPE   +  + T   
Sbjct: 311 DLKPENILLDDHGHIRISDLGLAVHVP--EGQTIKGRV-GTVGYMAPEVV-KNERYTFSP 366
Query: 875 DVYGFGVLVLEVVTGKRPLSTWK 897
           D +  G L+ E++ G+ P    K
Sbjct: 367 DWWALGCLLYEMIAGQSPFQQRK 389

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 19/220 (8%)
Query: 698 LGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQEDFER--EVKKLGKVRHPNLVTL 752
           LG+G FG V   ++R+   GR  A+K L    ++   E      E + L   RHP L  L
Sbjct: 13  LGKGTFGKV--ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           +  + T      + E+ +GG L  HL       F     RF   +    +L +LH  +++
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRDVV 127
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVK 869
           + +IK  N+++D  G  K+ D+GL +     +     + +++  G   Y+APE       
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAPE-VLEDND 181
Query: 870 ITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE 909
                D +G GV++ E++ G+ P         F +  +EE
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 97/227 (42%), Gaps = 18/227 (7%)
Query: 685 STGTHALLNKDCELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGK 743
           ST  H  L  D  LG+G    V+R    + G   AIK     S ++  +   RE + L K
Sbjct: 5   STSNHLWLLSDI-LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63
Query: 744 VRHPNLVTLEGYY--WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAK 801
           + H N+V L       T   ++LI EF   GSL+  L E S    L  +E   V++    
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 802 SLAHLHQSNIIHYNIKSSNVLI----DGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG 857
            + HL ++ I+H NIK  N++     DG    K+ D+G AR L   +++V    +     
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV---SLYGTEE 180
Query: 858 YMAPEFACRTVKITDKCDVYG-------FGVLVLEVVTGKRPLSTWK 897
           Y+ P+   R V   D    YG        GV      TG  P   ++
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 698 LGRGGFGAVYRTVL--RDGRPV--AIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +GRG FG VY   L   DG+ +  A+K L   + +     F  E   +    HPN+++L 
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 754 GYYW-TQSLQLLIYEFVSGGSLHKHL----HEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           G    ++   L++  ++  G L   +    H  +  + + +  +       AK + +L  
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYLAS 143
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL--GYMAPEFACR 866
              +H ++ + N ++D     KV D+GLAR +   + Y + +K  + L   +MA E + +
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-SLQ 202
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRP 892
           T K T K DV+ FGVL+ E++T   P
Sbjct: 203 TQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G F  V     +  G+  A+K +   +L   +   E E+  L K++H N+V LE  Y
Sbjct: 30  LGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIY 89
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
            + +   L+ + VSGG L   + E     F +  +   +I+    ++ +LH+  I+H ++
Sbjct: 90  ESPNHLYLVMQLVSGGELFDRIVE---KGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDL 146
Query: 817 KSSNVLI---DGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
           K  N+L    D   +  + D+GL+++    D  V+S+   +  GY+APE   +    +  
Sbjct: 147 KPENLLYYSQDEESKIMISDFGLSKMEGKGD--VMSTACGTP-GYVAPEVLAQK-PYSKA 202
Query: 874 CDVYGFGVLVLEVVTGKRPL 893
            D +  GV+   ++ G  P 
Sbjct: 203 VDCWSIGVIAYILLCGYPPF 222

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 104/208 (50%), Gaps = 26/208 (12%)
Query: 698 LGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQEDFE---REVKKLGKVRHPNLVT 751
           LG+G FG V   + +D   G+  A+K ++    VK + D E   REV+ L ++ HPN++ 
Sbjct: 57  LGKGSFGEV--ILCKDKITGQECAVKVIS-KRQVKQKTDKESLLREVQLLKQLDHPNIMK 113
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L  ++  +    L+ E  +GG L     E       S  +   +I+     + ++H++ I
Sbjct: 114 LYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDAARIIRQVLSGITYMHKNKI 170
Query: 812 IHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFAC 865
           +H ++K  N+L++   +    ++ D+GL+        +  S K++  +G   Y+APE   
Sbjct: 171 VHRDLKPENLLLESKSKDANIRIIDFGLST------HFEASKKMKDKIGTAYYIAPEVLH 224
Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRPL 893
            T    +KCDV+  GV++  +++G  P 
Sbjct: 225 GTY--DEKCDVWSTGVILYILLSGCPPF 250

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 698 LGRGGFGAVYRTV---LRDGRP-----VAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V       L   +P     VA+K L   +  K   D   E++ +  + +H N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH-EGSGGNFLSWNERFN------------V 795
           ++ L G         +I E+ S G+L ++L      G   S+N   N             
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+      K+ D+GLAR +  +D Y  ++  +  
Sbjct: 197 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 256
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     +  T + DV+ FGVL+ E+ T
Sbjct: 257 VKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 288

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 11/202 (5%)
Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEG 754
           ELG+G F  V R V +  G+  A K +    L  +  +  ERE +    ++HPN+V L  
Sbjct: 29  ELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 88
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
               +    LI++ V+GG L + +       + S  +  + IQ   +++ H HQ  ++H 
Sbjct: 89  SISEEGHHYLIFDLVTGGELFEDI---VAREYYSEADASHCIQQILEAVLHCHQMGVVHR 145
Query: 815 NIKSSNVLIDGS---GEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           ++K  N+L+         K+ D+GLA  + +              GY++PE   R     
Sbjct: 146 DLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLSPE-VLRKDPYG 202
Query: 872 DKCDVYGFGVLVLEVVTGKRPL 893
              D++  GV++  ++ G  P 
Sbjct: 203 KPVDLWACGVILYILLVGYPPF 224

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 698 LGRGGFGAVYRTVL--RDGRPV--AIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +GRG FG VY   L   DG+ +  A+K L   + +     F  E   +    HPN+++L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 754 GYYW-TQSLQLLIYEFVSGGSLHKHL----HEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           G    ++   L++  ++  G L   +    H  +  + + +  +       AK + +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYLAS 151
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL--GYMAPEFACR 866
              +H ++ + N ++D     KV D+GLAR +   + Y + +K  + L   +MA E + +
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-SLQ 210
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRP 892
           T K T K DV+ FGVL+ E++T   P
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 104/208 (50%), Gaps = 26/208 (12%)
Query: 698 LGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQEDFE---REVKKLGKVRHPNLVT 751
           LG+G FG V   + +D   G+  A+K ++    VK + D E   REV+ L ++ HPN++ 
Sbjct: 58  LGKGSFGEV--ILCKDKITGQECAVKVIS-KRQVKQKTDKESLLREVQLLKQLDHPNIMK 114
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L  ++  +    L+ E  +GG L     E       S  +   +I+     + ++H++ I
Sbjct: 115 LYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDAARIIRQVLSGITYMHKNKI 171
Query: 812 IHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFAC 865
           +H ++K  N+L++   +    ++ D+GL+        +  S K++  +G   Y+APE   
Sbjct: 172 VHRDLKPENLLLESKSKDANIRIIDFGLST------HFEASKKMKDKIGTAYYIAPEVLH 225
Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRPL 893
            T    +KCDV+  GV++  +++G  P 
Sbjct: 226 GTY--DEKCDVWSTGVILYILLSGCPPF 251

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 697 ELGRGGFGAVYRTVLRDGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           ++G G FG     ++RD +    VA+K +      K  E+ +RE+     +RHPN+V  +
Sbjct: 26  DIGSGNFGVA--RLMRDKQSNELVAVKYIERGE--KIDENVKREIINHRSLRHPNIVRFK 81
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
               T +   ++ E+ SGG L + +   + G F     RF   Q     +++ H   + H
Sbjct: 82  EVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARF-FFQQLISGVSYCHAMQVCH 138
Query: 814 YNIKSSNVLIDGSGEP--KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTV 868
            ++K  N L+DGS  P  K+  +G ++        VL S+ +  +G   Y+APE   +  
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSK------SSVLHSQPKDTVGTPAYIAPEVLLKKE 192
Query: 869 KITDKCDVYGFGVLVLEVVTGKRPLS 894
                 DV+  GV +  ++ G  P  
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 108/235 (45%), Gaps = 20/235 (8%)
Query: 665 SPTTDANSGKLVMFSGDPDFSTGTH-ALLNKDCE-LGRGGFGAVYRTVLRDGRPVAIKKL 722
           +P  D N    V+ S   D  TG    +   +C+ +G G FG V++  L +   VAIKK+
Sbjct: 16  NPLDDPNKVIKVLAS---DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV 72
Query: 723 TVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWT------QSLQLLIYEFVSGGSLHK 776
                 K+     RE++ +  V+HPN+V L+ ++++      +    L+ E+V       
Sbjct: 73  LQDKRFKN-----RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRA 127
Query: 777 HLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYG 835
             H       +        +    +SLA++H   I H +IK  N+L+D  SG  K+ D+G
Sbjct: 128 SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG 187
Query: 836 LARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGK 890
            A++L   +  V  S I S   Y APE        T   D++  G ++ E++ G+
Sbjct: 188 SAKILIAGEPNV--SXICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEG 754
           ELG+G F  V R + +  G+  A K +    L  +  +  ERE +    ++HPN+V L  
Sbjct: 11  ELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 70
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
               +    L+++ V+GG L + +       + S  +  + IQ   +S+ H H + I+H 
Sbjct: 71  SISEEGFHYLVFDLVTGGELFEDI---VAREYYSEADASHCIQQILESVNHCHLNGIVHR 127
Query: 815 NIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           ++K  N+L+    +    K+ D+GLA  + +              GY++PE   R     
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPE-VLRKDPYG 184
Query: 872 DKCDVYGFGVLVLEVVTGKRPL 893
              D++  GV++  ++ G  P 
Sbjct: 185 KPVDMWACGVILYILLVGYPPF 206

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 19/220 (8%)
Query: 698 LGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQEDFER--EVKKLGKVRHPNLVTL 752
           LG+G FG V   ++R+   GR  A+K L    ++   E      E + L   RHP L  L
Sbjct: 16  LGKGTFGKV--ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 73
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           +  + T      + E+ +GG L  HL       F     RF   +    +L +LH  +++
Sbjct: 74  KYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRDVV 130
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVK 869
           + +IK  N+++D  G  K+ D+GL +     +     + +++  G   Y+APE       
Sbjct: 131 YRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAPE-VLEDND 184
Query: 870 ITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE 909
                D +G GV++ E++ G+ P         F +  +EE
Sbjct: 185 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 224

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 698 LGRGGFGAVYRTVL--RDGRPV--AIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +GRG FG VY   L   DG+ +  A+K L   + +     F  E   +    HPN+++L 
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 754 GYYW-TQSLQLLIYEFVSGGSLHKHL----HEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           G    ++   L++  ++  G L   +    H  +  + + +  +       AK + +L  
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYLAS 148
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL--GYMAPEFACR 866
              +H ++ + N ++D     KV D+GLAR +   + Y + +K  + L   +MA E + +
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-SLQ 207
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRP 892
           T K T K DV+ FGVL+ E++T   P
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 20/201 (9%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEG 754
           ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+V L  
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW-------NERFNVIQGTAKSLAHLH 807
              T++   L++E V     H+ L      + L+        +  F ++QG    LA  H
Sbjct: 69  VIHTENKLYLVFEHV-----HQDLKTFMDASALTGIPLPLIKSYLFQLLQG----LAFCH 119
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
              ++H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE     
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGC 177
Query: 868 VKITDKCDVYGFGVLVLEVVT 888
              +   D++  G +  E+VT
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVT 198

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 698 LGRGGFGAV---YRTVLRDGRPVAIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTL 752
           LG G FG V   Y T    G+ VA+K +    L KS  Q   ERE+  L  +RHP+++ L
Sbjct: 12  LGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 69
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
                ++   +++ E+ +G  L  ++ +      +S  E     Q    ++ + H+  I+
Sbjct: 70  YDVIKSKDEIIMVIEY-AGNELFDYIVQRDK---MSEQEARRFFQQIISAVEYCHRHKIV 125
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           H ++K  N+L+D     K+ D+GL+ +  M D   L +   S   Y APE     +    
Sbjct: 126 HRDLKPENLLLDEHLNVKIADFGLSNI--MTDGNFLKTSCGSP-NYAAPEVISGKLYAGP 182
Query: 873 KCDVYGFGVLVLEVVTGKRPL 893
           + DV+  GV++  ++  + P 
Sbjct: 183 EVDVWSCGVILYVMLCRRLPF 203

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 698 LGRGGFGAVYRTVL--RDGRPV--AIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +GRG FG VY   L   DG+ +  A+K L   + +     F  E   +    HPN+++L 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 754 GYYW-TQSLQLLIYEFVSGGSLHKHL----HEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           G    ++   L++  ++  G L   +    H  +  + + +  +       AK + +L  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYLAS 149
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL--GYMAPEFACR 866
              +H ++ + N ++D     KV D+GLAR +   + Y + +K  + L   +MA E + +
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-SLQ 208
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRP 892
           T K T K DV+ FGVL+ E++T   P
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 698 LGRGGFGAV---YRTVLRDGRPVAIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTL 752
           LG G FG V   Y T    G+ VA+K +    L KS  Q   ERE+  L  +RHP+++ L
Sbjct: 22  LGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 79
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
                ++   +++ E+ +G  L  ++ +      +S  E     Q    ++ + H+  I+
Sbjct: 80  YDVIKSKDEIIMVIEY-AGNELFDYIVQRDK---MSEQEARRFFQQIISAVEYCHRHKIV 135
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           H ++K  N+L+D     K+ D+GL+ +  M D   L +   S   Y APE     +    
Sbjct: 136 HRDLKPENLLLDEHLNVKIADFGLSNI--MTDGNFLKTSCGSP-NYAAPEVISGKLYAGP 192
Query: 873 KCDVYGFGVLVLEVVTGKRPL 893
           + DV+  GV++  ++  + P 
Sbjct: 193 EVDVWSCGVILYVMLCRRLPF 213

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 698 LGRGGFGAV---YRTVLRDGRPVAIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTL 752
           LG G FG V   Y T    G+ VA+K +    L KS  Q   ERE+  L  +RHP+++ L
Sbjct: 16  LGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 73
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
                ++   +++ E+ +G  L  ++ +      +S  E     Q    ++ + H+  I+
Sbjct: 74  YDVIKSKDEIIMVIEY-AGNELFDYIVQRDK---MSEQEARRFFQQIISAVEYCHRHKIV 129
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           H ++K  N+L+D     K+ D+GL+ +  M D   L +   S   Y APE     +    
Sbjct: 130 HRDLKPENLLLDEHLNVKIADFGLSNI--MTDGNFLKTSCGSP-NYAAPEVISGKLYAGP 186
Query: 873 KCDVYGFGVLVLEVVTGKRPL 893
           + DV+  GV++  ++  + P 
Sbjct: 187 EVDVWSCGVILYVMLCRRLPF 207

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 57/238 (23%), Positives = 111/238 (46%), Gaps = 25/238 (10%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQED-FEREVKKLGKVRHPNLVTLEGY 755
           +G G +G   +   + DG+ +  K+L   S+ ++++     EV  L +++HPN+V    Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR---Y 70
Query: 756 Y-----WTQSLQLLIYEFVSGGSLHKHLHEGSGG-NFLSWNERFNVIQGTAKSLAHLHQS 809
           Y      T +   ++ E+  GG L   + +G+    +L       V+     +L   H+ 
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 810 N-----IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
           +     ++H ++K +NV +DG    K+GD+GLAR+L   + +  + +      YM+PE  
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDF--AKEFVGTPYYMSPEQM 188
Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVSMR 922
            R +   +K D++  G L+ E+     P +       FS   L    ++ ++R +  R
Sbjct: 189 NR-MSYNEKSDIWSLGCLLYELCALMPPFTA------FSQKELAGKIREGKFRRIPYR 239

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 19/220 (8%)
Query: 698 LGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQEDFER--EVKKLGKVRHPNLVTL 752
           LG+G FG V   ++R+   GR  A+K L    ++   E      E + L   RHP L  L
Sbjct: 13  LGKGTFGKV--ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           +  + T      + E+ +GG L  HL       F     RF   +    +L +LH  +++
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAE-IVSALEYLHSRDVV 127
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVK 869
           + +IK  N+++D  G  K+ D+GL +     +     + +++  G   Y+APE       
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAPE-VLEDND 181
Query: 870 ITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE 909
                D +G GV++ E++ G+ P         F +  +EE
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 698 LGRGGFGAVYRTVL--RDGRPV--AIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +GRG FG VY   L   DG+ +  A+K L   + +     F  E   +    HPN+++L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 754 GYYW-TQSLQLLIYEFVSGGSLHKHL----HEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           G    ++   L++  ++  G L   +    H  +  + + +  +       AK + +L  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYLAS 150
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL--GYMAPEFACR 866
              +H ++ + N ++D     KV D+GLAR +   + Y + +K  + L   +MA E + +
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-SLQ 209
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRP 892
           T K T K DV+ FGVL+ E++T   P
Sbjct: 210 TQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 698 LGRGGFGAVYRTV---LRDGRP-----VAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V       L   +P     VA+K L   +  K   D   E++ +  + +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH-EGSGGNFLSWNERFN------------V 795
           ++ L G         +I E+ S G+L ++L      G   S+N   N             
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+      K+ D+GLAR +  +D Y  ++  +  
Sbjct: 156 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 215
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     +  T + DV+ FGVL+ E+ T
Sbjct: 216 VKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 247

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 698 LGRGGFGAVYRTVL--RDGRPV--AIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +GRG FG VY   L   DG+ +  A+K L   + +     F  E   +    HPN+++L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 754 GYYW-TQSLQLLIYEFVSGGSLHKHL----HEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           G    ++   L++  ++  G L   +    H  +  + + +  +       AK + +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYLAS 151
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL--GYMAPEFACR 866
              +H ++ + N ++D     KV D+GLAR +   + Y + +K  + L   +MA E + +
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-SLQ 210
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRP 892
           T K T K DV+ FGVL+ E++T   P
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 12/197 (6%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEG 754
           ++G G +G VY+   +  G  VA+KK+ + +  +       RE+  L ++ HPN+V L  
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNF---LSWNERFNVIQGTAKSLAHLHQSNI 811
              T++   L++E V    L K +   +       L  +  F ++QG    LA  H   +
Sbjct: 73  VIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG----LAFCHSHRV 127
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE        +
Sbjct: 128 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKYYS 185
Query: 872 DKCDVYGFGVLVLEVVT 888
              D++  G +  E+VT
Sbjct: 186 TAVDIWSLGCIFAEMVT 202

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 11/202 (5%)
Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEG 754
           ELG+G F  V R V +  G+  A   +    L  +  +  ERE +    ++HPN+V L  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
               +    LI++ V+GG L + +       + S  +  + IQ   +++ H HQ  ++H 
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDI---VAREYYSEADASHCIQQILEAVLHCHQMGVVHR 134
Query: 815 NIKSSNVLIDGS---GEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           N+K  N+L+         K+ D+GLA  + +              GY++PE   R     
Sbjct: 135 NLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLSPE-VLRKDPYG 191
Query: 872 DKCDVYGFGVLVLEVVTGKRPL 893
              D++  GV++  ++ G  P 
Sbjct: 192 KPVDLWACGVILYILLVGYPPF 213

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 698 LGRGGFGAVY--------RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V         +   ++   VA+K L   +  K   D   E++ +  + +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH--EGSGGNF-----------LSWNERFNV 795
           ++ L G         +I E+ S G+L ++L      G  +           +++ +  + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+  +   K+ D+GLAR +  +D Y  ++  +  
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLP 222
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     V  T + DV+ FGVL+ E+ T
Sbjct: 223 VKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 10/202 (4%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFE---REVKKLGKVR-HPNLVTLE 753
           LG+G FG V    +++   +   K+    ++   +D E    E + L   R HP L  L 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
             + T      + EFV+GG L  H+ +     F     RF   +    +L  LH   II+
Sbjct: 91  CCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAE-IISALMFLHDKGIIY 147
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            ++K  NVL+D  G  K+ D+G+ +    +   V ++       Y+APE   + +     
Sbjct: 148 RDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEI-LQEMLYGPA 204
Query: 874 CDVYGFGVLVLEVVTGKRPLST 895
            D +  GVL+ E++ G  P   
Sbjct: 205 VDWWAMGVLLYEMLCGHAPFEA 226

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 27/226 (11%)
Query: 674 KLVMFSGDPDFSTGTHALLNKDCELGRGGFGAV-YRTVLRDGRPVAIKKLTVSSLVKSQE 732
           +LV+  GDP         L    ++G G  G V   T    G+ VA+KK+ +    + + 
Sbjct: 35  QLVVSPGDP------REYLANFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL 88
Query: 733 DFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSL-----HKHLHEGSGGNFL 787
            F  EV  +    H N+V +   Y       ++ EF+ GG+L     H  ++E       
Sbjct: 89  LFN-EVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------- 140
Query: 788 SWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV 847
              +   V     ++L++LH   +IH +IKS ++L+   G  K+ D+G       + + V
Sbjct: 141 --EQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFC---AQVSKEV 195
Query: 848 LSSKIQSALGY-MAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
              K      Y MAPE   R    T+  D++  G++V+E++ G+ P
Sbjct: 196 PKRKXLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMIDGEPP 240

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 698 LGRGGFGAVYRTVL--RDGRPV--AIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +GRG FG VY   L   DG+ +  A+K L   + +     F  E   +    HPN+++L 
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 754 GYYW-TQSLQLLIYEFVSGGSLHKHL----HEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           G    ++   L++  ++  G L   +    H  +  + + +  +       AK + +L  
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYLAS 146
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL--GYMAPEFACR 866
              +H ++ + N ++D     KV D+GLAR +   + Y + +K  + L   +MA E + +
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-SLQ 205
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRP 892
           T K T K DV+ FGVL+ E++T   P
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 666 PTTDANSGKLVMFSGDPDFSTGTHALLNKDCELGR----GGFGAVYRTVLRD----GRPV 717
           PTT+      + F G    ST  + +  +  ELGR    G FG V++ +          V
Sbjct: 15  PTTEN-----LYFQGAMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAV 69
Query: 718 AIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKH 777
           AIK     +    +E F +E   + +  HP++V L G   T++   +I E  + G L   
Sbjct: 70  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSF 128
Query: 778 LHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLA 837
           L        L+    +     TA  LA+L     +H +I + NVL+  +   K+GD+GL+
Sbjct: 129 LQVRKYSLDLASLILYAYQLSTA--LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 186
Query: 838 RLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLS 894
           R +     Y  +SK +  + +MAPE +    + T   DV+ FGV + E++  G +P  
Sbjct: 187 RYMED-STYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 242

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 698 LGRGGFGAVYRTVLRDGRP-VAIKKLTVSSLVKSQED----FEREVKKLGKVRHPNLVTL 752
           +G+G FG V     +      A+K L   +++K +E+     ER V  L  V+HP LV L
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVL-LKNVKHPFLVGL 104
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
              + T      + ++++GG L  HL       FL    RF   +  A +L +LH  NI+
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAE-IASALGYLHSLNIV 161
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           + ++K  N+L+D  G   + D+GL +    ++    +S       Y+APE          
Sbjct: 162 YRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPE-VLHKQPYDR 218
Query: 873 KCDVYGFGVLVLEVVTGKRPLST 895
             D +  G ++ E++ G  P  +
Sbjct: 219 TVDWWCLGAVLYEMLYGLPPFYS 241

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 698 LGRGGFGAVY--------RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V         +   ++   VA+K L   +  K   D   E++ +  + +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH--EGSGGNF-----------LSWNERFNV 795
           ++ L G         +I E+ S G+L ++L      G  +           +++ +  + 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+  +   K+ D+GLAR +  +D Y  ++  +  
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     V  T + DV+ FGVL+ E+ T
Sbjct: 223 VKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 698 LGRGGFGAVY--------RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V         +   ++   VA+K L   +  K   D   E++ +  + +H N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH--EGSGGNF-----------LSWNERFNV 795
           ++ L G         +I E+ S G+L ++L      G  +           +++ +  + 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+  +   K+ D+GLAR +  +D Y  ++  +  
Sbjct: 209 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 268
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     V  T + DV+ FGVL+ E+ T
Sbjct: 269 VKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 300

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 698 LGRGGFGAVYR-TVLRDGRP-----VAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LG G FG V   T    G+      VA+K L  ++    +E    E+K +  + +H N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLH-------EGSGGNFLSWNERFNVIQGTAKSL 803
            L G        L+I E+   G L   L        +   G  L   +  +     A+ +
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE- 862
           A L   N IH ++ + NVL+      K+GD+GLAR +     Y++    +  + +MAPE 
Sbjct: 166 AFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPES 225
Query: 863 -FACRTVKITDKCDVYGFGVLVLEVVT 888
            F C     T + DV+ +G+L+ E+ +
Sbjct: 226 IFDCV---YTVQSDVWSYGILLWEIFS 249

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 698 LGRGGFGAVYRTV---LRDGRP-----VAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V       L   +P     VA+K L   +  K   D   E++ +  + +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH--EGSGGNF-----------LSWNERFNV 795
           ++ L G         +I E+ S G+L ++L      G  +           LS  +  + 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+      K+ D+GLAR +  +D Y  ++  +  
Sbjct: 156 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 215
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     +  T + DV+ FGVL+ E+ T
Sbjct: 216 VKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 247

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 698 LGRGGFGAVY--------RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V         +   ++   VA+K L   +  K   D   E++ +  + +H N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH--EGSGGNF-----------LSWNERFNV 795
           ++ L G         +I E+ S G+L ++L      G  +           +++ +  + 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+  +   K+ D+GLAR +  +D Y  ++  +  
Sbjct: 155 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 214
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     V  T + DV+ FGVL+ E+ T
Sbjct: 215 VKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 698 LGRGGFGAVY--------RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V         +   ++   VA+K L   +  K   D   E++ +  + +H N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH--EGSGGNF-----------LSWNERFNV 795
           ++ L G         +I E+ S G+L ++L      G  +           +++ +  + 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+  +   K+ D+GLAR +  +D Y  ++  +  
Sbjct: 152 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 211
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     V  T + DV+ FGVL+ E+ T
Sbjct: 212 VKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 243

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 19/220 (8%)
Query: 698 LGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQEDFER--EVKKLGKVRHPNLVTL 752
           LG+G FG V   ++R+   GR  A+K L    ++   E      E + L   RHP L  L
Sbjct: 13  LGKGTFGKV--ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           +  + T      + E+ +GG L  HL       F     RF   +    +L +LH  +++
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRDVV 127
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVK 869
           + +IK  N+++D  G  K+ D+GL +     +     + ++   G   Y+APE       
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKXFCGTPEYLAPE-VLEDND 181
Query: 870 ITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE 909
                D +G GV++ E++ G+ P         F +  +EE
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 19/220 (8%)
Query: 698 LGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQEDFER--EVKKLGKVRHPNLVTL 752
           LG+G FG V   ++R+   GR  A+K L    ++   E      E + L   RHP L  L
Sbjct: 13  LGKGTFGKV--ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           +  + T      + E+ +GG L  HL       F     RF   +    +L +LH  +++
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRDVV 127
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVK 869
           + +IK  N+++D  G  K+ D+GL +     +     + ++   G   Y+APE       
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKXFCGTPEYLAPE-VLEDND 181
Query: 870 ITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE 909
                D +G GV++ E++ G+ P         F +  +EE
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 14/219 (6%)
Query: 685 STGTHALLNKDCELGR----GGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFER 736
           ST  + +  +  ELGR    G FG V++ +          VAIK     +    +E F +
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 737 EVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVI 796
           E   + +  HP++V L G   T++   +I E  + G L   L        L+    +   
Sbjct: 61  EALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 119
Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL 856
             TA  LA+L     +H +I + NVL+  +   K+GD+GL+R +     Y  +SK +  +
Sbjct: 120 LSTA--LAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMED-STYYKASKGKLPI 176
Query: 857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLS 894
            +MAPE +    + T   DV+ FGV + E++  G +P  
Sbjct: 177 KWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 698 LGRGGFGAVY--------RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V         +   ++   VA+K L   +  K   D   E++ +  + +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH--EGSGGNF-----------LSWNERFNV 795
           ++ L G         +I E+ S G+L ++L      G  +           +++ +  + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+  +   ++ D+GLAR +  +D Y  ++  +  
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLP 222
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     V  T + DV+ FGVL+ E+ T
Sbjct: 223 VKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 19/220 (8%)
Query: 698 LGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQEDFER--EVKKLGKVRHPNLVTL 752
           LG+G FG V   ++R+   GR  A+K L    ++   E      E + L   RHP L  L
Sbjct: 18  LGKGTFGKV--ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 75
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           +  + T      + E+ +GG L  HL       F     RF   +    +L +LH  +++
Sbjct: 76  KYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRDVV 132
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVK 869
           + +IK  N+++D  G  K+ D+GL +     +     + ++   G   Y+APE       
Sbjct: 133 YRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKXFCGTPEYLAPE-VLEDND 186
Query: 870 ITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE 909
                D +G GV++ E++ G+ P         F +  +EE
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 226

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V     +  G  VAIKK+             RE+K L   +H N++T+    
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
              S +     ++    +   LH       LS +     I  T +++  LH SN+IH ++
Sbjct: 79  RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDL 138
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS-----------KIQSALGYMAPEFAC 865
           K SN+LI+ + + KV D+GLAR+   +D     +           +  +   Y APE   
Sbjct: 139 KPSNLLINSNCDLKVCDFGLARI---IDESAADNSEPTGQQSGMVEFVATRWYRAPEVML 195
Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRPL 893
            + K +   DV+  G ++ E+   +RP+
Sbjct: 196 TSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 50/202 (24%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEG 754
           ELG+G F  V R + +  G+  A K +    L  +  +  ERE +    ++HPN+V L  
Sbjct: 11  ELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 70
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
               +    L+++ V+GG L + +       + S  +  + IQ   +S+ H H + I+H 
Sbjct: 71  SISEEGFHYLVFDLVTGGELFEDI---VAREYYSEADASHCIQQILESVNHCHLNGIVHR 127
Query: 815 NIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           ++K  N+L+    +    K+ D+GLA  + +              GY++PE   R     
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPE-VLRKDPYG 184
Query: 872 DKCDVYGFGVLVLEVVTGKRPL 893
              D++  GV++  ++ G  P 
Sbjct: 185 KPVDMWACGVILYILLVGYPPF 206

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDF----EREVKKLGKVRH-PNLVT 751
           +GRGGFG VY     D G+  A+K L    +   Q +     ER +  L      P +V 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF---NVIQGTAKSLAHLHQ 808
           +   + T      I + ++GG LH HL     G F   + RF    +I G    L H+H 
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILG----LEHMHN 310
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA----LGYMAPEFA 864
             +++ ++K +N+L+D  G  ++ D GLA           S K   A     GYMAPE  
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLA--------CDFSKKKPHASVGTHGYMAPEVL 362
Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWK 897
            + V      D +  G ++ +++ G  P    K
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDF----EREVKKLGKVRH-PNLVT 751
           +GRGGFG VY     D G+  A+K L    +   Q +     ER +  L      P +V 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF---NVIQGTAKSLAHLHQ 808
           +   + T      I + ++GG LH HL     G F   + RF    +I G    L H+H 
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILG----LEHMHN 310
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA----LGYMAPEFA 864
             +++ ++K +N+L+D  G  ++ D GLA           S K   A     GYMAPE  
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLA--------CDFSKKKPHASVGTHGYMAPEVL 362
Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWK 897
            + V      D +  G ++ +++ G  P    K
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDF----EREVKKLGKVRH-PNLVT 751
           +GRGGFG VY     D G+  A+K L    +   Q +     ER +  L      P +V 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF---NVIQGTAKSLAHLHQ 808
           +   + T      I + ++GG LH HL     G F   + RF    +I G    L H+H 
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILG----LEHMHN 310
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA----LGYMAPEFA 864
             +++ ++K +N+L+D  G  ++ D GLA           S K   A     GYMAPE  
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLA--------CDFSKKKPHASVGTHGYMAPEVL 362
Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWK 897
            + V      D +  G ++ +++ G  P    K
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDF----EREVKKLGKVRH-PNLVT 751
           +GRGGFG VY     D G+  A+K L    +   Q +     ER +  L      P +V 
Sbjct: 196 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 255
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF---NVIQGTAKSLAHLHQ 808
           +   + T      I + ++GG LH HL     G F   + RF    +I G    L H+H 
Sbjct: 256 MSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILG----LEHMHN 309
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA----LGYMAPEFA 864
             +++ ++K +N+L+D  G  ++ D GLA           S K   A     GYMAPE  
Sbjct: 310 RFVVYRDLKPANILLDEHGHVRISDLGLA--------CDFSKKKPHASVGTHGYMAPEVL 361
Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWK 897
            + V      D +  G ++ +++ G  P    K
Sbjct: 362 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 394

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 698 LGRGGFGAVYR-TVLRDGRP-----VAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LG G FG V   T    G+      VA+K L  ++    +E    E+K +  + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLH-------EGSGGNFLSWNERFNVIQGTAKSL 803
            L G        L+I E+   G L   L        +   G  L   +  +     A+ +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE- 862
           A L   N IH ++ + NVL+      K+GD+GLAR +     Y++    +  + +MAPE 
Sbjct: 174 AFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPES 233
Query: 863 -FACRTVKITDKCDVYGFGVLVLEVVT 888
            F C     T + DV+ +G+L+ E+ +
Sbjct: 234 IFDC---VYTVQSDVWSYGILLWEIFS 257

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 698 LGRGGFGAVY--------RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V         +   ++   VA+K L   +  +   D   E++ +  + +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH--EGSGGNF-----------LSWNERFNV 795
           ++ L G         +I E+ S G+L ++L      G  +           +++ +  + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+  +   K+ D+GLAR +  +D Y  ++  +  
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     V  T + DV+ FGVL+ E+ T
Sbjct: 223 VKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 57/238 (23%), Positives = 109/238 (45%), Gaps = 25/238 (10%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQED-FEREVKKLGKVRHPNLVTLEGY 755
           +G G +G   +   + DG+ +  K+L   S+ ++++     EV  L +++HPN+V    Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR---Y 70
Query: 756 Y-----WTQSLQLLIYEFVSGGSLHKHLHEGSGG-NFLSWNERFNVIQGTAKSLAHLHQS 809
           Y      T +   ++ E+  GG L   + +G+    +L       V+     +L   H+ 
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 810 N-----IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
           +     ++H ++K +NV +DG    K+GD+GLAR+L     +  +        YM+PE  
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKTFVGTPYYMSPEQM 188
Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVSMR 922
            R +   +K D++  G L+ E+     P +       FS   L    ++ ++R +  R
Sbjct: 189 NR-MSYNEKSDIWSLGCLLYELCALMPPFTA------FSQKELAGKIREGKFRRIPYR 239

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 19/220 (8%)
Query: 698 LGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQEDFER--EVKKLGKVRHPNLVTL 752
           LG+G FG V   ++R+   GR  A+K L    ++   E      E + L   RHP L  L
Sbjct: 13  LGKGTFGKV--ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           +  + T      + E+ +GG L  HL       F     RF   +    +L +LH  +++
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYLHSRDVV 127
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVK 869
           + +IK  N+++D  G  K+ D+GL +     +     + ++   G   Y+APE       
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKXFCGTPEYLAPE-VLEDND 181
Query: 870 ITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE 909
                D +G GV++ E++ G+ P         F +  +EE
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 57/238 (23%), Positives = 109/238 (45%), Gaps = 25/238 (10%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQED-FEREVKKLGKVRHPNLVTLEGY 755
           +G G +G   +   + DG+ +  K+L   S+ ++++     EV  L +++HPN+V    Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR---Y 70
Query: 756 Y-----WTQSLQLLIYEFVSGGSLHKHLHEGSGG-NFLSWNERFNVIQGTAKSLAHLHQS 809
           Y      T +   ++ E+  GG L   + +G+    +L       V+     +L   H+ 
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 810 N-----IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
           +     ++H ++K +NV +DG    K+GD+GLAR+L     +  +        YM+PE  
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMSPEQM 188
Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVSMR 922
            R +   +K D++  G L+ E+     P +       FS   L    ++ ++R +  R
Sbjct: 189 NR-MSYNEKSDIWSLGCLLYELCALMPPFTA------FSQKELAGKIREGKFRRIPYR 239

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 57/194 (29%), Positives = 94/194 (48%), Gaps = 15/194 (7%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLG---KV-RHPNLVTL 752
           LG G +G V++   + DGR  A+K+    S  +  +D  R++ ++G   KV +HP  V L
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSM--SPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           E   W +   L +   + G SL +H    + G  L   + +  ++ T  +LAHLH   ++
Sbjct: 123 E-QAWEEGGILYLQTELCGPSLQQHCE--AWGASLPEAQVWGYLRDTLLALAHLHSQGLV 179
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           H ++K +N+ +   G  K+GD+G   LL  L         +    YMAPE    +     
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFG---LLVELGTAGAGEVQEGDPRYMAPELLQGSYGTA- 235
Query: 873 KCDVYGFGVLVLEV 886
             DV+  G+ +LEV
Sbjct: 236 -ADVFSLGLTILEV 248

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 11/201 (5%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQE---DFEREVKKLGKVRHPNLVTLE 753
           LG G FG V        G  VA+K L     ++S +      RE++ L   RHP+++ L 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQK-IRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
               T S   ++ E+VSGG L  ++        L   E   + Q     + + H+  ++H
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQILSGVDYCHRHMVVH 139
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            ++K  NVL+D     K+ D+GL+ +  M D   L     S   Y APE     +    +
Sbjct: 140 RDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRXSCGSP-NYAAPEVISGRLYAGPE 196
Query: 874 CDVYGFGVLVLEVVTGKRPLS 894
            D++  GV++  ++ G  P  
Sbjct: 197 VDIWSSGVILYALLCGTLPFD 217

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 698 LGRGGFGAVYRTV---LRDGRP-----VAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V       L   +P     VA+K L   +  K   D   E++ +  + +H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH--EGSGGNF-----------LSWNERFNV 795
           ++ L G         +I E+ S G+L ++L      G  F           LS  +  + 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+      K+ D+GLAR +  +D    ++  +  
Sbjct: 156 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLP 215
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     +  T + DV+ FGVL+ E+ T
Sbjct: 216 VKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 247

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 698 LGRGGFGAVYR-TVLRDGRP-----VAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LG G FG V   T    G+      VA+K L  ++    +E    E+K +  + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGS-----------GGNFLSWNERFNVIQGT 799
            L G        L+I E+   G L   L   S             + LS  +  +     
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQV 173
Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYM 859
           A+ +A L   N IH ++ + NVL+      K+GD+GLAR +     Y++    +  + +M
Sbjct: 174 AQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWM 233
Query: 860 APE--FACRTVKITDKCDVYGFGVLVLEVVT 888
           APE  F C     T + DV+ +G+L+ E+ +
Sbjct: 234 APESIFDC---VYTVQSDVWSYGILLWEIFS 261

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 14/219 (6%)
Query: 685 STGTHALLNKDCELGR----GGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFER 736
           ST  + +  +  ELGR    G FG V++ +          VAIK     +    +E F +
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 737 EVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVI 796
           E   + +  HP++V L G   T++   +I E  + G L   L        L+    +   
Sbjct: 61  EALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 119
Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL 856
             TA  LA+L     +H +I + NVL+  +   K+GD+GL+R +     Y  +SK +  +
Sbjct: 120 LSTA--LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPI 176
Query: 857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLS 894
            +MAPE +    + T   DV+ FGV + E++  G +P  
Sbjct: 177 KWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 28/212 (13%)
Query: 694 KDCEL-GRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           K+ EL G GGFG V++   R DG+   IK++  ++     E  EREVK L K+ H N+V 
Sbjct: 14  KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVH 68
Query: 752 LEGYY---------------WTQSLQLLI-YEFVSGGSLHKHLHEGSGGNFLSWNERFNV 795
             G +                +++  L I  EF   G+L + + E   G  L       +
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALEL 127
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
            +   K + ++H   +I+ ++K SN+ +  + + K+GD+GL   L    +   S   +  
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS---KGT 184
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVV 887
           L YM+PE    +     + D+Y  G+++ E++
Sbjct: 185 LRYMSPE-QISSQDYGKEVDLYALGLILAELL 215

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQE---DFEREVKKLGKVRHPNLVTLE 753
           LG G FG V     +  G  VA+K L     ++S +     +RE++ L   RHP+++ L 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQK-IRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
               T +   ++ E+VSGG L  ++ +   G       R  + Q    ++ + H+  ++H
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEAR-RLFQQILSAVDYCHRHMVVH 134
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            ++K  NVL+D     K+ D+GL+ +  M D   L +   S   Y APE     +    +
Sbjct: 135 RDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRTSCGSP-NYAAPEVISGRLYAGPE 191
Query: 874 CDVYGFGVLVLEVVTGKRPL 893
            D++  GV++  ++ G  P 
Sbjct: 192 VDIWSCGVILYALLCGTLPF 211

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V+GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFXEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V+GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFXEPHARFYAAQ-IVLTFEYLHSLDLIYR 186
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 187 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 240
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 241 DWWALGVLIYEMAAGYPPF 259

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 698 LGRGGFGAVYRTV---LRDGRP-----VAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V       L   +P     VA+K L   +  K   D   E++ +  + +H N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH-EGSGGNFLSWNERFN------------V 795
           ++ L G         +I E+ S G+L ++L      G   S+N   N             
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+      K+ D+GLAR +  +D Y  ++  +  
Sbjct: 149 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 208
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     +  T + DV+ FGVL+ E+ T
Sbjct: 209 VKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 240

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 97/200 (48%), Gaps = 7/200 (3%)
Query: 698 LGRGGFGAV---YRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           +G G +G V   Y  V  +   VAIKK++        +   RE+K L + RH N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
                +++ +   ++    +   L++      LS +     +    + L ++H +N++H 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHR 148
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
           ++K SN+L++ + + K+ D+GLAR+  P  D     ++  +   Y APE    +   T  
Sbjct: 149 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 208
Query: 874 CDVYGFGVLVLEVVTGKRPL 893
            D++  G ++ E+++  RP+
Sbjct: 209 IDIWSVGCILAEMLSN-RPI 227

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 9/201 (4%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFE---REVKKLGKVRHPNLVTLEG 754
           LGRGGFG V+   ++    +   K      +K ++ ++    E K L KV    +V+L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGN--FLSWNERFNVIQGTAKSLAHLHQSNII 812
            + T++   L+   ++GG +  H++     N  F      F   Q     L HLHQ NII
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQRNII 311
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           + ++K  NVL+D  G  ++ D GLA  + +      +       G+MAPE      +   
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGE-EYDF 368
Query: 873 KCDVYGFGVLVLEVVTGKRPL 893
             D +  GV + E++  + P 
Sbjct: 369 SVDYFALGVTLYEMIAARGPF 389

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 97/200 (48%), Gaps = 7/200 (3%)
Query: 698 LGRGGFGAV---YRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           +G G +G V   Y  V  +   VAIKK++        +   RE+K L + RH N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
                +++ +   ++    +   L++      LS +     +    + L ++H +N++H 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHR 148
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
           ++K SN+L++ + + K+ D+GLAR+  P  D     ++  +   Y APE    +   T  
Sbjct: 149 DLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 208
Query: 874 CDVYGFGVLVLEVVTGKRPL 893
            D++  G ++ E+++  RP+
Sbjct: 209 IDIWSVGCILAEMLSN-RPI 227

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 9/201 (4%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFE---REVKKLGKVRHPNLVTLEG 754
           LGRGGFG V+   ++    +   K      +K ++ ++    E K L KV    +V+L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGN--FLSWNERFNVIQGTAKSLAHLHQSNII 812
            + T++   L+   ++GG +  H++     N  F      F   Q     L HLHQ NII
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQRNII 311
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           + ++K  NVL+D  G  ++ D GLA  + +      +       G+MAPE      +   
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGE-EYDF 368
Query: 873 KCDVYGFGVLVLEVVTGKRPL 893
             D +  GV + E++  + P 
Sbjct: 369 SVDYFALGVTLYEMIAARGPF 389

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 698 LGRGGFGAVYRTV---LRDGRP-----VAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V       L   +P     VA+K L   +  K   D   E++ +  + +H N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH-EGSGGNFLSWNERFN------------V 795
           ++ L G         +I E+ S G+L ++L      G   S+N   N             
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+      K+ D+GLAR +  +D Y  ++  +  
Sbjct: 148 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 207
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     +  T + DV+ FGVL+ E+ T
Sbjct: 208 VKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 239

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 19/171 (11%)
Query: 731 QEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWN 790
           +E+ EREV  L +V HPN++TL   Y  ++  +LI E VSGG L   L +      LS  
Sbjct: 59  REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEE 115
Query: 791 ERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRY 846
           E  + I+     + +LH   I H+++K  N+++     P    K+ D+GLA        +
Sbjct: 116 EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--------H 167
Query: 847 VLSSKIQSALGYMAPEFACRTVKITD----KCDVYGFGVLVLEVVTGKRPL 893
            +   ++    +  PEF    +   +    + D++  GV+   +++G  P 
Sbjct: 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 9/201 (4%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFE---REVKKLGKVRHPNLVTLEG 754
           LGRGGFG V+   ++    +   K      +K ++ ++    E K L KV    +V+L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGN--FLSWNERFNVIQGTAKSLAHLHQSNII 812
            + T++   L+   ++GG +  H++     N  F      F   Q     L HLHQ NII
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQRNII 311
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           + ++K  NVL+D  G  ++ D GLA  + +      +       G+MAPE      +   
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGE-EYDF 368
Query: 873 KCDVYGFGVLVLEVVTGKRPL 893
             D +  GV + E++  + P 
Sbjct: 369 SVDYFALGVTLYEMIAARGPF 389

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V+GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +        +  +     Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLXGTPEYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 9/201 (4%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFE---REVKKLGKVRHPNLVTLEG 754
           LGRGGFG V+   ++    +   K      +K ++ ++    E K L KV    +V+L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGN--FLSWNERFNVIQGTAKSLAHLHQSNII 812
            + T++   L+   ++GG +  H++     N  F      F   Q     L HLHQ NII
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLEHLHQRNII 311
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           + ++K  NVL+D  G  ++ D GLA  + +      +       G+MAPE      +   
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGE-EYDF 368
Query: 873 KCDVYGFGVLVLEVVTGKRPL 893
             D +  GV + E++  + P 
Sbjct: 369 SVDYFALGVTLYEMIAARGPF 389

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V+GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFXEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 97/200 (48%), Gaps = 7/200 (3%)
Query: 698 LGRGGFGAV---YRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           +G G +G V   Y  V  +   VAIKK++        +   RE+K L + RH N++ +  
Sbjct: 39  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 96
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
                +++ +   ++    +   L++      LS +     +    + L ++H +N++H 
Sbjct: 97  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHR 156
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
           ++K SN+L++ + + K+ D+GLAR+  P  D     ++  +   Y APE    +   T  
Sbjct: 157 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 216
Query: 874 CDVYGFGVLVLEVVTGKRPL 893
            D++  G ++ E+++  RP+
Sbjct: 217 IDIWSVGCILAEMLSN-RPI 235

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 97/200 (48%), Gaps = 7/200 (3%)
Query: 698 LGRGGFGAV---YRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           +G G +G V   Y  V  +   VAIKK++        +   RE+K L + RH N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
                +++ +   ++    +   L++      LS +     +    + L ++H +N++H 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHR 148
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
           ++K SN+L++ + + K+ D+GLAR+  P  D     ++  +   Y APE    +   T  
Sbjct: 149 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 208
Query: 874 CDVYGFGVLVLEVVTGKRPL 893
            D++  G ++ E+++  RP+
Sbjct: 209 IDIWSVGCILAEMLSN-RPI 227

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 96/199 (48%), Gaps = 5/199 (2%)
Query: 698 LGRGGFGAVYRTV--LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +G G +G V      L   R VAIKK++        +   RE+K L + RH N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDI 93
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
               +++ +   ++    +   L++      LS +     +    + L ++H +N++H +
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRD 153
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +K SN+L++ + + K+ D+GLAR+  P  D     ++  +   Y APE    +   T   
Sbjct: 154 LKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 213
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  G ++ E+++  RP+
Sbjct: 214 DIWSVGCILAEMLSN-RPI 231

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 698 LGRGGFGAVYRTV---LRDGRP-----VAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V       L   +P     VA+K L   +  K   D   E++ +  + +H N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH-EGSGGNFLSWNERFN------------V 795
           ++ L G         +I E+ S G+L ++L      G   S+N   N             
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+      K+ D+GLAR +  +D Y  ++  +  
Sbjct: 145 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 204
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     +  T + DV+ FGVL+ E+ T
Sbjct: 205 VKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 236

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 14/219 (6%)
Query: 685 STGTHALLNKDCELGR----GGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFER 736
           ST  + +  +  ELGR    G FG V++ +          VAIK     +    +E F +
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 60
Query: 737 EVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVI 796
           E   + +  HP++V L G   T++   +I E  + G L   L        L+    +   
Sbjct: 61  EALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 119
Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL 856
             TA  LA+L     +H +I + NVL+  +   K+GD+GL+R +     Y  +SK +  +
Sbjct: 120 LSTA--LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPI 176
Query: 857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLS 894
            +MAPE +    + T   DV+ FGV + E++  G +P  
Sbjct: 177 KWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V+GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFXEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 97/200 (48%), Gaps = 7/200 (3%)
Query: 698 LGRGGFGAV---YRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           +G G +G V   Y  V  +   VAIKK++        +   RE+K L + RH N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 90
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
                +++ +   ++    +   L++      LS +     +    + L ++H +N++H 
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHR 150
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
           ++K SN+L++ + + K+ D+GLAR+  P  D     ++  +   Y APE    +   T  
Sbjct: 151 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 210
Query: 874 CDVYGFGVLVLEVVTGKRPL 893
            D++  G ++ E+++  RP+
Sbjct: 211 IDIWSVGCILAEMLSN-RPI 229

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 698 LGRGGFGAVY--------RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V         +   ++   VA+K L   +  K   D   E++ +  + +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH--EGSGGNF-----------LSWNERFNV 795
           ++ L G         +I  + S G+L ++L      G  +           +++ +  + 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+  +   K+ D+GLAR +  +D Y  ++  +  
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     V  T + DV+ FGVL+ E+ T
Sbjct: 223 VKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V+GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +        +  +     Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLAGTPEYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 103
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V+GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 104 SFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFXEPHARFYAAQ-IVLTFEYLHSLDLIYR 160
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 161 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 214
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 215 DWWALGVLIYEMAAGYPPF 233

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V+GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFAEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 97/200 (48%), Gaps = 7/200 (3%)
Query: 698 LGRGGFGAV---YRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           +G G +G V   Y  V  +   VAIKK++        +   RE+K L + RH N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
                +++ +   ++    +   L++      LS +     +    + L ++H +N++H 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHR 148
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
           ++K SN+L++ + + K+ D+GLAR+  P  D     ++  +   Y APE    +   T  
Sbjct: 149 DLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 208
Query: 874 CDVYGFGVLVLEVVTGKRPL 893
            D++  G ++ E+++  RP+
Sbjct: 209 IDIWSVGCILAEMLSN-RPI 227

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 99/202 (49%), Gaps = 16/202 (7%)
Query: 698 LGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G FG V++      G  +A K +    + K +E+ + E+  + ++ H NL+ L   +
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
            +++  +L+ E+V GG L   + + S    L+  +    ++   + + H+HQ  I+H ++
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESYN--LTELDTILFMKQICEGIRHMHQMYILHLDL 213
Query: 817 KSSNVLI--DGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKIT 871
           K  N+L     + + K+ D+GLAR      RY    K++   G   ++APE       ++
Sbjct: 214 KPENILCVNRDAKQIKIIDFGLAR------RYKPREKLKVNFGTPEFLAPEVVNYDF-VS 266
Query: 872 DKCDVYGFGVLVLEVVTGKRPL 893
              D++  GV+   +++G  P 
Sbjct: 267 FPTDMWSVGVIAYMLLSGLSPF 288

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 698 LGRGGFGAVYRTVL--RDGRPV--AIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +GRG FG VY   L   DG+ +  A+K L   + +     F  E   +    HPN+++L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 754 GYYW-TQSLQLLIYEFVSGGSLHKHL----HEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           G    ++   L++  ++  G L   +    H  +  + + +  +       AK + +L  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYLAS 150
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA----LGYMAPEFA 864
              +H ++ + N ++D     KV D+GLAR   M D+   S   ++     + +MA E +
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEXXSVHNKTGAKLPVKWMALE-S 207
Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRP 892
            +T K T K DV+ FGVL+ E++T   P
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 698 LGRGGFGAVYRTV---LRDGRP-----VAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V       L   +P     VA+K L   +  K   D   E++ +  + +H N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNF-------------LSWNERFNV 795
           ++ L G         +I E+ S G+L ++L                     LS  +  + 
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+      K+ D+GLAR +  +D Y  ++  +  
Sbjct: 141 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 200
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     +  T + DV+ FGVL+ E+ T
Sbjct: 201 VKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 232

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 97/200 (48%), Gaps = 7/200 (3%)
Query: 698 LGRGGFGAV---YRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           +G G +G V   Y  V  +   VAIKK++        +   RE+K L + RH N++ +  
Sbjct: 51  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
                +++ +   ++    +   L++      LS +     +    + L ++H +N++H 
Sbjct: 109 IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHR 168
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
           ++K SN+L++ + + K+ D+GLAR+  P  D     ++  +   Y APE    +   T  
Sbjct: 169 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 228
Query: 874 CDVYGFGVLVLEVVTGKRPL 893
            D++  G ++ E+++  RP+
Sbjct: 229 IDIWSVGCILAEMLSN-RPI 247

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 97/200 (48%), Gaps = 7/200 (3%)
Query: 698 LGRGGFGAV---YRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           +G G +G V   Y  V  +   VAIKK++        +   RE+K L + RH N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
                +++ +   ++    +   L++      LS +     +    + L ++H +N++H 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHR 148
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
           ++K SN+L++ + + K+ D+GLAR+  P  D     ++  +   Y APE    +   T  
Sbjct: 149 DLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 208
Query: 874 CDVYGFGVLVLEVVTGKRPL 893
            D++  G ++ E+++  RP+
Sbjct: 209 IDIWSVGCILAEMLSN-RPI 227

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 14/219 (6%)
Query: 685 STGTHALLNKDCELGR----GGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFER 736
           ST  + +  +  ELGR    G FG V++ +          VAIK     +    +E F +
Sbjct: 3   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 62
Query: 737 EVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVI 796
           E   + +  HP++V L G   T++   +I E  + G L   L        L+    +   
Sbjct: 63  EALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 121
Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL 856
             TA  LA+L     +H +I + NVL+  +   K+GD+GL+R +     Y  +SK +  +
Sbjct: 122 LSTA--LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPI 178
Query: 857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLS 894
            +MAPE +    + T   DV+ FGV + E++  G +P  
Sbjct: 179 KWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 216

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 14/219 (6%)
Query: 685 STGTHALLNKDCELGR----GGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFER 736
           ST  + +  +  ELGR    G FG V++ +          VAIK     +    +E F +
Sbjct: 4   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 63
Query: 737 EVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVI 796
           E   + +  HP++V L G   T++   +I E  + G L   L        L+    +   
Sbjct: 64  EALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 122
Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL 856
             TA  LA+L     +H +I + NVL+  +   K+GD+GL+R +     Y  +SK +  +
Sbjct: 123 LSTA--LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPI 179
Query: 857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLS 894
            +MAPE +    + T   DV+ FGV + E++  G +P  
Sbjct: 180 KWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 217

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 14/219 (6%)
Query: 685 STGTHALLNKDCELGR----GGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFER 736
           ST  + +  +  ELGR    G FG V++ +          VAIK     +    +E F +
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 65
Query: 737 EVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVI 796
           E   + +  HP++V L G   T++   +I E  + G L   L        L+    +   
Sbjct: 66  EALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 124
Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL 856
             TA  LA+L     +H +I + NVL+  +   K+GD+GL+R +     Y  +SK +  +
Sbjct: 125 LSTA--LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPI 181
Query: 857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLS 894
            +MAPE +    + T   DV+ FGV + E++  G +P  
Sbjct: 182 KWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 219

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQE---DFEREVKKLGKVRHPNLVTLE 753
           LG G FG V     +  G  VA+K L     ++S +     +RE++ L   RHP+++ L 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQK-IRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
               T +   ++ E+VSGG L  ++ +   G       R  + Q    ++ + H+  ++H
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEAR-RLFQQILSAVDYCHRHMVVH 134
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            ++K  NVL+D     K+ D+GL+ +  M D   L     S   Y APE     +    +
Sbjct: 135 RDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRDSCGSP-NYAAPEVISGRLYAGPE 191
Query: 874 CDVYGFGVLVLEVVTGKRPL 893
            D++  GV++  ++ G  P 
Sbjct: 192 VDIWSCGVILYALLCGTLPF 211

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 698 LGRGGFGAVY--------RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V         +   ++   VA+K L   +  K   D   E++ +  + +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHE----GSGGNF---------LSWNERFNV 795
           ++ L G         +I E+ S G+L ++L      G   ++         +++ +  + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+  +   K+ D+GLAR +  +D    ++  +  
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     V  T + DV+ FGVL+ E+ T
Sbjct: 223 VKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 14/219 (6%)
Query: 685 STGTHALLNKDCELGR----GGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFER 736
           ST  + +  +  ELGR    G FG V++ +          VAIK     +    +E F +
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 440
Query: 737 EVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVI 796
           E   + +  HP++V L G   T++   +I E  + G L   L        L+    +   
Sbjct: 441 EALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL 856
             TA  LA+L     +H +I + NVL+  +   K+GD+GL+R +     Y  +SK +  +
Sbjct: 500 LSTA--LAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMED-STYYKASKGKLPI 556
Query: 857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLS 894
            +MAPE +    + T   DV+ FGV + E++  G +P  
Sbjct: 557 KWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 594

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V+GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 96/199 (48%), Gaps = 5/199 (2%)
Query: 698 LGRGGFGAVYRTV--LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +G G +G V      L   R VAIKK++        +   RE+K L + RH N++ +   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 94
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
               +++ +   ++    +   L++      LS +     +    + L ++H +N++H +
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRD 154
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +K SN+L++ + + K+ D+GLAR+  P  D     ++  +   Y APE    +   T   
Sbjct: 155 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 214
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  G ++ E+++  RP+
Sbjct: 215 DIWSVGCILAEMLSN-RPI 232

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 96/199 (48%), Gaps = 5/199 (2%)
Query: 698 LGRGGFGAVYRTV--LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +G G +G V      L   R VAIKK++        +   RE+K L + RH N++ +   
Sbjct: 37  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 95
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
               +++ +   ++    +   L++      LS +     +    + L ++H +N++H +
Sbjct: 96  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRD 155
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +K SN+L++ + + K+ D+GLAR+  P  D     ++  +   Y APE    +   T   
Sbjct: 156 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 215
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  G ++ E+++  RP+
Sbjct: 216 DIWSVGCILAEMLSN-RPI 233

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 96/199 (48%), Gaps = 5/199 (2%)
Query: 698 LGRGGFGAVYRTV--LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +G G +G V      L   R VAIKK++        +   RE+K L + RH N++ +   
Sbjct: 28  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 86
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
               +++ +   ++    +   L++      LS +     +    + L ++H +N++H +
Sbjct: 87  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRD 146
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +K SN+L++ + + K+ D+GLAR+  P  D     ++  +   Y APE    +   T   
Sbjct: 147 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 206
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  G ++ E+++  RP+
Sbjct: 207 DIWSVGCILAEMLSN-RPI 224

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 96/199 (48%), Gaps = 5/199 (2%)
Query: 698 LGRGGFGAVYRTV--LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +G G +G V      L   R VAIKK++        +   RE+K L + RH N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
               +++ +   ++    +   L++      LS +     +    + L ++H +N++H +
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRD 153
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +K SN+L++ + + K+ D+GLAR+  P  D     ++  +   Y APE    +   T   
Sbjct: 154 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 213
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  G ++ E+++  RP+
Sbjct: 214 DIWSVGCILAEMLSN-RPI 231

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 11/168 (6%)
Query: 730 SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW 789
           S+E+ EREV  L +V H N++TL   Y  ++  +LI E VSGG L   L +      LS 
Sbjct: 58  SREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSE 114
Query: 790 NERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDR 845
            E  + I+     + +LH   I H+++K  N+++     P    K+ D+GLA     ++ 
Sbjct: 115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIED 171
Query: 846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
            V    I     ++APE       +  + D++  GV+   +++G  P 
Sbjct: 172 GVEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 96/199 (48%), Gaps = 5/199 (2%)
Query: 698 LGRGGFGAVYRTV--LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +G G +G V      L   R VAIKK++        +   RE+K L + RH N++ +   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 87
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
               +++ +   ++    +   L++      LS +     +    + L ++H +N++H +
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRD 147
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +K SN+L++ + + K+ D+GLAR+  P  D     ++  +   Y APE    +   T   
Sbjct: 148 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 207
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  G ++ E+++  RP+
Sbjct: 208 DIWSVGCILAEMLSN-RPI 225

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V+GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 110 SFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 166
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 167 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 220
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 221 DWWALGVLIYEMAAGYPPF 239

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 96/199 (48%), Gaps = 5/199 (2%)
Query: 698 LGRGGFGAVYRTV--LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +G G +G V      L   R VAIKK++        +   RE+K L + RH N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
               +++ +   ++    +   L++      LS +     +    + L ++H +N++H +
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSANVLHRD 153
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +K SN+L++ + + K+ D+GLAR+  P  D     ++  +   Y APE    +   T   
Sbjct: 154 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 213
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  G ++ E+++  RP+
Sbjct: 214 DIWSVGCILAEMLSN-RPI 231

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 14/205 (6%)
Query: 697 ELGRGGFGAVYRTVLRD------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG+G FG VY    RD         VA+K +  S+ ++ + +F  E   +      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHL-------HEGSGGNFLSWNERFNVIQGTAKSL 803
            L G        L++ E ++ G L  +L           G    +  E   +    A  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
           A+L+    +H N+ + N ++      K+GD+G+ R +   D Y    K    + +MAPE 
Sbjct: 144 AYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE- 202
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVT 888
           + +    T   D++ FGV++ E+ +
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 698 LGRGGFGAVY--------RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V         +   ++   VA+K L   +  K   D   E++ +  + +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH--EGSGGNF-----------LSWNERFNV 795
           ++ L G         +I E+ S G+L ++L      G  +           +++ +  + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+  +   K+ D+GLAR +  +D    ++  +  
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     V  T + DV+ FGVL+ E+ T
Sbjct: 223 VKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 14/205 (6%)
Query: 697 ELGRGGFGAVYRTVLRD------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG+G FG VY    RD         VA+K +  S+ ++ + +F  E   +      ++V
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHE-------GSGGNFLSWNERFNVIQGTAKSL 803
            L G        L++ E ++ G L  +L           G    +  E   +    A  +
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
           A+L+    +H N+ + N ++      K+GD+G+ R +   D Y    K    + +MAPE 
Sbjct: 145 AYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE- 203
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVT 888
           + +    T   D++ FGV++ E+ +
Sbjct: 204 SLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V+GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 186
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 187 DLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGTP-----EYLAPEIIL-SKGYNKAV 240
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 241 DWWALGVLIYEMAAGYPPF 259

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 96/199 (48%), Gaps = 5/199 (2%)
Query: 698 LGRGGFGAVYRTV--LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +G G +G V      L   R VAIKK++        +   RE+K L + RH N++ +   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 87
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
               +++ +   ++    +   L++      LS +     +    + L ++H +N++H +
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRD 147
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +K SN+L++ + + K+ D+GLAR+  P  D     ++  +   Y APE    +   T   
Sbjct: 148 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 207
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  G ++ E+++  RP+
Sbjct: 208 DIWSVGCILAEMLSN-RPI 225

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 29/221 (13%)
Query: 698 LGRGGFGAVYRTVLRDG-RPVAIKKLTVS-----SLVKSQEDFEREVKKLGKVR----HP 747
           LGRG    V R + +   +  A+K + V+     S  + QE  E  +K++  +R    HP
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 748 NLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH 807
           N++ L+  Y T +   L+++ +  G L  +L E      LS  E   +++   + +  LH
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICALH 141
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLA-RLLPMLDRYVLSSKIQSALG---YMAPEF 863
           + NI+H ++K  N+L+D     K+ D+G + +L P         K++S  G   Y+APE 
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-------GEKLRSVCGTPSYLAPEI 194
Query: 864 ACRTVK-----ITDKCDVYGFGVLVLEVVTGKRPLSTWKMM 899
              ++         + D++  GV++  ++ G  P    K M
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 235

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V+GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V+GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 96/199 (48%), Gaps = 5/199 (2%)
Query: 698 LGRGGFGAVYRTV--LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +G G +G V      L   R VAIKK++        +   RE+K L + RH N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
               +++ +   ++    +   L++      LS +     +    + L ++H +N++H +
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRD 153
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +K SN+L++ + + K+ D+GLAR+  P  D     ++  +   Y APE    +   T   
Sbjct: 154 LKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 213
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  G ++ E+++  RP+
Sbjct: 214 DIWSVGCILAEMLSN-RPI 231

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 28/218 (12%)
Query: 698 LGRGGFGAVYRTVL--RDGRP----VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           LG G FG V +       GR     VA+K L  ++      D   E   L +V HP+++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGS--GGNFLSW------------NER----- 792
           L G        LLI E+   GSL   L E    G  +L              +ER     
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 793 --FNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS 850
              +     ++ + +L +  ++H ++ + N+L+    + K+ D+GL+R +   D YV  S
Sbjct: 151 DLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRS 210
Query: 851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +  + +MA E     +  T + DV+ FGVL+ E+VT
Sbjct: 211 QGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVT 247

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 698 LGRGGFGAVYRT-VLRDG--RPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLE 753
           +G G FG V +  + +DG     AIK++   +      DF  E++ L K+  HPN++ L 
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEG-------------SGGNFLSWNERFNVIQGTA 800
           G    +    L  E+   G+L   L +              S  + LS  +  +     A
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 801 KSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMA 860
           + + +L Q   IH N+ + N+L+  +   K+ D+GL+R   +   YV  +  +  + +MA
Sbjct: 150 RGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMA 206
Query: 861 PEFACRTVKITDKCDVYGFGVLVLEVVT 888
            E    +V  T+  DV+ +GVL+ E+V+
Sbjct: 207 IESLNYSVYTTNS-DVWSYGVLLWEIVS 233

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 27/213 (12%)
Query: 698 LGRGGFGAVYR-TVLRDGRP-----VAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LG G FG V   T    G+      VA+K L  ++    +E    E+K +  + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTA---------- 800
            L G        L+I E+   G L   L   S    L  +  F +   TA          
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKS--RVLETDPAFAIANSTASTRDLLHFSS 171
Query: 801 ---KSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG 857
              + +A L   N IH ++ + NVL+      K+GD+GLAR +     Y++    +  + 
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 231
Query: 858 YMAPE--FACRTVKITDKCDVYGFGVLVLEVVT 888
           +MAPE  F C     T + DV+ +G+L+ E+ +
Sbjct: 232 WMAPESIFDC---VYTVQSDVWSYGILLWEIFS 261

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V+GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V+GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 698 LGRGGFGAVY--------RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V         +   ++   VA+K L   +  K   D   E++ +  + +H N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH--EGSGGNF-----------LSWNERFNV 795
           ++ L G         +I E+ S G+L ++L      G  +           +++ +  + 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+  +   K+ D+GLAR +  +D Y  ++  +  
Sbjct: 150 TYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 209
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     V  T + DV+ FGVL+ E+ T
Sbjct: 210 VKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 241

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 95
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V+GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 96  SFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 152
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 153 DLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 206
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 207 DWWALGVLIYEMAAGYPPF 225

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 96/200 (48%), Gaps = 7/200 (3%)
Query: 698 LGRGGFGAV---YRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           +G G +G V   Y  V  +   VAIKK++        +   RE+K L   RH N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
                +++ +   ++    +   L++      LS +     +    + L ++H +N++H 
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHR 150
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
           ++K SN+L++ + + K+ D+GLAR+  P  D     ++  +   Y APE    +   T  
Sbjct: 151 DLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 210
Query: 874 CDVYGFGVLVLEVVTGKRPL 893
            D++  G ++ E+++  RP+
Sbjct: 211 IDIWSVGCILAEMLSN-RPI 229

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFXEPHARFYAAQ-IVLTFEYLHSLDLIYR 158
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 159 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 212
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 213 DWWALGVLIYEMAAGYPPF 231

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 87/199 (43%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           +G G FG V     +  G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  KV D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/201 (22%), Positives = 91/201 (45%), Gaps = 9/201 (4%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV---KSQEDFEREVKKLGKVRHPNLVTLEG 754
           LG+GGF   Y     D + V   K+   S++     +E    E+     + +P++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           ++       ++ E     SL + LH+      ++  E    ++ T + + +LH + +IH 
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLE-LHKRRKA--VTEPEARYFMRQTIQGVQYLHNNRVIHR 166
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+ ++   + K+GD+GLA  +           +     Y+APE  C+    + + 
Sbjct: 167 DLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAPEVLCKKGH-SFEV 223
Query: 875 DVYGFGVLVLEVVTGKRPLST 895
           D++  G ++  ++ GK P  T
Sbjct: 224 DIWSLGCILYTLLVGKPPFET 244

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 698 LGRGGFGAVY--------RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPN 748
           LG G FG V         +   ++   VA+K L   +  K   D   E++ +  + +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH--EGSGGNF-----------LSWNERFNV 795
           ++ L G         +I  + S G+L ++L      G  +           +++ +  + 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               A+ + +L     IH ++ + NVL+  +   K+ D+GLAR +  +D Y  ++  +  
Sbjct: 163 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE     V  T + DV+ FGVL+ E+ T
Sbjct: 223 VKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 698 LGRGGFGAVYRTVL--RDGRPV--AIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +GRG FG VY   L   DG+ +  A+K L   + +     F  E   +    HPN+++L 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 754 GYYW-TQSLQLLIYEFVSGGSLHKHL----HEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           G    ++   L++  ++  G L   +    H  +  + + +  +       AK +  L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFLAS 152
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA----LGYMAPEFA 864
              +H ++ + N ++D     KV D+GLAR   MLD+   S   ++     + +MA E +
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMLDKEFDSVHNKTGAKLPVKWMALE-S 209
Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRP 892
            +T K T K DV+ FGVL+ E++T   P
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 698 LGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQEDFE---REVKKLGKVRHPNLVT 751
           LG+G FG V   + +D   G+  A+K ++    VK + D E   REV+ L ++ HPN+  
Sbjct: 34  LGKGSFGEV--ILCKDKITGQECAVKVIS-KRQVKQKTDKESLLREVQLLKQLDHPNIXK 90
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L  ++  +    L+ E  +GG L     E       S  +   +I+     + + H++ I
Sbjct: 91  LYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDAARIIRQVLSGITYXHKNKI 147
Query: 812 IHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFAC 865
           +H ++K  N+L++   +    ++ D+GL+        +  S K +  +G   Y+APE   
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLST------HFEASKKXKDKIGTAYYIAPEVLH 201
Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRPL 893
            T    +KCDV+  GV++  +++G  P 
Sbjct: 202 GTY--DEKCDVWSTGVILYILLSGCPPF 227

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/201 (22%), Positives = 91/201 (45%), Gaps = 9/201 (4%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV---KSQEDFEREVKKLGKVRHPNLVTLEG 754
           LG+GGF   Y     D + V   K+   S++     +E    E+     + +P++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           ++       ++ E     SL + LH+      ++  E    ++ T + + +LH + +IH 
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLE-LHKRRKA--VTEPEARYFMRQTIQGVQYLHNNRVIHR 166
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+ ++   + K+GD+GLA  +           +     Y+APE  C+    + + 
Sbjct: 167 DLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKXLCGTPNYIAPEVLCKKGH-SFEV 223
Query: 875 DVYGFGVLVLEVVTGKRPLST 895
           D++  G ++  ++ GK P  T
Sbjct: 224 DIWSLGCILYTLLVGKPPFET 244

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/201 (22%), Positives = 91/201 (45%), Gaps = 9/201 (4%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV---KSQEDFEREVKKLGKVRHPNLVTLEG 754
           LG+GGF   Y     D + V   K+   S++     +E    E+     + +P++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           ++       ++ E     SL + LH+      ++  E    ++ T + + +LH + +IH 
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLE-LHKRRKA--VTEPEARYFMRQTIQGVQYLHNNRVIHR 166
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+ ++   + K+GD+GLA  +           +     Y+APE  C+    + + 
Sbjct: 167 DLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKTLCGTPNYIAPEVLCKKGH-SFEV 223
Query: 875 DVYGFGVLVLEVVTGKRPLST 895
           D++  G ++  ++ GK P  T
Sbjct: 224 DIWSLGCILYTLLVGKPPFET 244

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 96/200 (48%), Gaps = 7/200 (3%)
Query: 698 LGRGGFGAV---YRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           +G G +G V   Y  V  +   VAIKK++        +   RE+K L   RH N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
                +++ +   ++    +   L++      LS +     +    + L ++H +N++H 
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHR 150
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
           ++K SN+L++ + + K+ D+GLAR+  P  D     ++  +   Y APE    +   T  
Sbjct: 151 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 210
Query: 874 CDVYGFGVLVLEVVTGKRPL 893
            D++  G ++ E+++  RP+
Sbjct: 211 IDIWSVGCILAEMLSN-RPI 229

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 87/199 (43%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     +  G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLR--RIGRFXEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 87/199 (43%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     +  G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLR--RIGRFXEPHARFYAAQ-IVLTFEYLHSLDLIYR 166
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 167 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 220
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 221 DWWALGVLIYEMAAGYPPF 239

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     +  G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V+GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     +  G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 166
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKIT 871
           ++K  N+LID  G  +V D+G A+         +  +  +  G   Y+APE    +    
Sbjct: 167 DLKPENLLIDQQGYIQVTDFGFAKR--------VKGRTWTLCGTPEYLAPEIIL-SKGYN 217
Query: 872 DKCDVYGFGVLVLEVVTGKRPL 893
              D +  GVL+ E+  G  P 
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPF 239

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 43/225 (19%)
Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKL--TVSSLVKSQEDFEREVKKLGKVR-HPNLVTL 752
           +LG+G +G V++++  R G  VA+KK+     +   +Q  F RE+  L ++  H N+V L
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHENIVNL 74
Query: 753 EGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
                  + +   L+++++        LH     N L    +  V+    K + +LH   
Sbjct: 75  LNVLRADNDRDVYLVFDYMETD-----LHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLL-------------------------PMLDR 845
           ++H ++K SN+L++     KV D+GL+R                           P+L  
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGK 890
           YV      +   Y APE    + K T   D++  G ++ E++ GK
Sbjct: 190 YV------ATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 14/219 (6%)
Query: 685 STGTHALLNKDCELGR----GGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFER 736
           ST  + +  +  ELGR    G FG V++ +          VAIK     +    +E F +
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 440
Query: 737 EVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVI 796
           E   + +  HP++V L G   T++   +I E  + G L   L        L+    +   
Sbjct: 441 EALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL 856
             TA  LA+L     +H +I + NVL+  +   K+GD+GL+R +     Y  +SK +  +
Sbjct: 500 LSTA--LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPI 556
Query: 857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLS 894
            +MAPE +    + T   DV+ FGV + E++  G +P  
Sbjct: 557 KWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 594

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 87/199 (43%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     +  G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLR--RIGRFXEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V+GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N++ID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIII-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 96/199 (48%), Gaps = 5/199 (2%)
Query: 698 LGRGGFGAVYRTV--LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +G G +G V      L   R VAI+K++        +   RE+K L + RH N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-VAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
               +++ +   ++    +   L++      LS +     +    + L ++H +N++H +
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRD 153
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +K SN+L++ + + K+ D+GLAR+  P  D     ++  +   Y APE    +   T   
Sbjct: 154 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 213
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  G ++ E+++  RP+
Sbjct: 214 DIWSVGCILAEMLSN-RPI 231

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     +  G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 94
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 95  SFKDNSNLYMVMEYVPGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 151
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKIT 871
           ++K  N+LID  G  +V D+G A+         +  +  +  G   Y+APE    +    
Sbjct: 152 DLKPENLLIDQQGYIQVTDFGFAKR--------VKGRTWTLCGTPEYLAPEIIL-SKGYN 202
Query: 872 DKCDVYGFGVLVLEVVTGKRPL 893
              D +  GVL+ E+  G  P 
Sbjct: 203 KAVDWWALGVLIYEMAAGYPPF 224

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 95/199 (47%), Gaps = 5/199 (2%)
Query: 698 LGRGGFGAVYRTV--LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +G G +G V      L   R VAIKK++        +   RE+K L + RH N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
               +++ +   ++    +   L++      LS +     +    + L ++H +N++H +
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRD 153
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +K SN+L++ + + K+ D+GLAR+  P  D      +  +   Y APE    +   T   
Sbjct: 154 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSI 213
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  G ++ E+++  RP+
Sbjct: 214 DIWSVGCILAEMLSN-RPI 231

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/199 (23%), Positives = 95/199 (47%), Gaps = 5/199 (2%)
Query: 698 LGRGGFGAVYRTV--LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +G G +G V      L   R VAIKK++        +   RE+K L + RH N++ +   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 94
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
               +++ +   ++    +   L++      LS +     +    + L ++H +N++H +
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRD 154
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           +K SN+L++ + + K+ D+GLAR+  P  D      +  +   Y APE    +   T   
Sbjct: 155 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSI 214
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  G ++ E+++  RP+
Sbjct: 215 DIWSVGCILAEMLSN-RPI 232

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 166
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 167 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 220
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 221 DWWALGVLIYEMAAGYPPF 239

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 88/200 (44%), Gaps = 14/200 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFER---EVKKLGKVRHPNLVTLE 753
           LG G FG V     +  G   A+K L    +VK +E  E    E + L  V  P LV LE
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKE-IEHTLNEKRILQAVNFPFLVKLE 107
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
             +   S   ++ E+  GG +  HL     G F   + RF   Q    +  +LH  ++I+
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIY 164
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            ++K  N++ID  G  KV D+GLA+ +      +  +       Y+APE    +      
Sbjct: 165 RDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKA 218
Query: 874 CDVYGFGVLVLEVVTGKRPL 893
            D +  GVL+ E+  G  P 
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 158
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 159 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 212
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 213 DWWALGVLIYEMAAGYPPF 231

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 698 LGRGGFGAVYRTVLRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           LG G FG VY  V  + +     VA+K       + ++E F  E   +  + HP++V L 
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
           G    +    +I E    G L  +L      N L             K++A+L   N +H
Sbjct: 92  GII-EEEPTWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESINCVH 148
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            +I   N+L+      K+GD+GL+R +   D Y  +S  +  + +M+PE +    + T  
Sbjct: 149 RDIAVRNILVASPECVKLGDFGLSRYIEDED-YYKASVTRLPIKWMSPE-SINFRRFTTA 206
Query: 874 CDVYGFGVLVLEVVT-GKRPL 893
            DV+ F V + E+++ GK+P 
Sbjct: 207 SDVWMFAVCMWEILSFGKQPF 227

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 698 LGRGGFGAVYRTVLRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           LG G FG VY  V  + +     VA+K       + ++E F  E   +  + HP++V L 
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
           G    +    +I E    G L  +L      N L             K++A+L   N +H
Sbjct: 76  GII-EEEPTWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESINCVH 132
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            +I   N+L+      K+GD+GL+R +   D Y  +S  +  + +M+PE +    + T  
Sbjct: 133 RDIAVRNILVASPECVKLGDFGLSRYIEDED-YYKASVTRLPIKWMSPE-SINFRRFTTA 190
Query: 874 CDVYGFGVLVLEVVT-GKRPL 893
            DV+ F V + E+++ GK+P 
Sbjct: 191 SDVWMFAVCMWEILSFGKQPF 211

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 698 LGRGGFGAVYRTVLRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           LG G FG VY  V  + +     VA+K       + ++E F  E   +  + HP++V L 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
           G    +    +I E    G L  +L      N L             K++A+L   N +H
Sbjct: 80  GII-EEEPTWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESINCVH 136
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            +I   N+L+      K+GD+GL+R +   D Y  +S  +  + +M+PE +    + T  
Sbjct: 137 RDIAVRNILVASPECVKLGDFGLSRYIEDED-YYKASVTRLPIKWMSPE-SINFRRFTTA 194
Query: 874 CDVYGFGVLVLEVVT-GKRPL 893
            DV+ F V + E+++ GK+P 
Sbjct: 195 SDVWMFAVCMWEILSFGKQPF 215

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 166
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 167 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 220
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 221 DWWALGVLIYEMAAGYPPF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 166
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 167 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 220
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 221 DWWALGVLIYEMAAGYPPF 239

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 130 SFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 186
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 187 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 240
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 241 DWWALGVLIYEMAAGYPPF 259

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 106/237 (44%), Gaps = 40/237 (16%)
Query: 697 ELGRGGFGAVYRTVLRDGRP-VAIKKLTVSSLVKSQEDFE-------REVKKLGKVRHPN 748
           ++G G +G V++   R+    VA+K+      V+  +D E       RE+  L +++H N
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKR------VRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGG-------NFLSWNERFNVIQGTAK 801
           +V L     +     L++EF     L K+    +G        +FL     F +++G   
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFL-----FQLLKG--- 113
Query: 802 SLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAP 861
            L   H  N++H ++K  N+LI+ +GE K+ D+GLAR   +  R   S+++ + L Y  P
Sbjct: 114 -LGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-CYSAEVVT-LWYRPP 170
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVTGKRPL-------STWKMMWWFSVTWLEEHW 911
           +        +   D++  G +  E+    RPL          K ++    T  EE W
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQW 227

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 41/225 (18%)
Query: 694 KDCEL-GRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           K+ EL G GGFG V++   R DG+   I+++  ++     E  EREVK L K+ H N+V 
Sbjct: 15  KEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN-----EKAEREVKALAKLDHVNIVH 69
Query: 752 LEGYY---------WTQSLQLLIY--------------------EFVSGGSLHKHLHEGS 782
             G +            SL+   Y                    EF   G+L + + E  
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKR 128
Query: 783 GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM 842
            G  L       + +   K + ++H   +IH ++K SN+ +  + + K+GD+GL   L  
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 188
Query: 843 LDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVV 887
             +    ++ +  L YM+PE    +     + D+Y  G+++ E++
Sbjct: 189 DGK---RTRSKGTLRYMSPE-QISSQDYGKEVDLYALGLILAELL 229

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 87/199 (43%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     +  G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 87/199 (43%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     +  G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 166
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 167 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 220
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 221 DWWALGVLIYEMAAGYPPF 239

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 87/199 (43%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     +  G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           +G G FG V     +  G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E++ GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRI--GRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  KV D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKL-TVSSLVKSQEDFEREVKKLGKVRHPNLVTLE-- 753
           +G G +G V     R  G+ VAIKK+     +V + +   RE+K L   +H N++ ++  
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 754 -------GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHL 806
                  G + +  + L + E      LH+ +H  S       + R+ + Q   + L ++
Sbjct: 123 LRPTVPYGEFKSVYVVLDLME----SDLHQIIH--SSQPLTLEHVRYFLYQ-LLRGLKYM 175
Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAPEF 863
           H + +IH ++K SN+L++ + E K+GD+G+AR L   P   +Y ++  + +   Y APE 
Sbjct: 176 HSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW-YRAPEL 234
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKR 891
                + T   D++  G +  E++  ++
Sbjct: 235 MLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 87/199 (43%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     +  G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V+GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ ++  G  P 
Sbjct: 220 DWWALGVLIYQMAAGYPPF 238

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 698 LGRGGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +G G FG V++ +          VAIK     +    +E F +E   + +  HP++V L 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
           G   T++   +I E  + G L   L        L+    +     TA  LA+L     +H
Sbjct: 75  GVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLESKRFVH 131
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            +I + NVL+  +   K+GD+GL+R +     Y  +SK +  + +MAPE +    + T  
Sbjct: 132 RDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPE-SINFRRFTSA 189
Query: 874 CDVYGFGVLVLEVVT-GKRPLS 894
            DV+ FGV + E++  G +P  
Sbjct: 190 SDVWMFGVCMWEILMHGVKPFQ 211

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 698 LGRGGFGAVYRTVL-RDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           +G G +GAV   V  R G  VAIKKL     S + ++  + RE++ L  +RH N++ L  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHENVIGLLD 91
Query: 755 YY--------WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHL 806
            +        +T    ++ +     G L KH  E  G + + +     ++    K L ++
Sbjct: 92  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQF-----LVYQMLKGLRYI 144
Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           H + IIH ++K  N+ ++   E K+ D+GLAR     D  +    +     Y APE    
Sbjct: 145 HAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMXGXVVTR--WYRAPEVILN 199
Query: 867 TVKITDKCDVYGFGVLVLEVVTGK 890
            ++ T   D++  G ++ E++TGK
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 697 ELGRGGFGAVYRTVLR---DGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG+G FG VY  V +      P   VAIK +  ++ ++ + +F  E   + +    ++V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLH----EGSGGNFLSWNERFNVIQ---GTAKSL 803
            L G        L+I E ++ G L  +L     E      L+      +IQ     A  +
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 151
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
           A+L+ +  +H ++ + N ++      K+GD+G+ R +   D Y    K    + +M+PE 
Sbjct: 152 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE- 210
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVT 888
           + +    T   DV+ FGV++ E+ T
Sbjct: 211 SLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 697 ELGRGGFGAVYRTVLR---DGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG+G FG VY  V +      P   VAIK +  ++ ++ + +F  E   + +    ++V
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLH----EGSGGNFLSWNERFNVIQ---GTAKSL 803
            L G        L+I E ++ G L  +L     E      L+      +IQ     A  +
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
           A+L+ +  +H ++ + N ++      K+GD+G+ R +   D Y    K    + +M+PE 
Sbjct: 145 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE- 203
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVT 888
           + +    T   DV+ FGV++ E+ T
Sbjct: 204 SLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           +G G FG V     +  G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E++ GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  KV D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     +  G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+  GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLR--RIGRFXEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N++ID  G  KV D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 698 LGRGGFGAVYRT-VLRDG--RPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLE 753
           +G G FG V +  + +DG     AIK++   +      DF  E++ L K+  HPN++ L 
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEG-------------SGGNFLSWNERFNVIQGTA 800
           G    +    L  E+   G+L   L +              S  + LS  +  +     A
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 801 KSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMA 860
           + + +L Q   IH ++ + N+L+  +   K+ D+GL+R   +   YV  +  +  + +MA
Sbjct: 153 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMA 209
Query: 861 PEFACRTVKITDKCDVYGFGVLVLEVVT 888
            E    +V  T+  DV+ +GVL+ E+V+
Sbjct: 210 IESLNYSVYTTNS-DVWSYGVLLWEIVS 236

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 90/205 (43%), Gaps = 14/205 (6%)
Query: 697 ELGRGGFGAVYRTVLRD------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG+G FG VY    RD         VA+K +  S+ ++ + +F  E   +      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHE-------GSGGNFLSWNERFNVIQGTAKSL 803
            L G        L++ E ++ G L  +L           G    +  E   +    A  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
           A+L+    +H ++ + N ++      K+GD+G+ R +   D Y    K    + +MAPE 
Sbjct: 144 AYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE- 202
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVT 888
           + +    T   D++ FGV++ E+ +
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 33/212 (15%)
Query: 697 ELGRGGFGAVYRTVLRDG-----RPVAI-KKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           +LG G +G V   + RD      R + I +K +VS+   S      EV  L  + HPN++
Sbjct: 44  KLGSGAYGEV--LLCRDKVTHVERAIKIIRKTSVST--SSNSKLLEEVAVLKLLDHPNIM 99
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHL-HEGSGGNFLSWNE--RFNVIQGTAKSLAHLH 807
            L  ++  +    L+ E   GG L   + H       + +NE     +I+     + +LH
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHR------MKFNEVDAAVIIKQVLSGVTYLH 153
Query: 808 QSNIIHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAP 861
           + NI+H ++K  N+L++   +    K+ D+GL+ +           K++  LG   Y+AP
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN------QKKMKERLGTAYYIAP 207
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           E   +  K  +KCDV+  GV++  ++ G  P 
Sbjct: 208 EVLRK--KYDEKCDVWSIGVILFILLAGYPPF 237

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 698 LGRGGFGAV---YRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           +G G +G V   Y  V  +   VAIKK++        +   RE+K L + RH N++ +  
Sbjct: 51  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 755 YYWTQSLQ----LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
                +++    + +   + G  L+K L      N       + +++G    L ++H +N
Sbjct: 109 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG----LKYIHSAN 164
Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           ++H ++K SN+L++ + + K+ D+GLAR+  P  D     ++  +   Y APE    +  
Sbjct: 165 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 224
Query: 870 ITDKCDVYGFGVLVLEVVTGKRPL 893
            T   D++  G ++ E+++  RP+
Sbjct: 225 YTKSIDIWSVGCILAEMLSN-RPI 247

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 10/201 (4%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFE---REVKKLGKVRHPNLVT-LE 753
           LG+G FG V     +    +   K+    +V   +D E    E + L  +  P  +T L 
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
             + T      + E+V+GG L  H+ +   G F      F   +  +  L  LH+  II+
Sbjct: 87  SCFQTVDRLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAE-ISIGLFFLHKRGIIY 143
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            ++K  NV++D  G  K+ D+G+ +   M+D  V + +      Y+APE           
Sbjct: 144 RDLKLDNVMLDSEGHIKIADFGMCKEH-MMDG-VTTREFCGTPDYIAPEIIAYQ-PYGKS 200
Query: 874 CDVYGFGVLVLEVVTGKRPLS 894
            D + +GVL+ E++ G+ P  
Sbjct: 201 VDWWAYGVLLYEMLAGQPPFD 221

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 29/221 (13%)
Query: 698 LGRGGFGAVYRTVLRDG-RPVAIKKLTVS-----SLVKSQEDFEREVKKLGKVR----HP 747
           LGRG    V R + +   +  A+K + V+     S  + QE  E  +K++  +R    HP
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 748 NLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH 807
           N++ L+  Y T +   L+++ +  G L  +L E      LS  E   +++   + +  LH
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICALH 141
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLA-RLLPMLDRYVLSSKIQSALG---YMAPEF 863
           + NI+H ++K  N+L+D     K+ D+G + +L P         K++   G   Y+APE 
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-------GEKLREVCGTPSYLAPEI 194
Query: 864 ACRTVK-----ITDKCDVYGFGVLVLEVVTGKRPLSTWKMM 899
              ++         + D++  GV++  ++ G  P    K M
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 235

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 29/221 (13%)
Query: 698 LGRGGFGAVYRTVLRDG-RPVAIKKLTVS-----SLVKSQEDFEREVKKLGKVR----HP 747
           LGRG    V R + +   +  A+K + V+     S  + QE  E  +K++  +R    HP
Sbjct: 12  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 71
Query: 748 NLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH 807
           N++ L+  Y T +   L+++ +  G L  +L E      LS  E   +++   + +  LH
Sbjct: 72  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICALH 128
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLA-RLLPMLDRYVLSSKIQSALG---YMAPEF 863
           + NI+H ++K  N+L+D     K+ D+G + +L P         K++   G   Y+APE 
Sbjct: 129 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-------GEKLREVCGTPSYLAPEI 181
Query: 864 ACRTVK-----ITDKCDVYGFGVLVLEVVTGKRPLSTWKMM 899
              ++         + D++  GV++  ++ G  P    K M
Sbjct: 182 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 222

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 48/202 (23%), Positives = 89/202 (44%), Gaps = 11/202 (5%)
Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEG 754
           ++G+G F  V R V L  G   A K +    L  +  +  ERE +    ++H N+V L  
Sbjct: 11  DIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHD 70
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
               +    L+++ V+GG L + +       + S  +  + IQ   +++ H HQ  ++H 
Sbjct: 71  SISEEGFHYLVFDLVTGGELFEDI---VAREYYSEADASHCIQQILEAVLHCHQMGVVHR 127
Query: 815 NIKSSNVLIDGS---GEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           ++K  N+L+         K+ D+GLA  + +              GY++PE   R     
Sbjct: 128 DLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPE-VLRKEAYG 184
Query: 872 DKCDVYGFGVLVLEVVTGKRPL 893
              D++  GV++  ++ G  P 
Sbjct: 185 KPVDIWACGVILYILLVGYPPF 206

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 698 LGRGGFGAVYRT-VLRDG--RPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLE 753
           +G G FG V +  + +DG     AIK++   +      DF  E++ L K+  HPN++ L 
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEG-------------SGGNFLSWNERFNVIQGTA 800
           G    +    L  E+   G+L   L +              S  + LS  +  +     A
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 801 KSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMA 860
           + + +L Q   IH ++ + N+L+  +   K+ D+GL+R   +   YV  +  +  + +MA
Sbjct: 143 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMA 199
Query: 861 PEFACRTVKITDKCDVYGFGVLVLEVVT 888
            E    +V  T+  DV+ +GVL+ E+V+
Sbjct: 200 IESLNYSVYTTNS-DVWSYGVLLWEIVS 226

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 87/194 (44%), Gaps = 6/194 (3%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           ++GRG FG V+   LR D   VA+K    +     +  F +E + L +  HPN+V L G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    ++ E V GG     L   + G  L       ++   A  + +L     IH +
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRD 238
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI-QSALGYMAPEFACRTVKITDKC 874
           + + N L+      K+ D+G++R       Y  S  + Q  + + APE A    + + + 
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWTAPE-ALNYGRYSSES 296
Query: 875 DVYGFGVLVLEVVT 888
           DV+ FG+L+ E  +
Sbjct: 297 DVWSFGILLWETFS 310

>pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 107/392 (27%), Positives = 161/392 (41%), Gaps = 50/392 (12%)
Query: 175 LATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFS 234
           L ++ L SN  SS      +    L+ LD  +N +     + + SL+  + INLS N F+
Sbjct: 128 LESLYLGSNHISSIKFPKDFPARNLKVLDFQNNAIHYISREDMRSLE--QAINLSLN-FN 184
Query: 235 GSIPDGIG----SCSLLRTIDFSENS-----FSGNLPETMQKLSLCNFMNLRKNLFSGEV 285
           G+   GI       ++ ++++F         F+G    T Q L L  F ++     S  +
Sbjct: 185 GNNVKGIELGAFDSTIFQSLNFGGTPNLSVIFNGLQNSTTQSLWLGTFEDIDDEDISSAM 244
Query: 286 PKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVA 345
            K + E+ S+E+L+L  ++FS     +     +L+ L+ +A  L G LP  M     L  
Sbjct: 245 LKGLCEM-SVESLNLQEHRFSDISSTTFQCFTQLQELDLTATHLKG-LPSGMKGLNLLKK 302
Query: 346 LDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSG--SSFESLQFLDLSHNE 403
           L  S N  +    Q    S  N  S     IR  +       G      +LQ LDLSHN+
Sbjct: 303 LVLSVNHFD----QLCQISAANFPSLTHLYIRGNVKKLHLGVGCLEKLGNLQTLDLSHND 358
Query: 404 FSGETPATIGA--LSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPE-- 459
                  ++    LS LQ LNLS N  +G    A  +   L +LDL+   L+ + P    
Sbjct: 359 IEASDCCSLQLKNLSHLQTLNLSHNEPLGLQSQAFKECPQLELLDLAFTRLHINAPQSPF 418
Query: 460 -----------------------IGGAYSLKELRLERN-FLAGKIPTS--IENCSSLVSL 493
                                  + G   L+ L L+ N F  G I  +  ++   SL  L
Sbjct: 419 QNLHFLQVLNLTYCFLDTSNQHLLAGLPVLRHLNLKGNHFQDGTITKTNLLQTVGSLEVL 478
Query: 494 ILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLT 525
           ILS   L      A   L  + +VDLS NSLT
Sbjct: 479 ILSSCGLLSIDQQAFHSLGKMSHVDLSHNSLT 510

>pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 111/265 (41%), Gaps = 10/265 (3%)
Query: 289 IGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTG-SLPD--SMANCMNLVA 345
           +  LE+LE+L L  N  S          + LKVL+F  N +   S  D  S+   +NL +
Sbjct: 122 VHNLENLESLYLGSNHISSIKFPKDFPARNLKVLDFQNNAIHYISREDMRSLEQAINL-S 180
Query: 346 LDFSQNSMNGDLPQWIFSSGLNKVSFAEN-KIREGMNGPFASSGSSFESLQFLDLSHNEF 404
           L+F+ N++ G       S+    ++F     +    NG   S+  S     F D+   + 
Sbjct: 181 LNFNGNNVKGIELGAFDSTIFQSLNFGGTPNLSVIFNGLQNSTTQSLWLGTFEDIDDEDI 240
Query: 405 SGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAY 464
           S      +  +S ++ LNL  +               L  LDL+   L G +P  + G  
Sbjct: 241 SSAMLKGLCEMS-VESLNLQEHRFSDISSTTFQCFTQLQELDLTATHLKG-LPSGMKGLN 298
Query: 465 SLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPI-AIAKLTNLQNVDLSFNS 523
            LK+L L  N        S  N  SL  L +  N     + +  + KL NLQ +DLS N 
Sbjct: 299 LLKKLVLSVNHFDQLCQISAANFPSLTHLYIRGNVKKLHLGVGCLEKLGNLQTLDLSHND 358
Query: 524 LTGG--LPKQLVNLVHLSSFNISHN 546
           +        QL NL HL + N+SHN
Sbjct: 359 IEASDCCSLQLKNLSHLQTLNLSHN 383

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKL-TVSSLVKSQEDFEREVKKLGKVRHPNLVTLE-- 753
           +G G +G V     R  G+ VAIKK+     +V + +   RE+K L   +H N++ ++  
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 754 -------GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHL 806
                  G + +  + L + E      LH+ +H  S       + R+ + Q   + L ++
Sbjct: 122 LRPTVPYGEFKSVYVVLDLME----SDLHQIIH--SSQPLTLEHVRYFLYQ-LLRGLKYM 174
Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAPEF 863
           H + +IH ++K SN+L++ + E K+GD+G+AR L   P   +Y ++  + +   Y APE 
Sbjct: 175 HSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW-YRAPEL 233
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKR 891
                + T   D++  G +  E++  ++
Sbjct: 234 MLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 697 ELGRGGFGAVY----RTVLRDGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNL 749
           ELG+G FG VY    + V++D  P   VAIK +  ++ ++ + +F  E   + +    ++
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKD-EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 83
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLH----EGSGGNFLSWNERFNVIQGT---AKS 802
           V L G        L+I E ++ G L  +L     E      L+      +IQ     A  
Sbjct: 84  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 143
Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           +A+L+ +  +H ++ + N ++      K+GD+G+ R +   D Y    K    + +M+PE
Sbjct: 144 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 203
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVT 888
            + +    T   DV+ FGV++ E+ T
Sbjct: 204 -SLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 47/222 (21%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDF--EREVKKLGKVRHPNL------ 749
           +GRG +GAVY+  L D RPVA+K  + ++    +++F  E+ + ++  + H N+      
Sbjct: 21  IGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 750 ---VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHL 806
              VT +G    +   LL+ E+   GSL K+L   +      W     +     + LA+L
Sbjct: 76  DERVTADG----RMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYL 127
Query: 807 H---------QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA-- 855
           H         +  I H ++ S NVL+   G   + D+GL+  L   +R V   +  +A  
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG-NRLVRPGEEDNAAI 186
Query: 856 -----LGYMAPEFACRTVKITD------KCDVYGFGVLVLEV 886
                + YMAPE     V + D      + D+Y  G++  E+
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 698 LGRGGFGAVYRTVL--RDGRPV--AIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +GRG FG VY   L   DG+ +  A+K L   + +     F  E   +    HPN+++L 
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 754 GYYW-TQSLQLLIYEFVSGGSLHKHL----HEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           G    ++   L++  ++  G L   +    H  +  + + +  +       AK +  L  
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFLAS 210
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA----LGYMAPEFA 864
              +H ++ + N ++D     KV D+GLAR   M D+   S   ++     + +MA E +
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWMALE-S 267
Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRP 892
            +T K T K DV+ FGVL+ E++T   P
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 90/205 (43%), Gaps = 14/205 (6%)
Query: 697 ELGRGGFGAVYRTVLRD------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG+G FG VY    RD         VA+K +  S+ ++ + +F  E   +      ++V
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHE-------GSGGNFLSWNERFNVIQGTAKSL 803
            L G        L++ E ++ G L  +L           G    +  E   +    A  +
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
           A+L+    +H ++ + N ++      K+GD+G+ R +   D Y    K    + +MAPE 
Sbjct: 143 AYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE- 201
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVT 888
           + +    T   D++ FGV++ E+ +
Sbjct: 202 SLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVA---IKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           ELGRG F  V + + +  G+  A   +KK       +++   E  V +L K   P ++ L
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK-SCPRVINL 94
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
              Y   S  +LI E+ +GG +   L        +S N+   +I+   + + +LHQ+NI+
Sbjct: 95  HEVYENTSEIILILEYAAGGEIFS-LCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153
Query: 813 HYNIKSSNVLIDGS---GEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACR 866
           H ++K  N+L+      G+ K+ D+G++R +        + +++  +G   Y+APE    
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH------ACELREIMGTPEYLAPEI-LN 206
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPL 893
              IT   D++  G++   ++T   P 
Sbjct: 207 YDPITTATDMWNIGIIAYMLLTHTSPF 233

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 81/172 (47%), Gaps = 19/172 (11%)
Query: 730 SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW 789
           S+E+ EREV  L +V H N++TL   Y  ++  +LI E VSGG L   L +      LS 
Sbjct: 58  SREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSE 114
Query: 790 NERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDR 845
            E  + I+     + +LH   I H+++K  N+++     P    K+ D+GLA        
Sbjct: 115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-------- 166
Query: 846 YVLSSKIQSALGYMAPEFACRTVKITD----KCDVYGFGVLVLEVVTGKRPL 893
           + +   ++    +  PEF    +   +    + D++  GV+   +++G  P 
Sbjct: 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 697 ELGRGGFGAVY----RTVLRDGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNL 749
           ELG+G FG VY    + V++D  P   VAIK +  ++ ++ + +F  E   + +    ++
Sbjct: 23  ELGQGSFGMVYEGVAKGVVKD-EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 81
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLH----EGSGGNFLSWNERFNVIQGT---AKS 802
           V L G        L+I E ++ G L  +L     E      L+      +IQ     A  
Sbjct: 82  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 141
Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           +A+L+ +  +H ++ + N ++      K+GD+G+ R +   D Y    K    + +M+PE
Sbjct: 142 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 201
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVT 888
            + +    T   DV+ FGV++ E+ T
Sbjct: 202 -SLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 81/172 (47%), Gaps = 19/172 (11%)
Query: 730 SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW 789
           S+E+ EREV  L +V H N++TL   Y  ++  +LI E VSGG L   L +      LS 
Sbjct: 58  SREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSE 114
Query: 790 NERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDR 845
            E  + I+     + +LH   I H+++K  N+++     P    K+ D+GLA        
Sbjct: 115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-------- 166
Query: 846 YVLSSKIQSALGYMAPEFACRTVKITD----KCDVYGFGVLVLEVVTGKRPL 893
           + +   ++    +  PEF    +   +    + D++  GV+   +++G  P 
Sbjct: 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 81/172 (47%), Gaps = 19/172 (11%)
Query: 730 SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW 789
           S+E+ EREV  L +V H N++TL   Y  ++  +LI E VSGG L   L +      LS 
Sbjct: 58  SREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSE 114
Query: 790 NERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDR 845
            E  + I+     + +LH   I H+++K  N+++     P    K+ D+GLA        
Sbjct: 115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-------- 166
Query: 846 YVLSSKIQSALGYMAPEFACRTVKITD----KCDVYGFGVLVLEVVTGKRPL 893
           + +   ++    +  PEF    +   +    + D++  GV+   +++G  P 
Sbjct: 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 32/220 (14%)
Query: 698 LGRGGFGAVYR-TVLRDGRP-----VAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LG G FG V   T    G+      VA+K L  ++    +E    E+K +  + +H N+V
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLH--------------------EGSGGNFLSWN 790
            L G        L+I E+   G L   L                     +   G  L   
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 791 ERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS 850
           +  +     A+ +A L   N IH ++ + NVL+      K+GD+GLAR +     Y++  
Sbjct: 159 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 218
Query: 851 KIQSALGYMAPE--FACRTVKITDKCDVYGFGVLVLEVVT 888
             +  + +MAPE  F C     T + DV+ +G+L+ E+ +
Sbjct: 219 NARLPVKWMAPESIFDC---VYTVQSDVWSYGILLWEIFS 255

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 698 LGRGGFGAVYRTVL--RDGRPV--AIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +GRG FG VY   L   DG+ +  A+K L   + +     F  E   +    HPN+++L 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 754 GYYW-TQSLQLLIYEFVSGGSLHKHL----HEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           G    ++   L++  ++  G L   +    H  +  + + +  +       AK +  L  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFLAS 149
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA----LGYMAPEFA 864
              +H ++ + N ++D     KV D+GLAR   M D+   S   ++     + +MA E +
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWMALE-S 206
Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRP 892
            +T K T K DV+ FGVL+ E++T   P
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+  GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 166
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N++ID  G  KV D+G A+ +      +  +       Y+APE    +       
Sbjct: 167 DLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 220
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 221 DWWALGVLIYEMAAGYPPF 239

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 14/200 (7%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFER---EVKKLGKVRHPNLVTLE 753
           LG G FG V     +  G   A+K L    +VK +E  E    E + L  V  P LV LE
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKE-IEHTLNEKRILQAVNFPFLVKLE 107
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
             +   S   ++ E+  GG +  HL     G F   + RF   Q    +  +LH  ++I+
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIY 164
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            ++K  N++ID  G  +V D+GLA+ +      +  +       Y+APE    +      
Sbjct: 165 RDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKA 218
Query: 874 CDVYGFGVLVLEVVTGKRPL 893
            D +  GVL+ E+  G  P 
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 697 ELGRGGFGAVY----RTVLRDGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNL 749
           ELG+G FG VY    + V++D  P   VAIK +  ++ ++ + +F  E   + +    ++
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKD-EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 84
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLH----EGSGGNFLSWNERFNVIQGT---AKS 802
           V L G        L+I E ++ G L  +L     E      L+      +IQ     A  
Sbjct: 85  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           +A+L+ +  +H ++ + N ++      K+GD+G+ R +   D Y    K    + +M+PE
Sbjct: 145 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 204
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVT 888
            + +    T   DV+ FGV++ E+ T
Sbjct: 205 -SLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 16/220 (7%)
Query: 685 STGTHALLNKDCELGR----GGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFER 736
           ST  + +  +  ELGR    G FG V++ +          VAIK     +    +E F +
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 737 EVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVI 796
           E   + +  HP++V L G   T++   +I E  + G L   L        L+    +   
Sbjct: 61  EALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 119
Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL-SSKIQSA 855
             TA  LA+L     +H +I + NVL+  +   K+GD+GL+R   M D     +SK +  
Sbjct: 120 LSTA--LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTXXKASKGKLP 175
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLS 894
           + +MAPE +    + T   DV+ FGV + E++  G +P  
Sbjct: 176 IKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 697 ELGRGGFGAVY----RTVLRDGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNL 749
           ELG+G FG VY    + V++D  P   VAIK +  ++ ++ + +F  E   + +    ++
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKD-EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 77
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLH----EGSGGNFLSWNERFNVIQGT---AKS 802
           V L G        L+I E ++ G L  +L     E      L+      +IQ     A  
Sbjct: 78  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 137
Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           +A+L+ +  +H ++ + N ++      K+GD+G+ R +   D Y    K    + +M+PE
Sbjct: 138 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 197
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVT 888
            + +    T   DV+ FGV++ E+ T
Sbjct: 198 -SLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 698 LGRGGFGAVYRTVL--RDGRPV--AIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +GRG FG VY   L   DG+ +  A+K L   + +     F  E   +    HPN+++L 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 754 GYYW-TQSLQLLIYEFVSGGSLHKHL----HEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           G    ++   L++  ++  G L   +    H  +  + + +  +       AK +  L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFLAS 152
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA----LGYMAPEFA 864
              +H ++ + N ++D     KV D+GLAR   M D+   S   ++     + +MA E +
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWMALE-S 209
Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRP 892
            +T K T K DV+ FGVL+ E++T   P
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 697 ELGRGGFGAVYRTVLR---DGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG+G FG VY  V +      P   VAIK +  ++ ++ + +F  E   + +    ++V
Sbjct: 54  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 113
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLH----EGSGGNFLSWNERFNVIQ---GTAKSL 803
            L G        L+I E ++ G L  +L     E      L+      +IQ     A  +
Sbjct: 114 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 173
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
           A+L+ +  +H ++ + N ++      K+GD+G+ R +   D Y    K    + +M+PE 
Sbjct: 174 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE- 232
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVT 888
           + +    T   DV+ FGV++ E+ T
Sbjct: 233 SLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 81/172 (47%), Gaps = 19/172 (11%)
Query: 730 SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW 789
           S+E+ EREV  L +V H N++TL   Y  ++  +LI E VSGG L   L +      LS 
Sbjct: 58  SREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSE 114
Query: 790 NERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDR 845
            E  + I+     + +LH   I H+++K  N+++     P    K+ D+GLA        
Sbjct: 115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-------- 166
Query: 846 YVLSSKIQSALGYMAPEFACRTVKITD----KCDVYGFGVLVLEVVTGKRPL 893
           + +   ++    +  PEF    +   +    + D++  GV+   +++G  P 
Sbjct: 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 84/193 (43%), Gaps = 4/193 (2%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           ++GRG FG V+   LR D   VA+K    +     +  F +E + L +  HPN+V L G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    ++ E V GG     L   + G  L       ++   A  + +L     IH +
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRD 238
Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+      K+ D+G++R              Q  + + APE A    + + + D
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPE-ALNYGRYSSESD 297
Query: 876 VYGFGVLVLEVVT 888
           V+ FG+L+ E  +
Sbjct: 298 VWSFGILLWETFS 310

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 698 LGRGGFGAVYRTVL--RDGRPV--AIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +GRG FG VY   L   DG+ +  A+K L   + +     F  E   +    HPN+++L 
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 754 GYYW-TQSLQLLIYEFVSGGSLHKHL----HEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           G    ++   L++  ++  G L   +    H  +  + + +  +       AK +  L  
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFLAS 156
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA----LGYMAPEFA 864
              +H ++ + N ++D     KV D+GLAR   M D+   S   ++     + +MA E +
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWMALE-S 213
Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRP 892
            +T K T K DV+ FGVL+ E++T   P
Sbjct: 214 LQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 56/209 (26%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 693 NKDCELGRGGFGAVYRTVLRDGRP----VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPN 748
           + D  +G+G FG VY     D        AIK L+  + ++  E F RE   +  + HPN
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 749 LVTLEGYYWT-QSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH 807
           ++ L G     + L  ++  ++  G L + +        +     F +    A+ + +L 
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL--QVARGMEYLA 141
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK----IQSALGYMAPEF 863
           +   +H ++ + N ++D S   KV D+GLAR   +LDR   S +     +  + + A E 
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLAR--DILDREYYSVQQHRHARLPVKWTALE- 198
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
           + +T + T K DV+ FGVL+ E++T   P
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 45/201 (22%), Positives = 91/201 (45%), Gaps = 9/201 (4%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV---KSQEDFEREVKKLGKVRHPNLVTLEG 754
           LG+GGF   Y     D + V   K+   S++     +E    E+     + +P++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           ++       ++ E     SL + LH+      ++  E    ++ T + + +LH + +IH 
Sbjct: 94  FFEDDDFVYVVLEICRRRSLLE-LHKRRKA--VTEPEARYFMRQTIQGVQYLHNNRVIHR 150
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+ ++   + K+GD+GLA  +           +     Y+APE  C+    + + 
Sbjct: 151 DLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAPEVLCKKGH-SFEV 207
Query: 875 DVYGFGVLVLEVVTGKRPLST 895
           D++  G ++  ++ GK P  T
Sbjct: 208 DIWSLGCILYTLLVGKPPFET 228

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     +  G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+  GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N++ID  G  KV D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 698 LGRGGFGAVYRTVL--RDGRPV--AIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +GRG FG VY   L   DG+ +  A+K L   + +     F  E   +    HPN+++L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 754 GYYW-TQSLQLLIYEFVSGGSLHKHL----HEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           G    ++   L++  ++  G L   +    H  +  + + +  +       AK +  L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFLAS 151
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA----LGYMAPEFA 864
              +H ++ + N ++D     KV D+GLAR   M D+   S   ++     + +MA E +
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWMALE-S 208
Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRP 892
            +T K T K DV+ FGVL+ E++T   P
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 698 LGRGGFGAVYRTVL--RDGRPV--AIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +GRG FG VY   L   DG+ +  A+K L   + +     F  E   +    HPN+++L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 754 GYYW-TQSLQLLIYEFVSGGSLHKHL----HEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           G    ++   L++  ++  G L   +    H  +  + + +  +       AK +  L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFLAS 151
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA----LGYMAPEFA 864
              +H ++ + N ++D     KV D+GLAR   M D+   S   ++     + +MA E +
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVHNKTGAKLPVKWMALE-S 208
Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRP 892
            +T K T K DV+ FGVL+ E++T   P
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 37/226 (16%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LGRGGFG V+    + D    AIK++ + +   ++E   REVK L K+ HP +V     Y
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR----Y 68
Query: 757 WTQSLQLLIYEFVSGGS----LHKHLHEGSGGNFLSW-------NER-----FNVIQGTA 800
           +   L+    E +   S    L+  +      N   W        ER      ++    A
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128
Query: 801 KSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR-----------LLPMLDRYVLS 849
           +++  LH   ++H ++K SN+        KVGD+GL             L PM      +
Sbjct: 129 EAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLST 895
            ++ + L YM+PE        + K D++  G+++ E++    P ST
Sbjct: 189 GQVGTKL-YMSPE-QIHGNSYSHKVDIFSLGLILFELLY---PFST 229

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 88/199 (44%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V+GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +      +  +       Y+AP     +       
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPAIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 697 ELGRGGFGAVYRTVLR---DGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG+G FG VY  V +      P   VAIK +  ++ ++ + +F  E   + +    ++V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHE---GSGGNFL----SWNERFNVIQGTAKSL 803
            L G        L+I E ++ G L  +L         N +    S ++   +    A  +
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
           A+L+ +  +H ++ + N ++      K+GD+G+ R +   D Y    K    + +M+PE 
Sbjct: 152 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE- 210
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVT 888
           + +    T   DV+ FGV++ E+ T
Sbjct: 211 SLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 11/200 (5%)
Query: 697 ELGRGGFGAVYRTVL-----RDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG G FG V            G  VA+K L   S      D ++E++ L  + H N+V 
Sbjct: 16  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 75
Query: 752 LEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
            +G           LI EF+  GSL ++L +    N ++  ++        K + +L   
Sbjct: 76  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSR 133
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPEFACRTV 868
             +H ++ + NVL++   + K+GD+GL + +    +   +     S + + APE   ++ 
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS- 192
Query: 869 KITDKCDVYGFGVLVLEVVT 888
           K     DV+ FGV + E++T
Sbjct: 193 KFYIASDVWSFGVTLHELLT 212

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 101/208 (48%), Gaps = 12/208 (5%)
Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH-PNLVTLEG 754
           E+GRG +G+V + V +  G+ +A+K++  +   K Q+    ++  + +    P +V   G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 755 YYWTQSLQLLIYEFVSGG--SLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS-NI 811
             + +    +  E +S      +K+++     + +       +   T K+L HL ++  I
Sbjct: 89  ALFREGDCWICMELMSTSFDKFYKYVY-SVLDDVIPEEILGKITLATVKALNHLKENLKI 147
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF---ACRTV 868
           IH +IK SN+L+D SG  K+ D+G++  L  +D  +  ++      YMAPE    +    
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISGQL--VDS-IAKTRDAGCRPYMAPERIDPSASRQ 204
Query: 869 KITDKCDVYGFGVLVLEVVTGKRPLSTW 896
               + DV+  G+ + E+ TG+ P   W
Sbjct: 205 GYDVRSDVWSLGITLYELATGRFPYPKW 232

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 25/213 (11%)
Query: 698 LGRGGFGAVYR-TVLRDGRP-----VAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LG G FG V   T    G+      VA+K L  ++    +E    E+K +  + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSG-GNFLSWNERFNVIQG----------- 798
            L G        L+I E+   G L   L      G   S+N   N  +            
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 799 -TAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG 857
             A+ +A L   N IH ++ + NVL+      K+GD+GLAR +     Y++    +  + 
Sbjct: 174 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 233
Query: 858 YMAPE--FACRTVKITDKCDVYGFGVLVLEVVT 888
           +MAPE  F C     T + DV+ +G+L+ E+ +
Sbjct: 234 WMAPESIFDC---VYTVQSDVWSYGILLWEIFS 263

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 697 ELGRGGFGAVY----RTVLRDGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNL 749
           ELG+G FG VY    + V++D  P   VAIK +  ++ ++ + +F  E   + +    ++
Sbjct: 22  ELGQGSFGMVYEGVAKGVVKD-EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 80
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHE---GSGGNFL----SWNERFNVIQGTAKS 802
           V L G        L+I E ++ G L  +L         N +    S ++   +    A  
Sbjct: 81  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 140
Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           +A+L+ +  +H ++ + N ++      K+GD+G+ R +   D Y    K    + +M+PE
Sbjct: 141 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 200
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVT 888
            + +    T   DV+ FGV++ E+ T
Sbjct: 201 -SLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 30/210 (14%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFE-----REVKKLGKVRHPNLVTL 752
           LG+G FG V+    +        K     +V   +D E     + V  L    HP L  +
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHM 83
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKS------LAHL 806
              + T+     + E+++GG L  H+             +F++ + T  +      L  L
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDLMYHIQSCH---------KFDLSRATFYAAEIILGLQFL 134
Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEF 863
           H   I++ ++K  N+L+D  G  K+ D+G+ +     +  +  +K     G   Y+APE 
Sbjct: 135 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCK-----ENMLGDAKTNXFCGTPDYIAPEI 189
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
                K     D + FGVL+ E++ G+ P 
Sbjct: 190 LLGQ-KYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 21/201 (10%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           +G+G FG V     R G  VA+K +   +  ++   F  E   + ++RH NLV L G   
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 69
Query: 758 TQSLQLLIY-EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
            +   L I  E+++ GSL  +L    G + L  +          +++ +L  +N +H ++
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 128
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA----LGYMAPEFACRTVKITD 872
            + NVL+      KV D+GL +          +S  Q      + + APE A R  K + 
Sbjct: 129 AARNVLVSEDNVAKVSDFGLTK---------EASSTQDTGKLPVKWTAPE-ALREKKFST 178
Query: 873 KCDVYGFGVLVLEVVT-GKRP 892
           K DV+ FG+L+ E+ + G+ P
Sbjct: 179 KSDVWSFGILLWEIYSFGRVP 199

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 30/211 (14%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFE-----REVKKLGKVRHPNLVTL 752
           LG+G FG V+    +        K     +V   +D E     + V  L    HP L  +
Sbjct: 26  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHM 84
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKS------LAHL 806
              + T+     + E+++GG L  H+             +F++ + T  +      L  L
Sbjct: 85  FCTFQTKENLFFVMEYLNGGDLMYHIQSCH---------KFDLSRATFYAAEIILGLQFL 135
Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEF 863
           H   I++ ++K  N+L+D  G  K+ D+G+ +     +  +  +K     G   Y+APE 
Sbjct: 136 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCK-----ENMLGDAKTNEFCGTPDYIAPEI 190
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
                K     D + FGVL+ E++ G+ P  
Sbjct: 191 LLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFH 220

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+V+GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  +V D+G A+ +     + L    ++    +APE    +       
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKG-RTWXLCGTPEA----LAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 21/201 (10%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           +G+G FG V     R G  VA+K +   +  ++   F  E   + ++RH NLV L G   
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 84
Query: 758 TQSLQLLIY-EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
            +   L I  E+++ GSL  +L    G + L  +          +++ +L  +N +H ++
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 143
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA----LGYMAPEFACRTVKITD 872
            + NVL+      KV D+GL +          +S  Q      + + APE A R  K + 
Sbjct: 144 AARNVLVSEDNVAKVSDFGLTK---------EASSTQDTGKLPVKWTAPE-ALREKKFST 193
Query: 873 KCDVYGFGVLVLEVVT-GKRP 892
           K DV+ FG+L+ E+ + G+ P
Sbjct: 194 KSDVWSFGILLWEIYSFGRVP 214

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 28/218 (12%)
Query: 698 LGRGGFGAVYRTVL--RDGRP----VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           LG G FG V +       GR     VA+K L  ++      D   E   L +V HP+++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGS--GGNFLSW------------NER----- 792
           L G        LLI E+   GSL   L E    G  +L              +ER     
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 793 --FNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS 850
              +     ++ + +L + +++H ++ + N+L+    + K+ D+GL+R +   D  V  S
Sbjct: 151 DLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRS 210
Query: 851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +  + +MA E     +  T + DV+ FGVL+ E+VT
Sbjct: 211 QGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVT 247

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 33/217 (15%)
Query: 693 NKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFE----REVKKLGKVRHP 747
            K  ++G+G FG V++   R  G+ VA+KK+ + +    +E F     RE+K L  ++H 
Sbjct: 21  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN---EKEGFPITALREIKILQLLKHE 77
Query: 748 NLVTL--------EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFL---SWNERFNVI 796
           N+V L          Y   ++   L+++F       +H   G   N L   + +E   V+
Sbjct: 78  NVVNLIEICRTKASPYNRCKASIYLVFDFC------EHDLAGLLSNVLVKFTLSEIKRVM 131
Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML-----DRYVLSSK 851
           Q     L ++H++ I+H ++K++NVLI   G  K+ D+GLAR   +      +RY   ++
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY--XNR 189
Query: 852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + + L Y  PE            D++G G ++ E+ T
Sbjct: 190 VVT-LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     ++ G   A+K L    +VK +  E    E +    V  P LV LE 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEF 109
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+  GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 110 SFKDNSNLYMVLEYAPGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 166
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LID  G  KV D+G A+ +      +  +       Y+APE    +       
Sbjct: 167 DLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 220
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 221 DWWALGVLIYEMAAGYPPF 239

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 41/228 (17%)
Query: 698 LGRGGFGAVY--RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           LG+G FG V   R  L D R  AIKK+  +   +       EV  L  + H  +V    Y
Sbjct: 14  LGQGAFGQVVKARNAL-DSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQYVVR---Y 67
Query: 756 Y--WTQ--------------SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGT 799
           Y  W +              S   +  E+   G+L+  +H  +       +E + + +  
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ--QRDEYWRLFRQI 125
Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR-LLPMLDRYVLSSK------- 851
            ++L+++H   IIH ++K  N+ ID S   K+GD+GLA+ +   LD   L S+       
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 852 -IQSALG---YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLST 895
            + SA+G   Y+A E    T    +K D+Y  G++  E++    P ST
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 11/200 (5%)
Query: 697 ELGRGGFGAVYRTVL-----RDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG G FG V            G  VA+K L   S      D ++E++ L  + H N+V 
Sbjct: 28  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 752 LEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
            +G           LI EF+  GSL ++L +    N ++  ++        K + +L   
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSR 145
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPEFACRTV 868
             +H ++ + NVL++   + K+GD+GL + +    +   +     S + + APE   ++ 
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS- 204
Query: 869 KITDKCDVYGFGVLVLEVVT 888
           K     DV+ FGV + E++T
Sbjct: 205 KFYIASDVWSFGVTLHELLT 224

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 85/199 (42%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     +  G   A+K L    +VK +  E    E + L  V  P L  LE 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+  GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLR--RIGRFXEPHARFYAAQ-IVLTFEYLHSLDLIYR 166
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N++ID  G  KV D+G A+ +      +  +       Y+APE    +       
Sbjct: 167 DLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 220
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 221 DWWALGVLIYEMAAGYPPF 239

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 697 ELGRGGFGAVY----RTVLRDGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNL 749
           ELG+G FG VY    + V++D  P   VAIK +  ++ ++ + +F  E   + +    ++
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKD-EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 77
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLH----EGSGGNFLSWNERFNVIQGT---AKS 802
           V L G        L+I E ++ G L  +L     E      L+      +IQ     A  
Sbjct: 78  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 137
Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           +A+L+ +  +H ++ + N  +      K+GD+G+ R +   D Y    K    + +M+PE
Sbjct: 138 MAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 197
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVT 888
            + +    T   DV+ FGV++ E+ T
Sbjct: 198 -SLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 698 LGRGGFGAVYRTVL--RDGRP----VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           LG G FG V +       GR     VA+K L  ++      D   E   L +V HP+++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGS--GGNFLSW------------NER----- 792
           L G        LLI E+   GSL   L E    G  +L              +ER     
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 793 --FNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS 850
              +     ++ + +L +  ++H ++ + N+L+    + K+ D+GL+R +   D  V  S
Sbjct: 151 DLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRS 210
Query: 851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + +  + +MA E     +  T + DV+ FGVL+ E+VT
Sbjct: 211 QGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVT 247

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 100/199 (50%), Gaps = 18/199 (9%)
Query: 698 LGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQEDFER----EVKKLGKVRHPNLV 750
           LG G F  VY+   RD    + VAIKK+ +    ++++   R    E+K L ++ HPN++
Sbjct: 18  LGEGQFATVYKA--RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
            L   +  +S   L+++F+    L   + + S     S  + + ++  T + L +LHQ  
Sbjct: 76  GLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM--TLQGLEYLHQHW 132
Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE--FACRTV 868
           I+H ++K +N+L+D +G  K+ D+GLA+     +R      +     Y APE  F  R  
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTR--WYRAPELLFGARMY 190
Query: 869 KITDKCDVYGFGVLVLEVV 887
            +    D++  G ++ E++
Sbjct: 191 GVG--VDMWAVGCILAELL 207

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     +  G   A+K L    +VK +  E    E + L  V  P LV LE 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+  GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N++ID  G  +V D+G A+ +      +  +       Y+APE    +       
Sbjct: 166 DLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 219
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 220 DWWALGVLIYEMAAGYPPF 238

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 106/237 (44%), Gaps = 40/237 (16%)
Query: 697 ELGRGGFGAVYRTVLRDGRP-VAIKKLTVSSLVKSQEDFE-------REVKKLGKVRHPN 748
           ++G G +G V++   R+    VA+K+      V+  +D E       RE+  L +++H N
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKR------VRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGG-------NFLSWNERFNVIQGTAK 801
           +V L     +     L++EF     L K+    +G        +FL     F +++G   
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFL-----FQLLKG--- 113
Query: 802 SLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAP 861
            L   H  N++H ++K  N+LI+ +GE K+ ++GLAR   +  R   S+++ + L Y  P
Sbjct: 114 -LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVT-LWYRPP 170
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVTGKRPL-------STWKMMWWFSVTWLEEHW 911
           +        +   D++  G +  E+    RPL          K ++    T  EE W
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 89  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ DYGLAR     +  YV +        Y APE     
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR------WYRAPEIMLNW 197
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 89/205 (43%), Gaps = 14/205 (6%)
Query: 697 ELGRGGFGAVYRTVLRD------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG+G FG VY    RD         VA+K +  S+ ++ + +F  E   +      ++V
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHL-------HEGSGGNFLSWNERFNVIQGTAKSL 803
            L G        L++ E ++ G L  +L           G    +  E   +    A  +
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
           A+L+    +H ++ + N ++      K+GD+G+ R +   D      K    + +MAPE 
Sbjct: 141 AYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPE- 199
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVT 888
           + +    T   D++ FGV++ E+ +
Sbjct: 200 SLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 89/205 (43%), Gaps = 14/205 (6%)
Query: 697 ELGRGGFGAVYRTVLRD------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG+G FG VY    RD         VA+K +  S+ ++ + +F  E   +      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHE-------GSGGNFLSWNERFNVIQGTAKSL 803
            L G        L++ E ++ G L  +L           G    +  E   +    A  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
           A+L+    +H ++ + N ++      K+GD+G+ R +   D      K    + +MAPE 
Sbjct: 144 AYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPE- 202
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVT 888
           + +    T   D++ FGV++ E+ +
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 33/217 (15%)
Query: 693 NKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFE----REVKKLGKVRHP 747
            K  ++G+G FG V++   R  G+ VA+KK+ + +    +E F     RE+K L  ++H 
Sbjct: 21  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN---EKEGFPITALREIKILQLLKHE 77
Query: 748 NLVTL--------EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFL---SWNERFNVI 796
           N+V L          Y   +    L+++F       +H   G   N L   + +E   V+
Sbjct: 78  NVVNLIEICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKFTLSEIKRVM 131
Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML-----DRYVLSSK 851
           Q     L ++H++ I+H ++K++NVLI   G  K+ D+GLAR   +      +RY   ++
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY--XNR 189
Query: 852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + + L Y  PE            D++G G ++ E+ T
Sbjct: 190 VVT-LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 85/199 (42%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     +  G   A+K L    +VK +  E    E + L  V  P L  LE 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+  GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 166
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N++ID  G  KV D+G A+ +      +  +       Y+APE    +       
Sbjct: 167 DLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 220
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 221 DWWALGVLIYEMAAGYPPF 239

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 89/205 (43%), Gaps = 14/205 (6%)
Query: 697 ELGRGGFGAVYRTVLRD------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG+G FG VY    RD         VA+K +  S+ ++ + +F  E   +      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHL-------HEGSGGNFLSWNERFNVIQGTAKSL 803
            L G        L++ E ++ G L  +L           G    +  E   +    A  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
           A+L+    +H ++ + N ++      K+GD+G+ R +   D      K    + +MAPE 
Sbjct: 144 AYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPE- 202
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVT 888
           + +    T   D++ FGV++ E+ +
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 33/217 (15%)
Query: 693 NKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFE----REVKKLGKVRHP 747
            K  ++G+G FG V++   R  G+ VA+KK+ + +    +E F     RE+K L  ++H 
Sbjct: 21  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN---EKEGFPITALREIKILQLLKHE 77
Query: 748 NLVTL--------EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFL---SWNERFNVI 796
           N+V L          Y   +    L+++F       +H   G   N L   + +E   V+
Sbjct: 78  NVVNLIEICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKFTLSEIKRVM 131
Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML-----DRYVLSSK 851
           Q     L ++H++ I+H ++K++NVLI   G  K+ D+GLAR   +      +RY   ++
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY--XNR 189
Query: 852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + + L Y  PE            D++G G ++ E+ T
Sbjct: 190 VVT-LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 85/199 (42%), Gaps = 12/199 (6%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V     +  G   A+K L    +VK +  E    E + L  V  P L  LE 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +   S   ++ E+  GG +  HL     G F   + RF   Q    +  +LH  ++I+ 
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLR--RIGRFSEPHARFYAAQ-IVLTFEYLHSLDLIYR 166
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N++ID  G  KV D+G A+ +      +  +       Y+APE    +       
Sbjct: 167 DLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTP-----EYLAPEIIL-SKGYNKAV 220
Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D +  GVL+ E+  G  P 
Sbjct: 221 DWWALGVLIYEMAAGYPPF 239

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           +G+G FG V     R G  VA+K +   +  ++   F  E   + ++RH NLV L G   
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 75
Query: 758 TQSLQLLIY-EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
            +   L I  E+++ GSL  +L    G + L  +          +++ +L  +N +H ++
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 134
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA----LGYMAPEFACRTVKITD 872
            + NVL+      KV D+GL +          +S  Q      + + APE A R    + 
Sbjct: 135 AARNVLVSEDNVAKVSDFGLTK---------EASSTQDTGKLPVKWTAPE-ALREAAFST 184
Query: 873 KCDVYGFGVLVLEVVT-GKRP 892
           K DV+ FG+L+ E+ + G+ P
Sbjct: 185 KSDVWSFGILLWEIYSFGRVP 205

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 33/217 (15%)
Query: 693 NKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFE----REVKKLGKVRHP 747
            K  ++G+G FG V++   R  G+ VA+KK+ + +    +E F     RE+K L  ++H 
Sbjct: 20  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN---EKEGFPITALREIKILQLLKHE 76
Query: 748 NLVTL--------EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFL---SWNERFNVI 796
           N+V L          Y   +    L+++F       +H   G   N L   + +E   V+
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKFTLSEIKRVM 130
Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML-----DRYVLSSK 851
           Q     L ++H++ I+H ++K++NVLI   G  K+ D+GLAR   +      +RY   ++
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY--XNR 188
Query: 852 IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           + + L Y  PE            D++G G ++ E+ T
Sbjct: 189 VVT-LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 21/201 (10%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           +G+G FG V     R G  VA+K +   +  ++   F  E   + ++RH NLV L G   
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 256
Query: 758 TQSLQLLIY-EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
            +   L I  E+++ GSL  +L    G + L  +          +++ +L  +N +H ++
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 315
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA----LGYMAPEFACRTVKITD 872
            + NVL+      KV D+GL +          +S  Q      + + APE A R  K + 
Sbjct: 316 AARNVLVSEDNVAKVSDFGLTK---------EASSTQDTGKLPVKWTAPE-ALREKKFST 365
Query: 873 KCDVYGFGVLVLEVVT-GKRP 892
           K DV+ FG+L+ E+ + G+ P
Sbjct: 366 KSDVWSFGILLWEIYSFGRVP 386

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 36/214 (16%)
Query: 697 ELGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQED--FEREVKKLGKVRHPNLVT 751
           +LG G +G V   + +D   G   AIK +  SS+  +        EV  L ++ HPN++ 
Sbjct: 28  KLGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMK 85
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN------VIQGTAKSLAH 805
           L  ++  +    L+ E   GG L   +            ++F+      +++       +
Sbjct: 86  LYEFFEDKRNYYLVMEVYRGGELFDEI---------ILRQKFSEVDAAVIMKQVLSGTTY 136
Query: 806 LHQSNIIHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALG---YM 859
           LH+ NI+H ++K  N+L++        K+ D+GL+        + +  K++  LG   Y+
Sbjct: 137 LHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSA------HFEVGGKMKERLGTAYYI 190
Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           APE   +  K  +KCDV+  GV++  ++ G  P 
Sbjct: 191 APEVLRK--KYDEKCDVWSCGVILYILLCGYPPF 222

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 89  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNA 197
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 34/218 (15%)
Query: 696 CELGRGGFGAVY---RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           C++GRG +G VY   R   +D +  A+K++  + +  S     RE+  L +++HPN+++L
Sbjct: 27  CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA---CREIALLRELKHPNVISL 83
Query: 753 EGYYWTQSLQ--LLIYEFVSGGSLH-KHLHEGSGGNFLSWNERFNVIQGTAKSL------ 803
           +  + + + +   L++++      H    H  S  N     +   + +G  KSL      
Sbjct: 84  QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN----KKPVQLPRGMVKSLLYQILD 139
Query: 804 --AHLHQSNIIHYNIKSSNVLIDGSGEP----KVGDYGLARLL-----PMLDRYVLSSKI 852
              +LH + ++H ++K +N+L+ G G      K+ D G ARL      P+ D       +
Sbjct: 140 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD----LDPV 195
Query: 853 QSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGK 890
                Y APE        T   D++  G +  E++T +
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 89  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 197
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 16/219 (7%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFER--EVKKLGKVRHPNLVTLEG 754
           LG+G FG V     +  GR  A+K L    +V   E      E + L   RHP L  L+ 
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 77
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH-QSNIIH 813
            + T      + E+ +GG L  HL       F     RF   +    +L +LH + N+++
Sbjct: 78  SFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYLHSEKNVVY 134
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKI 870
            ++K  N+++D  G  K+ D+GL +     +     + ++   G   Y+APE        
Sbjct: 135 RDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKXFCGTPEYLAPE-VLEDNDY 188
Query: 871 TDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE 909
               D +G GV++ E++ G+ P         F +  +EE
Sbjct: 189 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 227

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 16/219 (7%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFER--EVKKLGKVRHPNLVTLEG 754
           LG+G FG V     +  GR  A+K L    +V   E      E + L   RHP L  L+ 
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 75
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH-QSNIIH 813
            + T      + E+ +GG L  HL       F     RF   +    +L +LH + N+++
Sbjct: 76  SFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYLHSEKNVVY 132
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKI 870
            ++K  N+++D  G  K+ D+GL +     +     + ++   G   Y+APE        
Sbjct: 133 RDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKXFCGTPEYLAPE-VLEDNDY 186
Query: 871 TDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE 909
               D +G GV++ E++ G+ P         F +  +EE
Sbjct: 187 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 225

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 17/210 (8%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGYY 756
           +G+G FG VY    R    VAI+ + +    + Q + F+REV    + RH N+V   G  
Sbjct: 41  IGKGRFGQVYHG--RWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
            +     +I     G +L+  + +      L  N+   + Q   K + +LH   I+H ++
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDL 156
Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLD--RYVLSSKIQSA-LGYMAPEFACRTVKITDK 873
           KS NV  D +G+  + D+GL  +  +L   R     +IQ+  L ++APE   +    T++
Sbjct: 157 KSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEE 215
Query: 874 --------CDVYGFGVLVLEVVTGKRPLST 895
                    DV+  G +  E+   + P  T
Sbjct: 216 DKLPFSKHSDVFALGTIWYELHAREWPFKT 245

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 89/205 (43%), Gaps = 14/205 (6%)
Query: 697 ELGRGGFGAVYRTVLRD------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG+G FG VY    RD         VA+K +  S+ ++ + +F  E   +      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHE-------GSGGNFLSWNERFNVIQGTAKSL 803
            L G        L++ E ++ G L  +L           G    +  E   +    A  +
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
           A+L+    +H ++ + N ++      K+GD+G+ R +     Y    K    + +MAPE 
Sbjct: 144 AYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPE- 202
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVT 888
           + +    T   D++ FGV++ E+ +
Sbjct: 203 SLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 84
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 85  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 139
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 193
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 697 ELGRGGFGAVY----RTVLRDGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNL 749
           ELG+G FG VY    + V++D  P   VAIK +  ++ ++ + +F  E   + +    ++
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKD-EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 84
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLH----EGSGGNFLSWNERFNVIQGT---AKS 802
           V L G        L+I E ++ G L  +L     E      L+      +IQ     A  
Sbjct: 85  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           +A+L+ +  +H ++ + N ++      K+GD+G+ R +   D      K    + +M+PE
Sbjct: 145 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPE 204
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVT 888
            + +    T   DV+ FGV++ E+ T
Sbjct: 205 -SLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 98
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 99  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 153
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 154 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 207
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 208 MHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 16/219 (7%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFER--EVKKLGKVRHPNLVTLEG 754
           LG+G FG V     +  GR  A+K L    +V   E      E + L   RHP L  L+ 
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 76
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH-QSNIIH 813
            + T      + E+ +GG L  HL       F     RF   +    +L +LH + N+++
Sbjct: 77  SFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYLHSEKNVVY 133
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKI 870
            ++K  N+++D  G  K+ D+GL +     +     + ++   G   Y+APE        
Sbjct: 134 RDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKXFCGTPEYLAPE-VLEDNDY 187
Query: 871 TDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE 909
               D +G GV++ E++ G+ P         F +  +EE
Sbjct: 188 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 226

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 697 ELGRGGFGAVY----RTVLRDGRP---VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNL 749
           ELG+G FG VY    + V++D  P   VAIK +  ++ ++ + +F  E   + +    ++
Sbjct: 17  ELGQGSFGMVYEGVAKGVVKD-EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 75
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLH----EGSGGNFLSWNERFNVIQGT---AKS 802
           V L G        L+I E ++ G L  +L     E      L+      +IQ     A  
Sbjct: 76  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 135
Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           +A+L+ +  +H ++ + N ++      K+GD+G+ R +   D      K    + +M+PE
Sbjct: 136 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPE 195
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVT 888
            + +    T   DV+ FGV++ E+ T
Sbjct: 196 -SLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 95  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 150 ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 203
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 108
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 109 VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 163
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 164 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 217
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 96  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLAR-LLPMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR------WYRAPEIMLNW 204
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 91  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 145
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 146 ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 199
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 96  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLAR-LLPMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR------WYRAPEIMLNW 204
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+  L D G  VAIKK+      K+     RE++ + K+ H N+V L  ++
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-----RELQIMRKLDHCNIVRLRYFF 82
Query: 757 WTQSLQL------LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           ++   +       L+ ++V         H       L        +    +SLA++H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 811 IIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           I H +IK  N+L+D  +   K+ D+G A+ L   +  V  S I S   Y APE       
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXICSRY-YRAPELIFGATD 199
Query: 870 ITDKCDVYGFGVLVLEVVTGK 890
            T   DV+  G ++ E++ G+
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQ 220

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 107
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 108 VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 162
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 163 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 216
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 696 CELGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
             +G G +G+V   +  R G  VAIKKL+    S + ++  + RE+  L  ++H N++ L
Sbjct: 48  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHENVIGL 106
Query: 753 EGYYWTQSLQLLIYEF-VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
              +   S     Y+F +    +   L +  G  F     ++ V Q   K L ++H + +
Sbjct: 107 LDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQ-MLKGLKYIHSAGV 165
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPEFACRTVKI 870
           +H ++K  N+ ++   E K+ D+GLAR     +  YV++        Y APE     +  
Sbjct: 166 VHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR------WYRAPEVILSWMHY 219
Query: 871 TDKCDVYGFGVLVLEVVTGK 890
               D++  G ++ E++TGK
Sbjct: 220 NQTVDIWSVGCIMAEMLTGK 239

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 96  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLAR-LLPMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR------WYRAPEIMLNW 204
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 94  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 149 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 202
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 89  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 197
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 89  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 197
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 89  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 197
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 89  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 197
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 89  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 197
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 84
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 85  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHS 139
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 193
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 94  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 149 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 202
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 91  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 145
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 199
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 84
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 85  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 139
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 193
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 96  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 204
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 111
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 112 VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 166
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 167 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR------WYRAPEIMLNW 220
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 89  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 197
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 63/228 (27%), Positives = 99/228 (43%), Gaps = 41/228 (17%)
Query: 698 LGRGGFGAVY--RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           LG+G FG V   R  L D R  AIKK+  +   +       EV  L  + H  +V    Y
Sbjct: 14  LGQGAFGQVVKARNAL-DSRYYAIKKIRHTE--EKLSTILSEVXLLASLNHQYVVR---Y 67
Query: 756 Y--WTQ--------------SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGT 799
           Y  W +              S   +  E+    +L+  +H  +       +E + + +  
Sbjct: 68  YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQ--QRDEYWRLFRQI 125
Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR-LLPMLDRYVLSSK------- 851
            ++L+++H   IIH N+K  N+ ID S   K+GD+GLA+ +   LD   L S+       
Sbjct: 126 LEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 852 -IQSALG---YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLST 895
            + SA+G   Y+A E    T    +K D Y  G++  E +    P ST
Sbjct: 186 NLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY---PFST 230

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKL---TVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           ELG G  G V +   R    +  +KL    +   +++Q    RE++ L +   P +V   
Sbjct: 23  ELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPYIVGFY 80
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN-II 812
           G +++     +  E + GGSL + L E      +       V     + LA+L + + I+
Sbjct: 81  GAFYSDGEISICMEHMDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLAYLREKHQIM 137
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVK 869
           H ++K SN+L++  GE K+ D+G++  L       + S   S +G   YMAPE   +   
Sbjct: 138 HRDVKPSNILVNSRGEIKLCDFGVSGQL-------IDSMANSFVGTRSYMAPE-RLQGTH 189
Query: 870 ITDKCDVYGFGVLVLEVVTGKRPL 893
            + + D++  G+ ++E+  G+ P+
Sbjct: 190 YSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 89  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 144 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 197
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3RG1|A Chain A, Crystal Structure Of The Rp105MD-1 Complex Length = 612

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 103/391 (26%), Positives = 164/391 (41%), Gaps = 46/391 (11%)
Query: 175 LATINLSSNRFSS-PLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMF 233
           L +++L SN  SS  LP   +    L+ LD  +N +     K   SL+  +  NLS N F
Sbjct: 130 LESLHLGSNHISSINLPEN-FPTQNLKVLDFQNNAIHYISRKDTNSLE--QATNLSLN-F 185
Query: 234 SGSIPDGIGSCSLLRTIDFSENSFSGNLP----------ETMQKLSLCNFMNLRKNLFSG 283
           +G+   GI   + +  I F    F G+L            T+Q L L  F +      + 
Sbjct: 186 NGNDIKGIEPGAFISKI-FQSLKFGGSLNLFIIFKGLQNSTLQSLWLGTFEDTDDQYLTS 244
Query: 284 EVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNL 343
              + + ++ S+E+++L  ++FS     +     R++ L+ +A  L G LP  +    +L
Sbjct: 245 ATFEGLCDM-SVESINLQKHRFSDLSSSTFRCFTRVQELDLTAAHLNG-LPSGIEGMNSL 302
Query: 344 VALDFSQNSMNG----------DLPQWIFSSGLNKVSFAENKIREGMN-GPFASSGSSFE 392
             L  + NS +            L        + K+      + +  N      S S  E
Sbjct: 303 KKLVLNANSFDQLCQINAASFPSLRDLYIKGNMRKLDLGTRCLEKLENLQKLDLSHSDIE 362
Query: 393 S-------------LQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVA-IGD 438
           +             LQ+L+LS+NE  G           L+LL+++   L    P +   +
Sbjct: 363 ASDCCNLQLKNLRHLQYLNLSYNEPLGLEDQAFKECPQLELLDVAFTHLHVKAPHSPFQN 422
Query: 439 LKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERN-FLAGKIPTS--IENCSSLVSLIL 495
           L  L VL+LS   L+ S    + G   L+ L L+ N F  G I  +  ++   SL  LIL
Sbjct: 423 LHLLRVLNLSHCLLDTSNQHLLAGLQDLRHLNLQGNSFQDGSISKTNLLQMVGSLEILIL 482
Query: 496 SKNNLTGPIPIAIAKLTNLQNVDLSFNSLTG 526
           S  NL      A   L N+ ++DLS NSLTG
Sbjct: 483 SSCNLLSIDQQAFHGLRNVNHLDLSHNSLTG 513

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 95  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 203
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 91  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 145
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 199
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 86
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 87  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 141
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 142 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 195
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 196 MHYNQTVDIWSVGCIMAELLTGR 218

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 94  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 149 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 202
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 95  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 203
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+  L D G  VAIKK+      K+     RE++ + K+ H N+V L  ++
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFF 116
Query: 757 WTQSLQL------LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           ++   +       L+ ++V         H       L        +    +SLA++H   
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 811 IIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           I H +IK  N+L+D  +   K+ D+G A+ L   +  V  S I S   Y APE       
Sbjct: 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXICSRY-YRAPELIFGATD 233
Query: 870 ITDKCDVYGFGVLVLEVVTGK 890
            T   DV+  G ++ E++ G+
Sbjct: 234 YTSSIDVWSAGCVLAELLLGQ 254

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 16/219 (7%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFER--EVKKLGKVRHPNLVTLEG 754
           LG+G FG V     +  GR  A+K L    +V   E      E + L   RHP L  L+ 
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH-QSNIIH 813
            + T      + E+ +GG L  HL       F     RF   +    +L +LH + N+++
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYLHSEKNVVY 272
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKI 870
            ++K  N+++D  G  K+ D+GL +     +     + +++  G   Y+APE        
Sbjct: 273 RDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKTFCGTPEYLAPE-VLEDNDY 326
Query: 871 TDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE 909
               D +G GV++ E++ G+ P         F +  +EE
Sbjct: 327 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 365

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 85
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 86  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 140
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 141 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 194
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 85
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 86  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 140
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 141 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 194
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 100
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 101 VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 155
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 156 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 209
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 100
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 101 VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 155
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 156 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 209
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 84
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 85  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 139
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTV 868
           ++IIH ++K SN+ ++   E K+ D+GLAR     D  +  +   +   Y APE     +
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--AGFVATRWYRAPEIMLNWM 194
Query: 869 KITDKCDVYGFGVLVLEVVTGK 890
                 D++  G ++ E++TG+
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGR 216

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 94  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 149 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 202
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 87
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 88  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 142
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 143 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 196
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 197 MHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 16/219 (7%)
Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFER--EVKKLGKVRHPNLVTLEG 754
           LG+G FG V     +  GR  A+K L    +V   E      E + L   RHP L  L+ 
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 218
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH-QSNIIH 813
            + T      + E+ +GG L  HL       F     RF   +    +L +LH + N+++
Sbjct: 219 SFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYLHSEKNVVY 275
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKI 870
            ++K  N+++D  G  K+ D+GL +     +     + +++  G   Y+APE        
Sbjct: 276 RDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKTFCGTPEYLAPE-VLEDNDY 329
Query: 871 TDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE 909
               D +G GV++ E++ G+ P         F +  +EE
Sbjct: 330 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 368

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 100
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 101 VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 155
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 156 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 209
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 89  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 197
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 89  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTV 868
           ++IIH ++K SN+ ++   E K+ D+GLAR     D  +  +   +   Y APE     +
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--AGFVATRWYRAPEIMLNWM 198
Query: 869 KITDKCDVYGFGVLVLEVVTGK 890
                 D++  G ++ E++TG+
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 89  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTV 868
           ++IIH ++K SN+ ++   E K+ D+GLAR     D  +  +   +   Y APE     +
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--AGFVATRWYRAPEIMLNWM 198
Query: 869 KITDKCDVYGFGVLVLEVVTGK 890
                 D++  G ++ E++TG+
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 91  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 145
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 199
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 111
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 112 VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 166
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 167 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 220
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGR 243

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+  L D G  VAIKK+      K+     RE++ + K+ H N+V L  ++
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFF 90
Query: 757 WTQSLQL------LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           ++   +       L+ ++V         H       L        +    +SLA++H   
Sbjct: 91  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 150
Query: 811 IIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           I H +IK  N+L+D  +   K+ D+G A+ L   +  V  S I S   Y APE       
Sbjct: 151 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXICSRY-YRAPELIFGATD 207
Query: 870 ITDKCDVYGFGVLVLEVVTGK 890
            T   DV+  G ++ E++ G+
Sbjct: 208 YTSSIDVWSAGCVLAELLLGQ 228

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 36/214 (16%)
Query: 697 ELGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQED--FEREVKKLGKVRHPNLVT 751
           +LG G +G V   + +D   G   AIK +  SS+  +        EV  L ++ HPN++ 
Sbjct: 11  KLGSGAYGEV--LLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMK 68
Query: 752 LEGYYWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFNVIQGTAKSLAH 805
           L  ++  +    L+ E   GG L       +   E      +       V+ GT     +
Sbjct: 69  LYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK-----QVLSGTT----Y 119
Query: 806 LHQSNIIHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALG---YM 859
           LH+ NI+H ++K  N+L++        K+ D+GL+        + +  K++  LG   Y+
Sbjct: 120 LHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSA------HFEVGGKMKERLGTAYYI 173
Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           APE   +  K  +KCDV+  GV++  ++ G  P 
Sbjct: 174 APEVLRK--KYDEKCDVWSCGVILYILLCGYPPF 205

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+  L D G  VAIKK+      K+     RE++ + K+ H N+V L  ++
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFF 101
Query: 757 WTQSLQL------LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           ++   +       L+ ++V         H       L        +    +SLA++H   
Sbjct: 102 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 161
Query: 811 IIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           I H +IK  N+L+D  +   K+ D+G A+ L   +  V  S I S   Y APE       
Sbjct: 162 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXICSRY-YRAPELIFGATD 218
Query: 870 ITDKCDVYGFGVLVLEVVTGK 890
            T   DV+  G ++ E++ G+
Sbjct: 219 YTSSIDVWSAGCVLAELLLGQ 239

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 14/203 (6%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFE------REVKKLGKVRHPNLVT 751
           LG+G FG V  +  +    +   K+    +V   +D E      R +   GK   P L  
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP--PFLTQ 406
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L   + T      + E+V+GG L  H+ +   G F   +  F   +  A  L  L    I
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAE-IAIGLFFLQSKGI 463
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           I+ ++K  NV++D  G  K+ D+G+ +    +   V +        Y+APE         
Sbjct: 464 IYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEIIAYQ-PYG 520
Query: 872 DKCDVYGFGVLVLEVVTGKRPLS 894
              D + FGVL+ E++ G+ P  
Sbjct: 521 KSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 99
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 100 VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 154
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 155 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 208
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 696 CELGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
             +G G +G+V   +  R G  VAIKKL+    S + ++  + RE+  L  ++H N++ L
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHENVIGL 88
Query: 753 EGYYWTQSLQLLIYEF-VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
              +   S     Y+F +    +   L +  G  F     ++ V Q   K L ++H + +
Sbjct: 89  LDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQ-MLKGLKYIHSAGV 147
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPEFACRTVKI 870
           +H ++K  N+ ++   E K+ D+GLAR     +  YV++        Y APE     +  
Sbjct: 148 VHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR------WYRAPEVILSWMHY 201
Query: 871 TDKCDVYGFGVLVLEVVTGK 890
               D++  G ++ E++TGK
Sbjct: 202 NQTVDIWSVGCIMAEMLTGK 221

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+  L D G  VAIKK+      K+     RE++ + K+ H N+V L  ++
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFF 94
Query: 757 WTQSLQL------LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           ++   +       L+ ++V         H       L        +    +SLA++H   
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 154
Query: 811 IIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           I H +IK  N+L+D  +   K+ D+G A+ L   +  V  S I S   Y APE       
Sbjct: 155 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXICSRY-YRAPELIFGATD 211
Query: 870 ITDKCDVYGFGVLVLEVVTGK 890
            T   DV+  G ++ E++ G+
Sbjct: 212 YTSSIDVWSAGCVLAELLLGQ 232

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 698 LGRGGFGAVY-RTVLRDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLEG 754
           LG G F  V     L   R  AIK L    ++K  +     RE   + ++ HP  V L  
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 102
Query: 755 YYWTQSLQLLIY--EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           Y+  Q  + L +   +   G L K++ +   G+F     RF   +    +L +LH   II
Sbjct: 103 YFCFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAE-IVSALEYLHGKGII 159
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF-----ACRT 867
           H ++K  N+L++     ++ D+G A++L    +   ++       Y++PE      AC++
Sbjct: 160 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 219
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
                  D++  G ++ ++V G  P 
Sbjct: 220 ------SDLWALGCIIYQLVAGLPPF 239

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 89  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 197
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 108
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 109 VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 163
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 164 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 217
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+  L D G  VAIKK+      K+     RE++ + K+ H N+V L  ++
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFF 94
Query: 757 WTQSLQL------LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           ++   +       L+ ++V         H       L        +    +SLA++H   
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 154
Query: 811 IIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           I H +IK  N+L+D  +   K+ D+G A+ L   +  V  S I S   Y APE       
Sbjct: 155 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXICSRY-YRAPELIFGATD 211
Query: 870 ITDKCDVYGFGVLVLEVVTGK 890
            T   DV+  G ++ E++ G+
Sbjct: 212 YTSSIDVWSAGCVLAELLLGQ 232

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 99
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 100 VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 154
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 155 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 208
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+  L D G  VAIKK+      K+     RE++ + K+ H N+V L  ++
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFF 110
Query: 757 WTQSLQL------LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           ++   +       L+ ++V         H       L        +    +SLA++H   
Sbjct: 111 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 170
Query: 811 IIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           I H +IK  N+L+D  +   K+ D+G A+ L   +  V  S I S   Y APE       
Sbjct: 171 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRY-YRAPELIFGATD 227
Query: 870 ITDKCDVYGFGVLVLEVVTGK 890
            T   DV+  G ++ E++ G+
Sbjct: 228 YTSSIDVWSAGCVLAELLLGQ 248

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+  L D G  VAIKK+      K+     RE++ + K+ H N+V L  ++
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFF 116
Query: 757 WTQSLQL------LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           ++   +       L+ ++V         H       L        +    +SLA++H   
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 811 IIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           I H +IK  N+L+D  +   K+ D+G A+ L   +  V  S I S   Y APE       
Sbjct: 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRY-YRAPELIFGATD 233
Query: 870 ITDKCDVYGFGVLVLEVVTGK 890
            T   DV+  G ++ E++ G+
Sbjct: 234 YTSSIDVWSAGCVLAELLLGQ 254

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+  L D G  VAIKK+      K+     RE++ + K+ H N+V L  ++
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFF 82
Query: 757 WTQSLQL------LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           ++   +       L+ ++V         H       L        +    +SLA++H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 811 IIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           I H +IK  N+L+D  +   K+ D+G A+ L   +  V  S I S   Y APE       
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXICSRY-YRAPELIFGATD 199
Query: 870 ITDKCDVYGFGVLVLEVVTGK 890
            T   DV+  G ++ E++ G+
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQ 220

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 23/209 (11%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYY 756
           LG G  G +    + D R VA+K++       +    +REV+ L +   HPN++    Y+
Sbjct: 32  LGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA----DREVQLLRESDEHPNVIR---YF 84
Query: 757 WTQSLQLLIYEFVS--GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            T+  +   Y  +     +L +++ +    +     E   ++Q T   LAHLH  NI+H 
Sbjct: 85  CTEKDRQFQYIAIELCAATLQEYVEQKDFAHL--GLEPITLLQQTTSGLAHLHSLNIVHR 142
Query: 815 NIKSSNVLI-----DGSGEPKVGDYGLARLLPMLDRYVLSSK--IQSALGYMAPEFACRT 867
           ++K  N+LI      G  +  + D+GL + L  + R+  S +  +    G++APE     
Sbjct: 143 DLKPHNILISMPNAHGKIKAMISDFGLCKKL-AVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 868 VKI--TDKCDVYGFGVLVLEVVT-GKRPL 893
            K   T   D++  G +   V++ G  P 
Sbjct: 202 CKENPTYTVDIFSAGCVFYYVISEGSHPF 230

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKL---TVSSLVKSQEDFEREVKKLGKVRHPN 748
             K  ELG G  G V++   +    V  +KL    +   +++Q    RE++ L +   P 
Sbjct: 70  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPY 127
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHE-GSGGNFLSWNERFNVIQGTAKSLAHLH 807
           +V   G +++     +  E + GGSL + L + G     +       VI+G    L +L 
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTYLR 183
Query: 808 QSN-IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEF 863
           + + I+H ++K SN+L++  GE K+ D+G++  L       + S   S +G   YM+PE 
Sbjct: 184 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-------IDSMANSFVGTRSYMSPE- 235
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
             +    + + D++  G+ ++E+  G+ P+
Sbjct: 236 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 107
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 108 VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 162
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 163 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 216
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+  L D G  VAIKK+      K+     RE++ + K+ H N+V L  ++
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFF 83
Query: 757 WTQSLQL------LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           ++   +       L+ ++V         H       L        +    +SLA++H   
Sbjct: 84  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 143
Query: 811 IIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           I H +IK  N+L+D  +   K+ D+G A+ L   +  V  S I S   Y APE       
Sbjct: 144 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXICSRY-YRAPELIFGATD 200
Query: 870 ITDKCDVYGFGVLVLEVVTGK 890
            T   DV+  G ++ E++ G+
Sbjct: 201 YTSSIDVWSAGCVLAELLLGQ 221

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+  L D G  VAIKK+      K+     RE++ + K+ H N+V L  ++
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFF 82
Query: 757 WTQSLQL------LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           ++   +       L+ ++V         H       L        +    +SLA++H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 811 IIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           I H +IK  N+L+D  +   K+ D+G A+ L   +  V  S I S   Y APE       
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXICSRY-YRAPELIFGATD 199
Query: 870 ITDKCDVYGFGVLVLEVVTGK 890
            T   DV+  G ++ E++ G+
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQ 220

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+  L D G  VAIKK+      K+     RE++ + K+ H N+V L  ++
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFF 87
Query: 757 WTQSLQL------LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           ++   +       L+ ++V         H       L        +    +SLA++H   
Sbjct: 88  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 147
Query: 811 IIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           I H +IK  N+L+D  +   K+ D+G A+ L   +  V  S I S   Y APE       
Sbjct: 148 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRY-YRAPELIFGATD 204
Query: 870 ITDKCDVYGFGVLVLEVVTGK 890
            T   DV+  G ++ E++ G+
Sbjct: 205 YTSSIDVWSAGCVLAELLLGQ 225

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+  L D G  VAIKK+      K+     RE++ + K+ H N+V L  ++
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFF 86
Query: 757 WTQSLQL------LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           ++   +       L+ ++V         H       L        +    +SLA++H   
Sbjct: 87  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 146
Query: 811 IIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           I H +IK  N+L+D  +   K+ D+G A+ L   +  V  S I S   Y APE       
Sbjct: 147 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXICSRY-YRAPELIFGATD 203
Query: 870 ITDKCDVYGFGVLVLEVVTGK 890
            T   DV+  G ++ E++ G+
Sbjct: 204 YTSSIDVWSAGCVLAELLLGQ 224

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+  L D G  VAIKK+      K+     RE++ + K+ H N+V L  ++
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFF 95
Query: 757 WTQSLQL------LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           ++   +       L+ ++V         H       L        +    +SLA++H   
Sbjct: 96  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 155
Query: 811 IIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           I H +IK  N+L+D  +   K+ D+G A+ L   +  V  S I S   Y APE       
Sbjct: 156 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRY-YRAPELIFGATD 212
Query: 870 ITDKCDVYGFGVLVLEVVTGK 890
            T   DV+  G ++ E++ G+
Sbjct: 213 YTSSIDVWSAGCVLAELLLGQ 233

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+  L D G  VAIKK+      K+     RE++ + K+ H N+V L  ++
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFF 82
Query: 757 WTQSLQL------LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           ++   +       L+ ++V         H       L        +    +SLA++H   
Sbjct: 83  YSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 811 IIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           I H +IK  N+L+D  +   K+ D+G A+ L   +  V  S I S   Y APE       
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SXICSRY-YRAPELIFGATD 199
Query: 870 ITDKCDVYGFGVLVLEVVTGK 890
            T   DV+  G ++ E++ G+
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQ 220

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 14/203 (6%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFE------REVKKLGKVRHPNLVT 751
           LG+G FG V  +  +    +   K+    +V   +D E      R +   GK   P L  
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP--PFLTQ 85
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L   + T      + E+V+GG L  H+ +   G F   +  F   +  A  L  L    I
Sbjct: 86  LHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAE-IAIGLFFLQSKGI 142
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           I+ ++K  NV++D  G  K+ D+G+ +    +   V +        Y+APE         
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEIIAYQ-PYG 199
Query: 872 DKCDVYGFGVLVLEVVTGKRPLS 894
              D + FGVL+ E++ G+ P  
Sbjct: 200 KSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 698 LGRGGFGAVYRT-VLRDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLEG 754
           LG G F  V     L   R  AIK L    ++K  +     RE   + ++ HP  V L  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 94
Query: 755 YYWTQSLQLLIY--EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           Y+  Q  + L +   +   G L K++ +   G+F     RF   +    +L +LH   II
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAE-IVSALEYLHGKGII 151
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF-----ACRT 867
           H ++K  N+L++     ++ D+G A++L    +   ++       Y++PE      AC++
Sbjct: 152 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS 211
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
                  D++  G ++ ++V G  P 
Sbjct: 212 ------SDLWALGCIIYQLVAGLPPF 231

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 698 LGRGGFGAVY-RTVLRDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLEG 754
           LG G F  V     L   R  AIK L    ++K  +     RE   + ++ HP  V L  
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 98
Query: 755 YYWTQSLQLLIY--EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           Y+  Q  + L +   +   G L K++ +   G+F     RF   +    +L +LH   II
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAE-IVSALEYLHGKGII 155
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF-----ACRT 867
           H ++K  N+L++     ++ D+G A++L    +   ++       Y++PE      AC++
Sbjct: 156 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 215
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
                  D++  G ++ ++V G  P 
Sbjct: 216 ------SDLWALGCIIYQLVAGLPPF 235

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 698 LGRGGFGAVY-RTVLRDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLEG 754
           LG G F  V     L   R  AIK L    ++K  +     RE   + ++ HP  V L  
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 100
Query: 755 YYWTQSLQLLIY--EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           Y+  Q  + L +   +   G L K++ +   G+F     RF   +    +L +LH   II
Sbjct: 101 YFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAE-IVSALEYLHGKGII 157
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF-----ACRT 867
           H ++K  N+L++     ++ D+G A++L    +   ++       Y++PE      AC++
Sbjct: 158 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 217
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
                  D++  G ++ ++V G  P 
Sbjct: 218 ------SDLWALGCIIYQLVAGLPPF 237

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+  L D G  VAIKK+      K+     RE++ + K+ H N+V L  ++
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFF 118
Query: 757 WTQSLQL------LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           ++   +       L+ ++V         H       L        +    +SLA++H   
Sbjct: 119 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 178
Query: 811 IIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           I H +IK  N+L+D  +   K+ D+G A+ L   +  V  S I S   Y APE       
Sbjct: 179 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRY-YRAPELIFGATD 235
Query: 870 ITDKCDVYGFGVLVLEVVTGK 890
            T   DV+  G ++ E++ G+
Sbjct: 236 YTSSIDVWSAGCVLAELLLGQ 256

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 108
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 109 VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 163
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTV 868
           ++IIH ++K SN+ ++   E K+ D+GLAR         ++++      Y APE     +
Sbjct: 164 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATR-----WYRAPEIMLNWM 218
Query: 869 KITDKCDVYGFGVLVLEVVTGK 890
                 D++  G ++ E++TG+
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGR 240

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+  L D G  VAIKK+      K+     RE++ + K+ H N+V L  ++
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFF 120
Query: 757 WTQSLQL------LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           ++   +       L+ ++V         H       L        +    +SLA++H   
Sbjct: 121 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 180
Query: 811 IIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           I H +IK  N+L+D  +   K+ D+G A+ L   +  V  S I S   Y APE       
Sbjct: 181 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRY-YRAPELIFGATD 237
Query: 870 ITDKCDVYGFGVLVLEVVTGK 890
            T   DV+  G ++ E++ G+
Sbjct: 238 YTSSIDVWSAGCVLAELLLGQ 258

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+  L D G  VAIKK+      K+     RE++ + K+ H N+V L  ++
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFF 82
Query: 757 WTQSLQL------LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           ++   +       L+ ++V         H       L        +    +SLA++H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 811 IIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           I H +IK  N+L+D  +   K+ D+G A+ L   +  V  S I S   Y APE       
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRY-YRAPELIFGATD 199
Query: 870 ITDKCDVYGFGVLVLEVVTGK 890
            T   DV+  G ++ E++ G+
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQ 220

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 698 LGRGGFGAVY-RTVLRDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLEG 754
           LG G F  V     L   R  AIK L    ++K  +     RE   + ++ HP  V L  
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 98
Query: 755 YYWTQSLQLLIY--EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           Y+  Q  + L +   +   G L K++ +   G+F     RF   +    +L +LH   II
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAE-IVSALEYLHGKGII 155
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF-----ACRT 867
           H ++K  N+L++     ++ D+G A++L    +   ++       Y++PE      AC++
Sbjct: 156 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS 215
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
                  D++  G ++ ++V G  P 
Sbjct: 216 ------SDLWALGCIIYQLVAGLPPF 235

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+  L D G  VAIKK+      K+     RE++ + K+ H N+V L  ++
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFF 161
Query: 757 WTQSLQL------LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           ++   +       L+ ++V         H       L        +    +SLA++H   
Sbjct: 162 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 221
Query: 811 IIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           I H +IK  N+L+D  +   K+ D+G A+ L   +  V  S I S   Y APE       
Sbjct: 222 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRY-YRAPELIFGATD 278
Query: 870 ITDKCDVYGFGVLVLEVVTGK 890
            T   DV+  G ++ E++ G+
Sbjct: 279 YTSSIDVWSAGCVLAELLLGQ 299

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 698 LGRGGFGAVYRT-VLRDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLEG 754
           LG G F  V     L   R  AIK L    ++K  +     RE   + ++ HP  V L  
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 74
Query: 755 YYWTQSLQLLIY--EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           Y+  Q  + L +   +   G L K++ +   G+F     RF   +    +L +LH   II
Sbjct: 75  YFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAE-IVSALEYLHGKGII 131
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF-----ACRT 867
           H ++K  N+L++     ++ D+G A++L    +   ++       Y++PE      AC++
Sbjct: 132 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 191
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
                  D++  G ++ ++V G  P 
Sbjct: 192 ------SDLWALGCIIYQLVAGLPPF 211

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 698 LGRGGFGAVYRT-VLRDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLEG 754
           LG G F  V     L   R  AIK L    ++K  +     RE   + ++ HP  V L  
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 75
Query: 755 YYWTQSLQLLIY--EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           Y+  Q  + L +   +   G L K++ +   G+F     RF   +    +L +LH   II
Sbjct: 76  YFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAE-IVSALEYLHGKGII 132
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF-----ACRT 867
           H ++K  N+L++     ++ D+G A++L    +   ++       Y++PE      AC++
Sbjct: 133 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 192
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
                  D++  G ++ ++V G  P 
Sbjct: 193 ------SDLWALGCIIYQLVAGLPPF 212

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 698 LGRGGFGAVYRT-VLRDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLEG 754
           LG G F  V     L   R  AIK L    ++K  +     RE   + ++ HP  V L  
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 73
Query: 755 YYWTQSLQLLIY--EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           Y+  Q  + L +   +   G L K++ +   G+F     RF   +    +L +LH   II
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAE-IVSALEYLHGKGII 130
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF-----ACRT 867
           H ++K  N+L++     ++ D+G A++L    +   ++       Y++PE      AC++
Sbjct: 131 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 190
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
                  D++  G ++ ++V G  P 
Sbjct: 191 ------SDLWALGCIIYQLVAGLPPF 210

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 698 LGRGGFGAVYRT-VLRDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLEG 754
           LG G F  V     L   R  AIK L    ++K  +     RE   + ++ HP  V L  
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 72
Query: 755 YYWTQSLQLLIY--EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           Y+  Q  + L +   +   G L K++ +   G+F     RF   +    +L +LH   II
Sbjct: 73  YFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAE-IVSALEYLHGKGII 129
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF-----ACRT 867
           H ++K  N+L++     ++ D+G A++L    +   ++       Y++PE      AC++
Sbjct: 130 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 189
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
                  D++  G ++ ++V G  P 
Sbjct: 190 ------SDLWALGCIIYQLVAGLPPF 209

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 698 LGRGGFGAVYRT-VLRDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLEG 754
           LG G F  V     L   R  AIK L    ++K  +     RE   + ++ HP  V L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 95
Query: 755 YYWTQSLQLLIY--EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           Y+  Q  + L +   +   G L K++ +   G+F     RF   +    +L +LH   II
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAE-IVSALEYLHGKGII 152
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF-----ACRT 867
           H ++K  N+L++     ++ D+G A++L    +   ++       Y++PE      AC++
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 212
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
                  D++  G ++ ++V G  P 
Sbjct: 213 ------SDLWALGCIIYQLVAGLPPF 232

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 698 LGRGGFGAVYRT-VLRDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLEG 754
           LG G F  V     L   R  AIK L    ++K  +     RE   + ++ HP  V L  
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 79
Query: 755 YYWTQSLQLLIY--EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           Y+  Q  + L +   +   G L K++ +   G+F     RF   +    +L +LH   II
Sbjct: 80  YFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAE-IVSALEYLHGKGII 136
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF-----ACRT 867
           H ++K  N+L++     ++ D+G A++L    +   ++       Y++PE      AC++
Sbjct: 137 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 196
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
                  D++  G ++ ++V G  P 
Sbjct: 197 ------SDLWALGCIIYQLVAGLPPF 216

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 698 LGRGGFGAVYRT-VLRDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLEG 754
           LG G F  V     L   R  AIK L    ++K  +     RE   + ++ HP  V L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 95
Query: 755 YYWTQSLQLLIY--EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           Y+  Q  + L +   +   G L K++ +   G+F     RF   +    +L +LH   II
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAE-IVSALEYLHGKGII 152
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF-----ACRT 867
           H ++K  N+L++     ++ D+G A++L    +   ++       Y++PE      AC++
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 212
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
                  D++  G ++ ++V G  P 
Sbjct: 213 ------SDLWALGCIIYQLVAGLPPF 232

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 698 LGRGGFGAVYRT-VLRDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLEG 754
           LG G F  V     L   R  AIK L    ++K  +     RE   + ++ HP  V L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 97
Query: 755 YYWTQSLQLLIY--EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           Y+  Q  + L +   +   G L K++ +   G+F     RF   +    +L +LH   II
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAE-IVSALEYLHGKGII 154
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF-----ACRT 867
           H ++K  N+L++     ++ D+G A++L    +   ++       Y++PE      AC++
Sbjct: 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 214
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
                  D++  G ++ ++V G  P 
Sbjct: 215 ------SDLWALGCIIYQLVAGLPPF 234

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 698 LGRGGFGAVYRT-VLRDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLEG 754
           LG G F  V     L   R  AIK L    ++K  +     RE   + ++ HP  V L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 97
Query: 755 YYWTQSLQLLIY--EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           Y+  Q  + L +   +   G L K++ +   G+F     RF   +    +L +LH   II
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAE-IVSALEYLHGKGII 154
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF-----ACRT 867
           H ++K  N+L++     ++ D+G A++L    +   ++       Y++PE      AC++
Sbjct: 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 214
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
                  D++  G ++ ++V G  P 
Sbjct: 215 ------SDLWALGCIIYQLVAGLPPF 234

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 698 LGRGGFGAVYRT-VLRDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLEG 754
           LG G F  V     L   R  AIK L    ++K  +     RE   + ++ HP  V L  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 94
Query: 755 YYWTQSLQLLIY--EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           Y+  Q  + L +   +   G L K++ +   G+F     RF   +    +L +LH   II
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAE-IVSALEYLHGKGII 151
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF-----ACRT 867
           H ++K  N+L++     ++ D+G A++L    +   ++       Y++PE      AC++
Sbjct: 152 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 211
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
                  D++  G ++ ++V G  P 
Sbjct: 212 ------SDLWALGCIIYQLVAGLPPF 231

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 698 LGRGGFGAVYRT-VLRDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLEG 754
           LG G F  V     L   R  AIK L    ++K  +     RE   + ++ HP  V L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 97
Query: 755 YYWTQSLQLLIY--EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           Y+  Q  + L +   +   G L K++ +   G+F     RF   +    +L +LH   II
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAE-IVSALEYLHGKGII 154
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF-----ACRT 867
           H ++K  N+L++     ++ D+G A++L    +   ++       Y++PE      AC++
Sbjct: 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 214
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
                  D++  G ++ ++V G  P 
Sbjct: 215 ------SDLWALGCIIYQLVAGLPPF 234

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 698 LGRGGFGAVYRT-VLRDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLEG 754
           LG G F  V     L   R  AIK L    ++K  +     RE   + ++ HP  V L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 97
Query: 755 YYWTQSLQLLIY--EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           Y+  Q  + L +   +   G L K++ +   G+F     RF   +    +L +LH   II
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAE-IVSALEYLHGKGII 154
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF-----ACRT 867
           H ++K  N+L++     ++ D+G A++L    +   ++       Y++PE      AC++
Sbjct: 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 214
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
                  D++  G ++ ++V G  P 
Sbjct: 215 ------SDLWALGCIIYQLVAGLPPF 234

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 41/228 (17%)
Query: 698 LGRGGFGAVY--RTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           LG+G FG V   R  L D R  AIKK+  +   +       EV  L  + H  +V    Y
Sbjct: 14  LGQGAFGQVVKARNAL-DSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQYVVR---Y 67
Query: 756 Y--WTQ--------------SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGT 799
           Y  W +              S   +  E+    +L+  +H  +       +E + + +  
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQ--QRDEYWRLFRQI 125
Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR-LLPMLDRYVLSSK------- 851
            ++L+++H   IIH ++K  N+ ID S   K+GD+GLA+ +   LD   L S+       
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 852 -IQSALG---YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLST 895
            + SA+G   Y+A E    T    +K D+Y  G++  E++    P ST
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 698 LGRGGFGAVYRT-VLRDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLEG 754
           LG G F  V     L   R  AIK L    ++K  +     RE   + ++ HP  V L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 95
Query: 755 YYWTQSLQLLIY--EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           Y+  Q  + L +   +   G L K++ +   G+F     RF   +    +L +LH   II
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAE-IVSALEYLHGKGII 152
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF-----ACRT 867
           H ++K  N+L++     ++ D+G A++L    +   ++       Y++PE      AC++
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKS 212
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
                  D++  G ++ ++V G  P 
Sbjct: 213 ------SDLWALGCIIYQLVAGLPPF 232

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 698 LGRGGFGA-VYRTVLRDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLEG 754
           LG G F   V    L   R  AIK L    ++K  +     RE   + ++ HP  V L  
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 95
Query: 755 YYWTQSLQLLIY--EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           Y+  Q  + L +   +   G L K++ +   G+F     RF   +    +L +LH   II
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAE-IVSALEYLHGKGII 152
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF-----ACRT 867
           H ++K  N+L++     ++ D+G A++L    +   ++       Y++PE      AC++
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 212
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPL 893
                  D++  G ++ ++V G  P 
Sbjct: 213 ------SDLWALGCIIYQLVAGLPPF 232

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+  L D G  VAIKK+      K+     RE++ + K+ H N+V L  ++
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-----RELQIMRKLDHCNIVRLRYFF 82
Query: 757 WTQSLQL------LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           ++   +       L+ ++V         H       L        +    +SLA++H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 811 IIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           I H +IK  N+L+D  +   K+ D+G A+ L   +  V  S I S   Y APE       
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRY-YRAPELIFGATD 199
Query: 870 ITDKCDVYGFGVLVLEVVTGK 890
            T   DV+  G ++ E++ G+
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQ 220

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 95  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNW 203
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+  L D G  VAIKK+      K+     RE++ + K+ H N+V L  ++
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-----RELQIMRKLDHCNIVRLRYFF 82
Query: 757 WTQSLQL------LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           ++   +       L+ ++V         H       L        +    +SLA++H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 811 IIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           I H +IK  N+L+D  +   K+ D+G A+ L   +  V  S I S   Y APE       
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRY-YRAPELIFGATD 199
Query: 870 ITDKCDVYGFGVLVLEVVTGK 890
            T   DV+  G ++ E++ G+
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQ 220

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 16/211 (7%)
Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG GGF  V     L DG   A+K++      + +E+ +RE        HPN++ L  Y
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 756 YW----TQSLQLLIYEFVSGGSLHKHLHE-GSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
                  +    L+  F   G+L   +      GNFL+ ++   ++ G  + L  +H   
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154
Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYG---LARLLPMLDRYVLSSKIQSA----LGYMAPE- 862
             H ++K +N+L+   G+P + D G    A +     R  L+ +  +A    + Y APE 
Sbjct: 155 YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL 214
Query: 863 FACRTVKITD-KCDVYGFGVLVLEVVTGKRP 892
           F+ ++  + D + DV+  G ++  ++ G+ P
Sbjct: 215 FSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLT---VSSLVKSQEDFEREVKKLGKVRHPN 748
             K  ELG G  G V++   +    V  +KL    +   +++Q    RE++ L +   P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPY 65
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHE-GSGGNFLSWNERFNVIQGTAKSLAHLH 807
           +V   G +++     +  E + GGSL + L + G     +       VI+G    L +L 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTYLR 121
Query: 808 QSN-IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEF 863
           + + I+H ++K SN+L++  GE K+ D+G++  L       + S   S +G   YM+PE 
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-------IDSMANSFVGTRSYMSPE- 173
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
             +    + + D++  G+ ++E+  G+ P+
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLT---VSSLVKSQEDFEREVKKLGKVRHPN 748
             K  ELG G  G V++   +    V  +KL    +   +++Q    RE++ L +   P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPY 65
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHE-GSGGNFLSWNERFNVIQGTAKSLAHLH 807
           +V   G +++     +  E + GGSL + L + G     +       VI+G    L +L 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTYLR 121
Query: 808 QSN-IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEF 863
           + + I+H ++K SN+L++  GE K+ D+G++  L       + S   S +G   YM+PE 
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-------IDSMANSFVGTRSYMSPE- 173
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
             +    + + D++  G+ ++E+  G+ P+
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 62/219 (28%), Positives = 88/219 (40%), Gaps = 19/219 (8%)
Query: 692 LNKDCELGRGGFGAVYRT------VLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV- 744
           LN    LGRG FG V              R VA+K L   +          E+K L  + 
Sbjct: 29  LNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 745 RHPNLVTLEGYYWTQSLQLL-IYEFVSGGSLHKHLHEGSG---------GNFLSWNERFN 794
            H N+V L G        L+ I EF   G+L  +L               +FL+      
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIX 148
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQS 854
                AK +  L     IH ++ + N+L+      K+ D+GLAR +     YV     + 
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 855 ALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
            L +MAPE     V  T + DV+ FGVL+ E+ + G  P
Sbjct: 209 PLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           +G G +G+V  +  ++ G  +A+KKL+    S++ ++  + RE++ L  ++H N++ L  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 117
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQS 809
            + T +  L   E  +   L  HL      N +   +  +     +I    + L ++H +
Sbjct: 118 VF-TPATSL---EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 173
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTV 868
           +IIH ++K SN+ ++   E K+ D+GLAR     +  YV +        Y APE     +
Sbjct: 174 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR------WYRAPEIMLNWM 227
Query: 869 KITDKCDVYGFGVLVLEVVTGK 890
                 D++  G ++ E++TG+
Sbjct: 228 HYNMTVDIWSVGCIMAELLTGR 249

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 89  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTV 868
           ++IIH ++K SN+ ++   E K+ D+GLAR         ++++      Y APE     +
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATR-----WYRAPEIMLNWM 198
Query: 869 KITDKCDVYGFGVLVLEVVTGK 890
                 D++  G ++ E++TG+
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLT---VSSLVKSQEDFEREVKKLGKVRHPN 748
             K  ELG G  G V++   +    V  +KL    +   +++Q    RE++ L +   P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPY 65
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHE-GSGGNFLSWNERFNVIQGTAKSLAHLH 807
           +V   G +++     +  E + GGSL + L + G     +       VI+G    L +L 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTYLR 121
Query: 808 QSN-IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEF 863
           + + I+H ++K SN+L++  GE K+ D+G++  L       + S   S +G   YM+PE 
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-------IDSMANSFVGTRSYMSPE- 173
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
             +    + + D++  G+ ++E+  G+ P+
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLT---VSSLVKSQEDFEREVKKLGKVRHPN 748
             K  ELG G  G V++   +    V  +KL    +   +++Q    RE++ L +   P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPY 65
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHE-GSGGNFLSWNERFNVIQGTAKSLAHLH 807
           +V   G +++     +  E + GGSL + L + G     +       VI+G    L +L 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTYLR 121
Query: 808 QSN-IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEF 863
           + + I+H ++K SN+L++  GE K+ D+G++  L       + S   S +G   YM+PE 
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-------IDSMANSFVGTRSYMSPE- 173
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
             +    + + D++  G+ ++E+  G+ P+
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLT---VSSLVKSQEDFEREVKKLGKVRHPN 748
             K  ELG G  G V++   +    V  +KL    +   +++Q    RE++ L +   P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPY 65
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHE-GSGGNFLSWNERFNVIQGTAKSLAHLH 807
           +V   G +++     +  E + GGSL + L + G     +       VI+G    L +L 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTYLR 121
Query: 808 QSN-IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEF 863
           + + I+H ++K SN+L++  GE K+ D+G++  L       + S   S +G   YM+PE 
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-------IDSMANSFVGTRSYMSPE- 173
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
             +    + + D++  G+ ++E+  G+ P+
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 28/218 (12%)
Query: 698 LGRGGFGAVYRT----VLRDGR--PVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LG G FG V       + + G    VA+K L   +    +E    E+K + ++  H N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSL--------------------HKHLHEGSGGNFLSWN 790
            L G         LI+E+   G L                     K L E    N L++ 
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 791 ERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS 850
           +        AK +  L   + +H ++ + NVL+      K+ D+GLAR +     YV+  
Sbjct: 173 DLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRG 232
Query: 851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
             +  + +MAPE     +  T K DV+ +G+L+ E+ +
Sbjct: 233 NARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFS 269

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 49/201 (24%), Positives = 88/201 (43%), Gaps = 11/201 (5%)
Query: 698 LGRGGFGAVYRT-VLRDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLEG 754
           LG G F  V     L   R  AIK L    ++K  +     RE   + ++ HP  V L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 97
Query: 755 YYWTQSLQLLIY--EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           Y+  Q  + L +   +   G L K++ +   G+F     RF   +    +L +LH   II
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGCLLKYIRKI--GSFDETCTRFYTAE-IVSALEYLHGKGII 154
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           H ++K  N+L++     ++ D+G A++L    +   ++       Y++PE        + 
Sbjct: 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SASK 213
Query: 873 KCDVYGFGVLVLEVVTGKRPL 893
             D++  G ++ ++V G  P 
Sbjct: 214 SSDLWALGCIIYQLVAGLPPF 234

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLT---VSSLVKSQEDFEREVKKLGKVRHPN 748
             K  ELG G  G V++   +    V  +KL    +   +++Q    RE++ L +   P 
Sbjct: 11  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPY 68
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHE-GSGGNFLSWNERFNVIQGTAKSLAHLH 807
           +V   G +++     +  E + GGSL + L + G     +       VI+G    L +L 
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTYLR 124
Query: 808 QSN-IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           + + I+H ++K SN+L++  GE K+ D+G++  L  +D   ++++      YM+PE   +
Sbjct: 125 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDE--MANEFVGTRSYMSPE-RLQ 179
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRP 892
               + + D++  G+ ++E+  G+ P
Sbjct: 180 GTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 50/178 (28%), Positives = 78/178 (43%), Gaps = 22/178 (12%)
Query: 732 EDFEREVKKLGKVRHPNLVTL--------EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSG 783
           E   +E+  L K+ HPN+V L        E + +      +++E V+ G +     E   
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLY------MVFELVNQGPVM----EVPT 130
Query: 784 GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML 843
              LS ++     Q   K + +LH   IIH +IK SN+L+   G  K+ D+G++      
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 844 DRYVLSSKIQSALGYMAPEFACRTVKI--TDKCDVYGFGVLVLEVVTGKRPLSTWKMM 899
           D   L S       +MAPE    T KI      DV+  GV +   V G+ P    ++M
Sbjct: 191 D--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
            +   +SL+     ++    +   L+       L+ +    +I    + L ++H ++IIH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIH 148
Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
            ++K SN+ ++   E K+ D+GL R     +  YV +        Y APE     +    
Sbjct: 149 RDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATR------WYRAPEIMLNWMHYNQ 202
Query: 873 KCDVYGFGVLVLEVVTGK 890
             D++  G ++ E++TG+
Sbjct: 203 TVDIWSVGCIMAELLTGR 220

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 14/204 (6%)
Query: 698 LGRGGFGAVYRTVLR--DGR--PVAIKKLTVS-SLVKSQEDFEREVKKLGKVRHPNLVTL 752
           LG G FG+V    L+  DG    VA+K + +  S  +  E+F  E   +    HPN++ L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 753 EGYYWTQSLQ-----LLIYEFVSGGSLHKHL---HEGSGGNFLSWNERFNVIQGTAKSLA 804
            G     S Q     ++I  F+  G LH +L      +G   +        +   A  + 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
           +L   N +H ++ + N ++       V D+GL++ +   D Y      +  + ++A E  
Sbjct: 162 YLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL 221
Query: 865 CRTVKITDKCDVYGFGVLVLEVVT 888
              V  T K DV+ FGV + E+ T
Sbjct: 222 ADRV-YTSKSDVWAFGVTMWEIAT 244

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 87/201 (43%), Gaps = 9/201 (4%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV---KSQEDFEREVKKLGKVRHPNLVTLEG 754
           LG+GGF   +     D + V   K+   SL+     +E    E+     + H ++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           ++       ++ E     SL + LH+      L+  E    ++       +LH++ +IH 
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLE-LHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIHR 141
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+ ++   E K+GD+GLA  +           +     Y+APE   +    + + 
Sbjct: 142 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNYIAPEVLSKKGH-SFEV 198
Query: 875 DVYGFGVLVLEVVTGKRPLST 895
           DV+  G ++  ++ GK P  T
Sbjct: 199 DVWSIGCIMYTLLVGKPPFET 219

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKL---TVSSLVKSQEDFEREVKKLGKVRHPN 748
             K  ELG G  G V++   +    V  +KL    +   +++Q    RE++ L +   P 
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPY 92
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHE-GSGGNFLSWNERFNVIQGTAKSLAHLH 807
           +V   G +++     +  E + GGSL + L + G     +       VI+G    L +L 
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTYLR 148
Query: 808 QSN-IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEF 863
           + + I+H ++K SN+L++  GE K+ D+G++  L       + S   S +G   YM+PE 
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-------IDSMANSFVGTRSYMSPE- 200
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
             +    + + D++  G+ ++E+  G+ P+
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 87/201 (43%), Gaps = 9/201 (4%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV---KSQEDFEREVKKLGKVRHPNLVTLEG 754
           LG+GGF   +     D + V   K+   SL+     +E    E+     + H ++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           ++       ++ E     SL + LH+      L+  E    ++       +LH++ +IH 
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLE-LHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIHR 145
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+ ++   E K+GD+GLA  +           +     Y+APE   +    + + 
Sbjct: 146 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNYIAPEVLSKKGH-SFEV 202
Query: 875 DVYGFGVLVLEVVTGKRPLST 895
           DV+  G ++  ++ GK P  T
Sbjct: 203 DVWSIGCIMYTLLVGKPPFET 223

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 87/201 (43%), Gaps = 9/201 (4%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV---KSQEDFEREVKKLGKVRHPNLVTLEG 754
           LG+GGF   +     D + V   K+   SL+     +E    E+     + H ++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           ++       ++ E     SL + LH+      L+  E    ++       +LH++ +IH 
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLE-LHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIHR 141
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+ ++   E K+GD+GLA  +           +     Y+APE   +    + + 
Sbjct: 142 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNYIAPEVLSKKGH-SFEV 198
Query: 875 DVYGFGVLVLEVVTGKRPLST 895
           DV+  G ++  ++ GK P  T
Sbjct: 199 DVWSIGCIMYTLLVGKPPFET 219

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 13/203 (6%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV---KSQEDFEREVKKLGKVRHPNLVTLEG 754
           LG+GGF   +     D + V   K+   SL+     +E    E+     + H ++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           ++       ++ E     SL + LH+      L+  E    ++       +LH++ +IH 
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLE-LHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIHR 163
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK--IQSALGYMAPEFACRTVKITD 872
           ++K  N+ ++   E K+GD+GLA  +     Y    K  +     Y+APE   +    + 
Sbjct: 164 DLKLGNLFLNEDLEVKIGDFGLATKV----EYDGERKKVLCGTPNYIAPEVLSKKGH-SF 218
Query: 873 KCDVYGFGVLVLEVVTGKRPLST 895
           + DV+  G ++  ++ GK P  T
Sbjct: 219 EVDVWSIGCIMYTLLVGKPPFET 241

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 13/203 (6%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV---KSQEDFEREVKKLGKVRHPNLVTLEG 754
           LG+GGF   +     D + V   K+   SL+     +E    E+     + H ++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           ++       ++ E     SL + LH+      L+  E    ++       +LH++ +IH 
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLE-LHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIHR 165
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK--IQSALGYMAPEFACRTVKITD 872
           ++K  N+ ++   E K+GD+GLA  +     Y    K  +     Y+APE   +    + 
Sbjct: 166 DLKLGNLFLNEDLEVKIGDFGLATKV----EYDGERKKVLCGTPNYIAPEVLSKKGH-SF 220
Query: 873 KCDVYGFGVLVLEVVTGKRPLST 895
           + DV+  G ++  ++ GK P  T
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFET 243

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 13/202 (6%)
Query: 698 LGRGGFGAVYRT-VLRDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLEG 754
           LG G F  V     L   R  AIK L    ++K  +     RE   + ++ HP  V L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL-- 97
Query: 755 YYWTQSLQLLIY--EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           Y+  Q  + L +   +   G L K++ +   G+F     RF   +    +L +LH   II
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAE-IVSALEYLHGKGII 154
Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           H ++K  N+L++     ++ D+G A++L    +   ++       Y++PE    T K   
Sbjct: 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL--TEKSAX 212
Query: 873 K-CDVYGFGVLVLEVVTGKRPL 893
           K  D++  G ++ ++V G  P 
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPF 234

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 89  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D GLAR     +  YV +        Y APE     
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR------WYRAPEIMLNW 197
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 89  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D GLAR     +  YV +        Y APE     
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATR------WYRAPEIMLNW 197
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/223 (22%), Positives = 97/223 (43%), Gaps = 34/223 (15%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQE----------------DFEREVKKL 741
           L +G F  +     +D +  A+KK   S L K ++                DF+ E++ +
Sbjct: 39  LNQGKFNKII-LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 742 GKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKH-----LHEGSGGNFLSWNERFNVI 796
             +++   +T EG         +IYE++   S+ K      + + +   F+       +I
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 797 QGTAKSLAHLH-QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
           +    S +++H + NI H ++K SN+L+D +G  K+ D+G +        Y++  KI+ +
Sbjct: 158 KSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES-------EYMVDKKIKGS 210
Query: 856 LG---YMAPEFACRTVKIT-DKCDVYGFGVLVLEVVTGKRPLS 894
            G   +M PEF          K D++  G+ +  +     P S
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLT---VSSLVKSQEDFEREVKKLGKVRHPN 748
             K  ELG G  G V++   +    V  +KL    +   +++Q    RE++ L +   P 
Sbjct: 27  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPY 84
Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHE-GSGGNFLSWNERFNVIQGTAKSLAHLH 807
           +V   G +++     +  E + GGSL + L + G     +       VI+G    L +L 
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LTYLR 140
Query: 808 QSN-IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEF 863
           + + I+H ++K SN+L++  GE K+ D+G++  L       + S   S +G   YM+PE 
Sbjct: 141 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-------IDSMANSFVGTRSYMSPE- 192
Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRPLST 895
             +    + + D++  G+ ++E+  G+ P+ +
Sbjct: 193 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGS 224

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 62/219 (28%), Positives = 88/219 (40%), Gaps = 19/219 (8%)
Query: 692 LNKDCELGRGGFGAVYRT------VLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV- 744
           LN    LGRG FG V              R VA+K L   +          E+K L  + 
Sbjct: 29  LNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 745 RHPNLVTLEGYYWTQSLQLL-IYEFVSGGSLHKHLHEGSG---------GNFLSWNERFN 794
            H N+V L G        L+ I EF   G+L  +L               +FL+      
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIC 148
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQS 854
                AK +  L     IH ++ + N+L+      K+ D+GLAR +     YV     + 
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 855 ALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
            L +MAPE     V  T + DV+ FGVL+ E+ + G  P
Sbjct: 209 PLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 89  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D+ LAR     +  YV +        Y APE     
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR------WYRAPEIMLNW 197
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 689 HALLNKDC----ELGRGGFGAVYRTVLR---DGRPVAIKKLTVSSLVKSQ----EDFERE 737
           H + N+D      LG+G F  +++ V R   D   +   ++ +  L K+     E F   
Sbjct: 3   HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA 62
Query: 738 VKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ 797
              + K+ H +LV   G  +     +L+ EFV  GSL  +L +      + W  +  V +
Sbjct: 63  ASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAK 120
Query: 798 GTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKI-QSA 855
             A ++  L ++ +IH N+ + N+L+    + K G+    +L  P +   VL   I Q  
Sbjct: 121 QLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER 180
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLST 895
           + ++ PE       +    D + FG  + E+ + G +PLS 
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           +GRG +G V   V +  R     K      V+  + F++E++ +  + HPN++ L   + 
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 758 TQSLQLLIYEFVSGGSL-----HKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
             +   L+ E  +GG L     HK +   S            +++    ++A+ H+ N+ 
Sbjct: 77  DNTDIYLVMELCTGGELFERVVHKRVFRESDAA--------RIMKDVLSAVAYCHKLNVA 128
Query: 813 HYNIKSSNVLI--DGSGEP-KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACR 866
           H ++K  N L   D    P K+ D+GLA       R+     +++ +G   Y++P+    
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAA------RFKPGKMMRTKVGTPYYVSPQVL-- 180
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPLST 895
                 +CD +  GV++  ++ G  P S 
Sbjct: 181 EGLYGPECDEWSAGVMMYVLLCGYPPFSA 209

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 85/212 (40%), Gaps = 22/212 (10%)
Query: 698 LGRGGFGAVYRT------VLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LGRG FG V              R VA+K L   +          E+K L  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 751 TLEGYYWTQSLQLL-IYEFVSGGSLHKHLH-------------EGSGGNFLSWNERFNVI 796
            L G        L+ I EF   G+L  +L              E    +FL+        
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL 856
              AK +  L     IH ++ + N+L+      K+ D+GLAR +     YV     +  L
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 214
Query: 857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
            +MAPE     V  T + DV+ FGVL+ E+ +
Sbjct: 215 KWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 85/212 (40%), Gaps = 22/212 (10%)
Query: 698 LGRGGFGAVYRT------VLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LGRG FG V              R VA+K L   +          E+K L  +  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 751 TLEGYYWTQSLQLL-IYEFVSGGSLHKHLH-------------EGSGGNFLSWNERFNVI 796
            L G        L+ I EF   G+L  +L              E    +FL+        
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL 856
              AK +  L     IH ++ + N+L+      K+ D+GLAR +     YV     +  L
Sbjct: 157 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 216
Query: 857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
            +MAPE     V  T + DV+ FGVL+ E+ +
Sbjct: 217 KWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 247

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           +GRG +G V   V +  R     K      V+  + F++E++ +  + HPN++ L   + 
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 93
Query: 758 TQSLQLLIYEFVSGGSL-----HKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
             +   L+ E  +GG L     HK +   S            +++    ++A+ H+ N+ 
Sbjct: 94  DNTDIYLVMELCTGGELFERVVHKRVFRESDAA--------RIMKDVLSAVAYCHKLNVA 145
Query: 813 HYNIKSSNVLI--DGSGEP-KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACR 866
           H ++K  N L   D    P K+ D+GLA       R+     +++ +G   Y++P+    
Sbjct: 146 HRDLKPENFLFLTDSPDSPLKLIDFGLA------ARFKPGKMMRTKVGTPYYVSPQVL-- 197
Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPLST 895
                 +CD +  GV++  ++ G  P S 
Sbjct: 198 EGLYGPECDEWSAGVMMYVLLCGYPPFSA 226

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 85/212 (40%), Gaps = 22/212 (10%)
Query: 698 LGRGGFGAVYRT------VLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LGRG FG V              R VA+K L   +          E+K L  +  H N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 751 TLEGYYWTQSLQLL-IYEFVSGGSLHKHLH-------------EGSGGNFLSWNERFNVI 796
            L G        L+ I EF   G+L  +L              E    +FL+        
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL 856
              AK +  L     IH ++ + N+L+      K+ D+GLAR +     YV     +  L
Sbjct: 192 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 251
Query: 857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
            +MAPE     V  T + DV+ FGVL+ E+ +
Sbjct: 252 KWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 282

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 20/214 (9%)
Query: 698 LGRGGFGAVYRTVLR--DGR--PVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTL 752
           LG+G FG+V    L+  DG    VA+K L    +  S  E+F RE   + +  HP++  L
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 753 EGYYWTQS------LQLLIYEFVSGGSLHKHLHEGSGGNF-----LSWNERFNVIQGTAK 801
            G            + ++I  F+  G LH  L     G       L    RF V    A 
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV--DIAC 148
Query: 802 SLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAP 861
            + +L   N IH ++ + N ++       V D+GL+R +   D Y      +  + ++A 
Sbjct: 149 GMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLAL 208
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLS 894
           E     +  T   DV+ FGV + E++T G+ P +
Sbjct: 209 ESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYA 241

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 40/216 (18%)
Query: 699 GRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT------- 751
            RG FG V++  L +   VA+K   +    K     ERE+     ++H NL+        
Sbjct: 24  ARGRFGCVWKAQLMNDF-VAVKIFPLQD--KQSWQSEREIFSTPGMKHENLLQFIAAEKR 80
Query: 752 ---LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
              LE   W      LI  F   GSL  +L     GN ++WNE  +V +  ++ L++LH+
Sbjct: 81  GSNLEVELW------LITAFHDKGSLTDYLK----GNIITWNELCHVAETMSRGLSYLHE 130
Query: 809 S-----------NIIHYNIKSSNVLIDGSGEPKVGDYGLA-RLLPMLDRYVLSSKIQSAL 856
                       +I H + KS NVL+       + D+GLA R  P         ++ +  
Sbjct: 131 DVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRR 190
Query: 857 GYMAPEFACRTVKITD----KCDVYGFGVLVLEVVT 888
            YMAPE     +        + D+Y  G+++ E+V+
Sbjct: 191 -YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 698 LGRGGFGAV---YRTVLRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-T 751
           +G G +G+V   Y   LR  + VA+KKL+    SL+ ++  + RE++ L  ++H N++  
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGL 92
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L+ +    S++     ++    +   L+       LS      ++    + L ++H + I
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAGI 152
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKI 870
           IH ++K SNV ++   E ++ D+GLAR     +  YV +        Y APE     +  
Sbjct: 153 IHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR------WYRAPEIMLNWMHY 206
Query: 871 TDKCDVYGFGVLVLEVVTGK 890
               D++  G ++ E++ GK
Sbjct: 207 NQTVDIWSVGCIMAELLQGK 226

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 88/215 (40%), Gaps = 27/215 (12%)
Query: 698 LGRGGFGAV-----YRTVLRDGR-PVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LG G FG V     Y  +  D    VA+K L  S+ +  +E    E+K L  +  H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNE---------------RFNV 795
            L G        L+I E+   G L   L         S                    + 
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               AK +A L   N IH ++ + N+L+      K+ D+GLAR +     YV+    +  
Sbjct: 167 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 226
Query: 856 LGYMAPE--FACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE  F C     T + DV+ +G+ + E+ +
Sbjct: 227 VKWMAPESIFNC---VYTFESDVWSYGIFLWELFS 258

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 88/215 (40%), Gaps = 27/215 (12%)
Query: 698 LGRGGFGAV-----YRTVLRDGR-PVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LG G FG V     Y  +  D    VA+K L  S+ +  +E    E+K L  +  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNE---------------RFNV 795
            L G        L+I E+   G L   L         S                    + 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               AK +A L   N IH ++ + N+L+      K+ D+GLAR +     YV+    +  
Sbjct: 151 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210
Query: 856 LGYMAPE--FACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE  F C     T + DV+ +G+ + E+ +
Sbjct: 211 VKWMAPESIFNC---VYTFESDVWSYGIFLWELFS 242

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 85/212 (40%), Gaps = 22/212 (10%)
Query: 698 LGRGGFGAVYRT------VLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LGRG FG V              R VA+K L   +          E+K L  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 751 TLEGYYWTQSLQLL-IYEFVSGGSLHKHLH-------------EGSGGNFLSWNERFNVI 796
            L G        L+ I EF   G+L  +L              E    +FL+        
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL 856
              AK +  L     IH ++ + N+L+      K+ D+GLAR +     YV     +  L
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
            +MAPE     V  T + DV+ FGVL+ E+ +
Sbjct: 206 KWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 236

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 89  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+ D GLAR     +  YV +        Y APE     
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR------WYRAPEIMLNW 197
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 110/241 (45%), Gaps = 13/241 (5%)
Query: 663 SRSPTTDANSGKLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTV-LRDGRPVAIKK 721
           S +P  D +S K  +  G+ +F      L     ELGRG +G V +   +  G+ +A+K+
Sbjct: 26  SSTPPRDLDS-KACISIGNQNFEVKADDL-EPIMELGRGAYGVVEKMRHVPSGQIMAVKR 83
Query: 722 LTVSSLVKSQEDFEREVK-KLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHE 780
           +  +   + Q+    ++   +  V  P  VT  G  + +    +  E +   SL K   +
Sbjct: 84  IRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQ 142
Query: 781 G-SGGNFLSWNERFNVIQGTAKSLAHLHQS-NIIHYNIKSSNVLIDGSGEPKVGDYGLAR 838
               G  +  +    +     K+L HLH   ++IH ++K SNVLI+  G+ K+ D+G++ 
Sbjct: 143 VIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG 202
Query: 839 LLPMLDRYVLSSKIQSALGYMAPEFACRTVK---ITDKCDVYGFGVLVLEVVTGKRPLST 895
            L  +D  V  +       YMAPE     +     + K D++  G+ ++E+   + P  +
Sbjct: 203 YL--VDS-VAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 259
Query: 896 W 896
           W
Sbjct: 260 W 260

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 85/212 (40%), Gaps = 22/212 (10%)
Query: 698 LGRGGFGAVYRT------VLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LGRG FG V              R VA+K L   +          E+K L  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 751 TLEGYYWTQSLQLL-IYEFVSGGSLHKHLH-------------EGSGGNFLSWNERFNVI 796
            L G        L+ I EF   G+L  +L              E    +FL+        
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL 856
              AK +  L     IH ++ + N+L+      K+ D+GLAR +     YV     +  L
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
            +MAPE     V  T + DV+ FGVL+ E+ +
Sbjct: 206 KWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 236

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 698 LGRGGFGAV---YRTVLRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-T 751
           +G G +G+V   Y   LR  + VA+KKL+    SL+ ++  + RE++ L  ++H N++  
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGL 92
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L+ +    S++     ++    +   L+       LS      ++    + L ++H + I
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGI 152
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKI 870
           IH ++K SNV ++   E ++ D+GLAR     +  YV +        Y APE     +  
Sbjct: 153 IHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR------WYRAPEIMLNWMHY 206
Query: 871 TDKCDVYGFGVLVLEVVTGK 890
               D++  G ++ E++ GK
Sbjct: 207 NQTVDIWSVGCIMAELLQGK 226

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-TLE 753
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++  L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN-----VIQGTAKSLAHLHQ 808
            +   +SL+    EF +   L  HL      N +   +  +     +I    + L ++H 
Sbjct: 89  VFTPARSLE----EF-NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IIH ++K SN+ ++   E K+  +GLAR     +  YV +        Y APE     
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR------WYRAPEIMLNW 197
Query: 868 VKITDKCDVYGFGVLVLEVVTGK 890
           +      D++  G ++ E++TG+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 16/221 (7%)
Query: 689 HALLNKDC----ELGRGGFGAVYRTVLR---DGRPVAIKKLTVSSLVKSQ----EDFERE 737
           H + N+D      LG+G F  +++ V R   D   +   ++ +  L K+     E F   
Sbjct: 3   HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA 62
Query: 738 VKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQ 797
              + K+ H +LV   G        +L+ EFV  GSL  +L +      + W  +  V +
Sbjct: 63  ASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAK 120
Query: 798 GTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKI-QSA 855
             A ++  L ++ +IH N+ + N+L+    + K G+    +L  P +   VL   I Q  
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER 180
Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLST 895
           + ++ PE       +    D + FG  + E+ + G +PLS 
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 88/215 (40%), Gaps = 27/215 (12%)
Query: 698 LGRGGFGAV-----YRTVLRDG-RPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LG G FG V     Y  +  D    VA+K L  S+ +  +E    E+K L  +  H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNE---------------RFNV 795
            L G        L+I E+   G L   L         S                    + 
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               AK +A L   N IH ++ + N+L+      K+ D+GLAR +     YV+    +  
Sbjct: 169 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 228
Query: 856 LGYMAPE--FACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE  F C     T + DV+ +G+ + E+ +
Sbjct: 229 VKWMAPESIFNC---VYTFESDVWSYGIFLWELFS 260

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 88/215 (40%), Gaps = 27/215 (12%)
Query: 698 LGRGGFGAV-----YRTVLRDGR-PVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LG G FG V     Y  +  D    VA+K L  S+ +  +E    E+K L  +  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNE---------------RFNV 795
            L G        L+I E+   G L   L         S                    + 
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               AK +A L   N IH ++ + N+L+      K+ D+GLAR +     YV+    +  
Sbjct: 174 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLP 233
Query: 856 LGYMAPE--FACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE  F C     T + DV+ +G+ + E+ +
Sbjct: 234 VKWMAPESIFNC---VYTFESDVWSYGIFLWELFS 265

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 698 LGRGGFGAV---YRTVLRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLV-T 751
           +G G +G+V   Y   LR  + VA+KKL+    SL+ ++  + RE++ L  ++H N++  
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGL 84
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L+ +    S++     ++    +   L+       LS      ++    + L ++H + I
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGI 144
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKI 870
           IH ++K SNV ++   E ++ D+GLAR     +  YV +        Y APE     +  
Sbjct: 145 IHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR------WYRAPEIMLNWMHY 198
Query: 871 TDKCDVYGFGVLVLEVVTGK 890
               D++  G ++ E++ GK
Sbjct: 199 NQTVDIWSVGCIMAELLQGK 218

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 88/215 (40%), Gaps = 27/215 (12%)
Query: 698 LGRGGFGAV-----YRTVLRDGR-PVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LG G FG V     Y  +  D    VA+K L  S+ +  +E    E+K L  +  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNE---------------RFNV 795
            L G        L+I E+   G L   L         S                    + 
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               AK +A L   N IH ++ + N+L+      K+ D+GLAR +     YV+    +  
Sbjct: 174 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 233
Query: 856 LGYMAPE--FACRTVKITDKCDVYGFGVLVLEVVT 888
           + +MAPE  F C     T + DV+ +G+ + E+ +
Sbjct: 234 VKWMAPESIFNC---VYTFESDVWSYGIFLWELFS 265

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 30/214 (14%)
Query: 697 ELGRGGFGAVY--RTVLRDGRPVAIKKLTVSSLVKSQEDFE----REV---KKLGKVRHP 747
           E+G G +G V+  R +   GR VA+K++ V +    +E       REV   + L    HP
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAVLRHLETFEHP 74
Query: 748 NLVTLEGYYWT-----QSLQLLIYEFVSGG---SLHKHLHEGSGGNFLSWNERFNVIQGT 799
           N+V L           ++   L++E V       L K    G     +  +  F +++G 
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-DMMFQLLRG- 132
Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYM 859
              L  LH   ++H ++K  N+L+  SG+ K+ D+GLAR+     +  L+S + + L Y 
Sbjct: 133 ---LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVT-LWYR 186
Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           APE   ++   T   D++  G +  E+   ++PL
Sbjct: 187 APEVLLQSSYAT-PVDLWSVGCIFAEMFR-RKPL 218

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 51/212 (24%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGY 755
           LG G +  V   V L++G+  A+K +   +   S+    REV+ L + + + N++ L  +
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQA-GHSRSRVFREVETLYQCQGNKNILELIEF 79
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNER--FNVIQGTAKSLAHLHQSNIIH 813
           +   +   L++E + GGS+  H+ +        +NER    V++  A +L  LH   I H
Sbjct: 80  FEDDTRFYLVFEKLQGGSILAHIQKQK-----HFNEREASRVVRDVAAALDFLHTKGIAH 134
Query: 814 YNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRY--VLSSKIQSALG---YMAPE--- 862
            ++K  N+L +   +    K+ D+ L   + + +    + + ++ +  G   YMAPE   
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVE 194
Query: 863 -FACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
            F  +      +CD++  GV++  +++G  P 
Sbjct: 195 VFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 102/231 (44%), Gaps = 49/231 (21%)
Query: 686 TGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV- 744
           T  H +   +C +G+G +G V+R   + G  VA+K  +     + ++ + RE +    V 
Sbjct: 5   TVAHQITLLEC-VGKGRYGEVWRGSWQ-GENVAVKIFSS----RDEKSWFRETELYNTVM 58
Query: 745 -RHPNLVTLEGYYWTQ---SLQL-LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGT 799
            RH N++       T    S QL LI  +   GSL+ +L   +    L       ++   
Sbjct: 59  LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSI 114
Query: 800 AKSLAHLH--------QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK 851
           A  LAHLH        +  I H ++KS N+L+  +G+  + D GLA         V+ S+
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA---------VMHSQ 165
Query: 852 IQSALG-----------YMAPEFACRTVKIT-----DKCDVYGFGVLVLEV 886
             + L            YMAPE    T+++       + D++ FG+++ EV
Sbjct: 166 STNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 84/210 (40%), Gaps = 20/210 (9%)
Query: 698 LGRGGFGAVYRT------VLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LGRG FG V              R VA+K L   +          E+K L  +  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 751 TLEGYYWTQSLQLL-IYEFVSGGSLHKHLH-----------EGSGGNFLSWNERFNVIQG 798
            L G        L+ I EF   G+L  +L            E    +FL+          
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 799 TAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGY 858
            AK +  L     IH ++ + N+L+      K+ D+GLAR +      V     +  L +
Sbjct: 157 VAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKW 216
Query: 859 MAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           MAPE     V  T + DV+ FGVL+ E+ +
Sbjct: 217 MAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 102/244 (41%), Gaps = 49/244 (20%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVK-SQEDFER---EVKKLGKVRHPNLVTL 752
           +G+G +G V   +    R + AIK +  + + + + +D ER   EV+ + K+ HPN+  L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLH---------------------------EGSGGN 785
              Y  +    L+ E   GG L   L+                           E   G+
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 786 FLSWNERF----------NVIQGTAKSLAHLHQSNIIHYNIKSSNVLI--DGSGEPKVGD 833
              + E            N+++    +L +LH   I H +IK  N L   + S E K+ D
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVD 213
Query: 834 YGLARLLPML---DRYVLSSKIQSALGYMAPEFACRTVK-ITDKCDVYGFGVLVLEVVTG 889
           +GL++    L   + Y +++K  +   ++APE    T +    KCD +  GVL+  ++ G
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPY-FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272
Query: 890 KRPL 893
             P 
Sbjct: 273 AVPF 276

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 48/219 (21%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV--RHPNLVTLEGY 755
           +G+G +G V+R   + G  VA+K  +     + ++ + RE +    V  RH N++     
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIAS 99
Query: 756 YWTQ---SLQL-LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH---- 807
             T    S QL LI  +   GSL+ +L   +    L       ++   A  LAHLH    
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEIF 155
Query: 808 ----QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG------ 857
               +  I H ++KS N+L+  +G+  + D GLA         V+ S+  + L       
Sbjct: 156 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA---------VMHSQSTNQLDVGNNPR 206
Query: 858 -----YMAPEFACRTVKIT-----DKCDVYGFGVLVLEV 886
                YMAPE    T+++       + D++ FG+++ EV
Sbjct: 207 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 13/203 (6%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV---KSQEDFEREVKKLGKVRHPNLVTLEG 754
           LG+GGF   +     D + V   K+   SL+     +E    E+     + H ++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           ++       ++ E     SL + LH+      L+  E    ++       +LH++ +IH 
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLE-LHKRRKA--LTEPEARYYLRQIVLGCQYLHRNRVIHR 139
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK--IQSALGYMAPEFACRTVKITD 872
           ++K  N+ ++   E K+GD+GLA  +     Y    K  +     Y+APE   +    + 
Sbjct: 140 DLKLGNLFLNEDLEVKIGDFGLATKV----EYDGERKKVLCGTPNYIAPEVLSKKGH-SF 194
Query: 873 KCDVYGFGVLVLEVVTGKRPLST 895
           + DV+  G ++  ++ GK P  T
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFET 217

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 84/211 (39%), Gaps = 21/211 (9%)
Query: 698 LGRGGFGAVYRT------VLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LGRG FG V              R VA+K L   +          E+K L  +  H N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 751 TLEGYYWTQSLQLL-IYEFVSGGSLHKHLH------------EGSGGNFLSWNERFNVIQ 797
            L G        L+ I EF   G+L  +L             E    +FL+         
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 798 GTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG 857
             AK +  L     IH ++ + N+L+      K+ D+GLAR +      V     +  L 
Sbjct: 156 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK 215
Query: 858 YMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           +MAPE     V  T + DV+ FGVL+ E+ +
Sbjct: 216 WMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 694 KDCELGRGGFGAVYRTVLRDGRPVAIKKLTV----SSLVKSQEDFEREVKKLGKVRHPNL 749
           +D ELG G FG V +   +  + V    + +    ++    +++   E   + ++ +P +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
           V + G    +S  +L+ E    G L+K+L +      +       ++   +  + +L +S
Sbjct: 81  VRMIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES 136
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQS----ALGYMAPEFAC 865
           N +H ++ + NVL+      K+ D+GL++ L   + Y    K Q+     + + APE   
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY---KAQTHGKWPVKWYAPE-CI 192
Query: 866 RTVKITDKCDVYGFGVLVLEVVT-GKRP 892
              K + K DV+ FGVL+ E  + G++P
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 694 KDCELGRGGFGAVYRTVLRDGRPVAIKKLTV----SSLVKSQEDFEREVKKLGKVRHPNL 749
           +D ELG G FG V +   +  + V    + +    ++    +++   E   + ++ +P +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
           V + G    +S  +L+ E    G L+K+L +      +       ++   +  + +L +S
Sbjct: 91  VRMIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES 146
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQS----ALGYMAPEFAC 865
           N +H ++ + NVL+      K+ D+GL++ L   + Y    K Q+     + + APE   
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY---KAQTHGKWPVKWYAPE-CI 202
Query: 866 RTVKITDKCDVYGFGVLVLEVVT-GKRP 892
              K + K DV+ FGVL+ E  + G++P
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 694 KDCELGRGGFGAVYRTVLRDGRPVAIKKLTV----SSLVKSQEDFEREVKKLGKVRHPNL 749
           +D ELG G FG V +   +  + V    + +    ++    +++   E   + ++ +P +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
           V + G    +S  +L+ E    G L+K+L +      +       ++   +  + +L +S
Sbjct: 91  VRMIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES 146
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQS----ALGYMAPEFAC 865
           N +H ++ + NVL+      K+ D+GL++ L   + Y    K Q+     + + APE   
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY---KAQTHGKWPVKWYAPE-CI 202
Query: 866 RTVKITDKCDVYGFGVLVLEVVT-GKRP 892
              K + K DV+ FGVL+ E  + G++P
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 694 KDCELGRGGFGAVYRTVLRDGRPVAIKKLTV----SSLVKSQEDFEREVKKLGKVRHPNL 749
           +D ELG G FG V +   +  + V    + +    ++    +++   E   + ++ +P +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
           V + G    +S  +L+ E    G L+K+L +      +       ++   +  + +L +S
Sbjct: 75  VRMIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES 130
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQS----ALGYMAPEFAC 865
           N +H ++ + NVL+      K+ D+GL++ L   + Y    K Q+     + + APE   
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY---KAQTHGKWPVKWYAPE-CI 186
Query: 866 RTVKITDKCDVYGFGVLVLEVVT-GKRP 892
              K + K DV+ FGVL+ E  + G++P
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 694 KDCELGRGGFGAVYRTVLRDGRPVAIKKLTV----SSLVKSQEDFEREVKKLGKVRHPNL 749
           +D ELG G FG V +   +  + V    + +    ++    +++   E   + ++ +P +
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
           V + G    +S  +L+ E    G L+K+L +      +       ++   +  + +L +S
Sbjct: 89  VRMIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES 144
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQS----ALGYMAPEFAC 865
           N +H ++ + NVL+      K+ D+GL++ L   + Y    K Q+     + + APE   
Sbjct: 145 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY---KAQTHGKWPVKWYAPE-CI 200
Query: 866 RTVKITDKCDVYGFGVLVLEVVT-GKRP 892
              K + K DV+ FGVL+ E  + G++P
Sbjct: 201 NYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 699 GRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL---EGY 755
            RG FG V++  L +   VA+K   +      Q ++E  V  L  ++H N++     E  
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEYE--VYSLPGMKHENILQFIGAEKR 89
Query: 756 YWTQSLQL-LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS----- 809
             +  + L LI  F   GSL   L      N +SWNE  ++ +  A+ LA+LH+      
Sbjct: 90  GTSVDVDLWLITAFHEKGSLSDFLK----ANVVSWNELCHIAETMARGLAYLHEDIPGLK 145
Query: 810 -----NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA 864
                 I H +IKS NVL+  +    + D+GLA           +        YMAPE  
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL 205
Query: 865 CRTVKITD----KCDVYGFGVLVLEVVT 888
              +        + D+Y  G+++ E+ +
Sbjct: 206 EGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 694 KDCELGRGGFGAVYRTVLRDGRPVAIKKLTV----SSLVKSQEDFEREVKKLGKVRHPNL 749
           +D ELG G FG V +   +  + V    + +    ++    +++   E   + ++ +P +
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
           V + G    +S  +L+ E    G L+K+L +      +       ++   +  + +L +S
Sbjct: 69  VRMIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES 124
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQS----ALGYMAPEFAC 865
           N +H ++ + NVL+      K+ D+GL++ L   + Y    K Q+     + + APE   
Sbjct: 125 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY---KAQTHGKWPVKWYAPE-CI 180
Query: 866 RTVKITDKCDVYGFGVLVLEVVT-GKRP 892
              K + K DV+ FGVL+ E  + G++P
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 49/208 (23%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 694 KDCELGRGGFGAVYRTVLRDGRPVAIKKLTV----SSLVKSQEDFEREVKKLGKVRHPNL 749
           +D ELG G FG V +   +  + V    + +    ++    +++   E   + ++ +P +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
           V + G    +S  +L+ E    G L+K+L +      +       ++   +  + +L +S
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES 126
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQS----ALGYMAPEFAC 865
           N +H ++ + NVL+      K+ D+GL++ L   + Y    K Q+     + + APE   
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY---KAQTHGKWPVKWYAPE-CI 182
Query: 866 RTVKITDKCDVYGFGVLVLEVVT-GKRP 892
              K + K DV+ FGVL+ E  + G++P
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 99/210 (47%), Gaps = 11/210 (5%)
Query: 694 KDCELGRGGFGAVYRTVLRDGRPVAIKKLTV----SSLVKSQEDFEREVKKLGKVRHPNL 749
           +D ELG G FG V +   +  + V    + +    ++    +++   E   + ++ +P +
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
           V + G    +S  +L+ E    G L+K+L +      +       ++   +  + +L +S
Sbjct: 433 VRMIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES 488
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS-SKIQSALGYMAPEFACRTV 868
           N +H ++ + NVL+      K+ D+GL++ L   + Y  + +  +  + + APE      
Sbjct: 489 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE-CINYY 547
Query: 869 KITDKCDVYGFGVLVLEVVT-GKRPLSTWK 897
           K + K DV+ FGVL+ E  + G++P    K
Sbjct: 548 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 577

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 84/212 (39%), Gaps = 22/212 (10%)
Query: 698 LGRGGFGAVYRT------VLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LGRG FG V              R VA+K L   +          E+K L  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 751 TLEGYYWTQSLQLL-IYEFVSGGSLHKHLH-------------EGSGGNFLSWNERFNVI 796
            L G        L+ I EF   G+L  +L              E    +FL+        
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL 856
              AK +  L     IH ++ + N+L+      K+ D+GLAR +      V     +  L
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
            +MAPE     V  T + DV+ FGVL+ E+ +
Sbjct: 215 KWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 30/214 (14%)
Query: 697 ELGRGGFGAVY--RTVLRDGRPVAIKKLTVSSLVKSQEDFE----REV---KKLGKVRHP 747
           E+G G +G V+  R +   GR VA+K++ V +    +E       REV   + L    HP
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAVLRHLETFEHP 74
Query: 748 NLVTLEGYYWT-----QSLQLLIYEFVSGG---SLHKHLHEGSGGNFLSWNERFNVIQGT 799
           N+V L           ++   L++E V       L K    G     +  +  F +++G 
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-DMMFQLLRG- 132
Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYM 859
              L  LH   ++H ++K  N+L+  SG+ K+ D+GLAR+     +  L+S + + L Y 
Sbjct: 133 ---LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVT-LWYR 186
Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           APE   ++   T   D++  G +  E+   ++PL
Sbjct: 187 APEVLLQSSYAT-PVDLWSVGCIFAEMFR-RKPL 218

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 30/214 (14%)
Query: 697 ELGRGGFGAVY--RTVLRDGRPVAIKKLTVSSLVKSQEDFE----REV---KKLGKVRHP 747
           E+G G +G V+  R +   GR VA+K++ V +    +E       REV   + L    HP
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAVLRHLETFEHP 74
Query: 748 NLVTLEGYYWT-----QSLQLLIYEFVSGG---SLHKHLHEGSGGNFLSWNERFNVIQGT 799
           N+V L           ++   L++E V       L K    G     +  +  F +++G 
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-DMMFQLLRG- 132
Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYM 859
              L  LH   ++H ++K  N+L+  SG+ K+ D+GLAR+     +  L+S + + L Y 
Sbjct: 133 ---LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVT-LWYR 186
Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           APE   ++   T   D++  G +  E+   ++PL
Sbjct: 187 APEVLLQSSYAT-PVDLWSVGCIFAEMFR-RKPL 218

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 48/219 (21%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV--RHPNLVTLEGY 755
           +G+G +G V+R   + G  VA+K  +     + ++ + RE +    V  RH N++     
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 756 YWTQ---SLQL-LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH---- 807
             T    S QL LI  +   GSL+ +L   +    L       ++   A  LAHLH    
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 808 ----QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG------ 857
               +  I H ++KS N+L+  +G+  + D GLA         V+ S+  + L       
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA---------VMHSQSTNQLDVGNNPR 177
Query: 858 -----YMAPEFACRTVKIT-----DKCDVYGFGVLVLEV 886
                YMAPE    T+++       + D++ FG+++ EV
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 99/210 (47%), Gaps = 11/210 (5%)
Query: 694 KDCELGRGGFGAVYRTVLRDGRPVAIKKLTV----SSLVKSQEDFEREVKKLGKVRHPNL 749
           +D ELG G FG V +   +  + V    + +    ++    +++   E   + ++ +P +
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
           V + G    +S  +L+ E    G L+K+L +      +       ++   +  + +L +S
Sbjct: 434 VRMIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES 489
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS-SKIQSALGYMAPEFACRTV 868
           N +H ++ + NVL+      K+ D+GL++ L   + Y  + +  +  + + APE      
Sbjct: 490 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE-CINYY 548
Query: 869 KITDKCDVYGFGVLVLEVVT-GKRPLSTWK 897
           K + K DV+ FGVL+ E  + G++P    K
Sbjct: 549 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 578

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 47/205 (22%), Positives = 97/205 (47%), Gaps = 11/205 (5%)
Query: 694 KDCELGRGGFGAVYRTVLRDGRPVAIKKLTV----SSLVKSQEDFEREVKKLGKVRHPNL 749
           +D ELG G FG V +   +  + V    + +    ++    +++   E   + ++ +P +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
           V + G    +S  +L+ E    G L+K+L +      +       ++   +  + +L +S
Sbjct: 75  VRMIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES 130
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPEFACRTV 868
           N +H ++ + NVL+      K+ D+GL++ L    + Y   +  +  + + APE      
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPE-CINYY 189
Query: 869 KITDKCDVYGFGVLVLEVVT-GKRP 892
           K + K DV+ FGVL+ E  + G++P
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG GG G V+  V  D  + VAIKK+ ++   +S +   RE+K + ++ H N+V +    
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEIL 77
Query: 757 WTQSLQLL-----IYEFVSGGSLHKHLHEG-----SGGNFLSWNERFNVIQGTAKSLAHL 806
                QL      + E  S   + +++          G  L  + R  + Q   + L ++
Sbjct: 78  GPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQ-LLRGLKYI 136
Query: 807 HQSNIIHYNIKSSNVLIDGSGEP-KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE 862
           H +N++H ++K +N+ I+      K+GD+GLAR+  M   Y     +   L    Y +P 
Sbjct: 137 HSANVLHRDLKPANLFINTEDLVLKIGDFGLARI--MDPHYSHKGHLSEGLVTKWYRSPR 194
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVTGK 890
                   T   D++  G +  E++TGK
Sbjct: 195 LLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 84/212 (39%), Gaps = 22/212 (10%)
Query: 698 LGRGGFGAVYRT------VLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LGRG FG V              R VA+K L   +          E+K L  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 751 TLEGYYWTQSLQLL-IYEFVSGGSLHKHLH-------------EGSGGNFLSWNERFNVI 796
            L G        L+ I EF   G+L  +L              E    +FL+        
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL 856
              AK +  L     IH ++ + N+L+      K+ D+GLAR +      V     +  L
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPL 214
Query: 857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
            +MAPE     V  T + DV+ FGVL+ E+ +
Sbjct: 215 KWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 84/212 (39%), Gaps = 22/212 (10%)
Query: 698 LGRGGFGAVYRT------VLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LGRG FG V              R VA+K L   +          E+K L  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 751 TLEGYYWTQSLQLL-IYEFVSGGSLHKHLH-------------EGSGGNFLSWNERFNVI 796
            L G        L+ I EF   G+L  +L              E    +FL+        
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL 856
              AK +  L     IH ++ + N+L+      K+ D+GLAR +      V     +  L
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
            +MAPE     V  T + DV+ FGVL+ E+ +
Sbjct: 206 KWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 236

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLG----KVRHPNLVT 751
           ELGRG +G V +   +  G+ +A+K+  + + V SQE  +R +  L      V  P  VT
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKR--IRATVNSQEQ-KRLLMDLDISMRTVDCPFTVT 70
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEG-SGGNFLSWNERFNVIQGTAKSLAHLHQS- 809
             G  + +    +  E +   SL K   +    G  +  +    +     K+L HLH   
Sbjct: 71  FYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG-YMAPEFACRTV 868
           ++IH ++K SNVLI+  G+ K+ D+G++  L  +D   ++  I +    YMAPE     +
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDD--VAKDIDAGCKPYMAPERINPEL 185
Query: 869 K---ITDKCDVYGFGVLVLEVVTGKRPLSTW 896
                + K D++  G+ ++E+   + P  +W
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRFPYDSW 216

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 34/215 (15%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKSQEDF----EREVKKLGKVRHPNLVTL 752
           +GRG FG V    L++   V A+K L    ++K  E      ER+V   G  +       
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK------- 134
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN----------VIQGTAKS 802
               W  +L    Y F    +L+  +    GG+ L+   +F            +     +
Sbjct: 135 ----WITTLH---YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA 187
Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           +  +HQ + +H +IK  N+L+D +G  ++ D+G    L M D  V SS       Y++PE
Sbjct: 188 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAVGTPDYISPE 246
Query: 863 FACRTV----KITDKCDVYGFGVLVLEVVTGKRPL 893
                     +   +CD +  GV + E++ G+ P 
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 84/212 (39%), Gaps = 22/212 (10%)
Query: 698 LGRGGFGAVYRT------VLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLV 750
           LGRG FG V              R VA+K L   +          E+K L  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 751 TLEGYYWTQSLQLL-IYEFVSGGSLHKHLH-------------EGSGGNFLSWNERFNVI 796
            L G        L+ I EF   G+L  +L              E    +FL+        
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL 856
              AK +  L     IH ++ + N+L+      K+ D+GLAR +      V     +  L
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
            +MAPE     V  T + DV+ FGVL+ E+ +
Sbjct: 206 KWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 236

>pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 68/124 (54%), Gaps = 6/124 (4%)
Query: 120 LAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATIN 179
           L +L NL  + L+GN L  S+P+  F +  +L+ + L +N+            + L  +N
Sbjct: 81  LKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139
Query: 180 LSSNRFSSPLPLGIWG-LSALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKNMFSGSI 237
           L+ N+  S LP G++  L+ L  LDLS N L+  +P+GV + L  L+ + L +N    S+
Sbjct: 140 LAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLK-SV 196
Query: 238 PDGI 241
           PDG+
Sbjct: 197 PDGV 200

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 99/224 (44%), Gaps = 36/224 (16%)
Query: 701 GGFGAVYR---TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKL-GKVRHPNLVTLEGYY 756
           G F  VY+    VL +G    ++  T  +L+ SQE   + ++K  G +R      +E  Y
Sbjct: 8   GRFEDVYQLQEDVLGEGAHARVQ--TCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLY 65
Query: 757 WTQSLQ---------------LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAK 801
             Q  +                L++E + GGS+  H+H+    N L   E   V+Q  A 
Sbjct: 66  QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL---EASVVVQDVAS 122
Query: 802 SLAHLHQSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRY--VLSSKIQSAL 856
           +L  LH   I H ++K  N+L +   +    K+ D+GL   + +      + + ++ +  
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPC 182
Query: 857 G---YMAPEFA---CRTVKITDK-CDVYGFGVLVLEVVTGKRPL 893
           G   YMAPE          I DK CD++  GV++  +++G  P 
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 109/274 (39%), Gaps = 31/274 (11%)
Query: 289 IGELESLETLDLSGNKFSGAVPISIGNLQ--RLKVLNFSANRLTGSLPDSMANCMN---- 342
            G+L SL+++D S N+        +  LQ   L   + +AN L   +      CMN    
Sbjct: 144 FGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRN 203
Query: 343 --LVALDFSQNSMNGDLP-------------QWIFSSGLNKVSFAENKIREGMNGPFASS 387
             L  LD S N    D+                I +  +    F  + I++     FA  
Sbjct: 204 MVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFA-- 261
Query: 388 GSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDL 447
           G +  S++ LDLSH             L  L++LNL+ N +      A   L  L VL+L
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNL 321
Query: 448 SENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIA 507
           S N L         G   +  + L++N +A     + +    L +L L  N LT      
Sbjct: 322 SYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----T 376
Query: 508 IAKLTNLQNVDLSFNSLTGGLPK--QLVNLVHLS 539
           I  + ++ ++ LS N L   LPK     NL+HLS
Sbjct: 377 IHFIPSIPDIFLSGNKLV-TLPKINLTANLIHLS 409

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL----- 752
           +G+G FG V+R   R G  VA+K    SS  +     E E+ +   +RH N++       
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVK--IFSSREERSWFREAEIYQTVMLRHENILGFIAADN 106
Query: 753 -EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH---- 807
            +   WTQ    L+ ++   GSL  +L+  +    ++      +   TA  LAHLH    
Sbjct: 107 KDNGTWTQ--LWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 160
Query: 808 ----QSNIIHYNIKSSNVLIDGSGEPKVGDYGLA-RLLPMLDRYVLSSKIQSALG-YMAP 861
               +  I H ++KS N+L+  +G   + D GLA R     D   ++   +     YMAP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 862 EFACRTVKIT-----DKCDVYGFGVLVLEVV 887
           E    ++ +       + D+Y  G++  E+ 
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 697 ELGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQEDFE----REV---KKLGKVRH 746
           E+G G +G VY+   RD   G  VA+K + V +    +E       REV   ++L    H
Sbjct: 11  EIGVGAYGTVYKA--RDPHSGHFVALKSVRVPN---GEEGLPISTVREVALLRRLEAFEH 65
Query: 747 PNLVTLEGYYWTQSLQ-----LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAK 801
           PN+V L     T          L++E V    L  +L +       +   + ++++   +
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK-DLMRQFLR 123
Query: 802 SLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP---MLDRYVLSSKIQSALGY 858
            L  LH + I+H ++K  N+L+   G  K+ D+GLAR+      LD  V++      L Y
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVT------LWY 177
Query: 859 MAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
            APE   ++   T   D++  G +  E+   ++PL
Sbjct: 178 RAPEVLLQSTYAT-PVDMWSVGCIFAEMFR-RKPL 210

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 30/210 (14%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL----- 752
           +G+G FG V+R   R G  VA+K    SS  +     E E+ +   +RH N++       
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVK--IFSSREERSWFREAEIYQTVMLRHENILGFIAADN 68
Query: 753 -EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH---- 807
            +   WTQ    L+ ++   GSL  +L+  +    ++      +   TA  LAHLH    
Sbjct: 69  KDNGTWTQ--LWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 122
Query: 808 ----QSNIIHYNIKSSNVLIDGSGEPKVGDYGLA-RLLPMLDRYVLSSKIQSALG-YMAP 861
               +  I H ++KS N+L+  +G   + D GLA R     D   ++   +     YMAP
Sbjct: 123 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 182
Query: 862 EFACRTVKIT-----DKCDVYGFGVLVLEV 886
           E    ++ +       + D+Y  G++  E+
Sbjct: 183 EVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 30/210 (14%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL----- 752
           +G+G FG V+R   R G  VA+K    SS  +     E E+ +   +RH N++       
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVK--IFSSREERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 753 -EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH---- 807
            +   WTQ    L+ ++   GSL  +L+  +    ++      +   TA  LAHLH    
Sbjct: 68  KDNGTWTQ--LWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 121
Query: 808 ----QSNIIHYNIKSSNVLIDGSGEPKVGDYGLA-RLLPMLDRYVLSSKIQSALG-YMAP 861
               +  I H ++KS N+L+  +G   + D GLA R     D   ++   +     YMAP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 862 EFACRTVKIT-----DKCDVYGFGVLVLEV 886
           E    ++ +       + D+Y  G++  E+
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 30/210 (14%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL----- 752
           +G+G FG V+R   R G  VA+K    SS  +     E E+ +   +RH N++       
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVK--IFSSREERSWFREAEIYQTVMLRHENILGFIAADN 73
Query: 753 -EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH---- 807
            +   WTQ    L+ ++   GSL  +L+  +    ++      +   TA  LAHLH    
Sbjct: 74  KDNGTWTQ--LWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 127
Query: 808 ----QSNIIHYNIKSSNVLIDGSGEPKVGDYGLA-RLLPMLDRYVLSSKIQSALG-YMAP 861
               +  I H ++KS N+L+  +G   + D GLA R     D   ++   +     YMAP
Sbjct: 128 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 187
Query: 862 EFACRTVKIT-----DKCDVYGFGVLVLEV 886
           E    ++ +       + D+Y  G++  E+
Sbjct: 188 EVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 30/210 (14%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL----- 752
           +G+G FG V+R   R G  VA+K    SS  +     E E+ +   +RH N++       
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVK--IFSSREERSWFREAEIYQTVMLRHENILGFIAADN 70
Query: 753 -EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH---- 807
            +   WTQ    L+ ++   GSL  +L+  +    ++      +   TA  LAHLH    
Sbjct: 71  KDNGTWTQ--LWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 124
Query: 808 ----QSNIIHYNIKSSNVLIDGSGEPKVGDYGLA-RLLPMLDRYVLSSKIQSALG-YMAP 861
               +  I H ++KS N+L+  +G   + D GLA R     D   ++   +     YMAP
Sbjct: 125 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 184
Query: 862 EFACRTVKIT-----DKCDVYGFGVLVLEV 886
           E    ++ +       + D+Y  G++  E+
Sbjct: 185 EVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Composition-based stats.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 697 ELGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQEDFE----REV---KKLGKVRH 746
           E+G G +G VY+   RD   G  VA+K + V +             REV   ++L    H
Sbjct: 16  EIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEH 73
Query: 747 PNLVTLEGYYWTQSLQ-----LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAK 801
           PN+V L     T          L++E V    L  +L +       +   + ++++   +
Sbjct: 74  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK-DLMRQFLR 131
Query: 802 SLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS-SKIQSALGYMA 860
            L  LH + I+H ++K  N+L+   G  K+ D+GLAR+      Y ++ + +   L Y A
Sbjct: 132 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY----SYQMALTPVVVTLWYRA 187
Query: 861 PEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           PE   ++   T   D++  G +  E+   ++PL
Sbjct: 188 PEVLLQSTYAT-PVDMWSVGCIFAEMFR-RKPL 218

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 697 ELGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQEDFE----REV---KKLGKVRH 746
           E+G G +G VY+   RD   G  VA+K + V +    +E       REV   ++L    H
Sbjct: 11  EIGVGAYGTVYKA--RDPHSGHFVALKSVRVPN---GEEGLPISTVREVALLRRLEAFEH 65
Query: 747 PNLVTLEGYYWTQSLQ-----LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAK 801
           PN+V L     T          L++E V    L  +L +       +   + ++++   +
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK-DLMRQFLR 123
Query: 802 SLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS-SKIQSALGYMA 860
            L  LH + I+H ++K  N+L+   G  K+ D+GLAR+      Y ++ + +   L Y A
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY----SYQMALAPVVVTLWYRA 179
Query: 861 PEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           PE   ++   T   D++  G +  E+   ++PL
Sbjct: 180 PEVLLQSTYAT-PVDMWSVGCIFAEMFR-RKPL 210

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 30/210 (14%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL----- 752
           +G+G FG V+R   R G  VA+K    SS  +     E E+ +   +RH N++       
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVK--IFSSREERSWFREAEIYQTVMLRHENILGFIAADN 93
Query: 753 -EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH---- 807
            +   WTQ    L+ ++   GSL  +L+  +    ++      +   TA  LAHLH    
Sbjct: 94  KDNGTWTQ--LWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 147
Query: 808 ----QSNIIHYNIKSSNVLIDGSGEPKVGDYGLA-RLLPMLDRYVLSSKIQSALG-YMAP 861
               +  I H ++KS N+L+  +G   + D GLA R     D   ++   +     YMAP
Sbjct: 148 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 207
Query: 862 EFACRTVKIT-----DKCDVYGFGVLVLEV 886
           E    ++ +       + D+Y  G++  E+
Sbjct: 208 EVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 92/218 (42%), Gaps = 40/218 (18%)
Query: 698 LGRGGFGAVYRTVLRDG-RPVAIKKLTVSSLVKSQEDF----EREVKKLGKVRHPNLVTL 752
           +GRG FG V    +++  R  A+K L    ++K  E      ER+V   G  +       
Sbjct: 82  IGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ------- 134
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN----------VIQGTAKS 802
               W  +L    Y F     L+  +    GG+ L+   +F            I     +
Sbjct: 135 ----WITALH---YAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLA 187
Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YM 859
           +  +HQ + +H +IK  NVL+D +G  ++ D+G    L M D   + S +  A+G   Y+
Sbjct: 188 IDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSV--AVGTPDYI 243
Query: 860 APEFACRTV----KITDKCDVYGFGVLVLEVVTGKRPL 893
           +PE          K   +CD +  GV + E++ G+ P 
Sbjct: 244 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 92/218 (42%), Gaps = 40/218 (18%)
Query: 698 LGRGGFGAVYRTVLRDG-RPVAIKKLTVSSLVKSQEDF----EREVKKLGKVRHPNLVTL 752
           +GRG FG V    +++  R  A+K L    ++K  E      ER+V   G  +       
Sbjct: 98  IGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ------- 150
Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN----------VIQGTAKS 802
               W  +L    Y F     L+  +    GG+ L+   +F            I     +
Sbjct: 151 ----WITALH---YAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLA 203
Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YM 859
           +  +HQ + +H +IK  NVL+D +G  ++ D+G    L M D   + S +  A+G   Y+
Sbjct: 204 IDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSV--AVGTPDYI 259
Query: 860 APEFACRTV----KITDKCDVYGFGVLVLEVVTGKRPL 893
           +PE          K   +CD +  GV + E++ G+ P 
Sbjct: 260 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 94/387 (24%), Positives = 152/387 (39%), Gaps = 44/387 (11%)
Query: 212 EIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLC 271
            IP  + S  N+ V+NL+ N      P      S L  +D   NS S   PE  Q L L 
Sbjct: 18  HIPDDLPS--NITVLNLTHNQLRRLPPTNFTRYSQLAILDAGFNSISKLEPELCQILPLL 75
Query: 272 NFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTG 331
             +NL+ N  S    +      +L  LDL  N           N + L  L+ S N L+ 
Sbjct: 76  KVLNLQHNELSQISDQTFVFCTNLTELDLMSNSIHKIKSNPFKNQKNLIKLDLSHNGLSS 135
Query: 332 SLPDSMANCMNLVALDFSQN---SMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSG 388
           +   +     NL  L  ++N   ++  +  +++ +S L K+  + N ++E   G F + G
Sbjct: 136 TKLGTGVQLENLQELLLAKNKILALRSEELEFLGNSSLRKLDLSSNPLKEFSPGCFQTIG 195
Query: 389 SSFE-----------------------SLQFLDLSHNEFSGETPATIGAL--SGLQLLNL 423
             F                        S+Q L L++N+    + +T   L  + L  L+L
Sbjct: 196 KLFALLLNNAQLNPHLTEKLCWELSNTSIQNLSLANNQLLATSESTFSGLKWTNLTQLDL 255
Query: 424 SRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPT- 482
           S N+L      +   L +L  L L  N +    P    G  +L+ L L+R F    +   
Sbjct: 256 SYNNLHDVGNGSFSYLPSLRYLSLEYNNIQRLSPRSFYGLSNLRYLSLKRAFTKQSVSLA 315
Query: 483 --------SIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLS--FNSLTGGLPKQL 532
                   S +    L  L +  NN+          L +L+ + LS  F SL     +  
Sbjct: 316 SHPNIDDFSFQWLKYLEYLNMDDNNIPSTKSNTFTGLVSLKYLSLSKTFTSLQTLTNETF 375
Query: 533 VNLVH--LSSFNISHNHLQGELPAGGF 557
           V+L H  L + N++ NH+  ++  G F
Sbjct: 376 VSLAHSPLLTLNLTKNHI-SKIANGTF 401

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 100/219 (45%), Gaps = 38/219 (17%)
Query: 698 LGRGGFGAVYRTVLRDG-RPVAIK-----KLTVSSLVKSQE--DFEREVKKLGKVRHPNL 749
           LG G  G V     R   + VAIK     K  + S  ++    + E E++ L K+ HP +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFNVIQGTAKSL 803
           + ++ ++  +   +++ E + GG L      +K L E +    L + +    +Q      
Sbjct: 78  IKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCK--LYFYQMLLAVQ------ 128
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALG--- 857
            +LH++ IIH ++K  NVL+    E    K+ D+G +++L        +S +++  G   
Sbjct: 129 -YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE------TSLMRTLCGTPT 181
Query: 858 YMAPE--FACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
           Y+APE   +  T       D +  GV++   ++G  P S
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 100/219 (45%), Gaps = 38/219 (17%)
Query: 698 LGRGGFGAVYRTVLRDG-RPVAIK-----KLTVSSLVKSQE--DFEREVKKLGKVRHPNL 749
           LG G  G V     R   + VAIK     K  + S  ++    + E E++ L K+ HP +
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFNVIQGTAKSL 803
           + ++ ++  +   +++ E + GG L      +K L E +    L + +    +Q      
Sbjct: 77  IKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCK--LYFYQMLLAVQ------ 127
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALG--- 857
            +LH++ IIH ++K  NVL+    E    K+ D+G +++L        +S +++  G   
Sbjct: 128 -YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE------TSLMRTLCGTPT 180
Query: 858 YMAPE--FACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
           Y+APE   +  T       D +  GV++   ++G  P S
Sbjct: 181 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 219

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 100/219 (45%), Gaps = 38/219 (17%)
Query: 698 LGRGGFGAVYRTVLRDG-RPVAIK-----KLTVSSLVKSQE--DFEREVKKLGKVRHPNL 749
           LG G  G V     R   + VAIK     K  + S  ++    + E E++ L K+ HP +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFNVIQGTAKSL 803
           + ++ ++  +   +++ E + GG L      +K L E +    L + +    +Q      
Sbjct: 78  IKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCK--LYFYQMLLAVQ------ 128
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALG--- 857
            +LH++ IIH ++K  NVL+    E    K+ D+G +++L        +S +++  G   
Sbjct: 129 -YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE------TSLMRTLCGTPT 181
Query: 858 YMAPE--FACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
           Y+APE   +  T       D +  GV++   ++G  P S
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 36/224 (16%)
Query: 701 GGFGAVYR---TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKL-GKVRHPNLVTLEGYY 756
           G F  VY+    VL +G    ++  T  +L+ SQE   + ++K  G +R      +E  Y
Sbjct: 8   GRFEDVYQLQEDVLGEGAHARVQ--TCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLY 65
Query: 757 WTQSLQ---------------LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAK 801
             Q  +                L++E + GGS+  H+H+    N L   E   V+Q  A 
Sbjct: 66  QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL---EASVVVQDVAS 122
Query: 802 SLAHLHQSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRY--VLSSKIQSAL 856
           +L  LH   I H ++K  N+L +   +    K+ D+ L   + +      + + ++ +  
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 857 G---YMAPEFA---CRTVKITDK-CDVYGFGVLVLEVVTGKRPL 893
           G   YMAPE          I DK CD++  GV++  +++G  P 
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 698 LGRGGFGAVYRTVLRDG-RPVAIK-----KLTVSSLVKSQE--DFEREVKKLGKVRHPNL 749
           LG G  G V     R   + VAIK     K  + S  ++    + E E++ L K+ HP +
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 83
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFNVIQGTAKSL 803
           + ++ ++  +   +++ E + GG L      +K L E +    L + +    +Q      
Sbjct: 84  IKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCK--LYFYQMLLAVQ------ 134
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALGYMA 860
            +LH++ IIH ++K  NVL+    E    K+ D+G +++   L    L   +     Y+A
Sbjct: 135 -YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLA 190
Query: 861 PE--FACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWK 897
           PE   +  T       D +  GV++   ++G  P S  +
Sbjct: 191 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 229

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 99/219 (45%), Gaps = 38/219 (17%)
Query: 698 LGRGGFGAVYRTVLRDG------RPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNL 749
           LG G  G V     R        R ++ +K  + S  ++    + E E++ L K+ HP +
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 216
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFNVIQGTAKSL 803
           + ++ ++  +   +++ E + GG L      +K L E +    L + +    +Q      
Sbjct: 217 IKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCK--LYFYQMLLAVQ------ 267
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALG--- 857
            +LH++ IIH ++K  NVL+    E    K+ D+G +++L        +S +++  G   
Sbjct: 268 -YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE------TSLMRTLCGTPT 320
Query: 858 YMAPE--FACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
           Y+APE   +  T       D +  GV++   ++G  P S
Sbjct: 321 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 359

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 100/219 (45%), Gaps = 38/219 (17%)
Query: 698 LGRGGFGAVYRTVLRDG-RPVAIK-----KLTVSSLVKSQE--DFEREVKKLGKVRHPNL 749
           LG G  G V     R   + VAIK     K  + S  ++    + E E++ L K+ HP +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFNVIQGTAKSL 803
           + ++ ++  +   +++ E + GG L      +K L E +    L + +    +Q      
Sbjct: 78  IKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCK--LYFYQMLLAVQ------ 128
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALG--- 857
            +LH++ IIH ++K  NVL+    E    K+ D+G +++L        +S +++  G   
Sbjct: 129 -YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE------TSLMRTLCGTPT 181
Query: 858 YMAPE--FACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
           Y+APE   +  T       D +  GV++   ++G  P S
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 88/216 (40%), Gaps = 33/216 (15%)
Query: 698 LGRGGFGAVYR-TVLRDGRPVAIKKLTVS-----SLVKSQEDFEREVKKLGKVR----HP 747
           LG+GGFG V+    L D   VAIK +  +     S +        EV  L KV     HP
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 748 NLVTLEGYYWTQSLQLLIYEF-VSGGSLHKHLHE----GSGGNFLSWNERFNVIQGTAKS 802
            ++ L  ++ TQ   +L+ E  +    L  ++ E    G G +   + +    IQ     
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ----- 153
Query: 803 LAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGY 858
             H H   ++H +IK  N+LID   G  K+ D+G   LL   P  D             Y
Sbjct: 154 --HCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-------FDGTRVY 204
Query: 859 MAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
             PE+  R         V+  G+L+ ++V G  P  
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 29/213 (13%)
Query: 697 ELGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQEDFE----REV---KKLGKVRH 746
           E+G G +G VY+   RD   G  VA+K + V +    +E       REV   ++L    H
Sbjct: 11  EIGVGAYGTVYKA--RDPHSGHFVALKSVRVPN---GEEGLPISTVREVALLRRLEAFEH 65
Query: 747 PNLVTLEGYYWTQSLQ-----LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAK 801
           PN+V L     T          L++E V    L  +L +       +   + ++++   +
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK-DLMRQFLR 123
Query: 802 SLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS-SKIQSALGYMA 860
            L  LH + I+H ++K  N+L+   G  K+ D+GLAR+      Y ++   +   L Y A
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY----SYQMALFPVVVTLWYRA 179
Query: 861 PEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           PE   ++   T   D++  G +  E+   ++PL
Sbjct: 180 PEVLLQSTYAT-PVDMWSVGCIFAEMFR-RKPL 210

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 99/219 (45%), Gaps = 38/219 (17%)
Query: 698 LGRGGFGAVYRTVLRDG------RPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNL 749
           LG G  G V     R        R ++ +K  + S  ++    + E E++ L K+ HP +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFNVIQGTAKSL 803
           + ++ ++  +   +++ E + GG L      +K L E +    L + +    +Q      
Sbjct: 203 IKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCK--LYFYQMLLAVQ------ 253
Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALG--- 857
            +LH++ IIH ++K  NVL+    E    K+ D+G +++L        +S +++  G   
Sbjct: 254 -YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE------TSLMRTLCGTPT 306
Query: 858 YMAPE--FACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
           Y+APE   +  T       D +  GV++   ++G  P S
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 98/244 (40%), Gaps = 27/244 (11%)
Query: 665 SPTTDANSG-------KLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTVLRD-GRP 716
           SP T+ N G       K V +    +    TH L      LGRG FG V+R   +  G  
Sbjct: 66  SPKTEDNEGVLLTEKLKPVDYEYREEVHWATHQL-----RLGRGSFGEVHRMEDKQTGFQ 120
Query: 717 VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHK 776
            A+KK+ +            E+     +  P +V L G         +  E + GGSL +
Sbjct: 121 CAVKKVRLEVFRAE------ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 174
Query: 777 HLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG-EPKVGDYG 835
            + E      L  +     +    + L +LH   I+H ++K+ NVL+   G    + D+G
Sbjct: 175 LVKEQ---GCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFG 231
Query: 836 LARLLPM--LDRYVLSSK-IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
            A  L    L + +L+   I     +MAPE          K DV+    ++L ++ G  P
Sbjct: 232 HAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVL-GRSCDAKVDVWSSCCMMLHMLNGCHP 290
Query: 893 LSTW 896
            + +
Sbjct: 291 WTQF 294

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 699 GRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           G+G FG V     +  G  VAIKK+      +++E   + ++ L  + HPN+V L+ Y++
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE--LQIMQDLAVLHHPNIVQLQSYFY 89
Query: 758 T------QSLQL-LIYEFVSGGSLHK-----HLHEGSGGNFLSWNERFNVIQGTAKSLAH 805
           T      + + L ++ E+V   +LH+     +  + +    L     F +I+       H
Sbjct: 90  TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIG--CLH 146
Query: 806 LHQSNIIHYNIKSSNVLI-DGSGEPKVGDYGLARLLPMLD---RYVLSSKIQSALGYMAP 861
           L   N+ H +IK  NVL+ +  G  K+ D+G A+ L   +    Y+ S        Y AP
Sbjct: 147 LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY------YRAP 200
Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVTGK 890
           E        T   D++  G +  E++ G+
Sbjct: 201 ELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLG----KVRHPNLVT 751
           ELGRG +G V +   +  G+  A+K+  + + V SQE  +R +  L      V  P  VT
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVKR--IRATVNSQEQ-KRLLXDLDISXRTVDCPFTVT 97
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEG-SGGNFLSWNERFNVIQGTAKSLAHLHQS- 809
             G  + +    +  E +   SL K   +    G  +  +    +     K+L HLH   
Sbjct: 98  FYGALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 156
Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLL--PMLDRYVLSSKIQSALGYMAPEFACRT 867
           ++IH ++K SNVLI+  G+ K  D+G++  L   +        K   A   + PE   + 
Sbjct: 157 SVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKG 216
Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPLSTW 896
             +  K D++  G+  +E+   + P  +W
Sbjct: 217 YSV--KSDIWSLGITXIELAILRFPYDSW 243

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 29/211 (13%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKSQED--FEREVKKLGKVRHPNLVTLEG 754
           +GRG FG V     +  R V A+K L+   ++K  +   F  E   +     P +V L  
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +       ++ E++ GG L   ++  S  +      RF   +    +L  +H    IH 
Sbjct: 142 AFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARFYTAE-VVLALDAIHSMGFIHR 197
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE--------- 862
           ++K  N+L+D SG  K+ D+G    + M    ++  +  +A+G   Y++PE         
Sbjct: 198 DVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMV--RCDTAVGTPDYISPEVLKSQGGDG 253
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           +  R      +CD +  GV + E++ G  P 
Sbjct: 254 YYGR------ECDWWSVGVFLYEMLVGDTPF 278

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 29/211 (13%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKSQED--FEREVKKLGKVRHPNLVTLEG 754
           +GRG FG V     +  R V A+K L+   ++K  +   F  E   +     P +V L  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +       ++ E++ GG L   ++  S  +      RF   +    +L  +H    IH 
Sbjct: 137 AFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARFYTAE-VVLALDAIHSMGFIHR 192
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE--------- 862
           ++K  N+L+D SG  K+ D+G    + M    ++  +  +A+G   Y++PE         
Sbjct: 193 DVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMV--RCDTAVGTPDYISPEVLKSQGGDG 248
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           +  R      +CD +  GV + E++ G  P 
Sbjct: 249 YYGR------ECDWWSVGVFLYEMLVGDTPF 273

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 98/244 (40%), Gaps = 27/244 (11%)
Query: 665 SPTTDANSG-------KLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTVLRD-GRP 716
           SP T+ N G       K V +    +    TH L      LGRG FG V+R   +  G  
Sbjct: 47  SPKTEDNEGVLLTEKLKPVDYEYREEVHWATHQL-----RLGRGSFGEVHRMEDKQTGFQ 101
Query: 717 VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHK 776
            A+KK+ +            E+     +  P +V L G         +  E + GGSL +
Sbjct: 102 CAVKKVRLEVFRAE------ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 155
Query: 777 HLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG-EPKVGDYG 835
            + E      L  +     +    + L +LH   I+H ++K+ NVL+   G    + D+G
Sbjct: 156 LVKEQ---GCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFG 212
Query: 836 LARLLPM--LDRYVLSSK-IQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
            A  L    L + +L+   I     +MAPE          K DV+    ++L ++ G  P
Sbjct: 213 HAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGR-SCDAKVDVWSSCCMMLHMLNGCHP 271
Query: 893 LSTW 896
            + +
Sbjct: 272 WTQF 275

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/195 (22%), Positives = 84/195 (43%), Gaps = 24/195 (12%)
Query: 714 GRPVAIKKLTVSSLVKSQEDF---EREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS 770
           G  V ++++ + +       F   E  V KL    HPN+V     +   +   ++  F++
Sbjct: 36  GEYVTVRRINLEACSNEMVTFLQGELHVSKL--FNHPNIVPYRATFIADNELWVVTSFMA 93
Query: 771 GGS----LHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS 826
            GS    +  H  +G     +++     ++QG  K+L ++H    +H ++K+S++LI   
Sbjct: 94  YGSAKDLICTHFMDGMNELAIAY-----ILQGVLKALDYIHHMGYVHRSVKASHILISVD 148
Query: 827 GEPKVGDYGLARLLPMLDRYVLSSKIQS-------ALGYMAPEFACRTVKITD-KCDVYG 878
           G  KV   GL   L M+        +          L +++PE   + ++  D K D+Y 
Sbjct: 149 G--KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 206
Query: 879 FGVLVLEVVTGKRPL 893
            G+   E+  G  P 
Sbjct: 207 VGITACELANGHVPF 221

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 29/211 (13%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKSQED--FEREVKKLGKVRHPNLVTLEG 754
           +GRG FG V     +  R V A+K L+   ++K  +   F  E   +     P +V L  
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
            +       ++ E++ GG L   ++  S  +      RF   +    +L  +H    IH 
Sbjct: 142 AFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARFYTAE-VVLALDAIHSMGFIHR 197
Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE--------- 862
           ++K  N+L+D SG  K+ D+G    + M    ++  +  +A+G   Y++PE         
Sbjct: 198 DVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMV--RCDTAVGTPDYISPEVLKSQGGDG 253
Query: 863 FACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           +  R      +CD +  GV + E++ G  P 
Sbjct: 254 YYGR------ECDWWSVGVFLYEMLVGDTPF 278

>pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 80/195 (41%), Gaps = 26/195 (13%)
Query: 291 ELESLETLDLSGN--KFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDF 348
           +L SLE LDLS N   F G    S      LK L+ S N +  ++  +      L  LDF
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF 403
Query: 349 SQNSMNGDLPQWIFSSGLNKV--SFAENKIREGMNGPF---------ASSGSSFE----- 392
             +++       +F S  N +    +    R   NG F           +G+SF+     
Sbjct: 404 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 463
Query: 393 -------SLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVL 445
                  +L FLDLS  +    +P    +LS LQ+LN+S N+           L +L VL
Sbjct: 464 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 523
Query: 446 DLSENWLNGSIPPEI 460
           D S N +  S   E+
Sbjct: 524 DYSLNHIMTSKKQEL 538

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/195 (22%), Positives = 84/195 (43%), Gaps = 24/195 (12%)
Query: 714 GRPVAIKKLTVSSLVKSQEDF---EREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS 770
           G  V ++++ + +       F   E  V KL    HPN+V     +   +   ++  F++
Sbjct: 52  GEYVTVRRINLEACSNEMVTFLQGELHVSKL--FNHPNIVPYRATFIADNELWVVTSFMA 109
Query: 771 GGS----LHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS 826
            GS    +  H  +G     +++     ++QG  K+L ++H    +H ++K+S++LI   
Sbjct: 110 YGSAKDLICTHFMDGMNELAIAY-----ILQGVLKALDYIHHMGYVHRSVKASHILISVD 164
Query: 827 GEPKVGDYGLARLLPMLDRYVLSSKIQS-------ALGYMAPEFACRTVKITD-KCDVYG 878
           G  KV   GL   L M+        +          L +++PE   + ++  D K D+Y 
Sbjct: 165 G--KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 222
Query: 879 FGVLVLEVVTGKRPL 893
            G+   E+  G  P 
Sbjct: 223 VGITACELANGHVPF 237

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 1/90 (1%)
Query: 799 TAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGY 858
            AK +  L     IH ++ + N+L+      K+ D+GLAR +     YV     +  L +
Sbjct: 207 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 266
Query: 859 MAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           MAPE     V  T + DV+ FGVL+ E+ +
Sbjct: 267 MAPETIFDRV-YTIQSDVWSFGVLLWEIFS 295

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 1/90 (1%)
Query: 799 TAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGY 858
            AK +  L     IH ++ + N+L+      K+ D+GLAR +     YV     +  L +
Sbjct: 202 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261
Query: 859 MAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           MAPE     V  T + DV+ FGVL+ E+ +
Sbjct: 262 MAPETIFDRV-YTIQSDVWSFGVLLWEIFS 290

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 1/90 (1%)
Query: 799 TAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGY 858
            AK +  L     IH ++ + N+L+      K+ D+GLAR +     YV     +  L +
Sbjct: 209 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 268
Query: 859 MAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           MAPE     V  T + DV+ FGVL+ E+ +
Sbjct: 269 MAPETIFDRV-YTIQSDVWSFGVLLWEIFS 297

>pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 51/199 (25%), Positives = 77/199 (38%), Gaps = 1/199 (0%)
Query: 154 ISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNL-LEGE 212
           I L  NR S    +S   C  L  + L SN  +        GL+ L  LDLSDN  L   
Sbjct: 36  IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 95
Query: 213 IPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCN 272
            P     L  L  ++L +       P      + L+ +   +N+      +T + L    
Sbjct: 96  DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLT 155
Query: 273 FMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGS 332
            + L  N  S    +    L SL+ L L  N+ +   P +  +L RL  L   AN L+  
Sbjct: 156 HLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL 215
Query: 333 LPDSMANCMNLVALDFSQN 351
             +++A    L  L  + N
Sbjct: 216 PTEALAPLRALQYLRLNDN 234

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 1/90 (1%)
Query: 799 TAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGY 858
            AK +  L     IH ++ + N+L+      K+ D+GLAR +     YV     +  L +
Sbjct: 200 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 259
Query: 859 MAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           MAPE     V  T + DV+ FGVL+ E+ +
Sbjct: 260 MAPETIFDRV-YTIQSDVWSFGVLLWEIFS 288

>pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 51/199 (25%), Positives = 77/199 (38%), Gaps = 1/199 (0%)
Query: 154 ISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNL-LEGE 212
           I L  NR S    +S   C  L  + L SN  +        GL+ L  LDLSDN  L   
Sbjct: 37  IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 96
Query: 213 IPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCN 272
            P     L  L  ++L +       P      + L+ +   +N+      +T + L    
Sbjct: 97  DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLT 156
Query: 273 FMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGS 332
            + L  N  S    +    L SL+ L L  N+ +   P +  +L RL  L   AN L+  
Sbjct: 157 HLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL 216
Query: 333 LPDSMANCMNLVALDFSQN 351
             +++A    L  L  + N
Sbjct: 217 PTEALAPLRALQYLRLNDN 235

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 108/232 (46%), Gaps = 35/232 (15%)
Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH----PNLVT 751
           E+G G  G V++   R  G  +A+K++  S    ++E+ +R +  L  V      P +V 
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG---NKEENKRILMDLDVVLKSHDCPYIVQ 88
Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAKSLAHLHQS 809
             G + T +   +  E +  G+  + L +   G      ER    +     K+L +L + 
Sbjct: 89  CFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPI---PERILGKMTVAIVKALYYLKEK 143
Query: 810 N-IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA--LGYMAPEFACR 866
           + +IH ++K SN+L+D  G+ K+ D+G++  L + D+    +K +SA    YMAPE    
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRL-VDDK----AKDRSAGCAAYMAPE---- 194
Query: 867 TVKITD--------KCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEH 910
            +   D        + DV+  G+ ++E+ TG+ P    K  +      L+E 
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE 246

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 70/162 (43%), Gaps = 3/162 (1%)
Query: 397 LDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAI-GDLKALNVLDLSENWLNGS 455
           LDL  N+ S         L+ L+LL L+ N L   +P  I  +LK L  L +++N L   
Sbjct: 42  LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQAL 100
Query: 456 IPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQ 515
                    +L ELRL+RN L    P   ++ + L  L L  N L         KLT+L+
Sbjct: 101 PIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLK 160
Query: 516 NVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGF 557
            + L  N L          L  L +  + +N L+  +P G F
Sbjct: 161 ELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAF 201

>pdb|3T6Q|A Chain A, Crystal Structure Of Mouse Rp105MD-1 Complex Length = 606

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 97/361 (26%), Positives = 140/361 (38%), Gaps = 70/361 (19%)
Query: 203 DLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLP 262
           D+S  + EG     VES      INL K+ F     +     S L+ +D +    S    
Sbjct: 242 DISPAVFEGLCEMSVES------INLQKHYFFNISSNTFHCFSGLQELDLTATHLS---- 291
Query: 263 ETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVL 322
                                E+P  +  L +L+ L LS NKF     IS  N   L  L
Sbjct: 292 ---------------------ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHL 330
Query: 323 NFSAN--RL---TGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIR 377
           +   N  RL   TG L     N  NL  LD S + +         S   N       ++R
Sbjct: 331 SIKGNTKRLELGTGCL----ENLENLRELDLSHDDIET-------SDCCNL------QLR 373
Query: 378 EGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSL-VGPIPVAI 436
                       +   LQ L+LS+NE              L+LL+L+   L V       
Sbjct: 374 ------------NLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPF 421
Query: 437 GDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERN-FLAGKI--PTSIENCSSLVSL 493
            +L  L VL+LS + L+ S      G  +L+ L L+ N F  G I    S++    L  L
Sbjct: 422 QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL 481
Query: 494 ILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELP 553
           +LS  +L+     A   L  + +VDLS N LT    + L +L  +   N++ NH+   LP
Sbjct: 482 VLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILP 540
Query: 554 A 554
           +
Sbjct: 541 S 541

>pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 106/249 (42%), Gaps = 22/249 (8%)
Query: 298 LDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDL 357
           LDL  N+          +   L+ L  + N ++   P +  N  NL  L    N +   +
Sbjct: 37  LDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKL-I 95
Query: 358 PQWIFS--SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLD-----LSHNEFSGETPA 410
           P  +F+  S L K+  +ENKI   ++  F     + +SL+  D     +SH  FSG    
Sbjct: 96  PLGVFTGLSNLTKLDISENKIVILLDYMFQDL-YNLKSLEVGDNDLVYISHRAFSG---- 150
Query: 411 TIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELR 470
               L+ L+ L L + +L      A+  L  L VL L    +N          Y LK L 
Sbjct: 151 ----LNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLE 206
Query: 471 LER-NFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFN---SLTG 526
           +    +L    P  +   + L SL ++  NLT    +A+  L  L+ ++LS+N   ++ G
Sbjct: 207 ISHWPYLDTMTPNCLYGLN-LTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEG 265
Query: 527 GLPKQLVNL 535
            +  +L+ L
Sbjct: 266 SMLHELLRL 274

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 100/237 (42%), Gaps = 32/237 (13%)
Query: 682 PDFSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKL 741
           P+F      L+  +  LG G  G V       GRPVA+K++    L+   +    E+K L
Sbjct: 25  PNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM----LIDFCDIALMEIKLL 80
Query: 742 GKVR-HPNLVTLEGYYWTQSLQLLIYEFVSGGSLH-KHLHEGS--GGNFLSWNERFN--- 794
            +   HPN++    YY +++    +Y  +   +L+ + L E        L   + +N   
Sbjct: 81  TESDDHPNVIR---YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 137
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDY-GLARLLPMLDRYVLSSKIQ 853
           +++  A  +AHLH   IIH ++K  N+L+  S         G   L  ++  + L  K+ 
Sbjct: 138 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 197
Query: 854 SAL--------------GYMAPEFACRTVK--ITDKCDVYGFGVLVLEVVT-GKRPL 893
           S                G+ APE    + K  +T   D++  G +   +++ GK P 
Sbjct: 198 SGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF 254

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 103/241 (42%), Gaps = 23/241 (9%)
Query: 666 PTTDANSGKLVMFSGDP---DFSTGTHALLNKDCELGRGGFGAVYRTVLRD-GRPVAIKK 721
           P T+ N G L+     P   ++    H + ++   LGRG FG V+R   +  G   A+KK
Sbjct: 46  PETEDNEGVLLTEKLKPVDYEYREEVHWMTHQP-RLGRGSFGEVHRMKDKQTGFQCAVKK 104
Query: 722 LTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHE 780
           + +       E F   E+     +  P +V L G         +  E + GGSL + + +
Sbjct: 105 VRL-------EVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ 157
Query: 781 GSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG-EPKVGDYGLARL 839
                 L  +     +    + L +LH   I+H ++K+ NVL+   G    + D+G A  
Sbjct: 158 M---GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALC 214
Query: 840 LP--MLDRYVLSSK-IQSALGYMAPEFACRTVKITD-KCDVYGFGVLVLEVVTGKRPLST 895
           L    L + +L+   I     +MAPE      K  D K D++    ++L ++ G  P + 
Sbjct: 215 LQPDGLGKSLLTGDYIPGTETHMAPEVV--MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 272
Query: 896 W 896
           +
Sbjct: 273 Y 273

>pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 80/195 (41%), Gaps = 26/195 (13%)
Query: 291 ELESLETLDLSGN--KFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDF 348
           +L SLE LDLS N   F G    S      LK L+ S N +  ++  +      L  LDF
Sbjct: 369 DLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF 427
Query: 349 SQNSMNGDLPQWIFSSGLNKV--SFAENKIREGMNGPF---------ASSGSSFE----- 392
             +++       +F S  N +    +    R   NG F           +G+SF+     
Sbjct: 428 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 487
Query: 393 -------SLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVL 445
                  +L FLDLS  +    +P    +LS LQ+LN+S N+           L +L VL
Sbjct: 488 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 547
Query: 446 DLSENWLNGSIPPEI 460
           D S N +  S   E+
Sbjct: 548 DYSLNHIMTSKKQEL 562

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 100/237 (42%), Gaps = 32/237 (13%)
Query: 682 PDFSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKL 741
           P+F      L+  +  LG G  G V       GRPVA+K++    L+   +    E+K L
Sbjct: 25  PNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM----LIDFCDIALMEIKLL 80
Query: 742 GKVR-HPNLVTLEGYYWTQSLQLLIYEFVSGGSLH-KHLHEGS--GGNFLSWNERFN--- 794
            +   HPN++    YY +++    +Y  +   +L+ + L E        L   + +N   
Sbjct: 81  TESDDHPNVIR---YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 137
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDY-GLARLLPMLDRYVLSSKIQ 853
           +++  A  +AHLH   IIH ++K  N+L+  S         G   L  ++  + L  K+ 
Sbjct: 138 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 197
Query: 854 SAL--------------GYMAPEFACRTVK--ITDKCDVYGFGVLVLEVVT-GKRPL 893
           S                G+ APE    + K  +T   D++  G +   +++ GK P 
Sbjct: 198 SGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF 254

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 46/90 (51%), Gaps = 1/90 (1%)
Query: 799 TAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGY 858
            A+ +  L     IH ++ + N+L+  +   K+ D+GLAR +     YV     +  L +
Sbjct: 208 VARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKW 267
Query: 859 MAPEFACRTVKITDKCDVYGFGVLVLEVVT 888
           MAPE     +  T K DV+ +GVL+ E+ +
Sbjct: 268 MAPESIFDKIYST-KSDVWSYGVLLWEIFS 296

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 26/221 (11%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTL--- 752
           L  GGF  VY    +  GR  A+K+L  +   K++   + EV  + K+  HPN+V     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ-EVCFMKKLSGHPNIVQFCSA 94
Query: 753 -----EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH 807
                E     Q+  LL+ E   G  L + L +      LS +    +   T +++ H+H
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 808 QSN--IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG-------- 857
           +    IIH ++K  N+L+   G  K+ D+G A  +     Y  S++ ++ +         
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 858 --YMAPEFA--CRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
             Y  PE         I +K D++  G ++  +   + P  
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 32/214 (14%)
Query: 696 CELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFE----REVKKLGKVRHPNLV 750
            +LG G +G VY+ +       VAIK++    L   +E       REV  L +++H N++
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEEGVPGTAIREVSLLKELQHRNII 96
Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSG------GNFLSWNERFNVIQGTAKSLA 804
            L+          LI+E+     L K++ +          +FL     + +I G    + 
Sbjct: 97  ELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFL-----YQLING----VN 146
Query: 805 HLHQSNIIHYNIKSSNVLI---DGSGEP--KVGDYGLARLLPMLDRYVLSSKIQSALGYM 859
             H    +H ++K  N+L+   D S  P  K+GD+GLAR   +  R      I   L Y 
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TLWYR 204
Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
            PE    +   +   D++    +  E++  K PL
Sbjct: 205 PPEILLGSRHYSTSVDIWSIACIWAEMLM-KTPL 237

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 27/210 (12%)
Query: 698 LGRGGFGAVYRTVLRDGRPV-AIKKLTVSSLVKSQED--FEREVKKLGKVRHPNLVTLEG 754
           +GRG FG V     +  + V A+K L+   ++K  +   F  E   +     P +V L  
Sbjct: 83  IGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 142
Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAK--------SLAHL 806
            +       ++ E++ GG L          N +S    ++V +  AK        +L  +
Sbjct: 143 AFQDDKYLYMVMEYMPGGDL---------VNLMS---NYDVPEKWAKFYTAEVVLALDAI 190
Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           H   +IH ++K  N+L+D  G  K+ D+G    +         + + +   Y++PE    
Sbjct: 191 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTP-DYISPEVLKS 249
Query: 867 T---VKITDKCDVYGFGVLVLEVVTGKRPL 893
                    +CD +  GV + E++ G  P 
Sbjct: 250 QGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 45/221 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEEL-----ARSFFWQ---- 151
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 152 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 203
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
               Y  PE+            V+  G+L+ ++V G  P  
Sbjct: 204 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 45/221 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEEL-----ARSFFWQ---- 150
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 151 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 202
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
               Y  PE+            V+  G+L+ ++V G  P  
Sbjct: 203 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 45/221 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEEL-----ARSFFWQ---- 151
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 152 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 203
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
               Y  PE+            V+  G+L+ ++V G  P  
Sbjct: 204 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 87/194 (44%), Gaps = 21/194 (10%)
Query: 294 SLETLDLSGNKFSGAVPIS--IGNLQRLKVLNFSANRLTGSLPDSM-ANCMNLVALDFSQ 350
           SL+ LDLS   F+G + +S     L++L+ L+F  + L      S+  +  NL+ LD S 
Sbjct: 79  SLKYLDLS---FNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 135
Query: 351 N----SMNGDLPQWIFS--SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEF 404
                + NG     IF+  S L  +  A N  +E          +   +L FLDLS  + 
Sbjct: 136 THTRVAFNG-----IFNGLSSLEVLKMAGNSFQENF---LPDIFTELRNLTFLDLSQCQL 187
Query: 405 SGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGG-A 463
              +P    +LS LQ+LN+S N+           L +L VLD S N +  S   E+    
Sbjct: 188 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 247
Query: 464 YSLKELRLERNFLA 477
            SL  L L +N  A
Sbjct: 248 SSLAFLNLTQNDFA 261

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 45/221 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEEL-----ARSFFWQ---- 151
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 152 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 203
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
               Y  PE+            V+  G+L+ ++V G  P  
Sbjct: 204 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 10/90 (11%)
Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP---MLDRYVLSSKIQSALGYM 859
           + HLH + IIH ++K SN+++      K+ D+GLAR      M+  YV++        Y 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRY------YR 192
Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTG 889
           APE     +   +  D++  GV++ E++ G
Sbjct: 193 APEVIL-GMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 45/221 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEEL-----ARSFFWQ---- 150
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 151 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 202
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
               Y  PE+            V+  G+L+ ++V G  P  
Sbjct: 203 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 45/221 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 119 IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEEL-----ARSFFWQ---- 165
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 166 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 217
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
               Y  PE+            V+  G+L+ ++V G  P  
Sbjct: 218 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 45/220 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 76  IRLLDWFERPDSFVLILERMEPVQDL----FDFITERGALQEELARS-----FFWQ---- 122
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 123 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 174
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
               Y  PE+            V+  G+L+ ++V G  P 
Sbjct: 175 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 45/221 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEEL-----ARSFFWQ---- 150
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 151 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 202
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
               Y  PE+            V+  G+L+ ++V G  P  
Sbjct: 203 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 45/221 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEEL-----ARSFFWQ---- 151
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 152 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 203
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
               Y  PE+            V+  G+L+ ++V G  P  
Sbjct: 204 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 10/90 (11%)
Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP---MLDRYVLSSKIQSALGYM 859
           + HLH + IIH ++K SN+++      K+ D+GLAR      M+  YV++        Y 
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRY------YR 192
Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTG 889
           APE     +   +  D++  GV++ E++ G
Sbjct: 193 APEVIL-GMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 103/241 (42%), Gaps = 23/241 (9%)
Query: 666 PTTDANSGKLVMFSGDP---DFSTGTHALLNKDCELGRGGFGAVYRTVLRD-GRPVAIKK 721
           P T+ N G L+     P   ++    H + ++   +GRG FG V+R   +  G   A+KK
Sbjct: 32  PETEDNEGVLLTEKLKPVDYEYREEVHWMTHQP-RVGRGSFGEVHRMKDKQTGFQCAVKK 90
Query: 722 LTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHE 780
           + +       E F   E+     +  P +V L G         +  E + GGSL + + +
Sbjct: 91  VRL-------EVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ 143
Query: 781 GSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG-EPKVGDYGLARL 839
                 L  +     +    + L +LH   I+H ++K+ NVL+   G    + D+G A  
Sbjct: 144 M---GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALC 200
Query: 840 LP--MLDRYVLSSK-IQSALGYMAPEFACRTVKITD-KCDVYGFGVLVLEVVTGKRPLST 895
           L    L + +L+   I     +MAPE      K  D K D++    ++L ++ G  P + 
Sbjct: 201 LQPDGLGKSLLTGDYIPGTETHMAPEVV--MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258
Query: 896 W 896
           +
Sbjct: 259 Y 259

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 45/221 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEEL-----ARSFFWQ---- 150
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 151 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 202
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
               Y  PE+            V+  G+L+ ++V G  P  
Sbjct: 203 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 45/221 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 119 IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEEL-----ARSFFWQ---- 165
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 166 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 217
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
               Y  PE+            V+  G+L+ ++V G  P  
Sbjct: 218 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 45/221 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 124 IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEEL-----ARSFFWQ---- 170
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 171 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 222
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
               Y  PE+            V+  G+L+ ++V G  P  
Sbjct: 223 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 263

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 45/221 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEEL-----ARSFFWQ---- 157
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 158 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 209
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
               Y  PE+            V+  G+L+ ++V G  P  
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 43/210 (20%)
Query: 699 GRGGFGAVYRTVLRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
            +G   A + TVL  G  VA+KKL+    +   ++  + RE+  L  V H N+++L   +
Sbjct: 36  AQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISLLNVF 92
Query: 757 WTQ-SLQ-----LLIYEFVSGG---SLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH 807
             Q +L+      L+ E +       +H  L        L     + ++ G    + HLH
Sbjct: 93  TPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLL-----YQMLCG----IKHLH 143
Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR-------LLP-MLDRYVLSSKIQSALGYM 859
            + IIH ++K SN+++      K+ D+GLAR       + P ++ RY  + ++   +GY 
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYA 203
Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTG 889
           A              D++  G ++ E+V G
Sbjct: 204 A------------NVDIWSVGCIMGELVKG 221

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 45/220 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARS-----FFWQ---- 118
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 119 ----VLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 170
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
               Y  PE+            V+  G+L+ ++V G  P 
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 45/220 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARS-----FFWQ---- 118
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 119 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 170
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
               Y  PE+            V+  G+L+ ++V G  P 
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 103/241 (42%), Gaps = 23/241 (9%)
Query: 666 PTTDANSGKLVMFSGDP---DFSTGTHALLNKDCELGRGGFGAVYRTVLRD-GRPVAIKK 721
           P T+ N G L+     P   ++    H + ++   +GRG FG V+R   +  G   A+KK
Sbjct: 48  PETEDNEGVLLTEKLKPVDYEYREEVHWMTHQP-RVGRGSFGEVHRMKDKQTGFQCAVKK 106
Query: 722 LTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHE 780
           + +       E F   E+     +  P +V L G         +  E + GGSL + + +
Sbjct: 107 VRL-------EVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ 159
Query: 781 GSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG-EPKVGDYGLARL 839
                 L  +     +    + L +LH   I+H ++K+ NVL+   G    + D+G A  
Sbjct: 160 M---GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALC 216
Query: 840 LP--MLDRYVLSSK-IQSALGYMAPEFACRTVKITD-KCDVYGFGVLVLEVVTGKRPLST 895
           L    L + +L+   I     +MAPE      K  D K D++    ++L ++ G  P + 
Sbjct: 217 LQPDGLGKSLLTGDYIPGTETHMAPEVV--MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 274
Query: 896 W 896
           +
Sbjct: 275 Y 275

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 45/220 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 75  IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARS-----FFWQ---- 121
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 122 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 173
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
               Y  PE+            V+  G+L+ ++V G  P 
Sbjct: 174 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 213

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 45/220 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARS-----FFWQ---- 118
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 119 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 170
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
               Y  PE+            V+  G+L+ ++V G  P 
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 95/202 (47%), Gaps = 27/202 (13%)
Query: 699 GRGGFGAVYRTVLRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
            +G   A + TVL  G  VA+KKL+    +   ++  + RE+  L  V H N+++L   +
Sbjct: 34  AQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISLLNVF 90
Query: 757 WTQ-SLQ-----LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
             Q +L+      L+ E +   +L + +H       +S+     ++      + HLH + 
Sbjct: 91  TPQKTLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSY-----LLYQMLCGIKHLHSAG 144
Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLP---MLDRYVLSSKIQSALGYMAPEFACRT 867
           IIH ++K SN+++      K+ D+GLAR      M+  YV++        Y APE     
Sbjct: 145 IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRY------YRAPEVIL-G 197
Query: 868 VKITDKCDVYGFGVLVLEVVTG 889
           +   +  D++  G ++ E+V G
Sbjct: 198 MGYKENVDIWSVGCIMGELVKG 219

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 34/212 (16%)
Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV--RHPNLVTLEGY 755
           +G+G +G V+R  L  G  VA+K  +     + ++ + RE +    V  RH N++     
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSS----RDEQSWFRETEIYNTVLLRHDNILGFIAS 70
Query: 756 YWTQ---SLQL-LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH---- 807
             T    S QL LI  +   GSL+  L   +    L+      +    A  LAHLH    
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLA----LRLAVSAACGLAHLHVEIF 126
Query: 808 ----QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY--VLSSKIQSALGYMAP 861
               +  I H + KS NVL+  + +  + D GLA +      Y  + ++       YMAP
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAP 186
Query: 862 EFACRTVKITDKC-------DVYGFGVLVLEV 886
           E     ++ TD C       D++ FG+++ E+
Sbjct: 187 EVLDEQIR-TD-CFESYKWTDIWAFGLVLWEI 216

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 25/202 (12%)
Query: 699 GRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKL---GKVRHPNLVTLEGY 755
            +G   A Y  VL   R VAIKKL  S   ++Q   +R  ++L     V H N+++L   
Sbjct: 36  AQGIVCAAYDAVL--DRNVAIKKL--SRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW---NERFN-VIQGTAKSLAHLHQSNI 811
           +  Q     + EF     L   L + +    +     +ER + ++      + HLH + I
Sbjct: 92  FTPQKT---LEEF-QDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGI 147
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLP---MLDRYVLSSKIQSALGYMAPEFACRTV 868
           IH ++K SN+++      K+ D+GLAR      M+  YV++        Y APE     +
Sbjct: 148 IHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTR------YYRAPEVIL-GM 200
Query: 869 KITDKCDVYGFGVLVLEVVTGK 890
              +  D++  G ++ E+V  K
Sbjct: 201 GYKENVDIWSVGCIMGEMVRHK 222

>pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 63/115 (54%), Gaps = 6/115 (5%)
Query: 129 IDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSP 188
           +DL  NSL  S+P+  F +  SL  + L  N+         +  ++L  +NLS+N+  S 
Sbjct: 33  LDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS- 90
Query: 189 LPLGIWG-LSALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKNMFSGSIPDGI 241
           LP G++  L+ L+ L L+ N L+  +P GV + L  L+ + L +N    S+PDG+
Sbjct: 91  LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGV 143

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 87/191 (45%), Gaps = 21/191 (10%)
Query: 714 GRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSL--QLLIYEFVS 770
           G  + +K L V     +   DF  E  +L    HPN++ + G   +       LI  ++ 
Sbjct: 33  GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP 92
Query: 771 GGSLHKHLHEGSGGNF-LSWNERFNVIQGTAKSLAHLH--QSNIIHYNIKSSNVLIDGSG 827
            GSL+  LHEG+  NF +  ++        A+ +A LH  +  I  + + S +V+ID   
Sbjct: 93  YGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM 150
Query: 828 EPKVGDYGLARLLPMLD-RYVLSSKIQ-SALGYMAPEFACRTVKITDK--CDVYGFGVLV 883
             ++          M D ++   S  +  A  ++APE   +  + T++   D++ F VL+
Sbjct: 151 TARIS---------MADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLL 201
Query: 884 LEVVTGKRPLS 894
            E+VT + P +
Sbjct: 202 WELVTREVPFA 212

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 45/220 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 76  IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARS-----FFWQ---- 122
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 123 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 174
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
               Y  PE+            V+  G+L+ ++V G  P 
Sbjct: 175 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 45/220 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARS-----FFWQ---- 123
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 124 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 175
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
               Y  PE+            V+  G+L+ ++V G  P 
Sbjct: 176 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 45/220 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARS-----FFWQ---- 123
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 124 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 175
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
               Y  PE+            V+  G+L+ ++V G  P 
Sbjct: 176 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 45/220 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARS-----FFWQ---- 138
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 139 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 190
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
               Y  PE+            V+  G+L+ ++V G  P 
Sbjct: 191 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 45/220 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 99  IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARS-----FFWQ---- 145
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 146 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 197
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
               Y  PE+            V+  G+L+ ++V G  P 
Sbjct: 198 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 237

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 45/220 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 91  IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARS-----FFWQ---- 137
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 138 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 189
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
               Y  PE+            V+  G+L+ ++V G  P 
Sbjct: 190 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 45/220 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARS-----FFWQ---- 138
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 139 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 190
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
               Y  PE+            V+  G+L+ ++V G  P 
Sbjct: 191 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 45/220 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARS-----FFWQ---- 138
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 139 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 190
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
               Y  PE+            V+  G+L+ ++V G  P 
Sbjct: 191 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 45/220 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 91  IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARS-----FFWQ---- 137
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 138 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 189
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
               Y  PE+            V+  G+L+ ++V G  P 
Sbjct: 190 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 36/241 (14%)
Query: 682 PDFSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKL 741
           P+F      L+  +  LG G  G V       GRPVA+K++    L+   +    E+K L
Sbjct: 7   PNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM----LIDFCDIALMEIKLL 62
Query: 742 GKVR-HPNLVTLEGYYWTQSLQLLIYEFVSGGSLH-KHLHEGS--GGNFLSWNERFN--- 794
            +   HPN++    YY +++    +Y  +   +L+ + L E        L   + +N   
Sbjct: 63  TESDDHPNVIR---YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 119
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDY-GLARLLPMLDRYVLSSKIQ 853
           +++  A  +AHLH   IIH ++K  N+L+  S         G   L  ++  + L  K+ 
Sbjct: 120 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 854 SAL--------------GYMAPEFACRT------VKITDKCDVYGFGVLVLEVVT-GKRP 892
           S                G+ APE    +       ++T   D++  G +   +++ GK P
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
Query: 893 L 893
Sbjct: 240 F 240

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 45/220 (20%)
Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKK-------------------LTVSSLVKSQEDFERE 737
           LG GGFG+VY  + + D  PVAIK                    + V  L K    F   
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 738 VKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFN 794
           ++ L     P+  ++ LE     Q L    ++F++  G+L + L          W     
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDL----FDFITERGALQEELARS-----FFWQ---- 123
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQ 853
                 +++ H H   ++H +IK  N+LID   GE K+ D+G   LL    +  + +   
Sbjct: 124 ----VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 175
Query: 854 SALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
               Y  PE+            V+  G+L+ ++V G  P 
Sbjct: 176 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 102/240 (42%), Gaps = 36/240 (15%)
Query: 671 NSGKLVMFSG-DPD-FSTGTHALLNKDCELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSL 727
           +SG  V+F G +P  ++      L+K   LG G  G V      R G+  A+K L  S  
Sbjct: 9   SSGLEVLFQGPEPKKYAVTDDYQLSKQV-LGLGVNGKVLECFHRRTGQKCALKLLYDSP- 66
Query: 728 VKSQEDFEREVKKLGKVRHPNLVTL----EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSG 783
            K++++ +   +  G    P++V +    E  +  +   L+I E + GG L   + E  G
Sbjct: 67  -KARQEVDHHWQASGG---PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQE-RG 121
Query: 784 GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEP---KVGDYGLARLL 840
               +  E   +++    ++  LH  NI H ++K  N+L     +    K+ D+G A+  
Sbjct: 122 DQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-- 179
Query: 841 PMLDRYVLSSKIQSALG-------YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
                       Q+AL        Y+APE      K    CD++  GV++  ++ G  P 
Sbjct: 180 ---------ETTQNALQTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 25/202 (12%)
Query: 699 GRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKL---GKVRHPNLVTLEGY 755
            +G   A Y  VL   R VAIKKL  S   ++Q   +R  ++L     V H N+++L   
Sbjct: 36  AQGIVCAAYDAVL--DRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW---NERFN-VIQGTAKSLAHLHQSNI 811
           +  Q     + EF     L   L + +    +     +ER + ++      + HLH + I
Sbjct: 92  FTPQKT---LEEF-QDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGI 147
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLP---MLDRYVLSSKIQSALGYMAPEFACRTV 868
           IH ++K SN+++      K+ D+GLAR      M+  YV++        Y APE     +
Sbjct: 148 IHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTR------YYRAPEVIL-GM 200
Query: 869 KITDKCDVYGFGVLVLEVVTGK 890
              +  D++  G ++ E+V  K
Sbjct: 201 GYKENVDIWSVGCIMGEMVRHK 222

>pdb|4FCG|A Chain A, Structure Of The Leucine-Rich Repeat Domain Of The Type Iii Effector Xcv3220 (Xopl) Length = 328

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 96/233 (41%), Gaps = 46/233 (19%)
Query: 332 SLPDSMANCMNLVALDFSQNSMNGDLPQWIFS-SGLNKVSFAENKIREGMNGPFASSGSS 390
            LPD+      L  L  ++N +   LP  I S + L ++S         +  P AS+ +S
Sbjct: 118 ELPDTXQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 391 FESLQFLDLS--HNEFSG--ETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLD 446
            E    ++L     E++G    PA+I  L  L+ L + RNS +  +  AI  L  L  LD
Sbjct: 177 GEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKI-RNSPLSALGPAIHHLPKLEELD 235
Query: 447 LSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPI 506
           L       + PP  GG   LK L L             ++CS+L++L           P+
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLIL-------------KDCSNLLTL-----------PL 271
Query: 507 AIAKLTNLQNVDL-------SFNSLTGGLPKQLVNLVHLSSFNISHNHLQGEL 552
            I +LT L+ +DL          SL   LP   + LV          HLQ +L
Sbjct: 272 DIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILV--------PPHLQAQL 316

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 25/202 (12%)
Query: 699 GRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKL---GKVRHPNLVTLEGY 755
            +G   A Y  VL   R VAIKKL  S   ++Q   +R  ++L     V H N+++L   
Sbjct: 29  AQGIVCAAYDAVL--DRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW---NERFN-VIQGTAKSLAHLHQSNI 811
           +  Q     + EF     L   L + +    +     +ER + ++      + HLH + I
Sbjct: 85  FTPQKT---LEEF-QDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGI 140
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLP---MLDRYVLSSKIQSALGYMAPEFACRTV 868
           IH ++K SN+++      K+ D+GLAR      M+  YV++        Y APE     +
Sbjct: 141 IHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRY------YRAPEVIL-GM 193
Query: 869 KITDKCDVYGFGVLVLEVVTGK 890
              +  D++  G ++ E+V  K
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHK 215

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 36/241 (14%)
Query: 682 PDFSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKL 741
           P+F      L+  +  LG G  G V       GRPVA+K++    L+   +    E+K L
Sbjct: 7   PNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM----LIDFCDIALMEIKLL 62
Query: 742 GKVR-HPNLVTLEGYYWTQSLQLLIYEFVSGGSLH-KHLHEGS--GGNFLSWNERFN--- 794
            +   HPN++    YY +++    +Y  +   +L+ + L E        L   + +N   
Sbjct: 63  TESDDHPNVIR---YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 119
Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDY-GLARLLPMLDRYVLSSKIQ 853
           +++  A  +AHLH   IIH ++K  N+L+  S         G   L  ++  + L  K+ 
Sbjct: 120 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 854 SAL--------------GYMAPEFACRT------VKITDKCDVYGFGVLVLEVVT-GKRP 892
           S                G+ APE    +       ++T   D++  G +   +++ GK P
Sbjct: 180 SGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
Query: 893 L 893
Sbjct: 240 F 240

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 25/202 (12%)
Query: 699 GRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKL---GKVRHPNLVTLEGY 755
            +G   A Y  VL   R VAIKKL  S   ++Q   +R  ++L     V H N+++L   
Sbjct: 36  AQGIVCAAYDAVL--DRNVAIKKL--SRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW---NERFN-VIQGTAKSLAHLHQSNI 811
           +  Q     + EF     L   L + +    +     +ER + ++      + HLH + I
Sbjct: 92  FTPQKT---LEEF-QDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLHSAGI 147
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLP---MLDRYVLSSKIQSALGYMAPEFACRTV 868
           IH ++K SN+++      K+ D+GLAR      M+  YV++        Y APE     +
Sbjct: 148 IHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRY------YRAPEVIL-GM 200
Query: 869 KITDKCDVYGFGVLVLEVVTGK 890
              +  D++  G ++ E+V  K
Sbjct: 201 GYKENVDIWSVGCIMGEMVRHK 222

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/150 (24%), Positives = 68/150 (45%), Gaps = 11/150 (7%)
Query: 698 LGRGGFGAVYRTVLRDG-RPVAIKKLT--VSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           +GRG +G VY    ++  + VAIKK+      L+  +    RE+  L +++   ++ L  
Sbjct: 36  IGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRIL-REITILNRLKSDYIIRLHD 94
Query: 755 YYWTQSL----QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
               + L    +L I   ++   L K         FL+      ++         +H+S 
Sbjct: 95  LIIPEDLLKFDELYIVLEIADSDLKKLF---KTPIFLTEQHVKTILYNLLLGEKFIHESG 151
Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLL 840
           IIH ++K +N L++     K+ D+GLAR +
Sbjct: 152 IIHRDLKPANCLLNQDCSVKICDFGLARTI 181

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 25/202 (12%)
Query: 699 GRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKL---GKVRHPNLVTLEGY 755
            +G   A Y  VL   R VAIKKL  S   ++Q   +R  ++L     V H N+++L   
Sbjct: 36  AQGIVCAAYDAVL--DRNVAIKKL--SRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW---NERFN-VIQGTAKSLAHLHQSNI 811
           +  Q     + EF     L   L + +    +     +ER + ++      + HLH + I
Sbjct: 92  FTPQKT---LEEF-QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI 147
Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLP---MLDRYVLSSKIQSALGYMAPEFACRTV 868
           IH ++K SN+++      K+ D+GLAR      M+  YV++        Y APE     +
Sbjct: 148 IHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRY------YRAPEVIL-GM 200
Query: 869 KITDKCDVYGFGVLVLEVVTGK 890
              +  D++  G ++ E+V  K
Sbjct: 201 GYKENVDIWSVGCIMGEMVRHK 222

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	936
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-143
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-126
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-43
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-87
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-84
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-82
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-79
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-78
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-70
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-50
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-33
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-28
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-84
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-83
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-80
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-32
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-78
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-78
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-62
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-45
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-43
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-33
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-76
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-70
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-63
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-05
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-76
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-68
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-61
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-42
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-30
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-76
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-73
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-42
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-35
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-72
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-69
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-68
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-68
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-65
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-60
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-16
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-67
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-55
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-50
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-41
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-53
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-52
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-31
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-24
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-52
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-51
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-41
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-49
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-44
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-27
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-20
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-16
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-47
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-42
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-38
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-37
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-47
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-46
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-44
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-43
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-31
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-18
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-47
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-46
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-37
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-35
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-46
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-45
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-45
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-37
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-37
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-08
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-46
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-45
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-44
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-44
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-43
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-43
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-43
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-43
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-42
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-41
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-31
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-30
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-42
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-40
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	8e-40
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-20
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-08
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-38
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-38
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-38
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-38
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-38
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-34
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-28
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-25
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-11
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-37
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-37
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-28
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-24
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-08
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-35
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-30
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-23
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-35
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-34
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-25
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-23
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-23
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-34
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-32
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-31
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-31
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-31
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-10
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-04
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-33
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-33
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-32
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-32
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-26
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-26
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-24
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-32
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-32
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-32
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-31
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-11
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-32
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	8e-32
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-32
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	9e-32
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-31
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-31
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-31
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-31
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-31
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	8e-31
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-29
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-27
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-30
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-30
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-30
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-30
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-30
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-30
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-30
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-30
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-30
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-30
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-30
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-29
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-29
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-29
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-29
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-29
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-29
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-29
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-29
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-29
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-29
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-29
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-29
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	9e-29
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-28
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-28
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-28
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-28
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-28
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-28
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-22
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-19
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-28
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-28
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-28
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-28
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-14
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-13
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-08
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-08
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-28
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-27
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-27
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-25
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-22
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-20
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-27
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-27
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-27
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-27
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-25
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-27
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-23
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	8e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-15
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-27
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-27
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-27
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-27
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-26
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-26
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-26
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	9e-26
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-25
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-25
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-25
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-25
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-25
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-25
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-25
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-24
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-24
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-24
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-24
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-24
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-24
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-24
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-24
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-24
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-23
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-23
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-23
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-23
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-23
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-23
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-23
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-23
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-23
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-23
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-23
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-23
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-22
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-16
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-23
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	8e-23
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-22
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-22
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-22
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-22
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-18
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-17
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	9e-17
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-08
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-22
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-04
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-22
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-22
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-22
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	7e-22
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-22
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	9e-22
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-21
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-21
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-21
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-21
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-16
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-21
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-21
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-19
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	9e-18
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-21
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-21
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-21
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-21
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-21
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-21
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-20
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-20
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-20
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-20
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-20
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-20
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-20
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-20
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	9e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-12
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-09
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-04
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-19
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-19
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-19
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-19
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-18
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-18
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-18
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-13
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-07
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-18
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-18
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-18
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	7e-14
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-12
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-17
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-17
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-16
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-12
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-17
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-17
3niz_A	311	Rhodanese family protein; structural genomics, str	9e-17
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-15
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-14
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	8e-10
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-16
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-16
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-16
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	9e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-11
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-16
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-15
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-15
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-15
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-15
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	5e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-09
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-07
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-15
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-15
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-15
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	9e-15
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	7e-14
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	7e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-11
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-10
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-04
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-04
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	9e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-05
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-15
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-15
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-15
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-14
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-14
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-09
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	9e-09
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	7e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-09
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-04
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-14
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	9e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	7e-06
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	8e-05
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	8e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-08
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-08
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-08
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-13
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-13
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-12
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	1e-12
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	7e-07
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	1e-04
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-12
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-12
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-04
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-12
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-12
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-11
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-05
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	9e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	7e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-10
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-10
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-04
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	2e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-10
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	8e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-08
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	7e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	9e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	6e-05
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-08
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	4e-08
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-07
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	3e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	6e-04
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	6e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	8e-04
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	9e-06
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	7e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	9e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  443 bits (1142), Expect = e-143
 Identities = 146/530 (27%), Positives = 238/530 (44%), Gaps = 45/530 (8%)

Query: 80  ELTLNGLSLTGRIGRGLL-QLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSG 138
            L+L     TG I   L      L  L LS N+  G++ P       L  + LS N+ SG
Sbjct: 273 YLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSG 332

Query: 139 SIPDEFFKQCGSLRVISLAKNRFSGKIPSSLS-LCSTLATINLSSNRFSSPLPLGIWG-- 195
            +P +   +   L+V+ L+ N FSG++P SL+ L ++L T++LSSN FS P+   +    
Sbjct: 333 ELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNP 392

Query: 196 LSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSEN 255
            + L+ L L +N   G+IP  + +   L  ++LS N  SG+IP  +GS S LR +    N
Sbjct: 393 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLN 452

Query: 256 SFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGN 315
              G +P+ +  +     + L  N  +GE+P  +    +L  + LS N+ +G +P  IG 
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512

Query: 316 LQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENK 375
           L+ L +L  S N  +G++P  + +C +L+ LD + N  NG +P  +F             
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK------------ 560

Query: 376 IREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRN--SLVGPIP 433
                              Q   ++ N  +G+    I      +  + + N     G   
Sbjct: 561 -------------------QSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRS 601

Query: 434 VAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSL 493
             +  L   N  +++     G   P      S+  L +  N L+G IP  I +   L  L
Sbjct: 602 EQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFIL 661

Query: 494 ILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELP 553
            L  N+++G IP  +  L  L  +DLS N L G +P+ +  L  L+  ++S+N+L G +P
Sbjct: 662 NLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721

Query: 554 AGGFFNTISPSSVLGNPSLCGSAVNKSCPAVLPKPIVLNPNSSSDSTTSS 603
             G F T  P+  L NP LCG  + +  P+        N +  +    S 
Sbjct: 722 EMGQFETFPPAKFLNNPGLCGYPLPRCDPS--------NADGYAHHQRSH 763

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  399 bits (1028), Expect = e-126
 Identities = 163/543 (30%), Positives = 254/543 (46%), Gaps = 72/543 (13%)

Query: 23  ALTRSLNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELT 82
           +   S + SL  ++  LI FK  + D N  L  WS + + PC + GV C    ++V  + 
Sbjct: 1   SFQASPSQSLYREIHQLISFKDVLPDKN-LLPDWSSNKN-PCTFDGVTCR--DDKVTSID 56

Query: 83  LNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPD 142
           L+   L                          ++S +L  L  L  + LS + ++GS+  
Sbjct: 57  LSSKPLNVGFS---------------------AVSSSLLSLTGLESLFLSNSHINGSVSG 95

Query: 143 EFFKQCGSLRVISLAKNRFSGKIPSSLSL--CSTLATINLSSNRFSSPLPLGIW-GLSAL 199
             FK   SL  + L++N  SG + +  SL  CS L  +N+SSN    P  +     L++L
Sbjct: 96  --FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSL 153

Query: 200 RTLDLSDNLLEGEIPKGVE---SLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENS 256
             LDLS N + G    G         L+ + +S N  SG +   +  C  L  +D S N+
Sbjct: 154 EVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNN 211

Query: 257 FSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNL 316
           FS  +P                         ++G+  +L+ LD+SGNK SG    +I   
Sbjct: 212 FSTGIP-------------------------FLGDCSALQHLDISGNKLSGDFSRAISTC 246

Query: 317 QRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFS--SGLNKVSFAEN 374
             LK+LN S+N+  G +P       +L  L  ++N   G++P ++      L  +  + N
Sbjct: 247 TELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304

Query: 375 KIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPA-TIGALSGLQLLNLSRNSLVGPIP 433
                  G       S   L+ L LS N FSGE P  T+  + GL++L+LS N   G +P
Sbjct: 305 HF----YGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360

Query: 434 VAIGDLKA-LNVLDLSENWLNGSIPPEIGGAY--SLKELRLERNFLAGKIPTSIENCSSL 490
            ++ +L A L  LDLS N  +G I P +      +L+EL L+ N   GKIP ++ NCS L
Sbjct: 361 ESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSEL 420

Query: 491 VSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQG 550
           VSL LS N L+G IP ++  L+ L+++ L  N L G +P++L+ +  L +  +  N L G
Sbjct: 421 VSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTG 480

Query: 551 ELP 553
           E+P
Sbjct: 481 EIP 483

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  169 bits (430), Expect = 1e-43
 Identities = 65/254 (25%), Positives = 109/254 (42%), Gaps = 40/254 (15%)

Query: 315 NLQRLKVLNFSANRLT---GSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSF 371
              ++  ++ S+  L     ++  S+ +   L +L  S + +NG +  +           
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGF----------- 96

Query: 372 AENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPA--TIGALSGLQLLNLSRNSLV 429
                                SL  LDLS N  SG      ++G+ SGL+ LN+S N+L 
Sbjct: 97  -----------------KCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLD 139

Query: 430 GPIPVAIG-DLKALNVLDLSENWLNGSIPPEIGGAY---SLKELRLERNFLAGKIPTSIE 485
            P  V+ G  L +L VLDLS N ++G+       +     LK L +  N ++G +   + 
Sbjct: 140 FPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VS 197

Query: 486 NCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISH 545
            C +L  L +S NN +  IP  +   + LQ++D+S N L+G   + +     L   NIS 
Sbjct: 198 RCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISS 256

Query: 546 NHLQGELPAGGFFN 559
           N   G +P     +
Sbjct: 257 NQFVGPIPPLPLKS 270

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  293 bits (751), Expect = 2e-87
 Identities = 103/511 (20%), Positives = 176/511 (34%), Gaps = 30/511 (5%)

Query: 80  ELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGS 139
            L +   +++        +L  L+ L+L  N L+       A   NL  + L  NS+   
Sbjct: 53  SLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKI 112

Query: 140 IPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSS--PLPLGIWGLS 197
             +  F +  +L  + L+ N  S     +      L  + LS+N+  +     L I+  S
Sbjct: 113 KNNP-FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANS 171

Query: 198 ALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIG---SCSLLRTIDFSE 254
           +L+ L+LS N ++   P    ++  L  + L+      S+ + +    + + +R +  S 
Sbjct: 172 SLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSN 231

Query: 255 NSFSGNLPETMQKLSLCN--FMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPIS 312
           +  S     T   L   N   ++L  N  +         L  LE   L  N        S
Sbjct: 232 SQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHS 291

Query: 313 IGNLQRLKVLN---------FSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFS 363
           +  L  ++ LN          S   L      S      L  L+   N + G        
Sbjct: 292 LHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTG 351

Query: 364 -SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLN 422
              L  +S + +               +   L  L+L+ N+ S         L  L++L+
Sbjct: 352 LINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLD 411

Query: 423 LSRNSLVGPIPV-AIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAG--K 479
           L  N +   +       L+ +  + LS N              SL+ L L R  L     
Sbjct: 412 LGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDS 471

Query: 480 IPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLT--------GGLPKQ 531
            P+  +   +L  L LS NN+       +  L  L+ +DL  N+L         GG    
Sbjct: 472 SPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYF 531

Query: 532 LVNLVHLSSFNISHNHLQGELPAGGFFNTIS 562
           L  L HL   N+  N     +P   F +   
Sbjct: 532 LKGLSHLHILNLESNGFDE-IPVEVFKDLFE 561

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  284 bits (729), Expect = 2e-84
 Identities = 109/511 (21%), Positives = 181/511 (35%), Gaps = 30/511 (5%)

Query: 78  VIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLS 137
           +  L L    L         +   L  L +  N ++        KL  L+V++L  N LS
Sbjct: 27  ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86

Query: 138 GSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLS 197
             + D+ F  C +L  + L  N       +       L T++LS N  SS        L 
Sbjct: 87  Q-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLE 145

Query: 198 ALRTLDLSDNLLEGEIPKGVESLKN--LRVINLSKNMFSGSIPDGIGSCSLLRTIDFSEN 255
            L+ L LS+N ++    + ++   N  L+ + LS N      P    +   L  +  +  
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 205

Query: 256 SFSGNLPETMQKLSLCN---FMNLRKNLFSGEVPKWIGELE--SLETLDLSGNKFSGAVP 310
               +L E +           ++L  +  S         L+  +L  LDLS N  +    
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265

Query: 311 ISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFS------- 363
            S   L +L+      N +      S+    N+  L+  ++     +             
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325

Query: 364 ---SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIG----ALS 416
                L  ++  +N I     G  ++  +   +L++L LS++  S  T         A S
Sbjct: 326 QWLKCLEHLNMEDNDI----PGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHS 381

Query: 417 GLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPP-EIGGAYSLKELRLERNF 475
            L +LNL++N +      A   L  L VLDL  N +   +   E  G  ++ E+ L  N 
Sbjct: 382 PLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNK 441

Query: 476 LAGKIPTSIENCSSLVSLILSKNNLTG--PIPIAIAKLTNLQNVDLSFNSLTGGLPKQLV 533
                  S     SL  L+L +  L      P     L NL  +DLS N++       L 
Sbjct: 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLE 501

Query: 534 NLVHLSSFNISHNHLQGELPAGGFFNTISPS 564
            L  L   ++ HN+L   L            
Sbjct: 502 GLEKLEILDLQHNNLA-RLWKHANPGGPIYF 531

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  279 bits (717), Expect = 1e-82
 Identities = 102/546 (18%), Positives = 189/546 (34%), Gaps = 41/546 (7%)

Query: 77  RVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSL 136
           + + L+ N +         +     L+KL LSSN +          +  L  + L+   L
Sbjct: 148 QELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQL 207

Query: 137 SGSIPDEFFKQCG--SLRVISLAKNRFSGKIPSSLSLC--STLATINLSSNRFSSPLPLG 192
             S+ ++   +    S+R +SL+ ++ S    ++      + L  ++LS N  +      
Sbjct: 208 GPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDS 267

Query: 193 IWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDF 252
              L  L    L  N ++      +  L N+R +NL ++                     
Sbjct: 268 FAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS---------------FTKQSI 312

Query: 253 SENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPIS 312
           S  S       + Q L     +N+  N   G        L +L+ L LS +  S     +
Sbjct: 313 SLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTN 372

Query: 313 IG----NLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFS--SGL 366
                     L +LN + N+++    D+ +   +L  LD   N +  +L    +     +
Sbjct: 373 ETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENI 432

Query: 367 NKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSG--ETPATIGALSGLQLLNLS 424
            ++  + NK  +     F    +   SLQ L L          +P+    L  L +L+LS
Sbjct: 433 FEIYLSYNKYLQLTRNSF----ALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLS 488

Query: 425 RNSLVGPIPVAIGDLKALNVLDLSEN--------WLNGSIPPEIGGAYSLKELRLERNFL 476
            N++       +  L+ L +LDL  N           G     + G   L  L LE N  
Sbjct: 489 NNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGF 548

Query: 477 AGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQL-VNL 535
                   ++   L  + L  NNL            +L++++L  N +T    K      
Sbjct: 549 DEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAF 608

Query: 536 VHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKSCPAVLPKPIV-LNPN 594
            +L+  ++  N       +  +F      +    P L    +  + P     P+   + +
Sbjct: 609 RNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTS 668

Query: 595 SSSDST 600
           S  DS 
Sbjct: 669 SCKDSA 674

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  269 bits (690), Expect = 7e-79
 Identities = 84/480 (17%), Positives = 149/480 (31%), Gaps = 30/480 (6%)

Query: 102 LRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRF 161
                 S   LT  +  +L    N+ V++L+ N L       F  +   L  + +  N  
Sbjct: 6   HEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANF-TRYSQLTSLDVGFNTI 61

Query: 162 SGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLK 221
           S   P        L  +NL  N  S          + L  L L  N ++          K
Sbjct: 62  SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121

Query: 222 NLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCN--FMNLRKN 279
           NL  ++LS N  S +          L+ +  S N       E +   +  +   + L  N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181

Query: 280 LFSGEVPKWIGELESLETLDLSGNKFSGAVPISIG---NLQRLKVLNFSANRLTGSLPDS 336
                 P     +  L  L L+  +   ++   +        ++ L+ S ++L+ +   +
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241

Query: 337 MANC--MNLVALDFSQNSMNGDLPQWIFS-SGLNKVSFAENKIREGMNGPFASSGSSFES 393
                  NL  LD S N++N            L       N I       F+ S     +
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNI----QHLFSHSLHGLFN 297

Query: 394 LQFLDLSHN---------EFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNV 444
           +++L+L  +                 +   L  L+ LN+  N + G        L  L  
Sbjct: 298 VRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKY 357

Query: 445 LDLSENWLNGSIPPEIG----GAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNL 500
           L LS ++ +                L  L L +N ++     +      L  L L  N +
Sbjct: 358 LSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEI 417

Query: 501 TGPIPI-AIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFN 559
              +       L N+  + LS+N            +  L    +    L+    +   F 
Sbjct: 418 GQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  268 bits (687), Expect = 2e-78
 Identities = 110/527 (20%), Positives = 184/527 (34%), Gaps = 61/527 (11%)

Query: 80  ELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQN--LRVIDLSGNSLS 137
            L L+   L+       +QL+ L++L LS+N +    S  L    N  L+ ++LS N + 
Sbjct: 125 TLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK 184

Query: 138 GSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSL---CSTLATINLSSNRFSSPLPLGIW 194
                  F   G L  + L   +    +   L L    +++  ++LS+++ S+       
Sbjct: 185 E-FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243

Query: 195 GL--SALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDF 252
           GL  + L  LDLS N L          L  L    L  N         +     +R ++ 
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303

Query: 253 SENSFSGNL---------PETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGN 303
             +    ++           + Q L     +N+  N   G        L +L+ L LS +
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363

Query: 304 KFSGAVPISIG----NLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQ 359
             S     +          L +LN + N+++    D+ +   +L  LD   N +  +L  
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423

Query: 360 WIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQ 419
             +                             E++  + LS+N++   T  +   +  LQ
Sbjct: 424 QEWRG--------------------------LENIFEIYLSYNKYLQLTRNSFALVPSLQ 457

Query: 420 LLNLSRNSL--VGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFL- 476
            L L R +L  V   P     L+ L +LDLS N +       + G   L+ L L+ N L 
Sbjct: 458 RLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA 517

Query: 477 -------AGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLP 529
                   G     ++  S L  L L  N            L  L+ +DL  N+L     
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577

Query: 530 KQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVL---GNPSLC 573
               N V L S N+  N +   +    F       + L    NP  C
Sbjct: 578 SVFNNQVSLKSLNLQKNLITS-VEKKVFGPAFRNLTELDMRFNPFDC 623

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  245 bits (627), Expect = 5e-70
 Identities = 87/454 (19%), Positives = 157/454 (34%), Gaps = 49/454 (10%)

Query: 125 NLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNR 184
           +  V D S   L+  +PD+      ++ V++L  N+      ++ +  S L ++++  N 
Sbjct: 5   SHEVADCSHLKLT-QVPDDLPT---NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 185 FSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSC 244
            S   P     L  L+ L+L  N L     K      NL  ++L  N       +     
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120

Query: 245 SLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNK 304
             L T+D S N  S     T                          +LE+L+ L LS NK
Sbjct: 121 KNLITLDLSHNGLSSTKLGT------------------------QVQLENLQELLLSNNK 156

Query: 305 FSGAVP--ISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIF 362
                   + I     LK L  S+N++    P        L  L  +   +   L + + 
Sbjct: 157 IQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLC 216

Query: 363 S----SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGL 418
                + +  +S + +++    N  F   G  + +L  LDLS+N  +     +   L  L
Sbjct: 217 LELANTSIRNLSLSNSQLSTTSNTTF--LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQL 274

Query: 419 QLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSI---------PPEIGGAYSLKEL 469
           +   L  N++      ++  L  +  L+L  ++   SI                  L+ L
Sbjct: 275 EYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHL 334

Query: 470 RLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIA----KLTNLQNVDLSFNSLT 525
            +E N + G          +L  L LS +  +              + L  ++L+ N ++
Sbjct: 335 NMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKIS 394

Query: 526 GGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFN 559
                    L HL   ++  N +  EL    +  
Sbjct: 395 KIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRG 428

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  187 bits (478), Expect = 3e-50
 Identities = 72/370 (19%), Positives = 132/370 (35%), Gaps = 43/370 (11%)

Query: 75  SNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGN 134
                + +++  SL          L+ L  L++  N++ G  S     L NL+ + LS +
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363

Query: 135 SLS-GSIPDEFFKQCG--SLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPL 191
             S  ++ +E F       L +++L KN+ S     + S    L  ++L  N     L  
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423

Query: 192 GIW-GLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSG--SIPDGIGSCSLLR 248
             W GL  +  + LS N            + +L+ + L +       S P        L 
Sbjct: 424 QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483

Query: 249 TIDFSENSFSGNLPETMQK--------LSLCNFMNLRKNLFSGEVPKWIGELESLETLDL 300
            +D S N+ +    + ++         L   N   L K+   G    ++  L  L  L+L
Sbjct: 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNL 543

Query: 301 SGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQW 360
             N F         +L  LK+++   N L         N ++L +L+  +N +       
Sbjct: 544 ESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI------- 596

Query: 361 IFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQL 420
              + + K  F                G +F +L  LD+  N F   T  +I     +  
Sbjct: 597 ---TSVEKKVF----------------GPAFRNLTELDMRFNPFDC-TCESIAWF--VNW 634

Query: 421 LNLSRNSLVG 430
           +N +  ++  
Sbjct: 635 INETHTNIPE 644

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  136 bits (345), Expect = 2e-33
 Identities = 42/225 (18%), Positives = 77/225 (34%), Gaps = 8/225 (3%)

Query: 342 NLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSH 401
           +    D S   +   +P  + ++ +  ++   N++R      F    + +  L  LD+  
Sbjct: 5   SHEVADCSHLKLT-QVPDDLPTN-ITVLNLTHNQLRRLPAANF----TRYSQLTSLDVGF 58

Query: 402 NEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIG 461
           N  S   P     L  L++LNL  N L             L  L L  N +         
Sbjct: 59  NTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV 118

Query: 462 GAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIA--KLTNLQNVDL 519
              +L  L L  N L+     +     +L  L+LS N +       +     ++L+ ++L
Sbjct: 119 KQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLEL 178

Query: 520 SFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPS 564
           S N +    P     +  L    +++  L   L         + S
Sbjct: 179 SSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTS 223

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  121 bits (306), Expect = 1e-28
 Identities = 44/180 (24%), Positives = 71/180 (39%), Gaps = 11/180 (6%)

Query: 393 SLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWL 452
           S +  D SH + + + P  +   + + +LNL+ N L             L  LD+  N +
Sbjct: 5   SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 453 NGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLT 512
           +   P        LK L L+ N L+     +   C++L  L L  N++         K  
Sbjct: 62  SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121

Query: 513 NLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSL 572
           NL  +DLS N L+       V L +L    +S+N +Q  L +           +  N SL
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA-LKSEEL-------DIFANSSL 173

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  284 bits (728), Expect = 1e-84
 Identities = 84/574 (14%), Positives = 178/574 (31%), Gaps = 80/574 (13%)

Query: 52  KLSSWSEDDDTPCNW---FGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLS-- 106
             ++W+ + +    W    GV  +  + RV  L+L G   +GR+   + QL  L  L+  
Sbjct: 56  PGANWNFNKE-LDMWGAQPGVSLN-SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALG 113

Query: 107 --------------------------LSSNNLTGSISPNLAKLQ--NLRVIDLSGNSLSG 138
                                         +   +      +    +L    ++ +    
Sbjct: 114 SHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQK 173

Query: 139 SIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSA 198
           SI             I    N  +  +  ++   + L    + ++ F +      W    
Sbjct: 174 SIKKSSR-ITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN-- 229

Query: 199 LRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFS 258
               +              ++LK+L  + +        +P  + +   ++ I+ + N   
Sbjct: 230 ---ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGI 286

Query: 259 GNLPETMQKLSLCNFMNLRK---------NLFSGEVPKWIGELESLETLDLSGNKFSGAV 309
                     +L +     K         NL +  V   + +++ L  L+   N+  G  
Sbjct: 287 SGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-K 345

Query: 310 PISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNK- 368
             + G+  +L  LN + N++T    +       +  L F+ N +   +P    +  ++  
Sbjct: 346 LPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVM 404

Query: 369 --VSFAENKIREGMNGPFAS---SGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNL 423
             + F+ N+I       F     +     ++  ++LS+N+ S          S L  +NL
Sbjct: 405 SAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINL 464

Query: 424 SRNSLVG-------PIPVAIGDLKALNVLDLSENWLNGSIPPEI--GGAYSLKELRLERN 474
             N L                +   L  +DL  N L   +  +        L  + L  N
Sbjct: 465 MGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYN 523

Query: 475 FLAGKIPTSIENCSSLVSL------ILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGL 528
             +   PT   N S+L             N      P  I    +L  + +  N +   +
Sbjct: 524 SFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KV 581

Query: 529 PKQLVNLVHLSSFNISHNHLQGELPAGGFFNTIS 562
            +++    ++S  +I  N     +        I 
Sbjct: 582 NEKI--TPNISVLDIKDNPNIS-IDLSYVCPYIE 612

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  280 bits (718), Expect = 3e-83
 Identities = 80/539 (14%), Positives = 157/539 (29%), Gaps = 68/539 (12%)

Query: 43  KADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFL 102
              I+D       W   +    +  G    P +N      L+      + G  L     +
Sbjct: 26  AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELD--MWGAQPGVSLNSNGRV 83

Query: 103 RKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCG---SLRVISLAKN 159
             LSL     +G +   + +L  L V+ L  +    +      K      S       + 
Sbjct: 84  TGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRM 143

Query: 160 RFSGKIPSSLSL--CSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGV 217
            +             S L    ++S+     +            +    N +   + K V
Sbjct: 144 HYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAV 202

Query: 218 ESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLR 277
             L  LR   +  + F          C      +                L     + + 
Sbjct: 203 MRLTKLRQFYMGNSPFVAENI-----CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVY 257

Query: 278 KNLFSGEVPKWIGELESLETLDLSGNKF--------SGAVPISIGNLQRLKVLNFSANRL 329
                 ++P ++  L  ++ ++++ N+                    ++++++    N L
Sbjct: 258 NCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNL 317

Query: 330 -TGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSG 388
            T  +  S+     L  L+   N + G LP           +F                 
Sbjct: 318 KTFPVETSLQKMKKLGMLECLYNQLEGKLP-----------AF----------------- 349

Query: 389 SSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVG-PIPVAIGDLKALNVLDL 447
            S   L  L+L++N+ +       G    ++ L+ + N L   P       +  ++ +D 
Sbjct: 350 GSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDF 409

Query: 448 SENWLNG-------SIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNL 500
           S N +          + P      ++  + L  N ++          S L S+ L  N L
Sbjct: 410 SYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML 469

Query: 501 TG-------PIPIAIAKLTNLQNVDLSFNSLTGGLPKQLV--NLVHLSSFNISHNHLQG 550
           T                   L ++DL FN LT  L        L +L   ++S+N    
Sbjct: 470 TEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK 527

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  272 bits (698), Expect = 2e-80
 Identities = 69/509 (13%), Positives = 154/509 (30%), Gaps = 80/509 (15%)

Query: 77  RVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSL 136
            +I+  +N       I +         ++   SNN+T  +S  + +L  LR   +  +  
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPF 218

Query: 137 SGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGL 196
                 E           +    +              L  + + +    + LP  +  L
Sbjct: 219 VAENICEA------WENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL 272

Query: 197 SALRTLDLSDNLL--------EGEIPKGVESLKNLRVINLSKNMF-SGSIPDGIGSCSLL 247
             ++ ++++ N          + +        + +++I +  N   +  +   +     L
Sbjct: 273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKL 332

Query: 248 RTIDFSENSFSGNLPETMQKLSLCNFMNLRK-----NLFSGEVPKWIGELESLETLDLSG 302
             ++   N   G LP         + + L       N  +     + G  E +E L  + 
Sbjct: 333 GMLECLYNQLEGKLPA------FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAH 386

Query: 303 NKFSG-AVPISIGNLQRLKVLNFSANRLTG-------SLPDSMANCMNLVALDFSQNSMN 354
           NK           ++  +  ++FS N +          L  +    +N+ +++ S N ++
Sbjct: 387 NKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS 446

Query: 355 GDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSG-------E 407
               +                             S+   L  ++L  N  +        +
Sbjct: 447 KFPKELF---------------------------STGSPLSSINLMGNMLTEIPKNSLKD 479

Query: 408 TPATIGALSGLQLLNLSRNSLVG-PIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSL 466
                     L  ++L  N L           L  L  +DLS N  +   P +   + +L
Sbjct: 480 ENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTL 538

Query: 467 KELRLE------RNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLS 520
           K   +        N    + P  I  C SL  L +  N++   +   I    N+  +D+ 
Sbjct: 539 KGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIK 595

Query: 521 FNSLTGGLPKQLVNLVHLSSFNISHNHLQ 549
            N         +   +    + + ++  Q
Sbjct: 596 DNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  132 bits (335), Expect = 3e-32
 Identities = 24/275 (8%), Positives = 68/275 (24%), Gaps = 31/275 (11%)

Query: 297 TLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGD 356
             +   + +     +S+ +  R+  L+      +G +PD++     L  L    +    +
Sbjct: 61  NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120

Query: 357 LPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALS 416
              +                            S+  S +        +            
Sbjct: 121 ERLFGPKGI-----------------------SANMSDEQKQKMRMHYQKTFVDYDPRED 157

Query: 417 GLQL--LNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERN 474
              L    ++ +     I  +         +    N +   +   +     L++  +  +
Sbjct: 158 FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNS 216

Query: 475 FLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVN 534
               +         +                +    L +L +V++        LP  L  
Sbjct: 217 PFVAENICEAWENENS-----EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA 271

Query: 535 LVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGN 569
           L  +   N++ N           +  ++ + V   
Sbjct: 272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  266 bits (682), Expect = 2e-78
 Identities = 100/502 (19%), Positives = 180/502 (35%), Gaps = 33/502 (6%)

Query: 80  ELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGS 139
            L L G  +          L  L+KL     NL    +  +  L+ L+ ++++ N +   
Sbjct: 80  TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139

Query: 140 IPDEFFKQCGSLRVISLAKNRFSGKIPSSL----SLCSTLATINLSSNRFSSPLPLGIWG 195
              E+F    +L  + L+ N+      + L     +     +++LS N  +  +  G + 
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFK 198

Query: 196 LSALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKNMFSGSI---PDGIGSCSLLRTID 251
              L  L L +N     + K   + L  L V  L    F            +   L  + 
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258

Query: 252 FSENSFS------GNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKF 305
             E   +       ++ +    L+  +  +L                   + L+L   KF
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKF 316

Query: 306 SGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMN--GDLPQWIFS 363
                     L+ LK L F++N+   +   S  +  +L  LD S+N ++  G   Q  F 
Sbjct: 317 GQ---FPTLKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371

Query: 364 -SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATI-GALSGLQLL 421
            + L  +  + N +   M+  F       E L+ LD  H+     +  ++  +L  L  L
Sbjct: 372 TTSLKYLDLSFNGV-ITMSSNF----LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426

Query: 422 NLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEI-GGAYSLKELRLERNFLAGKI 480
           ++S              L +L VL ++ N    +  P+I     +L  L L +  L    
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486

Query: 481 PTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLV-HLS 539
           PT+  + SSL  L +S NN           L +LQ +D S N +     ++L +    L+
Sbjct: 487 PTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLA 546

Query: 540 SFNISHNHLQGELPAGGFFNTI 561
             N++ N          F   I
Sbjct: 547 FLNLTQNDFACTCEHQSFLQWI 568

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  265 bits (680), Expect = 4e-78
 Identities = 101/498 (20%), Positives = 163/498 (32%), Gaps = 32/498 (6%)

Query: 75  SNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGN 134
                 L L+   L             L+ L LS   +          L +L  + L+GN
Sbjct: 27  PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86

Query: 135 SLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSS-PLPLGI 193
            +        F    SL+ +   +   +      +    TL  +N++ N   S  LP   
Sbjct: 87  PIQSLALGA-FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145

Query: 194 WGLSALRTLDLSDNLLEGEIPKGVESLKNLRV----INLSKNMFSGSIPDGIGSCSLLRT 249
             L+ L  LDLS N ++      +  L  + +    ++LS N  +   P        L  
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHK 204

Query: 250 IDFSENSFSGNLPET-MQKLSLCNFMNLRKNLFSGEVPKW---IGELESLETLDLSGNKF 305
           +    N  S N+ +T +Q L+      L    F  E          LE L  L +   + 
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264

Query: 306 S------GAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQ 359
           +        +      L  +   +  +  +      S         L+          P 
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQ-FPT 321

Query: 360 WIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHN--EFSGETPATIGALSG 417
               S L +++F  NK        F  S     SL+FLDLS N   F G    +    + 
Sbjct: 322 LKLKS-LKRLTFTSNKG----GNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374

Query: 418 LQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEI-GGAYSLKELRLERNFL 476
           L+ L+LS N ++  +      L+ L  LD   + L       +     +L  L +     
Sbjct: 375 LKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433

Query: 477 AGKIPTSIENCSSLVSLILSKNNLTGPI-PIAIAKLTNLQNVDLSFNSLTGGLPKQLVNL 535
                      SSL  L ++ N+      P    +L NL  +DLS   L    P    +L
Sbjct: 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 493

Query: 536 VHLSSFNISHNHLQGELP 553
             L   N+SHN+      
Sbjct: 494 SSLQVLNMSHNNFFSLDT 511

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  220 bits (562), Expect = 6e-62
 Identities = 78/456 (17%), Positives = 145/456 (31%), Gaps = 52/456 (11%)

Query: 118 PNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLAT 177
           P +  + N+        +    IPD       S + + L+ N        S      L  
Sbjct: 2   PCVEVVPNITY-QCMELNFY-KIPDNLPF---STKNLDLSFNPLRHLGSYSFFSFPELQV 56

Query: 178 INLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSI 237
           ++LS     +        LS L TL L+ N ++         L +L+ +   +   +   
Sbjct: 57  LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116

Query: 238 PDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLET 297
              IG    L+ ++ + N                          S ++P++   L +LE 
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQ-----------------------SFKLPEYFSNLTNLEH 153

Query: 298 LDLSGNKFSGAVPISIGNLQRLKV----LNFSANRLTGSLPDSMANCMNLVALDFSQNSM 353
           LDLS NK        +  L ++ +    L+ S N +   +       + L  L    N  
Sbjct: 154 LDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFD 212

Query: 354 NGDLPQWIFS--SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFS------ 405
           + ++ +      +GL        + R           S+ E L  L +     +      
Sbjct: 213 SLNVMKTCIQGLAGLEVHRLVLGEFR-NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL 271

Query: 406 GETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYS 465
            +       L+ +   +L   ++      +         L+L                  
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFGQ-----FPTLKL 324

Query: 466 LKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLT--GPIPIAIAKLTNLQNVDLSFNS 523
               RL      G    S  +  SL  L LS+N L+  G    +    T+L+ +DLSFN 
Sbjct: 325 KSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384

Query: 524 LTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFN 559
           +   +    + L  L   +  H++L+       F +
Sbjct: 385 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  172 bits (438), Expect = 2e-45
 Identities = 68/375 (18%), Positives = 120/375 (32%), Gaps = 55/375 (14%)

Query: 74  RSNRVIELTLNGLSLTGRIGRGLLQ-LQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLS 132
            +  + E  L  L         L   L  +   SL S  +      + +     + ++L 
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELV 312

Query: 133 GNSLSGSIPDEF------------------FKQCGSLRVISLAKNR--FSGKIPSSLSLC 172
                     +                        SL  + L++N   F G    S    
Sbjct: 313 NCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGT 372

Query: 173 STLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKN 231
           ++L  ++LS N   + +     GL  L  LD   + L+      V  SL+NL  +++S  
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431

Query: 232 MFSGSIPDGIGSCSLLRTIDFSENSFSGNL-PETMQKLSLCNFMNLRKNLFSGEVPKWIG 290
               +        S L  +  + NSF  N  P+   +L    F++L +       P    
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491

Query: 291 ELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCM-NLVALDFS 349
            L SL+ L++S N F          L  L+VL++S N +  S    + +   +L  L+ +
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 551

Query: 350 QNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETP 409
           QN          F   +                            + L +        TP
Sbjct: 552 QNDFACTCEHQSFLQWIK-------------------------DQRQLLVEVERMECATP 586

Query: 410 ATIGALSGLQLLNLS 424
                  G+ +L+L+
Sbjct: 587 ---SDKQGMPVLSLN 598

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  165 bits (421), Expect = 3e-43
 Identities = 58/279 (20%), Positives = 104/279 (37%), Gaps = 28/279 (10%)

Query: 74  RSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSG 133
            S   ++L+ NGLS  G   +       L+ L LS N +   +S N   L+ L  +D   
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQH 405

Query: 134 NSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGI 193
           ++L        F    +L  + ++            +  S+L  + ++ N F       I
Sbjct: 406 SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465

Query: 194 WG-LSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDF 252
           +  L  L  LDLS   LE   P    SL +L+V+N+S N F           + L+ +D+
Sbjct: 466 FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDY 525

Query: 253 SENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPIS 312
           S N    +  + +Q                           SL  L+L+ N F+      
Sbjct: 526 SLNHIMTSKKQELQHF-----------------------PSSLAFLNLTQNDFACTCEHQ 562

Query: 313 --IGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFS 349
             +  ++  + L     R+  + P      M +++L+ +
Sbjct: 563 SFLQWIKDQRQLLVEVERMECATPSDKQG-MPVLSLNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  134 bits (340), Expect = 6e-33
 Identities = 43/175 (24%), Positives = 70/175 (40%), Gaps = 6/175 (3%)

Query: 391 FESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSEN 450
             S + LDLS N        +  +   LQ+L+LSR  +      A   L  L+ L L+ N
Sbjct: 27  PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86

Query: 451 WLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTG-PIPIAIA 509
            +         G  SL++L      LA      I +  +L  L ++ N +    +P   +
Sbjct: 87  PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 510 KLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSF----NISHNHLQGELPAGGFFNT 560
            LTNL+++DLS N +       L  L  +       ++S N +   +  G F   
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEI 200

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  252 bits (646), Expect = 1e-76
 Identities = 89/347 (25%), Positives = 143/347 (41%), Gaps = 53/347 (15%)

Query: 33  NDDVLGLIVFKADIQDPNGKLSSWSEDDD-TPCNWFGVKCSPRSN--RVIELTLNGLSLT 89
             D   L+  K D+ +P   LSSW    D     W GV C   +   RV  L L+GL+L 
Sbjct: 5   PQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63

Query: 90  GRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCG 149
                                     I  +LA L  L  + + G                
Sbjct: 64  K----------------------PYPIPSSLANLPYLNFLYIGGI--------------- 86

Query: 150 SLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLL 209
                    N   G IP +++  + L  + ++    S  +P  +  +  L TLD S N L
Sbjct: 87  ---------NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNAL 137

Query: 210 EGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSC-SLLRTIDFSENSFSGNLPETMQKL 268
            G +P  + SL NL  I    N  SG+IPD  GS   L  ++  S N  +G +P T   L
Sbjct: 138 SGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL 197

Query: 269 SLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANR 328
           +L  F++L +N+  G+     G  ++ + + L+ N  +  +   +G  + L  L+   NR
Sbjct: 198 NL-AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNR 255

Query: 329 LTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENK 375
           + G+LP  +     L +L+ S N++ G++PQ       +  ++A NK
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  235 bits (603), Expect = 1e-70
 Identities = 83/348 (23%), Positives = 130/348 (37%), Gaps = 60/348 (17%)

Query: 185 FSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGS--IPDGIG 242
             +P  L  W    L T D  +    G +         +  ++LS         IP  + 
Sbjct: 18  LGNPTTLSSW----LPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73

Query: 243 SCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSG 302
           +   L  +                            N   G +P  I +L  L  L ++ 
Sbjct: 74  NLPYLNFLYIGGI-----------------------NNLVGPIPPAIAKLTQLHYLYITH 110

Query: 303 NKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIF 362
              SGA+P  +  ++ L  L+FS N L+G+LP S+++  NLV + F  N ++G +P    
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170

Query: 363 S-SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLL 421
           S S L                              + +S N  +G+ P T   L+ L  +
Sbjct: 171 SFSKL---------------------------FTSMTISRNRLTGKIPPTFANLN-LAFV 202

Query: 422 NLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIP 481
           +LSRN L G   V  G  K    + L++N L   +  ++G + +L  L L  N + G +P
Sbjct: 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLP 261

Query: 482 TSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLP 529
             +     L SL +S NNL G IP     L        + N    G P
Sbjct: 262 QGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  215 bits (549), Expect = 4e-63
 Identities = 75/308 (24%), Positives = 117/308 (37%), Gaps = 57/308 (18%)

Query: 296 ETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGS--LPDSMANCMNLVALDFS-QNS 352
            T D     + G +  +     R+  L+ S   L     +P S+AN   L  L     N+
Sbjct: 29  PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN 88

Query: 353 MNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATI 412
           + G +P  I                           +    L +L ++H   SG  P  +
Sbjct: 89  LVGPIPPAI---------------------------AKLTQLHYLYITHTNVSGAIPDFL 121

Query: 413 GALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKE-LRL 471
             +  L  L+ S N+L G +P +I  L  L  +    N ++G+IP   G    L   + +
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181

Query: 472 ERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQ 531
            RN L GKIP +  N  +L  + LS+N L G   +      N Q + L+ NSL   L K 
Sbjct: 182 SRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK- 239

Query: 532 LVNLVHLSSFNISHN------------------------HLQGELPAGGFFNTISPSSVL 567
           +    +L+  ++ +N                        +L GE+P GG       S+  
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYA 299

Query: 568 GNPSLCGS 575
            N  LCGS
Sbjct: 300 NNKCLCGS 307

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 47.1 bits (113), Expect = 2e-05
 Identities = 20/54 (37%), Positives = 27/54 (50%), Gaps = 1/54 (1%)

Query: 88  LTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIP 141
           + G + +GL QL+FL  L++S NNL G I P    LQ   V   + N      P
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSP 308

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  260 bits (667), Expect = 2e-76
 Identities = 108/509 (21%), Positives = 178/509 (34%), Gaps = 23/509 (4%)

Query: 80  ELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGS 139
            L L    +             L  L L++N L       L+  + L+ +      +S S
Sbjct: 61  FLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS-S 119

Query: 140 IPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSAL 199
           I         +L  + L  N  S            L  ++  +N         +  L   
Sbjct: 120 IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQA 179

Query: 200 R--TLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSL--LRTIDFSEN 255
              +L+L+ N +   I  G       + +N         I  G+ + ++  L    F + 
Sbjct: 180 TNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238

Query: 256 SFSGNLPETMQKLSLCN--FMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISI 313
                 P   + L   +   +NL+K+ F             L+ LDL+    S  +P  +
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGL 297

Query: 314 GNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFS--SGLNKVSF 371
             L  LK L  SAN+       S +N  +L  L    N+   +L          L ++  
Sbjct: 298 VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDL 357

Query: 372 AENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVG- 430
           + + I             S   LQ L+LS+NE              L+LL+L+   L   
Sbjct: 358 SHDDIETSDCCNLQLRNLS--HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVK 415

Query: 431 PIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKI---PTSIENC 487
                  +L  L VL+LS + L+ S      G  +L+ L L+ N           S++  
Sbjct: 416 DAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475

Query: 488 SSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNH 547
             L  L+LS  +L+     A   L  + +VDLS N LT    + L +L  +   N++ NH
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNH 534

Query: 548 LQGELPAGGFFNTISPSSVL---GNPSLC 573
           +   LP       +S    +    NP  C
Sbjct: 535 ISIILP--SLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  237 bits (606), Expect = 7e-68
 Identities = 93/497 (18%), Positives = 161/497 (32%), Gaps = 25/497 (5%)

Query: 80  ELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGS 139
                 L L   I   L        L  S N L    +   ++L NL  +DL+   +   
Sbjct: 16  TYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY-W 71

Query: 140 IPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSAL 199
           I ++ F+    L  + L  N       ++LS    L  +       SS   + +     L
Sbjct: 72  IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131

Query: 200 RTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLR--TIDFSENSF 257
            +L L  N +           + L+V++   N       + + S       +++ + N  
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191

Query: 258 SGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIG--ELESLETLDLSGNKFSGAVPISIGN 315
           +G  P           +N         + K +    ++SL              P     
Sbjct: 192 AGIEPGAFDSAVF-QSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250

Query: 316 LQR--LKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFS-SGLNKVSFA 372
           L    ++ +N   +       ++      L  LD +   ++ +LP  +   S L K+  +
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLS 309

Query: 373 ENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGE-TPATIGALSGLQLLNLSRNSL--V 429
            NK             S+F SL  L +  N    E     +  L  L+ L+LS + +   
Sbjct: 310 ANKFENLCQISA----SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETS 365

Query: 430 GPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSI-ENCS 488
               + + +L  L  L+LS N               L+ L L    L  K   S  +N  
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH 425

Query: 489 SLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQ---LVNLVHLSSFNISH 545
            L  L LS + L          L  LQ+++L  N    G  ++   L  L  L    +S 
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485

Query: 546 NHLQGELPAGGFFNTIS 562
             L   +    F +   
Sbjct: 486 CDLS-SIDQHAFTSLKM 501

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  219 bits (559), Expect = 2e-61
 Identities = 74/441 (16%), Positives = 148/441 (33%), Gaps = 40/441 (9%)

Query: 127 RVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFS 186
           +  +     L+  IP        S   +  + N       ++ S    L  ++L+  +  
Sbjct: 15  KTYNCENLGLN-EIPGTLPN---STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY 70

Query: 187 SPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSL 246
                       L TL L+ N L       +   K L+ +   +   S      + +   
Sbjct: 71  WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130

Query: 247 LRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFS 306
           L ++    N  S                +++               E L+ LD   N   
Sbjct: 131 LESLYLGSNHIS----------------SIKLPKGFP--------TEKLKVLDFQNNAIH 166

Query: 307 GAVPISIGNLQRLKV--LNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSS 364
                 + +LQ+     LN + N +   +     +     +L+F        + + + +S
Sbjct: 167 YLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNS 225

Query: 365 GLNK---VSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLL 421
            +      +F +    +     F        S++ ++L  + F   +  T    SGLQ L
Sbjct: 226 TIQSLWLGTFEDMDDEDISPAVFEGLCEM--SVESINLQKHYFFNISSNTFHCFSGLQEL 283

Query: 422 NLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIP 481
           +L+   L   +P  +  L  L  L LS N              SL  L ++ N    ++ 
Sbjct: 284 DLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELG 342

Query: 482 T-SIENCSSLVSLILSKNNLT--GPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHL 538
           T  +EN  +L  L LS +++       + +  L++LQ+++LS+N       +       L
Sbjct: 343 TGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQL 402

Query: 539 SSFNISHNHLQGELPAGGFFN 559
              +++   L+ +     F N
Sbjct: 403 ELLDLAFTRLKVKDAQSPFQN 423

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  164 bits (417), Expect = 1e-42
 Identities = 61/293 (20%), Positives = 118/293 (40%), Gaps = 13/293 (4%)

Query: 80  ELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGS 139
           EL L    L+  +  GL+ L  L+KL LS+N        + +   +L  + + GN+    
Sbjct: 282 ELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLE 340

Query: 140 IPDEFFKQCGSLRVISLAKNRFSGKIPSSLSL--CSTLATINLSSNRFSSPLPLGIWGLS 197
           +     +   +LR + L+ +        +L L   S L ++NLS N   S          
Sbjct: 341 LGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECP 400

Query: 198 ALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENS 256
            L  LDL+   L+ +  +   ++L  L+V+NLS ++   S          L+ ++   N 
Sbjct: 401 QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNH 460

Query: 257 FSGN---LPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISI 313
           F         ++Q L     + L     S         L+ +  +DLS N+ + +   ++
Sbjct: 461 FPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEAL 520

Query: 314 GNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGD-----LPQWI 361
            +L+ +  LN ++N ++  LP  +        ++  QN ++         +W 
Sbjct: 521 SHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWY 572

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  124 bits (314), Expect = 9e-30
 Identities = 44/234 (18%), Positives = 77/234 (32%), Gaps = 28/234 (11%)

Query: 77  RVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSL 136
           R ++L+ + +  +      L  L  L+ L+LS N      +    +   L ++DL+   L
Sbjct: 353 RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRL 412

Query: 137 SGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPL---GI 193
                   F+    L+V++L+ +               L  +NL  N F          +
Sbjct: 413 KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSL 472

Query: 194 WGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFS 253
             L  L  L LS   L         SLK +  ++LS N  + S  + +     +      
Sbjct: 473 QTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY----- 527

Query: 254 ENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSG 307
                               +NL  N  S  +P  +  L    T++L  N    
Sbjct: 528 --------------------LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  266 bits (682), Expect = 2e-76
 Identities = 91/621 (14%), Positives = 176/621 (28%), Gaps = 128/621 (20%)

Query: 42  FKADIQDPNGKLSSWSEDDDTPCNWFGVKCS--PRSNRVIELTLNGLSLTGRIGRGLLQL 99
           + +   +      +W+ + +    W          + RV  L+L G    GR+   + QL
Sbjct: 288 YYSGTINNTIHSLNWNFNKE-LDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQL 346

Query: 100 QFLRKLS------------------------LSSNNLTGSISPN-LAKLQNLRVIDLSGN 134
             L+ LS                           + +        L   Q L + DL  +
Sbjct: 347 TELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQD 406

Query: 135 SLSG----------------------------SIPDEFFKQCGSLRVISLAKNRFSGKIP 166
           +++                              I      +   L++I  A + F+    
Sbjct: 407 AINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQ-RLTKLQIIYFANSPFTYDNI 465

Query: 167 SSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVI 226
           +           N    +      L    L  L  ++L +     ++P  +  L  L+ +
Sbjct: 466 AVDWE-----DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSL 520

Query: 227 NLSKNMFSG---------SIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLR 277
           N++ N              + D   +   ++      N+     P               
Sbjct: 521 NIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPA-------------- 565

Query: 278 KNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSM 337
                      + ++  L  LD   NK    +  + G   +L  L    N++   +P+  
Sbjct: 566 --------SASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDF 614

Query: 338 ANCM-NLVALDFSQNSMNGDLPQWIFSSGLNK---VSFAENKIREGMNGPFASSGSS-FE 392
                 +  L FS N +   +P    +  +     V F+ NKI         S       
Sbjct: 615 CAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGI 673

Query: 393 SLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSL-------VGPIPVAIGDLKALNVL 445
           +   + LS+NE            S +  + LS N +       + P      +   L  +
Sbjct: 674 NASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTI 733

Query: 446 DLSENWLNGSIPPEI--GGAYSLKELRLERNFLAGKIPTSIENCSSLVSL------ILSK 497
           DL  N L  S+  +        L  + +  N  +   PT   N S L +           
Sbjct: 734 DLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEG 791

Query: 498 NNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGF 557
           N +    P  I    +L  + +  N +   + ++L     L   +I+ N     +     
Sbjct: 792 NRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNI-SIDVTSV 847

Query: 558 FNTISPSSVL----GNPSLCG 574
              I     +        + G
Sbjct: 848 CPYIEAGMYVLLYDKTQDIRG 868

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  258 bits (660), Expect = 3e-73
 Identities = 85/562 (15%), Positives = 175/562 (31%), Gaps = 50/562 (8%)

Query: 43  KADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSL-TGRIGRGLLQLQF 101
              I+D     + W   D     ++    +   + +       L +   + G  L     
Sbjct: 265 AEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGR 324

Query: 102 LRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRF 161
           +  LSL+     G +   + +L  L+V+    +S +      F  +  +  +    K+R 
Sbjct: 325 VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETV-SGRLFGDEELTPDMSEERKHRI 383

Query: 162 SGKIPS-SLSLCSTLATINLSSNRFSS-----PLPLGIWGLSALRTLDLSDNLLEGEIPK 215
                   L     L   +L  +  +      P+            +    N +   I K
Sbjct: 384 RMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISK 442

Query: 216 GVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMN 275
            ++ L  L++I  + + F+                +        N   +   L     + 
Sbjct: 443 AIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDYAKQYENEELSWSNLKDLTDVE 497

Query: 276 LRKNLFSGEVPKWIGELESLETLDLSGNKFSG---------AVPISIGNLQRLKVLNFSA 326
           L       ++P ++ +L  L++L+++ N+             +        ++++     
Sbjct: 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGY 557

Query: 327 NRLTGSLPDSMA--NCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPF 384
           N L    P S +    + L  LD   N +   L  +  +  L  +    N+I E      
Sbjct: 558 NNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYNQIEE----IP 611

Query: 385 ASSGSSFESLQFLDLSHNEFSG-ETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALN 443
               +  + ++ L  SHN+           ++  +  ++ S N +          +    
Sbjct: 612 EDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYK 671

Query: 444 -----VLDLSENWLNGSIPPEIGGAYSLKELRLERNFL-------AGKIPTSIENCSSLV 491
                 + LS N +             +  + L  N +             + +N   L 
Sbjct: 672 GINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLT 731

Query: 492 SLILSKNNLTG-PIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQG 550
           ++ L  N LT          L  L N+D+S+N  +   P Q +N   L +F I H     
Sbjct: 732 TIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQR--- 787

Query: 551 ELPAGGFFNTISPSSVLGNPSL 572
               G       P+ +   PSL
Sbjct: 788 -DAEGNRILRQWPTGITTCPSL 808

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  166 bits (421), Expect = 2e-42
 Identities = 51/316 (16%), Positives = 101/316 (31%), Gaps = 32/316 (10%)

Query: 92  IGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSL 151
               L ++  L  L    N +   +         L  + L  N +   IP++F      +
Sbjct: 565 ASASLQKMVKLGLLDCVHNKVR-HL-EAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQV 621

Query: 152 RVISLAKNRFSGKIPSSLSL--CSTLATINLSSNRFSS-----PLPLGIWGLSALRTLDL 204
             +  + N+    IP+  +      + +++ S N+  S        +  +      T+ L
Sbjct: 622 EGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTL 680

Query: 205 SDNLLEGEIPKGVESLKNLRVINLSKNMFS-------GSIPDGIGSCSLLRTIDFSENSF 257
           S N ++    +   +   +  I LS N+ +               +  LL TID   N  
Sbjct: 681 SYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL 740

Query: 258 SGNLPETMQKLSLCN--FMNLRKNLFSGEVPKWIGELESLETLDL------SGNKFSGAV 309
           +  L +  +  +L     M++  N FS   P        L+   +       GN+     
Sbjct: 741 TS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQW 798

Query: 310 PISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSM-NGDLPQWIFSSGLNK 368
           P  I     L  L   +N +   + + +     L  LD + N   + D+           
Sbjct: 799 PTGITTCPSLIQLQIGSNDIR-KVDEKLTP--QLYILDIADNPNISIDVTSVCPYIEAGM 855

Query: 369 VSFAENKIREGMNGPF 384
                +K ++      
Sbjct: 856 YVLLYDKTQDIRGCDA 871

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  143 bits (361), Expect = 4e-35
 Identities = 58/443 (13%), Positives = 124/443 (27%), Gaps = 62/443 (13%)

Query: 139 SIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSA 198
           ++ + F +    L+ + +     S +  +  +       I +++   +  LP G + + A
Sbjct: 161 TVMNSFNRVTTELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVVA 220

Query: 199 LRTLD---LSDNLLEGEIPKGVE------SLKNLRVINLSKNMFSGSIPDGIGSCSLLRT 249
             T     +  + LE +  +G         L     + +     +  I D     ++   
Sbjct: 221 YTTYSQSGIKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEA 280

Query: 250 IDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAV 309
           +D     +              NF N   +++  +    +     +  L L+G    G V
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNWNF-NKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339

Query: 310 PISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKV 369
           P +IG L  LKVL+F  +  T S        +     +  ++ +     +          
Sbjct: 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKK---------- 389

Query: 370 SFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLV 429
                                 + L   DL  +  +      +  +     ++L    + 
Sbjct: 390 ----------------MFLDYDQRLNLSDLLQDAINRNP--EMKPIKKDSRISLKDTQI- 430

Query: 430 GPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSS 489
                               N +   I   I     L+ +    +       T       
Sbjct: 431 ----------------GNLTNRI-TFISKAIQRLTKLQIIYFANSPF-----TYDNIAVD 468

Query: 490 LVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQ 549
                           ++ + L +L +V+L        LP  L +L  L S NI+ N   
Sbjct: 469 WEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGI 528

Query: 550 GELPAGGFFNTISPSSVLGNPSL 572
                   +  +        P +
Sbjct: 529 SAAQLKADWTRL-ADDEDTGPKI 550

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  240 bits (614), Expect = 4e-72
 Identities = 75/205 (36%), Positives = 125/205 (60%), Gaps = 6/205 (2%)

Query: 693 NKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           +    LGRGGFG VY+  L DG  VA+K+L        +  F+ EV+ +    H NL+ L
Sbjct: 33  SNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 92

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGN-FLSWNERFNVIQGTAKSLAHLH-QSN 810
            G+  T + +LL+Y +++ GS+   L E       L W +R  +  G+A+ LA+LH   +
Sbjct: 93  RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152

Query: 811 --IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTV 868
             IIH ++K++N+L+D   E  VGD+GLA+L+   D +V ++ ++  +G++APE+   T 
Sbjct: 153 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYL-STG 210

Query: 869 KITDKCDVYGFGVLVLEVVTGKRPL 893
           K ++K DV+G+GV++LE++TG+R  
Sbjct: 211 KSSEKTDVFGYGVMLLELITGQRAF 235

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  232 bits (594), Expect = 2e-69
 Identities = 73/216 (33%), Positives = 118/216 (54%), Gaps = 8/216 (3%)

Query: 683 DFSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ---EDFEREVK 739
           +F      +     ++G GGFG VY+  + +   VA+KKL     + ++   + F++E+K
Sbjct: 26  NFDE--RPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIK 82

Query: 740 KLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGT 799
            + K +H NLV L G+        L+Y ++  GSL   L    G   LSW+ R  + QG 
Sbjct: 83  VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGA 142

Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYM 859
           A  +  LH+++ IH +IKS+N+L+D +   K+ D+GLAR      + V++S+I     YM
Sbjct: 143 ANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYM 202

Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLST 895
           APE      +IT K D+Y FGV++LE++TG   +  
Sbjct: 203 APEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDE 236

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  238 bits (610), Expect = 2e-68
 Identities = 86/487 (17%), Positives = 160/487 (32%), Gaps = 31/487 (6%)

Query: 80  ELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGS 139
            L L G  +          L  L  L      L    S  + +L  L+ ++++ N +   
Sbjct: 84  NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSC 143

Query: 140 IPDEFFKQCGSLRVISLAKNRFSGKIPSSLS----LCSTLATINLSSNRFSSPLPLGIWG 195
               +F    +L  + L+ N       + L           ++++S N     +    + 
Sbjct: 144 KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQ 202

Query: 196 LSALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKNMFSGSIPDGIGSCSLLR------ 248
              L  L L  N     I K   ++L  L V  L    F       I   S++       
Sbjct: 203 GIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVT 262

Query: 249 --TIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFS 306
                 +  +   +       L+  + M+L            + +    ++L +   +  
Sbjct: 263 IDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED--VPKHFKWQSLSIIRCQLK 320

Query: 307 GAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNG---DLPQWIFS 363
                   +L  LK L  + N+   S+        +L  LD S+N+++         + +
Sbjct: 321 Q---FPTLDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGT 375

Query: 364 SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPA-TIGALSGLQLLN 422
           + L  +  + N     M+  F       E LQ LD  H+     T      +L  L  L+
Sbjct: 376 NSLRHLDLSFNGAII-MSANF----MGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLD 430

Query: 423 LSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEI-GGAYSLKELRLERNFLAGKIP 481
           +S  +           L +LN L ++ N    +    +     +L  L L +  L     
Sbjct: 431 ISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISW 490

Query: 482 TSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSF 541
              +    L  L +S NNL         +L +L  +D SFN +             L+ F
Sbjct: 491 GVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFF 550

Query: 542 NISHNHL 548
           N+++N +
Sbjct: 551 NLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  238 bits (608), Expect = 4e-68
 Identities = 91/485 (18%), Positives = 160/485 (32%), Gaps = 32/485 (6%)

Query: 96  LLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVIS 155
                 L+ L LS   +          L +L  + L+GN +  S     F    SL  + 
Sbjct: 52  FSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ-SFSPGSFSGLTSLENLV 110

Query: 156 LAKNRFSGKIPSSLSLCSTLATINLSSNRFSS-PLPLGIWGLSALRTLDLSDNLLEGEIP 214
             + + +      +    TL  +N++ N   S  LP     L+ L  +DLS N ++    
Sbjct: 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV 170

Query: 215 KGVESLKNLR----VINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPET-MQKLS 269
             ++ L+        +++S N     I D       L  +    N  S N+ +T +Q L+
Sbjct: 171 NDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLA 229

Query: 270 LCNFMNLRKNLFSGEV------PKWIGELESL--ETLDLSGNKFSGAVPISIGNLQRLKV 321
             +   L    F  E       P  +  L  +  +   L+         +    L  +  
Sbjct: 230 GLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSA 289

Query: 322 LNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMN 381
           ++ +   +     + +       +L   +  +    P       L  ++   NK      
Sbjct: 290 MSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-QFPTLDLPF-LKSLTLTMNKGS---- 341

Query: 382 GPFASSGSSFESLQFLDLSHNEFSGETPAT--IGALSGLQLLNLSRNSLVGPIPVAIGDL 439
              +    +  SL +LDLS N  S     +      + L+ L+LS N  +  +      L
Sbjct: 342 --ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGL 398

Query: 440 KALNVLDLSENWLNGSIPPE-IGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKN 498
           + L  LD   + L              L  L +                +SL +L ++ N
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458

Query: 499 NLTGPIP-IAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGF 557
           +          A  TNL  +DLS   L          L  L   N+SHN+L   L +  +
Sbjct: 459 SFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF-LDSSHY 517

Query: 558 FNTIS 562
               S
Sbjct: 518 NQLYS 522

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  229 bits (585), Expect = 6e-65
 Identities = 89/494 (18%), Positives = 159/494 (32%), Gaps = 57/494 (11%)

Query: 105 LSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGK 164
                  L+  +  ++    + + IDLS N L   +    F     L+ + L++      
Sbjct: 16  YQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLK-ILKSYSFSNFSELQWLDLSRCEIETI 71

Query: 165 IPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLR 224
              +      L+ + L+ N   S  P    GL++L  L   +  L       +  L  L+
Sbjct: 72  EDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK 131

Query: 225 VINLSKNMFSG-SIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFS- 282
            +N++ N      +P    + + L  +D S N         +Q L     +NL  ++   
Sbjct: 132 KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191

Query: 283 --GEVPKWIGELESLETLDLSGNKFSGAVP-ISIGNLQRLKV------------------ 321
               +     +   L  L L GN  S  +    + NL  L V                  
Sbjct: 192 PIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFE 251

Query: 322 --------------LNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLN 367
                            +                N+ A+  +  S+   L          
Sbjct: 252 PSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQ 310

Query: 368 KVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNS 427
            +S    ++++               L+ L L+ N+ S        AL  L  L+LSRN+
Sbjct: 311 SLSIIRCQLKQ-------FPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNA 361

Query: 428 L--VGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTS-I 484
           L   G    +     +L  LDLS N     +     G   L+ L  + + L      S  
Sbjct: 362 LSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAF 420

Query: 485 ENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQ-LVNLVHLSSFNI 543
            +   L+ L +S  N           LT+L  + ++ NS           N  +L+  ++
Sbjct: 421 LSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDL 480

Query: 544 SHNHLQGELPAGGF 557
           S   L+ ++  G F
Sbjct: 481 SKCQLE-QISWGVF 493

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  215 bits (550), Expect = 3e-60
 Identities = 86/462 (18%), Positives = 157/462 (33%), Gaps = 27/462 (5%)

Query: 80  ELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTG-SISPNLAKLQNLRVIDLSGNSLSG 138
            L      L       + QL  L+KL+++ N +    +    + L NL  +DLS N +  
Sbjct: 108 NLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167

Query: 139 SIPDEF---FKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSS-PLPLGIW 194
              ++     +       + ++ N     I         L  + L  N  SS  +   + 
Sbjct: 168 ITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQ 226

Query: 195 GLSALRTLDLSDNLLEGEI------PKGVESLKNLRV--INLSKNMFSGSIPDGIGSCSL 246
            L+ L    L     + E       P  +E L ++ +    L+               + 
Sbjct: 227 NLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLAN 286

Query: 247 LRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFS 306
           +  +  +  S    L +  +       +++ +             L  L++L L+ NK S
Sbjct: 287 VSAMSLAGVSIK-YLEDVPKHFKW-QSLSIIRCQLKQFPTLD---LPFLKSLTLTMNKGS 341

Query: 307 GAVPISIGNLQRLKVLNFSANRLTGSLPDSMAN--CMNLVALDFSQNSMNGDLPQWIFSS 364
             +      L  L  L+ S N L+ S   S ++    +L  LD S N        ++   
Sbjct: 342 --ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLE 399

Query: 365 GLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLS 424
            L  + F  + ++        S+  S E L +LD+S+     +       L+ L  L ++
Sbjct: 400 ELQHLDFQHSTLKRV---TEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMA 456

Query: 425 RNSLVGPIPV-AIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTS 483
            NS           +   L  LDLS+  L           + L+ L +  N L     + 
Sbjct: 457 GNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSH 516

Query: 484 IENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLT 525
                SL +L  S N +     I      +L   +L+ NS+ 
Sbjct: 517 YNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 82.0 bits (203), Expect = 4e-16
 Identities = 29/138 (21%), Positives = 49/138 (35%), Gaps = 4/138 (2%)

Query: 421 LNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKI 480
                  L   +P  I    +   +DLS N L             L+ L L R  +    
Sbjct: 16  YQCMDQKLSK-VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE 72

Query: 481 PTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSS 540
             +      L +LIL+ N +    P + + LT+L+N+      L       +  L+ L  
Sbjct: 73  DKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKK 132

Query: 541 FNISHNHLQGELPAGGFF 558
            N++HN +        +F
Sbjct: 133 LNVAHNFIHS-CKLPAYF 149

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  227 bits (581), Expect = 1e-67
 Identities = 74/204 (36%), Positives = 123/204 (60%), Gaps = 3/204 (1%)

Query: 693 NKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           +    +G G FG VY+ VLRDG  VA+K+ T  S    +E FE E++ L   RHP+LV+L
Sbjct: 42  DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE-FETEIETLSFCRHPHLVSL 100

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLH-EGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
            G+   ++  +LIY+++  G+L +HL+        +SW +R  +  G A+ L +LH   I
Sbjct: 101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           IH ++KS N+L+D +  PK+ D+G+++    LD+  LS+ ++  LGY+ PE+     ++T
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYF-IKGRLT 219

Query: 872 DKCDVYGFGVLVLEVVTGKRPLST 895
           +K DVY FGV++ EV+  +  +  
Sbjct: 220 EKSDVYSFGVVLFEVLCARSAIVQ 243

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  199 bits (509), Expect = 5e-55
 Identities = 102/506 (20%), Positives = 172/506 (33%), Gaps = 39/506 (7%)

Query: 73  PRSNRVIELTLNGLSLTGRIGRGLLQ-LQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDL 131
           P S + ++L+ N L     +G         L+ L LS   +          L +L  + L
Sbjct: 27  PFSTKNLDLSFNPLR---HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLIL 83

Query: 132 SGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSS-PLP 190
           +GN +  S+    F    SL+ +   +   +      +    TL  +N++ N   S  LP
Sbjct: 84  TGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142

Query: 191 LGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRV----INLSKNMFSGSIPDGIGSCSL 246
                L+ L  LDLS N ++      +  L  + +    ++LS N  +  I  G      
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIR 201

Query: 247 LRTIDFSENSFSGNLPETM-------QKLSLCNFMNLRKNLFSGEVPKWIGELESLETLD 299
           L  +    N  S N+ +T        +   L       +          +  L +L   +
Sbjct: 202 LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE 261

Query: 300 LSGNK---FSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGD 356
                   +   +      L  +   +  +  +      S         L+         
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFG-Q 318

Query: 357 LPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNE--FSGETPATIGA 414
            P     S L +++F  NK         A S     SL+FLDLS N   F G    +   
Sbjct: 319 FPTLKLKS-LKRLTFTSNKGGN------AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371

Query: 415 LSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEI--GGAYSLKELRLE 472
            + L+ L+LS N ++  +      L+ L  LD   + L   +          +L  L + 
Sbjct: 372 TTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDIS 429

Query: 473 RNFLAGKIPTSIENCSSLVSLILSKNNLTGPI-PIAIAKLTNLQNVDLSFNSLTGGLPKQ 531
                          SSL  L ++ N+      P    +L NL  +DLS   L    P  
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489

Query: 532 LVNLVHLSSFNISHNHLQGELPAGGF 557
             +L  L   N++ N L+  +P G F
Sbjct: 490 FNSLSSLQVLNMASNQLK-SVPDGIF 514

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  186 bits (475), Expect = 2e-50
 Identities = 88/488 (18%), Positives = 165/488 (33%), Gaps = 36/488 (7%)

Query: 80  ELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGS 139
            L L G  +          L  L+KL     NL    +  +  L+ L+ ++++ N +   
Sbjct: 80  TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139

Query: 140 IPDEFFKQCGSLRVISLAKNRFSGKIPSSL----SLCSTLATINLSSNRFSSPLPLGIWG 195
              E+F    +L  + L+ N+      + L     +     +++LS N  +  +  G + 
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFK 198

Query: 196 LSALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSE 254
              L  L L +N     + K   + L  L V  L    F           +      F +
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR----------NEGNLEKFDK 248

Query: 255 NSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISI- 313
           ++  G     +  L++  F     + +  ++      L ++ +  L           S  
Sbjct: 249 SALEG-----LCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN 303

Query: 314 GNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAE 373
              Q L+++N    +             +L  L F+ N    +    +    L  +  + 
Sbjct: 304 FGWQHLELVNCKFGQFPTLKLK------SLKRLTFTSNKGG-NAFSEVDLPSLEFLDLSR 356

Query: 374 NKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVG-PI 432
           N +        +  G++  SL++LDLS N       +    L  L+ L+   ++L     
Sbjct: 357 NGLSFKGCCSQSDFGTT--SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSE 413

Query: 433 PVAIGDLKALNVLDLSENWLNGSIPPEI-GGAYSLKELRLERNFLAGKIPTSI-ENCSSL 490
                 L+ L  LD+S           I  G  SL+ L++  N         I     +L
Sbjct: 414 FSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472

Query: 491 VSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQG 550
             L LS+  L    P A   L++LQ ++++ N L          L  L    +  N    
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 532

Query: 551 ELPAGGFF 558
             P   + 
Sbjct: 533 SCPRIDYL 540

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  158 bits (401), Expect = 7e-41
 Identities = 81/451 (17%), Positives = 152/451 (33%), Gaps = 53/451 (11%)

Query: 122 KLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLS 181
            + N+        +    IPD       S + + L+ N        S      L  ++LS
Sbjct: 6   VVPNITY-QCMELNFY-KIPDNLPF---STKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60

Query: 182 SNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGI 241
                +        LS L TL L+ N ++         L +L+ +   +   +      I
Sbjct: 61  RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120

Query: 242 GSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLS 301
           G    L+ ++ + N                        + S ++P++   L +LE LDLS
Sbjct: 121 GHLKTLKELNVAHN-----------------------LIQSFKLPEYFSNLTNLEHLDLS 157

Query: 302 GNKFSGAVPISIGNLQRLKV----LNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDL 357
            NK        +  L ++ +    L+ S N +   +       + L  L    N  + ++
Sbjct: 158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNV 216

Query: 358 PQWIFS--SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNE------FSGETP 409
            +      +GL        + R   N       S+ E L  L +          +  +  
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK-SALEGLCNLTIEEFRLAYLDYYLDDII 275

Query: 410 ATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKEL 469
                L+ +   +L   ++   +     +      L+L         P       SLK L
Sbjct: 276 DLFNCLTNVSSFSLVSVTIER-VKDFSYNFG-WQHLELVNCKFG-QFPT--LKLKSLKRL 330

Query: 470 RLERNFLAGKIPTSIENCSSLVSLILSKNNLT--GPIPIAIAKLTNLQNVDLSFNSLTGG 527
               N   G   + + +  SL  L LS+N L+  G    +    T+L+ +DLSFN +   
Sbjct: 331 TFTSNKG-GNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-T 387

Query: 528 LPKQLVNLVHLSSFNISHNHLQGELPAGGFF 558
           +    + L  L   +  H++L+ ++     F
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVF 417

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  192 bits (490), Expect = 2e-53
 Identities = 91/471 (19%), Positives = 172/471 (36%), Gaps = 45/471 (9%)

Query: 102 LRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRF 161
           L   +++ +     I      L       L   +++ ++          +  +   +   
Sbjct: 3   LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS---QTDLDQVTTLQADRLGI 58

Query: 162 SGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLK 221
                  +   + L  IN S+N+ +   PL    L+ L  + +++N +    P  + +L 
Sbjct: 59  K--SIDGVEYLNNLTQINFSNNQLTDITPLK--NLTKLVDILMNNNQIADITP--LANLT 112

Query: 222 NLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLF 281
           NL  + L  N  +   P  + + + L  ++ S N+ S      +  L+    ++    + 
Sbjct: 113 NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVT 168

Query: 282 SGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCM 341
             +    +  L +LE LD+S NK S      +  L  L+ L  + N+++   P       
Sbjct: 169 DLKP---LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLG--ILT 221

Query: 342 NLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSH 401
           NL  L  + N +  D+      + L  +  A N+I         +  S    L  L L  
Sbjct: 222 NLDELSLNGNQLK-DIGTLASLTNLTDLDLANNQISN------LAPLSGLTKLTELKLGA 274

Query: 402 NEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIG 461
           N+ S  +P  +  L+ L  L L+ N L    P  I +LK L  L L  N ++   P  + 
Sbjct: 275 NQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VS 328

Query: 462 GAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSF 521
               L+ L    N +     +S+ N +++  L    N ++   P  +A LT +  + L+ 
Sbjct: 329 SLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 384

Query: 522 NSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSL 572
            + T        N+      N   N     +       TIS       P +
Sbjct: 385 QAWTNAPVNYKANVSIP---NTVKNVTGALIAP----ATISDGGSYTEPDI 428

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  189 bits (482), Expect = 3e-52
 Identities = 87/448 (19%), Positives = 173/448 (38%), Gaps = 39/448 (8%)

Query: 78  VIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLS 137
            ++  L   ++T  +      L  +  L      +  SI   +  L NL  I+ S N L+
Sbjct: 26  KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLT 81

Query: 138 GSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLS 197
              P    K    L  I +  N+ +    + L+  + L  + L +N+ +   PL    L+
Sbjct: 82  DITP---LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDPLK--NLT 134

Query: 198 ALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSF 257
            L  L+LS N +       +  L +L+ ++    +   +    + + + L  +D S N  
Sbjct: 135 NLNRLELSSNTISD--ISALSGLTSLQQLSFGNQV---TDLKPLANLTTLERLDISSNKV 189

Query: 258 SGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQ 317
           S      + KL+    +    N  S   P  +G L +L+ L L+GN+       ++ +L 
Sbjct: 190 SD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLT 243

Query: 318 RLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIR 377
            L  L+ + N+++   P  ++    L  L    N ++ ++      + L  +   EN++ 
Sbjct: 244 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS-NISPLAGLTALTNLELNENQLE 300

Query: 378 EGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIG 437
           +       S  S+ ++L +L L  N  S  +P  + +L+ LQ L    N +       + 
Sbjct: 301 D------ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSS--LA 350

Query: 438 DLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSK 497
           +L  +N L    N ++   P  +     + +L L              N S   ++    
Sbjct: 351 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVT 408

Query: 498 NNLTGPIPIAIAKLTNLQNVDLSFNSLT 525
             L    P  I+   +    D+++N  +
Sbjct: 409 GALI--APATISDGGSYTEPDITWNLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  126 bits (318), Expect = 8e-31
 Identities = 66/316 (20%), Positives = 114/316 (36%), Gaps = 31/316 (9%)

Query: 95  GLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVI 154
            L  L  L +L +SSN ++      LAKL NL  +  + N +S   P        +L  +
Sbjct: 172 PLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP---LGILTNLDEL 226

Query: 155 SLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIP 214
           SL  N+       +L+  + L  ++L++N+ S+  PL   GL+ L  L L  N +    P
Sbjct: 227 SLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISNISP 282

Query: 215 KGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLP-ETMQKLSLCNF 273
             +  L  L  + L++N      P  I +   L  +    N+ S   P  ++ KL     
Sbjct: 283 --LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQ---R 335

Query: 274 MNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSL 333
           +    N  S      +  L ++  L    N+ S      + NL R+  L  +    T + 
Sbjct: 336 LFFYNNKVSD--VSSLANLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAWTNAP 391

Query: 334 PDSMANCMNLVALDFSQNSMNGDLPQWIFSSG--LNKVSFAENKIREGMNGPFASSGSSF 391
            +      N+   +  +N     +     S G    +     N         +     +F
Sbjct: 392 VNY---KANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSY-----TF 443

Query: 392 ESLQFLDLSHNEFSGE 407
                +      FSG 
Sbjct: 444 SQPVTIGKGTTTFSGT 459

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  107 bits (269), Expect = 1e-24
 Identities = 43/242 (17%), Positives = 83/242 (34%), Gaps = 38/242 (15%)

Query: 95  GLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVI 154
            L  L  L  L L++N ++      L+ L  L  + L  N +S   P        +L  +
Sbjct: 238 TLASLTNLTDLDLANNQISNL--APLSGLTKLTELKLGANQISNISP---LAGLTALTNL 292

Query: 155 SLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIP 214
            L +N+      S +S    L  + L  N  S   P+    L+ L+ L   +N +     
Sbjct: 293 ELNENQLED--ISPISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFYNNKVSD--V 346

Query: 215 KGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFM 274
             + +L N+  ++   N  S   P  + + + +  +  ++ +++         +S+ N +
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTV 404

Query: 275 NLRKNLFSGEVPKWIGELESLETLDLSGN-----------------------KFSGAVPI 311
                      P  I +  S    D++ N                        FSG V  
Sbjct: 405 KNVTGALI--APATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVTQ 462

Query: 312 SI 313
            +
Sbjct: 463 PL 464

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  184 bits (470), Expect = 3e-52
 Identities = 57/234 (24%), Positives = 89/234 (38%), Gaps = 30/234 (12%)

Query: 679 SGDPDFSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREV 738
            G  +    +  L   +    RG FG V++  L     VA+K   +    K     E EV
Sbjct: 14  LGTENLYFQSMPLQLLEV-KARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEV 69

Query: 739 KKLGKVRHPNLVTLEGY------YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNER 792
             L  ++H N++   G               LI  F   GSL   L      N +SWNE 
Sbjct: 70  YSLPGMKHENILQFIGAEKRGTSVDVDLW--LITAFHEKGSLSDFLK----ANVVSWNEL 123

Query: 793 FNVIQGTAKSLAHLHQS----------NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM 842
            ++ +  A+ LA+LH+            I H +IKS NVL+  +    + D+GLA     
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183

Query: 843 LDRYVLSSKIQSALGYMAPEFACRTVKITD----KCDVYGFGVLVLEVVTGKRP 892
                 +        YMAPE     +        + D+Y  G+++ E+ +    
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  193 bits (492), Expect = 3e-51
 Identities = 130/621 (20%), Positives = 220/621 (35%), Gaps = 84/621 (13%)

Query: 80  ELTLNGLSLTGRIGRGLLQ-LQFLRKLSLSSNNLTGSISPN-LAKLQNLRVIDLSGNSLS 137
            L L        I +   + L  LR L L S+ +   + P+    L +L  + L    LS
Sbjct: 52  LLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLS 110

Query: 138 -GSIPDEFFKQCGSLRVISLAKNRFSG-KIPSSLSLCSTLATINLSSNRFSSPLPLGIWG 195
              + D +F+   +L  + L+KN+     +  S    ++L +I+ SSN+        +  
Sbjct: 111 DAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170

Query: 196 LSA--LRTLDLSDNLLEGEIPKGVESLKN------LRVINLSKNMFSGSIPDGIGSCSLL 247
           L    L    L+ N L   +        N      L ++++S N ++  I       + +
Sbjct: 171 LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGN--FSNAI 228

Query: 248 RTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSG 307
                     + ++          N  +  +N F+G          S+  LDLS      
Sbjct: 229 SKSQAFSLILAHHI--MGAGFGFHNIKDPDQNTFAGL------ARSSVRHLDLSHGFVFS 280

Query: 308 AVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSS--G 365
                   L+ LKVLN + N++     ++     NL  L+ S N +  +L    F     
Sbjct: 281 LNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPK 339

Query: 366 LNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEF--------------SGETPAT 411
           +  +   +N I    +  F       E LQ LDL  N                SG    T
Sbjct: 340 VAYIDLQKNHIAIIQDQTF----KFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVT 395

Query: 412 IGALS-GLQLLNLSRNSLVG-PIPVAIGDLKALNVLDLSENWLNGSIPPE--IGGAYSLK 467
           +  ++    L++LS N L    I   +  +  L +L L++N  + S   +       SL+
Sbjct: 396 LPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS-SCSGDQTPSENPSLE 454

Query: 468 ELRLERNFLAGKIPTSI-----ENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFN 522
           +L L  N L     T +     E  S L  L L+ N L    P   + LT L+ + L+ N
Sbjct: 455 QLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSN 514

Query: 523 SLT----GGLPKQLVNL---------------VHLSSFNISHNHLQGELPAGGFFNTISP 563
            LT      LP  L  L               V LS  +I+HN    E     F N ++ 
Sbjct: 515 RLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELSTFINWLNH 574

Query: 564 SSVLGNPSLCGSAVNKSCPAVLPKPIVLNPNSSSDSTTSSVAPNPRHKRIILSISAIIAI 623
           +    N ++ G   +  C      P   +  S    +T         K +  S+  +  +
Sbjct: 575 T----NVTIAGPPADIYCVY----PDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTV 626

Query: 624 GAAAVIVIGVIAITVLNLRVR 644
               + +  +  +TV   R  
Sbjct: 627 ---TLTLFLMTILTVTKFRGF 644

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  161 bits (410), Expect = 5e-41
 Identities = 91/469 (19%), Positives = 150/469 (31%), Gaps = 80/469 (17%)

Query: 103 RKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFS 162
           R       NLT  +   L   + L    LS N +  ++    F     L+++ L      
Sbjct: 7   RIAFYRFCNLT-QVPQVLNTTERL---LLSFNYIR-TVTASSFPFLEQLQLLELGSQYTP 61

Query: 163 GKI-PSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEI--PKGVES 219
             I   +      L  ++L S++     P    GL  L  L L    L   +       +
Sbjct: 62  LTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRN 121

Query: 220 LKNLRVINLSKNMFSG-SIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRK 278
           LK L  ++LSKN      +    G  + L++IDFS N         ++ L          
Sbjct: 122 LKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT------ 175

Query: 279 NLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQ------RLKVLNFSANRLTGS 332
                           L    L+ N     V +  G          L++L+ S N  T  
Sbjct: 176 ----------------LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVD 219

Query: 333 LPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFE 392
           +  + +N ++         + +           +    F  + I++     FA    S  
Sbjct: 220 ITGNFSNAISKSQAFSLILAHH-----------IMGAGFGFHNIKDPDQNTFAGLARS-- 266

Query: 393 SLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWL 452
           S++ LDLSH             L  L++LNL+ N +      A   L  L VL+LS N L
Sbjct: 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326

Query: 453 NGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLT 512
              +                          +      +  + L KN++          L 
Sbjct: 327 G-ELYSS-----------------------NFYGLPKVAYIDLQKNHIAIIQDQTFKFLE 362

Query: 513 NLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTI 561
            LQ +DL  N+LT      +  +  +    +S N L   LP       +
Sbjct: 363 KLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKINLTANL 405

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  182 bits (463), Expect = 5e-49
 Identities = 91/481 (18%), Positives = 176/481 (36%), Gaps = 43/481 (8%)

Query: 96  LLQLQFLRKLSLSSNNLTGSISPN-LAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVI 154
           L     L+ L L S+ +  +I  +    L +L  +DLS N LS S+   +F    SL+ +
Sbjct: 46  LRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYL 103

Query: 155 SLAKNRFSG-KIPSSLSLCSTLATINLSS-NRFSSPLPLGIWGLSALRTLDLSDNLLEGE 212
           +L  N +    + S     + L T+ + +   FS    +   GL++L  L++    L   
Sbjct: 104 NLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-N 162

Query: 213 IPKGV-ESLKNLRVINLSKNMFSGSIPDGIGSC-SLLRTIDFSENSFSGN------LPET 264
                 +S++++  + L  +  +  + +      S +R ++  + + +        + E 
Sbjct: 163 YQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEV 221

Query: 265 MQKLSLCNFMNLRKNLFSG----EVPKWIGELESLETLDLSGNKFSGAVPISIGNLQR-- 318
              +    F        S     ++ ++I EL  +E  D + N      P     +    
Sbjct: 222 SSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELG 281

Query: 319 ------LKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFS--SGLNKVS 370
                 ++ L+     L   L    +    +  +    + +   +P         L  + 
Sbjct: 282 KVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLD 340

Query: 371 FAENKIREGMNGPFASSGSSFESLQFLDLSHNEFS--GETPATIGALSGLQLLNLSRNSL 428
            +EN + E      A  G ++ SLQ L LS N      +T   +  L  L  L++SRN+ 
Sbjct: 341 LSENLMVEEYLKNSACKG-AWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF 399

Query: 429 VGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCS 488
             P+P +    + +  L+LS   +   +   I    +L+ L +  N L       +    
Sbjct: 400 -HPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPR-- 452

Query: 489 SLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHL 548
            L  L +S+N L   +P   +    L  + +S N L          L  L    +  N  
Sbjct: 453 -LQELYISRNKLKT-LP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

Query: 549 Q 549
            
Sbjct: 510 D 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  167 bits (426), Expect = 3e-44
 Identities = 80/446 (17%), Positives = 162/446 (36%), Gaps = 51/446 (11%)

Query: 148 CGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDN 207
           C +  V       F+  IPS L+  + + +++LS N+ +      +   + L+ L L  +
Sbjct: 4   CDASGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60

Query: 208 LLEGEIPKGV-ESLKNLRVINLSKNMFSGSIPDG-IGSCSLLRTIDFSENSFS------- 258
            +   I      SL +L  ++LS N  S S+     G  S L+ ++   N +        
Sbjct: 61  RIN-TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118

Query: 259 -GNLPETMQKLSLCN---FMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIG 314
             NL   +Q L + N   F  +R+  F+G        L SL  L++           S+ 
Sbjct: 119 FPNLTN-LQTLRIGNVETFSEIRRIDFAG--------LTSLNELEIKALSLRNYQSQSLK 169

Query: 315 NLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMN----GDLPQWIFSSGLNKVS 370
           +++ +  L    +     L        ++  L+    ++       LP    SS + K++
Sbjct: 170 SIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLA 229

Query: 371 FAENKIREGMNGPFASSGSSFESL---QFLDLSHNEFSGETPATIGALSG--------LQ 419
           F  + + +               L   +F D + N      P+    +S         ++
Sbjct: 230 FRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIR 289

Query: 420 LLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIG-GAYSLKELRLERNFLAG 478
            L++ +  L   +      L+ +  + +  + +   +P        SL+ L L  N +  
Sbjct: 290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVE 348

Query: 479 KI---PTSIENCSSLVSLILSKNNLT--GPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLV 533
           +            SL +L+LS+N+L         +  L NL ++D+S N+    +P    
Sbjct: 349 EYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQ 407

Query: 534 NLVHLSSFNISHNHLQGELPAGGFFN 559
               +   N+S   ++  +       
Sbjct: 408 WPEKMRFLNLSSTGIR-VVKTCIPQT 432

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  117 bits (294), Expect = 2e-27
 Identities = 60/373 (16%), Positives = 123/373 (32%), Gaps = 37/373 (9%)

Query: 80  ELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGS 139
           EL +  LSL     + L  ++ +  L+L  +     +      L ++R ++L   +L+  
Sbjct: 152 ELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARF 211

Query: 140 IPDEFFKQC-----------------GSLRVISLAKNRFSGKIPSSLSLCSTLATINLSS 182
                                      S   +                 C+     + + 
Sbjct: 212 QFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNP 271

Query: 183 NRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIG 242
           +       LG      +R L +    L  ++      L+ ++ I +  +     +P    
Sbjct: 272 SESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFS 330

Query: 243 S-CSLLRTIDFSENSFSGNLPETMQKLSLCNFM---NLRKNLFS--GEVPKWIGELESLE 296
                L  +D SEN       +          +    L +N      +  + +  L++L 
Sbjct: 331 QHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLT 390

Query: 297 TLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGD 356
           +LD+S N F   +P S    ++++ LN S+  +   +   +     L  LD S N+++  
Sbjct: 391 SLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ--TLEVLDVSNNNLD-S 445

Query: 357 LPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALS 416
               +F   L ++  + NK++           S F  L  + +S N+           L+
Sbjct: 446 FS--LFLPRLQELYISRNKLKT------LPDASLFPVLLVMKISRNQLKSVPDGIFDRLT 497

Query: 417 GLQLLNLSRNSLV 429
            LQ + L  N   
Sbjct: 498 SLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 94.8 bits (236), Expect = 2e-20
 Identities = 37/214 (17%), Positives = 74/214 (34%), Gaps = 8/214 (3%)

Query: 339 NCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLD 398
           +C      D    S    +P  + ++ +  +  + NKI    +G       +  +LQ L 
Sbjct: 3   SCDASGVCDGRSRSFT-SIPSGLTAA-MKSLDLSFNKITYIGHGDL----RACANLQVLI 56

Query: 399 LSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNG-SIP 457
           L  +  +        +L  L+ L+LS N L        G L +L  L+L  N      + 
Sbjct: 57  LKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVT 116

Query: 458 PEIGGAYSLKELRLERNFLAGKIP-TSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQN 516
                  +L+ LR+       +I        +SL  L +   +L      ++  + ++ +
Sbjct: 117 SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHH 176

Query: 517 VDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQG 550
           + L  +     L      L  +    +   +L  
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 81.3 bits (201), Expect = 5e-16
 Identities = 36/174 (20%), Positives = 70/174 (40%), Gaps = 13/174 (7%)

Query: 61  DTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNL 120
           +        K +  S + + L+ N L    + G  LL L+ L  L +S N     +  + 
Sbjct: 348 EEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSC 406

Query: 121 AKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINL 180
              + +R ++LS   +   +     +   +L V+ ++ N         L     L  + +
Sbjct: 407 QWPEKMRFLNLSSTGIR-VVKTCIPQ---TLEVLDVSNNNLD-SFSLFL---PRLQELYI 458

Query: 181 SSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKNMF 233
           S N+  + LP        L  + +S N L+  +P G+ + L +L+ I L  N +
Sbjct: 459 SRNKLKT-LPDA-SLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 509

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  172 bits (437), Expect = 1e-47
 Identities = 56/342 (16%), Positives = 106/342 (30%), Gaps = 30/342 (8%)

Query: 196 LSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSEN 255
            S    L    +         +   +     + ++   +    +     +  +    +  
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS----NNPQIETRTGR 66

Query: 256 SFSGNLPETMQKLSLCN--FMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISI 313
           +      + ++  +      + LR      + P     L  L+ + +        +P ++
Sbjct: 67  ALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123

Query: 314 GNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAE 373
                L+ L  + N L  +LP S+A+   L  L         +LP+ +            
Sbjct: 124 QQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLA----------- 171

Query: 374 NKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIP 433
                  +   +       +LQ L L         PA+I  L  L+ L +  + L   + 
Sbjct: 172 -------STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LG 222

Query: 434 VAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSL 493
            AI  L  L  LDL       + PP  GG   LK L L+       +P  I   + L  L
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKL 282

Query: 494 ILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNL 535
            L        +P  IA+L     + +  +        + V  
Sbjct: 283 DLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  155 bits (393), Expect = 9e-42
 Identities = 57/361 (15%), Positives = 105/361 (29%), Gaps = 69/361 (19%)

Query: 114 GSISPNLAKLQNLRVIDLSGNSLSGSIPDEF-------------------FKQCGSLRVI 154
           GS   +         +   G++      D                          + ++ 
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61

Query: 155 SLAKNRFSGKIPSSLSLCS--TLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGE 212
           +             L   +      + L S       P   + LS L+ + +    L  E
Sbjct: 62  TRTGRALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-E 118

Query: 213 IPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCN 272
           +P  ++    L  + L++N    ++P  I S + LR +          LPE +       
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDA-- 175

Query: 273 FMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGS 332
                              L +L++L L       ++P SI NLQ LK L    + L+ +
Sbjct: 176 -------------SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-A 220

Query: 333 LPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFE 392
           L  ++ +   L  LD    +   + P                                  
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRNYPPIF---------------------------GGRA 253

Query: 393 SLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWL 452
            L+ L L         P  I  L+ L+ L+L     +  +P  I  L A  ++ +  +  
Sbjct: 254 PLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313

Query: 453 N 453
            
Sbjct: 314 A 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  146 bits (370), Expect = 1e-38
 Identities = 50/339 (14%), Positives = 90/339 (26%), Gaps = 58/339 (17%)

Query: 220 LKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPE-TMQKLSLCNFMNLRK 278
                 +    +       D +         D +    +         ++       L+ 
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK- 69

Query: 279 NLFSGEVPKWIGEL--ESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDS 336
                     + +        L+L         P     L  L+ +   A  L   LPD+
Sbjct: 70  -----ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDT 122

Query: 337 MANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQF 396
           M     L  L  ++N +   LP  I                           +S   L+ 
Sbjct: 123 MQQFAGLETLTLARNPLR-ALPASI---------------------------ASLNRLRE 154

Query: 397 LDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSI 456
           L +       E P  + +                        L  L  L L    +  S+
Sbjct: 155 LSIRACPELTELPEPLASTD---------------ASGEHQGLVNLQSLRLEWTGIR-SL 198

Query: 457 PPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQN 516
           P  I    +LK L++  + L+  +  +I +   L  L L         P        L+ 
Sbjct: 199 PASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKR 257

Query: 517 VDLS-FNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPA 554
           + L   ++L   LP  +  L  L   ++        LP+
Sbjct: 258 LILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPS 295

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  142 bits (360), Expect = 2e-37
 Identities = 50/272 (18%), Positives = 93/272 (34%), Gaps = 16/272 (5%)

Query: 73  PRSNRVIELTLNGLSLTGRIGR-GLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDL 131
             SN     T  G +L                 L L S  L         +L +L+ + +
Sbjct: 53  ANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTI 111

Query: 132 SGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSS-NRFSS--- 187
               L   +PD    Q   L  ++LA+N     +P+S++  + L  +++ +    +    
Sbjct: 112 DAAGLM-ELPDTMQ-QFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPE 168

Query: 188 -----PLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIG 242
                       GL  L++L L    +   +P  + +L+NL+ + +  +  S ++   I 
Sbjct: 169 PLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIH 226

Query: 243 SCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSG 302
               L  +D    +   N P      +    + L+       +P  I  L  LE LDL G
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRG 286

Query: 303 NKFSGAVPISIGNLQRLKVLNFSANRLTGSLP 334
                 +P  I  L    ++    +       
Sbjct: 287 CVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 46.1 bits (110), Expect = 3e-05
 Identities = 16/121 (13%), Positives = 28/121 (23%), Gaps = 23/121 (19%)

Query: 454 GSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIP-------- 505
           GS       +   + L  + +         +       +   ++ +              
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61

Query: 506 -------------IAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGEL 552
                        +  A       ++L    L    P Q   L HL    I    L  EL
Sbjct: 62  TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-EL 119

Query: 553 P 553
           P
Sbjct: 120 P 120

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  172 bits (438), Expect = 2e-47
 Identities = 77/376 (20%), Positives = 148/376 (39%), Gaps = 32/376 (8%)

Query: 175 LATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFS 234
            AT+       +   P     L+      L    +   + +  E L+++  + ++    +
Sbjct: 2   AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVTQ--EELESITKLVVAGEKVA 57

Query: 235 GSIPDGIGSCSLLRTIDFSENSFSGNLP-ETMQKLSLCNFMNLRKNLFSGEVPKWIGELE 293
            SI  GI   + L  ++ + N  +   P   + KL     + +  N  +      +  L 
Sbjct: 58  -SIQ-GIEYLTNLEYLNLNGNQITDISPLSNLVKL---TNLYIGTNKITD--ISALQNLT 110

Query: 294 SLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSM 353
           +L  L L+ +  S      + NL ++  LN  AN    S    ++N   L  L  +++ +
Sbjct: 111 NLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKV 167

Query: 354 NGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIG 413
             D+      + L  +S   N+I +       S  +S  SL +     N+ +  TP  + 
Sbjct: 168 K-DVTPIANLTDLYSLSLNYNQIED------ISPLASLTSLHYFTAYVNQITDITP--VA 218

Query: 414 ALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLER 473
            ++ L  L +  N +    P  + +L  L  L++  N ++      +     LK L +  
Sbjct: 219 NMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGS 274

Query: 474 NFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLV 533
           N ++    + + N S L SL L+ N L       I  LTNL  + LS N +T   P  L 
Sbjct: 275 NQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LA 330

Query: 534 NLVHLSSFNISHNHLQ 549
           +L  + S + ++  ++
Sbjct: 331 SLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  169 bits (431), Expect = 1e-46
 Identities = 71/424 (16%), Positives = 151/424 (35%), Gaps = 79/424 (18%)

Query: 102 LRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRF 161
              L+     +   I P  A L       L   S++  +     ++  S+  + +A  + 
Sbjct: 2   AATLATLPAPIN-QIFP-DADLAEGIRAVLQKASVTDVVT---QEELESITKLVVAGEKV 56

Query: 162 SGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLK 221
           +      +   + L  +NL+ N+ +   PL    L  L  L +  N +       +++L 
Sbjct: 57  AS--IQGIEYLTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKI--TDISALQNLT 110

Query: 222 NLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLF 281
           NLR + L+++  S   P  + + + + +++   N    +L                    
Sbjct: 111 NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP------------------ 150

Query: 282 SGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCM 341
                  +  +  L  L ++ +K        I NL  L  L+ + N++       +A+  
Sbjct: 151 -------LSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDI--SPLASLT 199

Query: 342 NLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSH 401
           +L                              N+I +       +  ++   L  L + +
Sbjct: 200 SLHYFTAY-----------------------VNQITD------ITPVANMTRLNSLKIGN 230

Query: 402 NEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIG 461
           N+ +  +P  +  LS L  L +  N +       + DL  L +L++  N ++      + 
Sbjct: 231 NKITDLSP--LANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISD--ISVLN 284

Query: 462 GAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSF 521
               L  L L  N L  +    I   ++L +L LS+N++T   P  +A L+ + + D + 
Sbjct: 285 NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFAN 342

Query: 522 NSLT 525
             + 
Sbjct: 343 QVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  163 bits (415), Expect = 2e-44
 Identities = 73/406 (17%), Positives = 144/406 (35%), Gaps = 77/406 (18%)

Query: 96  LLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVIS 155
              L    +  L   ++T  +     +L+++  + ++G  ++ SI     +   +L  ++
Sbjct: 18  DADLAEGIRAVLQKASVTDVV--TQEELESITKLVVAGEKVA-SIQG--IEYLTNLEYLN 72

Query: 156 LAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPK 215
           L  N+ +   P  LS    L  + + +N+ +    L    L+ LR L L+++ +    P 
Sbjct: 73  LNGNQITDISP--LSNLVKLTNLYIGTNKITDISALQ--NLTNLRELYLNEDNISDISP- 127

Query: 216 GVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMN 275
            + +L  +  +NL  N    S    + + + L  +  +E+      P             
Sbjct: 128 -LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP------------- 172

Query: 276 LRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPD 335
                        I  L  L +L L+ N+        + +L  L       N++T     
Sbjct: 173 -------------IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDI--T 215

Query: 336 SMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQ 395
            +AN   L +L    N              +  +S   N                   L 
Sbjct: 216 PVANMTRLNSLKIGNNK-------------ITDLSPLAN----------------LSQLT 246

Query: 396 FLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGS 455
           +L++  N+ S      +  L+ L++LN+  N +       + +L  LN L L+ N L   
Sbjct: 247 WLEIGTNQIS--DINAVKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNE 302

Query: 456 IPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLT 501
               IGG  +L  L L +N +    P  + + S + S   +   + 
Sbjct: 303 DMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  160 bits (407), Expect = 2e-43
 Identities = 71/373 (19%), Positives = 140/373 (37%), Gaps = 53/373 (14%)

Query: 78  VIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLS 137
            I   L   S+T  +     +L+ + KL ++   +  SI   +  L NL  ++L+GN ++
Sbjct: 24  GIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQIT 79

Query: 138 GSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLS 197
              P         L  + +  N+ +    S+L   + L  + L+ +  S   PL    L+
Sbjct: 80  DISP---LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISPLA--NLT 132

Query: 198 ALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSF 257
            + +L+L  N         + ++  L  + ++++      P  I + + L ++  + N  
Sbjct: 133 KMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI 189

Query: 258 SGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQ 317
               P                          +  L SL       N+ +      + N+ 
Sbjct: 190 EDISP--------------------------LASLTSLHYFTAYVNQITD--ITPVANMT 221

Query: 318 RLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIR 377
           RL  L    N++T      +AN   L  L+   N ++ D+      + L  ++   N+I 
Sbjct: 222 RLNSLKIGNNKITDL--SPLANLSQLTWLEIGTNQIS-DINAVKDLTKLKMLNVGSNQIS 278

Query: 378 EGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIG 437
           +       S  ++   L  L L++N+   E    IG L+ L  L LS+N +    P  + 
Sbjct: 279 D------ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LA 330

Query: 438 DLKALNVLDLSEN 450
            L  ++  D +  
Sbjct: 331 SLSKMDSADFANQ 343

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  124 bits (314), Expect = 4e-31
 Identities = 53/262 (20%), Positives = 101/262 (38%), Gaps = 22/262 (8%)

Query: 289 IGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDF 348
             +L       L     +    ++   L+ +  L  +  ++  S+   +    NL  L+ 
Sbjct: 18  DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNL 73

Query: 349 SQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGET 408
           + N +    P       L  +    NKI +       S+  +  +L+ L L+ +  S  +
Sbjct: 74  NGNQITDISPLSNLVK-LTNLYIGTNKITD------ISALQNLTNLRELYLNEDNISDIS 126

Query: 409 PATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKE 468
           P  +  L+ +  LNL  N  +  +   + ++  LN L ++E+ +    P  I     L  
Sbjct: 127 P--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYS 181

Query: 469 LRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGL 528
           L L  N +    P  + + +SL       N +T   P+A   +T L ++ +  N +T   
Sbjct: 182 LSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVA--NMTRLNSLKIGNNKITDLS 237

Query: 529 PKQLVNLVHLSSFNISHNHLQG 550
           P  L NL  L+   I  N +  
Sbjct: 238 P--LANLSQLTWLEIGTNQISD 257

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 86.4 bits (215), Expect = 3e-18
 Identities = 33/161 (20%), Positives = 63/161 (39%), Gaps = 12/161 (7%)

Query: 394 LQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLN 453
              L       +   P     L+      L + S+   +     +L+++  L ++   + 
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 454 GSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTN 513
            SI   I    +L+ L L  N +    P  + N   L +L +  N +T    +    LTN
Sbjct: 58  -SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISALQ--NLTN 111

Query: 514 LQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPA 554
           L+ + L+ ++++      L NL  + S N+  NH   +L  
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSP 150

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  169 bits (431), Expect = 4e-47
 Identities = 67/203 (33%), Positives = 103/203 (50%), Gaps = 15/203 (7%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGY 755
           ++G G FG V+R     G  VA+K L        +  +F REV  + ++RHPN+V   G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN--IIH 813
                   ++ E++S GSL++ LH+      L    R ++    AK + +LH  N  I+H
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVH 162

Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE-FACRTVK 869
            N+KS N+L+D     KV D+GL+RL     +       +SA G   +MAPE        
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRL-----KASTFLSSKSAAGTPEWMAPEVLRDEPS- 216

Query: 870 ITDKCDVYGFGVLVLEVVTGKRP 892
             +K DVY FGV++ E+ T ++P
Sbjct: 217 -NEKSDVYSFGVILWELATLQQP 238

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  172 bits (437), Expect = 3e-46
 Identities = 70/454 (15%), Positives = 139/454 (30%), Gaps = 41/454 (9%)

Query: 97  LQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISL 156
                 +   ++ ++L  +++       N++ +DLSGN LS  I          L +++L
Sbjct: 7   QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNL 65

Query: 157 AKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKG 216
           + N         L   STL T++L++N         +    ++ TL  ++N +   +   
Sbjct: 66  SSNVLYE--TLDLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNIS-RVSC- 116

Query: 217 VESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSG-NLPETMQKLSLCNFMN 275
               +  + I L+ N  +       G  S ++ +D   N     N  E          +N
Sbjct: 117 -SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175

Query: 276 LRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPD 335
           L+ N    +V   +     L+TLDLS NK +  +     +   +  ++   N+L   +  
Sbjct: 176 LQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK 231

Query: 336 SMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQ 395
           ++    NL   D   N  +    +  FS      + A+  +++        +G + E   
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKK-------LTGQNEEECT 284

Query: 396 FLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGS 455
              L H                L  L    ++L                L    +     
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHAL----------------LSGQGSETE-R 327

Query: 456 IPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQ 515
           +  E       +E+   +      I        + ++L   K  L   +         L 
Sbjct: 328 LECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELD 387

Query: 516 NVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQ 549
                       L         L          +
Sbjct: 388 GTLQQAVGQI-ELQHATEEQSPLQLLRAIVKRYE 420

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  144 bits (365), Expect = 9e-37
 Identities = 61/413 (14%), Positives = 122/413 (29%), Gaps = 25/413 (6%)

Query: 143 EFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTL 202
           E  +     ++  +  +     + S       +  ++LS N  S      +   + L  L
Sbjct: 4   EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63

Query: 203 DLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLP 262
           +LS N+L   +   +ESL  LR ++L+ N     +  G      + T+  + N+ S    
Sbjct: 64  NLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLVG----PSIETLHAANNNISRVSC 116

Query: 263 ETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSG-AVPISIGNLQRLKV 321
              Q       + L  N  +       G    ++ LDL  N+           +   L+ 
Sbjct: 117 SRGQGKK---NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH 173

Query: 322 LNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFS-SGLNKVSFAENKIREGM 380
           LN   N +   +         L  LD S N +   +     S +G+  +S   NK+    
Sbjct: 174 LNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-- 228

Query: 381 NGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLK 440
                 +    ++L+  DL  N F   T          ++  +++ ++         +  
Sbjct: 229 ---IEKALRFSQNLEHFDLRGNGFHCGTLRDFF-SKNQRVQTVAKQTVKKLTGQNEEECT 284

Query: 441 ALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAG----KIPTSIENCSSLVSLILS 496
              +             P      +LK          G    ++    EN +    +   
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDAL 344

Query: 497 KNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQ 549
           K      I     +      ++    +L   +         L           
Sbjct: 345 KEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI 397

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  140 bits (355), Expect = 2e-35
 Identities = 63/370 (17%), Positives = 125/370 (33%), Gaps = 27/370 (7%)

Query: 261 LPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLK 320
           + E  Q  +      +  +     +        +++ LDLSGN  S      +    +L+
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 321 VLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGM 380
           +LN S+N L     D + +   L  LD + N +  +L        +  +  A N I    
Sbjct: 62  LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-ELLV---GPSIETLHAANNNISR-- 113

Query: 381 NGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVG-PIPVAIGDL 439
                 S S  +  + + L++N+ +       G  S +Q L+L  N +            
Sbjct: 114 -----VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168

Query: 440 KALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNN 499
             L  L+L  N++   +  ++     LK L L  N LA  +    ++ + +  + L  N 
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225

Query: 500 LTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFN 559
           L   I  A+    NL++ DL  N    G  +      +     ++   ++ +L       
Sbjct: 226 LVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFF-SKNQRVQTVAKQTVK-KLTGQNEEE 282

Query: 560 TISPSSVLGNPSLCGSAVNKSCPAVLPK------PIVLNPNSSSDSTTSSVAPNPRHKRI 613
              P ++    + C   +       L         ++    S ++          R + I
Sbjct: 283 CTVP-TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREI 341

Query: 614 ILSISAIIAI 623
                    +
Sbjct: 342 DALKEQYRTV 351

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 62.9 bits (153), Expect = 3e-10
 Identities = 23/101 (22%), Positives = 46/101 (45%), Gaps = 3/101 (2%)

Query: 455 SIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNL 514
           +I          K  ++  + L   + +  ++  ++  L LS N L+      +A  T L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 515 QNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAG 555
           + ++LS N L       L +L  L + ++++N++Q EL  G
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVG 98

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 49.5 bits (118), Expect = 4e-06
 Identities = 18/154 (11%), Positives = 42/154 (27%), Gaps = 4/154 (2%)

Query: 81  LTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSI 140
            T+   ++    G+   +          +       +P   +L  L+  + +  S  GS 
Sbjct: 265 QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSE 324

Query: 141 PDEF---FKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLS 197
            +      +     R I   K ++   I           T+          +  G    +
Sbjct: 325 TERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHA 384

Query: 198 ALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKN 231
            L        + + E+    E    L+++     
Sbjct: 385 ELDGTLQ-QAVGQIELQHATEEQSPLQLLRAIVK 417

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  171 bits (435), Expect = 4e-46
 Identities = 100/452 (22%), Positives = 174/452 (38%), Gaps = 67/452 (14%)

Query: 97  LQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISL 156
              +   +L L++  L+ S+      L++L     S NSL+  +P+       SL V + 
Sbjct: 68  CLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQ-SLKSLLVDNN 121

Query: 157 AKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKG 216
                S        L   L  + +S+N+    LP  +   S L+ +D+ +N L+ ++P  
Sbjct: 122 NLKALS-------DLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLK-KLP-- 169

Query: 217 VESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNL 276
            +   +L  I    N     +P+ + +   L  I    NS    LP+    L     +  
Sbjct: 170 -DLPPSLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLSLE---SIVA 222

Query: 277 RKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDS 336
             N+   E+P+ +  L  L T+    N     +P    +L+ L V +   N LT  LP+ 
Sbjct: 223 GNNILE-ELPE-LQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRD---NYLT-DLPEL 275

Query: 337 MANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQF 396
             +   L  LD S+N  +G L +      L  ++ + N+IR        S      SL+ 
Sbjct: 276 PQS---LTFLDVSENIFSG-LSELP--PNLYYLNASSNEIR--------SLCDLPPSLEE 321

Query: 397 LDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSI 456
           L++S+N+   E PA       L+ L  S N L   +P    +LK    L +  N L    
Sbjct: 322 LNVSNNKLI-ELPALPP---RLERLIASFNHLAE-VPELPQNLK---QLHVEYNPLR-EF 372

Query: 457 PPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQN 516
           P       S+++LR+  +    ++P   +N   L  L +  N L    P     + +L  
Sbjct: 373 PDIPE---SVEDLRMNSHL--AEVPELPQN---LKQLHVETNPLRE-FPDIPESVEDL-- 421

Query: 517 VDLSFNSLTGGLPKQLVNLVHLSSFNISHNHL 548
             ++   +             L      H+H 
Sbjct: 422 -RMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  169 bits (431), Expect = 1e-45
 Identities = 97/483 (20%), Positives = 169/483 (34%), Gaps = 81/483 (16%)

Query: 80  ELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKL-------------QNL 126
           E   +  +LT  +      ++   +   + +    +  P   +              +  
Sbjct: 15  EPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQA 73

Query: 127 RVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFS 186
             ++L+   LS S+P+        L  +  + N  + ++P       +L   N +    S
Sbjct: 74  HELELNNLGLS-SLPEL----PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS 127

Query: 187 SPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSL 246
              PL       L  L +S+N LE ++P+ +++   L++I++  N     +PD   S   
Sbjct: 128 DLPPL-------LEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPS--- 174

Query: 247 LRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFS 306
           L  I    N     LPE      L        N    ++P       SLE++    N   
Sbjct: 175 LEFIAAGNNQLE-ELPELQNLPFLTAI-YADNNSLK-KLP---DLPLSLESIVAGNNILE 228

Query: 307 GAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGL 366
                 + NL  L  +    N L  +LPD      +L AL+   N +  DLP+      L
Sbjct: 229 --ELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYLT-DLPELP--QSL 279

Query: 367 NKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRN 426
             +  +EN        P         +L +L+ S NE      +       L+ LN+S N
Sbjct: 280 TFLDVSENIFSGLSELP--------PNLYYLNASSNEIR----SLCDLPPSLEELNVSNN 327

Query: 427 SLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIEN 486
            L+  +P     L+    L  S N L   +P       +LK+L +E N L  + P   E+
Sbjct: 328 KLIE-LPALPPRLE---RLIASFNHLA-EVPELPQ---NLKQLHVEYNPLR-EFPDIPES 378

Query: 487 CSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHN 546
                   L  N+    +P     L  L    +  N L    P    ++  L    ++  
Sbjct: 379 VED-----LRMNSHLAEVPELPQNLKQL---HVETNPLR-EFPDIPESVEDL---RMNSE 426

Query: 547 HLQ 549
            + 
Sbjct: 427 RVV 429

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  167 bits (426), Expect = 6e-45
 Identities = 96/469 (20%), Positives = 163/469 (34%), Gaps = 76/469 (16%)

Query: 97  LQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQ--------- 147
           +   FL++    S+NLT  +      +++      + +    + P    +Q         
Sbjct: 8   VSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLR 66

Query: 148 ---CGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDL 204
                    + L     S  +P        L ++  S N  +  LP     L +L   + 
Sbjct: 67  DCLDRQAHELELNNLGLS-SLPELP---PHLESLVASCNSLTE-LPELPQSLKSLLVDNN 121

Query: 205 SDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPET 264
           +   L    P        L  + +S N     +P+ + + S L+ ID   NS    LP+ 
Sbjct: 122 NLKALSDLPP-------LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDL 171

Query: 265 MQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNF 324
              L    F+    N    E+P+ +  L  L  +    N     +P    +L+ +   N 
Sbjct: 172 PPSLE---FIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLPLSLESIVAGN- 224

Query: 325 SANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPF 384
             N L       + N   L  +    N +   LP       L  ++  +N + +      
Sbjct: 225 --NILE--ELPELQNLPFLTTIYADNNLLK-TLPDLP--PSLEALNVRDNYLTDLP---- 273

Query: 385 ASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNV 444
                  +SL FLD+S N FSG +         L  LN S N +   +        +L  
Sbjct: 274 ----ELPQSLTFLDVSENIFSGLSE----LPPNLYYLNASSNEIRS-LC---DLPPSLEE 321

Query: 445 LDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPI 504
           L++S N L   +P        L+ L    N LA ++P   +N   L  L +  N L    
Sbjct: 322 LNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLRE-F 372

Query: 505 PIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELP 553
           P     + +L+      NS    +P+   NL  L   ++  N L+ E P
Sbjct: 373 PDIPESVEDLR-----MNSHLAEVPELPQNLKQL---HVETNPLR-EFP 412

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  145 bits (369), Expect = 2e-37
 Identities = 74/422 (17%), Positives = 144/422 (34%), Gaps = 63/422 (14%)

Query: 80  ELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGS 139
            L  +  SLT  +      L+ L   + +   L+            L  + +S N L   
Sbjct: 95  SLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-K 145

Query: 140 IPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSAL 199
           +P+   +    L++I +  N    K+P       +L  I   +N+      L    L  L
Sbjct: 146 LPE--LQNSSFLKIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQLEELPELQ--NLPFL 197

Query: 200 RTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSG 259
             +   +N L+ ++P   +   +L  I    N+    +P+ + +   L TI    N    
Sbjct: 198 TAIYADNNSLK-KLP---DLPLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLK- 250

Query: 260 NLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRL 319
            LP+    L   N  +        ++P+    L  L+  +   +           NL  L
Sbjct: 251 TLPDLPPSLEALNVRDNYLT----DLPELPQSLTFLDVSENIFSGL----SELPPNLYYL 302

Query: 320 KVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREG 379
              +   N +  SL D   +   L  L+ S N +  +LP       L ++  + N +   
Sbjct: 303 NASS---NEIR-SLCDLPPS---LEELNVSNNKLI-ELPALP--PRLERLIASFNHLA-- 350

Query: 380 MNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDL 439
                       ++L+ L + +N    E P    ++  L++ +         +P    +L
Sbjct: 351 ------EVPELPQNLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAE-----VPELPQNL 398

Query: 440 KALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNN 499
           K    L +  N L    P       S+++LR+    +      + E    L   +   ++
Sbjct: 399 K---QLHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHH 451

Query: 500 LT 501
             
Sbjct: 452 HH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  143 bits (364), Expect = 7e-37
 Identities = 81/402 (20%), Positives = 133/402 (33%), Gaps = 65/402 (16%)

Query: 166 PSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESL----- 220
           P ++S    L      S+  +  +P+    + +      + +  E   P G         
Sbjct: 5   PRNVSNT-FLQEPLRHSSNLTE-MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62

Query: 221 --------KNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCN 272
                   +    + L+    S S+P+       L ++  S NS +  LPE  Q L    
Sbjct: 63  SRLRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLL 117

Query: 273 FMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGS 332
             N      S            LE L +S N+    +P  + N   LK+++   N L   
Sbjct: 118 VDNNNLKALS-------DLPPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-K 167

Query: 333 LPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFE 392
           LPD      +L  +    N +  +LP+      L  +    N ++               
Sbjct: 168 LPDLPP---SLEFIAAGNNQLE-ELPELQNLPFLTAIYADNNSLK--------KLPDLPL 215

Query: 393 SLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWL 452
           SL+ +   +N         +  L  L  +    N L   +P     L+ALNV D      
Sbjct: 216 SLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLT-- 270

Query: 453 NGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLT 512
              +P       SL  L +  N  +  +     N   L  L  S N +   +        
Sbjct: 271 --DLPELPQ---SLTFLDVSENIFS-GLSELPPN---LYYLNASSNEIRS-LC---DLPP 317

Query: 513 NLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPA 554
           +L+ +++S N L   LP     L  L     S NHL  E+P 
Sbjct: 318 SLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPE 354

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 55.8 bits (135), Expect = 4e-08
 Identities = 22/111 (19%), Positives = 35/111 (31%), Gaps = 19/111 (17%)

Query: 456 IPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKL---- 511
           I P       L+E     + L  ++P   EN  S      + +      P    +     
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 512 ---------TNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELP 553
                         ++L+   L+  LP+   +L  L     S N L  ELP
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELP 107

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  164 bits (417), Expect = 3e-45
 Identities = 57/203 (28%), Positives = 102/203 (50%), Gaps = 22/203 (10%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
            +GRG FG V +   R  + VAIK++   S    ++ F  E+++L +V HPN+V L G  
Sbjct: 15  VVGRGAFGVVCKAKWR-AKDVAIKQIESESE---RKAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN---IIH 813
               +  L+ E+  GGSL+  LH      + +     +     ++ +A+LH      +IH
Sbjct: 71  -LNPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128

Query: 814 YNIKSSNVLIDGSGE-PKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVK 869
            ++K  N+L+   G   K+ D+G A          + + + +  G   +MAPE       
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC--------DIQTHMTNNKGSAAWMAPEV-FEGSN 179

Query: 870 ITDKCDVYGFGVLVLEVVTGKRP 892
            ++KCDV+ +G+++ EV+T ++P
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKP 202

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  160 bits (408), Expect = 3e-44
 Identities = 54/211 (25%), Positives = 106/211 (50%), Gaps = 24/211 (11%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTV------SSLVKSQEDFEREVKKLGKVRHPNL 749
           ++G+GGFG V++  +++D   VAIK L +      + +++  ++F+REV  +  + HPN+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85

Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
           V L G         ++ EFV  G L+  L      + + W+ +  ++   A  + ++   
Sbjct: 86  VKLYGLMHNPPR--MVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALGIEYMQNQ 141

Query: 810 N--IIHYNIKSSNVLIDGSGE-----PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           N  I+H +++S N+ +    E      KV D+GL++       + +S  + +   +MAPE
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGN-FQWMAPE 196

Query: 863 -FACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
                    T+K D Y F +++  ++TG+ P
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGP 227

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  160 bits (407), Expect = 4e-44
 Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 14/202 (6%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGY 755
            +G G FG VY+        VA+K L V++    Q + F+ EV  L K RH N++   GY
Sbjct: 31  RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
             T     ++ ++  G SL+ HLH  +        +  ++ + TA+ + +LH  +IIH +
Sbjct: 89  -STAPQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHAKSIIHRD 145

Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACR--TVKI 870
           +KS+N+ +      K+GD+GLA       R+  S + +   G   +MAPE      +   
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATE---KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202

Query: 871 TDKCDVYGFGVLVLEVVTGKRP 892
           + + DVY FG+++ E++TG+ P
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLP 224

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  158 bits (402), Expect = 3e-43
 Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 17/216 (7%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
            LG+G FG   +   R+ G  + +K+L +    ++Q  F +EVK +  + HPN++   G 
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKEL-IRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
            +       I E++ GG+L   +   S  +   W++R +  +  A  +A+LH  NIIH +
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIK--SMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRD 133

Query: 816 IKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALG---------YMAPEF 863
           + S N L+  +    V D+GLARL+         + S K               +MAPE 
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE- 192

Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM 899
                   +K DV+ FG+++ E++        +   
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR 228

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  158 bits (402), Expect = 5e-43
 Identities = 51/209 (24%), Positives = 88/209 (42%), Gaps = 19/209 (9%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGY 755
            +G+G FG VY         VAI+ + +    + Q + F+REV    + RH N+V   G 
Sbjct: 40  LIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97

Query: 756 YWTQSLQL-LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
                  L +I     G +L+  +        L  N+   + Q   K + +LH   I+H 
Sbjct: 98  -CMSPPHLAIITSLCKGRTLYSVVR--DAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHK 154

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE--------F 863
           ++KS NV  D +G+  + D+GL  +  +L       K++   G   ++APE         
Sbjct: 155 DLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213

Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
               +  +   DV+  G +  E+   + P
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHAREWP 242

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  157 bits (398), Expect = 5e-43
 Identities = 66/227 (29%), Positives = 105/227 (46%), Gaps = 33/227 (14%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSS---LVKSQEDFEREVKKLGKVRHPNLVTLE 753
            +G GGFG VYR     G  VA+K         + ++ E+  +E K    ++HPN++ L 
Sbjct: 14  IIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN--- 810
           G    +    L+ EF  GG L++ L     G  +  +   N     A+ + +LH      
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVP 128

Query: 811 IIHYNIKSSNVLIDGSGEP--------KVGDYGLARLLPMLDRYVLSSKIQSALG---YM 859
           IIH ++KSSN+LI    E         K+ D+GLAR           +   SA G   +M
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE-------WHRTTKMSAAGAYAWM 181

Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW 906
           APE   R    +   DV+ +GVL+ E++TG+ P   ++ +   +V +
Sbjct: 182 APE-VIRASMFSKGSDVWSYGVLLWELLTGEVP---FRGIDGLAVAY 224

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  156 bits (397), Expect = 6e-43
 Identities = 42/203 (20%), Positives = 81/203 (39%), Gaps = 16/203 (7%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +L     G +++   + G  + +K L V     +   DF  E  +L    HPN++ + G 
Sbjct: 17  KLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 756 YWTQSLQLL--IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN--I 811
             +        I  ++  GSL+  LHEG+    +  ++        A+ +A LH     I
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFLHTLEPLI 134

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF--ACRTVK 869
             + + S +V+ID     ++    +              ++ +   ++APE         
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYA-PAWVAPEALQKKPEDT 187

Query: 870 ITDKCDVYGFGVLVLEVVTGKRP 892
                D++ F VL+ E+VT + P
Sbjct: 188 NRRSADMWSFAVLLWELVTREVP 210

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  159 bits (404), Expect = 1e-42
 Identities = 75/445 (16%), Positives = 147/445 (33%), Gaps = 76/445 (17%)

Query: 92  IGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSL 151
           I   L        + +               L N +++    +++   +P         +
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71

Query: 152 RVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGI-WGLSALRTLDLSDNLLE 210
            +++L   +       + +   T+  + +  N     LP  +   +  L  L L  N L 
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS 130

Query: 211 GEIPKGV-ESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLS 269
             +P+G+  +   L  +++S N                                      
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNN-------------------------------------- 151

Query: 270 LCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRL 329
             N   +  + F            SL+ L LS N+ +    + +  +  L   N S N L
Sbjct: 152 --NLERIEDDTFQA--------TTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLL 198

Query: 330 TGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGS 389
           +     ++A  + +  LD S NS+N  +   +    L  +    N + +       +   
Sbjct: 199 S-----TLAIPIAVEELDASHNSIN-VVRGPVNVE-LTILKLQHNNLTD------TAWLL 245

Query: 390 SFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSE 449
           ++  L  +DLS+NE           +  L+ L +S N LV  + +    +  L VLDLS 
Sbjct: 246 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSH 304

Query: 450 NWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIA 509
           N L   +         L+ L L+ N +   +   +    +L +L LS N+       A+ 
Sbjct: 305 NHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL- 359

Query: 510 KLTNLQNVDLSFNSLTGGLPKQLVN 534
              N+    +        +  QL +
Sbjct: 360 -FRNVARPAVDDADQHCKIDYQLEH 383

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  156 bits (396), Expect = 2e-41
 Identities = 72/412 (17%), Positives = 135/412 (32%), Gaps = 52/412 (12%)

Query: 165 IPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGV-ESLKNL 223
           I S+L        +++               L+  + +   ++ +  ++P  + +S + +
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71

Query: 224 RVINLSKNMFSGSIPDGI-GSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFS 282
            ++NL+       I          ++ +    N+                   L  ++F 
Sbjct: 72  ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR----------------YLPPHVFQ 114

Query: 283 GEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMN 342
                    +  L  L L  N  S        N  +L  L+ S N L     D+     +
Sbjct: 115 N--------VPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS 166

Query: 343 LVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHN 402
           L  L  S N +   +   +  S L   + + N +         S+ +   +++ LD SHN
Sbjct: 167 LQNLQLSSNRLT-HVDLSLIPS-LFHANVSYNLL---------STLAIPIAVEELDASHN 215

Query: 403 EFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEI-G 461
             +            L +L L  N+L       + +   L  +DLS N L   I      
Sbjct: 216 SINVVRG---PVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFV 269

Query: 462 GAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSF 521
               L+ L +  N L   +    +   +L  L LS N+L   +     +   L+N+ L  
Sbjct: 270 KMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDH 327

Query: 522 NSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLC 573
           NS+          L +L    +SHN           F  ++  +V      C
Sbjct: 328 NSIVTLKLSTHHTLKNL---TLSHNDWD-CNSLRALFRNVARPAVDDADQHC 375

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  125 bits (316), Expect = 4e-31
 Identities = 61/307 (19%), Positives = 114/307 (37%), Gaps = 36/307 (11%)

Query: 80  ELTLNGLSLTGRIGRGLLQ-LQFLRKLSLSSNNLTGSISPN-LAKLQNLRVIDLSGNSLS 137
            L LN L +   I          ++KL +  N +   + P+    +  L V+ L  N LS
Sbjct: 73  LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130

Query: 138 GSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLS 197
            S+P   F     L  +S++ N        +    ++L  + LSSNR +  + L    + 
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VDLS--LIP 186

Query: 198 ALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSF 257
           +L   ++S NLL       +     +  ++ S N  +  +   +     L  +    N+ 
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL 238

Query: 258 S-----GNLPETMQKLSLCN--FMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVP 310
           +      N P  + ++ L       +  + F          ++ LE L +S N+   A+ 
Sbjct: 239 TDTAWLLNYPG-LVEVDLSYNELEKIMYHPFVK--------MQRLERLYISNNRLV-ALN 288

Query: 311 ISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVS 370
           +    +  LKVL+ S N L   +  +      L  L    NS+   L      + L  ++
Sbjct: 289 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHT-LKNLT 345

Query: 371 FAENKIR 377
            + N   
Sbjct: 346 LSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  124 bits (313), Expect = 1e-30
 Identities = 66/327 (20%), Positives = 119/327 (36%), Gaps = 28/327 (8%)

Query: 236 SIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCN--FMNLRKNLFSGEVPKWI-GEL 292
            I   +    +    D   +  + ++    + ++L N   +  + +    ++P  +    
Sbjct: 12  CIDSNLQYDCVFY--DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSF 68

Query: 293 ESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNS 352
             +E L+L+  +       +      ++ L    N +    P    N   L  L   +N 
Sbjct: 69  RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 128

Query: 353 MNGDLPQWIFS--SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPA 410
           ++  LP+ IF     L  +S + N +    +  F     +  SLQ L LS N     T  
Sbjct: 129 LS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTF----QATTSLQNLQLSSNRL---THV 180

Query: 411 TIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELR 470
            +  +  L   N+S N L       +    A+  LD S N +N  +   +     L  L+
Sbjct: 181 DLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILK 232

Query: 471 LERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPK 530
           L+ N L       + N   LV + LS N L   +     K+  L+ + +S N L   L  
Sbjct: 233 LQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNL 289

Query: 531 QLVNLVHLSSFNISHNHLQGELPAGGF 557
               +  L   ++SHNHL   +     
Sbjct: 290 YGQPIPTLKVLDLSHNHLL-HVERNQP 315

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  156 bits (397), Expect = 3e-42
 Identities = 53/240 (22%), Positives = 96/240 (40%), Gaps = 33/240 (13%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY-- 755
           +GRG +GAVY+  L   RPVA+K  + ++  +     E+ + ++  + H N+        
Sbjct: 21  IGRGRYGAVYKGSLD-ERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDE 77

Query: 756 --YWTQSLQL-LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS--- 809
                  ++  L+ E+   GSL K+L      +   W     +     + LA+LH     
Sbjct: 78  RVTADGRMEYLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPR 133

Query: 810 ------NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA------LG 857
                  I H ++ S NVL+   G   + D+GL+  L          +  +A      + 
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIR 193

Query: 858 YMAPEFACRTVKITD------KCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHW 911
           YMAPE     V + D      + D+Y  G++  E+      L   + +  + + +  E  
Sbjct: 194 YMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVG 253

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  158 bits (400), Expect = 1e-40
 Identities = 75/447 (16%), Positives = 148/447 (33%), Gaps = 76/447 (17%)

Query: 92  IGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSL 151
           I   L        + +               L N +++    +++   +P         +
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77

Query: 152 RVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGI-WGLSALRTLDLSDNLLE 210
            +++L   +       + +   T+  + +  N     LP  +   +  L  L L  N L 
Sbjct: 78  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLS 136

Query: 211 GEIPKGV-ESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLS 269
             +P+G+  +   L  +++S N                                      
Sbjct: 137 -SLPRGIFHNTPKLTTLSMSNN-------------------------------------- 157

Query: 270 LCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRL 329
             N   +  + F            SL+ L LS N+ +    + +  +  L   N S N L
Sbjct: 158 --NLERIEDDTFQA--------TTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLL 204

Query: 330 TGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGS 389
           +     ++A  + +  LD S NS+N  +   +    L  +    N + +       +   
Sbjct: 205 S-----TLAIPIAVEELDASHNSIN-VVRGPVNVE-LTILKLQHNNLTD------TAWLL 251

Query: 390 SFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSE 449
           ++  L  +DLS+NE           +  L+ L +S N LV  + +    +  L VLDLS 
Sbjct: 252 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSH 310

Query: 450 NWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIA 509
           N L   +         L+ L L+ N +   +   +    +L +L LS N+       A+ 
Sbjct: 311 NHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL- 365

Query: 510 KLTNLQNVDLSFNSLTGGLPKQLVNLV 536
              N+    +        +  QL + +
Sbjct: 366 -FRNVARPAVDDADQHCKIDYQLEHGL 391

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  155 bits (393), Expect = 8e-40
 Identities = 74/413 (17%), Positives = 139/413 (33%), Gaps = 54/413 (13%)

Query: 165 IPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGV-ESLKNL 223
           I S+L        +++               L+  + +   ++ +  ++P  + +S + +
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77

Query: 224 RVINLSKNMFSGSIPDGI-GSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFS 282
            ++NL+       I          ++ +    N+                   L  ++F 
Sbjct: 78  ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR----------------YLPPHVFQ 120

Query: 283 GEVPKWIGELESLETLDLSGNKFSGAVPISI-GNLQRLKVLNFSANRLTGSLPDSMANCM 341
                    +  L  L L  N  S ++P  I  N  +L  L+ S N L     D+     
Sbjct: 121 N--------VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATT 171

Query: 342 NLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSH 401
           +L  L  S N +   +   +  S L   + + N +         S+ +   +++ LD SH
Sbjct: 172 SLQNLQLSSNRLT-HVDLSLIPS-LFHANVSYNLL---------STLAIPIAVEELDASH 220

Query: 402 NEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEI- 460
           N  +            L +L L  N+L       + +   L  +DLS N L   I     
Sbjct: 221 NSINVVRG---PVNVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPF 274

Query: 461 GGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLS 520
                L+ L +  N L   +    +   +L  L LS N+L   +     +   L+N+ L 
Sbjct: 275 VKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLD 332

Query: 521 FNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLC 573
            NS+          L +L    +SHN           F  ++  +V      C
Sbjct: 333 HNSIVTLKLSTHHTLKNL---TLSHNDWD-CNSLRALFRNVARPAVDDADQHC 381

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 94.6 bits (235), Expect = 4e-20
 Identities = 57/342 (16%), Positives = 103/342 (30%), Gaps = 55/342 (16%)

Query: 102 LRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRF 161
           L   ++S N L+      LA    +  +D S NS++  +          L ++ L  N  
Sbjct: 194 LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNV---ELTILKLQHNNL 244

Query: 162 SGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLK 221
           +    + L     L  ++LS N     +      +  L  L +S+N L   +    + + 
Sbjct: 245 TD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 301

Query: 222 NLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLF 281
            L+V++LS N     +         L  +    NS    L                    
Sbjct: 302 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK------------------- 340

Query: 282 SGEVPKWIGELESLETLDLSGNKFSGAVPISI-GNLQRLKVLNFSANRLTGSLPDSMANC 340
                  +    +L+ L LS N +      ++  N+ R  V +   +       +    C
Sbjct: 341 -------LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCC 393

Query: 341 MN---------LVALDFSQNSMNGDLPQWIFSSG--LNKVSFAENKIREGMNGPFASSGS 389
                      L  +  +         Q   S+   +N V    + I +    P   +  
Sbjct: 394 KESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQ 453

Query: 390 SFESLQFLDLSHNEFSGETPATIGALSGLQLL---NLSRNSL 428
               +  L     + + E       L GL      NL R  L
Sbjct: 454 LEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRL 495

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 57.6 bits (139), Expect = 1e-08
 Identities = 26/147 (17%), Positives = 52/147 (35%), Gaps = 4/147 (2%)

Query: 415 LSGLQLLN-LSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLER 473
           + G Q  N   R      I   +        + +     +     E     + K +  + 
Sbjct: 1   VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN 60

Query: 474 NFLAGKIPTSI-ENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQL 532
           + +  K+P ++ ++   +  L L+   +      A A    +Q + + FN++    P   
Sbjct: 61  STMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVF 119

Query: 533 VNLVHLSSFNISHNHLQGELPAGGFFN 559
            N+  L+   +  N L   LP G F N
Sbjct: 120 QNVPLLTVLVLERNDLS-SLPRGIFHN 145

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  144 bits (364), Expect = 3e-38
 Identities = 51/214 (23%), Positives = 83/214 (38%), Gaps = 26/214 (12%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           +G+G +G V+R   + G  VA+K    SS  +     E E+     +RH N++       
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIF--SSRDEKSWFRETELYNTVMLRHENILGFIASDM 72

Query: 758 TQSLQ----LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH------ 807
           T         LI  +   GSL+ +L        L       ++   A  LAHLH      
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGT 128

Query: 808 --QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA--LGYMAPE- 862
             +  I H ++KS N+L+  +G+  + D GLA +       +            YMAPE 
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188

Query: 863 ----FACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
                         + D++ FG+++ EV      
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS 222

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  145 bits (367), Expect = 3e-38
 Identities = 50/214 (23%), Positives = 85/214 (39%), Gaps = 26/214 (12%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           +G+G FG V+R   R G  VA+K    SS  +     E E+ +   +RH N++       
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIF--SSREERSWFREAEIYQTVMLRHENILGFIAADN 106

Query: 758 TQSLQ----LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS---- 809
             +       L+ ++   GSL  +L+       ++      +   TA  LAHLH      
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGT 162

Query: 810 ----NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA--LGYMAPEF 863
                I H ++KS N+L+  +G   + D GLA         +  +         YMAPE 
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222

Query: 864 ACRTVKITD-----KCDVYGFGVLVLEVVTGKRP 892
              ++ +       + D+Y  G++  E+      
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  143 bits (363), Expect = 6e-38
 Identities = 60/333 (18%), Positives = 121/333 (36%), Gaps = 25/333 (7%)

Query: 97  LQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISL 156
                 +   ++ ++L  +++       N++ +DLSGN LS  I          L +++L
Sbjct: 7   QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNL 65

Query: 157 AKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKG 216
           + N         L   STL T++L++N         +    ++ TL  ++N +   +   
Sbjct: 66  SSNVLYE--TLDLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNIS-RVSC- 116

Query: 217 VESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSG-NLPETMQKLSLCNFMN 275
               +  + I L+ N  +       G  S ++ +D   N     N  E          +N
Sbjct: 117 -SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175

Query: 276 LRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPD 335
           L+ N    +V   +     L+TLDLS NK +  +     +   +  ++   N+L   +  
Sbjct: 176 LQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK 231

Query: 336 SMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQ 395
           ++    NL   D   N  +    +  FS      + A+  +++        +G + E   
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKK-------LTGQNEEECT 284

Query: 396 FLDLSHNEFSGETPATIGALSGLQLLNLSRNSL 428
              L H          + A    +L+ L  +  
Sbjct: 285 VPTLGHYGAY--CCEDLPAPFADRLIALGHHHH 315

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  143 bits (362), Expect = 9e-38
 Identities = 59/314 (18%), Positives = 112/314 (35%), Gaps = 20/314 (6%)

Query: 261 LPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLK 320
           + E  Q  +      +  +     +        +++ LDLSGN  S      +    +L+
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 321 VLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGM 380
           +LN S+N L     D + +   L  LD + N +  +L        +  +  A N I    
Sbjct: 62  LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-ELLV---GPSIETLHAANNNISR-- 113

Query: 381 NGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVG-PIPVAIGDL 439
                 S S  +  + + L++N+ +       G  S +Q L+L  N +            
Sbjct: 114 -----VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168

Query: 440 KALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNN 499
             L  L+L  N++   +  ++     LK L L  N LA  +    ++ + +  + L  N 
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225

Query: 500 LTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFN 559
           L   I  A+    NL++ DL  N    G  +      +     ++   ++ +L       
Sbjct: 226 LVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVK-KLTGQNEEE 282

Query: 560 TISPSSVLGNPSLC 573
              P+        C
Sbjct: 283 CTVPTLGHYGAYCC 296

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  133 bits (336), Expect = 2e-34
 Identities = 61/407 (14%), Positives = 126/407 (30%), Gaps = 92/407 (22%)

Query: 115 SISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCST 174
           +I          ++  ++ +SL         +   +++ + L+ N  S    + L+  + 
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59

Query: 175 LATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFS 234
           L  +NLSSN     L L    LS LRTLDL++N ++ E+        ++  ++ + N  S
Sbjct: 60  LELLNLSSNVLYETLDLE--SLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNIS 112

Query: 235 GSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELES 294
             +                                                       + 
Sbjct: 113 -RVSCSR--------------------------------------------------GQG 121

Query: 295 LETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTG-SLPDSMANCMNLVALDFSQNSM 353
            + + L+ NK +    +  G   R++ L+   N +   +  +  A+   L  L+   N +
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181

Query: 354 NGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIG 413
             D+   +                             F  L+ LDLS N+ +        
Sbjct: 182 Y-DVKGQVV----------------------------FAKLKTLDLSSNKLA-FMGPEFQ 211

Query: 414 ALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLER 473
           + +G+  ++L  N LV  I  A+   + L   DL  N  +         + + +   + +
Sbjct: 212 SAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAK 269

Query: 474 NFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLS 520
             +      + E C+                     +L  L +    
Sbjct: 270 QTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  115 bits (291), Expect = 2e-28
 Identities = 60/267 (22%), Positives = 104/267 (38%), Gaps = 17/267 (6%)

Query: 80  ELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGS 139
           EL L+G  L+      L     L  L+LSSN L    + +L  L  LR +DL+ N +   
Sbjct: 38  ELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-E 94

Query: 140 IPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSAL 199
           +         S+  +  A N  S ++    S       I L++N+ +    L     S +
Sbjct: 95  LL-----VGPSIETLHAANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRV 146

Query: 200 RTLDLSDNLLEG-EIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFS 258
           + LDL  N ++     +   S   L  +NL  N     +   +   + L+T+D S N  +
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA 204

Query: 259 GNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFS-GAVPISIGNLQ 317
             +    Q  +   +++LR N     + K +   ++LE  DL GN F  G +       Q
Sbjct: 205 -FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262

Query: 318 RLKVLNFSANRLTGSLPDSMANCMNLV 344
           R++ +     +      +       L 
Sbjct: 263 RVQTVAKQTVKKLTGQNEEECTVPTLG 289

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  105 bits (264), Expect = 7e-25
 Identities = 43/232 (18%), Positives = 76/232 (32%), Gaps = 12/232 (5%)

Query: 96  LLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVIS 155
           LL    +  L  ++NN++  +S +    Q  + I L+ N ++  + D        ++ + 
Sbjct: 95  LLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKIT-MLRDLDEGCRSRVQYLD 150

Query: 156 LAKNRFSG-KIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIP 214
           L  N           +   TL  +NL  N     +   +   + L+TLDLS N L   + 
Sbjct: 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMG 207

Query: 215 KGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFM 274
              +S   +  I+L  N     I   +     L   D   N F                 
Sbjct: 208 PEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF-SKNQRVQ 265

Query: 275 NLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIG-NLQRLKVLNFS 325
            + K     ++     E  ++ TL   G      +P      L  L   +  
Sbjct: 266 TVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 64.6 bits (158), Expect = 3e-11
 Identities = 23/101 (22%), Positives = 46/101 (45%), Gaps = 3/101 (2%)

Query: 455 SIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNL 514
           +I          K  ++  + L   + +  ++  ++  L LS N L+      +A  T L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 515 QNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAG 555
           + ++LS N L       L +L  L + ++++N++Q EL  G
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVG 98

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  142 bits (359), Expect = 3e-37
 Identities = 52/218 (23%), Positives = 82/218 (37%), Gaps = 32/218 (14%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG-- 754
           ++G+G +G V+    R G  VA+K     +  ++    E E+ +   +RH N++      
Sbjct: 44  QIGKGRYGEVWMGKWR-GEKVAVKVF--FTTEEASWFRETEIYQTVLMRHENILGFIAAD 100

Query: 755 ----YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
                 WTQ    LI ++   GSL+ +L        L       +   +   L HLH   
Sbjct: 101 IKGTGSWTQ--LYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 811 --------IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA--LGYMA 860
                   I H ++KS N+L+  +G   + D GLA         V            YM 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 861 PEFACRTVKITD-----KCDVYGFGVLVL-EVVTGKRP 892
           PE    ++           D+Y FG L+L EV      
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFG-LILWEVARRCVS 251

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  147 bits (372), Expect = 5e-37
 Identities = 83/384 (21%), Positives = 139/384 (36%), Gaps = 73/384 (19%)

Query: 171 LCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSK 230
           L +  A +N+  +  ++ LP  +   + + TL + DN L   +P        LR + +S 
Sbjct: 38  LNNGNAVLNVGESGLTT-LPDCL--PAHITTLVIPDNNLT-SLP---ALPPELRTLEVSG 90

Query: 231 NMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIG 290
           N  + S+P        L             LP  + KL       +  N  +  +P    
Sbjct: 91  NQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKL------WIFGNQLT-SLPV--- 138

Query: 291 ELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQ 350
               L+ L +S N+ + ++P     L +L   N   N+LT SLP   +    L  L  S 
Sbjct: 139 LPPGLQELSVSDNQLA-SLPALPSELCKLWAYN---NQLT-SLPMLPSG---LQELSVSD 190

Query: 351 NSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPA 410
           N +   LP                              +    L  L   +N  +   PA
Sbjct: 191 NQLA-SLP------------------------------TLPSELYKLWAYNNRLT-SLPA 218

Query: 411 TIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELR 470
                 GL+ L +S N L   +PV   +LK    L +S N L  S+P        L  L 
Sbjct: 219 LPS---GLKELIVSGNRLTS-LPVLPSELK---ELMVSGNRLT-SLPMLPS---GLLSLS 267

Query: 471 LERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPK 530
           + RN L  ++P S+ + SS  ++ L  N L+     A+ ++T+                 
Sbjct: 268 VYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGAS 326

Query: 531 --QLVNLVHLSSFNISHNHLQGEL 552
             +    +HL++ +      +GE 
Sbjct: 327 APRETRALHLAAADWLVPAREGEP 350

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  121 bits (305), Expect = 1e-28
 Identities = 62/297 (20%), Positives = 110/297 (37%), Gaps = 53/297 (17%)

Query: 70  KCSPRSNRVIELTLNGL-SLTGRIGRGLLQLQF--------------LRKLSLSSNNLTG 114
            C    N V+ +  +GL +L   +   +  L                LR L +S N LT 
Sbjct: 36  ACLNNGNAVLNVGESGLTTLPDCLPAHITTLVIPDNNLTSLPALPPELRTLEVSGNQLT- 94

Query: 115 SISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCST 174
           S+      L  L +       L              L  + +  N+ +  +P        
Sbjct: 95  SLPVLPPGLLELSIFSNPLTHLPALPS--------GLCKLWIFGNQLT-SLPVLP---PG 142

Query: 175 LATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFS 234
           L  +++S N+ +S LP      S L  L   +N L   +P        L+ +++S N  +
Sbjct: 143 LQELSVSDNQLAS-LPALP---SELCKLWAYNNQLT-SLP---MLPSGLQELSVSDNQLA 194

Query: 235 GSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELES 294
            S+P        L  +    N  + +LP     L     + +  N  +  +P    EL+ 
Sbjct: 195 -SLPTLPSE---LYKLWAYNNRLT-SLPALPSGLK---ELIVSGNRLT-SLPVLPSELKE 245

Query: 295 LETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQN 351
              L +SGN+ + ++P+    L  L V     N+LT  LP+S+ +  +   ++   N
Sbjct: 246 ---LMVSGNRLT-SLPMLPSGLLSLSVYR---NQLT-RLPESLIHLSSETTVNLEGN 294

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  107 bits (269), Expect = 3e-24
 Identities = 61/327 (18%), Positives = 113/327 (34%), Gaps = 56/327 (17%)

Query: 80  ELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGS 139
            L ++G  LT  +      L  L   S    +L    S        L  + + GN L+ S
Sbjct: 85  TLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-S 135

Query: 140 IPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSAL 199
           +P         L+ +S++ N+ +  +P+  S    L      +N+ +S LP+     S L
Sbjct: 136 LPVLP----PGLQELSVSDNQLA-SLPALPSELCKL---WAYNNQLTS-LPMLP---SGL 183

Query: 200 RTLDLSDNLLEGEIPKGVESLK-----------------NLRVINLSKNMFSGSIPDGIG 242
           + L +SDN L   +P     L                   L+ + +S N  + S+P    
Sbjct: 184 QELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLT-SLPVLPS 241

Query: 243 SCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSG 302
               L+ +  S N  + +LP     L     +++ +N  +  +P+ +  L S  T++L G
Sbjct: 242 E---LKELMVSGNRLT-SLPMLPSGLL---SLSVYRNQLT-RLPESLIHLSSETTVNLEG 293

Query: 303 NKFSGAVPISIGNLQRLKVLN---FSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQ 359
           N  S     ++  +      +      +    S P          A            P 
Sbjct: 294 NPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPA 353

Query: 360 WIFSS-----GLNKVSFAENKIREGMN 381
             +         +  S   +++ E  N
Sbjct: 354 DRWHMFGQEDNADAFSLFLDRLSETEN 380

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 57.6 bits (139), Expect = 1e-08
 Identities = 23/90 (25%), Positives = 38/90 (42%), Gaps = 8/90 (8%)

Query: 465 SLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSL 524
               L +  + L   +P  +   + + +L++  NNLT  +P    +L  L   ++S N L
Sbjct: 41  GNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LPALPPELRTL---EVSGNQL 93

Query: 525 TGGLPKQLVNLVHLSSFNISHNHLQGELPA 554
           T  LP     L+ LS F+    HL      
Sbjct: 94  TS-LPVLPPGLLELSIFSNPLTHLPALPSG 122

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  140 bits (355), Expect = 1e-35
 Identities = 76/386 (19%), Positives = 134/386 (34%), Gaps = 70/386 (18%)

Query: 71  CSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPN-LAKLQNLRVI 129
           CS +   V     +       +  G+      R L L  N +  +++ +  A   +L  +
Sbjct: 9   CSAQDRAV---LCHRKRFV-AVPEGIPT--ETRLLDLGKNRIK-TLNQDEFASFPHLEEL 61

Query: 130 DLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPL 189
           +L+ N +S ++    F    +LR + L  NR                   +    F+   
Sbjct: 62  ELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK----------------LIPLGVFT--- 101

Query: 190 PLGIWGLSALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKNMFSGSIPDGIGSCSLLR 248
                GLS L  LD+S+N +   +   + + L NL+ + +  N     I           
Sbjct: 102 -----GLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHR-------- 146

Query: 249 TIDFSENSFSGNLPETMQKLSL--CNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFS 306
                  +FSG L  ++++L+L  CN  ++     S         L  L  L L     +
Sbjct: 147 -------AFSG-LN-SLEQLTLEKCNLTSIPTEALSH--------LHGLIVLRLRHLNIN 189

Query: 307 GAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFS--S 364
                S   L RLKVL  S      ++  +    +NL +L  +  ++   +P        
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLV 248

Query: 365 GLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLS 424
            L  ++ + N I                 LQ + L   + +   P     L+ L++LN+S
Sbjct: 249 YLRFLNLSYNPISTIEGSML----HELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVS 304

Query: 425 RNSLVGPIPVAIGDLKALNVLDLSEN 450
            N L          +  L  L L  N
Sbjct: 305 GNQLTTLEESVFHSVGNLETLILDSN 330

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  125 bits (316), Expect = 2e-30
 Identities = 73/322 (22%), Positives = 122/322 (37%), Gaps = 24/322 (7%)

Query: 260 NLPETMQKLSL--CNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQ 317
            +P   + L L       L ++ F+            LE L+L+ N  S   P +  NL 
Sbjct: 29  GIPTETRLLDLGKNRIKTLNQDEFAS--------FPHLEELELNENIVSAVEPGAFNNLF 80

Query: 318 RLKVLNFSANRLTGSLPDSM-ANCMNLVALDFSQNSMNGDLPQWIFS--SGLNKVSFAEN 374
            L+ L   +NRL   +P  +     NL  LD S+N +   L  ++F     L  +   +N
Sbjct: 81  NLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDN 138

Query: 375 KIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPV 434
            +    +  F    S   SL+ L L     +      +  L GL +L L   ++      
Sbjct: 139 DLVYISHRAF----SGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDY 194

Query: 435 AIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPT-SIENCSSLVSL 493
           +   L  L VL++S      ++ P      +L  L +    L   +P  ++ +   L  L
Sbjct: 195 SFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFL 253

Query: 494 ILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELP 553
            LS N ++      + +L  LQ + L    L    P     L +L   N+S N L   L 
Sbjct: 254 NLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLE 312

Query: 554 AGGFFNTISPSSVL--GNPSLC 573
              F +  +  +++   NP  C
Sbjct: 313 ESVFHSVGNLETLILDSNPLAC 334

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  102 bits (255), Expect = 7e-23
 Identities = 51/235 (21%), Positives = 95/235 (40%), Gaps = 37/235 (15%)

Query: 77  RVIELTLNGLSLTGRIGRGLLQ-LQFLRKLSLSSNNLTGSISPN-LAKLQNLRVIDLSGN 134
           + +E+  N L     I       L  L +L+L   NLT SI    L+ L  L V+ L   
Sbjct: 131 KSLEVGDNDLV---YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHL 186

Query: 135 SLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIW 194
           +++ +I D  FK+   L+V+ ++   +   +  +      L +++++    ++   L + 
Sbjct: 187 NIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVR 245

Query: 195 GLSALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFS 253
            L  LR L+LS N +   I   +   L  L+ I L                  L  ++  
Sbjct: 246 HLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQ--------------LAVVE-- 288

Query: 254 ENSFSGNLPETMQKLSL--CNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFS 306
             +F G L   ++ L++       L +++F          + +LETL L  N  +
Sbjct: 289 PYAFRG-LNY-LRVLNVSGNQLTTLEESVFHS--------VGNLETLILDSNPLA 333

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  134 bits (338), Expect = 6e-35
 Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 24/218 (11%)

Query: 694 KDCELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVT 751
            D E+GRG F  VY+ +       VA  +L    L KS+ + F+ E + L  ++HPN+V 
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 752 LEGYYWTQSLQ---LLIY-EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH 807
               + +       +++  E ++ G+L  +L        +      +  +   K L  LH
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLH 146

Query: 808 QSN--IIHYNIKSSNVLIDG-SGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAP 861
                IIH ++K  N+ I G +G  K+GD GLA L         +S  ++ +G   +MAP
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-------ASFAKAVIGTPEFMAP 199

Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM 899
           E      K  +  DVY FG+ +LE+ T + P S  +  
Sbjct: 200 EMY--EEKYDESVDVYAFGMCMLEMATSEYPYSECQNA 235

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  136 bits (345), Expect = 2e-34
 Identities = 78/486 (16%), Positives = 149/486 (30%), Gaps = 82/486 (16%)

Query: 102 LRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRF 161
                 ++  +  + + +  +L  L  +D   +S++  +     ++   L  +    N  
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG--IEKLTGLTKLICTSNNI 76

Query: 162 SGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLK 221
           +  +   LS  + L  +   SN+ ++ L +    L+ L  L+   N L  ++   V    
Sbjct: 77  T-TLD--LSQNTNLTYLACDSNKLTN-LDVT--PLTKLTYLNCDTNKLT-KLD--VSQNP 127

Query: 222 NLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLF 281
            L  +N ++N  +  I   +   + L  +D   N     L                    
Sbjct: 128 LLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD------------------- 165

Query: 282 SGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCM 341
                  +     L TLD S NK +    + +   + L  LN   N +T  L   +   +
Sbjct: 166 -------VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNI 212

Query: 342 NLVALDFSQNSMN----GDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFL 397
            L  LD S N +       L Q      L     + N + E          S+   L  L
Sbjct: 213 QLTFLDCSSNKLTEIDVTPLTQ------LTYFDCSVNPLTE-------LDVSTLSKLTTL 259

Query: 398 DLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIP 457
                +        I      QL+            + +     L +LD     +   + 
Sbjct: 260 HCIQTDLL-----EIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD 313

Query: 458 PEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNV 517
             +     L  L L    L  ++   + + + L SL     ++      ++ K+  L N 
Sbjct: 314 --LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNN 366

Query: 518 DLSFNSLT-----GGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSL 572
             +                L   V     +   N +  E   GG ++  + +    N S 
Sbjct: 367 FEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLST 426

Query: 573 CGSAVN 578
              AV 
Sbjct: 427 DNPAVT 432

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  110 bits (277), Expect = 1e-25
 Identities = 66/438 (15%), Positives = 129/438 (29%), Gaps = 91/438 (20%)

Query: 96  LLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVIS 155
           L Q   L  L+  SN LT   + ++  L  L  ++   N L+  +      Q   L  ++
Sbjct: 81  LSQNTNLTYLACDSNKLT---NLDVTPLTKLTYLNCDTNKLT-KLD---VSQNPLLTYLN 133

Query: 156 LAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPK 215
            A+N  + +I   +S  + L  ++   N+  + L +     + L TLD S N +  E+  
Sbjct: 134 CARNTLT-EID--VSHNTQLTELDCHLNKKITKLDVT--PQTQLTTLDCSFNKIT-ELD- 186

Query: 216 GVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMN 275
            V   K L  +N   N  +  +   +     L  +D S N  +  +              
Sbjct: 187 -VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID------------- 228

Query: 276 LRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPD 335
                        +  L  L   D S N  +    + +  L +L  L+     L   +  
Sbjct: 229 -------------VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL-EIDL 271

Query: 336 SMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQ 395
           +  +   L+                     + ++    N                   L 
Sbjct: 272 T--HNTQLIYFQAEGCRK------------IKELDVTHNT-----------------QLY 300

Query: 396 FLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGS 455
            LD         T   +     L  L L+   L   +   +     L  L      +   
Sbjct: 301 LLDCQAAGI---TELDLSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQ-D 353

Query: 456 IPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTG---PIPIAIAKLT 512
               +G   +L                ++ N S  +++     +  G    I      + 
Sbjct: 354 FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVY 412

Query: 513 NLQNVDLSFNSLTGGLPK 530
           +     +++ +L+   P 
Sbjct: 413 DQATNTITWENLSTDNPA 430

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  104 bits (261), Expect = 1e-23
 Identities = 63/365 (17%), Positives = 114/365 (31%), Gaps = 44/365 (12%)

Query: 197 SALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENS 256
               +   +   ++       E L  L  ++   +  +  +  GI   + L  +  + N+
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNN 75

Query: 257 FSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNL 316
            +  L   + + +   ++    N  +  +   +  L  L  L+   NK +    + +   
Sbjct: 76  IT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQN 126

Query: 317 QRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKI 376
             L  LN + N LT  +  S  +   L  LD   N     L     +  L  +  + NKI
Sbjct: 127 PLLTYLNCARNTLT-EIDVS--HNTQLTELDCHLNKKITKLDVTPQTQ-LTTLDCSFNKI 182

Query: 377 REGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAI 436
            E          S  + L  L+   N     T   +     L  L+ S N L   I   +
Sbjct: 183 TE-------LDVSQNKLLNRLNCDTNNI---TKLDLNQNIQLTFLDCSSNKLTE-ID--V 229

Query: 437 GDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIE--NCSSLVSLI 494
             L  L   D S N L   +   +     L  L   +  L       I+  + + L+   
Sbjct: 230 TPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDL-----LEIDLTHNTQLIYFQ 281

Query: 495 LSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPA 554
                    +   +   T L  +D     +T  L   L     L    +++  L  EL  
Sbjct: 282 AEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELDV 335

Query: 555 GGFFN 559
                
Sbjct: 336 SHNTK 340

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  103 bits (258), Expect = 3e-23
 Identities = 64/422 (15%), Positives = 132/422 (31%), Gaps = 76/422 (18%)

Query: 96  LLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVIS 155
           +  L  L  L+  +N LT     ++++   L  ++ + N+L+  I          L  + 
Sbjct: 102 VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID---VSHNTQLTELD 154

Query: 156 LAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPK 215
              N+   K+   ++  + L T++ S N+ +  L +       L  L+   N +  ++  
Sbjct: 155 CHLNKKITKLD--VTPQTQLTTLDCSFNKITE-LDVS--QNKLLNRLNCDTNNIT-KLD- 207

Query: 216 GVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMN 275
            +     L  ++ S N  +  I   +   + L   D S N  +        +L +     
Sbjct: 208 -LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT--------ELDVSTLSK 255

Query: 276 LRKNLFSG----EVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTG 331
           L           E+   +     L      G +    + ++  +  +L +L+  A  +T 
Sbjct: 256 LTTLHCIQTDLLEID--LTHNTQLIYFQAEGCRKIKELDVT--HNTQLYLLDCQAAGIT- 310

Query: 332 SLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSF 391
            L  S      LV L  +                L ++  + N                 
Sbjct: 311 ELDLS--QNPKLVYLYLNNTE-------------LTELDVSHNT---------------- 339

Query: 392 ESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLK-----ALNVLD 446
             L+ L   +      +   +G +  L     +    +      + +       + ++LD
Sbjct: 340 -KLKSLSCVNAHIQDFSS--VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLD 396

Query: 447 LSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPI 506
              N +N  I P  GG Y      +    L+   P      +S    I+         P 
Sbjct: 397 QFGNPMN--IEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGAIVGTVTTPFEAPQ 454

Query: 507 AI 508
            I
Sbjct: 455 PI 456

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  131 bits (331), Expect = 2e-33
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 10/207 (4%)

Query: 692 LNKDCELGRGGFGAVYRTVLRDGR-----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRH 746
             K   LG G FG VY+ +          PVAIK+L  ++  K+ ++   E   +  V +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76

Query: 747 PNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHL 806
           P++  L G   T ++Q LI + +  G L  ++ E      +      N     AK + +L
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYL 133

Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
               ++H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E +  
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE-SIL 192

Query: 867 TVKITDKCDVYGFGVLVLEVVT-GKRP 892
               T + DV+ +GV V E++T G +P
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  130 bits (328), Expect = 2e-33
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 17/205 (8%)

Query: 697 ELGRGGFGAVYRTVLR--DGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTL 752
           ++GRG F  VYR      DG PVA+KK+ +  L+ ++   D  +E+  L ++ HPN++  
Sbjct: 39  KIGRGQFSEVYR-AACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 753 EGYYWTQSLQLLIY-EFVSGGSLHKHLHE-GSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
              +   + +L I  E    G L + +         +     +        +L H+H   
Sbjct: 98  YASFIEDN-ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR 156

Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRT 867
           ++H +IK +NV I  +G  K+GD GL R          ++   S +G   YM+PE     
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFFSS-----KTTAAHSLVGTPYYMSPE-RIHE 210

Query: 868 VKITDKCDVYGFGVLVLEVVTGKRP 892
                K D++  G L+ E+   + P
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSP 235

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  130 bits (329), Expect = 2e-32
 Identities = 59/197 (29%), Positives = 103/197 (52%), Gaps = 7/197 (3%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +LG+G FG V+         VAIK L   ++  S E F +E + + K+RH  LV L    
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
            ++    ++ E++S GSL   L     G +L   +  ++    A  +A++ + N +H ++
Sbjct: 249 -SEEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 306

Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           +++N+L+  +   KV D+GLARL+   + Y      +  + + APE A    + T K DV
Sbjct: 307 RAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE-AALYGRFTIKSDV 364

Query: 877 YGFGVLVLEVVT-GKRP 892
           + FG+L+ E+ T G+ P
Sbjct: 365 WSFGILLTELTTKGRVP 381

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  127 bits (321), Expect = 3e-32
 Identities = 61/331 (18%), Positives = 112/331 (33%), Gaps = 61/331 (18%)

Query: 102 LRKLSLSSNNLTGSISPN-LAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNR 160
              L L +N +T  I       L+NL  + L  N +S  I    F     L  + L+KN+
Sbjct: 54  TALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQ 111

Query: 161 FSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIW-GLSALRTLDLSDNLL-EGEIPKGV- 217
              ++P  +    TL  + +  N  +  +   ++ GL+ +  ++L  N L    I  G  
Sbjct: 112 LK-ELPEKMP--KTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167

Query: 218 ESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLR 277
           + +K L  I ++    + +IP G+     L  +    N  +                 + 
Sbjct: 168 QGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT----------------KVD 208

Query: 278 KNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSM 337
                G        L +L  L LS N  S     S+ N   L+ L+ + N+L   +P  +
Sbjct: 209 AASLKG--------LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259

Query: 338 ANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFL 397
           A+   +  +    N++          S +    F                     S   +
Sbjct: 260 ADHKYIQVVYLHNNNI----------SAIGSNDFCPPGYNTKKA-----------SYSGV 298

Query: 398 DLSHN--EFSGETPATIGALSGLQLLNLSRN 426
            L  N  ++    P+T   +     + L   
Sbjct: 299 SLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  110 bits (278), Expect = 1e-26
 Identities = 69/332 (20%), Positives = 115/332 (34%), Gaps = 59/332 (17%)

Query: 243 SCSLLRTIDFSENSFS---GNLPETMQKLSLCN--FMNLRKNLFSGEVPKWIGELESLET 297
            C L R +  S+        +LP     L L N     ++   F          L++L T
Sbjct: 30  QCHL-RVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKN--------LKNLHT 80

Query: 298 LDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDL 357
           L L  NK S   P +   L +L+ L  S N+L   LP+ M     L  L   +N +   +
Sbjct: 81  LILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK--TLQELRVHENEIT-KV 136

Query: 358 PQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGET--PATIGAL 415
            + +F+ GLN                          +  ++L  N              +
Sbjct: 137 RKSVFN-GLN-------------------------QMIVVELGTNPLKSSGIENGAFQGM 170

Query: 416 SGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEI-GGAYSLKELRLERN 474
             L  + ++  ++   IP   G   +L  L L  N +   +      G  +L +L L  N
Sbjct: 171 KKLSYIRIADTNITT-IPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFN 226

Query: 475 FLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTG------GL 528
            ++     S+ N   L  L L+ N L   +P  +A    +Q V L  N+++         
Sbjct: 227 SISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCP 285

Query: 529 PKQLVNLVHLSSFNISHNHLQ-GELPAGGFFN 559
           P         S  ++  N +Q  E+    F  
Sbjct: 286 PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  108 bits (272), Expect = 8e-26
 Identities = 68/403 (16%), Positives = 122/403 (30%), Gaps = 110/403 (27%)

Query: 125 NLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNR 184
           +LRV+  S   L   +P +         ++ L  N+ +            L T+ L +N+
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLPP---DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 87

Query: 185 FSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSC 244
            S   P     L  L  L LS N L+ E+P+ +   K L+ + + +N  +  +       
Sbjct: 88  ISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKS---- 139

Query: 245 SLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNK 304
                       F+G                                L  +  ++L  N 
Sbjct: 140 -----------VFNG--------------------------------LNQMIVVELGTNP 156

Query: 305 FSGAVPISIG---NLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWI 361
              +  I  G    +++L  +  +   +T                          +PQ +
Sbjct: 157 LK-SSGIENGAFQGMKKLSYIRIADTNIT-------------------------TIPQGL 190

Query: 362 FSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLL 421
             S L ++    NKI +              +L  L LS N  S     ++     L+ L
Sbjct: 191 PPS-LTELHLDGNKITKVDAASL----KGLNNLAKLGLSFNSISAVDNGSLANTPHLREL 245

Query: 422 NLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIP 481
           +L+ N LV  +P  + D K + V+ L  N ++ +I                        P
Sbjct: 246 HLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS-AIGSN-----------------DFCPP 286

Query: 482 TSIENCSSLVSLILSKNNLTGPI--PIAIAKLTNLQNVDLSFN 522
                 +S   + L  N +      P     +     V L   
Sbjct: 287 GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  102 bits (257), Expect = 8e-24
 Identities = 42/223 (18%), Positives = 83/223 (37%), Gaps = 35/223 (15%)

Query: 102 LRKLSLSSNNLTGSISPN-LAKLQNLRVIDLSGNSL-SGSIPDEFFKQCGSLRVISLAKN 159
           L++L +  N +T  +  +    L  + V++L  N L S  I +  F+    L  I +A  
Sbjct: 123 LQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181

Query: 160 RFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGV-E 218
             +  IP  L    +L  ++L  N+ +      + GL+ L  L LS N +   +  G   
Sbjct: 182 NIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLA 237

Query: 219 SLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFS-------------GNLPETM 265
           +  +LR ++L+ N     +P G+     ++ +    N+ S                    
Sbjct: 238 NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKAS-Y 295

Query: 266 QKLSLCN----FMNLRKNLFSGEVPKWIGELESLETLDLSGNK 304
             +SL +    +  ++ + F          +     + L   K
Sbjct: 296 SGVSLFSNPVQYWEIQPSTFRC--------VYVRAAVQLGNYK 330

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  127 bits (322), Expect = 3e-32
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 24/207 (11%)

Query: 697 ELGRGGFGAVYRTVLR--DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLE 753
           ++G G FG     V    DGR   IK++ +S +  K +E+  REV  L  ++HPN+V   
Sbjct: 31  KIGEGSFGKAIL-VKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNF-----LSWNERFNVIQGTAKSLAHLHQ 808
             +       ++ ++  GG L K ++   G  F     L W      +Q    +L H+H 
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW-----FVQ-ICLALKHVHD 143

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFAC 865
             I+H +IKS N+ +   G  ++GD+G+AR+L            ++ +G   Y++PE  C
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-----TVELARACIGTPYYLSPE-IC 197

Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRP 892
                 +K D++  G ++ E+ T K  
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHA 224

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  128 bits (324), Expect = 4e-32
 Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 5/198 (2%)

Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           ++GRG FG V+   LR D   VA+K    +     +  F +E + L +  HPN+V L G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    ++ E V GG     L   + G  L       ++   A  + +L     IH +
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRD 238

Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+      K+ D+G++R              Q  + + APE A    + + + D
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPE-ALNYGRYSSESD 297

Query: 876 VYGFGVLVLEVVT-GKRP 892
           V+ FG+L+ E  + G  P
Sbjct: 298 VWSFGILLWETFSLGASP 315

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  131 bits (330), Expect = 4e-32
 Identities = 93/488 (19%), Positives = 164/488 (33%), Gaps = 37/488 (7%)

Query: 73  PRSNRVIELTLNGLSLTGRIGRGLLQ-LQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDL 131
            +   ++ ++ N +S    +    +  L  LR L +S N +           Q L  +DL
Sbjct: 20  SQKTTILNISQNYIS---ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDL 76

Query: 132 SGNSLSGSIPDEFFKQCGSLRVISLAKNRF-SGKIPSSLSLCSTLATINLSSNRFSSPLP 190
           S N L   I         +L+ + L+ N F +  I       S L  + LS+        
Sbjct: 77  SHNKLV-KIS---CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSV 132

Query: 191 LGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTI 250
           L I  L+  + L +       +       L++    +L     +      I   S+    
Sbjct: 133 LPIAHLNISKVLLVLGETYGEKEDPE--GLQDFNTESLHIVFPTNKEFHFILDVSVKTVA 190

Query: 251 DFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVP 310
           +   ++    L +      L     L+ N     +        +L  ++ + N F     
Sbjct: 191 NLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL--------TLNNIETTWNSFIR--I 240

Query: 311 ISIGNLQRLKVLNFSANRLTGSLPDSMANCM--NLVALDFSQNSMN--GDLPQWIFS--S 364
           + +     +   + S  +L G L     +    +L AL   Q   +  G    +I+   S
Sbjct: 241 LQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFS 300

Query: 365 GLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLS 424
            +N  +F  +  R           S       LD S+N  +       G L+ L+ L L 
Sbjct: 301 NMNIKNFTVSGTRMVHMLCP----SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQ 356

Query: 425 RNSL--VGPIPVAIGDLKALNVLDLSENWLNGSIPPEI-GGAYSLKELRLERNFLAGKIP 481
            N L  +  I      +K+L  LD+S+N ++            SL  L +  N L   I 
Sbjct: 357 MNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIF 416

Query: 482 TSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSF 541
             +     +  L L  N +   IP  + KL  LQ ++++ N L          L  L   
Sbjct: 417 RCLP--PRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKI 473

Query: 542 NISHNHLQ 549
            +  N   
Sbjct: 474 WLHTNPWD 481

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  128 bits (324), Expect = 2e-31
 Identities = 78/459 (16%), Positives = 169/459 (36%), Gaps = 28/459 (6%)

Query: 105 LSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGK 164
           +  S N L   +  +L++     ++++S N +S  +          LR++ ++ NR    
Sbjct: 5   VDRSKNGLI-HVPKDLSQ--KTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYL 60

Query: 165 IPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVE--SLKN 222
             S       L  ++LS N+    +         L+ LDLS N  +  +P   E  ++  
Sbjct: 61  DISVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQ 116

Query: 223 LRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFS 282
           L+ + LS      S    I   ++ + +            E      L +F     ++  
Sbjct: 117 LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGE----TYGEKEDPEGLQDFNTESLHI-- 170

Query: 283 GEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMN 342
                +    E    LD+S    +     +I  +      ++  + L     +   + + 
Sbjct: 171 ----VFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLT 226

Query: 343 LVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNG-PFASSGSSFESLQFLDLSH 401
           L  ++ + NS    + Q ++ + +   S +  K++  ++   F  SG+S ++L    +  
Sbjct: 227 LNNIETTWNSFI-RILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS 285

Query: 402 NEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIG 461
           + F           S + + N + +       +    +     LD S N L  ++    G
Sbjct: 286 DVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCG 345

Query: 462 GAYSLKELRLERNFLA--GKIPTSIENCSSLVSLILSKNNLT-GPIPIAIAKLTNLQNVD 518
               L+ L L+ N L    KI        SL  L +S+N+++        +   +L +++
Sbjct: 346 HLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLN 405

Query: 519 LSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGF 557
           +S N LT  + + L     +   ++  N ++  +P    
Sbjct: 406 MSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVV 441

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 66.4 bits (162), Expect = 2e-11
 Identities = 32/167 (19%), Positives = 53/167 (31%), Gaps = 26/167 (15%)

Query: 393 SLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWL 452
               L++S N  S    + I +LS L++L +S N +           + L  LDLS N L
Sbjct: 22  KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81

Query: 453 NGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLT 512
              I        +LK L L  N        ++                  PI      ++
Sbjct: 82  V-KIS--CHPTVNLKHLDLSFNAF-----DAL------------------PICKEFGNMS 115

Query: 513 NLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFN 559
            L+ + LS   L       + +L       +       +    G  +
Sbjct: 116 QLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQD 162

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  125 bits (316), Expect = 5e-32
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 9/203 (4%)

Query: 695 DCELGRGGFGAVYRTVLRDGR---PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           D ELG G FG+V + V R  +    VAIK L   +     E+  RE + + ++ +P +V 
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L G    ++L +L+ E   GG LHK L        +  +    ++   +  + +L + N 
Sbjct: 75  LIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEEKNF 131

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR-YVLSSKIQSALGYMAPEFACRTVKI 870
           +H ++ + NVL+      K+ D+GL++ L   D  Y   S  +  L + APE      K 
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRKF 190

Query: 871 TDKCDVYGFGVLVLEVVT-GKRP 892
           + + DV+ +GV + E ++ G++P
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  125 bits (317), Expect = 8e-32
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 10/207 (4%)

Query: 692 LNKDCELGRGGFGAVYRTVLRDGR-----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRH 746
           L K   LG G FG V++ V          PV IK +   S  +S +     +  +G + H
Sbjct: 15  LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH 74

Query: 747 PNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHL 806
            ++V L G     SLQ L+ +++  GSL  H+ +  G   L      N     AK + +L
Sbjct: 75  AHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQIAKGMYYL 131

Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
            +  ++H N+ + NVL+    + +V D+G+A LLP  D+ +L S+ ++ + +MA E +  
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE-SIH 190

Query: 867 TVKITDKCDVYGFGVLVLEVVT-GKRP 892
             K T + DV+ +GV V E++T G  P
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEP 217

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  125 bits (315), Expect = 9e-32
 Identities = 51/226 (22%), Positives = 94/226 (41%), Gaps = 29/226 (12%)

Query: 698 LGRGGFGAVYRTVLR--DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           LGRGGFG V+       D    AIK++ + +   ++E   REVK L K+ HP +V     
Sbjct: 13  LGRGGFGVVFE-AKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 756 YWT---------QSLQLLIY---EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSL 803
           +            S ++ +Y   +     +L   ++          +   ++    A+++
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131

Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-------PMLDRYVLSSKIQSAL 856
             LH   ++H ++K SN+        KVGD+GL   +        +L      ++    +
Sbjct: 132 EFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQV 191

Query: 857 G---YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM 899
           G   YM+PE        + K D++  G+++ E++    P ST    
Sbjct: 192 GTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER 233

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  125 bits (316), Expect = 9e-32
 Identities = 60/213 (28%), Positives = 88/213 (41%), Gaps = 23/213 (10%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
            LG+G    V+R   +  G   AIK     S ++  +   RE + L K+ H N+V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 756 YWTQSLQL--LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
               + +   LI EF   GSL+  L E S    L  +E   V++     + HL ++ I+H
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135

Query: 814 YNIKSSNVLI----DGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACR 866
            NIK  N++     DG    K+ D+G AR L          +  S  G   Y+ P+   R
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELED------DEQFVSLYGTEEYLHPDMYER 189

Query: 867 TVKITD-------KCDVYGFGVLVLEVVTGKRP 892
            V   D         D++  GV      TG  P
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  125 bits (317), Expect = 1e-31
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 10/202 (4%)

Query: 697 ELGRGGFGAVYRTVLRDGR-----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
            LG G FG VY+ +          PVAIK+L  ++  K+ ++   E   +  V +P++  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L G   T ++Q LI + +  G L  ++ E      +      N     AK + +L    +
Sbjct: 82  LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRRL 138

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E +      T
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE-SILHRIYT 197

Query: 872 DKCDVYGFGVLVLEVVT-GKRP 892
            + DV+ +GV V E++T G +P
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKP 219

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  124 bits (314), Expect = 2e-31
 Identities = 49/210 (23%), Positives = 89/210 (42%), Gaps = 16/210 (7%)

Query: 698 LGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG GGF  V     L DG   A+K++      + +E+ +RE        HPN++ L  Y 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQ-QDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 757 WTQSLQ----LLIYEFVSGGSLHKHLHE-GSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
             +        L+  F   G+L   +      GNFL+ ++   ++ G  + L  +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGY 155

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG-------YMAPE-F 863
            H ++K +N+L+   G+P + D G      +       +              Y APE F
Sbjct: 156 AHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELF 215

Query: 864 ACRT-VKITDKCDVYGFGVLVLEVVTGKRP 892
           + ++   I ++ DV+  G ++  ++ G+ P
Sbjct: 216 SVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  128 bits (324), Expect = 2e-31
 Identities = 59/197 (29%), Positives = 103/197 (52%), Gaps = 7/197 (3%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +LG+G FG V+         VAIK L   ++  S E F +E + + K+RH  LV L    
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
            ++    ++ E++S GSL   L     G +L   +  ++    A  +A++ + N +H ++
Sbjct: 332 -SEEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 389

Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           +++N+L+  +   KV D+GLARL+   + Y      +  + + APE A    + T K DV
Sbjct: 390 RAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE-AALYGRFTIKSDV 447

Query: 877 YGFGVLVLEVVT-GKRP 892
           + FG+L+ E+ T G+ P
Sbjct: 448 WSFGILLTELTTKGRVP 464

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  122 bits (309), Expect = 3e-31
 Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 7/197 (3%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           E+G G FG V+     +   VAIK +   ++  S+EDF  E + + K+ HP LV L G  
Sbjct: 15  EIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             Q+   L+ EF+  G L  +L    G    +      +     + +A+L ++ +IH ++
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIHRDL 130

Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
            + N L+  +   KV D+G+ R +   D+Y  S+  +  + + +PE      + + K DV
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPE-VFSFSRYSSKSDV 188

Query: 877 YGFGVLVLEVVT-GKRP 892
           + FGVL+ EV + GK P
Sbjct: 189 WSFGVLMWEVFSEGKIP 205

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  123 bits (311), Expect = 3e-31
 Identities = 51/204 (25%), Positives = 90/204 (44%), Gaps = 20/204 (9%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIK--KLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           LG GG   VY          VAIK   +      ++ + FEREV    ++ H N+V++  
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
                    L+ E++ G +L +++        LS +   N        + H H   I+H 
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDMRIVHR 135

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI---QSALG---YMAPEFACRTV 868
           +IK  N+LID +   K+ D+G+A+        +  + +      LG   Y +PE A +  
Sbjct: 136 DIKPQNILIDSNKTLKIFDFGIAKA-------LSETSLTQTNHVLGTVQYFSPEQA-KGE 187

Query: 869 KITDKCDVYGFGVLVLEVVTGKRP 892
              +  D+Y  G+++ E++ G+ P
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPP 211

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  127 bits (321), Expect = 3e-31
 Identities = 59/197 (29%), Positives = 98/197 (49%), Gaps = 7/197 (3%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +LG G FG V+         VA+K +   S+  S E F  E   +  ++H  LV L    
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
            T+    +I EF++ GSL   L     G+     +  +     A+ +A + Q N IH ++
Sbjct: 253 -TKEPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310

Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           +++N+L+  S   K+ D+GLAR++   + Y      +  + + APE A      T K DV
Sbjct: 311 RAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAPE-AINFGSFTIKSDV 368

Query: 877 YGFGVLVLEVVT-GKRP 892
           + FG+L++E+VT G+ P
Sbjct: 369 WSFGILLMEIVTYGRIP 385

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  126 bits (317), Expect = 8e-31
 Identities = 77/431 (17%), Positives = 150/431 (34%), Gaps = 63/431 (14%)

Query: 102 LRKLSLSSNNLTGSISPN-LAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNR 160
           +  + LS N++   ++    ++LQ+L+ + +   +    I +  F+   SL ++ L  N+
Sbjct: 32  VNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 161 FSGKIPSSLSLCSTLATINLSSNRF-SSPLPLGIW-GLSALRTLDLSDNLLEGEIPKGV- 217
           F      + +  + L  + L+      + L    +  L++L  L L DN ++   P    
Sbjct: 91  FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150

Query: 218 ESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFM--N 275
            +++   V++L+ N    SI +                       +    L L +    +
Sbjct: 151 LNMRRFHVLDLTFNKVK-SICEED---------------LLNFQGKHFTLLRLSSITLQD 194

Query: 276 LRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPD 335
           + +     E      +  S+ TLDLSGN F  ++     +                 +  
Sbjct: 195 MNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGT-----------KIQS 243

Query: 336 SMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQ 395
            + +    +   F   +   D   + F                         G     ++
Sbjct: 244 LILSNSYNMGSSFGHTNFK-DPDNFTF------------------------KGLEASGVK 278

Query: 396 FLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGS 455
             DLS ++      +     + L+ L L++N +      A   L  L  L+LS+N+L GS
Sbjct: 279 TCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL-GS 337

Query: 456 IPPEI-GGAYSLKELRLERNFLAGKIPTSI-ENCSSLVSLILSKNNLTGPIPIAIAKLTN 513
           I   +      L+ L L  N +   +         +L  L L  N L         +LT+
Sbjct: 338 IDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTS 396

Query: 514 LQNVDLSFNSL 524
           LQ + L  N  
Sbjct: 397 LQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  121 bits (306), Expect = 2e-29
 Identities = 78/387 (20%), Positives = 140/387 (36%), Gaps = 37/387 (9%)

Query: 173 STLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKN 231
           + +  ++LS N  +         L  L+ L +        I       L +L ++ L  N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 232 MFSGSIPDGI-GSCSLLRTIDFSENSF-SGNLPETM-QKLSLCNFMNLRKNLFSGEVPKW 288
            F   +  G     + L  +  ++ +     L     + L+    + LR N      P  
Sbjct: 90  QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148

Query: 289 I-GELESLETLDLSGNKFS----------GAVPISIGNLQRLKVLNFSANRLTGSLPDSM 337
               +     LDL+ NK                 ++  L  + + + +   L      + 
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208

Query: 338 ANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFL 397
               ++  LD S N     + +  F       + A  KI+  +     + GSSF    F 
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFD------AIAGTKIQSLILSNSYNMGSSFGHTNFK 262

Query: 398 DLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAI-GDLKALNVLDLSENWLNGSI 456
           D  +  F G         SG++  +LS++ +   +  ++      L  L L++N +N  I
Sbjct: 263 DPDNFTFKGLEA------SGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEIN-KI 314

Query: 457 PPEI-GGAYSLKELRLERNFLAGKIPTSI-ENCSSLVSLILSKNNLTGPIPIAIAKLTNL 514
                 G   L +L L +NFL G I + + EN   L  L LS N++      +   L NL
Sbjct: 315 DDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNL 373

Query: 515 QNVDLSFNSLT---GGLPKQLVNLVHL 538
           + + L  N L     G+  +L +L  +
Sbjct: 374 KELALDTNQLKSVPDGIFDRLTSLQKI 400

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  114 bits (288), Expect = 4e-27
 Identities = 78/389 (20%), Positives = 132/389 (33%), Gaps = 59/389 (15%)

Query: 80  ELTLNGLSLTGRIGRGLLQ-LQFLRKLSLSSNNLTGSISPN-LAKLQNLRVIDLSGNSL- 136
            L +   +    I     + L  L  L L  N     +       L NL V+ L+  +L 
Sbjct: 58  FLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLD 116

Query: 137 SGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSL--SLCSTLATINLSSNRFSSPLPLGIW 194
              +   FFK   SL ++ L  N      P+S   ++      ++L+ N+  S +     
Sbjct: 117 GAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNM-RRFHVLDLTFNKVKS-ICEEDL 174

Query: 195 -----------GLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGS 243
                       LS++   D+++  L  E         ++  ++LS N F  S+      
Sbjct: 175 LNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRF-- 232

Query: 244 CSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGN 303
              +          S N           NF +     F G       E   ++T DLS +
Sbjct: 233 FDAIAGTKIQSLILS-NSYNMGSSFGHTNFKDPDNFTFKGL------EASGVKTCDLSKS 285

Query: 304 KFSGAVPISI-GNLQRLKVLNFSANRLTGSLPDSM-ANCMNLVALDFSQNSMNGDLPQWI 361
           K   A+  S+  +   L+ L  + N +   + D+      +L+ L+ SQN + G +   +
Sbjct: 286 KIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRM 342

Query: 362 FSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLL 421
           F   L+K                         L+ LDLS+N        +   L  L+ L
Sbjct: 343 F-ENLDK-------------------------LEVLDLSYNHIRALGDQSFLGLPNLKEL 376

Query: 422 NLSRNSLVGPIPVAIGDLKALNVLDLSEN 450
            L  N L          L +L  + L  N
Sbjct: 377 ALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  121 bits (306), Expect = 1e-30
 Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 7/197 (3%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           ELG G FG V     R    VAIK +   S+  S+++F  E K +  + H  LV L G  
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             Q    +I E+++ G L  +L E          +   + +   +++ +L     +H ++
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESKQFLHRDL 146

Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
            + N L++  G  KV D+GL+R + + D Y  S   +  + +  PE      K + K D+
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPE-VLMYSKFSSKSDI 204

Query: 877 YGFGVLVLEVVT-GKRP 892
           + FGVL+ E+ + GK P
Sbjct: 205 WAFGVLMWEIYSLGKMP 221

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  122 bits (308), Expect = 1e-30
 Identities = 47/213 (22%), Positives = 87/213 (40%), Gaps = 38/213 (17%)

Query: 698 LGRGGFGAVYR---TVLRDGRPVAIKKLTVSSLVK---SQEDFEREVKKLGKVRHPNLVT 751
           +GRGG G VY    TV    R VA+K ++  +L      +   +RE +  G+++ P++V 
Sbjct: 42  VGRGGMGDVYEAEDTVR--ERIVALKLMS-ETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 752 L------EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAH 805
           +      +G  +      +    ++G  L   L        L+      +++    +L  
Sbjct: 99  IHDFGEIDGQLY------VDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDA 149

Query: 806 LHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI---QSALG---YM 859
            H +   H ++K  N+L+       + D+G+A             K+    + +G   YM
Sbjct: 150 AHAAGATHRDVKPENILVSADDFAYLVDFGIASATT-------DEKLTQLGNTVGTLYYM 202

Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
           APE        T + D+Y    ++ E +TG  P
Sbjct: 203 APERF-SESHATYRADIYALTCVLYECLTGSPP 234

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  120 bits (303), Expect = 2e-30
 Identities = 59/197 (29%), Positives = 98/197 (49%), Gaps = 7/197 (3%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           ELG G FG V     +    VA+K +   S+  S+++F +E + + K+ HP LV   G  
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             +    ++ E++S G L  +L   S G  L  ++   +     + +A L     IH ++
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLR--SHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDL 130

Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
            + N L+D     KV D+G+ R + + D+YV S   +  + + APE      K + K DV
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWSAPE-VFHYFKYSSKSDV 188

Query: 877 YGFGVLVLEVVT-GKRP 892
           + FG+L+ EV + GK P
Sbjct: 189 WAFGILMWEVFSLGKMP 205

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  120 bits (304), Expect = 2e-30
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 7/197 (3%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
            LG G FG V+         VA+K L   S+  S + F  E   + +++H  LV L    
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
            TQ    +I E++  GSL   L     G  L+ N+  ++    A+ +A + + N IH ++
Sbjct: 78  -TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135

Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           +++N+L+  +   K+ D+GLARL+   + Y      +  + + APE A      T K DV
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPE-AINYGTFTIKSDV 193

Query: 877 YGFGVLVLEVVT-GKRP 892
           + FG+L+ E+VT G+ P
Sbjct: 194 WSFGILLTEIVTHGRIP 210

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  120 bits (304), Expect = 2e-30
 Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 37/218 (16%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
            +G GGFG V++     DG+   IK++       + E  EREVK L K+ H N+V   G 
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVK-----YNNEKAEREVKALAKLDHVNIVHYNGC 72

Query: 756 Y---------------WTQSLQLLIY-EFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQ 797
           +                +++  L I  EF   G+L + + +  G      ++     + +
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL---DKVLALELFE 129

Query: 798 GTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG 857
              K + ++H   +I+ ++K SN+ +  + + K+GD+GL   L          K   + G
Sbjct: 130 QITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN------DGKRTRSKG 183

Query: 858 ---YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
              YM+PE    +     + D+Y  G+++ E++     
Sbjct: 184 TLRYMSPE-QISSQDYGKEVDLYALGLILAELLHVCDT 220

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  120 bits (304), Expect = 3e-30
 Identities = 51/218 (23%), Positives = 93/218 (42%), Gaps = 30/218 (13%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG+G FG V +     D R  AIKK+  +   +       EV  L  + H  +V     +
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQYVVRYYAAW 71

Query: 757 WTQSLQLL----------IY---EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSL 803
             +   +           ++   E+   G+L+  +H          +E + + +   ++L
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEAL 129

Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---------PMLDRYVLSSKIQS 854
           +++H   IIH ++K  N+ ID S   K+GD+GLA+ +            +    S  + S
Sbjct: 130 SYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS 189

Query: 855 ALG---YMAPEFACRTVKITDKCDVYGFGVLVLEVVTG 889
           A+G   Y+A E    T    +K D+Y  G++  E++  
Sbjct: 190 AIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  120 bits (304), Expect = 3e-30
 Identities = 57/213 (26%), Positives = 89/213 (41%), Gaps = 22/213 (10%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKS-QEDFEREVKKLGKV-RHPNLVTLE 753
            LG G +G V++     DGR  A+K+          +     EV    KV +HP  V LE
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 754 GYYWTQSLQLLIY-EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
              W +   L +  E   G SL +H      G  L   + +  ++ T  +LAHLH   ++
Sbjct: 124 QA-WEEGGILYLQTEL-CGPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQGLV 179

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVK 869
           H ++K +N+ +   G  K+GD+GL   L        +   +   G   YMAPE   +   
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGT------AGAGEVQEGDPRYMAPE-LLQG-S 231

Query: 870 ITDKCDVYGFGVLVLEVVTGKRP---LSTWKMM 899
                DV+  G+ +LEV            W+ +
Sbjct: 232 YGTAADVFSLGLTILEVACNMELPHGGEGWQQL 264

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  120 bits (303), Expect = 3e-30
 Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 12/204 (5%)

Query: 697 ELGRGGFGAVYRTVLR----DGRPVAIK--KLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           +LG G FG V R            VA+K  K  V S  ++ +DF REV  +  + H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
            L G   T  ++ ++ E    GSL   L +  G                A+ + +L    
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGMGYLESKR 141

Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML-DRYVLSSKIQSALGYMAPEFACRTVK 869
            IH ++ + N+L+      K+GD+GL R LP   D YV+    +    + APE + +T  
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE-SLKTRT 200

Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            +   D + FGV + E+ T G+ P
Sbjct: 201 FSHASDTWMFGVTLWEMFTYGQEP 224

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  124 bits (314), Expect = 4e-30
 Identities = 60/198 (30%), Positives = 101/198 (51%), Gaps = 7/198 (3%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E      +S      +    + ++ +L + N IH N
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRN 343

Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D Y   +  +  + + APE +    K + K D
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSD 401

Query: 876 VYGFGVLVLEVVT-GKRP 892
           V+ FGVL+ E+ T G  P
Sbjct: 402 VWAFGVLLWEIATYGMSP 419

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  120 bits (303), Expect = 6e-30
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 9/202 (4%)

Query: 697 ELGRGGFGAVYRTVLRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
            +G G  G V    LR       PVAIK L      + + DF  E   +G+  HPN++ L
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           EG      L +++ E++  GSL   L    G    +  +   +++G    + +L     +
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRYLSDLGYV 173

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           H ++ + NVL+D +   KV D+GL+R+L    D    ++  +  + + APE A      +
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE-AIAFRTFS 232

Query: 872 DKCDVYGFGVLVLEVVT-GKRP 892
              DV+ FGV++ EV+  G+RP
Sbjct: 233 SASDVWSFGVVMWEVLAYGERP 254

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  125 bits (315), Expect = 6e-30
 Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 9/207 (4%)

Query: 691 LLNKDCELGRGGFGAVYRTVLRDGR---PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHP 747
           LL  D ELG G FG+V + V R  +    VAIK L   +     E+  RE + + ++ +P
Sbjct: 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 396

Query: 748 NLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH 807
            +V L G    ++L +L+ E   GG LHK L        +  +    ++   +  + +L 
Sbjct: 397 YIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLE 453

Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR-YVLSSKIQSALGYMAPEFACR 866
           + N +H N+ + NVL+      K+ D+GL++ L   D  Y   S  +  L + APE    
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CIN 512

Query: 867 TVKITDKCDVYGFGVLVLEVVT-GKRP 892
             K + + DV+ +GV + E ++ G++P
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKP 539

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  121 bits (306), Expect = 8e-30
 Identities = 59/212 (27%), Positives = 87/212 (41%), Gaps = 23/212 (10%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG+G    V+R   +  G   AIK     S ++  +   RE + L K+ H N+V L    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76

Query: 757 --WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
              T   ++LI EF   GSL+  L E S    L  +E   V++     + HL ++ I+H 
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHR 136

Query: 815 NIKSSNVLI----DGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE----- 862
           NIK  N++     DG    K+ D+G AR L          +  S  G   Y+ P+     
Sbjct: 137 NIKPGNIMRVIGEDGQSVYKLTDFGAARELED------DEQFVSLYGTEEYLHPDMYERA 190

Query: 863 --FACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
                   K     D++  GV      TG  P
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  118 bits (299), Expect = 1e-29
 Identities = 50/205 (24%), Positives = 99/205 (48%), Gaps = 11/205 (5%)

Query: 694 KDCELGRGGFGAVYRTVLRDGR---PVAIKKLTVSSLVKS-QEDFEREVKKLGKVRHPNL 749
           +D ELG G FG V +   +  +    VA+K L   +   + +++   E   + ++ +P +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
           V + G    +S  +L+ E    G L+K+L +      +       ++   +  + +L +S
Sbjct: 81  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES 136

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML-DRYVLSSKIQSALGYMAPEFACRTV 868
           N +H ++ + NVL+      K+ D+GL++ L    + Y   +  +  + + APE      
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE-CINYY 195

Query: 869 KITDKCDVYGFGVLVLEVVT-GKRP 892
           K + K DV+ FGVL+ E  + G++P
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKP 220

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  118 bits (298), Expect = 1e-29
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 10/201 (4%)

Query: 697 ELGRGGFGAVYRTVLRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
            LG G FG VY  V  + +     VA+K       + ++E F  E   +  + HP++V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
            G    +    +I E    G L  +L        L             K++A+L   N +
Sbjct: 79  IGII-EEEPTWIIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAYLESINCV 135

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           H +I   N+L+      K+GD+GL+R +   + Y  +S  +  + +M+PE +    + T 
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPE-SINFRRFTT 193

Query: 873 KCDVYGFGVLVLEVVT-GKRP 892
             DV+ F V + E+++ GK+P
Sbjct: 194 ASDVWMFAVCMWEILSFGKQP 214

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  118 bits (298), Expect = 1e-29
 Identities = 52/210 (24%), Positives = 95/210 (45%), Gaps = 21/210 (10%)

Query: 697 ELGRGGFGAVYRTVLR--DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTL- 752
            +G G +G   + + R  DG+ +  K+L   S+    ++    EV  L +++HPN+V   
Sbjct: 13  TIGTGSYGRCQK-IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71

Query: 753 EGYYWTQSLQLLIY-EFVSGGSLHKHL-HEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           +      +  L I  E+  GG L   +        +L       V+     +L   H+ +
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131

Query: 811 -----IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE 862
                ++H ++K +NV +DG    K+GD+GLAR+L        +S  ++ +G   YM+PE
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-----DTSFAKTFVGTPYYMSPE 186

Query: 863 FACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
                +   +K D++  G L+ E+     P
Sbjct: 187 -QMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  119 bits (300), Expect = 1e-29
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 16/205 (7%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIK--KLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL-- 752
           LG GG   V+    LRD R VA+K  +  ++        F RE +    + HP +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79

Query: 753 --EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
             E       L  ++ E+V G +L   +H       ++      VI    ++L   HQ+ 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136

Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRT 867
           IIH ++K +N++I  +   KV D+G+AR   + D     ++  + +G   Y++PE A R 
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIAR--AIADSGNSVTQTAAVIGTAQYLSPEQA-RG 193

Query: 868 VKITDKCDVYGFGVLVLEVVTGKRP 892
             +  + DVY  G ++ EV+TG+ P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP 218

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  124 bits (314), Expect = 1e-29
 Identities = 41/203 (20%), Positives = 80/203 (39%), Gaps = 23/203 (11%)

Query: 698 LGRGGFGAVYR---TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL-- 752
           +  GG G +Y      + +GRPV +K L  S   ++Q     E + L +V HP++V +  
Sbjct: 88  IAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 753 ---EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
                      +  ++ E+V G SL +   +      L   E    +     +L++LH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLHSI 201

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
            +++ ++K  N+++      K+ D G       ++ +       +  G+ APE       
Sbjct: 202 GLVYNDLKPENIMLTEEQ-LKLIDLGAVS---RINSF--GYLYGTP-GFQAPEIV--RTG 252

Query: 870 ITDKCDVYGFGVLVLEVVTGKRP 892
            T   D+Y  G  +  +      
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPT 275

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  118 bits (298), Expect = 2e-29
 Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 7/198 (3%)

Query: 697 ELGRGGFGAVYRTVLRDGR-PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   ++    E+F +E   + +++HPNLV L G 
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E +    +S      +    + ++ +L + N IH +
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKNFIHRD 136

Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D Y   +  +  + + APE +    K + K D
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE-SLAYNKFSIKSD 194

Query: 876 VYGFGVLVLEVVT-GKRP 892
           V+ FGVL+ E+ T G  P
Sbjct: 195 VWAFGVLLWEIATYGMSP 212

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  118 bits (299), Expect = 2e-29
 Identities = 46/209 (22%), Positives = 88/209 (42%), Gaps = 20/209 (9%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNL--VTLEG 754
           +G GG   V++ +    +  AIK + +        + +  E+  L K++  +   + L  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y  T     ++ E      L+  L +      +   ER +  +   +++  +HQ  I+H 
Sbjct: 96  YEITDQYIYMVMEC-GNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHGIVHS 151

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDR-YVLSSKIQSALGYMAPE----------F 863
           ++K +N LI   G  K+ D+G+A  +       V  S++ + + YM PE           
Sbjct: 152 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT-VNYMPPEAIKDMSSSREN 209

Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
                KI+ K DV+  G ++  +  GK P
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  120 bits (302), Expect = 2e-29
 Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 9/202 (4%)

Query: 697 ELGRGGFGAVYRTVL----RDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
            +G G FG V    L    +    VAIK L V    K + DF  E   +G+  HPN++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           EG        +++ E++  GSL   L +       +  +   +++G A  + +L     +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMKYLSDMGYV 169

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLP-MLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           H ++ + N+LI+ +   KV D+GL R+L    +    +   +  + + +PE A    K T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE-AIAYRKFT 228

Query: 872 DKCDVYGFGVLVLEVVT-GKRP 892
              DV+ +G+++ EV++ G+RP
Sbjct: 229 SASDVWSYGIVLWEVMSYGERP 250

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  119 bits (300), Expect = 2e-29
 Identities = 63/204 (30%), Positives = 106/204 (51%), Gaps = 12/204 (5%)

Query: 697 ELGRGGFGAVYRTVLRDGR-----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
            +G G FG VY+ +L+        PVAIK L      K + DF  E   +G+  H N++ 
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           LEG        ++I E++  G+L K L E  G    S  +   +++G A  + +L   N 
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYLANMNY 168

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLP-MLDRYVLSSKIQSALGYMAPE-FACRTVK 869
           +H ++ + N+L++ +   KV D+GL+R+L    +    +S  +  + + APE  + R  K
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR--K 226

Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T   DV+ FG+++ EV+T G+RP
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGERP 250

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  124 bits (311), Expect = 3e-29
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL--- 752
            LG GGFG V R + +D G  VAIK+       K++E +  E++ + K+ HPN+V+    
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 753 ---EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
                      L LL  E+  GG L K+L++      L       ++   + +L +LH++
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140

Query: 810 NIIHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE- 862
            IIH ++K  N+++    +    K+ D G A+ L               +G   Y+APE 
Sbjct: 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ------GELCTEFVGTLQYLAPEL 194

Query: 863 FACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
              +  K T   D + FG L  E +TG RP 
Sbjct: 195 LEQK--KYTVTVDYWSFGTLAFECITGFRPF 223

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  119 bits (299), Expect = 3e-29
 Identities = 45/208 (21%), Positives = 85/208 (40%), Gaps = 18/208 (8%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNL--VTLEG 754
           +G GG   V++ +    +  AIK + +        + +  E+  L K++  +   + L  
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y  T     ++ E      L+  L +      +   ER +  +   +++  +HQ  I+H 
Sbjct: 77  YEITDQYIYMVMEC-GNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHGIVHS 132

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE----------FA 864
           ++K +N LI   G  K+ D+G+A  +      V+       + YM PE            
Sbjct: 133 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENG 191

Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRP 892
               KI+ K DV+  G ++  +  GK P
Sbjct: 192 KSKSKISPKSDVWSLGCILYYMTYGKTP 219

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  117 bits (295), Expect = 3e-29
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 13/198 (6%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
            +G+G FG V     R G  VA+K +   +   + + F  E   + ++RH NLV L G  
Sbjct: 28  TIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 757 WTQSLQLLI-YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
             +   L I  E+++ GSL  +L    G + L  +          +++ +L  +N +H +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 142

Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + NVL+      KV D+GL +     +        +  + + APE A R  K + K D
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPE-ALREKKFSTKSD 196

Query: 876 VYGFGVLVLEVVT-GKRP 892
           V+ FG+L+ E+ + G+ P
Sbjct: 197 VWSFGILLWEIYSFGRVP 214

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  117 bits (295), Expect = 3e-29
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 19/202 (9%)

Query: 698 LGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY     +    +A+K L  + L K+  +    REV+    +RHPN++ L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   LI E+   G++++ L +     F        + +  A +L++ H   +IH 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITE-LANALSYCHSKRVIHR 133

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKIT 871
           +IK  N+L+  +GE K+ D+G +   P       SS+     G   Y+ PE      ++ 
Sbjct: 134 DIKPENLLLGSAGELKIADFGWSVHAP-------SSRRTDLCGTLDYLPPEMIEG--RMH 184

Query: 872 D-KCDVYGFGVLVLEVVTGKRP 892
           D K D++  GVL  E + GK P
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPP 206

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  116 bits (294), Expect = 4e-29
 Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 10/201 (4%)

Query: 697 ELGRGGFGAVYRTVLRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
            +G G FG V++ +          VAIK     +    +E F +E   + +  HP++V L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
            G   T++   +I E  + G L   L        L            + +LA+L     +
Sbjct: 82  IGVI-TENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLESKRFV 138

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           H +I + NVL+  +   K+GD+GL+R +     Y  +SK +  + +MAPE +    + T 
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPE-SINFRRFTS 196

Query: 873 KCDVYGFGVLVLEVVT-GKRP 892
             DV+ FGV + E++  G +P
Sbjct: 197 ASDVWMFGVCMWEILMHGVKP 217

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  117 bits (295), Expect = 4e-29
 Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 12/219 (5%)

Query: 697 ELGRGGFGAVYRTVL-----RDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG G FG V            G  VA+K L   S      D ++E++ L  + H N+V 
Sbjct: 28  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87

Query: 752 LEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
            +G           LI EF+  GSL ++L +      ++  ++        K + +L   
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK--INLKQQLKYAVQICKGMDYLGSR 145

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPEFACRTV 868
             +H ++ + NVL++   + K+GD+GL + +    + Y +     S + + APE      
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE-CLMQS 204

Query: 869 KITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW 906
           K     DV+ FGV + E++T      S   +        
Sbjct: 205 KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT 243

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  119 bits (301), Expect = 9e-29
 Identities = 51/198 (25%), Positives = 93/198 (46%), Gaps = 13/198 (6%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
            +G+G FG V     R G  VA+K +   +   + + F  E   + ++RH NLV L G  
Sbjct: 200 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 757 WTQSLQL-LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
             +   L ++ E+++ GSL  +L    G + L  +          +++ +L  +N +H +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 314

Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + NVL+      KV D+GL +     +        +  + + APE      K + K D
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREK-KFSTKSD 368

Query: 876 VYGFGVLVLEVVT-GKRP 892
           V+ FG+L+ E+ + G+ P
Sbjct: 369 VWSFGILLWEIYSFGRVP 386

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  115 bits (291), Expect = 2e-28
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 16/208 (7%)

Query: 697 ELGRGGFGAVYRTVLRD-----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG G FG V            G  VA+K L   +  + +  +++E+  L  + H +++ 
Sbjct: 38  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97

Query: 752 LEG---YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
            +G        SLQ L+ E+V  GSL  +L      + +   +     Q   + +A+LH 
Sbjct: 98  YKGCCEDAGAASLQ-LVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHA 152

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPEFACRT 867
            + IH ++ + NVL+D     K+GD+GLA+ +P   + Y +     S + + APE   + 
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE-CLKE 211

Query: 868 VKITDKCDVYGFGVLVLEVVT-GKRPLS 894
            K     DV+ FGV + E++T      S
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQS 239

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  115 bits (290), Expect = 2e-28
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 22/208 (10%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG+G +G VY    L +   +AIK++      +  +    E+     ++H N+V   G +
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 757 WTQSLQLLIY-EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKS----LAHLHQSNI 811
                 + I+ E V GGSL   L    G   L  NE    I    K     L +LH + I
Sbjct: 89  SENG-FIKIFMEQVPGGSLSALLRSKWGP--LKDNE--QTIGFYTKQILEGLKYLHDNQI 143

Query: 812 IHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRT 867
           +H +IK  NVLI+  SG  K+ D+G ++ L       ++   ++  G   YMAPE   + 
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAG-----INPCTETFTGTLQYMAPEIIDKG 198

Query: 868 VK-ITDKCDVYGFGVLVLEVVTGKRPLS 894
            +      D++  G  ++E+ TGK P  
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPPFY 226

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  118 bits (297), Expect = 2e-28
 Identities = 48/206 (23%), Positives = 83/206 (40%), Gaps = 18/206 (8%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGY 755
            LG G  G +    + D R VA+K++    L +     +REV+ L +   HPN++     
Sbjct: 31  VLGHGAEGTIVYRGMFDNRDVAVKRI----LPECFSFADREVQLLRESDEHPNVIRYFCT 86

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +  Q +  E     +L +++ +          E   ++Q T   LAHLH  NI+H +
Sbjct: 87  EKDRQFQYIAIELC-AATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRD 143

Query: 816 IKSSNVLIDGSGE-----PKVGDYGLARLL--PMLDRYVLSSKIQSALGYMAPE--FACR 866
           +K  N+LI            + D+GL + L          S    +  G++APE      
Sbjct: 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE-GWIAPEMLSEDC 202

Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRP 892
               T   D++  G +   V++    
Sbjct: 203 KENPTYTVDIFSAGCVFYYVISEGSH 228

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  115 bits (291), Expect = 3e-28
 Identities = 61/267 (22%), Positives = 105/267 (39%), Gaps = 29/267 (10%)

Query: 643 VRSSTSRSAAALT----LSAGDDFSRSPTTDANSGKLV---MFSGDPDFSTGTHALLNKD 695
           V S  + S A+L       +       P T+ N G L+   +   D ++    H + ++ 
Sbjct: 5   VSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQP 64

Query: 696 CELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
             +GRG FG V+R    + G   A+KK      V+ +     E+     +  P +V L G
Sbjct: 65  R-VGRGSFGEVHRMKDKQTGFQCAVKK------VRLEVFRVEELVACAGLSSPRIVPLYG 117

Query: 755 YYWTQSLQLLIY-EFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAKSLAHLHQSNI 811
                   + I+ E + GGSL + + +   G      E      +    + L +LH   I
Sbjct: 118 AVREGP-WVNIFMELLEGGSLGQLIKQM--GCL---PEDRALYYLGQALEGLEYLHTRRI 171

Query: 812 IHYNIKSSNVLIDGSGEP-KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRT 867
           +H ++K+ NVL+   G    + D+G A  L                G   +MAPE     
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231

Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPLS 894
                K D++    ++L ++ G  P +
Sbjct: 232 -PCDAKVDIWSSCCMMLHMLNGCHPWT 257

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  115 bits (290), Expect = 4e-28
 Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 15/210 (7%)

Query: 697 ELGRGGFGAVYRTVLRDGRP------VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
            LG G FG VY   +           VA+K L      + + DF  E   + K  H N+V
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHL----HEGSGGNFLSWNERFNVIQGTAKSLAHL 806
              G       + ++ E ++GG L   L       S  + L+  +  +V +  A    +L
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156

Query: 807 HQSNIIHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
            +++ IH +I + N L+   G     K+GD+G+AR +     Y         + +M PE 
Sbjct: 157 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPE- 215

Query: 864 ACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           A      T K D + FGVL+ E+ + G  P
Sbjct: 216 AFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  115 bits (290), Expect = 4e-28
 Identities = 54/330 (16%), Positives = 106/330 (32%), Gaps = 60/330 (18%)

Query: 102 LRKLSLSSNNLTGSISPN-LAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNR 160
              L L +N+++  +  +    LQ+L  + L  N +S  I ++ F     L+ + ++KN 
Sbjct: 56  TTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNH 113

Query: 161 FSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIW-GLSALRTLDLSDNLL-EGEIPKGVE 218
              +IP +L   S+L  + +  NR    +P G++ GL  +  +++  N L       G  
Sbjct: 114 LV-EIPPNLP--SSLVELRIHDNRIRK-VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAF 169

Query: 219 SLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRK 278
               L  + +S+   +  IP  +     L  +    N                    +  
Sbjct: 170 DGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ----------------AIEL 210

Query: 279 NLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMA 338
                           L  L L  N+       S+  L  L+ L+   N+L+  +P  + 
Sbjct: 211 EDLLR--------YSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLP 261

Query: 339 NCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLD 398
           +   L  +    N++   +    F                         G        + 
Sbjct: 262 DLKLLQVVYLHTNNIT-KVGVNDFCP--------------------VGFGVKRAYYNGIS 300

Query: 399 LSHNEFSGET--PATIGALSGLQLLNLSRN 426
           L +N        PAT   ++    +     
Sbjct: 301 LFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  108 bits (271), Expect = 1e-25
 Identities = 69/286 (24%), Positives = 111/286 (38%), Gaps = 24/286 (8%)

Query: 284 EVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNL 343
            VPK I        LDL  N  S         LQ L  L    N+++     + +    L
Sbjct: 47  AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104

Query: 344 VALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNE 403
             L  S+N +  ++P  + SS L ++   +N+IR+   G F    S   ++  +++  N 
Sbjct: 105 QKLYISKNHLV-EIPPNLPSS-LVELRIHDNRIRKVPKGVF----SGLRNMNCIEMGGNP 158

Query: 404 FSGETPATIGALSGLQL--LNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEI- 460
               +    GA  GL+L  L +S   L G IP  +   + LN L L  N +  +I  E  
Sbjct: 159 LE-NSGFEPGAFDGLKLNYLRISEAKLTG-IPKDL--PETLNELHLDHNKIQ-AIELEDL 213

Query: 461 GGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLS 520
                L  L L  N +      S+    +L  L L  N L+  +P  +  L  LQ V L 
Sbjct: 214 LRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLH 272

Query: 521 FNSLTG------GLPKQLVNLVHLSSFNISHNHLQ-GELPAGGFFN 559
            N++T             V   + +  ++ +N +   E+    F  
Sbjct: 273 TNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 97.4 bits (243), Expect = 4e-22
 Identities = 42/232 (18%), Positives = 81/232 (34%), Gaps = 30/232 (12%)

Query: 102 LRKLSLSSNNLTGSISPN-LAKLQNLRVIDLSGNSL-SGSIPDEFFKQCGSLRVISLAKN 159
           L +L +  N +   +     + L+N+  I++ GN L +       F     L  + +++ 
Sbjct: 125 LVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEA 182

Query: 160 RFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGV-E 218
           + +  IP  L    TL  ++L  N+  +     +   S L  L L  N +   I  G   
Sbjct: 183 KLT-GIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLS 238

Query: 219 SLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRK 278
            L  LR ++L  N  S  +P G+    LL+ +    N+ +                 +  
Sbjct: 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT----------------KVGV 281

Query: 279 NLFSGEVPKWIGELESLETLDLSGN--KFSGAVPISIGNLQRLKVLNFSANR 328
           N F      +  +      + L  N   +    P +   +     + F   +
Sbjct: 282 NDFCP--VGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 88.2 bits (219), Expect = 6e-19
 Identities = 41/188 (21%), Positives = 66/188 (35%), Gaps = 16/188 (8%)

Query: 77  RVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSL 136
             IE+  N L  +G    G      L  L +S   LT  I  +L   + L  + L  N +
Sbjct: 150 NCIEMGGNPLENSG-FEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKI 205

Query: 137 SGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGL 196
             +I  E   +   L  + L  N+       SLS   TL  ++L +N+ S  +P G+  L
Sbjct: 206 Q-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDL 263

Query: 197 SALRTLDLSDNLLEGEIPKGV-------ESLKNLRVINLSKNMFS-GSIPDGIGSC-SLL 247
             L+ + L  N +  ++                   I+L  N      +      C +  
Sbjct: 264 KLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDR 322

Query: 248 RTIDFSEN 255
             I F   
Sbjct: 323 LAIQFGNY 330

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  116 bits (292), Expect = 5e-28
 Identities = 47/209 (22%), Positives = 88/209 (42%), Gaps = 20/209 (9%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNL--VTLEG 754
           +G GG   V++ +    +  AIK + +        + +  E+  L K++  +   + L  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y  T     ++ E      L+  L +      +   ER +  +   +++  +HQ  I+H 
Sbjct: 124 YEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQHGIVHS 179

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPE----------F 863
           ++K +N LI   G  K+ D+G+A  + P     V  S++ +   YM PE           
Sbjct: 180 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVN-YMPPEAIKDMSSSREN 237

Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
                KI+ K DV+  G ++  +  GK P
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  114 bits (288), Expect = 5e-28
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 15/206 (7%)

Query: 697 ELGRGGFGAVYRTVLR-----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG+G FG+V            G  VA+K+L  S     Q DF+RE++ L  +    +V 
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVK 88

Query: 752 LEG---YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
             G       QSL+ L+ E++  G L   L        L  +          K + +L  
Sbjct: 89  YRGVSYGPGRQSLR-LVMEYLPSGCLRDFLQRHRAR--LDASRLLLYSSQICKGMEYLGS 145

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPEFACRT 867
              +H ++ + N+L++     K+ D+GLA+LLP+  D YV+    QS + + APE +   
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE-SLSD 204

Query: 868 VKITDKCDVYGFGVLVLEVVT-GKRP 892
              + + DV+ FGV++ E+ T   + 
Sbjct: 205 NIFSRQSDVWSFGVVLYELFTYCDKS 230

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  113 bits (285), Expect = 6e-28
 Identities = 48/235 (20%), Positives = 91/235 (38%), Gaps = 41/235 (17%)

Query: 694 KDCELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKV-RHPNLV 750
           +  ++G G FG+V++ V   DG   AIK+          +++  REV     + +H ++V
Sbjct: 15  ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 74

Query: 751 TLEGYY--WTQSLQLLIY-EFVSGGSLHKHLHE-GSGGNFLSWNERFNVIQGTAKSLAHL 806
               Y+  W +   +LI  E+ +GGSL   + E     ++    E  +++    + L ++
Sbjct: 75  ---RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131

Query: 807 HQSNIIHYNIKSSNVLIDGSGEP-------------------KVGDYGLARLLPMLDRYV 847
           H  +++H +IK SN+ I  +  P                   K+GD G    +       
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI------- 184

Query: 848 LSSKIQSALG---YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM 899
             S  Q   G   ++A E          K D++   + V+     +         
Sbjct: 185 --SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  118 bits (298), Expect = 6e-28
 Identities = 92/467 (19%), Positives = 171/467 (36%), Gaps = 40/467 (8%)

Query: 102 LRKLSLSSNNLTGSISP-NLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNR 160
            + LSLS N+++  +   +++ L  LRV+ LS N +  S+    F     L  + ++ NR
Sbjct: 54  TKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNR 111

Query: 161 FSGKIPSSLSLCSTLATINLSSNRFSS-PLPLGIWGLSALRTLDLSDNLLEGEIPKGVES 219
               I     + S L  ++LS N F   P+      L+ L  L LS           V  
Sbjct: 112 LQ-NISCC-PMAS-LRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAH 168

Query: 220 LK-NLRVINLSKNMFSGSIPDGIGS-CSLLRTIDFSENS-FSGNLPETMQKLSLCNFMNL 276
           L  +  +++L      G   + +    + +  + F  NS FS  +  ++  L      N+
Sbjct: 169 LHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNI 228

Query: 277 RKNLFSG----EVPKWIGELESLETLDLSGNKFSGAVPISIGNLQ---RLKVLNFSANRL 329
           + N  +          +    +L  + L   + +    + +        ++ LN     +
Sbjct: 229 KLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTI 288

Query: 330 TGSLPDSMANCMN--LVALDFSQNSMNG--DLPQWIFS--SGLNKVSFAENKIREGMNGP 383
           T  +           L +L              + ++S  + +N    + +         
Sbjct: 289 TERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVC 348

Query: 384 FASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSL--VGPIPVAIGDLKA 441
                 S  S  FL+ + N F+         L  LQ L L RN L     + +   ++ +
Sbjct: 349 P----PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSS 404

Query: 442 LNVLDLSENWLN-GSIPPEIGGAYSLKELRLERNFLAGKIPTSIENC--SSLVSLILSKN 498
           L  LD+S N LN  +       A S+  L L  N     +  S+  C    +  L L  N
Sbjct: 405 LETLDVSLNSLNSHAYDRTCAWAESILVLNLSSN----MLTGSVFRCLPPKVKVLDLHNN 460

Query: 499 NLTGPIPIAIAKLTNLQNVDLSFNSLT---GGLPKQLVNLVHLSSFN 542
            +   IP  +  L  LQ ++++ N L     G+  +L +L ++   +
Sbjct: 461 RIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHD 506

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 74.9 bits (184), Expect = 5e-14
 Identities = 36/164 (21%), Positives = 70/164 (42%), Gaps = 9/164 (5%)

Query: 98  QLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFK--QCGSLRVIS 155
                  L+ + N  T S+    + L+ L+ + L  N L  +            SL  + 
Sbjct: 351 SPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLD 409

Query: 156 LAKNRFSGKIPSSL-SLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIP 214
           ++ N  +        +   ++  +NLSSN  +  +   +     ++ LDL +N +   IP
Sbjct: 410 VSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIP 466

Query: 215 KGVESLKNLRVINLSKNMFSGSIPDGI-GSCSLLRTIDFSENSF 257
           K V  L+ L+ +N++ N    S+PDG+    + L+ I   +N +
Sbjct: 467 KDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 73.4 bits (180), Expect = 1e-13
 Identities = 56/337 (16%), Positives = 111/337 (32%), Gaps = 58/337 (17%)

Query: 75  SNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVI---DL 131
               I+L              L +   L  ++L     T   S  L +    R +   ++
Sbjct: 224 QLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNI 283

Query: 132 SGNSLSGSIPDEFFKQCG----SLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSS 187
              +++  I  E F        SL +  +    F     +  S+ + +    LS +    
Sbjct: 284 YNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPF 343

Query: 188 PLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLL 247
              +     S+   L+ + N+    + +G  +LK L+ + L +N    +           
Sbjct: 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVAL----- 397

Query: 248 RTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSG 307
                        + + M  L   +      +L S    +     ES+  L+LS N  +G
Sbjct: 398 -------------MTKNMSSLETLD--VSLNSLNSHAYDRTCAWAESILVLNLSSNMLTG 442

Query: 308 AVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLN 367
           +V   +    ++KVL+   NR+  S+P  + +   L  L+ + N +   +P  +F     
Sbjct: 443 SVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDR--- 495

Query: 368 KVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEF 404
                                    SLQ++ L  N +
Sbjct: 496 -----------------------LTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 57.2 bits (138), Expect = 2e-08
 Identities = 54/286 (18%), Positives = 97/286 (33%), Gaps = 29/286 (10%)

Query: 278 KNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSM 337
           +NL    VPK +      + L LS N  S      I  L  L+VL  S NR+  SL   +
Sbjct: 41  RNLTH--VPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHV 95

Query: 338 -ANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIRE-GMNGPFASSGSSFESLQ 395
                +L  LD S N +  ++     +S L  +  + N      +   F     +   L 
Sbjct: 96  FLFNQDLEYLDVSHNRL-QNISCCPMAS-LRHLDLSFNDFDVLPVCKEF----GNLTKLT 149

Query: 396 FLDLSHNEFSGETPATIGALS-GLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNG 454
           FL LS  +F       +  L     LL+L    + G    ++       +  +       
Sbjct: 150 FLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLF 209

Query: 455 SIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNL 514
           S+   +    +L  L+L    L  +    +    S ++   +  N+T            L
Sbjct: 210 SVQVNMSVN-ALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT------------L 256

Query: 515 QNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNT 560
           Q+++ ++         Q      +   NI +  +   +    F  +
Sbjct: 257 QHIETTWKCSVKLF--QFFWPRPVEYLNIYNLTITERIDREEFTYS 300

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 56.4 bits (136), Expect = 3e-08
 Identities = 40/184 (21%), Positives = 63/184 (34%), Gaps = 7/184 (3%)

Query: 393 SLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGD-LKALNVLDLSENW 451
             + L LS N  S      I  LS L++L LS N +   +   +    + L  LD+S N 
Sbjct: 53  RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVSHNR 111

Query: 452 LNGSIPPEIGGAYSLKELRLERN-FLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAK 510
           L  +I        SL+ L L  N F    +     N + L  L LS         + +A 
Sbjct: 112 L-QNISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAH 168

Query: 511 L-TNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGN 569
           L  +   +DL    + GG  + L          + H +    +      N +    +   
Sbjct: 169 LHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNI 228

Query: 570 PSLC 573
               
Sbjct: 229 KLND 232

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  115 bits (289), Expect = 9e-28
 Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 15/210 (7%)

Query: 697 ELGRGGFGAVYRTVLRDGRP------VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
            LG G FG VY   +           VA+K L      + + DF  E   + K  H N+V
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHL----HEGSGGNFLSWNERFNVIQGTAKSLAHL 806
              G       + ++ E ++GG L   L       S  + L+  +  +V +  A    +L
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197

Query: 807 HQSNIIHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
            +++ IH +I + N L+   G     K+GD+G+AR +     Y         + +M PE 
Sbjct: 198 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPE- 256

Query: 864 ACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           A      T K D + FGVL+ E+ + G  P
Sbjct: 257 AFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  112 bits (283), Expect = 1e-27
 Identities = 56/201 (27%), Positives = 101/201 (50%), Gaps = 14/201 (6%)

Query: 697 ELGRGGFGAVYRTVLR-----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG+G FG+V            G  VA+KKL  S+  +   DFERE++ L  ++H N+V 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVK 75

Query: 752 LEG---YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
            +G       ++L+ LI E++  GSL  +L +      +   +         K + +L  
Sbjct: 76  YKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGT 132

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPEFACRT 867
              IH ++ + N+L++     K+GD+GL ++LP   + + +    +S + + APE +   
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE-SLTE 191

Query: 868 VKITDKCDVYGFGVLVLEVVT 888
            K +   DV+ FGV++ E+ T
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  112 bits (283), Expect = 2e-27
 Identities = 55/256 (21%), Positives = 90/256 (35%), Gaps = 33/256 (12%)

Query: 102 LRKLSLSSNNLTGSISPN-LAKLQNLRVIDLSGNSLS-GSIPDEFFKQCGSLRVISLAKN 159
             +L L SN L  S+      KL  L  + LS N LS      +      SL+ + L+ N
Sbjct: 30  ATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88

Query: 160 RFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGI-WGLSALRTLDLSDNLLEGEIPKGV- 217
                + S+      L  ++   +         +   L  L  LD+S          G+ 
Sbjct: 89  GVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIF 146

Query: 218 ESLKNLRVINLSKNMFSGSIPDGI-GSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNL 276
             L +L V+ ++ N F  +    I      L  +D S+                     L
Sbjct: 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE----------------QL 190

Query: 277 RKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDS 336
               F+         L SL+ L++S N F          L  L+VL++S N +  S    
Sbjct: 191 SPTAFNS--------LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 242

Query: 337 MAN-CMNLVALDFSQN 351
           + +   +L  L+ +QN
Sbjct: 243 LQHFPSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  107 bits (268), Expect = 2e-25
 Identities = 57/286 (19%), Positives = 92/286 (32%), Gaps = 37/286 (12%)

Query: 294 SLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSM 353
           S   +  +    + +VP  I        L   +N+L             L  L  S N  
Sbjct: 8   SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSN-- 62

Query: 354 NGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIG 413
                                 +        +  G++  SL++LDLS N       +   
Sbjct: 63  ---------------------GLSFKGCCSQSDFGTT--SLKYLDLSFNGVI-TMSSNFL 98

Query: 414 ALSGLQLLNLSRNSLVG-PIPVAIGDLKALNVLDLSENWLNGSIPPEI-GGAYSLKELRL 471
            L  L+ L+   ++L           L+ L  LD+S           I  G  SL+ L++
Sbjct: 99  GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKM 157

Query: 472 ERN-FLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPK 530
             N F    +P       +L  L LS+  L    P A   L++LQ +++S N+       
Sbjct: 158 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 217

Query: 531 QLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVL---GNPSLC 573
               L  L   + S NH+          +  S  + L    N   C
Sbjct: 218 PYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFAC 262

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 55/279 (19%), Positives = 103/279 (36%), Gaps = 34/279 (12%)

Query: 77  RVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSL 136
             + L+ NGLS  G   +       L+ L LS N +  ++S N   L+ L  +D   ++L
Sbjct: 55  TKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL 113

Query: 137 SGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIW-G 195
                   F    +L  + ++            +  S+L  + ++ N F       I+  
Sbjct: 114 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173

Query: 196 LSALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKNMFSGSIPDGI-GSCSLLRTIDFS 253
           L  L  LDLS   LE ++      SL +L+V+N+S N F  S+        + L+ +D+S
Sbjct: 174 LRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYS 231

Query: 254 ENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFS---GAVP 310
            N       +           +   +               L  L+L+ N F+       
Sbjct: 232 LNHIM-TSKKQE-------LQHFPSS---------------LAFLNLTQNDFACTCEHQS 268

Query: 311 ISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFS 349
                ++  + L     R+  + P      M +++L+ +
Sbjct: 269 FL-QWIKDQRQLLVEVERMECATPSDKQG-MPVLSLNIT 305

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 60/288 (20%), Positives = 103/288 (35%), Gaps = 41/288 (14%)

Query: 125 NLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNR 184
           +   I  +   L+ S+P        S   + L  N+            + L  ++LSSN 
Sbjct: 8   SGTEIRCNSKGLT-SVPTGIPS---SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNG 63

Query: 185 --FSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGI- 241
             F        +G ++L+ LDLS N +   +      L+ L  ++   +         + 
Sbjct: 64  LSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 122

Query: 242 GSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLS 301
            S   L  +D S                          +F+G        L SLE L ++
Sbjct: 123 LSLRNLIYLDISHTHTR----------------VAFNGIFNG--------LSSLEVLKMA 158

Query: 302 GNKFSGAVPISI-GNLQRLKVLNFSANRLTGSLPDSMANCM-NLVALDFSQNSMNGDLPQ 359
           GN F       I   L+ L  L+ S  +L   L  +  N + +L  L+ S N+    L  
Sbjct: 159 GNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDT 216

Query: 360 WIFS--SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFS 405
           + +   + L  + ++ N I            S   SL FL+L+ N+F+
Sbjct: 217 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPS---SLAFLNLTQNDFA 261

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  112 bits (283), Expect = 2e-27
 Identities = 46/208 (22%), Positives = 95/208 (45%), Gaps = 9/208 (4%)

Query: 696 CELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
             +G G    V           VAIK++ +     S ++  +E++ + +  HPN+V+   
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80

Query: 755 YYWTQSLQLLIYEFVSGGSLH---KHLHEGSGGNFLSWNERF--NVIQGTAKSLAHLHQS 809
            +  +    L+ + +SGGS+    KH+           +E     +++   + L +LH++
Sbjct: 81  SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACR 866
             IH ++K+ N+L+   G  ++ D+G++  L        +   ++ +G   +MAPE   +
Sbjct: 141 GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ 200

Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPLS 894
                 K D++ FG+  +E+ TG  P  
Sbjct: 201 VRGYDFKADIWSFGITAIELATGAAPYH 228

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  113 bits (284), Expect = 2e-27
 Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 14/201 (6%)

Query: 697 ELGRGGFGAVYRTVL-----RDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +LG+G FG+V            G  VA+KKL  S+  +   DFERE++ L  ++H N+V 
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVK 106

Query: 752 LEG---YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
            +G       ++L+ LI E++  GSL  +L +      +   +         K + +L  
Sbjct: 107 YKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGT 163

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPEFACRT 867
              IH ++ + N+L++     K+GD+GL ++LP   + Y +    +S + + APE +   
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE-SLTE 222

Query: 868 VKITDKCDVYGFGVLVLEVVT 888
            K +   DV+ FGV++ E+ T
Sbjct: 223 SKFSVASDVWSFGVVLYELFT 243

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  117 bits (295), Expect = 2e-27
 Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 10/201 (4%)

Query: 697 ELGRGGFGAVYRTVLRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
            +G G FG V++ +          VAIK     +    +E F +E   + +  HP++V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
            G   T++   +I E  + G L   L        L            + +LA+L     +
Sbjct: 457 IGVI-TENPVWIIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYLESKRFV 513

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           H +I + NVL+  +   K+GD+GL+R +     Y  +SK +  + +MAPE +    + T 
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPE-SINFRRFTS 571

Query: 873 KCDVYGFGVLVLEVVT-GKRP 892
             DV+ FGV + E++  G +P
Sbjct: 572 ASDVWMFGVCMWEILMHGVKP 592

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  116 bits (292), Expect = 3e-27
 Identities = 67/361 (18%), Positives = 131/361 (36%), Gaps = 44/361 (12%)

Query: 98  QLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLA 157
            +    +L L+  NL+ S+  NL     + V++++ N+L  S+P+       SL  +   
Sbjct: 57  LINQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELP----ASLEYLDAC 108

Query: 158 KNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGV 217
            NR S  +P   +    L   ++ +N+ +  LP      + L  ++  +N L   +P   
Sbjct: 109 DNRLS-TLPELPASLKHL---DVDNNQLTM-LPELP---ALLEYINADNNQLT-MLP--- 156

Query: 218 ESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKL----SLCNF 273
           E   +L V+++  N  +  +P+   S   L  +D S N    +LP    +         F
Sbjct: 157 ELPTSLEVLSVRNNQLT-FLPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIF 211

Query: 274 MNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSL 333
              R+N  +  +P+ I  L+   T+ L  N  S  +  S+         +      +   
Sbjct: 212 FRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS--- 267

Query: 334 PDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIR--EGMNGPFASSGSSF 391
                  M+    +     +   +  W   +  + VS   +     E  N   A      
Sbjct: 268 -------MSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLS 320

Query: 392 ESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENW 451
           +++   + S   F  +  A +  LS    L     ++      +  D  AL   +L +  
Sbjct: 321 DTVSARNTS--GFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTL 378

Query: 452 L 452
           L
Sbjct: 379 L 379

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  110 bits (275), Expect = 4e-25
 Identities = 60/321 (18%), Positives = 116/321 (36%), Gaps = 41/321 (12%)

Query: 244 CSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGE----VPKWIGE--LESLET 297
             +      S+NSF   +  T        +    K    GE        + E  +     
Sbjct: 5   LPINNNFSLSQNSFYNTISGTYADYFSA-WDKWEKQALPGENRNEAVSLLKECLINQFSE 63

Query: 298 LDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDL 357
           L L+    S ++P ++    ++ VL  + N L  SLP+  A+   L  LD   N ++  L
Sbjct: 64  LQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPAS---LEYLDACDNRLS-TL 115

Query: 358 PQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSG 417
           P+    + L  +    N++                 L++++  +N+ +   P        
Sbjct: 116 PELP--ASLKHLDVDNNQLT--------MLPELPALLEYINADNNQLT-MLPELPT---S 161

Query: 418 LQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKE----LRLER 473
           L++L++  N L   +P     L+    LD+S N L  S+P      +  +E     R   
Sbjct: 162 LEVLSVRNNQLTF-LPELPESLE---ALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRE 216

Query: 474 NFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLV 533
           N +   IP +I +     ++IL  N L+  I  ++++ T   +        +    +Q  
Sbjct: 217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ-- 273

Query: 534 NLVHLSSFNISHNHLQGELPA 554
           N +H    +           +
Sbjct: 274 NTLHRPLADAVTAWFPENKQS 294

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  112 bits (281), Expect = 4e-27
 Identities = 59/321 (18%), Positives = 110/321 (34%), Gaps = 45/321 (14%)

Query: 28  LNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNGLS 87
             P  +     L     ++      L    +  DT  +        +S  +  LT+    
Sbjct: 20  PKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAAR 79

Query: 88  LTGRIGRGLLQL---QFLRKLSLSSNNLTGSISPNLAKLQ--NLRVIDLSGNSLSG---S 139
           +  RI  G L++     L++L+L +  +TG+  P L +    +L +++L   S +     
Sbjct: 80  IPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAW 139

Query: 140 IPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGI----WG 195
           + +        L+V+S+A+          + +   L+T++LS N       L        
Sbjct: 140 LAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK 199

Query: 196 LSALRTLDLSDNLLE---GEIPKGVESLKNLRVINLSKNMFSGSIPDGIGS-CSLLRTID 251
              L+ L L +  +E   G       +   L+ ++LS N    +         S L +++
Sbjct: 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLN 259

Query: 252 FSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPI 311
            S                              +VPK +     L  LDLS N+     P 
Sbjct: 260 LSFTGLK-------------------------QVPKGL--PAKLSVLDLSYNRLDR-NP- 290

Query: 312 SIGNLQRLKVLNFSANRLTGS 332
           S   L ++  L+   N    S
Sbjct: 291 SPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =   99 bits (249), Expect = 4e-23
 Identities = 63/315 (20%), Positives = 94/315 (29%), Gaps = 42/315 (13%)

Query: 233 FSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGEL 292
           FS   PD     S    +  ++    G         SL   +              I + 
Sbjct: 17  FSDPKPD---WSSAFNCLGAADVELYGGG------RSLEYLLKRVDTEADLGQFTDIIKS 67

Query: 293 ESLETLDLSGNKFSGAVP---ISIGNLQRLKVLNFSANRLTGSLPDSMANCM--NLVALD 347
            SL+ L +   +    +    + +  +  L+ L      +TG+ P  +      +L  L+
Sbjct: 68  LSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILN 127

Query: 348 FSQNSMNG------DLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSH 401
               S         +L QW+    L  +S A+       N         F +L  LDLS 
Sbjct: 128 LRNVSWATRDAWLAELQQWLKPG-LKVLSIAQAHSL---NFSC-EQVRVFPALSTLDLSD 182

Query: 402 NEFSGETPATI----GALSGLQLLNLSRN---SLVGPIPVAIGDLKALNVLDLSENWLNG 454
           N   GE              LQ+L L      +  G           L  LDLS N L  
Sbjct: 183 NPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD 242

Query: 455 SIPPEI-GGAYSLKELRLERNFLAGKIPTSIENC--SSLVSLILSKNNLTGPIPIAIAKL 511
           +           L  L L    L       +     + L  L LS N L    P    +L
Sbjct: 243 AAGAPSCDWPSQLNSLNLSFTGL-----KQVPKGLPAKLSVLDLSYNRLDR-NPS-PDEL 295

Query: 512 TNLQNVDLSFNSLTG 526
             + N+ L  N    
Sbjct: 296 PQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 95.7 bits (238), Expect = 1e-21
 Identities = 52/278 (18%), Positives = 81/278 (29%), Gaps = 20/278 (7%)

Query: 288 WIGELESLETLDLSGNKFSGAVPIS-IGNLQRLKVLNFSANRLTGSLPDSMANCMN---L 343
             G   SLE L    +  +     + I     LK L   A R+   +       +    L
Sbjct: 38  LYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGL 97

Query: 344 VALDFSQNSMNGDLPQWIFS---SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLS 400
             L      + G  P  +       LN ++                       L+ L ++
Sbjct: 98  QELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIA 157

Query: 401 HNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAI----GDLKALNVLDLSENWLN--- 453
                  +   +     L  L+LS N  +G   +           L VL L    +    
Sbjct: 158 QAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPS 217

Query: 454 GSIPPEIGGAYSLKELRLERNFLAGKIPTSI-ENCSSLVSLILSKNNLTGPIPIAIAKLT 512
           G           L+ L L  N L         +  S L SL LS   L   +P  +    
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL--PA 274

Query: 513 NLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQG 550
            L  +DLS+N L    P     L  + + ++  N    
Sbjct: 275 KLSVLDLSYNRLD-RNPSPD-ELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 92.3 bits (229), Expect = 2e-20
 Identities = 52/272 (19%), Positives = 89/272 (32%), Gaps = 43/272 (15%)

Query: 174 TLATINLSSNRFSSPLP---LGIWGLSALRTLDLSDNLLEGEIPK--GVESLKNLRVINL 228
           +L  + + + R  S +    L + G+S L+ L L +  + G  P      +  +L ++NL
Sbjct: 69  SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128

Query: 229 SKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKW 288
               ++                D         L   ++ LS+                + 
Sbjct: 129 RNVSWAT--------------RDAWLAELQQWLKPGLKVLSIAQ------AHSLNFSCEQ 168

Query: 289 IGELESLETLDLSGNKFSG-------AVPISIGNLQRLKVLNFSANRLTGSLPDSMANCM 341
           +    +L TLDLS N   G         P+    LQ L + N      +G      A  +
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228

Query: 342 NLVALDFSQNSMNGDLPQWIFS--SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDL 399
            L  LD S NS+            S LN ++ +   +++               L  LDL
Sbjct: 229 QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQV-------PKGLPAKLSVLDL 281

Query: 400 SHNEFSGETPATIGALSGLQLLNLSRNSLVGP 431
           S+N            L  +  L+L  N  +  
Sbjct: 282 SYNRLDRNPS--PDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 90.3 bits (224), Expect = 8e-20
 Identities = 54/272 (19%), Positives = 89/272 (32%), Gaps = 22/272 (8%)

Query: 246 LLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELES---LETLDLSG 302
           LL+ +D   +       + ++ LSL   + +R       +      +     L+ L L  
Sbjct: 48  LLKRVDTEADLG--QFTDIIKSLSL-KRLTVRAARIPSRILFGALRVLGISGLQELTLEN 104

Query: 303 NKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMAN------CMNLVALDFSQNSMNG- 355
            + +G  P  +       +   +   ++ +  D+            L  L  +Q      
Sbjct: 105 LEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNF 164

Query: 356 DLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEF---SGETPATI 412
              Q      L+ +  ++N          A     F +LQ L L +      SG   A  
Sbjct: 165 SCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALA 224

Query: 413 GALSGLQLLNLSRNSLVG-PIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRL 471
            A   LQ L+LS NSL       +      LN L+LS   L   +P  +     L  L L
Sbjct: 225 AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDL 281

Query: 472 ERNFLAGKIPTSIENCSSLVSLILSKNNLTGP 503
             N L    P S +    + +L L  N     
Sbjct: 282 SYNRLDR-NP-SPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 75.7 bits (186), Expect = 6e-15
 Identities = 43/257 (16%), Positives = 77/257 (29%), Gaps = 33/257 (12%)

Query: 317 QRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKI 376
           +     NFS  +   S   S  NC+    ++      + +       +  +   F +   
Sbjct: 10  EESCSCNFSDPKPDWS---SAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDI-- 64

Query: 377 REGMNGPFASSGSSFESLQFLDLSHNEFSGETPAT---IGALSGLQLLNLSRNSLVGPIP 433
                           SL+ L +               +  +SGLQ L L    + G  P
Sbjct: 65  ------------IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAP 112

Query: 434 VAIGDLKALNVLDLS-ENWLNGSIPPEIGGAY-----SLKELRLERNFLAGKIPTSIENC 487
             + +    ++  L+  N    +    +          LK L + +          +   
Sbjct: 113 PPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF 172

Query: 488 SSLVSLILSKNNLTGPIPIAIA----KLTNLQNVDLSFN---SLTGGLPKQLVNLVHLSS 540
            +L +L LS N   G   +  A    K   LQ + L      + +G         V L  
Sbjct: 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQG 232

Query: 541 FNISHNHLQGELPAGGF 557
            ++SHN L+    A   
Sbjct: 233 LDLSHNSLRDAAGAPSC 249

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  111 bits (279), Expect = 4e-27
 Identities = 46/218 (21%), Positives = 86/218 (39%), Gaps = 26/218 (11%)

Query: 697 ELGRGGFGAVYRTVLRDGR--------PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPN 748
            LG+G F  +++ V R+           V +K L  +      E F      + K+ H +
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-NYSESFFEAASMMSKLSHKH 73

Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           LV   G        +L+ EFV  GSL  +L +      ++   +  V +  A ++  L +
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC--INILWKLEVAKQLAAAMHFLEE 131

Query: 809 SNIIHYNIKSSNVLIDGSGEP--------KVGDYGLARLLPMLDRYVLSSKIQSALGYMA 860
           + +IH N+ + N+L+    +         K+ D G++  +   D             ++ 
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP------WVP 185

Query: 861 PEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWK 897
           PE       +    D + FG  + E+ + G +PLS   
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  111 bits (279), Expect = 5e-27
 Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 11/209 (5%)

Query: 692 LNKDCELGRGGFGAVYRTVLRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHP 747
            + D  +G+G FG VY     D        AIK L+  + ++  E F RE   +  + HP
Sbjct: 23  THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82

Query: 748 NLVTLEGY-YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHL 806
           N++ L G     + L  ++  ++  G L + +   S     +  +  +     A+ + +L
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR--SPQRNPTVKDLISFGLQVARGMEYL 140

Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL--GYMAPEFA 864
            +   +H ++ + N ++D S   KV D+GLAR +   + Y +     + L   + A E +
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE-S 199

Query: 865 CRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
            +T + T K DV+ FGVL+ E++T G  P
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  111 bits (279), Expect = 6e-27
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 11/204 (5%)

Query: 697 ELGRGGFGAVYRTVLRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
            +GRG FG VY   L D        A+K L   + +     F  E   +    HPN+++L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91

Query: 753 EGY-YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
            G    ++   L++  ++  G L   +   +     +  +        AK + +L     
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYLASKKF 149

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL--GYMAPEFACRTVK 869
           +H ++ + N ++D     KV D+GLAR +   + Y + +K  + L   +MA E + +T K
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-SLQTQK 208

Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T K DV+ FGVL+ E++T G  P
Sbjct: 209 FTTKSDVWSFGVLLWELMTRGAPP 232

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  110 bits (277), Expect = 8e-27
 Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 19/202 (9%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G FG VY    +     +A+K L  S L K   +    RE++    +RHPN++ +  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+  +    L+ EF   G L+K L     G F        + +  A +L + H+  +IH 
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQ--KHGRFDEQRSATFMEE-LADALHYCHERKVIHR 138

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKIT 871
           +IK  N+L+   GE K+ D+G +   P       S + ++  G   Y+ PE      K  
Sbjct: 139 DIKPENLLMGYKGELKIADFGWSVHAP-------SLRRRTMCGTLDYLPPEMIEG--KTH 189

Query: 872 D-KCDVYGFGVLVLEVVTGKRP 892
           D K D++  GVL  E + G  P
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPP 211

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  111 bits (279), Expect = 1e-26
 Identities = 29/230 (12%), Positives = 53/230 (23%), Gaps = 40/230 (17%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLE 753
            L  G    V+    +      A+K  T+ +       E          ++   +     
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 754 GY---------------------------YWTQSLQLLIYEFVSG--GSLHKHLHE-GSG 783
                                        Y   +  LL+    S     L   L      
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANY-LLLMPAASVDLELLFSTLDFVYVF 187

Query: 784 GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML 843
                      +     +  A+L    ++H +    N+ I   G   +GD      +   
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT- 246

Query: 844 DRYVLSSKIQSALGYMAPEFA-CRTVKITDKCDVYGFGVLVLEVVTGKRP 892
                       + Y   EF    T   T   + +  G+ +  V     P
Sbjct: 247 ----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  112 bits (281), Expect = 3e-26
 Identities = 47/238 (19%), Positives = 87/238 (36%), Gaps = 33/238 (13%)

Query: 682 PDFSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKL 741
           P+F      L+  +  LG G  G V       GRPVA+K++    L+   +    E+K L
Sbjct: 7   PNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM----LIDFCDIALMEIKLL 62

Query: 742 GKV-RHPNLVTLEGYYWTQSLQLLIYEFVSGGSLH----KHLHEGSGGNFLSWNERFNVI 796
            +   HPN++       T     +  E     +L                       +++
Sbjct: 63  TESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLL 121

Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEP-------------KVGDYGLARLLPML 843
           +  A  +AHLH   IIH ++K  N+L+  S                 + D+GL + L   
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS- 180

Query: 844 DRYVLSSKIQSALG---YMAPE------FACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
            +    + + +  G   + APE            ++T   D++  G +   +++  + 
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  109 bits (275), Expect = 6e-26
 Identities = 37/211 (17%), Positives = 83/211 (39%), Gaps = 15/211 (7%)

Query: 696 CELGRG--GFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVT 751
             +G+G      V        G  V ++++ + +         + E+       HPN+V 
Sbjct: 31  TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAKSLAHLHQS 809
               +   +   ++  F++ GS    +           NE     ++QG  K+L ++H  
Sbjct: 91  YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM---NELAIAYILQGVLKALDYIHHM 147

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLL--PMLDRYVLSSKIQSALG---YMAPEFA 864
             +H ++K+S++LI   G+  +        +      + V+    + ++    +++PE  
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207

Query: 865 CRTVKITD-KCDVYGFGVLVLEVVTGKRPLS 894
            + ++  D K D+Y  G+   E+  G  P  
Sbjct: 208 QQNLQGYDAKSDIYSVGITACELANGHVPFK 238

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  108 bits (271), Expect = 7e-26
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 16/210 (7%)

Query: 696 CELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
            ++G+G FG V++ +  R  + VAIK + +       ED ++E+  L +   P +    G
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87

Query: 755 -YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
            Y     L +++ E++ GGS    L  G     L   +   +++   K L +LH    IH
Sbjct: 88  SYLKDTKLWIIM-EYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSEKKIH 142

Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKI 870
            +IK++NVL+   GE K+ D+G+A  L          K  + +G   +MAPE   +    
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTD-----TQIKRNTFVGTPFWMAPEVI-KQSAY 196

Query: 871 TDKCDVYGFGVLVLEVVTGKRPLSTWKMMW 900
             K D++  G+  +E+  G+ P S    M 
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELHPMK 226

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  107 bits (269), Expect = 9e-26
 Identities = 53/201 (26%), Positives = 96/201 (47%), Gaps = 14/201 (6%)

Query: 698 LGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+G F  VYR   +  G  VAIK +   ++ K+   +  + EVK   +++HP+++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           Y+   +   L+ E    G ++++L         S NE  + +      + +LH   I+H 
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKP--FSENEARHFMHQIITGMLYLHSHGILHR 136

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKIT 871
           ++  SN+L+  +   K+ D+GLA  L M        K  +  G   Y++PE A R+    
Sbjct: 137 DLTLSNLLLTRNMNIKIADFGLATQLKMPH-----EKHYTLCGTPNYISPEIATRS-AHG 190

Query: 872 DKCDVYGFGVLVLEVVTGKRP 892
            + DV+  G +   ++ G+ P
Sbjct: 191 LESDVWSLGCMFYTLLIGRPP 211

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  108 bits (272), Expect = 1e-25
 Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 11/204 (5%)

Query: 697 ELGRGGFGAVYRTVLRDGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
            +GRG FG VY   L D        A+K L   + +     F  E   +    HPN+++L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155

Query: 753 EGY-YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
            G    ++   L++  ++  G L   +   +     +  +        AK +  L     
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFLASKKF 213

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL--GYMAPEFACRTVK 869
           +H ++ + N ++D     KV D+GLAR +   +   + +K  + L   +MA E + +T K
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE-SLQTQK 272

Query: 870 ITDKCDVYGFGVLVLEVVT-GKRP 892
            T K DV+ FGVL+ E++T G  P
Sbjct: 273 FTTKSDVWSFGVLLWELMTRGAPP 296

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  107 bits (268), Expect = 2e-25
 Identities = 68/229 (29%), Positives = 107/229 (46%), Gaps = 26/229 (11%)

Query: 676 VMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDF 734
           V    DP+       +     ELG G FG VY+      G   A K +   S  +  ED+
Sbjct: 11  VRRDLDPN------EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-LEDY 63

Query: 735 EREVKKLGKVRHPNLVTLEG-YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF 793
             E++ L    HP +V L G YY    L ++I EF  GG++   + E   G  L+  +  
Sbjct: 64  IVEIEILATCDHPYIVKLLGAYYHDGKLWIMI-EFCPGGAVDAIMLELDRG--LTEPQIQ 120

Query: 794 NVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGL-ARLLPMLDRYVLSSKI 852
            V +   ++L  LH   IIH ++K+ NVL+   G+ ++ D+G+ A+ L  L       K 
Sbjct: 121 VVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL------QKR 174

Query: 853 QSALG---YMAPE-FACRTVKITD---KCDVYGFGVLVLEVVTGKRPLS 894
            S +G   +MAPE   C T+K T    K D++  G+ ++E+   + P  
Sbjct: 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 223

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  107 bits (268), Expect = 4e-25
 Identities = 30/242 (12%), Positives = 67/242 (27%), Gaps = 21/242 (8%)

Query: 697 ELGRGGFGAVYR------TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
            LG G F  VY          ++ +   +K     +         + +++L        +
Sbjct: 72  LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-PANPWEFYIGTQLMERLKPSMQHMFM 130

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNF--LSWNERFNVIQGTAKSLAHLHQ 808
                +  Q+  +L+ E  S G+L   ++         +      +        +  +H 
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190

Query: 809 SNIIHYNIKSSNVLIDGSGEP-----------KVGDYGLARLLPMLDRYVLSSKIQSALG 857
             IIH +IK  N ++                  + D G +  + +  +  + +      G
Sbjct: 191 CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSG 250

Query: 858 YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWR 917
           +   E          + D +G    V  ++ G       +                  W 
Sbjct: 251 FQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWN 309

Query: 918 NV 919
             
Sbjct: 310 EF 311

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  106 bits (266), Expect = 4e-25
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 16/211 (7%)

Query: 697 ELGRGGFGAVYRTVLRDG----RPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVT 751
            LG+G FG+V    L+        VA+K L    +  S  E+F RE   + +  HP++  
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89

Query: 752 LEG------YYWTQSLQLLIYEFVSGGSLHKHLHE---GSGGNFLSWNERFNVIQGTAKS 802
           L G            + ++I  F+  G LH  L     G     L        +   A  
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE 862
           + +L   N IH ++ + N ++       V D+GL+R +   D Y      +  + ++A E
Sbjct: 150 MEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE 209

Query: 863 FACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
            +      T   DV+ FGV + E++T G+ P
Sbjct: 210 -SLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  106 bits (267), Expect = 4e-25
 Identities = 47/222 (21%), Positives = 93/222 (41%), Gaps = 36/222 (16%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ----------------EDFEREVKKL 741
           L +G F  +     +D +  A+KK   S L K +                +DF+ E++ +
Sbjct: 39  LNQGKFNKIIL-CEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 742 GKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFNV 795
             +++   +T EG         +IYE++   S+         L +           +  +
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC-I 156

Query: 796 IQGTAKSLAHLH-QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQS 854
           I+    S +++H + NI H ++K SN+L+D +G  K+ D+G +  +          KI+ 
Sbjct: 157 IKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV-------DKKIKG 209

Query: 855 ALG---YMAPE-FACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
           + G   +M PE F+  +     K D++  G+ +  +     P
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  106 bits (266), Expect = 5e-25
 Identities = 60/229 (26%), Positives = 109/229 (47%), Gaps = 29/229 (12%)

Query: 674 KLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQE 732
           ++V+  GDP        LL+   ++G G  G V        GR VA+K + +    + Q+
Sbjct: 35  RMVVDQGDPR------LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDL----RKQQ 84

Query: 733 DFE---REVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW 789
             E    EV  +   +H N+V +   Y       ++ EF+ GG+L   + +      L+ 
Sbjct: 85  RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR----LNE 140

Query: 790 NERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGL-ARLLPMLDRYVL 848
            +   V +   ++LA+LH   +IH +IKS ++L+   G  K+ D+G  A++   +     
Sbjct: 141 EQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV----- 195

Query: 849 SSKIQSALG---YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
             K +S +G   +MAPE   R+     + D++  G++V+E+V G+ P  
Sbjct: 196 -PKRKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYF 242

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  105 bits (265), Expect = 8e-25
 Identities = 49/218 (22%), Positives = 90/218 (41%), Gaps = 24/218 (11%)

Query: 698 LGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGY 755
           L  GGF  VY    +  GR  A+K+L  +   +      +EV  + K+  HPN+V     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEE-EKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 756 YW-------TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
                    T   + L+   +  G L + L +      LS +    +   T +++ H+H+
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154

Query: 809 SN--IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG--------- 857
               IIH ++K  N+L+   G  K+ D+G A  +     Y  S++ ++ +          
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214

Query: 858 -YMAPE-FACRTVK-ITDKCDVYGFGVLVLEVVTGKRP 892
            Y  PE     +   I +K D++  G ++  +   + P
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  106 bits (266), Expect = 1e-24
 Identities = 27/239 (11%), Positives = 61/239 (25%), Gaps = 38/239 (15%)

Query: 691 LLNKDCELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKS--QEDFEREV---KKLGKV 744
            L +   LG+    A    T    G    +     +    S   +  + EV   + L  +
Sbjct: 79  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138

Query: 745 RHPNLV--------------------------TLEGYYWTQSLQLLIYEFVSGGSLHKHL 778
           ++                                   +      L      +  +  + L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198

Query: 779 HE-GSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLA 837
               S    L  + R  +     + LA LH   ++H  ++  ++++D  G   +  +   
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 258

Query: 838 RLLPMLDRYVLSSKIQSALGYMAPEFAC----RTVKITDKCDVYGFGVLVLEVVTGKRP 892
                        +  +     A             +T   D +  G+ +  +     P
Sbjct: 259 VRD-GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  105 bits (263), Expect = 1e-24
 Identities = 50/210 (23%), Positives = 95/210 (45%), Gaps = 15/210 (7%)

Query: 697 ELGRGGFGAVYRTVLRDGRP------VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG+G FG VY  V +          VAIK +  ++ ++ + +F  E   + +    ++V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHL-------HEGSGGNFLSWNERFNVIQGTAKSL 803
            L G        L+I E ++ G L  +L                S ++   +    A  +
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151

Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
           A+L+ +  +H ++ + N ++      K+GD+G+ R +   D Y    K    + +M+PE 
Sbjct: 152 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE- 210

Query: 864 ACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           + +    T   DV+ FGV++ E+ T  ++P
Sbjct: 211 SLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  103 bits (260), Expect = 2e-24
 Identities = 53/242 (21%), Positives = 107/242 (44%), Gaps = 23/242 (9%)

Query: 663 SRSPTTDANSGKLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTV-LRDGRPVAIKK 721
              P            +  P+       + +   +LG G +G+VY+ +    G+ VAIK+
Sbjct: 8   RNPPRRQLKKLDEDSLTKQPE------EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ 61

Query: 722 LTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEG 781
           +    +    ++  +E+  + +   P++V   G Y+  +   ++ E+   GS+   +   
Sbjct: 62  V---PVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR 118

Query: 782 SGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGL-ARLL 840
           +    L+ +E   ++Q T K L +LH    IH +IK+ N+L++  G  K+ D+G+  +L 
Sbjct: 119 NKT--LTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176

Query: 841 PMLDRYVLSSKIQSALG---YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWK 897
             +      +K  + +G   +MAPE            D++  G+  +E+  GK P +   
Sbjct: 177 DTM------AKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIH 229

Query: 898 MM 899
            M
Sbjct: 230 PM 231

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  104 bits (261), Expect = 2e-24
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 27/218 (12%)

Query: 694 KDCELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVT 751
               +G G +G VY+   ++ G+  AIK + V+     +E+ ++E+  L K   H N+ T
Sbjct: 28  LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIAT 85

Query: 752 LEGYYWTQSLQL------LIYEFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAKSL 803
             G +  ++         L+ EF   GS+   +    G       E +   + +   + L
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL---KEEWIAYICREILRGL 142

Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMA 860
           +HLHQ  +IH +IK  NVL+  + E K+ D+G++  L          +  + +G   +MA
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-----TVGRRNTFIGTPYWMA 197

Query: 861 PE-FACRTVKITD---KCDVYGFGVLVLEVVTGKRPLS 894
           PE  AC          K D++  G+  +E+  G  PL 
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  103 bits (259), Expect = 2e-24
 Identities = 56/229 (24%), Positives = 107/229 (46%), Gaps = 29/229 (12%)

Query: 674 KLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQE 732
           + ++  GDP           +  ++G+G  G VY    +  G+ VAI+++ +    + Q 
Sbjct: 10  RSIVSVGDPK------KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL----QQQP 59

Query: 733 DFE---REVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW 789
             E    E+  + + ++PN+V     Y       ++ E+++GGSL   + E      +  
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDE 115

Query: 790 NERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGL-ARLLPMLDRYVL 848
            +   V +   ++L  LH + +IH +IKS N+L+   G  K+ D+G  A++ P       
Sbjct: 116 GQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----- 170

Query: 849 SSKIQSALG---YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLS 894
            SK  + +G   +MAPE   R      K D++  G++ +E++ G+ P  
Sbjct: 171 -SKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYL 217

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  103 bits (260), Expect = 3e-24
 Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 15/210 (7%)

Query: 697 ELGRGGFGAVYRTVLRDGR----PVAIKKL-TVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
            LG G FG+V    L+        VA+K +   +S  +  E+F  E   +    HPN++ 
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100

Query: 752 LEG-----YYWTQSLQLLIYEFVSGGSLHKHLHE---GSGGNFLSWNERFNVIQGTAKSL 803
           L G             ++I  F+  G LH +L      +G   +        +   A  +
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160

Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
            +L   N +H ++ + N ++       V D+GL++ +   D Y      +  + ++A E 
Sbjct: 161 EYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE- 219

Query: 864 ACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           +      T K DV+ FGV + E+ T G  P
Sbjct: 220 SLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  103 bits (258), Expect = 6e-24
 Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 21/215 (9%)

Query: 697 ELGRGGFGAVYRTVLRDGRP------VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG G FG V+     +  P      VA+K L  +S   +++DF+RE + L  ++H ++V
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-SARQDFQREAELLTMLQHQHIV 106

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHL------------HEGSGGNFLSWNERFNVIQG 798
              G        L+++E++  G L++ L             E      L   +   V   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 799 TAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGY 858
            A  + +L   + +H ++ + N L+      K+GD+G++R +   D Y +  +    + +
Sbjct: 167 VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 226

Query: 859 MAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           M PE +    K T + DV+ FGV++ E+ T GK+P
Sbjct: 227 MPPE-SILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  102 bits (256), Expect = 8e-24
 Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 22/214 (10%)

Query: 697 ELGRGGFGAVYRTVLRDG---RPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTL 752
            +G G FG V +  ++        AIK++   +      DF  E++ L K+  HPN++ L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGT------------- 799
            G    +    L  E+   G+L   L +             N    T             
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151

Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYM 859
           A+ + +L Q   IH ++ + N+L+  +   K+ D+GL+R     + YV  +  +  + +M
Sbjct: 152 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWM 208

Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           A E +      T   DV+ +GVL+ E+V+ G  P
Sbjct: 209 AIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  103 bits (259), Expect = 9e-24
 Identities = 48/194 (24%), Positives = 84/194 (43%), Gaps = 20/194 (10%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           ELG G FG V+R V +  GR    K +        +   + E+  + ++ HP L+ L   
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDA 116

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNER--FNVIQGTAKSLAHLHQSNIIH 813
           +  +   +LI EF+SGG L   +           +E    N ++   + L H+H+ +I+H
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAA-EDYKM---SEAEVINYMRQACEGLKHMHEHSIVH 172

Query: 814 YNIKSSNVLIDGSGEP--KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTV 868
            +IK  N++ +       K+ D+GLA       +      ++       + APE   R  
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLAT------KLNPDEIVKVTTATAEFAAPEIVDRE- 225

Query: 869 KITDKCDVYGFGVL 882
            +    D++  GVL
Sbjct: 226 PVGFYTDMWAIGVL 239

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  100 bits (252), Expect = 1e-23
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 21/216 (9%)

Query: 697 ELGRGGFGAVYRTVLRDGRP------VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG   FG VY+  L    P      VAIK L   +    +E+F  E     +++HPN+V
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGT----------- 799
            L G         +I+ + S G LH+ L   S  + +   +    ++             
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135

Query: 800 --AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG 857
             A  + +L   +++H ++ + NVL+      K+ D GL R +   D Y L       + 
Sbjct: 136 QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR 195

Query: 858 YMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           +MAPE A    K +   D++ +GV++ EV + G +P
Sbjct: 196 WMAPE-AIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  102 bits (257), Expect = 2e-23
 Identities = 49/199 (24%), Positives = 93/199 (46%), Gaps = 20/199 (10%)

Query: 692 LNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ++K   LG G FG V++      G  +A K +    + K +E+ + E+  + ++ H NL+
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLI 149

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNER--FNVIQGTAKSLAHLHQ 808
            L   + +++  +L+ E+V GG L   + +    N     E      ++   + + H+HQ
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIID-ESYNL---TELDTILFMKQICEGIRHMHQ 205

Query: 809 SNIIHYNIKSSNVLIDGSGEP--KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEF 863
             I+H ++K  N+L         K+ D+GLAR      RY    K++   G   ++APE 
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLAR------RYKPREKLKVNFGTPEFLAPEV 259

Query: 864 ACRTVKITDKCDVYGFGVL 882
                 ++   D++  GV+
Sbjct: 260 VNYDF-VSFPTDMWSVGVI 277

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  104 bits (261), Expect = 2e-23
 Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 17/203 (8%)

Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKS-QEDFEREVKKLGKVRHPNLVTLEG 754
           +LG G +G V     +      AIK +  +S+  S       EV  L  + HPN++ L  
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNER--FNVIQGTAKSLAHLHQSNII 812
           ++  +    L+ E   GG L   +       F   NE     +I+     + +LH+ NI+
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIH--RMKF---NEVDAAVIIKQVLSGVTYLHKHNIV 158

Query: 813 HYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           H ++K  N+L++   +    K+ D+GL+ +    ++  +  ++ +A  Y+APE   +  K
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAV--FENQKKMKERLGTA-YYIAPEVLRK--K 213

Query: 870 ITDKCDVYGFGVLVLEVVTGKRP 892
             +KCDV+  GV++  ++ G  P
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPP 236

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  100 bits (251), Expect = 2e-23
 Identities = 28/203 (13%), Positives = 62/203 (30%), Gaps = 42/203 (20%)

Query: 697 ELGRGGFGAVYR---TVLRDGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVT 751
             G       ++   T L   R VA+  +    ++     ++      +L ++  P +  
Sbjct: 38  FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           +     T++  L++ E++ GGSL +           S       +Q  A +    H++ +
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAGV 150

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
                  S V +   G+  +                           M            
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAY----------------------PATMPDA--------N 180

Query: 872 DKCDVYGFGVLVLEVVTGKRPLS 894
            + D+ G G  +  ++  + PL 
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLP 203

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  101 bits (253), Expect = 2e-23
 Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 23/199 (11%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIK-----KLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG G F  V +   +  G   A K     +   S    S+E+ EREV  L +V H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           TL   Y  ++  +LI E VSGG L   L +      LS  E  + I+     + +LH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK 135

Query: 811 IIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEF 863
           I H+++K  N+++     P    K+ D+GLA             + ++  G   ++APE 
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH------EIEDGVEFKNIFGTPEFVAPEI 189

Query: 864 ACRTVKITDKCDVYGFGVL 882
                 +  + D++  GV+
Sbjct: 190 VNYE-PLGLEADMWSIGVI 207

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  102 bits (255), Expect = 2e-23
 Identities = 31/238 (13%), Positives = 67/238 (28%), Gaps = 49/238 (20%)

Query: 698 LGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKS--QEDFEREVKKLGKVR--------- 745
           LG+    A    T    G    +     +    S   +  + EV +L  +R         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 746 ----------------HPNLVTLEGYYWTQSLQ--LLIYEFVSG--GSLHKHLHE-GSGG 784
                              ++ +        +     +Y  +     +  + L    S  
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 785 NFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD 844
             L  + R  +     + LA LH   ++H  ++  ++++D  G   +  +          
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARV 260

Query: 845 RYVLSSKIQSALGYMAPEF----------ACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
              +S       G+  PE             R   +T   D +  G+++  +     P
Sbjct: 261 VSSVS------RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  101 bits (254), Expect = 2e-23
 Identities = 52/196 (26%), Positives = 93/196 (47%), Gaps = 14/196 (7%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKS----QEDFEREVKKLGKVRHPNLVT 751
            +G+G F  V R + R+ G+  A+K + V+    S     ED +RE      ++HP++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 752 LEGYYWTQSLQLLIYEFVSGGSL-HKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           L   Y +  +  +++EF+ G  L  + +     G   S     + ++   ++L + H +N
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150

Query: 811 IIHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
           IIH ++K   VL+         K+G +G+A  L      V   ++ +   +MAPE   R 
Sbjct: 151 IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-SGLVAGGRVGTP-HFMAPEVVKR- 207

Query: 868 VKITDK-CDVYGFGVL 882
            +   K  DV+G GV+
Sbjct: 208 -EPYGKPVDVWGCGVI 222

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  101 bits (254), Expect = 3e-23
 Identities = 69/235 (29%), Positives = 109/235 (46%), Gaps = 32/235 (13%)

Query: 676 VMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQE-- 732
           + F  DP+       L +   E+G G FGAVY    +R+   VAIKK++ S    +++  
Sbjct: 46  LFFKDDPE------KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ 99

Query: 733 DFEREVKKLGKVRHPNLVTLEG-YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNE 791
           D  +EV+ L K+RHPN +   G Y    +  L++ E+  G +    L E          E
Sbjct: 100 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM-EYCLGSASD--LLEVHKKPL---QE 153

Query: 792 RF--NVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS 849
                V  G  + LA+LH  N+IH ++K+ N+L+   G  K+GD+G A ++         
Sbjct: 154 VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM--------- 204

Query: 850 SKIQSALG---YMAPEFACRTVKIT--DKCDVYGFGVLVLEVVTGKRPLSTWKMM 899
           +   S +G   +MAPE      +     K DV+  G+  +E+   K PL     M
Sbjct: 205 APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 259

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 99.6 bits (249), Expect = 3e-23
 Identities = 50/190 (26%), Positives = 85/190 (44%), Gaps = 10/190 (5%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G FG V+    R  G    IK +         E  E E++ L  + HPN++ +   
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88

Query: 756 YWTQSLQLLIYEFVSGGSL-HKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
           +       ++ E   GG L  + +   + G  LS      +++    +LA+ H  +++H 
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHK 148

Query: 815 NIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           ++K  N+L   +      K+ D+GLA L         ++   +A  YMAPE   R   +T
Sbjct: 149 DLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHSTNAAGTA-LYMAPEVFKR--DVT 203

Query: 872 DKCDVYGFGV 881
            KCD++  GV
Sbjct: 204 FKCDIWSAGV 213

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =   99 bits (250), Expect = 4e-23
 Identities = 46/208 (22%), Positives = 85/208 (40%), Gaps = 29/208 (13%)

Query: 698 LGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+GGF   +  +        A K +  S L+K   +E    E+     + H ++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 755 YYWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           ++       ++ E     SL       K L E     +         ++       +LH+
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY---------LRQIVLGCQYLHR 133

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFAC 865
           + +IH ++K  N+ ++   E K+GD+GLA  +          + +   G   Y+APE   
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-----ERKKVLCGTPNYIAPEVLS 188

Query: 866 RTVKITD-KCDVYGFGVLVLEVVTGKRP 892
           +  K    + DV+  G ++  ++ GK P
Sbjct: 189 K--KGHSFEVDVWSIGCIMYTLLVGKPP 214

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  100 bits (251), Expect = 6e-23
 Identities = 50/220 (22%), Positives = 95/220 (43%), Gaps = 30/220 (13%)

Query: 696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
            ELG G  G V++   +  G  +A K + +      +    RE++ L +   P +V   G
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAKSLAHLH-QSNI 811
            +++     +  E + GGSL + L +          E+    V     K L +L  +  I
Sbjct: 99  AFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYLREKHKI 153

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTV 868
           +H ++K SN+L++  GE K+ D+G++  L       + S   S +G   YM+PE      
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQL-------IDSMANSFVGTRSYMSPE------ 200

Query: 869 KITD-----KCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS 903
           ++       + D++  G+ ++E+  G+ P+          
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 99.2 bits (248), Expect = 6e-23
 Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 23/199 (11%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIK-----KLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG G F  V +   +  G+  A K     +L+ S    S+E+ EREV  L ++RHPN++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           TL   +  ++  +LI E VSGG L   L E      L+ +E    ++     + +LH   
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR 128

Query: 811 IIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEF 863
           I H+++K  N+++     P    K+ D+G+A       +    ++ ++  G   ++APE 
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH------KIEAGNEFKNIFGTPEFVAPEI 182

Query: 864 ACRTVKITDKCDVYGFGVL 882
                 +  + D++  GV+
Sbjct: 183 VNYE-PLGLEADMWSIGVI 200

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  102 bits (256), Expect = 6e-23
 Identities = 50/204 (24%), Positives = 99/204 (48%), Gaps = 18/204 (8%)

Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLE 753
            LG+G FG V     +  G+  A+K ++   + +   +E   REV+ L ++ HPN++ L 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNER--FNVIQGTAKSLAHLHQSNI 811
            ++  +    L+ E  +GG L   +       F   +E     +I+     + ++H++ I
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIIS--RKRF---SEVDAARIIRQVLSGITYMHKNKI 147

Query: 812 IHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTV 868
           +H ++K  N+L++   +    ++ D+GL+          +  KI +A  Y+APE      
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKMKDKIGTA-YYIAPEVLHG-- 202

Query: 869 KITDKCDVYGFGVLVLEVVTGKRP 892
              +KCDV+  GV++  +++G  P
Sbjct: 203 TYDEKCDVWSTGVILYILLSGCPP 226

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  102 bits (255), Expect = 7e-23
 Identities = 58/283 (20%), Positives = 93/283 (32%), Gaps = 36/283 (12%)

Query: 294 SLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSM 353
               +  +    S  VP  I      + LN   N +     D+  +  +L  L       
Sbjct: 55  QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLG---- 107

Query: 354 NGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIG 413
                               N IR+   G F    +   SL  L+L  N  +        
Sbjct: 108 -------------------RNSIRQIEVGAF----NGLASLNTLELFDNWLTVIPSGAFE 144

Query: 414 ALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEI-GGAYSLKELRLE 472
            LS L+ L L  N +      A   + +L  LDL E      I      G ++LK L L 
Sbjct: 145 YLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG 204

Query: 473 RNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQL 532
              +   +P  +     L  L +S N+     P +   L++L+ + +  + ++       
Sbjct: 205 MCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAF 262

Query: 533 VNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVL--GNPSLC 573
             L  L   N++HN+L   LP   F        +    NP  C
Sbjct: 263 DGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWNC 304

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 98.7 bits (246), Expect = 8e-22
 Identities = 62/256 (24%), Positives = 102/256 (39%), Gaps = 16/256 (6%)

Query: 125 NLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNR 184
               +  +   LS  +P        + R ++L +N        +      L  + L  N 
Sbjct: 55  QFSKVVCTRRGLS-EVPQGIPS---NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110

Query: 185 FSSPLPLGI-WGLSALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKNMFSGSIPDGI- 241
               + +G   GL++L TL+L DN L   IP G  E L  LR + L  N    SIP    
Sbjct: 111 IRQ-IEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAF 167

Query: 242 GSCSLLRTIDFSENSFSGNLPETM-QKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDL 300
                L  +D  E      + E   + L    ++NL       ++P     L  LE L++
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTP-LVGLEELEM 225

Query: 301 SGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQW 360
           SGN F    P S   L  LK L    ++++    ++     +LV L+ + N+++  LP  
Sbjct: 226 SGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS-LPHD 284

Query: 361 IFSS--GLNKVSFAEN 374
           +F+    L ++    N
Sbjct: 285 LFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 80.9 bits (200), Expect = 4e-16
 Identities = 34/157 (21%), Positives = 63/157 (40%), Gaps = 8/157 (5%)

Query: 80  ELTLNGLSLTGRIGRGLLQ-LQFLRKLSLSSNNLTGSISPN-LAKLQNLRVIDLSGNSLS 137
           EL L    +   I       +  L +L L        IS      L NL+ ++L   ++ 
Sbjct: 151 ELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK 209

Query: 138 GSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLS 197
             +P+        L  + ++ N F    P S    S+L  + + +++ S        GL+
Sbjct: 210 -DMPN--LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLA 266

Query: 198 ALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKNMF 233
           +L  L+L+ N L   +P  +   L+ L  ++L  N +
Sbjct: 267 SLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 99.7 bits (249), Expect = 8e-23
 Identities = 46/208 (22%), Positives = 85/208 (40%), Gaps = 29/208 (13%)

Query: 698 LGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG+GGF   +  +        A K +  S L+K   +E    E+     + H ++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 755 YYWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           ++       ++ E     SL       K L E     +         ++       +LH+
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY---------LRQIVLGCQYLHR 159

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFAC 865
           + +IH ++K  N+ ++   E K+GD+GLA  +          + +   G   Y+APE   
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-----ERKKVLCGTPNYIAPEVLS 214

Query: 866 RTVKITD-KCDVYGFGVLVLEVVTGKRP 892
           +  K    + DV+  G ++  ++ GK P
Sbjct: 215 K--KGHSFEVDVWSIGCIMYTLLVGKPP 240

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  102 bits (257), Expect = 8e-23
 Identities = 51/193 (26%), Positives = 87/193 (45%), Gaps = 16/193 (8%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           ELG G FG V+R   R  G   A K +        +E   +E++ +  +RHP LV L   
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDA 222

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           +   +  ++IYEF+SGG L + + +      +S +E    ++   K L H+H++N +H +
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENNYVHLD 280

Query: 816 IKSSNVLIDGSGEP--KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVKI 870
           +K  N++         K+ D+GL               ++   G   + APE A     +
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTA------HLDPKQSVKVTTGTAEFAAPEVAEGKP-V 333

Query: 871 TDKCDVYGFGVLV 883
               D++  GVL 
Sbjct: 334 GYYTDMWSVGVLS 346

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 98.9 bits (247), Expect = 1e-22
 Identities = 62/244 (25%), Positives = 105/244 (43%), Gaps = 24/244 (9%)

Query: 671 NSGKLVMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVK 729
           +SGKL   S +  +   T   L    E+GRG +G+V + V    G+ +A+K++  +   K
Sbjct: 5   SSGKLK-ISPEQHWDF-TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK 62

Query: 730 SQEDFEREVK-KLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLH--KHLHEGSGGNF 786
            Q+    ++   +     P +V   G  + +    +  E +S       K+++       
Sbjct: 63  EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVI 122

Query: 787 LSWNERF--NVIQGTAKSLAHLH-QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML 843
               E     +   T K+L HL     IIH +IK SN+L+D SG  K+ D+G++  L   
Sbjct: 123 ---PEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL--- 176

Query: 844 DRYVLSSKIQSALG---YMAPE-FACRTVKI--TDKCDVYGFGVLVLEVVTGKRPLSTWK 897
              V S       G   YMAPE       +     + DV+  G+ + E+ TG+ P   W 
Sbjct: 177 ---VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233

Query: 898 MMWW 901
            ++ 
Sbjct: 234 SVFD 237

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 98.1 bits (245), Expect = 1e-22
 Identities = 54/216 (25%), Positives = 102/216 (47%), Gaps = 22/216 (10%)

Query: 697 ELGRGGFGAVYRTVLRDGRP------VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG G FG V+     +  P      VA+K L   +L  +++DF+RE + L  ++H ++V
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIV 80

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGT----------- 799
              G        ++++E++  G L+K L        +  + +    +G            
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 800 --AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG 857
             A  + +L   + +H ++ + N L+  +   K+GD+G++R +   D Y +       + 
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 200

Query: 858 YMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           +M PE +    K T + DV+ FGV++ E+ T GK+P
Sbjct: 201 WMPPE-SIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 99.3 bits (248), Expect = 2e-22
 Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 23/199 (11%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIK-----KLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG G F  V +   +  G   A K     +   S     +E+ EREV  L +V HPN++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           TL   Y  ++  +LI E VSGG L   L +      LS  E  + I+     + +LH   
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK 135

Query: 811 IIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEF 863
           I H+++K  N+++     P    K+ D+GLA             + ++  G   ++APE 
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH------EIEDGVEFKNIFGTPEFVAPEI 189

Query: 864 ACRTVKITDKCDVYGFGVL 882
                 +  + D++  GV+
Sbjct: 190 VNYE-PLGLEADMWSIGVI 207

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score =  100 bits (252), Expect = 2e-22
 Identities = 78/461 (16%), Positives = 148/461 (32%), Gaps = 82/461 (17%)

Query: 124 QNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGK----IPSSLSLCSTLATIN 179
            +++ +D+    LS +   E        +V+ L     +      I S+L +   LA +N
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 180 LSSNRFSSPLPLGIWGLSA--------LRTLDLSDNLLEGE----IPKGVESLKNLRVIN 227
           L SN        G+  +          ++ L L +  L G     +   + +L  L+ ++
Sbjct: 63  LRSNELGDV---GVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 119

Query: 228 LSKNMFSGS----IPDGIGS-CSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFS 282
           LS N+   +    + +G+      L  +     S S     + + L+      LR     
Sbjct: 120 LSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS---AASCEPLASV----LRAK--- 169

Query: 283 GEVPKWIGELESLETLDLSGNKFS--GAVPISIG---NLQRLKVLNFSANRLT----GSL 333
                        + L +S N  +  G   +  G   +  +L+ L   +  +T      L
Sbjct: 170 ----------PDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDL 219

Query: 334 PDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLN------KVSFAENKIREGMNGPFASS 387
              +A+  +L  L    N +       +    L+       +   E  I     G     
Sbjct: 220 CGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV 279

Query: 388 GSSFESLQFLDLSHNEFSGETPATIGAL-----SGLQLLNLSRNSL----VGPIPVAIGD 438
             + ESL+ L L+ NE   E    +          L+ L +   S            +  
Sbjct: 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQ 339

Query: 439 LKALNVLDLSENWLNGSIPPEIGGA-----YSLKELRLERNFL----AGKIPTSIENCSS 489
            + L  L +S N L  +   E+          L+ L L    +       +  ++    S
Sbjct: 340 NRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHS 399

Query: 490 LVSLILSKNNLTGPIPIAIAKL-----TNLQNVDLSFNSLT 525
           L  L LS N L     + + +        L+ + L     +
Sbjct: 400 LRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 88.9 bits (221), Expect = 1e-18
 Identities = 59/352 (16%), Positives = 107/352 (30%), Gaps = 47/352 (13%)

Query: 247 LRTIDFSENSFSGN-LPETMQKLSLCNFMNLRKNLFSGEVPKWIGEL----ESLETLDLS 301
           ++++D      S     E +  L  C  + L     +    K I        +L  L+L 
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64

Query: 302 GNKF--SGAVPISIG---NLQRLKVLNFSANRLT----GSLPDSMANCMNLVALDFSQNS 352
            N+    G   +  G      +++ L+     LT    G L  ++     L  L  S N 
Sbjct: 65  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124

Query: 353 MNGDLPQWIFS------SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSG 406
           +     Q +          L K+      +      P AS   +    + L +S+N+ + 
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 184

Query: 407 ETPATIGAL-----SGLQLLNLSRNSL----VGPIPVAIGDLKALNVLDLSENWLNGSIP 457
                +          L+ L L    +       +   +    +L  L L  N L     
Sbjct: 185 AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGM 244

Query: 458 PEIGGA-----YSLKELRLERNFL----AGKIPTSIENCSSLVSLILSKNNLTGPIPIAI 508
            E+          L+ L +    +     G +   +    SL  L L+ N L       +
Sbjct: 245 AELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL 304

Query: 509 AKL-----TNLQNVDLSFNSLTG----GLPKQLVNLVHLSSFNISHNHLQGE 551
            +        L+++ +   S T          L     L    IS+N L+  
Sbjct: 305 CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 85.0 bits (211), Expect = 2e-17
 Identities = 74/377 (19%), Positives = 121/377 (32%), Gaps = 74/377 (19%)

Query: 102 LRKLSLSSNNLT----GSISPNLAKLQNLRVIDLSGNSLSGS----IPDEFFKQCGSLRV 153
           ++KLSL +  LT    G +S  L  L  L+ + LS N L  +    + +        L  
Sbjct: 87  IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK 146

Query: 154 ISLAKNRFSGK----IPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSA--------LRT 201
           + L     S      + S L        + +S+N  +     G+  L          L  
Sbjct: 147 LQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEA---GVRVLCQGLKDSPCQLEA 203

Query: 202 LDLSDNLLEGE----IPKGVESLKNLRVINLSKNMFSGS----IPDGIGSCSL-LRTIDF 252
           L L    +  +    +   V S  +LR + L  N         +  G+   S  LRT+  
Sbjct: 204 LKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 263

Query: 253 SENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKF--SGAVP 310
            E   +    +    L       LR               ESL+ L L+GN+    GA  
Sbjct: 264 WECGIT---AKGCGDLCRV----LRAK-------------ESLKELSLAGNELGDEGARL 303

Query: 311 ISIG---NLQRLKVLNFSANRLTG----SLPDSMANCMNLVALDFSQNSMNGDLPQWIFS 363
           +         +L+ L   +   T          +A    L+ L  S N +  D       
Sbjct: 304 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRL-EDAGVRELC 362

Query: 364 SGLNKV-------SFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGAL- 415
            GL +          A+  + +      A++  +  SL+ LDLS+N         +    
Sbjct: 363 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 422

Query: 416 ----SGLQLLNLSRNSL 428
                 L+ L L     
Sbjct: 423 RQPGCLLEQLVLYDIYW 439

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 83.1 bits (206), Expect = 9e-17
 Identities = 53/297 (17%), Positives = 100/297 (33%), Gaps = 38/297 (12%)

Query: 293 ESLETLDLSGNKFS-GAVPISIGNLQRLKVLNFSANRLT----GSLPDSMANCMNLVALD 347
             +++LD+   + S       +  LQ+ +V+      LT      +  ++     L  L+
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 348 FSQNSMNGDLPQWIF------SSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSH 401
              N +       +       S  + K+S     +     G  +S+  +  +LQ L LS 
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 402 NEFSGETPATIGAL-----SGLQLLNLSRNSL----VGPIPVAIGDLKALNVLDLSENWL 452
           N         +          L+ L L   SL      P+   +        L +S N +
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182

Query: 453 NGSIPPEIGGA-----YSLKELRLERNFL----AGKIPTSIENCSSLVSLILSKNNLT-- 501
           N +    +          L+ L+LE   +       +   + + +SL  L L  N L   
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242

Query: 502 GPIPIAIAKL---TNLQNVDLSFNSLT----GGLPKQLVNLVHLSSFNISHNHLQGE 551
           G   +    L   + L+ + +    +T    G L + L     L   +++ N L  E
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 55.4 bits (134), Expect = 5e-08
 Identities = 41/178 (23%), Positives = 68/178 (38%), Gaps = 30/178 (16%)

Query: 77  RVIELTLNGLSLTG--RIGRGLLQLQF-LRKLSLSSNNLTG----SISPNLAKLQNLRVI 129
           + + L  N L   G   +   LL+    L  L + S + T       S  LA+ + L  +
Sbjct: 287 KELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLEL 346

Query: 130 DLSGNSLSGS----IPDEFFKQCGSLRVISLAKNRFSGK----IPSSLSLCSTLATINLS 181
            +S N L  +    +     +    LRV+ LA    S      + ++L    +L  ++LS
Sbjct: 347 QISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLS 406

Query: 182 SNRFSSPLPLGIWGLSA--------LRTLDLSDNLLEGEIPKGVESL----KNLRVIN 227
           +N        GI  L          L  L L D     E+   +++L     +LRVI+
Sbjct: 407 NNCLG---DAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 98.5 bits (246), Expect = 2e-22
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 23/199 (11%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIK-----KLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG G F  V +   +  G   A K     +   S    S+ED EREV  L +++HPN++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           TL   Y  ++  +LI E V+GG L   L E      L+  E    ++     + +LH   
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ 134

Query: 811 IIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEF 863
           I H+++K  N+++     P    K+ D+GLA       +    ++ ++  G   ++APE 
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH------KIDFGNEFKNIFGTPEFVAPEI 188

Query: 864 ACRTVKITDKCDVYGFGVL 882
                 +  + D++  GV+
Sbjct: 189 VNYE-PLGLEADMWSIGVI 206

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  100 bits (252), Expect = 2e-22
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 17/203 (8%)

Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEG 754
            LG+G FG V +   R   +  A+K +  +S   K      REV+ L K+ HPN++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNER--FNVIQGTAKSLAHLHQSNII 812
                S   ++ E  +GG L   + +     F   +E     +I+     + ++H+ NI+
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIK--RKRF---SEHDAARIIKQVFSGITYMHKHNIV 143

Query: 813 HYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           H ++K  N+L++   +    K+ D+GL+          +  +I +A  Y+APE       
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTA-YYIAPEVLRG--T 198

Query: 870 ITDKCDVYGFGVLVLEVVTGKRP 892
             +KCDV+  GV++  +++G  P
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPP 221

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 25/196 (12%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEG 754
            LG+G FG V +   R   +  A+K +  +S          REV+ L K+ HPN++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 755 YYWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
                S   ++ E  +GG L       K   E         ++   +I+     + ++H+
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE---------HDAARIIKQVFSGITYMHK 139

Query: 809 SNIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFAC 865
            NI+H ++K  N+L++   +    K+ D+GL+          +  +I +A  Y+APE   
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTA-YYIAPEVLR 196

Query: 866 RTVKITDKCDVYGFGV 881
                 +KCDV+  GV
Sbjct: 197 G--TYDEKCDVWSAGV 210

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 96.9 bits (242), Expect = 3e-22
 Identities = 40/195 (20%), Positives = 84/195 (43%), Gaps = 25/195 (12%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
            +GRG +G V   V +      A KK+    + +  + F++E++ +  + HPN++ L   
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYET 74

Query: 756 YWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
           +   +   L+ E  +GG L       +   E         ++   +++    ++A+ H+ 
Sbjct: 75  FEDNTDIYLVMELCTGGELFERVVHKRVFRE---------SDAARIMKDVLSAVAYCHKL 125

Query: 810 NIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           N+ H ++K  N L          K+ D+GLA         ++ +K+ +   Y++P+    
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKVGTP-YYVSPQVLEG 182

Query: 867 TVKITDKCDVYGFGV 881
                 +CD +  GV
Sbjct: 183 --LYGPECDEWSAGV 195

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 48/237 (20%), Positives = 79/237 (33%), Gaps = 38/237 (16%)

Query: 73  PRSNRVIELTLNGLSLTGRIGRGLLQ-LQFLRKLSLSSNNLTGSISPN-LAKLQNLRVID 130
           P +++ I L  N +S    +     +  + L  L L SN L   I       L  L  +D
Sbjct: 31  PAASQRIFLHGNRIS---HVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLD 86

Query: 131 LSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPS-SLSLCSTLATINLSSNRFSSPL 189
           LS N+   S+    F   G L  + L +     ++        + L  + L  N   + L
Sbjct: 87  LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-L 144

Query: 190 PLGIW-GLSALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKNMFSGSIPDGI-GSCSL 246
           P   +  L  L  L L  N +   +P+     L +L  + L +N  +  +          
Sbjct: 145 PDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGR 202

Query: 247 LRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGN 303
           L T+    N                N   L     +         L +L+ L L+ N
Sbjct: 203 LMTLYLFAN----------------NLSALPTEALAP--------LRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 46/217 (21%), Positives = 80/217 (36%), Gaps = 12/217 (5%)

Query: 362 FSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLL 421
             +   ++    N+I       F     +  +L  L L  N  +    A    L+ L+ L
Sbjct: 30  IPAASQRIFLHGNRISHVPAASF----RACRNLTILWLHSNVLARIDAAAFTGLALLEQL 85

Query: 422 NLSRNSLVGPIPV-AIGDLKALNVLDLSENWLNGSIPPEI-GGAYSLKELRLERNFLAGK 479
           +LS N+ +  +       L  L+ L L    L   + P +  G  +L+ L L+ N L   
Sbjct: 86  DLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-A 143

Query: 480 IPTSI-ENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHL 538
           +P     +  +L  L L  N ++     A   L +L  + L  N +    P    +L  L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203

Query: 539 SSFNISHNHLQGELPAGGFFNTISPSSVL--GNPSLC 573
            +  +  N+L   LP        +   +    NP +C
Sbjct: 204 MTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWVC 239

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 54/232 (23%), Positives = 89/232 (38%), Gaps = 11/232 (4%)

Query: 124 QNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSN 183
           +           L  ++P        + + I L  NR S    +S   C  L  + L SN
Sbjct: 11  EPKVTTSCPQQGLQ-AVPVGIPA---ASQRIFLHGNRISHVPAASFRACRNLTILWLHSN 66

Query: 184 RFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKNMFSGSIPDGI- 241
             +        GL+ L  LDLSDN     +       L  L  ++L +      +  G+ 
Sbjct: 67  VLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLF 125

Query: 242 GSCSLLRTIDFSENSFSGNLPETM-QKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDL 300
              + L+ +   +N+    LP+   + L     + L  N  S    +    L SL+ L L
Sbjct: 126 RGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184

Query: 301 SGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLP-DSMANCMNLVALDFSQN 351
             N+ +   P +  +L RL  L   AN L+ +LP +++A    L  L  + N
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 50/233 (21%), Positives = 80/233 (34%), Gaps = 30/233 (12%)

Query: 294 SLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSM 353
           + + + L GN+ S     S    + L +L   +N L      +      L  LD S N+ 
Sbjct: 33  ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92

Query: 354 NGDLPQWIFS--SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPAT 411
              +    F     L+ +      ++E   G F        +LQ+L L  N        T
Sbjct: 93  LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRG----LAALQYLYLQDNALQALPDDT 148

Query: 412 IGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRL 471
              L  L  L L  N +      A   L +L+ L L +N +   + P             
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPH------------ 195

Query: 472 ERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSL 524
                      +  +   L++L L  NNL+     A+A L  LQ + L+ N  
Sbjct: 196 -----------AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 41.9 bits (99), Expect = 6e-04
 Identities = 14/78 (17%), Positives = 25/78 (32%), Gaps = 2/78 (2%)

Query: 480 IPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLS 539
           +P  I   ++   + L  N ++     +     NL  + L  N L          L  L 
Sbjct: 26  VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 540 SFNISHNHLQGELPAGGF 557
             ++S N     +    F
Sbjct: 84  QLDLSDNAQLRSVDPATF 101

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 96.5 bits (241), Expect = 4e-22
 Identities = 52/196 (26%), Positives = 87/196 (44%), Gaps = 24/196 (12%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKS-QEDFEREVKKLGKVRHPNLVTLEG 754
           ELG+G F  V R V +  G   A K +    L     +  ERE +   K++HPN+V L  
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72

Query: 755 YYWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
               +S   L+++ V+GG L       +   E          +  + IQ   +S+A+ H 
Sbjct: 73  SIQEESFHYLVFDLVTGGELFEDIVAREFYSE---------ADASHCIQQILESIAYCHS 123

Query: 809 SNIIHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFAC 865
           + I+H N+K  N+L+    +    K+ D+GLA  +   D         +  GY++PE   
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTP-GYLSPEVLK 180

Query: 866 RTVKITDKCDVYGFGV 881
           +    +   D++  GV
Sbjct: 181 KD-PYSKPVDIWACGV 195

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 98.6 bits (246), Expect = 5e-22
 Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 38/214 (17%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEGYY 756
           +G G FG V++  L +   VAIKK      V   + F+ RE++ +  V+HPN+V L+ ++
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKK------VLQDKRFKNRELQIMRIVKHPNVVDLKAFF 101

Query: 757 WTQSLQL------LIYEFVSGGSLHKHL-HEGSGGNFLSWNE-RFNVIQGTAKSLAHLHQ 808
           ++   +       L+ E+V   ++++   H       +     +  + Q   +SLA++H 
Sbjct: 102 YSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQ-LLRSLAYIHS 159

Query: 809 SNIIHYNIKSSNVLIDG-SGEPKVGDYGLARLL----PMLDRYVLSSKIQSALGYMAPE- 862
             I H +IK  N+L+D  SG  K+ D+G A++L    P +  Y+ S        Y APE 
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS-YICS------RYYRAPEL 212

Query: 863 -FACR--TVKITDKCDVYGFGVLVLEVVTGKRPL 893
            F     T  I    D++  G ++ E++ G+ PL
Sbjct: 213 IFGATNYTTNI----DIWSTGCVMAELMQGQ-PL 241

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 96.9 bits (242), Expect = 6e-22
 Identities = 47/191 (24%), Positives = 83/191 (43%), Gaps = 15/191 (7%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LGRG FG V+R V     +    K + V      Q   ++E+  L   RH N++ L   
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHES 69

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNER--FNVIQGTAKSLAHLHQSNIIH 813
           + +    ++I+EF+SG  + + ++  S       NER   + +    ++L  LH  NI H
Sbjct: 70  FESMEELVMIFEFISGLDIFERINT-SAFEL---NEREIVSYVHQVCEALQFLHSHNIGH 125

Query: 814 YNIKSSNVLIDGSGEP--KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           ++I+  N++         K+ ++G AR L             +   Y APE       ++
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLK--PGDNFRLLFTAP-EYYAPEVHQHD-VVS 181

Query: 872 DKCDVYGFGVL 882
              D++  G L
Sbjct: 182 TATDMWSLGTL 192

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  100 bits (250), Expect = 7e-22
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 19/204 (9%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDF----EREV-KKLGKVRHPNLVT 751
           +GRGGFG VY     D G+  A+K L    +   Q +     ER +   +     P +V 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           +   + T      I + ++GG LH HL +   G F   + RF   +     L H+H   +
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAE-IILGLEHMHNRFV 313

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTV 868
           ++ ++K +N+L+D  G  ++ D GLA             K  +++G   YMAPE   + V
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFS-------KKKPHASVGTHGYMAPEVLQKGV 366

Query: 869 KITDKCDVYGFGVLVLEVVTGKRP 892
                 D +  G ++ +++ G  P
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSP 390

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 96.8 bits (241), Expect = 9e-22
 Identities = 54/244 (22%), Positives = 93/244 (38%), Gaps = 49/244 (20%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSL----VKSQEDFEREVKKLGKVRHPNLVT 751
            +G+G +G V   +        AIK +  + +     K  E  + EV+ + K+ HPN+  
Sbjct: 33  AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92

Query: 752 LEGYYWTQSLQLLIYEFVSGGSL-----------------------------------HK 776
           L   Y  +    L+ E   GG L                                   + 
Sbjct: 93  LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152

Query: 777 HLHEGSGGNFLSWNERF--NVIQGTAKSLAHLHQSNIIHYNIKSSNVLI--DGSGEPKVG 832
            +H           E+   N+++    +L +LH   I H +IK  N L   + S E K+ 
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLV 212

Query: 833 DYGLARLLPML---DRYVLSSKIQSALGYMAPE-FACRTVKITDKCDVYGFGVLVLEVVT 888
           D+GL++    L   + Y +++K  +   ++APE           KCD +  GVL+  ++ 
Sbjct: 213 DFGLSKEFYKLNNGEYYGMTTKAGTP-YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271

Query: 889 GKRP 892
           G  P
Sbjct: 272 GAVP 275

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 96.2 bits (240), Expect = 9e-22
 Identities = 55/221 (24%), Positives = 85/221 (38%), Gaps = 28/221 (12%)

Query: 697 ELGRGGFGAVYRTVLRDGR------PVAIKKLTVSSLVKSQEDFEREV---KKLGKVRHP 747
            LG G FG V                VA+K L  S+ +  +E    E+     LG   H 
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG--NHM 87

Query: 748 NLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGT-------- 799
           N+V L G        L+I E+   G L   L         S      +            
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 800 -------AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI 852
                  AK +A L   N IH ++ + N+L+      K+ D+GLAR +     YV+    
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 853 QSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           +  + +MAPE +      T + DV+ +G+ + E+ + G  P
Sbjct: 208 RLPVKWMAPE-SIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 50/218 (22%), Positives = 94/218 (43%), Gaps = 23/218 (10%)

Query: 696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVK-KLGKVRHPNLVTLE 753
            ELGRG +G V +      G+ +A+K++  +   + Q+    ++   +  V  P  VT  
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72

Query: 754 GYYWTQSLQLLIYEFVSGG--SLHKHLHEGSGGNFLSWNERF--NVIQGTAKSLAHLH-Q 808
           G  + +    +  E +       +K + +          E     +     K+L HLH +
Sbjct: 73  GALFREGDVWICMELMDTSLDKFYKQVIDKGQT----IPEDILGKIAVSIVKALEHLHSK 128

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE-FA 864
            ++IH ++K SNVLI+  G+ K+ D+G++  L      V         G   YMAPE   
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGISGYL------VDDVAKDIDAGCKPYMAPERIN 182

Query: 865 CRTVKI--TDKCDVYGFGVLVLEVVTGKRPLSTWKMMW 900
               +   + K D++  G+ ++E+   + P  +W   +
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF 220

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 96.2 bits (240), Expect = 1e-21
 Identities = 56/221 (25%), Positives = 85/221 (38%), Gaps = 29/221 (13%)

Query: 697 ELGRGGFGAVYRTVLRD------GRPVAIKKLTVSSLVKSQEDFEREV---KKLGKVRHP 747
            LGRG FG V              R VA+K L   +          E+     +G   H 
Sbjct: 34  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG--HHL 91

Query: 748 NLVTLEGYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGT------ 799
           N+V L G   T+     ++I EF   G+L  +L               ++ +        
Sbjct: 92  NVVNLLGAC-TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 800 -------AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI 852
                  AK +  L     IH ++ + N+L+      K+ D+GLAR +     YV     
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210

Query: 853 QSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           +  L +MAPE        T + DV+ FGVL+ E+ + G  P
Sbjct: 211 RLPLKWMAPE-TIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 98.3 bits (245), Expect = 1e-21
 Identities = 64/255 (25%), Positives = 103/255 (40%), Gaps = 14/255 (5%)

Query: 125 NLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNR 184
               +     +L   +PD       + R+++L +N+      +S      L  + LS N 
Sbjct: 44  QFSKVICVRKNLR-EVPDGIST---NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 185 FSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKNMFSGSIPDGI-G 242
             +       GL+ L TL+L DN L   IP G    L  L+ + L  N    SIP     
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFN 157

Query: 243 SCSLLRTIDFSENSFSGNLPETM-QKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLS 301
               LR +D  E      + E   + LS   ++NL       E+P     L  L+ LDLS
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTP-LIKLDELDLS 215

Query: 302 GNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWI 361
           GN  S   P S   L  L+ L    +++     ++  N  +LV ++ + N++   LP  +
Sbjct: 216 GNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDL 274

Query: 362 FSS--GLNKVSFAEN 374
           F+    L ++    N
Sbjct: 275 FTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 97.9 bits (244), Expect = 1e-21
 Identities = 62/283 (21%), Positives = 94/283 (33%), Gaps = 36/283 (12%)

Query: 294 SLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSM 353
               +          VP  I      ++LN   N++     +S  +  +L  L  S    
Sbjct: 44  QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLS---- 96

Query: 354 NGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIG 413
                               N IR    G F    +   +L  L+L  N  +        
Sbjct: 97  -------------------RNHIRTIEIGAF----NGLANLNTLELFDNRLTTIPNGAFV 133

Query: 414 ALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEI-GGAYSLKELRLE 472
            LS L+ L L  N +      A   + +L  LDL E      I      G  +L+ L L 
Sbjct: 134 YLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLA 193

Query: 473 RNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQL 532
              L  +IP  +     L  L LS N+L+   P +   L +LQ + +  + +        
Sbjct: 194 MCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAF 251

Query: 533 VNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVL--GNPSLC 573
            NL  L   N++HN+L   LP   F        +    NP  C
Sbjct: 252 DNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWNC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 81.3 bits (201), Expect = 3e-16
 Identities = 36/157 (22%), Positives = 59/157 (37%), Gaps = 8/157 (5%)

Query: 80  ELTLNGLSLTGRIGRGLLQ-LQFLRKLSLSSNNLTGSISPN-LAKLQNLRVIDLSGNSLS 137
           EL L    +   I       +  LR+L L        IS      L NLR ++L+  +L 
Sbjct: 140 ELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR 198

Query: 138 GSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLS 197
             IP+        L  + L+ N  S   P S      L  + +  ++           L 
Sbjct: 199 -EIPN--LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQ 255

Query: 198 ALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKNMF 233
           +L  ++L+ N L   +P  +   L +L  I+L  N +
Sbjct: 256 SLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 96.7 bits (241), Expect = 1e-21
 Identities = 60/350 (17%), Positives = 120/350 (34%), Gaps = 54/350 (15%)

Query: 105 LSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGK 164
             + S +   S +          +   S  SL+ SIP    +   +++ + L+ NR +  
Sbjct: 12  GVIISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGLTE---AVKSLDLSNNRITYI 67

Query: 165 IPSSLSLCSTLATINLSSNRFSSPLPLGI-WGLSALRTLDLSDNLLEGEIPKGV-ESLKN 222
             S L  C  L  + L+SN  ++ +       L +L  LDLS N L   +     + L +
Sbjct: 68  SNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSS 125

Query: 223 LRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCN--FMNLRKNL 280
           L  +NL  N +  ++ +                S   +L +           F  +++  
Sbjct: 126 LTFLNLLGNPYK-TLGET---------------SLFSHLTKLQILRVGNMDTFTKIQRKD 169

Query: 281 FSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANC 340
           F+G        L  LE L++  +      P S+ ++Q +  L     +    L   +   
Sbjct: 170 FAG--------LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVT 221

Query: 341 MNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLS 400
            ++  L+     ++               +F  +++  G             + + + ++
Sbjct: 222 SSVECLELRDTDLD---------------TFHFSELSTGETNSLIKK----FTFRNVKIT 262

Query: 401 HNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSEN 450
                 +    +  +SGL  L  SRN L          L +L  + L  N
Sbjct: 263 DESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 96.3 bits (240), Expect = 2e-21
 Identities = 49/259 (18%), Positives = 99/259 (38%), Gaps = 28/259 (10%)

Query: 99  LQFLRKLSLSSNNLTGSISPNL-AKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLA 157
              L+ L L+SN +  +I  +  + L +L  +DLS N LS ++   +FK   SL  ++L 
Sbjct: 75  CVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLL 132

Query: 158 KNRFSGKIPSSL-SLCSTLATINLSSNRFSSPLPLGI-WGLSALRTLDLSDNLLEGEIPK 215
            N +     +SL S  + L  + + +    + +      GL+ L  L++  + L+     
Sbjct: 133 GNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEP 191

Query: 216 GV-ESLKNLRVINLSKNMFSGSIPDGI-GSCSLLRTIDFSENSFSGNLPETMQKLSLCNF 273
              +S++N+  + L        + +      S +  ++  +            +LS    
Sbjct: 192 KSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTF---HFSELSTGET 247

Query: 274 MNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSL 333
            +L K               +   + ++       V   +  +  L  L FS N+L  S+
Sbjct: 248 NSLIK-------------KFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SV 292

Query: 334 PDSM-ANCMNLVALDFSQN 351
           PD +     +L  +    N
Sbjct: 293 PDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 89.4 bits (222), Expect = 3e-19
 Identities = 52/301 (17%), Positives = 106/301 (35%), Gaps = 33/301 (10%)

Query: 243 SCSLLRTIDFSENSFS---GNLPETMQKLSL--CNFMNLRKNLFSGEVPKWIGELESLET 297
           SC        S  S +     L E ++ L L       +  +              +L+ 
Sbjct: 29  SCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQR--------CVNLQA 80

Query: 298 LDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSM-ANCMNLVALDFSQNSMNGD 356
           L L+ N  +     S  +L  L+ L+ S N L+ +L  S      +L  L+   N     
Sbjct: 81  LVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-T 138

Query: 357 LPQWIFSSGLNKVSFAE----NKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATI 412
           L +    S L K+        +   +     FA        L+ L++  ++     P ++
Sbjct: 139 LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAG----LTFLEELEIDASDLQSYEPKSL 194

Query: 413 GALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEI--------GGAY 464
            ++  +  L L     +  + + +    ++  L+L +  L+     E+           +
Sbjct: 195 KSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKF 254

Query: 465 SLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSL 524
           + + +++    L  ++   +   S L+ L  S+N L         +LT+LQ + L  N  
Sbjct: 255 TFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313

Query: 525 T 525
            
Sbjct: 314 D 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 84.8 bits (210), Expect = 9e-18
 Identities = 38/236 (16%), Positives = 77/236 (32%), Gaps = 24/236 (10%)

Query: 99  LQFLRKLSLSSNNLTGSISPNL-AKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLA 157
           L  L  L LS N L+ ++S +    L +L  ++L GN          F     L+++ + 
Sbjct: 99  LGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVG 157

Query: 158 KNRFSGKIPS-SLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKG 216
                 KI     +  + L  + + ++   S  P  +  +  +  L L        + + 
Sbjct: 158 NMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEI 216

Query: 217 V-ESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMN 275
             +   ++  + L                       F  +  S     ++ K      + 
Sbjct: 217 FVDVTSSVECLELRDTDLDT----------------FHFSELSTGETNSLIKKFTFRNVK 260

Query: 276 LRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISI-GNLQRLKVLNFSANRLT 330
           +       +V K + ++  L  L+ S N+    VP  I   L  L+ +    N   
Sbjct: 261 ITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 98.2 bits (245), Expect = 2e-21
 Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 28/214 (13%)

Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV------------KSQEDFEREVKKLGK 743
           +LG G +G V     +      AIK +  S               K  E+   E+  L  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102

Query: 744 VRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNER--FNVIQGTAK 801
           + HPN++ L   +  +    L+ EF  GG L + +       F   +E    N+++    
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN--RHKF---DECDAANIMKQILS 157

Query: 802 SLAHLHQSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLDRYVLSSKIQSALGY 858
            + +LH+ NI+H +IK  N+L++        K+ D+GL+        Y L  ++ +A  Y
Sbjct: 158 GICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF--FSKDYKLRDRLGTA-YY 214

Query: 859 MAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
           +APE   +  K  +KCDV+  GV++  ++ G  P
Sbjct: 215 IAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPP 246

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 95.4 bits (238), Expect = 2e-21
 Identities = 46/204 (22%), Positives = 87/204 (42%), Gaps = 32/204 (15%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIK-----KLTVSSLVKS--QEDFEREVKKLGKVRHPN 748
            LG G  G V     R   + VAIK     K  + S  ++    + E E++ L K+ HP 
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFNVIQGTAKS 802
           ++ ++ ++  +    ++ E + GG L      +K L E                     +
Sbjct: 77  IIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKE---------ATCKLYFYQMLLA 126

Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALGYM 859
           + +LH++ IIH ++K  NVL+    E    K+ D+G +++  + +  ++ +   +   Y+
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTP-TYL 183

Query: 860 APE--FACRTVKITDKCDVYGFGV 881
           APE   +  T       D +  GV
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGV 207

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 96.7 bits (241), Expect = 2e-21
 Identities = 45/206 (21%), Positives = 89/206 (43%), Gaps = 32/206 (15%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIK-----KLTVSSLVKS--QEDFEREVKKLGKVRHPN 748
            LG G  G V     R   + VAI+     K  + S  ++    + E E++ L K+ HP 
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFNVIQGTAKS 802
           ++ ++ ++  +    ++ E + GG L      +K L E                     +
Sbjct: 202 IIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKE---------ATCKLYFYQMLLA 251

Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALGYM 859
           + +LH++ IIH ++K  NVL+    E    K+ D+G +++  + +  ++ +   +   Y+
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTP-TYL 308

Query: 860 APE--FACRTVKITDKCDVYGFGVLV 883
           APE   +  T       D +  GV++
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVIL 334

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 95.5 bits (238), Expect = 3e-21
 Identities = 52/196 (26%), Positives = 87/196 (44%), Gaps = 24/196 (12%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKS-QEDFEREVKKLGKVRHPNLVTLEG 754
           ELG+G F  V R V +  G   A K +    L     +  ERE +   K++HPN+V L  
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95

Query: 755 YYWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
               +S   L+++ V+GG L       +   E          +  + IQ   +S+A+ H 
Sbjct: 96  SIQEESFHYLVFDLVTGGELFEDIVAREFYSE---------ADASHCIQQILESIAYCHS 146

Query: 809 SNIIHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFAC 865
           + I+H N+K  N+L+    +    K+ D+GLA  +   D         +  GY++PE   
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTP-GYLSPEVLK 203

Query: 866 RTVKITDKCDVYGFGV 881
           +    +   D++  GV
Sbjct: 204 KD-PYSKPVDIWACGV 218

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 95.0 bits (237), Expect = 3e-21
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 28/221 (12%)

Query: 697 ELGRGGFGAVYRTVLRDGR--------PVAIKKLTVSSLVKSQEDFEREV---KKLGKVR 745
            LG G FG V                  VA+K L   +  K   D   E+   K +G  +
Sbjct: 42  PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG--K 99

Query: 746 HPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGT------ 799
           H N++ L G         +I E+ S G+L ++L            +   V +        
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 800 -------AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI 852
                  A+ + +L     IH ++ + NVL+  +   K+ D+GLAR +  +D Y  ++  
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219

Query: 853 QSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           +  + +MAPE A      T + DV+ FGVL+ E+ T G  P
Sbjct: 220 RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 94.2 bits (235), Expect = 4e-21
 Identities = 54/191 (28%), Positives = 91/191 (47%), Gaps = 17/191 (8%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
            LG G F  V+    R  G+  A+K +  S   +     E E+  L K++H N+VTLE  
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR-DSSLENEIAVLKKIKHENIVTLEDI 74

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNER--FNVIQGTAKSLAHLHQSNIIH 813
           Y + +   L+ + VSGG L   + E   G +    E+    VIQ    ++ +LH++ I+H
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRILE--RGVY---TEKDASLVIQQVLSAVKYLHENGIVH 129

Query: 814 YNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKI 870
            ++K  N+L     E     + D+GL++   M    ++S+   +  GY+APE   +    
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMSTACGTP-GYVAPEVLAQK-PY 184

Query: 871 TDKCDVYGFGV 881
           +   D +  GV
Sbjct: 185 SKAVDCWSIGV 195

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 94.2 bits (235), Expect = 5e-21
 Identities = 46/197 (23%), Positives = 88/197 (44%), Gaps = 21/197 (10%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKS-QEDFEREVKKLGKVRH-PNLVTLE 753
           ELGRG F  V + + +  G+  A K L      +  + +   E+  L   +  P ++ L 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNER--FNVIQGTAKSLAHLHQSNI 811
             Y   S  +LI E+ +GG +               +E     +I+   + + +LHQ+NI
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCLPELAEMV---SENDVIRLIKQILEGVYYLHQNNI 152

Query: 812 IHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFAC 865
           +H ++K  N+L+         K+ D+G++R      +   + +++  +G   Y+APE   
Sbjct: 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSR------KIGHACELREIMGTPEYLAPEILN 206

Query: 866 RTVKITDKCDVYGFGVL 882
               IT   D++  G++
Sbjct: 207 YD-PITTATDMWNIGII 222

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 94.0 bits (234), Expect = 6e-21
 Identities = 50/217 (23%), Positives = 91/217 (41%), Gaps = 23/217 (10%)

Query: 696 CELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGK-VRHPNLVTLE 753
            E+G G  G V++    + G  +A+K++  S   +  +    ++  + K    P +V   
Sbjct: 31  GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAKSLAHLH-QSN 810
           G + T +   +  E + G    K      G       ER    +     K+L +L  +  
Sbjct: 91  GTFITNTDVFIAMELM-GTCAEKLKKRMQGP----IPERILGKMTVAIVKALYYLKEKHG 145

Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE----F 863
           +IH ++K SN+L+D  G+ K+ D+G++  L      V       + G   YMAPE     
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRL------VDDKAKDRSAGCAAYMAPERIDPP 199

Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMW 900
                    + DV+  G+ ++E+ TG+ P    K  +
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF 236

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 95.2 bits (237), Expect = 9e-21
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 39/215 (18%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFE-REVKKLGKVRHPNLVTLEGY 755
           +G G FG VY+  L D G  VAIKK      V   + F+ RE++ + K+ H N+V L  +
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKK------VLQDKRFKNRELQIMRKLDHCNIVRLRYF 115

Query: 756 YWTQSLQL------LIYEFVSGGSLHKHL-HEGSGGNFLSWNE-RFNVIQGTAKSLAHLH 807
           +++   +       L+ ++V   ++++   H       L     +  + Q   +SLA++H
Sbjct: 116 FYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSLAYIH 173

Query: 808 QSNIIHYNIKSSNVLIDG-SGEPKVGDYGLARLL----PMLDRYVLSSKIQSALGYMAPE 862
              I H +IK  N+L+D  +   K+ D+G A+ L    P +  Y+ S        Y APE
Sbjct: 174 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YICS------RYYRAPE 226

Query: 863 --FACR--TVKITDKCDVYGFGVLVLEVVTGKRPL 893
             F     T  I    DV+  G ++ E++ G +P+
Sbjct: 227 LIFGATDYTSSI----DVWSAGCVLAELLLG-QPI 256

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 96.0 bits (239), Expect = 1e-20
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 35/213 (16%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDF----EREVKKLGKVRHPNLVTL 752
           LGRGGFG V+   ++  G+  A KKL    L K +       E+++  L KV    +V+L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI--LAKVHSRFIVSL 250

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFN----------VIQGTAKS 802
              + T++   L+   ++GG +  H++     N    N  F           ++ G    
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIY-----NVDEDNPGFQEPRAIFYTAQIVSG---- 301

Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YM 859
           L HLHQ NII+ ++K  NVL+D  G  ++ D GLA  L         +K +   G   +M
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-----TKTKGYAGTPGFM 356

Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
           APE      +     D +  GV + E++  + P
Sbjct: 357 APELLLGE-EYDFSVDYFALGVTLYEMIAARGP 388

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 94.0 bits (234), Expect = 1e-20
 Identities = 56/221 (25%), Positives = 90/221 (40%), Gaps = 28/221 (12%)

Query: 697 ELGRGGFGAVYRTVLRD--------GRPVAIKKLTVSSLVKSQEDFEREV---KKLGKVR 745
            LG G FG V                  VA+K L   +  K   D   E+   K +G  +
Sbjct: 76  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG--K 133

Query: 746 HPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGT------ 799
           H N++ L G         +I E+ S G+L ++L               +  +        
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 800 -------AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI 852
                  A+ + +L     IH ++ + NVL+      K+ D+GLAR +  +D Y  ++  
Sbjct: 194 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253

Query: 853 QSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           +  + +MAPE A      T + DV+ FGVL+ E+ T G  P
Sbjct: 254 RLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 92.3 bits (230), Expect = 2e-20
 Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 24/202 (11%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGY 755
           LG G    V   +     +  A+K +        +    REV+ L + + H N++ L  +
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAKSLAHLHQSNIIH 813
           +  +    L++E + GGS+  H+H+    +F   NE     V+Q  A +L  LH   I H
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHK--RRHF---NELEASVVVQDVASALDFLHNKGIAH 134

Query: 814 YNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRY------VLSSKIQSALGYMAPE-- 862
            ++K  N+L +   +    K+ D+ L   + +           L +   SA  YMAPE  
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA-EYMAPEVV 193

Query: 863 --FACRTVKITDKCDVYGFGVL 882
             F+        +CD++  GV+
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVI 215

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 92.3 bits (230), Expect = 2e-20
 Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 29/224 (12%)

Query: 697 ELGRGGFGAVYRTVLRDGR------PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
            LG G FG V +      +       VA+K L  ++      D   E   L +V HP+++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHL-----HEGSGGNFLSWNERFNVIQGTAKSL-- 803
            L G        LLI E+   GSL   L                    ++     ++L  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149

Query: 804 --------------AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS 849
                          +L +  ++H ++ + N+L+    + K+ D+GL+R +   D YV  
Sbjct: 150 GDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKR 209

Query: 850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           S+ +  + +MA E +      T + DV+ FGVL+ E+VT G  P
Sbjct: 210 SQGRIPVKWMAIE-SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 93.9 bits (234), Expect = 2e-20
 Identities = 48/196 (24%), Positives = 84/196 (42%), Gaps = 23/196 (11%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLVTLEG 754
           ELG+G F  V R V    G+  A   +    L     +  ERE +    ++HPN+V L  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77

Query: 755 YYWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
               +    LI++ V+GG L       ++  E          +  + IQ   +++ H HQ
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDIVAREYYSE---------ADASHCIQQILEAVLHCHQ 128

Query: 809 SNIIHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFAC 865
             ++H N+K  N+L+    +    K+ D+GLA  +   ++        +  GY++PE   
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFAGTP-GYLSPEVLR 186

Query: 866 RTVKITDKCDVYGFGV 881
           +        D++  GV
Sbjct: 187 KD-PYGKPVDLWACGV 201

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 51/224 (22%), Positives = 96/224 (42%), Gaps = 29/224 (12%)

Query: 697 ELGRGGFGAVYRTVLRDGRP------VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ++G G FG V++       P      VA+K L   +    Q DF+RE   + +  +PN+V
Sbjct: 54  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGT----------- 799
            L G         L++E+++ G L++ L   S     S +      +             
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173

Query: 800 ----------AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS 849
                     A  +A+L +   +H ++ + N L+  +   K+ D+GL+R +   D Y   
Sbjct: 174 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAD 233

Query: 850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
                 + +M PE +    + T + DV+ +GV++ E+ + G +P
Sbjct: 234 GNDAIPIRWMPPE-SIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 95.2 bits (237), Expect = 2e-20
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 18/203 (8%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDF----EREVKKLGKVRHPNLVTL 752
           LG+GGFG V    +R  G+  A KKL    + K + +     E+++  L KV    +V+L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI--LEKVNSRFVVSL 249

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
              Y T+    L+   ++GG L  H++      F      F   +     L  LH+  I+
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLHRERIV 308

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVK 869
           + ++K  N+L+D  G  ++ D GLA  +P          I+  +G   YMAPE      +
Sbjct: 309 YRDLKPENILLDDHGHIRISDLGLAVHVPEGQT------IKGRVGTVGYMAPEVVKNE-R 361

Query: 870 ITDKCDVYGFGVLVLEVVTGKRP 892
            T   D +  G L+ E++ G+ P
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSP 384

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 92.3 bits (230), Expect = 3e-20
 Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 24/217 (11%)

Query: 697 ELGRGGFGAVYRTVLRDGR------PVAIKKLTVSSLVKSQEDFEREV---KKLGKVRHP 747
            LG G FG V                VA+K L  ++    +E    E+     LG  +H 
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG--QHE 110

Query: 748 NLVTLEGYYWTQSLQLLIYEFVSGGSLHKHL-----------HEGSGGNFLSWNERFNVI 796
           N+V L G        L+I E+   G L   L                 +  S  +  +  
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 797 QGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL 856
              A+ +A L   N IH ++ + NVL+      K+GD+GLAR +     Y++    +  +
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230

Query: 857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
            +MAPE +      T + DV+ +G+L+ E+ + G  P
Sbjct: 231 KWMAPE-SIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 90.8 bits (226), Expect = 5e-20
 Identities = 48/206 (23%), Positives = 84/206 (40%), Gaps = 33/206 (16%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIK--------KLTVSSLVKSQEDFEREVKKLGKV-RH 746
            LGRG    V R + +   +  A+K          +   + + +E   +EV  L KV  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 747 PNLVTLEGYYWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFNVIQGTA 800
           PN++ L+  Y T +   L+++ +  G L         L E          E   +++   
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE---------KETRKIMRALL 134

Query: 801 KSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMA 860
           + +  LH+ NI+H ++K  N+L+D     K+ D+G +  L       L     +   Y+A
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTP-SYLA 191

Query: 861 PE-FACRTVKITD----KCDVYGFGV 881
           PE   C           + D++  GV
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGV 217

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 90.7 bits (226), Expect = 5e-20
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 27/208 (12%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQE----DFEREVKKLGKVRHPNLVTL 752
           LG G F  V         R  AIK L    ++K  +      ER+V  + ++ HP  V L
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV--MSRLDHPFFVKL 95

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
              +           +   G L K++ +   G+F     RF   +  + +L +LH   II
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVS-ALEYLHGKGII 152

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVK 869
           H ++K  N+L++     ++ D+G A++L    +    ++  S +G   Y++PE       
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAKVLSPESK---QARANSFVGTAQYVSPEL------ 203

Query: 870 ITDK-----CDVYGFGVLVLEVVTGKRP 892
           +T+K      D++  G ++ ++V G  P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPP 231

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 91.7 bits (228), Expect = 7e-20
 Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 28/221 (12%)

Query: 697 ELGRGGFGAVYR--------TVLRDGRPVAIKKLTVSSLVKSQEDFEREV---KKLGKVR 745
            LG G FG V             ++   VA+K L   +  K   D   E+   K +G  +
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG--K 145

Query: 746 HPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGT------ 799
           H N++ L G         +I E+ S G+L ++L            +   V +        
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 800 -------AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKI 852
                  A+ + +L     IH ++ + NVL+  +   K+ D+GLAR +  +D Y  ++  
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265

Query: 853 QSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           +  + +MAPE A      T + DV+ FGVL+ E+ T G  P
Sbjct: 266 RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 92.9 bits (230), Expect = 1e-19
 Identities = 53/233 (22%), Positives = 89/233 (38%), Gaps = 15/233 (6%)

Query: 95  GLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVI 154
           G+  L  + KL L+ N LT  I P L  L+NL  + L  N +   +     K    L+ +
Sbjct: 60  GIQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DL--SSLKDLKKLKSL 114

Query: 155 SLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIP 214
           SL  N  S  I + L     L ++ L +N+ +    L    L+ L TL L DN +  +I 
Sbjct: 115 SLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS-DIV 169

Query: 215 KGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFM 274
             +  L  L+ + LSKN  S  +   +     L  ++                L + N  
Sbjct: 170 -PLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPN-- 224

Query: 275 NLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSAN 327
            ++    S   P+ I +    E  ++  +       +S    Q + +    A 
Sbjct: 225 TVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKAR 277

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 89.8 bits (222), Expect = 1e-18
 Identities = 45/253 (17%), Positives = 96/253 (37%), Gaps = 19/253 (7%)

Query: 102 LRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRF 161
           + +    S  +   I P           +L   S++ ++      +  S+  I    +  
Sbjct: 1   MGETITVSTPIK-QIFP-DDAFAETIKDNLKKKSVTDAVT---QNELNSIDQIIANNSDI 55

Query: 162 SGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLK 221
              +   +     +  + L+ N+ +   PL    L  L  L L +N ++ ++   ++ LK
Sbjct: 56  K-SV-QGIQYLPNVTKLFLNGNKLTDIKPLT--NLKNLGWLFLDENKIK-DLS-SLKDLK 109

Query: 222 NLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLF 281
            L+ ++L  N  S  I +G+     L ++    N  +      + +L+  + ++L  N  
Sbjct: 110 KLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI 165

Query: 282 SGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCM 341
           S  VP  +  L  L+ L LS N  S    ++   L+ L VL   +        +  +N +
Sbjct: 166 SDIVP--LAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQSNLV 221

Query: 342 NLVALDFSQNSMN 354
               +  +  S+ 
Sbjct: 222 VPNTVKNTDGSLV 234

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 87.9 bits (217), Expect = 5e-18
 Identities = 48/274 (17%), Positives = 101/274 (36%), Gaps = 43/274 (15%)

Query: 78  VIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLS 137
            I+  L   S+T  +     +L  + ++  +++++  S+   +  L N+  + L+GN L+
Sbjct: 23  TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLT 78

Query: 138 GSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLS 197
             I  +      +L  + L +N+    + SSL     L +++L  N  S  +  G+  L 
Sbjct: 79  -DI--KPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGISD-IN-GLVHLP 131

Query: 198 ALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSF 257
            L +L L +N +       +  L  L  ++L  N  S  I   +   + L+ +  S+N  
Sbjct: 132 QLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHI 187

Query: 258 SGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQ 317
           S           L     L+                 L+ L+L   +          NL 
Sbjct: 188 S----------DLRALAGLKN----------------LDVLELFSQECLNKPINHQSNLV 221

Query: 318 RLKVLNFSANRLTGSLPDSMANCMNLVALDFSQN 351
               +  +   L    P+ +++  +    +   +
Sbjct: 222 VPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWH 253

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 84.0 bits (207), Expect = 9e-17
 Identities = 51/282 (18%), Positives = 92/282 (32%), Gaps = 43/282 (15%)

Query: 292 LESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQN 351
                  +L     + AV  +   L  +  +  + + +  S+   +    N+  L  + N
Sbjct: 20  FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGN 75

Query: 352 SMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPAT 411
            +  D+        L  +   ENKI++       SS    + L+ L L HN  S      
Sbjct: 76  KLT-DIKPLTNLKNLGWLFLDENKIKD------LSSLKDLKKLKSLSLEHNGISDING-- 126

Query: 412 IGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRL 471
           +  L  L+ L L  N +       +  L  L+ L L +N ++  I P             
Sbjct: 127 LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIVP------------- 170

Query: 472 ERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQ 531
                       +   + L +L LSKN+++    +A   L NL  ++L            
Sbjct: 171 ------------LAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINH 216

Query: 532 LVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLC 573
             NLV  ++   +   L          +   P+     P   
Sbjct: 217 QSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFT 258

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 70.9 bits (173), Expect = 1e-12
 Identities = 35/165 (21%), Positives = 63/165 (38%), Gaps = 22/165 (13%)

Query: 389 SSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRN---SLVGPIPVAIGDLKALNVL 445
            +F      +L     +         L+ +  +  + +   S+ G     I  L  +  L
Sbjct: 18  DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG-----IQYLPNVTKL 70

Query: 446 DLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPT--SIENCSSLVSLILSKNNLTGP 503
            L+ N L   I P +    +L  L L+ N    KI    S+++   L SL L  N ++  
Sbjct: 71  FLNGNKLT-DIKP-LTNLKNLGWLFLDEN----KIKDLSSLKDLKKLKSLSLEHNGISD- 123

Query: 504 IPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHL 548
           I   +  L  L+++ L  N +T      L  L  L + ++  N +
Sbjct: 124 IN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI 165

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 59.7 bits (144), Expect = 3e-09
 Identities = 35/179 (19%), Positives = 69/179 (38%), Gaps = 10/179 (5%)

Query: 95  GLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVI 154
           GL+ L  L  L L +N +T  I+  L++L  L  + L  N +S  I          L+ +
Sbjct: 126 GLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DI--VPLAGLTKLQNL 180

Query: 155 SLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIP 214
            L+KN  S     +L+    L  + L S    +        L    T+  +D  L    P
Sbjct: 181 YLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTP 236

Query: 215 KGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNF 273
           + +    +    N+  ++      +         TI  ++  F G + + ++++   ++
Sbjct: 237 EIISDDGDYEKPNVKWHL-PEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSY 294

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 7/66 (10%), Positives = 26/66 (39%), Gaps = 4/66 (6%)

Query: 484 IENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNI 543
            +  +  +   L K ++T  +     +L ++  +  + + +       +  L +++   +
Sbjct: 17  DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFL 72

Query: 544 SHNHLQ 549
           + N L 
Sbjct: 73  NGNKLT 78

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 90.0 bits (224), Expect = 2e-19
 Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 21/194 (10%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGK-VRHPNLVTLEG 754
           ++G G +    R + +      A+K      + KS+ D   E++ L +  +HPN++TL+ 
Sbjct: 29  DIGVGSYSVCKRCIHKATNMEFAVK-----IIDKSKRDPTEEIEILLRYGQHPNIITLKD 83

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAKSLAHLHQSNII 812
            Y       ++ E + GG L   +       F   +ER    V+    K++ +LH   ++
Sbjct: 84  VYDDGKYVYVVTELMKGGELLDKILR--QKFF---SEREASAVLFTITKTVEYLHAQGVV 138

Query: 813 HYNIKSSNVL-IDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTV 868
           H ++K SN+L +D SG P   ++ D+G A+ L   +  +L +   +A  ++APE   R  
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLMTPCYTA-NFVAPEVLERQ- 195

Query: 869 KITDKCDVYGFGVL 882
                CD++  GVL
Sbjct: 196 GYDAACDIWSLGVL 209

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 46/194 (23%), Positives = 87/194 (44%), Gaps = 21/194 (10%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVR-HPNLVTLE 753
            LG G F    + V +   +  A+K      + K    + ++E+  L     HPN+V L 
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVK-----IISKRMEANTQKEITALKLCEGHPNIVKLH 72

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAKSLAHLHQSNI 811
             +  Q    L+ E ++GG L + + +    +F   +E     +++    +++H+H   +
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIKK--KKHF---SETEASYIMRKLVSAVSHMHDVGV 127

Query: 812 IHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTV 868
           +H ++K  N+L     +    K+ D+G ARL P  D   L +   +   Y APE   +  
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPCFTL-HYAAPELLNQN- 184

Query: 869 KITDKCDVYGFGVL 882
              + CD++  GV+
Sbjct: 185 GYDESCDLWSLGVI 198

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 54/226 (23%), Positives = 87/226 (38%), Gaps = 33/226 (14%)

Query: 697 ELGRGGFGAVYRTVLRDGR------PVAIKKLTVSSLVKSQEDFEREV---KKLGKVRHP 747
            LG G FG V                VA+K L   +    +E    E+    +LG   H 
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG--SHE 109

Query: 748 NLVTLEGYYWTQSLQLLIYEFVSGGSLHKHL----HEGSGGNFLSWNERFNVIQGTAKSL 803
           N+V L G         LI+E+   G L  +L     + S       N++    +     L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 804 ----------------AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV 847
                             L   + +H ++ + NVL+      K+ D+GLAR +     YV
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229

Query: 848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRP 892
           +    +  + +MAPE +      T K DV+ +G+L+ E+ + G  P
Sbjct: 230 VRGNARLPVKWMAPE-SLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 90.2 bits (224), Expect = 2e-19
 Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 32/205 (15%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIK-------KLTVSSLVKSQEDFEREVKKLGKVR-HP 747
            +GRG    V R V R  G   A+K       +L+   L + +E   RE   L +V  HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160

Query: 748 NLVTLEGYYWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFNVIQGTAK 801
           +++TL   Y + S   L+++ +  G L         L E          E  ++++   +
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE---------KETRSIMRSLLE 211

Query: 802 SLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAP 861
           +++ LH +NI+H ++K  N+L+D + + ++ D+G +    +     L     +  GY+AP
Sbjct: 212 AVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEKLRELCGTP-GYLAP 268

Query: 862 EFACRTVKITDK-----CDVYGFGV 881
           E    ++  T        D++  GV
Sbjct: 269 EILKCSMDETHPGYGKEVDLWACGV 293

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 88.9 bits (221), Expect = 4e-19
 Identities = 48/196 (24%), Positives = 77/196 (39%), Gaps = 25/196 (12%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGY 755
           LG G  G V     R  G+  A+K      L  S     +EV    +    P++V +   
Sbjct: 37  LGLGVNGKVLECFHRRTGQKCALK-----LLYDS-PKARQEVDHHWQASGGPHIVCILDV 90

Query: 756 YWTQSLQ----LLIYEFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAKSLAHLHQS 809
           Y          L+I E + GG L   + E     F    ER    +++    ++  LH  
Sbjct: 91  YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF---TEREAAEIMRDIGTAIQFLHSH 147

Query: 810 NIIHYNIKSSNVLI---DGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           NI H ++K  N+L    +     K+ D+G A+      +  L +   +   Y+APE    
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNALQTPCYTP-YYVAPEVLGP 203

Query: 867 TVKITDKCDVYGFGVL 882
             K    CD++  GV+
Sbjct: 204 E-KYDKSCDMWSLGVI 218

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 88.9 bits (221), Expect = 5e-19
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 37/217 (17%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
            G+G FG V     +  G  VAIKK+      +++E   + ++ L  + HPN+V L+ Y+
Sbjct: 31  AGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE--LQIMQDLAVLHHPNIVQLQSYF 88

Query: 757 WTQSLQ-------LLIYEFVSGGSLHKHL-HEGSGGNFLSWNE-RFNVIQGTAKSLAHLH 807
           +T   +        ++ E+V   +LH+   +             +  + Q   +S+  LH
Sbjct: 89  YTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQ-LIRSIGCLH 146

Query: 808 QS--NIIHYNIKSSNVLIDGS-GEPKVGDYGLARLL----PMLDRYVLSSKIQSALGYMA 860
               N+ H +IK  NVL++ + G  K+ D+G A+ L    P +  Y+ S        Y A
Sbjct: 147 LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA-YICS------RYYRA 199

Query: 861 PE--FACR--TVKITDKCDVYGFGVLVLEVVTGKRPL 893
           PE  F  +  T  +    D++  G +  E++ G+ P+
Sbjct: 200 PELIFGNQHYTTAV----DIWSVGCIFAEMMLGE-PI 231

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 88.5 bits (220), Expect = 9e-19
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 31/210 (14%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQE----DFEREVKKLGKVRHPNLVTL 752
           +G+G FG V      D  +  A+K +     V+  E      E ++  +  + HP LV L
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQI--MQGLEHPFLVNL 80

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAK--------SLA 804
              +  +    ++ + + GG L  HL           N  F   + T K        +L 
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHL---------QQNVHFK--EETVKLFICELVMALD 129

Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE-F 863
           +L    IIH ++K  N+L+D  G   + D+ +A +LP      +++   +   YMAPE F
Sbjct: 130 YLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP--RETQITTMAGT-KPYMAPEMF 186

Query: 864 ACRTVKITDKC-DVYGFGVLVLEVVTGKRP 892
           + R         D +  GV   E++ G+RP
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 87.1 bits (216), Expect = 1e-18
 Identities = 53/273 (19%), Positives = 107/273 (39%), Gaps = 22/273 (8%)

Query: 95  GLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVI 154
               L    K++   +N+T +++   A L  +  +   G  ++ +I  E  +   +L  +
Sbjct: 14  PDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI--EGVQYLNNLIGL 68

Query: 155 SLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIP 214
            L  N+ +    + L   + +  + LS N   +   +   GL +++TLDL+   +    P
Sbjct: 69  ELKDNQITD--LAPLKNLTKITELELSGNPLKNVSAIA--GLQSIKTLDLTSTQITDVTP 124

Query: 215 KGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFM 274
             +  L NL+V+ L  N  + +I   +   + L+ +       S +L   +  LS    +
Sbjct: 125 --LAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTL 178

Query: 275 NLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLP 334
               N  S   P  +  L +L  + L  N+ S   P++  N   L ++  +   +T + P
Sbjct: 179 KADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTNQTIT-NQP 233

Query: 335 DSMANCMNLVALDFSQNSMNGDLPQWIFSSGLN 367
               N  NLV  +  +      +     S    
Sbjct: 234 VFYNN--NLVVPNVVKGPSGAPIAPATISDNGT 264

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 87.1 bits (216), Expect = 1e-18
 Identities = 48/248 (19%), Positives = 103/248 (41%), Gaps = 21/248 (8%)

Query: 291 ELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQ 350
            L +   +    +  +  V  +  +L  +  L+     +T ++   +    NL+ L+   
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72

Query: 351 NSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPA 410
           N +  DL      + + ++  + N ++        S+ +  +S++ LDL+  + +  TP 
Sbjct: 73  NQIT-DLAPLKNLTKITELELSGNPLKN------VSAIAGLQSIKTLDLTSTQITDVTP- 124

Query: 411 TIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELR 470
            +  LS LQ+L L  N +    P  +  L  L  L +    ++  + P +     L  L+
Sbjct: 125 -LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLK 179

Query: 471 LERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPK 530
            + N ++  I   + +  +L+ + L  N ++   P+A    +NL  V L+  ++T     
Sbjct: 180 ADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTNQTITNQPVF 235

Query: 531 QLVNLVHL 538
              NLV  
Sbjct: 236 YNNNLVVP 243

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 49/246 (19%), Positives = 99/246 (40%), Gaps = 19/246 (7%)

Query: 78  VIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLS 137
            I++     ++T  +      L  +  LS     +T +I   +  L NL  ++L  N ++
Sbjct: 21  AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQIT 76

Query: 138 GSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLS 197
             +     K    +  + L+ N    K  S+++   ++ T++L+S + +   PL   GLS
Sbjct: 77  -DLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTPLA--GLS 129

Query: 198 ALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSF 257
            L+ L L  N +   I   +  L NL+ +++     S  +   + + S L T+   +N  
Sbjct: 130 NLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKI 185

Query: 258 SGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQ 317
           S ++       +L    +L+ N  S   P  +    +L  + L+    +        NL 
Sbjct: 186 S-DISPLASLPNLIEV-HLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLV 241

Query: 318 RLKVLN 323
              V+ 
Sbjct: 242 VPNVVK 247

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 45/248 (18%), Positives = 96/248 (38%), Gaps = 24/248 (9%)

Query: 106 SLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKI 165
           S++       I P    L N   I    ++++ ++          +  +S      +  I
Sbjct: 2   SITQPTAINVIFP-DPALANAIKIAAGKSNVTDTVT---QADLDGITTLSAFGTGVT-TI 56

Query: 166 PSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRV 225
              +   + L  + L  N+ +   PL    L+ +  L+LS N L  +    +  L++++ 
Sbjct: 57  -EGVQYLNNLIGLELKDNQITDLAPLK--NLTKITELELSGNPL--KNVSAIAGLQSIKT 111

Query: 226 INLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLP--ETMQKLSLCNFMNLRKNLFSG 283
           ++L+    +   P  +   S L+ +    N  + N+     +  L    ++++     S 
Sbjct: 112 LDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISPLAGLTNL---QYLSIGNAQVSD 165

Query: 284 EVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNL 343
             P  +  L  L TL    NK S   P++  +L  L  ++   N+++   P  +AN  NL
Sbjct: 166 LTP--LANLSKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSP--LANTSNL 219

Query: 344 VALDFSQN 351
             +  +  
Sbjct: 220 FIVTLTNQ 227

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 39/160 (24%), Positives = 65/160 (40%), Gaps = 12/160 (7%)

Query: 389 SSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLS 448
           +  + +  L       +      +  L+ L  L L  N +    P  + +L  +  L+LS
Sbjct: 38  ADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELS 93

Query: 449 ENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAI 508
            N L  ++   I G  S+K L L    +    P  +   S+L  L L  N +T   P+A 
Sbjct: 94  GNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISPLA- 148

Query: 509 AKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHL 548
             LTNLQ + +    ++   P  L NL  L++     N +
Sbjct: 149 -GLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI 185

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 50.8 bits (122), Expect = 8e-07
 Identities = 19/136 (13%), Positives = 46/136 (33%), Gaps = 32/136 (23%)

Query: 414 ALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLER 473
           AL+    +   ++++   +     DL  +  L      +  +I                 
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG--------------- 58

Query: 474 NFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLV 533
                     ++  ++L+ L L  N +T   P+    LT +  ++LS N L       + 
Sbjct: 59  ----------VQYLNNLIGLELKDNQITDLAPLK--NLTKITELELSGNPLKN--VSAIA 104

Query: 534 NLVHLSSFNISHNHLQ 549
            L  + + +++   + 
Sbjct: 105 GLQSIKTLDLTSTQIT 120

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 86.1 bits (214), Expect = 2e-18
 Identities = 47/177 (26%), Positives = 79/177 (44%), Gaps = 27/177 (15%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFE-------REVKKLGKVRHPNL 749
           +G G +G V++   RD G+ VAIKK          ED         RE++ L +++HPNL
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKK------FLESEDDPVIKKIALREIRMLKQLKHPNL 64

Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
           V L   +  +    L++E+    ++   L     G  +  +   ++   T +++   H+ 
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRG--VPEHLVKSITWQTLQAVNFCHKH 121

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR----YVLSSKIQSALGYMAPE 862
           N IH ++K  N+LI      K+ D+G ARLL          V      +   Y +PE
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV------ATRWYRSPE 172

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 86.1 bits (214), Expect = 3e-18
 Identities = 47/151 (31%), Positives = 69/151 (45%), Gaps = 17/151 (11%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFE-------REVKKLGKVRHPNL 749
           +G G +G V +   +D GR VAIKK          +D +       RE+K L ++RH NL
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKK------FLESDDDKMVKKIAMREIKLLKQLRHENL 86

Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
           V L      +    L++EFV   ++   L     G  L +      +      +   H  
Sbjct: 87  VNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHSH 143

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLL 840
           NIIH +IK  N+L+  SG  K+ D+G AR L
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTL 174

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 86.2 bits (214), Expect = 3e-18
 Identities = 48/191 (25%), Positives = 95/191 (49%), Gaps = 18/191 (9%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           ELGRG    VYR   +   +P A+K L  +     ++    E+  L ++ HPN++ L+  
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKT---VDKKIVRTEIGVLLRLSHPNIIKLKEI 116

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAKSLAHLHQSNIIH 813
           + T +   L+ E V+GG L   + E   G +   +ER   + ++   +++A+LH++ I+H
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVE--KGYY---SERDAADAVKQILEAVAYLHENGIVH 171

Query: 814 YNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKI 870
            ++K  N+L          K+ D+GL++++    + ++ +   +  GY APE        
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTP-GYCAPEILRGC-AY 227

Query: 871 TDKCDVYGFGV 881
             + D++  G+
Sbjct: 228 GPEVDMWSVGI 238

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 86.7 bits (215), Expect = 3e-18
 Identities = 56/333 (16%), Positives = 110/333 (33%), Gaps = 74/333 (22%)

Query: 74  RSNRVIELTLNGLSLTG--RIGRGLLQLQFLRKLSLSSNNLTG----SISPNLAKLQNLR 127
            S     L L+ ++      +   LL+   ++++ LS N +       +S N+A  ++L 
Sbjct: 4   FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63

Query: 128 VIDLSGNSLSGSIPDEF----------FKQCGSLRVISLAKNRFSGK----IPSSLSLCS 173
           + + S     G + DE             +C  L  + L+ N F       +   LS  +
Sbjct: 64  IAEFSDIFT-GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 122

Query: 174 TLATINLSSNRFS-------------SPLPLGIWGLSALRTLDLSDNLLEGE----IPKG 216
            L  + L +N                  +         LR++    N LE        K 
Sbjct: 123 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182

Query: 217 VESLKNLRVINLSKNMF-----SGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLC 271
            +S + L  + + +N          + +G+  C  L+ +D  +N+F+         L++ 
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT---HLGSSALAIA 239

Query: 272 NFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFS--GAVPIS----IGNLQRLKVLNFS 325
               L+                +L  L L+    S  GA  +           L+ L   
Sbjct: 240 ----LKSW-------------PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQ 282

Query: 326 ANRLTG----SLPDSMA-NCMNLVALDFSQNSM 353
            N +      +L   +     +L+ L+ + N  
Sbjct: 283 YNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 73.6 bits (181), Expect = 7e-14
 Identities = 60/408 (14%), Positives = 113/408 (27%), Gaps = 128/408 (31%)

Query: 150 SLRVISLAKNRFSGK----IPSSLSLCSTLATINLSSNRFS----SPLPLGIWGLSALRT 201
           S+   SL  +  + +    + + L    ++  I LS N         L   I     L  
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64

Query: 202 LDLSDN---LLEGEIPKGVESL-------KNLRVINLSKNMFSG----SIPDGIGSCSLL 247
            + SD     ++ EIP+ +  L         L  + LS N F       + D +   + L
Sbjct: 65  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124

Query: 248 RTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFS- 306
             +    N      P+   K++        + L    V K       L ++    N+   
Sbjct: 125 EHLYLHNNGLG---PQAGAKIA--------RALQELAVNKKAKNAPPLRSIICGRNRLEN 173

Query: 307 -GAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSG 365
                 +                       +  +   L  +   QN +            
Sbjct: 174 GSMKEWA----------------------KTFQSHRLLHTVKMVQNGI-RP--------- 201

Query: 366 LNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSR 425
                       EG+        +  + L+ LDL  N F+       G+ +      L+ 
Sbjct: 202 ------------EGIEHLLLEGLAYCQELKVLDLQDNTFTHL-----GSSA------LAI 238

Query: 426 NSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIG--GAYSL-KELRLERNFLAGKIPT 482
                    A+     L  L L++          +   GA ++        N        
Sbjct: 239 ---------ALKSWPNLRELGLNDC--------LLSARGAAAVVDAFSKLEN-------- 273

Query: 483 SIENCSSLVSLILSKNNLTGPIPIAIA-----KLTNLQNVDLSFNSLT 525
                  L +L L  N +       +      K+ +L  ++L+ N  +
Sbjct: 274 -----IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 69.4 bits (170), Expect = 2e-12
 Identities = 46/303 (15%), Positives = 94/303 (31%), Gaps = 63/303 (20%)

Query: 294 SLETLDLSGNKFS--GAVPIS--IGNLQRLKVLNFSANRLTG----SLPDSMANCMNLVA 345
           S+E   L  +  +      +   +     +K +  S N +       L +++A+  +L  
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64

Query: 346 LDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFS 405
            +FS                       +++I E +      +      L  + LS N F 
Sbjct: 65  AEFSDIFTGR----------------VKDEIPEALRL-LLQALLKCPKLHTVRLSDNAFG 107

Query: 406 GETPATIGAL----SGLQLLNLSRNSL-------------VGPIPVAIGDLKALNVLDLS 448
                 +       + L+ L L  N L                +     +   L  +   
Sbjct: 108 PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICG 167

Query: 449 ENWLNGSIPPEIGGAY----SLKELRLERNFL-----AGKIPTSIENCSSLVSLILSKNN 499
            N L      E    +     L  +++ +N +        +   +  C  L  L L  N 
Sbjct: 168 RNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT 227

Query: 500 LT--GPIPIA--IAKLTNLQNVDLSFNSLT--GGLP-----KQLVNLVHLSSFNISHNHL 548
            T  G   +A  +    NL+ + L+   L+  G         +L N+  L +  + +N +
Sbjct: 228 FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENI-GLQTLRLQYNEI 286

Query: 549 QGE 551
           + +
Sbjct: 287 ELD 289

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 87.1 bits (216), Expect = 5e-18
 Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 20/207 (9%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVK-SQEDF---EREVKKLGKVRHPNLVTL 752
           +GRG FG V    L++  +  A+K L    ++K ++      ER+V  L       + TL
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV--LVNGDSKWITTL 139

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
              +   +   L+ ++  GG L   L +           RF + +    ++  +HQ + +
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFED-RLPEEMARFYLAE-MVIAIDSVHQLHYV 197

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE----FAC 865
           H +IK  N+L+D +G  ++ D+G    L M D  V SS    A+G   Y++PE       
Sbjct: 198 HRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSS---VAVGTPDYISPEILQAMEG 253

Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRP 892
              +   +CD +  GV + E++ G+ P
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETP 280

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 85.1 bits (211), Expect = 1e-17
 Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 26/211 (12%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLV-KSQEDF---EREVKKLGKVRHPNLVTL 752
           +GRG F  V    ++  G+  A+K +    ++ + +      ER+V  L       +  L
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDV--LVNGDRRWITQL 126

Query: 753 EGYYWTQSLQLL--IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
             ++  Q    L  + E+  GG L   L +  G    +   RF + +    ++  +H+  
Sbjct: 127 --HFAFQDENYLYLVMEYYVGGDLLTLLSK-FGERIPAEMARFYLAE-IVMAIDSVHRLG 182

Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE----- 862
            +H +IK  N+L+D  G  ++ D+G    L   D  V S     A+G   Y++PE     
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKL-RADGTVRSL---VAVGTPDYLSPEILQAV 238

Query: 863 -FACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
                T     +CD +  GV   E+  G+ P
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 85.1 bits (211), Expect = 1e-17
 Identities = 48/206 (23%), Positives = 86/206 (41%), Gaps = 21/206 (10%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVK-SQEDF---EREVKKLGKVRHPNLVTL 752
           +GRG FG V     +   +  A+K L+   ++K S   F   ER++  +     P +V L
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI--MAFANSPWVVQL 134

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
              +       ++ E++ GG L   +      +      RF   +    +L  +H    I
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVL-ALDAIHSMGFI 190

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE---FACR 866
           H ++K  N+L+D SG  K+ D+G    +          +  +A+G   Y++PE       
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG----MVRCDTAVGTPDYISPEVLKSQGG 246

Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRP 892
                 +CD +  GV + E++ G  P
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTP 272

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 84.3 bits (209), Expect = 2e-17
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 32/208 (15%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQE----DFEREVKKLGKVRHPNLVTL 752
           LG G FG V     ++ G   A+K L    +VK ++      E+ +  L  V  P LV L
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI--LQAVNFPFLVKL 106

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           E  +   S   ++ E+V+GG +  HL     G F   + RF   Q    +  +LH  ++I
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQ-IVLTFEYLHSLDLI 163

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVK 869
           + ++K  N+LID  G  +V D+G A+         +  +  +  G    +APE       
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWTLCGTPEALAPEI------ 209

Query: 870 ITDK-----CDVYGFGVLVLEVVTGKRP 892
           I  K      D +  GVL+ E+  G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 37/228 (16%), Positives = 74/228 (32%), Gaps = 31/228 (13%)

Query: 102 LRKLSLSSNNLTGSISPN-LAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNR 160
            + L L   +L  +I  +  + L N+  I +S +     +    F     +  I +   R
Sbjct: 33  TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91

Query: 161 FSGKIPSS-LSLCSTLATINLSSNRFSS-PLPLGIWGLSALRTLDLSDNLLEGEIPKGV- 217
               I    L     L  + + +      P    ++       L+++DN     IP    
Sbjct: 92  NLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151

Query: 218 ESLKN-LRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNL 276
           + L N    + L  N F+ S+     + + L  +  ++N +   + +         F  +
Sbjct: 152 QGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDA-------FGGV 203

Query: 277 RKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISI-GNLQRLKVLN 323
                                LD+S    + A+P     +L+ L   N
Sbjct: 204 YSG---------------PSLLDVSQTSVT-ALPSKGLEHLKELIARN 235

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 34/215 (15%), Positives = 73/215 (33%), Gaps = 16/215 (7%)

Query: 73  PRSNRVIELTLNGLSLTGRIGRGLLQ-LQFLRKLSLSSNNLTGSISPNL-AKLQNLRVID 130
           P S + ++L    L     I       L  + ++ +S +     +  +    L  +  I+
Sbjct: 30  PPSTQTLKLIETHLR---TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIE 86

Query: 131 LSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIP--SSLSLCSTLATINLSSNRFSSP 188
           +        I  +  K+   L+ + +         P  + +        + ++ N + + 
Sbjct: 87  IRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTS 145

Query: 189 LPLGI-WGLSA-LRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGI--GSC 244
           +P+    GL     TL L +N     +     +   L  + L+KN +   I      G  
Sbjct: 146 IPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY 204

Query: 245 SLLRTIDFSEN---SFSGNLPETMQKLSLCNFMNL 276
           S    +D S+    +      E +++L   N   L
Sbjct: 205 SGPSLLDVSQTSVTALPSKGLEHLKELIARNTWTL 239

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 39/258 (15%), Positives = 80/258 (31%), Gaps = 40/258 (15%)

Query: 294 SLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSM 353
             E   ++       +P    + Q L         L      + +N  N+  +  S +  
Sbjct: 12  QEEDFRVTCKDIQ-RIPSLPPSTQTL---KLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67

Query: 354 NGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHN-EFSGETPATI 412
              L    F   L+                          +  +++ +    +   P  +
Sbjct: 68  LQQLESHSF-YNLS-------------------------KVTHIEIRNTRNLTYIDPDAL 101

Query: 413 GALSGLQLLNLSRNSLVG-PIPVAIGDLKALNVLDLSENWLNGSIPPEI--GGAYSLKEL 469
             L  L+ L +    L   P    +       +L++++N    SIP     G       L
Sbjct: 102 KELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTL 161

Query: 470 RLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPI-AIAKL-TNLQNVDLSFNSLT-- 525
           +L  N     +     N + L ++ L+KN     I   A   + +    +D+S  S+T  
Sbjct: 162 KLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL 220

Query: 526 -GGLPKQLVNLVHLSSFN 542
                + L  L+  +++ 
Sbjct: 221 PSKGLEHLKELIARNTWT 238

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 30/176 (17%), Positives = 55/176 (31%), Gaps = 8/176 (4%)

Query: 393 SLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPV-AIGDLKALNVLDLSENW 451
           S Q L L               L  +  + +S +  +  +   +  +L  +  +++    
Sbjct: 32  STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91

Query: 452 LNGSIPPEI-GGAYSLKELRLERNFLAGKIP--TSIENCSSLVSLILSKNNLTGPIPI-A 507
               I P+       LK L +    L    P  T + +      L ++ N     IP+ A
Sbjct: 92  NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150

Query: 508 IAKLTN-LQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTIS 562
              L N    + L  N  T  +     N   L +  ++ N     +    F    S
Sbjct: 151 FQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYS 205

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 82.2 bits (203), Expect = 6e-17
 Identities = 29/168 (17%), Positives = 63/168 (37%), Gaps = 13/168 (7%)

Query: 729 KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLI-YEFVSGGSLHKHLHEGSGGNFL 787
              +    +++++      N V       +  + L I  +     +L   ++        
Sbjct: 103 SPMDAPSVKIRRMDPFSTKNTVGQL-QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161

Query: 788 SWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL--PMLDR 845
                 ++    A+++  LH   ++H ++K SN+        KVGD+GL   +     ++
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221

Query: 846 YVLSSKIQSALG--------YMAPEFACRTVKITDKCDVYGFGVLVLE 885
            VL+     A          YM+PE        + K D++  G+++ E
Sbjct: 222 TVLTPMPAYATHTGQVGTKLYMSPE-QIHGNNYSHKVDIFSLGLILFE 268

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 81.8 bits (203), Expect = 6e-17
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 53/222 (23%)

Query: 698 LGRGGFGAVY---RTVLRD-GRPVAIKKLTVSSLVKSQEDF-----EREVKKLGKVRHPN 748
           LG+GG+G V+   +    + G+  A+K L  + +V++ +D      ER +  L +V+HP 
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI--LEEVKHPF 82

Query: 749 LVTLEGYYWTQSLQLL--IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAK----- 801
           +V L   Y  Q+   L  I E++SGG L   L              F   + TA      
Sbjct: 83  IVDL--IYAFQTGGKLYLILEYLSGGELFMQLER---------EGIFM--EDTACFYLAE 129

Query: 802 ---SLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG- 857
              +L HLHQ  II+ ++K  N++++  G  K+ D+GL +   + D     +   +  G 
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHD----GTVTHTFCGT 184

Query: 858 --YMAPEFACRTVKITDK-----CDVYGFGVLVLEVVTGKRP 892
             YMAPE       +         D +  G L+ +++TG  P
Sbjct: 185 IEYMAPEI------LMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 82.9 bits (205), Expect = 6e-17
 Identities = 43/197 (21%), Positives = 80/197 (40%), Gaps = 24/197 (12%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEG 754
            LG G  G V +   +      A+K      +++      REV+   +  + P++V +  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALK------MLQDCPKARREVELHWRASQCPHIVRIVD 122

Query: 755 YYWTQSLQ----LLIYEFVSGGSLHKHLHEGSGGNFLSWNER--FNVIQGTAKSLAHLHQ 808
            Y          L++ E + GG L   + +     F    ER    +++   +++ +LH 
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF---TEREASEIMKSIGEAIQYLHS 179

Query: 809 SNIIHYNIKSSNVLIDGSGEP---KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFAC 865
            NI H ++K  N+L          K+ D+G A+         L++   +   Y+APE   
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCYTP-YYVAPEVLG 236

Query: 866 RTVKITDKCDVYGFGVL 882
              K    CD++  GV+
Sbjct: 237 PE-KYDKSCDMWSLGVI 252

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 81.4 bits (202), Expect = 9e-17
 Identities = 45/154 (29%), Positives = 76/154 (49%), Gaps = 19/154 (12%)

Query: 692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFE-------REVKKLGKV 744
           L K   +G G +G VY+     GR VA+K+      ++   + E       RE+  L ++
Sbjct: 26  LEK---VGEGTYGVVYKAKDSQGRIVALKR------IRLDAEDEGIPSTAIREISLLKEL 76

Query: 745 RHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLA 804
            HPN+V+L     ++    L++EF+    L K L + +         +  + Q   + +A
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVA 133

Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR 838
           H HQ  I+H ++K  N+LI+  G  K+ D+GLAR
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLAR 167

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 81.5 bits (202), Expect = 1e-16
 Identities = 40/154 (25%), Positives = 80/154 (51%), Gaps = 15/154 (9%)

Query: 692 LNKDCELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQEDFE----REVKKLGKVRH 746
           L+    LG G F  VY+       + VAIKK+ +    ++++       RE+K L ++ H
Sbjct: 15  LDF---LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71

Query: 747 PNLVTLEGYYWTQSLQLLIYEFVSGGSLH--KHLHEGSGGNFLSWNERFNVIQGTAKSLA 804
           PN++ L   +  +S   L+++F+        + + + +       + +  ++  T + L 
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLM-TLQGLE 126

Query: 805 HLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR 838
           +LHQ  I+H ++K +N+L+D +G  K+ D+GLA+
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK 160

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 81.4 bits (201), Expect = 1e-16
 Identities = 47/287 (16%), Positives = 85/287 (29%), Gaps = 43/287 (14%)

Query: 71  CSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPN-LAKLQNLRVI 129
           CS R             +T  I   L +     +L      L   I     +   +L  I
Sbjct: 9   CSNRV-----FLCQESKVT-EIPSDLPR--NAIELRFVLTKLR-VIQKGAFSGFGDLEKI 59

Query: 130 DLSGNSLSGSIPDEFFKQCGSLRVISLAK-NRFSGKIPSSLSLCSTLATINLSSNRFSSP 188
           ++S N +   I  + F     L  I + K N      P +      L  + +S+      
Sbjct: 60  EISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHL 119

Query: 189 LPLGIWGLSALRTLDLSDNLLEGEIPKGV-ESL-KNLRVINLSKNMFSGSIPDGI-GSCS 245
             +          LD+ DN+    I +     L     ++ L+KN     I +       
Sbjct: 120 PDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQ 178

Query: 246 LLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKF 305
           L        N+                   L  ++F G              LD+S  + 
Sbjct: 179 LDELNLSDNNNLE----------------ELPNDVFHG--------ASGPVILDISRTRI 214

Query: 306 SGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNS 352
                  + NL++L+  +    +    LP ++   + L+    +  S
Sbjct: 215 HSLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 77.6 bits (191), Expect = 2e-15
 Identities = 47/258 (18%), Positives = 84/258 (32%), Gaps = 37/258 (14%)

Query: 294 SLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSM 353
           S        +K +  +P  +   +    L F   +L      + +   +L  ++ SQN +
Sbjct: 10  SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66

Query: 354 NGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSH-NEFSGETPATI 412
              +   +FS  L K                         L  + +   N      P   
Sbjct: 67  LEVIEADVFS-NLPK-------------------------LHEIRIEKANNLLYINPEAF 100

Query: 413 GALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEI--GGAYSLKELR 470
             L  LQ L +S   +     V         +LD+ +N    +I      G ++    L 
Sbjct: 101 QNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILW 160

Query: 471 LERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPI-AIAKLTNLQNVDLSFNSLT---G 526
           L +N +  +I  S  N + L  L LS NN    +P       +    +D+S   +     
Sbjct: 161 LNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 219

Query: 527 GLPKQLVNLVHLSSFNIS 544
              + L  L   S++N+ 
Sbjct: 220 YGLENLKKLRARSTYNLK 237

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 73.3 bits (180), Expect = 7e-14
 Identities = 46/294 (15%), Positives = 90/294 (30%), Gaps = 47/294 (15%)

Query: 166 PSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGV-ESLKNLR 224
              +  CS         ++ +  +P  +        L      L   I KG      +L 
Sbjct: 3   HHRICHCSN-RVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLE 57

Query: 225 VINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRK---NLF 281
            I +S+N     I                   FS NLP+ + ++ +    NL       F
Sbjct: 58  KIEISQNDVLEVIEAD---------------VFS-NLPK-LHEIRIEKANNLLYINPEAF 100

Query: 282 SGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPD-SMANC 340
                     L +L+ L +S         +   +  +  +L+   N    ++   S    
Sbjct: 101 QN--------LPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL 152

Query: 341 M-NLVALDFSQNSMNGDLPQWIFSS-GLNKVSFAE-NKIREGMNGPFASSGSSFESLQFL 397
               V L  ++N +  ++    F+   L++++ ++ N + E  N  F            L
Sbjct: 153 SFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVF----HGASGPVIL 207

Query: 398 DLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENW 451
           D+S           +  L  L+  +      +      +  L AL    L+   
Sbjct: 208 DISRTRIHSLPSYGLENLKKLRARSTYNLKKLPT----LEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 60.6 bits (147), Expect = 8e-10
 Identities = 35/200 (17%), Positives = 63/200 (31%), Gaps = 35/200 (17%)

Query: 391 FESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPV-AIGDLKALNVLDLSE 449
             +   L     +              L+ + +S+N ++  I      +L  L+ + + +
Sbjct: 29  PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88

Query: 450 -NWLNGSIPPEI-GGAYSLKELRLERNFLAGKIP---------------------TSIEN 486
            N L   I PE      +L+ L +    +   +P                      +IE 
Sbjct: 89  ANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIER 146

Query: 487 ------CSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSF-NSLTGGLPKQLVNLVHLS 539
                     V L L+KN +   I  +    T L  ++LS  N+L               
Sbjct: 147 NSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPV 205

Query: 540 SFNISHNHLQGELPAGGFFN 559
             +IS   +   LP+ G  N
Sbjct: 206 ILDISRTRIH-SLPSYGLEN 224

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 80.2 bits (199), Expect = 1e-16
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 16/148 (10%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFE-------REVKKLGKVRHPNLV 750
           +G G +G VY+     G   A+KK      ++ +++ E       RE+  L +++H N+V
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKK------IRLEKEDEGIPSTTIREISILKELKHSNIV 63

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
            L     T+   +L++E +    L K L +   G   S   +  ++Q     +A+ H   
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQ-DLKKLL-DVCEGGLESVTAKSFLLQ-LLNGIAYCHDRR 120

Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLAR 838
           ++H ++K  N+LI+  GE K+ D+GLAR
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLAR 148

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 80.7 bits (200), Expect = 2e-16
 Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 50/217 (23%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQE----DFEREVKKLGKVRHPNLVTL 752
           LG G FG V+    R  GR  A+K L    +V+ ++    + ER +  L  V HP ++ +
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLM--LSIVTHPFIIRM 71

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHL-HEGSGGNFLSWNERFNVIQGTAK--------SL 803
            G +       +I +++ GG L   L              RF      AK        +L
Sbjct: 72  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQ----------RFP--NPVAKFYAAEVCLAL 119

Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMA 860
            +LH  +II+ ++K  N+L+D +G  K+ D+G A+ +P            +  G   Y+A
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP--------DVTYTLCGTPDYIA 171

Query: 861 PEFACRTVKITDK-----CDVYGFGVLVLEVVTGKRP 892
           PE       ++ K      D + FG+L+ E++ G  P
Sbjct: 172 PEV------VSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 79.5 bits (197), Expect = 3e-16
 Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 19/155 (12%)

Query: 692 LNKDCELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQEDFE-------REVKKLGK 743
           + K   +G G +G VY+      G  VA+KK      ++   + E       RE+  L +
Sbjct: 8   VEK---IGEGTYGVVYKARNKLTGEVVALKK------IRLDTETEGVPSTAIREISLLKE 58

Query: 744 VRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSL 803
           + HPN+V L     T++   L++EF+    L K +   +         +  + Q   + L
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQ-LLQGL 116

Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR 838
           A  H   ++H ++K  N+LI+  G  K+ D+GLAR
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 80.9 bits (200), Expect = 4e-16
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 30/209 (14%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQE----DFEREVKKLGKVRHPNLVTL 752
           LG+G FG V     +  GR  A+K L    +V   E      E  V  L   RHP L  L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV--LQNSRHPFLTAL 213

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH-QSNI 811
           +  + T      + E+ +GG L  HL       F     RF   +    +L +LH + N+
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAE-IVSALDYLHSEKNV 270

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTV 868
           ++ ++K  N+++D  G  K+ D+GL +   + D     + +++  G   Y+APE      
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCK-EGIKD----GATMKTFCGTPEYLAPEV----- 320

Query: 869 KITDK-----CDVYGFGVLVLEVVTGKRP 892
            + D       D +G GV++ E++ G+ P
Sbjct: 321 -LEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 79.1 bits (196), Expect = 6e-16
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 35/212 (16%)

Query: 698 LGRGGFGAVY----RTVLRDGRPVAIKKLTVSSLVKSQED---FEREVKKLGKVRHPNLV 750
           LG+G FG V+     +     +  A+K L  ++L          ER++  L +V HP +V
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI--LVEVNHPFIV 89

Query: 751 TLEGYYWTQSLQLL--IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
            L  +Y  Q+   L  I +F+ GG L   L +     F   + +F + +  A +L HLH 
Sbjct: 90  KL--HYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAE-LALALDHLHS 144

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFAC 865
             II+ ++K  N+L+D  G  K+ D+GL++   +        K  S  G   YMAPE   
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDH----EKKAYSFCGTVEYMAPEV-- 197

Query: 866 RTVKITDK-----CDVYGFGVLVLEVVTGKRP 892
               +  +      D + FGVL+ E++TG  P
Sbjct: 198 ----VNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 78.6 bits (194), Expect = 6e-16
 Identities = 47/253 (18%), Positives = 91/253 (35%), Gaps = 41/253 (16%)

Query: 78  VIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLS 137
            I+  L   S+T  +     +L  + ++  +++++  S+   +  L N+  + L+GN L+
Sbjct: 26  TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT 81

Query: 138 GSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLS 197
             I  +      +L  + L +N+    + SSL     L +++L  N  S    L    L 
Sbjct: 82  -DI--KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGISDINGLV--HLP 134

Query: 198 ALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSF 257
            L +L L +N +       +  L  L  ++L  N  S  I   +   + L+ +  S+N  
Sbjct: 135 QLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHI 190

Query: 258 SGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQ 317
           S           L     L+                 L+ L+L   +          NL 
Sbjct: 191 S----------DLRALAGLKN----------------LDVLELFSQECLNKPINHQSNLV 224

Query: 318 RLKVLNFSANRLT 330
               +  +   L 
Sbjct: 225 VPNTVKNTDGSLV 237

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 75.9 bits (187), Expect = 5e-15
 Identities = 50/256 (19%), Positives = 94/256 (36%), Gaps = 31/256 (12%)

Query: 275 NLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLP 334
           NL+K   +  V     EL S++ +  + +       I    L  +  L  + N+LT   P
Sbjct: 30  NLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNGNKLTDIKP 85

Query: 335 DSMANCMNLVALDFSQNSMN-----GDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGS 389
            +  N  NL  L   +N +       DL +      L  +S   N I +       +   
Sbjct: 86  LA--NLKNLGWLFLDENKVKDLSSLKDLKK------LKSLSLEHNGISD------INGLV 131

Query: 390 SFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSE 449
               L+ L L +N+ +      +  L+ L  L+L  N +   +P  +  L  L  L LS+
Sbjct: 132 HLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187

Query: 450 NWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIA 509
           N ++  +   + G  +L  L L       K      N     ++  +  +L  P    I+
Sbjct: 188 NHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI--IS 243

Query: 510 KLTNLQNVDLSFNSLT 525
              + +  ++ ++   
Sbjct: 244 DDGDYEKPNVKWHLPE 259

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 75.5 bits (186), Expect = 5e-15
 Identities = 51/281 (18%), Positives = 93/281 (33%), Gaps = 50/281 (17%)

Query: 292 LESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQN 351
                  +L     + AV  +   L  +  +  + + +  S+   +    N+  L  + N
Sbjct: 23  FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGN 78

Query: 352 SMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPAT 411
            +  D+        L  +   ENK+++       SS    + L+ L L HN  S      
Sbjct: 79  KLT-DIKPLANLKNLGWLFLDENKVKD------LSSLKDLKKLKSLSLEHNGISDING-- 129

Query: 412 IGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRL 471
           +  L  L+ L L  N +       +  L  L+ L L +N ++  I P             
Sbjct: 130 LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIVP------------- 173

Query: 472 ERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQ 531
                       +   + L +L LSKN+++    +A   L NL  ++L            
Sbjct: 174 ------------LAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINH 219

Query: 532 LVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSL 572
             NLV  ++   +   L            IS       P++
Sbjct: 220 QSNLVVPNTVKNTDGSLVTP-------EIISDDGDYEKPNV 253

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 75.1 bits (185), Expect = 9e-15
 Identities = 52/299 (17%), Positives = 107/299 (35%), Gaps = 30/299 (10%)

Query: 102 LRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRF 161
           L   +++       I             +L   S++ ++      +  S+  I    +  
Sbjct: 3   LGSETITVPTPIKQIFS-DDAFAETIKDNLKKKSVTDAVT---QNELNSIDQIIANNSDI 58

Query: 162 SGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLK 221
              +   +     +  + L+ N+ +   PL    L  L  L L +N ++ ++   ++ LK
Sbjct: 59  K-SV-QGIQYLPNVTKLFLNGNKLTDIKPLA--NLKNLGWLFLDENKVK-DL-SSLKDLK 112

Query: 222 NLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLF 281
            L+ ++L  N  S  I +G+     L ++    N  +      + +L+  + ++L  N  
Sbjct: 113 KLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI 168

Query: 282 SGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCM 341
           S  VP  +  L  L+ L LS N  S    ++   L+ L VL   +        +  +N +
Sbjct: 169 SDIVP--LAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQSNLV 224

Query: 342 NLVALDFSQNSM--------NGDLP----QWIFSSGLNKVSFAENKIREGMNGPFASSG 388
               +  +  S+        +GD      +W      N+VSF   +            G
Sbjct: 225 VPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHG 283

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 72.8 bits (179), Expect = 5e-14
 Identities = 50/215 (23%), Positives = 88/215 (40%), Gaps = 14/215 (6%)

Query: 95  GLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVI 154
            L  L+ L  L L  N +   +S  L  L+ L+ + L  N +S  I          L  +
Sbjct: 85  PLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DI--NGLVHLPQLESL 139

Query: 155 SLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIP 214
            L  N+ +  I + LS  + L T++L  N+ S  +PL   GL+ L+ L LS N +  ++ 
Sbjct: 140 YLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYLSKNHIS-DL- 193

Query: 215 KGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFM 274
           + +  LKNL V+ L          +   +  +  T+  ++ S     PE +         
Sbjct: 194 RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKP 251

Query: 275 NLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAV 309
           N++ +L      +         T+  +  +F G V
Sbjct: 252 NVKWHL-PEFTNEVSFIFYQPVTIGKAKARFHGRV 285

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 30/160 (18%), Positives = 62/160 (38%), Gaps = 12/160 (7%)

Query: 389 SSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLS 448
            +F      +L     +         L+ +  +  + + +   +   I  L  +  L L+
Sbjct: 21  DAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLN 76

Query: 449 ENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAI 508
            N L   I P +    +L  L L+ N +   + +S+++   L SL L  N ++      +
Sbjct: 77  GNKLT-DIKP-LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGISDING--L 130

Query: 509 AKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHL 548
             L  L+++ L  N +T      L  L  L + ++  N +
Sbjct: 131 VHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI 168

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 79.2 bits (196), Expect = 6e-16
 Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 12/146 (8%)

Query: 698 LGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQEDFE----REVKKLGKVRHPNLVTL 752
           LG G +  VY+         VA+K++     ++ +E       REV  L  ++H N+VTL
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLKHANIVTL 65

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
                T+    L++E++    L ++L +  G      N +  + Q   + LA+ H+  ++
Sbjct: 66  HDIIHTEKSLTLVFEYLDK-DLKQYL-DDCGNIINMHNVKLFLFQ-LLRGLAYCHRQKVL 122

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLAR 838
           H ++K  N+LI+  GE K+ D+GLAR
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLAR 148

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 79.6 bits (197), Expect = 6e-16
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 41/218 (18%)

Query: 698 LGRGGFGAVY---RTVLRD-GRPVAIKKLTVSSLVKSQEDF-----EREVKKLGKVRH-P 747
           LG G +G V+   +    D G+  A+K L  +++V+  +       ER+V  L  +R  P
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV--LEHIRQSP 119

Query: 748 NLVTLEGYYWTQSLQLLIYEFVSGGSLHKHL-HEGSGGNFLSWNERFNVIQGTAK----- 801
            LVTL   + T++   LI ++++GG L  HL              RF   +   +     
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE----------RFT--EHEVQIYVGE 167

Query: 802 ---SLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG- 857
              +L HLH+  II+ +IK  N+L+D +G   + D+GL++   + D    + +     G 
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFVADE---TERAYDFCGT 223

Query: 858 --YMAPEFACRTVKITDK-CDVYGFGVLVLEVVTGKRP 892
             YMAP+         DK  D +  GVL+ E++TG  P
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 78.9 bits (195), Expect = 7e-16
 Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 28/207 (13%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIK-----KLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
           +G+G F  V     +  GR VAIK     +L  +SL K      REV+ +  + HPN+V 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK----LFREVRIMKILNHPNIVK 78

Query: 752 LEGYYWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFNVIQGTAKSLAH 805
           L     T+    LI E+ SGG +      H  + E    +       F  I     ++ +
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK------FRQI---VSAVQY 129

Query: 806 LHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFAC 865
            HQ  I+H ++K+ N+L+D     K+ D+G +          L +   +   Y APE   
Sbjct: 130 CHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFCGA-PPYAAPELFQ 186

Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRP 892
                  + DV+  GV++  +V+G  P
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLP 213

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 79.3 bits (196), Expect = 8e-16
 Identities = 46/217 (21%), Positives = 85/217 (39%), Gaps = 32/217 (14%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLT-VSSLVKSQEDFE---------REVKKLGKVRH 746
            +  G +GAV   V  +G PVAIK++    S  ++              RE++ L    H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 747 PNLVTLEGYYWTQSLQL-----LIYEFVSGGSLHKHLHEGSGGNFLSWNE--RFNVIQGT 799
           PN++ L   +            L+ E +    L + +H       +S  +  ++ +    
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIH--DQRIVIS-PQHIQYFMYH-I 143

Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSAL 856
              L  LH++ ++H ++   N+L+  + +  + D+ LAR          YV         
Sbjct: 144 LLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR------ 197

Query: 857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
            Y APE   +    T   D++  G ++ E+   K  L
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK-AL 233

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 79.0 bits (195), Expect = 1e-15
 Identities = 48/241 (19%), Positives = 83/241 (34%), Gaps = 57/241 (23%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
            LG G FG V      + G+  A+KK+      K+     RE+  +  + H N++ L  Y
Sbjct: 14  TLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-----RELDIMKVLDHVNIIKLVDY 68

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSW------NERF-------------NVI 796
           ++T   +                      N            ++              V+
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128

Query: 797 QGTAKS-------------------LAHLHQSNIIHYNIKSSNVLIDG-SGEPKVGDYGL 836
           +   +S                   +  +H   I H +IK  N+L++      K+ D+G 
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGS 188

Query: 837 ARLL----PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
           A+ L    P +  Y+ S        Y APE      + T   D++  G +  E++ GK P
Sbjct: 189 AKKLIPSEPSVA-YICS------RFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK-P 240

Query: 893 L 893
           L
Sbjct: 241 L 241

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 77.6 bits (192), Expect = 1e-15
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 26/212 (12%)

Query: 692 LNKDCELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQEDFE-------REVKKLGK 743
           L K   +G G +G V++         VA+K+      V+  +D E       RE+  L +
Sbjct: 7   LEK---IGEGTYGTVFKAKNRETHEIVALKR------VRLDDDDEGVPSSALREICLLKE 57

Query: 744 VRHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSL 803
           ++H N+V L     +     L++EF     L K+  +   G+      +  + Q   K L
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF-DSCNGDLDPEIVKSFLFQ-LLKGL 114

Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE- 862
              H  N++H ++K  N+LI+ +GE K+ ++GLAR   +  R   S+++   L Y  P+ 
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEV-VTLWYRPPDV 172

Query: 863 -FACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
            F  +    +   D++  G +  E+    RPL
Sbjct: 173 LFGAKLY--STSIDMWSAGCIFAELANAGRPL 202

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 53/215 (24%), Positives = 86/215 (40%), Gaps = 35/215 (16%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIK-----KLTVSSLVKSQEDFEREVKKLGKVRH--PN 748
            LG GGFG+VY  + + D  PVAIK     +++    + +      EV  L KV      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 749 LVTLEGYYWTQSLQLLIYEFVSGG-------SLHKHLHEGSGGNFLSWNERFN-VIQGTA 800
           ++ L  ++      +LI E            +    L E    +F      F  V++   
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF------FWQVLEA-- 161

Query: 801 KSLAHLHQSNIIHYNIKSSNVLIDG-SGEPKVGDYGLARLLP--MLDRYVLSSKIQSALG 857
             + H H   ++H +IK  N+LID   GE K+ D+G   LL   +   +  +        
Sbjct: 162 --VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGT------RV 213

Query: 858 YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
           Y  PE+            V+  G+L+ ++V G  P
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 26/205 (12%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGY 755
           LGRG +  V+  + + +   V +K L     VK ++  +RE+K L  +R  PN++TL   
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILK---PVKKKK-IKREIKILENLRGGPNIITLADI 99

Query: 756 YWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNE-RFNVIQGTAKSLAHLHQSNII 812
                 +   L++E V+     +          L+  + RF + +   K+L + H   I+
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYE-ILKALDYCHSMGIM 152

Query: 813 HYNIKSSNVLIDGS-GEPKVGDYGLARLLPMLDRY---VLSSKIQSALGYMAPEFACRTV 868
           H ++K  NV+ID    + ++ D+GLA        Y   V S        +  PE      
Sbjct: 153 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS------RYFKGPELLVDYQ 206

Query: 869 KITDKCDVYGFGVLVLEVVTGKRPL 893
                 D++  G ++  ++  K P 
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPF 231

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 24/176 (13%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V   V       VA+K + +   V   E+ ++E+     + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 757 WTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFN-VIQGTAKSLAHLHQS 809
              ++Q L  E+ SGG L         + E     F      F+ ++ G    + +LH  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF------FHQLMAG----VVYLHGI 124

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE 862
            I H +IK  N+L+D     K+ D+GLA +    +R  L   +    G   Y+APE
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL---LNKMCGTLPYVAPE 177

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 77.6 bits (192), Expect = 2e-15
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 29/208 (13%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQE----DFEREVKKLGKVRHPNLVTL 752
           LG+G FG V     +  GR  A+K L    ++   E      E  V  L   RHP L  L
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRV--LQNTRHPFLTAL 70

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           +  + T      + E+ +GG L  HL       F     RF   +    +L +LH  +++
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAE-IVSALEYLHSRDVV 127

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTVK 869
           + +IK  N+++D  G  K+ D+GL +   + D     + +++  G   Y+APE       
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCK-EGISD----GATMKTFCGTPEYLAPEV------ 176

Query: 870 ITDK-----CDVYGFGVLVLEVVTGKRP 892
           + D       D +G GV++ E++ G+ P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 58/223 (26%), Positives = 87/223 (39%), Gaps = 49/223 (21%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIK-----KLTVSSLVKSQEDFEREVKKLGKVR----H 746
            LG+GGFG V+    L D   VAIK     ++   S +        EV  L KV     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 747 PNLVTLEGYYWTQSLQLLIYEF-VSGGSL------HKHLHEGSGGNFLSWNERFN-VIQG 798
           P ++ L  ++ TQ   +L+ E  +    L         L EG    F      F  V+  
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCF------FGQVVAA 151

Query: 799 TAKSLAHLHQSNIIHYNIKSSNVLIDG-SGEPKVGDYGLARLLP--MLDRYVLSSKIQSA 855
               + H H   ++H +IK  N+LID   G  K+ D+G   LL       +  +      
Sbjct: 152 ----IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGT------ 201

Query: 856 LGYMAPEFACRTVKITDK------CDVYGFGVLVLEVVTGKRP 892
             Y  PE+      I+          V+  G+L+ ++V G  P
Sbjct: 202 RVYSPPEW------ISRHQYHALPATVWSLGILLYDMVCGDIP 238

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 57/186 (30%), Positives = 78/186 (41%), Gaps = 9/186 (4%)

Query: 391 FESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSEN 450
            +    L LS N     + AT+   + L  LNL R  L   + V  G L  L  LDLS N
Sbjct: 30  PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDLSHN 87

Query: 451 WLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSI-ENCSSLVSLILSKNNLTGPIPIAIA 509
            L  S+P       +L  L +  N L   +P         L  L L  N L    P  + 
Sbjct: 88  QLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLT 145

Query: 510 KLTNLQNVDLSFNSLTGGLPKQL-VNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVL- 567
               L+ + L+ N+LT  LP  L   L +L +  +  N L   +P G F + + P + L 
Sbjct: 146 PTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLH 203

Query: 568 GNPSLC 573
           GNP LC
Sbjct: 204 GNPWLC 209

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 50/188 (26%), Positives = 76/188 (40%), Gaps = 17/188 (9%)

Query: 73  PRSNRVIELTLNGLSLTGRIGRGLL-QLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDL 131
           P+   ++ L+ N L          L     L +L+L    LT         L  L  +DL
Sbjct: 30  PKDTTILHLSENLLY---TFSLATLMPYTRLTQLNLDRAELT--KLQVDGTLPVLGTLDL 84

Query: 132 SGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSL--SLCSTLATINLSSNRFSSPL 189
           S N L  S+P    +   +L V+ ++ NR +  +P      L   L  + L  N   + L
Sbjct: 85  SHNQLQ-SLPLL-GQTLPALTVLDVSFNRLT-SLPLGALRGL-GELQELYLKGNELKT-L 139

Query: 190 PLGIW-GLSALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKNMFSGSIPDGIGSCSLL 247
           P G+      L  L L++N L  E+P G+   L+NL  + L +N    +IP G     LL
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197

Query: 248 RTIDFSEN 255
                  N
Sbjct: 198 PFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 42/168 (25%), Positives = 61/168 (36%), Gaps = 13/168 (7%)

Query: 393 SLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWL 452
           S   ++      +   P          +L+LS N L       +     L  L+L    L
Sbjct: 11  SHLEVNCDKRNLT-ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67

Query: 453 NGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLT 512
             +     G    L  L L  N L   +P   +   +L  L +S N LT     A+  L 
Sbjct: 68  --TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124

Query: 513 NLQNVDLSFNSLT---GGLPKQLVNLVHLSSFNISHNHLQGELPAGGF 557
            LQ + L  N L     GL      L  L   ++++N+L  ELPAG  
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKL---SLANNNLT-ELPAGLL 168

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 69.7 bits (171), Expect = 5e-13
 Identities = 47/205 (22%), Positives = 73/205 (35%), Gaps = 35/205 (17%)

Query: 102 LRKLSLSSNNLTGSISPN-LAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNR 160
              L LS N L  + S   L     L  ++L    L+  +          L  + L+ N+
Sbjct: 33  TTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELT-KLQ--VDGTLPVLGTLDLSHNQ 88

Query: 161 FSGKIPSSLSLCSTLATINLSSNRFSSPLPLGI-WGLSALRTLDLSDNLLEGEIPKGV-E 218
               +P        L  +++S NR +S LPLG   GL  L+ L L  N L+  +P G+  
Sbjct: 89  LQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELK-TLPPGLLT 145

Query: 219 SLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRK 278
               L  ++L+ N  +  +P G+           +       L   +  L L    N   
Sbjct: 146 PTPKLEKLSLANNNLT-ELPAGL----------LN------GLEN-LDTLLLQE--NSLY 185

Query: 279 NLFSGEVPKWIGELESLETLDLSGN 303
                 +PK       L    L GN
Sbjct: 186 T-----IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 47/184 (25%), Positives = 68/184 (36%), Gaps = 13/184 (7%)

Query: 294 SLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSM 353
               L LS N        ++    RL  LN     LT  L         L  LD S N +
Sbjct: 32  DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQL 89

Query: 354 NGDLPQWIFS--SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPAT 411
              LP  +      L  +  + N++     G           LQ L L  NE     P  
Sbjct: 90  Q-SLPL-LGQTLPALTVLDVSFNRLTSLPLGALR----GLGELQELYLKGNELKTLPPGL 143

Query: 412 IGALSGLQLLNLSRNSLVGPIPVAIGD-LKALNVLDLSENWLNGSIPPEIGGAYSLKELR 470
           +     L+ L+L+ N+L   +P  + + L+ L+ L L EN L  +IP    G++ L    
Sbjct: 144 LTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAF 201

Query: 471 LERN 474
           L  N
Sbjct: 202 LHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 41/197 (20%), Positives = 67/197 (34%), Gaps = 26/197 (13%)

Query: 165 IPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLR 224
           +P  L        ++LS N   +     +   + L  L+L    L  ++     +L  L 
Sbjct: 25  LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLG 80

Query: 225 VINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETM-------QKLSLCN--FMN 275
            ++LS N    S+P    +   L  +D S N  + +LP          Q+L L       
Sbjct: 81  TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT 138

Query: 276 LRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISI-GNLQRLKVLNFSANRLTGSLP 334
           L   L +            LE L L+ N  +  +P  +   L+ L  L    N L  ++P
Sbjct: 139 LPPGLLTP--------TPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIP 188

Query: 335 DSMANCMNLVALDFSQN 351
                   L       N
Sbjct: 189 KGFFGSHLLPFAFLHGN 205

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 77.5 bits (191), Expect = 3e-15
 Identities = 41/183 (22%), Positives = 70/183 (38%), Gaps = 33/183 (18%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIK-----KLTVSSLVKSQED--FEREVKKLGKVRHPNL 749
           LG G FG V+  V     + V +K     K+     ++  +      E+  L +V H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 750 VTLEGYYWTQSLQLLIYEF-VSGGSL------HKHLHEGSGGNFLSWNERFNVIQGTAKS 802
           + +   +  Q    L+ E   SG  L      H  L E              + +    +
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE---------PLASYIFRQLVSA 142

Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYM 859
           + +L   +IIH +IK  N++I      K+ D+G A  L    +   +  +      + Y 
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGT------IEYC 196

Query: 860 APE 862
           APE
Sbjct: 197 APE 199

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 77.9 bits (192), Expect = 3e-15
 Identities = 36/167 (21%), Positives = 76/167 (45%), Gaps = 31/167 (18%)

Query: 694 KDCELGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLVKSQEDFE----REVKKLGKVRH 746
           + C++GRG +G VY+   +D    +  A+K++                 RE+  L +++H
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI-------EGTGISMSACREIALLRELKH 77

Query: 747 PNLVTLEGYYWTQSLQL--LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKS-- 802
           PN+++L+  + + + +   L++++     L   +             +    +G  KS  
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLP--RGMVKSLL 134

Query: 803 ------LAHLHQSNIIHYNIKSSNVLIDGS----GEPKVGDYGLARL 839
                 + +LH + ++H ++K +N+L+ G     G  K+ D G ARL
Sbjct: 135 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 44/233 (18%), Positives = 73/233 (31%), Gaps = 35/233 (15%)

Query: 102 LRKLSLSSNNLTGSISPN-LAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNR 160
            + L LS N L   +          L+V+DLS   +  +I D  ++    L  + L  N 
Sbjct: 30  TKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87

Query: 161 FSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIW-GLSALRTLDLSDNLLEGEIPKGV-E 218
                  + S  S+L  +       +S L       L  L+ L+++ NL++         
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 219 SLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSG--NLPETMQKLSLCN--FM 274
           +L NL  ++LS N    SI                         +P     L L      
Sbjct: 147 NLTNLEHLDLSSNKIQ-SIYCTD---------------LRVLHQMPLLNLSLDLSLNPMN 190

Query: 275 NLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSAN 327
            ++   F             L+ L L  N+           L  L+ +    N
Sbjct: 191 FIQPGAFKE---------IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 74.6 bits (184), Expect = 9e-15
 Identities = 46/172 (26%), Positives = 76/172 (44%), Gaps = 10/172 (5%)

Query: 393 SLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPV-AIGDLKALNVLDLSENW 451
           S + LDLS N        +  +   LQ+L+LSR  +   I   A   L  L+ L L+ N 
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNP 87

Query: 452 LNGSIPPEI-GGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTG-PIPIAIA 509
           +  S+      G  SL++L      LA      I +  +L  L ++ N +    +P   +
Sbjct: 88  IQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 510 KLTNLQNVDLSFNSLT---GGLPKQLVNLVHLS-SFNISHNHLQGELPAGGF 557
            LTNL+++DLS N +        + L  +  L+ S ++S N +   +  G F
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF 197

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 71.9 bits (177), Expect = 7e-14
 Identities = 41/189 (21%), Positives = 70/189 (37%), Gaps = 13/189 (6%)

Query: 99  LQFLRKLSLSSNNLTGSISPNL-AKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLA 157
              L+ L LS   +  +I       L +L  + L+GN +  S+    F    SL+ +   
Sbjct: 51  FPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAV 108

Query: 158 KNRFSGKIPSSL-SLCSTLATINLSSNRFSS-PLPLGIWGLSALRTLDLSDNLLEGEIPK 215
           +   +  + +       TL  +N++ N   S  LP     L+ L  LDLS N ++  I  
Sbjct: 109 ETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYC 166

Query: 216 GV-ESLKNLRVIN----LSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSL 270
                L  + ++N    LS N  +  I  G      L+ +    N           +L+ 
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTS 225

Query: 271 CNFMNLRKN 279
              + L  N
Sbjct: 226 LQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 68.8 bits (169), Expect = 7e-13
 Identities = 52/224 (23%), Positives = 81/224 (36%), Gaps = 19/224 (8%)

Query: 308 AVPISI-GNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFS--S 364
            +P ++  + + L   + S N L      S  +   L  LD S+  +   +    +   S
Sbjct: 21  KIPDNLPFSTKNL---DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLS 76

Query: 365 GLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLS 424
            L+ +    N I+    G F+   S    LQ L       +      IG L  L+ LN++
Sbjct: 77  HLSTLILTGNPIQSLALGAFSGLSS----LQKLVAVETNLASLENFPIGHLKTLKELNVA 132

Query: 425 RNSL-VGPIPVAIGDLKALNVLDLSENWLNGSIPPEI-GGAYSLK----ELRLERNFLAG 478
            N +    +P    +L  L  LDLS N +  SI        + +      L L  N +  
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN- 190

Query: 479 KIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFN 522
            I         L  L L  N L         +LT+LQ + L  N
Sbjct: 191 FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 63.8 bits (156), Expect = 4e-11
 Identities = 32/141 (22%), Positives = 61/141 (43%), Gaps = 11/141 (7%)

Query: 98  QLQFLRKLSLSSNNLTGSISPNLA-KLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISL 156
            L  L+KL     NL  S+       L+ L+ ++++ N +      E+F    +L  + L
Sbjct: 98  GLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156

Query: 157 AKNRFSGKIPSSL-----SLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEG 211
           + N+    I  +       +     +++LS N  +  +  G +    L+ L L  N L+ 
Sbjct: 157 SSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLK- 213

Query: 212 EIPKGV-ESLKNLRVINLSKN 231
            +P G+ + L +L+ I L  N
Sbjct: 214 SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 56/261 (21%), Positives = 86/261 (32%), Gaps = 48/261 (18%)

Query: 177 TINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKNMFSG 235
           T       F   +P  +    + + LDLS N L   +      S   L+V++LS+     
Sbjct: 11  TYQCMELNFYK-IPDNL--PFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ- 65

Query: 236 SIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCN--FMNLRKNLFSGEVPKWIGELE 293
           +I DG                +   L   +  L L      +L    FSG        L 
Sbjct: 66  TIEDGA---------------YQS-LSH-LSTLILTGNPIQSLALGAFSG--------LS 100

Query: 294 SLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLP--DSMANCMNLVALDFSQN 351
           SL+ L       +      IG+L+ LK LN + N +  S    +  +N  NL  LD S N
Sbjct: 101 SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSN 159

Query: 352 SMNGDLPQWIFSS------GLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFS 405
            +   +                 +  + N +     G F         L+ L L  N+  
Sbjct: 160 KIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-----RLKELALDTNQLK 213

Query: 406 GETPATIGALSGLQLLNLSRN 426
                    L+ LQ + L  N
Sbjct: 214 SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 43.0 bits (102), Expect = 2e-04
 Identities = 22/81 (27%), Positives = 32/81 (39%), Gaps = 13/81 (16%)

Query: 480 IPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLT---GGLPKQLVNLV 536
           +P S +N      L LS N L      +      LQ +DLS   +     G  + L +L 
Sbjct: 26  LPFSTKN------LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79

Query: 537 HLSSFNISHNHLQGELPAGGF 557
            L    ++ N +Q  L  G F
Sbjct: 80  TL---ILTGNPIQ-SLALGAF 96

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 42.3 bits (100), Expect = 4e-04
 Identities = 25/74 (33%), Positives = 33/74 (44%), Gaps = 3/74 (4%)

Query: 87  SLTGRIGRGLLQLQFLR-KLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFF 145
           S+     R L Q+  L   L LS N +   I P   K   L+ + L  N L  S+PD  F
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIF 220

Query: 146 KQCGSLRVISLAKN 159
            +  SL+ I L  N
Sbjct: 221 DRLTSLQKIWLHTN 234

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 73.8 bits (182), Expect = 4e-15
 Identities = 30/210 (14%), Positives = 74/210 (35%), Gaps = 35/210 (16%)

Query: 98  QLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLA 157
             +      L   + T +I+   A++ +L  I L+  +++  +     +   +++ +++ 
Sbjct: 21  TFKAYLNGLLG-QSSTANITE--AQMNSLTYITLANINVT-DL--TGIEYAHNIKDLTIN 74

Query: 158 KNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGV 217
               +    + +S  S L  + +     +S     + GL++L  LD+S +  +  I   +
Sbjct: 75  NIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132

Query: 218 ESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLR 277
            +L  +  I+LS N     I   + +   L++++   +                      
Sbjct: 133 NTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHD------------------ 173

Query: 278 KNLFSGEVPKWIGELESLETLDLSGNKFSG 307
              + G     I +   L  L        G
Sbjct: 174 ---YRG-----IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 72.3 bits (178), Expect = 1e-14
 Identities = 31/160 (19%), Positives = 60/160 (37%), Gaps = 8/160 (5%)

Query: 389 SSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLS 448
           S+F++     L  +        T   ++ L  + L+  ++       I     +  L ++
Sbjct: 20  STFKAYLNGLLGQSST---ANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTIN 74

Query: 449 ENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAI 508
                   P  I G  +L+ LR+    +      ++   +SL  L +S +     I   I
Sbjct: 75  NIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132

Query: 509 AKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHL 548
             L  + ++DLS+N     +   L  L  L S NI  + +
Sbjct: 133 NTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGV 171

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 31/236 (13%), Positives = 66/236 (27%), Gaps = 61/236 (25%)

Query: 291 ELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQ 350
             ++     L  +  +    I+   +  L  +  +   +T  L   +    N+  L  + 
Sbjct: 21  TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75

Query: 351 NSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPA 410
                                              +  S   +L+ L +   + + +   
Sbjct: 76  I-----------------------HATN------YNPISGLSNLERLRIMGKDVTSDKIP 106

Query: 411 TIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELR 470
            +  L+ L LL++S ++    I   I  L  +N +DLS N     I P            
Sbjct: 107 NLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP------------ 154

Query: 471 LERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTG 526
                        ++    L SL +  + +       I     L  +     ++ G
Sbjct: 155 -------------LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 70.0 bits (172), Expect = 9e-14
 Identities = 24/142 (16%), Positives = 62/142 (43%), Gaps = 8/142 (5%)

Query: 95  GLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVI 154
           G+     ++ L++++ + T + +P ++ L NL  + + G  ++            SL ++
Sbjct: 61  GIEYAHNIKDLTINNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKI-PNLSGLTSLTLL 117

Query: 155 SLAKNRFSGKIPSSLSLCSTLATINLSSNRF-SSPLPLGIWGLSALRTLDLSDNLLEGEI 213
            ++ +     I + ++    + +I+LS N   +  +PL    L  L++L++  + +    
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLK--TLPELKSLNIQFDGVHD-- 173

Query: 214 PKGVESLKNLRVINLSKNMFSG 235
            +G+E    L  +        G
Sbjct: 174 YRGIEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 27/209 (12%), Positives = 56/209 (26%), Gaps = 58/209 (27%)

Query: 218 ESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLR 277
             + +L  I L+    +  +  GI     ++ +  +    +   P               
Sbjct: 41  AQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNYNP--------------- 83

Query: 278 KNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSM 337
                      I  L +LE L + G   +     ++  L  L +L+ S +    S+   +
Sbjct: 84  -----------ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132

Query: 338 ANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFL 397
                + ++D S N    D+        L                       +   L+ L
Sbjct: 133 NTLPKVNSIDLSYNGAITDI------MPL----------------------KTLPELKSL 164

Query: 398 DLSHNEFSGETPATIGALSGLQLLNLSRN 426
           ++  +         I     L  L     
Sbjct: 165 NIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 44.2 bits (105), Expect = 5e-05
 Identities = 13/84 (15%), Positives = 27/84 (32%), Gaps = 4/84 (4%)

Query: 80  ELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGS 139
            L ++  +    I   +  L  +  + LS N     I P L  L  L+ +++  + +   
Sbjct: 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDY 174

Query: 140 IPDEFFKQCGSLRVISLAKNRFSG 163
                 +    L  +        G
Sbjct: 175 RG---IEDFPKLNQLYAFSQTIGG 195

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 76.5 bits (189), Expect = 4e-15
 Identities = 39/159 (24%), Positives = 73/159 (45%), Gaps = 24/159 (15%)

Query: 692 LNKDCELGRGGFGAVYR-TVLRDGRPVAIKKLT--------VSSLVKSQEDFEREVKKLG 742
           L K   LG G +  VY+      G  VA+K++          +++        RE+  + 
Sbjct: 10  LEK---LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI--------REISLMK 58

Query: 743 KVRHPNLVTLEGYYWTQSLQLLIYEFVS---GGSLHKHLHEGSGGNFLSWNERFNVIQGT 799
           +++H N+V L     T++   L++EF+       +       +         ++   Q  
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ-L 117

Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR 838
            + LA  H++ I+H ++K  N+LI+  G+ K+GD+GLAR
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 75.8 bits (187), Expect = 5e-15
 Identities = 46/214 (21%), Positives = 87/214 (40%), Gaps = 33/214 (15%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIK---KLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL- 752
           LG G +G V   +        A+K   K  +  +   + + ++E++ L ++RH N++ L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 753 EGYYWTQSLQL-LIYEFVSGGSL-------HKHLHEGSGGNFLSWNERFN-VIQGTAKSL 803
           +  Y  +  ++ ++ E+   G          K         +      F  +I G    L
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGY------FCQLIDG----L 122

Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMA 860
            +LH   I+H +IK  N+L+   G  K+   G+A     L  +      +++ G   +  
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA---LHPFAADDTCRTSQGSPAFQP 179

Query: 861 PEFACRTVKITD--KCDVYGFGVLVLEVVTGKRP 892
           PE A   +      K D++  GV +  + TG  P
Sbjct: 180 PEIA-NGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 76.5 bits (189), Expect = 5e-15
 Identities = 45/170 (26%), Positives = 75/170 (44%), Gaps = 42/170 (24%)

Query: 692 LNKDCELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDF----EREVKKLGKVRH 746
           L K   +G+G FG V++    + G+ VA+KK+    +   +E F     RE+K L  ++H
Sbjct: 22  LAK---IGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKH 75

Query: 747 PNLVTLEGYYWTQSLQL--------LIYEFVSGGSLH--KHLHEGSGGNFLSWNERFNVI 796
            N+V L     T++           L+++F      H    L       F          
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFT--------- 122

Query: 797 QGTAKS--------LAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR 838
               K         L ++H++ I+H ++K++NVLI   G  K+ D+GLAR
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 75.8 bits (187), Expect = 6e-15
 Identities = 33/152 (21%), Positives = 61/152 (40%), Gaps = 20/152 (13%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEG 754
            LG G  G V +   +      A+K       ++      REV+   +  + P++V +  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKM------LQDCPKARREVELHWRASQCPHIVRIVD 78

Query: 755 YYWTQSLQ----LLIYEFVSGGSLHKHLHEGSGGNFLSWNERF--NVIQGTAKSLAHLHQ 808
            Y          L++ E + GG L   + +     F    ER    +++   +++ +LH 
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF---TEREASEIMKSIGEAIQYLHS 135

Query: 809 SNIIHYNIKSSNVLIDGSGEP---KVGDYGLA 837
            NI H ++K  N+L          K+ D+G A
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 75.8 bits (187), Expect = 6e-15
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 24/176 (13%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           LG G +G V   V       VA+K + +   V   E+ ++E+     + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 757 WTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFN-VIQGTAKSLAHLHQS 809
              ++Q L  E+ SGG L         + E     F      F+ ++ G    + +LH  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF------FHQLMAG----VVYLHGI 124

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE 862
            I H +IK  N+L+D     K+ D+GLA +    +R  L   +    G   Y+APE
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL---LNKMCGTLPYVAPE 177

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 56/232 (24%), Positives = 90/232 (38%), Gaps = 48/232 (20%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDF--------------------- 734
           E+G+G +G V       D    A+K L+   L++                          
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 735 ----EREVKKLGKVRHPNLVTLEGYY--WTQSLQLLIY---EFVSGGSLHKHLHEGSGGN 785
                +E+  L K+ HPN+V L           +  +Y   E V+ G + +         
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKL---VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP--- 133

Query: 786 FLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR 845
            LS ++     Q   K + +LH   IIH +IK SN+L+   G  K+ D+G++      D 
Sbjct: 134 -LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192

Query: 846 YVLSSKIQSALG---YMAPEFACRTVKITD--KCDVYGFGVLVLEVVTGKRP 892
                 + + +G   +MAPE    T KI      DV+  GV +   V G+ P
Sbjct: 193 L-----LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 76.2 bits (187), Expect = 3e-14
 Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 34/211 (16%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQE----DFEREVKKLGKVRHPNLVTL 752
           LG+G FG V  +  +      A+K L    +++  +      E+ V  L   + P L  L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL-PGKPPFLTQL 407

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF---NVIQGTAKSLAHLHQS 809
              + T      + E+V+GG L  H+ +   G F   +  F    +  G    L  L   
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIG----LFFLQSK 461

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACR 866
            II+ ++K  NV++D  G  K+ D+G+ +   + D        ++  G   Y+APE    
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWD----GVTTKTFCGTPDYIAPEI--- 513

Query: 867 TVKITDK-----CDVYGFGVLVLEVVTGKRP 892
              I  +      D + FGVL+ E++ G+ P
Sbjct: 514 ---IAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 73.8 bits (182), Expect = 3e-14
 Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 18/160 (11%)

Query: 692 LNKDCELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFE----REV---KKLGK 743
           + +   +G G +G VY+      G  VA+K + V +             REV   ++L  
Sbjct: 14  VAE---IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70

Query: 744 VRHPNLVTLE----GYYWTQSLQL-LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQG 798
             HPN+V L          + +++ L++E V    L  +L +       +   +  + Q 
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ- 128

Query: 799 TAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR 838
             + L  LH + I+H ++K  N+L+   G  K+ D+GLAR
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR 168

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 74.2 bits (183), Expect = 3e-14
 Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 30/209 (14%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQE----DFEREVKKLGKV-RHPNLVT 751
           +GRG +  V    L+   R  A+K +    +   ++      E+ V    +   HP LV 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV--FEQASNHPFLVG 74

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L   + T+S    + E+V+GG L  H+           + RF   +  + +L +LH+  I
Sbjct: 75  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAE-ISLALNYLHERGI 131

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFAC--- 865
           I+ ++K  NVL+D  G  K+ DYG+ +   +           +  G   Y+APE      
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRP----GDTTSTFCGTPNYIAPEILRGED 186

Query: 866 --RTVKITDKCDVYGFGVLVLEVVTGKRP 892
              +V      D +  GVL+ E++ G+ P
Sbjct: 187 YGFSV------DWWALGVLMFEMMAGRSP 209

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 73.8 bits (182), Expect = 4e-14
 Identities = 37/154 (24%), Positives = 65/154 (42%), Gaps = 23/154 (14%)

Query: 698 LGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQEDFE-------REVKKLGKVRHPNL 749
           LG G +G VY+         VAIK+      ++ + + E       REV  L +++H N+
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKR------IRLEHEEEGVPGTAIREVSLLKELQHRNI 95

Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
           + L+          LI+E+     L K++      +      +  + Q     +   H  
Sbjct: 96  IELKSVIHHNHRLHLIFEYAEN-DLKKYMD--KNPDVSMRVIKSFLYQ-LINGVNFCHSR 151

Query: 810 NIIHYNIKSSNVLIDGS-----GEPKVGDYGLAR 838
             +H ++K  N+L+  S        K+GD+GLAR
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 75.2 bits (184), Expect = 4e-14
 Identities = 43/306 (14%), Positives = 93/306 (30%), Gaps = 39/306 (12%)

Query: 45  DIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRK 104
            +    G L    ++      W       R + V    L   SL  ++ +   ++ +   
Sbjct: 266 TVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGS 325

Query: 105 LSLSSNNL----TGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVIS----- 155
            S     L          + A  + L   +LS    +  +     + C  L+ +      
Sbjct: 326 DSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST--VLQSELESCKELQELEPENKW 383

Query: 156 --------LAKNRFSGKIPSSLSLCSTLATIN--------LSSNRFSSPLPLGIWGLSAL 199
                   +           +L   STL  ++           ++F     +     + +
Sbjct: 384 CLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADV 443

Query: 200 RTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSG 259
           R L L+   L   +   +E L  +  ++LS N    ++P  + +   L  +  S+N+   
Sbjct: 444 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE- 499

Query: 260 NLPETMQKLSLCNFMNLRKNLFSG-EVPKWIGELESLETLDLSGNKFSGAVPISIGNLQR 318
           N+   +  L     + L  N        + +     L  L+L GN       +      +
Sbjct: 500 NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN------SLCQEEGIQ 552

Query: 319 LKVLNF 324
            ++   
Sbjct: 553 ERLAEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 69.4 bits (169), Expect = 2e-12
 Identities = 57/325 (17%), Positives = 107/325 (32%), Gaps = 47/325 (14%)

Query: 233 FSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPK----- 287
           FS  +  G    +LL  +D +  S     P+   + S     +L     + ++P+     
Sbjct: 261 FSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRV 320

Query: 288 -WIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVAL 346
            W G     E + L                ++L     S  + T  L   + +C  L  L
Sbjct: 321 IWTGSDSQKECVLLKDRPEC--WCRDSATDEQLFRCELSVEKST-VLQSELESCKELQEL 377

Query: 347 DFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSG 406
           +    +    L   +    L+ + + +  ++                  +LD   ++F  
Sbjct: 378 EP--ENKWCLLTIILLMRALDPLLYEKETLQYFST----LKAVDPMRAAYLDDLRSKFLL 431

Query: 407 ETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSL 466
           E        + +++L+L+   L       +  L  +  LDLS N L  ++PP +     L
Sbjct: 432 ENSVLKMEYADVRVLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCL 488

Query: 467 KELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTG 526
           + L+   N L      +++                      +A L  LQ + L  N L  
Sbjct: 489 EVLQASDNAL-----ENVDG---------------------VANLPRLQELLLCNNRLQ- 521

Query: 527 GLP--KQLVNLVHLSSFNISHNHLQ 549
                + LV+   L   N+  N L 
Sbjct: 522 QSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 59.4 bits (143), Expect = 3e-09
 Identities = 42/264 (15%), Positives = 83/264 (31%), Gaps = 12/264 (4%)

Query: 291 ELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQ 350
           ++     +       S      +    R+  L    +    S+     +  N  +  +  
Sbjct: 243 DVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLC 302

Query: 351 NSMNGDLPQWIFSSGLNKV-----SFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFS 405
           +     L   +       +     S  E  + +     +    ++ E L   +LS  + S
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEK-S 361

Query: 406 GETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYS 465
               + + +   LQ L       +  I   I  ++AL+ L   +  L      +      
Sbjct: 362 TVLQSELESCKELQELEPENKWCLLTI---ILLMRALDPLLYEKETLQYFSTLKAVDPMR 418

Query: 466 LKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLT 525
              L   R+    +        + +  L L+  +LT    +   +L  + ++DLS N L 
Sbjct: 419 AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLE--QLLLVTHLDLSHNRLR 476

Query: 526 GGLPKQLVNLVHLSSFNISHNHLQ 549
             LP  L  L  L     S N L+
Sbjct: 477 -ALPPALAALRCLEVLQASDNALE 499

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 58.2 bits (140), Expect = 9e-09
 Identities = 22/97 (22%), Positives = 35/97 (36%), Gaps = 5/97 (5%)

Query: 80  ELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGS 139
            L L+   L   +   L  L+ L  L  S N L  ++   +A L  L+ + L  N L   
Sbjct: 467 HLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NV-DGVANLPRLQELLLCNNRLQ-Q 522

Query: 140 IPD-EFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTL 175
               +    C  L +++L  N    +      L   L
Sbjct: 523 SAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 559

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 17/199 (8%)

Query: 393 SLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAI-GDLKALNVLDLSENW 451
             + LDL  N+ S         L+ L+LL L+ N L   +P  I  +LK L  L +++N 
Sbjct: 38  DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNK 96

Query: 452 LNGSIPPEI-GGAYSLKELRLERNFLAGKIPTSI-ENCSSLVSLILSKNNLTGPIPI-AI 508
           L  ++P  +     +L ELRL+RN L   +P  + ++ + L  L L  N L   +P    
Sbjct: 97  LQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS-LPKGVF 153

Query: 509 AKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSV-- 566
            KLT+L+ + L  N L          L  L +  + +N L+  +P G F +      +  
Sbjct: 154 DKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQL 212

Query: 567 LGNPSLCGSAVNKSCPAVL 585
             NP  C      +C  ++
Sbjct: 213 QENPWDC------TCNGII 225

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 46/164 (28%), Positives = 83/164 (50%), Gaps = 13/164 (7%)

Query: 98  QLQFLRKLSLSSNNLTGSISPNL-AKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISL 156
           +L  LR L L+ N L  ++   +  +L+NL  + ++ N L  ++P   F Q  +L  + L
Sbjct: 59  RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRL 116

Query: 157 AKNRFSGKIPSSL--SLCSTLATINLSSNRFSSPLPLGIW-GLSALRTLDLSDNLLEGEI 213
            +N+    +P  +  SL + L  ++L  N   S LP G++  L++L+ L L +N L+  +
Sbjct: 117 DRNQLK-SLPPRVFDSL-TKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLK-RV 172

Query: 214 PKGV-ESLKNLRVINLSKNMFSGSIPDGI-GSCSLLRTIDFSEN 255
           P+G  + L  L+ + L  N     +P+G   S   L+ +   EN
Sbjct: 173 PEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 60.0 bits (146), Expect = 7e-10
 Identities = 46/179 (25%), Positives = 67/179 (37%), Gaps = 16/179 (8%)

Query: 374 NKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIP 433
           NK+    +  F         L+ L L+ N+           L  L+ L ++ N L   +P
Sbjct: 47  NKLSSLPSKAF----HRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQA-LP 101

Query: 434 VAIGD-LKALNVLDLSENWLNGSIPPEIGGAY----SLKELRLERNFLAGKIPTSI-ENC 487
           + + D L  L  L L  N L  S+PP     +     L  L L  N L   +P  + +  
Sbjct: 102 IGVFDQLVNLAELRLDRNQLK-SLPP---RVFDSLTKLTYLSLGYNELQ-SLPKGVFDKL 156

Query: 488 SSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHN 546
           +SL  L L  N L      A  KLT L+ + L  N L         +L  L    +  N
Sbjct: 157 TSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 58/234 (24%), Positives = 88/234 (37%), Gaps = 42/234 (17%)

Query: 125 NLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNR 184
           N   +D S   L+ +IP          + + L  N+ S     +    + L  + L+ N+
Sbjct: 17  NKNSVDCSSKKLT-AIPSNIP---ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNK 72

Query: 185 FSSPLPLGIW-GLSALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKNMFSGSIPDGIG 242
             + LP GI+  L  L TL ++DN L+  +P GV + L NL  + L +N    S+P  + 
Sbjct: 73  LQT-LPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRV- 128

Query: 243 SCSLLRTIDFSENSFSG--NLPETMQKLSLCN--FMNLRKNLFSGEVPKWIGELESLETL 298
                         F     L      LSL      +L K +F          L SL+ L
Sbjct: 129 --------------FDSLTKL----TYLSLGYNELQSLPKGVFDK--------LTSLKEL 162

Query: 299 DLSGNKFSGAVPISI-GNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQN 351
            L  N+    VP      L  LK L    N+L      +  +   L  L   +N
Sbjct: 163 RLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 43.0 bits (102), Expect = 3e-04
 Identities = 26/81 (32%), Positives = 36/81 (44%), Gaps = 13/81 (16%)

Query: 480 IPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLT---GGLPKQLVNLV 536
           IP   +       L L  N L+     A  +LT L+ + L+ N L     G+ K+L NL 
Sbjct: 35  IPADTKK------LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLE 88

Query: 537 HLSSFNISHNHLQGELPAGGF 557
            L    ++ N LQ  LP G F
Sbjct: 89  TL---WVTDNKLQ-ALPIGVF 105

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 73.4 bits (181), Expect = 5e-14
 Identities = 43/164 (26%), Positives = 74/164 (45%), Gaps = 28/164 (17%)

Query: 692 LNKDCELGRGGFGAVY--RTVLRDGRPVAIKKLTVSSLVKSQEDFE-------REV---K 739
           + +   +G G +G V+  R +   GR VA+K+      V+ Q   E       REV   +
Sbjct: 16  VAE---IGEGAYGKVFKARDLKNGGRFVALKR------VRVQTGEEGMPLSTIREVAVLR 66

Query: 740 KLGKVRHPNLVTLE----GYYWTQSLQL-LIYEFVSGGSLHKHLHEGSGGNFLSWNERFN 794
            L    HPN+V L          +  +L L++E V    L  +L +      +      +
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETIKD 124

Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR 838
           ++    + L  LH   ++H ++K  N+L+  SG+ K+ D+GLAR
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 73.9 bits (182), Expect = 6e-14
 Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 36/212 (16%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQE----DFEREVKKLGKV-RHPNLVT 751
           +GRG +  V    L+   R  A++ +    +   ++      E+ V    +   HP LV 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHV--FEQASNHPFLVG 117

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF---NVIQGTAKSLAHLHQ 808
           L   + T+S    + E+V+GG L  H+           + RF    +       L +LH+
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLA----LNYLHE 171

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFAC 865
             II+ ++K  NVL+D  G  K+ DYG+ +   +           +  G   Y+APE   
Sbjct: 172 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRP----GDTTSTFCGTPNYIAPEILR 226

Query: 866 -----RTVKITDKCDVYGFGVLVLEVVTGKRP 892
                 +V      D +  GVL+ E++ G+ P
Sbjct: 227 GEDYGFSV------DWWALGVLMFEMMAGRSP 252

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 74.1 bits (182), Expect = 7e-14
 Identities = 35/213 (16%), Positives = 73/213 (34%), Gaps = 33/213 (15%)

Query: 643 VRSSTSRSAAALTLSAGDDFSRSPTTDANSGKLVMFSGDPDFSTGTHALLNKDCELGRGG 702
                +         +  +  +     ++     M     D+       +     +G G 
Sbjct: 8   AAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRH--LIGTGS 65

Query: 703 FGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFE---------REVKKLGKVRHPNLVTL 752
           +G V       + R VAIKK+           FE         RE+  L ++ H ++V +
Sbjct: 66  YGHVCEAYDKLEKRVVAIKKIL--------RVFEDLIDCKRILREIAILNRLNHDHVVKV 117

Query: 753 EGYYWTQSLQL-----LIYEFVSGGSLHKHLHEGSGGNFLSWNE--RFNVIQGTAKSLAH 805
                 + ++      ++ E        K         +L+     +  +       + +
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIA-DSDFKKLFR---TPVYLT-ELHIKTLLYN-LLVGVKY 171

Query: 806 LHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR 838
           +H + I+H ++K +N L++     KV D+GLAR
Sbjct: 172 VHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR 204

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 71.9 bits (177), Expect = 9e-14
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 29/208 (13%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V        G  VA+K L    +         +RE++ L   RHP+++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 755 YYWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFN-VIQGTAKSLAHLH 807
              T +   ++ E+VSGG L      H  + E            F  ++      + + H
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRL------FQQILSA----VDYCH 128

Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFA 864
           +  ++H ++K  NVL+D     K+ D+GL+ +  M D   L    +++ G   Y APE  
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFL----RTSCGSPNYAAPEVI 182

Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRP 892
              +    + D++  GV++  ++ G  P
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLP 210

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 72.7 bits (179), Expect = 1e-13
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 38/213 (17%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTV--SSLVKSQEDFEREVKKLGKVRHPNLVTL-- 752
           +G G +G+V   +  R G  VAIKKL+    S + ++  + RE+  L  ++H N++ L  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHENVIGLLD 90

Query: 753 -----------EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAK 801
                        +Y       L+  F+    L K +       F     ++ V Q   K
Sbjct: 91  VFTPASSLRNFYDFY-------LVMPFM-QTDLQKIMGL----KFSEEKIQYLVYQ-MLK 137

Query: 802 SLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMA 860
            L ++H + ++H ++K  N+ ++   E K+ D+GLAR     +  YV          Y A
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV------VTRWYRA 191

Query: 861 PEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           PE     +      D++  G ++ E++TGK  L
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK-TL 223

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 40/229 (17%), Positives = 83/229 (36%), Gaps = 43/229 (18%)

Query: 95  GLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVI 154
               L    K +L   ++T  +     +L  ++  +   +++  S+     +   +L+ +
Sbjct: 14  PDPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SL--AGMQFFTNLKEL 68

Query: 155 SLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIP 214
            L+ N+ S  + S L   + L  ++++ NR  +   +     + L  L L +N L     
Sbjct: 69  HLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGI---PSACLSRLFLDNNELRD--T 121

Query: 215 KGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFM 274
             +  LKNL ++++  N    SI   +G  S L  +D   N  +          +     
Sbjct: 122 DSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEIT----------NTGGLT 169

Query: 275 NLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLN 323
            L+K                +  +DL+G K        +     L + N
Sbjct: 170 RLKK----------------VNWIDLTGQKCV---NEPVKYQPELYITN 199

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 31/160 (19%), Positives = 63/160 (39%), Gaps = 13/160 (8%)

Query: 389 SSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLS 448
                +Q  +  ++         +   + L+ L+LS N +    P  + DL  L  L ++
Sbjct: 38  KELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVN 93

Query: 449 ENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAI 508
            N L  ++      +  L  L L+ N L  +   S+ +  +L  L +  N L   + +  
Sbjct: 94  RNRLK-NLNG--IPSACLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLKSIVMLG- 147

Query: 509 AKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHL 548
             L+ L+ +DL  N +T      L  L  ++  +++    
Sbjct: 148 -FLSKLEVLDLHGNEITN--TGGLTRLKKVNWIDLTGQKC 184

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 41/252 (16%), Positives = 68/252 (26%), Gaps = 70/252 (27%)

Query: 289 IGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDF 348
              L +    +L     +  V      L  ++  N   + +  SL   M    NL  L  
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHL 70

Query: 349 SQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGET 408
           S N              ++ +S  ++                   L+ L ++ N      
Sbjct: 71  SHNQ-------------ISDLSPLKD----------------LTKLEELSVNRNRLK--- 98

Query: 409 PATIGALSGLQL--LNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSL 466
              +  +    L  L L  N L       +  LK L +L +  N L  SI          
Sbjct: 99  --NLNGIPSACLSRLFLDNNELRDTDS--LIHLKNLEILSIRNNKLK-SIVM-------- 145

Query: 467 KELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTG 526
                            +   S L  L L  N +T    +   +L  +  +DL+      
Sbjct: 146 -----------------LGFLSKLEVLDLHGNEITNTGGLT--RLKKVNWIDLTGQKCVN 186

Query: 527 GLPKQLVNLVHL 538
              K    L   
Sbjct: 187 EPVKYQPELYIT 198

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 59.7 bits (145), Expect = 9e-10
 Identities = 41/257 (15%), Positives = 80/257 (31%), Gaps = 46/257 (17%)

Query: 195 GLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSE 254
           GL+     +L    +   +    + L  ++  N   +    S+  G+   + L+ +  S 
Sbjct: 17  GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSH 72

Query: 255 NSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIG 314
           N  S           L    +L K                LE L ++ N+      ++  
Sbjct: 73  NQIS----------DLSPLKDLTK----------------LEELSVNRNRLKN---LNGI 103

Query: 315 NLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAEN 374
               L  L    N L     DS+ +  NL  L    N +   +    F S L  +    N
Sbjct: 104 PSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGN 160

Query: 375 KIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPI-P 433
           +I            +  + + ++DL+  +   E    +     L + N  ++     I P
Sbjct: 161 EITN------TGGLTRLKKVNWIDLTGQKCVNE---PVKYQPELYITNTVKDPDGRWISP 211

Query: 434 VAIGDLKALNVLDLSEN 450
             I +  +     +   
Sbjct: 212 YYISNGGSYVDGCVLWE 228

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 47.7 bits (114), Expect = 7e-06
 Identities = 26/136 (19%), Positives = 45/136 (33%), Gaps = 34/136 (25%)

Query: 97  LQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISL 156
           +    L +L L +N L       L  L+NL ++ +  N L  SI                
Sbjct: 103 IPSACLSRLFLDNNELR-DTDS-LIHLKNLEILSIRNNKLK-SI---------------- 143

Query: 157 AKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKG 216
                       L   S L  ++L  N  ++   L    L  +  +DL+       + + 
Sbjct: 144 ----------VMLGFLSKLEVLDLHGNEITNTGGLT--RLKKVNWIDLTGQKC---VNEP 188

Query: 217 VESLKNLRVINLSKNM 232
           V+    L + N  K+ 
Sbjct: 189 VKYQPELYITNTVKDP 204

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 44.2 bits (105), Expect = 8e-05
 Identities = 21/138 (15%), Positives = 45/138 (32%), Gaps = 33/138 (23%)

Query: 412 IGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRL 471
              L+     NL + S+   +     +L  +   +   + +  S+               
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG------------- 58

Query: 472 ERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQ 531
                       ++  ++L  L LS N ++   P+    LT L+ + ++ N L       
Sbjct: 59  ------------MQFFTNLKELHLSHNQISDLSPLK--DLTKLEELSVNRNRLKNLNGIP 104

Query: 532 LVNLVHLSSFNISHNHLQ 549
              L  L    + +N L+
Sbjct: 105 SACLSRL---FLDNNELR 119

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 72.4 bits (178), Expect = 1e-13
 Identities = 47/178 (26%), Positives = 76/178 (42%), Gaps = 31/178 (17%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG             VA+K +   + +      +RE+     +RHPN+V  +   
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN--VQREIINHRSLRHPNIVRFKEVI 85

Query: 757 WTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFN-VIQGTAKSLAHLHQS 809
            T +   +I E+ SGG L           E     F      F  ++ G    +++ H  
Sbjct: 86  LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFF------FQQLLSG----VSYCHSM 135

Query: 810 NIIHYNIKSSNVLIDGSGEP--KVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPE 862
            I H ++K  N L+DGS  P  K+ D+G ++        VL S+ +S +G   Y+APE
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAYIAPE 187

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 44/164 (26%), Positives = 68/164 (41%), Gaps = 13/164 (7%)

Query: 73  PRSNRVIELTLNGLSLTGRIGRG--LLQLQFLRKLSLSSNNLTGSISPN-LAKLQNLRVI 129
           P    +++L+ N LS   R+       +L  L  L LS N+L   IS      + NLR +
Sbjct: 38  PSYTALLDLSHNNLS---RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYL 93

Query: 130 DLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPL 189
           DLS N L  ++ +  F    +L V+ L  N       ++    + L  + LS N+ S   
Sbjct: 94  DLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-F 151

Query: 190 PLGI----WGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLS 229
           P+ +      L  L  LDLS N L+      ++ L       L 
Sbjct: 152 PVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 69.5 bits (170), Expect = 1e-12
 Identities = 43/180 (23%), Positives = 71/180 (39%), Gaps = 14/180 (7%)

Query: 105 LSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGK 164
           LS S   L  ++  +L       ++DLS N+LS    +    +  +L  + L+ N  +  
Sbjct: 23  LSCSKQQLP-NVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-F 78

Query: 165 IPS-SLSLCSTLATINLSSNRFSSPLPLGI-WGLSALRTLDLSDNLLEGEIPKGV-ESLK 221
           I S +      L  ++LSSN   + L   +   L AL  L L +N +   + +   E + 
Sbjct: 79  ISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMA 136

Query: 222 NLRVINLSKNMFSGSIPDGI----GSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLR 277
            L+ + LS+N  S   P  +         L  +D S N         +QKL       L 
Sbjct: 137 QLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 63.7 bits (155), Expect = 8e-11
 Identities = 44/160 (27%), Positives = 62/160 (38%), Gaps = 12/160 (7%)

Query: 393 SLQFLDLSHNEFSGETPATIGA-LSGLQLLNLSRNSLVGPIPV-AIGDLKALNVLDLSEN 450
               LDLSHN  S          L+ L  L LS N L   I   A   +  L  LDLS N
Sbjct: 40  YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSN 98

Query: 451 WLNGSIPPEI-GGAYSLKELRLERNFLAGKIPTSI-ENCSSLVSLILSKNNLTGPIP--- 505
            L+ ++   +     +L+ L L  N +   +  +  E+ + L  L LS+N ++   P   
Sbjct: 99  HLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISR-FPVEL 155

Query: 506 -IAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNIS 544
                KL  L  +DLS N L       L  L       + 
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 61.0 bits (148), Expect = 7e-10
 Identities = 34/136 (25%), Positives = 56/136 (41%), Gaps = 12/136 (8%)

Query: 80  ELTLNGLSLTGRIGRGLL-QLQFLRKLSLSSNNLTGSISPN-LAKLQNLRVIDLSGNSLS 137
            L L+   L   I       +  LR L LSSN+L  ++     + LQ L V+ L  N + 
Sbjct: 68  SLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV 125

Query: 138 GSIPDEFFKQCGSLRVISLAKNRFSGKIP----SSLSLCSTLATINLSSNRFSSPLPLGI 193
             +    F+    L+ + L++N+ S + P       +    L  ++LSSN+        +
Sbjct: 126 -VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDL 183

Query: 194 WGLSAL--RTLDLSDN 207
             L A     L L +N
Sbjct: 184 QKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 52/192 (27%), Positives = 66/192 (34%), Gaps = 23/192 (11%)

Query: 271 CNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVP-ISIGNLQRLKVLNFSANRL 329
           C+   L        VP+ +        LDLS N  S      +   L  L  L  S N L
Sbjct: 25  CSKQQLP------NVPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL 76

Query: 330 TGSLPDSM-ANCMNLVALDFSQNSMNGDLPQWIFS--SGLNKVSFAENKIREGMNGPFAS 386
              +         NL  LD S N ++  L +++FS    L  +    N I       F  
Sbjct: 77  N-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAF-- 132

Query: 387 SGSSFESLQFLDLSHNE---FSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKAL- 442
                  LQ L LS N+   F  E       L  L LL+LS N L       +  L A  
Sbjct: 133 --EDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWV 190

Query: 443 -NVLDLSENWLN 453
            N L L  N L 
Sbjct: 191 KNGLYLHNNPLE 202

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 27/119 (22%), Positives = 42/119 (35%), Gaps = 6/119 (5%)

Query: 444 VLDLSENWLNGSIPPEI--GGAYSLKELRLERNFLAGKIPTSI-ENCSSLVSLILSKNNL 500
           +LDLS N L   +  E       +L  L L  N L   I +       +L  L LS N+L
Sbjct: 43  LLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHL 100

Query: 501 TGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFN 559
                   + L  L+ + L  N +         ++  L    +S N +    P     +
Sbjct: 101 HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKD 158

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 37/168 (22%), Positives = 65/168 (38%), Gaps = 11/168 (6%)

Query: 260 NLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRL 319
           +LP     L L +  NL + L +   P     L +L +L LS N  +     +   +  L
Sbjct: 36  SLPSYTALLDL-SHNNLSR-LRAEWTPT---RLTNLHSLLLSHNHLNFISSEAFVPVPNL 90

Query: 320 KVLNFSANRLTGSLPDSM-ANCMNLVALDFSQNSMNGDLPQWIFS--SGLNKVSFAENKI 376
           + L+ S+N L  +L + + ++   L  L    N +   + +  F   + L K+  ++N+I
Sbjct: 91  RYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQI 148

Query: 377 REGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLS 424
                      G+    L  LDLS N+        +  L       L 
Sbjct: 149 SRFPVELI-KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 71.5 bits (176), Expect = 3e-13
 Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 36/212 (16%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQE----DFEREVKKLGKV-RHPNLVT 751
           LG+G FG V  +  +      A+K L    +++  +      E+ V  L    + P L  
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV--LALPGKPPFLTQ 85

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF---NVIQGTAKSLAHLHQ 808
           L   + T      + E+V+GG L  H+ +   G F   +  F    +  G    L  L  
Sbjct: 86  LHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIG----LFFLQS 139

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFAC 865
             II+ ++K  NV++D  G  K+ D+G+ +   + D        ++  G   Y+APE   
Sbjct: 140 KGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWD----GVTTKTFCGTPDYIAPEI-- 192

Query: 866 RTVKITDK-----CDVYGFGVLVLEVVTGKRP 892
               I  +      D + FGVL+ E++ G+ P
Sbjct: 193 ----IAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 70.7 bits (174), Expect = 4e-13
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 34/211 (16%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQE----DFEREVKKLGKVRHPNLVTL 752
           LG+G FG V+    +   +  AIK L    ++   +      E+ V  L    HP L  +
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHM 83

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF---NVIQGTAKSLAHLHQS 809
              + T+     + E+++GG L  H+       F      F    +I G    L  LH  
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILG----LQFLHSK 137

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACR 866
            I++ ++K  N+L+D  G  K+ D+G+ +   ML      +K  +  G   Y+APE    
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLG----DAKTNTFCGTPDYIAPEI--- 189

Query: 867 TVKITDK-----CDVYGFGVLVLEVVTGKRP 892
              +  +      D + FGVL+ E++ G+ P
Sbjct: 190 ---LLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 71.4 bits (175), Expect = 4e-13
 Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 27/208 (12%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTV--SSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
           +G G  G V         R VAIKKL+    +   ++  + RE+  +  V H N+++L  
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLN 128

Query: 755 YYWTQSLQL------LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
            +  Q          L+ E +   +L + +        +     + + Q     + HLH 
Sbjct: 129 VFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERM----SYLLYQ-MLCGIKHLHS 182

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGYMAPEFAC 865
           + IIH ++K SN+++      K+ D+GLAR      M+  YV          Y APE   
Sbjct: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV------VTRYYRAPEV-I 235

Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRPL 893
             +   +  D++  G ++ E+V  K  L
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHK-IL 262

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 70.8 bits (174), Expect = 5e-13
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 30/209 (14%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDF----EREVKKLGK-VRHPNLVT 751
           +G+G FG V     +      A+K L   +++K +E+     ER V  L K V+HP LV 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV--LLKNVKHPFLVG 103

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L   + T      + ++++GG L  HL       FL    RF   +  A +L +LH  NI
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAE-IASALGYLHSLNI 160

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTV 868
           ++ ++K  N+L+D  G   + D+GL +   +      +S   +  G   Y+APE      
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCK-ENIEH----NSTTSTFCGTPEYLAPEV----- 210

Query: 869 KITDK-----CDVYGFGVLVLEVVTGKRP 892
            +  +      D +  G ++ E++ G  P
Sbjct: 211 -LHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 70.0 bits (172), Expect = 6e-13
 Identities = 52/219 (23%), Positives = 93/219 (42%), Gaps = 36/219 (16%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL---- 752
           LG GG G V+  V     + VAIKK+ ++     +    RE+K + ++ H N+V +    
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-REIKIIRRLDHDNIVKVFEIL 77

Query: 753 -----EGYYWTQSLQL-----LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKS 802
                +      SL       ++ E++    L   L     G  L  + R  + Q   + 
Sbjct: 78  GPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLE---QGPLLEEHARLFMYQ-LLRG 132

Query: 803 LAHLHQSNIIHYNIKSSNVLIDGSG-EPKVGDYGLARLL-------PMLDRYVLSSKIQS 854
           L ++H +N++H ++K +N+ I+      K+GD+GLAR++         L   +       
Sbjct: 133 LKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL------V 186

Query: 855 ALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
              Y +P         T   D++  G +  E++TGK  L
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-TL 224

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 70.0 bits (172), Expect = 7e-13
 Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 30/209 (14%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQE----DFEREVKKLGKV-RHPNLVT 751
           LG+G FG V    +++ G   A+K L    +++  +      E+ +  L     HP L  
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRI--LSLARNHPFLTQ 88

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L   + T      + EFV+GG L  H+ +     F     RF   +    +L  LH   I
Sbjct: 89  LFCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAE-IISALMFLHDKGI 145

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG---YMAPEFACRTV 868
           I+ ++K  NVL+D  G  K+ D+G+ +   + +         +  G   Y+APE      
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFGMCK-EGICN----GVTTATFCGTPDYIAPEI----- 195

Query: 869 KITDK-----CDVYGFGVLVLEVVTGKRP 892
            + +       D +  GVL+ E++ G  P
Sbjct: 196 -LQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 70.1 bits (172), Expect = 8e-13
 Identities = 48/215 (22%), Positives = 85/215 (39%), Gaps = 41/215 (19%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTV--SSLVKSQEDFEREVKKLGKVRHPNLVTL-- 752
           +G G  G V         R VAIKKL+    +   ++  + RE+  +  V H N++ L  
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGLLN 91

Query: 753 -----------EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAK 801
                      +  Y       ++ E +   +L + +              + + Q    
Sbjct: 92  VFTPQKSLEEFQDVY-------IVMELM-DANLCQVIQM----ELDHERMSYLLYQ-MLC 138

Query: 802 SLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL---PMLDRYVLSSKIQSALGY 858
            + HLH + IIH ++K SN+++      K+ D+GLAR      M+  YV          Y
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV------VTRYY 192

Query: 859 MAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
            APE     +   +  D++  G ++ E++ G   L
Sbjct: 193 RAPEV-ILGMGYKENVDIWSVGCIMGEMIKGG-VL 225

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 71.0 bits (174), Expect = 8e-13
 Identities = 41/152 (26%), Positives = 66/152 (43%), Gaps = 20/152 (13%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V        G  VA+K L    +          RE++ L   RHP+++ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 755 YYWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFN-VIQGTAKSLAHLH 807
              T S   ++ E+VSGG L      +  L E            F  ++ G    + + H
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRL------FQQILSG----VDYCH 133

Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL 839
           +  ++H ++K  NVL+D     K+ D+GL+ +
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 165

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 70.0 bits (172), Expect = 8e-13
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 26/214 (12%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTV-SSLVKSQEDFEREVKKLGKVRHPNLVTLEG 754
            LG G +G V        G  VAIKK+      + +     RE+K L   +H N++T+  
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKHENIITIFN 76

Query: 755 YYWTQSLQL-----LIYEFVSGGSLHKHLHEGSGGNFLSWNE--RFNVIQGTAKSLAHLH 807
                S +      +I E +    LH+ +        LS ++  ++ + Q T +++  LH
Sbjct: 77  IQRPDSFENFNEVYIIQELM-QTDLHRVIS----TQMLS-DDHIQYFIYQ-TLRAVKVLH 129

Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG--------YM 859
            SN+IH ++K SN+LI+ + + KV D+GLAR++            Q +          Y 
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189

Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           APE    + K +   DV+  G ++ E+   + P+
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRR-PI 222

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 69.7 bits (171), Expect = 1e-12
 Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 39/214 (18%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTV--SSLVKSQEDFEREVKKLGKVRHPNLVTL-- 752
           +G G +GAV   V  R G  VAIKKL     S + ++  + RE++ L  +RH N++ L  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHENVIGLLD 91

Query: 753 -----------EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNE-RFNVIQGTA 800
                        +Y       L+  F+ G  L K +        L  +  +F V Q   
Sbjct: 92  VFTPDETLDDFTDFY-------LVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQ-ML 138

Query: 801 KSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYM 859
           K L ++H + IIH ++K  N+ ++   E K+ D+GLAR     +  YV          Y 
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV------VTRWYR 192

Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           APE     ++ T   D++  G ++ E++TGK  L
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGK-TL 225

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 70.3 bits (172), Expect = 1e-12
 Identities = 60/473 (12%), Positives = 131/473 (27%), Gaps = 63/473 (13%)

Query: 101 FLRKLSLSSNNLTGSISPNLAKL----QNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISL 156
                +L  +   G + P +  +      L  I L    ++    +   K   + +V+ L
Sbjct: 78  HFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVL 137

Query: 157 AK-NRFSGK-IPSSLSLCSTLATINLSSNRFSSPLPLGI----WGLSALRTLDLSDNLLE 210
           +    FS   + +  + C  L  ++L  +         +       ++L +L++S   L 
Sbjct: 138 SSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISC--LA 195

Query: 211 GEI-PKGVESL----KNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETM 265
            E+    +E L     NL+ + L++ +    +   +     L  +      ++  +   +
Sbjct: 196 SEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTG--GYTAEVRPDV 253

Query: 266 QKLSLCNFMNLRK--------NLFSGEVPKWIGELESLETLDLSGNKFSGAVPISI-GNL 316
                      ++        +     +P        L TL+LS         + +    
Sbjct: 254 YSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQC 313

Query: 317 QRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFS-SGLNKVSFAENK 375
            +L+ L          L    + C +L  L    +      P    +  GL  VS     
Sbjct: 314 PKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVS----- 368

Query: 376 IREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGA-LSGLQLLNLSRNSLVGPIPV 434
                             L+ +     + +     TI      +    L       P   
Sbjct: 369 -------------MGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAP--- 412

Query: 435 AIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLI 494
              D   L  LD+            +     L+ L L                  +  L 
Sbjct: 413 ---DYLTLEPLDI-------GFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLS 462

Query: 495 LSKNNLTGPIPIAIAK-LTNLQNVDLSF-NSLTGGLPKQLVNLVHLSSFNISH 545
           ++    +      +     +L+ +++         L      L  + S  +S 
Sbjct: 463 VAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSS 515

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 51.8 bits (124), Expect = 7e-07
 Identities = 51/403 (12%), Positives = 126/403 (31%), Gaps = 72/403 (17%)

Query: 99  LQFLRKLSLSSNNLTGSISPNLAKL----QNLRVIDLSGNSLSGSIPDE----FFKQCGS 150
            + L++L L  +++       L+       +L  +++S   L+  +          +C +
Sbjct: 155 CRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISC--LASEVSFSALERLVTRCPN 212

Query: 151 LRVISLAKNRFSGKIPSSLSLCSTLATINLSS------NRFSSPLPLGIWGLSALRTLDL 204
           L+ + L +     K+ + L     L  +              S L + + G   LR L  
Sbjct: 213 LKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSG 272

Query: 205 SDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPET 264
             + +   +P        L  +NLS               ++     +         P+ 
Sbjct: 273 FWDAVPAYLPAVYSVCSRLTTLNLSY-------------ATV---QSYDLVKLLCQCPK- 315

Query: 265 MQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPIS-------IGNLQ 317
           +Q+L + +++     L    +     +L  L             V ++            
Sbjct: 316 LQRLWVLDYIEDA-GLEV--LASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCP 372

Query: 318 RLKVLNFSANRLTG-SLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKI 376
           +L+ + +   ++T  +L     N  N+                             +   
Sbjct: 373 KLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAP----------------DYLT 416

Query: 377 REGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALS----GLQLLNLS--RNSLVG 430
            E ++  F +     + L+ L LS       T      +      +++L+++   +S +G
Sbjct: 417 LEPLDIGFGAIVEHCKDLRRLSLSG----LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLG 472

Query: 431 PIPVAIGDLKALNVLDLSENWL-NGSIPPEIGGAYSLKELRLE 472
              V  G   +L  L++ +    + ++        +++ L + 
Sbjct: 473 MHHVLSG-CDSLRKLEIRDCPFGDKALLANASKLETMRSLWMS 514

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 39/267 (14%), Positives = 84/267 (31%), Gaps = 23/267 (8%)

Query: 294 SLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSM 353
            + +++L G         +  NL       +    +        ++   L  +   +  +
Sbjct: 67  KVRSVELKGKPH-----FADFNLVPDGWGGYVYPWIEAMS----SSYTWLEEIRLKRMVV 117

Query: 354 NGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIG 413
             D  + I  S  N      +          A+  ++  +L+ LDL  ++    +   + 
Sbjct: 118 TDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLS 177

Query: 414 ALS----GLQLLNLS-RNSLVGP--IPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSL 466
                   L  LN+S   S V    +   +     L  L L+       +   +  A  L
Sbjct: 178 HFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQL 237

Query: 467 KELRLE------RNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLS 520
           +EL         R  +   +  ++  C  L  L    + +   +P   +  + L  ++LS
Sbjct: 238 EELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLS 297

Query: 521 FNSLTG-GLPKQLVNLVHLSSFNISHN 546
           + ++    L K L     L    +   
Sbjct: 298 YATVQSYDLVKLLCQCPKLQRLWVLDY 324

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 69.3 bits (170), Expect = 2e-12
 Identities = 51/215 (23%), Positives = 99/215 (46%), Gaps = 41/215 (19%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTV--SSLVKSQEDFEREVKKLGKVRHPNLVTL-- 752
           +G G +G+V      + G  VA+KKL+    S++ ++  + RE++ L  ++H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95

Query: 753 -----------EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNE--RFNVIQGT 799
                         Y       L+   + G  L+  +        L+ ++  +F + Q  
Sbjct: 96  VFTPARSLEEFNDVY-------LVTHLM-GADLNNIVK----CQKLT-DDHVQFLIYQ-I 141

Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGY 858
            + L ++H ++IIH ++K SN+ ++   E K+ D+GLAR     +  YV      +   Y
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV------ATRWY 195

Query: 859 MAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
            APE     +      D++  G ++ E++TG+  L
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-TL 229

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 68.5 bits (168), Expect = 3e-12
 Identities = 50/212 (23%), Positives = 98/212 (46%), Gaps = 31/212 (14%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTV-SSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +G G +G V       +   VAIKK++        Q    RE+K L + RH N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 93

Query: 756 YWTQSLQL-----LIYEFVSGGSLHKHLHEGSGGNFLSWNE--RFNVIQGTAKSLAHLHQ 808
               +++      ++ + +    L+K L        LS N+   + + Q   + L ++H 
Sbjct: 94  IRAPTIEQMKDVYIVQDLM-ETDLYKLLK----TQHLS-NDHICYFLYQ-ILRGLKYIHS 146

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-------PMLDRYVLSSKIQSALGYMAP 861
           +N++H ++K SN+L++ + + K+ D+GLAR+          L  YV      +   Y AP
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV------ATRWYRAP 200

Query: 862 EFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
           E    +   T   D++  G ++ E+++ + P+
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI 231

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 65.5 bits (160), Expect = 3e-12
 Identities = 37/157 (23%), Positives = 68/157 (43%), Gaps = 34/157 (21%)

Query: 77  RVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSL 136
             +EL      +  ++   L  L+  + L+LS+NN+   IS +L+ ++NLR++ L  N +
Sbjct: 26  EKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLI 82

Query: 137 SGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGL 196
                                      KI +  ++  TL  + +S N+ +S   +    L
Sbjct: 83  K--------------------------KIENLDAVADTLEELWISYNQIASLSGIE--KL 114

Query: 197 SALRTLDLSDNLLE--GEIPKGVESLKNLRVINLSKN 231
             LR L +S+N +   GEI   + +L  L  + L+ N
Sbjct: 115 VNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 56.6 bits (137), Expect = 3e-09
 Identities = 34/162 (20%), Positives = 61/162 (37%), Gaps = 27/162 (16%)

Query: 202 LDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFS--- 258
           L      +E ++   + +LK  + + LS N     I   +     LR +    N      
Sbjct: 30  LHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKKIE 86

Query: 259 --GNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPIS-IGN 315
               + +T+++L +    N   +L SG     I +L +L  L +S NK +    I  +  
Sbjct: 87  NLDAVADTLEELWISY--NQIASL-SG-----IEKLVNLRVLYMSNNKITNWGEIDKLAA 138

Query: 316 LQRLKVLNFSANRLTGSLPDS----------MANCMNLVALD 347
           L +L+ L  + N L     ++          +    NL  LD
Sbjct: 139 LDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 34/202 (16%), Positives = 66/202 (32%), Gaps = 54/202 (26%)

Query: 259 GNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPIS-IGNLQ 317
             +    +K+ L   +   + + +      +  L++ + L LS N       IS +  ++
Sbjct: 19  SVVATEAEKVELHGMIPPIEKMDAT-----LSTLKACKHLALSTNNIEK---ISSLSGME 70

Query: 318 RLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIR 377
            L++L+   N +   + +  A    L  L  S                        N+I 
Sbjct: 71  NLRILSLGRNLIK-KIENLDAVADTLEELWIS-----------------------YNQIA 106

Query: 378 --EGMNGPFASSGSSFESLQFLDLSHNEFSGETP-ATIGALSGLQLLNLSRNSLVGPIPV 434
              G+            +L+ L +S+N+ +       + AL  L+ L L+ N L      
Sbjct: 107 SLSGI--------EKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158

Query: 435 A----------IGDLKALNVLD 446
                      +  L  L  LD
Sbjct: 159 NNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 35/141 (24%), Positives = 56/141 (39%), Gaps = 21/141 (14%)

Query: 421 LNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELR---LERNFLA 477
           L+     +   +   +  LKA   L LS N +      +I     ++ LR   L RN + 
Sbjct: 30  LHGMIPPIEK-MDATLSTLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRNLIK 83

Query: 478 GKIPTSIENCSSLVSLILSKNNLT---GPIPIAIAKLTNLQNVDLSFNSLT--GGLPKQL 532
            KI        +L  L +S N +    G     I KL NL+ + +S N +T  G +  +L
Sbjct: 84  -KIENLDAVADTLEELWISYNQIASLSG-----IEKLVNLRVLYMSNNKITNWGEI-DKL 136

Query: 533 VNLVHLSSFNISHNHLQGELP 553
             L  L    ++ N L  +  
Sbjct: 137 AALDKLEDLLLAGNPLYNDYK 157

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 67.3 bits (165), Expect = 5e-12
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 24/205 (11%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKS--QEDFEREVKKLGKVRHPNLVTLEG 754
           LG G FG V      +  + VA+K ++   L KS      ERE+  L  +RHP+++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 755 YYWTQSLQLLIYEFVSGGSL------HKHLHEGSGGNFLSWNERFN-VIQGTAKSLAHLH 807
              T +  +++ E+  GG L       K + E  G  F      F  +I      + + H
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRF------FQQIICA----IEYCH 125

Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
           +  I+H ++K  N+L+D +   K+ D+GL+ +  M D   L +   S   Y APE     
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI--MTDGNFLKTSCGS-PNYAAPEVINGK 182

Query: 868 VKITDKCDVYGFGVLVLEVVTGKRP 892
           +    + DV+  G+++  ++ G+ P
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLP 207

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 67.9 bits (166), Expect = 6e-12
 Identities = 39/152 (25%), Positives = 62/152 (40%), Gaps = 17/152 (11%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTV--SSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
            +GRG +G VY        + VAIKK+      L+  +    RE+  L +++   ++ L 
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL-REITILNRLKSDYIIRLY 91

Query: 754 GYYWTQSLQL-----LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVI--QGTAKSLAHL 806
                  L       ++ E      L K         FL+  E    I           +
Sbjct: 92  DLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTP---IFLT-EEHIKTILYN-LLLGENFI 145

Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR 838
           H+S IIH ++K +N L++     KV D+GLAR
Sbjct: 146 HESGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 66.7 bits (163), Expect = 1e-11
 Identities = 49/366 (13%), Positives = 111/366 (30%), Gaps = 80/366 (21%)

Query: 92  IGRGLLQLQFLRKLSLSSNNLTGSISPNLAKL-----QNLRVIDLSGNSLS----GSIPD 142
           +         +  L LS NNL    +  L +       ++  ++LSGNSL       +  
Sbjct: 14  VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQ 73

Query: 143 EFFKQCGSLRVISLAKNRFSGKIPSSL-----SLCSTLATINLSSNRFSSPLPLGIWGLS 197
                  ++  ++L+ N  S K    L     ++  T+  ++L  N FS           
Sbjct: 74  ILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS---SKSSSEFK 130

Query: 198 A--------LRTLDLSDNLLEGEIPKGVESL--------KNLRVINLSKNMFS----GSI 237
                    + +L+L  N L     K  + L         N+  +NL  N  +      +
Sbjct: 131 QAFSNLPASITSLNLRGNDLG---IKSSDELIQILAAIPANVNSLNLRGNNLASKNCAEL 187

Query: 238 PDGIGSCSL-LRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLE 296
              + S    + ++D S N       ++  +L+                         + 
Sbjct: 188 AKFLASIPASVTSLDLSANLLG---LKSYAELAYI----FSSI------------PNHVV 228

Query: 297 TLDLSGNKF--SGAVPIS--IGNLQRLKVLNFSANRLTG-------SLPDSMANCMNLVA 345
           +L+L  N         +     +L+ L+ +    + +         +L  +  N   ++ 
Sbjct: 229 SLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIIL 288

Query: 346 LDFSQNSMNGDLPQWIFSSGLNKVSFAENKIR--------EGMNGPFASSGSSFESLQFL 397
           +D +   +         S+ + ++S   +              +       +  + L+  
Sbjct: 289 VDKNGKEI-HPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRES 347

Query: 398 DLSHNE 403
             +   
Sbjct: 348 IQTCKP 353

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 65.9 bits (161), Expect = 2e-11
 Identities = 49/301 (16%), Positives = 93/301 (30%), Gaps = 43/301 (14%)

Query: 294 SLETLDLSGNKFS--GAVPIS---IGNLQRLKVLNFSANRLTGSLPDSMA-----NCMNL 343
            + +LDLS N       V +          +  LN S N L     D +         N+
Sbjct: 23  GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82

Query: 344 VALDFSQNSMNGDLPQWIFS------SGLNKVSFAENKIREGMNGPFASS-GSSFESLQF 396
            +L+ S N ++      +          +  +    N      +  F  +  +   S+  
Sbjct: 83  TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITS 142

Query: 397 LDLSHNEFSGETPATIG-ALSG----LQLLNLSRNSLVGPIPVAIGD-LKALN----VLD 446
           L+L  N+   ++   +   L+     +  LNL  N+L       +   L ++      LD
Sbjct: 143 LNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLD 202

Query: 447 LSENWLNGSIPPEIGGA-----YSLKELRLERNFL----AGKIPTSIENCSSLVSLILSK 497
           LS N L      E+          +  L L  N L       +    ++   L ++ L  
Sbjct: 203 LSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDY 262

Query: 498 NNLTGPIPI-------AIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQG 550
           + +             A   +  +  VD +   +       + NL+   S       L  
Sbjct: 263 DIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLN 322

Query: 551 E 551
           +
Sbjct: 323 Q 323

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 38/134 (28%), Positives = 68/134 (50%), Gaps = 11/134 (8%)

Query: 103 RKLSLSSNNLTGSISPN-LAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRF 161
            ++ L  N +   I P   +  + LR IDLS N +S  +  + F+   SL  + L  N+ 
Sbjct: 35  TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI 92

Query: 162 SGKIPSSL--SLCSTLATINLSSNRFSSPLPLGIW-GLSALRTLDLSDNLLEGEIPKGV- 217
           + ++P SL   L  +L  + L++N+ +  L +  +  L  L  L L DN L+  I KG  
Sbjct: 93  T-ELPKSLFEGL-FSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTF 148

Query: 218 ESLKNLRVINLSKN 231
             L+ ++ ++L++N
Sbjct: 149 SPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 30/134 (22%), Positives = 54/134 (40%), Gaps = 6/134 (4%)

Query: 392 ESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGD-LKALNVLDLSEN 450
           E++  + L  N      P        L+ ++LS N +   +       L++LN L L  N
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGN 90

Query: 451 WLNGSIPPEI-GGAYSLKELRLERNFLAGKIPTSI-ENCSSLVSLILSKNNLTGPIPIAI 508
            +   +P  +  G +SL+ L L  N +   +     ++  +L  L L  N L        
Sbjct: 91  KIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTF 148

Query: 509 AKLTNLQNVDLSFN 522
           + L  +Q + L+ N
Sbjct: 149 SPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 20/87 (22%), Positives = 43/87 (49%), Gaps = 3/87 (3%)

Query: 98  QLQFLRKLSLSSNNLTGSISPNL-AKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISL 156
            L+ L  L L  N +T  +  +L   L +L+++ L+ N ++  +  + F+   +L ++SL
Sbjct: 78  GLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSL 135

Query: 157 AKNRFSGKIPSSLSLCSTLATINLSSN 183
             N+       + S    + T++L+ N
Sbjct: 136 YDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 32/141 (22%), Positives = 53/141 (37%), Gaps = 29/141 (20%)

Query: 419 QLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGA-YSLKELRLERNFLA 477
             + L +N++    P A    K L  +DLS N ++  + P    A   L+ L        
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAP---DAFQGLRSLN------- 83

Query: 478 GKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQL-VNLV 536
                         SL+L  N +T         L +LQ + L+ N +   L      +L 
Sbjct: 84  --------------SLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLH 128

Query: 537 HLSSFNISHNHLQGELPAGGF 557
           +L+  ++  N LQ  +  G F
Sbjct: 129 NLNLLSLYDNKLQ-TIAKGTF 148

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 45.0 bits (107), Expect = 4e-05
 Identities = 32/130 (24%), Positives = 58/130 (44%), Gaps = 14/130 (10%)

Query: 374 NKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIP 433
           N I+    G F    S ++ L+ +DLS+N+ S   P     L  L  L L  N +   +P
Sbjct: 42  NTIKVIPPGAF----SPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE-LP 96

Query: 434 VAIGD-LKALNVLDLSENWLNGSIPPEIGGAY----SLKELRLERNFLAGKIPTSIENCS 488
            ++ + L +L +L L+ N +N  +      A+    +L  L L  N L      +     
Sbjct: 97  KSLFEGLFSLQLLLLNANKIN-CLRV---DAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152

Query: 489 SLVSLILSKN 498
           ++ ++ L++N
Sbjct: 153 AIQTMHLAQN 162

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 64.0 bits (156), Expect = 9e-11
 Identities = 51/223 (22%), Positives = 89/223 (39%), Gaps = 47/223 (21%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDF----EREVKKLGKVRHPNLVTL 752
           LG G F  V+    + +   VA+K      +V+  + +    E E+K L +V   +    
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMK------IVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHL---HEGSGGNFLSWNERFN-------VIQGTAK- 801
           +       L+LL + F   G    H+    E  G N L+  +++         ++  +K 
Sbjct: 81  DSMGANHILKLLDH-FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 139

Query: 802 ---SLAHLH-QSNIIHYNIKSSNVLIDGSGEP------KVGDYGLARLLPMLDRYVLSSK 851
               L ++H +  IIH +IK  NVL++    P      K+ D G A           ++ 
Sbjct: 140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYTNS 195

Query: 852 IQSALGYMAPEFACRTV----KITDKCDVYGFGVLVLEVVTGK 890
           IQ+   Y +PE     V          D++    L+ E++TG 
Sbjct: 196 IQTRE-YRSPE-----VLLGAPWGCGADIWSTACLIFELITGD 232

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 46/181 (25%), Positives = 71/181 (39%), Gaps = 41/181 (22%)

Query: 64  CNWFGVKCSPRSNRVI---------ELTLNGLSLTGRIGRGLLQ-LQFLRKLSLSSNNLT 113
           C    V CS +    I         EL LN    T     G+ + L  LRK++ S+N +T
Sbjct: 11  CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70

Query: 114 GSISPN-LAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLC 172
             I          +  I L+ N L  ++  + FK   SL+                    
Sbjct: 71  -DIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLK-------------------- 108

Query: 173 STLATINLSSNRFSSPLPLGIW-GLSALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSK 230
               T+ L SNR +  +    + GLS++R L L DN +   +  G  ++L +L  +NL  
Sbjct: 109 ----TLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLA 162

Query: 231 N 231
           N
Sbjct: 163 N 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 59.3 bits (144), Expect = 7e-10
 Identities = 27/120 (22%), Positives = 53/120 (44%), Gaps = 5/120 (4%)

Query: 124 QNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSN 183
           Q    + L+ N  +       FK+   LR I+ + N+ +     +    S +  I L+SN
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91

Query: 184 RFSSPLPLGI-WGLSALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKNMFSGSIPDGI 241
           R  + +   +  GL +L+TL L  N +   +       L ++R+++L  N  + ++  G 
Sbjct: 92  RLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGA 148

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 31/136 (22%), Positives = 50/136 (36%), Gaps = 16/136 (11%)

Query: 346 LDFSQNSMNGDLPQWIFS--SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNE 403
           L  + N         IF     L K++F+ NKI +   G F         +  + L+ N 
Sbjct: 37  LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAF----EGASGVNEILLTSNR 92

Query: 404 FSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGD-LKALNVLDLSENWLNGSIPPEIGG 462
                      L  L+ L L  N +   +       L ++ +L L +N +  ++ P   G
Sbjct: 93  LENVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQIT-TVAP---G 147

Query: 463 AY----SLKELRLERN 474
           A+    SL  L L  N
Sbjct: 148 AFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 32/146 (21%), Positives = 58/146 (39%), Gaps = 10/146 (6%)

Query: 284 EVPKWIGELESLETLDLSGNKFSGAVPISI-GNLQRLKVLNFSANRLTGSLPDSMANCMN 342
           ++P+ I +      L L+ N+F+      I   L +L+ +NFS N++T     +      
Sbjct: 25  KIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82

Query: 343 LVALDFSQNSMNGDLPQWIFSS--GLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLS 400
           +  +  + N +  ++   +F     L  +    N+I    N  F        S++ L L 
Sbjct: 83  VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSF----IGLSSVRLLSLY 137

Query: 401 HNEFSGETPATIGALSGLQLLNLSRN 426
            N+ +   P     L  L  LNL  N
Sbjct: 138 DNQITTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 20/117 (17%), Positives = 40/117 (34%), Gaps = 6/117 (5%)

Query: 444 VLDLSENWLNGSIPPEIG--GAYSLKELRLERNFLAGKIPTSI-ENCSSLVSLILSKNNL 500
            L L+ N     +           L+++    N +   I     E  S +  ++L+ N L
Sbjct: 36  ELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL 93

Query: 501 TGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGF 557
                     L +L+ + L  N +T       + L  +   ++  N +   +  G F
Sbjct: 94  ENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAF 149

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 59.7 bits (145), Expect = 1e-10
 Identities = 27/106 (25%), Positives = 50/106 (47%), Gaps = 5/106 (4%)

Query: 80  ELTLNGLSLT-GRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSG 138
           EL L+      G++     + + L  LS  +  LT SI+ NL KL  L+ ++LS N +S 
Sbjct: 21  ELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNRVS- 77

Query: 139 SIPDEFFKQCGSLRVISLAKNRFSG-KIPSSLSLCSTLATINLSSN 183
              +   ++C +L  ++L+ N+         L     L +++L + 
Sbjct: 78  GGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 56.6 bits (137), Expect = 1e-09
 Identities = 26/110 (23%), Positives = 46/110 (41%), Gaps = 9/110 (8%)

Query: 102 LRKLSLSSNNLT-GSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNR 160
           +++L L ++    G +     + + L  +      L+ SI      +   L+ + L+ NR
Sbjct: 19  VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI--ANLPKLNKLKKLELSDNR 75

Query: 161 FSGKIPSSLSLCSTLATINLSSNRFSSP---LPLGIWGLSALRTLDLSDN 207
            SG +      C  L  +NLS N+        PL    L  L++LDL + 
Sbjct: 76  VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLK--KLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 24/112 (21%), Positives = 48/112 (42%), Gaps = 4/112 (3%)

Query: 146 KQCGSLRVISLAKNRFS-GKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDL 204
           +    ++ + L  +R + GK+         L  ++  +   +S +   +  L+ L+ L+L
Sbjct: 14  RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IA-NLPKLNKLKKLEL 71

Query: 205 SDNLLEGEIPKGVESLKNLRVINLSKNMFSG-SIPDGIGSCSLLRTIDFSEN 255
           SDN + G +    E   NL  +NLS N     S  + +     L+++D    
Sbjct: 72  SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.7 bits (114), Expect = 1e-06
 Identities = 31/155 (20%), Positives = 50/155 (32%), Gaps = 29/155 (18%)

Query: 172 CSTLATINLSSNRFSSPLPLGIWG-LSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSK 230
            S +  + L ++R +     G+      L  L   +  L   I   +  L  L+ + LS 
Sbjct: 16  PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSD 73

Query: 231 NMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIG 290
           N  SG +      C  L  ++ S N              L     L+K            
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGNKIK----------DLSTIEPLKK------------ 111

Query: 291 ELESLETLDLSGN---KFSGAVPISIGNLQRLKVL 322
            LE+L++LDL        +         L +L  L
Sbjct: 112 -LENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYL 145

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.0 bits (112), Expect = 3e-06
 Identities = 24/86 (27%), Positives = 39/86 (45%), Gaps = 3/86 (3%)

Query: 465 SLKELRLE-RNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNS 523
            +KEL L+      GK+    +    L  L      LT  I   + KL  L+ ++LS N 
Sbjct: 18  DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IAN-LPKLNKLKKLELSDNR 75

Query: 524 LTGGLPKQLVNLVHLSSFNISHNHLQ 549
           ++GGL        +L+  N+S N ++
Sbjct: 76  VSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 24/136 (17%), Positives = 45/136 (33%), Gaps = 28/136 (20%)

Query: 218 ESLKNLRVINLSKNMFS-GSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNL 276
            +  +++ + L  +  + G +         L  +       +          S+ N   L
Sbjct: 14  RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT----------SIANLPKL 63

Query: 277 RKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTG-SLPD 335
            K                L+ L+LS N+ SG + +       L  LN S N++   S  +
Sbjct: 64  NK----------------LKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIE 107

Query: 336 SMANCMNLVALDFSQN 351
            +    NL +LD    
Sbjct: 108 PLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.8 bits (96), Expect = 3e-04
 Identities = 24/88 (27%), Positives = 37/88 (42%), Gaps = 3/88 (3%)

Query: 388 GSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDL 447
              FE L+FL   +   +  + A +  L+ L+ L LS N + G + V       L  L+L
Sbjct: 38  TDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95

Query: 448 SENWLNG-SIPPEIGGAYSLKELRLERN 474
           S N +   S    +    +LK L L   
Sbjct: 96  SGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.4 bits (95), Expect = 5e-04
 Identities = 23/116 (19%), Positives = 45/116 (38%), Gaps = 8/116 (6%)

Query: 390 SFESLQFLDLSHNEFS-GETPATIGALSGLQLLNLSRNSL--VGPIPVAIGDLKALNVLD 446
           +   ++ L L ++  + G+          L+ L+     L  +  +P     L  L  L+
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLE 70

Query: 447 LSENWLNGSIPPEIGGAYSLKELRLERNFLAG-KIPTSIENCSSLVSLILSKNNLT 501
           LS+N ++G +        +L  L L  N +        ++   +L SL L    +T
Sbjct: 71  LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 60.1 bits (146), Expect = 1e-10
 Identities = 22/114 (19%), Positives = 36/114 (31%), Gaps = 5/114 (4%)

Query: 95  GLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVI 154
                   R+L L    +   I    A L     ID S N +   +  + F     L+ +
Sbjct: 14  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL--DGFPLLRRLKTL 69

Query: 155 SLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPL-GIWGLSALRTLDLSDN 207
            +  NR              L  + L++N       L  +  L +L  L +  N
Sbjct: 70  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 22/113 (19%), Positives = 41/113 (36%), Gaps = 6/113 (5%)

Query: 145 FKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDL 204
           +      R + L   +    I +  +       I+ S N     L  G   L  L+TL +
Sbjct: 15  YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLV 71

Query: 205 SDNLLEGEIPKGVESLKNLRVINLSKNMFS--GSIPDGIGSCSLLRTIDFSEN 255
           ++N +        ++L +L  + L+ N     G + D + S   L  +    N
Sbjct: 72  NNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 31/152 (20%), Positives = 51/152 (33%), Gaps = 32/152 (21%)

Query: 202 LDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNL 261
           + L+  L+E +      +    R ++L        I +   +      IDFS+N      
Sbjct: 2   VKLTAELIE-QAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--- 55

Query: 262 PETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKV 321
                   L  F  LR+                L+TL ++ N+           L  L  
Sbjct: 56  -------KLDGFPLLRR----------------LKTLLVNNNRICRIGEGLDQALPDLTE 92

Query: 322 LNFSANRLT--GSLPDSMANCMNLVALDFSQN 351
           L  + N L   G L D +A+  +L  L   +N
Sbjct: 93  LILTNNSLVELGDL-DPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 17/111 (15%), Positives = 38/111 (34%), Gaps = 15/111 (13%)

Query: 444 VLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIEN----CSSLVSLILSKNN 499
           ++ L+   +  +   +   A   +EL L    +       IEN         ++  S N 
Sbjct: 1   MVKLTAELIEQA--AQYTNAVRDRELDLRGYKI-----PVIENLGATLDQFDAIDFSDNE 53

Query: 500 LTGPIPIA-IAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQ 549
           +     +     L  L+ + ++ N +          L  L+   +++N L 
Sbjct: 54  IR---KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 17/68 (25%), Positives = 31/68 (45%), Gaps = 4/68 (5%)

Query: 94  RGLLQLQFLRKLSLSSNNLTGSISPNLA-KLQNLRVIDLSGNSLSGSIPD-EFFKQCGSL 151
            G   L+ L+ L +++N +   I   L   L +L  + L+ NSL   + D +      SL
Sbjct: 58  DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSL 115

Query: 152 RVISLAKN 159
             + + +N
Sbjct: 116 TYLCILRN 123

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 53/256 (20%), Positives = 100/256 (39%), Gaps = 20/256 (7%)

Query: 80  ELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGS 139
            L L G +L   +   LL    +       + +   ++ + +    ++ +DLS + +  S
Sbjct: 51  TLDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVS 108

Query: 140 IPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLG--IWGLS 197
                  QC  L+ +SL   R S  I ++L+  S L  +NLS     S   L   +   S
Sbjct: 109 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 168

Query: 198 ALRTLDLS------DNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTID 251
            L  L+LS      +  ++  +    E++  L +    KN+    +   +  C  L  +D
Sbjct: 169 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 228

Query: 252 FSENSFSGNLPETMQKLSLCNFMNLRK------NLFSGEVPKWIGELESLETLDLSGNKF 305
            S++    N  +  Q+    N   L+            E    +GE+ +L+TL + G   
Sbjct: 229 LSDSVMLKN--DCFQEFFQLN--YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVP 284

Query: 306 SGAVPISIGNLQRLKV 321
            G + +    L  L++
Sbjct: 285 DGTLQLLKEALPHLQI 300

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 54/223 (24%), Positives = 100/223 (44%), Gaps = 36/223 (16%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTV--SSLVKSQEDFEREVKKLGKVR-HPNLVTLE 753
           LG+G +G V++++  R G  VA+KK+     +   +Q  F RE+  L ++  H N+V L 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHENIVNLL 75

Query: 754 GYYWTQSLQ--LLIYEFVSGGSLHKHLHEGSGGNFLSWNE--RFNVIQGTAKSLAHLHQS 809
                 + +   L+++++    LH  +      N L      ++ V Q   K + +LH  
Sbjct: 76  NVLRADNDRDVYLVFDYM-ETDLHAVIR----ANILE-PVHKQYVVYQ-LIKVIKYLHSG 128

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALG------------ 857
            ++H ++K SN+L++     KV D+GL+R    + R   +  +                 
Sbjct: 129 GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188

Query: 858 -------YMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
                  Y APE    + K T   D++  G ++ E++ GK P+
Sbjct: 189 DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK-PI 230

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 60.1 bits (146), Expect = 5e-10
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 11/158 (6%)

Query: 103 RKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFS 162
            KL L S  L          L  L  ++L  N L  ++    F     L  + LA N+ +
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96

Query: 163 GKIPSSL--SLCSTLATINLSSNRFSSPLPLGIW-GLSALRTLDLSDNLLEGEIPKGV-E 218
             +P  +   L + L  + L  N+  S LP G++  L+ L+ L L+ N L+  IP G  +
Sbjct: 97  -SLPLGVFDHL-TQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFD 152

Query: 219 SLKNLRVINLSKNMFSGSIPDGI-GSCSLLRTIDFSEN 255
            L NL+ ++LS N    S+P G       L+TI    N
Sbjct: 153 KLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 53.9 bits (130), Expect = 5e-08
 Identities = 49/165 (29%), Positives = 80/165 (48%), Gaps = 15/165 (9%)

Query: 73  PRSNRVIELTLNGL-SLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNL-AKLQNLRVID 130
           P     ++L   GL +L+    RGL +L +L   +L  N L  ++S  +   L  L  + 
Sbjct: 34  PADTEKLDLQSTGLATLSDATFRGLTKLTWL---NLDYNQLQ-TLSAGVFDDLTELGTLG 89

Query: 131 LSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSL--SLCSTLATINLSSNRFSSP 188
           L+ N L+ S+P   F     L  + L  N+    +PS +   L + L  + L++N+  S 
Sbjct: 90  LANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRL-TKLKELRLNTNQLQS- 145

Query: 189 LPLGIW-GLSALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKN 231
           +P G +  L+ L+TL LS N L+  +P G  + L  L+ I L  N
Sbjct: 146 IPAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 41/160 (25%), Positives = 61/160 (38%), Gaps = 15/160 (9%)

Query: 419 QLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEI-GGAYSLKELRLERNFLA 477
           + L+L    L          L  L  L+L  N L  ++   +      L  L L  N LA
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA 96

Query: 478 GKIPTSI-ENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPK----QL 532
             +P  + ++ + L  L L  N L         +LT L+ + L+ N L   +P     +L
Sbjct: 97  -SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154

Query: 533 VNLVHLSSFNISHNHLQGELPAGGFFNTISPSSV--LGNP 570
            NL  LS      N LQ  +P G F       ++   GN 
Sbjct: 155 TNLQTLSLST---NQLQS-VPHGAFDRLGKLQTITLFGNQ 190

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 43/161 (26%), Positives = 66/161 (40%), Gaps = 15/161 (9%)

Query: 296 ETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCM-NLVALDFSQNSMN 354
           E LDL     +     +   L +L  LN   N+L  +L   + + +  L  L  + N + 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96

Query: 355 GDLPQWIFSS--GLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATI 412
             LP  +F     L+K+    N+++   +G F         L+ L L+ N+     PA  
Sbjct: 97  -SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVF----DRLTKLKELRLNTNQLQ-SIPA-- 148

Query: 413 GA---LSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSEN 450
           GA   L+ LQ L+LS N L      A   L  L  + L  N
Sbjct: 149 GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 57.8 bits (140), Expect = 8e-10
 Identities = 31/127 (24%), Positives = 50/127 (39%), Gaps = 7/127 (5%)

Query: 85  GLSLTGRIGRGLLQLQF--LRKLSLSSNNLT-GSISPNLAKLQNLRVIDLSGNSLSGSIP 141
           G+ +  RI   L       +R+L L +     G I    A+  NL  + L    L  S+ 
Sbjct: 7   GMDMKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV- 64

Query: 142 DEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIW-GLSALR 200
                +   L+ + L++NR  G +         L  +NLS N+      L     L  L+
Sbjct: 65  -SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLK 123

Query: 201 TLDLSDN 207
           +LDL + 
Sbjct: 124 SLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 26/108 (24%), Positives = 48/108 (44%), Gaps = 4/108 (3%)

Query: 150 SLRVISLAKNRFS-GKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNL 208
           ++R + L   + + GKI    +    L  ++L +    S +   +  L  L+ L+LS+N 
Sbjct: 25  AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VS-NLPKLPKLKKLELSENR 82

Query: 209 LEGEIPKGVESLKNLRVINLSKNMFSG-SIPDGIGSCSLLRTIDFSEN 255
           + G +    E L NL  +NLS N     S  + +     L+++D    
Sbjct: 83  IFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.9 bits (109), Expect = 9e-06
 Identities = 34/140 (24%), Positives = 53/140 (37%), Gaps = 8/140 (5%)

Query: 387 SGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLD 446
             S    +      H E    TPA +  L     L+  +++  G I     +   L  L 
Sbjct: 1   GSSGSSGMDMKRRIHLELRNRTPAAVRELV----LDNCKSND-GKIEGLTAEFVNLEFLS 55

Query: 447 LSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPI 506
           L    L  S+   +     LK+L L  N + G +    E   +L  L LS N L     +
Sbjct: 56  LINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL 113

Query: 507 A-IAKLTNLQNVDLSFNSLT 525
             + KL  L+++DL    +T
Sbjct: 114 EPLKKLECLKSLDLFNCEVT 133

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.9 bits (109), Expect = 9e-06
 Identities = 25/87 (28%), Positives = 41/87 (47%), Gaps = 5/87 (5%)

Query: 465 SLKELRLE-RNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIA-IAKLTNLQNVDLSFN 522
           +++EL L+      GKI        +L  L L    L     ++ + KL  L+ ++LS N
Sbjct: 25  AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS---VSNLPKLPKLKKLELSEN 81

Query: 523 SLTGGLPKQLVNLVHLSSFNISHNHLQ 549
            + GGL      L +L+  N+S N L+
Sbjct: 82  RIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 40.9 bits (96), Expect = 4e-04
 Identities = 29/159 (18%), Positives = 50/159 (31%), Gaps = 31/159 (19%)

Query: 195 GLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSE 254
           G S    +D+   +      +   +++ L V++  K+   G I         L  +    
Sbjct: 1   GSSGSSGMDMKRRIHLELRNRTPAAVREL-VLDNCKSN-DGKIEGLTAEFVNLEFLSLIN 58

Query: 255 NSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIG 314
                         S+ N   L K                L+ L+LS N+  G + +   
Sbjct: 59  VGLI----------SVSNLPKLPK----------------LKKLELSENRIFGGLDMLAE 92

Query: 315 NLQRLKVLNFSANRLTGSLPD--SMANCMNLVALDFSQN 351
            L  L  LN S N+L   +     +     L +LD    
Sbjct: 93  KLPNLTHLNLSGNKLK-DISTLEPLKKLECLKSLDLFNC 130

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 60.3 bits (146), Expect = 1e-09
 Identities = 40/183 (21%), Positives = 73/183 (39%), Gaps = 6/183 (3%)

Query: 711 LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS 770
           LR  R   +   T  +  +  +D+   +    K R  ++ + +    +  ++      V 
Sbjct: 118 LRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177

Query: 771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPK 830
                + L++      L+           AK +  L     IH ++ + N+L+      K
Sbjct: 178 EEEAPEDLYKDF----LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 233

Query: 831 VGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-G 889
           + D+GLAR +     YV     +  L +MAPE        T + DV+ FGVL+ E+ + G
Sbjct: 234 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPE-TIFDRVYTIQSDVWSFGVLLWEIFSLG 292

Query: 890 KRP 892
             P
Sbjct: 293 ASP 295

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 59.1 bits (142), Expect = 2e-09
 Identities = 33/188 (17%), Positives = 57/188 (30%), Gaps = 52/188 (27%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKL-------TVSSLVKSQEDFEREV---------KKL 741
           +G G FG V++T+  D  PVAIK +          S  K+ E+   E+            
Sbjct: 28  IGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86

Query: 742 GKVRHPNLVTLEGYY-----WTQSLQL-------------------------LIYEFVSG 771
              R    + L   +     +   L                           ++ EF  G
Sbjct: 87  VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146

Query: 772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS-NIIHYNIKSSNVLIDGSGEPK 830
           G   + +         S     +++     SLA    S    H ++   NVL+  +   K
Sbjct: 147 GIDLEQMRT----KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKK 202

Query: 831 VGDYGLAR 838
           +      +
Sbjct: 203 LHYTLNGK 210

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 57.4 bits (138), Expect = 7e-09
 Identities = 20/99 (20%), Positives = 37/99 (37%), Gaps = 1/99 (1%)

Query: 109 SNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSS 168
           + +       +L   +NL  + +        +     +  G LR +++ K+      P +
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 169 LSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDN 207
                 L+ +NLS N   S L        +L+ L LS N
Sbjct: 76  FHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 53.6 bits (128), Expect = 1e-07
 Identities = 24/96 (25%), Positives = 38/96 (39%), Gaps = 2/96 (2%)

Query: 455 SIPPEIGGAYSLKELRLERNFLAGKIPT-SIENCSSLVSLILSKNNLTGPIPIAIAKLTN 513
                + GA +L EL +E       +    +     L +L + K+ L    P A      
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 514 LQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQ 549
           L  ++LSFN+L   L  + V  + L    +S N L 
Sbjct: 82  LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 53.2 bits (127), Expect = 2e-07
 Identities = 20/117 (17%), Positives = 39/117 (33%), Gaps = 6/117 (5%)

Query: 70  KCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPN-LAKLQNLRV 128
            C P  +  +  T +G          L   + L +L + +      +    L  L  LR 
Sbjct: 4   ACCPHGSSGLRCTRDGAL---DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60

Query: 129 IDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRF 185
           + +  + L   +  + F     L  ++L+ N     +        +L  + LS N  
Sbjct: 61  LTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 19/101 (18%), Positives = 32/101 (31%), Gaps = 4/101 (3%)

Query: 159 NRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLG-IWGLSALRTLDLSDNLLEGEIPKGV 217
              +      L     L  + + + +    L L  + GL  LR L +  + L   +    
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75

Query: 218 -ESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSF 257
                 L  +NLS N    S+         L+ +  S N  
Sbjct: 76  FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.0 bits (116), Expect = 4e-06
 Identities = 23/86 (26%), Positives = 37/86 (43%), Gaps = 2/86 (2%)

Query: 392 ESLQFLDLSHNEFSGE-TPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSEN 450
           E+L  L + + +         +  L  L+ L + ++ L    P A      L+ L+LS N
Sbjct: 31  ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90

Query: 451 WLNGSIPPEIGGAYSLKELRLERNFL 476
            L  S+  +     SL+EL L  N L
Sbjct: 91  ALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 46.3 bits (109), Expect = 3e-05
 Identities = 16/103 (15%), Positives = 34/103 (33%), Gaps = 3/103 (2%)

Query: 276 LRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVP-ISIGNLQRLKVLNFSANRLTGSLP 334
            R           +   E+L  L +   +    +    +  L  L+ L    + L    P
Sbjct: 16  TRDGALD--SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73

Query: 335 DSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIR 377
           D+      L  L+ S N++     + +    L ++  + N + 
Sbjct: 74  DAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 41.6 bits (97), Expect = 8e-04
 Identities = 18/121 (14%), Positives = 34/121 (28%), Gaps = 28/121 (23%)

Query: 212 EIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSL- 270
           +    +   +NL  + +        +             D         L E ++ L++ 
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELR----------DLR------GLGE-LRNLTIV 64

Query: 271 -CNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRL 329
                 +  + F             L  L+LS N        ++  L  L+ L  S N L
Sbjct: 65  KSGLRFVAPDAFHF--------TPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115

Query: 330 T 330
            
Sbjct: 116 H 116

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.9 bits (139), Expect = 1e-08
 Identities = 77/562 (13%), Positives = 157/562 (27%), Gaps = 138/562 (24%)

Query: 346 LDFSQNSM---NGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHN 402
           +DF          D+   +F       +F    +++      +            ++ H 
Sbjct: 7   MDFETGEHQYQYKDILS-VFEDAFVD-NFDCKDVQDMPKSILSKE----------EIDH- 53

Query: 403 EFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPE-IG 461
                  A  G L     L   +  +V      + +     VL ++  +L   I  E   
Sbjct: 54  -IIMSKDAVSGTLRLFWTLLSKQEEMV---QKFVEE-----VLRINYKFLMSPIKTEQRQ 104

Query: 462 GAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPI-----AIAKLTNLQN 516
            +   +    +R+ L                 + +K N++   P      A+ +L   +N
Sbjct: 105 PSMMTRMYIEQRDRLYNDNQ------------VFAKYNVSRLQPYLKLRQALLELRPAKN 152

Query: 517 VDLSFNSLTG--GLPKQ-LVNLVHLSSFNISHNHLQGELPAGGFFNTI----SPSSVLGN 569
           V      + G  G  K  +   V   S+ +     Q ++    F+  +    SP +VL  
Sbjct: 153 V-----LIDGVLGSGKTWVALDV-CLSYKV-----QCKMDFKIFWLNLKNCNSPETVLEM 201

Query: 570 P-SLCGSAVNKSCPAV-LPKPIVLNPNSSSDSTTSSVAPNPRHKR--IIL---SISAIIA 622
              L                 I L  +S        +  +  ++   ++L     +    
Sbjct: 202 LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLK-SKPYENCLLVLLNVQNAKAWN 260

Query: 623 ---IGAAAVIV---IGVIAITVLNLRVRSSTSRSAAALTLSAGDD-FSRSPTTDANSGKL 675
              +    ++      V            S    +  LT         +           
Sbjct: 261 AFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPR 320

Query: 676 VMFSGDPDFSTGTHALLNKDCELGRGGFGAVYRTVLRDG-------RPVAIKKL--TVSS 726
            + + +P                            +RDG       + V   KL   + S
Sbjct: 321 EVLTTNP---------------RRLSIIAES----IRDGLATWDNWKHVNCDKLTTIIES 361

Query: 727 LVKSQEDFE-REV-KKLG----KVRHPNLVTLEGYYWTQS----LQLLIYEFVSGGSLHK 776
            +   E  E R++  +L         P  + L    W       + +++ +      + K
Sbjct: 362 SLNVLEPAEYRKMFDRLSVFPPSAHIP-TILLS-LIWFDVIKSDVMVVVNKLHKYSLVEK 419

Query: 777 HLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGL 836
              E +    +S    +  ++   ++   LH+S + HYNI  +    D            
Sbjct: 420 QPKEST----ISIPSIYLELKVKLENEYALHRSIVDHYNIPKT---FDSDDLIP------ 466

Query: 837 ARLLPMLDRYVLSSKIQSALGY 858
               P LD+Y       S +G+
Sbjct: 467 ----PYLDQY-----FYSHIGH 479

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 53.7 bits (128), Expect = 3e-07
 Identities = 91/597 (15%), Positives = 166/597 (27%), Gaps = 188/597 (31%)

Query: 41  VFKADIQDPNGK--LSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQ 98
            F  ++   N K  +S    +   P        S  +   IE   + L            
Sbjct: 81  KFVEEVLRINYKFLMSPIKTEQRQP--------SMMTRMYIE-QRDRLYNDN-------- 123

Query: 99  LQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAK 158
            Q   K ++S       +   L +L+  + + + G   SG       K    +  + +  
Sbjct: 124 -QVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG-------KTW--V-ALDVCL 172

Query: 159 N-----RFSGKI----------PSSL-----SLCSTLATINLSSNRFSSPLPLGI-WGLS 197
           +     +   KI          P ++      L   +     S +  SS + L I    +
Sbjct: 173 SYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQA 232

Query: 198 ALRTL----DLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFS 253
            LR L       + LL   +   V++ K     NLS              C +L T    
Sbjct: 233 ELRRLLKSKPYENCLL---VLLNVQNAKAWNAFNLS--------------CKILLT---- 271

Query: 254 ENSFSGNLPETMQKLSLCNFMN--LRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPI 311
                     T  K  + +F++     ++        +   E    L             
Sbjct: 272 ----------TRFK-QVTDFLSAATTTHISLDHHSMTLTPDEVKSLL------------- 307

Query: 312 SIGNLQRLKVLNFSANRLTGSLPDSMANC----MNLVA---------LDFSQNSMNGDLP 358
                  LK L+         LP  +       ++++A          D  ++     L 
Sbjct: 308 -------LKYLDCRP----QDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLT 356

Query: 359 QWIFSSGLNKVSFAENK--------IREGMNGPFA------SSGSSFESLQFLDLSHNE- 403
             I  S LN +  AE +             + P              + +  ++  H   
Sbjct: 357 T-IIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYS 415

Query: 404 --FSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALN--VLD---LSENW-LNGS 455
                   +TI  +  + L    +            +  AL+  ++D   + + +  +  
Sbjct: 416 LVEKQPKESTIS-IPSIYLELKVKLE----------NEYALHRSIVDHYNIPKTFDSDDL 464

Query: 456 IPPEIGG------AYSLKELRLER------------NFLAGKI---PTSIENCSSLVSLI 494
           IPP +         + LK +                 FL  KI    T+     S+++ +
Sbjct: 465 IPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTL 524

Query: 495 LSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGE 551
                    I     K   L N  L F      LPK   NL+     ++    L  E
Sbjct: 525 QQLKFYKPYICDNDPKYERLVNAILDF------LPKIEENLICSKYTDLLRIALMAE 575

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.4 bits (122), Expect = 1e-06
 Identities = 39/241 (16%), Positives = 72/241 (29%), Gaps = 77/241 (31%)

Query: 683 DFSTGTHALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLG 742
           DF TG H    KD              +L       +         K  +D  + +    
Sbjct: 8   DFETGEHQYQYKD--------------ILSVFEDAFVDNFD----CKDVQDMPKSILSKE 49

Query: 743 KVRH----PNLVTLEGYY---WT--QSLQLLIYEFVSGGSLHKHLHEGSGGNFL--SWNE 791
           ++ H     +   + G     WT     + ++ +FV    L  +        FL      
Sbjct: 50  EIDHIIMSKD--AVSGTLRLFWTLLSKQEEMVQKFV-EEVLRINY------KFLMSPIKT 100

Query: 792 RFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK 851
                Q +  +  ++ Q + ++            +       Y ++RL P L       K
Sbjct: 101 EQR--QPSMMTRMYIEQRDRLY------------NDNQVFAKYNVSRLQPYL-------K 139

Query: 852 IQSALGYMAPEFACRTVKITDKCDVY---GFG--VLVLEVVTGKRPLSTWKMMWWFSVTW 906
           ++ AL  + P        +     +    G G   + L+V    +     KM   F + W
Sbjct: 140 LRQALLELRPA-----KNVL----IDGVLGSGKTWVALDVCLSYKVQC--KMD--FKIFW 186

Query: 907 L 907
           L
Sbjct: 187 L 187

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 56.9 bits (136), Expect = 2e-08
 Identities = 30/206 (14%), Positives = 68/206 (33%), Gaps = 30/206 (14%)

Query: 41  VFKADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQ 100
           +F  DI     ++S   + D           SP  + +  L    +  T  +  G     
Sbjct: 144 LFWGDIDFEEQEISWIEQVD----------LSPVLDAMPLLNNLKIKGTNNLSIGKKPRP 193

Query: 101 FLRKLSLSSNNLTGSISPNLA--KLQNLRVIDLS--------GNSLSGSIPDEFFKQCGS 150
            L+ L + S  L  S+  ++    L NL  + L            ++   P     +  +
Sbjct: 194 NLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPN 253

Query: 151 LRVISLAKNRFSGKIPSSLS---LCSTLATINLSSNRFS----SPLPLGIWGLSALRTLD 203
           L+ + +        +        +   L T+++S+   +      L   +  +  L+ ++
Sbjct: 254 LKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFIN 313

Query: 204 LSDNLLEGEIPKGVESLKNLRVINLS 229
           +  N L  E     + L+    + + 
Sbjct: 314 MKYNYLSDE---MKKELQKSLPMKID 336

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 51.5 bits (122), Expect = 7e-07
 Identities = 29/195 (14%), Positives = 53/195 (27%), Gaps = 27/195 (13%)

Query: 366 LNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSR 425
              + F E +I        +    +   L  L +                  L+ L +  
Sbjct: 146 WGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKK---PRPNLKSLEIIS 202

Query: 426 N--SLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTS 483
                     +   DL  L  L L     +       G    +   R      +      
Sbjct: 203 GGLPDSVVEDILGSDLPNLEKLVLYVGVED------YGFDGDMNVFR---PLFSK----- 248

Query: 484 IENCSSLVSLILSKNNLTGPIPIAIAK---LTNLQNVDLSFNSLTGG----LPKQLVNLV 536
            +   +L  L +        +     +   L  L+ +D+S   LT      L   +  + 
Sbjct: 249 -DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIK 307

Query: 537 HLSSFNISHNHLQGE 551
           HL   N+ +N+L  E
Sbjct: 308 HLKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 51.1 bits (121), Expect = 9e-07
 Identities = 30/233 (12%), Positives = 66/233 (28%), Gaps = 31/233 (13%)

Query: 323 NFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGM-- 380
               + +   + ++     +   L +           WI    L+ V  A   +      
Sbjct: 121 GEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIK 180

Query: 381 -NGPFASSGSSFESLQFLDLSHNEFSGETPATIGA--LSGLQLLNLSRNSLVGPIPVAIG 437
                +       +L+ L++            I    L  L+ L L            + 
Sbjct: 181 GTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMN 240

Query: 438 DLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSI---ENCSSLVSLI 494
             + L          +    P      +LK L +        +       +    L ++ 
Sbjct: 241 VFRPL---------FSKDRFP------NLKWLGIVDAEEQNVVVEMFLESDILPQLETMD 285

Query: 495 LSKNNLTGPIPIAIA----KLTNLQNVDLSFNSLTGG----LPKQLVNLVHLS 539
           +S   LT      +     K+ +L+ +++ +N L+      L K L   + +S
Sbjct: 286 ISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVS 338

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 49.6 bits (117), Expect = 3e-06
 Identities = 30/186 (16%), Positives = 64/186 (34%), Gaps = 27/186 (14%)

Query: 163 GKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVES--L 220
             +   L     L  + +   + ++ L +G      L++L++    L   + + +    L
Sbjct: 162 VDLSPVLDAMPLLNNLKI---KGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218

Query: 221 KNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNL 280
            NL  + L   +        +     L         FS +    ++ L + +        
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPL---------FSKDRFPNLKWLGIVD------AE 263

Query: 281 FSGEVPKWIGE---LESLETLDLSGNKFS--GAVPI--SIGNLQRLKVLNFSANRLTGSL 333
               V +   E   L  LET+D+S    +  GA  +   +  ++ LK +N   N L+  +
Sbjct: 264 EQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEM 323

Query: 334 PDSMAN 339
              +  
Sbjct: 324 KKELQK 329

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 45.3 bits (106), Expect = 6e-05
 Identities = 21/192 (10%), Positives = 58/192 (30%), Gaps = 21/192 (10%)

Query: 237 IPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIG------ 290
           I +     +    + + +  F       ++++ L   ++    L + ++           
Sbjct: 131 IVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKK 190

Query: 291 ELESLETLDLSGNKFSGAVPISIG-----NLQRLKVLNFSANRLTGSLPDSMA------N 339
              +L++L++       +V   I      NL++L +     +       +          
Sbjct: 191 PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDR 250

Query: 340 CMNLVALDFSQNSMNGDLPQWIFSS----GLNKVSFAENKIREGMNGPFASSGSSFESLQ 395
             NL  L          + +    S     L  +  +   + +             + L+
Sbjct: 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLK 310

Query: 396 FLDLSHNEFSGE 407
           F+++ +N  S E
Sbjct: 311 FINMKYNYLSDE 322

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 56.3 bits (136), Expect = 3e-08
 Identities = 50/218 (22%), Positives = 97/218 (44%), Gaps = 46/218 (21%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFER----EVKKLGKVRH------ 746
           +G+G FG V +    +  + VA+K      +V++++ F R    E++ L  +R       
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALK------MVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 747 PNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF-----NVIQGTAK 801
            N++ +   +  ++   + +E      L  +L+E      +  N +F      +++  A 
Sbjct: 159 MNVIHMLENFTFRNHICMTFE-----LLSMNLYE-----LIKKN-KFQGFSLPLVRKFAH 207

Query: 802 ----SLAHLHQSNIIHYNIKSSNVLIDGSGEP--KVGDYGLARLLPMLDRYVLSSKIQSA 855
                L  LH++ IIH ++K  N+L+   G    KV D+G +      +   + + IQS 
Sbjct: 208 SILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQS- 262

Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL 893
             Y APE      +     D++  G ++ E++TG  PL
Sbjct: 263 RFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGY-PL 298

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 56.1 bits (135), Expect = 4e-08
 Identities = 50/332 (15%), Positives = 102/332 (30%), Gaps = 43/332 (12%)

Query: 226 INLSKNMFSGSIPDGI----GSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRK--- 278
            NL    + G +   +     +   L+++ F     S      + +L+     +L     
Sbjct: 89  FNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVS---DLDLDRLAKARADDLETLKL 145

Query: 279 ---NLFSGEVPKWIGE-LESLETLDLSGNKFSGAVPISIG----NLQRLKVLNFSANRLT 330
              + F+ +    I      ++TL +  + FS      +     +   L+VLNF      
Sbjct: 146 DKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFA 205

Query: 331 G----SLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFAS 386
                 L     NC +LV++      +   +  +  ++ L    F    + E +  P   
Sbjct: 206 KISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANL--EEFCGGSLNEDIGMPEKY 263

Query: 387 SGSSFESLQFLDLSHNEFSGETPATIGAL-SGLQLLNLSRNSLVGPIPV-AIGDLKALNV 444
               F   +   L  +         +    + ++ L+L    L        I     L V
Sbjct: 264 MNLVF-PRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEV 322

Query: 445 LDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSI------------ENCSSLVS 492
           L+      +  +         LK LR+ER      +                + C  L  
Sbjct: 323 LETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEY 382

Query: 493 LILSKNNLTGPIPIAIAK----LTNLQNVDLS 520
           + +  +++T     +I      L + + V L 
Sbjct: 383 MAVYVSDITNESLESIGTYLKNLCDFRLVLLD 414

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 53.8 bits (129), Expect = 2e-07
 Identities = 46/334 (13%), Positives = 94/334 (28%), Gaps = 56/334 (16%)

Query: 80  ELTLNGLSLTGRIGRGLLQLQFLRKLSLSS-NNLTGSISPNLAKL-QNLRVIDLSGNSLS 137
           E     L+    +    + L F RKL     + +  +  P L      +R +DL    L 
Sbjct: 247 EFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLE 306

Query: 138 GSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLS 197
                   ++C +L V+          +      C  L  + +        +      +S
Sbjct: 307 TEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVS 366

Query: 198 ------------ALRTLDLSDNLLEGE----IPKGVESLKNLRVINLSKNMFSGSIP--D 239
                        L  + +  + +  E    I   +++L + R++ L +      +P  +
Sbjct: 367 QRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDN 426

Query: 240 GIG----SCSLLRTIDFSENSFS---------GNLPETMQKLSLCN-------FMNLRKN 279
           G+      C  LR   F               G     ++ + L          M   + 
Sbjct: 427 GVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRG 486

Query: 280 LFSGEVPKWIGELESLETLDLSGNKFSGAVPISI-GNLQRLKVLNFSANRLTGSLPDSMA 338
                         +L+ L++ G  FS     +    L  L+ L     R + +  D M 
Sbjct: 487 ------------CPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQ 534

Query: 339 ---NCMNLVALDFSQNSMNGDLPQWIFSSGLNKV 369
                 N+  +   +        +         +
Sbjct: 535 MARPYWNIELIPSRRVPEVNQQGEIREMEHPAHI 568

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 53.0 bits (127), Expect = 3e-07
 Identities = 48/382 (12%), Positives = 107/382 (28%), Gaps = 61/382 (15%)

Query: 102 LRKLSLSSNNLT-------GSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVI 154
           ++ L +  ++ +         ++ +   L+ L         +S    +   + C SL  +
Sbjct: 166 IKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSV 225

Query: 155 SLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSD--NLLEGE 212
            +       ++       + L      S      +P     L   R L       +   E
Sbjct: 226 KVGDFEIL-ELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE 284

Query: 213 IPKGVESLKNLRVINLSK-NMFSGSIPDGIGSCSLLRTIDFSEN-------SFSGNLPET 264
           +P        +R ++L    + +      I  C  L  ++             +    + 
Sbjct: 285 MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQ- 343

Query: 265 MQKLSLCNFMNLRKNLFSGEVPKWIGELE------SLETLDLSGNKFSGAVPISIG---- 314
           +++L +    + +       +    G +        LE + +  +  +     SIG    
Sbjct: 344 LKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLK 403

Query: 315 NLQRLKVLNFSA-NRLTGSLPDSM-----ANCMNLVALDFSQNSMNGDLPQWIFSSGLNK 368
           NL   +++      R+T    D+        C  L    F            +   GL+ 
Sbjct: 404 NLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQ------GGLTDLGLSY 457

Query: 369 VSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGA-LSGLQLLNLSRNS 427
           +                  G    +++++ L +   S E           LQ L +    
Sbjct: 458 I------------------GQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCC 499

Query: 428 LVGPIPVAIGD-LKALNVLDLS 448
                  A    L +L  L + 
Sbjct: 500 FSERAIAAAVTKLPSLRYLWVQ 521

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 27/109 (24%), Positives = 48/109 (44%), Gaps = 8/109 (7%)

Query: 127 RVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSL--SLCSTLATINLSSNR 184
             + L+ N L     D  F +   L  + L +N+ +  I  +      S +  + L  N+
Sbjct: 32  TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGA-SHIQELQLGENK 89

Query: 185 FSSPLPLGIW-GLSALRTLDLSDNLLEGEIPKGV-ESLKNLRVINLSKN 231
               +   ++ GL  L+TL+L DN +   +  G  E L +L  +NL+ N
Sbjct: 90  IKE-ISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 33/108 (30%), Positives = 49/108 (45%), Gaps = 8/108 (7%)

Query: 80  ELTLNGLSLTGRIGRGLL-QLQFLRKLSLSSNNLTGSISPNL-AKLQNLRVIDLSGNSLS 137
           EL LN   L      GL  +L  L KL L  N LT  I PN      +++ + L  N + 
Sbjct: 33  ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91

Query: 138 GSIPDEFFKQCGSLRVISLAKNRFSGKIPSSL--SLCSTLATINLSSN 183
             I ++ F     L+ ++L  N+ S  +       L S L ++NL+SN
Sbjct: 92  -EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNS-LTSLNLASN 136

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 51.6 bits (124), Expect = 6e-07
 Identities = 47/314 (14%), Positives = 97/314 (30%), Gaps = 72/314 (22%)

Query: 150 SLRVISLAKNRFSGKIPSSL-----SLCSTLATINLSSNRFSSPLPLGIW----GLSALR 200
           SLR ++LA  R +    + +     S    L  +NL+S +     P G+          R
Sbjct: 73  SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLD---PAGLRTLLPVFLRAR 129

Query: 201 TLDLSDNLLEGEIPKGVESL--------KNLRVINLSKNMFSGS----IPDGIGSCSLLR 248
            L L  N L    P+  + L          +  + LS N  + +    + +G+   + + 
Sbjct: 130 KLGLQLNSLG---PEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVT 186

Query: 249 TIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKF--S 306
            +            E ++ L+      L +N               L+ L+++ N    +
Sbjct: 187 HLSLLHTGLG---DEGLELLAAQ----LDRN-------------RQLQELNVAYNGAGDT 226

Query: 307 GAVPIS--IGNLQRLKVLNFSANRLTGS----LPDSMANCMNLVALD--FSQNSMNGDLP 358
            A+ ++        L++L+   N L+      L D          +    ++ +   +  
Sbjct: 227 AALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYW 286

Query: 359 QWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGAL--- 415
             I S     ++  +            +       L   DL  +  +   P     L   
Sbjct: 287 SVILSEVQRNLNSWDR-----------ARVQRHLELLLRDLEDSRGATLNPWRKAQLLRV 335

Query: 416 -SGLQLLNLSRNSL 428
              ++ L     S 
Sbjct: 336 EGEVRALLEQLGSS 349

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 42/133 (31%), Positives = 59/133 (44%), Gaps = 11/133 (8%)

Query: 395 QFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGD-LKALNVLDLSENWLN 453
           Q L L  N+ +   P    +L  L+ L L  N L   +PV + D L  L VLDL  N L 
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLT 101

Query: 454 GSIPPEIGGAY----SLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIA 509
             +P      +     LKEL +  N L  ++P  IE  + L  L L +N L      A  
Sbjct: 102 -VLPS---AVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFD 156

Query: 510 KLTNLQNVDLSFN 522
           +L++L +  L  N
Sbjct: 157 RLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 31/117 (26%), Positives = 59/117 (50%), Gaps = 9/117 (7%)

Query: 127 RVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSL--SLCSTLATINLSSNR 184
           +++ L  N ++  +    F    +L+ + L  N+    +P  +  SL + L  ++L +N+
Sbjct: 43  QILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSL-TQLTVLDLGTNQ 99

Query: 185 FSSPLPLGIWG-LSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDG 240
            +  LP  ++  L  L+ L +  N L  E+P+G+E L +L  + L +N    SIP G
Sbjct: 100 LTV-LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHG 153

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 40.8 bits (96), Expect = 8e-04
 Identities = 23/81 (28%), Positives = 32/81 (39%), Gaps = 13/81 (16%)

Query: 480 IPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLT---GGLPKQLVNLV 536
           IPT+ +       L L  N +T   P     L NL+ + L  N L     G+   L  L 
Sbjct: 38  IPTNAQI------LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT 91

Query: 537 HLSSFNISHNHLQGELPAGGF 557
            L   ++  N L   LP+  F
Sbjct: 92  VL---DLGTNQLT-VLPSAVF 108

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 47.3 bits (113), Expect = 9e-06
 Identities = 50/182 (27%), Positives = 78/182 (42%), Gaps = 23/182 (12%)

Query: 385 ASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIG---DLKA 441
           A + +   S+  +  ++++        I  L  ++ L L  N L       I    +L  
Sbjct: 34  AVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLH-----DISALKELTN 86

Query: 442 LNVLDLSENWLNGSIPPEI-GGAYSLKELRLERNFLAGKIPTSI-ENCSSLVSLILSKNN 499
           L  L L+ N L  S+P  +     +LKEL L  N L   +P  + +  ++L  L L+ N 
Sbjct: 87  LTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQ 144

Query: 500 LTGPIPIAIAKLTNLQNVDLSFNSLTGGLPK----QLVNLVHLSSFNISHNHLQGELPAG 555
           L         KLTNL  +DLS+N L   LP+    +L  L  L    +  N L+  +P G
Sbjct: 145 LQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLR---LYQNQLKS-VPDG 199

Query: 556 GF 557
            F
Sbjct: 200 VF 201

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 38/143 (26%), Positives = 59/143 (41%), Gaps = 19/143 (13%)

Query: 421 LNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKI 480
            NL + S+          L +++ +  + + +       I    +++ L L  N L    
Sbjct: 24  ANLKKKSVTD-AVTQNE-LNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKL---- 75

Query: 481 PTSIENCSSLVS---LILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLT---GGLPKQLVN 534
              I     L +   LIL+ N L         KLTNL+ + L  N L     G+  +L N
Sbjct: 76  -HDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTN 134

Query: 535 LVHLSSFNISHNHLQGELPAGGF 557
           L +L   N++HN LQ  LP G F
Sbjct: 135 LTYL---NLAHNQLQ-SLPKGVF 153

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 48/223 (21%), Positives = 91/223 (40%), Gaps = 54/223 (24%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFER----EVKKLGKVRHP----- 747
           +G+G FG V +     +   VAIK      ++K+++ F      EV+ L  +        
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIK------IIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 748 -NLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNER----FNVIQGTAK- 801
             +V L+ ++  ++   L++E      L  +L++      L          N+ +  A+ 
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFE-----MLSYNLYD-----LLRNTNFRGVSLNLTRKFAQQ 165

Query: 802 ---SLAHLHQS--NIIHYNIKSSNVLIDGSGEP--KVGDYGLARLLPMLDRYVLSSKIQS 854
              +L  L     +IIH ++K  N+L+        K+ D+G +          +   IQS
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQS 221

Query: 855 ALGYMAPEFACRTV----KITDKCDVYGFGVLVLEVVTGKRPL 893
              Y +PE     V          D++  G +++E+ TG+ PL
Sbjct: 222 RF-YRSPE-----VLLGMPYDLAIDMWSLGCILVEMHTGE-PL 257

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 43.8 bits (104), Expect = 7e-05
 Identities = 29/129 (22%), Positives = 44/129 (34%), Gaps = 35/129 (27%)

Query: 64  CNWFGVKCS-----------PRSNRVIELTLNGLSLTGRIGRGLLQLQF----------- 101
           C    V+CS           PR    + L  N  +L  +       L             
Sbjct: 10  CLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTL 69

Query: 102 ----------LRKLSLSSNNLTGSISPNL-AKLQNLRVIDLSGNSLSGSIPDEFFKQCGS 150
                     L  L LS N L   I P     L++LR++ L GN +S  +P+  F    +
Sbjct: 70  SNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSA 127

Query: 151 LRVISLAKN 159
           L  +++  N
Sbjct: 128 LSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 20/82 (24%), Positives = 34/82 (41%), Gaps = 16/82 (19%)

Query: 480 IPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPK----QLVNL 535
           IP  +        L L  N  T  +P  ++   +L  +DLS N ++  L       +  L
Sbjct: 29  IPRDVTE------LYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80

Query: 536 VHLSSFNISHNHLQGELPAGGF 557
           + L    +S+N L+  +P   F
Sbjct: 81  LTL---ILSYNRLR-CIPPRTF 98

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 44.7 bits (106), Expect = 9e-05
 Identities = 32/166 (19%), Positives = 54/166 (32%), Gaps = 34/166 (20%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREV-KKLGKVRHPNLVTLEGY 755
           +G GGFG +Y           A   + V          E +  +++ K         +  
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK----KWI 100

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFL-------------SWNERFNVIQGTAKS 802
              Q   L I  F   G       +G    F+               N  F     T   
Sbjct: 101 ERKQLDYLGIPLFYGSGL---TEFKGRSYRFMVMERLGIDLQKISGQNGTFKK--STVLQ 155

Query: 803 LA--------HLHQSNIIHYNIKSSNVLIDGSGEPKV--GDYGLAR 838
           L         ++H++  +H +IK++N+L+      +V   DYGL+ 
Sbjct: 156 LGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 33/179 (18%), Positives = 59/179 (32%), Gaps = 57/179 (31%)

Query: 698 LGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW 757
           +G+GGFG +Y   +     V                    V K+    +  L T   +Y 
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSD--------------APCVVKVEPSDNGPLFTELKFYQ 88

Query: 758 TQSLQLLIYEFVSGGSLHKH---------LHEGSGGNFLSWNERFNVIQGTAKSLAHL-- 806
             +    I +++    L            LH+ +G ++     RF ++      L  +  
Sbjct: 89  RAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSY-----RFMIMDRFGSDLQKIYE 143

Query: 807 -------------------------HQSNIIHYNIKSSNVLIDGSGEPKV--GDYGLAR 838
                                    H+   +H +IK+SN+L++     +V   DYGLA 
Sbjct: 144 ANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 43.2 bits (102), Expect = 3e-04
 Identities = 33/175 (18%), Positives = 54/175 (30%), Gaps = 49/175 (28%)

Query: 698 LGRGGFGAVY---------RTVLRDGRPVAIK-KLTVSSLVKSQEDFEREVK-------- 739
             R   G +Y                +  ++K       L   Q  F+R  K        
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 740 KLGKVRHPNLVTLEGYYWTQS------LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERF 793
           KL       + T  G+   Q       L  L      G SL     + S  + LS     
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL------GRSLQS-ALDVSPKHVLS----- 157

Query: 794 NVIQGTAKSLA--------HLHQSNIIHYNIKSSNVLIDGSGEPKV--GDYGLAR 838
              + +   +A         LH++  +H N+ + N+ +D   + +V    YG A 
Sbjct: 158 ---ERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 41.6 bits (98), Expect = 7e-04
 Identities = 37/149 (24%), Positives = 59/149 (39%), Gaps = 17/149 (11%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREV-KKLGKVRH-PNLVTL-- 752
           +G G FG +Y    +  G  VAIK   V +    Q   E ++ K +      P +     
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGA 75

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           EG Y    ++LL      G SL + L       F S      +       + ++H  N I
Sbjct: 76  EGDYNVMVMELL------GPSL-EDLFNFCSRKF-SLKTVLLLADQMISRIEYIHSKNFI 127

Query: 813 HYNIKSSNVLIDGSGEPK---VGDYGLAR 838
           H ++K  N L+    +     + D+GLA+
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 41.6 bits (98), Expect = 8e-04
 Identities = 38/163 (23%), Positives = 56/163 (34%), Gaps = 43/163 (26%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKL--GKVRHPNLVTL-- 752
           +G G FG +     L     VAIK   + S    Q   E    K        P +     
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGP 75

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKS---LA----- 804
            G Y    L+LL      G SL + L +     F            + K+   +A     
Sbjct: 76  CGKYNAMVLELL------GPSL-EDLFDLCDRTF------------SLKTVLMIAIQLIS 116

Query: 805 ---HLHQSNIIHYNIKSSNVLIDGSGEPKVG------DYGLAR 838
              ++H  N+I+ ++K  N LI G    K        D+ LA+
Sbjct: 117 RMEYVHSKNLIYRDVKPENFLI-GRPGNKTQQVIHIIDFALAK 158

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	936
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.98
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.93
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.92
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.92
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.91
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.91
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.91
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.91
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.91
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.91
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.9
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.9
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.9
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.89
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.89
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.89
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.89
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.88
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.88
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.88
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.88
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.88
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.86
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.84
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.84
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.84
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.83
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.83
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.82
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.82
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.81
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.81
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.81
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.81
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.81
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.81
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.8
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.8
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.79
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.78
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.78
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.76
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.76
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.76
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.76
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.74
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.74
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.73
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.7
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.68
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.68
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.67
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.67
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.66
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.65
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.65
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.65
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.64
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.64
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.63
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.62
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.59
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.58
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.57
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.57
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.55
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.51
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.47
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.47
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.44
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.4
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.38
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.38
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.32
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.3
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.28
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.17
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.12
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.07
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.05
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.03
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.99
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.98
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.93
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.9
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.57
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.52
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.47
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.44
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.33
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.33
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.24
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.15
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.08
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.95
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.91
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.77
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.71
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.57
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.52
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.34
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.26
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.21
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.14
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.13
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.12
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.08
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.99
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.92
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.81
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.77
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.56
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.46
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	95.88
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.41
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.9
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	92.04
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	89.57
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.61
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	84.32
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	80.67

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.9e-77  Score=735.45  Aligned_cols=544  Identities=33%  Similarity=0.566  Sum_probs=448.8

Q ss_pred             CChhHHHHHHHHHHhccCCCCCCCCCCCCCCCCccceeEEecCCCCceEEeccCCCCCCcc---cc--------------
Q 002321           31 SLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSLTGR---IG--------------   93 (936)
Q Consensus        31 ~~~~~~~aLl~~k~~~~d~~~~l~sW~~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~---~~--------------   93 (936)
                      +.++|++||++||+++.||. .+++|+.+++ ||.|.||+|+  +++|+.|+|+++++.|.   +|              
T Consensus         9 ~~~~~~~all~~k~~~~~~~-~l~~W~~~~~-~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~   84 (768)
T 3rgz_A            9 SLYREIHQLISFKDVLPDKN-LLPDWSSNKN-PCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFL   84 (768)
T ss_dssp             CHHHHHHHHHHHHTTCSCTT-SSTTCCTTSC-GGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEEC
T ss_pred             CCHHHHHHHHHHHhhCCCcc-cccCCCCCCC-CcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcccccCC
Confidence            45789999999999999998 8999986655 9999999999  59999999999999887   44              


Q ss_pred             ---------cccccCccccEEeccCCcccCcCCC--chhhcCCCcEEEccCcccccccchhhh-----------------
Q 002321           94 ---------RGLLQLQFLRKLSLSSNNLTGSISP--NLAKLQNLRVIDLSGNSLSGSIPDEFF-----------------  145 (936)
Q Consensus        94 ---------~~l~~l~~L~~L~L~~n~l~~~~~~--~l~~l~~L~~L~Ls~N~l~~~i~~~~f-----------------  145 (936)
                               +.++++++|++|+|++|+++|.+|.  .++++++|++|||++|++++.+|...+                 
T Consensus        85 ~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~  164 (768)
T 3rgz_A           85 SNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSIS  164 (768)
T ss_dssp             TTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCE
T ss_pred             cCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccC
Confidence                     4677888999999999999988887  888888888888888887766665432                 


Q ss_pred             --------------------------------hcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCC
Q 002321          146 --------------------------------KQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGI  193 (936)
Q Consensus       146 --------------------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~  193 (936)
                                                      ..+++|++|+|++|++++.+|. ++.+++|++|+|++|++++.+|..+
T Consensus       165 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l  243 (768)
T 3rgz_A          165 GANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAI  243 (768)
T ss_dssp             EETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHT
T ss_pred             CcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHH
Confidence                                            2344555555556666655555 7778888888888888887777777


Q ss_pred             CCCCCCCEEecCCCCCC----------------------CCCccCccCC-CCcceeecccccccccCCcccccccCccee
Q 002321          194 WGLSALRTLDLSDNLLE----------------------GEIPKGVESL-KNLRVINLSKNMFSGSIPDGIGSCSLLRTI  250 (936)
Q Consensus       194 ~~l~~L~~L~L~~N~l~----------------------~~~~~~~~~l-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  250 (936)
                      .++++|++|+|++|.++                      +.+|..+..+ ++|++|+|++|++++.+|..|+.+++|++|
T Consensus       244 ~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L  323 (768)
T 3rgz_A          244 STCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESL  323 (768)
T ss_dssp             TTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEE
T ss_pred             hcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEE
Confidence            77766666666666554                      3556666554 888888888888888888888888888888


Q ss_pred             eccccccCCCCchh-hhccccccEEeccCccccCCCCcccccCC---------------------------ccceecccC
Q 002321          251 DFSENSFSGNLPET-MQKLSLCNFMNLRKNLFSGEVPKWIGELE---------------------------SLETLDLSG  302 (936)
Q Consensus       251 ~Ls~N~l~~~~~~~-l~~l~~L~~L~L~~N~l~~~~~~~~~~l~---------------------------~L~~L~L~~  302 (936)
                      +|++|++++.+|.. +..+++|+.|+|++|.+++.+|..+..++                           +|++|++++
T Consensus       324 ~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~  403 (768)
T 3rgz_A          324 ALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQN  403 (768)
T ss_dssp             ECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCS
T ss_pred             ECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCC
Confidence            88888888777755 77788888888888887777776665544                           455555555


Q ss_pred             ceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhc-cCCccccccccccccCCC
Q 002321          303 NKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFS-SGLNKVSFAENKIREGMN  381 (936)
Q Consensus       303 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~l~~n~l~~~~~  381 (936)
                      |++++.+|..+.++++|++|+|++|++++.+|..+..+++|+.|++++|.+.+.+|..+.. ..++.|++.+|.+..   
T Consensus       404 n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~---  480 (768)
T 3rgz_A          404 NGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTG---  480 (768)
T ss_dssp             SEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCS---
T ss_pred             CccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccC---
Confidence            5555566666777777777777777777777777777777777777777777777765543 577888888887763   


Q ss_pred             CCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCC--
Q 002321          382 GPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPE--  459 (936)
Q Consensus       382 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~--  459 (936)
                       .+|..+..+++|++|+|++|++++.+|..++.+++|++|+|++|++++.+|..++.+++|++|+|++|+++|.+|..  
T Consensus       481 -~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~  559 (768)
T 3rgz_A          481 -EIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMF  559 (768)
T ss_dssp             -CCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGG
T ss_pred             -cCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHh
Confidence             45566778899999999999999999999999999999999999999999999999999999999999988776643  


Q ss_pred             --------------------------------------------------------------------CCCcCCCcEEEe
Q 002321          460 --------------------------------------------------------------------IGGAYSLKELRL  471 (936)
Q Consensus       460 --------------------------------------------------------------------~~~l~~L~~L~L  471 (936)
                                                                                          ++.+++|+.|+|
T Consensus       560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdL  639 (768)
T 3rgz_A          560 KQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDM  639 (768)
T ss_dssp             TTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEEC
T ss_pred             cccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEEC
Confidence                                                                                344678999999


Q ss_pred             cCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCccccc
Q 002321          472 ERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGE  551 (936)
Q Consensus       472 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~  551 (936)
                      ++|+++|.+|.+++++++|+.|+|++|+++|.+|..++++++|++|||++|+++|.+|..+.++++|++|||++|+++|.
T Consensus       640 s~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~  719 (768)
T 3rgz_A          640 SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGP  719 (768)
T ss_dssp             CSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEE
T ss_pred             cCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCccCcCCCccccCCCCCCCCCCCCCCCCC
Q 002321          552 LPAGGFFNTISPSSVLGNPSLCGSAVNKSCPAV  584 (936)
Q Consensus       552 ~p~~~~~~~~~~~~~~gn~~~c~~~~~~~~~~~  584 (936)
                      ||.+++|.+++..+|.|||++||.|+. .|...
T Consensus       720 iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~~  751 (768)
T 3rgz_A          720 IPEMGQFETFPPAKFLNNPGLCGYPLP-RCDPS  751 (768)
T ss_dssp             CCSSSSGGGSCGGGGCSCTEEESTTSC-CCCSC
T ss_pred             CCCchhhccCCHHHhcCCchhcCCCCc-CCCCC
Confidence            999999999999999999999999986 78544

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=2.2e-60  Score=570.51  Aligned_cols=482  Identities=20%  Similarity=0.264  Sum_probs=353.5

Q ss_pred             hhHHHHHHHHHHhccCC-CC-------CCCCCCCCCCCCccc---eeEEecCCCCceEEeccCCCCCCcccccccccCcc
Q 002321           33 NDDVLGLIVFKADIQDP-NG-------KLSSWSEDDDTPCNW---FGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQF  101 (936)
Q Consensus        33 ~~~~~aLl~~k~~~~d~-~~-------~l~sW~~~~~~~c~w---~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~  101 (936)
                      ..|++||.+|++++.++ ..       ...+|+.+.+ ||.|   .||+|+.. +||++|+|++++++|.+|+++++|++
T Consensus        29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~-~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~~  106 (636)
T 4eco_A           29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKE-LDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLTE  106 (636)
T ss_dssp             HHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSC-GGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCTT
T ss_pred             HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCC-cccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCcc
Confidence            46999999999998755 22       2348998766 9999   99999876 99999999999999999999999999


Q ss_pred             ccEEeccCCcc------cC------cCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEcc------------
Q 002321          102 LRKLSLSSNNL------TG------SISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLA------------  157 (936)
Q Consensus       102 L~~L~L~~n~l------~~------~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~------------  157 (936)
                      |++|+|++|++      .+      .+|...  +.+|+ +++++|.+.+.+|..+...+.++..+++.            
T Consensus       107 L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l  183 (636)
T 4eco_A          107 LEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL  183 (636)
T ss_dssp             CCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCC
T ss_pred             ceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccch
Confidence            99999999987      33      344444  66778 89999998887776554333333333333            


Q ss_pred             --------CccCCCCCCCCccccccccccccccccccCC-----------------CCCCCC--CCCCCCEEecCCCCCC
Q 002321          158 --------KNRFSGKIPSSLSLCSTLATINLSSNRFSSP-----------------LPLGIW--GLSALRTLDLSDNLLE  210 (936)
Q Consensus       158 --------~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----------------~~~~~~--~l~~L~~L~L~~N~l~  210 (936)
                              +|++++ +|..|+++++|++|+|++|+|++.                 +|..++  ++++|++|+|++|++.
T Consensus       184 ~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~  262 (636)
T 4eco_A          184 KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNL  262 (636)
T ss_dssp             CTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTC
T ss_pred             hhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCC
Confidence                    456666 666666666666666666666664                 666666  6666666666666666


Q ss_pred             CCCccCccCCCCcceeeccccc-ccc-cCCcccccc------cCcceeeccccccCCCCch--hhhccccccEEeccCcc
Q 002321          211 GEIPKGVESLKNLRVINLSKNM-FSG-SIPDGIGSC------SLLRTIDFSENSFSGNLPE--TMQKLSLCNFMNLRKNL  280 (936)
Q Consensus       211 ~~~~~~~~~l~~L~~L~L~~N~-l~~-~~p~~l~~l------~~L~~L~Ls~N~l~~~~~~--~l~~l~~L~~L~L~~N~  280 (936)
                      +.+|..|.++++|++|+|++|+ +++ .+|..++.+      ++|++|+|++|+++ .+|.  .+..+++|+.|+|++|.
T Consensus       263 ~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~  341 (636)
T 4eco_A          263 TKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQ  341 (636)
T ss_dssp             SSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCC
T ss_pred             ccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCc
Confidence            6666666666666666666666 665 566666554      66666666666666 5555  66666666666666666


Q ss_pred             ccCCCCcccccCCccceecccCceeccccCcccccccc-cceEEccCCcccccCChhhhccC--CCCEEEccCCcCccCC
Q 002321          281 FSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQR-LKVLNFSANRLTGSLPDSMANCM--NLVALDFSQNSMNGDL  357 (936)
Q Consensus       281 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~-L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~  357 (936)
                      ++|.+| .++.+++|++|+|++|+++ .+|..+.++++ |++|++++|+++ .+|..+..+.  +|+.|++++|.+.+.+
T Consensus       342 l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~  418 (636)
T 4eco_A          342 LEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVD  418 (636)
T ss_dssp             CEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTT
T ss_pred             Cccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcc
Confidence            666666 6666666666666666666 55666666666 666666666666 5555555443  6666666666666555


Q ss_pred             ChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCc-cc
Q 002321          358 PQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPV-AI  436 (936)
Q Consensus       358 p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~  436 (936)
                      |..+..                    .......+++|++|+|++|++++..+..+..+++|++|+|++|+++ .+|. .+
T Consensus       419 p~~l~~--------------------~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~  477 (636)
T 4eco_A          419 GKNFDP--------------------LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSL  477 (636)
T ss_dssp             TCSSCT--------------------TCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSS
T ss_pred             hhhhcc--------------------cccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHh
Confidence            433210                    0011114668999999999998666666777899999999999998 4554 33


Q ss_pred             cCc-------ccCCeeecCCccccccCCCCCC--CcCCCcEEEecCCccCCcCccccccccccccccc------cCcccc
Q 002321          437 GDL-------KALNVLDLSENWLNGSIPPEIG--GAYSLKELRLERNFLAGKIPTSIENCSSLVSLIL------SKNNLT  501 (936)
Q Consensus       437 ~~l-------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L------~~N~l~  501 (936)
                      ...       ++|++|+|++|+++ .+|..+.  .+++|+.|+|++|+|++ +|..+.++++|++|+|      ++|++.
T Consensus       478 ~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~  555 (636)
T 4eco_A          478 KDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTL  555 (636)
T ss_dssp             EETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCC
T ss_pred             ccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCccc
Confidence            333       38999999999998 6787776  89999999999999996 8999999999999999      567888


Q ss_pred             CCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCcccc
Q 002321          502 GPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQG  550 (936)
Q Consensus       502 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~  550 (936)
                      +.+|..+..+++|++|+|++|+| +.+|..+.  ++|+.|+|++|++..
T Consensus       556 ~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~  601 (636)
T 4eco_A          556 REWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNIS  601 (636)
T ss_dssp             CCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCE
T ss_pred             ccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCcc
Confidence            89999999999999999999999 58888766  799999999998875

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=5.5e-59  Score=571.61  Aligned_cols=466  Identities=33%  Similarity=0.500  Sum_probs=413.4

Q ss_pred             CceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEE
Q 002321           76 NRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVIS  155 (936)
Q Consensus        76 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~  155 (936)
                      ..++.|+|+++.+++.+|. ++++++|++|+|++|++++.+|..|.++++|++|+|++|++++.+|..   .+++|++|+
T Consensus       200 ~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~---~l~~L~~L~  275 (768)
T 3rgz_A          200 VNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL---PLKSLQYLS  275 (768)
T ss_dssp             TTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC---CCTTCCEEE
T ss_pred             CcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc---ccCCCCEEE
Confidence            5677888888888887776 888888888888888888888888888888888888888888777753   788888888


Q ss_pred             ccCccCCCCCCCCcccc-ccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccC-ccCCCCcceeecccccc
Q 002321          156 LAKNRFSGKIPSSLSLC-STLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKG-VESLKNLRVINLSKNMF  233 (936)
Q Consensus       156 L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l  233 (936)
                      |++|++++.+|..+... ++|++|+|++|++++.+|..|.++++|++|+|++|.+++.+|.. +.++++|++|+|++|++
T Consensus       276 L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l  355 (768)
T 3rgz_A          276 LAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEF  355 (768)
T ss_dssp             CCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEE
T ss_pred             CcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCcc
Confidence            88888888888888765 88999999999998888888889999999999999988777765 88889999999999999


Q ss_pred             cccCCccccccc-CcceeeccccccCCCCchhhhc--cccccEEeccCccccCCCCcccccCCccceecccCceeccccC
Q 002321          234 SGSIPDGIGSCS-LLRTIDFSENSFSGNLPETMQK--LSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVP  310 (936)
Q Consensus       234 ~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~~~l~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  310 (936)
                      ++.+|..+..++ +|++|++++|++++.+|..+..  +++|+.|++++|.+++.+|..++.+++|++|+|++|++++.+|
T Consensus       356 ~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p  435 (768)
T 3rgz_A          356 SGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP  435 (768)
T ss_dssp             EECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCC
T ss_pred             CccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCccc
Confidence            888888888887 8999999999988888887776  7889999999999999999999999999999999999999999


Q ss_pred             cccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhc-cCCccccccccccccCCCCCCCCCCC
Q 002321          311 ISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFS-SGLNKVSFAENKIREGMNGPFASSGS  389 (936)
Q Consensus       311 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-~~l~~l~l~~n~l~~~~~~~~~~~~~  389 (936)
                      ..+.++++|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|..+.. ..++.|++.+|++..    .+|..++
T Consensus       436 ~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~----~~p~~~~  511 (768)
T 3rgz_A          436 SSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTG----EIPKWIG  511 (768)
T ss_dssp             GGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCS----CCCGGGG
T ss_pred             HHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCC----cCChHHh
Confidence            99999999999999999999999999999999999999999999988876654 689999999999863    4566677


Q ss_pred             CCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccc---------------------------------
Q 002321          390 SFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAI---------------------------------  436 (936)
Q Consensus       390 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---------------------------------  436 (936)
                      .+++|++|+|++|++++.+|..++.+++|++|+|++|+++|.+|..+                                 
T Consensus       512 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (768)
T 3rgz_A          512 RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAG  591 (768)
T ss_dssp             GCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSE
T ss_pred             cCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccc
Confidence            89999999999999999999999999999999999999987777543                                 


Q ss_pred             -------------------------------------cCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCc
Q 002321          437 -------------------------------------GDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGK  479 (936)
Q Consensus       437 -------------------------------------~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  479 (936)
                                                           +.+++|++|||++|+++|.+|..++.+++|+.|+|++|+++|.
T Consensus       592 ~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~  671 (768)
T 3rgz_A          592 NLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGS  671 (768)
T ss_dssp             EEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSC
T ss_pred             cccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCC
Confidence                                                 3457899999999999999999999999999999999999999


Q ss_pred             CccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCc-ccc
Q 002321          480 IPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNH-LQG  550 (936)
Q Consensus       480 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~-l~~  550 (936)
                      +|..|+++++|++|+|++|+++|.+|..+..+++|++|||++|+|+|.+|.. ..+..+....+.+|+ |+|
T Consensus       672 ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg  742 (768)
T 3rgz_A          672 IPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCG  742 (768)
T ss_dssp             CCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEES
T ss_pred             CChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhcC
Confidence            9999999999999999999999999999999999999999999999999964 556667777788886 565

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=5.2e-58  Score=557.54  Aligned_cols=473  Identities=19%  Similarity=0.265  Sum_probs=368.7

Q ss_pred             ChhHHHHHHHHHHhccCCCCCCCCCCCCC----CCC--ccc------------eeEEecCCCCceEEeccCCCCCCcccc
Q 002321           32 LNDDVLGLIVFKADIQDPNGKLSSWSEDD----DTP--CNW------------FGVKCSPRSNRVIELTLNGLSLTGRIG   93 (936)
Q Consensus        32 ~~~~~~aLl~~k~~~~d~~~~l~sW~~~~----~~~--c~w------------~gv~c~~~~~~v~~l~l~~~~l~g~~~   93 (936)
                      ..+|++||++||+++.||     +|+.++    .+|  |.|            .||+|+. .+||++|+|++++++|.+|
T Consensus       267 ~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ip  340 (876)
T 4ecn_A          267 YIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVP  340 (876)
T ss_dssp             HHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEEC
T ss_pred             chHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCcCc
Confidence            357999999999999887     787654    234  999            9999987 4999999999999999999


Q ss_pred             cccccCccccEEec-cCCcccCcCCCch---------------------------------------------------h
Q 002321           94 RGLLQLQFLRKLSL-SSNNLTGSISPNL---------------------------------------------------A  121 (936)
Q Consensus        94 ~~l~~l~~L~~L~L-~~n~l~~~~~~~l---------------------------------------------------~  121 (936)
                      ++|++|++|++|+| ++|.++|..|...                                                   .
T Consensus       341 ~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~  420 (876)
T 4ecn_A          341 DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD  420 (876)
T ss_dssp             GGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCC
T ss_pred             hHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccc
Confidence            99999999999999 8898877633221                                                   1


Q ss_pred             hcCCCcEEEccC--cccccccchhhhhcCCCCcEEEccCccCCC-----------------CCCCCcc--cccccccccc
Q 002321          122 KLQNLRVIDLSG--NSLSGSIPDEFFKQCGSLRVISLAKNRFSG-----------------KIPSSLS--LCSTLATINL  180 (936)
Q Consensus       122 ~l~~L~~L~Ls~--N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~-----------------~~p~~~~--~l~~L~~L~L  180 (936)
                      ....++.+.++.  |+++| ||.. |.++++|++|+|++|+|++                 .+|..++  ++++|++|+|
T Consensus       421 ~~l~l~~l~l~~~~N~L~~-IP~~-l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~L  498 (876)
T 4ecn_A          421 SRISLKDTQIGNLTNRITF-ISKA-IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVEL  498 (876)
T ss_dssp             CCCCCCTTTTTCCSCEEEE-ECGG-GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEE
T ss_pred             cccchhhceeccccCcccc-hhHH-HhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEEC
Confidence            112344444443  88987 8864 7899999999999999998                 3888887  9999999999


Q ss_pred             ccccccCCCCCCCCCCCCCCEEecCCCC-CCC-CCccCccCCC-------CcceeecccccccccCCc--ccccccCcce
Q 002321          181 SSNRFSSPLPLGIWGLSALRTLDLSDNL-LEG-EIPKGVESLK-------NLRVINLSKNMFSGSIPD--GIGSCSLLRT  249 (936)
Q Consensus       181 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~~~~~~~l~-------~L~~L~L~~N~l~~~~p~--~l~~l~~L~~  249 (936)
                      ++|++.+.+|..|.++++|++|+|++|+ +++ .+|..+++++       +|++|+|++|+++ .+|.  .|+.+++|++
T Consensus       499 s~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~  577 (876)
T 4ecn_A          499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGL  577 (876)
T ss_dssp             ESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCE
T ss_pred             cCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCE
Confidence            9999999999999999999999999998 887 7887666665       9999999999999 7888  8999999999


Q ss_pred             eeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCc-cceecccCceeccccCcccccccc--cceEEccC
Q 002321          250 IDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELES-LETLDLSGNKFSGAVPISIGNLQR--LKVLNFSA  326 (936)
Q Consensus       250 L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~l~~l~~--L~~L~L~~  326 (936)
                      |+|++|+++ .+| .|..+++|+.|+|++|.++ .+|..+..+++ |+.|+|++|+++ .+|..+..+..  |+.|+|++
T Consensus       578 L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~  653 (876)
T 4ecn_A          578 LDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSY  653 (876)
T ss_dssp             EECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCS
T ss_pred             EECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcC
Confidence            999999999 777 8999999999999999999 88888999998 999999999998 77887777654  99999999


Q ss_pred             CcccccCChhh---h--ccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccC
Q 002321          327 NRLTGSLPDSM---A--NCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSH  401 (936)
Q Consensus       327 N~l~~~~~~~~---~--~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~  401 (936)
                      |++++.+|...   .  .+.+|+.|+|++|.+. .+|..++                          ..+++|+.|+|++
T Consensus       654 N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~--------------------------~~l~~L~~L~Ls~  706 (876)
T 4ecn_A          654 NKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELF--------------------------ATGSPISTIILSN  706 (876)
T ss_dssp             SCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHH--------------------------HTTCCCSEEECCS
T ss_pred             CcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHH--------------------------ccCCCCCEEECCC
Confidence            99998766432   2  3458999999999998 5665543                          1356788888888


Q ss_pred             cccCCCChhhhcc-------cccCCeeeccCccccCCCCcccc--CcccCCeeecCCccccccCCCCCCCcCCCcEEEec
Q 002321          402 NEFSGETPATIGA-------LSGLQLLNLSRNSLVGPIPVAIG--DLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLE  472 (936)
Q Consensus       402 N~l~~~~~~~~~~-------l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  472 (936)
                      |+|+...+..+..       +++|++|+|++|+++ .+|..+.  .+++|+.|+|++|+|++ +|..+..+++|+.|+|+
T Consensus       707 N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls  784 (876)
T 4ecn_A          707 NLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIR  784 (876)
T ss_dssp             CCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECC
T ss_pred             CcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECC
Confidence            8887333333332       337888888888888 6777776  88888888888888886 67778888888888887


Q ss_pred             C------CccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCC
Q 002321          473 R------NFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHN  546 (936)
Q Consensus       473 ~------N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N  546 (936)
                      +      |++.+.+|..|.++++|+.|+|++|++ +.+|..+.  ++|+.|||++|++....+..+.....+..+.|++|
T Consensus       785 ~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n  861 (876)
T 4ecn_A          785 HQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYD  861 (876)
T ss_dssp             CCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECC
T ss_pred             CCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCC
Confidence            7      555555555555566666666666655 35555543  35556666666555444444444444455555555


Q ss_pred             ccc
Q 002321          547 HLQ  549 (936)
Q Consensus       547 ~l~  549 (936)
                      +++
T Consensus       862 ~~~  864 (876)
T 4ecn_A          862 KTQ  864 (876)
T ss_dssp             TTS
T ss_pred             Ccc
Confidence            443

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=2.6e-56  Score=543.05  Aligned_cols=510  Identities=23%  Similarity=0.237  Sum_probs=382.8

Q ss_pred             CccceeEEecCC---------CCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccC
Q 002321           63 PCNWFGVKCSPR---------SNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSG  133 (936)
Q Consensus        63 ~c~w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~  133 (936)
                      .|.+.-|.|+..         +.+++.|+|+++++++..+..+.++++|++|+|++|++++..|..|+++++|++|+|++
T Consensus         3 ~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~   82 (680)
T 1ziw_A            3 TVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH   82 (680)
T ss_dssp             -CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCS
T ss_pred             eeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCC
Confidence            456666777641         35899999999999987777899999999999999999999999999999999999999


Q ss_pred             cccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCC
Q 002321          134 NSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEI  213 (936)
Q Consensus       134 N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  213 (936)
                      |+++ .+|...|.++++|++|+|++|++++..|..|+.+++|++|+|++|++++..|..+.++++|++|+|++|.+++..
T Consensus        83 n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  161 (680)
T 1ziw_A           83 NELS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK  161 (680)
T ss_dssp             SCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBC
T ss_pred             CccC-ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccC
Confidence            9999 789889999999999999999999888899999999999999999999999999999999999999999999877


Q ss_pred             ccCcc--CCCCcceeecccccccccCCcccccc---------------------------cCcceeeccccccCCCCchh
Q 002321          214 PKGVE--SLKNLRVINLSKNMFSGSIPDGIGSC---------------------------SLLRTIDFSENSFSGNLPET  264 (936)
Q Consensus       214 ~~~~~--~l~~L~~L~L~~N~l~~~~p~~l~~l---------------------------~~L~~L~Ls~N~l~~~~~~~  264 (936)
                      +..+.  .+++|++|++++|++++..|..|..+                           ++|++|++++|.+++..|..
T Consensus       162 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~  241 (680)
T 1ziw_A          162 SEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT  241 (680)
T ss_dssp             HHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTT
T ss_pred             HHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhH
Confidence            76554  45889999999999988777666543                           44566667777777666777


Q ss_pred             hhcccc--ccEEeccCccccCCCCcccccCCccceecccCceeccccCcccc----------------------------
Q 002321          265 MQKLSL--CNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIG----------------------------  314 (936)
Q Consensus       265 l~~l~~--L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~----------------------------  314 (936)
                      |..++.  |+.|+|++|.+++..|..|+.+++|++|+|++|++++..|..+.                            
T Consensus       242 ~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~  321 (680)
T 1ziw_A          242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKID  321 (680)
T ss_dssp             TGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEEC
T ss_pred             hhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccC
Confidence            776654  77777777777777677777777777777777777666555444                            


Q ss_pred             -----cccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccC-CChhhhc----cCCccccccccccccCCCCCC
Q 002321          315 -----NLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGD-LPQWIFS----SGLNKVSFAENKIREGMNGPF  384 (936)
Q Consensus       315 -----~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~----~~l~~l~l~~n~l~~~~~~~~  384 (936)
                           .+++|++|++++|++++..+..|..+++|+.|++++|.+... ++...+.    ..++.+++.+|++.....   
T Consensus       322 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~---  398 (680)
T 1ziw_A          322 DFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES---  398 (680)
T ss_dssp             TTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECT---
T ss_pred             hhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeECh---
Confidence                 445555555556666655555666666666666666554321 1111111    345556666666554332   


Q ss_pred             CCCCCCCCcccEEeccCcccCCCCh-hhhcccccCCeeeccCcccc--------------------------CCCCcccc
Q 002321          385 ASSGSSFESLQFLDLSHNEFSGETP-ATIGALSGLQLLNLSRNSLV--------------------------GPIPVAIG  437 (936)
Q Consensus       385 ~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~--------------------------~~~~~~~~  437 (936)
                       ..+..+++|++|+|++|.+++.++ ..|.++++|++|+|++|++.                          +.+|..|+
T Consensus       399 -~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~  477 (680)
T 1ziw_A          399 -DAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ  477 (680)
T ss_dssp             -TTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTT
T ss_pred             -hhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccc
Confidence             233456666666666666654333 45556666666666666554                          34566677


Q ss_pred             CcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCc--------cccccccccccccccCccccCCCccccc
Q 002321          438 DLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIP--------TSIENCSSLVSLILSKNNLTGPIPIAIA  509 (936)
Q Consensus       438 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------~~l~~l~~L~~L~L~~N~l~~~~p~~~~  509 (936)
                      .+++|++|+|++|++++..+..+.++++|++|+|++|++++..+        ..|.++++|++|+|++|+++...+..|.
T Consensus       478 ~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~  557 (680)
T 1ziw_A          478 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFK  557 (680)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             cCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcc
Confidence            77788888888888877666677888888888888888775321        2367788888888888888855455688


Q ss_pred             ccCCccEEEcCCCcccCCCCcccccccccCeeecCCCcccccCCCC-C-ccCcCCCccccCCCCCCCCCC
Q 002321          510 KLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAG-G-FFNTISPSSVLGNPSLCGSAV  577 (936)
Q Consensus       510 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~-~-~~~~~~~~~~~gn~~~c~~~~  577 (936)
                      .+++|++|||++|+|++..+..+..+++|+.|+|++|++++..|.. + .+..+....+.||||.|+|+.
T Consensus       558 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          558 DLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             cccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            8888999999999888655566788889999999999888765542 1 467778888899999999874

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=8.4e-57  Score=539.90  Aligned_cols=506  Identities=22%  Similarity=0.229  Sum_probs=441.1

Q ss_pred             ceeEEecCC---------CCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCccc
Q 002321           66 WFGVKCSPR---------SNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSL  136 (936)
Q Consensus        66 w~gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l  136 (936)
                      +.-|.|...         +..++.|+|+++.+++..|..|.++++|++|+|++|+++++.|.+|.++++|++|+|++|++
T Consensus        14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l   93 (606)
T 3t6q_A           14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL   93 (606)
T ss_dssp             TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence            556888642         35789999999999988888899999999999999999988899999999999999999999


Q ss_pred             ccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccC
Q 002321          137 SGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKG  216 (936)
Q Consensus       137 ~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  216 (936)
                      + .+++..|.++++|++|+|++|+|++..+..++.+++|++|+|++|++++.....+.++++|++|+|++|.+++..|..
T Consensus        94 ~-~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  172 (606)
T 3t6q_A           94 I-FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED  172 (606)
T ss_dssp             S-EECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred             c-ccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhh
Confidence            8 566677899999999999999999877888999999999999999999866566667999999999999999888888


Q ss_pred             ccCCCCcc--eeecccccccccCCcccccccCcceeecccccc--------------------------CCCCchhhhcc
Q 002321          217 VESLKNLR--VINLSKNMFSGSIPDGIGSCSLLRTIDFSENSF--------------------------SGNLPETMQKL  268 (936)
Q Consensus       217 ~~~l~~L~--~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l--------------------------~~~~~~~l~~l  268 (936)
                      +..+++|+  .|++++|++++..|..|.. .+|++|++++|..                          ....+..+..+
T Consensus       173 ~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l  251 (606)
T 3t6q_A          173 MSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL  251 (606)
T ss_dssp             HHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGG
T ss_pred             hhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchh
Confidence            99999999  8999999999887776654 6788888887751                          11223334444


Q ss_pred             c--cccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEE
Q 002321          269 S--LCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVAL  346 (936)
Q Consensus       269 ~--~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  346 (936)
                      .  .++.|++++|.+++..+..|..+++|++|++++|+++ .+|..+.++++|++|++++|++++..|..+..+++|+.|
T Consensus       252 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  330 (606)
T 3t6q_A          252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHL  330 (606)
T ss_dssp             GGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEE
T ss_pred             hcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEE
Confidence            3  7889999999999888888999999999999999998 778889999999999999999998888899999999999


Q ss_pred             EccCCcCccCCChhhhc--cCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeecc
Q 002321          347 DFSQNSMNGDLPQWIFS--SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLS  424 (936)
Q Consensus       347 ~Ls~N~l~~~~p~~~~~--~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  424 (936)
                      ++++|.+.+.+|...+.  ..++.|++.+|.+.....  .+..+..+++|++|++++|++.+..+..|..+++|++|+|+
T Consensus       331 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~--~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  408 (606)
T 3t6q_A          331 SIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDC--CNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLA  408 (606)
T ss_dssp             ECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEE--STTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECT
T ss_pred             ECCCCCcccccchhhhhccCcCCEEECCCCccccccC--cchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECC
Confidence            99999998877765433  689999999999876431  23455778999999999999998999999999999999999


Q ss_pred             CccccCCCCc-cccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCc---CccccccccccccccccCccc
Q 002321          425 RNSLVGPIPV-AIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGK---IPTSIENCSSLVSLILSKNNL  500 (936)
Q Consensus       425 ~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~l~~l~~L~~L~L~~N~l  500 (936)
                      +|++++..+. .+..+++|++|++++|.+++..|..+.++++|++|+|++|++++.   .+..+..+++|++|+|++|++
T Consensus       409 ~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l  488 (606)
T 3t6q_A          409 FTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL  488 (606)
T ss_dssp             TCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCC
T ss_pred             CCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCcc
Confidence            9999977655 489999999999999999988899999999999999999999863   346799999999999999999


Q ss_pred             cCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCcccccCCCC-CccCcCCCccccCCCCCCCCCC
Q 002321          501 TGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAG-GFFNTISPSSVLGNPSLCGSAV  577 (936)
Q Consensus       501 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~gn~~~c~~~~  577 (936)
                      ++..|..|..+++|++|+|++|++++..|..+.++++| .|++++|++++.+|.. ..+..+....+.|||+.|+++.
T Consensus       489 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  565 (606)
T 3t6q_A          489 SSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN  565 (606)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred             CccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence            99889999999999999999999999999999999999 9999999999877652 4566778888999999998765

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-55  Score=547.16  Aligned_cols=494  Identities=22%  Similarity=0.232  Sum_probs=425.9

Q ss_pred             ccceeEEecCCCCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcC-CCchhhcCCCcEEEccCcccccccch
Q 002321           64 CNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSI-SPNLAKLQNLRVIDLSGNSLSGSIPD  142 (936)
Q Consensus        64 c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~Ls~N~l~~~i~~  142 (936)
                      |+|..|-+  -+.+++.|+|++|.+++..+..+.++++|++|+|++|++.+.+ |.+|.++++|++|+|++|+|+ .+++
T Consensus        14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~-~~~p   90 (844)
T 3j0a_A           14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHP   90 (844)
T ss_dssp             CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCC-EECT
T ss_pred             CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCc-ccCH
Confidence            46777776  4578999999999999888899999999999999999776666 788999999999999999999 5666


Q ss_pred             hhhhcCCCCcEEEccCccCCCCCCCC--ccccccccccccccccccCCCC-CCCCCCCCCCEEecCCCCCCCCCccCccC
Q 002321          143 EFFKQCGSLRVISLAKNRFSGKIPSS--LSLCSTLATINLSSNRFSSPLP-LGIWGLSALRTLDLSDNLLEGEIPKGVES  219 (936)
Q Consensus       143 ~~f~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  219 (936)
                      ..|.++++|++|+|++|.+++.+|..  |+.+++|++|+|++|++++..+ ..|.++++|++|+|++|.+++..+..+..
T Consensus        91 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~  170 (844)
T 3j0a_A           91 DAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP  170 (844)
T ss_dssp             TSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHH
T ss_pred             hHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccc
Confidence            77899999999999999999877665  9999999999999999998765 57999999999999999999999999988


Q ss_pred             C--CCcceeecccccccccCCcccccccC------cceeeccccccCCCCchhhhcc-----------------------
Q 002321          220 L--KNLRVINLSKNMFSGSIPDGIGSCSL------LRTIDFSENSFSGNLPETMQKL-----------------------  268 (936)
Q Consensus       220 l--~~L~~L~L~~N~l~~~~p~~l~~l~~------L~~L~Ls~N~l~~~~~~~l~~l-----------------------  268 (936)
                      +  ++|+.|+|++|.+++..|..++.+.+      |++|++++|.+++..+..+...                       
T Consensus       171 l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~  250 (844)
T 3j0a_A          171 LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFH  250 (844)
T ss_dssp             HHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCS
T ss_pred             ccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccc
Confidence            8  89999999999999988888777766      9999999998887666554321                       


Q ss_pred             ---------------ccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccC
Q 002321          269 ---------------SLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSL  333 (936)
Q Consensus       269 ---------------~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~  333 (936)
                                     ++|+.|+|++|.+.+..+..|..+++|+.|+|++|++++..+..|.++++|++|+|++|++++..
T Consensus       251 ~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  330 (844)
T 3j0a_A          251 NIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELY  330 (844)
T ss_dssp             SSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCC
T ss_pred             ccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccC
Confidence                           57899999999999888889999999999999999999888888999999999999999999888


Q ss_pred             ChhhhccCCCCEEEccCCcCccCCChhhh-ccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhh
Q 002321          334 PDSMANCMNLVALDFSQNSMNGDLPQWIF-SSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATI  412 (936)
Q Consensus       334 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  412 (936)
                      +..|..+++|+.|++++|.+.+..+..+. ...|+.|++.+|.++.+.         .+++|+.|++++|+++. +|.. 
T Consensus       331 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~---------~~~~L~~L~l~~N~l~~-l~~~-  399 (844)
T 3j0a_A          331 SSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIH---------FIPSIPDIFLSGNKLVT-LPKI-  399 (844)
T ss_dssp             SCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCS---------SCCSCSEEEEESCCCCC-CCCC-
T ss_pred             HHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCccc---------CCCCcchhccCCCCccc-cccc-
Confidence            89999999999999999999755554332 368899999999887533         26789999999999973 3432 


Q ss_pred             cccccCCeeeccCccccCCC-CccccCcccCCeeecCCccccccCCC-CCCCcCCCcEEEecCCccC-----CcCccccc
Q 002321          413 GALSGLQLLNLSRNSLVGPI-PVAIGDLKALNVLDLSENWLNGSIPP-EIGGAYSLKELRLERNFLA-----GKIPTSIE  485 (936)
Q Consensus       413 ~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~l~  485 (936)
                        ..+++.|++++|++++.. +..+..+++|++|+|++|++++..+. .+..+++|+.|+|++|.++     +..+..|.
T Consensus       400 --~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~  477 (844)
T 3j0a_A          400 --NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFE  477 (844)
T ss_dssp             --CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSS
T ss_pred             --ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhc
Confidence              467899999999998643 23456899999999999999965443 4667899999999999997     45567799


Q ss_pred             cccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCcccccCCCCCccCcCCCcc
Q 002321          486 NCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSS  565 (936)
Q Consensus       486 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~  565 (936)
                      ++++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..|..+.  ++|+.|+|++|++++.+|.  .|..+....
T Consensus       478 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~--~~~~L~~l~  553 (844)
T 3j0a_A          478 GLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPD--VFVSLSVLD  553 (844)
T ss_dssp             CBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSC--CCSSCCEEE
T ss_pred             CcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChh--HhCCcCEEE
Confidence            999999999999999999999999999999999999999976666665  8999999999999998885  467888888


Q ss_pred             ccCCCCCCCCCC
Q 002321          566 VLGNPSLCGSAV  577 (936)
Q Consensus       566 ~~gn~~~c~~~~  577 (936)
                      +.|||+.|+|++
T Consensus       554 l~~Np~~C~c~~  565 (844)
T 3j0a_A          554 ITHNKFICECEL  565 (844)
T ss_dssp             EEEECCCCSSSC
T ss_pred             ecCCCccccccc
Confidence            999999998876

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1.2e-55  Score=529.81  Aligned_cols=502  Identities=20%  Similarity=0.188  Sum_probs=412.4

Q ss_pred             Cccce----eEEecCC---------CCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEE
Q 002321           63 PCNWF----GVKCSPR---------SNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVI  129 (936)
Q Consensus        63 ~c~w~----gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L  129 (936)
                      ||.|.    .|.|...         +.+++.|+|+++.+++..+..+.++++|++|+|++|+++++.|.+|.++++|++|
T Consensus         6 ~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L   85 (606)
T 3vq2_A            6 PCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNL   85 (606)
T ss_dssp             CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEE
T ss_pred             CceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEe
Confidence            56653    5778641         3578899999999988777789999999999999999998888899999999999


Q ss_pred             EccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccC-CCCCCCCCCCCCCEEecCCCC
Q 002321          130 DLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSS-PLPLGIWGLSALRTLDLSDNL  208 (936)
Q Consensus       130 ~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~  208 (936)
                      +|++|+++ .+++..|.++++|++|+|++|++++..+..|+.+++|++|+|++|++++ .+|..|.++++|++|+|++|+
T Consensus        86 ~Ls~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~  164 (606)
T 3vq2_A           86 ILTGNPIQ-SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY  164 (606)
T ss_dssp             ECTTCCCC-CCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSC
T ss_pred             ECCCCccc-ccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCc
Confidence            99999998 4555678999999999999999998887889999999999999999986 458889999999999999999


Q ss_pred             CCCCCccCccCCCCcc----eeecccccccccCCcccccccCcceeeccccccC-CCCchhhhccccccEEec-------
Q 002321          209 LEGEIPKGVESLKNLR----VINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFS-GNLPETMQKLSLCNFMNL-------  276 (936)
Q Consensus       209 l~~~~~~~~~~l~~L~----~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~~~~l~~l~~L~~L~L-------  276 (936)
                      +++..+..+..+++|+    +|++++|.+++..+..+... +|++|++++|.++ +..|..+.+++.++.+++       
T Consensus       165 l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~  243 (606)
T 3vq2_A          165 IQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD  243 (606)
T ss_dssp             CCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTT
T ss_pred             ceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhcccccccccccccccccc
Confidence            9988888888777665    79999999987666666555 8999999999886 345566666666666555       


Q ss_pred             --------------------------cCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCccc
Q 002321          277 --------------------------RKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLT  330 (936)
Q Consensus       277 --------------------------~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~  330 (936)
                                                ..|.+.+.+|. +..+++|+.|++++|.+. .+| .+..+++|+.|++++|.+ 
T Consensus       244 ~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-  319 (606)
T 3vq2_A          244 ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-  319 (606)
T ss_dssp             SCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-
T ss_pred             CCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-
Confidence                                      55666666666 788888999999999887 455 788888999999999998 


Q ss_pred             ccCChhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChh
Q 002321          331 GSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPA  410 (936)
Q Consensus       331 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  410 (936)
                      +.+| .+ .+++|+.|++++|+..+.++ ......++.|++.+|.+.....  .+..+..+++|++|++++|.+++ +|.
T Consensus       320 ~~lp-~~-~l~~L~~L~l~~n~~~~~~~-~~~l~~L~~L~ls~n~l~~~~~--~~~~~~~~~~L~~L~L~~n~l~~-~~~  393 (606)
T 3vq2_A          320 KQFP-TL-DLPFLKSLTLTMNKGSISFK-KVALPSLSYLDLSRNALSFSGC--CSYSDLGTNSLRHLDLSFNGAII-MSA  393 (606)
T ss_dssp             SSCC-CC-CCSSCCEEEEESCSSCEECC-CCCCTTCCEEECCSSCEEEEEE--CCHHHHCCSCCCEEECCSCSEEE-ECC
T ss_pred             cccc-cC-CCCccceeeccCCcCccchh-hccCCCCCEEECcCCccCCCcc--hhhhhccCCcccEeECCCCcccc-chh
Confidence            4677 44 88899999999986655442 2234678888999888875421  23344567889999999999875 557


Q ss_pred             hhcccccCCeeeccCccccCCCC-ccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCC-cCcccccccc
Q 002321          411 TIGALSGLQLLNLSRNSLVGPIP-VAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAG-KIPTSIENCS  488 (936)
Q Consensus       411 ~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~  488 (936)
                      .+..+++|++|++++|++.+..| ..+..+++|++|++++|.+++..|..+.++++|++|+|++|++++ .+|..++.++
T Consensus       394 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~  473 (606)
T 3vq2_A          394 NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTT  473 (606)
T ss_dssp             CCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCT
T ss_pred             hccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCC
Confidence            88889999999999999988777 688899999999999999998888889999999999999999987 4788899999


Q ss_pred             ccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCcccccCCCC-CccC-cCCCccc
Q 002321          489 SLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAG-GFFN-TISPSSV  566 (936)
Q Consensus       489 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~-~~~~-~~~~~~~  566 (936)
                      +|++|+|++|++++..|..+..+++|++|+|++|++++.+|..+..+++|++|+|++|+++ .+|.. ..+. .+....+
T Consensus       474 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l  552 (606)
T 3vq2_A          474 NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNL  552 (606)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEEC
T ss_pred             CCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEc
Confidence            9999999999999888888999999999999999999888999999999999999999998 45553 2333 3666778


Q ss_pred             cCCCCCCCCCC
Q 002321          567 LGNPSLCGSAV  577 (936)
Q Consensus       567 ~gn~~~c~~~~  577 (936)
                      .+||+.|++++
T Consensus       553 ~~N~~~c~c~~  563 (606)
T 3vq2_A          553 TNNSVACICEH  563 (606)
T ss_dssp             CSCCCCCSSTT
T ss_pred             cCCCcccCCcc
Confidence            89999998886

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=5.8e-53  Score=513.53  Aligned_cols=481  Identities=22%  Similarity=0.237  Sum_probs=368.2

Q ss_pred             CceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEE
Q 002321           76 NRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVIS  155 (936)
Q Consensus        76 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~  155 (936)
                      .+++.|+|+++.+++..|..++++++|++|+|++|++++..+.+|+++++|++|+|++|+++ .+++..|..+++|++|+
T Consensus        49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~  127 (680)
T 1ziw_A           49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQ-KIKNNPFVKQKNLITLD  127 (680)
T ss_dssp             TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCSCTTTTCTTCCEEE
T ss_pred             CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccC-ccChhHccccCCCCEEE
Confidence            46888889888888888888888999999999999988766667888999999999999887 57777788899999999


Q ss_pred             ccCccCCCCCCCCccccccccccccccccccCCCCCCCC--CCCCCCEEecCCCCCCCCCccCcc---------------
Q 002321          156 LAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIW--GLSALRTLDLSDNLLEGEIPKGVE---------------  218 (936)
Q Consensus       156 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~---------------  218 (936)
                      |++|++++..|..++.+++|++|+|++|++++..+..+.  .+++|++|+|++|.+++..|..+.               
T Consensus       128 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l  207 (680)
T 1ziw_A          128 LSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQL  207 (680)
T ss_dssp             CCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCC
T ss_pred             CCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhcccccc
Confidence            999998888888888888888888888888876665443  456777777777777665554443               


Q ss_pred             ------------------------------------CCCC--cceeecccccccccCCcccccccCcceeeccccccCCC
Q 002321          219 ------------------------------------SLKN--LRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGN  260 (936)
Q Consensus       219 ------------------------------------~l~~--L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~  260 (936)
                                                          +++.  |++|+|++|++++..|..|+.+++|++|+|++|++++.
T Consensus       208 ~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  287 (680)
T 1ziw_A          208 GPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHL  287 (680)
T ss_dssp             HHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEE
T ss_pred             ChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCcc
Confidence                                                3322  55555555555555555555555555555555555554


Q ss_pred             CchhhhccccccEEeccCccccC-----CCCc----ccccCCccceecccCceeccccCcccccccccceEE--------
Q 002321          261 LPETMQKLSLCNFMNLRKNLFSG-----EVPK----WIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLN--------  323 (936)
Q Consensus       261 ~~~~l~~l~~L~~L~L~~N~l~~-----~~~~----~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~--------  323 (936)
                      .|..|..+++|+.|++++|...+     .+|.    .|..+++|++|++++|++++..+..|.++++|++|+        
T Consensus       288 ~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~  367 (680)
T 1ziw_A          288 FSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL  367 (680)
T ss_dssp             CTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCC
T ss_pred             ChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhh
Confidence            44444444444444443332221     1111    445566666777777777766666666655555555        


Q ss_pred             --------------------ccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhc--cCCccccccccccccCCC
Q 002321          324 --------------------FSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFS--SGLNKVSFAENKIREGMN  381 (936)
Q Consensus       324 --------------------L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~--~~l~~l~l~~n~l~~~~~  381 (936)
                                          +++|++++..|..|..+++|+.|++++|.+.+.+|...+.  ..++.+++.+|++.....
T Consensus       368 ~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~  447 (680)
T 1ziw_A          368 RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR  447 (680)
T ss_dssp             CEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCT
T ss_pred             hhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeCh
Confidence                                4556666667788888999999999999998777754443  678899999998877655


Q ss_pred             CCCCCCCCCCCcccEEeccCcccC--CCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCC--
Q 002321          382 GPFASSGSSFESLQFLDLSHNEFS--GETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIP--  457 (936)
Q Consensus       382 ~~~~~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p--  457 (936)
                      ..|    ..+++|+.|++++|.++  +..|..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+  
T Consensus       448 ~~~----~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  523 (680)
T 1ziw_A          448 NSF----ALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHA  523 (680)
T ss_dssp             TTT----TTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTT
T ss_pred             hhh----hcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhh
Confidence            444    56889999999999987  5788999999999999999999998888899999999999999999986422  


Q ss_pred             ------CCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcc
Q 002321          458 ------PEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQ  531 (936)
Q Consensus       458 ------~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  531 (936)
                            ..+.++++|+.|+|++|+++...+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|+|++..|..
T Consensus       524 ~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~  603 (680)
T 1ziw_A          524 NPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKV  603 (680)
T ss_dssp             STTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHH
T ss_pred             ccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhH
Confidence                  24789999999999999999555567999999999999999999877788899999999999999999877777


Q ss_pred             cc-cccccCeeecCCCcccccCCC-CCccCcC
Q 002321          532 LV-NLVHLSSFNISHNHLQGELPA-GGFFNTI  561 (936)
Q Consensus       532 l~-~l~~L~~L~ls~N~l~~~~p~-~~~~~~~  561 (936)
                      +. .+++|+.|++++|++.+.++. .++..++
T Consensus       604 ~~~~~~~L~~l~l~~N~~~c~c~~~~~~~~~~  635 (680)
T 1ziw_A          604 FGPAFRNLTELDMRFNPFDCTCESIAWFVNWI  635 (680)
T ss_dssp             HHHHHTTCSEEECTTCCCCBCCCCCSSEECCS
T ss_pred             hcccccccCEEEccCCCcccCCccHHHHHHHH
Confidence            77 799999999999999999886 4444443

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=5.1e-53  Score=523.97  Aligned_cols=488  Identities=21%  Similarity=0.214  Sum_probs=426.7

Q ss_pred             CceEEeccCCCCCCccc-ccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccch-hhhhcCCCCcE
Q 002321           76 NRVIELTLNGLSLTGRI-GRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPD-EFFKQCGSLRV  153 (936)
Q Consensus        76 ~~v~~l~l~~~~l~g~~-~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~-~~f~~l~~L~~  153 (936)
                      ..+..|+|+++...+.+ |.++.++++|++|+|++|+|++..|..|.++++|++|+|++|++++.+|. .+|..+++|++
T Consensus        48 ~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~  127 (844)
T 3j0a_A           48 EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR  127 (844)
T ss_dssp             CSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCE
T ss_pred             ccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCE
Confidence            57889999999888888 56799999999999999999999999999999999999999999976654 46899999999


Q ss_pred             EEccCccCCCCCC-CCccccccccccccccccccCCCCCCCCCC--CCCCEEecCCCCCCCCCccCccCCCC------cc
Q 002321          154 ISLAKNRFSGKIP-SSLSLCSTLATINLSSNRFSSPLPLGIWGL--SALRTLDLSDNLLEGEIPKGVESLKN------LR  224 (936)
Q Consensus       154 L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~------L~  224 (936)
                      |+|++|++++..+ ..|+++++|++|+|++|.+++..+..+..+  ++|+.|+|++|.+.+..|..+..+++      |+
T Consensus       128 L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~  207 (844)
T 3j0a_A          128 LDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLE  207 (844)
T ss_dssp             EEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBS
T ss_pred             EECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCcee
Confidence            9999999998765 579999999999999999999999998888  89999999999999988888777766      99


Q ss_pred             eeecccccccccCCccccc--------------------------------------ccCcceeeccccccCCCCchhhh
Q 002321          225 VINLSKNMFSGSIPDGIGS--------------------------------------CSLLRTIDFSENSFSGNLPETMQ  266 (936)
Q Consensus       225 ~L~L~~N~l~~~~p~~l~~--------------------------------------l~~L~~L~Ls~N~l~~~~~~~l~  266 (936)
                      +|++++|++++..+..+..                                      .++|++|+|++|.+.+..+..|.
T Consensus       208 ~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~  287 (844)
T 3j0a_A          208 ILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFE  287 (844)
T ss_dssp             EEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSS
T ss_pred             EEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhh
Confidence            9999999887766654432                                      26899999999999999999999


Q ss_pred             ccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEE
Q 002321          267 KLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVAL  346 (936)
Q Consensus       267 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  346 (936)
                      .+++|+.|+|++|.+++..|..|..+++|++|+|++|++++..|..|.++++|+.|++++|++++..+..|..+++|+.|
T Consensus       288 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  367 (844)
T 3j0a_A          288 TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTL  367 (844)
T ss_dssp             SCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEE
T ss_pred             cCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEE
Confidence            99999999999999999999999999999999999999998889999999999999999999998888899999999999


Q ss_pred             EccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCC-hhhhcccccCCeeeccC
Q 002321          347 DFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGET-PATIGALSGLQLLNLSR  425 (936)
Q Consensus       347 ~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~  425 (936)
                      +|++|.+++ ++.   ...++.+.+.+|++...+..        ..+++.|++++|++++.. +..+..+++|++|+|++
T Consensus       368 ~Ls~N~l~~-i~~---~~~L~~L~l~~N~l~~l~~~--------~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~  435 (844)
T 3j0a_A          368 DLRDNALTT-IHF---IPSIPDIFLSGNKLVTLPKI--------NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQ  435 (844)
T ss_dssp             EEETCCSCC-CSS---CCSCSEEEEESCCCCCCCCC--------CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEES
T ss_pred             ECCCCCCCc-ccC---CCCcchhccCCCCccccccc--------ccccceeecccCccccCchhhhhhcCCccceeeCCC
Confidence            999999984 332   46789999999999865432        457999999999998753 34567899999999999


Q ss_pred             ccccCCCCc-cccCcccCCeeecCCcccc-----ccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCcc
Q 002321          426 NSLVGPIPV-AIGDLKALNVLDLSENWLN-----GSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNN  499 (936)
Q Consensus       426 N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~  499 (936)
                      |++++..+. .+..+++|+.|+|++|.++     +..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+
T Consensus       436 N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  515 (844)
T 3j0a_A          436 NRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNR  515 (844)
T ss_dssp             CCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCC
T ss_pred             CcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCC
Confidence            999865443 4667899999999999997     4455678999999999999999999999999999999999999999


Q ss_pred             ccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCcccccCCCCCccCcCCCccccCCCCCCCCCCCC
Q 002321          500 LTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNK  579 (936)
Q Consensus       500 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~gn~~~c~~~~~~  579 (936)
                      |++..|..+.  ++|+.|||++|+|++..|..+   .+|+.|++++|++.+.++...+..++    ..+|..+||.+...
T Consensus       516 l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~~~~f~~~~----~~~~~~~~~~~~~~  586 (844)
T 3j0a_A          516 LTVLSHNDLP--ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECELSTFINWL----NHTNVTIAGPPADI  586 (844)
T ss_dssp             CSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSSCCSHHHHH----HHTTTTTCCCGGGC
T ss_pred             CCccChhhhh--ccccEEECCCCcCCCCChhHh---CCcCEEEecCCCcccccccHHHHHHH----HhcCcccccccccC
Confidence            9987777776  899999999999999888765   47899999999999998865544432    23567778877777


Q ss_pred             CCCCC
Q 002321          580 SCPAV  584 (936)
Q Consensus       580 ~~~~~  584 (936)
                      .|..+
T Consensus       587 ~C~~p  591 (844)
T 3j0a_A          587 YCVYP  591 (844)
T ss_dssp             CCSSC
T ss_pred             ccCCc
Confidence            77543

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=8.3e-53  Score=505.21  Aligned_cols=478  Identities=20%  Similarity=0.170  Sum_probs=418.9

Q ss_pred             CceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEE
Q 002321           76 NRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVIS  155 (936)
Q Consensus        76 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~  155 (936)
                      .+++.|+|+++.+++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|+++ .++...|..+++|++|+
T Consensus        57 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~-~l~~~~~~~l~~L~~L~  135 (606)
T 3t6q_A           57 INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS-SIDFIPLHNQKTLESLY  135 (606)
T ss_dssp             TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCS-CGGGSCCTTCTTCCEEE
T ss_pred             ccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcc-cCCcchhccCCcccEEE
Confidence            57899999999999888999999999999999999999999999999999999999999999 56667789999999999


Q ss_pred             ccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCC--EEecCCCCCCCCCccCccCCCCcceeecccccc
Q 002321          156 LAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALR--TLDLSDNLLEGEIPKGVESLKNLRVINLSKNMF  233 (936)
Q Consensus       156 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~--~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  233 (936)
                      |++|++++..+..+..+++|++|+|++|++++..+..|..+++|+  .|++++|.+++..|..+.. .+|++|++++|..
T Consensus       136 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~~  214 (606)
T 3t6q_A          136 LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQN  214 (606)
T ss_dssp             CCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCSC
T ss_pred             CCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCchh
Confidence            999999986555566699999999999999998888999999999  9999999999877776654 6899999888751


Q ss_pred             c--------------------------ccCCccccccc--CcceeeccccccCCCCchhhhccccccEEeccCccccCCC
Q 002321          234 S--------------------------GSIPDGIGSCS--LLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEV  285 (936)
Q Consensus       234 ~--------------------------~~~p~~l~~l~--~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~  285 (936)
                      .                          ...+..|..+.  +|++|++++|.+++..+..|..+++|+.|++++|.++ .+
T Consensus       215 ~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~l  293 (606)
T 3t6q_A          215 LLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-EL  293 (606)
T ss_dssp             HHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CC
T ss_pred             HHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CC
Confidence            0                          11122233333  7899999999999888888999999999999999998 67


Q ss_pred             CcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCCh-hhhccCCCCEEEccCCcCccCC--Chhh-
Q 002321          286 PKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPD-SMANCMNLVALDFSQNSMNGDL--PQWI-  361 (936)
Q Consensus       286 ~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~--p~~~-  361 (936)
                      |..+..+++|++|++++|++++..|..+.++++|++|++++|.+.+.++. .+..+++|+.|++++|.+.+..  +..+ 
T Consensus       294 p~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~  373 (606)
T 3t6q_A          294 PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR  373 (606)
T ss_dssp             CSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTT
T ss_pred             ChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcc
Confidence            88899999999999999999988888899999999999999999866654 5889999999999999998654  3322 


Q ss_pred             hccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChh-hhcccccCCeeeccCccccCCCCccccCcc
Q 002321          362 FSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPA-TIGALSGLQLLNLSRNSLVGPIPVAIGDLK  440 (936)
Q Consensus       362 ~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  440 (936)
                      ....++.|++.+|.+....    +..+..+++|++|++++|++++..+. .+..+++|++|++++|.+++..|..++.++
T Consensus       374 ~l~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  449 (606)
T 3t6q_A          374 NLSHLQSLNLSYNEPLSLK----TEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP  449 (606)
T ss_dssp             TCTTCCEEECCSCSCEEEC----TTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCT
T ss_pred             cCCCCCEEECCCCcCCcCC----HHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCC
Confidence            3368999999999887654    34456789999999999999877654 489999999999999999999999999999


Q ss_pred             cCCeeecCCcccccc---CCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEE
Q 002321          441 ALNVLDLSENWLNGS---IPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNV  517 (936)
Q Consensus       441 ~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  517 (936)
                      +|++|+|++|++++.   .+..+..+++|+.|+|++|++++..|..|+++++|++|+|++|++++..|..+.++++| +|
T Consensus       450 ~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L  528 (606)
T 3t6q_A          450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YL  528 (606)
T ss_dssp             TCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EE
T ss_pred             CCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EE
Confidence            999999999999873   33568999999999999999999889999999999999999999999999999999999 99


Q ss_pred             EcCCCcccCCCCcccccccccCeeecCCCcccccCCCCCccCcC
Q 002321          518 DLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTI  561 (936)
Q Consensus       518 ~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~  561 (936)
                      +|++|++++..|..+..+++|+.|++++|++.+.++..++..++
T Consensus       529 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~~~w~  572 (606)
T 3t6q_A          529 NLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWY  572 (606)
T ss_dssp             ECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGHHHHHHH
T ss_pred             ECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcHHHHHHH
Confidence            99999999888889999999999999999999988865544443

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=8.5e-52  Score=496.42  Aligned_cols=475  Identities=20%  Similarity=0.190  Sum_probs=421.1

Q ss_pred             EEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccC
Q 002321           79 IELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAK  158 (936)
Q Consensus        79 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~  158 (936)
                      ..++.++++++ .+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|+++ .+++..|.++++|++|+|++
T Consensus        14 ~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~i~~~~~~~l~~L~~L~Ls~   89 (606)
T 3vq2_A           14 ITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIE-TIEDKAWHGLHHLSNLILTG   89 (606)
T ss_dssp             TEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC-EECTTTTTTCTTCCEEECTT
T ss_pred             CceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCccc-ccCHHHhhchhhcCEeECCC
Confidence            36788898887 6777655  89999999999999988889999999999999999999 67778899999999999999


Q ss_pred             ccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCC-CCccCccCCCCcceeecccccccccC
Q 002321          159 NRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEG-EIPKGVESLKNLRVINLSKNMFSGSI  237 (936)
Q Consensus       159 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~  237 (936)
                      |+|++..|..|+++++|++|+|++|++++..+..++++++|++|+|++|.+++ .+|..+.++++|++|+|++|++++..
T Consensus        90 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~  169 (606)
T 3vq2_A           90 NPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTIT  169 (606)
T ss_dssp             CCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEEC
T ss_pred             CcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecC
Confidence            99999999999999999999999999999888899999999999999999986 57999999999999999999999998


Q ss_pred             CcccccccCcc----eeeccccccCCCCchhhhccccccEEeccCcccc-CCCCcccccCCccceecc------------
Q 002321          238 PDGIGSCSLLR----TIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFS-GEVPKWIGELESLETLDL------------  300 (936)
Q Consensus       238 p~~l~~l~~L~----~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L------------  300 (936)
                      +..|+.+++|+    +|++++|.+++..+..+... +|+.|++++|.++ +..|..+..+++|+.+++            
T Consensus       170 ~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~  248 (606)
T 3vq2_A          170 VNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE  248 (606)
T ss_dssp             TTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCS
T ss_pred             hhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCccc
Confidence            99999888776    89999999997777766665 8999999999986 455666777777766655            


Q ss_pred             ---------------------cCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCCh
Q 002321          301 ---------------------SGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQ  359 (936)
Q Consensus       301 ---------------------~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  359 (936)
                                           ..|.+.+.+|. +..+++|+.|++++|.++ .+| .+..+++|+.|++++|.+ +.+|.
T Consensus       249 ~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp~  324 (606)
T 3vq2_A          249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFPT  324 (606)
T ss_dssp             CCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCCC
T ss_pred             ccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-ccccc
Confidence                                 66677777776 889999999999999997 455 888999999999999999 68886


Q ss_pred             hhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCC--ChhhhcccccCCeeeccCccccCCCCcccc
Q 002321          360 WIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGE--TPATIGALSGLQLLNLSRNSLVGPIPVAIG  437 (936)
Q Consensus       360 ~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  437 (936)
                      + ....++.|.+.+|......      .+..+++|++|++++|++++.  .+..+..+++|++|+|++|.+++ +|..+.
T Consensus       325 ~-~l~~L~~L~l~~n~~~~~~------~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~  396 (606)
T 3vq2_A          325 L-DLPFLKSLTLTMNKGSISF------KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFM  396 (606)
T ss_dssp             C-CCSSCCEEEEESCSSCEEC------CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCT
T ss_pred             C-CCCccceeeccCCcCccch------hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhcc
Confidence            6 6678999999999543311      345789999999999999876  38889999999999999999985 668999


Q ss_pred             CcccCCeeecCCccccccCC-CCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccC-CCcccccccCCcc
Q 002321          438 DLKALNVLDLSENWLNGSIP-PEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTG-PIPIAIAKLTNLQ  515 (936)
Q Consensus       438 ~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~  515 (936)
                      .+++|+.|++++|++++..| ..+..+++|+.|++++|.+++..|..+.++++|++|+|++|++++ .+|..+..+++|+
T Consensus       397 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~  476 (606)
T 3vq2_A          397 GLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLT  476 (606)
T ss_dssp             TCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCC
T ss_pred             CCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCC
Confidence            99999999999999998777 689999999999999999999999999999999999999999998 4799999999999


Q ss_pred             EEEcCCCcccCCCCcccccccccCeeecCCCcccccCCC-CCccCcCCCccccCCC
Q 002321          516 NVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPA-GGFFNTISPSSVLGNP  570 (936)
Q Consensus       516 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~-~~~~~~~~~~~~~gn~  570 (936)
                      +|+|++|++++..|..+..+++|++|+|++|++++.+|. -..+..+....+.+|.
T Consensus       477 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~  532 (606)
T 3vq2_A          477 FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR  532 (606)
T ss_dssp             EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSC
T ss_pred             EEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCc
Confidence            999999999998899999999999999999999998775 3445566666677774

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.6e-52  Score=493.83  Aligned_cols=472  Identities=19%  Similarity=0.192  Sum_probs=348.5

Q ss_pred             CceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEE
Q 002321           76 NRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVIS  155 (936)
Q Consensus        76 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~  155 (936)
                      .+++.|+|+++.+++..+..+.++++|++|+|++|++++..+..|.++++|++|+|++|+++ .+++..|.++++|++|+
T Consensus        28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~  106 (570)
T 2z63_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLV  106 (570)
T ss_dssp             SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC-EECTTTTTTCTTCCEEE
T ss_pred             ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCC-ccCHhhhcCcccccccc
Confidence            46788888888888777777888888888888888888777778888888888888888887 56777788888888888


Q ss_pred             ccCccCCCCCCCCccccccccccccccccccCC-CCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCc----ceeeccc
Q 002321          156 LAKNRFSGKIPSSLSLCSTLATINLSSNRFSSP-LPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNL----RVINLSK  230 (936)
Q Consensus       156 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L----~~L~L~~  230 (936)
                      |++|++++..+..|+.+++|++|+|++|++++. +|..|.++++|++|++++|++++..+..+..+++|    +.|++++
T Consensus       107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~  186 (570)
T 2z63_A          107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL  186 (570)
T ss_dssp             CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred             ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence            888888876666788888888888888888873 57888888888888888888887777778777777    7888888


Q ss_pred             ccccccCCcccccccCcceeeccccccCC-CCchhhhcccc--------------------------------ccEEecc
Q 002321          231 NMFSGSIPDGIGSCSLLRTIDFSENSFSG-NLPETMQKLSL--------------------------------CNFMNLR  277 (936)
Q Consensus       231 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~~~~l~~l~~--------------------------------L~~L~L~  277 (936)
                      |.+++..|..|..+ +|++|++++|.... ..+..+..++.                                ++.++++
T Consensus       187 n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~  265 (570)
T 2z63_A          187 NPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA  265 (570)
T ss_dssp             CCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEE
T ss_pred             CCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhh
Confidence            88887777777665 78888888874321 11222222222                                3344555


Q ss_pred             Cc-cccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccC
Q 002321          278 KN-LFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGD  356 (936)
Q Consensus       278 ~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  356 (936)
                      +| .+.+..|..+..+++|++|++++|+++ .+|..+..+ +|+.|++++|.++ .+|.  ..+++|+.|++++|.+.+.
T Consensus       266 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~  340 (570)
T 2z63_A          266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNA  340 (570)
T ss_dssp             ETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCB
T ss_pred             cchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCccccc
Confidence            55 566667777777777788888877777 466666666 7778888777777 4443  4667777778877777665


Q ss_pred             CChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCC-cc
Q 002321          357 LPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIP-VA  435 (936)
Q Consensus       357 ~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~  435 (936)
                      .+. .....++.|++.+|.+....  ..+..+..+++|++|++++|.+++..+. +..+++|++|++++|++.+..+ ..
T Consensus       341 ~~~-~~~~~L~~L~l~~n~l~~~~--~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~  416 (570)
T 2z63_A          341 FSE-VDLPSLEFLDLSRNGLSFKG--CCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSV  416 (570)
T ss_dssp             CCC-CBCTTCCEEECCSSCCBEEE--EEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCT
T ss_pred             ccc-ccCCCCCEEeCcCCccCccc--cccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhh
Confidence            554 33356777777777765432  1122334567778888888877755444 7777788888888888776555 46


Q ss_pred             ccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccC-CcCccccccccccccccccCccccCCCcccccccCCc
Q 002321          436 IGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLA-GKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNL  514 (936)
Q Consensus       436 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  514 (936)
                      +..+++|++|++++|.+++..|..+.++++|+.|+|++|.++ +.+|..+..+++|++|+|++|++++..|..+..+++|
T Consensus       417 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  496 (570)
T 2z63_A          417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL  496 (570)
T ss_dssp             TTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred             hhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCC
Confidence            777778888888888877777777777788888888888776 4677777778888888888888877777777778888


Q ss_pred             cEEEcCCCcccCCCCcccccccccCeeecCCCcccccCCCCCcc
Q 002321          515 QNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFF  558 (936)
Q Consensus       515 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~  558 (936)
                      ++|+|++|++++..|..+.++++|+.|++++|+++|.+|...++
T Consensus       497 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~  540 (570)
T 2z63_A          497 QVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL  540 (570)
T ss_dssp             CEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHH
T ss_pred             CEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHH
Confidence            88888888887766667777788888888888888777765554

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.3e-50  Score=480.12  Aligned_cols=478  Identities=19%  Similarity=0.220  Sum_probs=282.6

Q ss_pred             CccceeEEecCC-----------CCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEc
Q 002321           63 PCNWFGVKCSPR-----------SNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDL  131 (936)
Q Consensus        63 ~c~w~gv~c~~~-----------~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L  131 (936)
                      .|.|.|| |+..           ..+++.|+|+++++++..|..+.++++|++|+|++|+|++..|.+|.++++|++|||
T Consensus         3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L   81 (549)
T 2z81_A            3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL   81 (549)
T ss_dssp             EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence            5999999 8642           125666666666666555555666666666666666666555566666666666666


Q ss_pred             cCcccccccchhhhhcCCCCcEEEccCccCCC-CCCCCcccccccccccccccc-ccCCCCCCCCCCCCCCEEecCCCCC
Q 002321          132 SGNSLSGSIPDEFFKQCGSLRVISLAKNRFSG-KIPSSLSLCSTLATINLSSNR-FSSPLPLGIWGLSALRTLDLSDNLL  209 (936)
Q Consensus       132 s~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l  209 (936)
                      ++|+++ .+++..|..+++|++|+|++|++++ ..|..++.+++|++|+|++|+ +..+.+..|.++++|++|+|++|.+
T Consensus        82 s~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l  160 (549)
T 2z81_A           82 SDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL  160 (549)
T ss_dssp             TTSCCC-SCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred             CCCccC-ccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence            666666 3455555666666666666666654 234556666666666666665 3333334566666666666666666


Q ss_pred             CCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCC--c-hhhhccccccEEeccCccccCCCC
Q 002321          210 EGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNL--P-ETMQKLSLCNFMNLRKNLFSGEVP  286 (936)
Q Consensus       210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~--~-~~l~~l~~L~~L~L~~N~l~~~~~  286 (936)
                      ++.+|..+.++++|++|+++.|.+.......+..+++|++|++++|++++..  + .....+++|+.|++++|.+++..+
T Consensus       161 ~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~  240 (549)
T 2z81_A          161 RNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF  240 (549)
T ss_dssp             CEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHH
T ss_pred             cccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHH
Confidence            6656666666666666666666655322222334566666666666665532  1 122334556666666666554333


Q ss_pred             c----ccccCCccceecccCceeccccC------cccccccccceEEccCCccccc-----CChhhhccCCCCEEEccCC
Q 002321          287 K----WIGELESLETLDLSGNKFSGAVP------ISIGNLQRLKVLNFSANRLTGS-----LPDSMANCMNLVALDFSQN  351 (936)
Q Consensus       287 ~----~~~~l~~L~~L~L~~N~l~~~~~------~~l~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~Ls~N  351 (936)
                      .    .+..+++|+.|++++|.+.+...      ..+..+.+|+.|++.++.+...     ++..+....+|+.|++++|
T Consensus       241 ~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n  320 (549)
T 2z81_A          241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS  320 (549)
T ss_dssp             HHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESS
T ss_pred             HHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccC
Confidence            2    22445566666666666554211      1234455666666666654421     1223344556677777777


Q ss_pred             cCccCCChhhh--ccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCCh--hhhcccccCCeeeccCcc
Q 002321          352 SMNGDLPQWIF--SSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETP--ATIGALSGLQLLNLSRNS  427 (936)
Q Consensus       352 ~l~~~~p~~~~--~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~L~L~~N~  427 (936)
                      .+. .+|..++  ...++.|++.+|.+....... +..++.+++|++|+|++|++++..+  ..+..+++|++|+|++|+
T Consensus       321 ~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~  398 (549)
T 2z81_A          321 KVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKN-SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNT  398 (549)
T ss_dssp             CCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHH-HTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCC
T ss_pred             ccc-cCCHHHHhcCccccEEEccCCccccccccc-hhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCC
Confidence            665 5555543  356666666666665321000 1123456667777777777764432  446667777777777777


Q ss_pred             ccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCccc
Q 002321          428 LVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIA  507 (936)
Q Consensus       428 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~  507 (936)
                      ++ .+|..++.+++|++|+|++|++++ +|..+  .++|+.|+|++|+|++.+    ..+++|++|+|++|+++ .+|. 
T Consensus       399 l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-  468 (549)
T 2z81_A          399 FH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-  468 (549)
T ss_dssp             CC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-
T ss_pred             Cc-cCChhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-
Confidence            76 466666667777777777777663 34333  246777777777776432    45667777777777776 4554 


Q ss_pred             ccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCcccccCCC
Q 002321          508 IAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPA  554 (936)
Q Consensus       508 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~  554 (936)
                      ...+++|++|||++|++++.+|..+..+++|+.|++++|++.|.+|.
T Consensus       469 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  515 (549)
T 2z81_A          469 ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  515 (549)
T ss_dssp             GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred             cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence            35667777777777777766666677777777777777777766664

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=8.4e-51  Score=487.42  Aligned_cols=437  Identities=20%  Similarity=0.270  Sum_probs=382.8

Q ss_pred             ccccEEeccCCcccCcCCCchhhcCCCcEEEccCccc------cc------ccchhhhhcCCCCcEEEccCccCCCCCCC
Q 002321          100 QFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSL------SG------SIPDEFFKQCGSLRVISLAKNRFSGKIPS  167 (936)
Q Consensus       100 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l------~~------~i~~~~f~~l~~L~~L~L~~N~l~~~~p~  167 (936)
                      .+++.|+|++|+++|.+|++|++|++|++|||++|.+      .|      .+|.+.   +.+|+ +++++|.+.+.+|.
T Consensus        81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~---~~~l~-l~l~~~~l~~~~~~  156 (636)
T 4eco_A           81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ---KQKMR-MHYQKTFVDYDPRE  156 (636)
T ss_dssp             CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH---HHHHH-THHHHHHTCCCGGG
T ss_pred             CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH---HHHHH-hhHHHhhhccCchh
Confidence            4688999999999999999999999999999999987      33      455554   45566 89999999988887


Q ss_pred             Cccc-cccccccccc--------------------cccccCCCCCCCCCCCCCCEEecCCCCCCCC--------------
Q 002321          168 SLSL-CSTLATINLS--------------------SNRFSSPLPLGIWGLSALRTLDLSDNLLEGE--------------  212 (936)
Q Consensus       168 ~~~~-l~~L~~L~L~--------------------~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--------------  212 (936)
                      .+.. +..+..+++.                    +|++++ +|..++++++|++|+|++|.+++.              
T Consensus       157 ~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~  235 (636)
T 4eco_A          157 DFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYA  235 (636)
T ss_dssp             GSCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHH
T ss_pred             hHHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchh
Confidence            7663 2223333332                    789999 899999999999999999999985              


Q ss_pred             ---CccCcc--CCCCcceeecccccccccCCcccccccCcceeeccccc-cCC-CCchhhhcc------ccccEEeccCc
Q 002321          213 ---IPKGVE--SLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENS-FSG-NLPETMQKL------SLCNFMNLRKN  279 (936)
Q Consensus       213 ---~~~~~~--~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~-~~~~~l~~l------~~L~~L~L~~N  279 (936)
                         +|..++  ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..+..+      ++|+.|+|++|
T Consensus       236 ~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n  315 (636)
T 4eco_A          236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN  315 (636)
T ss_dssp             HHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSS
T ss_pred             cccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCC
Confidence               999999  99999999999999999999999999999999999998 998 899998887      99999999999


Q ss_pred             cccCCCCc--ccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCC-CCEEEccCCcCccC
Q 002321          280 LFSGEVPK--WIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMN-LVALDFSQNSMNGD  356 (936)
Q Consensus       280 ~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~  356 (936)
                      +++ .+|.  .++.+++|++|++++|+++|.+| .+.++++|++|+|++|+++ .+|..+..+++ |+.|++++|+++ .
T Consensus       316 ~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~  391 (636)
T 4eco_A          316 NLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-Y  391 (636)
T ss_dssp             CCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-S
T ss_pred             cCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-c
Confidence            999 7888  89999999999999999999999 8999999999999999999 78889999999 999999999997 5


Q ss_pred             CChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhc-------ccccCCeeeccCcccc
Q 002321          357 LPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIG-------ALSGLQLLNLSRNSLV  429 (936)
Q Consensus       357 ~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-------~l~~L~~L~L~~N~l~  429 (936)
                      +|..+.                         ...+++|++|++++|++++..|..+.       .+++|++|+|++|+++
T Consensus       392 lp~~~~-------------------------~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~  446 (636)
T 4eco_A          392 IPNIFD-------------------------AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS  446 (636)
T ss_dssp             CCSCCC-------------------------TTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC
T ss_pred             cchhhh-------------------------hcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC
Confidence            554221                         01245899999999999999999888       7889999999999999


Q ss_pred             CCCCccccCcccCCeeecCCccccccCCCCCCC-c-------CCCcEEEecCCccCCcCccccc--cccccccccccCcc
Q 002321          430 GPIPVAIGDLKALNVLDLSENWLNGSIPPEIGG-A-------YSLKELRLERNFLAGKIPTSIE--NCSSLVSLILSKNN  499 (936)
Q Consensus       430 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l-------~~L~~L~Ls~N~l~~~~p~~l~--~l~~L~~L~L~~N~  499 (936)
                      ...+..+..+++|++|+|++|+++ .+|..+.. .       ++|+.|+|++|+|+ .+|..+.  .+++|++|+|++|+
T Consensus       447 ~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~  524 (636)
T 4eco_A          447 KFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNS  524 (636)
T ss_dssp             SCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSC
T ss_pred             cCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCC
Confidence            655556677999999999999999 56654433 3       29999999999999 7898887  99999999999999


Q ss_pred             ccCCCcccccccCCccEEEc------CCCcccCCCCcccccccccCeeecCCCcccccCCCCCccCcCCCccccCCCCCC
Q 002321          500 LTGPIPIAIAKLTNLQNVDL------SFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLC  573 (936)
Q Consensus       500 l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~gn~~~c  573 (936)
                      +++ +|..+.++++|++|+|      ++|++.+.+|..+.++++|++|+|++|++ +.+|.. .+..+....+.+|+..|
T Consensus       525 l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~-~~~~L~~L~Ls~N~l~~  601 (636)
T 4eco_A          525 FSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEK-ITPNISVLDIKDNPNIS  601 (636)
T ss_dssp             CSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCTTCCEEECCSCTTCE
T ss_pred             CCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHh-HhCcCCEEECcCCCCcc
Confidence            997 8999999999999999      56888999999999999999999999999 788875 44788888889999887


Q ss_pred             CC
Q 002321          574 GS  575 (936)
Q Consensus       574 ~~  575 (936)
                      -.
T Consensus       602 ~~  603 (636)
T 4eco_A          602 ID  603 (636)
T ss_dssp             EE
T ss_pred             cc
Confidence            43

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-49  Score=472.27  Aligned_cols=477  Identities=21%  Similarity=0.230  Sum_probs=414.2

Q ss_pred             CCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCC
Q 002321           85 GLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGK  164 (936)
Q Consensus        85 ~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~  164 (936)
                      +.+++ .+|..+.  +.+++|+|++|++++..+.+|.++++|++|||++|+++ .+++..|.++++|++|+|++|++++.
T Consensus        16 ~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~-~i~~~~~~~l~~L~~L~L~~n~l~~~   91 (570)
T 2z63_A           16 ELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSL   91 (570)
T ss_dssp             SSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEE
T ss_pred             CCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCC-ccCcccccCchhCCEEeCcCCcCCcc
Confidence            33444 4555443  57999999999999888889999999999999999998 68888899999999999999999998


Q ss_pred             CCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCC-CCccCccCCCCcceeecccccccccCCccccc
Q 002321          165 IPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEG-EIPKGVESLKNLRVINLSKNMFSGSIPDGIGS  243 (936)
Q Consensus       165 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~  243 (936)
                      .|..|+++++|++|+|++|++++..+..++++++|++|+|++|.+++ .+|..|.++++|++|++++|++++..+..++.
T Consensus        92 ~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  171 (570)
T 2z63_A           92 ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV  171 (570)
T ss_dssp             CTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHH
T ss_pred             CHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccc
Confidence            88999999999999999999998777789999999999999999997 46999999999999999999999888889999


Q ss_pred             ccCc----ceeeccccccCCCCchhhhccccccEEeccCccccCC-CC------------------------------cc
Q 002321          244 CSLL----RTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGE-VP------------------------------KW  288 (936)
Q Consensus       244 l~~L----~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~-~~------------------------------~~  288 (936)
                      +++|    +.|++++|.+++..+..+... +|+.|++++|..... ++                              ..
T Consensus       172 l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~  250 (570)
T 2z63_A          172 LHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA  250 (570)
T ss_dssp             HHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTT
T ss_pred             hhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhh
Confidence            9999    899999999998888888776 799999998843211 11                              11


Q ss_pred             cccCC--ccceecccCc-eeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccC
Q 002321          289 IGELE--SLETLDLSGN-KFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSG  365 (936)
Q Consensus       289 ~~~l~--~L~~L~L~~N-~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~  365 (936)
                      +..+.  .++.+++++| .+.+..+..+..+++|+.|++++|.++ .+|..+..+ +|+.|++++|.+. .+|.. ....
T Consensus       251 ~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~~-~l~~  326 (570)
T 2z63_A          251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPTL-KLKS  326 (570)
T ss_dssp             TGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCBC-BCSS
T ss_pred             hccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCcc-cccc
Confidence            22222  2456677777 778888899999999999999999998 588888888 9999999999998 66663 3467


Q ss_pred             CccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCC--hhhhcccccCCeeeccCccccCCCCccccCcccCC
Q 002321          366 LNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGET--PATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALN  443 (936)
Q Consensus       366 l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  443 (936)
                      ++.+.+.+|.+.....    .  ..+++|++|++++|++++..  +..+..+++|++|++++|++.+..+. +..+++|+
T Consensus       327 L~~L~l~~n~~~~~~~----~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~  399 (570)
T 2z63_A          327 LKRLTFTSNKGGNAFS----E--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLE  399 (570)
T ss_dssp             CCEEEEESCBSCCBCC----C--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCC
T ss_pred             cCEEeCcCCccccccc----c--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCC
Confidence            9999999998764332    1  56899999999999998664  78899999999999999999965544 99999999


Q ss_pred             eeecCCccccccCC-CCCCCcCCCcEEEecCCccCCcCccccccccccccccccCcccc-CCCcccccccCCccEEEcCC
Q 002321          444 VLDLSENWLNGSIP-PEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLT-GPIPIAIAKLTNLQNVDLSF  521 (936)
Q Consensus       444 ~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~  521 (936)
                      +|++++|.+++..| ..+..+++|++|++++|.+++..|..+.++++|++|+|++|+++ +.+|..+..+++|++|+|++
T Consensus       400 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~  479 (570)
T 2z63_A          400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ  479 (570)
T ss_dssp             EEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred             EEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCC
Confidence            99999999998766 57899999999999999999999999999999999999999998 57899999999999999999


Q ss_pred             CcccCCCCcccccccccCeeecCCCcccccCCC-CCccCcCCCccccCCCCCCCCCC
Q 002321          522 NSLTGGLPKQLVNLVHLSSFNISHNHLQGELPA-GGFFNTISPSSVLGNPSLCGSAV  577 (936)
Q Consensus       522 N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~-~~~~~~~~~~~~~gn~~~c~~~~  577 (936)
                      |++++..|..+..+++|++|++++|++++.+|. -..+..+....+.+||+.|.++.
T Consensus       480 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  536 (570)
T 2z63_A          480 CQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  536 (570)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             CccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence            999988899999999999999999999987665 24567778888999999997664

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.5e-49  Score=471.17  Aligned_cols=484  Identities=22%  Similarity=0.227  Sum_probs=406.4

Q ss_pred             EecCCCCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCC
Q 002321           70 KCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCG  149 (936)
Q Consensus        70 ~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~  149 (936)
                      .|..  ..|  .+.++++++ .+|+.+.  ++|++|+|++|+|++..|.+|.++++|++|+|++|+++ .+++..|..++
T Consensus         3 ~C~~--~~~--c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~-~~~~~~~~~l~   74 (549)
T 2z81_A            3 SCDA--SGV--CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLG   74 (549)
T ss_dssp             EECT--TSE--EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCC-EECTTTTTTCT
T ss_pred             cCCC--Cce--EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcC-ccChhhccccc
Confidence            5765  344  578888887 6777665  79999999999999988999999999999999999999 57778899999


Q ss_pred             CCcEEEccCccCCCCCCCCccccccccccccccccccCC-CCCCCCCCCCCCEEecCCCCCCCCCc-cCccCCCCcceee
Q 002321          150 SLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSP-LPLGIWGLSALRTLDLSDNLLEGEIP-KGVESLKNLRVIN  227 (936)
Q Consensus       150 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~  227 (936)
                      +|++|+|++|++++..|..|+.+++|++|+|++|++++. .|..+.++++|++|+|++|.+.+.+| ..|.++++|++|+
T Consensus        75 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~  154 (549)
T 2z81_A           75 SLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELE  154 (549)
T ss_dssp             TCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEE
T ss_pred             cCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeee
Confidence            999999999999988888899999999999999999974 57789999999999999999554555 6899999999999


Q ss_pred             cccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCC--C-cccccCCccceecccCce
Q 002321          228 LSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEV--P-KWIGELESLETLDLSGNK  304 (936)
Q Consensus       228 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~--~-~~~~~l~~L~~L~L~~N~  304 (936)
                      +++|++++..|..++.+++|++|+++.|.+.......+..+++|+.|++++|++++..  + .....+++|+.|++++|+
T Consensus       155 L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~  234 (549)
T 2z81_A          155 IKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV  234 (549)
T ss_dssp             EEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCE
T ss_pred             ccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccc
Confidence            9999999999999999999999999999987443334567999999999999999753  2 223457899999999999


Q ss_pred             eccccCc----ccccccccceEEccCCcccccC------ChhhhccCCCCEEEccCCcCccC-----CCh-hhhccCCcc
Q 002321          305 FSGAVPI----SIGNLQRLKVLNFSANRLTGSL------PDSMANCMNLVALDFSQNSMNGD-----LPQ-WIFSSGLNK  368 (936)
Q Consensus       305 l~~~~~~----~l~~l~~L~~L~L~~N~l~~~~------~~~~~~l~~L~~L~Ls~N~l~~~-----~p~-~~~~~~l~~  368 (936)
                      +++..+.    .+..+++|+.|++++|.+.+..      ...+..+.+|+.|++.++.+...     ++. ......++.
T Consensus       235 l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~  314 (549)
T 2z81_A          235 LTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKR  314 (549)
T ss_dssp             EEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCE
T ss_pred             cchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceE
Confidence            9875543    3467789999999999987632      23456788999999999987532     111 122357899


Q ss_pred             ccccccccccCCCCCCCCCC-CCCCcccEEeccCcccCCCChh---hhcccccCCeeeccCccccCCCC--ccccCcccC
Q 002321          369 VSFAENKIREGMNGPFASSG-SSFESLQFLDLSHNEFSGETPA---TIGALSGLQLLNLSRNSLVGPIP--VAIGDLKAL  442 (936)
Q Consensus       369 l~l~~n~l~~~~~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L  442 (936)
                      +.+.+|.+..++     ..+ ..+++|++|+|++|++++..|.   .++.+++|++|+|++|++++..+  ..+..+++|
T Consensus       315 L~l~~n~l~~ip-----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L  389 (549)
T 2z81_A          315 ITVENSKVFLVP-----CSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNL  389 (549)
T ss_dssp             EEEESSCCCCCC-----HHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTC
T ss_pred             EEeccCccccCC-----HHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCC
Confidence            999999987543     222 3578999999999999887653   47889999999999999986532  568999999


Q ss_pred             CeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCC
Q 002321          443 NVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFN  522 (936)
Q Consensus       443 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  522 (936)
                      ++|+|++|+++ .+|..+..+++|++|+|++|+++ .+|..+.  ++|++|+|++|++++.+    ..+++|++|+|++|
T Consensus       390 ~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N  461 (549)
T 2z81_A          390 TSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRN  461 (549)
T ss_dssp             CEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSS
T ss_pred             CEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCC
Confidence            99999999999 58889999999999999999998 4555443  68999999999999753    57899999999999


Q ss_pred             cccCCCCcccccccccCeeecCCCcccccCCC-CCccCcCCCccccCCCCCCCCC
Q 002321          523 SLTGGLPKQLVNLVHLSSFNISHNHLQGELPA-GGFFNTISPSSVLGNPSLCGSA  576 (936)
Q Consensus       523 ~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~-~~~~~~~~~~~~~gn~~~c~~~  576 (936)
                      +|+ .+|. ...+++|+.|+|++|++++.+|. -+.+..+....+.+||+.|+++
T Consensus       462 ~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  514 (549)
T 2z81_A          462 KLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  514 (549)
T ss_dssp             CCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred             ccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence            998 7776 57899999999999999987775 3566778888899999999876

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1.2e-49  Score=484.23  Aligned_cols=440  Identities=18%  Similarity=0.205  Sum_probs=282.0

Q ss_pred             ccccEEeccCCcccCcCCCchhhcCCCcEEEc-cCcccccccchhhhh--------------------------------
Q 002321          100 QFLRKLSLSSNNLTGSISPNLAKLQNLRVIDL-SGNSLSGSIPDEFFK--------------------------------  146 (936)
Q Consensus       100 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L-s~N~l~~~i~~~~f~--------------------------------  146 (936)
                      ..++.|+|++|+++|.+|++|++|++|++||| ++|.++|..|.....                                
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            57899999999999999999999999999999 999998774422110                                


Q ss_pred             ------------------cCCCCcEEEccC--ccCCCCCCCCccccccccccccccccccC-----------------CC
Q 002321          147 ------------------QCGSLRVISLAK--NRFSGKIPSSLSLCSTLATINLSSNRFSS-----------------PL  189 (936)
Q Consensus       147 ------------------~l~~L~~L~L~~--N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-----------------~~  189 (936)
                                        ....++.+.+..  |++++ +|..|+++++|++|+|++|+|++                 .+
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i  481 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE  481 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence                              011122222222  44444 44445555555555555555554                 14


Q ss_pred             CCCCC--CCCCCCEEecCCCCCCCCCccCccCCCCcceeeccccc-ccc-cCCccccccc-------CcceeeccccccC
Q 002321          190 PLGIW--GLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNM-FSG-SIPDGIGSCS-------LLRTIDFSENSFS  258 (936)
Q Consensus       190 ~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~p~~l~~l~-------~L~~L~Ls~N~l~  258 (936)
                      |..++  ++++|++|+|++|.+.+.+|..|.++++|++|+|++|+ +++ .+|..++.++       +|++|+|++|+++
T Consensus       482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~  561 (876)
T 4ecn_A          482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE  561 (876)
T ss_dssp             TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred             ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence            44444  44555555555554444444444445555555555554 444 4444333333       4555555555444


Q ss_pred             CCCch--hhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccc-cceEEccCCcccccCCh
Q 002321          259 GNLPE--TMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQR-LKVLNFSANRLTGSLPD  335 (936)
Q Consensus       259 ~~~~~--~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~-L~~L~L~~N~l~~~~~~  335 (936)
                       .+|.  .+.++++|+.|+|++|.++ .+| .++.+++|+.|+|++|+++ .+|..+.++++ |+.|+|++|+++ .+|.
T Consensus       562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~  636 (876)
T 4ecn_A          562 -EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPN  636 (876)
T ss_dssp             -BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCS
T ss_pred             -ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCch
Confidence             3444  4444444555555555444 344 4444444555555555444 44444444444 555555555444 3444


Q ss_pred             hhhccCC--CCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCC--CCCcccEEeccCcccCCCChhh
Q 002321          336 SMANCMN--LVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGS--SFESLQFLDLSHNEFSGETPAT  411 (936)
Q Consensus       336 ~~~~l~~--L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~  411 (936)
                      .+..+..  |+.|++++|++.+.+|.                        ++..+.  .+++|+.|+|++|+++...+..
T Consensus       637 ~~~~~~~~~L~~L~Ls~N~l~g~ip~------------------------l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~  692 (876)
T 4ecn_A          637 IFNAKSVYVMGSVDFSYNKIGSEGRN------------------------ISCSMDDYKGINASTVTLSYNEIQKFPTEL  692 (876)
T ss_dssp             CCCTTCSSCEEEEECCSSCTTTTSSS------------------------CSSCTTTCCCCCEEEEECCSSCCCSCCHHH
T ss_pred             hhhccccCCCCEEECcCCcCCCcccc------------------------chhhhccccCCCcCEEEccCCcCCccCHHH
Confidence            4433322  44445554444433332                        122222  3458999999999999665566


Q ss_pred             hcccccCCeeeccCccccCCCCccccC--------cccCCeeecCCccccccCCCCCC--CcCCCcEEEecCCccCCcCc
Q 002321          412 IGALSGLQLLNLSRNSLVGPIPVAIGD--------LKALNVLDLSENWLNGSIPPEIG--GAYSLKELRLERNFLAGKIP  481 (936)
Q Consensus       412 ~~~l~~L~~L~L~~N~l~~~~~~~~~~--------l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p  481 (936)
                      +..+++|+.|+|++|+++ .+|..+..        +++|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|+|++ +|
T Consensus       693 ~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp  769 (876)
T 4ecn_A          693 FATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FP  769 (876)
T ss_dssp             HHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CC
T ss_pred             HccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cc
Confidence            678999999999999999 55554433        339999999999999 6888887  99999999999999996 89


Q ss_pred             cccccccccccccccC------ccccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCcccccCCCC
Q 002321          482 TSIENCSSLVSLILSK------NNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAG  555 (936)
Q Consensus       482 ~~l~~l~~L~~L~L~~------N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~  555 (936)
                      ..+.++++|+.|+|++      |++.+.+|..+.++++|+.|+|++|+| +.+|..+.  ++|+.|+|++|++...-+. 
T Consensus       770 ~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~-  845 (876)
T 4ecn_A          770 TQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVT-  845 (876)
T ss_dssp             CGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECG-
T ss_pred             hhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChH-
Confidence            9999999999999976      888999999999999999999999999 68998876  6999999999999854332 


Q ss_pred             CccC--cCCCccccCCCCCC--CCC
Q 002321          556 GFFN--TISPSSVLGNPSLC--GSA  576 (936)
Q Consensus       556 ~~~~--~~~~~~~~gn~~~c--~~~  576 (936)
                      .+..  ......+.+|+..|  ||+
T Consensus       846 ~~~~~~~~~~~~L~~n~~~~I~gC~  870 (876)
T 4ecn_A          846 SVCPYIEAGMYVLLYDKTQDIRGCD  870 (876)
T ss_dssp             GGHHHHHTTCCEEECCTTSEEESCG
T ss_pred             HccccccchheeecCCCccccCCCC
Confidence            2211  12334455666544  544

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.6e-50  Score=434.00  Aligned_cols=244  Identities=25%  Similarity=0.313  Sum_probs=204.3

Q ss_pred             cccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      .++..++||+|+||+||+|++.      +++.||||+++........++|.+|+.++++++|||||+++|+|.+++..++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3455678999999999999963      4678999999766555557889999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEE
Q 002321          765 IYEFVSGGSLHKHLHEGSG-------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKV  831 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl  831 (936)
                      |||||++|+|.++++....             ...+++.++.+|+.|||+||+|||+++||||||||+|||+++++.+||
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki  186 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKI  186 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEE
Confidence            9999999999999965321             124899999999999999999999999999999999999999999999


Q ss_pred             eeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH---
Q 002321          832 GDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL---  907 (936)
Q Consensus       832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~---  907 (936)
                      +|||+|+.....+.........||+.|||||++. ...|+.++|||||||++|||+| |+.||.+............   
T Consensus       187 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~-~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~  265 (308)
T 4gt4_A          187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV  265 (308)
T ss_dssp             CCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCC
T ss_pred             CCcccceeccCCCceeEecccccCCcccCHHHHh-CCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            9999998775544444455677999999999984 4579999999999999999998 8999988766433321110   


Q ss_pred             --HHHhhhccccceeecccccccccccccC
Q 002321          908 --EEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       908 --~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                        .+...++.+.+++.+||..||.+||+|+
T Consensus       266 ~~~p~~~~~~~~~li~~C~~~dP~~RPs~~  295 (308)
T 4gt4_A          266 LPCPDDCPAWVYALMIECWNEFPSRRPRFK  295 (308)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCcccchHHHHHHHHHHcCCChhHCcCHH
Confidence              1233456788999999999999999984

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.8e-50  Score=431.83  Aligned_cols=244  Identities=23%  Similarity=0.350  Sum_probs=204.2

Q ss_pred             ccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  763 (936)
                      ..|...++||+|+||+||+|++.      +++.||||+++... ....++|.+|++++++++|||||+++|+|.+++..+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            44567789999999999999864      47789999997543 344678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEee
Q 002321          764 LIYEFVSGGSLHKHLHEGS----------GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGD  833 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D  833 (936)
                      +|||||++|+|.++++...          ....+++.++.+|+.|||+||+|||+++|+||||||+|||+++++.+||+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~D  171 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD  171 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECC
Confidence            9999999999999997642          223599999999999999999999999999999999999999999999999


Q ss_pred             ccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----H
Q 002321          834 YGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----L  907 (936)
Q Consensus       834 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~  907 (936)
                      ||+|+.....+.........||+.|||||++. ...|+.++|||||||++|||+| |+.||...+.........     .
T Consensus       172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~-~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~  250 (299)
T 4asz_A          172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ  250 (299)
T ss_dssp             CSCHHHHTGGGCEEETTTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCC
T ss_pred             cccceecCCCCceeecCceecChhhcCHHHHc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99998775544444445567899999999984 5579999999999999999999 999998876643332111     1


Q ss_pred             HHHhhhccccceeecccccccccccccC
Q 002321          908 EEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       908 ~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .|...++++.+++.+||..||.+||+|+
T Consensus       251 ~p~~~~~~~~~li~~cl~~dP~~RPs~~  278 (299)
T 4asz_A          251 RPRTCPQEVYELMLGCWQREPHMRKNIK  278 (299)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCccchHHHHHHHHHHcCCChhHCcCHH
Confidence            1334557889999999999999999985

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.7e-49  Score=467.23  Aligned_cols=456  Identities=21%  Similarity=0.255  Sum_probs=388.0

Q ss_pred             EEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccC
Q 002321           79 IELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAK  158 (936)
Q Consensus        79 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~  158 (936)
                      ..|++++++++ .+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|+ .+++..|.++++|++|+|++
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~   78 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSH   78 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCC-EEEGGGGTTCTTCCEEECCS
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccC-CcChHHhhcccCCCEEecCC
Confidence            36889999998 6887776  89999999999999888889999999999999999998 56667789999999999999


Q ss_pred             ccCCCCCCCCccccccccccccccccccC-CCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCc--ceeecccccc--
Q 002321          159 NRFSGKIPSSLSLCSTLATINLSSNRFSS-PLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNL--RVINLSKNMF--  233 (936)
Q Consensus       159 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~N~l--  233 (936)
                      |+|++ +|..  .+++|++|+|++|+|++ ..|..|+++++|++|+|++|.+++   ..+..+++|  ++|++++|++  
T Consensus        79 N~l~~-lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~  152 (520)
T 2z7x_B           79 NKLVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYG  152 (520)
T ss_dssp             SCCCE-EECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTT
T ss_pred             Cceee-cCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccc
Confidence            99994 5655  79999999999999998 468899999999999999999985   456777777  9999999999  


Q ss_pred             cccCCccccccc-CcceeeccccccCCCCch-hhhccccccEEeccCcc-------ccCCCCcccccCCccceecccCce
Q 002321          234 SGSIPDGIGSCS-LLRTIDFSENSFSGNLPE-TMQKLSLCNFMNLRKNL-------FSGEVPKWIGELESLETLDLSGNK  304 (936)
Q Consensus       234 ~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~~-~l~~l~~L~~L~L~~N~-------l~~~~~~~~~~l~~L~~L~L~~N~  304 (936)
                      ++..|..+..+. +...+++++|.+.+.+++ .+..+++|+.|++++|.       +.+.+| .++.+++|+.|++++|.
T Consensus       153 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~  231 (520)
T 2z7x_B          153 EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIE  231 (520)
T ss_dssp             SSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEE
T ss_pred             cccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccc
Confidence            778888887766 455678889988876654 57789999999999997       666666 78889999999999999


Q ss_pred             eccccCcccc---cccccceEEccCCcccccCChhh-----hccCCCCEEEccCCcCccCCC-hhhhc----cCCccccc
Q 002321          305 FSGAVPISIG---NLQRLKVLNFSANRLTGSLPDSM-----ANCMNLVALDFSQNSMNGDLP-QWIFS----SGLNKVSF  371 (936)
Q Consensus       305 l~~~~~~~l~---~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~~p-~~~~~----~~l~~l~l  371 (936)
                      +++..+..+.   ..++|++|++++|++++.+|..+     ..+++|+.+++++|.+  .+| ..+..    ..++.|.+
T Consensus       232 l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l  309 (520)
T 2z7x_B          232 TTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTV  309 (520)
T ss_dssp             EEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEE
T ss_pred             cCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEc
Confidence            8864433221   23589999999999998899888     8899999999999998  566 33222    46899999


Q ss_pred             cccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccC--CCCccccCcccCCeeecCC
Q 002321          372 AENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVG--PIPVAIGDLKALNVLDLSE  449 (936)
Q Consensus       372 ~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~  449 (936)
                      .+|.+.....   +   ..+++|++|++++|++++..|..+..+++|++|+|++|++++  .+|..++.+++|++|+|++
T Consensus       310 ~~n~l~~~~~---~---~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~  383 (520)
T 2z7x_B          310 SGTRMVHMLC---P---SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQ  383 (520)
T ss_dssp             ESSCCCCCCC---C---SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCS
T ss_pred             CCCccccccc---h---hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCC
Confidence            9998765431   1   467899999999999999899999999999999999999986  5567899999999999999


Q ss_pred             ccccccCCC-CCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCC
Q 002321          450 NWLNGSIPP-EIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGL  528 (936)
Q Consensus       450 N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  528 (936)
                      |++++.+|. .+..+++|++|+|++|++++.+|..+.  ++|++|+|++|+++ .+|..+..+++|++|+|++|+|+ .+
T Consensus       384 N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l  459 (520)
T 2z7x_B          384 NSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SV  459 (520)
T ss_dssp             SCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CC
T ss_pred             CcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-cc
Confidence            999985665 488899999999999999988888775  79999999999999 78888889999999999999999 56


Q ss_pred             Ccc-cccccccCeeecCCCcccccCCCCCc
Q 002321          529 PKQ-LVNLVHLSSFNISHNHLQGELPAGGF  557 (936)
Q Consensus       529 p~~-l~~l~~L~~L~ls~N~l~~~~p~~~~  557 (936)
                      |.. +..+++|++|++++|++++.++..++
T Consensus       460 ~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~  489 (520)
T 2z7x_B          460 PDGIFDRLTSLQKIWLHTNPWDCSCPRIDY  489 (520)
T ss_dssp             CTTTTTTCTTCCEEECCSSCBCCCHHHHHH
T ss_pred             CHHHhccCCcccEEECcCCCCcccCCchHH
Confidence            765 89999999999999999998775444

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.3e-50  Score=429.41  Aligned_cols=241  Identities=18%  Similarity=0.212  Sum_probs=206.7

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||+||+|+.+ +|+.||||++.....  ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            45788899999999999999976 689999999965432  233578999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||++||+|.+++++.+.   +++.++..++.||+.||+|||+++|+||||||+|||++.+|.+||+|||+|+.+......
T Consensus       112 Ey~~gG~L~~~i~~~~~---l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             CCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             ecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            99999999999987543   999999999999999999999999999999999999999999999999999987544444


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceeec
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSMR  922 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  922 (936)
                      ......+||+.|||||++ .+..|+.++||||+||++|||++|+.||...+.........    ..+...+++.++++.+
T Consensus       189 ~~~~~~~GTp~YmAPEvl-~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~  267 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELL-TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK  267 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHH-HHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHH
T ss_pred             ccccCcccCcccCCHHHH-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHH
Confidence            445567899999999998 45578999999999999999999999998876543332111    1123345678899999


Q ss_pred             cccccccccccc
Q 002321          923 SCKGSSRQRRRF  934 (936)
Q Consensus       923 ~l~~~p~~Rp~f  934 (936)
                      ||..||.+||+.
T Consensus       268 lL~~dp~~R~t~  279 (311)
T 4aw0_A          268 LLVLDATKRLGC  279 (311)
T ss_dssp             HSCSSGGGSTTS
T ss_pred             HccCCHhHCcCh
Confidence            999999999975

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.5e-49  Score=432.26  Aligned_cols=244  Identities=24%  Similarity=0.350  Sum_probs=196.1

Q ss_pred             ccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  763 (936)
                      ..+...++||+|+||+||+|+++      +++.||||+++... ....++|.+|++++++++|||||+++|+|.+....+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            34566778999999999999865      47889999997543 334678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEE
Q 002321          764 LIYEFVSGGSLHKHLHEGSG------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKV  831 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl  831 (936)
                      +|||||++|+|.++++....            ...+++.++++|+.|+|+||+|||+++||||||||+|||+++++.+||
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki  199 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKI  199 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEE
Confidence            99999999999999976432            235899999999999999999999999999999999999999999999


Q ss_pred             eeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH----
Q 002321          832 GDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW----  906 (936)
Q Consensus       832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~----  906 (936)
                      +|||+|+.....+.........||+.|||||++ ....|+.++|||||||++|||+| |+.||.............    
T Consensus       200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~-~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~  278 (329)
T 4aoj_A          200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI-LYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE  278 (329)
T ss_dssp             CCCC----------------CCCCGGGCCHHHH-TTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCC
T ss_pred             cccccceeccCCCcceecCcccccccccChhhh-cCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999999877554444455567799999999998 45578999999999999999999 999998876543322111    


Q ss_pred             -HHHHhhhccccceeecccccccccccccC
Q 002321          907 -LEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       907 -~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                       ..|...++++.+++.+||..||.+||+|+
T Consensus       279 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~  308 (329)
T 4aoj_A          279 LERPRACPPEVYAIMRGCWQREPQQRHSIK  308 (329)
T ss_dssp             CCCCTTCCHHHHHHHHHHCCSSTTTSCCHH
T ss_pred             CCCcccccHHHHHHHHHHcCcChhHCcCHH
Confidence             11334567889999999999999999985

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-49  Score=424.97  Aligned_cols=242  Identities=25%  Similarity=0.358  Sum_probs=193.0

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ...++..++||+|+||+||+|++++  .||||+++..... ...++|.+|++++++++|||||++++++.+ +..++|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            3445677889999999999999753  6999999754432 345789999999999999999999999864 56799999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      ||++|+|.++++....  .+++.++.+|+.|||+||+|||+++||||||||+|||+++++.+||+|||+|+.........
T Consensus       112 y~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~  189 (307)
T 3omv_A          112 WCEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ  189 (307)
T ss_dssp             CCSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred             cCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence            9999999999976432  39999999999999999999999999999999999999999999999999998765433333


Q ss_pred             ccccccCcccccCcccccC--cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH----------HHhhhcc
Q 002321          848 LSSKIQSALGYMAPEFACR--TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE----------EHWKKAE  915 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~----------~~~~~~~  915 (936)
                      ......||+.|||||++..  ...|+.++|||||||++|||+||+.||.+.+...........          +...++.
T Consensus       190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  269 (307)
T 3omv_A          190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKA  269 (307)
T ss_dssp             ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHH
T ss_pred             eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHH
Confidence            4455689999999998853  335899999999999999999999999876543222111111          1123466


Q ss_pred             ccceeecccccccccccccC
Q 002321          916 WRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++++.+||..||.+||+|+
T Consensus       270 l~~li~~cl~~dP~~RPs~~  289 (307)
T 3omv_A          270 MKRLVADCVKKVKEERPLFP  289 (307)
T ss_dssp             HHHHHHHHTCSSSTTSCCHH
T ss_pred             HHHHHHHHcCCCHhHCcCHH
Confidence            88999999999999999984

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2e-49  Score=430.60  Aligned_cols=243  Identities=23%  Similarity=0.396  Sum_probs=198.9

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      -+.|+..++||+|+||+||+|+++ +|+.||||++...... ...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            346788899999999999999976 6999999999765433 34578999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||++||+|.+++...+. ..+++.++..|+.||+.||+|||++||+||||||+|||++++|.+||+|||+|+......  
T Consensus       103 Ey~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--  179 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--  179 (350)
T ss_dssp             ECCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH--
T ss_pred             eCCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc--
Confidence            99999999999976442 347899999999999999999999999999999999999999999999999998764321  


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-----HHhhhccccceee
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-----EHWKKAEWRNVSM  921 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~  921 (936)
                      .......||+.|||||++ .+..|+.++||||+||++|||++|+.||...+...........     +...++++++++.
T Consensus       180 ~~~~~~~GT~~YmAPE~l-~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~  258 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEIC-ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS  258 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred             ccccccCCCccccCHHHH-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence            223446799999999998 4557899999999999999999999999887664333221111     1223467889999


Q ss_pred             cccccccccccccC
Q 002321          922 RSCKGSSRQRRRFQ  935 (936)
Q Consensus       922 ~~l~~~p~~Rp~f~  935 (936)
                      +||..||.+||+++
T Consensus       259 ~~L~~dP~~R~s~~  272 (350)
T 4b9d_A          259 QLFKRNPRDRPSVN  272 (350)
T ss_dssp             HHTCSSGGGSCCHH
T ss_pred             HHccCChhHCcCHH
Confidence            99999999999863

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=8.8e-49  Score=424.85  Aligned_cols=236  Identities=22%  Similarity=0.333  Sum_probs=201.5

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .|+..++||+|+||+||+|+++ +|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus        75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            4677788999999999999986 699999999965432 23466889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      +||+|.+++.+..    +++.++..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+....  ...
T Consensus       154 ~gg~L~~~l~~~~----l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~  227 (346)
T 4fih_A          154 EGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRR  227 (346)
T ss_dssp             TTEEHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCB
T ss_pred             CCCcHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--Ccc
Confidence            9999999997643    8999999999999999999999999999999999999999999999999998764322  223


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-------HHhhhccccceeec
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-------EHWKKAEWRNVSMR  922 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~  922 (936)
                      ....||+.|||||++ ....|+.++||||+||++|||++|+.||.+.............       +...++++++++.+
T Consensus       228 ~~~~GTp~YmAPEvl-~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~  306 (346)
T 4fih_A          228 KSLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR  306 (346)
T ss_dssp             CCCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred             cccccCcCcCCHHHH-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence            456899999999998 5567899999999999999999999999887664433221111       12234678899999


Q ss_pred             cccccccccccc
Q 002321          923 SCKGSSRQRRRF  934 (936)
Q Consensus       923 ~l~~~p~~Rp~f  934 (936)
                      ||..||.+||+.
T Consensus       307 ~L~~dP~~R~ta  318 (346)
T 4fih_A          307 LLVRDPAQRATA  318 (346)
T ss_dssp             HSCSSTTTSCCH
T ss_pred             HcCCChhHCcCH
Confidence            999999999985

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=5e-48  Score=454.58  Aligned_cols=453  Identities=20%  Similarity=0.207  Sum_probs=386.8

Q ss_pred             cEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCcccccccccccccc
Q 002321          103 RKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSS  182 (936)
Q Consensus       103 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  182 (936)
                      ++|++++|+|+ .+|..+.  ++|++|+|++|+++ .+++..|..+++|++|+|++|+|++..|..|+.+++|++|+|++
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~   78 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSH   78 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCC-CCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCS
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCccc-ccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCC
Confidence            57999999999 5777776  89999999999999 57777899999999999999999998899999999999999999


Q ss_pred             ccccCCCCCCCCCCCCCCEEecCCCCCCC-CCccCccCCCCcceeecccccccccCCcccccccCc--ceeecccccc--
Q 002321          183 NRFSSPLPLGIWGLSALRTLDLSDNLLEG-EIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLL--RTIDFSENSF--  257 (936)
Q Consensus       183 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L--~~L~Ls~N~l--  257 (936)
                      |+|+. +|..  .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++   ..+..+++|  ++|++++|.+  
T Consensus        79 N~l~~-lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~  152 (520)
T 2z7x_B           79 NKLVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYG  152 (520)
T ss_dssp             SCCCE-EECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTT
T ss_pred             Cceee-cCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccc
Confidence            99996 5555  89999999999999997 478999999999999999999986   467788888  9999999999  


Q ss_pred             CCCCchhhhccc-cccEEeccCccccCCCCc-ccccCCccceecccCce-------eccccCcccccccccceEEccCCc
Q 002321          258 SGNLPETMQKLS-LCNFMNLRKNLFSGEVPK-WIGELESLETLDLSGNK-------FSGAVPISIGNLQRLKVLNFSANR  328 (936)
Q Consensus       258 ~~~~~~~l~~l~-~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~-------l~~~~~~~l~~l~~L~~L~L~~N~  328 (936)
                      .+..|..+..+. ....+++++|.+.+.++. .+..+++|+.|++++|.       +.+.++ .+..+++|+.|++++|.
T Consensus       153 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~  231 (520)
T 2z7x_B          153 EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIE  231 (520)
T ss_dssp             SSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEE
T ss_pred             cccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccc
Confidence            888899888876 455678899998876654 67889999999999998       777776 78999999999999999


Q ss_pred             ccccCChhhh---ccCCCCEEEccCCcCccCCChhhh------ccCCccccccccccccCCCCCCCCCCCCC---CcccE
Q 002321          329 LTGSLPDSMA---NCMNLVALDFSQNSMNGDLPQWIF------SSGLNKVSFAENKIREGMNGPFASSGSSF---ESLQF  396 (936)
Q Consensus       329 l~~~~~~~~~---~l~~L~~L~Ls~N~l~~~~p~~~~------~~~l~~l~l~~n~l~~~~~~~~~~~~~~l---~~L~~  396 (936)
                      +++..+..+.   ..++|+.|++++|++.|.+|..++      ...++.+++.+|.+ ..+.    ..+..+   .+|+.
T Consensus       232 l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~----~~~~~~~~~~~L~~  306 (520)
T 2z7x_B          232 TTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQ----SYIYEIFSNMNIKN  306 (520)
T ss_dssp             EEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCT----HHHHHHHHTCCCSE
T ss_pred             cCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-ecch----hhhhcccccCceeE
Confidence            8864433222   246999999999999999998763      24677778888777 3221    111111   46999


Q ss_pred             EeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccc--cCCCCCCCcCCCcEEEecCC
Q 002321          397 LDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNG--SIPPEIGGAYSLKELRLERN  474 (936)
Q Consensus       397 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N  474 (936)
                      |++++|.+....  .+..+++|++|+|++|++++.+|..++.+++|++|+|++|++++  .+|..+..+++|+.|+|++|
T Consensus       307 L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N  384 (520)
T 2z7x_B          307 FTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQN  384 (520)
T ss_dssp             EEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSS
T ss_pred             EEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCC
Confidence            999999986543  23688999999999999999899999999999999999999996  55677899999999999999


Q ss_pred             ccCCcCcc-ccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCcccccCC
Q 002321          475 FLAGKIPT-SIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELP  553 (936)
Q Consensus       475 ~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p  553 (936)
                      ++++.+|. .+..+++|++|+|++|++++.+|..+.  ++|++|+|++|+|+ .+|..+..+++|++|+|++|+++ .+|
T Consensus       385 ~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~  460 (520)
T 2z7x_B          385 SVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVP  460 (520)
T ss_dssp             CCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCC
T ss_pred             cCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccC
Confidence            99985666 488999999999999999988887765  79999999999999 89998999999999999999999 466


Q ss_pred             CC--CccCcCCCccccCCCCCCCCCC
Q 002321          554 AG--GFFNTISPSSVLGNPSLCGSAV  577 (936)
Q Consensus       554 ~~--~~~~~~~~~~~~gn~~~c~~~~  577 (936)
                      ..  ..+..+....+.+||+.|+|++
T Consensus       461 ~~~~~~l~~L~~L~l~~N~~~c~c~~  486 (520)
T 2z7x_B          461 DGIFDRLTSLQKIWLHTNPWDCSCPR  486 (520)
T ss_dssp             TTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             HHHhccCCcccEEECcCCCCcccCCc
Confidence            54  3455677788899999998765

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.9e-48  Score=408.00  Aligned_cols=237  Identities=21%  Similarity=0.296  Sum_probs=188.6

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      .|+..++||+|+||+||+|+.+ +|+.||||++......  ...+.+.+|++++++++|||||++++++.+++..++|||
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE   93 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE   93 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence            4777889999999999999975 6999999999755432  235679999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+ +|+|.+++.+...   +++.++..++.|++.||+|||++||+||||||+|||+++++.+||+|||+|+......   
T Consensus        94 y~-~g~L~~~l~~~~~---l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---  166 (275)
T 3hyh_A           94 YA-GNELFDYIVQRDK---MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---  166 (275)
T ss_dssp             CC-CEEHHHHHHHSCS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             CC-CCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC---
Confidence            99 7899999987543   9999999999999999999999999999999999999999999999999998654322   


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceeecc
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSMRS  923 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  923 (936)
                      ......||+.|||||++.+..+++.++||||+||++|||++|+.||.+...........    ..+...++++++++.+|
T Consensus       167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  246 (275)
T 3hyh_A          167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM  246 (275)
T ss_dssp             --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred             ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            23456799999999999665556789999999999999999999998866543322111    11234557789999999


Q ss_pred             ccccccccccc
Q 002321          924 CKGSSRQRRRF  934 (936)
Q Consensus       924 l~~~p~~Rp~f  934 (936)
                      |..||.+||+.
T Consensus       247 L~~dP~~R~s~  257 (275)
T 3hyh_A          247 LIVNPLNRISI  257 (275)
T ss_dssp             SCSSGGGSCCH
T ss_pred             ccCChhHCcCH
Confidence            99999999975

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.3e-48  Score=410.84  Aligned_cols=234  Identities=26%  Similarity=0.378  Sum_probs=193.2

Q ss_pred             cCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEe----CCeeEEEE
Q 002321          693 NKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWT----QSLQLLIY  766 (936)
Q Consensus       693 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  766 (936)
                      +..++||+|+||+||+|+++ +++.||||++...... ...+.+.+|++++++++|||||++++++.+    +...++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45567999999999999976 5889999999755433 335779999999999999999999999875    34578999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEcC-CCCeEEeeccCccccCCC
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN--IIHYNIKSSNVLIDG-SGEPKVGDYGLARLLPML  843 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~  843 (936)
                      |||++|+|.+++++...   +++.++..|+.||+.||+|||+++  |+||||||+|||++. +|.+||+|||+|+.... 
T Consensus       109 Ey~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred             eCCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence            99999999999987543   899999999999999999999998  999999999999984 79999999999986432 


Q ss_pred             ccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH-------HHHHhhhccc
Q 002321          844 DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW-------LEEHWKKAEW  916 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~-------~~~~~~~~~~  916 (936)
                         .......||+.|||||++. + .|+.++||||+||++|||++|+.||.+.+.........       ..+...++++
T Consensus       185 ---~~~~~~~GTp~YmAPE~~~-~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  259 (290)
T 3fpq_A          185 ---SFAKAVIGTPEFMAPEMYE-E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV  259 (290)
T ss_dssp             ---TSBEESCSSCCCCCGGGGG-T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred             ---CccCCcccCccccCHHHcC-C-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHH
Confidence               2234567999999999884 4 58999999999999999999999997654422211111       1122234578


Q ss_pred             cceeecccccccccccccC
Q 002321          917 RNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       917 ~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ++++.+||..||.+||+++
T Consensus       260 ~~li~~~L~~dP~~R~s~~  278 (290)
T 3fpq_A          260 KEIIEGCIRQNKDERYSIK  278 (290)
T ss_dssp             HHHHHHHSCSSGGGSCCHH
T ss_pred             HHHHHHHccCChhHCcCHH
Confidence            8999999999999999864

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=3.5e-46  Score=450.58  Aligned_cols=519  Identities=19%  Similarity=0.177  Sum_probs=292.5

Q ss_pred             CCCCCCCCCCCCCC---CCccce----eEEecCC---------CCceEEeccCCCCCCcccccccccCccccEEeccCCc
Q 002321           48 DPNGKLSSWSEDDD---TPCNWF----GVKCSPR---------SNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNN  111 (936)
Q Consensus        48 d~~~~l~sW~~~~~---~~c~w~----gv~c~~~---------~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~  111 (936)
                      |+...+++|..+.+   ++|.|.    .|.|...         +..++.|||++|.+++..+.+|.++++|++|+|++|+
T Consensus         8 ~~~~~~~~~~~~~p~~~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~   87 (635)
T 4g8a_A            8 DDDDKLAAANSSIPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE   87 (635)
T ss_dssp             -----------------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             CCcchhhcccCCCCCCCCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCc
Confidence            33344566654432   235442    4667532         2356777777777775555567777777777777777


Q ss_pred             ccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCC-CC
Q 002321          112 LTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSP-LP  190 (936)
Q Consensus       112 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~  190 (936)
                      |+++.+.+|.+|++|++|+|++|+|+ .+|..+|.++++|++|+|++|+|++..+..|+++++|++|+|++|+|++. .|
T Consensus        88 i~~i~~~~f~~L~~L~~L~Ls~N~l~-~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~  166 (635)
T 4g8a_A           88 IQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP  166 (635)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTCCCC-EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCC
T ss_pred             CCCcChhHhcCCCCCCEEEccCCcCC-CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCc
Confidence            77666667777777777777777776 56666777777777777777777766666677777777777777777653 45


Q ss_pred             CCCCCCCCCCEEecCCCCCCCCCccCccCCCCcc----eeecccccccccCCcccccccCcceeeccccccCCC-Cchhh
Q 002321          191 LGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLR----VINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGN-LPETM  265 (936)
Q Consensus       191 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~~~~l  265 (936)
                      ..+..+++|++|+|++|+|++..+..+..+.+++    .++++.|.++...+..+ ....++.+++.+|..... .+..+
T Consensus       167 ~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~  245 (635)
T 4g8a_A          167 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCI  245 (635)
T ss_dssp             GGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHH
T ss_pred             hhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccchhh
Confidence            6666777777777777777766666665554433    46666777664443333 333455566655543311 11223


Q ss_pred             hccccccEEeccCcc------------------------------cc---CCCCcccccCCccceecccCceeccccCcc
Q 002321          266 QKLSLCNFMNLRKNL------------------------------FS---GEVPKWIGELESLETLDLSGNKFSGAVPIS  312 (936)
Q Consensus       266 ~~l~~L~~L~L~~N~------------------------------l~---~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  312 (936)
                      ..+..++...+..+.                              ..   ...+..+..+.+++.+++.+|.+....  .
T Consensus       246 ~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~  323 (635)
T 4g8a_A          246 QGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--D  323 (635)
T ss_dssp             HTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--G
T ss_pred             cCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc--c
Confidence            333333333222111                              11   011122233344555555555544222  1


Q ss_pred             cccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCC
Q 002321          313 IGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFE  392 (936)
Q Consensus       313 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~  392 (936)
                      +.....|+.|++.+|.+.+..+.   .+..|+.++++.|.+... +.......++.+.+..|.+.....  .+.....+.
T Consensus       324 ~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~-~~~~~l~~L~~L~ls~n~l~~~~~--~~~~~~~~~  397 (635)
T 4g8a_A          324 FSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA-FSEVDLPSLEFLDLSRNGLSFKGC--CSQSDFGTI  397 (635)
T ss_dssp             GGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB-CCCCBCTTCCEEECCSSCCBEEEE--CCHHHHSCS
T ss_pred             cccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCC-cccccccccccchhhccccccccc--cccchhhhh
Confidence            33344555555555555433221   234445555555544321 112222344555555554432211  111122344


Q ss_pred             cccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCC-ccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEe
Q 002321          393 SLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIP-VAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRL  471 (936)
Q Consensus       393 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  471 (936)
                      +|+.|+++.|.+.. .+..+..+++|+.+++++|......+ ..+..+++++.++++.|.+.+..+..+..+++|+.|+|
T Consensus       398 ~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~L  476 (635)
T 4g8a_A          398 SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM  476 (635)
T ss_dssp             CCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEEC
T ss_pred             hhhhhhcccccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhh
Confidence            55666666555542 33445566666677776666654333 35666777777777777777666666777777777777


Q ss_pred             cCCccC-CcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCcccc
Q 002321          472 ERNFLA-GKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQG  550 (936)
Q Consensus       472 s~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~  550 (936)
                      ++|.+. +..|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..+..+++|++|+|++|++++
T Consensus       477 s~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~  556 (635)
T 4g8a_A          477 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT  556 (635)
T ss_dssp             TTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCB
T ss_pred             hhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCC
Confidence            777643 3456677777777777777777776667777777777777777777776666667777777777777777776


Q ss_pred             cCCCC-Ccc-CcCCCccccCCCCCCCCCC
Q 002321          551 ELPAG-GFF-NTISPSSVLGNPSLCGSAV  577 (936)
Q Consensus       551 ~~p~~-~~~-~~~~~~~~~gn~~~c~~~~  577 (936)
                      .+|.. ..+ ..+....+.+|||.|+|.+
T Consensus       557 ~~~~~l~~l~~~L~~L~L~~Np~~C~C~~  585 (635)
T 4g8a_A          557 SKKQELQHFPSSLAFLNLTQNDFACTCEH  585 (635)
T ss_dssp             CCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred             CCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence            66542 112 3455566667777776655

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=426.32  Aligned_cols=237  Identities=22%  Similarity=0.333  Sum_probs=202.4

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..++||+|+||+||+|+++ +|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+.+..|+||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            45788889999999999999986 599999999975533 2346689999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      |+||+|.++++...    +++.++..|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+....  ..
T Consensus       230 ~~gG~L~~~i~~~~----l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~  303 (423)
T 4fie_A          230 LEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PR  303 (423)
T ss_dssp             CTTEEHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CC
T ss_pred             CCCCcHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--cc
Confidence            99999999997643    8999999999999999999999999999999999999999999999999998764322  22


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-------HHhhhccccceee
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-------EHWKKAEWRNVSM  921 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~  921 (936)
                      ....+||+.|||||++ ....|+.++||||+||++|||++|+.||.+.............       ....++++++++.
T Consensus       304 ~~~~~GTp~YmAPEvl-~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~  382 (423)
T 4fie_A          304 RKSLVGTPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD  382 (423)
T ss_dssp             BCCCEECTTTCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred             ccccccCcCcCCHHHH-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHH
Confidence            3456899999999998 5567999999999999999999999999887664433221111       1123467889999


Q ss_pred             ccccccccccccc
Q 002321          922 RSCKGSSRQRRRF  934 (936)
Q Consensus       922 ~~l~~~p~~Rp~f  934 (936)
                      +||..||.+||+.
T Consensus       383 ~~L~~dP~~R~ta  395 (423)
T 4fie_A          383 RLLVRDPAQRATA  395 (423)
T ss_dssp             HHSCSSTTTSCCH
T ss_pred             HHcCCChhHCcCH
Confidence            9999999999985

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5e-48  Score=417.75  Aligned_cols=235  Identities=20%  Similarity=0.253  Sum_probs=193.9

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .|+..++||+|+||+||+|+++ +|+.||||+++....      ..+|+.++++++|||||++++++.+++..++||||+
T Consensus        59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            4566778999999999999976 589999999975533      247999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-CeEEeeccCccccCCCcc---
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG-EPKVGDYGLARLLPMLDR---  845 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~---  845 (936)
                      +||+|.+++++...   +++.++..++.|++.||+|||+++|+||||||+|||++.+| .+||+|||+|+.+.....   
T Consensus       133 ~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~  209 (336)
T 4g3f_A          133 EGGSLGQLIKQMGC---LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS  209 (336)
T ss_dssp             TTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred             CCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence            99999999987543   99999999999999999999999999999999999999998 699999999987643221   


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HHHHHH------HHhhhccccc
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVTWLE------EHWKKAEWRN  918 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~~~~------~~~~~~~~~~  918 (936)
                      ........||+.|||||++. +..|+.++||||+||++|||++|+.||......... .....+      +...++.+++
T Consensus       210 ~~~~~~~~GT~~YmAPE~~~-~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~  288 (336)
T 4g3f_A          210 LLTGDYIPGTETHMAPEVVM-GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQ  288 (336)
T ss_dssp             ----CCCCCCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHH
T ss_pred             eecCCccccCccccCHHHHC-CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHH
Confidence            11233467999999999994 557999999999999999999999999876543222 111111      1224467889


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..||.+||+++
T Consensus       289 li~~~L~~dP~~R~sa~  305 (336)
T 4g3f_A          289 AIQEGLRKEPVHRASAM  305 (336)
T ss_dssp             HHHHHTCSSGGGSCCHH
T ss_pred             HHHHHccCCHhHCcCHH
Confidence            99999999999999863

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.5e-48  Score=423.89  Aligned_cols=246  Identities=27%  Similarity=0.347  Sum_probs=205.7

Q ss_pred             cccccCCCcccccCceEEEEEEeCC------CcEEEEEEeeccCccchHHHHHHHHHHHHcCCC-CCcceeeeEEEeC-C
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRD------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH-PNLVTLEGYYWTQ-S  760 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~-~  760 (936)
                      ...|+..++||+|+||+||+|++..      ++.||||+++........+++.+|++++++++| ||||+++|+|... .
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~  142 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  142 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence            4567888899999999999998652      357999999776555556789999999999965 8999999999764 5


Q ss_pred             eeEEEEEecCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSG-------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG  827 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~  827 (936)
                      ..++|||||++|+|.++++....             ...+++.++..++.|||+||+|||+++||||||||+|||+++++
T Consensus       143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~  222 (353)
T 4ase_A          143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN  222 (353)
T ss_dssp             CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCC
Confidence            68999999999999999975421             23589999999999999999999999999999999999999999


Q ss_pred             CeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH
Q 002321          828 EPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW  906 (936)
Q Consensus       828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~  906 (936)
                      .+||+|||+|+.+.............||+.|||||++. ...|+.++|||||||++|||+| |+.||.+.+.........
T Consensus       223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~-~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i  301 (353)
T 4ase_A          223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL  301 (353)
T ss_dssp             CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred             CEEECcchhhhhcccCCCceeeccccccccccCHHHHh-cCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99999999998775544444555677899999999984 5579999999999999999998 999998865432221111


Q ss_pred             ------HHHHhhhccccceeecccccccccccccC
Q 002321          907 ------LEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       907 ------~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                            ..|...++++++++.+||..||.+||+|+
T Consensus       302 ~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~  336 (353)
T 4ase_A          302 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS  336 (353)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHH
Confidence                  11345567899999999999999999984

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.2e-48  Score=414.41  Aligned_cols=239  Identities=25%  Similarity=0.310  Sum_probs=195.6

Q ss_pred             ccccCCCcccccCceEEEEEEeC----CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      ..|+..+.||+|+||+||+|+..    +++.||||+++..... .....+.+|++++++++|||||++++++.+++..++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            35788899999999999999863    4688999999654332 234568899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ||||++||+|.+++.+...   +++.++..++.|++.||+|||++||+||||||+|||++++|.+||+|||+|+......
T Consensus       104 vmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVM---FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEEcCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            9999999999999987653   9999999999999999999999999999999999999999999999999998653222


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhcccccee
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVS  920 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~  920 (936)
                        .......||+.|||||++ .+..|+.++||||+||++|||++|+.||...+.........    ..+...++++++++
T Consensus       181 --~~~~~~~GT~~YmAPE~~-~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  257 (304)
T 3ubd_A          181 --KKAYSFCGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL  257 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHH-HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             --ccccccccCcccCCHHHh-ccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence              233456799999999998 45578999999999999999999999998876643332211    11344567889999


Q ss_pred             eccccccccccccc
Q 002321          921 MRSCKGSSRQRRRF  934 (936)
Q Consensus       921 ~~~l~~~p~~Rp~f  934 (936)
                      .+||..||.+||+.
T Consensus       258 ~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          258 RMLFKRNPANRLGA  271 (304)
T ss_dssp             HHHTCSSGGGSTTC
T ss_pred             HHHcccCHHHCCCC
Confidence            99999999999973

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=7.9e-47  Score=448.20  Aligned_cols=458  Identities=20%  Similarity=0.235  Sum_probs=376.0

Q ss_pred             EEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccC
Q 002321           79 IELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAK  158 (936)
Q Consensus        79 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~  158 (936)
                      ..++++++++++ +|..+.  ++|++|+|++|+|++..+.+|.++++|++|+|++|+|+ .++++.|.++++|++|+|++
T Consensus        34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~  109 (562)
T 3a79_B           34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSH  109 (562)
T ss_dssp             CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCC-EECTTTTTTCTTCCEEECTT
T ss_pred             cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCC-cCCHHHhCCCCCCCEEECCC
Confidence            678888999985 777665  89999999999999888889999999999999999999 56777889999999999999


Q ss_pred             ccCCCCCCCCccccccccccccccccccCC-CCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCc--ceeecccccc--
Q 002321          159 NRFSGKIPSSLSLCSTLATINLSSNRFSSP-LPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNL--RVINLSKNMF--  233 (936)
Q Consensus       159 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~N~l--  233 (936)
                      |+|+ .+|..  .+++|++|+|++|++++. .|..|.++++|++|+|++|++++.   .+..+++|  ++|++++|++  
T Consensus       110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~  183 (562)
T 3a79_B          110 NRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHI  183 (562)
T ss_dssp             SCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCC
T ss_pred             CcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccc
Confidence            9999 45655  799999999999999984 468899999999999999999863   45555555  9999999999  


Q ss_pred             cccCCccccccc-CcceeeccccccCCCCch-hhhccccccEEeccCcc-----ccCCCCcccccCCccceecccCceec
Q 002321          234 SGSIPDGIGSCS-LLRTIDFSENSFSGNLPE-TMQKLSLCNFMNLRKNL-----FSGEVPKWIGELESLETLDLSGNKFS  306 (936)
Q Consensus       234 ~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~~-~l~~l~~L~~L~L~~N~-----l~~~~~~~~~~l~~L~~L~L~~N~l~  306 (936)
                      ++..|..|..+. ..-.+++++|.+.+.+++ .+..+++|+.+++++|.     +.+. ...+..+++|+.|+++++.++
T Consensus       184 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~-~~~l~~l~~L~~L~L~~~~l~  262 (562)
T 3a79_B          184 KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF-LSELTRGPTLLNVTLQHIETT  262 (562)
T ss_dssp             CSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHH-HHHHHSCSSCEEEEEEEEEEC
T ss_pred             cccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHH-HHHHhccCcceEEEecCCcCc
Confidence            888888887765 222668899998876654 46678899999999985     2222 235677888888888888876


Q ss_pred             cccCcc---cccccccceEEccCCcccccCChhh-----hccCCCCEEEccCCcCccCCChh-hh----ccCCccccccc
Q 002321          307 GAVPIS---IGNLQRLKVLNFSANRLTGSLPDSM-----ANCMNLVALDFSQNSMNGDLPQW-IF----SSGLNKVSFAE  373 (936)
Q Consensus       307 ~~~~~~---l~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~~~p~~-~~----~~~l~~l~l~~  373 (936)
                      +.....   ....++|++|++++|.+++.+|..+     ..++.|+.++++.|.+  .+|.. ++    ...++.|.+.+
T Consensus       263 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~  340 (562)
T 3a79_B          263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISD  340 (562)
T ss_dssp             HHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEES
T ss_pred             HHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccC
Confidence            432111   1123489999999999998888877     6777777777777777  55532 21    24688899999


Q ss_pred             cccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCC--CCccccCcccCCeeecCCcc
Q 002321          374 NKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGP--IPVAIGDLKALNVLDLSENW  451 (936)
Q Consensus       374 n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~  451 (936)
                      |.+.....      ...+++|++|++++|++++..|..+..+++|++|+|++|++++.  +|..++.+++|++|+|++|+
T Consensus       341 n~~~~~~~------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~  414 (562)
T 3a79_B          341 TPFIHMVC------PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNS  414 (562)
T ss_dssp             SCCCCCCC------CSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSC
T ss_pred             CCcccccC------ccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCc
Confidence            88754331      14678999999999999999999999999999999999999963  34679999999999999999


Q ss_pred             ccccCCC-CCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCc
Q 002321          452 LNGSIPP-EIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPK  530 (936)
Q Consensus       452 l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  530 (936)
                      +++.+|. .+..+++|++|+|++|++++.+|..+.  ++|++|+|++|+++ .+|..+..+++|++|+|++|+|+ .+|.
T Consensus       415 l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~  490 (562)
T 3a79_B          415 LNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPD  490 (562)
T ss_dssp             CBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCT
T ss_pred             CCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCH
Confidence            9985655 588999999999999999988887765  79999999999999 67887789999999999999999 5776


Q ss_pred             c-cccccccCeeecCCCcccccCCCCCccC
Q 002321          531 Q-LVNLVHLSSFNISHNHLQGELPAGGFFN  559 (936)
Q Consensus       531 ~-l~~l~~L~~L~ls~N~l~~~~p~~~~~~  559 (936)
                      . +..+++|+.|++++|+++|.+|..+++.
T Consensus       491 ~~~~~l~~L~~L~l~~N~~~c~c~~~~~~~  520 (562)
T 3a79_B          491 GVFDRLTSLQYIWLHDNPWDCTCPGIRYLS  520 (562)
T ss_dssp             TSTTTCTTCCCEECCSCCBCCCHHHHHHHH
T ss_pred             HHHhcCCCCCEEEecCCCcCCCcchHHHHH
Confidence            6 9999999999999999999988655533

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=6.1e-46  Score=399.01  Aligned_cols=240  Identities=21%  Similarity=0.281  Sum_probs=184.6

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC---------
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS---------  760 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---------  760 (936)
                      .|+..+.||+|+||+||+|+++ +|+.||||+++........+.+.+|++++++++|||||++++++.+.+         
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            3677789999999999999976 689999999976655455678999999999999999999999987544         


Q ss_pred             ---eeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCc
Q 002321          761 ---LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLA  837 (936)
Q Consensus       761 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  837 (936)
                         ..++||||+++|+|.+++.........++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla  165 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV  165 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccc
Confidence               36899999999999999987654344667778899999999999999999999999999999999999999999999


Q ss_pred             cccCCCccc----------cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH--HHH
Q 002321          838 RLLPMLDRY----------VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF--SVT  905 (936)
Q Consensus       838 ~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~--~~~  905 (936)
                      +........          .......||+.|||||++. +..|+.++||||+||++|||++   ||.........  ...
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~-~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~  241 (299)
T 4g31_A          166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH-GNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVR  241 (299)
T ss_dssp             --------------------------CCCTTSCHHHHT-TCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHH
T ss_pred             eecCCCccccccccccccccccCCcccCccccCHHHHc-CCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHh
Confidence            876432211          1223456999999999984 5579999999999999999996   88764321111  110


Q ss_pred             H--HHH--Hhhhccccceeeccccccccccccc
Q 002321          906 W--LEE--HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       906 ~--~~~--~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      .  .++  ....+...+++.+||..||.+||+.
T Consensus       242 ~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~  274 (299)
T 4g31_A          242 NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEA  274 (299)
T ss_dssp             TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCH
Confidence            0  011  1122456789999999999999985

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=1.6e-45  Score=437.07  Aligned_cols=455  Identities=20%  Similarity=0.215  Sum_probs=376.2

Q ss_pred             ccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccc
Q 002321          102 LRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLS  181 (936)
Q Consensus       102 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  181 (936)
                      .+++++++|++++ +|..+.  ++|++|||++|+|+ .++...|..+++|++|+|++|+|++..|..|+.+++|++|+|+
T Consensus        33 ~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  108 (562)
T 3a79_B           33 ESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS  108 (562)
T ss_dssp             CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCC-CCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCcc-ccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECC
Confidence            4899999999995 777664  89999999999999 6777889999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCCCCEEecCCCCCCCC-CccCccCCCCcceeecccccccccCCcccccccCc--ceeecccccc-
Q 002321          182 SNRFSSPLPLGIWGLSALRTLDLSDNLLEGE-IPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLL--RTIDFSENSF-  257 (936)
Q Consensus       182 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L--~~L~Ls~N~l-  257 (936)
                      +|+|+. +|..  .+++|++|+|++|++++. +|..|.++++|++|+|++|++++.   .+..+++|  ++|++++|++ 
T Consensus       109 ~N~l~~-lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~  182 (562)
T 3a79_B          109 HNRLQN-ISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYH  182 (562)
T ss_dssp             TSCCCE-ECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCC
T ss_pred             CCcCCc-cCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccc
Confidence            999995 5555  899999999999999963 468999999999999999999863   45666666  9999999999 


Q ss_pred             -CCCCchhhhccc-cccEEeccCccccCCCCc-ccccCCccceecccCce-----eccccCcccccccccceEEccCCcc
Q 002321          258 -SGNLPETMQKLS-LCNFMNLRKNLFSGEVPK-WIGELESLETLDLSGNK-----FSGAVPISIGNLQRLKVLNFSANRL  329 (936)
Q Consensus       258 -~~~~~~~l~~l~-~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~-----l~~~~~~~l~~l~~L~~L~L~~N~l  329 (936)
                       ++..|..+..+. ..-.++++.|.+.+.++. .+..+++|+.|++++|+     +.+. ...+..+++|+.|++.++.+
T Consensus       183 ~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~-~~~l~~l~~L~~L~L~~~~l  261 (562)
T 3a79_B          183 IKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF-LSELTRGPTLLNVTLQHIET  261 (562)
T ss_dssp             CCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHH-HHHHHSCSSCEEEEEEEEEE
T ss_pred             ccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHH-HHHHhccCcceEEEecCCcC
Confidence             888898888765 223568899998876665 56688999999999995     3322 23577888999999998887


Q ss_pred             cccC----ChhhhccCCCCEEEccCCcCccCCChhhhc---cCCccccccccccccCCCCCCCC-CCC---CCCcccEEe
Q 002321          330 TGSL----PDSMANCMNLVALDFSQNSMNGDLPQWIFS---SGLNKVSFAENKIREGMNGPFAS-SGS---SFESLQFLD  398 (936)
Q Consensus       330 ~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~---~~l~~l~l~~n~l~~~~~~~~~~-~~~---~l~~L~~L~  398 (936)
                      ++..    +..+ ...+|+.|++++|.+.|.+|..++.   ..++.|.+.++.....   .+|. .+.   ...+|++|+
T Consensus       262 ~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~---~~p~~~~~~~~~~~~L~~L~  337 (562)
T 3a79_B          262 TWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF---LFSKEALYSVFAEMNIKMLS  337 (562)
T ss_dssp             CHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC---SSCHHHHHHHHHTCCCSEEE
T ss_pred             cHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee---ecChhhhhhhhccCcceEEE
Confidence            7532    2222 2359999999999999999987753   4566666666555433   2221 000   124699999


Q ss_pred             ccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCcccccc--CCCCCCCcCCCcEEEecCCcc
Q 002321          399 LSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGS--IPPEIGGAYSLKELRLERNFL  476 (936)
Q Consensus       399 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l  476 (936)
                      +++|.+....  ....+++|++|+|++|++++.+|..++.+++|++|+|++|++++.  +|..+.++++|+.|+|++|++
T Consensus       338 l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l  415 (562)
T 3a79_B          338 ISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSL  415 (562)
T ss_dssp             EESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCC
T ss_pred             ccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcC
Confidence            9999986432  226889999999999999998999999999999999999999973  356789999999999999999


Q ss_pred             CCcCcc-ccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCcccccCCCC
Q 002321          477 AGKIPT-SIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAG  555 (936)
Q Consensus       477 ~~~~p~-~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~  555 (936)
                      ++.+|. .+..+++|++|+|++|++++.+|..+.  ++|++|+|++|+|+ .+|..+..+++|++|+|++|+++ .+|..
T Consensus       416 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~  491 (562)
T 3a79_B          416 NSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDG  491 (562)
T ss_dssp             BSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTT
T ss_pred             CCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHH
Confidence            985665 588999999999999999987777665  79999999999998 78988889999999999999999 46653


Q ss_pred             --CccCcCCCccccCCCCCCCCCC
Q 002321          556 --GFFNTISPSSVLGNPSLCGSAV  577 (936)
Q Consensus       556 --~~~~~~~~~~~~gn~~~c~~~~  577 (936)
                        ..+..+....+.+||+.|+++.
T Consensus       492 ~~~~l~~L~~L~l~~N~~~c~c~~  515 (562)
T 3a79_B          492 VFDRLTSLQYIWLHDNPWDCTCPG  515 (562)
T ss_dssp             STTTCTTCCCEECCSCCBCCCHHH
T ss_pred             HHhcCCCCCEEEecCCCcCCCcch
Confidence              4566777888899999998765

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.8e-45  Score=397.67  Aligned_cols=237  Identities=22%  Similarity=0.284  Sum_probs=182.1

Q ss_pred             ccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC----eeEEEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS----LQLLIYE  767 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e  767 (936)
                      +...++||+|+||+||+|+++ |+.||||+++...  ......++|+..+.+++|||||++++++.+++    ..++|||
T Consensus         5 i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            5 IVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             EEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            455678999999999999985 8999999996442  12233445666778899999999999998653    5689999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS--------NIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~--------~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      |+++|+|.++++...    +++..+.+++.|+++||+|||++        +|+||||||+|||++.++++||+|||+|+.
T Consensus        82 y~~~gsL~~~l~~~~----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           82 YHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             CCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCCCCcHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            999999999998653    89999999999999999999986        999999999999999999999999999987


Q ss_pred             cCCCccc--cccccccCcccccCcccccCcc-----cCCchhhHHHHHHHHHHHHcCCCCCCccchh------------H
Q 002321          840 LPMLDRY--VLSSKIQSALGYMAPEFACRTV-----KITDKCDVYGFGVLVLEVVTGKRPLSTWKMM------------W  900 (936)
Q Consensus       840 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~------------~  900 (936)
                      .......  .......||+.|||||++.+..     .++.++|||||||++|||+||..||......            .
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~  237 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence            6433222  1223457999999999885432     4678999999999999999998776432210            0


Q ss_pred             HHHH-HHH-H--------HHh----hhccccceeecccccccccccccC
Q 002321          901 WFSV-TWL-E--------EHW----KKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       901 ~~~~-~~~-~--------~~~----~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .... ... .        ..+    ....+.+++.+||..||.+||+|+
T Consensus       238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  286 (303)
T 3hmm_A          238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL  286 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHH
T ss_pred             HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHH
Confidence            0000 000 0        011    113567899999999999999984

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=2e-44  Score=416.60  Aligned_cols=378  Identities=20%  Similarity=0.220  Sum_probs=282.5

Q ss_pred             ccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccc
Q 002321          100 QFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATIN  179 (936)
Q Consensus       100 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  179 (936)
                      ++|++|+|++|+|++..|..|.++++|++|+|++|.+.+.++...|.++++|++|+|++|++++..|..|+.+++|++|+
T Consensus        30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  109 (455)
T 3v47_A           30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT  109 (455)
T ss_dssp             TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred             CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence            78999999999999888999999999999999999998888888899999999999999999888888888888888888


Q ss_pred             cccccccCCCCC--CCCCCCCCCEEecCCCCCCCCCccC-ccCCCCcceeecccccccccCCcccccc--cCcceeeccc
Q 002321          180 LSSNRFSSPLPL--GIWGLSALRTLDLSDNLLEGEIPKG-VESLKNLRVINLSKNMFSGSIPDGIGSC--SLLRTIDFSE  254 (936)
Q Consensus       180 L~~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~l~~l--~~L~~L~Ls~  254 (936)
                      |++|++++..+.  .|..+++|++|+|++|++++..|.. +.++++|++|+|++|++++..+..+..+  .+|+.|++++
T Consensus       110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~  189 (455)
T 3v47_A          110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS  189 (455)
T ss_dssp             CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred             CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence            888888874443  3788888888888888888776765 6778888888888888887777777665  5677777777


Q ss_pred             cccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccc---cccceEEccCCcccc
Q 002321          255 NSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNL---QRLKVLNFSANRLTG  331 (936)
Q Consensus       255 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l---~~L~~L~L~~N~l~~  331 (936)
                      |.+.+..+..+..                .....+..+++|++|++++|++++..|..+..+   ++|+.|++++|.+.+
T Consensus       190 n~l~~~~~~~~~~----------------~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~  253 (455)
T 3v47_A          190 ITLQDMNEYWLGW----------------EKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG  253 (455)
T ss_dssp             CBCTTCSTTCTTH----------------HHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTS
T ss_pred             Ccccccchhhccc----------------cccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccc
Confidence            7766543332210                001123356788888888888887777666544   566677776666543


Q ss_pred             cCChhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhh
Q 002321          332 SLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPAT  411 (936)
Q Consensus       332 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  411 (936)
                      ..              +..+.+.                                                   +..+..
T Consensus       254 ~~--------------~~~~~~~---------------------------------------------------~~~~~~  268 (455)
T 3v47_A          254 SS--------------FGHTNFK---------------------------------------------------DPDNFT  268 (455)
T ss_dssp             CC--------------TTCCSSC---------------------------------------------------CCCTTT
T ss_pred             cc--------------cchhhhc---------------------------------------------------cCcccc
Confidence            21              0111111                                                   111111


Q ss_pred             hcc--cccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccc
Q 002321          412 IGA--LSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSS  489 (936)
Q Consensus       412 ~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~  489 (936)
                      +..  .++|++|++++|++++.+|..++.+++|++|+|++|++++..|..+.++++|+.|+|++|++++..|..|.++++
T Consensus       269 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  348 (455)
T 3v47_A          269 FKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDK  348 (455)
T ss_dssp             TGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTT
T ss_pred             cccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCccc
Confidence            111  245666666666666666666777777777777777777767777777888888888888887777788888888


Q ss_pred             cccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCcccccCCCCCcc
Q 002321          490 LVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFF  558 (936)
Q Consensus       490 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~  558 (936)
                      |++|+|++|++++..|..|..+++|++|+|++|+|++..+..+..+++|++|+|++|+++|.+|...++
T Consensus       349 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~l  417 (455)
T 3v47_A          349 LEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL  417 (455)
T ss_dssp             CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHH
T ss_pred             CCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcchHH
Confidence            888888888888777888888889999999999988666667788899999999999999988865443

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1.6e-44  Score=394.24  Aligned_cols=295  Identities=34%  Similarity=0.564  Sum_probs=260.3

Q ss_pred             CChhHHHHHHHHHHhccCCCCCCCCCCCCCCCCcc--ceeEEecCCC--CceEEeccCCCCCCc--ccccccccCccccE
Q 002321           31 SLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCN--WFGVKCSPRS--NRVIELTLNGLSLTG--RIGRGLLQLQFLRK  104 (936)
Q Consensus        31 ~~~~~~~aLl~~k~~~~d~~~~l~sW~~~~~~~c~--w~gv~c~~~~--~~v~~l~l~~~~l~g--~~~~~l~~l~~L~~  104 (936)
                      |.++|++||++||+++.||. .+++|..+++ ||.  |.||+|+..+  ++|+.|+|++++++|  .+|+.++++++|++
T Consensus         3 c~~~~~~aL~~~k~~~~~~~-~l~~W~~~~~-~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~   80 (313)
T 1ogq_A            3 CNPQDKQALLQIKKDLGNPT-TLSSWLPTTD-CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF   80 (313)
T ss_dssp             SCHHHHHHHHHHHHHTTCCG-GGTTCCTTSC-TTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred             CCHHHHHHHHHHHHhcCCcc-cccCCCCCCC-CCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCe
Confidence            56799999999999999886 7899987666 888  9999998765  899999999999999  89999999999999


Q ss_pred             EeccC-CcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccc
Q 002321          105 LSLSS-NNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSN  183 (936)
Q Consensus       105 L~L~~-n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  183 (936)
                      |+|++ |++++.+|..|.++++|++|+|++|++++.+|. .|..+++|++|+|++|+|++.+|..|+.+++|++|+|++|
T Consensus        81 L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  159 (313)
T 1ogq_A           81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD-FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN  159 (313)
T ss_dssp             EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCG-GGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred             eeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCH-HHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence            99995 999999999999999999999999999977765 5788999999999999999889999999999999999999


Q ss_pred             cccCCCCCCCCCCC-CCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCc
Q 002321          184 RFSSPLPLGIWGLS-ALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLP  262 (936)
Q Consensus       184 ~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~  262 (936)
                      ++++.+|..+..++ +|++|+|++|++++.+|..+..++ |++|+|++|++++..|..|..+++|++|+|++|++++.+|
T Consensus       160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  238 (313)
T 1ogq_A          160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG  238 (313)
T ss_dssp             CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG
T ss_pred             cccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecC
Confidence            99988898898888 899999999999988888888887 9999999999988888888899999999999999887666


Q ss_pred             hhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCc-ccc
Q 002321          263 ETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANR-LTG  331 (936)
Q Consensus       263 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~-l~~  331 (936)
                      . +..+++|+.|+|++|++++.+|.++..+++|++|+|++|++++.+|.. ..+++|+.|++++|+ +.|
T Consensus       239 ~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~  306 (313)
T 1ogq_A          239 K-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG  306 (313)
T ss_dssp             G-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEES
T ss_pred             c-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCCCccC
Confidence            5 777888888888888888888888888888888888888888777765 778888888888887 554

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=8.7e-44  Score=411.27  Aligned_cols=386  Identities=18%  Similarity=0.214  Sum_probs=265.4

Q ss_pred             cEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCC-CCCccccccccccccc
Q 002321          103 RKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKI-PSSLSLCSTLATINLS  181 (936)
Q Consensus       103 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~  181 (936)
                      +.++.++++++ .+|. +  .++|++|||++|+|+ .+++..|..+++|++|+|++|.+.+.+ +..|..+++|++|+|+
T Consensus        13 ~~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls   87 (455)
T 3v47_A           13 YNAICINRGLH-QVPE-L--PAHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD   87 (455)
T ss_dssp             TEEECCSSCCS-SCCC-C--CTTCCEEECCSSCCC-EECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECT
T ss_pred             cccCcCCCCcc-cCCC-C--CCccCEEEecCCccC-cCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCC
Confidence            45667777776 3444 2  266777777777776 444455667777777777777665433 4456666666666666


Q ss_pred             cccccCCCCCCCCCCCCCCEEecCCCCCCCCCccC--ccCCCCcceeecccccccccCCcc-cccccCcceeeccccccC
Q 002321          182 SNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKG--VESLKNLRVINLSKNMFSGSIPDG-IGSCSLLRTIDFSENSFS  258 (936)
Q Consensus       182 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~  258 (936)
                      +|++++..|..|.++++|++|+|++|++++.++..  +.++++|++|+|++|++++..|.. +..+++|++|++++|+++
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~  167 (455)
T 3v47_A           88 YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK  167 (455)
T ss_dssp             TCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBS
T ss_pred             CCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccc
Confidence            66666666666666666666666666666544333  556666666666666666554544 555556666666555555


Q ss_pred             CCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcc--------cccccccceEEccCCccc
Q 002321          259 GNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPIS--------IGNLQRLKVLNFSANRLT  330 (936)
Q Consensus       259 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~--------l~~l~~L~~L~L~~N~l~  330 (936)
                      +..+..+..+.                      ..+|+.|++++|.+.+..+..        +..+++|+.|++++|+++
T Consensus       168 ~~~~~~l~~l~----------------------~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~  225 (455)
T 3v47_A          168 SICEEDLLNFQ----------------------GKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFK  225 (455)
T ss_dssp             CCCTTTSGGGT----------------------TCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCC
T ss_pred             ccChhhhhccc----------------------cccccccccccCcccccchhhccccccccccccceeeeEecCCCccc
Confidence            54444443331                      034455555555544332221        223455555666655555


Q ss_pred             ccCChhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChh
Q 002321          331 GSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPA  410 (936)
Q Consensus       331 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  410 (936)
                      +..|..+....                                                ..++|+.|++++|.+.+..  
T Consensus       226 ~~~~~~~~~~~------------------------------------------------~~~~L~~L~l~~~~~~~~~--  255 (455)
T 3v47_A          226 ESMAKRFFDAI------------------------------------------------AGTKIQSLILSNSYNMGSS--  255 (455)
T ss_dssp             HHHHHHHHHHT------------------------------------------------TTCCEEEEECTTCTTTSCC--
T ss_pred             ccchhhhhccc------------------------------------------------cccceeeEeeccccccccc--
Confidence            54444443320                                                1246777777777765431  


Q ss_pred             hhcccccCCeeeccCccccCCCCccccCc--ccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCcccccccc
Q 002321          411 TIGALSGLQLLNLSRNSLVGPIPVAIGDL--KALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCS  488 (936)
Q Consensus       411 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~  488 (936)
                                  +..+.+.+..+..+..+  ++|+.|++++|.+++..|..+..+++|++|+|++|++++..|..|.+++
T Consensus       256 ------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~  323 (455)
T 3v47_A          256 ------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLT  323 (455)
T ss_dssp             ------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred             ------------cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcc
Confidence                        12233333333344433  6899999999999999999999999999999999999988899999999


Q ss_pred             ccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCcccccCCCC-CccCcCCCcccc
Q 002321          489 SLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAG-GFFNTISPSSVL  567 (936)
Q Consensus       489 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~-~~~~~~~~~~~~  567 (936)
                      +|++|+|++|++++..|..+..+++|++|+|++|++++..|..+..+++|++|+|++|++++..+.. ..+..+....+.
T Consensus       324 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  403 (455)
T 3v47_A          324 HLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLH  403 (455)
T ss_dssp             TCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred             cCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEcc
Confidence            9999999999999888999999999999999999999888999999999999999999999755432 456778888899


Q ss_pred             CCCCCCCCCC
Q 002321          568 GNPSLCGSAV  577 (936)
Q Consensus       568 gn~~~c~~~~  577 (936)
                      +|++.|.++.
T Consensus       404 ~N~l~~~~~~  413 (455)
T 3v47_A          404 TNPWDCSCPR  413 (455)
T ss_dssp             SSCBCCCTTT
T ss_pred             CCCcccCCCc
Confidence            9999999873

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.6e-44  Score=398.53  Aligned_cols=241  Identities=20%  Similarity=0.282  Sum_probs=196.2

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeC------Ce
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ------SL  761 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  761 (936)
                      ..|+..++||+|+||+||+|+++ +|+.||||+++..... ...+.+.+|+++|++++|||||++++++...      ..
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            35788889999999999999976 6999999999654332 3356788999999999999999999997643      56


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .|+|||||+ |+|.+++....   .+++.++..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+.
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC  209 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred             EEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence            799999995 78999997654   39999999999999999999999999999999999999999999999999998764


Q ss_pred             CCc--cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-----------
Q 002321          842 MLD--RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-----------  908 (936)
Q Consensus       842 ~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-----------  908 (936)
                      ...  .........||+.|||||++.+..+++.++||||+||++|||++|+.||.+.+...........           
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~  289 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA  289 (398)
T ss_dssp             ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred             cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            321  1223345689999999999877677899999999999999999999999887653322111000           


Q ss_pred             ----------------------H--Hhhhccccceeeccccccccccccc
Q 002321          909 ----------------------E--HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       909 ----------------------~--~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                            .  .-.+++..+++.+||..||.+||+-
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta  339 (398)
T 4b99_A          290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISA  339 (398)
T ss_dssp             ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCH
Confidence                                  0  0123456789999999999999974

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=9.4e-43  Score=399.25  Aligned_cols=388  Identities=24%  Similarity=0.328  Sum_probs=213.2

Q ss_pred             CceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCC-------------cEEEccCcccccccch
Q 002321           76 NRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNL-------------RVIDLSGNSLSGSIPD  142 (936)
Q Consensus        76 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L-------------~~L~Ls~N~l~~~i~~  142 (936)
                      .++..++++++++ |.+|++++++++|++|++++|+++|.+|.+++++++|             ++|++++|++++ +|.
T Consensus        11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~   88 (454)
T 1jl5_A           11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPE   88 (454)
T ss_dssp             ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCS
T ss_pred             ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCC
Confidence            5677888888888 7888888999999999999988888888888887765             777777777773 443


Q ss_pred             hhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCC
Q 002321          143 EFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKN  222 (936)
Q Consensus       143 ~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  222 (936)
                          -.++|++|+|++|++++ +|..   +++|++|++++|++++. +..   .++|++|+|++|++++ +| .+.++++
T Consensus        89 ----~~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~  154 (454)
T 1jl5_A           89 ----LPPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK-LP-ELQNSSF  154 (454)
T ss_dssp             ----CCTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS-CC-CCTTCTT
T ss_pred             ----CcCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC-Cc-ccCCCCC
Confidence                23677777777777776 5543   36777777777777752 211   2577777777777774 55 4777777


Q ss_pred             cceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccC
Q 002321          223 LRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSG  302 (936)
Q Consensus       223 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  302 (936)
                      |++|++++|++++ +|..+   .+|++|++++|++++ +| .+..+++|+.|++++|.+++ +|..   .++|++|++++
T Consensus       155 L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~  224 (454)
T 1jl5_A          155 LKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL---PLSLESIVAGN  224 (454)
T ss_dssp             CCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC---CTTCCEEECCS
T ss_pred             CCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC---cCcccEEECcC
Confidence            7777777777774 44433   467777777777775 34 46777777777777777765 3332   24677777777


Q ss_pred             ceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCC
Q 002321          303 NKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNG  382 (936)
Q Consensus       303 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~  382 (936)
                      |+++ .+| .++.+++|++|++++|++++ +|..   .++|+.|++++|++.+ +|..                      
T Consensus       225 n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~----------------------  275 (454)
T 1jl5_A          225 NILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL----------------------  275 (454)
T ss_dssp             SCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC----------------------
T ss_pred             CcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc----------------------
Confidence            7776 455 36677777777777777764 3332   3567777777776653 2211                      


Q ss_pred             CCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCc-ccCCeeecCCccccccCCCCCC
Q 002321          383 PFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDL-KALNVLDLSENWLNGSIPPEIG  461 (936)
Q Consensus       383 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~  461 (936)
                              +++|++|++++|++++.. .   ..++|++|++++|++++ ++    .+ ++|++|++++|++++ +|..  
T Consensus       276 --------~~~L~~L~ls~N~l~~l~-~---~~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~--  335 (454)
T 1jl5_A          276 --------PQSLTFLDVSENIFSGLS-E---LPPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL--  335 (454)
T ss_dssp             --------CTTCCEEECCSSCCSEES-C---CCTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC--
T ss_pred             --------cCcCCEEECcCCccCccc-C---cCCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc--
Confidence                    245666666666665421 1   11456666666666653 11    22 366666666666664 4433  


Q ss_pred             CcCCCcEEEecCCccCCcCccccccccccccccccCccccC--CCcccccccCCccEEEcCCCcccCCCCcccccccccC
Q 002321          462 GAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTG--PIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLS  539 (936)
Q Consensus       462 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~  539 (936)
                       +++|+.|++++|+++ .+|.   .+++|++|+|++|++++  .+|.++..+        +.|.+.|.+|..   +++|+
T Consensus       336 -~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~i~~~---~~~L~  399 (454)
T 1jl5_A          336 -PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLAEVPEL---PQNLK  399 (454)
T ss_dssp             -CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC----------------
T ss_pred             -CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------hhcccccccccc---cCcCC
Confidence             356666666666666 3444   35666666666666665  455544432        234444455442   35667


Q ss_pred             eeecCCCcccc--cCCC
Q 002321          540 SFNISHNHLQG--ELPA  554 (936)
Q Consensus       540 ~L~ls~N~l~~--~~p~  554 (936)
                      .|++++|+++|  .+|.
T Consensus       400 ~L~ls~N~l~~~~~iP~  416 (454)
T 1jl5_A          400 QLHVETNPLREFPDIPE  416 (454)
T ss_dssp             -----------------
T ss_pred             EEECCCCcCCccccchh
Confidence            77777777776  5553

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4e-43  Score=387.67  Aligned_cols=199  Identities=21%  Similarity=0.319  Sum_probs=170.6

Q ss_pred             ccccCCCcccccCceEEEEEEeC----CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  764 (936)
                      +.|+..++||+|+||+||+|+.+    +++.||||++....   ...++.+|+++++++ +||||+++++++.+.+..++
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l   97 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI   97 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence            45788899999999999999864    46789999986542   346688999999998 69999999999999999999


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-CCeEEeeccCccccCCC
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS-GEPKVGDYGLARLLPML  843 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~  843 (936)
                      ||||+++|+|.++++.      +++.++..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus        98 vmE~~~g~~L~~~~~~------l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~  171 (361)
T 4f9c_A           98 AMPYLEHESFLDILNS------LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT  171 (361)
T ss_dssp             EEECCCCCCHHHHHTT------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred             EEeCCCcccHHHHHcC------CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence            9999999999999853      8999999999999999999999999999999999999877 89999999999865422


Q ss_pred             ccc--------------------------cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccc
Q 002321          844 DRY--------------------------VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWK  897 (936)
Q Consensus       844 ~~~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~  897 (936)
                      ...                          .......||+.|||||++.+...|+.++||||+||++|||++|+.||...+
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence            110                          112235699999999998776679999999999999999999999996543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.1e-43  Score=406.47  Aligned_cols=239  Identities=21%  Similarity=0.284  Sum_probs=197.8

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHH---HHHHHHHcCCCCCcceeeeEEEeCCee
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFE---REVKKLGKVRHPNLVTLEGYYWTQSLQ  762 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~  762 (936)
                      -+.|+..+.||+|+||+||+|+.+ +|+.||||++......  .....+.   +++.+++.++|||||++++++.+.+..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            345788899999999999999977 5999999999654321  1223333   346677788999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCC
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM  842 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  842 (936)
                      |+||||++||+|.+++.+...   +++..+..++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+..
T Consensus       268 ylVmEy~~GGdL~~~l~~~~~---l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            999999999999999987653   99999999999999999999999999999999999999999999999999987643


Q ss_pred             CccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHH---HHHHHH----HHHhhhcc
Q 002321          843 LDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWW---FSVTWL----EEHWKKAE  915 (936)
Q Consensus       843 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~---~~~~~~----~~~~~~~~  915 (936)
                      ..    ....+||+.|||||++.++..|+.++||||+||++|||++|+.||.+.+....   ......    .+...+++
T Consensus       345 ~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~  420 (689)
T 3v5w_A          345 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE  420 (689)
T ss_dssp             CC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             CC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHH
Confidence            22    24468999999999986666799999999999999999999999987543211   111111    12334577


Q ss_pred             ccceeeccccccccccccc
Q 002321          916 WRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f  934 (936)
                      +++++.+||..||.+|++.
T Consensus       421 a~dLI~~lL~~dP~~Rl~~  439 (689)
T 3v5w_A          421 LRSLLEGLLQRDVNRRLGC  439 (689)
T ss_dssp             HHHHHHHHTCSCGGGCTTC
T ss_pred             HHHHHHHHccCCHhHCCCC
Confidence            8999999999999999874

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=5.6e-42  Score=392.82  Aligned_cols=391  Identities=22%  Similarity=0.276  Sum_probs=267.8

Q ss_pred             cccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCC-------------CcEEEccCcc
Q 002321           94 RGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGS-------------LRVISLAKNR  160 (936)
Q Consensus        94 ~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~-------------L~~L~L~~N~  160 (936)
                      |.-...++|++|++++|++ +.+|++|+++++|++|++++|+++|.+|.. ++.+++             |++|++++|.
T Consensus         5 p~~~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~-~~~l~~L~~l~l~~c~~~~l~~L~l~~~~   82 (454)
T 1jl5_A            5 PRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPG-NGEQREMAVSRLRDCLDRQAHELELNNLG   82 (454)
T ss_dssp             ------------------------------CCHHHHHHHHHHHHHTSCTT-SCCCHHHHHHHHHHHHHHTCSEEECTTSC
T ss_pred             ccccccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcc-cccchhcchhhhhhhhccCCCEEEecCCc
Confidence            3334568999999999999 789999999999999999999999888865 455554             5999999999


Q ss_pred             CCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcc
Q 002321          161 FSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDG  240 (936)
Q Consensus       161 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  240 (936)
                      +++ +|..   .++|++|++++|++++ +|..   +++|++|++++|++++ +|..   .++|++|++++|++++ +| .
T Consensus        83 l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~  148 (454)
T 1jl5_A           83 LSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-E  148 (454)
T ss_dssp             CSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-C
T ss_pred             ccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-c
Confidence            986 3432   3789999999999998 5543   4789999999999985 3322   1689999999999986 66 5


Q ss_pred             cccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccc
Q 002321          241 IGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLK  320 (936)
Q Consensus       241 l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~  320 (936)
                      |+.+++|++|++++|++++ +|..+   .+|+.|++++|.+++ +| .++.+++|++|++++|++++ +|...   ++|+
T Consensus       149 ~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~  218 (454)
T 1jl5_A          149 LQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLE  218 (454)
T ss_dssp             CTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCC
T ss_pred             cCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---Cccc
Confidence            8999999999999999986 45433   488999999999987 45 58889999999999999985 44322   5899


Q ss_pred             eEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEecc
Q 002321          321 VLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLS  400 (936)
Q Consensus       321 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls  400 (936)
                      +|++++|+++ .+|. +..+++|+.|++++|++++ +|.                              .+++|++|+++
T Consensus       219 ~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~------------------------------~~~~L~~L~l~  265 (454)
T 1jl5_A          219 SIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPD------------------------------LPPSLEALNVR  265 (454)
T ss_dssp             EEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCS------------------------------CCTTCCEEECC
T ss_pred             EEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-ccc------------------------------cccccCEEECC
Confidence            9999999998 5664 8889999999999998863 221                              13689999999


Q ss_pred             CcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcC
Q 002321          401 HNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKI  480 (936)
Q Consensus       401 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  480 (936)
                      +|++++ +|..   .++|++|++++|++++. |..   .++|++|++++|++++ ++..   .++|+.|++++|++++ +
T Consensus       266 ~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls~N~l~~-l  332 (454)
T 1jl5_A          266 DNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLIE-L  332 (454)
T ss_dssp             SSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-ECCC---CTTCCEEECCSSCCSC-C
T ss_pred             CCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-ccCC---cCcCCEEECCCCcccc-c
Confidence            999986 4443   47899999999999862 211   2689999999999986 3321   2589999999999995 6


Q ss_pred             ccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccC--CCCcccccccccCeeecCCCcccccCCCCCcc
Q 002321          481 PTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTG--GLPKQLVNLVHLSSFNISHNHLQGELPAGGFF  558 (936)
Q Consensus       481 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~  558 (936)
                      |..   +++|++|++++|++++ +|.   .+++|++|+|++|++++  .+|.++..        ++.|++.|.+|.  ..
T Consensus       333 p~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~--~~  395 (454)
T 1jl5_A          333 PAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPE--LP  395 (454)
T ss_dssp             CCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC-----------
T ss_pred             ccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhccccccccc--cc
Confidence            664   5899999999999994 666   47899999999999998  67776654        346888888886  34


Q ss_pred             CcCCCccccCCCCCC
Q 002321          559 NTISPSSVLGNPSLC  573 (936)
Q Consensus       559 ~~~~~~~~~gn~~~c  573 (936)
                      ..+....+.+|+...
T Consensus       396 ~~L~~L~ls~N~l~~  410 (454)
T 1jl5_A          396 QNLKQLHVETNPLRE  410 (454)
T ss_dssp             ---------------
T ss_pred             CcCCEEECCCCcCCc
Confidence            667777777886543

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=3.4e-41  Score=406.93  Aligned_cols=472  Identities=21%  Similarity=0.196  Sum_probs=380.0

Q ss_pred             CceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEE
Q 002321           76 NRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVIS  155 (936)
Q Consensus        76 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~  155 (936)
                      .+++.|+|++|.+++..+.+|.+|++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+|...|+++++|++|+
T Consensus        76 ~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~~L~  154 (635)
T 4g8a_A           76 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELN  154 (635)
T ss_dssp             TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCC-CSTTCCCTTCTTCCEEE
T ss_pred             CCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCC-CCChhhhhcCcccCeec
Confidence            57899999999999776778999999999999999999877788999999999999999999 68888899999999999


Q ss_pred             ccCccCCCC-CCCCccccccccccccccccccCCCCCCCCCCCCC----CEEecCCCCCCCCCccCccCCCCcceeeccc
Q 002321          156 LAKNRFSGK-IPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSAL----RTLDLSDNLLEGEIPKGVESLKNLRVINLSK  230 (936)
Q Consensus       156 L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L----~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  230 (936)
                      |++|+|++. .|..++.+++|++|+|++|+|++..+..|..+.++    ..++++.|.++...+..+ ....++.+++.+
T Consensus       155 Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~  233 (635)
T 4g8a_A          155 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRN  233 (635)
T ss_dssp             CCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEES
T ss_pred             cccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhc
Confidence            999999864 67888999999999999999999888888766554    478999999985544444 445677777777


Q ss_pred             cccccc-CCcccccccCcc------------------------------eeeccccccCC---CCchhhhccccccEEec
Q 002321          231 NMFSGS-IPDGIGSCSLLR------------------------------TIDFSENSFSG---NLPETMQKLSLCNFMNL  276 (936)
Q Consensus       231 N~l~~~-~p~~l~~l~~L~------------------------------~L~Ls~N~l~~---~~~~~l~~l~~L~~L~L  276 (936)
                      |..+.. .+..+..+..++                              .+++..+....   ..+..+..+..++.+.+
T Consensus       234 n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~  313 (635)
T 4g8a_A          234 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSL  313 (635)
T ss_dssp             CCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEE
T ss_pred             ccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccc
Confidence            754321 122233333333                              33333332221   12334555667888888


Q ss_pred             cCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCcc-
Q 002321          277 RKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNG-  355 (936)
Q Consensus       277 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-  355 (936)
                      ..|.+....  .+....+|+.|++.+|.+.+..+   ..+..|+.+++..|.+...  .....+++|+.|++++|.+.. 
T Consensus       314 ~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~---~~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~  386 (635)
T 4g8a_A          314 VSVTIERVK--DFSYNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFK  386 (635)
T ss_dssp             ESCEEEECG--GGGSCCCCSEEEEESCEESSCCC---CBCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEE
T ss_pred             ccccccccc--ccccchhhhhhhcccccccCcCc---ccchhhhhcccccccCCCC--cccccccccccchhhccccccc
Confidence            888876543  35667789999999999985544   3567889999999988743  345578999999999999863 


Q ss_pred             -CCChhhh-ccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCC-hhhhcccccCCeeeccCccccCCC
Q 002321          356 -DLPQWIF-SSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGET-PATIGALSGLQLLNLSRNSLVGPI  432 (936)
Q Consensus       356 -~~p~~~~-~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~  432 (936)
                       ..+...+ ...++.+++..+.+....     ..+..+++|+.+++++|++.... +..+..+++++.+++++|.+.+..
T Consensus       387 ~~~~~~~~~~~~L~~L~~~~~~~~~~~-----~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~  461 (635)
T 4g8a_A          387 GCCSQSDFGTISLKYLDLSFNGVITMS-----SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF  461 (635)
T ss_dssp             EECCHHHHSCSCCCEEECCSCSEEEEC-----SCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECC
T ss_pred             cccccchhhhhhhhhhhcccccccccc-----ccccccccccchhhhhcccccccccccccccccccccccccccccccc
Confidence             2333332 256777887777765433     33456899999999998876554 456889999999999999999999


Q ss_pred             CccccCcccCCeeecCCcccc-ccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCccccccc
Q 002321          433 PVAIGDLKALNVLDLSENWLN-GSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKL  511 (936)
Q Consensus       433 ~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l  511 (936)
                      +..+..+++|+.|+|++|.+. +..|..+..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+
T Consensus       462 ~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l  541 (635)
T 4g8a_A          462 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL  541 (635)
T ss_dssp             TTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTC
T ss_pred             ccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCC
Confidence            999999999999999999854 4678899999999999999999999999999999999999999999999999999999


Q ss_pred             CCccEEEcCCCcccCCCCcccccc-cccCeeecCCCcccccCCCCCccCcC
Q 002321          512 TNLQNVDLSFNSLTGGLPKQLVNL-VHLSSFNISHNHLQGELPAGGFFNTI  561 (936)
Q Consensus       512 ~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~L~ls~N~l~~~~p~~~~~~~~  561 (936)
                      ++|++|||++|+|++..|..+..+ ++|+.|+|++|+|.+.+...++..++
T Consensus       542 ~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~~~~wl  592 (635)
T 4g8a_A          542 NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWI  592 (635)
T ss_dssp             TTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHHHHHHH
T ss_pred             CCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHHHHHHH
Confidence            999999999999999999999998 68999999999999988765554443

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=8.4e-41  Score=383.42  Aligned_cols=363  Identities=19%  Similarity=0.197  Sum_probs=273.9

Q ss_pred             CCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCC
Q 002321           88 LTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPS  167 (936)
Q Consensus        88 l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~  167 (936)
                      ..+..+..++++++|++|+|++|+|++. | .+..+++|++|+|++|+|++ +|   |..+++|++|+|++|+|++. + 
T Consensus        30 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~---~~~l~~L~~L~Ls~N~l~~~-~-  101 (457)
T 3bz5_A           30 MQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD---LSQNTNLTYLACDSNKLTNL-D-  101 (457)
T ss_dssp             CCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC---CTTCTTCSEEECCSSCCSCC-C-
T ss_pred             cCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec---cccCCCCCEEECcCCCCcee-e-
Confidence            3444555678888999999999999864 4 68889999999999999885 44   78888899999999988864 3 


Q ss_pred             CccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCc
Q 002321          168 SLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLL  247 (936)
Q Consensus       168 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L  247 (936)
                       ++.+++|++|+|++|++++. +  +..+++|++|++++|++++. +  ++++++|++|++++|+..+.+  .+..+++|
T Consensus       102 -~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L  172 (457)
T 3bz5_A          102 -VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQL  172 (457)
T ss_dssp             -CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTC
T ss_pred             -cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcC
Confidence             78888888888888888874 3  78888888888888888864 3  778888888888888655454  47778888


Q ss_pred             ceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCC
Q 002321          248 RTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSAN  327 (936)
Q Consensus       248 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N  327 (936)
                      ++|++++|++++. |  +..+++|+.|++++|.+++.   .++.+++|++|++++|++++ +|  ++.+++|+.|++++|
T Consensus       173 ~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N  243 (457)
T 3bz5_A          173 TTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVN  243 (457)
T ss_dssp             CEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSS
T ss_pred             CEEECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCC
Confidence            8888888888864 3  67777888888888888765   36777788888888888876 44  677778888888888


Q ss_pred             cccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCC
Q 002321          328 RLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGE  407 (936)
Q Consensus       328 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~  407 (936)
                      ++++..   +..+++|+.|+++.|+                                         |+.|++++|.+.+.
T Consensus       244 ~l~~~~---~~~l~~L~~L~l~~n~-----------------------------------------L~~L~l~~n~~~~~  279 (457)
T 3bz5_A          244 PLTELD---VSTLSKLTTLHCIQTD-----------------------------------------LLEIDLTHNTQLIY  279 (457)
T ss_dssp             CCSCCC---CTTCTTCCEEECTTCC-----------------------------------------CSCCCCTTCTTCCE
T ss_pred             cCCCcC---HHHCCCCCEEeccCCC-----------------------------------------CCEEECCCCccCCc
Confidence            877643   3456677777766553                                         34566677766555


Q ss_pred             ChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccc
Q 002321          408 TPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENC  487 (936)
Q Consensus       408 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l  487 (936)
                      +|  ++.+++|+.|+|++|.+.+.+|.   ...+|+.|++++|             ++|+.|+|++|+|++.   .++++
T Consensus       280 ~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l---~l~~l  338 (457)
T 3bz5_A          280 FQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL---DVSHN  338 (457)
T ss_dssp             EE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC---CCTTC
T ss_pred             cc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc---ccccC
Confidence            55  45667777777777776665553   3345556655554             5788888888888863   38888


Q ss_pred             cccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCcccccCCC
Q 002321          488 SSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPA  554 (936)
Q Consensus       488 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~  554 (936)
                      ++|+.|++++|++++        ++.|+.|++++|+++|.     .++..|..+++++|+++|.||.
T Consensus       339 ~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~  392 (457)
T 3bz5_A          339 TKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSP  392 (457)
T ss_dssp             TTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCT
T ss_pred             CcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcCh
Confidence            888888888888885        35667778888888865     3566788889999999998886

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.9e-41  Score=397.31  Aligned_cols=238  Identities=24%  Similarity=0.359  Sum_probs=200.2

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..++||+|+||+||+|+.+ +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+....++||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            45778889999999999999976 699999999976542 3457789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC--CCeEEeeccCccccCCCccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS--GEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~--~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      |+||+|.+++....  ..+++.++..++.||+.||+|||+++|+||||||+|||++.+  +.+||+|||+|+.+....  
T Consensus       236 ~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--  311 (573)
T 3uto_A          236 MSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--  311 (573)
T ss_dssp             CCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--
T ss_pred             cCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--
Confidence            99999999986533  238999999999999999999999999999999999999854  899999999998775332  


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH-H-----HH--Hhhhccccc
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW-L-----EE--HWKKAEWRN  918 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~-~-----~~--~~~~~~~~~  918 (936)
                       ......||+.|||||++ .+..|+.++||||+||++|||++|+.||.+.+......... .     ++  ...++..++
T Consensus       312 -~~~~~~GT~~y~APEv~-~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d  389 (573)
T 3uto_A          312 -SVKVTTGTAEFAAPEVA-EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD  389 (573)
T ss_dssp             -EEEEECSSGGGCCHHHH-TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred             -ceeeeEECccccCHHHh-CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence             22345799999999998 45678999999999999999999999998876643332111 0     11  123466789


Q ss_pred             eeeccccccccccccc
Q 002321          919 VSMRSCKGSSRQRRRF  934 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f  934 (936)
                      ++.+||..||.+||+.
T Consensus       390 li~~~L~~dp~~R~t~  405 (573)
T 3uto_A          390 FIRKLLLADPNTRMTI  405 (573)
T ss_dssp             HHHTTSCSSGGGSCCH
T ss_pred             HHHHHccCChhHCcCH
Confidence            9999999999999975

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=4e-39  Score=372.59  Aligned_cols=346  Identities=26%  Similarity=0.386  Sum_probs=166.3

Q ss_pred             cCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccc
Q 002321           98 QLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLAT  177 (936)
Q Consensus        98 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  177 (936)
                      .+++|+.|+++++.++. +| .+..+++|++|||++|++++ ++.  |..+++|++|+|++|+++               
T Consensus        44 ~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~-~~~--~~~l~~L~~L~l~~n~l~---------------  103 (466)
T 1o6v_A           44 DLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTD-ITP--LKNLTKLVDILMNNNQIA---------------  103 (466)
T ss_dssp             HHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCC---------------
T ss_pred             HhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCC-chh--hhccccCCEEECCCCccc---------------
Confidence            34555555555555553 22 35555555555555555552 222  444444444444444444               


Q ss_pred             cccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeecccccc
Q 002321          178 INLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSF  257 (936)
Q Consensus       178 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l  257 (936)
                               +..+  +.++++|++|+|++|.+++..+  +.++++|++|++++|++++. + .+..+++|++|+++ |.+
T Consensus       104 ---------~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~  167 (466)
T 1o6v_A          104 ---------DITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQV  167 (466)
T ss_dssp             ---------CCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESC
T ss_pred             ---------cChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-Ccc
Confidence                     3322  4455555555555555553322  45555555555555555432 2 24555555555553 333


Q ss_pred             CCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhh
Q 002321          258 SGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSM  337 (936)
Q Consensus       258 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~  337 (936)
                      .+..  .+.++++|+.|++++|.+++.  ..+..+++|++|++++|++++..+  ++.+++|+.|++++|++++.  ..+
T Consensus       168 ~~~~--~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l  239 (466)
T 1o6v_A          168 TDLK--PLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTL  239 (466)
T ss_dssp             CCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGG
T ss_pred             cCch--hhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhh
Confidence            3221  134444444444444444322  124444555555555555543333  34445555555555554432  234


Q ss_pred             hccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhccccc
Q 002321          338 ANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSG  417 (936)
Q Consensus       338 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  417 (936)
                      ..+++|+.|++++|.+                                                   ++..+  +..+++
T Consensus       240 ~~l~~L~~L~l~~n~l---------------------------------------------------~~~~~--~~~l~~  266 (466)
T 1o6v_A          240 ASLTNLTDLDLANNQI---------------------------------------------------SNLAP--LSGLTK  266 (466)
T ss_dssp             GGCTTCSEEECCSSCC---------------------------------------------------CCCGG--GTTCTT
T ss_pred             hcCCCCCEEECCCCcc---------------------------------------------------ccchh--hhcCCC
Confidence            4444444444444444                                                   33222  334444


Q ss_pred             CCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccC
Q 002321          418 LQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSK  497 (936)
Q Consensus       418 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~  497 (936)
                      |++|++++|++++..+  +..+++|+.|+|++|++++..+  +..+++|+.|+|++|++++..|  +..+++|++|++++
T Consensus       267 L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~  340 (466)
T 1o6v_A          267 LTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYN  340 (466)
T ss_dssp             CSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCS
T ss_pred             CCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCC
Confidence            4444444444443222  4444455555555555443222  4455555555555555554333  45555555555555


Q ss_pred             ccccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCcccc
Q 002321          498 NNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQG  550 (936)
Q Consensus       498 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~  550 (936)
                      |++++.  ..+.++++|++|++++|++++..|  +..+++|+.|++++|++++
T Consensus       341 n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          341 NKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             SCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred             CccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence            555543  345555666666666666655444  5556666666666666655

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=4.7e-39  Score=372.04  Aligned_cols=344  Identities=24%  Similarity=0.355  Sum_probs=221.3

Q ss_pred             CceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEE
Q 002321           76 NRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVIS  155 (936)
Q Consensus        76 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~  155 (936)
                      .+++.|++.+++++. +| .+..+++|++|+|++|++++..+  +.++++|++|+|++|++++ ++.  |..+++|++|+
T Consensus        46 ~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~--~~~l~~L~~L~  118 (466)
T 1o6v_A           46 DQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-ITP--LANLTNLTGLT  118 (466)
T ss_dssp             HTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CGG--GTTCTTCCEEE
T ss_pred             ccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCcccc-Chh--hcCCCCCCEEE
Confidence            578899999998874 44 48899999999999999997654  9999999999999999995 444  89999999999


Q ss_pred             ccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccc
Q 002321          156 LAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSG  235 (936)
Q Consensus       156 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  235 (936)
                      |++|++++..+  +..+++|++|+|++|++++. + .+.++++|++|+++ |.+.+..+  +.++++|++|++++|++++
T Consensus       119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~~  191 (466)
T 1o6v_A          119 LFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD  191 (466)
T ss_dssp             CCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred             CCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCCC
Confidence            99999996543  88999999999999999874 3 48888999999986 55554433  7788888888888888874


Q ss_pred             cCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCccccc
Q 002321          236 SIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGN  315 (936)
Q Consensus       236 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~  315 (936)
                      .  ..+..+++|++|++++|.+++..|  +..+++|+.|++++|.+++.  ..+..+++|++|++++|++++..+  +..
T Consensus       192 ~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~  263 (466)
T 1o6v_A          192 I--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSG  263 (466)
T ss_dssp             C--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTT
T ss_pred             C--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhc
Confidence            3  346777778888888777775544  55556666666666655542  234455555555555555543332  444


Q ss_pred             ccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCccc
Q 002321          316 LQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQ  395 (936)
Q Consensus       316 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~  395 (936)
                      +++|+.|++++|++++..+  +..++                                                   +|+
T Consensus       264 l~~L~~L~l~~n~l~~~~~--~~~l~---------------------------------------------------~L~  290 (466)
T 1o6v_A          264 LTKLTELKLGANQISNISP--LAGLT---------------------------------------------------ALT  290 (466)
T ss_dssp             CTTCSEEECCSSCCCCCGG--GTTCT---------------------------------------------------TCS
T ss_pred             CCCCCEEECCCCccCcccc--ccCCC---------------------------------------------------ccC
Confidence            4445555555554443222  33444                                                   444


Q ss_pred             EEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCc
Q 002321          396 FLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNF  475 (936)
Q Consensus       396 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  475 (936)
                      .|+|++|++++..+  +..+++|++|+|++|++++..|  +..+++|+.|++++|++++.  ..+..+++|+.|++++|+
T Consensus       291 ~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~  364 (466)
T 1o6v_A          291 NLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQ  364 (466)
T ss_dssp             EEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSC
T ss_pred             eEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCc
Confidence            44444444443322  3444445555555554443332  34444445555555544432  234444455555555555


Q ss_pred             cCCcCccccccccccccccccCccccC
Q 002321          476 LAGKIPTSIENCSSLVSLILSKNNLTG  502 (936)
Q Consensus       476 l~~~~p~~l~~l~~L~~L~L~~N~l~~  502 (936)
                      +++..|  +..+++|+.|++++|++++
T Consensus       365 l~~~~~--~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          365 ISDLTP--LANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             CCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred             cCccch--hhcCCCCCEEeccCCcccC
Confidence            544333  4445555555555555543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.6e-40  Score=360.90  Aligned_cols=240  Identities=23%  Similarity=0.292  Sum_probs=203.1

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ..|+..+.||+|+||.||+|++. +|+.||||++...... ...+.+.+|++++++++||||+++++++......++|||
T Consensus        15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   94 (328)
T 3fe3_A           15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME   94 (328)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence            34677889999999999999974 7999999999765432 335678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+++|+|.+++.....   +++.++..++.|+++||+|||++||+||||||+||+++.++.+||+|||+++......   
T Consensus        95 ~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---  168 (328)
T 3fe3_A           95 YASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---  168 (328)
T ss_dssp             CCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---
T ss_pred             CCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---
Confidence            9999999999977543   8999999999999999999999999999999999999999999999999998664322   


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceeecc
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSMRS  923 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  923 (936)
                      ......||+.|+|||++.+....+.++||||+||++|||++|+.||...+.........    ..+...+..+.+++.+|
T Consensus       169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  248 (328)
T 3fe3_A          169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRF  248 (328)
T ss_dssp             GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence            23456789999999998666555689999999999999999999998876543332211    11234557788999999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..||.+||+++
T Consensus       249 L~~dP~~R~t~~  260 (328)
T 3fe3_A          249 LVLNPIKRGTLE  260 (328)
T ss_dssp             CCSSTTTSCCHH
T ss_pred             CCCChhHCcCHH
Confidence            999999999863

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.5e-39  Score=352.52  Aligned_cols=239  Identities=21%  Similarity=0.342  Sum_probs=202.0

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ...|+..+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            345788889999999999999964 689999999865533 345778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+++|+|.+++....    +++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......  .
T Consensus        98 ~~~~~~L~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  171 (297)
T 3fxz_A           98 YLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S  171 (297)
T ss_dssp             CCTTCBHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--C
T ss_pred             CCCCCCHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--c
Confidence            999999999998653    8999999999999999999999999999999999999999999999999998664322  2


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-------HHhhhcccccee
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-------EHWKKAEWRNVS  920 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~~~  920 (936)
                      ......+|+.|+|||++. +..++.++||||+||++|||++|+.||...+...........       +...+..+++++
T Consensus       172 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  250 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL  250 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHH-CSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHH
T ss_pred             ccCCccCCcCccChhhhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHH
Confidence            234567899999999984 457899999999999999999999999887654333221111       223345688999


Q ss_pred             ecccccccccccccC
Q 002321          921 MRSCKGSSRQRRRFQ  935 (936)
Q Consensus       921 ~~~l~~~p~~Rp~f~  935 (936)
                      .+||..||.+||+++
T Consensus       251 ~~~l~~dp~~Rps~~  265 (297)
T 3fxz_A          251 NRCLEMDVEKRGSAK  265 (297)
T ss_dssp             HHHSCSSTTTSCCHH
T ss_pred             HHHccCChhHCcCHH
Confidence            999999999999863

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=7.4e-39  Score=367.28  Aligned_cols=355  Identities=21%  Similarity=0.244  Sum_probs=305.3

Q ss_pred             CceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEE
Q 002321           76 NRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVIS  155 (936)
Q Consensus        76 ~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~  155 (936)
                      .+++.|+++++++++. | .+..+++|++|+|++|+|++. |  ++.+++|++|+|++|+|++ ++   |..+++|++|+
T Consensus        42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~---~~~l~~L~~L~  112 (457)
T 3bz5_A           42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD---VTPLTKLTYLN  112 (457)
T ss_dssp             TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC---CTTCTTCCEEE
T ss_pred             CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee---cCCCCcCCEEE
Confidence            6789999999999974 4 799999999999999999975 3  8999999999999999995 44   78999999999


Q ss_pred             ccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccc
Q 002321          156 LAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSG  235 (936)
Q Consensus       156 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  235 (936)
                      |++|++++. |  ++.+++|++|++++|++++.   .+..+++|++|++++|...+.+  .+..+++|++|++++|++++
T Consensus       113 L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~  184 (457)
T 3bz5_A          113 CDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE  184 (457)
T ss_dssp             CCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC
T ss_pred             CCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce
Confidence            999999974 4  89999999999999999985   3889999999999999666565  48899999999999999997


Q ss_pred             cCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCccccc
Q 002321          236 SIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGN  315 (936)
Q Consensus       236 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~  315 (936)
                       +|  +..+++|++|++++|++++.   .+..+++|+.|++++|++++ +|  ++.+++|+.|++++|++++..   ++.
T Consensus       185 -l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~  252 (457)
T 3bz5_A          185 -LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD---VST  252 (457)
T ss_dssp             -CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC---CTT
T ss_pred             -ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC---HHH
Confidence             44  88999999999999999976   38889999999999999998 55  889999999999999999754   467


Q ss_pred             ccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCccc
Q 002321          316 LQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQ  395 (936)
Q Consensus       316 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~  395 (936)
                      +++|+.|++++|+              |+.|++++|.+.+.+|.                             +.+++|+
T Consensus       253 l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~~-----------------------------~~l~~L~  289 (457)
T 3bz5_A          253 LSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQA-----------------------------EGCRKIK  289 (457)
T ss_dssp             CTTCCEEECTTCC--------------CSCCCCTTCTTCCEEEC-----------------------------TTCTTCC
T ss_pred             CCCCCEEeccCCC--------------CCEEECCCCccCCcccc-----------------------------cccccCC
Confidence            7899999988764              56788899987654431                             3467899


Q ss_pred             EEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCc
Q 002321          396 FLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNF  475 (936)
Q Consensus       396 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  475 (936)
                      .|++++|...+.+|.   ..++|+.|++++|             ++|++|+|++|++++. +  ++.+++|+.|++++|+
T Consensus       290 ~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~  350 (457)
T 3bz5_A          290 ELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAH  350 (457)
T ss_dssp             CCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSC
T ss_pred             EEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCC
Confidence            999999988777664   3456777766665             6899999999999984 3  8999999999999999


Q ss_pred             cCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCccccc
Q 002321          476 LAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVN  534 (936)
Q Consensus       476 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~  534 (936)
                      |++        ++.|..|++++|++.|.     +++..|+.++|++|+++|.+|..+..
T Consensus       351 l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~~  396 (457)
T 3bz5_A          351 IQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLLD  396 (457)
T ss_dssp             CCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCBC
T ss_pred             CCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHhc
Confidence            985        46788899999999975     46678889999999999999977543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9e-40  Score=365.41  Aligned_cols=246  Identities=24%  Similarity=0.330  Sum_probs=204.3

Q ss_pred             cccccCCCcccccCceEEEEEEeC--------CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeC
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR--------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQ  759 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  759 (936)
                      ...|+..+.||+|+||.||+|++.        ++..||||+++........+.+.+|+++++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            345778889999999999999863        35679999997665555567899999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC
Q 002321          760 SLQLLIYEFVSGGSLHKHLHEGSG-------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS  826 (936)
Q Consensus       760 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~  826 (936)
                      +..++||||+++|+|.+++.....             ...+++.++++++.|+++||+|||++||+||||||+|||++.+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~  239 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN  239 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCC
Confidence            999999999999999999986542             1348899999999999999999999999999999999999999


Q ss_pred             CCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHH
Q 002321          827 GEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVT  905 (936)
Q Consensus       827 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~  905 (936)
                      +.+||+|||+++...............+++.|+|||++. +..++.++|||||||++|||++ |+.||............
T Consensus       240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~  318 (370)
T 2psq_A          240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL  318 (370)
T ss_dssp             CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHH-TCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred             CCEEEccccCCcccCcccceecccCCCcccceECHhHhc-CCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999999998765444333344456778999999884 4578999999999999999999 99999887654333221


Q ss_pred             HH-----HHHhhhccccceeecccccccccccccC
Q 002321          906 WL-----EEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       906 ~~-----~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..     .+...+..+.+++.+||..||.+||+++
T Consensus       319 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~  353 (370)
T 2psq_A          319 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFK  353 (370)
T ss_dssp             HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence            11     1122345788899999999999999874

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=9.4e-39  Score=360.90  Aligned_cols=336  Identities=19%  Similarity=0.214  Sum_probs=196.8

Q ss_pred             cCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEE
Q 002321          123 LQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTL  202 (936)
Q Consensus       123 l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  202 (936)
                      +++|++|++++|.++ .+|..+|..+++|++|+|++|+|++..+..|+.+++|++|+|++|++++..|..|.++++|++|
T Consensus        44 l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  122 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  122 (390)
T ss_dssp             GCCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             cCCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence            556677777777766 5676667777777777777777766666667777777777777777776666667777777777


Q ss_pred             ecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCcccc
Q 002321          203 DLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFS  282 (936)
Q Consensus       203 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~  282 (936)
                      +|++|+++...+..|.++++|++|++++|++++..+..|..+++|++|++++|++++..                     
T Consensus       123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---------------------  181 (390)
T 3o6n_A          123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---------------------  181 (390)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---------------------
T ss_pred             ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---------------------
Confidence            77777777444444566777777777777776666666666666666666666655221                     


Q ss_pred             CCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhh
Q 002321          283 GEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIF  362 (936)
Q Consensus       283 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  362 (936)
                            +..+++|+.|++++|.+++.     ...++|+.|++++|.++.. |.                           
T Consensus       182 ------~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~---------------------------  222 (390)
T 3o6n_A          182 ------LSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVV-RG---------------------------  222 (390)
T ss_dssp             ------GGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEE-EC---------------------------
T ss_pred             ------cccccccceeeccccccccc-----CCCCcceEEECCCCeeeec-cc---------------------------
Confidence                  22334444455555444321     1112333444444333311 00                           


Q ss_pred             ccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccC
Q 002321          363 SSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKAL  442 (936)
Q Consensus       363 ~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  442 (936)
                                                ..+++|+.|++++|++++.  ..+..+++|++|+|++|++++..|..|..+++|
T Consensus       223 --------------------------~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L  274 (390)
T 3o6n_A          223 --------------------------PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL  274 (390)
T ss_dssp             --------------------------CCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSC
T ss_pred             --------------------------cccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccC
Confidence                                      0123566666666666543  345555566666666666555555555555555


Q ss_pred             CeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCC
Q 002321          443 NVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFN  522 (936)
Q Consensus       443 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  522 (936)
                      ++|+|++|++++                         +|..+..+++|++|+|++|+++ .+|..+..+++|++|+|++|
T Consensus       275 ~~L~L~~n~l~~-------------------------~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N  328 (390)
T 3o6n_A          275 ERLYISNNRLVA-------------------------LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHN  328 (390)
T ss_dssp             CEEECCSSCCCE-------------------------EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSS
T ss_pred             CEEECCCCcCcc-------------------------cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCC
Confidence            555555555543                         3333344555555555555555 34445556666666666666


Q ss_pred             cccCCCCcccccccccCeeecCCCcccccCCCCCccCcCCCccccCCCCCCCCCC
Q 002321          523 SLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAV  577 (936)
Q Consensus       523 ~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~gn~~~c~~~~  577 (936)
                      ++++ +|  +..+++|+.|++++|++.+... ...+..+....+.+++..|..+.
T Consensus       329 ~i~~-~~--~~~~~~L~~L~l~~N~~~~~~~-~~~~~~~~~~~~~~~~~~c~~~~  379 (390)
T 3o6n_A          329 SIVT-LK--LSTHHTLKNLTLSHNDWDCNSL-RALFRNVARPAVDDADQHCKIDY  379 (390)
T ss_dssp             CCCC-CC--CCTTCCCSEEECCSSCEEHHHH-HHHTTTCCTTTBCCCCSCCCTTC
T ss_pred             ccce-eC--chhhccCCEEEcCCCCccchhH-HHHHHHHHhhcccccCceecccc
Confidence            6653 22  5556677777777777766432 23455566666778888887544

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.6e-40  Score=359.64  Aligned_cols=243  Identities=23%  Similarity=0.326  Sum_probs=200.4

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..+.||+|+||+||+|++. +++.||||++.........+.+.+|+.++++++||||+++++++.+....++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            34677889999999999999977 68999999997655444457789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++|+|.+++.....   +++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.+........
T Consensus        87 ~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           87 CSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             CTTEEGGGGSBTTTB---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             CCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence            999999999976433   89999999999999999999999999999999999999999999999999987644333333


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHH-------Hhhhccccceee
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE-------HWKKAEWRNVSM  921 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~  921 (936)
                      .....||+.|+|||++.+...++.++||||+||++|||++|+.||............+...       ...+..+.+++.
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  243 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHH
Confidence            4456789999999998655555889999999999999999999998766533322222211       223456778999


Q ss_pred             cccccccccccccC
Q 002321          922 RSCKGSSRQRRRFQ  935 (936)
Q Consensus       922 ~~l~~~p~~Rp~f~  935 (936)
                      +||..||.+||+++
T Consensus       244 ~~L~~dP~~R~t~~  257 (323)
T 3tki_A          244 KILVENPSARITIP  257 (323)
T ss_dssp             HHSCSSTTTSCCHH
T ss_pred             HHccCChhhCcCHH
Confidence            99999999999863

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.5e-39  Score=373.89  Aligned_cols=348  Identities=18%  Similarity=0.175  Sum_probs=213.1

Q ss_pred             cccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeecccc
Q 002321          176 ATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSEN  255 (936)
Q Consensus       176 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N  255 (936)
                      +.++.++++++. +|..+  .++|++|+|++|+|++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~~-ip~~~--~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n   90 (477)
T 2id5_A           14 RAVLCHRKRFVA-VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN   90 (477)
T ss_dssp             TEEECCSCCCSS-CCSCC--CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcCc-CCCCC--CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence            467777777774 45444  357788888888888777777888888888888888888777778888888888888888


Q ss_pred             ccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCCh
Q 002321          256 SFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPD  335 (936)
Q Consensus       256 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~  335 (936)
                      ++++..+..|.++++|+.|+|++|.+++..+..|..+++|++|+|++|++++..+..|.++++|+.|+|++|++++..+.
T Consensus        91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  170 (477)
T 2id5_A           91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE  170 (477)
T ss_dssp             CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred             cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence            87766666667777777777777777766666667777777777777777666666666667777777777766655555


Q ss_pred             hhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhccc
Q 002321          336 SMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGAL  415 (936)
Q Consensus       336 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  415 (936)
                      .|..+++|+.|++++|.+.+..+                           ..+..+++|++|++++|.+.+.++......
T Consensus       171 ~l~~l~~L~~L~l~~n~i~~~~~---------------------------~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~  223 (477)
T 2id5_A          171 ALSHLHGLIVLRLRHLNINAIRD---------------------------YSFKRLYRLKVLEISHWPYLDTMTPNCLYG  223 (477)
T ss_dssp             HHTTCTTCCEEEEESCCCCEECT---------------------------TCSCSCTTCCEEEEECCTTCCEECTTTTTT
T ss_pred             HhcccCCCcEEeCCCCcCcEeCh---------------------------hhcccCcccceeeCCCCccccccCcccccC
Confidence            56666666666666665542111                           112334555555555555444444333333


Q ss_pred             ccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccc
Q 002321          416 SGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLIL  495 (936)
Q Consensus       416 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  495 (936)
                      .+|++|+|++|++++..+..+                        ..+++|+.|+|++|.+++..+..|.++++|++|+|
T Consensus       224 ~~L~~L~l~~n~l~~~~~~~~------------------------~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  279 (477)
T 2id5_A          224 LNLTSLSITHCNLTAVPYLAV------------------------RHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQL  279 (477)
T ss_dssp             CCCSEEEEESSCCCSCCHHHH------------------------TTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEEC
T ss_pred             ccccEEECcCCcccccCHHHh------------------------cCccccCeeECCCCcCCccChhhccccccCCEEEC
Confidence            345555555554443322344                        44455555555555555444445555555555555


Q ss_pred             cCccccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCcccccCCCCCccCcCCCccccCCCCCCCC
Q 002321          496 SKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGS  575 (936)
Q Consensus       496 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~gn~~~c~~  575 (936)
                      ++|++++..|..|..+++|++|+|++|+|++..+..+..+++|++|+|++|++.+.++..+++.......+.++...|..
T Consensus       280 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~  359 (477)
T 2id5_A          280 VGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCAT  359 (477)
T ss_dssp             CSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEE
T ss_pred             CCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCC
Confidence            55555555555555555566666666665544444555556666666666666655544444444444445566666655


Q ss_pred             CC
Q 002321          576 AV  577 (936)
Q Consensus       576 ~~  577 (936)
                      |.
T Consensus       360 p~  361 (477)
T 2id5_A          360 PE  361 (477)
T ss_dssp             SG
T ss_pred             ch
Confidence            54

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.1e-39  Score=353.52  Aligned_cols=237  Identities=22%  Similarity=0.281  Sum_probs=199.4

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||+||+|+.+ +|+.||||+++....  ......+.+|++++++++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            45677889999999999999976 589999999965432  233567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++|+|.+++.+...   +++.++..++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++......  
T Consensus        85 E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--  159 (337)
T 1o6l_A           85 EYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--  159 (337)
T ss_dssp             ECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--
T ss_pred             eCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC--
Confidence            99999999999986543   8999999999999999999999999999999999999999999999999997542211  


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH----HHHhhhccccceeec
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL----EEHWKKAEWRNVSMR  922 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~  922 (936)
                      .......||+.|+|||++. +..++.++||||+||++|||++|+.||...+..........    .+...+.++++++.+
T Consensus       160 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  238 (337)
T 1o6l_A          160 ATMKTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGS-SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             CcccccccChhhCChhhhc-CCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            2234567899999999984 55789999999999999999999999988765433322111    123345778999999


Q ss_pred             cccccccccc
Q 002321          923 SCKGSSRQRR  932 (936)
Q Consensus       923 ~l~~~p~~Rp  932 (936)
                      ||..||.+||
T Consensus       239 lL~~dP~~R~  248 (337)
T 1o6l_A          239 LLKKDPKQRL  248 (337)
T ss_dssp             HTCSSTTTST
T ss_pred             HhhcCHHHhc
Confidence            9999999998

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.4e-39  Score=358.54  Aligned_cols=239  Identities=23%  Similarity=0.293  Sum_probs=197.9

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  765 (936)
                      ..|+..+.||+|+||+||+|+.+ +|+.||||+++....  ....+.+.+|.++++.+ +||||+++++++.+....++|
T Consensus        23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv  102 (353)
T 3txo_A           23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV  102 (353)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence            34677889999999999999976 589999999975432  23356788999999998 799999999999999999999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      |||+++|+|.+++.+...   +++.++..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.....  
T Consensus       103 ~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~--  177 (353)
T 3txo_A          103 MEFVNGGDLMFHIQKSRR---FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN--  177 (353)
T ss_dssp             EECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred             EeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC--
Confidence            999999999999987543   899999999999999999999999999999999999999999999999999754321  


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceee
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSM  921 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~  921 (936)
                      ........||+.|+|||++ .+..++.++||||+||++|||++|+.||...+.........    ..+.+.+..+.+++.
T Consensus       178 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  256 (353)
T 3txo_A          178 GVTTATFCGTPDYIAPEIL-QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILK  256 (353)
T ss_dssp             --------CCGGGCCHHHH-HHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             CccccccCCCcCeEChhhc-CCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            2233456799999999988 45578999999999999999999999998876643332211    113445677899999


Q ss_pred             ccccccccccccc
Q 002321          922 RSCKGSSRQRRRF  934 (936)
Q Consensus       922 ~~l~~~p~~Rp~f  934 (936)
                      +||..||.+||+.
T Consensus       257 ~lL~~dP~~R~~~  269 (353)
T 3txo_A          257 SFMTKNPTMRLGS  269 (353)
T ss_dssp             HHTCSSGGGSTTS
T ss_pred             HHhhhCHHHccCC
Confidence            9999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.4e-40  Score=367.48  Aligned_cols=244  Identities=22%  Similarity=0.280  Sum_probs=200.6

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ...|+..+.||+|+||+||+|++. +++.||||+++........+++.+|++++++++||||+++++++.+....++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            445677889999999999999987 6899999999755433445678899999999999999999999999889999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+++|+|.++++...  ..+++.++..++.|+++||+|||+++|+||||||+|||++.++.+||+|||+++.........
T Consensus       193 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~  270 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA  270 (377)
T ss_dssp             CCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred             cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence            999999999997643  238999999999999999999999999999999999999999999999999998654322222


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceee
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSM  921 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~  921 (936)
                      ......+++.|+|||.+. ...++.++|||||||++|||++ |+.||...+.........     ..+...++.+.+++.
T Consensus       271 ~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  349 (377)
T 3cbl_A          271 SGGLRQVPVKWTAPEALN-YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLME  349 (377)
T ss_dssp             CSSCCEEEGGGSCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             cCCCCCCCcCcCCHhHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            222233567899999884 4468999999999999999998 999998876543221111     012234567889999


Q ss_pred             cccccccccccccC
Q 002321          922 RSCKGSSRQRRRFQ  935 (936)
Q Consensus       922 ~~l~~~p~~Rp~f~  935 (936)
                      +||..||.+||+|+
T Consensus       350 ~cl~~dP~~Rps~~  363 (377)
T 3cbl_A          350 QCWAYEPGQRPSFS  363 (377)
T ss_dssp             HHTCSSGGGSCCHH
T ss_pred             HHcCCCchhCcCHH
Confidence            99999999999985

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.3e-39  Score=352.90  Aligned_cols=243  Identities=28%  Similarity=0.402  Sum_probs=193.9

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ...|+..+.||+|+||+||+|++ +|+.||||++...... ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            44577888999999999999987 4889999999765433 335678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN--IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      |+++|+|.+++........+++..++.++.|++.||+|||++|  |+||||||+||+++.++.+||+|||+++.....  
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--  192 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST--  192 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc--
Confidence            9999999999986543334899999999999999999999999  999999999999999999999999999754322  


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH------HHHhhhccccce
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL------EEHWKKAEWRNV  919 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~~  919 (936)
                      ........+|+.|+|||++. +..++.++||||+||++|||++|+.||...+..........      .+...++.+.++
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  271 (309)
T 3p86_A          193 FLSSKSAAGTPEWMAPEVLR-DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAI  271 (309)
T ss_dssp             ---------CCTTSCHHHHT-TCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred             ccccccCCCCccccChhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHH
Confidence            12234456899999999984 55689999999999999999999999988766433322110      012344678899


Q ss_pred             eecccccccccccccC
Q 002321          920 SMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       920 ~~~~l~~~p~~Rp~f~  935 (936)
                      +.+||..||.+||+++
T Consensus       272 i~~~l~~dP~~Rps~~  287 (309)
T 3p86_A          272 IEGCWTNEPWKRPSFA  287 (309)
T ss_dssp             HHHHTCSSGGGSCCHH
T ss_pred             HHHHccCChhhCcCHH
Confidence            9999999999999874

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7.9e-39  Score=355.28  Aligned_cols=239  Identities=24%  Similarity=0.294  Sum_probs=200.7

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc-----hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCee
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK-----SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQ  762 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  762 (936)
                      ...|+..+.||+|+||.||+|+.+ +|+.||||+++......     ..+.+.+|+.++++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            345778889999999999999976 58999999997654321     357899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC----CeEEeeccCcc
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG----EPKVGDYGLAR  838 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg~a~  838 (936)
                      ++||||+++|+|.+++....   .+++.++..++.|++.||+|||+.||+||||||+||+++.++    .+||+|||+++
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            99999999999999997643   389999999999999999999999999999999999998877    79999999998


Q ss_pred             ccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH--------HHHH
Q 002321          839 LLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW--------LEEH  910 (936)
Q Consensus       839 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~--------~~~~  910 (936)
                      ......   ......||+.|+|||++ ....++.++||||+||++|+|++|..||.............        ....
T Consensus       168 ~~~~~~---~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  243 (361)
T 2yab_A          168 EIEDGV---EFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS  243 (361)
T ss_dssp             ECCTTC---CCCCCCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             EcCCCC---ccccCCCCccEECchHH-cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence            764322   22445689999999998 45578999999999999999999999998866533221110        1112


Q ss_pred             hhhccccceeeccccccccccccc
Q 002321          911 WKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       911 ~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      ..++.+++++.+||..||.+||+.
T Consensus       244 ~~s~~~~~li~~~L~~dP~~R~t~  267 (361)
T 2yab_A          244 QTSELAKDFIRKLLVKETRKRLTI  267 (361)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             CCCHHHHHHHHHHCCCChhHCcCH
Confidence            345678999999999999999985

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.5e-39  Score=354.22  Aligned_cols=240  Identities=22%  Similarity=0.333  Sum_probs=201.0

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  765 (936)
                      ..|+..+.||+|+||.||+|+.+ +|+.||||+++....  ....+.+.+|..++..+ +||||+++++++.+....++|
T Consensus        17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv   96 (345)
T 1xjd_A           17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   96 (345)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence            44677789999999999999986 589999999975432  23356788899999887 999999999999999999999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      |||+++|+|.+++.....   +++.++..++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++...... 
T Consensus        97 ~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-  172 (345)
T 1xjd_A           97 MEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-  172 (345)
T ss_dssp             EECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred             EeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC-
Confidence            999999999999987543   8999999999999999999999999999999999999999999999999997543211 


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceee
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSM  921 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~  921 (936)
                       .......||+.|+|||++. +..++.++||||+||++|||++|+.||...+.........    ..+.+.+..+++++.
T Consensus       173 -~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  250 (345)
T 1xjd_A          173 -AKTNTFCGTPDYIAPEILL-GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV  250 (345)
T ss_dssp             -CCBCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             -CcccCCCCCcccCChhhhc-CCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHH
Confidence             2234567899999999984 4578999999999999999999999998876543332111    112345577889999


Q ss_pred             cccccccccccccC
Q 002321          922 RSCKGSSRQRRRFQ  935 (936)
Q Consensus       922 ~~l~~~p~~Rp~f~  935 (936)
                      +||..||.+||+.+
T Consensus       251 ~lL~~dp~~R~~~~  264 (345)
T 1xjd_A          251 KLFVREPEKRLGVR  264 (345)
T ss_dssp             HHSCSSGGGSBTTB
T ss_pred             HHhcCCHhHcCCCh
Confidence            99999999999874

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=348.72  Aligned_cols=243  Identities=24%  Similarity=0.391  Sum_probs=199.5

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ...|...+.||+|+||+||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            345677889999999999999986 58999999885432 3446789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+++|+|.++++....  .+++.++..++.|+++||+|||+++|+||||||+||+++.++.+||+|||+++.........
T Consensus        88 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           88 YIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CCTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             ecCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            9999999999987432  38999999999999999999999999999999999999999999999999998764322111


Q ss_pred             ------------ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHH----HHHHHHH---
Q 002321          848 ------------LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWW----FSVTWLE---  908 (936)
Q Consensus       848 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~----~~~~~~~---  908 (936)
                                  ......||+.|+|||.+ .+..++.++||||+||++|||++|..||........    .......   
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMI-NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC  244 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTC
T ss_pred             cccccccccccccccccCCCcceeCHHHh-cCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccC
Confidence                        11145689999999998 455789999999999999999999999976432111    1111111   


Q ss_pred             HHhhhccccceeecccccccccccccC
Q 002321          909 EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 ~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +...++.+.+++.+||..||.+||+++
T Consensus       245 ~~~~~~~l~~li~~~l~~dP~~Rps~~  271 (310)
T 3s95_A          245 PPNCPPSFFPITVRCCDLDPEKRPSFV  271 (310)
T ss_dssp             CTTCCTTHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHH
Confidence            234557899999999999999999974

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=8.1e-38  Score=372.72  Aligned_cols=336  Identities=20%  Similarity=0.216  Sum_probs=207.8

Q ss_pred             cCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEE
Q 002321          123 LQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTL  202 (936)
Q Consensus       123 l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  202 (936)
                      +++++.|++++|.+. .+|..+|..+++|++|+|++|.|++..|..|+.+++|++|+|++|.|++..|..|+++++|++|
T Consensus        50 l~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  128 (597)
T 3oja_B           50 LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  128 (597)
T ss_dssp             GCCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence            556777777777776 6777777777777777777777777667777777777777777777777777777777777777


Q ss_pred             ecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCcccc
Q 002321          203 DLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFS  282 (936)
Q Consensus       203 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~  282 (936)
                      +|++|.|++..+..|.++++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..                     
T Consensus       129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---------------------  187 (597)
T 3oja_B          129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---------------------  187 (597)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---------------------
T ss_pred             EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---------------------
Confidence            77777777555555677777777777777777666666666777777776666665321                     


Q ss_pred             CCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhh
Q 002321          283 GEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIF  362 (936)
Q Consensus       283 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  362 (936)
                            ++.+++|+.|++++|.+++.     ....+                        |+.|++++|.+....+    
T Consensus       188 ------~~~l~~L~~L~l~~n~l~~l-----~~~~~------------------------L~~L~ls~n~l~~~~~----  228 (597)
T 3oja_B          188 ------LSLIPSLFHANVSYNLLSTL-----AIPIA------------------------VEELDASHNSINVVRG----  228 (597)
T ss_dssp             ------GGGCTTCSEEECCSSCCSEE-----ECCTT------------------------CSEEECCSSCCCEEEC----
T ss_pred             ------hhhhhhhhhhhcccCccccc-----cCCch------------------------hheeeccCCccccccc----
Confidence                  12234445555555544421     11123                        3444444443321000    


Q ss_pred             ccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccC
Q 002321          363 SSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKAL  442 (936)
Q Consensus       363 ~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  442 (936)
                                          .      ..++|+.|+|++|.+++.  ..+..+++|++|+|++|.+++.+|..|+.+++|
T Consensus       229 --------------------~------~~~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  280 (597)
T 3oja_B          229 --------------------P------VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL  280 (597)
T ss_dssp             --------------------S------CCSCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSC
T ss_pred             --------------------c------cCCCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCCHHHhcCccCC
Confidence                                0      013466666666666542  445555555555555555555555555555555


Q ss_pred             CeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCC
Q 002321          443 NVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFN  522 (936)
Q Consensus       443 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  522 (936)
                      +.|+|++|++++                         +|..+..+++|+.|+|++|+++ .+|..+..+++|++|+|++|
T Consensus       281 ~~L~Ls~N~l~~-------------------------l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N  334 (597)
T 3oja_B          281 ERLYISNNRLVA-------------------------LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHN  334 (597)
T ss_dssp             CEEECTTSCCCE-------------------------EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSS
T ss_pred             CEEECCCCCCCC-------------------------CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCC
Confidence            555555555543                         3444445556666666666665 45556666677777777777


Q ss_pred             cccCCCCcccccccccCeeecCCCcccccCCCCCccCcCCCccccCCCCCCCCCC
Q 002321          523 SLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAV  577 (936)
Q Consensus       523 ~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~gn~~~c~~~~  577 (936)
                      +|++. |  +..+++|+.|+|++|++.|..+ ...+..+....+.+++..|+.+.
T Consensus       335 ~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~-~~~~~~~~~~~~~~~~~~C~~~~  385 (597)
T 3oja_B          335 SIVTL-K--LSTHHTLKNLTLSHNDWDCNSL-RALFRNVARPAVDDADQHCKIDY  385 (597)
T ss_dssp             CCCCC-C--CCTTCCCSEEECCSSCEEHHHH-HHHTTTCCTTTBCCCCCCCCTTC
T ss_pred             CCCCc-C--hhhcCCCCEEEeeCCCCCChhH-HHHHHHHhhhccccccccCCcch
Confidence            77633 2  5566778888888888877643 34566677777889999998643

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=6.3e-39  Score=352.32  Aligned_cols=244  Identities=25%  Similarity=0.357  Sum_probs=199.1

Q ss_pred             cccccCCCcccccCceEEEEEEeC----CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      ...|+..+.||+|+||.||+|++.    .+..||||+++........+.+.+|+.++++++||||+++++++.+....++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            445778889999999999999975    3456999999765545556789999999999999999999999999889999


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ||||+++|+|.++++...  ..+++.++..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus       128 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  205 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP  205 (325)
T ss_dssp             EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred             EeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence            999999999999997543  238999999999999999999999999999999999999999999999999998764322


Q ss_pred             c-ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH-----HHHhhhcccc
Q 002321          845 R-YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL-----EEHWKKAEWR  917 (936)
Q Consensus       845 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~  917 (936)
                      . ........+|+.|+|||++ ....++.++||||+||++|||++ |+.||..............     .+...+..+.
T Consensus       206 ~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  284 (325)
T 3kul_A          206 DAAYTTTGGKIPIRWTAPEAI-AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALH  284 (325)
T ss_dssp             -CCEECC---CCGGGSCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cceeeccCCCCcccccCHhHh-cCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHH
Confidence            2 1122334457789999988 44578999999999999999999 9999988766433322111     0122346788


Q ss_pred             ceeecccccccccccccC
Q 002321          918 NVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++.+||..||.+||+++
T Consensus       285 ~li~~~l~~dp~~Rps~~  302 (325)
T 3kul_A          285 QLMLDCWHKDRAQRPRFS  302 (325)
T ss_dssp             HHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHccCChhhCcCHH
Confidence            999999999999999874

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.4e-38  Score=344.53  Aligned_cols=240  Identities=23%  Similarity=0.334  Sum_probs=194.8

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  765 (936)
                      ...|+..+.||+|+||.||+|++. +++.||||++......  ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            345778889999999999999976 5899999998654332  2357789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      |||+++++|.+++.....   +++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...... 
T Consensus        90 ~e~~~g~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  165 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-  165 (294)
T ss_dssp             EECCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             EeCCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc-
Confidence            999999999999987543   8999999999999999999999999999999999999999999999999998664322 


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH---------HHHHhhhccc
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW---------LEEHWKKAEW  916 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~---------~~~~~~~~~~  916 (936)
                      ........||+.|+|||.+. +..++.++||||+||++|||++|+.||.............         ..+.-.++.+
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (294)
T 4eqm_A          166 LTQTNHVLGTVQYFSPEQAK-GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL  244 (294)
T ss_dssp             ---------CCSSCCHHHHH-TCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHH
T ss_pred             ccccCccccCccccCHhHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHH
Confidence            12233456899999999884 4568999999999999999999999998876543221111         0012234678


Q ss_pred             cceeecccccccccccc
Q 002321          917 RNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       917 ~~~~~~~l~~~p~~Rp~  933 (936)
                      .+++.+||..||.+||+
T Consensus       245 ~~li~~~l~~dp~~R~~  261 (294)
T 4eqm_A          245 SNVILRATEKDKANRYK  261 (294)
T ss_dssp             HHHHHHHSCSSGGGSCS
T ss_pred             HHHHHHHhcCCHhHccc
Confidence            89999999999999983

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-38  Score=346.86  Aligned_cols=235  Identities=24%  Similarity=0.353  Sum_probs=199.3

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||.||+|+.+ +|+.||||+++.....  ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            45677889999999999999976 6899999999654321  33567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++|+|.+++.....   +++..+..++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++.....   
T Consensus        86 e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---  159 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  159 (318)
T ss_dssp             CCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             eCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence            99999999999987543   899999999999999999999999999999999999999999999999999865432   


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH----HHHhhhccccceeec
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL----EEHWKKAEWRNVSMR  922 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~  922 (936)
                        .....||+.|+|||++ ....++.++||||+||++|||++|+.||...+..........    .+...+.++++++.+
T Consensus       160 --~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  236 (318)
T 1fot_A          160 --TYTLCGTPDYIAPEVV-STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR  236 (318)
T ss_dssp             --BCCCCSCTTTCCHHHH-TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             --cccccCCccccCHhHh-cCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence              2345789999999988 455789999999999999999999999988765433221111    123345678999999


Q ss_pred             ccccccccccc
Q 002321          923 SCKGSSRQRRR  933 (936)
Q Consensus       923 ~l~~~p~~Rp~  933 (936)
                      |+..||.+||.
T Consensus       237 lL~~dp~~R~~  247 (318)
T 1fot_A          237 LITRDLSQRLG  247 (318)
T ss_dssp             HTCSCTTTCTT
T ss_pred             HhccCHHHcCC
Confidence            99999999993

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.1e-39  Score=359.81  Aligned_cols=246  Identities=23%  Similarity=0.310  Sum_probs=202.0

Q ss_pred             cccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCee
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQ  762 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  762 (936)
                      ...|+..+.||+|+||+||+|++.      +++.||||+++..........+.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            455777889999999999999953      46789999997654455567899999999999999999999999999899


Q ss_pred             EEEEEecCCCChhhhhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---CeEEeecc
Q 002321          763 LLIYEFVSGGSLHKHLHEGSG----GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG---EPKVGDYG  835 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg  835 (936)
                      ++||||+++|+|.+++.....    ...+++.+++.++.|+++||+|||++||+||||||+|||++.++   .+||+|||
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG  229 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG  229 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCc
Confidence            999999999999999986532    13489999999999999999999999999999999999999655   59999999


Q ss_pred             CccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH-----HH
Q 002321          836 LARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL-----EE  909 (936)
Q Consensus       836 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~-----~~  909 (936)
                      +++...............+|+.|+|||++. ...++.++|||||||++|||++ |..||..............     .+
T Consensus       230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~  308 (367)
T 3l9p_A          230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP  308 (367)
T ss_dssp             HHHHHHHHSSCTTCCGGGSCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred             cccccccccccccCCCcCCcccEECHHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            998654333333344556788999999884 4578999999999999999998 9999988766433322111     11


Q ss_pred             HhhhccccceeecccccccccccccC
Q 002321          910 HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       910 ~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ...+..+.+++.+||..||.+||+++
T Consensus       309 ~~~~~~l~~li~~~l~~dP~~Rps~~  334 (367)
T 3l9p_A          309 KNCPGPVYRIMTQCWQHQPEDRPNFA  334 (367)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             ccCCHHHHHHHHHHcCCCHhHCcCHH
Confidence            23446688999999999999999874

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.8e-38  Score=346.55  Aligned_cols=242  Identities=24%  Similarity=0.288  Sum_probs=195.2

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ...|+..++||+|+||+||+|++.+|+.||||++...... ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            3457888899999999999999988999999999654332 234678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |++ |++.+++.....  .+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......  .
T Consensus       100 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~  174 (311)
T 3niz_A          100 FME-KDLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV--R  174 (311)
T ss_dssp             CCS-EEHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC--C
T ss_pred             CCC-CCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc--c
Confidence            997 588888776432  38999999999999999999999999999999999999999999999999998764322  2


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-H------------------
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-E------------------  908 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-~------------------  908 (936)
                      ......+|+.|+|||++.+...++.++||||+||++|||++|+.||.............. .                  
T Consensus       175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  254 (311)
T 3niz_A          175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK  254 (311)
T ss_dssp             ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred             cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence            223456789999999986666789999999999999999999999987655322211110 0                  


Q ss_pred             ---------------HHhhhccccceeecccccccccccccC
Q 002321          909 ---------------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 ---------------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                                     ....++++.+++.+||..||.+||+.+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  296 (311)
T 3niz_A          255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISAR  296 (311)
T ss_dssp             SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred             hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHH
Confidence                           000123556899999999999999863

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.2e-38  Score=353.60  Aligned_cols=238  Identities=21%  Similarity=0.280  Sum_probs=198.7

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||||++.....  ....+.+.+|++++++++||||+++++++.+....++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            45778889999999999999976 488999999865432  223567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++|+|.+++.....   +++..+..++.|++.||+|||+.||+||||||+|||++.+|.+||+|||+++.....   
T Consensus        95 e~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~---  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNVH---FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---  168 (384)
T ss_dssp             CCCTTEEHHHHHHTTCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT---
T ss_pred             ecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC---
Confidence            99999999999986543   899999999999999999999999999999999999999999999999999876432   


Q ss_pred             cccccccCcccccCcccccC--cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-HHHHHH------HHhhhcccc
Q 002321          847 VLSSKIQSALGYMAPEFACR--TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-SVTWLE------EHWKKAEWR  917 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~~~~~~------~~~~~~~~~  917 (936)
                      .......||+.|+|||++..  +..++.++||||+||++|||++|+.||......... ......      +...+..+.
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~  248 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMV  248 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHH
Confidence            22345679999999998853  345899999999999999999999999765432111 111111      223446788


Q ss_pred             ceeecccccccccccc
Q 002321          918 NVSMRSCKGSSRQRRR  933 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~  933 (936)
                      +++.+||..||.+||+
T Consensus       249 ~li~~lL~~dP~~R~s  264 (384)
T 4fr4_A          249 SLLKKLLEPNPDQRFS  264 (384)
T ss_dssp             HHHHHHSCSSGGGSCC
T ss_pred             HHHHHHhcCCHhHhcc
Confidence            9999999999999997

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.9e-39  Score=355.05  Aligned_cols=239  Identities=22%  Similarity=0.321  Sum_probs=198.2

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|...+.||+|+||.||+|++. +++.||||++......  .....+.+|+.+++.++||||+++++++.+....++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            45778889999999999999974 6899999998643221  22457899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+ +|+|.+++.....   +++.++..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.......  
T Consensus        89 E~~-~g~l~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--  162 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKKR---MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--  162 (336)
T ss_dssp             CCC-CEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred             ECC-CCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence            999 7899998876543   8999999999999999999999999999999999999999999999999998664322  


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH----HHHHHHHHhhhccccceeec
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF----SVTWLEEHWKKAEWRNVSMR  922 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  922 (936)
                       ......||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.......    ...+..+...++.+.+++.+
T Consensus       163 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  241 (336)
T 3h4j_B          163 -FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRR  241 (336)
T ss_dssp             -TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHT
T ss_pred             -ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence             2234568999999999965554588999999999999999999999775432111    11111234456778899999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      ||..||.+||+++
T Consensus       242 ~L~~dP~~Rpt~~  254 (336)
T 3h4j_B          242 MIVADPMQRITIQ  254 (336)
T ss_dssp             TSCSSGGGSCCHH
T ss_pred             HcCCChhHCcCHH
Confidence            9999999999863

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.8e-38  Score=351.31  Aligned_cols=239  Identities=22%  Similarity=0.249  Sum_probs=200.0

Q ss_pred             ccccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCc--cchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSL--VKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  765 (936)
                      ..|+..+.||+|+||.||+|+.+. ++.||||+++....  ....+.+.+|.+++..+ +||+|+++++++.+.+..++|
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   99 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   99 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence            456778899999999999999874 78999999975432  23356788999999998 799999999999999999999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      |||+++|+|.+++.....   +++.++..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.....  
T Consensus       100 ~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--  174 (353)
T 2i0e_A          100 MEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--  174 (353)
T ss_dssp             EECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--
T ss_pred             EeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC--
Confidence            999999999999987543   899999999999999999999999999999999999999999999999999753221  


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH----HHHhhhccccceee
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL----EEHWKKAEWRNVSM  921 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~  921 (936)
                      ........||+.|+|||++. ...++.++||||+||++|||++|+.||...+..........    .+...+.++.+++.
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  253 (353)
T 2i0e_A          175 GVTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK  253 (353)
T ss_dssp             TCCBCCCCSCGGGCCHHHHT-TCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             CcccccccCCccccChhhhc-CCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            12234567899999999984 55789999999999999999999999988765433321111    12334567889999


Q ss_pred             ccccccccccccc
Q 002321          922 RSCKGSSRQRRRF  934 (936)
Q Consensus       922 ~~l~~~p~~Rp~f  934 (936)
                      +||..||.+||++
T Consensus       254 ~lL~~dP~~R~~~  266 (353)
T 2i0e_A          254 GLMTKHPGKRLGC  266 (353)
T ss_dssp             HHTCSCTTSCTTC
T ss_pred             HHhhcCHHHcCCC
Confidence            9999999999975

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.7e-38  Score=363.06  Aligned_cols=322  Identities=21%  Similarity=0.195  Sum_probs=220.2

Q ss_pred             CcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecC
Q 002321          126 LRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLS  205 (936)
Q Consensus       126 L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  205 (936)
                      -+.++.++++++ .+|..+   .++|++|+|++|+|++..+..|..+++|++|+|++|+|+++.|..|.++++|++|+|+
T Consensus        13 ~~~v~c~~~~l~-~ip~~~---~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~   88 (477)
T 2id5_A           13 DRAVLCHRKRFV-AVPEGI---PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLR   88 (477)
T ss_dssp             TTEEECCSCCCS-SCCSCC---CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEEeCCCCcC-cCCCCC---CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECC
Confidence            357888888887 677644   2467777777777777667777777777777777777777667777777777777777


Q ss_pred             CCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCC
Q 002321          206 DNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEV  285 (936)
Q Consensus       206 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~  285 (936)
                      +|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..                     
T Consensus        89 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~---------------------  147 (477)
T 2id5_A           89 SNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRA---------------------  147 (477)
T ss_dssp             SSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTS---------------------
T ss_pred             CCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhh---------------------
Confidence            77777555555666777777777777776666666666666666666666665544444                     


Q ss_pred             CcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccC
Q 002321          286 PKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSG  365 (936)
Q Consensus       286 ~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~  365 (936)
                         |..+++|++|+|++|++++..+..+.++++|+.|+|++|.+++..+..|..+++|+.|++++|.+.+.+|...    
T Consensus       148 ---~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~----  220 (477)
T 2id5_A          148 ---FSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNC----  220 (477)
T ss_dssp             ---STTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTT----
T ss_pred             ---ccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCccc----
Confidence               4445555555555555554444445555666666666666665555566666666666666666554333321    


Q ss_pred             CccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCee
Q 002321          366 LNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVL  445 (936)
Q Consensus       366 l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  445 (936)
                                             ....+|++|+|++|++++..+..+..+++|++|+|++|++++..+..|..+++|+.|
T Consensus       221 -----------------------~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L  277 (477)
T 2id5_A          221 -----------------------LYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEI  277 (477)
T ss_dssp             -----------------------TTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEE
T ss_pred             -----------------------ccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEE
Confidence                                   123478899999999987777888999999999999999887777777788888888


Q ss_pred             ecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccC
Q 002321          446 DLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTG  502 (936)
Q Consensus       446 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  502 (936)
                      +|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|++..
T Consensus       278 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c  334 (477)
T 2id5_A          278 QLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC  334 (477)
T ss_dssp             ECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred             ECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccC
Confidence            888888777667777777777777777777775555566666666666666666653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.5e-38  Score=339.89  Aligned_cols=240  Identities=25%  Similarity=0.362  Sum_probs=200.8

Q ss_pred             ccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      ..|+..+.||+|+||.||+|++.+++.||||++.....  ..+++.+|++++++++||||+++++++.+....++||||+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc--CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            45677889999999999999998899999999975533  3577999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++++|.+++....  ..+++..++.++.|+++||+|||+++|+||||||+||+++.++.+||+|||+++...... ....
T Consensus        88 ~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~  164 (269)
T 4hcu_A           88 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSS  164 (269)
T ss_dssp             TTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHST
T ss_pred             CCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc-cccc
Confidence            9999999997643  248999999999999999999999999999999999999999999999999998664322 2223


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceeecc
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSMRS  923 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  923 (936)
                      ....+++.|+|||.+ ....++.++||||+|+++|||++ |+.||.............     ..+...++.+.+++.+|
T Consensus       165 ~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  243 (269)
T 4hcu_A          165 TGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC  243 (269)
T ss_dssp             TSTTCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHH
T ss_pred             cCcccccccCCHHHh-cCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHH
Confidence            345567789999988 45578999999999999999999 999998876543321111     11223456688899999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..||.+||+++
T Consensus       244 l~~~p~~Rps~~  255 (269)
T 4hcu_A          244 WRERPEDRPAFS  255 (269)
T ss_dssp             TCSSGGGSCCHH
T ss_pred             ccCCcccCcCHH
Confidence            999999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-38  Score=345.76  Aligned_cols=237  Identities=23%  Similarity=0.279  Sum_probs=198.7

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||+|+++...  .....+.+|++++++++||||+++++++.+....++||||
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            34677788999999999999976 58899999986543  3456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC--CCCeEEeeccCccccCCCccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG--SGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      +++|+|.+++....  ..+++.++..++.|++.||+|||++||+||||||+||+++.  ++.+||+|||+++......  
T Consensus        83 ~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--  158 (321)
T 1tki_A           83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--  158 (321)
T ss_dssp             CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred             CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--
Confidence            99999999997643  23899999999999999999999999999999999999987  7899999999998764332  


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH--------HHHHhhhccccc
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW--------LEEHWKKAEWRN  918 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~  918 (936)
                       ......+++.|+|||++. ...++.++||||+||++|||++|..||.............        ......+.++.+
T Consensus       159 -~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T 1tki_A          159 -NFRLLFTAPEYYAPEVHQ-HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             -EEEEEESCGGGSCHHHHT-TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             -ccccccCChhhcCcHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence             223456899999999984 4468999999999999999999999998866533221111        011234567889


Q ss_pred             eeeccccccccccccc
Q 002321          919 VSMRSCKGSSRQRRRF  934 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f  934 (936)
                      ++.+||..||.+||+.
T Consensus       237 li~~~L~~dp~~Rpt~  252 (321)
T 1tki_A          237 FVDRLLVKERKSRMTA  252 (321)
T ss_dssp             HHHTTSCSSGGGSCCH
T ss_pred             HHHHHcCCChhHCcCH
Confidence            9999999999999985

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.4e-38  Score=351.27  Aligned_cols=239  Identities=23%  Similarity=0.359  Sum_probs=199.2

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ...|+..+.||+|+||.||+|+.+ +|+.||||++...... ...+.+.+|++++++++||||+++++++.+....++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            345788889999999999999976 5899999999765433 33567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---CeEEeeccCccccCCC
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG---EPKVGDYGLARLLPML  843 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~  843 (936)
                      ||+++|+|.+++....   .+++.++..++.|++.||+|||++||+||||||+||+++.++   .+||+|||+++.....
T Consensus       108 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          108 DLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             CCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            9999999999887643   389999999999999999999999999999999999998654   5999999999866432


Q ss_pred             ccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH------HHH--hhhcc
Q 002321          844 DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL------EEH--WKKAE  915 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~------~~~--~~~~~  915 (936)
                      .   ......||+.|+|||++. ...++.++||||+||++|||++|+.||...+..........      .+.  ..+..
T Consensus       185 ~---~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  260 (362)
T 2bdw_A          185 E---AWHGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE  260 (362)
T ss_dssp             C---SCCCSCSCTTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHH
T ss_pred             c---ccccCCCCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence            2   223467899999999984 55789999999999999999999999988765433221110      111  23467


Q ss_pred             ccceeeccccccccccccc
Q 002321          916 WRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f  934 (936)
                      +++++.+||..||.+||+.
T Consensus       261 ~~~li~~~L~~dP~~R~t~  279 (362)
T 2bdw_A          261 AKSLIDSMLTVNPKKRITA  279 (362)
T ss_dssp             HHHHHHHHSCSSGGGSCCH
T ss_pred             HHHHHHHHcCCChhhCcCH
Confidence            8899999999999999985

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5e-38  Score=345.34  Aligned_cols=239  Identities=25%  Similarity=0.330  Sum_probs=199.8

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-----chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-----KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  763 (936)
                      ..|+..+.||+|+||.||+|+.. +|+.||||+++.....     ...+.+.+|+.++++++||||+++++++.+....+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45778889999999999999976 5899999999654332     13678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC----CeEEeeccCccc
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG----EPKVGDYGLARL  839 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg~a~~  839 (936)
                      +||||+++|+|.+++....   .+++.++..++.|++.||+|||+.+|+||||||+||+++.++    .+||+|||+++.
T Consensus        91 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  167 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  167 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence            9999999999999997643   389999999999999999999999999999999999999887    899999999987


Q ss_pred             cCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHH-HHH-------HHHHh
Q 002321          840 LPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS-VTW-------LEEHW  911 (936)
Q Consensus       840 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~-~~~-------~~~~~  911 (936)
                      .....   ......+|+.|+|||++ ....++.++||||+||++|||++|+.||.......... ...       .....
T Consensus       168 ~~~~~---~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (326)
T 2y0a_A          168 IDFGN---EFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN  243 (326)
T ss_dssp             CCTTS---CCCCCCSCTTTCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred             CCCCC---ccccccCCcCcCCceee-cCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence            64322   22345689999999988 45578999999999999999999999998765432221 110       11123


Q ss_pred             hhccccceeecccccccccccccC
Q 002321          912 KKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       912 ~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+..+++++.+||..||.+||+++
T Consensus       244 ~~~~~~~li~~~L~~dP~~Rpt~~  267 (326)
T 2y0a_A          244 TSALAKDFIRRLLVKDPKKRMTIQ  267 (326)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             CCHHHHHHHHHHccCChhhCCCHH
Confidence            456788999999999999999863

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9.1e-39  Score=357.46  Aligned_cols=244  Identities=24%  Similarity=0.351  Sum_probs=188.9

Q ss_pred             cccccCCCcccccCceEEEEEEeC----CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      ...|+..+.||+|+||.||+|++.    ++..||||+++........+++.+|+.++++++||||+++++++.+....++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            345788889999999999999875    4778999999765444556789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ||||+++|+|.++++...  ..+++.+++.++.|+++||+|||+++|+||||||+||+++.++.+||+|||+++......
T Consensus       124 v~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  201 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP  201 (373)
T ss_dssp             EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence            999999999999997643  238999999999999999999999999999999999999999999999999998764322


Q ss_pred             cc-cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH-----HHHhhhcccc
Q 002321          845 RY-VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL-----EEHWKKAEWR  917 (936)
Q Consensus       845 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~  917 (936)
                      .. .......+++.|+|||++ ....++.++|||||||++|||++ |+.||..............     .+...+..+.
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  280 (373)
T 2qol_A          202 EAAYTTRGGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY  280 (373)
T ss_dssp             ------------CTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHH
T ss_pred             ccceeccCCCcCCCccChhhh-ccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHH
Confidence            11 112223356789999988 45578999999999999999998 9999987665432211110     0122346688


Q ss_pred             ceeecccccccccccccC
Q 002321          918 NVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++.+||..||.+||+++
T Consensus       281 ~li~~cl~~dp~~RPs~~  298 (373)
T 2qol_A          281 QLMLDCWQKDRNNRPKFE  298 (373)
T ss_dssp             HHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHhCcChhhCcCHH
Confidence            999999999999999874

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.1e-38  Score=346.20  Aligned_cols=236  Identities=23%  Similarity=0.322  Sum_probs=197.8

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      ++..+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++......++||||++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  125 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ  125 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence            455668999999999999987 69999999997543 2346778999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                      +|+|.+++....    +++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++......  ....
T Consensus       126 ~~~L~~~l~~~~----l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  199 (321)
T 2c30_A          126 GGALTDIVSQVR----LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRK  199 (321)
T ss_dssp             SCBHHHHHTTCC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBC
T ss_pred             CCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--cccc
Confidence            999999987532    8999999999999999999999999999999999999999999999999998764322  1234


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-------HHhhhccccceeecc
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-------EHWKKAEWRNVSMRS  923 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~  923 (936)
                      ...||+.|+|||++ ....++.++||||+||++|||++|+.||...............       ....+..+++++.+|
T Consensus       200 ~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  278 (321)
T 2c30_A          200 SLVGTPYWMAPEVI-SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM  278 (321)
T ss_dssp             CCCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred             cccCCccccCHhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence            55789999999998 4557899999999999999999999999876653322111100       112345678999999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..||.+||+++
T Consensus       279 l~~dp~~Rps~~  290 (321)
T 2c30_A          279 LVRDPQERATAQ  290 (321)
T ss_dssp             SCSSTTTSCCHH
T ss_pred             ccCChhhCcCHH
Confidence            999999999863

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.9e-38  Score=346.05  Aligned_cols=242  Identities=22%  Similarity=0.284  Sum_probs=187.0

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..++||+|+||.||+|+.+ +|+.||||+++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   84 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF   84 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence            35678889999999999999976 58999999997665444457788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          769 VSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       769 ~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      ++ |+|.+++....   ....+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...... 
T Consensus        85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-  162 (317)
T 2pmi_A           85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV-  162 (317)
T ss_dssp             CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC-
T ss_pred             cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc-
Confidence            97 69999886532   12348899999999999999999999999999999999999999999999999998764322 


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-----------------
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-----------------  908 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-----------------  908 (936)
                       .......+|+.|+|||++.+...++.++||||+||++|||++|+.||...............                 
T Consensus       163 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  241 (317)
T 2pmi_A          163 -NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK  241 (317)
T ss_dssp             -CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred             -ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence             12234567899999999866567899999999999999999999999876653322111100                 


Q ss_pred             ---------------------HHhhhccccceeeccccccccccccc
Q 002321          909 ---------------------EHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       909 ---------------------~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                           +...+..+.+++.+||..||.+||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  288 (317)
T 2pmi_A          242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA  288 (317)
T ss_dssp             CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCH
Confidence                                 00123457789999999999999985

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.1e-38  Score=352.00  Aligned_cols=244  Identities=22%  Similarity=0.321  Sum_probs=199.2

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc----cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL----VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  763 (936)
                      ...|+..+.||+|+||.||+|+.+ +++.||||++.....    ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            345788889999999999999976 589999999864321    123578999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCC---eEEeeccCccc
Q 002321          764 LIYEFVSGGSLHKHLHEGS-GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARL  839 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a~~  839 (936)
                      +||||+++|+|.+++.... ....+++..+..++.|++.||+|||+++|+||||||+||+++.++.   +||+|||+++.
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            9999999999988776432 2334899999999999999999999999999999999999987654   99999999987


Q ss_pred             cCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH-----HHH--Hhh
Q 002321          840 LPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW-----LEE--HWK  912 (936)
Q Consensus       840 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~-----~~~--~~~  912 (936)
                      .....  .......+|+.|+|||++. ...++.++||||+||++|||++|+.||.............     ..+  ...
T Consensus       183 ~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (351)
T 3c0i_A          183 LGESG--LVAGGRVGTPHFMAPEVVK-REPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHI  259 (351)
T ss_dssp             CCTTS--CBCCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred             ecCCC--eeecCCcCCcCccCHHHHc-CCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCccccccC
Confidence            64322  2233457899999999984 4568999999999999999999999998765432221111     011  224


Q ss_pred             hccccceeecccccccccccccC
Q 002321          913 KAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       913 ~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+++++.+||..||.+||+++
T Consensus       260 s~~~~~li~~~L~~dP~~R~s~~  282 (351)
T 3c0i_A          260 SESAKDLVRRMLMLDPAERITVY  282 (351)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             CHHHHHHHHHHCCCChhHCcCHH
Confidence            57789999999999999999863

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.9e-38  Score=342.56  Aligned_cols=240  Identities=22%  Similarity=0.271  Sum_probs=192.8

Q ss_pred             cccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .|+..+.||+|+||+||+|+..+|+.||||++...... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence            35677889999999999999988999999999655432 22467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      + ++|.+++.....  .+++.++..++.|+++||+|||++||+||||||+||+++.++.+||+|||+++......  ...
T Consensus        83 ~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~  157 (288)
T 1ob3_A           83 D-QDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKY  157 (288)
T ss_dssp             S-EEHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             C-CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--ccc
Confidence            7 599998876432  38999999999999999999999999999999999999999999999999998654221  122


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-H-------------------
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-E-------------------  909 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-~-------------------  909 (936)
                      ....+|+.|+|||++.+...++.++||||+||++|||++|+.||............... .                   
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence            34467899999999866667899999999999999999999999886653222111100 0                   


Q ss_pred             -------------HhhhccccceeecccccccccccccC
Q 002321          910 -------------HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       910 -------------~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                                   ...++.+.+++.+||..||.+||+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  276 (288)
T 1ob3_A          238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK  276 (288)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHH
Confidence                         00123445789999999999999853

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.8e-38  Score=353.81  Aligned_cols=240  Identities=22%  Similarity=0.279  Sum_probs=196.5

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  764 (936)
                      ...|+..+.||+|+||+||+|+.+ +++.||||+++.....  ...+.+.+|..++.++ +||||+++++++.+....++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            345778889999999999999977 4789999999765332  2235678899999887 89999999999999999999


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ||||+++|+|.+++.+...   +++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..... 
T Consensus       131 V~E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-  206 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-  206 (396)
T ss_dssp             EEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred             EEEcCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC-
Confidence            9999999999999987543   899999999999999999999999999999999999999999999999999753221 


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch---------hHHHHHHH----HHHHh
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM---------MWWFSVTW----LEEHW  911 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~---------~~~~~~~~----~~~~~  911 (936)
                       ........||+.|+|||++. +..++.++||||+||++|||++|+.||.....         ........    ..+..
T Consensus       207 -~~~~~~~~gt~~Y~aPE~l~-~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~  284 (396)
T 4dc2_A          207 -GDTTSTFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS  284 (396)
T ss_dssp             -TCCBCCCCBCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred             -CCccccccCCcccCCchhhc-CCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence             12334567999999999984 55789999999999999999999999964321         10111100    01223


Q ss_pred             hhccccceeeccccccccccccc
Q 002321          912 KKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       912 ~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      .+..+++++.+||..||.+||+.
T Consensus       285 ~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          285 LSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             CCHHHHHHHHHHhcCCHhHcCCC
Confidence            45678899999999999999974

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1e-38  Score=352.35  Aligned_cols=245  Identities=20%  Similarity=0.268  Sum_probs=195.7

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC--------
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS--------  760 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  760 (936)
                      ..|+..+.||+|+||.||+|+++ +|+.||||+++........+.+.+|++++++++||||+++++++.+..        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            34677889999999999999987 699999999976655556788999999999999999999999986543        


Q ss_pred             -------------------------------------------------eeEEEEEecCCCChhhhhhccCCCCCCCHHH
Q 002321          761 -------------------------------------------------LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNE  791 (936)
Q Consensus       761 -------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  791 (936)
                                                                       ..++||||+++|+|.+++.........++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                             2789999999999999998766555577788


Q ss_pred             HHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc----------ccccccccCcccccCc
Q 002321          792 RFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR----------YVLSSKIQSALGYMAP  861 (936)
Q Consensus       792 ~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~----------~~~~~~~~~~~~y~aP  861 (936)
                      +++++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.......          ........+|+.|+||
T Consensus       166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  245 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP  245 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred             HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence            999999999999999999999999999999999999999999999987654321          1222345689999999


Q ss_pred             ccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH---HHHHhhhccccceeecccccccccccccC
Q 002321          862 EFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW---LEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       862 E~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      |.+. +..++.++||||+||++|||++|..|+.............   .......+.+.+++.+||..||.+||+++
T Consensus       246 E~~~-~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  321 (332)
T 3qd2_B          246 EQIH-GNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT  321 (332)
T ss_dssp             HHHH-CCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHH
T ss_pred             HHhc-CCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHH
Confidence            9984 4578999999999999999999988764432211111100   01122335668899999999999999863

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.1e-38  Score=345.70  Aligned_cols=244  Identities=32%  Similarity=0.546  Sum_probs=200.8

Q ss_pred             ccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      ..|+..+.||+|+||.||+|++++++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        39 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  117 (321)
T 2qkw_B           39 NNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM  117 (321)
T ss_dssp             CCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECC
T ss_pred             hccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcC
Confidence            4578888999999999999998889999999986543 234678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          770 SGGSLHKHLHEGSGG-NFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      ++|+|.+++...... ..+++.++.+++.|+++||+|||++||+||||||+||+++.++.+||+|||+++..........
T Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  197 (321)
T 2qkw_B          118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL  197 (321)
T ss_dssp             TTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred             CCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            999999999765422 2489999999999999999999999999999999999999999999999999987654333333


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHH-HHHHHHH-------------------
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWW-FSVTWLE-------------------  908 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~-~~~~~~~-------------------  908 (936)
                      .....+++.|+|||++. ...++.++||||+||++|||++|+.||........ ....+..                   
T Consensus       198 ~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (321)
T 2qkw_B          198 STVVKGTLGYIDPEYFI-KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADK  276 (321)
T ss_dssp             BCCCEEETTTCCHHHHH-HCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTC
T ss_pred             ccccCCCccccCHHHhc-CCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccc
Confidence            44556889999999884 44689999999999999999999999976533111 1111110                   


Q ss_pred             -HHhhhccccceeecccccccccccccC
Q 002321          909 -EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 -~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                       +......+.+++.+||..||.+||+++
T Consensus       277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~  304 (321)
T 2qkw_B          277 IRPESLRKFGDTAVKCLALSSEDRPSMG  304 (321)
T ss_dssp             SCHHHHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             cCHHHHHHHHHHHHHHcCCCcccCcCHH
Confidence             011234567788899999999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.8e-38  Score=349.81  Aligned_cols=235  Identities=22%  Similarity=0.274  Sum_probs=199.9

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||.||+|+.+ +|+.||||++.....  ....+.+.+|++++++++||||+++++++.+....++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            45677889999999999999976 589999999965432  133567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++|+|.+++.+...   +++.++..++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++.....   
T Consensus       121 e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred             cCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC---
Confidence            99999999999987543   899999999999999999999999999999999999999999999999999866432   


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH----HHHhhhccccceeec
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL----EEHWKKAEWRNVSMR  922 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~  922 (936)
                        .....||+.|+|||++. +..++.++||||+||++|||++|+.||...+..........    .+...+..+++++.+
T Consensus       195 --~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  271 (350)
T 1rdq_E          195 --TWTLCGTPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN  271 (350)
T ss_dssp             --BCCCEECGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred             --cccccCCccccCHHHhc-CCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence              23457899999999984 45789999999999999999999999988765433221111    123345778999999


Q ss_pred             ccccccccccc
Q 002321          923 SCKGSSRQRRR  933 (936)
Q Consensus       923 ~l~~~p~~Rp~  933 (936)
                      ||..||.+||+
T Consensus       272 lL~~dp~~R~~  282 (350)
T 1rdq_E          272 LLQVDLTKRFG  282 (350)
T ss_dssp             HSCSCTTTCTT
T ss_pred             HhhcCHHhccC
Confidence            99999999997

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.3e-38  Score=346.88  Aligned_cols=239  Identities=24%  Similarity=0.339  Sum_probs=189.9

Q ss_pred             ccccCCCcccccCceEEEEEEe----CCCcEEEEEEeeccCcc---chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCee
Q 002321          690 ALLNKDCELGRGGFGAVYRTVL----RDGRPVAIKKLTVSSLV---KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQ  762 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  762 (936)
                      ..|+..+.||+|+||.||+|+.    .+++.||||+++.....   .....+.+|+.++++++||||+++++++.+.+..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            4577888999999999999997    36899999999765322   2345678999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCC
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM  842 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  842 (936)
                      ++||||+++|+|.+++.....   +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  173 (327)
T 3a62_A           97 YLILEYLSGGELFMQLEREGI---FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH  173 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred             EEEEeCCCCCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence            999999999999999986543   88999999999999999999999999999999999999999999999999975432


Q ss_pred             CccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH----HHHhhhccccc
Q 002321          843 LDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL----EEHWKKAEWRN  918 (936)
Q Consensus       843 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~  918 (936)
                      ..  .......|++.|+|||++. ...++.++||||+||++|||++|+.||...+..........    .+...++.+++
T Consensus       174 ~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  250 (327)
T 3a62_A          174 DG--TVTHTFCGTIEYMAPEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD  250 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHT-TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHH
T ss_pred             CC--ccccccCCCcCccCHhhCc-CCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            11  2233457899999999984 45689999999999999999999999987665332211110    12334577899


Q ss_pred             eeeccccccccccccc
Q 002321          919 VSMRSCKGSSRQRRRF  934 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f  934 (936)
                      ++.+||..||.+||+.
T Consensus       251 li~~~L~~dp~~R~~~  266 (327)
T 3a62_A          251 LLKKLLKRNAASRLGA  266 (327)
T ss_dssp             HHHHHSCSCGGGSTTS
T ss_pred             HHHHHHhcCHhhccCC
Confidence            9999999999999964

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4e-38  Score=348.06  Aligned_cols=239  Identities=23%  Similarity=0.279  Sum_probs=196.9

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  765 (936)
                      ..|+..+.||+|+||.||+|+.+ +++.||||+++.....  ...+.+.+|..+++++ +||||+++++++.+....++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            45677889999999999999986 5889999999765432  2346688999999998 899999999999999999999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      |||+++|+|.+++.+...   +++..+..++.|++.||+|||++||+||||||+||+++.+|.+||+|||+++...... 
T Consensus        89 ~e~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-  164 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-  164 (345)
T ss_dssp             ECCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-
T ss_pred             EeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC-
Confidence            999999999999987543   8999999999999999999999999999999999999999999999999997543211 


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchh-------HHHHHHH-HH-----HHhh
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM-------WWFSVTW-LE-----EHWK  912 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~-------~~~~~~~-~~-----~~~~  912 (936)
                       .......||+.|+|||++. +..++.++||||+||++|||++|+.||......       ....... ..     +...
T Consensus       165 -~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~  242 (345)
T 3a8x_A          165 -DTTSTFCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL  242 (345)
T ss_dssp             -CCBCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS
T ss_pred             -CcccccCCCccccCccccC-CCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC
Confidence             2234567899999999984 457899999999999999999999999753110       0000111 11     1234


Q ss_pred             hccccceeeccccccccccccc
Q 002321          913 KAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       913 ~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      +..+++++.+||..||.+||+.
T Consensus       243 s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          243 SVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CHHHHHHHHHHhcCCHhHCCCC
Confidence            5677899999999999999985

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=347.25  Aligned_cols=244  Identities=25%  Similarity=0.290  Sum_probs=199.4

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC--eeEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS--LQLLI  765 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  765 (936)
                      ...|...+.||+|+||+||+|++. +++.||||+++........+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            345778889999999999999987 489999999976655556778899999999999999999999998765  67999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE----cCCCCeEEeeccCccccC
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLI----DGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~a~~~~  841 (936)
                      |||+++|+|.+++........+++.++..++.|++.||+|||++||+||||||+||++    +.++.+||+|||+++...
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~  167 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE  167 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence            9999999999999876554458999999999999999999999999999999999999    788889999999998764


Q ss_pred             CCccccccccccCcccccCcccccC-------cccCCchhhHHHHHHHHHHHHcCCCCCCccchh---HHHHHHHHHH--
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACR-------TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM---WWFSVTWLEE--  909 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~---~~~~~~~~~~--  909 (936)
                      ...   ......+++.|+|||++..       ...++.++||||+||++|||++|+.||......   ..........  
T Consensus       168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p  244 (319)
T 4euu_A          168 DDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (319)
T ss_dssp             TTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred             CCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence            332   2234568999999998742       357899999999999999999999999753321   1111111111  


Q ss_pred             ----------------------------HhhhccccceeecccccccccccccC
Q 002321          910 ----------------------------HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       910 ----------------------------~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                                                  ......+.+++.+||..||.+||+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~  298 (319)
T 4euu_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD  298 (319)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHH
T ss_pred             cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHH
Confidence                                        11224577888999999999999874

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-38  Score=353.49  Aligned_cols=246  Identities=23%  Similarity=0.305  Sum_probs=202.2

Q ss_pred             cccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCee
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQ  762 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  762 (936)
                      ...|+..+.||+|+||.||+|++.      +++.||||+++........+.+.+|++++++++||||+++++++.+....
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  125 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM  125 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence            345677889999999999999975      24789999997665445567899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 002321          763 LLIYEFVSGGSLHKHLHEGSG---------------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNV  821 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NI  821 (936)
                      ++||||+++|+|.+++.....                     ...+++.+++.++.|+++||+|||++||+||||||+||
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI  205 (343)
T 1luf_A          126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC  205 (343)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceE
Confidence            999999999999999976421                     13589999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhH
Q 002321          822 LIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMW  900 (936)
Q Consensus       822 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~  900 (936)
                      +++.++.+||+|||+++...............+++.|+|||.+. ...++.++||||+||++|||++ |+.||.......
T Consensus       206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  284 (343)
T 1luf_A          206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE  284 (343)
T ss_dssp             EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhc-cCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH
Confidence            99999999999999998765433333344556788999999884 4468999999999999999999 999998876543


Q ss_pred             HHHHHHH-----HHHhhhccccceeecccccccccccccC
Q 002321          901 WFSVTWL-----EEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       901 ~~~~~~~-----~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .......     .+...+..+.+++.+||..||.+||+++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  324 (343)
T 1luf_A          285 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFC  324 (343)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence            3211110     1123446788999999999999999874

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=344.15  Aligned_cols=240  Identities=25%  Similarity=0.320  Sum_probs=191.5

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc-------------------------hHHHHHHHHHHHHc
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK-------------------------SQEDFEREVKKLGK  743 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------------------------~~~~~~~E~~~l~~  743 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||||++.......                         ..+.+.+|++++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            34677889999999999999975 58899999996543211                         13568899999999


Q ss_pred             CCCCCcceeeeEEEe--CCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 002321          744 VRHPNLVTLEGYYWT--QSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNV  821 (936)
Q Consensus       744 l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NI  821 (936)
                      ++||||+++++++.+  ....++||||+++++|.++....    .+++.++..++.|+++||+|||++||+||||||+||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            999999999999986  56789999999999998876432    389999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeeccCccccCCCccccccccccCcccccCcccccCccc--CCchhhHHHHHHHHHHHHcCCCCCCccchh
Q 002321          822 LIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK--ITDKCDVYGFGVLVLEVVTGKRPLSTWKMM  899 (936)
Q Consensus       822 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~  899 (936)
                      +++.++.+||+|||+++.......  ......+|+.|+|||.+.+...  ++.++||||+||++|||++|+.||...+..
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  246 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM  246 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             EECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence            999999999999999987643222  2234578999999998854432  478899999999999999999999887654


Q ss_pred             HHHHHHHHH------HHhhhccccceeecccccccccccccC
Q 002321          900 WWFSVTWLE------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       900 ~~~~~~~~~------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .........      ....++.+.+++.+||..||.+||+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~  288 (298)
T 2zv2_A          247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVP  288 (298)
T ss_dssp             HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred             HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHH
Confidence            332211110      012346688999999999999999863

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5.1e-39  Score=352.86  Aligned_cols=240  Identities=25%  Similarity=0.258  Sum_probs=193.6

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC----eeEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS----LQLL  764 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l  764 (936)
                      ...|+..++||+|+||+||+|++. ++.||||+++...  ......++|+.++++++||||+++++++.+..    ..++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            445788889999999999999986 8999999996542  23455677999999999999999999998754    3689


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CcccCCCCCCCEEEcCCCCeEEeec
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS----------NIIHYNIKSSNVLIDGSGEPKVGDY  834 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~----------~ivH~Dlkp~NIll~~~~~~kl~Df  834 (936)
                      ||||+++|+|.++++...    +++.++..++.|+++||+|||+.          +|+||||||+||+++.++.+||+||
T Consensus       100 v~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            999999999999997643    89999999999999999999999          9999999999999999999999999


Q ss_pred             cCccccCCCccccccccccCcccccCcccccCc----ccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH--------
Q 002321          835 GLARLLPMLDRYVLSSKIQSALGYMAPEFACRT----VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF--------  902 (936)
Q Consensus       835 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~--------  902 (936)
                      |+++...............+|+.|+|||++.+.    ..++.++||||+||++|||++|+.||.........        
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            999876544433334446789999999988542    35667899999999999999999999764321000        


Q ss_pred             ---HHHHHHH----------------HhhhccccceeecccccccccccccC
Q 002321          903 ---SVTWLEE----------------HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       903 ---~~~~~~~----------------~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                         .......                ....+.+.+++.+||..||.+||+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  307 (322)
T 3soc_A          256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG  307 (322)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHH
Confidence               0000000                01113378899999999999999864

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=8.6e-39  Score=357.20  Aligned_cols=247  Identities=27%  Similarity=0.353  Sum_probs=202.0

Q ss_pred             ccccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCC
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQS  760 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  760 (936)
                      ....|+..+.||+|+||.||+|++.      +++.||||+++........+.+.+|+++++++ +||||+++++++.+.+
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~   99 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   99 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence            3456788889999999999999842      46899999997665445567899999999999 7999999999998754


Q ss_pred             -eeEEEEEecCCCChhhhhhccCC--------------------------------------------------------
Q 002321          761 -LQLLIYEFVSGGSLHKHLHEGSG--------------------------------------------------------  783 (936)
Q Consensus       761 -~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------  783 (936)
                       ..++||||+++|+|.++++....                                                        
T Consensus       100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (359)
T 3vhe_A          100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  179 (359)
T ss_dssp             SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred             CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence             48999999999999999976532                                                        


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccccccCcc
Q 002321          784 -------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSAL  856 (936)
Q Consensus       784 -------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~  856 (936)
                             ...+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...............+|+
T Consensus       180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~  259 (359)
T 3vhe_A          180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL  259 (359)
T ss_dssp             ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred             ccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCc
Confidence                   1228899999999999999999999999999999999999999999999999998765444444445567888


Q ss_pred             cccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHHH------HHhhhccccceeecccccccc
Q 002321          857 GYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWLE------EHWKKAEWRNVSMRSCKGSSR  929 (936)
Q Consensus       857 ~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~p~  929 (936)
                      .|+|||++. ...++.++||||+||++|||++ |+.||...............      +...++.+.+++.+||..||.
T Consensus       260 ~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~  338 (359)
T 3vhe_A          260 KWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS  338 (359)
T ss_dssp             GGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             eeEChhhhc-CCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            999999884 5578999999999999999998 99999876543222111111      233456788999999999999


Q ss_pred             cccccC
Q 002321          930 QRRRFQ  935 (936)
Q Consensus       930 ~Rp~f~  935 (936)
                      +||+++
T Consensus       339 ~Rps~~  344 (359)
T 3vhe_A          339 QRPTFS  344 (359)
T ss_dssp             GSCCHH
T ss_pred             hCCCHH
Confidence            999863

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.2e-38  Score=358.64  Aligned_cols=240  Identities=22%  Similarity=0.310  Sum_probs=198.9

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ...|+..++||+|+||.||+|... +|+.||+|++...... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            345788889999999999999975 6899999999765433 33567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc---CCCCeEEeeccCccccCCC
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLID---GSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~  843 (936)
                      ||+++|+|.+.+.....   +++.++..++.|++.||+|||++||+||||||+||+++   .++.+||+|||+++.....
T Consensus        90 E~~~gg~L~~~i~~~~~---~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           90 DLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             CCCBCCBHHHHHHHCSC---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             EeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            99999999999887543   89999999999999999999999999999999999998   5678999999999866432


Q ss_pred             ccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH------H--Hhhhcc
Q 002321          844 DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE------E--HWKKAE  915 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~------~--~~~~~~  915 (936)
                      .  .......||+.|+|||++ ....++.++||||+||++|+|++|+.||.+.+...........      +  ...++.
T Consensus       167 ~--~~~~~~~gt~~Y~APE~l-~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  243 (444)
T 3soa_A          167 Q--QAWFGFAGTPGYLSPEVL-RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE  243 (444)
T ss_dssp             C--CBCCCSCSCGGGCCHHHH-TTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred             C--ceeecccCCcccCCHHHh-cCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHH
Confidence            2  222346789999999998 4557899999999999999999999999887654333221110      1  123467


Q ss_pred             ccceeeccccccccccccc
Q 002321          916 WRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f  934 (936)
                      +++++.+||..||.+||+.
T Consensus       244 ~~~li~~~L~~dP~~Rpta  262 (444)
T 3soa_A          244 AKDLINKMLTINPSKRITA  262 (444)
T ss_dssp             HHHHHHHHSCSSTTTSCCH
T ss_pred             HHHHHHHHcCCChhHCCCH
Confidence            8899999999999999985

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=356.00  Aligned_cols=246  Identities=25%  Similarity=0.314  Sum_probs=204.7

Q ss_pred             cccccCCCcccccCceEEEEEEeC--------CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeC
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR--------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQ  759 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  759 (936)
                      ...|...++||+|+||+||+|++.        ++..||||+++........+.+.+|+++++++ +||||+++++++.+.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            345678889999999999999863        23579999997765555567899999999999 999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC
Q 002321          760 SLQLLIYEFVSGGSLHKHLHEGSG-------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS  826 (936)
Q Consensus       760 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~  826 (936)
                      +..++||||+++|+|.+++.....             ...+++.++++++.|++.||+|||+++|+||||||+||+++.+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~  227 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED  227 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCC
Confidence            999999999999999999986542             1348999999999999999999999999999999999999999


Q ss_pred             CCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHH
Q 002321          827 GEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVT  905 (936)
Q Consensus       827 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~  905 (936)
                      +.+||+|||+++...............+++.|+|||++. +..++.++||||+||++|||++ |..||............
T Consensus       228 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~  306 (382)
T 3tt0_A          228 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL  306 (382)
T ss_dssp             CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             CcEEEcccCcccccccccccccccCCCCCcceeCHHHhc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            999999999998765544334444556788999999884 4578999999999999999999 99999887654333221


Q ss_pred             HHH-----HHhhhccccceeecccccccccccccC
Q 002321          906 WLE-----EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       906 ~~~-----~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ...     +...+..+.+++.+||..||.+||+++
T Consensus       307 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~  341 (382)
T 3tt0_A          307 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK  341 (382)
T ss_dssp             HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHH
Confidence            110     122346788899999999999999874

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.9e-38  Score=337.24  Aligned_cols=243  Identities=23%  Similarity=0.302  Sum_probs=203.0

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||||++.........+.+.+|+.++++++||||+++++++.+....++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            34677789999999999999986 68999999997655455568899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++++|.+++....   .+++.++..++.|++.||+|||++|++||||||+||+++.++.+||+|||.+...........
T Consensus        87 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  163 (276)
T 2yex_A           87 CSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (276)
T ss_dssp             CTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             cCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence            99999999987543   389999999999999999999999999999999999999999999999999986643333333


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-------HHhhhccccceee
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-------EHWKKAEWRNVSM  921 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~  921 (936)
                      .....+++.|+|||.+.+...++.++||||+|+++|||++|+.||............+..       ....+..+.+++.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (276)
T 2yex_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  243 (276)
T ss_dssp             BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHH
Confidence            345678999999999865544578999999999999999999999876543222222211       1223466788999


Q ss_pred             cccccccccccccC
Q 002321          922 RSCKGSSRQRRRFQ  935 (936)
Q Consensus       922 ~~l~~~p~~Rp~f~  935 (936)
                      +||..||.+||+++
T Consensus       244 ~~l~~~p~~Rps~~  257 (276)
T 2yex_A          244 KILVENPSARITIP  257 (276)
T ss_dssp             HHSCSSTTTSCCHH
T ss_pred             HHCCCCchhCCCHH
Confidence            99999999999863

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-38  Score=353.09  Aligned_cols=247  Identities=25%  Similarity=0.321  Sum_probs=199.7

Q ss_pred             ccccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCC
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQS  760 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  760 (936)
                      ....|+..+.||+|+||.||+|++.      +++.||||+++........+.+.+|+.+++++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            3455778889999999999999962      35689999997654444557899999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhccCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSGG--------------------NFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSN  820 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~N  820 (936)
                      ..++||||+++|+|.+++......                    ..+++..++.++.|++.||+|||++||+||||||+|
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N  202 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN  202 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhh
Confidence            999999999999999999765421                    237899999999999999999999999999999999


Q ss_pred             EEEcCCCCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchh
Q 002321          821 VLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMM  899 (936)
Q Consensus       821 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~  899 (936)
                      |+++.++.+||+|||+++...............+++.|+|||.+. ...++.++||||+||++|||++ |..||......
T Consensus       203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  281 (344)
T 1rjb_A          203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  281 (344)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhc-cCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence            999999999999999998665433333344556788899999884 4568999999999999999998 99999876543


Q ss_pred             HHHHHHHH------HHHhhhccccceeecccccccccccccC
Q 002321          900 WWFSVTWL------EEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       900 ~~~~~~~~------~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ........      .+...++.+.+++.+||..||.+||+++
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  323 (344)
T 1rjb_A          282 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP  323 (344)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence            22211111      1233457788999999999999999874

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.9e-38  Score=347.38  Aligned_cols=246  Identities=25%  Similarity=0.330  Sum_probs=204.6

Q ss_pred             cccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCee
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQ  762 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  762 (936)
                      ...|...+.||+|+||.||+|+..      +++.||||+++........+.+.+|++++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            445678889999999999999862      35789999997655445567899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 002321          763 LLIYEFVSGGSLHKHLHEGSG---------------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNV  821 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NI  821 (936)
                      ++||||+++|+|.+++.....                     ...+++.++++++.|+++||+|||+++|+||||||+||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NI  181 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNI  181 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheE
Confidence            999999999999999986542                     12488999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhH
Q 002321          822 LIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMW  900 (936)
Q Consensus       822 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~  900 (936)
                      +++.++.+||+|||+++...............+++.|+|||.+. +..++.++||||+||++|||++ |+.||.......
T Consensus       182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  260 (314)
T 2ivs_A          182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER  260 (314)
T ss_dssp             EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc-CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999998765444433444556788899999884 4568999999999999999999 999998876643


Q ss_pred             HHHHHHH-----HHHhhhccccceeecccccccccccccC
Q 002321          901 WFSVTWL-----EEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       901 ~~~~~~~-----~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .......     .+...++.+.+++.+||..||.+||+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  300 (314)
T 2ivs_A          261 LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFA  300 (314)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence            3322111     1123456788999999999999999864

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.8e-38  Score=337.53  Aligned_cols=241  Identities=24%  Similarity=0.337  Sum_probs=201.4

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ...|+..+.||+|+||.||+|+++++..||||+++....  ..+++.+|++++++++||||+++++++.+....++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            345678889999999999999998888999999975543  356799999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++++|.+++....  ..+++.+++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....... ..
T Consensus        85 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~  161 (268)
T 3sxs_A           85 ISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VS  161 (268)
T ss_dssp             CTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EE
T ss_pred             cCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh-hc
Confidence            99999999997643  2389999999999999999999999999999999999999999999999999987643322 22


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceeec
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSMR  922 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  922 (936)
                      .....+++.|+|||.+ ....++.++||||+|+++|||++ |+.||.............     ..+...++.+.+++.+
T Consensus       162 ~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  240 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVF-HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYS  240 (268)
T ss_dssp             CCSCCCCGGGCCHHHH-HHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred             ccCCCcCcccCCHHHH-hccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHH
Confidence            3344567789999988 45568999999999999999999 999998776543322111     1123345678899999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      ||..||.+||+++
T Consensus       241 ~l~~~p~~Rps~~  253 (268)
T 3sxs_A          241 CWHELPEKRPTFQ  253 (268)
T ss_dssp             TTCSSGGGSCCHH
T ss_pred             HcCCChhhCcCHH
Confidence            9999999999874

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.9e-38  Score=351.04  Aligned_cols=240  Identities=20%  Similarity=0.258  Sum_probs=192.4

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHH-HHcCCCCCcceeeeEEEeCCeeEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKK-LGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      ...|+..+.||+|+||.||+|+.+ +++.||||+++.....  .....+.+|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            445788889999999999999987 4889999999765432  224556677776 577899999999999999999999


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ||||+++|+|.+++.+...   +++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++..... 
T Consensus       117 v~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~-  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRERC---FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-
T ss_pred             EEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC-
Confidence            9999999999999987543   889999999999999999999999999999999999999999999999999854221 


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH----HHhhhcccccee
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE----EHWKKAEWRNVS  920 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~  920 (936)
                       ........||+.|+|||++. +..++.++||||+||++|||++|+.||...+...........    +...+..+++++
T Consensus       193 -~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li  270 (373)
T 2r5t_A          193 -NSTTSTFCGTPEYLAPEVLH-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL  270 (373)
T ss_dssp             -CCCCCSBSCCCCCCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred             -CCccccccCCccccCHHHhC-CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence             12234567899999999984 557899999999999999999999999887664333221111    122446788999


Q ss_pred             eccccccccccccc
Q 002321          921 MRSCKGSSRQRRRF  934 (936)
Q Consensus       921 ~~~l~~~p~~Rp~f  934 (936)
                      .+||..||.+||+.
T Consensus       271 ~~lL~~dp~~R~~~  284 (373)
T 2r5t_A          271 EGLLQKDRTKRLGA  284 (373)
T ss_dssp             HHHTCSSGGGSTTT
T ss_pred             HHHcccCHHhCCCC
Confidence            99999999999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.2e-38  Score=338.44  Aligned_cols=239  Identities=22%  Similarity=0.259  Sum_probs=192.2

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc-hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      .|+..++||+|+||+||+|+.. +++.||||+++...... ....+.+|+.++++++||||+++++++.+....++||||
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   82 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence            3677789999999999999986 58999999997654332 357788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++ ++.+.+....  ..+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......  ..
T Consensus        83 ~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  157 (292)
T 3o0g_A           83 CDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RC  157 (292)
T ss_dssp             CSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--SC
T ss_pred             CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--cc
Confidence            975 6666555432  238999999999999999999999999999999999999999999999999998764322  22


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHH--H----------------
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE--H----------------  910 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~--~----------------  910 (936)
                      .....+|+.|+|||++.+...++.++||||+||++|||++|..||................  .                
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence            3445678999999998666568999999999999999999888864443322211111110  0                


Q ss_pred             ----------------hhhccccceeeccccccccccccc
Q 002321          911 ----------------WKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       911 ----------------~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                      ..++.+++++.+|+..||.+||+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  277 (292)
T 3o0g_A          238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA  277 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCH
Confidence                            122445689999999999999985

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.2e-38  Score=348.51  Aligned_cols=244  Identities=24%  Similarity=0.323  Sum_probs=192.6

Q ss_pred             ccccccCCCcccccCceEEEEEEeC-CCc----EEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCee
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLR-DGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQ  762 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  762 (936)
                      ....|+..+.||+|+||+||+|++. +++    +||+|+++........+++.+|+.++++++||||+++++++.+.. .
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~   91 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence            3456788889999999999999965 344    468888865544455688999999999999999999999998765 6


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCC
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM  842 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  842 (936)
                      ++|+||+++|+|.+++.....  .+++..++.++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++....
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            789999999999999987542  389999999999999999999999999999999999999999999999999987754


Q ss_pred             CccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccc
Q 002321          843 LDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEW  916 (936)
Q Consensus       843 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~  916 (936)
                      ...........+|+.|+|||.+. +..++.++||||+||++|||++ |+.||.............     ..+...+..+
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV  248 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred             CcccccccCCCccccccChHHhc-cCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence            44433344455688999999884 5578999999999999999999 999998876543332211     1122344568


Q ss_pred             cceeecccccccccccccC
Q 002321          917 RNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       917 ~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+++.+||..||.+||+++
T Consensus       249 ~~li~~~l~~~p~~Rps~~  267 (327)
T 3poz_A          249 YMIMVKCWMIDADSRPKFR  267 (327)
T ss_dssp             HHHHHHHTCSCGGGSCCHH
T ss_pred             HHHHHHHcCCChhhCCCHH
Confidence            8899999999999999874

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4e-38  Score=344.59  Aligned_cols=246  Identities=25%  Similarity=0.341  Sum_probs=204.1

Q ss_pred             cccccCCCcccccCceEEEEEEe------CCCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCe
Q 002321          689 HALLNKDCELGRGGFGAVYRTVL------RDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSL  761 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  761 (936)
                      ...|+..+.||+|+||.||+|++      .+++.||||+++........+.+.+|+++++++ +||||+++++++.+.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            44577888999999999999985      246899999997665445567899999999999 99999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhccCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGG---------------NFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS  826 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~  826 (936)
                      .++||||+++|+|.+++......               ..+++.++++++.|++.||+|||++||+||||||+||+++.+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~  181 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG  181 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCC
Confidence            99999999999999999865421               248999999999999999999999999999999999999999


Q ss_pred             CCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHH
Q 002321          827 GEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVT  905 (936)
Q Consensus       827 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~  905 (936)
                      +.+||+|||+++...............+++.|+|||.+. ...++.++||||+||++|||++ |+.||............
T Consensus       182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  260 (313)
T 1t46_A          182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM  260 (313)
T ss_dssp             TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred             CCEEEccccccccccccccceeccCCCCcceeeChHHhc-CCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHH
Confidence            999999999998775544333344556778899999884 4578999999999999999999 99999876543222111


Q ss_pred             HHH------HHhhhccccceeecccccccccccccC
Q 002321          906 WLE------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       906 ~~~------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ...      +...++.+.+++.+||..||.+||+++
T Consensus       261 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  296 (313)
T 1t46_A          261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK  296 (313)
T ss_dssp             HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHH
Confidence            111      223456788999999999999999863

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.9e-38  Score=338.60  Aligned_cols=241  Identities=24%  Similarity=0.349  Sum_probs=198.6

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ...|+..+.||+|+||.||+|+++++..||||+++....  ..+++.+|++++++++||||+++++++.+....++||||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            345678889999999999999999888999999976543  357799999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++++|.+++.....  .+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...... ...
T Consensus       101 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~  177 (283)
T 3gen_A          101 MANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS  177 (283)
T ss_dssp             CTTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHS
T ss_pred             cCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc-ccc
Confidence            999999999976332  38999999999999999999999999999999999999999999999999998664322 222


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceeec
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSMR  922 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  922 (936)
                      .....+++.|+|||.+. ...++.++||||+|+++|||++ |+.||.............     ..+...++.+.+++.+
T Consensus       178 ~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  256 (283)
T 3gen_A          178 SVGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS  256 (283)
T ss_dssp             TTSTTSCGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             ccCCccCcccCCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHH
Confidence            33445677899999884 4468999999999999999998 999998876543222111     1123345678899999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      ||..||.+||+++
T Consensus       257 ~l~~~p~~Rps~~  269 (283)
T 3gen_A          257 CWHEKADERPTFK  269 (283)
T ss_dssp             TTCSSGGGSCCHH
T ss_pred             HccCChhHCcCHH
Confidence            9999999999874

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.9e-38  Score=363.33  Aligned_cols=242  Identities=27%  Similarity=0.381  Sum_probs=199.5

Q ss_pred             ccccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ....|+..++||+|+||+||+|+++++..||||+++...  ...+.+.+|++++++++||||+++++++. ....++|||
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            344567788999999999999999888999999997653  34678999999999999999999999986 567899999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+++|+|.++++.... ..+++.+++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus       263 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~  340 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YT  340 (454)
T ss_dssp             CCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HH
T ss_pred             ecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-ee
Confidence            9999999999975421 137889999999999999999999999999999999999999999999999998764321 22


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceee
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSM  921 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~  921 (936)
                      ......+++.|+|||++. ...++.++|||||||++|||++ |+.||...+.........     ..+...++.+.+++.
T Consensus       341 ~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  419 (454)
T 1qcf_A          341 AREGAKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMM  419 (454)
T ss_dssp             TTCSSSSCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred             ccCCCcccccccCHHHhc-cCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            223345677899999984 4568999999999999999999 999998766543221111     012234567889999


Q ss_pred             cccccccccccccC
Q 002321          922 RSCKGSSRQRRRFQ  935 (936)
Q Consensus       922 ~~l~~~p~~Rp~f~  935 (936)
                      +||..||.+||+|+
T Consensus       420 ~cl~~dp~~RPt~~  433 (454)
T 1qcf_A          420 RCWKNRPEERPTFE  433 (454)
T ss_dssp             HHTCSSGGGSCCHH
T ss_pred             HHccCChhHCcCHH
Confidence            99999999999984

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6.1e-38  Score=355.81  Aligned_cols=242  Identities=19%  Similarity=0.245  Sum_probs=197.5

Q ss_pred             ccccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..++||+|+||+||+|+.++ ++.||||+++.....  .....+.+|+.++..++||||+++++++.+....++||
T Consensus        74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~  153 (437)
T 4aw2_A           74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM  153 (437)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence            456788899999999999999874 789999999653221  12234889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++|+|.+++.+..  ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+|+....... 
T Consensus       154 Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-  230 (437)
T 4aw2_A          154 DYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-  230 (437)
T ss_dssp             CCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-
T ss_pred             ecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC-
Confidence            9999999999998632  2389999999999999999999999999999999999999999999999999976643222 


Q ss_pred             cccccccCcccccCccccc----CcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-H-----HH---hhh
Q 002321          847 VLSSKIQSALGYMAPEFAC----RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-E-----EH---WKK  913 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-~-----~~---~~~  913 (936)
                      .......||+.|+|||++.    +...++.++||||+||++|||++|+.||...+.......... .     +.   ..+
T Consensus       231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s  310 (437)
T 4aw2_A          231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVS  310 (437)
T ss_dssp             EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSC
T ss_pred             cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCC
Confidence            2234467999999999885    245689999999999999999999999988766433322111 1     11   145


Q ss_pred             ccccceeeccccccccc--cccc
Q 002321          914 AEWRNVSMRSCKGSSRQ--RRRF  934 (936)
Q Consensus       914 ~~~~~~~~~~l~~~p~~--Rp~f  934 (936)
                      +.+++++.+|+..+|.+  ||+.
T Consensus       311 ~~~~dLi~~lL~~~~~r~~r~~~  333 (437)
T 4aw2_A          311 ENAKDLIRRLICSREHRLGQNGI  333 (437)
T ss_dssp             HHHHHHHHTTSSCGGGCTTTTTT
T ss_pred             HHHHHHHHHHhcccccccCCCCH
Confidence            67889999999888876  6654

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.4e-38  Score=349.55  Aligned_cols=246  Identities=24%  Similarity=0.330  Sum_probs=201.2

Q ss_pred             cccccCCCcccccCceEEEEEEeCC------CcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCe
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRD------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSL  761 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  761 (936)
                      ...|+..+.||+|+||.||+|+...      +..||||++.........+.+.+|+++++++ +||||+++++++.+.+.
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  124 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP  124 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence            3456777899999999999999753      2479999997665445567899999999999 89999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeE
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSG-----------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPK  830 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~k  830 (936)
                      .++||||+++|+|.+++.....           ...+++..++.++.|++.||+|||++||+||||||+||+++.++.+|
T Consensus       125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k  204 (333)
T 2i1m_A          125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAK  204 (333)
T ss_dssp             CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEE
T ss_pred             eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEE
Confidence            9999999999999999975321           23478999999999999999999999999999999999999999999


Q ss_pred             EeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH--
Q 002321          831 VGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL--  907 (936)
Q Consensus       831 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~--  907 (936)
                      |+|||+++...............+++.|+|||.+. ...++.++||||+||++|||++ |..||..............  
T Consensus       205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  283 (333)
T 2i1m_A          205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG  283 (333)
T ss_dssp             BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHT
T ss_pred             ECccccccccccccceeecCCCCCCccccCHHHhc-cCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcC
Confidence            99999998664433333334455678899999884 4568999999999999999998 9999987654322211111  


Q ss_pred             ----HHHhhhccccceeecccccccccccccC
Q 002321          908 ----EEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       908 ----~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                          .+...+..+.+++.+||..||.+||+++
T Consensus       284 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~  315 (333)
T 2i1m_A          284 YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQ  315 (333)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHhccChhhCcCHH
Confidence                1233456788999999999999999874

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.1e-37  Score=351.99  Aligned_cols=246  Identities=14%  Similarity=0.192  Sum_probs=199.3

Q ss_pred             cccccCCCccccc--CceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          689 HALLNKDCELGRG--GFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       689 ~~~~~~~~~iG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      ...|+..++||+|  +||.||+|+.. +|+.||||++...... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4457888899999  99999999987 6899999999765433 235678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ||||+++|+|.+++..... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||.+.......
T Consensus       104 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~  182 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG  182 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred             EEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence            9999999999999987532 238999999999999999999999999999999999999999999999999986542211


Q ss_pred             c-----ccccccccCcccccCcccccCc-ccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH------------
Q 002321          845 R-----YVLSSKIQSALGYMAPEFACRT-VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW------------  906 (936)
Q Consensus       845 ~-----~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~------------  906 (936)
                      .     ........+++.|+|||++.+. ..++.++||||+||++|||++|+.||.+.+.........            
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (389)
T 3gni_B          183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST  262 (389)
T ss_dssp             EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred             ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence            1     1112234678899999998553 568999999999999999999999998754322111000            


Q ss_pred             --------------------------------------HHHHhhhccccceeecccccccccccccC
Q 002321          907 --------------------------------------LEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       907 --------------------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                                                            ..+...++.+.+++.+||..||.+||+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~  329 (389)
T 3gni_B          263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS  329 (389)
T ss_dssp             -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred             cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHH
Confidence                                                  01122345688899999999999999863

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.5e-38  Score=355.10  Aligned_cols=240  Identities=19%  Similarity=0.243  Sum_probs=196.8

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||+||+|+.+ +++.||||+++.....  ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~  148 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  148 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            45677889999999999999987 5889999999653221  12345789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++|+|.++++...    +++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++...... .
T Consensus       149 E~~~gg~L~~~l~~~~----~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~  223 (410)
T 3v8s_A          149 EYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-M  223 (410)
T ss_dssp             CCCTTEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-E
T ss_pred             eCCCCCcHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC-c
Confidence            9999999999997643    8999999999999999999999999999999999999999999999999998764322 2


Q ss_pred             cccccccCcccccCcccccCcc---cCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH------HH--hhhcc
Q 002321          847 VLSSKIQSALGYMAPEFACRTV---KITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE------EH--WKKAE  915 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~---~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~------~~--~~~~~  915 (936)
                      .......||+.|+|||++....   .++.++||||+||++|||++|+.||...+...........      +.  ..+..
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~  303 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE  303 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHH
T ss_pred             ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHH
Confidence            2234567999999999885432   2789999999999999999999999887654333221111      11  24467


Q ss_pred             ccceeeccccccccc--cccc
Q 002321          916 WRNVSMRSCKGSSRQ--RRRF  934 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~--Rp~f  934 (936)
                      +++++.+||..+|.+  ||+.
T Consensus       304 ~~~li~~lL~~~~~rlgR~~~  324 (410)
T 3v8s_A          304 AKNLICAFLTDREVRLGRNGV  324 (410)
T ss_dssp             HHHHHHHHSSCGGGCTTSSCH
T ss_pred             HHHHHHHHccChhhhCCCCCH
Confidence            889999999988777  7764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=8e-38  Score=345.39  Aligned_cols=246  Identities=24%  Similarity=0.330  Sum_probs=202.5

Q ss_pred             cccccCCCcccccCceEEEEEEeC--------CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeC
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR--------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQ  759 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  759 (936)
                      ...|+..+.||+|+||.||+|++.        +++.||||+++........+.+.+|+++++++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            456788889999999999999863        46789999997665445567899999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC
Q 002321          760 SLQLLIYEFVSGGSLHKHLHEGSG-------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS  826 (936)
Q Consensus       760 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~  826 (936)
                      +..++||||+++|+|.+++.....             ...+++.++++++.|++.||+|||+.||+||||||+||+++.+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~  193 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN  193 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCC
Confidence            999999999999999999986542             1238899999999999999999999999999999999999999


Q ss_pred             CCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHH
Q 002321          827 GEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVT  905 (936)
Q Consensus       827 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~  905 (936)
                      +.+||+|||+++...............+++.|+|||++. ...++.++||||+||++|||++ |+.||............
T Consensus       194 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  272 (334)
T 2pvf_A          194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL  272 (334)
T ss_dssp             CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             CCEEEccccccccccccccccccCCCCcccceeChHHhc-CCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHH
Confidence            999999999998765444333344456778899999884 4568999999999999999999 99999877654332211


Q ss_pred             HHH-----HHhhhccccceeecccccccccccccC
Q 002321          906 WLE-----EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       906 ~~~-----~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ...     +...+..+.+++.+||..||.+||+++
T Consensus       273 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  307 (334)
T 2pvf_A          273 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFK  307 (334)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence            110     122346788999999999999999864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.1e-38  Score=363.23  Aligned_cols=240  Identities=21%  Similarity=0.316  Sum_probs=201.6

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|...+.||+|+||.||+|++. +|+.||||++......  ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            34677889999999999999976 6999999999654321  23567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++|+|.+++.+..   .+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......  
T Consensus        96 E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~--  170 (476)
T 2y94_A           96 EYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--  170 (476)
T ss_dssp             ECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc--
Confidence            9999999999997644   38999999999999999999999999999999999999999999999999998764322  


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceeec
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSMR  922 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  922 (936)
                       ......|++.|+|||++.+....+.++||||+||++|||++|+.||.+...........    ..+...++.+.+++.+
T Consensus       171 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~  249 (476)
T 2y94_A          171 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKH  249 (476)
T ss_dssp             -CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHH
T ss_pred             -cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHH
Confidence             22345789999999998665556889999999999999999999998876533221111    1123345678899999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      ||..||.+||+++
T Consensus       250 ~L~~dP~~Rpt~~  262 (476)
T 2y94_A          250 MLQVDPMKRATIK  262 (476)
T ss_dssp             HTCSSTTTSCCHH
T ss_pred             HcCCCchhCcCHH
Confidence            9999999999863

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.5e-38  Score=345.71  Aligned_cols=241  Identities=23%  Similarity=0.321  Sum_probs=190.5

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCe----e
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSL----Q  762 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~  762 (936)
                      ..|+..+.||+|+||.||+|++. +++.||||+++.....  .....+.+|+.++++++||||+++++++.....    .
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            45777889999999999999974 6899999999765332  234678999999999999999999999876543    3


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCC
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM  842 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  842 (936)
                      ++||||+++++|.++++....   +++.++..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++....
T Consensus        92 ~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  168 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred             EEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence            899999999999999986543   89999999999999999999999999999999999999999999999999986643


Q ss_pred             Cccc-cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH--------HHhhh
Q 002321          843 LDRY-VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE--------EHWKK  913 (936)
Q Consensus       843 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~--------~~~~~  913 (936)
                      .... .......|++.|+|||.+. +..++.++||||+||++|||++|+.||...............        ....+
T Consensus       169 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (311)
T 3ork_A          169 SGNSVTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS  247 (311)
T ss_dssp             -------------CCTTCCHHHHH-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCC
T ss_pred             cccccccccccCcCcccCCHHHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCC
Confidence            2221 2233456899999999984 457899999999999999999999999887654332211111        11245


Q ss_pred             ccccceeeccccccccccccc
Q 002321          914 AEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       914 ~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      ..+.+++.+||..||.+||+.
T Consensus       248 ~~l~~li~~~l~~dP~~R~~~  268 (311)
T 3ork_A          248 ADLDAVVLKALAKNPENRYQT  268 (311)
T ss_dssp             HHHHHHHHHHTCSSGGGSCSS
T ss_pred             HHHHHHHHHHHhcCHhhChhh
Confidence            678899999999999999964

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.4e-38  Score=348.06  Aligned_cols=243  Identities=26%  Similarity=0.324  Sum_probs=195.1

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcE----EEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRP----VAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  763 (936)
                      ...|+..+.||+|+||+||+|++. +++.    ||+|++...........+.+|+.++++++||||+++++++. ....+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            345677889999999999999975 3443    78888754433333456788999999999999999999986 45678


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      +||||+++|+|.+++....  ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        91 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             EEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            9999999999999997642  23888999999999999999999999999999999999999999999999999887554


Q ss_pred             ccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH-----HHHhhhcccc
Q 002321          844 DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL-----EEHWKKAEWR  917 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~  917 (936)
                      ..........+++.|+|||.+. ...++.++||||+||++|||++ |+.||..............     .+...+..+.
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIH-FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVY  247 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTT
T ss_pred             cccccccCCCCcccccChHHhc-cCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHH
Confidence            4444445566788999999984 4568999999999999999999 9999988765433222111     1233456789


Q ss_pred             ceeecccccccccccccC
Q 002321          918 NVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++.+||..||.+||+++
T Consensus       248 ~li~~~l~~dp~~Rps~~  265 (325)
T 3kex_A          248 MVMVKCWMIDENIRPTFK  265 (325)
T ss_dssp             HHHHHHTCSCTTTSCCHH
T ss_pred             HHHHHHcCCChhhCcCHH
Confidence            999999999999999874

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=345.84  Aligned_cols=236  Identities=22%  Similarity=0.371  Sum_probs=181.9

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ...|+..+.||+|+||.||+|+.. +++.||||+++...   ..+.+.+|++++++++||||+++++++.+....++|||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            345778889999999999999987 47899999997542   34668899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCCeEEeeccCccccCCCc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG---SGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~~  844 (936)
                      |+++|+|.+++....   .+++.++..++.|++.||+|||+.||+||||||+||+++.   ++.+||+|||+++..... 
T Consensus       129 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-  204 (349)
T 2w4o_A          129 LVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-  204 (349)
T ss_dssp             CCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             eCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence            999999999997644   3899999999999999999999999999999999999975   889999999999865322 


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHH---------Hhhhcc
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE---------HWKKAE  915 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~---------~~~~~~  915 (936)
                        .......+++.|+|||++. +..++.++||||+||++|||++|+.||................         .-.+..
T Consensus       205 --~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  281 (349)
T 2w4o_A          205 --VLMKTVCGTPGYCAPEILR-GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN  281 (349)
T ss_dssp             ----------CGGGSCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred             --cccccccCCCCccCHHHhc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence              1223456899999999984 4568999999999999999999999997765432221111111         113456


Q ss_pred             ccceeeccccccccccccc
Q 002321          916 WRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f  934 (936)
                      +.+++.+||..||.+||+.
T Consensus       282 ~~~li~~~L~~dP~~Rpt~  300 (349)
T 2w4o_A          282 AKDLVRKLIVLDPKKRLTT  300 (349)
T ss_dssp             HHHHHHTTSCSSGGGSCCH
T ss_pred             HHHHHHHHccCChhhCcCH
Confidence            7889999999999999985

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=6e-38  Score=364.10  Aligned_cols=242  Identities=25%  Similarity=0.355  Sum_probs=202.1

Q ss_pred             cccccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ...|+..++||+|+||.||+|+++. +..||||+++...  ...+++.+|++++++++||||+++++++.+....++|||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            4456778899999999999999874 8899999997543  246789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+++|+|.++++.... ..+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus       297 ~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~  374 (495)
T 1opk_A          297 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-TYT  374 (495)
T ss_dssp             CCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC-CEE
T ss_pred             ccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC-cee
Confidence            9999999999986443 34899999999999999999999999999999999999999999999999999876432 222


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceee
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSM  921 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~  921 (936)
                      ......+++.|+|||++. ...++.++|||||||++|||++ |+.||...+.........     ..+...++.+.+++.
T Consensus       375 ~~~~~~~~~~y~aPE~~~-~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  453 (495)
T 1opk_A          375 AHAGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR  453 (495)
T ss_dssp             CCTTCCCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ecCCCcCCcceeCHhHHh-cCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            233445677899999984 4568999999999999999999 999998876543332111     012234567889999


Q ss_pred             cccccccccccccC
Q 002321          922 RSCKGSSRQRRRFQ  935 (936)
Q Consensus       922 ~~l~~~p~~Rp~f~  935 (936)
                      +||..||.+||+|+
T Consensus       454 ~cl~~dP~~RPs~~  467 (495)
T 1opk_A          454 ACWQWNPSDRPSFA  467 (495)
T ss_dssp             HHTCSSGGGSCCHH
T ss_pred             HHcCcChhHCcCHH
Confidence            99999999999974

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.1e-38  Score=353.36  Aligned_cols=239  Identities=20%  Similarity=0.239  Sum_probs=196.9

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||+||+|+.+ +|+.||||+++.....  ...+.+.+|..++.+++||||+++++++.+....++||
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm  140 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM  140 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            45678889999999999999986 6899999999653221  12345789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++|+|.+++.+..  ..+++..+..++.|++.||+|||++||+||||||+|||++.+|++||+|||+++....... 
T Consensus       141 E~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~-  217 (412)
T 2vd5_A          141 EYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-  217 (412)
T ss_dssp             CCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-
T ss_pred             cCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc-
Confidence            9999999999998643  2389999999999999999999999999999999999999999999999999987643221 


Q ss_pred             cccccccCcccccCcccccC------cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH--HH-------HHh
Q 002321          847 VLSSKIQSALGYMAPEFACR------TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW--LE-------EHW  911 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~--~~-------~~~  911 (936)
                      .......||+.|+|||++..      ...++.++||||+||++|||++|+.||...+.........  ..       +..
T Consensus       218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  297 (412)
T 2vd5_A          218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG  297 (412)
T ss_dssp             EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----C
T ss_pred             cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccC
Confidence            12234579999999998852      3468999999999999999999999998876543331111  11       123


Q ss_pred             hhccccceeeccccccccccc
Q 002321          912 KKAEWRNVSMRSCKGSSRQRR  932 (936)
Q Consensus       912 ~~~~~~~~~~~~l~~~p~~Rp  932 (936)
                      .+.++++++.+||. +|.+|+
T Consensus       298 ~s~~~~dli~~lL~-~p~~Rl  317 (412)
T 2vd5_A          298 VPEEARDFIQRLLC-PPETRL  317 (412)
T ss_dssp             CCHHHHHHHHTTSS-CGGGCT
T ss_pred             CCHHHHHHHHHHcC-ChhhcC
Confidence            55778999999998 999985

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-37  Score=348.17  Aligned_cols=239  Identities=23%  Similarity=0.340  Sum_probs=198.0

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..+.||+|+||.||+|+.. +|+.||+|++..... .....+.+|++++++++||||+++++++.+....++||||
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            45778889999999999999976 588999999865432 2356789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC--CCCeEEeeccCccccCCCccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG--SGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      +++|+|.+++....  ..+++.++..++.|++.||+|||+.||+||||||+||+++.  ++.+||+|||+++......  
T Consensus       130 ~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~--  205 (387)
T 1kob_A          130 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--  205 (387)
T ss_dssp             CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred             CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc--
Confidence            99999999987543  23899999999999999999999999999999999999974  5789999999998764322  


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-H-----H--Hhhhccccc
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-E-----E--HWKKAEWRN  918 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-~-----~--~~~~~~~~~  918 (936)
                       ......+|+.|+|||++. ...++.++||||+||++|||++|+.||...+.......... .     +  ...+..+++
T Consensus       206 -~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  283 (387)
T 1kob_A          206 -IVKVTTATAEFAAPEIVD-REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD  283 (387)
T ss_dssp             -CEEEECSSGGGCCHHHHT-TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred             -ceeeeccCCCccCchhcc-CCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence             223456899999999884 55789999999999999999999999988765322211110 0     0  123467889


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..||.+||+++
T Consensus       284 li~~~L~~dP~~Rpt~~  300 (387)
T 1kob_A          284 FIKNLLQKEPRKRLTVH  300 (387)
T ss_dssp             HHHTTSCSSGGGSCCHH
T ss_pred             HHHHHcCCChhHCcCHH
Confidence            99999999999999863

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=8.5e-38  Score=348.17  Aligned_cols=239  Identities=22%  Similarity=0.289  Sum_probs=186.3

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ...|+..+.||+|+||+||+|+.. +++.||||++.....  ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            345788889999999999999987 689999999975432  23668899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCC--eEEeeccCccccCCCcc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGE--PKVGDYGLARLLPMLDR  845 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~  845 (936)
                      |+++|+|.+++.....   +++.++..++.|++.||+|||++||+||||||+||+++.++.  +||+|||+++....   
T Consensus        97 ~~~~~~L~~~l~~~~~---~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~---  170 (361)
T 3uc3_A           97 YASGGELYERICNAGR---FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---  170 (361)
T ss_dssp             CCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             eCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc---
Confidence            9999999999976543   899999999999999999999999999999999999987765  99999999974322   


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH--HHHH-HHHH-------hhhcc
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF--SVTW-LEEH-------WKKAE  915 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~--~~~~-~~~~-------~~~~~  915 (936)
                      ........||+.|+|||++.+....+.++||||+||++|||++|+.||.........  .... ....       ..++.
T Consensus       171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  250 (361)
T 3uc3_A          171 HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE  250 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHH
T ss_pred             cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHH
Confidence            122234568999999999865544455699999999999999999999875442111  1111 1111       13456


Q ss_pred             ccceeecccccccccccccC
Q 002321          916 WRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +.+++.+||..||.+||+++
T Consensus       251 ~~~li~~~L~~dP~~Rps~~  270 (361)
T 3uc3_A          251 CCHLISRIFVADPATRISIP  270 (361)
T ss_dssp             HHHHHHHHSCSCTTTSCCHH
T ss_pred             HHHHHHHHccCChhHCcCHH
Confidence            78899999999999999863

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.1e-38  Score=345.38  Aligned_cols=246  Identities=22%  Similarity=0.301  Sum_probs=184.3

Q ss_pred             cccccCCCcccccCceEEEEEEeCCC----cEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCee-
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDG----RPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQ-  762 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-  762 (936)
                      ...|+..+.||+|+||.||+|++...    ..||||+++.... ....+.+.+|++++++++||||+++++++...... 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            34567788999999999999997642    2799999975432 23467899999999999999999999999876655 


Q ss_pred             -----EEEEEecCCCChhhhhhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeec
Q 002321          763 -----LLIYEFVSGGSLHKHLHEGSG---GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDY  834 (936)
Q Consensus       763 -----~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df  834 (936)
                           ++||||+++|+|.+++.....   ...+++.++.+++.|+++||+|||++||+||||||+||+++.++.+||+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Df  181 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADF  181 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeec
Confidence                 899999999999999865432   124899999999999999999999999999999999999999999999999


Q ss_pred             cCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH-----H
Q 002321          835 GLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL-----E  908 (936)
Q Consensus       835 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~-----~  908 (936)
                      |+++...............+++.|+|||.+ ....++.++||||+||++|||++ |+.||...+..........     .
T Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~  260 (323)
T 3qup_A          182 GLSRKIYSGDYYRQGCASKLPVKWLALESL-ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQ  260 (323)
T ss_dssp             CC-----------------CCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC
T ss_pred             cccccccccccccccccccCcccccCchhh-cCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCC
Confidence            999876544433334445567889999988 45578999999999999999999 9999988766433322111     1


Q ss_pred             HHhhhccccceeecccccccccccccC
Q 002321          909 EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 ~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +...++.+.+++.+||..||.+||+++
T Consensus       261 ~~~~~~~l~~li~~~l~~dp~~Rps~~  287 (323)
T 3qup_A          261 PPECMEEVYDLMYQCWSADPKQRPSFT  287 (323)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred             CCccCHHHHHHHHHHccCChhhCcCHH
Confidence            222346788999999999999999853

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.7e-38  Score=349.70  Aligned_cols=245  Identities=32%  Similarity=0.582  Sum_probs=198.0

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ...|+..+.||+|+||.||+|+..+++.||||++...........+.+|++++++++||||+++++++.+....++||||
T Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  108 (326)
T 3uim_A           29 SDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY  108 (326)
T ss_dssp             TTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEEC
T ss_pred             hhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEe
Confidence            34578889999999999999998889999999997654433345789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          769 VSGGSLHKHLHEGSG-GNFLSWNERFNVIQGTAKSLAHLHQS---NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      +++|+|.++++.... ...+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|||+++......
T Consensus       109 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  188 (326)
T 3uim_A          109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD  188 (326)
T ss_dssp             CTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSS
T ss_pred             ccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCccc
Confidence            999999999986543 33589999999999999999999999   99999999999999999999999999998764322


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchh---HHHHHHHHH-------------
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM---WWFSVTWLE-------------  908 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~---~~~~~~~~~-------------  908 (936)
                      . .......+|+.|+|||++. ...++.++||||+||++|||++|+.||......   ......+..             
T Consensus       189 ~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (326)
T 3uim_A          189 T-HVTTAVRGTIGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVD  266 (326)
T ss_dssp             S-CEECCCCSCGGGCCHHHHH-HSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSC
T ss_pred             c-cccccccCCcCccCHHHhc-cCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcC
Confidence            2 2234456899999999884 446899999999999999999999999632210   000111111             


Q ss_pred             -------HHhhhccccceeecccccccccccccC
Q 002321          909 -------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 -------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                             +......+.+++.+||..||.+||+++
T Consensus       267 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  300 (326)
T 3uim_A          267 VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS  300 (326)
T ss_dssp             TTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHH
T ss_pred             hhhccccCHHHHHHHHHHHHHHhCcCCccCCCHH
Confidence                   111225677888999999999999864

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.2e-37  Score=340.16  Aligned_cols=247  Identities=25%  Similarity=0.273  Sum_probs=197.8

Q ss_pred             ccccccccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc-hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCe
Q 002321          684 FSTGTHALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSL  761 (936)
Q Consensus       684 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  761 (936)
                      +.......|+..+.||+|+||.||+|+.. +|+.||||++....... ..+.+.+|+.++++++||||+++++++.+...
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   98 (331)
T 4aaa_A           19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR   98 (331)
T ss_dssp             CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence            33445566888899999999999999986 48999999986554332 24668899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .++||||++++++.++......   +++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus        99 ~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHSTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             EEEEEecCCcchHHHHHhhccC---CCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence            9999999999999888765433   8999999999999999999999999999999999999999999999999997654


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-------------H
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-------------E  908 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-------------~  908 (936)
                      ...  .......+++.|+|||.+.+...++.++||||+||++|||++|+.||..............             .
T Consensus       176 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (331)
T 4aaa_A          176 APG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN  253 (331)
T ss_dssp             ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred             CCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence            322  1223456889999999986655789999999999999999999999988765322211100             0


Q ss_pred             H----------------------HhhhccccceeecccccccccccccC
Q 002321          909 E----------------------HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 ~----------------------~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .                      ...++.+.+++.+||..||.+||+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  302 (331)
T 4aaa_A          254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCA  302 (331)
T ss_dssp             HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGG
T ss_pred             hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHH
Confidence            0                      01245678899999999999999874

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=9.9e-38  Score=336.41  Aligned_cols=242  Identities=22%  Similarity=0.292  Sum_probs=196.7

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      .+.|...++||+|+||.||+|+.+ ++..||+|++.........+.+.+|++++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            456788889999999999999976 5889999999766555557889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE---cCCCCeEEeeccCccccCCC
Q 002321          768 FVSGGSLHKHLHEGS-GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLI---DGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      |+++|+|.+++.... ....+++..+..++.|+++||+|||++||+||||||+||++   +.++.+||+|||+++.....
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~  180 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD  180 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence            999999999886431 12348999999999999999999999999999999999999   45678999999999765432


Q ss_pred             ccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-H------Hhhhccc
Q 002321          844 DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-E------HWKKAEW  916 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-~------~~~~~~~  916 (936)
                         .......+++.|+|||.+.  ..++.++||||+||++|||++|+.||............... +      ...++.+
T Consensus       181 ---~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (285)
T 3is5_A          181 ---EHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA  255 (285)
T ss_dssp             ---------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHH
T ss_pred             ---ccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHH
Confidence               2234456899999999883  35789999999999999999999999887654333222111 1      1134567


Q ss_pred             cceeecccccccccccccC
Q 002321          917 RNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       917 ~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+++.+||..||.+||+++
T Consensus       256 ~~li~~~L~~dP~~Rps~~  274 (285)
T 3is5_A          256 VDLLKQMLTKDPERRPSAA  274 (285)
T ss_dssp             HHHHHHHTCSCTTTSCCHH
T ss_pred             HHHHHHHccCChhhCcCHH
Confidence            8899999999999999863

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.1e-37  Score=350.92  Aligned_cols=241  Identities=21%  Similarity=0.297  Sum_probs=192.6

Q ss_pred             ccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCC--CCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVR--HPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||.||+|...+++.||||++...... ...+.+.+|++++++++  ||||+++++++......++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            457888899999999999999888999999999765432 34578899999999996  599999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      | +.+++|.+++....   .+++.++..++.||+.||+|||+.+|+||||||+|||++ ++.+||+|||+++.+......
T Consensus       136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence            9 45899999998754   388999999999999999999999999999999999996 589999999999876543333


Q ss_pred             cccccccCcccccCcccccC----------cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-------H
Q 002321          847 VLSSKIQSALGYMAPEFACR----------TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-------E  909 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~----------~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-------~  909 (936)
                      .......||+.|+|||++.+          ...++.++||||+||++|||++|+.||...............       +
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  290 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP  290 (390)
T ss_dssp             ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCC
T ss_pred             ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCC
Confidence            33345679999999998843          135889999999999999999999999875432111111111       1


Q ss_pred             HhhhccccceeecccccccccccccC
Q 002321          910 HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       910 ~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+.+..+.+++.+||..||.+||+++
T Consensus       291 ~~~~~~~~~li~~~L~~dP~~Rps~~  316 (390)
T 2zmd_A          291 DIPEKDLQDVLKCCLKRDPKQRISIP  316 (390)
T ss_dssp             CCSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             ccchHHHHHHHHHHcccChhhCCCHH
Confidence            22345688999999999999999863

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=347.80  Aligned_cols=235  Identities=21%  Similarity=0.296  Sum_probs=190.4

Q ss_pred             cCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          693 NKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       693 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      ...+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+....++||||+++
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~  170 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG  170 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            34567999999999999975 589999999976543 3457899999999999999999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE--cCCCCeEEeeccCccccCCCcccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLI--DGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      |+|.+++....  ..+++.++..++.|+++||+|||+.+|+||||||+|||+  +.++.+||+|||+++......   ..
T Consensus       171 ~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~  245 (373)
T 2x4f_A          171 GELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KL  245 (373)
T ss_dssp             CEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BC
T ss_pred             CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---cc
Confidence            99999886543  238999999999999999999999999999999999999  667899999999998764322   22


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH------HH--Hhhhccccceee
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL------EE--HWKKAEWRNVSM  921 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~------~~--~~~~~~~~~~~~  921 (936)
                      ....+|+.|+|||++ ....++.++||||+||++|||++|+.||..............      .+  ...++.+.+++.
T Consensus       246 ~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  324 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVV-NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFIS  324 (373)
T ss_dssp             CCCCSSCTTCCHHHH-TTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHH
T ss_pred             ccccCCCcEeChhhc-cCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHH
Confidence            344689999999988 455789999999999999999999999988765432211110      01  123467889999


Q ss_pred             ccccccccccccc
Q 002321          922 RSCKGSSRQRRRF  934 (936)
Q Consensus       922 ~~l~~~p~~Rp~f  934 (936)
                      +||..||.+||+.
T Consensus       325 ~~L~~dp~~Rps~  337 (373)
T 2x4f_A          325 KLLIKEKSWRISA  337 (373)
T ss_dssp             TTSCSSGGGSCCH
T ss_pred             HHcCCChhhCCCH
Confidence            9999999999985

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=9.4e-38  Score=358.43  Aligned_cols=236  Identities=22%  Similarity=0.310  Sum_probs=195.5

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC-eeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS-LQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  767 (936)
                      ...|+..+.||+|+||.||+|++. |+.||||+++...   ..+.+.+|++++++++||||+++++++.... ..++|||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            345677789999999999999986 7899999997553   3577999999999999999999999987765 7899999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+++|+|.++++.... ..+++..+..++.|+++||+|||+++|+||||||+|||++.++.+||+|||+++.....    
T Consensus       268 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  342 (450)
T ss_dssp             CCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             ecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----
Confidence            9999999999987542 33789999999999999999999999999999999999999999999999999854321    


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHH-----HHHHHhhhccccceee
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVT-----WLEEHWKKAEWRNVSM  921 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  921 (936)
                       .....+++.|+|||.+. ...++.++|||||||++|||++ |+.||............     ...+...+..+.+++.
T Consensus       343 -~~~~~~~~~y~aPE~~~-~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  420 (450)
T 1k9a_A          343 -QDTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMK  420 (450)
T ss_dssp             -----CCCTTTSCHHHHH-SSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             -ccCCCCCcceeCHHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence             12235678899999984 4578999999999999999998 99999876553322111     0112334577899999


Q ss_pred             cccccccccccccC
Q 002321          922 RSCKGSSRQRRRFQ  935 (936)
Q Consensus       922 ~~l~~~p~~Rp~f~  935 (936)
                      +||..||.+||+|+
T Consensus       421 ~cl~~dp~~Rpt~~  434 (450)
T 1k9a_A          421 NCWHLDAATRPTFL  434 (450)
T ss_dssp             HHTCSSGGGSCCHH
T ss_pred             HHcCCChhHCcCHH
Confidence            99999999999984

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=355.53  Aligned_cols=240  Identities=13%  Similarity=0.124  Sum_probs=195.8

Q ss_pred             cccccCCCcccccCceEEEEEE------eCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCC---CCCcceeeeEEEeC
Q 002321          689 HALLNKDCELGRGGFGAVYRTV------LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR---HPNLVTLEGYYWTQ  759 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  759 (936)
                      ...|...+.||+|+||+||+|+      ..+++.||||+++..    ...++.+|++++++++   |+||+++++++...
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            3456778899999999999994      346889999998644    3567888999988887   99999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-----------C
Q 002321          760 SLQLLIYEFVSGGSLHKHLHEGS--GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG-----------S  826 (936)
Q Consensus       760 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~-----------~  826 (936)
                      +..++||||+++|+|.+++....  ....+++.++..++.|+++||+|||++||+||||||+|||++.           +
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~  219 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLS  219 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------C
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccccc
Confidence            99999999999999999997532  2234999999999999999999999999999999999999998           8


Q ss_pred             CCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH
Q 002321          827 GEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW  906 (936)
Q Consensus       827 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~  906 (936)
                      +.+||+|||+|+.+.............||+.|+|||++. +..++.++||||+||++|||++|+.||.............
T Consensus       220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~  298 (365)
T 3e7e_A          220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS-NKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL  298 (365)
T ss_dssp             TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHT-TCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEECSC
T ss_pred             CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhc-CCCCCccccHHHHHHHHHHHHhCCCccccCCCCceeechh
Confidence            999999999997654333333445567999999999984 4568999999999999999999999996654321111111


Q ss_pred             HHHHhhhccccceeecccccccccccc
Q 002321          907 LEEHWKKAEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       907 ~~~~~~~~~~~~~~~~~l~~~p~~Rp~  933 (936)
                      ....+..+.|.+++.+|+..+|.+|+.
T Consensus       299 ~~~~~~~~~~~~~~~~~l~~~p~~r~~  325 (365)
T 3e7e_A          299 FRRLPHLDMWNEFFHVMLNIPDCHHLP  325 (365)
T ss_dssp             CTTCSSHHHHHHHHHHHHCCCCTTCCC
T ss_pred             ccccCcHHHHHHHHHHHcCCCCCCcch
Confidence            122245678999999999999998853

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-37  Score=349.60  Aligned_cols=240  Identities=21%  Similarity=0.289  Sum_probs=185.5

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCC-CCCcceeeeEEEeCC--eeEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQS--LQLL  764 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~l  764 (936)
                      ..|+..+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.+++++. ||||+++++++...+  ..++
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l   88 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL   88 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence            45777889999999999999976 689999999854322 234567889999999997 999999999997544  6799


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ||||++ |+|.++++...    +++..+..++.|+++||+|||+.||+||||||+|||++.++.+||+|||+|+.+....
T Consensus        89 v~e~~~-~~L~~~~~~~~----~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           89 VFDYME-TDLHAVIRANI----LEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR  163 (388)
T ss_dssp             EEECCS-EEHHHHHHHTC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred             EecccC-cCHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence            999996 69999987642    8999999999999999999999999999999999999999999999999998653211


Q ss_pred             -------------------cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH
Q 002321          845 -------------------RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT  905 (936)
Q Consensus       845 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~  905 (936)
                                         .........+|+.|+|||++.+...++.++||||+||++|||++|+.||.+.+........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  243 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI  243 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                               1112234578999999999866678999999999999999999999999886653222110


Q ss_pred             HH-------------------------H--------------------------HHhhhccccceeeccccccccccccc
Q 002321          906 WL-------------------------E--------------------------EHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       906 ~~-------------------------~--------------------------~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      ..                         .                          +...++.+.+++.+||..||.+||+.
T Consensus       244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~  323 (388)
T 3oz6_A          244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA  323 (388)
T ss_dssp             HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence            00                         0                          00224567899999999999999985

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.6e-37  Score=337.90  Aligned_cols=240  Identities=22%  Similarity=0.259  Sum_probs=192.5

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc-hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      .|+..++||+|+||+||+|++. +|+.||||++....... ..+.+.+|++++++++||||+++++++.+....++||||
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (311)
T 4agu_A            4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY   83 (311)
T ss_dssp             CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence            3667789999999999999986 48999999986554332 256788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++++|.+++.....   +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.......  .
T Consensus        84 ~~~~~l~~~~~~~~~---~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  158 (311)
T 4agu_A           84 CDHTVLHELDRYQRG---VPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--Y  158 (311)
T ss_dssp             CSEEHHHHHHHTSSC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             CCCchHHHHHhhhcC---CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc--c
Confidence            999999998876443   89999999999999999999999999999999999999999999999999987643222  2


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH---------H----------
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE---------E----------  909 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~---------~----------  909 (936)
                      .....+++.|+|||.+.+...++.++||||+||++|||++|+.||...............         .          
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG  238 (311)
T ss_dssp             -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred             cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence            234568889999999866667899999999999999999999999887653322111000         0          


Q ss_pred             ----------------HhhhccccceeecccccccccccccC
Q 002321          910 ----------------HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       910 ----------------~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                                      ...+..+.+++.+||..||.+||+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  280 (311)
T 4agu_A          239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCE  280 (311)
T ss_dssp             CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHH
T ss_pred             CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHH
Confidence                            01223466799999999999999863

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.2e-38  Score=345.20  Aligned_cols=246  Identities=21%  Similarity=0.274  Sum_probs=202.4

Q ss_pred             cccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCee
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQ  762 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  762 (936)
                      ...|+..+.||+|+||.||+|++.      +++.||||++...........+.+|++++++++||||+++++++.+....
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  103 (322)
T 1p4o_A           24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT  103 (322)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence            455788889999999999999865      36789999997655445567799999999999999999999999998999


Q ss_pred             EEEEEecCCCChhhhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeecc
Q 002321          763 LLIYEFVSGGSLHKHLHEGS-------GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYG  835 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  835 (936)
                      ++||||+++|+|.+++....       ....+++..+++++.|++.||+|||++||+||||||+||+++.++.+||+|||
T Consensus       104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg  183 (322)
T 1p4o_A          104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG  183 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred             EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCc
Confidence            99999999999999987532       11337899999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH-----HH
Q 002321          836 LARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL-----EE  909 (936)
Q Consensus       836 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~-----~~  909 (936)
                      +++...............+++.|+|||++. +..++.++||||+||++|||++ |+.||...+..........     .+
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  262 (322)
T 1p4o_A          184 MTRDIYETDYYRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP  262 (322)
T ss_dssp             CCCGGGGGGCEEGGGSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred             cccccccccccccccCCCCCCCccChhhhc-cCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCC
Confidence            998664433333334455688899999884 4568999999999999999999 8999988765433322111     11


Q ss_pred             HhhhccccceeecccccccccccccC
Q 002321          910 HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       910 ~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ...+..+.+++.+||..||.+||+++
T Consensus       263 ~~~~~~l~~li~~~l~~dp~~Rps~~  288 (322)
T 1p4o_A          263 DNCPDMLFELMRMCWQYNPKMRPSFL  288 (322)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcCHH
Confidence            23346688999999999999999863

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.2e-37  Score=337.80  Aligned_cols=241  Identities=31%  Similarity=0.501  Sum_probs=197.3

Q ss_pred             ccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCc---cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSL---VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      +...+.||+|+||.||+|+. +++.||||++.....   ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  111 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY  111 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             cccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEe
Confidence            34557899999999999987 588999999865321   23357899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++|+|.+++........+++..+.+++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..........
T Consensus       112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  191 (307)
T 2nru_A          112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM  191 (307)
T ss_dssp             CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEE
T ss_pred             cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccccc
Confidence            99999999997654445599999999999999999999999999999999999999999999999999987654333333


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-H-HHHHH-----------------H
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-S-VTWLE-----------------E  909 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-~-~~~~~-----------------~  909 (936)
                      .....+++.|+|||.+. + .++.++||||+|+++|||++|+.||......... . .....                 +
T Consensus       192 ~~~~~g~~~y~aPE~~~-~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (307)
T 2nru_A          192 TSRIVGTTAYMAPEALR-G-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD  269 (307)
T ss_dssp             CSSCCSCGGGCCHHHHT-T-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCC
T ss_pred             ccccCCCcCcCChHHhc-C-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccc
Confidence            44567899999999884 3 4789999999999999999999999875432110 0 00000                 0


Q ss_pred             HhhhccccceeecccccccccccccC
Q 002321          910 HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       910 ~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ......+.+++.+||..||.+||+++
T Consensus       270 ~~~~~~l~~li~~cl~~~p~~Rps~~  295 (307)
T 2nru_A          270 STSVEAMYSVASQCLHEKKNKRPDIK  295 (307)
T ss_dssp             HHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hHHHHHHHHHHHHHcCCCcccCcCHH
Confidence            11234577899999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8.7e-38  Score=336.21  Aligned_cols=242  Identities=23%  Similarity=0.285  Sum_probs=186.8

Q ss_pred             cccccCCCcccccCceEEEEEEeCC----CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      ...|+..+.||+|+||.||+|++..    +..||||+++........+.+.+|+.++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            3457788899999999999999753    45799999876544445678999999999999999999999984 456789


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ||||+++|+|.+++....  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  170 (281)
T ss_dssp             EEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence            999999999999997643  238999999999999999999999999999999999999999999999999998764322


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH-----HHHhhhccccc
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL-----EEHWKKAEWRN  918 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~  918 (936)
                      . .......+++.|+|||.+ ....++.++||||+||++|||++ |..||..............     .+...++.+.+
T Consensus       171 ~-~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  248 (281)
T 1mp8_A          171 Y-YKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS  248 (281)
T ss_dssp             ---------CCGGGCCHHHH-HHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             c-cccccCCCcccccChhhc-ccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            1 122334567789999988 45578999999999999999997 9999987665432211100     11223467889


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..||.+||+++
T Consensus       249 li~~~l~~~p~~Rps~~  265 (281)
T 1mp8_A          249 LMTKCWAYDPSRRPRFT  265 (281)
T ss_dssp             HHHHHTCSSGGGSCCHH
T ss_pred             HHHHHccCChhhCcCHH
Confidence            99999999999999874

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.8e-37  Score=338.00  Aligned_cols=232  Identities=22%  Similarity=0.402  Sum_probs=174.8

Q ss_pred             CCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-CCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          694 KDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       694 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      ..+.||+|+||.||+|+.. +++.||||++...    ....+.+|+.+++++. ||||+++++++.+....++||||+++
T Consensus        15 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~   90 (325)
T 3kn6_A           15 KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG   90 (325)
T ss_dssp             TSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             CCCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence            4578999999999999986 5899999998643    3567889999999997 99999999999999999999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---CeEEeeccCccccCCCccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG---EPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      |+|.+++.....   +++.++..++.|++.||+|||++||+||||||+||+++.++   .+||+|||+++......  ..
T Consensus        91 ~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~  165 (325)
T 3kn6_A           91 GELFERIKKKKH---FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QP  165 (325)
T ss_dssp             CBHHHHHHHCSC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             CcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Cc
Confidence            999999987543   89999999999999999999999999999999999998766   89999999998654322  22


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhH-----HHHHHHHH--------H--Hhhh
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMW-----WFSVTWLE--------E--HWKK  913 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~-----~~~~~~~~--------~--~~~~  913 (936)
                      .....+|+.|+|||++ ....++.++||||+||++|||++|+.||...+...     ........        +  ...+
T Consensus       166 ~~~~~~t~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s  244 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELL-NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS  244 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred             ccccCCCcCccCHHHh-cCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence            2345678999999998 45578999999999999999999999998754311     01111100        1  2245


Q ss_pred             ccccceeecccccccccccccC
Q 002321          914 AEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       914 ~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +.+++++.+||..||.+||+.+
T Consensus       245 ~~~~~li~~~L~~dP~~Rpt~~  266 (325)
T 3kn6_A          245 QEAKDLIQGLLTVDPNKRLKMS  266 (325)
T ss_dssp             HHHHHHHHHHHCCCTTTCCCTT
T ss_pred             HHHHHHHHHHCCCChhHCCCHH
Confidence            6788999999999999999864

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=345.19  Aligned_cols=240  Identities=20%  Similarity=0.302  Sum_probs=190.9

Q ss_pred             ccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCC--CCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRH--PNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||.||+|...+++.||||++...... ...+.+.+|+.++++++|  +||+++++++.+....++||
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~   88 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM   88 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence            457788899999999999999988999999999755433 234778999999999976  99999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      |+ .+++|.+++.....   +++.++..++.|++.||+|||+++|+||||||+|||++ ++.+||+|||+++........
T Consensus        89 e~-~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A           89 EC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             CC-CSEEHHHHHHHSCC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred             eC-CCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence            95 58899999987543   89999999999999999999999999999999999997 688999999999876543333


Q ss_pred             cccccccCcccccCcccccC----------cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-------H
Q 002321          847 VLSSKIQSALGYMAPEFACR----------TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-------E  909 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~----------~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-------~  909 (936)
                      .......||+.|+|||++.+          ...++.++||||+||++|||++|+.||...............       +
T Consensus       164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T 3dbq_A          164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP  243 (343)
T ss_dssp             ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred             ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCc
Confidence            33445678999999998743          256889999999999999999999999875432222111111       1


Q ss_pred             Hhhhccccceeeccccccccccccc
Q 002321          910 HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       910 ~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      ...+..+.+++.+||..||.+||++
T Consensus       244 ~~~~~~l~~li~~~L~~dp~~Rpt~  268 (343)
T 3dbq_A          244 DIPEKDLQDVLKCCLKRDPKQRISI  268 (343)
T ss_dssp             CCSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCCCH
Confidence            2223467899999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.7e-37  Score=335.23  Aligned_cols=245  Identities=24%  Similarity=0.358  Sum_probs=204.3

Q ss_pred             ccccccccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCee
Q 002321          684 FSTGTHALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQ  762 (936)
Q Consensus       684 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  762 (936)
                      +.......|+..+.||+|+||.||+|+.. +++.||||++.........+.+.+|+.++++++||||+++++++.+....
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   95 (303)
T 3a7i_A           16 LKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL   95 (303)
T ss_dssp             CEECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence            33344556788889999999999999975 58999999997765555678899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCC
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM  842 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  842 (936)
                      ++||||+++++|.+++...    .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus        96 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A           96 WIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             EEEEECCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             EEEEEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence            9999999999999998753    389999999999999999999999999999999999999999999999999976643


Q ss_pred             CccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-----HHhhhcccc
Q 002321          843 LDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-----EHWKKAEWR  917 (936)
Q Consensus       843 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~  917 (936)
                      ..  .......+++.|+|||++. ...++.++||||+|+++|||++|+.||...............     +...+..+.
T Consensus       172 ~~--~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  248 (303)
T 3a7i_A          172 TQ--IKRNTFVGTPFWMAPEVIK-QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLK  248 (303)
T ss_dssp             TB--CCBCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHH
T ss_pred             cc--cccCccCCCcCccCHHHHh-cCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHH
Confidence            22  2234456889999999984 457889999999999999999999999877654332211100     011235578


Q ss_pred             ceeecccccccccccccC
Q 002321          918 NVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++.+||..||.+||+++
T Consensus       249 ~li~~~l~~dp~~Rps~~  266 (303)
T 3a7i_A          249 EFVEACLNKEPSFRPTAK  266 (303)
T ss_dssp             HHHHHHCCSSGGGSCCHH
T ss_pred             HHHHHHcCCChhhCcCHH
Confidence            899999999999999863

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.4e-37  Score=358.29  Aligned_cols=242  Identities=24%  Similarity=0.293  Sum_probs=200.0

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||.||+|+.+ +|+.||||++......  ...+.+.+|++++++++||||+++++++.+....++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            44677788999999999999986 5899999999654322  23567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          767 EFVSGGSLHKHLHEGSG-GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      ||++||+|.+++..... ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+.....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~  344 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT  344 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence            99999999999876432 23589999999999999999999999999999999999999999999999999987643221


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch----hHHHHHHHH----HHHhhhcccc
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM----MWWFSVTWL----EEHWKKAEWR  917 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~----~~~~~~~~~----~~~~~~~~~~  917 (936)
                        ......||+.|+|||++. +..++.++||||+||++|||++|+.||.....    .........    .+...+..++
T Consensus       345 --~~~~~~GT~~Y~APE~l~-~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~  421 (543)
T 3c4z_A          345 --KTKGYAGTPGFMAPELLL-GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK  421 (543)
T ss_dssp             --CBCCCCSCTTTSCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             --ccccccCCccccChhhhc-CCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHH
Confidence              223457999999999984 45789999999999999999999999987532    111111110    1223456788


Q ss_pred             ceeeccccccccccccc
Q 002321          918 NVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f  934 (936)
                      +++.+||..||.+||++
T Consensus       422 ~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          422 DFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             HHHHHHSCSSGGGSCCC
T ss_pred             HHHHHhccCCHhHCCCC
Confidence            99999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.5e-37  Score=331.67  Aligned_cols=240  Identities=25%  Similarity=0.353  Sum_probs=200.0

Q ss_pred             ccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      ..|+..+.||+|+||.||+|++.+++.||||++.....  ..+.+.+|++++++++||||+++++++.+....++||||+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            44677788999999999999998889999999976543  3577999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++++|.+++....  ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++..... .....
T Consensus        86 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~  162 (267)
T 3t9t_A           86 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSS  162 (267)
T ss_dssp             TTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHST
T ss_pred             CCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc-ccccc
Confidence            9999999997643  23889999999999999999999999999999999999999999999999999865432 12222


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceeecc
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSMRS  923 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  923 (936)
                      ....+++.|+|||++ ....++.++||||+|+++|||++ |+.||.............     ..+...+..+.+++.+|
T Consensus       163 ~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~  241 (267)
T 3t9t_A          163 TGTKFPVKWASPEVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC  241 (267)
T ss_dssp             TSTTCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHH
T ss_pred             ccccccccccChhhh-cCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHH
Confidence            344567789999988 44568999999999999999999 999998765533221110     01223456788999999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..||.+||+++
T Consensus       242 l~~~p~~Rps~~  253 (267)
T 3t9t_A          242 WRERPEDRPAFS  253 (267)
T ss_dssp             TCSSGGGSCCHH
T ss_pred             ccCChhhCcCHH
Confidence            999999999864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-37  Score=334.56  Aligned_cols=238  Identities=25%  Similarity=0.349  Sum_probs=195.0

Q ss_pred             CCCcccccCceEEEEEEeC---CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          694 KDCELGRGGFGAVYRTVLR---DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       694 ~~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      ..+.||+|+||.||+|++.   ++..||||+++........+.+.+|++++++++||||+++++++ ..+..++||||++
T Consensus        14 ~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~   92 (287)
T 1u59_A           14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAG   92 (287)
T ss_dssp             EEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCT
T ss_pred             hhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCC
Confidence            3348999999999999864   57889999997665445567899999999999999999999999 4556899999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc-ccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY-VLS  849 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~  849 (936)
                      +++|.+++....  ..+++.++.+++.|++.||+|||+.+|+||||||+||+++.++.+||+|||+++........ ...
T Consensus        93 ~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  170 (287)
T 1u59_A           93 GGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  170 (287)
T ss_dssp             TEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred             CCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecc
Confidence            999999997533  23899999999999999999999999999999999999999999999999999876433222 222


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH-----HHHhhhccccceeecc
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL-----EEHWKKAEWRNVSMRS  923 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  923 (936)
                      ....+++.|+|||++ ....++.++||||+||++|||++ |+.||...+..........     .+...++.+.+++.+|
T Consensus       171 ~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~  249 (287)
T 1u59_A          171 SAGKWPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDC  249 (287)
T ss_dssp             CSSCCCGGGCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHT
T ss_pred             ccccccccccCHHHh-ccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHHHHHHH
Confidence            334567889999988 44568999999999999999998 9999987665332211110     0123456788899999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..||.+||+++
T Consensus       250 l~~~p~~Rps~~  261 (287)
T 1u59_A          250 WIYKWEDRPDFL  261 (287)
T ss_dssp             TCSSGGGSCCHH
T ss_pred             cCCChhhCcCHH
Confidence            999999999874

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.1e-37  Score=337.67  Aligned_cols=240  Identities=24%  Similarity=0.287  Sum_probs=200.6

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc-----hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCee
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK-----SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQ  762 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  762 (936)
                      ...|+..+.||+|+||.||+|+.. +|+.||||+++......     ..+.+.+|+.++++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            445788889999999999999976 58999999997544322     367899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC----CeEEeeccCcc
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG----EPKVGDYGLAR  838 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg~a~  838 (936)
                      ++||||+++++|.+++....   .+++..+..++.|++.||+|||+.||+||||||+||+++.++    .+||+|||+++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            99999999999999997643   389999999999999999999999999999999999999888    79999999998


Q ss_pred             ccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH--------HHHHH
Q 002321          839 LLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT--------WLEEH  910 (936)
Q Consensus       839 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~--------~~~~~  910 (936)
                      ......   ......+++.|+|||++ ....++.++||||+||++|||++|+.||............        .....
T Consensus       168 ~~~~~~---~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  243 (321)
T 2a2a_A          168 EIEDGV---EFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS  243 (321)
T ss_dssp             ECCTTC---CCCCCCSCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             ecCccc---cccccCCCCCccCcccc-cCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence            764322   22345689999999988 4557899999999999999999999999876543222110        01112


Q ss_pred             hhhccccceeecccccccccccccC
Q 002321          911 WKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       911 ~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..++.+.+++.+||..||.+||+.+
T Consensus       244 ~~~~~~~~li~~~l~~dp~~Rps~~  268 (321)
T 2a2a_A          244 HTSELAKDFIRKLLVKETRKRLTIQ  268 (321)
T ss_dssp             TCCHHHHHHHHTTSCSSTTTSCCHH
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHH
Confidence            3456788999999999999999863

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=7.6e-38  Score=359.42  Aligned_cols=241  Identities=26%  Similarity=0.377  Sum_probs=193.2

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ...|+..++||+|+||.||+|+++++..||||+++....  ..+++.+|++++++++||||+++++++.+ ...++||||
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            445677889999999999999998888899999976542  35789999999999999999999999876 668999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++|+|.++++.... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus       260 ~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~  337 (452)
T 1fmk_A          260 MSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTA  337 (452)
T ss_dssp             CTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             hcCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-eec
Confidence            999999999975321 238999999999999999999999999999999999999999999999999998764322 222


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceeec
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSMR  922 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  922 (936)
                      .....+++.|+|||.+. ...++.++|||||||++|||++ |+.||.............     ..+...++.+.+++.+
T Consensus       338 ~~~~~~~~~y~aPE~~~-~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~  416 (452)
T 1fmk_A          338 RQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ  416 (452)
T ss_dssp             -----CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred             ccCCcccccccCHhHHh-cCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence            23345678899999884 4478999999999999999999 999998766533221110     0022345678899999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      ||..||.+||+|+
T Consensus       417 cl~~dP~~Rpt~~  429 (452)
T 1fmk_A          417 CWRKEPEERPTFE  429 (452)
T ss_dssp             HTCSSGGGSCCHH
T ss_pred             HccCChhhCcCHH
Confidence            9999999999985

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=8.8e-38  Score=358.89  Aligned_cols=238  Identities=23%  Similarity=0.282  Sum_probs=190.3

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  765 (936)
                      ...|+..+.||+|+||.||+|+.. +|+.||||+++....  ......+.+|++++++++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            345788889999999999999976 589999999975422  22345678899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ-SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      |||+++|+|.+++.....   +++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++..... 
T Consensus       227 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSRERV---FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-  302 (446)
T ss_dssp             ECCCSSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             EeeCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC-
Confidence            999999999999977543   8999999999999999999998 99999999999999999999999999999754322 


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH----HHhhhcccccee
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE----EHWKKAEWRNVS  920 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~  920 (936)
                       ........||+.|+|||++ .+..++.++||||+||++|||++|+.||...+...........    +...++.+.+++
T Consensus       303 -~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  380 (446)
T 4ejn_A          303 -GATMKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL  380 (446)
T ss_dssp             -----CCSSSCGGGCCHHHH-HTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             -CcccccccCCccccCHhhc-CCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence             2223456789999999998 4557899999999999999999999999887654333221111    223456788999


Q ss_pred             eccccccccccc
Q 002321          921 MRSCKGSSRQRR  932 (936)
Q Consensus       921 ~~~l~~~p~~Rp  932 (936)
                      .+||..||.+||
T Consensus       381 ~~~L~~dP~~R~  392 (446)
T 4ejn_A          381 SGLLKKDPKQRL  392 (446)
T ss_dssp             HHHTCSSTTTST
T ss_pred             HHHcccCHHHhC
Confidence            999999999998

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.1e-37  Score=361.67  Aligned_cols=240  Identities=24%  Similarity=0.286  Sum_probs=198.8

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||.||+|+.+ +|+.||||++.....  ......+.+|++++++++||||+++++++.+....++||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            34677788999999999999986 689999999965432  223567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||++||+|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......  
T Consensus       264 Ey~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~--  340 (576)
T 2acx_A          264 TLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--  340 (576)
T ss_dssp             CCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--
T ss_pred             EcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc--
Confidence            99999999999976542 238999999999999999999999999999999999999999999999999998764322  


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchh----HHHHHHHH----HHHhhhccccc
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM----WWFSVTWL----EEHWKKAEWRN  918 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~----~~~~~~~~----~~~~~~~~~~~  918 (936)
                       ......||+.|+|||++. +..++.++||||+||++|||++|+.||......    ........    .+...+..+++
T Consensus       341 -~~~~~~GT~~Y~APEvl~-~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~d  418 (576)
T 2acx_A          341 -TIKGRVGTVGYMAPEVVK-NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARS  418 (576)
T ss_dssp             -CEECCCSCGGGCCHHHHT-TCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             -cccccCCCccccCHHHHc-CCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHH
Confidence             223457999999999984 456899999999999999999999999876431    11111110    01224567889


Q ss_pred             eeeccccccccccccc
Q 002321          919 VSMRSCKGSSRQRRRF  934 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f  934 (936)
                      ++.+||..||.+||++
T Consensus       419 LI~~lL~~dP~~R~g~  434 (576)
T 2acx_A          419 LCSQLLCKDPAERLGC  434 (576)
T ss_dssp             HHHHHTCSSGGGSTTC
T ss_pred             HHHHhccCCHHHcCCC
Confidence            9999999999999953

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=342.67  Aligned_cols=243  Identities=24%  Similarity=0.320  Sum_probs=191.6

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCc----EEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  763 (936)
                      ...|+..+.||+|+||.||+|++. +++    +||+|.+.........+.+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            445778889999999999999975 344    357787765555556788999999999999999999999998765 68


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      +|+||+++|+|.+++.....  .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~  170 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred             EEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence            89999999999999986532  3899999999999999999999999999999999999999999999999999876544


Q ss_pred             ccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH-----HHHhhhcccc
Q 002321          844 DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL-----EEHWKKAEWR  917 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~  917 (936)
                      ..........+++.|+|||.+. +..++.++||||+||++|||++ |+.||..............     .+...+..+.
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  249 (327)
T 3lzb_A          171 EKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY  249 (327)
T ss_dssp             ---------CCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHH
T ss_pred             cccccccCCCccccccCHHHHc-CCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence            3333334455678899999884 5578999999999999999999 9999988766433322111     1223446788


Q ss_pred             ceeecccccccccccccC
Q 002321          918 NVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++.+||..||.+||+++
T Consensus       250 ~li~~~l~~dp~~Rps~~  267 (327)
T 3lzb_A          250 MIMRKCWMIDADSRPKFR  267 (327)
T ss_dssp             HHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHcCCChhHCcCHH
Confidence            899999999999999874

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.5e-37  Score=347.26  Aligned_cols=243  Identities=15%  Similarity=0.170  Sum_probs=189.7

Q ss_pred             cccccCCCcccccCceEEEEEEeCC------CcEEEEEEeeccCccch----------HHHHHHHHHHHHcCCCCCccee
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRD------GRPVAIKKLTVSSLVKS----------QEDFEREVKKLGKVRHPNLVTL  752 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~----------~~~~~~E~~~l~~l~h~niv~l  752 (936)
                      ...|+..+.||+|+||.||+|.+++      ++.||||++........          ...+.+|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4467888899999999999999764      47899999865432100          1234456677788899999999


Q ss_pred             eeEEEeC----CeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc--CC
Q 002321          753 EGYYWTQ----SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLID--GS  826 (936)
Q Consensus       753 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~--~~  826 (936)
                      ++++...    ...++||||+ +++|.+++....  ..+++.++..++.|++.||+|||+++|+||||||+|||++  .+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence            9999764    4579999999 999999998743  2399999999999999999999999999999999999999  88


Q ss_pred             CCeEEeeccCccccCCCccc-----cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchh--
Q 002321          827 GEPKVGDYGLARLLPMLDRY-----VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM--  899 (936)
Q Consensus       827 ~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~--  899 (936)
                      +.+||+|||+++.+......     .......||+.|+|||++. +..++.++|||||||++|||++|+.||......  
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHN-GVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhC-CCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            99999999999876432211     1123345899999999884 556899999999999999999999999864321  


Q ss_pred             HHHHH--HH-------HHH----HhhhccccceeecccccccccccccC
Q 002321          900 WWFSV--TW-------LEE----HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       900 ~~~~~--~~-------~~~----~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .....  .+       ..+    ...+.++.+++.+||..||.+||+|+
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~  318 (364)
T 3op5_A          270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYE  318 (364)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred             HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHH
Confidence            11111  00       011    12256789999999999999999974

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.7e-37  Score=342.06  Aligned_cols=237  Identities=28%  Similarity=0.391  Sum_probs=195.4

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||||++......  ...+.+.+|++++++++||||+++++++.+....++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            44677788999999999999974 6899999999754322  23467899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||++ |++.+++....  ..+++.++..++.|+++||+|||+++|+||||||+||+++.++.+||+|||+++....    
T Consensus       134 e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----  206 (348)
T ss_dssp             ECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred             ecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC----
Confidence            9996 68888876433  2389999999999999999999999999999999999999999999999999976532    


Q ss_pred             cccccccCcccccCccccc--CcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH------HHhhhccccc
Q 002321          847 VLSSKIQSALGYMAPEFAC--RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE------EHWKKAEWRN  918 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~~  918 (936)
                        .....+|+.|+|||++.  ....++.++||||+||++|||++|+.||...............      +...++.+++
T Consensus       207 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  284 (348)
T 1u5q_A          207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN  284 (348)
T ss_dssp             --BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred             --CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence              23456899999999874  2456899999999999999999999999876653322111100      1123456789


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..||.+||+++
T Consensus       285 li~~~l~~dP~~Rps~~  301 (348)
T 1u5q_A          285 FVDSCLQKIPQDRPTSE  301 (348)
T ss_dssp             HHHHHTCSSGGGSCCHH
T ss_pred             HHHHHcccChhhCcCHH
Confidence            99999999999999874

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2e-37  Score=341.55  Aligned_cols=238  Identities=14%  Similarity=0.127  Sum_probs=194.2

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEEEe
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      .|+..+.||+|+||+||+|+.. +++.||||++.....   .+.+.+|+++++++ +||||+++++++......++||||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A           10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            4677789999999999999964 689999999865432   34588999999999 999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCC-----eEEeeccCccccCCC
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGE-----PKVGDYGLARLLPML  843 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfg~a~~~~~~  843 (936)
                      + +++|.+++....  ..+++.++..++.|++.||+|||+.||+||||||+||+++.++.     +||+|||+++.....
T Consensus        87 ~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~  163 (330)
T 2izr_A           87 L-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP  163 (330)
T ss_dssp             C-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred             C-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence            9 999999998642  24999999999999999999999999999999999999999887     999999999876432


Q ss_pred             ccc-----cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHH----HHHHHHHHH----
Q 002321          844 DRY-----VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWW----FSVTWLEEH----  910 (936)
Q Consensus       844 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~----~~~~~~~~~----  910 (936)
                      ...     .......||+.|+|||++. +..++.++|||||||++|||++|+.||...+....    .........    
T Consensus       164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  242 (330)
T 2izr_A          164 ETKKHIPYREHKSLTGTARYMSINTHL-GKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE  242 (330)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred             CCCccccccccCCcCCCccccChHHHc-CCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH
Confidence            221     1224567899999999984 55789999999999999999999999987543111    111111100    


Q ss_pred             -h--hhccccceeecccccccccccccC
Q 002321          911 -W--KKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       911 -~--~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                       .  ..+++.+++.+||..||.+||+++
T Consensus       243 ~~~~~~p~~~~li~~~l~~~p~~RP~~~  270 (330)
T 2izr_A          243 VLCENFPEMATYLRYVRRLDFFEKPDYD  270 (330)
T ss_dssp             HHTTTCHHHHHHHHHHHHCCTTCCCCHH
T ss_pred             HHhccChHHHHHHHHHHhCCCCCCCCHH
Confidence             0  012889999999999999999874

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.1e-37  Score=332.88  Aligned_cols=238  Identities=26%  Similarity=0.391  Sum_probs=196.2

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||||++......  .....+.+|+.++++++||||+++++++.+....++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   88 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence            45677889999999999999976 4779999998654322  22567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++|+|.+++.....   +++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++......   
T Consensus        89 e~~~~~~l~~~l~~~~~---~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~---  162 (279)
T 3fdn_A           89 EYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---  162 (279)
T ss_dssp             CCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred             ecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc---
Confidence            99999999999987543   899999999999999999999999999999999999999999999999998654322   


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceeec
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSMR  922 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  922 (936)
                       ......+++.|+|||.+ .+..++.++||||+|+++|||++|+.||...+.........    ..+...++.+++++.+
T Consensus       163 -~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  240 (279)
T 3fdn_A          163 -RRTDLCGTLDYLPPEMI-EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR  240 (279)
T ss_dssp             ------CCCCTTCCHHHH-TTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred             -cccccCCCCCccCHhHh-ccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHH
Confidence             22345688999999988 45578899999999999999999999998776543321111    1123345678899999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      ||..||.+||+++
T Consensus       241 ~l~~~p~~Rps~~  253 (279)
T 3fdn_A          241 LLKHNPSQRPMLR  253 (279)
T ss_dssp             HCCSSGGGSCCHH
T ss_pred             HhccChhhCCCHH
Confidence            9999999999863

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.3e-38  Score=347.87  Aligned_cols=239  Identities=18%  Similarity=0.238  Sum_probs=199.0

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc-------hHHHHHHHHHHHHcCCCCCcceeeeEEEeCC
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK-------SQEDFEREVKKLGKVRHPNLVTLEGYYWTQS  760 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  760 (936)
                      ...|+..+.||+|+||.||+|+.. +++.||||+++......       ..+.+.+|++++++++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            356788889999999999999965 68999999997653211       2345778999999999999999999999999


Q ss_pred             eeEEEEEecCCC-ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          761 LQLLIYEFVSGG-SLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       761 ~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      ..++||||+.+| +|.+++.....   +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  179 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY  179 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCCC---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEEeCCCCccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence            999999999777 99999986543   89999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHHHhhhccccce
Q 002321          840 LPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNV  919 (936)
Q Consensus       840 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  919 (936)
                      .....   ......||+.|+|||++.+...++.++||||+||++|||++|+.||.........  ....+...+..+.++
T Consensus       180 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~l~~l  254 (335)
T 3dls_A          180 LERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA--AIHPPYLVSKELMSL  254 (335)
T ss_dssp             CCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTT--CCCCSSCCCHHHHHH
T ss_pred             CCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhh--ccCCCcccCHHHHHH
Confidence            64322   2234568999999999865554588999999999999999999999875442111  111223345778999


Q ss_pred             eecccccccccccccC
Q 002321          920 SMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       920 ~~~~l~~~p~~Rp~f~  935 (936)
                      +.+||..||.+||+++
T Consensus       255 i~~~L~~dP~~Rps~~  270 (335)
T 3dls_A          255 VSGLLQPVPERRTTLE  270 (335)
T ss_dssp             HHHHTCSSGGGSCCHH
T ss_pred             HHHHccCChhhCcCHH
Confidence            9999999999999863

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=6.3e-37  Score=330.65  Aligned_cols=238  Identities=26%  Similarity=0.452  Sum_probs=194.7

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccch------HHHHHHHHHHHHcCCCCCcceeeeEEEeCCe
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKS------QEDFEREVKKLGKVRHPNLVTLEGYYWTQSL  761 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  761 (936)
                      ...|+..+.||+|+||.||+|++. +++.||||++........      .+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            345777889999999999999975 689999999865433222      167899999999999999999999987655 


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEcCCCC-----eEEeec
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN--IIHYNIKSSNVLIDGSGE-----PKVGDY  834 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--ivH~Dlkp~NIll~~~~~-----~kl~Df  834 (936)
                       ++||||+++|+|.+++....  ..+++..+..++.|++.||+|||+++  |+||||||+||+++.++.     +||+||
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             -eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence             79999999999999887543  24899999999999999999999999  999999999999988876     999999


Q ss_pred             cCccccCCCccccccccccCcccccCccccc-CcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-----
Q 002321          835 GLARLLPMLDRYVLSSKIQSALGYMAPEFAC-RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-----  908 (936)
Q Consensus       835 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-----  908 (936)
                      |+++....     ......+++.|+|||.+. ....++.++||||+||++|||++|+.||...............     
T Consensus       174 g~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  248 (287)
T 4f0f_A          174 GLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR  248 (287)
T ss_dssp             TTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC
T ss_pred             Cccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC
Confidence            99975432     223456889999999873 2345789999999999999999999999876654332222211     


Q ss_pred             ---HHhhhccccceeecccccccccccccC
Q 002321          909 ---EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 ---~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                         +...++.+.+++.+||..||.+||+++
T Consensus       249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  278 (287)
T 4f0f_A          249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFS  278 (287)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCcccCHHHHHHHHHHhcCChhhCcCHH
Confidence               122345688999999999999999874

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=5.1e-37  Score=330.85  Aligned_cols=239  Identities=23%  Similarity=0.344  Sum_probs=198.7

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ..|+..++||+|+||.||+|... +++.||||++...... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   85 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   85 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            45677889999999999999976 5899999999765433 335678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCC---eEEeeccCccccCCCc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLD  844 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a~~~~~~~  844 (936)
                      |+++++|.+++.....   +++.++..++.|++.||+|||+.||+||||||+||+++.++.   +||+|||.+.......
T Consensus        86 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (284)
T 3kk8_A           86 LVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  162 (284)
T ss_dssp             CCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred             cCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence            9999999988876543   899999999999999999999999999999999999987655   9999999997664322


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH------H--Hhhhccc
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE------E--HWKKAEW  916 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~------~--~~~~~~~  916 (936)
                         ......+++.|+|||.+. ...++.++||||+|+++|+|++|+.||...+...........      +  ...++.+
T Consensus       163 ---~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 3kk8_A          163 ---AWHGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  238 (284)
T ss_dssp             ---BCCCSCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             ---cccCCCCCcCCcCchhhc-CCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence               223456899999999984 557899999999999999999999999887654333211110      0  1234668


Q ss_pred             cceeecccccccccccccC
Q 002321          917 RNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       917 ~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+++.+||..||.+||+.+
T Consensus       239 ~~li~~~l~~dp~~Rps~~  257 (284)
T 3kk8_A          239 KSLIDSMLTVNPKKRITAD  257 (284)
T ss_dssp             HHHHHHHSCSSTTTSCCHH
T ss_pred             HHHHHHHcccChhhCCCHH
Confidence            8999999999999999863

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.7e-38  Score=340.23  Aligned_cols=243  Identities=25%  Similarity=0.366  Sum_probs=191.5

Q ss_pred             cccccCCCcccccCceEEEEEEeC-----CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeC--Ce
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ--SL  761 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  761 (936)
                      ...|+..++||+|+||+||+|++.     +++.||||++.... ....+.+.+|++++++++||||+++++++...  ..
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            455778889999999999999842     58899999986543 23457799999999999999999999998653  45


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .++||||+++|+|.+++.....  .+++.++.+++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++...
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             eEEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            7999999999999999976532  38999999999999999999999999999999999999999999999999998764


Q ss_pred             CCccc-cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH--------------HHHH
Q 002321          842 MLDRY-VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF--------------SVTW  906 (936)
Q Consensus       842 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~--------------~~~~  906 (936)
                      ..... .......++..|+|||.+. ...++.++||||+|+++|||++|..||.........              ....
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  244 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhc-CCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence            33221 2233445677899999884 457899999999999999999999998765332111              0011


Q ss_pred             HH-------HHhhhccccceeecccccccccccccC
Q 002321          907 LE-------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       907 ~~-------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..       +...++.+.+++.+||..||.+||+++
T Consensus       245 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  280 (295)
T 3ugc_A          245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFR  280 (295)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHH
Confidence            11       122346688899999999999999874

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-38  Score=349.06  Aligned_cols=242  Identities=23%  Similarity=0.328  Sum_probs=186.5

Q ss_pred             cccCCCcccccCceEEEEEEeCC----CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEe-CCeeEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWT-QSLQLLI  765 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv  765 (936)
                      .|+..+.||+|+||.||+|++.+    +..||||.++........+++.+|+.++++++||||+++++++.. ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            45667789999999999998642    246899998765544557889999999999999999999999764 4577999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      |||+++|+|.++++...  ..+++.+++.++.|+++||+|||+++|+||||||+||+++.++.+||+|||+++.......
T Consensus       170 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             EECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence            99999999999997643  2378999999999999999999999999999999999999999999999999986543221


Q ss_pred             c--cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhcccc
Q 002321          846 Y--VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWR  917 (936)
Q Consensus       846 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~  917 (936)
                      .  .......+++.|+|||.+. ...++.++|||||||++|||++ |..||.............     ..+...+..+.
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~  326 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY  326 (373)
T ss_dssp             ----------CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             ccccccCCCCCcccccChHHhc-CCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            1  1223345678899999884 5578999999999999999999 788887765432221111     11234557789


Q ss_pred             ceeecccccccccccccC
Q 002321          918 NVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++.+||..||.+||+++
T Consensus       327 ~li~~cl~~dp~~RPs~~  344 (373)
T 3c1x_A          327 EVMLKCWHPKAEMRPSFS  344 (373)
T ss_dssp             HHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHcCCChhhCcCHH
Confidence            999999999999999874

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.5e-37  Score=340.45  Aligned_cols=246  Identities=27%  Similarity=0.358  Sum_probs=201.3

Q ss_pred             cccccCCCcccccCceEEEEEEe------CCCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCC-
Q 002321          689 HALLNKDCELGRGGFGAVYRTVL------RDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQS-  760 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-  760 (936)
                      ...|+..+.||+|+||.||+|++      .+++.||||+++........+.+.+|+++++++ +||||+++++++...+ 
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  105 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  105 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence            44577888999999999999984      246899999997665444567899999999999 7999999999997654 


Q ss_pred             eeEEEEEecCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSG-------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG  827 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~  827 (936)
                      ..++||||+++|+|.+++.....             ...+++..+..++.|+++||+|||++||+||||||+||+++.++
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~  185 (316)
T 2xir_A          106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN  185 (316)
T ss_dssp             CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC
Confidence            58999999999999999986543             12378999999999999999999999999999999999999999


Q ss_pred             CeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH
Q 002321          828 EPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW  906 (936)
Q Consensus       828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~  906 (936)
                      .+||+|||+++...............+++.|+|||++. ...++.++||||+||++|||++ |+.||.............
T Consensus       186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~  264 (316)
T 2xir_A          186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL  264 (316)
T ss_dssp             CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred             CEEECCCccccccccCccceeccCCCcceeecCchhhc-cccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHh
Confidence            99999999998765433333344556788999999884 4568999999999999999998 999998765432221111


Q ss_pred             HH------HHhhhccccceeecccccccccccccC
Q 002321          907 LE------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       907 ~~------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..      +...++.+.+++.+||..||.+||+++
T Consensus       265 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  299 (316)
T 2xir_A          265 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS  299 (316)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             ccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence            11      233456788999999999999999863

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.5e-38  Score=343.41  Aligned_cols=239  Identities=21%  Similarity=0.315  Sum_probs=188.4

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .|...++||+|+||+||+|+.. +++.||||+++..........+.+|++++++++||||+++++++.+....++||||+
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL   82 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence            3667788999999999999986 689999999965443222234568999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      + |+|.+++....  ..+++.++..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++......  ...
T Consensus        83 ~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~  157 (324)
T 3mtl_A           83 D-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTY  157 (324)
T ss_dssp             S-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred             c-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--ccc
Confidence            6 69999887653  248999999999999999999999999999999999999999999999999997654222  222


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH----------------------
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL----------------------  907 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~----------------------  907 (936)
                      ....+++.|+|||++.+...++.++||||+||++|||++|+.||...+..........                      
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY  237 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence            3446789999999986666789999999999999999999999988765332211110                      


Q ss_pred             ------------HHHhhhccccceeeccccccccccccc
Q 002321          908 ------------EEHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       908 ------------~~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                  .....++.+.+++.+||..||.+||+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  276 (324)
T 3mtl_A          238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA  276 (324)
T ss_dssp             CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCH
Confidence                        001123456789999999999999985

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-37  Score=337.76  Aligned_cols=238  Identities=24%  Similarity=0.306  Sum_probs=190.1

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..++||+|+||+||+|++. +|+.||||++...... .......+|+..+.++ +||||+++++++.+.+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            45788889999999999999987 6899999998654322 2334455666666555 8999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+ +++|.+++....  ..+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++......  
T Consensus       137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--  211 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG--  211 (311)
T ss_dssp             ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred             ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC--
Confidence            999 779999887654  238999999999999999999999999999999999999999999999999998664322  


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH---HHHHHHhhhccccceeecc
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV---TWLEEHWKKAEWRNVSMRS  923 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  923 (936)
                       ......||+.|+|||++. + .++.++||||+||++|||++|..||...+.......   ....+...++.+.+++.+|
T Consensus       212 -~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  288 (311)
T 3p1a_A          212 -AGEVQEGDPRYMAPELLQ-G-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMM  288 (311)
T ss_dssp             ----CCCCCGGGCCGGGGG-T-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred             -CCcccCCCccccCHhHhc-C-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHHHHHH
Confidence             234456899999999884 3 689999999999999999999777765433211110   1112233557889999999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..||.+||+++
T Consensus       289 L~~dP~~Rpt~~  300 (311)
T 3p1a_A          289 LEPDPKLRATAE  300 (311)
T ss_dssp             SCSSTTTSCCHH
T ss_pred             cCCChhhCcCHH
Confidence            999999999863

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.7e-37  Score=338.53  Aligned_cols=241  Identities=18%  Similarity=0.251  Sum_probs=200.8

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  765 (936)
                      ...|...+.||+|+||.||+|++. +++.||+|++......  ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            456788889999999999999987 4789999998654322  3457789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      |||+++++|.+++.....   +++.++..++.|+++||+|||++||+||||||+||+++.++.+||+|||+++...... 
T Consensus       120 ~e~~~~~~L~~~~~~~~~---l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-  195 (335)
T 2owb_A          120 LELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-  195 (335)
T ss_dssp             ECCCTTCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             EecCCCCCHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc-
Confidence            999999999999876543   8999999999999999999999999999999999999999999999999998764322 


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH----HHHhhhccccceee
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL----EEHWKKAEWRNVSM  921 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~  921 (936)
                       .......+++.|+|||++. ...++.++||||+||++|||++|+.||..............    .+...+..+.+++.
T Consensus       196 -~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  273 (335)
T 2owb_A          196 -ERKKVLCGTPNYIAPEVLS-KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ  273 (335)
T ss_dssp             -CCBCCCCSCCSSCCHHHHH-TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred             -ccccccCCCccccCHHHhc-cCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHH
Confidence             1223456889999999884 45689999999999999999999999987654332211110    11223466788999


Q ss_pred             cccccccccccccC
Q 002321          922 RSCKGSSRQRRRFQ  935 (936)
Q Consensus       922 ~~l~~~p~~Rp~f~  935 (936)
                      +||..||.+||+++
T Consensus       274 ~~l~~dp~~Rps~~  287 (335)
T 2owb_A          274 KMLQTDPTARPTIN  287 (335)
T ss_dssp             HHTCSSGGGSCCGG
T ss_pred             HHccCChhHCcCHH
Confidence            99999999999975

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.5e-37  Score=340.50  Aligned_cols=240  Identities=18%  Similarity=0.230  Sum_probs=189.5

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc-hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ...|+..++||+|+||+||+|+.. +++.||||+++...... ..+.+.+|++++++++||||+++++++.+....++||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            345788889999999999999966 68999999997554322 2456789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc-----CCCCeEEeeccCccccC
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLID-----GSGEPKVGDYGLARLLP  841 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~-----~~~~~kl~Dfg~a~~~~  841 (936)
                      ||++ |+|.+++.....   +++.++..++.|++.||+|||+++|+||||||+||+++     .++.+||+|||+++...
T Consensus       113 e~~~-~~L~~~~~~~~~---~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          113 EYAE-NDLKKYMDKNPD---VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             ECCS-EEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             ecCC-CCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence            9997 699999987543   89999999999999999999999999999999999994     45569999999998664


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH--------------
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL--------------  907 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~--------------  907 (936)
                      ...  .......+|+.|+|||++.+...++.++||||+||++|||++|+.||..............              
T Consensus       189 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (329)
T 3gbz_A          189 IPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT  266 (329)
T ss_dssp             -------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             Ccc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence            322  1223456789999999986666689999999999999999999999988765332211111              


Q ss_pred             --------------------HHHhhhccccceeeccccccccccccc
Q 002321          908 --------------------EEHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       908 --------------------~~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                          .+...++.+.+++.+||..||.+||+.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  313 (329)
T 3gbz_A          267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA  313 (329)
T ss_dssp             GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCH
Confidence                                111134566789999999999999985

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8.8e-37  Score=328.79  Aligned_cols=238  Identities=24%  Similarity=0.329  Sum_probs=196.5

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-----chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-----KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      .|+..+.||+|+||.||+|+.. +++.||||+++.....     ...+.+.+|+.++++++||||+++++++.+....++
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (283)
T 3bhy_A            6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL   85 (283)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence            4677789999999999999987 5899999999754332     136789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC----CeEEeeccCcccc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG----EPKVGDYGLARLL  840 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg~a~~~  840 (936)
                      ||||+++++|.+++.....   +++.++..++.|++.||+|||++|++||||||+||+++.++    .+||+|||.++..
T Consensus        86 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           86 ILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             EEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEeecCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence            9999999999999976443   89999999999999999999999999999999999999877    8999999999866


Q ss_pred             CCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH--------HHHHHhh
Q 002321          841 PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT--------WLEEHWK  912 (936)
Q Consensus       841 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~--------~~~~~~~  912 (936)
                      ....   ......+++.|+|||.+ ....++.++||||+|+++|||++|+.||............        .......
T Consensus       163 ~~~~---~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T 3bhy_A          163 EAGN---EFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT  238 (283)
T ss_dssp             C-----------CCCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred             cCCC---cccccCCCcCccCccee-cCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccC
Confidence            4322   22345688999999988 4557899999999999999999999999876553222110        1111234


Q ss_pred             hccccceeecccccccccccccC
Q 002321          913 KAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       913 ~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+.+++.+||..||.+||+++
T Consensus       239 ~~~~~~li~~~l~~dp~~Rps~~  261 (283)
T 3bhy_A          239 SELAKDFIRRLLVKDPKRRMTIA  261 (283)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHH
Confidence            56788999999999999999863

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.1e-37  Score=333.26  Aligned_cols=242  Identities=25%  Similarity=0.395  Sum_probs=184.4

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ...|+..++||+|+||+||+|++.  ..||||+++..... ...+.+.+|++++++++||||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            445677889999999999999865  36999999765433 3357789999999999999999999976 4556799999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+++++|.+++....  ..+++.++++++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++.........
T Consensus       100 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  177 (289)
T 3og7_A          100 WCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH  177 (289)
T ss_dssp             CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred             ecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence            999999999996543  238999999999999999999999999999999999999999999999999997654333333


Q ss_pred             ccccccCcccccCccccc--CcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHH----------Hhhhcc
Q 002321          848 LSSKIQSALGYMAPEFAC--RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE----------HWKKAE  915 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~----------~~~~~~  915 (936)
                      ......+++.|+|||.+.  ....++.++||||+|+++|||++|+.||................          ...++.
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (289)
T 3og7_A          178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR  257 (289)
T ss_dssp             ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHH
T ss_pred             cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHH
Confidence            334456899999999874  24467889999999999999999999998765432221111111          122356


Q ss_pred             ccceeecccccccccccccC
Q 002321          916 WRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +.+++.+||..||.+||+++
T Consensus       258 l~~li~~~l~~~p~~Rps~~  277 (289)
T 3og7_A          258 MKRLMAECLKKKRDERPSFP  277 (289)
T ss_dssp             HHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHccCChhhCCCHH
Confidence            78899999999999999874

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7.4e-37  Score=332.02  Aligned_cols=239  Identities=14%  Similarity=0.136  Sum_probs=195.9

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||||++.....   .+.+.+|+++++++ +|++++++++++.+....++|||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            34677889999999999999964 689999999865432   34578999999999 79999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCC-----eEEeeccCccccCC
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGE-----PKVGDYGLARLLPM  842 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfg~a~~~~~  842 (936)
                      |+ +++|.+++....  ..+++.++.+++.|++.||+|||++||+||||||+||+++.++.     +||+|||+++....
T Consensus        87 ~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~  163 (298)
T 1csn_A           87 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  163 (298)
T ss_dssp             CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             ec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence            99 999999998653  23899999999999999999999999999999999999988776     99999999987653


Q ss_pred             Cccc-----cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchh---HH-HHHH-HHH----
Q 002321          843 LDRY-----VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM---WW-FSVT-WLE----  908 (936)
Q Consensus       843 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~---~~-~~~~-~~~----  908 (936)
                      ....     .......+|+.|+|||.+ .+..++.++||||+||++|||++|+.||...+..   .. .... ...    
T Consensus       164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (298)
T 1csn_A          164 PVTKQHIPYREKKNLSGTARYMSINTH-LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  242 (298)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             ccccccccccCccCCCCCcccCCchhh-cCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence            3221     123456689999999998 4556899999999999999999999999875421   11 1110 000    


Q ss_pred             H---HhhhccccceeecccccccccccccC
Q 002321          909 E---HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 ~---~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +   ...++.+.+++.+||..||.+||+++
T Consensus       243 ~~~~~~~~~~l~~li~~~l~~dp~~RP~~~  272 (298)
T 1csn_A          243 RELCAGFPEEFYKYMHYARNLAFDATPDYD  272 (298)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHCCTTCCCCHH
T ss_pred             HHHHhhCcHHHHHHHHHHhcCCcccCCCHH
Confidence            1   12356789999999999999999874

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1e-36  Score=330.13  Aligned_cols=241  Identities=18%  Similarity=0.251  Sum_probs=200.4

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  765 (936)
                      ...|...+.||+|+||.||+|+.. +++.||+|++......  ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            345778889999999999999987 4789999998654322  3456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      |||+++++|.+++.....   +++.++..++.|+++||+|||++||+||||||+||+++.++.+||+|||+++...... 
T Consensus        94 ~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-  169 (294)
T 2rku_A           94 LELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-  169 (294)
T ss_dssp             EECCTTCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             EecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc-
Confidence            999999999999876543   8999999999999999999999999999999999999999999999999998764322 


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH----HHHhhhccccceee
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL----EEHWKKAEWRNVSM  921 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~  921 (936)
                       .......+++.|+|||.+ ....++.++||||+|+++|||++|+.||..............    .+...+..+.+++.
T Consensus       170 -~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  247 (294)
T 2rku_A          170 -ERKKVLCGTPNYIAPEVL-SKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ  247 (294)
T ss_dssp             -CCBCCCCSCCSSCCHHHH-TTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred             -cccccccCCCCcCCcchh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHH
Confidence             123345688999999988 455689999999999999999999999988665322211100    01223456788999


Q ss_pred             cccccccccccccC
Q 002321          922 RSCKGSSRQRRRFQ  935 (936)
Q Consensus       922 ~~l~~~p~~Rp~f~  935 (936)
                      +||..||.+||+++
T Consensus       248 ~~l~~~p~~Rps~~  261 (294)
T 2rku_A          248 KMLQTDPTARPTIN  261 (294)
T ss_dssp             HHTCSSGGGSCCGG
T ss_pred             HHcccChhhCcCHH
Confidence            99999999999875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.2e-37  Score=329.92  Aligned_cols=236  Identities=28%  Similarity=0.390  Sum_probs=185.4

Q ss_pred             ccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCcc---chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV---KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||.||+|++. ++.||||+++.....   ...+.+.+|++++++++||||+++++++.+....++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            34677789999999999999986 899999998654322   23467899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCCCCEEEcC--------CCCeEEeecc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN---IIHYNIKSSNVLIDG--------SGEPKVGDYG  835 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---ivH~Dlkp~NIll~~--------~~~~kl~Dfg  835 (936)
                      ||+++++|.+++...    .+++..+..++.|+++||+|||+++   |+||||||+||+++.        ++.+||+|||
T Consensus        86 e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           86 EFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             ECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            999999999998643    3899999999999999999999999   899999999999986        7789999999


Q ss_pred             CccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH------H
Q 002321          836 LARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE------E  909 (936)
Q Consensus       836 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~------~  909 (936)
                      +++......    .....+++.|+|||.+ .+..++.++||||+|+++|||++|+.||...+...........      +
T Consensus       162 ~~~~~~~~~----~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (271)
T 3dtc_A          162 LAREWHRTT----KMSAAGAYAWMAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP  236 (271)
T ss_dssp             C-----------------CCGGGSCHHHH-HHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC
T ss_pred             ccccccccc----ccCCCCccceeCHHHh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC
Confidence            998654322    2245688999999988 4557899999999999999999999999887654332211111      1


Q ss_pred             HhhhccccceeecccccccccccccC
Q 002321          910 HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       910 ~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ...++.+.+++.+||..||.+||+++
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rps~~  262 (271)
T 3dtc_A          237 STCPEPFAKLMEDCWNPDPHSRPSFT  262 (271)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             cccCHHHHHHHHHHhcCCcccCcCHH
Confidence            23346688999999999999999874

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.9e-37  Score=341.38  Aligned_cols=248  Identities=23%  Similarity=0.294  Sum_probs=196.8

Q ss_pred             cccccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC
Q 002321          687 GTHALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS  760 (936)
Q Consensus       687 ~~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  760 (936)
                      .....|+..+.||+|+||.||+|++.      +++.||||++..........++.+|+.++++++||||+++++++.+..
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            34556788889999999999999842      477899999975544455678999999999999999999999999998


Q ss_pred             eeEEEEEecCCCChhhhhhccCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC---CCeEEee
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSGG----NFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS---GEPKVGD  833 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~D  833 (936)
                      ..++||||+++|+|.+++......    ..+++.+++.++.|++.||+|||+.||+||||||+||+++.+   ..+||+|
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~D  186 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD  186 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECc
Confidence            999999999999999999865421    348899999999999999999999999999999999999954   4699999


Q ss_pred             ccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH-----
Q 002321          834 YGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL-----  907 (936)
Q Consensus       834 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~-----  907 (936)
                      ||+++...............+++.|+|||.+. ...++.++||||+||++|||++ |+.||..............     
T Consensus       187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~  265 (327)
T 2yfx_A          187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFM-EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD  265 (327)
T ss_dssp             CHHHHHHHC------CCGGGSCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             cccccccccccccccCCCcCCCcceeCHhHhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCC
Confidence            99997654333333334456788999999884 4568999999999999999998 9999987655332211110     


Q ss_pred             HHHhhhccccceeecccccccccccccC
Q 002321          908 EEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       908 ~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+...+..+.+++.+||..||.+||+++
T Consensus       266 ~~~~~~~~l~~li~~~l~~dp~~Rps~~  293 (327)
T 2yfx_A          266 PPKNCPGPVYRIMTQCWQHQPEDRPNFA  293 (327)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHH
Confidence            1123346688999999999999999864

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.1e-37  Score=335.25  Aligned_cols=235  Identities=25%  Similarity=0.399  Sum_probs=187.1

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ...|+..+.||+|+||.||+|++. ++.||||++...   ...+.+.+|++++++++||||+++++++.+  ..++||||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~   80 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY   80 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence            345677889999999999999986 789999998643   345789999999999999999999998864  46899999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCCCCEEEcCCCC-eEEeeccCccccCCCc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ---SNIIHYNIKSSNVLIDGSGE-PKVGDYGLARLLPMLD  844 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~~  844 (936)
                      +++|+|.+++........+++..+++++.|+++||+|||+   +||+||||||+||+++.++. +||+|||++...... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-  159 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-  159 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence            9999999999876544457899999999999999999999   89999999999999998886 799999999755321 


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-------HHhhhcccc
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-------EHWKKAEWR  917 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~  917 (936)
                          .....+++.|+|||++. +..++.++||||+||++|||++|+.||...............       ....+..+.
T Consensus       160 ----~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  234 (307)
T 2eva_A          160 ----MTNNKGSAAWMAPEVFE-GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE  234 (307)
T ss_dssp             ---------CCTTSSCHHHHT-CCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHH
T ss_pred             ----cccCCCCCceEChhhhC-CCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHH
Confidence                12345889999999984 557899999999999999999999999865432221111111       112345678


Q ss_pred             ceeecccccccccccccC
Q 002321          918 NVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++.+||..||.+||+++
T Consensus       235 ~li~~~l~~dp~~Rps~~  252 (307)
T 2eva_A          235 SLMTRCWSKDPSQRPSME  252 (307)
T ss_dssp             HHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHhcCChhhCcCHH
Confidence            899999999999999864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=351.38  Aligned_cols=244  Identities=25%  Similarity=0.290  Sum_probs=198.3

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC--eeEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS--LQLLI  765 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  765 (936)
                      ...|...+.||+|+||+||+|++. +|+.||||+++........+.+.+|++++++++||||+++++++.+..  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            345788889999999999999987 489999999976655556778899999999999999999999998765  67999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE----cCCCCeEEeeccCccccC
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLI----DGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~a~~~~  841 (936)
                      |||+++|+|.+++........+++.+++.++.|++.||+|||+.||+||||||+||++    +.++.+||+|||+++...
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~  167 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE  167 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence            9999999999999876544458999999999999999999999999999999999999    778889999999998764


Q ss_pred             CCccccccccccCcccccCcccccC-------cccCCchhhHHHHHHHHHHHHcCCCCCCccchh---HHHHHHHHHH--
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACR-------TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM---WWFSVTWLEE--  909 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~---~~~~~~~~~~--  909 (936)
                      ...   ......+++.|+|||++..       ...++.++||||+||++|||++|+.||......   ..........  
T Consensus       168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p  244 (396)
T 4eut_A          168 DDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (396)
T ss_dssp             CGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred             CCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence            322   2234568999999998743       146788999999999999999999999753321   0111111110  


Q ss_pred             ----------------------------HhhhccccceeecccccccccccccC
Q 002321          910 ----------------------------HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       910 ----------------------------~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                                                  ......+.+++.+||..||.+||+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~  298 (396)
T 4eut_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD  298 (396)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHH
T ss_pred             cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHH
Confidence                                        11234567888999999999999874

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.9e-37  Score=327.28  Aligned_cols=237  Identities=19%  Similarity=0.267  Sum_probs=198.6

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ...|+..+.||+|+||.||+|+.. ++..||+|++..... ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            345778889999999999999976 477999999865432 346789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE---cCCCCeEEeeccCccccCCCc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLI---DGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      |+++++|.+++.....   +++.++.+++.|++.||+|||++||+||||||+||++   +.++.+||+|||++.......
T Consensus        87 ~~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           87 LCTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             CCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             ccCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            9999999998876543   8999999999999999999999999999999999999   788999999999998664322


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH------HHH--Hhhhccc
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW------LEE--HWKKAEW  916 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~------~~~--~~~~~~~  916 (936)
                         ......+++.|+|||.+. + .++.++||||+|+++|||++|+.||...+.........      ...  ...++.+
T Consensus       164 ---~~~~~~~t~~y~aPE~~~-~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (277)
T 3f3z_A          164 ---MMRTKVGTPYYVSPQVLE-G-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA  238 (277)
T ss_dssp             ---CBCCCCSCTTTCCHHHHT-T-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHH
T ss_pred             ---chhccCCCCCccChHHhc-c-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHH
Confidence               234456899999999884 3 38999999999999999999999998866533221111      001  1245678


Q ss_pred             cceeeccccccccccccc
Q 002321          917 RNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       917 ~~~~~~~l~~~p~~Rp~f  934 (936)
                      .+++.+||..||.+||+.
T Consensus       239 ~~li~~~l~~dp~~R~s~  256 (277)
T 3f3z_A          239 ESLIRRLLTKSPKQRITS  256 (277)
T ss_dssp             HHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHHccCChhhCcCH
Confidence            899999999999999985

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.2e-36  Score=339.90  Aligned_cols=200  Identities=23%  Similarity=0.266  Sum_probs=173.6

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-----CCCcceeeeEEEeCCee
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-----HPNLVTLEGYYWTQSLQ  762 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~  762 (936)
                      ...|+..++||+|+||+||+|+.. +++.||||+++..  ......+.+|+.++++++     ||||+++++++...+..
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~  111 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM  111 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence            345788889999999999999985 5889999998643  234567788999999996     99999999999999999


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-----------------
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG-----------------  825 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~-----------------  825 (936)
                      ++||||+ +++|.+++...... .+++.++..++.|++.||+|||++||+||||||+|||++.                 
T Consensus       112 ~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~  189 (360)
T 3llt_A          112 CLIFEPL-GPSLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK  189 (360)
T ss_dssp             EEEECCC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred             EEEEcCC-CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccc
Confidence            9999999 99999999875432 3899999999999999999999999999999999999975                 


Q ss_pred             --------CCCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccc
Q 002321          826 --------SGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWK  897 (936)
Q Consensus       826 --------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~  897 (936)
                              ++.+||+|||+++.....     .....+|+.|+|||++. +..++.++||||+||++|||++|+.||...+
T Consensus       190 ~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~  263 (360)
T 3llt_A          190 KIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVIL-NLGWDVSSDMWSFGCVLAELYTGSLLFRTHE  263 (360)
T ss_dssp             EEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHc-CCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence                    789999999999865332     23456899999999984 4578999999999999999999999998765


Q ss_pred             h
Q 002321          898 M  898 (936)
Q Consensus       898 ~  898 (936)
                      .
T Consensus       264 ~  264 (360)
T 3llt_A          264 H  264 (360)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.1e-37  Score=328.71  Aligned_cols=240  Identities=21%  Similarity=0.316  Sum_probs=192.1

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|...+.||+|+||.||+|++. +|+.||||++.....  ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            34677789999999999999986 689999999865432  123567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++++|.+++.....   +++.++..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......  
T Consensus        91 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--  165 (276)
T 2h6d_A           91 EYVSGGELFDYICKHGR---VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--  165 (276)
T ss_dssp             ECCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred             eccCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc--
Confidence            99999999999977543   8999999999999999999999999999999999999999999999999998654322  


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH----HHHhhhccccceeec
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL----EEHWKKAEWRNVSMR  922 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~  922 (936)
                       ......+++.|+|||.+.+....+.++||||+|+++|||++|+.||...+..........    .+...+..+.+++.+
T Consensus       166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  244 (276)
T 2h6d_A          166 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMH  244 (276)
T ss_dssp             ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             -ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHH
Confidence             223456788999999986554457899999999999999999999987655332211110    122345678899999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      ||..||.+||+++
T Consensus       245 ~l~~~p~~Rps~~  257 (276)
T 2h6d_A          245 MLQVDPLKRATIK  257 (276)
T ss_dssp             HTCSSGGGSCCHH
T ss_pred             HccCChhhCCCHH
Confidence            9999999999863

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-37  Score=339.27  Aligned_cols=242  Identities=26%  Similarity=0.385  Sum_probs=191.1

Q ss_pred             cccCCCcccccCceEEEEEEeCC-----CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRD-----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  765 (936)
                      .|+..+.||+|+||.||+|+...     +..||||+++..........+.+|++++++++||||+++++++.+....++|
T Consensus        45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  124 (333)
T 1mqb_A           45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII  124 (333)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEE
Confidence            45667789999999999998653     2359999997655444567899999999999999999999999998999999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      |||+++|+|.+++....  ..+++.+++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus       125 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  202 (333)
T 1mqb_A          125 TEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  202 (333)
T ss_dssp             EECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             EeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence            99999999999997643  2389999999999999999999999999999999999999999999999999987643221


Q ss_pred             -ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH-----HHHhhhccccc
Q 002321          846 -YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL-----EEHWKKAEWRN  918 (936)
Q Consensus       846 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~  918 (936)
                       ........+++.|+|||.+. ...++.++||||+||++|||++ |+.||..............     .+...+..+.+
T Consensus       203 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  281 (333)
T 1mqb_A          203 ATYTTSGGKIPIRWTAPEAIS-YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQ  281 (333)
T ss_dssp             --------CCCGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHH
T ss_pred             cccccCCCCccccccCchhcc-cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHHH
Confidence             11222334577899999884 4578999999999999999999 9999987665332211110     01223467889


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..||.+||+++
T Consensus       282 li~~~l~~~p~~Rps~~  298 (333)
T 1mqb_A          282 LMMQCWQQERARRPKFA  298 (333)
T ss_dssp             HHHHHTCSSTTTSCCHH
T ss_pred             HHHHHcCCChhhCcCHH
Confidence            99999999999999874

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3e-37  Score=342.67  Aligned_cols=246  Identities=22%  Similarity=0.256  Sum_probs=194.9

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc----cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL----VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  763 (936)
                      ...|+..+.||+|+||.||+|+.. +++.||||++.....    ....+.+.+|++++++++||||+++++++.+....+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            455788889999999999999975 588999999865421    234578999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhccC-------------------------------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 002321          764 LIYEFVSGGSLHKHLHEGS-------------------------------------GGNFLSWNERFNVIQGTAKSLAHL  806 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~-------------------------------------~~~~~~~~~~~~i~~~i~~al~~L  806 (936)
                      +||||+++|+|.+++....                                     ....+++..+..++.|++.||+||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            9999999999999985210                                     011245777889999999999999


Q ss_pred             HhCCcccCCCCCCCEEEcCCC--CeEEeeccCccccCCCc--cccccccccCcccccCcccccC-cccCCchhhHHHHHH
Q 002321          807 HQSNIIHYNIKSSNVLIDGSG--EPKVGDYGLARLLPMLD--RYVLSSKIQSALGYMAPEFACR-TVKITDKCDVYGFGV  881 (936)
Q Consensus       807 H~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwSlG~  881 (936)
                      |+++|+||||||+||+++.++  .+||+|||+++.+....  .........+++.|+|||++.+ ...++.++||||+||
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~  264 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV  264 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred             HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence            999999999999999998777  89999999998653322  1122345668999999998853 256889999999999


Q ss_pred             HHHHHHcCCCCCCccchhHHHHHHHHH------HH--hhhccccceeeccccccccccccc
Q 002321          882 LVLEVVTGKRPLSTWKMMWWFSVTWLE------EH--WKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       882 ~l~el~~g~~Pf~~~~~~~~~~~~~~~------~~--~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      ++|||++|+.||...............      +.  ..++.+.+++.+||..||.+||+.
T Consensus       265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  325 (345)
T 3hko_A          265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA  325 (345)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence            999999999999887654332211111      11  135678899999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-36  Score=333.86  Aligned_cols=240  Identities=25%  Similarity=0.335  Sum_probs=195.9

Q ss_pred             cccCCCcccccCceEEEEEEeC-----CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeC--CeeE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ--SLQL  763 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  763 (936)
                      .|+..++||+|+||+||++.++     +++.||||+++........+.+.+|++++++++||||+++++++.+.  ...+
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            3477889999999999998753     58899999997665445567899999999999999999999999874  5778


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      +||||+++|+|.+++....    +++.+++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus       112 lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            9999999999999997654    899999999999999999999999999999999999999999999999999876543


Q ss_pred             ccc-cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH----------HHHHHH----
Q 002321          844 DRY-VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF----------SVTWLE----  908 (936)
Q Consensus       844 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~----------~~~~~~----  908 (936)
                      ... .......+++.|+|||.+. ...++.++||||+||++|||++|+.||.........          ......    
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLK-EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER  266 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred             ccccccccCCCCCceeeChHHhc-CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence            321 2234456788899999884 456889999999999999999999999765432111          000000    


Q ss_pred             ------HHhhhccccceeecccccccccccccC
Q 002321          909 ------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 ------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                            +...+..+.+++.+||..||.+||+++
T Consensus       267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~  299 (318)
T 3lxp_A          267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFE  299 (318)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             ccCCCCCccccHHHHHHHHHHcCCCcccCcCHH
Confidence                  112345688999999999999999874

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.5e-37  Score=366.05  Aligned_cols=235  Identities=26%  Similarity=0.347  Sum_probs=190.6

Q ss_pred             cccccCceEEEEEEeC---CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCCC
Q 002321          697 ELGRGGFGAVYRTVLR---DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGS  773 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  773 (936)
                      +||+|+||.||+|.++   ++..||||+++........+++.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999875   4567999999766545567889999999999999999999999976 55899999999999


Q ss_pred             hhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc-ccccccc
Q 002321          774 LHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR-YVLSSKI  852 (936)
Q Consensus       774 L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~  852 (936)
                      |.+++....  ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++....... .......
T Consensus       422 L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~  499 (613)
T 2ozo_A          422 LHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG  499 (613)
T ss_dssp             HHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------------
T ss_pred             HHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCC
Confidence            999997543  3489999999999999999999999999999999999999999999999999987643222 1122233


Q ss_pred             cCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceeeccccc
Q 002321          853 QSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSMRSCKG  926 (936)
Q Consensus       853 ~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~  926 (936)
                      .+++.|+|||++ ....++.++|||||||++|||++ |+.||...+.........     ..+...+..+.+++.+||..
T Consensus       500 ~~~~~y~APE~~-~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~  578 (613)
T 2ozo_A          500 KWPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIY  578 (613)
T ss_dssp             --CCTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCS
T ss_pred             CCccceeCHhhh-cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCC
Confidence            456789999998 45578999999999999999998 999998876543221110     01223457889999999999


Q ss_pred             ccccccccC
Q 002321          927 SSRQRRRFQ  935 (936)
Q Consensus       927 ~p~~Rp~f~  935 (936)
                      ||.+||+|+
T Consensus       579 dP~~RPs~~  587 (613)
T 2ozo_A          579 KWEDRPDFL  587 (613)
T ss_dssp             STTTSCCHH
T ss_pred             ChhHCcCHH
Confidence            999999984

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.7e-37  Score=336.13  Aligned_cols=244  Identities=24%  Similarity=0.332  Sum_probs=194.4

Q ss_pred             cccccCCCcccccCceEEEEEEe-----CCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeC--Ce
Q 002321          689 HALLNKDCELGRGGFGAVYRTVL-----RDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ--SL  761 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  761 (936)
                      ...|+..++||+|+||.||+|++     .+++.||||+++........+.+.+|++++++++||||+++++++.+.  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            44577888999999999999984     358899999997665555568899999999999999999999999876  56


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .++||||+++|+|.+++.....  .+++.+++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            7899999999999999965432  38999999999999999999999999999999999999999999999999998765


Q ss_pred             CCccc-cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHH------------H-HHHHH
Q 002321          842 MLDRY-VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWW------------F-SVTWL  907 (936)
Q Consensus       842 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~------------~-~~~~~  907 (936)
                      ..... .......++..|+|||.+. ...++.++||||+||++|||++|..|+........            . .....
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLM-QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL  256 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred             CCCcceeccCCCCCCccccCCeeec-CCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence            43322 2334456788899999884 44678999999999999999999998754321100            0 01111


Q ss_pred             H-------HHhhhccccceeecccccccccccccC
Q 002321          908 E-------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       908 ~-------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .       +...++.+.+++.+||..||.+||+++
T Consensus       257 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  291 (302)
T 4e5w_A          257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQ  291 (302)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred             hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHH
Confidence            1       112335688999999999999999874

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.9e-37  Score=333.95  Aligned_cols=238  Identities=23%  Similarity=0.288  Sum_probs=186.6

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHc--CCCCCcceeeeEEEeC----Cee
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGK--VRHPNLVTLEGYYWTQ----SLQ  762 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~  762 (936)
                      ...|+..+.||+|+||+||+|++ +++.||||++...    ....+.+|.+++..  ++||||+++++++.+.    ...
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            34567788999999999999998 5899999998643    34556667776666  7999999999997653    457


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCCEEEcCCCCeEEeec
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH--------QSNIIHYNIKSSNVLIDGSGEPKVGDY  834 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH--------~~~ivH~Dlkp~NIll~~~~~~kl~Df  834 (936)
                      ++||||+++|+|.++++..    .+++..+.+++.|++.||+|||        +++|+||||||+||+++.++.+||+||
T Consensus        82 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             EEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence            8999999999999999653    3899999999999999999999        999999999999999999999999999


Q ss_pred             cCccccCCCccc--cccccccCcccccCcccccCcc-----cCCchhhHHHHHHHHHHHHcC----------CCCCCccc
Q 002321          835 GLARLLPMLDRY--VLSSKIQSALGYMAPEFACRTV-----KITDKCDVYGFGVLVLEVVTG----------KRPLSTWK  897 (936)
Q Consensus       835 g~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwSlG~~l~el~~g----------~~Pf~~~~  897 (936)
                      |+++........  .......+|+.|+|||++.+..     .++.++||||+||++|||++|          +.||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            999765432221  1123347899999999885442     345799999999999999999          88986643


Q ss_pred             hhH--HHHHHHHH--------------HHhhhccccceeecccccccccccccC
Q 002321          898 MMW--WFSVTWLE--------------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       898 ~~~--~~~~~~~~--------------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ...  ........              +...++.+.+++.+||..||.+||+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  291 (301)
T 3q4u_A          238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL  291 (301)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHH
Confidence            211  11111000              011235678899999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.8e-37  Score=333.75  Aligned_cols=238  Identities=23%  Similarity=0.307  Sum_probs=194.0

Q ss_pred             cccccCCCcccccCceEEEEEEeCC-C-------cEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRD-G-------RPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS  760 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  760 (936)
                      ...|...+.||+|+||.||+|+... +       ..||+|++.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            4457778899999999999998663 3       479999986543 344678999999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCC--------eEEe
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGE--------PKVG  832 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~--------~kl~  832 (936)
                      ..++||||+++|+|.+++....  ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.        +||+
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            9999999999999999998643  23889999999999999999999999999999999999998887        9999


Q ss_pred             eccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcC-CCCCCccchhHHHHHHHHH---
Q 002321          833 DYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTG-KRPLSTWKMMWWFSVTWLE---  908 (936)
Q Consensus       833 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g-~~Pf~~~~~~~~~~~~~~~---  908 (936)
                      |||++......      ....+++.|+|||.+.+...++.++||||+||++|||++| ..||...+...........   
T Consensus       164 Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~  237 (289)
T 4fvq_A          164 DPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL  237 (289)
T ss_dssp             CCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC
T ss_pred             cCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCC
Confidence            99999754321      2344678899999986556789999999999999999995 5555554443222111111   


Q ss_pred             HHhhhccccceeecccccccccccccC
Q 002321          909 EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 ~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +...++.+.+++.+||..||.+||+++
T Consensus       238 ~~~~~~~l~~li~~~l~~dp~~Rps~~  264 (289)
T 4fvq_A          238 PAPKAAELANLINNCMDYEPDHRPSFR  264 (289)
T ss_dssp             CCCSSCTTHHHHHHHSCSSGGGSCCHH
T ss_pred             CCCCCHHHHHHHHHHcCCChhHCcCHH
Confidence            222356789999999999999999874

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6e-37  Score=353.55  Aligned_cols=203  Identities=20%  Similarity=0.263  Sum_probs=158.7

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeC-----Cee
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ-----SLQ  762 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  762 (936)
                      ..|+..+.||+|+||+||+|++. +++.||||++..... ....+++.+|++++++++||||+++++++...     ...
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            45788899999999999999976 689999999865322 23457789999999999999999999998543     467


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCC
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM  842 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  842 (936)
                      ++||||+ +|+|.+++....   .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+....
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  208 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY  208 (458)
T ss_dssp             EEEECCC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred             EEEEecc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence            9999998 589999987654   389999999999999999999999999999999999999999999999999987642


Q ss_pred             Cccc-------------------------cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc---------
Q 002321          843 LDRY-------------------------VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT---------  888 (936)
Q Consensus       843 ~~~~-------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~---------  888 (936)
                      ....                         .......+|+.|+|||++.....++.++||||+||++|||++         
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~  288 (458)
T 3rp9_A          209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH  288 (458)
T ss_dssp             CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred             ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence            2111                         112345679999999987666679999999999999999999         


Q ss_pred             --CCCCCCcc
Q 002321          889 --GKRPLSTW  896 (936)
Q Consensus       889 --g~~Pf~~~  896 (936)
                        |++||.+.
T Consensus       289 ~~~~p~f~g~  298 (458)
T 3rp9_A          289 ADRGPLFPGS  298 (458)
T ss_dssp             GGCCCSCC--
T ss_pred             ccccccCCCC
Confidence              66666553

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=332.37  Aligned_cols=239  Identities=22%  Similarity=0.270  Sum_probs=191.2

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc----chHHHHHHHHHHHHcCC---CCCcceeeeEEEeCC-
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV----KSQEDFEREVKKLGKVR---HPNLVTLEGYYWTQS-  760 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~-  760 (936)
                      ..|+..++||+|+||+||+|++. +++.||||++......    .....+.+|++++++++   ||||+++++++.... 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~   88 (308)
T 3g33_A            9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT   88 (308)
T ss_dssp             -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence            45778889999999999999974 6899999999643321    11356778888877774   999999999998755 


Q ss_pred             ----eeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccC
Q 002321          761 ----LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGL  836 (936)
Q Consensus       761 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  836 (936)
                          ..++||||++ |+|.+++..... ..+++.++..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  166 (308)
T 3g33_A           89 DREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL  166 (308)
T ss_dssp             SSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred             CCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence                4789999996 699999987543 2389999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHH-------
Q 002321          837 ARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE-------  909 (936)
Q Consensus       837 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~-------  909 (936)
                      ++.....   .......+|+.|+|||++. ...++.++||||+||++|||++|+.||...............-       
T Consensus       167 a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (308)
T 3g33_A          167 ARIYSYQ---MALTPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD  242 (308)
T ss_dssp             TTTSTTC---CCSGGGGCCCSSCCHHHHH-TSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccccCCC---cccCCccccccccCchHHc-CCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            9865422   2234567899999999984 4468999999999999999999999998876543322111100       


Q ss_pred             ------------------------Hhhhccccceeeccccccccccccc
Q 002321          910 ------------------------HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       910 ------------------------~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                              ...++.+.+++.+||..||.+||+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  291 (308)
T 3g33_A          243 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA  291 (308)
T ss_dssp             SCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             ccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCH
Confidence                                    0122455679999999999999985

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6.6e-37  Score=332.45  Aligned_cols=244  Identities=23%  Similarity=0.332  Sum_probs=194.0

Q ss_pred             cccccCCCcccccCceEEEEEEeCC----CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEE-eCCeeE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW-TQSLQL  763 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~  763 (936)
                      ...|+..+.||+|+||.||+|++.+    ...||||++.........+.+.+|+.++++++||||+++++++. .+...+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3456778899999999999999653    23689999876554455678999999999999999999999975 455779


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      +||||+++|+|.++++...  ..+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  181 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred             EEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence            9999999999999997643  33889999999999999999999999999999999999999999999999999866433


Q ss_pred             cc--ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhcc
Q 002321          844 DR--YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAE  915 (936)
Q Consensus       844 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~  915 (936)
                      ..  ........+++.|+|||.+ ....++.++||||+|+++|||++ |.+||.............     ..+...+..
T Consensus       182 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (298)
T 3f66_A          182 EYYSVHNKTGAKLPVKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP  260 (298)
T ss_dssp             GGCBC-----CCBCGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred             chhccccccCCCCCccccChHHh-cCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHH
Confidence            22  1223345567889999988 45578999999999999999999 666776655433221111     112334567


Q ss_pred             ccceeecccccccccccccC
Q 002321          916 WRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +.+++.+||..||.+||+++
T Consensus       261 l~~li~~~l~~~p~~Rps~~  280 (298)
T 3f66_A          261 LYEVMLKCWHPKAEMRPSFS  280 (298)
T ss_dssp             HHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHcCCChhhCcCHH
Confidence            88999999999999999864

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.7e-37  Score=333.54  Aligned_cols=241  Identities=22%  Similarity=0.342  Sum_probs=179.6

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||.||+|+.. +|+.||||++......  ...+.+.+|+.++++++||||+++++++.+....++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            34677889999999999999974 6899999999654321  22467899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++++|.+++....  ..+++.++..++.|+++||+|||+++|+||||||+||+++.++.+||+|||++........ 
T Consensus        91 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  167 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-  167 (278)
T ss_dssp             ECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred             ecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-
Confidence            9999999999997643  2389999999999999999999999999999999999999999999999999986643221 


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH----HHHHHHhhhccccceeec
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV----TWLEEHWKKAEWRNVSMR  922 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  922 (936)
                       ......+++.|+|||.+. ...++.++||||+|+++|||++|+.||...........    .+..+...+.++.+++.+
T Consensus       168 -~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  245 (278)
T 3cok_A          168 -KHYTLCGTPNYISPEIAT-RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQ  245 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHH
T ss_pred             -cceeccCCCCcCCcchhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHH
Confidence             123356889999999884 45678999999999999999999999987554221110    001123345678899999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      ||..||.+||+++
T Consensus       246 ~l~~dp~~Rps~~  258 (278)
T 3cok_A          246 LLRRNPADRLSLS  258 (278)
T ss_dssp             HSCSSGGGSCCHH
T ss_pred             HcccCHhhCCCHH
Confidence            9999999999863

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=6.1e-37  Score=327.70  Aligned_cols=237  Identities=22%  Similarity=0.276  Sum_probs=195.2

Q ss_pred             ccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeC--CeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ--SLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  766 (936)
                      ..|+..+.||+|+||.||+|+++ ++.||||+++..... ...+.+.+|+.++++++||||+++++++.+.  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            34677789999999999999986 899999999765433 3356799999999999999999999999876  6789999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN--IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ||+++|+|.+++..... ..+++.++..++.|++.||+|||+++  ++||||||+||+++.++.++++|||++.....  
T Consensus        89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~--  165 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS--  165 (271)
T ss_dssp             ECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--
T ss_pred             cccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc--
Confidence            99999999999986542 34899999999999999999999999  99999999999999999999999998754321  


Q ss_pred             cccccccccCcccccCcccccCccc--CCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH------HHhhhccc
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVK--ITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE------EHWKKAEW  916 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~------~~~~~~~~  916 (936)
                           ....+|+.|+|||.+.+...  ++.++||||+||++|||++|+.||...............      +...+..+
T Consensus       166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (271)
T 3kmu_A          166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV  240 (271)
T ss_dssp             -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHH
T ss_pred             -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHH
Confidence                 23467889999998854322  334899999999999999999999887654332211111      12345678


Q ss_pred             cceeecccccccccccccC
Q 002321          917 RNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       917 ~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+++.+||..||.+||+++
T Consensus       241 ~~li~~~l~~~p~~Rps~~  259 (271)
T 3kmu_A          241 SKLMKICMNEDPAKRPKFD  259 (271)
T ss_dssp             HHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHcCCChhhCcCHH
Confidence            8999999999999999874

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.5e-36  Score=331.57  Aligned_cols=245  Identities=24%  Similarity=0.393  Sum_probs=187.5

Q ss_pred             ccccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      ....|+..+.||+|+||.||+|+.. +|+.||||+++....  ....+.+.+|++++++++||||+++++++...+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            3455788889999999999999975 689999999975332  2345778999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          765 IYEFVSGGSLHKHLHEGS-GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      ||||+++++|.+++.... ....+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++.....
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~  189 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  189 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence            999999999999986521 2234899999999999999999999999999999999999999999999999999765432


Q ss_pred             ccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHH--------Hhhhcc
Q 002321          844 DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE--------HWKKAE  915 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~--------~~~~~~  915 (936)
                      .  .......+++.|+|||.+. ...++.++||||||+++|||++|+.||................        ...++.
T Consensus       190 ~--~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (310)
T 2wqm_A          190 T--TAAHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  266 (310)
T ss_dssp             -----------CCSSCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred             C--ccccccCCCeeEeChHHhC-CCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHH
Confidence            2  1223456788999999884 4578999999999999999999999997654322221111111        223467


Q ss_pred             ccceeecccccccccccccC
Q 002321          916 WRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +.+++.+||..||.+||+++
T Consensus       267 l~~li~~~l~~dp~~Rps~~  286 (310)
T 2wqm_A          267 LRQLVNMCINPDPEKRPDVT  286 (310)
T ss_dssp             HHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHcCCChhhCCCHH
Confidence            88999999999999999874

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6e-37  Score=329.69  Aligned_cols=242  Identities=24%  Similarity=0.307  Sum_probs=194.3

Q ss_pred             cccccCCCcccccCceEEEEEEeCC----CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      ...|+..+.||+|+||.||+|++..    +..||||++.........+.+.+|++++++++||||+++++++.++ ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            3456778899999999999998653    3469999997665445568899999999999999999999998654 5689


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ||||+++++|.+++.....  .+++..+..++.|+++||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        90 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  167 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED  167 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred             EEecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence            9999999999999976432  38999999999999999999999999999999999999999999999999998664322


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH-----HHHhhhccccc
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL-----EEHWKKAEWRN  918 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~  918 (936)
                       ........+++.|+|||.+ ....++.++||||+|+++|||++ |+.||...+..........     .+...++.+.+
T Consensus       168 -~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  245 (281)
T 3cc6_A          168 -YYKASVTRLPIKWMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYT  245 (281)
T ss_dssp             ------CCCCCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHH
T ss_pred             -ccccccCCCCcceeCchhh-ccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence             1222344567889999988 45578999999999999999998 9999986655432221111     12234466889


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..||.+||+++
T Consensus       246 li~~~l~~~p~~Rps~~  262 (281)
T 3cc6_A          246 LMTRCWDYDPSDRPRFT  262 (281)
T ss_dssp             HHHHHTCSSGGGSCCHH
T ss_pred             HHHHHccCCchhCcCHH
Confidence            99999999999999863

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.2e-37  Score=362.58  Aligned_cols=241  Identities=26%  Similarity=0.374  Sum_probs=198.3

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ...|+..++||+|+||+||+|++.++..||||+++....  ..+++.+|++++++++|+||+++++++.+ ...++||||
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            445677889999999999999998888899999976542  35789999999999999999999999876 668999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++|+|.++++.... ..+++.+++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++..... ....
T Consensus       343 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~  420 (535)
T 2h8h_A          343 MSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTA  420 (535)
T ss_dssp             CTTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH-HHHT
T ss_pred             hcCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC-ceec
Confidence            999999999975321 23889999999999999999999999999999999999999999999999999876432 1222


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH-----HHHhhhccccceeec
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL-----EEHWKKAEWRNVSMR  922 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~  922 (936)
                      .....++..|+|||++. ...++.++|||||||++|||++ |+.||..............     .+...++.+.+++.+
T Consensus       421 ~~~~~~~~~y~aPE~~~-~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~  499 (535)
T 2h8h_A          421 RQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ  499 (535)
T ss_dssp             TCSTTSCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             ccCCcCcccccCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence            23345677899999884 4468999999999999999999 9999987655332211100     012344668899999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      ||..||.+||+|+
T Consensus       500 cl~~dP~~RPt~~  512 (535)
T 2h8h_A          500 CWRKEPEERPTFE  512 (535)
T ss_dssp             HTCSSGGGSCCHH
T ss_pred             HcCCChhHCcCHH
Confidence            9999999999985

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-37  Score=331.12  Aligned_cols=243  Identities=22%  Similarity=0.297  Sum_probs=194.0

Q ss_pred             ccccCCCcccccCceEEEEEEeCC----CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCee-EE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQ-LL  764 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~l  764 (936)
                      ..|...+.||+|+||+||+|++.+    +..||+|++.........+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            345666889999999999998643    2379999997655445567899999999999999999999999876554 89


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ||||+.+|+|.+++....  ..+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus       101 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             EECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            999999999999997633  348899999999999999999999999999999999999999999999999998654322


Q ss_pred             c--ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCC-CCCccchhHHHHHHHH-----HHHhhhccc
Q 002321          845 R--YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKR-PLSTWKMMWWFSVTWL-----EEHWKKAEW  916 (936)
Q Consensus       845 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~-Pf~~~~~~~~~~~~~~-----~~~~~~~~~  916 (936)
                      .  ........+++.|+|||.+ ....++.++||||+||++|||++|.. ||...+..........     .+...++.+
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  257 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESL-QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL  257 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHH-TTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ccccccCcCCCCCccccChhhh-ccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHH
Confidence            1  1223345578889999998 45578999999999999999999554 4554444322211110     122344678


Q ss_pred             cceeecccccccccccccC
Q 002321          917 RNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       917 ~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+++.+||..||.+||+++
T Consensus       258 ~~li~~~l~~~p~~Rps~~  276 (298)
T 3pls_A          258 YQVMQQCWEADPAVRPTFR  276 (298)
T ss_dssp             HHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHccCChhhCcCHH
Confidence            8999999999999999874

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.6e-36  Score=332.30  Aligned_cols=240  Identities=20%  Similarity=0.274  Sum_probs=188.8

Q ss_pred             cccC-CCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEEE
Q 002321          691 LLNK-DCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       691 ~~~~-~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      .|+. .+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus        13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            4555 467999999999999965 68999999996553 23467889999999995 79999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCC---eEEeeccCccccCCCc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARLLPMLD  844 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a~~~~~~~  844 (936)
                      |+++|+|.+++.....   +++.++..++.|++.||+|||+++|+||||||+||+++.++.   +||+|||+++......
T Consensus        92 ~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  168 (316)
T 2ac3_A           92 KMRGGSILSHIHKRRH---FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG  168 (316)
T ss_dssp             CCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred             cCCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence            9999999999987543   899999999999999999999999999999999999998776   9999999997653221


Q ss_pred             c-----ccccccccCcccccCcccccC----cccCCchhhHHHHHHHHHHHHcCCCCCCccchhH-------------HH
Q 002321          845 R-----YVLSSKIQSALGYMAPEFACR----TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMW-------------WF  902 (936)
Q Consensus       845 ~-----~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~-------------~~  902 (936)
                      .     ........+++.|+|||++..    ...++.++||||+||++|||++|+.||.......             ..
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  248 (316)
T 2ac3_A          169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM  248 (316)
T ss_dssp             -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred             ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence            1     111223458999999998843    2457899999999999999999999997753210             00


Q ss_pred             HHHHHH--------H--Hhhhccccceeeccccccccccccc
Q 002321          903 SVTWLE--------E--HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       903 ~~~~~~--------~--~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      ......        .  ...+..+++++.+||..||.+||+.
T Consensus       249 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~  290 (316)
T 2ac3_A          249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA  290 (316)
T ss_dssp             HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             HHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCH
Confidence            001000        1  1234568899999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.8e-36  Score=332.60  Aligned_cols=235  Identities=20%  Similarity=0.252  Sum_probs=193.9

Q ss_pred             cccccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-CCCcceeeeEEEe--CCee
Q 002321          687 GTHALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGYYWT--QSLQ  762 (936)
Q Consensus       687 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~  762 (936)
                      .....|+..+.||+|+||+||+|+.. +++.||||+++..    ..+.+.+|++++++++ ||||+++++++.+  ....
T Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            34566888899999999999999865 6899999998643    3577899999999997 9999999999987  5677


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-CeEEeeccCccccC
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG-EPKVGDYGLARLLP  841 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~  841 (936)
                      ++||||+++++|.+++..      +++.++..++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++...
T Consensus       109 ~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EEEEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEEEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            999999999999999864      88899999999999999999999999999999999999777 89999999998664


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-----H-------
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-----E-------  909 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-----~-------  909 (936)
                      ...   ......+++.|+|||.+.+...++.++||||+||++|||++|+.||...............     .       
T Consensus       183 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          183 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            322   2234568889999999866567899999999999999999999999654332111110000     0       


Q ss_pred             ------------------------------Hhhhccccceeeccccccccccccc
Q 002321          910 ------------------------------HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       910 ------------------------------~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                                    ...++.+.+++.+||..||.+||+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta  314 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA  314 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCH
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCH
Confidence                                          0035667889999999999999985

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.1e-37  Score=341.15  Aligned_cols=242  Identities=15%  Similarity=0.153  Sum_probs=187.7

Q ss_pred             cccccCCCcccccCceEEEEEEeC----CCcEEEEEEeeccCccc----------hHHHHHHHHHHHHcCCCCCcceeee
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLVK----------SQEDFEREVKKLGKVRHPNLVTLEG  754 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~  754 (936)
                      ...|+..+.||+|+||.||+|+..    ++..||||++.......          ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            346788889999999999999976    47889999986543211          1134668889999999999999999


Q ss_pred             EEEe----CCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC--C
Q 002321          755 YYWT----QSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG--E  828 (936)
Q Consensus       755 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~--~  828 (936)
                      ++..    ....++||||+ +++|.+++....   .+++.+++.++.|++.||+|||+++|+||||||+||+++.++  .
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~  191 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ  191 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCc
Confidence            9987    67889999999 999999998654   389999999999999999999999999999999999999887  9


Q ss_pred             eEEeeccCccccCCCccc-----cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch--hHH
Q 002321          829 PKVGDYGLARLLPMLDRY-----VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM--MWW  901 (936)
Q Consensus       829 ~kl~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~--~~~  901 (936)
                      +||+|||+++.+......     .......+++.|+|||++. +..++.++|||||||++|||++|+.||.....  ...
T Consensus       192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK-GVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHH-TCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             EEEEeCCCceecccccccccchhccccccCCCccccCHHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            999999999876432211     1124457899999999884 45789999999999999999999999965322  111


Q ss_pred             HH--HHHHH--HH---------hhhccccceeecccccccccccccC
Q 002321          902 FS--VTWLE--EH---------WKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       902 ~~--~~~~~--~~---------~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..  .....  +.         ..++++.+++.+||..||.+||+++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  317 (345)
T 2v62_A          271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQ  317 (345)
T ss_dssp             HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred             HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHH
Confidence            11  11100  01         3345789999999999999999874

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9.7e-37  Score=328.61  Aligned_cols=238  Identities=24%  Similarity=0.352  Sum_probs=199.2

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||||++......  ...+.+.+|++++++++||||+++++++.+....++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            45778889999999999999976 5789999998654321  22467899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++|+|.+++.....   +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......  
T Consensus        94 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--  168 (284)
T 2vgo_A           94 EFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--  168 (284)
T ss_dssp             CCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC--
T ss_pred             EeCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc--
Confidence            99999999999987543   8999999999999999999999999999999999999999999999999997654321  


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceeec
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSMR  922 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  922 (936)
                        .....+++.|+|||.+. +..++.++||||+|+++|||++|+.||...+.........    ..+...+..+++++.+
T Consensus       169 --~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  245 (284)
T 2vgo_A          169 --RRTMCGTLDYLPPEMIE-GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISK  245 (284)
T ss_dssp             --BCCCCSCGGGCCHHHHT-TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred             --cccccCCCCcCCHHHhc-cCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHH
Confidence              23456889999999884 4568999999999999999999999998766543221111    0123345678899999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      ||..||.+||+.+
T Consensus       246 ~l~~~p~~Rps~~  258 (284)
T 2vgo_A          246 LLRYHPPQRLPLK  258 (284)
T ss_dssp             HSCSSGGGSCCHH
T ss_pred             HhhcCHhhCCCHH
Confidence            9999999999863

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-37  Score=338.50  Aligned_cols=240  Identities=22%  Similarity=0.239  Sum_probs=191.7

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccch----HHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKS----QEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      ..|+..+.||+|+||.||+|++. +|+.||||++........    .+.+.+|++++++++||||+++++++.+....++
T Consensus        10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (346)
T 1ua2_A           10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL   89 (346)
T ss_dssp             ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred             cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence            45777889999999999999976 589999999965432211    2467899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ||||+++ +|.+++....  ..+++.++..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus        90 v~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           90 VFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             EEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             EEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence            9999975 8888887643  238888999999999999999999999999999999999999999999999998764322


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHH---------------
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE---------------  909 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~---------------  909 (936)
                        .......+|+.|+|||++.+...++.++||||+||++|||++|..||............+...               
T Consensus       167 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  244 (346)
T 1ua2_A          167 --RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP  244 (346)
T ss_dssp             --CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred             --ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence              223345689999999998666668999999999999999999999998876543322211110               


Q ss_pred             -----------------Hhhhccccceeeccccccccccccc
Q 002321          910 -----------------HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       910 -----------------~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                       ...+..+.+++.+||..||.+||+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  286 (346)
T 1ua2_A          245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA  286 (346)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH
T ss_pred             ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCH
Confidence                             1123567789999999999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.5e-37  Score=337.94  Aligned_cols=234  Identities=21%  Similarity=0.304  Sum_probs=190.0

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ..|+..+.||+|+||.||+|+.+ +|+.||||+++....     ...+|++++.++ +||||+++++++.+....++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            45777889999999999999976 588999999965432     245788888888 79999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC----CCeEEeeccCccccCCC
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS----GEPKVGDYGLARLLPML  843 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~~~~~~  843 (936)
                      |+++|+|.+++....   .+++.++..++.|++.||+|||++||+||||||+||++..+    +.+||+|||+++.....
T Consensus        97 ~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A           97 LMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             CCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            999999999997654   38999999999999999999999999999999999998543    35999999999865432


Q ss_pred             ccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHH-HHHHHHHH----------Hhh
Q 002321          844 DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWW-FSVTWLEE----------HWK  912 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~-~~~~~~~~----------~~~  912 (936)
                      .  .......+|+.|+|||++. ...++.++||||+||++|||++|+.||........ ........          ...
T Consensus       174 ~--~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  250 (342)
T 2qr7_A          174 N--GLLMTPCYTANFVAPEVLE-RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV  250 (342)
T ss_dssp             T--CCBCCSSCCSSCCCHHHHH-HHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred             C--CceeccCCCccccCHHHhc-CCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence            2  1223456899999999884 44688999999999999999999999986432111 11111110          124


Q ss_pred             hccccceeeccccccccccccc
Q 002321          913 KAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       913 ~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      ++.+++++.+||..||.+||+.
T Consensus       251 s~~~~~li~~~L~~dP~~R~t~  272 (342)
T 2qr7_A          251 SDTAKDLVSKMLHVDPHQRLTA  272 (342)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCH
T ss_pred             CHHHHHHHHHHCCCChhHCcCH
Confidence            5678899999999999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.9e-36  Score=336.93  Aligned_cols=243  Identities=23%  Similarity=0.269  Sum_probs=195.9

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeC-------
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ-------  759 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  759 (936)
                      ...|+..++||+|+||.||+|+.. +|+.||||++...... .....+.+|++++++++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            356788889999999999999985 6899999998655432 2346788999999999999999999999873       


Q ss_pred             -CeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCcc
Q 002321          760 -SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLAR  838 (936)
Q Consensus       760 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  838 (936)
                       +..++||||++ |++.+.+.....  .+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++
T Consensus        96 ~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           96 KGSIYLVFDFCE-HDLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             -CEEEEEEECCS-EEHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CceEEEEEeccC-CCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence             46789999996 577777765432  38999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCcc--ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----------
Q 002321          839 LLPMLDR--YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----------  906 (936)
Q Consensus       839 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----------  906 (936)
                      .+.....  ........+|+.|+|||++.+...++.++||||+||++|||++|+.||.............          
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  252 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  252 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence            7643221  2223445679999999988666678999999999999999999999998866532221111          


Q ss_pred             --------------------------HHHHhhhccccceeeccccccccccccc
Q 002321          907 --------------------------LEEHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       907 --------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                                ......++.+.+++.+||..||.+||+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  306 (351)
T 3mi9_A          253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS  306 (351)
T ss_dssp             STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCH
Confidence                                      0011123457789999999999999985

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=8.3e-37  Score=344.70  Aligned_cols=229  Identities=21%  Similarity=0.271  Sum_probs=180.4

Q ss_pred             CcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHc-CCCCCcceeeeEEEe----CCeeEEEEEec
Q 002321          696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGK-VRHPNLVTLEGYYWT----QSLQLLIYEFV  769 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~lv~e~~  769 (936)
                      +.||+|+||+||+|+.. +++.||||++..      ...+.+|+.++.+ .+||||+++++++..    ....++||||+
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~  141 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL  141 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCc------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence            57999999999999976 588999999853      2457788888744 589999999999875    55679999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCCeEEeeccCccccCCCccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG---SGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ++|+|.+++..... ..+++.++..++.|++.||+|||+.||+||||||+|||++.   ++.+||+|||+++.....   
T Consensus       142 ~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~---  217 (400)
T 1nxk_A          142 DGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---  217 (400)
T ss_dssp             CSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----
T ss_pred             CCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC---
Confidence            99999999986432 34899999999999999999999999999999999999998   789999999999865422   


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHH-----HHHHHH-----HH--Hhhhc
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWW-----FSVTWL-----EE--HWKKA  914 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~-----~~~~~~-----~~--~~~~~  914 (936)
                      .......+|+.|+|||++ ....++.++||||+||++|||++|+.||........     ......     .+  ...+.
T Consensus       218 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  296 (400)
T 1nxk_A          218 NSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE  296 (400)
T ss_dssp             ---------CTTCCGGGS-CCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             CccccCCCCCCccCHhhc-CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCH
Confidence            122345689999999998 455789999999999999999999999977543211     111100     01  12446


Q ss_pred             cccceeecccccccccccccC
Q 002321          915 EWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       915 ~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ++++++.+||..||.+||+++
T Consensus       297 ~~~~li~~~L~~dP~~Rpt~~  317 (400)
T 1nxk_A          297 EVKMLIRNLLKTEPTQRMTIT  317 (400)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHH
T ss_pred             HHHHHHHHHCCCChhHCcCHH
Confidence            788999999999999999863

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=7.9e-37  Score=351.10  Aligned_cols=236  Identities=21%  Similarity=0.233  Sum_probs=186.0

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeC------C
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ------S  760 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  760 (936)
                      ...|+..+.||+|+||+||+|++. +++.||||++...... ...+.+.+|+.++++++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            345778889999999999999976 5899999999754322 3356788999999999999999999999654      3


Q ss_pred             eeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCcccc
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL  840 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  840 (936)
                      ..++||||+++ ++.+.+..     .+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  214 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred             eEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence            56999999965 56666643     2889999999999999999999999999999999999999999999999999865


Q ss_pred             CCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-------------
Q 002321          841 PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-------------  907 (936)
Q Consensus       841 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-------------  907 (936)
                      ...   .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..........             
T Consensus       215 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          215 GTS---FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             --C---CCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred             CCC---cccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence            432   22344678999999999854 5789999999999999999999999988764322211100             


Q ss_pred             -------------------H--------------HHhhhccccceeeccccccccccccc
Q 002321          908 -------------------E--------------EHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       908 -------------------~--------------~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                         +              ....+..+.+++.+||..||.+||+.
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta  350 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV  350 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCH
Confidence                               0              00013457899999999999999985

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.5e-37  Score=341.45  Aligned_cols=239  Identities=21%  Similarity=0.325  Sum_probs=197.8

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ...|+..+.||+|+||.||+|++. +++.||+|++.........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            345778889999999999999987 6899999999766444456789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS-NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      |+++++|.+++.....   +++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++....    
T Consensus       112 ~~~~~~L~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----  184 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----  184 (360)
T ss_dssp             CCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----
T ss_pred             CCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc----
Confidence            9999999999987543   89999999999999999999996 999999999999999999999999999975421    


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH----------------------
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV----------------------  904 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~----------------------  904 (936)
                      .......+++.|+|||++. +..++.++||||+||++|||++|+.||...+.......                      
T Consensus       185 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3eqc_A          185 SMANSFVGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  263 (360)
T ss_dssp             HC----CCCCTTCCHHHHT-TCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred             ccccCCCCCCCeECHHHHc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence            1223456899999999984 55789999999999999999999999987654322111                      


Q ss_pred             ------------------HHHHH--------HhhhccccceeecccccccccccccC
Q 002321          905 ------------------TWLEE--------HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       905 ------------------~~~~~--------~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                                        .....        ...+..+.+++.+||..||.+||+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  320 (360)
T 3eqc_A          264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK  320 (360)
T ss_dssp             ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHH
T ss_pred             ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHH
Confidence                              00000        01234678899999999999999863

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=8.7e-37  Score=333.95  Aligned_cols=246  Identities=22%  Similarity=0.314  Sum_probs=187.2

Q ss_pred             cccccCCCcccccCceEEEEEEeC----CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCC---
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS---  760 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  760 (936)
                      ...|...+.||+|+||.||+|+..    +++.||||+++..... ...+.+.+|+.++++++||||+++++++.+..   
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  112 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG  112 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence            445778889999999999999865    2458999999755332 33567899999999999999999999998754   


Q ss_pred             --eeEEEEEecCCCChhhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeecc
Q 002321          761 --LQLLIYEFVSGGSLHKHLHEGS---GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYG  835 (936)
Q Consensus       761 --~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  835 (936)
                        ..++||||+++|+|.+++....   ....+++.++++++.|+++||+|||++||+||||||+||+++.++.+||+|||
T Consensus       113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg  192 (313)
T 3brb_A          113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG  192 (313)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred             CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecC
Confidence              3489999999999999985432   23458999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH-----HH
Q 002321          836 LARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL-----EE  909 (936)
Q Consensus       836 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~-----~~  909 (936)
                      +++...............+++.|+|||.+. ...++.++||||+|+++|||++ |..||..............     .+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  271 (313)
T 3brb_A          193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLA-DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQP  271 (313)
T ss_dssp             CC----------------CCGGGSCHHHHH-SSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCB
T ss_pred             cceecccccccCcccccCCCccccCchhhc-CCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCC
Confidence            998765443333344456788899999984 5578999999999999999999 9999987765433322111     11


Q ss_pred             HhhhccccceeecccccccccccccC
Q 002321          910 HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       910 ~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ...++.+.+++.+||..||.+||+++
T Consensus       272 ~~~~~~l~~li~~~l~~dp~~Rps~~  297 (313)
T 3brb_A          272 EDCLDELYEIMYSCWRTDPLDRPTFS  297 (313)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred             ccccHHHHHHHHHHcCCChhhCcCHH
Confidence            22346688999999999999999874

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=7.7e-37  Score=328.49  Aligned_cols=241  Identities=26%  Similarity=0.355  Sum_probs=197.1

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ...|+..+.||+|+||.||+|+..+++.||||+++...  ...+.+.+|++++++++||||+++++++.+ +..++||||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            34567888999999999999999888899999996543  235789999999999999999999999864 457899999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++++|.+++..... ..+++.++.+++.|++.||+|||++||+||||||+||++++++.+||+|||+++...... ...
T Consensus        89 ~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  166 (279)
T 1qpc_A           89 MENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTA  166 (279)
T ss_dssp             CTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EEC
T ss_pred             CCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-ccc
Confidence            999999999975421 138999999999999999999999999999999999999999999999999998765322 222


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceeec
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSMR  922 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  922 (936)
                      .....+++.|+|||.+ ....++.++||||+|+++|||++ |+.||.............     ..+...++.+.+++.+
T Consensus       167 ~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  245 (279)
T 1qpc_A          167 REGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL  245 (279)
T ss_dssp             CTTCCCCTTTSCHHHH-HHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             ccCCCCccCccChhhh-ccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHH
Confidence            2344567789999988 44568999999999999999999 999998765532221110     0012334678899999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      ||..||.+||+++
T Consensus       246 ~l~~~p~~Rps~~  258 (279)
T 1qpc_A          246 CWKERPEDRPTFD  258 (279)
T ss_dssp             HTCSSGGGSCCHH
T ss_pred             HhccChhhCCCHH
Confidence            9999999999874

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=8.2e-37  Score=366.11  Aligned_cols=239  Identities=22%  Similarity=0.253  Sum_probs=201.3

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  765 (936)
                      ..|+..+.||+|+||.||+|+.+ +++.||||+++....  ....+.+.+|.+++..+ +||+|+++++++.+.+..++|
T Consensus       341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV  420 (674)
T 3pfq_A          341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV  420 (674)
T ss_dssp             TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred             cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence            44677889999999999999976 588999999975422  23356788899999988 799999999999999999999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      |||+++|+|.+++.....   +++.++..++.||+.||+|||+++|+||||||+|||++.+|.+||+|||+|+...... 
T Consensus       421 ~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-  496 (674)
T 3pfq_A          421 MEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-  496 (674)
T ss_dssp             EECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-
T ss_pred             EeCcCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC-
Confidence            999999999999987543   8999999999999999999999999999999999999999999999999998543221 


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH----HHHhhhccccceee
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL----EEHWKKAEWRNVSM  921 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~  921 (936)
                       .......||+.|+|||++ ....++.++||||+||++|||++|+.||...+..........    .+...+.++.+++.
T Consensus       497 -~~~~~~~GT~~Y~APE~l-~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  574 (674)
T 3pfq_A          497 -VTTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK  574 (674)
T ss_dssp             -CCBCCCCSCSSSCCHHHH-TCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHH
T ss_pred             -cccccccCCCcccCHhhh-cCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence             223456799999999998 455789999999999999999999999988766433322111    12345577899999


Q ss_pred             ccccccccccccc
Q 002321          922 RSCKGSSRQRRRF  934 (936)
Q Consensus       922 ~~l~~~p~~Rp~f  934 (936)
                      +||..||.+||++
T Consensus       575 ~lL~~dP~~R~~~  587 (674)
T 3pfq_A          575 GLMTKHPGKRLGC  587 (674)
T ss_dssp             HHSCSSSTTCTTC
T ss_pred             HHccCCHHHCCCC
Confidence            9999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-37  Score=341.75  Aligned_cols=241  Identities=24%  Similarity=0.323  Sum_probs=193.8

Q ss_pred             ccccCCCcccccCceEEEEEEe----CCCcEEEEEEeeccCc---cchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVL----RDGRPVAIKKLTVSSL---VKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSL  761 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  761 (936)
                      ..|+..+.||+|+||.||+|+.    .+++.||||+++....   ....+.+.+|+++++++ +||||+++++++.....
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            4578888999999999999997    3689999999865432   12345677899999999 69999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .++||||+++|+|.+++.....   +++.++..++.|+++||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             EEEEeecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            9999999999999999986543   8999999999999999999999999999999999999999999999999998654


Q ss_pred             CCccccccccccCcccccCcccccCc-ccCCchhhHHHHHHHHHHHHcCCCCCCccchh--HHHHHHH-HH-----HHhh
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRT-VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM--WWFSVTW-LE-----EHWK  912 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~--~~~~~~~-~~-----~~~~  912 (936)
                      ... ........+|+.|+|||++.+. ..++.++|||||||++|||++|+.||......  ....... ..     +...
T Consensus       211 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (355)
T 1vzo_A          211 ADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM  289 (355)
T ss_dssp             GGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             cCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCccc
Confidence            322 2223345689999999998542 35789999999999999999999999754321  1111111 11     1223


Q ss_pred             hccccceeeccccccccccccc
Q 002321          913 KAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       913 ~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      +..+++++.+||..||.+||++
T Consensus       290 ~~~~~~li~~~L~~dP~~R~~~  311 (355)
T 1vzo_A          290 SALAKDLIQRLLMKDPKKRLGC  311 (355)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTS
T ss_pred             CHHHHHHHHHHhhhCHHHhcCC
Confidence            3567889999999999999943

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8.2e-37  Score=329.91  Aligned_cols=242  Identities=25%  Similarity=0.357  Sum_probs=201.1

Q ss_pred             cccccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ...|+..+.||+|+||.||+|++.. +..||||++....  ...+.+.+|++++++++||||+++++++.+....++|||
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            4456778899999999999999874 8899999996543  346789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+++++|.+++..... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.++...... ..
T Consensus        90 ~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~  167 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YT  167 (288)
T ss_dssp             CCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-SE
T ss_pred             cCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-cc
Confidence            9999999999986443 348999999999999999999999999999999999999999999999999998764322 22


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHHH-----HHhhhccccceee
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWLE-----EHWKKAEWRNVSM  921 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~  921 (936)
                      ......+++.|+|||.+. ...++.++||||+|+++|+|++ |..||...+...........     +...++.+.+++.
T Consensus       168 ~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  246 (288)
T 3kfa_A          168 AHAGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR  246 (288)
T ss_dssp             EETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             cccCCccccCcCChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence            233445677899999884 4468999999999999999999 99999887654333221111     1223466889999


Q ss_pred             cccccccccccccC
Q 002321          922 RSCKGSSRQRRRFQ  935 (936)
Q Consensus       922 ~~l~~~p~~Rp~f~  935 (936)
                      +||..||.+||+++
T Consensus       247 ~~l~~dp~~Rps~~  260 (288)
T 3kfa_A          247 ACWQWNPSDRPSFA  260 (288)
T ss_dssp             HHTCSSGGGSCCHH
T ss_pred             HHhCCChhhCcCHH
Confidence            99999999999863

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-36  Score=338.52  Aligned_cols=235  Identities=24%  Similarity=0.270  Sum_probs=187.8

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCC------e
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS------L  761 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  761 (936)
                      ..|+..+.||+|+||.||+|++. +|+.||||++...... ...+++.+|++++++++||||+++++++....      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            45778889999999999999975 6899999998554322 33567899999999999999999999997653      4


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .++||||+ +++|.++++...    +++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus       105 ~~lv~e~~-~~~L~~~~~~~~----l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  179 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKHEK----LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD  179 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEecC-CCCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence            59999999 899999997632    8999999999999999999999999999999999999999999999999998654


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH---------------
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW---------------  906 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~---------------  906 (936)
                      ..     .....+|+.|+|||++.+...++.++||||+||++|||++|+.||...+.........               
T Consensus       180 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  254 (367)
T 1cm8_A          180 SE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  254 (367)
T ss_dssp             SS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             cc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            21     2345678999999998665678999999999999999999999998766532221100               


Q ss_pred             -------HHH-------------Hhhhccccceeeccccccccccccc
Q 002321          907 -------LEE-------------HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       907 -------~~~-------------~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                             ...             ...++.+.+++.+||..||.+||+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~  302 (367)
T 1cm8_A          255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA  302 (367)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCH
Confidence                   000             0124557788999999999999975

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.6e-36  Score=331.03  Aligned_cols=240  Identities=19%  Similarity=0.256  Sum_probs=188.8

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc--hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK--SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||||++.......  ..+.+.+|+.++++++||||+++++++...+..++||
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM  113 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence            45778889999999999999976 68899999996543322  2477899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++++|.+++.....   +++.++..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++....... .
T Consensus       114 e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~  189 (309)
T 2h34_A          114 RLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK-L  189 (309)
T ss_dssp             ECCCCEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred             EecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc-c
Confidence            99999999999987543   8999999999999999999999999999999999999999999999999997654322 1


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-------HHHhhhccccce
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-------EEHWKKAEWRNV  919 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~~~  919 (936)
                      .......+++.|+|||.+. ...++.++||||+|+++|||++|+.||...+..........       .+...+..+.++
T Consensus       190 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  268 (309)
T 2h34_A          190 TQLGNTVGTLYYMAPERFS-ESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAV  268 (309)
T ss_dssp             -------CCGGGCCGGGTC-C----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHH
T ss_pred             ccccccCCCcCccCHHHHc-CCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHH
Confidence            2223456889999999884 45789999999999999999999999988665422211100       011234668899


Q ss_pred             eeccccccccccc-cc
Q 002321          920 SMRSCKGSSRQRR-RF  934 (936)
Q Consensus       920 ~~~~l~~~p~~Rp-~f  934 (936)
                      +.+||..||.+|| +.
T Consensus       269 i~~~l~~dP~~Rp~s~  284 (309)
T 2h34_A          269 IARGMAKNPEDRYVTC  284 (309)
T ss_dssp             HHHHTCSSGGGSCSSH
T ss_pred             HHHhccCCHHHHHHhH
Confidence            9999999999999 54

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.5e-37  Score=343.94  Aligned_cols=238  Identities=22%  Similarity=0.271  Sum_probs=188.4

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC------ee
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS------LQ  762 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~  762 (936)
                      ...|+..+.||+|+||+||+|+...+..||+|++......     ..+|++++++++||||+++++++....      ..
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            4457888999999999999999987778999998544322     247999999999999999999996543      26


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc-CCCCeEEeeccCccccC
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLARLLP  841 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~  841 (936)
                      ++||||++++.+............+++..+..++.|+++||+|||++||+||||||+||+++ .++.+||+|||+|+...
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~  193 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI  193 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence            89999997654433332222233489999999999999999999999999999999999999 79999999999998764


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH--------------
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL--------------  907 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~--------------  907 (936)
                      ...   ......+++.|+|||++.+...++.++||||+||++|||++|+.||.+.+..........              
T Consensus       194 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~  270 (394)
T 4e7w_A          194 AGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN  270 (394)
T ss_dssp             TTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             CCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            322   223456789999999986666799999999999999999999999988765322211100              


Q ss_pred             -------------------HHHhhhccccceeeccccccccccccc
Q 002321          908 -------------------EEHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       908 -------------------~~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                         .+...++.+.+++.+||..||.+||+.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  316 (394)
T 4e7w_A          271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTA  316 (394)
T ss_dssp             GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCH
Confidence                               001134567899999999999999984

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.3e-37  Score=333.56  Aligned_cols=237  Identities=22%  Similarity=0.343  Sum_probs=193.0

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEe---------
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWT---------  758 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  758 (936)
                      ...|+..+.||+|+||.||+|++. +++.||||+++...     +.+.+|++++++++||||+++++++..         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            455788889999999999999987 68999999996543     356789999999999999999999864         


Q ss_pred             -------CCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEE
Q 002321          759 -------QSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKV  831 (936)
Q Consensus       759 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl  831 (936)
                             ....++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl  163 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI  163 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence                   3457899999999999999976432 23899999999999999999999999999999999999999999999


Q ss_pred             eeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHHHh
Q 002321          832 GDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHW  911 (936)
Q Consensus       832 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~  911 (936)
                      +|||+++......   ......+++.|+|||.+. ...++.++||||+|+++|||++|..||...............+..
T Consensus       164 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T 2a19_B          164 GDFGLVTSLKNDG---KRTRSKGTLRYMSPEQIS-SQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDI  239 (284)
T ss_dssp             CCCTTCEESSCCS---CCCCCCSCCTTSCHHHHH-CSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTTCCCTT
T ss_pred             Ccchhheeccccc---cccccCCcccccChhhhc-cCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhccccccc
Confidence            9999998764322   223456889999999884 456899999999999999999999998543221111111011123


Q ss_pred             hhccccceeecccccccccccccC
Q 002321          912 KKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       912 ~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+..+++++.+||..||.+||+++
T Consensus       240 ~~~~~~~li~~~l~~dp~~Rps~~  263 (284)
T 2a19_B          240 FDKKEKTLLQKLLSKKPEDRPNTS  263 (284)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCHHHHHHHHHHccCChhhCcCHH
Confidence            446678899999999999999863

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=7.6e-37  Score=330.17  Aligned_cols=241  Identities=18%  Similarity=0.229  Sum_probs=195.9

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  765 (936)
                      ...|+..+.||+|+||.||+|+.. +++.||||+++.... .....++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            455788889999999999999987 689999999975433 23457788999999999 999999999999999999999


Q ss_pred             EEecCCCChhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC------------------
Q 002321          766 YEFVSGGSLHKHLHEGSG-GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS------------------  826 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~------------------  826 (936)
                      |||+++++|.+++..... ...+++.++..++.|++.||+|||++||+||||||+||+++.+                  
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~  169 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN  169 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence            999999999999976421 1348999999999999999999999999999999999999854                  


Q ss_pred             -CCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH
Q 002321          827 -GEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT  905 (936)
Q Consensus       827 -~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~  905 (936)
                       ..+||+|||.+......      ....+++.|+|||.+.+...++.++||||+||++|||++|..|+...+........
T Consensus       170 ~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~  243 (289)
T 1x8b_A          170 KVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQG  243 (289)
T ss_dssp             CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHHTT
T ss_pred             ceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHHcC
Confidence             47999999999866432      23358899999999866556778999999999999999999887655432111100


Q ss_pred             H--HHHHhhhccccceeecccccccccccccC
Q 002321          906 W--LEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       906 ~--~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .  ..+...++.+.+++.+||..||.+||+++
T Consensus       244 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  275 (289)
T 1x8b_A          244 RLPRIPQVLSQEFTELLKVMIHPDPERRPSAM  275 (289)
T ss_dssp             CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCcccCHHHHHHHHHHhCCCcccCCCHH
Confidence            0  01123456788999999999999999864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.4e-37  Score=347.60  Aligned_cols=239  Identities=20%  Similarity=0.308  Sum_probs=185.9

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-------chHHHHHHHHHHHHcCCCCCcceeeeEEEeCC
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-------KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS  760 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  760 (936)
                      ...|...+.||+|+||+||+|... +++.||||++......       .....+.+|++++++++||||+++++++.. .
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            445778889999999999999976 5899999999654321       112357899999999999999999999754 5


Q ss_pred             eeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---CeEEeeccCc
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG---EPKVGDYGLA  837 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~---~~kl~Dfg~a  837 (936)
                      ..++||||+++|+|.+++.....   +++.++..++.|++.||+|||+++|+||||||+|||++.++   .+||+|||++
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a  289 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKR---LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  289 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred             ceEEEEEcCCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence            57899999999999998876543   89999999999999999999999999999999999997554   5999999999


Q ss_pred             cccCCCccccccccccCcccccCcccccC--cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH--HHH-----HHH
Q 002321          838 RLLPMLDRYVLSSKIQSALGYMAPEFACR--TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF--SVT-----WLE  908 (936)
Q Consensus       838 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~--~~~-----~~~  908 (936)
                      +.....   .......||+.|+|||++..  ...++.++||||+||++|||++|+.||.........  ...     +.+
T Consensus       290 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~  366 (419)
T 3i6u_A          290 KILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP  366 (419)
T ss_dssp             TSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred             eecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence            876432   22334668999999998743  356788999999999999999999999765432111  110     011


Q ss_pred             H--Hhhhccccceeeccccccccccccc
Q 002321          909 E--HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       909 ~--~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      +  ...++.+.+++.+||..||.+||+.
T Consensus       367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~  394 (419)
T 3i6u_A          367 EVWAEVSEKALDLVKKLLVVDPKARFTT  394 (419)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             hhhcccCHHHHHHHHHHccCChhHCcCH
Confidence            1  2245778899999999999999985

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3e-36  Score=325.81  Aligned_cols=236  Identities=25%  Similarity=0.377  Sum_probs=193.1

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEe----CCeeEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWT----QSLQLL  764 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l  764 (936)
                      .|...+.||+|+||.||+|.+. ++..||+|++...... ...+.+.+|+.++++++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            3566778999999999999976 5789999999755433 335778999999999999999999999875    345789


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEc-CCCCeEEeeccCccccC
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN--IIHYNIKSSNVLID-GSGEPKVGDYGLARLLP  841 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~  841 (936)
                      ||||+++|+|.+++.....   +++..+..++.|++.||+|||+.+  |+||||||+||+++ .++.+||+|||++....
T Consensus       107 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEecCCCCHHHHHHHccC---CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            9999999999999987543   899999999999999999999999  99999999999998 78999999999997543


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-------HHhhhc
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-------EHWKKA  914 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-------~~~~~~  914 (936)
                      ..    ......+++.|+|||.+. . .++.++||||+||++|+|++|+.||...............       +...++
T Consensus       184 ~~----~~~~~~~t~~y~aPE~~~-~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (290)
T 1t4h_A          184 AS----FAKAVIGTPEFMAPEMYE-E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP  257 (290)
T ss_dssp             TT----SBEESCSSCCCCCGGGGG-T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred             cc----ccccccCCcCcCCHHHHh-c-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence            22    223456889999999884 3 4899999999999999999999999875543222111111       112235


Q ss_pred             cccceeecccccccccccccC
Q 002321          915 EWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       915 ~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+.+++.+||..||.+||+++
T Consensus       258 ~l~~li~~~l~~dp~~Rps~~  278 (290)
T 1t4h_A          258 EVKEIIEGCIRQNKDERYSIK  278 (290)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHH
T ss_pred             HHHHHHHHHccCChhhCCCHH
Confidence            688999999999999999874

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2e-36  Score=338.20  Aligned_cols=239  Identities=19%  Similarity=0.234  Sum_probs=196.4

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeC-----CeeEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ-----SLQLL  764 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l  764 (936)
                      .|+..+.||+|+||.||+|+.. +++.||||++.........+.+.+|++++++++||||+++++++...     ...++
T Consensus        28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  107 (364)
T 3qyz_A           28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI  107 (364)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence            4778889999999999999976 58899999997654444557889999999999999999999999764     36799


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ||||++ |+|.+++....    +++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus       108 v~e~~~-~~L~~~l~~~~----~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          108 VQDLME-TDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEECCS-EEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEcccC-cCHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            999996 69999987643    8999999999999999999999999999999999999999999999999998764322


Q ss_pred             cc-cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH-----------------
Q 002321          845 RY-VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW-----------------  906 (936)
Q Consensus       845 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~-----------------  906 (936)
                      .. .......+|+.|+|||++.+...++.++||||+||++|||++|+.||...+.........                 
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence            21 122445789999999987667678999999999999999999999998765432221100                 


Q ss_pred             -----HH-------------HHhhhccccceeeccccccccccccc
Q 002321          907 -----LE-------------EHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       907 -----~~-------------~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                           ..             ....+..+.+++.+||..||.+||+.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  308 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV  308 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCH
Confidence                 00             01123567899999999999999985

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=7.2e-37  Score=330.82  Aligned_cols=240  Identities=23%  Similarity=0.316  Sum_probs=191.9

Q ss_pred             cccCCC-cccccCceEEEEEEeC---CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEE
Q 002321          691 LLNKDC-ELGRGGFGAVYRTVLR---DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       691 ~~~~~~-~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  765 (936)
                      .|+..+ .||+|+||.||+|.+.   +++.||||+++..... ...+++.+|++++++++||||+++++++ .....++|
T Consensus        17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv   95 (291)
T 1xbb_A           17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV   95 (291)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence            455555 8999999999999643   4688999999755433 2357899999999999999999999999 55677899


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      |||+++++|.+++.....   +++.++..++.|++.||+|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus        96 ~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (291)
T 1xbb_A           96 MEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  172 (291)
T ss_dssp             EECCTTEEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             EEeCCCCCHHHHHHhCcC---CCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence            999999999999987543   89999999999999999999999999999999999999999999999999987644332


Q ss_pred             c-cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHHH-----HHhhhccccc
Q 002321          846 Y-VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWLE-----EHWKKAEWRN  918 (936)
Q Consensus       846 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~  918 (936)
                      . .......+++.|+|||.+. ...++.++||||+|+++|||++ |+.||...+...........     +...+..+.+
T Consensus       173 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  251 (291)
T 1xbb_A          173 YYKAQTHGKWPVKWYAPECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD  251 (291)
T ss_dssp             EEEC----CCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cccccccCCCCceeeChHHhc-cCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            2 1223344678899999884 4468899999999999999999 99999887654332211100     1234567899


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..||.+||+++
T Consensus       252 li~~~l~~dp~~Rps~~  268 (291)
T 1xbb_A          252 LMNLCWTYDVENRPGFA  268 (291)
T ss_dssp             HHHHHTCSSTTTSCCHH
T ss_pred             HHHHHcCCChhhCcCHH
Confidence            99999999999999874

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.6e-37  Score=338.31  Aligned_cols=244  Identities=23%  Similarity=0.348  Sum_probs=194.6

Q ss_pred             ccccccCCCcccccCceEEEEEEeC-CCcE--EEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeE
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLR-DGRP--VAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  763 (936)
                      ....|+..+.||+|+||.||+|+.. ++..  ||||+++........+.+.+|+++++++ +||||+++++++.+.+..+
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            3456778889999999999999976 4554  4999987654444567789999999999 8999999999999999999


Q ss_pred             EEEEecCCCChhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeE
Q 002321          764 LIYEFVSGGSLHKHLHEGS-------------GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPK  830 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~k  830 (936)
                      +||||+++|+|.+++....             ....+++.+++.++.|++.||+|||++||+||||||+||+++.++.+|
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~k  182 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK  182 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEE
Confidence            9999999999999997643             123589999999999999999999999999999999999999999999


Q ss_pred             EeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH---
Q 002321          831 VGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW---  906 (936)
Q Consensus       831 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~---  906 (936)
                      |+|||+++....   ........+++.|+|||.+ ....++.++||||+||++|||++ |+.||.............   
T Consensus       183 L~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~  258 (327)
T 1fvr_A          183 IADFGLSRGQEV---YVKKTMGRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  258 (327)
T ss_dssp             ECCTTCEESSCE---ECCC----CCTTTCCHHHH-HHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred             EcccCcCccccc---cccccCCCCCccccChhhh-ccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC
Confidence            999999974321   2222334567889999988 45568999999999999999998 999998876543221110   


Q ss_pred             --HHHHhhhccccceeecccccccccccccC
Q 002321          907 --LEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       907 --~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                        ..+...+..+.+++.+||..||.+||+++
T Consensus       259 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  289 (327)
T 1fvr_A          259 RLEKPLNCDDEVYDLMRQCWREKPYERPSFA  289 (327)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence              01122346788999999999999999863

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.3e-37  Score=336.86  Aligned_cols=246  Identities=19%  Similarity=0.319  Sum_probs=180.0

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||||++.........+++.+|++++++++||||+++++++...+..++||||
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   94 (303)
T 2vwi_A           15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL   94 (303)
T ss_dssp             CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred             hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence            45677789999999999999965 68999999987654444567788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          769 VSGGSLHKHLHEG-----SGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       769 ~~~g~L~~~l~~~-----~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      +++++|.+++...     .....+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus        95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  174 (303)
T 2vwi_A           95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG  174 (303)
T ss_dssp             CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred             ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence            9999999998641     11234899999999999999999999999999999999999999999999999999766432


Q ss_pred             cc---ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-----------H
Q 002321          844 DR---YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-----------E  909 (936)
Q Consensus       844 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-----------~  909 (936)
                      ..   ........+++.|+|||++.....++.++||||+||++|||++|+.||...............           +
T Consensus       175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (303)
T 2vwi_A          175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDK  254 (303)
T ss_dssp             -------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----
T ss_pred             CCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccc
Confidence            21   112234568899999998855456899999999999999999999999886654332111100           0


Q ss_pred             ---HhhhccccceeecccccccccccccC
Q 002321          910 ---HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       910 ---~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                         ...+..+.+++.+||..||.+||+++
T Consensus       255 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~  283 (303)
T 2vwi_A          255 EMLKKYGKSFRKMISLCLQKDPEKRPTAA  283 (303)
T ss_dssp             CCCCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             hhhhhhhHHHHHHHHHHccCChhhCcCHH
Confidence               11224577899999999999999863

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.6e-38  Score=354.10  Aligned_cols=239  Identities=13%  Similarity=0.123  Sum_probs=183.3

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHH---HHHHcCCCCCcceee-------eEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREV---KKLGKVRHPNLVTLE-------GYY  756 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~~  756 (936)
                      ..|+..+.||+|+||+||+|++. +|+.||||++.....  ....+.+.+|+   +++++++||||++++       +++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            45677889999999999999964 689999999975422  23457899999   455566899999998       666


Q ss_pred             EeCC-----------------eeEEEEEecCCCChhhhhhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 002321          757 WTQS-----------------LQLLIYEFVSGGSLHKHLHEGSG----GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN  815 (936)
Q Consensus       757 ~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~D  815 (936)
                      .+.+                 ..++||||+ +|+|.+++.....    ...+++..++.|+.|++.||+|||++||+|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD  231 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY  231 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            6543                 268999999 6899999986422    11244588889999999999999999999999


Q ss_pred             CCCCCEEEcCCCCeEEeeccCccccCCCccccccccccCcccccCcccccCc----------ccCCchhhHHHHHHHHHH
Q 002321          816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT----------VKITDKCDVYGFGVLVLE  885 (936)
Q Consensus       816 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~~DvwSlG~~l~e  885 (936)
                      |||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.          ..++.++|||||||++||
T Consensus       232 ikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e  305 (377)
T 3byv_A          232 LRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW  305 (377)
T ss_dssp             CCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence            999999999999999999999985432     2234456 889999998543          268999999999999999


Q ss_pred             HHcCCCCCCccchhHHHHHHHHHHHhhhccccceeecccccccccccccC
Q 002321          886 VVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       886 l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      |++|+.||...................++.+.+++.+||..||.+||+++
T Consensus       306 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~  355 (377)
T 3byv_A          306 IWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPL  355 (377)
T ss_dssp             HHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHH
T ss_pred             HHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHH
Confidence            99999999775432111111111123456789999999999999999863

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.5e-36  Score=327.29  Aligned_cols=241  Identities=23%  Similarity=0.296  Sum_probs=194.2

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      +.....||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            344558999999999999975 58899999987553 2345779999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCCeEEeeccCccccCCCcccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG-SGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      +++|.+++........+++..+..++.|++.||+|||++||+||||||+||+++. ++.+||+|||+++......  ...
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~  180 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PCT  180 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--Ccc
Confidence            9999999987654445778999999999999999999999999999999999987 8999999999998664322  122


Q ss_pred             ccccCcccccCcccccCc-ccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-------HHhhhccccceee
Q 002321          850 SKIQSALGYMAPEFACRT-VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-------EHWKKAEWRNVSM  921 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~  921 (936)
                      ....+++.|+|||++... ..++.++||||+|+++|||++|+.||...............       +...+..+.+++.
T Consensus       181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  260 (295)
T 2clq_A          181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFIL  260 (295)
T ss_dssp             CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHH
T ss_pred             cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHH
Confidence            345688999999988443 24789999999999999999999999765443222111111       1223466788999


Q ss_pred             cccccccccccccC
Q 002321          922 RSCKGSSRQRRRFQ  935 (936)
Q Consensus       922 ~~l~~~p~~Rp~f~  935 (936)
                      +||..||.+||+++
T Consensus       261 ~~l~~dp~~Rps~~  274 (295)
T 2clq_A          261 KCFEPDPDKRACAN  274 (295)
T ss_dssp             HTTCSSTTTSCCHH
T ss_pred             HHccCChhhCCCHH
Confidence            99999999999863

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.2e-36  Score=329.70  Aligned_cols=240  Identities=23%  Similarity=0.377  Sum_probs=194.2

Q ss_pred             ccccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ....|+..+.||+|+||.||+|+.. +|+.||||++....   ..+.+.+|+.++++++||||+++++++......++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            3455778889999999999999986 48999999997543   3467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++++|.+++....  ..+++.++..++.|++.||+|||+.|++||||||+||+++.++.+||+|||.+.......  
T Consensus       104 e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--  179 (314)
T 3com_A          104 EYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--  179 (314)
T ss_dssp             ECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--
T ss_pred             ecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--
Confidence            9999999999987432  238999999999999999999999999999999999999999999999999997654321  


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-------HHhhhccccce
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-------EHWKKAEWRNV  919 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~~  919 (936)
                      .......+++.|+|||.+. ...++.++||||+|+++|||++|+.||...+...........       +...+..+.++
T Consensus       180 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  258 (314)
T 3com_A          180 AKRNTVIGTPFWMAPEVIQ-EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDF  258 (314)
T ss_dssp             SCBCCCCSCGGGCCHHHHS-SSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred             cccCccCCCCCccChhhcC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHH
Confidence            2233456889999999984 456899999999999999999999999876653322111100       12234667899


Q ss_pred             eecccccccccccccC
Q 002321          920 SMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       920 ~~~~l~~~p~~Rp~f~  935 (936)
                      +.+||..||.+||+++
T Consensus       259 i~~~l~~dp~~Rpt~~  274 (314)
T 3com_A          259 VKQCLVKSPEQRATAT  274 (314)
T ss_dssp             HHHHTCSCTTTSCCHH
T ss_pred             HHHHccCChhhCcCHH
Confidence            9999999999999863

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.4e-36  Score=345.38  Aligned_cols=237  Identities=22%  Similarity=0.245  Sum_probs=186.4

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeC------Ce
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ------SL  761 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  761 (936)
                      ...|+..+.||+|+||.||+|++. +|+.||||++....     ....+|++++++++||||+++++++...      ..
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            345788889999999999999986 58999999986442     2234799999999999999999998542      13


Q ss_pred             eEEEEEecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-CCeEEeeccCccc
Q 002321          762 QLLIYEFVSGGSLHKHLHEG-SGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS-GEPKVGDYGLARL  839 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~  839 (936)
                      .++||||+++ ++.+.+... .....+++..+..++.|+++||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus       128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~  206 (420)
T 1j1b_A          128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  206 (420)
T ss_dssp             EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence            5789999974 666655431 122348999999999999999999999999999999999999965 5789999999986


Q ss_pred             cCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-----------H
Q 002321          840 LPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-----------E  908 (936)
Q Consensus       840 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-----------~  908 (936)
                      .....   ......+|+.|+|||++.+...++.++||||+||++|||++|+.||...+..........           .
T Consensus       207 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~  283 (420)
T 1j1b_A          207 LVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  283 (420)
T ss_dssp             CCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             cccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            54322   223456799999999986666789999999999999999999999988654322211000           0


Q ss_pred             ----------------------HHhhhccccceeeccccccccccccc
Q 002321          909 ----------------------EHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       909 ----------------------~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                            +...+.++.+++.+||..||.+||+.
T Consensus       284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~  331 (420)
T 1j1b_A          284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP  331 (420)
T ss_dssp             HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCH
Confidence                                  01124567899999999999999974

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.7e-36  Score=352.00  Aligned_cols=237  Identities=22%  Similarity=0.301  Sum_probs=195.9

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc------------chHHHHHHHHHHHHcCCCCCcceeeeEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV------------KSQEDFEREVKKLGKVRHPNLVTLEGYY  756 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~l~~~~  756 (936)
                      ..|...++||+|+||+||+|+.+ +++.||||++......            ...+.+.+|+.++++++||||+++++++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  115 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF  115 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            45778889999999999999976 5789999999754322            2356789999999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---CeEEee
Q 002321          757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG---EPKVGD  833 (936)
Q Consensus       757 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~---~~kl~D  833 (936)
                      .+....++||||+++|+|.+++.....   +++..+..++.|++.||+|||++||+||||||+||+++.++   .+||+|
T Consensus       116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  192 (504)
T 3q5i_A          116 EDKKYFYLVTEFYEGGELFEQIINRHK---FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD  192 (504)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred             EcCCEEEEEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence            999999999999999999999876543   89999999999999999999999999999999999998876   699999


Q ss_pred             ccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH-------
Q 002321          834 YGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW-------  906 (936)
Q Consensus       834 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~-------  906 (936)
                      ||+++......   ......||+.|+|||++. . .++.++||||+||++|+|++|+.||.............       
T Consensus       193 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  267 (504)
T 3q5i_A          193 FGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-K-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD  267 (504)
T ss_dssp             CTTCEECCTTS---CBCCCCSCTTTCCHHHHT-T-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             CCCCEEcCCCC---ccccccCCcCCCCHHHhc-c-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            99998764322   234456899999999884 3 58999999999999999999999998876543322111       


Q ss_pred             -HHHHhhhccccceeeccccccccccccc
Q 002321          907 -LEEHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       907 -~~~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                       ......++.+++++.+||..||.+||+.
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~  296 (504)
T 3q5i_A          268 FNDWKNISDEAKELIKLMLTYDYNKRCTA  296 (504)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             ccccCCCCHHHHHHHHHHcCCChhHCCCH
Confidence             1112245778999999999999999985

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.1e-36  Score=336.21  Aligned_cols=239  Identities=23%  Similarity=0.372  Sum_probs=197.7

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-------chHHHHHHHHHHHHcC-CCCCcceeeeEEEeCC
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-------KSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQS  760 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  760 (936)
                      ..|+..+.||+|+||.||+|++. +|+.||||++......       ...+.+.+|+.+++++ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            34677789999999999999986 6999999998654321       1145678999999999 7999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCcccc
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL  840 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  840 (936)
                      ..++||||+++++|.+++.....   +++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++..+
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~---l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~  250 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVA---LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL  250 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence            99999999999999999986543   899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCccccccccccCcccccCcccccC-----cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH------HHH
Q 002321          841 PMLDRYVLSSKIQSALGYMAPEFACR-----TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW------LEE  909 (936)
Q Consensus       841 ~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~------~~~  909 (936)
                      ....   ......||+.|+|||++.+     ...++.++||||+||++|||++|+.||.............      ..+
T Consensus       251 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  327 (365)
T 2y7j_A          251 EPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP  327 (365)
T ss_dssp             CTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHH
T ss_pred             CCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence            4322   2244678999999998742     2357889999999999999999999998765532221110      011


Q ss_pred             H--hhhccccceeeccccccccccccc
Q 002321          910 H--WKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       910 ~--~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      .  ..+..+.+++.+||..||.+||++
T Consensus       328 ~~~~~~~~~~~li~~~L~~dP~~Rps~  354 (365)
T 2y7j_A          328 EWDDRSSTVKDLISRLLQVDPEARLTA  354 (365)
T ss_dssp             HHSSSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCH
Confidence            2  234568899999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=9.7e-37  Score=362.99  Aligned_cols=236  Identities=22%  Similarity=0.310  Sum_probs=190.3

Q ss_pred             CCcccccCceEEEEEEeC---CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          695 DCELGRGGFGAVYRTVLR---DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       695 ~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      .++||+|+||+||+|.+.   .++.||||+++..... ...+++.+|++++++++||||+++++++.. +..++||||++
T Consensus       374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~  452 (635)
T 4fl3_A          374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence            357999999999999754   4678999999765433 336789999999999999999999999965 45789999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc-cccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR-YVLS  849 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~  849 (936)
                      +|+|.+++.....   +++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+..... ....
T Consensus       453 ~g~L~~~l~~~~~---l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          453 LGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             TEEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCCHHHHHhhCCC---CCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            9999999976543   89999999999999999999999999999999999999999999999999987654322 2223


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH-----HHHhhhccccceeecc
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL-----EEHWKKAEWRNVSMRS  923 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~  923 (936)
                      ....+++.|+|||++ ....++.++|||||||++|||++ |+.||...+..........     .+...+..+.+++.+|
T Consensus       530 ~~~~~t~~y~APE~~-~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c  608 (635)
T 4fl3_A          530 THGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC  608 (635)
T ss_dssp             -----CGGGSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred             cCCCCceeeeChhhh-cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence            334567889999998 45578999999999999999998 9999988766433322111     1233456789999999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..||.+||+|+
T Consensus       609 l~~dP~~RPs~~  620 (635)
T 4fl3_A          609 WTYDVENRPGFA  620 (635)
T ss_dssp             TCSSTTTSCCHH
T ss_pred             cCCCHhHCcCHH
Confidence            999999999974

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.3e-36  Score=351.12  Aligned_cols=238  Identities=22%  Similarity=0.314  Sum_probs=197.0

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ...|+..++||+|+||+||+|+.+ +++.||||++..... ......+.+|++++++++||||+++++++.+....++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            455788889999999999999976 689999999864332 234678899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc---CCCCeEEeeccCccccCCC
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLID---GSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~  843 (936)
                      ||+++|+|.+++.....   +++.++..++.|++.||+|||++||+||||||+||+++   .++.+||+|||+++.....
T Consensus       101 e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             CCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             EcCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            99999999998876543   89999999999999999999999999999999999995   4568999999999866432


Q ss_pred             ccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH------H--Hhhhcc
Q 002321          844 DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE------E--HWKKAE  915 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~------~--~~~~~~  915 (936)
                      .   ......||+.|+|||++.+  .++.++||||+||++|+|++|+.||...............      +  ...++.
T Consensus       178 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  252 (486)
T 3mwu_A          178 T---KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD  252 (486)
T ss_dssp             -------CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred             C---ccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence            2   2234568999999999843  4899999999999999999999999887654332111100      1  123466


Q ss_pred             ccceeeccccccccccccc
Q 002321          916 WRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f  934 (936)
                      +++++.+||..||.+||+.
T Consensus       253 ~~~li~~~L~~dp~~R~t~  271 (486)
T 3mwu_A          253 AKDLIRKMLTFHPSLRITA  271 (486)
T ss_dssp             HHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHHHcCCChhhCcCH
Confidence            7899999999999999985

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.7e-36  Score=352.32  Aligned_cols=238  Identities=20%  Similarity=0.308  Sum_probs=199.5

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  765 (936)
                      ...|+..+.||+|+||.||+|+.. +|+.||||++.....  ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            345788889999999999999986 689999999965433  23467899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE---cCCCCeEEeeccCccccCC
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLI---DGSGEPKVGDYGLARLLPM  842 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~  842 (936)
                      |||+++|+|.+++.....   +++.++..++.|++.||+|||++||+||||||+||++   +.++.+||+|||+++....
T Consensus       105 ~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             ECCCCSCBHHHHHHTCSC---CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             EecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            999999999999876543   8999999999999999999999999999999999999   5678999999999987643


Q ss_pred             CccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH------HH--Hhhhc
Q 002321          843 LDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL------EE--HWKKA  914 (936)
Q Consensus       843 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~------~~--~~~~~  914 (936)
                      ..   ......||+.|+|||++.+  .++.++||||+||++|+|++|+.||..............      .+  ...++
T Consensus       182 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  256 (484)
T 3nyv_A          182 SK---KMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE  256 (484)
T ss_dssp             CC---SHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred             cc---ccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCH
Confidence            22   2234568999999998843  589999999999999999999999988766433221110      01  12346


Q ss_pred             cccceeeccccccccccccc
Q 002321          915 EWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       915 ~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      .+++++.+||..||.+||+.
T Consensus       257 ~~~~li~~~L~~dp~~R~s~  276 (484)
T 3nyv_A          257 SAKDLIRKMLTYVPSMRISA  276 (484)
T ss_dssp             HHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHCCCChhHCcCH
Confidence            67899999999999999985

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.8e-36  Score=331.73  Aligned_cols=240  Identities=22%  Similarity=0.298  Sum_probs=193.6

Q ss_pred             cccCC-CcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCC-CCCcceeeeEEEeCCeeEEEE
Q 002321          691 LLNKD-CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       691 ~~~~~-~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  766 (936)
                      .|... +.||+|+||.||+|+.. +++.||||+++..... .....+.+|+.++++++ ||||+++++++.+....++||
T Consensus        29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~  108 (327)
T 3lm5_A           29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL  108 (327)
T ss_dssp             HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence            34444 78999999999999977 5899999999754332 33678999999999995 699999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCCeEEeeccCccccCCC
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG---SGEPKVGDYGLARLLPML  843 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~  843 (936)
                      ||+++|+|.+++.... ...+++.++..++.|++.||+|||++||+||||||+||+++.   ++.+||+|||+++.....
T Consensus       109 e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  187 (327)
T 3lm5_A          109 EYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA  187 (327)
T ss_dssp             ECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred             EecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence            9999999999986543 234899999999999999999999999999999999999998   789999999999876432


Q ss_pred             ccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-H-----H--Hhhhcc
Q 002321          844 DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-E-----E--HWKKAE  915 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-~-----~--~~~~~~  915 (936)
                      .   ......+++.|+|||++ ....++.++||||+||++|||++|+.||...+.......... .     +  ...+..
T Consensus       188 ~---~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  263 (327)
T 3lm5_A          188 C---ELREIMGTPEYLAPEIL-NYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL  263 (327)
T ss_dssp             ---------CCCGGGCCHHHH-TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred             c---ccccccCCcCccCCeee-cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHH
Confidence            2   22345689999999988 455789999999999999999999999988765433221110 0     0  123356


Q ss_pred             ccceeecccccccccccccC
Q 002321          916 WRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +.+++.+||..||.+||+++
T Consensus       264 ~~~li~~~L~~dP~~Rpt~~  283 (327)
T 3lm5_A          264 ATDFIQSLLVKNPEKRPTAE  283 (327)
T ss_dssp             HHHHHHHHSCSSGGGSCCHH
T ss_pred             HHHHHHHHcCCChhhCcCHH
Confidence            78899999999999999863

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=4.1e-35  Score=331.12  Aligned_cols=283  Identities=15%  Similarity=0.118  Sum_probs=205.0

Q ss_pred             CCCCCCCCCCCccceeEEecCCCCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEcc
Q 002321           53 LSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLS  132 (936)
Q Consensus        53 l~sW~~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls  132 (936)
                      +++|....+|||.|.+..|.....++   +-..  ........-..+++++.|++++|.++...+..|.++++|++|+|+
T Consensus         3 ~~~~~~~~~C~~~~~~~~c~~~~~~i---~~~~--~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~   77 (390)
T 3o6n_A            3 VKPRQPEYKCIDSNLQYDCVFYDVHI---DMQT--QDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN   77 (390)
T ss_dssp             ----CCEECBCC------EEEESCEE---CSSC--CCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECT
T ss_pred             cCCCCCccceehhhhhhccceeeeee---eccc--ccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECC
Confidence            67899887855556555554211111   1111  111222233467899999999999996555568999999999999


Q ss_pred             CcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCC
Q 002321          133 GNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGE  212 (936)
Q Consensus       133 ~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  212 (936)
                      +|+++ .++...|..+++|++|+|++|++++..|..|+.+++|++|+|++|+++.+.+..|.++++|++|+|++|.+++.
T Consensus        78 ~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~  156 (390)
T 3o6n_A           78 DLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERI  156 (390)
T ss_dssp             TSCCC-EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBC
T ss_pred             CCccc-ccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCcc
Confidence            99998 67888899999999999999999998899999999999999999999987666789999999999999999988


Q ss_pred             CccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccC
Q 002321          213 IPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGEL  292 (936)
Q Consensus       213 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l  292 (936)
                      .+..+.++++|++|++++|++++.   .+..+++|++|++++|.+++     +.....|+.|++++|.++.. |..  ..
T Consensus       157 ~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~-~~~--~~  225 (390)
T 3o6n_A          157 EDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV-RGP--VN  225 (390)
T ss_dssp             CTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCEE-ECC--CC
T ss_pred             ChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccc-----cCCCCcceEEECCCCeeeec-ccc--cc
Confidence            888899999999999999999865   36778999999999998873     23334666777777766643 221  23


Q ss_pred             CccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCc
Q 002321          293 ESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMN  354 (936)
Q Consensus       293 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  354 (936)
                      ++|+.|++++|++++.  ..+..+++|++|+|++|.+++..|..|..+++|+.|++++|++.
T Consensus       226 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  285 (390)
T 3o6n_A          226 VELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV  285 (390)
T ss_dssp             SSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC
T ss_pred             ccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCc
Confidence            5666666666666643  34556666666666666666555666666666666666666554

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.8e-36  Score=328.40  Aligned_cols=237  Identities=23%  Similarity=0.316  Sum_probs=194.8

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|...+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            45677889999999999999976 689999999975432 2346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE---cCCCCeEEeeccCccccCCCcc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLI---DGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      +++++|.+++.....   +++.++..++.|++.||+|||+.||+||||||+||++   +.++.+||+|||+++.....  
T Consensus        88 ~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--  162 (304)
T 2jam_A           88 VSGGELFDRILERGV---YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--  162 (304)
T ss_dssp             CCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred             CCCccHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence            999999999876543   8999999999999999999999999999999999999   78899999999999754321  


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH------H--Hhhhcccc
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE------E--HWKKAEWR  917 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~------~--~~~~~~~~  917 (936)
                        ......+++.|+|||.+ ....++.++||||+||++|||++|+.||...............      +  ...+..+.
T Consensus       163 --~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  239 (304)
T 2jam_A          163 --IMSTACGTPGYVAPEVL-AQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK  239 (304)
T ss_dssp             --TTHHHHSCCCBCCTTTB-SSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred             --ccccccCCCCccChHHh-ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence              12334588999999988 4557899999999999999999999999876653322111000      0  12346788


Q ss_pred             ceeecccccccccccccC
Q 002321          918 NVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++.+||..||.+||+++
T Consensus       240 ~li~~~l~~dp~~Rps~~  257 (304)
T 2jam_A          240 DFICHLLEKDPNERYTCE  257 (304)
T ss_dssp             HHHHHHHCSSTTTSCCHH
T ss_pred             HHHHHHcCCChhHCcCHH
Confidence            999999999999999863

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.5e-36  Score=328.34  Aligned_cols=242  Identities=24%  Similarity=0.333  Sum_probs=182.2

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchH-HHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ..|+..+.||+|+||+||+|+.. +|+.||||+++........ +.+.++...++.++||||+++++++.+.+..++|||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e   86 (290)
T 3fme_A            7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME   86 (290)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred             HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence            45678889999999999999975 6899999999765433333 334455556888899999999999999999999999


Q ss_pred             ecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          768 FVSGGSLHKHLHEG-SGGNFLSWNERFNVIQGTAKSLAHLHQS-NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       768 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      |++ |+|.+++... .....+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++.....  
T Consensus        87 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  163 (290)
T 3fme_A           87 LMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD--  163 (290)
T ss_dssp             CCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred             hhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc--
Confidence            996 6888777542 1223499999999999999999999998 9999999999999999999999999999765432  


Q ss_pred             ccccccccCcccccCcccc---cCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHH-------Hhhhcc
Q 002321          846 YVLSSKIQSALGYMAPEFA---CRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE-------HWKKAE  915 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~---~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~-------~~~~~~  915 (936)
                       .......+++.|+|||.+   .....++.++||||+||++|||++|+.||................       ...+..
T Consensus       164 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (290)
T 3fme_A          164 -VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAE  242 (290)
T ss_dssp             -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHH
T ss_pred             -ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHH
Confidence             222334688999999986   345568999999999999999999999998754432222222221       123456


Q ss_pred             ccceeecccccccccccccC
Q 002321          916 WRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +.+++.+||..||.+||+++
T Consensus       243 ~~~li~~~l~~~p~~Rpt~~  262 (290)
T 3fme_A          243 FVDFTSQCLKKNSKERPTYP  262 (290)
T ss_dssp             HHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHhhcChhhCcCHH
Confidence            88899999999999999863

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.7e-36  Score=343.48  Aligned_cols=200  Identities=22%  Similarity=0.279  Sum_probs=166.2

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeC-----Cee
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ-----SLQ  762 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  762 (936)
                      ..|+..+.||+|+||.||+|++. +++.||||+++.... ....+++.+|++++++++||||+++++++...     ...
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            45778889999999999999976 588999999965422 23457889999999999999999999999766     568


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCC
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM  842 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  842 (936)
                      ++||||++ |+|.++++...   .+++..+..++.|+++||+|||+.||+||||||+|||++.++.+||+|||+|+....
T Consensus       106 ~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~  181 (432)
T 3n9x_A          106 YIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS  181 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred             EEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence            99999995 69999997653   389999999999999999999999999999999999999999999999999987643


Q ss_pred             Cccc--------------------cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCC
Q 002321          843 LDRY--------------------VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL  893 (936)
Q Consensus       843 ~~~~--------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf  893 (936)
                      ....                    .......+|+.|+|||++.....++.++||||+||++|||++|..||
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            2211                    12245678999999998766777999999999999999999854444

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.8e-36  Score=350.94  Aligned_cols=237  Identities=21%  Similarity=0.304  Sum_probs=193.2

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ..|+..++||+|+||+||+|+.+ +++.||||+++..... .....+.+|+.++++++||||+++++++.+....++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            45788889999999999999986 6889999999755432 335778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC---CCeEEeeccCccccCCCc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS---GEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~~  844 (936)
                      |+++|+|.+++.....   +++..+..++.|++.||+|||++||+||||||+||+++..   +.+||+|||+++......
T Consensus       117 ~~~~g~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~  193 (494)
T 3lij_A          117 CYKGGELFDEIIHRMK---FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK  193 (494)
T ss_dssp             CCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred             cCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence            9999999998876543   8999999999999999999999999999999999999764   459999999998764322


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH------HHH--hhhccc
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL------EEH--WKKAEW  916 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~------~~~--~~~~~~  916 (936)
                         ......||+.|+|||++.  ..++.++||||+||++|+|++|+.||..............      .+.  ..++.+
T Consensus       194 ---~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  268 (494)
T 3lij_A          194 ---KMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA  268 (494)
T ss_dssp             ---CBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHH
T ss_pred             ---cccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHH
Confidence               234456899999999883  3589999999999999999999999988766433321111      011  134567


Q ss_pred             cceeeccccccccccccc
Q 002321          917 RNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       917 ~~~~~~~l~~~p~~Rp~f  934 (936)
                      ++++.+||..||.+||+.
T Consensus       269 ~~li~~~L~~dp~~R~s~  286 (494)
T 3lij_A          269 KDLIKQMLQFDSQRRISA  286 (494)
T ss_dssp             HHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHHCCCChhhCccH
Confidence            889999999999999985

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.3e-36  Score=326.77  Aligned_cols=243  Identities=21%  Similarity=0.357  Sum_probs=195.8

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEe--CCeeEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWT--QSLQLLI  765 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  765 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||+|++...... ...+.+.+|++++++++||||+++++++.+  ....++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            34677789999999999999986 6899999999765433 345678999999999999999999998864  5678999


Q ss_pred             EEecCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          766 YEFVSGGSLHKHLHEGS-GGNFLSWNERFNVIQGTAKSLAHLHQSN-----IIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      |||+++++|.+++.... ....+++..+++++.|++.||+|||+.+     |+||||||+||+++.++.+||+|||.++.
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~  165 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  165 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence            99999999999997543 2234899999999999999999999999     99999999999999999999999999986


Q ss_pred             cCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-----HHhhhc
Q 002321          840 LPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-----EHWKKA  914 (936)
Q Consensus       840 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-----~~~~~~  914 (936)
                      ......  ......+++.|+|||.+. ...++.++||||+|+++|||++|+.||...+...........     +...+.
T Consensus       166 ~~~~~~--~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (279)
T 2w5a_A          166 LNHDTS--FAKTFVGTPYYMSPEQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD  242 (279)
T ss_dssp             C---CH--HHHHHHSCCTTCCHHHHH-CC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCH
T ss_pred             eccccc--cccccCCCccccChHHhc-cCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCH
Confidence            643221  122346788999999884 446899999999999999999999999887653322111000     112346


Q ss_pred             cccceeecccccccccccccC
Q 002321          915 EWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       915 ~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+.+++.+||..||.+||+++
T Consensus       243 ~l~~li~~~l~~~p~~Rps~~  263 (279)
T 2w5a_A          243 ELNEIITRMLNLKDYHRPSVE  263 (279)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHHcCCCcccCCCHH
Confidence            788999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.9e-36  Score=327.50  Aligned_cols=244  Identities=18%  Similarity=0.224  Sum_probs=194.5

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc---cchHHHHHHHHHHHHcCCCCCcceeeeEEE--eCCeeE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL---VKSQEDFEREVKKLGKVRHPNLVTLEGYYW--TQSLQL  763 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~  763 (936)
                      ..|+..+.||+|+||.||+|... +++.||||+++....   ....+.+.+|++++++++||||+++++++.  +....+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            35788899999999999999975 588999999965432   234578999999999999999999999985  445779


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      +||||++++ +.+++..... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.+......
T Consensus        85 lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  162 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF  162 (305)
T ss_dssp             EEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence            999999866 7777765432 34899999999999999999999999999999999999999999999999999876433


Q ss_pred             ccccccccccCcccccCcccccCc-ccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH----HHHhhhccccc
Q 002321          844 DRYVLSSKIQSALGYMAPEFACRT-VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL----EEHWKKAEWRN  918 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~  918 (936)
                      ..........+++.|+|||++.+. ..++.++||||+|+++|||++|+.||..............    .+...+..+.+
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~  242 (305)
T 2wtk_C          163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSD  242 (305)
T ss_dssp             CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHH
T ss_pred             ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHH
Confidence            333333455689999999988542 2347899999999999999999999988665332211100    01123456889


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..||.+||+++
T Consensus       243 li~~~l~~dp~~Rps~~  259 (305)
T 2wtk_C          243 LLKGMLEYEPAKRFSIR  259 (305)
T ss_dssp             HHHHHTCSSTTTSCCHH
T ss_pred             HHHHHccCChhhCCCHH
Confidence            99999999999999863

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.2e-36  Score=329.02  Aligned_cols=242  Identities=23%  Similarity=0.323  Sum_probs=193.8

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ...|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            445778889999999999999987 58899999986543 2346788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+++++|.+++.....  .+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.....  ...
T Consensus        97 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~  172 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--TLQ  172 (302)
T ss_dssp             CCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--HHH
T ss_pred             eCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc--ccc
Confidence            9999999998876432  389999999999999999999999999999999999999999999999998754321  111


Q ss_pred             ccccccCcccccCccccc----CcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-------HHHhhhccc
Q 002321          848 LSSKIQSALGYMAPEFAC----RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-------EEHWKKAEW  916 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~  916 (936)
                      ......+++.|+|||.+.    ....++.++||||+|+++|||++|+.||...+..........       .+...+..+
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  252 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEF  252 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHH
Confidence            223456889999999873    345688999999999999999999999988765432211110       012234567


Q ss_pred             cceeecccccccccccccC
Q 002321          917 RNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       917 ~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+++.+||..||.+||+++
T Consensus       253 ~~li~~~l~~dp~~Rps~~  271 (302)
T 2j7t_A          253 RDFLKIALDKNPETRPSAA  271 (302)
T ss_dssp             HHHHHHHSCSCTTTSCCHH
T ss_pred             HHHHHHHcccChhhCCCHH
Confidence            8999999999999999863

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6.8e-36  Score=324.45  Aligned_cols=239  Identities=23%  Similarity=0.331  Sum_probs=197.4

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--------cchHHHHHHHHHHHHcCC-CCCcceeeeEEEeC
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--------VKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQ  759 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  759 (936)
                      ..|+..+.||+|+||.||+|+.+ +|+.||||+++....        ....+.+.+|+++++++. ||||+++++++...
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (298)
T 1phk_A           17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   96 (298)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence            45677889999999999999986 589999999965431        122456889999999995 99999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          760 SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       760 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      ...++||||+++++|.+++.....   +++.++..++.|++.||+|||++|++||||||+||+++.++.+||+|||++..
T Consensus        97 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  173 (298)
T 1phk_A           97 TFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  173 (298)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             CeEEEEEeccCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence            999999999999999999987543   89999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCccccccccccCcccccCccccc-----CcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH------
Q 002321          840 LPMLDRYVLSSKIQSALGYMAPEFAC-----RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE------  908 (936)
Q Consensus       840 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~------  908 (936)
                      .....   ......+++.|+|||++.     ....++.++||||+|+++|||++|+.||...............      
T Consensus       174 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T 1phk_A          174 LDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS  250 (298)
T ss_dssp             CCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             cCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence            64322   223456889999999874     2345788999999999999999999999876654322111100      


Q ss_pred             H--Hhhhccccceeeccccccccccccc
Q 002321          909 E--HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       909 ~--~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      +  .-.+..+.+++.+||..||.+||++
T Consensus       251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~  278 (298)
T 1phk_A          251 PEWDDYSDTVKDLVSRFLVVQPQKRYTA  278 (298)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             ccccccCHHHHHHHHHHccCCcccCCCH
Confidence            1  1234568899999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.5e-36  Score=335.50  Aligned_cols=235  Identities=20%  Similarity=0.256  Sum_probs=176.5

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeC------Ce
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ------SL  761 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  761 (936)
                      ..|+..+.||+|+||.||+|.+. +|+.||||++..... ....+.+.+|++++++++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            45778889999999999999965 689999999965422 23456788999999999999999999999754      45


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .++||||+ +++|.+++...    .+++..+..++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus       109 ~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~  183 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA  183 (367)
T ss_dssp             CEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred             EEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence            69999999 78999988753    38999999999999999999999999999999999999999999999999998653


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH---------------
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW---------------  906 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~---------------  906 (936)
                      ..     .....+|+.|+|||++.+...++.++||||+||++|||++|+.||.+.+.........               
T Consensus       184 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~  258 (367)
T 2fst_X          184 DE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  258 (367)
T ss_dssp             ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred             cc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            21     2345688999999998665678999999999999999999999998876532221100               


Q ss_pred             -------HH-----------H--Hhhhccccceeeccccccccccccc
Q 002321          907 -------LE-----------E--HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       907 -------~~-----------~--~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                             ..           .  .-.++.+.+++.+||..||.+||+.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~  306 (367)
T 2fst_X          259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA  306 (367)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCH
Confidence                   00           0  0123557889999999999999985

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.4e-36  Score=338.73  Aligned_cols=236  Identities=22%  Similarity=0.243  Sum_probs=187.7

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeC---------
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ---------  759 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  759 (936)
                      ..|+..+.||+|+||.||+|+.. +|+.||||++.....     ...+|++++++++||||+++++++...         
T Consensus         7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~   81 (383)
T 3eb0_A            7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ   81 (383)
T ss_dssp             TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred             ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence            35677889999999999999975 689999999865432     234799999999999999999998543         


Q ss_pred             -----------------------------CeeEEEEEecCCCChhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 002321          760 -----------------------------SLQLLIYEFVSGGSLHKHLHEG-SGGNFLSWNERFNVIQGTAKSLAHLHQS  809 (936)
Q Consensus       760 -----------------------------~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~al~~LH~~  809 (936)
                                                   ...++||||++ |+|.+.+... .....+++..+..++.|+++||+|||+.
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  160 (383)
T 3eb0_A           82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL  160 (383)
T ss_dssp             ----------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence                                         33789999997 6887776531 1123489999999999999999999999


Q ss_pred             CcccCCCCCCCEEEc-CCCCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc
Q 002321          810 NIIHYNIKSSNVLID-GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT  888 (936)
Q Consensus       810 ~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~  888 (936)
                      ||+||||||+||+++ .++.+||+|||+|+......   ......+++.|+|||.+.+...++.++||||+||++|||++
T Consensus       161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  237 (383)
T 3eb0_A          161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL  237 (383)
T ss_dssp             TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred             cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence            999999999999998 68899999999998664322   22345678899999988666678999999999999999999


Q ss_pred             CCCCCCccchhHHHHHHHH---------------------------------HHHhhhccccceeeccccccccccccc
Q 002321          889 GKRPLSTWKMMWWFSVTWL---------------------------------EEHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       889 g~~Pf~~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      |+.||...+..........                                 .+...+..+.+++.+||..||.+||+.
T Consensus       238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  316 (383)
T 3eb0_A          238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP  316 (383)
T ss_dssp             SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence            9999988765322211100                                 011134557899999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.3e-36  Score=331.89  Aligned_cols=240  Identities=20%  Similarity=0.304  Sum_probs=190.9

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-------chHHHHHHHHHHHHcCCCCCcceeeeEEEeCC
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-------KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS  760 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  760 (936)
                      ...|+..+.||+|+||.||+|+.. +++.||||++......       .....+.+|++++++++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            345788889999999999999976 5889999998654321       12345889999999999999999999987655


Q ss_pred             eeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCC---eEEeeccCc
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGE---PKVGDYGLA  837 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a  837 (936)
                       .++||||+++++|.+++....   .+++.++..++.|++.||+|||++||+||||||+||+++.++.   +||+|||++
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             -eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence             799999999999999987643   3899999999999999999999999999999999999987664   999999999


Q ss_pred             cccCCCccccccccccCcccccCccccc--CcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH--HHHH-----HH
Q 002321          838 RLLPMLDRYVLSSKIQSALGYMAPEFAC--RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF--SVTW-----LE  908 (936)
Q Consensus       838 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~--~~~~-----~~  908 (936)
                      +......   ......+++.|+|||++.  ....++.++||||+||++|||++|+.||.........  ....     .+
T Consensus       165 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (322)
T 2ycf_A          165 KILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP  241 (322)
T ss_dssp             EECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCH
T ss_pred             eeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCc
Confidence            8764321   123456889999999863  3456889999999999999999999999765432111  1110     01


Q ss_pred             --HHhhhccccceeecccccccccccccC
Q 002321          909 --EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 --~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                        ....++.+.+++.+||..||.+||+++
T Consensus       242 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~  270 (322)
T 2ycf_A          242 EVWAEVSEKALDLVKKLLVVDPKARFTTE  270 (322)
T ss_dssp             HHHTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             hhhhhcCHHHHHHHHHHcccCHhhCCCHH
Confidence              122456788999999999999999863

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.4e-36  Score=334.41  Aligned_cols=243  Identities=25%  Similarity=0.356  Sum_probs=196.9

Q ss_pred             cccccCCCcccccCceEEEEEEe-----CCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEE--eCCe
Q 002321          689 HALLNKDCELGRGGFGAVYRTVL-----RDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW--TQSL  761 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~  761 (936)
                      ...|+..+.||+|+||.||+|++     .+++.||||++.... ....+.+.+|++++++++||||+++++++.  +...
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            34577888999999999999984     358899999996543 234567999999999999999999999987  4456


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .++||||+++++|.+++.....  .+++.+++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            7899999999999999976432  38999999999999999999999999999999999999999999999999998765


Q ss_pred             CCcc-ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHH-------------HHHH
Q 002321          842 MLDR-YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS-------------VTWL  907 (936)
Q Consensus       842 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~-------------~~~~  907 (936)
                      .... ........+++.|+|||.+ .+..++.++||||+||++|||++|+.||..........             ....
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESL-SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL  257 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHh-ccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence            3332 2233445678889999988 44568999999999999999999999997654421110             0000


Q ss_pred             H-------HHhhhccccceeecccccccccccccC
Q 002321          908 E-------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       908 ~-------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .       +...++.+.+++.+||..||.+||+++
T Consensus       258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~  292 (327)
T 3lxl_A          258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFS  292 (327)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHH
Confidence            0       112346688999999999999999864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.1e-36  Score=336.36  Aligned_cols=240  Identities=20%  Similarity=0.272  Sum_probs=197.1

Q ss_pred             ccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccc----------------hHHHHHHHHHHHHcCCCCCcceee
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVK----------------SQEDFEREVKKLGKVRHPNLVTLE  753 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~E~~~l~~l~h~niv~l~  753 (936)
                      ..|+..+.||+|+||.||+|+. +++.||||++.......                ..+.+.+|++++++++||||++++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            4577888999999999999999 89999999996543221                127899999999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCChhhh------hhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCC
Q 002321          754 GYYWTQSLQLLIYEFVSGGSLHKH------LHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ-SNIIHYNIKSSNVLIDGS  826 (936)
Q Consensus       754 ~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~ivH~Dlkp~NIll~~~  826 (936)
                      +++.+.+..++||||+++|+|.++      +.... ...+++..+..++.|++.||+|||+ .||+||||||+||+++.+
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN  188 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence            999999999999999999999998      55422 2459999999999999999999999 999999999999999999


Q ss_pred             CCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCc-hhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH
Q 002321          827 GEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD-KCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT  905 (936)
Q Consensus       827 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~  905 (936)
                      +.+||+|||.+......    ......+++.|+|||.+.+...++. ++||||+||++|||++|+.||............
T Consensus       189 ~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  264 (348)
T 2pml_X          189 GRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN  264 (348)
T ss_dssp             SCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred             CcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence            99999999999865432    2344568899999999865535555 999999999999999999999876542111111


Q ss_pred             HHH------------------------HHhhhccccceeecccccccccccccC
Q 002321          906 WLE------------------------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       906 ~~~------------------------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ...                        ....+..+.+++.+||..||.+||+++
T Consensus       265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~  318 (348)
T 2pml_X          265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE  318 (348)
T ss_dssp             HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHH
Confidence            000                        023456778999999999999999863

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2e-36  Score=336.74  Aligned_cols=238  Identities=14%  Similarity=0.151  Sum_probs=191.4

Q ss_pred             cccccCCCcccccCceEEEEEEeCC---------CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcce--------
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRD---------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT--------  751 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------  751 (936)
                      ...|+..+.||+|+||.||+|+...         ++.||||++...      +.+.+|++++++++||||++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            3457888899999999999999763         789999998643      45789999999999999887        


Q ss_pred             -------eeeEEEe-CCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE
Q 002321          752 -------LEGYYWT-QSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLI  823 (936)
Q Consensus       752 -------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll  823 (936)
                             +++++.. ....++||||+ +++|.+++.... ...+++.+++.++.|++.||+|||++||+||||||+||++
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV  192 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence                   6777776 67889999999 999999998652 1239999999999999999999999999999999999999


Q ss_pred             cCCC--CeEEeeccCccccCCCccc-----cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCcc
Q 002321          824 DGSG--EPKVGDYGLARLLPMLDRY-----VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTW  896 (936)
Q Consensus       824 ~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~  896 (936)
                      +.++  .+||+|||+++.+......     .......+++.|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK-GCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            9998  9999999999876432211     1123447899999999884 457899999999999999999999999876


Q ss_pred             chh--HHHHHH-HHHHH------------hhhccccceeecccccccccccccC
Q 002321          897 KMM--WWFSVT-WLEEH------------WKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       897 ~~~--~~~~~~-~~~~~------------~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ...  ...... .....            ..++.+.+++.+||..||.+||+++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  325 (352)
T 2jii_A          272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYA  325 (352)
T ss_dssp             TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred             CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHH
Confidence            421  111111 11111            1257788999999999999999874

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.7e-36  Score=333.49  Aligned_cols=240  Identities=23%  Similarity=0.266  Sum_probs=193.8

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeC-----CeeE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ-----SLQL  763 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  763 (936)
                      ..|+..+.||+|+||.||+|+.. +|+.||||++...........+.+|++++++++||||+++++++...     ...+
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            34677789999999999999976 58999999996554444467788999999999999999999998654     5679


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      +||||++ |+|.+++....    +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus        91 lv~e~~~-~~L~~~~~~~~----~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (353)
T 2b9h_A           91 IIQELMQ-TDLHRVISTQM----LSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES  165 (353)
T ss_dssp             EEECCCS-EEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEEeccC-ccHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence            9999996 69999987632    899999999999999999999999999999999999999999999999999876432


Q ss_pred             cccc--------ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH----------
Q 002321          844 DRYV--------LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT----------  905 (936)
Q Consensus       844 ~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~----------  905 (936)
                      ....        ......+++.|+|||++.....++.++||||+||++|||++|+.||...+........          
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T 2b9h_A          166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD  245 (353)
T ss_dssp             --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred             cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence            2111        1123467899999998766667899999999999999999999999887643221110          


Q ss_pred             -------------HHH-------------HHhhhccccceeeccccccccccccc
Q 002321          906 -------------WLE-------------EHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       906 -------------~~~-------------~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                   +..             ....+..+.+++.+||..||.+||+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  300 (353)
T 2b9h_A          246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA  300 (353)
T ss_dssp             TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCH
Confidence                         000             01234567789999999999999985

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-36  Score=329.31  Aligned_cols=237  Identities=21%  Similarity=0.267  Sum_probs=184.6

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcC--CCCCcceeeeEEEeC----Cee
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV--RHPNLVTLEGYYWTQ----SLQ  762 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~~~  762 (936)
                      ...|+..+.||+|+||.||+|+.. ++.||||++...    ......+|.+++...  +||||+++++++...    ...
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            346788889999999999999986 899999998543    234455566666555  899999999999887    678


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCCEEEcCCCCeEEeec
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS--------NIIHYNIKSSNVLIDGSGEPKVGDY  834 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~--------~ivH~Dlkp~NIll~~~~~~kl~Df  834 (936)
                      ++||||+++|+|.++++...    +++..++.++.|++.||+|||++        +|+||||||+||+++.++.+||+||
T Consensus       111 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  186 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL  186 (337)
T ss_dssp             EEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEeccCCCcHHHHhhccC----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence            99999999999999997643    89999999999999999999998        9999999999999999999999999


Q ss_pred             cCccccCCCccc--cccccccCcccccCcccccCcccCCc------hhhHHHHHHHHHHHHcC----------CCCCCcc
Q 002321          835 GLARLLPMLDRY--VLSSKIQSALGYMAPEFACRTVKITD------KCDVYGFGVLVLEVVTG----------KRPLSTW  896 (936)
Q Consensus       835 g~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~------~~DvwSlG~~l~el~~g----------~~Pf~~~  896 (936)
                      |+++........  .......||+.|+|||++.+. .++.      ++||||+||++|||++|          +.||...
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhcccc-cCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            999766432221  112345789999999988544 3333      49999999999999999          7777654


Q ss_pred             chhHHHHHHHHH----------------HHhhhccccceeecccccccccccccC
Q 002321          897 KMMWWFSVTWLE----------------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       897 ~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ............                +.-..+.+.+++.+||..||.+||+++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~  320 (337)
T 3mdy_A          266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL  320 (337)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             cCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHH
Confidence            321111000000                012234578899999999999999864

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=6.6e-36  Score=324.20  Aligned_cols=239  Identities=16%  Similarity=0.177  Sum_probs=189.7

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEE-EeCCeeEEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY-WTQSLQLLIYE  767 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e  767 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||||++.....   .+.+.+|++++++++|++++..+.++ ......++|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence            45778889999999999999974 689999998755432   24578899999999988877766665 56778899999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE---cCCCCeEEeeccCccccCCCc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLI---DGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      |+ +++|.+++.....  .+++.++..++.|++.||+|||+++|+||||||+||++   +.++.+||+|||+++......
T Consensus        86 ~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  162 (296)
T 4hgt_A           86 LL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             CC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             cc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence            99 9999999975432  38999999999999999999999999999999999999   789999999999998764432


Q ss_pred             cc-----cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchh----HHHHH---HHHH--H-
Q 002321          845 RY-----VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM----WWFSV---TWLE--E-  909 (936)
Q Consensus       845 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~----~~~~~---~~~~--~-  909 (936)
                      ..     .......+++.|+|||.+. +..++.++||||+||++|||++|+.||...+..    .....   ....  + 
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T 4hgt_A          163 THQHIPYRENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  241 (296)
T ss_dssp             TCCBCCCCCSCCCCSCGGGCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred             cCccCCCCcccccCCCccccchHHhc-CCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence            21     1233567899999999984 456899999999999999999999999874321    11111   1111  1 


Q ss_pred             --HhhhccccceeecccccccccccccC
Q 002321          910 --HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       910 --~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                        ...++.+.+++.+||..||.+||+++
T Consensus       242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~  269 (296)
T 4hgt_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYS  269 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHH
T ss_pred             hhccCCHHHHHHHHHHHhcCCCCCCCHH
Confidence              12257889999999999999999874

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=7.7e-36  Score=334.18  Aligned_cols=235  Identities=20%  Similarity=0.246  Sum_probs=183.3

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCC------e
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS------L  761 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  761 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||||++...... ...+.+.+|+.+++.++||||+++++++....      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            45778889999999999999976 5889999999754322 33567889999999999999999999997654      6


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .++||||++ |+|.+++..     .+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus       105 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          105 VYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             EEEEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             eEEEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence            799999996 578888753     28899999999999999999999999999999999999999999999999998653


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH---------------
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW---------------  906 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~---------------  906 (936)
                      ..   .......+|+.|+|||++. +..++.++||||+||++|||++|+.||...+.........               
T Consensus       179 ~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          179 TS---FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             --------------CTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             cc---cccCCceecCCccCHHHhc-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            21   1223456889999999985 4578999999999999999999999998765432211100               


Q ss_pred             ------HH-------------------------HHhhhccccceeeccccccccccccc
Q 002321          907 ------LE-------------------------EHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       907 ------~~-------------------------~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                            ..                         ....+..+++++.+||..||.+||+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~  313 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV  313 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCH
Confidence                  00                         01113567899999999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.5e-36  Score=338.58  Aligned_cols=202  Identities=21%  Similarity=0.395  Sum_probs=155.9

Q ss_pred             ccC-CCcccccCceEEEEEEeC---CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEe--CCeeEEE
Q 002321          692 LNK-DCELGRGGFGAVYRTVLR---DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWT--QSLQLLI  765 (936)
Q Consensus       692 ~~~-~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  765 (936)
                      |+. +++||+|+||+||+|+.+   +++.||||++.....   ...+.+|+.++++++||||+++++++..  ....++|
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            444 568999999999999976   478999999965432   3568899999999999999999999965  6688999


Q ss_pred             EEecCCCChhhhhhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE----cCCCCeEEeecc
Q 002321          766 YEFVSGGSLHKHLHEGS------GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLI----DGSGEPKVGDYG  835 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg  835 (936)
                      |||++ |+|.+++....      ....+++..+..++.|++.||+|||++||+||||||+|||+    +.++.+||+|||
T Consensus        99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  177 (405)
T 3rgf_A           99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  177 (405)
T ss_dssp             EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred             EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence            99995 68888775321      11248999999999999999999999999999999999999    678899999999


Q ss_pred             CccccCCCcc-ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccc
Q 002321          836 LARLLPMLDR-YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWK  897 (936)
Q Consensus       836 ~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~  897 (936)
                      +++....... ........+|+.|+|||++.+...++.++||||+||++|||++|+.||....
T Consensus       178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            9987643211 1223446789999999998666678999999999999999999999997543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6e-36  Score=334.45  Aligned_cols=239  Identities=18%  Similarity=0.204  Sum_probs=186.2

Q ss_pred             ccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCcc----------chHHHHHHHHHHHHcCCCCCcceeeeEEEeC
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV----------KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ  759 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  759 (936)
                      ..|+..+.||+|+||.||+|...+|+.||||++......          ...+.+.+|++++++++||||+++++++...
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  101 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF  101 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred             cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence            456778899999999999999888999999998543221          1137789999999999999999999998543


Q ss_pred             -----CeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeec
Q 002321          760 -----SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDY  834 (936)
Q Consensus       760 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df  834 (936)
                           ...++||||++ |+|.+++....  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+||
T Consensus       102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df  178 (362)
T 3pg1_A          102 EEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF  178 (362)
T ss_dssp             CTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred             cCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence                 35799999997 78888887543  24899999999999999999999999999999999999999999999999


Q ss_pred             cCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-------
Q 002321          835 GLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-------  907 (936)
Q Consensus       835 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-------  907 (936)
                      |+++.....   .......+++.|+|||++.+...++.++||||+||++|||++|+.||..............       
T Consensus       179 g~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          179 NLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             TC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             Ccccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            999754322   2234456888999999886656789999999999999999999999988654322211100       


Q ss_pred             -----------------------------HHHhhhccccceeeccccccccccccc
Q 002321          908 -----------------------------EEHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       908 -----------------------------~~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                                   .....++.+.+++.+||..||.+||+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  311 (362)
T 3pg1_A          256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST  311 (362)
T ss_dssp             HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH
Confidence                                         001123457789999999999999985

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.4e-36  Score=326.21  Aligned_cols=236  Identities=23%  Similarity=0.312  Sum_probs=187.4

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeC-CeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ-SLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e  767 (936)
                      ...|+..+.||+|+||.||+|+.. |+.||||+++...   ..+.+.+|++++++++||||+++++++.+. +..++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            345788889999999999999885 8899999986542   457789999999999999999999997654 46899999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+++++|.+++..... ..+++..+.+++.|+++||+|||++|++||||||+||+++.++.+||+|||+++.....    
T Consensus        96 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----  170 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  170 (278)
T ss_dssp             CCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             cCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc----
Confidence            9999999999976431 23788999999999999999999999999999999999999999999999999755322    


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceee
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSM  921 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~  921 (936)
                       .....+++.|+|||.+ ....++.++||||+|+++|||++ |+.||.............     ..+...++.+.+++.
T Consensus       171 -~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  248 (278)
T 1byg_A          171 -QDTGKLPVKWTAPEAL-REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK  248 (278)
T ss_dssp             ------CCTTTSCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHH
T ss_pred             -ccCCCccccccCHHHh-CCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHH
Confidence             1233567889999988 45578999999999999999998 999998765533221110     011233467889999


Q ss_pred             cccccccccccccC
Q 002321          922 RSCKGSSRQRRRFQ  935 (936)
Q Consensus       922 ~~l~~~p~~Rp~f~  935 (936)
                      +||..||.+||+++
T Consensus       249 ~~l~~~p~~Rps~~  262 (278)
T 1byg_A          249 NCWHLDAAMRPSFL  262 (278)
T ss_dssp             HHTCSSGGGSCCHH
T ss_pred             HHhcCChhhCCCHH
Confidence            99999999999863

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=7.7e-36  Score=323.65  Aligned_cols=239  Identities=16%  Similarity=0.171  Sum_probs=191.7

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEE-EeCCeeEEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY-WTQSLQLLIYE  767 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e  767 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||||++.....   .+.+.+|+.++++++|++++..+.++ ......++|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            45677889999999999999974 689999999865532   34688999999999988877666655 56677899999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE---cCCCCeEEeeccCccccCCCc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLI---DGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      |+ +++|.+++.....  .+++.++..++.|++.||+|||+++|+||||||+||++   +.++.+||+|||+++......
T Consensus        86 ~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             ec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence            99 9999999975432  38999999999999999999999999999999999999   488999999999998765432


Q ss_pred             cc-----cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchh----HHH---HHHHHH--H-
Q 002321          845 RY-----VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM----WWF---SVTWLE--E-  909 (936)
Q Consensus       845 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~----~~~---~~~~~~--~-  909 (936)
                      ..     .......+++.|+|||.+. +..++.++||||+||++|||++|+.||...+..    ...   ......  + 
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  241 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred             cccccccccccccccccccCChhhhc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence            21     1234567899999999984 456899999999999999999999999874321    111   111111  1 


Q ss_pred             --HhhhccccceeecccccccccccccC
Q 002321          910 --HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       910 --~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                        ...++.+.+++.+||..||.+||+++
T Consensus       242 ~~~~~~~~l~~li~~~l~~dp~~Rps~~  269 (296)
T 3uzp_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYS  269 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHH
T ss_pred             HHhhCCHHHHHHHHHHHhcCcCcCCCHH
Confidence              22357789999999999999999874

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.8e-36  Score=326.68  Aligned_cols=240  Identities=22%  Similarity=0.238  Sum_probs=186.7

Q ss_pred             ccccCCCcccccCceEEEEEEeCC-CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEE-----------
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYW-----------  757 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----------  757 (936)
                      ..|+..+.||+|+||.||+|+... ++.||||++.... ....+.+.+|++++++++||||+++++++.           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            346778899999999999999874 8999999987543 234577899999999999999999999874           


Q ss_pred             ---eCCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc-CCCCeEEee
Q 002321          758 ---TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGD  833 (936)
Q Consensus       758 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~-~~~~~kl~D  833 (936)
                         +....++||||++ |+|.+++...    .+++..+..++.|++.||+|||++||+||||||+||+++ +++.+||+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence               3457799999997 6999998653    289999999999999999999999999999999999997 567999999


Q ss_pred             ccCccccCCCcc-ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH----
Q 002321          834 YGLARLLPMLDR-YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE----  908 (936)
Q Consensus       834 fg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~----  908 (936)
                      ||+++....... ........+++.|+|||.+.....++.++||||+||++|||++|+.||...+...........    
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV  244 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999986542211 112233456888999998866567899999999999999999999999887653222110000    


Q ss_pred             ------------------------------HHhhhccccceeecccccccccccccC
Q 002321          909 ------------------------------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 ------------------------------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                                                    ....+..+.+++.+||..||.+||+.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  301 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAE  301 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred             chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHH
Confidence                                          011356788999999999999999863

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.9e-36  Score=327.32  Aligned_cols=241  Identities=20%  Similarity=0.295  Sum_probs=190.2

Q ss_pred             ccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCC--CCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVR--HPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||.||+|+..+++.||||++...... ...+.+.+|++++++++  |+||+++++++......++||
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  107 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  107 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred             ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence            457888899999999999999988999999999755432 34577899999999997  599999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      | +.+++|.+++....   .+++.++..++.|+++||+|||+++|+||||||+||+++ ++.+||+|||+++........
T Consensus       108 e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~  182 (313)
T 3cek_A          108 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  182 (313)
T ss_dssp             C-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-------
T ss_pred             e-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcccc
Confidence            9 45899999998754   389999999999999999999999999999999999997 489999999999876443333


Q ss_pred             cccccccCcccccCcccccC----------cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-------H
Q 002321          847 VLSSKIQSALGYMAPEFACR----------TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-------E  909 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~----------~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-------~  909 (936)
                      .......+++.|+|||.+..          ...++.++||||+||++|||++|+.||...............       +
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  262 (313)
T 3cek_A          183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP  262 (313)
T ss_dssp             -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred             ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCc
Confidence            23345568999999998843          136788999999999999999999999875432222111111       1


Q ss_pred             HhhhccccceeecccccccccccccC
Q 002321          910 HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       910 ~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ...+..+.+++.+||..||.+||+++
T Consensus       263 ~~~~~~l~~li~~~l~~dp~~Rps~~  288 (313)
T 3cek_A          263 DIPEKDLQDVLKCCLKRDPKQRISIP  288 (313)
T ss_dssp             CCSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             ccchHHHHHHHHHHccCCcccCcCHH
Confidence            22245688999999999999999863

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.2e-36  Score=333.22  Aligned_cols=245  Identities=21%  Similarity=0.309  Sum_probs=177.7

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-CCCcceeeeEEE--------e
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGYYW--------T  758 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~  758 (936)
                      ...|+..++||+|+||.||+|++. +++.||||++.... ....+.+.+|+.+++++. ||||+++++++.        .
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            345788889999999999999975 68999999985543 234567899999999996 999999999994        2


Q ss_pred             CCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEcCCCCeEEeeccC
Q 002321          759 QSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN--IIHYNIKSSNVLIDGSGEPKVGDYGL  836 (936)
Q Consensus       759 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~  836 (936)
                      ....++||||++ |+|.+++........+++.+++.++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||+
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  184 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS  184 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence            345789999995 799998876433345999999999999999999999999  99999999999999999999999999


Q ss_pred             ccccCCCcccc----------ccccccCcccccCccccc--CcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH
Q 002321          837 ARLLPMLDRYV----------LSSKIQSALGYMAPEFAC--RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV  904 (936)
Q Consensus       837 a~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~  904 (936)
                      ++.........          ......+++.|+|||++.  ....++.++||||+||++|||++|+.||...........
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~  264 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG  264 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence            98764322211          111345888999999873  344678999999999999999999999987655322211


Q ss_pred             HH--HHHHhhhccccceeecccccccccccccC
Q 002321          905 TW--LEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       905 ~~--~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..  ..+......+.+++.+||..||.+||+++
T Consensus       265 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  297 (337)
T 3ll6_A          265 KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIA  297 (337)
T ss_dssp             -CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHH
T ss_pred             cccCCcccccchHHHHHHHHHccCChhhCcCHH
Confidence            11  11222336688999999999999999863

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.8e-36  Score=328.44  Aligned_cols=242  Identities=24%  Similarity=0.337  Sum_probs=190.6

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEe------CC
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWT------QS  760 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~  760 (936)
                      ...|+..+.||+|+||.||+|++. +++.||||++....  ...+.+.+|+.+++++ +||||+++++++..      ..
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~  100 (326)
T 2x7f_A           23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD  100 (326)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence            345778889999999999999975 68999999986543  2357789999999999 79999999999987      45


Q ss_pred             eeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCcccc
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL  840 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  840 (936)
                      ..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++...
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  179 (326)
T 2x7f_A          101 QLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  179 (326)
T ss_dssp             EEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred             eEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence            7899999999999999998643 224889999999999999999999999999999999999999999999999999765


Q ss_pred             CCCccccccccccCcccccCcccccC----cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH------HH
Q 002321          841 PMLDRYVLSSKIQSALGYMAPEFACR----TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE------EH  910 (936)
Q Consensus       841 ~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~------~~  910 (936)
                      ....  .......+++.|+|||++..    ...++.++||||+||++|||++|+.||...............      ..
T Consensus       180 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  257 (326)
T 2x7f_A          180 DRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK  257 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCS
T ss_pred             CcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCcc
Confidence            4221  12234568899999998842    346889999999999999999999999876654322111100      01


Q ss_pred             hhhccccceeecccccccccccccC
Q 002321          911 WKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       911 ~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..+..+.+++.+||..||.+||+++
T Consensus       258 ~~~~~l~~li~~~l~~dp~~Rps~~  282 (326)
T 2x7f_A          258 KWSKKFQSFIESCLVKNHSQRPATE  282 (326)
T ss_dssp             CSCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             ccCHHHHHHHHHHhccChhhCCCHH
Confidence            1246688999999999999999863

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.3e-35  Score=332.44  Aligned_cols=234  Identities=20%  Similarity=0.247  Sum_probs=189.6

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCee-----
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQ-----  762 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----  762 (936)
                      ..|...+.||+|+||.||+|++. +|+.||||++...... ...+.+.+|+.++++++||||+++++++......     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            45677889999999999999976 5899999999754332 2357788999999999999999999999876654     


Q ss_pred             -EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          763 -LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       763 -~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                       ++||||++ ++|.+++..     .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus       122 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  195 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD  195 (371)
T ss_dssp             CEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred             EEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence             99999996 788887743     28999999999999999999999999999999999999999999999999998653


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH--------------
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL--------------  907 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~--------------  907 (936)
                      ..     .....+|+.|+|||++.+...++.++||||+||++|||++|+.||...+..........              
T Consensus       196 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  270 (371)
T 4exu_A          196 AE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  270 (371)
T ss_dssp             ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred             cC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence            21     23456789999999986656789999999999999999999999988654322211100              


Q ss_pred             --------H-------------HHhhhccccceeeccccccccccccc
Q 002321          908 --------E-------------EHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       908 --------~-------------~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                              .             ....++.+.+++.+||..||.+||+.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  318 (371)
T 4exu_A          271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA  318 (371)
T ss_dssp             CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCH
Confidence                    0             01124678899999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.3e-35  Score=338.22  Aligned_cols=200  Identities=20%  Similarity=0.231  Sum_probs=171.1

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcC------CCCCcceeeeEEEeCCee
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV------RHPNLVTLEGYYWTQSLQ  762 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~  762 (936)
                      ..|+..+.||+|+||+||+|+.. +++.||||+++...  .....+.+|+++++.+      +|+||+++++++......
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            34778889999999999999876 48999999996542  3346678888888877      577999999999999999


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCC--eEEeeccCcccc
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGE--PKVGDYGLARLL  840 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~  840 (936)
                      ++||||+. ++|.+++...... .+++..+.+++.|++.||+|||+++|+||||||+|||++.++.  +||+|||+++..
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~  252 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQ-GFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE  252 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EEEEeccC-CCHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence            99999995 7999998875432 3899999999999999999999999999999999999999987  999999999764


Q ss_pred             CCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchh
Q 002321          841 PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM  899 (936)
Q Consensus       841 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~  899 (936)
                      ...     .....+|+.|+|||++. +..++.++||||+||++|||++|+.||...+..
T Consensus       253 ~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~  305 (429)
T 3kvw_A          253 HQR-----VYTYIQSRFYRAPEVIL-GARYGMPIDMWSLGCILAELLTGYPLLPGEDEG  305 (429)
T ss_dssp             TCC-----CCSSCSCGGGCCHHHHH-TBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             CCc-----ccccCCCCCccChHHHh-CCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence            321     23456889999999985 446899999999999999999999999887653

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.2e-37  Score=343.95  Aligned_cols=237  Identities=14%  Similarity=0.045  Sum_probs=174.3

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcC--CCCCcceee-------eEEEe
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKV--RHPNLVTLE-------GYYWT  758 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~~  758 (936)
                      .|+..+.||+|+||.||+|++. +|+.||||++......  ...+.+.+|+.+++.+  +||||++++       +++..
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~  142 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV  142 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence            3677889999999999999976 6899999999775432  3356677885444444  799988754       45543


Q ss_pred             C-----------------CeeEEEEEecCCCChhhhhhccCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCcccCC
Q 002321          759 Q-----------------SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNER------FNVIQGTAKSLAHLHQSNIIHYN  815 (936)
Q Consensus       759 ~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~------~~i~~~i~~al~~LH~~~ivH~D  815 (936)
                      .                 ...++||||++ |+|.+++.....  .+.+..+      ..++.|+++||+|||++||+|||
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            3                 23699999998 899999986422  1344445      67889999999999999999999


Q ss_pred             CCCCCEEEcCCCCeEEeeccCccccCCCccccccccccCcccccCcccccC-cccCCchhhHHHHHHHHHHHHcCCCCCC
Q 002321          816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR-TVKITDKCDVYGFGVLVLEVVTGKRPLS  894 (936)
Q Consensus       816 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwSlG~~l~el~~g~~Pf~  894 (936)
                      |||+|||++.++.+||+|||+++......     ....+++.|+|||++.+ ...++.++||||+||++|||++|+.||.
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999998654211     13445689999999853 1578999999999999999999999998


Q ss_pred             ccchhHHH-------------HHHHHHHHhhhccccceeecccccccccccccC
Q 002321          895 TWKMMWWF-------------SVTWLEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       895 ~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ........             ...+......++.+.+++.+||..||.+||+++
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  348 (371)
T 3q60_A          295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL  348 (371)
T ss_dssp             BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHH
T ss_pred             CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHH
Confidence            76321100             000001123457788999999999999999863

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1e-35  Score=324.64  Aligned_cols=259  Identities=32%  Similarity=0.523  Sum_probs=218.8

Q ss_pred             CccceecccCceecc--ccCcccccccccceEEccC-CcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCccc
Q 002321          293 ESLETLDLSGNKFSG--AVPISIGNLQRLKVLNFSA-NRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKV  369 (936)
Q Consensus       293 ~~L~~L~L~~N~l~~--~~~~~l~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l  369 (936)
                      .+++.|+|++|.+++  .+|..+.++++|++|+|++ |.+++.+|..|.++++|++|++++|.+.+.+|..         
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~---------  120 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF---------  120 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGG---------
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHH---------
Confidence            356677777777776  6677777777777777774 7777777777777777777777777776544432         


Q ss_pred             cccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcc-cCCeeecC
Q 002321          370 SFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLK-ALNVLDLS  448 (936)
Q Consensus       370 ~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls  448 (936)
                                        +..+++|++|+|++|.+++.+|..+..+++|++|+|++|++++.+|..++.++ +|++|+|+
T Consensus       121 ------------------~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~  182 (313)
T 1ogq_A          121 ------------------LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS  182 (313)
T ss_dssp             ------------------GGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECC
T ss_pred             ------------------HhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECc
Confidence                              23467788888888888888888888888999999999999888888888887 89999999


Q ss_pred             CccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCC
Q 002321          449 ENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGL  528 (936)
Q Consensus       449 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  528 (936)
                      +|++++.+|..+..+. |+.|+|++|++++.+|..|..+++|++|+|++|++++.+|. +..+++|++|+|++|++++.+
T Consensus       183 ~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~  260 (313)
T 1ogq_A          183 RNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTL  260 (313)
T ss_dssp             SSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECC
T ss_pred             CCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcC
Confidence            9999988888888887 99999999999988999999999999999999999977665 888999999999999999999


Q ss_pred             CcccccccccCeeecCCCcccccCCCCCccCcCCCccccCCCCCCCCCCCCCC
Q 002321          529 PKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKSC  581 (936)
Q Consensus       529 p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~gn~~~c~~~~~~~~  581 (936)
                      |..+..+++|+.|+|++|+++|.+|..+.+..+....+.+||++||.|+. .|
T Consensus       261 p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~-~C  312 (313)
T 1ogq_A          261 PQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC  312 (313)
T ss_dssp             CGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred             ChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC-CC
Confidence            99999999999999999999999999988999999999999999999885 46

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.3e-36  Score=327.80  Aligned_cols=246  Identities=20%  Similarity=0.295  Sum_probs=191.8

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEe----CCeeE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWT----QSLQL  763 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  763 (936)
                      ...|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++..    ....+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            456788889999999999999974 68999999986543 2346778999999999999999999999973    34678


Q ss_pred             EEEEecCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCC
Q 002321          764 LIYEFVSGGSLHKHLHEGS-GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM  842 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  842 (936)
                      +||||+++|+|.+++.... ....+++.+++.++.|++.||+|||+.+|+||||||+||+++.++.+||+|||.++....
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  186 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI  186 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence            9999999999999987631 223489999999999999999999999999999999999999999999999999876532


Q ss_pred             Cccc-------cccccccCcccccCcccccCcc--cCCchhhHHHHHHHHHHHHcCCCCCCccchh---HHHHHH----H
Q 002321          843 LDRY-------VLSSKIQSALGYMAPEFACRTV--KITDKCDVYGFGVLVLEVVTGKRPLSTWKMM---WWFSVT----W  906 (936)
Q Consensus       843 ~~~~-------~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~---~~~~~~----~  906 (936)
                      ....       .......+++.|+|||.+....  .++.++||||+||++|||++|+.||......   ......    .
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  266 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI  266 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--C
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCC
Confidence            1110       0112344688999999884332  3688999999999999999999999653211   001000    0


Q ss_pred             HHHHhhhccccceeecccccccccccccC
Q 002321          907 LEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       907 ~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ......+..+.+++.+||..||.+||+++
T Consensus       267 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~  295 (317)
T 2buj_A          267 PQSPRHSSALWQLLNSMMTVDPHQRPHIP  295 (317)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CccccCCHHHHHHHHHHhhcChhhCCCHH
Confidence            01122346788999999999999999864

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=100.00  E-value=1.3e-35  Score=325.82  Aligned_cols=270  Identities=17%  Similarity=0.259  Sum_probs=193.9

Q ss_pred             CCChhHHHHHHHHHHhcc-CCCCCCCCCC---CCCCCCccceeEEecC--------CCCceEEeccCCCCCCcccccccc
Q 002321           30 PSLNDDVLGLIVFKADIQ-DPNGKLSSWS---EDDDTPCNWFGVKCSP--------RSNRVIELTLNGLSLTGRIGRGLL   97 (936)
Q Consensus        30 ~~~~~~~~aLl~~k~~~~-d~~~~l~sW~---~~~~~~c~w~gv~c~~--------~~~~v~~l~l~~~~l~g~~~~~l~   97 (936)
                      .+..+|++||++||+++. |+.+.+++|.   ....++|.|.||.|+.        ...+|+.|+|++++++ .+|+.++
T Consensus        23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~  101 (328)
T 4fcg_A           23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAF  101 (328)
T ss_dssp             CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGG
T ss_pred             ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhh
Confidence            356789999999999994 8877889994   2234489999999952        3478999999999998 8888899


Q ss_pred             cCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccc------
Q 002321           98 QLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSL------  171 (936)
Q Consensus        98 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~------  171 (936)
                      ++++|++|+|++|+|+ .+|..|+++++|++|+|++|+++ .+|.. |..+++|++|+|++|++.+.+|..+..      
T Consensus       102 ~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~-l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~  178 (328)
T 4fcg_A          102 RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPAS-IASLNRLRELSIRACPELTELPEPLASTDASGE  178 (328)
T ss_dssp             GGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGG-GGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred             hCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHH-HhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence            9999999999999998 78889999999999999999998 77754 688999999999998888888887664      


Q ss_pred             ---cccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcc
Q 002321          172 ---CSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLR  248 (936)
Q Consensus       172 ---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  248 (936)
                         +++|++|+|++|+|+ .+|..+..+++|++|+|++|++++ +|..+..+++|++|+|++|++.+.+|..|+.+++|+
T Consensus       179 ~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~  256 (328)
T 4fcg_A          179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK  256 (328)
T ss_dssp             EEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCC
T ss_pred             hccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCC
Confidence               666666666666666 455556666666666666666663 444566666666666666666666666666666666


Q ss_pred             eeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCcee
Q 002321          249 TIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKF  305 (936)
Q Consensus       249 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  305 (936)
                      +|+|++|.+.+.+|..+..+++|+.|+|++|.+.+.+|..++.+++|+.+++..|.+
T Consensus       257 ~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~  313 (328)
T 4fcg_A          257 RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ  313 (328)
T ss_dssp             EEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred             EEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence            666666655555555555555555555555555555555555555555555554433

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-35  Score=327.04  Aligned_cols=243  Identities=26%  Similarity=0.371  Sum_probs=194.5

Q ss_pred             cccccCCCcccccCceEEEEEEe-----CCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC--e
Q 002321          689 HALLNKDCELGRGGFGAVYRTVL-----RDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS--L  761 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~  761 (936)
                      ...|+..+.||+|+||.||+|++     .+++.||||++.... ....+.+.+|++++++++||||+++++++...+  .
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            44567788999999999999984     358899999986542 344678999999999999999999999987644  6


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .++||||+++++|.+++.....  .+++.++++++.|+++||+|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eEEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            7899999999999999987532  38999999999999999999999999999999999999999999999999998765


Q ss_pred             CCccc-cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH--------------HHHH
Q 002321          842 MLDRY-VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF--------------SVTW  906 (936)
Q Consensus       842 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~--------------~~~~  906 (936)
                      ..... .......++..|+|||.+. ...++.++||||+||++|||++|..||.........              ....
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  275 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhc-CCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence            43322 1223345677899999884 446889999999999999999999998754221100              0011


Q ss_pred             HH-------HHhhhccccceeecccccccccccccC
Q 002321          907 LE-------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       907 ~~-------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..       +...+..+.+++.+||..||.+||+++
T Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  311 (326)
T 2w1i_A          276 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFR  311 (326)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             hhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHH
Confidence            11       112346788999999999999999863

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.3e-35  Score=318.31  Aligned_cols=238  Identities=22%  Similarity=0.315  Sum_probs=195.9

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ...|+..+.||+|+||.||+|+.. +++.||||++..... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            345788889999999999999986 689999999965433 234678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC---CCeEEeeccCccccCCC
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS---GEPKVGDYGLARLLPML  843 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~  843 (936)
                      ||+++++|.+++.....   +++.++..++.|++.||+|||++|++||||||+||+++.+   +.+||+|||+++.....
T Consensus       101 e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A          101 ELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             CCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             EccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            99999999998876543   8999999999999999999999999999999999999764   47999999999865432


Q ss_pred             ccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH------H--Hhhhcc
Q 002321          844 DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE------E--HWKKAE  915 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~------~--~~~~~~  915 (936)
                      .   ......+++.|+|||.+. + .++.++||||+|+++|+|++|+.||...............      +  ...+..
T Consensus       178 ~---~~~~~~~~~~y~aPE~~~-~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (287)
T 2wei_A          178 T---KMKDRIGTAYYIAPEVLR-G-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD  252 (287)
T ss_dssp             S---SCSCHHHHHTTCCHHHHT-T-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHH
T ss_pred             C---ccccccCcccccChHHhc-C-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHH
Confidence            2   122345788899999884 3 4789999999999999999999999886654322111000      1  123456


Q ss_pred             ccceeeccccccccccccc
Q 002321          916 WRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f  934 (936)
                      +.+++.+||..||.+||++
T Consensus       253 ~~~li~~~l~~dp~~Rps~  271 (287)
T 2wei_A          253 AKDLIRKMLTFHPSLRITA  271 (287)
T ss_dssp             HHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHcccChhhCcCH
Confidence            7889999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.7e-35  Score=336.16  Aligned_cols=239  Identities=16%  Similarity=0.192  Sum_probs=193.0

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCC-CCcceeeeEEEeCCeeEEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH-PNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ..|+..++||+|+||.||+|++. +++.||||++.....   ...+.+|+++++.++| +++..+..++......++|||
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            45788899999999999999975 689999998865433   2457899999999987 556666666777888899999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE---cCCCCeEEeeccCccccCCCc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLI---DGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      |+ +++|.+++.....  .+++.+++.|+.||+.||+|||+++|+||||||+|||+   +.++.+||+|||+++.+....
T Consensus        84 ~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             CC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence            99 9999999975432  38999999999999999999999999999999999999   688999999999998765432


Q ss_pred             c-----ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHH-HHH-HHHH---------
Q 002321          845 R-----YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWW-FSV-TWLE---------  908 (936)
Q Consensus       845 ~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~-~~~-~~~~---------  908 (936)
                      .     ........+|+.|+|||++. +..++.++|||||||++|||++|+.||........ ... ....         
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (483)
T 3sv0_A          161 THQHIPYRENKNLTGTARYASVNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA  239 (483)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred             cccccccccccccCCCccccCHHHhc-CCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence            2     11223567899999999984 55789999999999999999999999987543111 100 0000         


Q ss_pred             -HHhhhccccceeecccccccccccccC
Q 002321          909 -EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 -~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                       ....+.++.+++.+||..||.+||+|+
T Consensus       240 l~~~~p~~l~~li~~cl~~dP~~RPs~~  267 (483)
T 3sv0_A          240 LCRGYPTEFASYFHYCRSLRFDDKPDYS  267 (483)
T ss_dssp             HHTTSCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred             HhcCCcHHHHHHHHHHhcCChhhCcCHH
Confidence             122357799999999999999999874

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.5e-36  Score=323.94  Aligned_cols=243  Identities=26%  Similarity=0.341  Sum_probs=186.9

Q ss_pred             cccccCCCcccccCceEEEEEEeC--CCc--EEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCee
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR--DGR--PVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQ  762 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  762 (936)
                      ...|+..+.||+|+||.||+|++.  +++  .||||+++....  ....+.+.+|++++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            345778889999999999999864  233  689999865432  234578899999999999999999999998765 7


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCC
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM  842 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  842 (936)
                      ++||||+++++|.+++....  ..+++..+.+++.|+++||+|||+++++||||||+||+++.++.+||+|||+++....
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence            89999999999999997643  2389999999999999999999999999999999999999999999999999987654


Q ss_pred             Cccc-cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH------HHHhhhc
Q 002321          843 LDRY-VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL------EEHWKKA  914 (936)
Q Consensus       843 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~------~~~~~~~  914 (936)
                      .... .......+++.|+|||.+ ....++.++||||+|+++|||++ |+.||...+..........      .+...++
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESL-KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ  252 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHH-HHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             cccchhhhccCCCCceeeCchhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCH
Confidence            3221 223345567789999988 44568899999999999999999 9999988765432211110      0123446


Q ss_pred             cccceeecccccccccccccC
Q 002321          915 EWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       915 ~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+.+++.+||..||.+||+++
T Consensus       253 ~l~~li~~~l~~~p~~Rps~~  273 (291)
T 1u46_A          253 DIYNVMVQCWAHKPEDRPTFV  273 (291)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHHccCCcccCcCHH
Confidence            788999999999999999874

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.2e-35  Score=329.61  Aligned_cols=241  Identities=21%  Similarity=0.242  Sum_probs=179.6

Q ss_pred             ccccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCe-----
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSL-----  761 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  761 (936)
                      ....|+..+.||+|+||.||+|+.. +|+.||||++.....  ......+|++.++.++||||+++++++.....     
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~   98 (360)
T 3e3p_A           21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD   98 (360)
T ss_dssp             HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred             hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence            3456788899999999999999986 589999999865432  23456678888899999999999999976433     


Q ss_pred             --eEEEEEecCCCChhhhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCCEEEcC-CCCeEEeecc
Q 002321          762 --QLLIYEFVSGGSLHKHLHE-GSGGNFLSWNERFNVIQGTAKSLAHLH--QSNIIHYNIKSSNVLIDG-SGEPKVGDYG  835 (936)
Q Consensus       762 --~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~i~~al~~LH--~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg  835 (936)
                        .++||||+++ ++.+.+.. ......+++..+..++.|++.|+.|||  ++||+||||||+||+++. ++.+||+|||
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg  177 (360)
T 3e3p_A           99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG  177 (360)
T ss_dssp             EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred             eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence              6899999975 55444332 222334889999999999999999999  999999999999999997 8999999999


Q ss_pred             CccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH--------
Q 002321          836 LARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL--------  907 (936)
Q Consensus       836 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~--------  907 (936)
                      +++......   ......+|+.|+|||++.+...++.++||||+||++|||++|+.||...+..........        
T Consensus       178 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (360)
T 3e3p_A          178 SAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE  254 (360)
T ss_dssp             TCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             CceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence            998664322   223456799999999986666689999999999999999999999988765322211100        


Q ss_pred             --H--------------------HHh------hhccccceeeccccccccccccc
Q 002321          908 --E--------------------EHW------KKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       908 --~--------------------~~~------~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                        .                    ..+      .+..+.+++.+||..||.+||+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  309 (360)
T 3e3p_A          255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP  309 (360)
T ss_dssp             HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCH
Confidence              0                    000      23567889999999999999985

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.1e-35  Score=323.70  Aligned_cols=240  Identities=21%  Similarity=0.273  Sum_probs=190.2

Q ss_pred             cccccCCCcccccCceEEEEEEeC--CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcC---CCCCcceeeeEEE-----
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR--DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKV---RHPNLVTLEGYYW-----  757 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----  757 (936)
                      ...|+..+.||+|+||.||+|+..  +|+.||||+++..... .....+.+|+.+++++   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            345788889999999999999983  5889999998654322 1123566777777666   8999999999987     


Q ss_pred             eCCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCc
Q 002321          758 TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLA  837 (936)
Q Consensus       758 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  837 (936)
                      .....++||||++ |+|.+++..... ..+++.++..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence            4567789999997 699999976543 23899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH------H--
Q 002321          838 RLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE------E--  909 (936)
Q Consensus       838 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~------~--  909 (936)
                      +.....   .......+++.|+|||++. ...++.++||||+||++|||++|+.||...............      .  
T Consensus       168 ~~~~~~---~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          168 RIYSFQ---MALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             CCCCGG---GGGCCCCCCCTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             ccccCC---CCccccccccceeCHHHHh-cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence            765422   2234456889999999984 446899999999999999999999999887653322111100      0  


Q ss_pred             -----------------------Hhhhccccceeeccccccccccccc
Q 002321          910 -----------------------HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       910 -----------------------~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                             ...+..+++++.+||..||.+||+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  291 (326)
T 1blx_A          244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA  291 (326)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCH
Confidence                                   0122345688999999999999975

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.5e-35  Score=353.95  Aligned_cols=241  Identities=23%  Similarity=0.283  Sum_probs=193.7

Q ss_pred             ccccCCCcccccCceEEEEEEeCC----CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  765 (936)
                      ..|+..+.||+|+||.||+|++..    +..||||+++........+.+.+|+.++++++||||+++++++. .+..++|
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv  468 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII  468 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence            456777889999999999999752    45799999876544445678999999999999999999999985 4567999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      |||+++|+|.+++....  ..+++..++.++.|+++||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       469 ~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~  546 (656)
T 2j0j_A          469 MELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  546 (656)
T ss_dssp             EECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred             EEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence            99999999999998643  2389999999999999999999999999999999999999999999999999987643222


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH-----HHHhhhccccce
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL-----EEHWKKAEWRNV  919 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~  919 (936)
                       .......+++.|+|||++ ....++.++||||+||++|||++ |..||.+.+..........     .+...+..+.++
T Consensus       547 -~~~~~~~~t~~y~aPE~~-~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  624 (656)
T 2j0j_A          547 -YKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL  624 (656)
T ss_dssp             --------CCGGGCCHHHH-HHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred             -eeccCCCCCcceeCHHHh-cCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHH
Confidence             222334567889999988 45578999999999999999997 9999988765432211110     112344678899


Q ss_pred             eecccccccccccccC
Q 002321          920 SMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       920 ~~~~l~~~p~~Rp~f~  935 (936)
                      +.+||..||.+||+++
T Consensus       625 i~~~l~~dP~~RPs~~  640 (656)
T 2j0j_A          625 MTKCWAYDPSRRPRFT  640 (656)
T ss_dssp             HHHHTCSSGGGSCCHH
T ss_pred             HHHHcCCChhHCcCHH
Confidence            9999999999999874

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=3.8e-34  Score=317.90  Aligned_cols=307  Identities=20%  Similarity=0.347  Sum_probs=181.2

Q ss_pred             cccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccc
Q 002321           96 LLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTL  175 (936)
Q Consensus        96 l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  175 (936)
                      +.++++|++|++++|+++.. + .+..+++|++|+|++|+++ .++.  |..+++|++|+|++|++++.  +.+..+++|
T Consensus        40 ~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~-~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L  112 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQIT-DISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNL  112 (347)
T ss_dssp             HHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTC
T ss_pred             chhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccc-cchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcC
Confidence            44677788888888887743 3 4777888888888888887 4444  67777888888888877742  357777777


Q ss_pred             cccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeecccc
Q 002321          176 ATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSEN  255 (936)
Q Consensus       176 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N  255 (936)
                      ++|+|++|++++..+  +..+++|++|++++|.....++ .+..+++|++|++++|.+++..+  +..+++|++|++++|
T Consensus       113 ~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n  187 (347)
T 4fmz_A          113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN  187 (347)
T ss_dssp             SEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTS
T ss_pred             CEEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCC
Confidence            777777777775433  6677777777777775543333 36667777777777777664433  666667777777776


Q ss_pred             ccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCCh
Q 002321          256 SFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPD  335 (936)
Q Consensus       256 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~  335 (936)
                      .+++..+  +..+++|+.|++++|.+++..+  +..+++|++|++++|++++..+  +..+++|++|++++|.+++.  .
T Consensus       188 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~  259 (347)
T 4fmz_A          188 QIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--N  259 (347)
T ss_dssp             CCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--G
T ss_pred             ccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--h
Confidence            6654322  4555555555555555543322  4444555555555555543222  44444444444444444421  2


Q ss_pred             hhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhccc
Q 002321          336 SMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGAL  415 (936)
Q Consensus       336 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  415 (936)
                      .+..+                                                   ++|++|++++|++++.  ..+..+
T Consensus       260 ~~~~l---------------------------------------------------~~L~~L~l~~n~l~~~--~~~~~l  286 (347)
T 4fmz_A          260 AVKDL---------------------------------------------------TKLKMLNVGSNQISDI--SVLNNL  286 (347)
T ss_dssp             GGTTC---------------------------------------------------TTCCEEECCSSCCCCC--GGGGGC
T ss_pred             hHhcC---------------------------------------------------CCcCEEEccCCccCCC--hhhcCC
Confidence            33344                                                   4555555555555433  234555


Q ss_pred             ccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccC
Q 002321          416 SGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLA  477 (936)
Q Consensus       416 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  477 (936)
                      ++|++|+|++|++++..+..++.+++|++|+|++|++++..|  +..+++|++|++++|.|+
T Consensus       287 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             TTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             CCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            555555555555555555555555566666666666554333  555666666666666554

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.9e-36  Score=333.43  Aligned_cols=237  Identities=23%  Similarity=0.302  Sum_probs=179.8

Q ss_pred             ccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHH--HHcCCCCCcceeeeEEEe-----CCee
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKK--LGKVRHPNLVTLEGYYWT-----QSLQ  762 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~  762 (936)
                      ..|+..+.||+|+||.||+|+. +++.||||++....    ...+..|.++  +..++||||+++++++..     ....
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            3467778999999999999987 58999999986432    3334444444  556899999999986643     2356


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcccCCCCCCCEEEcCCCCeEEee
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS---------NIIHYNIKSSNVLIDGSGEPKVGD  833 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---------~ivH~Dlkp~NIll~~~~~~kl~D  833 (936)
                      ++||||+++|+|.+++....    .++..+.+++.|+++||+|||+.         +|+||||||+|||++.++.+||+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             EEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            89999999999999997654    68899999999999999999999         999999999999999999999999


Q ss_pred             ccCccccCCCc------cccccccccCcccccCcccccCc------ccCCchhhHHHHHHHHHHHHcCCCCCCccchhHH
Q 002321          834 YGLARLLPMLD------RYVLSSKIQSALGYMAPEFACRT------VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWW  901 (936)
Q Consensus       834 fg~a~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~  901 (936)
                      ||+++.+....      .........||+.|+|||++.+.      ..++.++|||||||++|||++|..||........
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence            99998764321      11222345689999999988542      3567899999999999999999777644321000


Q ss_pred             ---------------HHHHH-HH--------------HHhhhccccceeecccccccccccccC
Q 002321          902 ---------------FSVTW-LE--------------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       902 ---------------~~~~~-~~--------------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                                     ..... ..              ....++.+.+++.+||..||.+||+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  307 (336)
T 3g2f_A          244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQ  307 (336)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchH
Confidence                           00000 00              001123588899999999999999864

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.2e-35  Score=319.83  Aligned_cols=239  Identities=22%  Similarity=0.277  Sum_probs=184.1

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEe----------
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWT----------  758 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------  758 (936)
                      ..|+..+.||+|+||.||+|+.. +++.||||++...  ....+.+.+|+.++++++||||+++++++.+          
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            34677789999999999999975 6899999999643  2345778999999999999999999998865          


Q ss_pred             ---CCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeecc
Q 002321          759 ---QSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYG  835 (936)
Q Consensus       759 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  835 (936)
                         ....++||||+++|+|.+++....  ..+++.+++.++.|++.||+|||++||+||||||+||+++.++.+||+|||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg  161 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG  161 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence               346789999999999999998643  237889999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCcc------------ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHH
Q 002321          836 LARLLPMLDR------------YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS  903 (936)
Q Consensus       836 ~a~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~  903 (936)
                      +++.......            ........+++.|+|||++.+...++.++||||+||++|||++   ||..........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~  238 (303)
T 1zy4_A          162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL  238 (303)
T ss_dssp             CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred             chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence            9976542210            1122345678899999998655578999999999999999998   665432211111


Q ss_pred             HHHHH------HH---hhhccccceeecccccccccccccC
Q 002321          904 VTWLE------EH---WKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       904 ~~~~~------~~---~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .....      +.   ..+..+++++.+||..||.+||+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  279 (303)
T 1zy4_A          239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGAR  279 (303)
T ss_dssp             HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHH
Confidence            11100      01   1123468899999999999999863

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=3.7e-34  Score=318.00  Aligned_cols=309  Identities=22%  Similarity=0.345  Sum_probs=222.4

Q ss_pred             CchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCC
Q 002321          118 PNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLS  197 (936)
Q Consensus       118 ~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  197 (936)
                      ..+..+++|++|++++|.+. .++.  |..+++|++|+|++|++++..+  +..+++|++|+|++|++++.  ..+.+++
T Consensus        38 ~~~~~l~~L~~L~l~~~~i~-~~~~--~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~  110 (347)
T 4fmz_A           38 VTQEELESITKLVVAGEKVA-SIQG--IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLT  110 (347)
T ss_dssp             ECHHHHTTCSEEECCSSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCT
T ss_pred             ccchhcccccEEEEeCCccc-cchh--hhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCC
Confidence            35677888888888888887 4543  6777777777777777775433  66677777777777776653  2466666


Q ss_pred             CCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEecc
Q 002321          198 ALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLR  277 (936)
Q Consensus       198 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~  277 (936)
                      +|++|+|++|.+++..+  +..+++|++|++++|.....++ .+..+++|++|++++|.+.+.                 
T Consensus       111 ~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~-----------------  170 (347)
T 4fmz_A          111 NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDV-----------------  170 (347)
T ss_dssp             TCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCC-----------------
T ss_pred             cCCEEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCc-----------------
Confidence            77777777766664322  5666666666666664442322 255555555555555555432                 


Q ss_pred             CccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCC
Q 002321          278 KNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDL  357 (936)
Q Consensus       278 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  357 (936)
                             .+  +..+++|++|++++|++.+..+  +..+++|+.|++++|.+++..+  +..+++|+.|++++|.+.+..
T Consensus       171 -------~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~  237 (347)
T 4fmz_A          171 -------TP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLS  237 (347)
T ss_dssp             -------GG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG
T ss_pred             -------hh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCc
Confidence                   22  4556666677777776664333  6667777777777777775433  677778888888888776221


Q ss_pred             ChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCcccc
Q 002321          358 PQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIG  437 (936)
Q Consensus       358 p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  437 (936)
                      +                             +..+++|++|++++|.+++.  ..+..+++|++|++++|++++.  ..+.
T Consensus       238 ~-----------------------------~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~  284 (347)
T 4fmz_A          238 P-----------------------------LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLN  284 (347)
T ss_dssp             G-----------------------------GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGG
T ss_pred             c-----------------------------hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhc
Confidence            1                             24567899999999998764  5688999999999999999864  5689


Q ss_pred             CcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCcccc
Q 002321          438 DLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLT  501 (936)
Q Consensus       438 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  501 (936)
                      .+++|+.|+|++|++++..|..+.++++|+.|+|++|.+++..|  +..+++|++|++++|+|+
T Consensus       285 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          285 NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             GCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             CCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            99999999999999998888889999999999999999997666  899999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.4e-36  Score=331.23  Aligned_cols=238  Identities=23%  Similarity=0.303  Sum_probs=194.9

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc-----hHHHHHHHHHHHHcCC--CCCcceeeeEEEeCC
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK-----SQEDFEREVKKLGKVR--HPNLVTLEGYYWTQS  760 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~  760 (936)
                      ...|+..+.||+|+||.||+|+.. +++.||||++.......     ..+.+.+|+.++++++  |+||+++++++...+
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~  121 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD  121 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence            345777889999999999999965 68999999996553321     2345778999999996  599999999999999


Q ss_pred             eeEEEEEecCC-CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc-CCCCeEEeeccCcc
Q 002321          761 LQLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGLAR  838 (936)
Q Consensus       761 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~  838 (936)
                      ..++||||+.+ ++|.+++.....   +++..+..++.|+++||+|||+.+|+||||||+||+++ .++.+||+|||+++
T Consensus       122 ~~~lv~e~~~~~~~L~~~l~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~  198 (320)
T 3a99_A          122 SFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA  198 (320)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             cEEEEEEcCCCCccHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence            99999999976 899999987543   89999999999999999999999999999999999999 78999999999998


Q ss_pred             ccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHHHhhhccccc
Q 002321          839 LLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRN  918 (936)
Q Consensus       839 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  918 (936)
                      ......    .....+++.|+|||++.....++.++|||||||++|||++|+.||...+.....  ....+...++.+.+
T Consensus       199 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~  272 (320)
T 3a99_A          199 LLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG--QVFFRQRVSSECQH  272 (320)
T ss_dssp             ECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHC--CCCCSSCCCHHHHH
T ss_pred             cccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcc--cccccccCCHHHHH
Confidence            764321    234568999999998855555578999999999999999999999765432110  00112234467889


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..||.+||+++
T Consensus       273 li~~~l~~dp~~Rps~~  289 (320)
T 3a99_A          273 LIRWCLALRPSDRPTFE  289 (320)
T ss_dssp             HHHHHTCSSGGGSCCHH
T ss_pred             HHHHHccCChhhCcCHH
Confidence            99999999999999864

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.6e-35  Score=324.66  Aligned_cols=238  Identities=21%  Similarity=0.284  Sum_probs=190.1

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHc--CCCCCcceeeeEEEeCC----ee
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGK--VRHPNLVTLEGYYWTQS----LQ  762 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~  762 (936)
                      ...|+..+.||+|+||.||+|++. ++.||||++...    ....+.+|++++..  ++||||+++++++....    ..
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~  115 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL  115 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred             cccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence            345788889999999999999985 899999998543    34667889998887  68999999999998775    78


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCCEEEcCCCCeEEeec
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH--------QSNIIHYNIKSSNVLIDGSGEPKVGDY  834 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH--------~~~ivH~Dlkp~NIll~~~~~~kl~Df  834 (936)
                      ++||||+++|+|.+++.+..    +++.++++++.|++.||+|||        +.+|+||||||+||+++.++.+||+||
T Consensus       116 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  191 (342)
T 1b6c_B          116 WLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  191 (342)
T ss_dssp             EEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEeecCCCcHHHHHhccC----ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence            99999999999999997643    899999999999999999999        899999999999999999999999999


Q ss_pred             cCccccCCCcccc--ccccccCcccccCcccccCcc-----cCCchhhHHHHHHHHHHHHcC----------CCCCCccc
Q 002321          835 GLARLLPMLDRYV--LSSKIQSALGYMAPEFACRTV-----KITDKCDVYGFGVLVLEVVTG----------KRPLSTWK  897 (936)
Q Consensus       835 g~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwSlG~~l~el~~g----------~~Pf~~~~  897 (936)
                      |+++.........  ......+++.|+|||++.+..     .++.++||||+||++|||++|          +.||....
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            9997664332211  234456899999999885432     233789999999999999999          78987653


Q ss_pred             hhH---HHHHHHH-H--------HH----hhhccccceeecccccccccccccC
Q 002321          898 MMW---WFSVTWL-E--------EH----WKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       898 ~~~---~~~~~~~-~--------~~----~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ...   ....... .        ..    -....+.+++.+||..||.+||+++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~  325 (342)
T 1b6c_B          272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL  325 (342)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHH
Confidence            211   1111111 0        00    1123567899999999999999864

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5.8e-35  Score=323.29  Aligned_cols=200  Identities=23%  Similarity=0.309  Sum_probs=171.3

Q ss_pred             ccccCCCcccccCceEEEEEEeC--CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCC------CcceeeeEEEeCCe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR--DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHP------NLVTLEGYYWTQSL  761 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~  761 (936)
                      ..|+..+.||+|+||.||+|.+.  +++.||||+++..  ....+.+.+|++++++++|+      +++++++++.+.+.
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            45778889999999999999873  5889999998643  23457788999999988665      49999999999999


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC----------------
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG----------------  825 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~----------------  825 (936)
                      .++||||+ +++|.+++..... ..+++.++.+++.|++.||+|||++||+||||||+||+++.                
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~  169 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER  169 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence            99999999 8999999977543 34889999999999999999999999999999999999987                


Q ss_pred             ---CCCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchh
Q 002321          826 ---SGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM  899 (936)
Q Consensus       826 ---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~  899 (936)
                         ++.+||+|||+++.....     .....+|+.|+|||++. +..++.++||||+||++|||++|+.||...+..
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          170 TLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             EESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHT-TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             cccCCCceEeeCcccccCccc-----cccccCCccccChHHhh-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence               668999999999864321     23456899999999984 557899999999999999999999999876653

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.9e-35  Score=325.70  Aligned_cols=234  Identities=20%  Similarity=0.245  Sum_probs=188.4

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCe------
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSL------  761 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  761 (936)
                      ..|...+.||+|+||.||+|++. +|+.||||++...... ...+.+.+|+.++++++||||+++++++.....      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            34677788999999999999976 5899999999654322 235678899999999999999999999987654      


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .++||||++ ++|.+++..     .+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus       104 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  177 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD  177 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred             EEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence            489999996 688887743     28999999999999999999999999999999999999999999999999997643


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH--------------
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL--------------  907 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~--------------  907 (936)
                      ..     .....+++.|+|||++.+...++.++||||+||++|||++|+.||...+..........              
T Consensus       178 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  252 (353)
T 3coi_A          178 AE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  252 (353)
T ss_dssp             -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred             CC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence            21     23456789999999886656789999999999999999999999987664322111000              


Q ss_pred             --------H-------------HHhhhccccceeeccccccccccccc
Q 002321          908 --------E-------------EHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       908 --------~-------------~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                              .             ....+..+.+++.+||..||.+||+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~  300 (353)
T 3coi_A          253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA  300 (353)
T ss_dssp             CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCH
Confidence                    0             01124567889999999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.4e-36  Score=328.05  Aligned_cols=242  Identities=22%  Similarity=0.294  Sum_probs=191.3

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ...|+..+.||+|+||.||+|++..  .||||+++..... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            3457888999999999999999853  5999999654332 224567889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc---
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD---  844 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---  844 (936)
                      |+++++|.+++....  ..+++.++..++.|++.||+|||++||+||||||+||+++ ++.+||+|||+++......   
T Consensus       110 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~  186 (319)
T 2y4i_B          110 LCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR  186 (319)
T ss_dssp             CCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred             cccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence            999999999997643  2488999999999999999999999999999999999998 7899999999987653211   


Q ss_pred             cccccccccCcccccCcccccC--------cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH--H----H
Q 002321          845 RYVLSSKIQSALGYMAPEFACR--------TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE--E----H  910 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~--~----~  910 (936)
                      .........+++.|+|||++..        ...++.++||||+||++|||++|+.||...............  +    .
T Consensus       187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  266 (319)
T 2y4i_B          187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQI  266 (319)
T ss_dssp             -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCS
T ss_pred             cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcC
Confidence            1122234458889999998853        235788999999999999999999999887654322111100  0    1


Q ss_pred             hhhccccceeecccccccccccccC
Q 002321          911 WKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       911 ~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..+..+.+++.+||..||.+||+++
T Consensus       267 ~~~~~l~~li~~~l~~~p~~Rpt~~  291 (319)
T 2y4i_B          267 GMGKEISDILLFCWAFEQEERPTFT  291 (319)
T ss_dssp             SCCTTHHHHHHHHHCSSTTTSCCHH
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHH
Confidence            2346788999999999999999874

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=3.4e-34  Score=341.46  Aligned_cols=349  Identities=17%  Similarity=0.137  Sum_probs=243.6

Q ss_pred             CCCCCCCCCCCCCc-c---ceeEEecCCCCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCC
Q 002321           51 GKLSSWSEDDDTPC-N---WFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNL  126 (936)
Q Consensus        51 ~~l~sW~~~~~~~c-~---w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L  126 (936)
                      ..+++|.++.+ || .   |.++.|+..      ++.......  ....-..+++++.|++++|.++...+..|.++++|
T Consensus         7 ~~l~~~~~~~~-C~~~~~~~~c~~~~~~------i~~~~~~~~--~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L   77 (597)
T 3oja_B            7 YNVKPRQPEYK-CIDSNLQYDCVFYDVH------IDMQTQDVY--FGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV   77 (597)
T ss_dssp             ----CCCSEEC-CCCC--CCSEEECSCE------ECSSCCCCE--ESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCC
T ss_pred             ccccCCCCCCc-CcccCcCceeEecCce------ecccccccc--cCcccccCCCceEEEeeCCCCCCcCHHHHccCCCC
Confidence            35789998777 45 3   776666521      111111111  11122357889999999999997666678999999


Q ss_pred             cEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCC
Q 002321          127 RVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSD  206 (936)
Q Consensus       127 ~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  206 (936)
                      ++|+|++|.|+ .+++..|..+++|++|+|++|.|++..|..|+.+++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus        78 ~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~  156 (597)
T 3oja_B           78 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSN  156 (597)
T ss_dssp             SEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             cEEECCCCCCC-CCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeC
Confidence            99999999999 57777899999999999999999999999999999999999999999987777789999999999999


Q ss_pred             CCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCC
Q 002321          207 NLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVP  286 (936)
Q Consensus       207 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~  286 (936)
                      |.+++..|..|.++++|++|+|++|.+++.   .+..+++|++|++++|.+++     +.....|+.|++++|.++...+
T Consensus       157 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~  228 (597)
T 3oja_B          157 NNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRG  228 (597)
T ss_dssp             SCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEEC
T ss_pred             CcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCccccccc
Confidence            999998888999999999999999999965   36678899999999998874     2333456666666666653322


Q ss_pred             cccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCC
Q 002321          287 KWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGL  366 (936)
Q Consensus       287 ~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l  366 (936)
                      ..   .++|+.|+|++|.+++  +..+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|.+             
T Consensus       229 ~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l-------------  290 (597)
T 3oja_B          229 PV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-------------  290 (597)
T ss_dssp             SC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCC-------------
T ss_pred             cc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCC-------------
Confidence            21   2355555555555553  23455555555555555555555555555555555555555544             


Q ss_pred             ccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeee
Q 002321          367 NKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLD  446 (936)
Q Consensus       367 ~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  446 (936)
                                                            ++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+
T Consensus       291 --------------------------------------~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~  330 (597)
T 3oja_B          291 --------------------------------------VA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY  330 (597)
T ss_dssp             --------------------------------------CE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEE
T ss_pred             --------------------------------------CC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEE
Confidence                                                  42 2333344555555555555555 3455555566666666


Q ss_pred             cCCccccccCCCCCCCcCCCcEEEecCCccCC
Q 002321          447 LSENWLNGSIPPEIGGAYSLKELRLERNFLAG  478 (936)
Q Consensus       447 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  478 (936)
                      |++|.+++. |  +..+++|+.|+|++|.+++
T Consensus       331 L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~  359 (597)
T 3oja_B          331 LDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC  359 (597)
T ss_dssp             CCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred             CCCCCCCCc-C--hhhcCCCCEEEeeCCCCCC
Confidence            666666542 2  5566777888888887764

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.7e-35  Score=323.87  Aligned_cols=235  Identities=20%  Similarity=0.248  Sum_probs=165.2

Q ss_pred             ccccCC-CcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEe----CCeeE
Q 002321          690 ALLNKD-CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWT----QSLQL  763 (936)
Q Consensus       690 ~~~~~~-~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  763 (936)
                      ..|... +.||+|+||.||+|+.+ +|+.||||++...     .....+....++.++||||+++++++..    ....+
T Consensus        28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            445663 46999999999999987 6899999998543     2222233344667799999999999976    44578


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCCeEEeeccCcccc
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG---SGEPKVGDYGLARLL  840 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~  840 (936)
                      +||||+++|+|.+++..... ..+++.+++.++.|++.||+|||++||+||||||+||+++.   ++.+||+|||+++..
T Consensus       103 lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~  181 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET  181 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence            99999999999999986542 34899999999999999999999999999999999999986   455999999999865


Q ss_pred             CCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-----HHHHHHH------
Q 002321          841 PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-----SVTWLEE------  909 (936)
Q Consensus       841 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-----~~~~~~~------  909 (936)
                      ...    ......+++.|+|||++ ....++.++||||+||++|||++|+.||.........     .......      
T Consensus       182 ~~~----~~~~~~~t~~y~aPE~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (336)
T 3fhr_A          182 TQN----ALQTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE  256 (336)
T ss_dssp             ---------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTT
T ss_pred             ccc----ccccCCCCcCccChhhh-CCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchh
Confidence            422    12345678999999988 4557899999999999999999999999776543221     0000000      


Q ss_pred             -HhhhccccceeecccccccccccccC
Q 002321          910 -HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       910 -~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                       ...++.+.+++.+||..||.+||+++
T Consensus       257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~  283 (336)
T 3fhr_A          257 WSEVSEDAKQLIRLLLKTDPTERLTIT  283 (336)
T ss_dssp             STTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             hccCCHHHHHHHHHHCCCChhHCcCHH
Confidence             12346788999999999999999863

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.6e-35  Score=326.09  Aligned_cols=243  Identities=23%  Similarity=0.333  Sum_probs=174.0

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHH-HHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVK-KLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ...|+..+.||+|+||.||+|+.. +|+.||||+++.........++.+|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            445778889999999999999986 689999999976544444556666666 677789999999999999999999999


Q ss_pred             EecCCCChhhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          767 EFVSGGSLHKHLHEG--SGGNFLSWNERFNVIQGTAKSLAHLHQS-NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       767 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      ||++ |+|.+++...  .....+++..+.+++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++.....
T Consensus       101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  179 (327)
T 3aln_A          101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS  179 (327)
T ss_dssp             CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred             eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence            9997 5888777531  1123489999999999999999999998 9999999999999999999999999999765422


Q ss_pred             ccccccccccCcccccCccccc---CcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH---H-------HH
Q 002321          844 DRYVLSSKIQSALGYMAPEFAC---RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL---E-------EH  910 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~---~-------~~  910 (936)
                      .   ......+++.|+|||++.   ....++.++||||+||++|||++|+.||..............   .       ..
T Consensus       180 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3aln_A          180 I---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER  256 (327)
T ss_dssp             -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSC
T ss_pred             c---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccc
Confidence            1   223346889999999873   244588999999999999999999999987543111100000   0       01


Q ss_pred             hhhccccceeecccccccccccccC
Q 002321          911 WKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       911 ~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..+..+.+++.+||..||.+||+++
T Consensus       257 ~~~~~l~~li~~~l~~dp~~Rps~~  281 (327)
T 3aln_A          257 EFSPSFINFVNLCLTKDESKRPKYK  281 (327)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             cCCHHHHHHHHHHhhCChhhCcCHH
Confidence            2345678899999999999999874

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.1e-35  Score=332.17  Aligned_cols=198  Identities=21%  Similarity=0.237  Sum_probs=166.4

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCC--------CCCcceeeeEEE---
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR--------HPNLVTLEGYYW---  757 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---  757 (936)
                      ..|+..++||+|+||+||+|+.. +++.||||+++..  ....+.+.+|++++++++        |+||+++++++.   
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            45788889999999999999975 5889999999643  234577889999999995        788999999987   


Q ss_pred             -eCCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCC--------
Q 002321          758 -TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS-NIIHYNIKSSNVLIDGSG--------  827 (936)
Q Consensus       758 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~ivH~Dlkp~NIll~~~~--------  827 (936)
                       .....++||||+ ++++.+++..... ..+++..+..++.|++.||+|||++ ||+||||||+|||++.++        
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~  192 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA  192 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence             445789999999 5677666655432 2389999999999999999999998 999999999999999776        


Q ss_pred             -----------------------------------------CeEEeeccCccccCCCccccccccccCcccccCcccccC
Q 002321          828 -----------------------------------------EPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR  866 (936)
Q Consensus       828 -----------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  866 (936)
                                                               .+||+|||+++.....     .....+|+.|+|||++. 
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~-  266 (397)
T 1wak_A          193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLI-  266 (397)
T ss_dssp             HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHH-
T ss_pred             hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhc-
Confidence                                                     7999999999865422     23456899999999985 


Q ss_pred             cccCCchhhHHHHHHHHHHHHcCCCCCCccc
Q 002321          867 TVKITDKCDVYGFGVLVLEVVTGKRPLSTWK  897 (936)
Q Consensus       867 ~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~  897 (936)
                      +..++.++||||+||++|||++|+.||....
T Consensus       267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~  297 (397)
T 1wak_A          267 GSGYNTPADIWSTACMAFELATGDYLFEPHS  297 (397)
T ss_dssp             TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            4468999999999999999999999997654

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=9e-35  Score=318.76  Aligned_cols=241  Identities=21%  Similarity=0.285  Sum_probs=176.0

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHH-HHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQE-DFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~-~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ...|+..+.||+|+||.||+|++. +|+.||||++.......... .+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            345677889999999999999986 68999999997654433333 3445556788889999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS-NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      ||+ ++.+..+.....  ..+++..+..++.|+++||+|||++ ||+||||||+||+++.++.+||+|||++....... 
T Consensus       104 e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             ecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-
Confidence            999 556665554322  2389999999999999999999995 99999999999999999999999999997654322 


Q ss_pred             ccccccccCcccccCccccc----CcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHHH--------hhh
Q 002321          846 YVLSSKIQSALGYMAPEFAC----RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEH--------WKK  913 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~--------~~~  913 (936)
                        ......+++.|+|||++.    ....++.++||||+||++|||++|+.||.................        ..+
T Consensus       180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (318)
T 2dyl_A          180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFS  257 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCC
T ss_pred             --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCC
Confidence              223456889999999884    244678899999999999999999999987543222211111111        134


Q ss_pred             ccccceeecccccccccccccC
Q 002321          914 AEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       914 ~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..+.+++.+||..||.+||+++
T Consensus       258 ~~l~~li~~~l~~dp~~Rps~~  279 (318)
T 2dyl_A          258 GDFQSFVKDCLTKDHRKRPKYN  279 (318)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHH
T ss_pred             HHHHHHHHHHccCChhHCcCHH
Confidence            6688999999999999999864

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3e-35  Score=335.90  Aligned_cols=242  Identities=21%  Similarity=0.262  Sum_probs=181.2

Q ss_pred             ccccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEE
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ....+...+.||+|+||+||.+...+|+.||||++...    ..+.+.+|+++++++ +||||+++++++.+....++||
T Consensus        13 l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~   88 (434)
T 2rio_A           13 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL   88 (434)
T ss_dssp             CSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             hhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence            34445566789999999998776667999999998643    245678999999886 8999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-------------CCe
Q 002321          767 EFVSGGSLHKHLHEGSGGN----FLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS-------------GEP  829 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~----~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~-------------~~~  829 (936)
                      ||++ |+|.+++.......    ..++..+++++.|++.||+|||++||+||||||+|||++.+             +.+
T Consensus        89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            9995 79999998654221    11333457899999999999999999999999999999754             489


Q ss_pred             EEeeccCccccCCCccc--cccccccCcccccCcccccC------cccCCchhhHHHHHHHHHHHHc-CCCCCCccchhH
Q 002321          830 KVGDYGLARLLPMLDRY--VLSSKIQSALGYMAPEFACR------TVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMW  900 (936)
Q Consensus       830 kl~Dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~  900 (936)
                      ||+|||+++........  .......||+.|+|||++.+      ...++.++||||+||++|||++ |+.||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999876532211  11234568999999998854      2468999999999999999999 999997654322


Q ss_pred             HHHHHHH---------HHHhhhccccceeeccccccccccccc
Q 002321          901 WFSVTWL---------EEHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       901 ~~~~~~~---------~~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      .......         .+...+.++.+++.+||..||.+||+.
T Consensus       248 ~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~  290 (434)
T 2rio_A          248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA  290 (434)
T ss_dssp             HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCH
Confidence            1111100         001123567899999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.2e-36  Score=326.50  Aligned_cols=238  Identities=23%  Similarity=0.296  Sum_probs=187.9

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc-----hHHHHHHHHHHHHcC----CCCCcceeeeEEEe
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK-----SQEDFEREVKKLGKV----RHPNLVTLEGYYWT  758 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l----~h~niv~l~~~~~~  758 (936)
                      ...|+..+.||+|+||.||+|+.. +++.||||++.......     ....+.+|+.++.++    +|+||+++++++..
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~  109 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET  109 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence            345778889999999999999875 68899999996543321     223456799999998    89999999999998


Q ss_pred             CCeeEEEEEe-cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc-CCCCeEEeeccC
Q 002321          759 QSLQLLIYEF-VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLID-GSGEPKVGDYGL  836 (936)
Q Consensus       759 ~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~  836 (936)
                      .+..++|||| +++++|.+++.....   +++..+..++.|+++||+|||+.||+||||||+||+++ .++.+||+|||+
T Consensus       110 ~~~~~~v~e~~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~  186 (312)
T 2iwi_A          110 QEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS  186 (312)
T ss_dssp             ---CEEEEECCSSEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred             CCeEEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence            8899999999 789999999987543   89999999999999999999999999999999999999 889999999999


Q ss_pred             ccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHHHhhhccc
Q 002321          837 ARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEW  916 (936)
Q Consensus       837 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  916 (936)
                      ++......    .....+++.|+|||++.+....+.++||||+||++|||++|+.||.........  ....+...+..+
T Consensus       187 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~  260 (312)
T 2iwi_A          187 GALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEA--ELHFPAHVSPDC  260 (312)
T ss_dssp             CEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHT--CCCCCTTSCHHH
T ss_pred             hhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhh--ccCCcccCCHHH
Confidence            98764322    234568899999998855544566999999999999999999999765432111  011112345678


Q ss_pred             cceeecccccccccccccC
Q 002321          917 RNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       917 ~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .+++.+||..||.+||+++
T Consensus       261 ~~li~~~l~~~p~~Rps~~  279 (312)
T 2iwi_A          261 CALIRRCLAPKPSSRPSLE  279 (312)
T ss_dssp             HHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHHHccCChhhCcCHH
Confidence            8999999999999999863

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.4e-34  Score=320.53  Aligned_cols=199  Identities=21%  Similarity=0.320  Sum_probs=168.6

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CC-cEEEEEEeeccCccchHHHHHHHHHHHHcCCCCC------cceeeeEEEeCCe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DG-RPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPN------LVTLEGYYWTQSL  761 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  761 (936)
                      ..|+..+.||+|+||+||+|+.. ++ +.||||+++..  ....+.+.+|+.++++++|++      ++.+++++...+.
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            45778889999999999999975 34 68999998643  234567889999999997655      8999999999999


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE------------------
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLI------------------  823 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll------------------  823 (936)
                      .++||||+ ++++.+++..... ..+++.++..++.|++.||+|||++||+||||||+||++                  
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~  174 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK  174 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred             EEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence            99999999 6777777765432 248999999999999999999999999999999999999                  


Q ss_pred             -cCCCCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch
Q 002321          824 -DGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM  898 (936)
Q Consensus       824 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~  898 (936)
                       +.++.+||+|||+++.....     .....+|+.|+|||++. +..++.++||||+||++|||++|+.||...+.
T Consensus       175 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          175 SVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             EESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeee-cCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence             56789999999999864322     23456899999999984 45789999999999999999999999987654

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.6e-34  Score=322.05  Aligned_cols=200  Identities=23%  Similarity=0.272  Sum_probs=168.8

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-CC-----CcceeeeEEEeCCee
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HP-----NLVTLEGYYWTQSLQ  762 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~  762 (936)
                      ..|+..+.||+|+||+||+|+.. +++.||||+++...  ....++.+|+++++.++ |+     +|+++++++......
T Consensus        54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  131 (382)
T 2vx3_A           54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL  131 (382)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred             eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence            45777889999999999999976 58899999996432  23567788999998885 55     499999999999999


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCCEEEc--CCCCeEEeeccCcc
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH--QSNIIHYNIKSSNVLID--GSGEPKVGDYGLAR  838 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH--~~~ivH~Dlkp~NIll~--~~~~~kl~Dfg~a~  838 (936)
                      ++||||++ |+|.+++..... ..+++..+..++.|++.||+|||  +.||+||||||+|||++  .++.+||+|||+++
T Consensus       132 ~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~  209 (382)
T 2vx3_A          132 CLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC  209 (382)
T ss_dssp             EEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence            99999995 699999987542 23899999999999999999999  57999999999999994  57889999999998


Q ss_pred             ccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchh
Q 002321          839 LLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM  899 (936)
Q Consensus       839 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~  899 (936)
                      .....     .....+|+.|+|||++. +..++.++||||+||++|||++|+.||...+..
T Consensus       210 ~~~~~-----~~~~~~t~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~  264 (382)
T 2vx3_A          210 QLGQR-----IYQYIQSRFYRSPEVLL-GMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV  264 (382)
T ss_dssp             ETTCC-----CCSSCSCGGGCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             ecccc-----cccccCCccccChHHHc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            66422     23456889999999985 446899999999999999999999999886653

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.6e-35  Score=342.47  Aligned_cols=242  Identities=27%  Similarity=0.331  Sum_probs=192.7

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEe------CCee
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWT------QSLQ  762 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~  762 (936)
                      ..|+..+.||+|+||.||+|.+. +|+.||||+++........+.+.+|++++++++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            45788999999999999999975 5899999998765444556789999999999999999999998765      5677


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCC---eEEeeccCccc
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGE---PKVGDYGLARL  839 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a~~  839 (936)
                      ++||||+++|+|.+++........+++..+..++.|++.||+|||+.||+||||||+||+++.++.   +||+|||.++.
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~  173 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE  173 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence            999999999999999987655445889999999999999999999999999999999999997765   99999999987


Q ss_pred             cCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH-------HH--------
Q 002321          840 LPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF-------SV--------  904 (936)
Q Consensus       840 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~-------~~--------  904 (936)
                      .....   ......+++.|+|||.+ .+..++.++||||+||++|||++|+.||.........       ..        
T Consensus       174 ~~~~~---~~~~~~gt~~Y~APE~l-~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  249 (676)
T 3qa8_A          174 LDQGE---LCTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD  249 (676)
T ss_dssp             TTSCC---CCCCCCSCCTTCSSCSS-CCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred             ccccc---ccccccCCcccCChHHh-ccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence            64322   23445789999999998 4557899999999999999999999999764221000       00        


Q ss_pred             -----HHH--------HHHhhhccccceeecccccccccccccC
Q 002321          905 -----TWL--------EEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       905 -----~~~--------~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                           .+.        .....+..+.+++.+||..||.+||+++
T Consensus       250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~  293 (676)
T 3qa8_A          250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP  293 (676)
T ss_dssp             CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCT
T ss_pred             hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHH
Confidence                 000        0011235678899999999999999974

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=8.3e-35  Score=326.70  Aligned_cols=198  Identities=21%  Similarity=0.234  Sum_probs=165.2

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-----------CCCcceeeeEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-----------HPNLVTLEGYYW  757 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  757 (936)
                      ..|+..+.||+|+||+||+|+.. +++.||||++....  ...+.+.+|+.++++++           |+||+++++++.
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            45778889999999999999975 68999999986432  23567889999999886           899999999998


Q ss_pred             eCC----eeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEc------CC
Q 002321          758 TQS----LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS-NIIHYNIKSSNVLID------GS  826 (936)
Q Consensus       758 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~ivH~Dlkp~NIll~------~~  826 (936)
                      ..+    ..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||++ ||+||||||+||+++      ..
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~  174 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  174 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence            654    678999999 8999999986443 2389999999999999999999998 999999999999994      44


Q ss_pred             CCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccc
Q 002321          827 GEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWK  897 (936)
Q Consensus       827 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~  897 (936)
                      +.+||+|||+++.....     .....+|+.|+|||++. +..++.++||||+||++|||++|+.||....
T Consensus       175 ~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          175 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHH-TCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             ceEEEcccccccccCCC-----CCCCCCCccccCcHHHh-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence            48999999999865422     23456899999999984 4468999999999999999999999998654

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-34  Score=329.50  Aligned_cols=238  Identities=22%  Similarity=0.286  Sum_probs=180.1

Q ss_pred             ccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..+.||+|+||+||.....+++.||||++......    .+.+|+++++++ +||||+++++++.+....++||||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            346777899999999966555567999999999654332    356899999999 799999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-----CCeEEeeccCccccCCC
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS-----GEPKVGDYGLARLLPML  843 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~-----~~~kl~Dfg~a~~~~~~  843 (936)
                      ++ |+|.+++......  ..+.++..++.|+++||+|||+++|+||||||+||+++.+     ..+||+|||+++.....
T Consensus       100 ~~-g~L~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A          100 CA-ATLQEYVEQKDFA--HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             CS-EEHHHHHHSSSCC--CCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             CC-CCHHHHHHhcCCC--ccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            95 6999999865432  4444567899999999999999999999999999999532     35889999999876432


Q ss_pred             cc-ccccccccCcccccCcccccC--cccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-------HHHHhh
Q 002321          844 DR-YVLSSKIQSALGYMAPEFACR--TVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-------LEEHWK  912 (936)
Q Consensus       844 ~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-------~~~~~~  912 (936)
                      .. ........||+.|+|||++..  ...++.++||||+||++|||++ |..||.............       ..+...
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE  256 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHH
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccc
Confidence            21 122344678999999999853  3457889999999999999999 999996654332221100       001122


Q ss_pred             hccccceeeccccccccccccc
Q 002321          913 KAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       913 ~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      +..+++++.+||..||.+||++
T Consensus       257 ~~~~~~li~~~L~~dP~~Rps~  278 (432)
T 3p23_A          257 DVIARELIEKMIAMDPQKRPSA  278 (432)
T ss_dssp             HHHHHHHHHHHSCSSGGGSCCH
T ss_pred             cHHHHHHHHHHHhCCHhhCCCH
Confidence            3446789999999999999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.5e-34  Score=347.38  Aligned_cols=228  Identities=20%  Similarity=0.245  Sum_probs=187.1

Q ss_pred             ccccCCCcccccCceEEEEEEeC--CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCe-----e
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR--DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSL-----Q  762 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~  762 (936)
                      ..|+..+.||+|+||.||+|++.  +|+.||||++...........+.+|++++++++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            45788889999999999999986  5899999998765444456778999999999999999999999987655     6


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCC
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM  842 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  842 (936)
                      ++||||+++++|.+++..     .+++.+++.++.|++.||+|||++||+||||||+||+++.+ .+||+|||+++....
T Consensus       160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~  233 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS  233 (681)
T ss_dssp             EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred             EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence            999999999999987754     38999999999999999999999999999999999999975 999999999986543


Q ss_pred             CccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHHHhhhccccceeec
Q 002321          843 LDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVSMR  922 (936)
Q Consensus       843 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  922 (936)
                      .      ....||+.|+|||++.+.  ++.++|||||||++|||++|..||..........  ..+....+..+.+++.+
T Consensus       234 ~------~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~  303 (681)
T 2pzi_A          234 F------GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE--DDPVLKTYDSYGRLLRR  303 (681)
T ss_dssp             C------SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCCT--TCHHHHHCHHHHHHHHH
T ss_pred             C------CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccccccc--cccccccCHHHHHHHhh
Confidence            2      345689999999988433  4889999999999999999999987643211110  01111234678899999


Q ss_pred             ccccccccccc
Q 002321          923 SCKGSSRQRRR  933 (936)
Q Consensus       923 ~l~~~p~~Rp~  933 (936)
                      ||..||.+||+
T Consensus       304 ~l~~dP~~R~~  314 (681)
T 2pzi_A          304 AIDPDPRQRFT  314 (681)
T ss_dssp             HTCSSGGGSCS
T ss_pred             hccCChhhCCC
Confidence            99999999996

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=6.5e-33  Score=305.69  Aligned_cols=242  Identities=21%  Similarity=0.299  Sum_probs=150.9

Q ss_pred             cccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCcccccccccccc
Q 002321          101 FLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINL  180 (936)
Q Consensus       101 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  180 (936)
                      +++.+++++++++ .+|..+.  ++|++|+|++|+|+ .++...|..+++|++|+|++|+|++..|..|+.+++|++|+|
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  109 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI  109 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCC-ccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence            5777788877776 4565553  57777788777777 556666777777777777777777766777777777777777


Q ss_pred             ccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeeccccccc--ccCCcccccccCcceeeccccccC
Q 002321          181 SSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFS--GSIPDGIGSCSLLRTIDFSENSFS  258 (936)
Q Consensus       181 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~Ls~N~l~  258 (936)
                      ++|+++. +|..+.  ++|++|++++|++++..+..|.++++|++|++++|.++  +..+..+..+ +|++|++++|+++
T Consensus       110 ~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~  185 (332)
T 2ft3_A          110 SKNHLVE-IPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT  185 (332)
T ss_dssp             CSSCCCS-CCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS
T ss_pred             CCCcCCc-cCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC
Confidence            7777774 343333  67777777777777555556777777777777777775  3556666666 6777777777766


Q ss_pred             CCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhh
Q 002321          259 GNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMA  338 (936)
Q Consensus       259 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~  338 (936)
                      + +|..+.  ++|+.|++++|.+++..+..+..+++|++|+|++|++++..+..+..+++|+.|+|++|+++ .+|..+.
T Consensus       186 ~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~  261 (332)
T 2ft3_A          186 G-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLP  261 (332)
T ss_dssp             S-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGG
T ss_pred             c-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhh
Confidence            4 333222  34555555555555554455555555555555555555444444555555555555555555 3444455


Q ss_pred             ccCCCCEEEccCCcCc
Q 002321          339 NCMNLVALDFSQNSMN  354 (936)
Q Consensus       339 ~l~~L~~L~Ls~N~l~  354 (936)
                      .+++|+.|++++|+++
T Consensus       262 ~l~~L~~L~l~~N~l~  277 (332)
T 2ft3_A          262 DLKLLQVVYLHTNNIT  277 (332)
T ss_dssp             GCTTCCEEECCSSCCC
T ss_pred             cCccCCEEECCCCCCC
Confidence            5555555555555544

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=4.1e-37  Score=356.03  Aligned_cols=111  Identities=20%  Similarity=0.236  Sum_probs=57.4

Q ss_pred             ccccEEeccCCcccCcCCCc-hhhcCCCcEEEccCccccccc---chhhhhcCCCCcEEEccCccCCCCCCCCcc-ccc-
Q 002321          100 QFLRKLSLSSNNLTGSISPN-LAKLQNLRVIDLSGNSLSGSI---PDEFFKQCGSLRVISLAKNRFSGKIPSSLS-LCS-  173 (936)
Q Consensus       100 ~~L~~L~L~~n~l~~~~~~~-l~~l~~L~~L~Ls~N~l~~~i---~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~-~l~-  173 (936)
                      +.|++|+|++|+++...... +..+++|++|+|++|++++..   -...|..+++|++|+|++|++++..+..+. .++ 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            45677777777776543333 666777777777777766321   123455566666666666666533222221 122 


Q ss_pred             ---cccccccccccccC----CCCCCCCCCCCCCEEecCCCCCC
Q 002321          174 ---TLATINLSSNRFSS----PLPLGIWGLSALRTLDLSDNLLE  210 (936)
Q Consensus       174 ---~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~  210 (936)
                         +|++|+|++|+|+.    .++..+..+++|++|+|++|.++
T Consensus        83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~  126 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG  126 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred             CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCc
Confidence               34444444444442    12334444444444444444443

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=2.3e-32  Score=301.09  Aligned_cols=220  Identities=24%  Similarity=0.333  Sum_probs=122.9

Q ss_pred             cccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCcccccccccccc
Q 002321          101 FLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINL  180 (936)
Q Consensus       101 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  180 (936)
                      +++.++++++.++ .+|..+.  ++|++|+|++|+|+ .++...|..+++|++|+|++|+|++..|..|+.+++|++|+|
T Consensus        32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (330)
T 1xku_A           32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL  107 (330)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCC-EeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence            5667777777776 3454443  56777777777776 455555666666666666666666666666666666666666


Q ss_pred             ccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccc--cCCcccccccCcceeeccccccC
Q 002321          181 SSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSG--SIPDGIGSCSLLRTIDFSENSFS  258 (936)
Q Consensus       181 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~Ls~N~l~  258 (936)
                      ++|+++. +|..+.  ++|++|++++|++++..+..+.++++|++|++++|.++.  ..+..|..+++|++|++++|.++
T Consensus       108 s~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~  184 (330)
T 1xku_A          108 SKNQLKE-LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT  184 (330)
T ss_dssp             CSSCCSB-CCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred             CCCcCCc-cChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence            6666663 333332  456666666666665555555556666666666665542  44445555555555555555554


Q ss_pred             CCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhh
Q 002321          259 GNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMA  338 (936)
Q Consensus       259 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~  338 (936)
                      .                         +|..+.  ++|++|++++|++++..+..+.++++|+.|+|++|++++..+..+.
T Consensus       185 ~-------------------------l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~  237 (330)
T 1xku_A          185 T-------------------------IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA  237 (330)
T ss_dssp             S-------------------------CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGG
T ss_pred             c-------------------------CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhcc
Confidence            2                         122111  3455555555555544444455555555555555555544444444


Q ss_pred             ccCCCCEEEccCCcCc
Q 002321          339 NCMNLVALDFSQNSMN  354 (936)
Q Consensus       339 ~l~~L~~L~Ls~N~l~  354 (936)
                      .+++|+.|++++|++.
T Consensus       238 ~l~~L~~L~L~~N~l~  253 (330)
T 1xku_A          238 NTPHLRELHLNNNKLV  253 (330)
T ss_dssp             GSTTCCEEECCSSCCS
T ss_pred             CCCCCCEEECCCCcCc
Confidence            4555555555554443

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2e-32  Score=301.70  Aligned_cols=287  Identities=19%  Similarity=0.244  Sum_probs=147.6

Q ss_pred             CCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccC
Q 002321          199 LRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRK  278 (936)
Q Consensus       199 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~  278 (936)
                      |+.+++++|.++ .+|..+.  ++|++|+|++|.+++..|..|..+++|++|+|++|++++..|..|..+++|+.|+|++
T Consensus        35 l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  111 (332)
T 2ft3_A           35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK  111 (332)
T ss_dssp             TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred             CCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence            444444444444 3333332  3444455555544444444444444444444444444444344444444444444444


Q ss_pred             ccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccc--cCChhhhccCCCCEEEccCCcCccC
Q 002321          279 NLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTG--SLPDSMANCMNLVALDFSQNSMNGD  356 (936)
Q Consensus       279 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~  356 (936)
                      |.++ .+|..+.  ++|++|++++|++++..+..+.++++|+.|++++|.++.  ..+..+..+ +|             
T Consensus       112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L-------------  174 (332)
T 2ft3_A          112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KL-------------  174 (332)
T ss_dssp             SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CC-------------
T ss_pred             CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-cc-------------
Confidence            4443 2222222  445555555555554444444555555555555555532  333333333 44             


Q ss_pred             CChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccc
Q 002321          357 LPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAI  436 (936)
Q Consensus       357 ~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  436 (936)
                                                            ++|++++|++++ +|..+.  ++|++|+|++|++++..+..+
T Consensus       175 --------------------------------------~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l  213 (332)
T 2ft3_A          175 --------------------------------------NYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDL  213 (332)
T ss_dssp             --------------------------------------SCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSS
T ss_pred             --------------------------------------CEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHh
Confidence                                                  444444444432 222211  345555555555555555555


Q ss_pred             cCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccc------
Q 002321          437 GDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAK------  510 (936)
Q Consensus       437 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~------  510 (936)
                      ..+++|++|+|++|++++..+..+..+++|++|+|++|+++ .+|..+..+++|++|+|++|++++..+..|..      
T Consensus       214 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~  292 (332)
T 2ft3_A          214 LRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVK  292 (332)
T ss_dssp             TTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSS
T ss_pred             cCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccc
Confidence            55556666666666665544555566666666666666665 55666666666666666666666555555543      


Q ss_pred             cCCccEEEcCCCccc--CCCCcccccccccCeeecCCCc
Q 002321          511 LTNLQNVDLSFNSLT--GGLPKQLVNLVHLSSFNISHNH  547 (936)
Q Consensus       511 l~~L~~L~Ls~N~l~--~~~p~~l~~l~~L~~L~ls~N~  547 (936)
                      ..+|+.|++++|++.  +..|..+..+++|+.+++++|+
T Consensus       293 ~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          293 RAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             SCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             cccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence            356778888888776  5566777778888888887774

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.9e-34  Score=325.59  Aligned_cols=237  Identities=13%  Similarity=0.089  Sum_probs=177.1

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCC-CCccee---------eeE--
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRH-PNLVTL---------EGY--  755 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h-~niv~l---------~~~--  755 (936)
                      .+...+.||+|+||+||+|++. +|+.||||+++.....  ...+.+.+|+.+++.++| ++....         .+.  
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            3566778999999999999965 6899999998743322  225779999999999987 322111         111  


Q ss_pred             ----------EEe-----CCeeEEEEEecCCCChhhhhhcc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 002321          756 ----------YWT-----QSLQLLIYEFVSGGSLHKHLHEG----SGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI  816 (936)
Q Consensus       756 ----------~~~-----~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dl  816 (936)
                                +..     ....+++|+++ +++|.+++...    .....+++..++.++.|+++||+|||+++|+||||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi  237 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL  237 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence                      111     12346677766 78999988521    12234788899999999999999999999999999


Q ss_pred             CCCCEEEcCCCCeEEeeccCccccCCCccccccccccCcccccCccccc---------CcccCCchhhHHHHHHHHHHHH
Q 002321          817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFAC---------RTVKITDKCDVYGFGVLVLEVV  887 (936)
Q Consensus       817 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~~~DvwSlG~~l~el~  887 (936)
                      ||+|||++.++.+||+|||+++.....     .....| +.|+|||++.         ....++.++|||||||++|||+
T Consensus       238 Kp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          238 RPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             CGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             ccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            999999999999999999999865322     234456 8999999883         3445888999999999999999


Q ss_pred             cCCCCCCccchhHHHHHHHHHHHhhhccccceeeccccccccccccc
Q 002321          888 TGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       888 ~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      +|+.||............+......++.+++++.+||..||.+||+.
T Consensus       312 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~  358 (413)
T 3dzo_A          312 CADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLP  358 (413)
T ss_dssp             HSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCH
Confidence            99999987654322211111112345778999999999999999984

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=6.2e-32  Score=297.63  Aligned_cols=295  Identities=19%  Similarity=0.213  Sum_probs=158.6

Q ss_pred             cccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeecc
Q 002321          174 TLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFS  253 (936)
Q Consensus       174 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls  253 (936)
                      +|+.++++++.++. +|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|..+++|++|+|+
T Consensus        32 ~l~~l~~~~~~l~~-lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  108 (330)
T 1xku_A           32 HLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS  108 (330)
T ss_dssp             ETTEEECTTSCCCS-CCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCeEEEecCCCccc-cCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence            56666666666653 343332  455666666666665544455556666666666666655555555555555555555


Q ss_pred             ccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccc--
Q 002321          254 ENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTG--  331 (936)
Q Consensus       254 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~--  331 (936)
                      +|+++                         .+|..+.  ++|++|++++|++++..+..+.++++|+.|++++|.++.  
T Consensus       109 ~n~l~-------------------------~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  161 (330)
T 1xku_A          109 KNQLK-------------------------ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG  161 (330)
T ss_dssp             SSCCS-------------------------BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGG
T ss_pred             CCcCC-------------------------ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccC
Confidence            55554                         2222221  456666666666665555556666666666666666642  


Q ss_pred             cCChhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhh
Q 002321          332 SLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPAT  411 (936)
Q Consensus       332 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  411 (936)
                      ..+..+..+++|+.|++++|.+.. +|..                           +  .++|++|++++|++++..+..
T Consensus       162 ~~~~~~~~l~~L~~L~l~~n~l~~-l~~~---------------------------~--~~~L~~L~l~~n~l~~~~~~~  211 (330)
T 1xku_A          162 IENGAFQGMKKLSYIRIADTNITT-IPQG---------------------------L--PPSLTELHLDGNKITKVDAAS  211 (330)
T ss_dssp             BCTTGGGGCTTCCEEECCSSCCCS-CCSS---------------------------C--CTTCSEEECTTSCCCEECTGG
T ss_pred             cChhhccCCCCcCEEECCCCcccc-CCcc---------------------------c--cccCCEEECCCCcCCccCHHH
Confidence            455566666666666666666641 2110                           0  145666666666665555555


Q ss_pred             hcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccc
Q 002321          412 IGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLV  491 (936)
Q Consensus       412 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~  491 (936)
                      +..+++|++|+|++|++++..+..+..+++|++|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|....   
T Consensus       212 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~---  287 (330)
T 1xku_A          212 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG---  287 (330)
T ss_dssp             GTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSS---
T ss_pred             hcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcc---
Confidence            555555555555555555444445555555555555555554 3444444455555555555555433333332110   


Q ss_pred             cccccCccccCCCcccccccCCccEEEcCCCcccC--CCCcccccccccCeeecCCCc
Q 002321          492 SLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTG--GLPKQLVNLVHLSSFNISHNH  547 (936)
Q Consensus       492 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~ls~N~  547 (936)
                                     .....+.|+.|++++|++..  ..|..+..+.+|+.++|++|+
T Consensus       288 ---------------~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          288 ---------------YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             ---------------CCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             ---------------cccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence                           00113566667777776642  345666667777777777664

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=2.4e-36  Score=349.53  Aligned_cols=393  Identities=17%  Similarity=0.132  Sum_probs=248.0

Q ss_pred             CceEEeccCCCCCCcccccc-cccCccccEEeccCCcccCc----CCCchhhcCCCcEEEccCcccccccchhhhhcCC-
Q 002321           76 NRVIELTLNGLSLTGRIGRG-LLQLQFLRKLSLSSNNLTGS----ISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCG-  149 (936)
Q Consensus        76 ~~v~~l~l~~~~l~g~~~~~-l~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~-  149 (936)
                      .+++.|+|++++++...... +..+++|++|+|++|++++.    ++..+..+++|++|||++|++++..+..++..++ 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            46889999999987654444 78899999999999999853    4677888899999999999998666667777777 


Q ss_pred             ---CCcEEEccCccCCC----CCCCCccccccccccccccccccCCCCCCCC-----CCCCCCEEecCCCCCCCCC----
Q 002321          150 ---SLRVISLAKNRFSG----KIPSSLSLCSTLATINLSSNRFSSPLPLGIW-----GLSALRTLDLSDNLLEGEI----  213 (936)
Q Consensus       150 ---~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~----  213 (936)
                         +|++|+|++|+|+.    .++..+..+++|++|+|++|++++..+..+.     ..++|++|+|++|++++..    
T Consensus        83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l  162 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL  162 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence               79999999999984    4588889999999999999999865444332     3567999999999888643    


Q ss_pred             ccCccCCCCcceeecccccccccCCccccc-----ccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcc
Q 002321          214 PKGVESLKNLRVINLSKNMFSGSIPDGIGS-----CSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKW  288 (936)
Q Consensus       214 ~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~-----l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~  288 (936)
                      +..+..+++|++|+|++|.+++..+..+..     .++|++|+|++|.+++....                    .++..
T Consensus       163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~--------------------~l~~~  222 (461)
T 1z7x_W          163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR--------------------DLCGI  222 (461)
T ss_dssp             HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHH--------------------HHHHH
T ss_pred             HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHH--------------------HHHHH
Confidence            445566778888888888776544333332     44666666666666543100                    12334


Q ss_pred             cccCCccceecccCceecccc-----CcccccccccceEEccCCccccc----CChhhhccCCCCEEEccCCcCccCCCh
Q 002321          289 IGELESLETLDLSGNKFSGAV-----PISIGNLQRLKVLNFSANRLTGS----LPDSMANCMNLVALDFSQNSMNGDLPQ  359 (936)
Q Consensus       289 ~~~l~~L~~L~L~~N~l~~~~-----~~~l~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~  359 (936)
                      +..+++|++|++++|++++..     +..+..+++|++|++++|.+++.    ++..+..+++|+.|++++|.+.+..+.
T Consensus       223 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~  302 (461)
T 1z7x_W          223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR  302 (461)
T ss_dssp             HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred             HHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHH
Confidence            445555666666666555322     12223466777777777777753    456666677777777777776533222


Q ss_pred             hhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCC----ChhhhcccccCCeeeccCccccCCCCcc
Q 002321          360 WIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGE----TPATIGALSGLQLLNLSRNSLVGPIPVA  435 (936)
Q Consensus       360 ~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~  435 (936)
                      .+...                   +   ....++|++|+|++|.+++.    ++..+..+++|++|+|++|++++..+..
T Consensus       303 ~l~~~-------------------l---~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~  360 (461)
T 1z7x_W          303 LLCET-------------------L---LEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRE  360 (461)
T ss_dssp             HHHHH-------------------H---TSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHH
T ss_pred             HHHHH-------------------h---ccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHH
Confidence            11100                   0   01124677777777777654    3444455566666666666665432222


Q ss_pred             ccCcccCCeeecCCccccccCCCCCC-CcCCCcEEEecCCccCC----cCccccccccccccccccCccccCCCccccc-
Q 002321          436 IGDLKALNVLDLSENWLNGSIPPEIG-GAYSLKELRLERNFLAG----KIPTSIENCSSLVSLILSKNNLTGPIPIAIA-  509 (936)
Q Consensus       436 ~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~-  509 (936)
                      +..                    .+. ..++|+.|+|++|.+++    .+|..+..+++|++|+|++|++++.....+. 
T Consensus       361 l~~--------------------~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~  420 (461)
T 1z7x_W          361 LCQ--------------------GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE  420 (461)
T ss_dssp             HHH--------------------HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHH
T ss_pred             HHH--------------------HHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHH
Confidence            221                    000 13345555555555543    4555555556666666666655532211111 


Q ss_pred             ----ccCCccEEEcCCCcccCCCCc
Q 002321          510 ----KLTNLQNVDLSFNSLTGGLPK  530 (936)
Q Consensus       510 ----~l~~L~~L~Ls~N~l~~~~p~  530 (936)
                          ...+|+.|++.+|.+....+.
T Consensus       421 ~l~~~~~~L~~L~~~~~~~~~~~~~  445 (461)
T 1z7x_W          421 SVRQPGCLLEQLVLYDIYWSEEMED  445 (461)
T ss_dssp             HHTSTTCCCCEEECTTCCCCHHHHH
T ss_pred             HhccCCcchhheeecccccCHHHHH
Confidence                123466666666665543333

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.2e-33  Score=301.73  Aligned_cols=209  Identities=15%  Similarity=0.111  Sum_probs=172.6

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..+.||+|+||.||+|++. +++.||||++......  ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            34677789999999999999986 4899999999765432  23477899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++++|.++++..     ....++.+++.|++.||+|||++||+||||||+||+++.+|.+||+++|           
T Consensus       111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-----------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-----------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred             EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence            999999999998642     3556788999999999999999999999999999999999999998543           


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhH--------HHH-HH--HHHHHhhhcc
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMW--------WFS-VT--WLEEHWKKAE  915 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~--------~~~-~~--~~~~~~~~~~  915 (936)
                                 |++|        ++.++||||+||++|||++|+.||...+...        ... ..  .......++.
T Consensus       175 -----------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T 3uqc_A          175 -----------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ  235 (286)
T ss_dssp             -----------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHH
T ss_pred             -----------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHH
Confidence                       3333        5789999999999999999999998754311        000 00  0111234567


Q ss_pred             ccceeeccccccccccccc
Q 002321          916 WRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f  934 (936)
                      +.+++.+||..||.+| +.
T Consensus       236 l~~li~~~l~~dP~~R-s~  253 (286)
T 3uqc_A          236 ISAVAARSVQGDGGIR-SA  253 (286)
T ss_dssp             HHHHHHHHHCTTSSCC-CH
T ss_pred             HHHHHHHHcccCCccC-CH
Confidence            8999999999999999 64

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1e-32  Score=299.44  Aligned_cols=212  Identities=21%  Similarity=0.282  Sum_probs=171.5

Q ss_pred             ccCC-CcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHH-HcCCCCCcceeeeEEEe----CCeeEE
Q 002321          692 LNKD-CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKL-GKVRHPNLVTLEGYYWT----QSLQLL  764 (936)
Q Consensus       692 ~~~~-~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~l  764 (936)
                      |... +.||+|+||.||+|... +++.||||+++.      ...+.+|+.++ +..+||||+++++++..    ....++
T Consensus        19 y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l   92 (299)
T 3m2w_A           19 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI   92 (299)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             hhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence            3443 67999999999999975 689999999853      24577888888 55699999999999987    667899


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCCeEEeeccCccccC
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG---SGEPKVGDYGLARLLP  841 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~~  841 (936)
                      ||||+++|+|.+++..... ..+++.++..++.|++.||+|||++||+||||||+||+++.   ++.+||+|||++....
T Consensus        93 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  171 (299)
T 3m2w_A           93 VMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  171 (299)
T ss_dssp             EECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred             EEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence            9999999999999987542 34899999999999999999999999999999999999998   7899999999986431


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH------------HHHHHHH
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF------------SVTWLEE  909 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~------------~~~~~~~  909 (936)
                                               ...++.++||||+||++|||++|+.||.........            .......
T Consensus       172 -------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (299)
T 3m2w_A          172 -------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW  226 (299)
T ss_dssp             -------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHH
T ss_pred             -------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhc
Confidence                                     124678999999999999999999999765432110            0001111


Q ss_pred             HhhhccccceeecccccccccccccC
Q 002321          910 HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       910 ~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ...++.+.+++.+||..||.+||+++
T Consensus       227 ~~~~~~~~~li~~~l~~dP~~Rps~~  252 (299)
T 3m2w_A          227 SEVSEEVKMLIRNLLKTEPTQRMTIT  252 (299)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             ccCCHHHHHHHHHHcccChhhCCCHH
Confidence            33567889999999999999999863

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.98  E-value=1.7e-33  Score=311.00  Aligned_cols=226  Identities=19%  Similarity=0.200  Sum_probs=175.9

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCc-------cchHHHHHHHHHHHHcCC---------CCCccee
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSL-------VKSQEDFEREVKKLGKVR---------HPNLVTL  752 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~---------h~niv~l  752 (936)
                      ...|+..+.||+|+||+||+|++ +|+.||||+++....       ....+.+.+|++++++++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            34578889999999999999998 589999999976532       223477899999998886         6666666


Q ss_pred             eeEE-----------------Ee-------------CCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHH
Q 002321          753 EGYY-----------------WT-------------QSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKS  802 (936)
Q Consensus       753 ~~~~-----------------~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~a  802 (936)
                      .+++                 .+             ....++||||+++|++.+.+.+    ..+++.++..++.|++.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            6654                 22             6788999999999977766644    238999999999999999


Q ss_pred             HHHHH-hCCcccCCCCCCCEEEcCCC--------------------CeEEeeccCccccCCCccccccccccCcccccCc
Q 002321          803 LAHLH-QSNIIHYNIKSSNVLIDGSG--------------------EPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAP  861 (936)
Q Consensus       803 l~~LH-~~~ivH~Dlkp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aP  861 (936)
                      |+||| +++|+||||||+|||++.++                    .+||+|||+|+....       ....||+.|+||
T Consensus       174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aP  246 (336)
T 2vuw_A          174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDE  246 (336)
T ss_dssp             HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCS
T ss_pred             HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccCh
Confidence            99999 99999999999999999887                    899999999986542       234689999999


Q ss_pred             ccccCcccCCchhhHHHHHHH-HHHHHcCCCCCCccchhHHHHHHH------------HHHHhhhccccceeeccccccc
Q 002321          862 EFACRTVKITDKCDVYGFGVL-VLEVVTGKRPLSTWKMMWWFSVTW------------LEEHWKKAEWRNVSMRSCKGSS  928 (936)
Q Consensus       862 E~~~~~~~~~~~~DvwSlG~~-l~el~~g~~Pf~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~l~~~p  928 (936)
                      |++.+. . +.++||||++++ .+++++|..||.............            ..+...++++.+++.+||..|.
T Consensus       247 E~~~g~-~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~ds  324 (336)
T 2vuw_A          247 DLFTGD-G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSS  324 (336)
T ss_dssp             GGGCCC-S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSSS
T ss_pred             hhhcCC-C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccCC
Confidence            999544 3 889999998777 888999999996531100000000            1122345678999999999874

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=5.6e-32  Score=300.91  Aligned_cols=283  Identities=19%  Similarity=0.222  Sum_probs=236.5

Q ss_pred             CCccceeEEecCCCCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccc
Q 002321           62 TPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIP  141 (936)
Q Consensus        62 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~  141 (936)
                      ++|.|.|+ |+-          ++++++ .+|..+.  ++|++|+|++|+|++..+..|.++++|++|+|++|+++ .++
T Consensus        28 ~~C~~~~~-c~~----------~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~   92 (353)
T 2z80_A           28 LSCDRNGI-CKG----------SSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIE   92 (353)
T ss_dssp             CEECTTSE-EEC----------CSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC-EEC
T ss_pred             CCCCCCeE-eeC----------CCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccC-ccC
Confidence            37999998 764          334444 4565554  48999999999999877778999999999999999998 577


Q ss_pred             hhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCC-CCCCCCCCCCEEecCCC-CCCCCCccCccC
Q 002321          142 DEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLP-LGIWGLSALRTLDLSDN-LLEGEIPKGVES  219 (936)
Q Consensus       142 ~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~  219 (936)
                      ...|.++++|++|+|++|+|++..+..|+.+++|++|+|++|++++..+ ..+.++++|++|++++| .+++..+..+.+
T Consensus        93 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~  172 (353)
T 2z80_A           93 EDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAG  172 (353)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTT
T ss_pred             HhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccC
Confidence            7788999999999999999997666668999999999999999997555 57899999999999999 577666788999


Q ss_pred             CCCcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccc---cCCccc
Q 002321          220 LKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIG---ELESLE  296 (936)
Q Consensus       220 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~  296 (936)
                      +++|++|++++|++++..|..|..+++|++|++++|+++...+..+..+++|+.|++++|.+++..+..+.   ....++
T Consensus       173 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~  252 (353)
T 2z80_A          173 LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK  252 (353)
T ss_dssp             CCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCC
T ss_pred             CCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhh
Confidence            99999999999999988899999999999999999999755445566789999999999999977655443   356678


Q ss_pred             eecccCceecc----ccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCCh
Q 002321          297 TLDLSGNKFSG----AVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQ  359 (936)
Q Consensus       297 ~L~L~~N~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  359 (936)
                      .++|+++.+++    .+|..+.++++|+.|+|++|+++...+..|..+++|+.|++++|++.+..|.
T Consensus       253 ~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~~  319 (353)
T 2z80_A          253 KFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  319 (353)
T ss_dssp             EEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             ccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence            88888888775    4677788999999999999999954444568999999999999999987764

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.97  E-value=4.1e-34  Score=341.85  Aligned_cols=451  Identities=14%  Similarity=0.086  Sum_probs=295.0

Q ss_pred             CccceeEEecCCCCceEEeccCCCCCCcccccccccCccccEEeccCCcc---cCcCCCchh------------hcCCCc
Q 002321           63 PCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNL---TGSISPNLA------------KLQNLR  127 (936)
Q Consensus        63 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l---~~~~~~~l~------------~l~~L~  127 (936)
                      |+.|.++.+..  .+...  +.+ ......+..+..+++|++|+|+++..   .+.+|..++            .+++|+
T Consensus        41 ck~W~~~~~~~--~~~l~--~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~  115 (592)
T 3ogk_B           41 CRRWFKIDSET--REHVT--MAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK  115 (592)
T ss_dssp             CHHHHHHHHHH--CCEEE--ESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred             hHHHHHhhhcc--ccEEE--Eee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCC
Confidence            45899985432  22222  222 22233344567889999999987532   133443332            788999


Q ss_pred             EEEccCcccccccchhhhhcCCC-CcEEEccCcc-CCC-CCCCCccccccccccccccccccCCC----CCCCCCCCCCC
Q 002321          128 VIDLSGNSLSGSIPDEFFKQCGS-LRVISLAKNR-FSG-KIPSSLSLCSTLATINLSSNRFSSPL----PLGIWGLSALR  200 (936)
Q Consensus       128 ~L~Ls~N~l~~~i~~~~f~~l~~-L~~L~L~~N~-l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~  200 (936)
                      +|+|++|.+++..+..+...+++ |++|+|++|. ++. .++.....+++|++|+|++|.+++..    +..+.++++|+
T Consensus       116 ~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~  195 (592)
T 3ogk_B          116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLE  195 (592)
T ss_dssp             EEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCC
T ss_pred             eEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCcc
Confidence            99999998886544443333444 9999999886 221 11222346789999999999887652    23445788999


Q ss_pred             EEecCCCCCCC----CCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccC---CCCchhhhccccccE
Q 002321          201 TLDLSDNLLEG----EIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFS---GNLPETMQKLSLCNF  273 (936)
Q Consensus       201 ~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~---~~~~~~l~~l~~L~~  273 (936)
                      +|+|++|.+++    .++..+.++++|++|+|++|.+.+ ++..+..+++|++|+++.+...   +..+..+..+++|+.
T Consensus       196 ~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~  274 (592)
T 3ogk_B          196 VLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCR  274 (592)
T ss_dssp             EEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCE
T ss_pred             EEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccc
Confidence            99999998873    334445678899999999998885 5677888899999998864332   233455667778888


Q ss_pred             EeccCccccCCCCcccccCCccceecccCceeccccC-cccccccccceEEccCCcccccCChhhhccCCCCEEEccC--
Q 002321          274 MNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVP-ISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQ--  350 (936)
Q Consensus       274 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~--  350 (936)
                      |+++++. .+.+|..+..+++|++|+|++|.+++... ..+..+++|+.|+++++-..+.++..+..+++|+.|++++  
T Consensus       275 L~l~~~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~  353 (592)
T 3ogk_B          275 LGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGA  353 (592)
T ss_dssp             EEETTCC-TTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCC
T ss_pred             cCccccc-hhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCc
Confidence            8887753 34567777788888888888888765443 2356788888888883333333444556778888888883  


Q ss_pred             ---------CcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcc-cccCCe
Q 002321          351 ---------NSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGA-LSGLQL  420 (936)
Q Consensus       351 ---------N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~  420 (936)
                               |.+++.....                          ....+++|++|+++.|++++..+..+.. +++|+.
T Consensus       354 ~~~~~~~~~~~~~~~~~~~--------------------------l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~  407 (592)
T 3ogk_B          354 DEQGMEDEEGLVSQRGLIA--------------------------LAQGCQELEYMAVYVSDITNESLESIGTYLKNLCD  407 (592)
T ss_dssp             CSSTTSSTTCCCCHHHHHH--------------------------HHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCE
T ss_pred             cccccccccCccCHHHHHH--------------------------HHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcE
Confidence                     4443211000                          0123567888888888887766666665 788888


Q ss_pred             eecc----CccccCC-----CCccccCcccCCeeecCCcc--ccccCCCCCC-CcCCCcEEEecCCccCC-cCccccccc
Q 002321          421 LNLS----RNSLVGP-----IPVAIGDLKALNVLDLSENW--LNGSIPPEIG-GAYSLKELRLERNFLAG-KIPTSIENC  487 (936)
Q Consensus       421 L~L~----~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~--l~~~~p~~~~-~l~~L~~L~Ls~N~l~~-~~p~~l~~l  487 (936)
                      |+|+    .|.+++.     ++..+..+++|++|+|+.|.  +++..+..+. .+++|+.|+|++|.+++ .++..+.++
T Consensus       408 L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~  487 (592)
T 3ogk_B          408 FRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGC  487 (592)
T ss_dssp             EEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCC
T ss_pred             EEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcC
Confidence            8885    6677653     23336667888888887433  5543333332 36778888888888775 345556777


Q ss_pred             cccccccccCccccCC-CcccccccCCccEEEcCCCcccCCCCccc-ccccccCeeecCCC
Q 002321          488 SSLVSLILSKNNLTGP-IPIAIAKLTNLQNVDLSFNSLTGGLPKQL-VNLVHLSSFNISHN  546 (936)
Q Consensus       488 ~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~~L~ls~N  546 (936)
                      ++|++|+|++|++++. ++..+..+++|++|+|++|++++.-...+ ..++.+....+..+
T Consensus       488 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~  548 (592)
T 3ogk_B          488 PNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR  548 (592)
T ss_dssp             TTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred             cccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence            8888888888887644 33444567888888888888775432222 24555555555544

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=2.2e-31  Score=289.92  Aligned_cols=254  Identities=21%  Similarity=0.235  Sum_probs=200.3

Q ss_pred             CCCccceeEEecCCCCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccc-
Q 002321           61 DTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGS-  139 (936)
Q Consensus        61 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~-  139 (936)
                      .|.|.|.+|.|+..  .++           .+|..+.  ++|++|+|++|+++...+..|.++++|++|+|++|+++.. 
T Consensus         4 ~C~C~~~~l~c~~~--~l~-----------~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~   68 (306)
T 2z66_A            4 RCSCSGTEIRCNSK--GLT-----------SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG   68 (306)
T ss_dssp             TCEEETTEEECCSS--CCS-----------SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEE
T ss_pred             CCeeCCCEEEcCCC--Ccc-----------cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCccc
Confidence            34689999999753  222           3344332  6899999999999966556689999999999999999732 


Q ss_pred             -cchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCC-CCCCCCCCCCEEecCCCCCCCCCccCc
Q 002321          140 -IPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLP-LGIWGLSALRTLDLSDNLLEGEIPKGV  217 (936)
Q Consensus       140 -i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~  217 (936)
                       ++ ..+..+++|++|+|++|.+++ +|..+..+++|++|+|++|++++..+ ..+..+++|++|++++|.+++..+..+
T Consensus        69 ~~~-~~~~~~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~  146 (306)
T 2z66_A           69 CCS-QSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF  146 (306)
T ss_dssp             EEE-HHHHSCSCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTT
T ss_pred             Ccc-cccccccccCEEECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhc
Confidence             23 345678999999999999984 66678889999999999999988665 678889999999999999988888888


Q ss_pred             cCCCCcceeecccccccc-cCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccc
Q 002321          218 ESLKNLRVINLSKNMFSG-SIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLE  296 (936)
Q Consensus       218 ~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  296 (936)
                      .++++|++|+|++|.+++ ..|..+..+++|++|+|++|++++..|..+..+++|+.|+|++|.+++..+..+..+++|+
T Consensus       147 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  226 (306)
T 2z66_A          147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ  226 (306)
T ss_dssp             TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCC
T ss_pred             ccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCC
Confidence            889999999999999886 5788888888899999888888877777777777777777777777766666677777777


Q ss_pred             eecccCceeccccCccccccc-ccceEEccCCcccc
Q 002321          297 TLDLSGNKFSGAVPISIGNLQ-RLKVLNFSANRLTG  331 (936)
Q Consensus       297 ~L~L~~N~l~~~~~~~l~~l~-~L~~L~L~~N~l~~  331 (936)
                      +|+|++|++++..|..+..++ +|+.|+|++|.+++
T Consensus       227 ~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~  262 (306)
T 2z66_A          227 VLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC  262 (306)
T ss_dssp             EEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred             EeECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence            777777777766666666663 67777777777664

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=2.5e-30  Score=287.57  Aligned_cols=260  Identities=18%  Similarity=0.219  Sum_probs=118.4

Q ss_pred             CCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecc
Q 002321          150 SLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLS  229 (936)
Q Consensus       150 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  229 (936)
                      +|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..+.++++|++|+|+
T Consensus        53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  132 (353)
T 2z80_A           53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLL  132 (353)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECT
T ss_pred             cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECC
Confidence            34444444444443333344444444444444444444444445555555555555555553333334555555555555


Q ss_pred             cccccccCC-cccccccCcceeeccccc-cCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceecc
Q 002321          230 KNMFSGSIP-DGIGSCSLLRTIDFSENS-FSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSG  307 (936)
Q Consensus       230 ~N~l~~~~p-~~l~~l~~L~~L~Ls~N~-l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  307 (936)
                      +|++++..+ ..|..+++|++|++++|. +++..+..|                        ..+++|++|++++|++++
T Consensus       133 ~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~------------------------~~l~~L~~L~l~~n~l~~  188 (353)
T 2z80_A          133 GNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF------------------------AGLTFLEELEIDASDLQS  188 (353)
T ss_dssp             TCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTT------------------------TTCCEEEEEEEEETTCCE
T ss_pred             CCCCcccCchhhhccCCCCcEEECCCCccccccCHHHc------------------------cCCCCCCEEECCCCCcCc
Confidence            555553222 244555555555555552 332222233                        333334444444444443


Q ss_pred             ccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCC
Q 002321          308 AVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASS  387 (936)
Q Consensus       308 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~  387 (936)
                      ..|..+.++++|++|++++|+++......+..+++|+.|++++|.+++..+..+.                        .
T Consensus       189 ~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~------------------------~  244 (353)
T 2z80_A          189 YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELS------------------------T  244 (353)
T ss_dssp             ECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC----------------------------
T ss_pred             cCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccc------------------------c
Confidence            3344444444444444444444322222233344455555555544422111000                        0


Q ss_pred             CCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCC-CCCcCCC
Q 002321          388 GSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPE-IGGAYSL  466 (936)
Q Consensus       388 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L  466 (936)
                      ......++.++|++|.+++                   |.+. .+|..+..+++|++|+|++|+++. +|.. +..+++|
T Consensus       245 ~~~~~~l~~l~L~~~~l~~-------------------~~l~-~l~~~l~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L  303 (353)
T 2z80_A          245 GETNSLIKKFTFRNVKITD-------------------ESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSL  303 (353)
T ss_dssp             --CCCCCCEEEEESCBCCH-------------------HHHH-HHHHHHHTCTTCCEEECCSSCCCC-CCTTTTTTCTTC
T ss_pred             ccccchhhccccccccccC-------------------cchh-hhHHHHhcccCCCEEECCCCCCCc-cCHHHHhcCCCC
Confidence            0112345555555555432                   2221 234455555666666666666653 4433 4666677


Q ss_pred             cEEEecCCccCC
Q 002321          467 KELRLERNFLAG  478 (936)
Q Consensus       467 ~~L~Ls~N~l~~  478 (936)
                      ++|+|++|.+++
T Consensus       304 ~~L~L~~N~~~~  315 (353)
T 2z80_A          304 QKIWLHTNPWDC  315 (353)
T ss_dssp             CEEECCSSCBCC
T ss_pred             CEEEeeCCCccC
Confidence            777777776664

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=2.3e-29  Score=288.59  Aligned_cols=239  Identities=24%  Similarity=0.263  Sum_probs=179.2

Q ss_pred             ccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCcc
Q 002321           91 RIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLS  170 (936)
Q Consensus        91 ~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~  170 (936)
                      .+|..+.  ++++.|+|++|+|++..+..|.++++|++|+|++|+|+ .++...|.++++|++|+|++|+|++..+..|.
T Consensus        57 ~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  133 (440)
T 3zyj_A           57 EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFV  133 (440)
T ss_dssp             SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCC-EECGGGGTTCSSCCEEECCSSCCSSCCTTTSC
T ss_pred             cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCC-ccChhhccCCccCCEEECCCCcCCeeCHhHhh
Confidence            4555544  67899999999999888889999999999999999998 67778888899999999999988877777788


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCEEecCCC-CCCCCCccCccCCCCcceeecccccccccCCcccccccCcce
Q 002321          171 LCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDN-LLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRT  249 (936)
Q Consensus       171 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~  249 (936)
                      .+++|++|+|++|+|+.+.+..|.++++|++|+|++| .+....+..|.++++|++|+|++|+++ .+| .+..+++|++
T Consensus       134 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~  211 (440)
T 3zyj_A          134 YLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDE  211 (440)
T ss_dssp             SCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCE
T ss_pred             ccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCE
Confidence            8888888888888888777777888888888888874 444333345677777777777777776 333 2555555555


Q ss_pred             eeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcc
Q 002321          250 IDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRL  329 (936)
Q Consensus       250 L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l  329 (936)
                      |+|++|+++                        +..|..|..+++|+.|+|++|++++..+..|.++++|+.|+|++|++
T Consensus       212 L~Ls~N~l~------------------------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l  267 (440)
T 3zyj_A          212 LDLSGNHLS------------------------AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL  267 (440)
T ss_dssp             EECTTSCCC------------------------EECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCC
T ss_pred             EECCCCccC------------------------ccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCC
Confidence            555555554                        44455566666677777777777766677777777778888888877


Q ss_pred             cccCChhhhccCCCCEEEccCCcCccCCC
Q 002321          330 TGSLPDSMANCMNLVALDFSQNSMNGDLP  358 (936)
Q Consensus       330 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  358 (936)
                      ++..+..|..+++|+.|+|++|++.++-.
T Consensus       268 ~~~~~~~~~~l~~L~~L~L~~Np~~CdC~  296 (440)
T 3zyj_A          268 TLLPHDLFTPLHHLERIHLHHNPWNCNCD  296 (440)
T ss_dssp             CCCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred             CccChhHhccccCCCEEEcCCCCccCCCC
Confidence            77777777778888888888888875543

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=4.5e-32  Score=324.17  Aligned_cols=420  Identities=13%  Similarity=0.062  Sum_probs=313.6

Q ss_pred             CceEEeccCCCCC---Ccccccccc------------cCccccEEeccCCcccCcCCCchhhc--CCCcEEEccCcc-cc
Q 002321           76 NRVIELTLNGLSL---TGRIGRGLL------------QLQFLRKLSLSSNNLTGSISPNLAKL--QNLRVIDLSGNS-LS  137 (936)
Q Consensus        76 ~~v~~l~l~~~~l---~g~~~~~l~------------~l~~L~~L~L~~n~l~~~~~~~l~~l--~~L~~L~Ls~N~-l~  137 (936)
                      .++.+|+|+++..   .|.+|..++            .+++|++|+|++|.+++..+..+..+  .+|++|+|++|. ++
T Consensus        73 ~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~  152 (592)
T 3ogk_B           73 PNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFT  152 (592)
T ss_dssp             TTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEE
T ss_pred             CCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcC
Confidence            4588888877432   133333322            78999999999999988777778774  459999999987 33


Q ss_pred             cccchhhhhcCCCCcEEEccCccCCCC----CCCCccccccccccccccccccCC----CCCCCCCCCCCCEEecCCCCC
Q 002321          138 GSIPDEFFKQCGSLRVISLAKNRFSGK----IPSSLSLCSTLATINLSSNRFSSP----LPLGIWGLSALRTLDLSDNLL  209 (936)
Q Consensus       138 ~~i~~~~f~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l  209 (936)
                      ..--..+...+++|++|+|++|.+++.    ++..+..+++|++|+|++|.+++.    ++..+.++++|++|+|++|.+
T Consensus       153 ~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~  232 (592)
T 3ogk_B          153 TDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEI  232 (592)
T ss_dssp             HHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBG
T ss_pred             HHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccH
Confidence            222223446899999999999998765    333456789999999999999843    334456789999999999999


Q ss_pred             CCCCccCccCCCCcceeeccccccc---ccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCC
Q 002321          210 EGEIPKGVESLKNLRVINLSKNMFS---GSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVP  286 (936)
Q Consensus       210 ~~~~~~~~~~l~~L~~L~L~~N~l~---~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~  286 (936)
                      .+ ++..+.++++|++|+++.+...   +..+..+..+++|+.|+++++. .+.+|..+..+++|+.|+|++|.+++...
T Consensus       233 ~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~  310 (592)
T 3ogk_B          233 LE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETEDH  310 (592)
T ss_dssp             GG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGGGGGGCCEEEETTCCCCHHHH
T ss_pred             HH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHHhhcCCCcEEecCCCcCCHHHH
Confidence            85 7788999999999999864333   2344667889999999999864 34678888899999999999999765443


Q ss_pred             -cccccCCccceecccCceeccccCcccccccccceEEcc-----------CCcccccC-ChhhhccCCCCEEEccCCcC
Q 002321          287 -KWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFS-----------ANRLTGSL-PDSMANCMNLVALDFSQNSM  353 (936)
Q Consensus       287 -~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~-----------~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l  353 (936)
                       ..+..+++|++|+++++...+.++.....+++|++|+++           .|.+++.. +..+..+++|+.|+++.|.+
T Consensus       311 ~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l  390 (592)
T 3ogk_B          311 CTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDI  390 (592)
T ss_dssp             HHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCC
T ss_pred             HHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCc
Confidence             346789999999999443333344444678999999999           46777543 33456689999999999988


Q ss_pred             ccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEecc----CcccCCC-----ChhhhcccccCCeeecc
Q 002321          354 NGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLS----HNEFSGE-----TPATIGALSGLQLLNLS  424 (936)
Q Consensus       354 ~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls----~N~l~~~-----~~~~~~~l~~L~~L~L~  424 (936)
                      ++..+..+.                          ..+++|+.|+++    .|.+++.     ++..+.++++|++|+|+
T Consensus       391 ~~~~~~~l~--------------------------~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~  444 (592)
T 3ogk_B          391 TNESLESIG--------------------------TYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFY  444 (592)
T ss_dssp             CHHHHHHHH--------------------------HHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEE
T ss_pred             cHHHHHHHH--------------------------hhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEe
Confidence            754433221                          125689999996    7788764     44457778999999998


Q ss_pred             Ccc--ccCCCCcccc-CcccCCeeecCCccccc-cCCCCCCCcCCCcEEEecCCccCCc-CccccccccccccccccCcc
Q 002321          425 RNS--LVGPIPVAIG-DLKALNVLDLSENWLNG-SIPPEIGGAYSLKELRLERNFLAGK-IPTSIENCSSLVSLILSKNN  499 (936)
Q Consensus       425 ~N~--l~~~~~~~~~-~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~L~~N~  499 (936)
                      +|.  +++..+..+. .+++|++|+|++|++++ .++..+.++++|+.|+|++|.+++. ++..+..+++|++|+|++|+
T Consensus       445 ~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~  524 (592)
T 3ogk_B          445 LRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR  524 (592)
T ss_dssp             CCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred             cCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence            544  6544444443 47899999999999986 3455567889999999999998754 45556789999999999999


Q ss_pred             ccCCCcccc-cccCCccEEEcCCCc
Q 002321          500 LTGPIPIAI-AKLTNLQNVDLSFNS  523 (936)
Q Consensus       500 l~~~~p~~~-~~l~~L~~L~Ls~N~  523 (936)
                      +++.....+ ..++.|....+..++
T Consensus       525 it~~~~~~l~~~~p~l~~~~~~~~~  549 (592)
T 3ogk_B          525 ASMTGQDLMQMARPYWNIELIPSRR  549 (592)
T ss_dssp             CCTTCTTGGGGCCTTEEEEEECCC-
T ss_pred             CCHHHHHHHHHhCCCcEEEEecCcc
Confidence            987644444 357777777666653

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=2.6e-31  Score=289.80  Aligned_cols=248  Identities=17%  Similarity=0.199  Sum_probs=148.4

Q ss_pred             cCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccc-cccchhhh------hcCCCCcEEEccCccCCCCCCCCc-
Q 002321           98 QLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLS-GSIPDEFF------KQCGSLRVISLAKNRFSGKIPSSL-  169 (936)
Q Consensus        98 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~-~~i~~~~f------~~l~~L~~L~L~~N~l~~~~p~~~-  169 (936)
                      ..++|++|++++|++  .+|..+...  |+.|+|++|+++ +.+|...+      .++++|++|+|++|+|++.+|..+ 
T Consensus        41 ~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  116 (312)
T 1wwl_A           41 GGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL  116 (312)
T ss_dssp             EEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSS
T ss_pred             cCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHH
Confidence            344555555666655  445544443  555566666552 23443322      145566666666666665555554 


Q ss_pred             -cccccccccccccccccCCCCCCCCCC-----CCCCEEecCCCCCCCCCccCccCCCCcceeeccccccccc--CCccc
Q 002321          170 -SLCSTLATINLSSNRFSSPLPLGIWGL-----SALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGS--IPDGI  241 (936)
Q Consensus       170 -~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~l  241 (936)
                       +.+++|++|+|++|++++. |..+..+     ++|++|+|++|++++..|..|.++++|++|+|++|++.+.  .+..+
T Consensus       117 ~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  195 (312)
T 1wwl_A          117 EATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL  195 (312)
T ss_dssp             SCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHS
T ss_pred             HhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHH
Confidence             5566666666666666654 5555544     5666666666666655556666666666666666665543  12222


Q ss_pred             --ccccCcceeeccccccCCC--C-chhhhccccccEEeccCccccCCCC-cccccCCccceecccCceeccccCccccc
Q 002321          242 --GSCSLLRTIDFSENSFSGN--L-PETMQKLSLCNFMNLRKNLFSGEVP-KWIGELESLETLDLSGNKFSGAVPISIGN  315 (936)
Q Consensus       242 --~~l~~L~~L~Ls~N~l~~~--~-~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~l~~  315 (936)
                        ..+++|++|+|++|++++.  + ...+..+++|+.|+|++|++++..| ..+..+++|++|+|++|+|+ .+|..+. 
T Consensus       196 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~-  273 (312)
T 1wwl_A          196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP-  273 (312)
T ss_dssp             CTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC-
T ss_pred             HhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc-
Confidence              5666666666666666521  1 1233455667777777777766554 34555677777777777777 5565554 


Q ss_pred             ccccceEEccCCcccccCChhhhccCCCCEEEccCCcCcc
Q 002321          316 LQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNG  355 (936)
Q Consensus       316 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  355 (936)
                       ++|++|+|++|+|++. |. +..+++|+.|++++|++++
T Consensus       274 -~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          274 -AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             -SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             -CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence             6777777777777754 44 7777777777777777763

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=2.9e-29  Score=288.73  Aligned_cols=232  Identities=25%  Similarity=0.241  Sum_probs=155.3

Q ss_pred             ccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccc
Q 002321          100 QFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATIN  179 (936)
Q Consensus       100 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  179 (936)
                      ++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .++...|.++++|++|+|++|+|++..+..|..+++|++|+
T Consensus        75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  153 (452)
T 3zyi_A           75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELW  153 (452)
T ss_dssp             TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEE
T ss_pred             CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccC-CcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEE
Confidence            56777777777777777777777777777777777777 45556667777777777777777665555666666666666


Q ss_pred             cccccccCCCCCCCCCCCCCCEEecCC-CCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccC
Q 002321          180 LSSNRFSSPLPLGIWGLSALRTLDLSD-NLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFS  258 (936)
Q Consensus       180 L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~  258 (936)
                      |++|+|+.+.+..|.++++|++|+|++ |.+....+..|.++++|++|+|++|++++. | .+..               
T Consensus       154 L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~---------------  216 (452)
T 3zyi_A          154 LRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTP---------------  216 (452)
T ss_dssp             CCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTT---------------
T ss_pred             CCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccc---------------
Confidence            666666665555666666666666666 333322233455555555555555555532 2 2344               


Q ss_pred             CCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhh
Q 002321          259 GNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMA  338 (936)
Q Consensus       259 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~  338 (936)
                               +++|+.|+|++|.+++..|..|..+++|+.|+|++|++++..+..|.++++|+.|+|++|+|++..+..|.
T Consensus       217 ---------l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  287 (452)
T 3zyi_A          217 ---------LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFT  287 (452)
T ss_dssp             ---------CTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSST
T ss_pred             ---------cccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhc
Confidence                     44555555555555555566666777777777777777777777777788888888888888877777778


Q ss_pred             ccCCCCEEEccCCcCccCCC
Q 002321          339 NCMNLVALDFSQNSMNGDLP  358 (936)
Q Consensus       339 ~l~~L~~L~Ls~N~l~~~~p  358 (936)
                      .+++|+.|+|++|++.++..
T Consensus       288 ~l~~L~~L~L~~Np~~CdC~  307 (452)
T 3zyi_A          288 PLRYLVELHLHHNPWNCDCD  307 (452)
T ss_dssp             TCTTCCEEECCSSCEECSTT
T ss_pred             cccCCCEEEccCCCcCCCCC
Confidence            88888888888888876543

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=2.5e-29  Score=270.63  Aligned_cols=255  Identities=20%  Similarity=0.212  Sum_probs=195.5

Q ss_pred             EEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccC
Q 002321           79 IELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAK  158 (936)
Q Consensus        79 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~  158 (936)
                      +.++.++++++ .+|..+  .++|++|+|++|+|++..+..|.++++|++|+|++|+++ .++...|..+++|++|+|++
T Consensus        14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~   89 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSD   89 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCS
T ss_pred             eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccc-eeCHhhcCCccCCCEEeCCC
Confidence            44555555665 345433  468899999999998877788899999999999999988 56666788889999999999


Q ss_pred             cc-CCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccC
Q 002321          159 NR-FSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSI  237 (936)
Q Consensus       159 N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  237 (936)
                      |+ ++...|..|..+++|++|+|++|++++..|..+.++++|++|+|++|++++..+..|.++++|++|+|++|++++..
T Consensus        90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  169 (285)
T 1ozn_A           90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP  169 (285)
T ss_dssp             CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence            87 77777888888888899999888888887888888888888888888888776677888888888888888888766


Q ss_pred             CcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCccccccc
Q 002321          238 PDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQ  317 (936)
Q Consensus       238 p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~  317 (936)
                      +..|..+++|++|+|++|++++..|..|..+++|+.|+|++|.+++..+..+..+++|++|+|++|.+....+.. .-..
T Consensus       170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~  248 (285)
T 1ozn_A          170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWA  248 (285)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHH
T ss_pred             HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHH
Confidence            667888888888888888888777778888888888888888887766666777777888888888776433321 1223


Q ss_pred             ccceEEccCCcccccCChhhh
Q 002321          318 RLKVLNFSANRLTGSLPDSMA  338 (936)
Q Consensus       318 ~L~~L~L~~N~l~~~~~~~~~  338 (936)
                      .++.+....+.+....|..+.
T Consensus       249 ~l~~~~~~~~~~~c~~p~~l~  269 (285)
T 1ozn_A          249 WLQKFRGSSSEVPCSLPQRLA  269 (285)
T ss_dssp             HHHHCCSEECCCBEEESGGGT
T ss_pred             HHHhcccccCccccCCchHhC
Confidence            344555556666655555543

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=5.1e-29  Score=271.21  Aligned_cols=248  Identities=22%  Similarity=0.245  Sum_probs=137.5

Q ss_pred             EEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCC--CchhhhccccccEEeccC
Q 002321          201 TLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGN--LPETMQKLSLCNFMNLRK  278 (936)
Q Consensus       201 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~~~~l~~l~~L~~L~L~~  278 (936)
                      .++++++.++ .+|..+.  ++|++|+|++|+++...+..|..+++|++|+|++|+++..  .+..+..+++|+.|+|++
T Consensus        11 ~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~   87 (306)
T 2z66_A           11 EIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF   87 (306)
T ss_dssp             EEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCS
T ss_pred             EEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCC
Confidence            3444444444 3333222  3455555555555433333345555555555555554421  234444455555555555


Q ss_pred             ccccCCCCcccccCCccceecccCceeccccC-cccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCC
Q 002321          279 NLFSGEVPKWIGELESLETLDLSGNKFSGAVP-ISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDL  357 (936)
Q Consensus       279 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  357 (936)
                      |.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..+..+..+++|+.|++++|.+.+. 
T Consensus        88 n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-  165 (306)
T 2z66_A           88 NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN-  165 (306)
T ss_dssp             CSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG-
T ss_pred             Cccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc-
Confidence            5554 244456666677777777777765443 4566667777777777777666666666666666666666665420 


Q ss_pred             ChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCcccc
Q 002321          358 PQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIG  437 (936)
Q Consensus       358 p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  437 (936)
                                               .++..+..+++|++|+|++|++++..|..+..+++|++|+|++|++++..+..+.
T Consensus       166 -------------------------~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  220 (306)
T 2z66_A          166 -------------------------FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK  220 (306)
T ss_dssp             -------------------------EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGT
T ss_pred             -------------------------cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhcc
Confidence                                     0122233455666666666666655566666666666666666666655555555


Q ss_pred             CcccCCeeecCCccccccCCCCCCCcC-CCcEEEecCCccCC
Q 002321          438 DLKALNVLDLSENWLNGSIPPEIGGAY-SLKELRLERNFLAG  478 (936)
Q Consensus       438 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~  478 (936)
                      .+++|++|+|++|++++..|..+..++ +|+.|+|++|.+++
T Consensus       221 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~  262 (306)
T 2z66_A          221 CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC  262 (306)
T ss_dssp             TCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred             CcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence            666666666666666655555555553 55566666555553

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=3.3e-29  Score=269.72  Aligned_cols=229  Identities=24%  Similarity=0.266  Sum_probs=145.1

Q ss_pred             cEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCcccccccccccccc
Q 002321          103 RKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSS  182 (936)
Q Consensus       103 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  182 (936)
                      +.++.++++++. +|..+  .++|++|+|++|+|+ .++...|..+++|++|+|++|+|++..|..|+.+++|++|+|++
T Consensus        14 ~~~~c~~~~l~~-ip~~~--~~~l~~L~l~~n~i~-~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   89 (285)
T 1ozn_A           14 VTTSCPQQGLQA-VPVGI--PAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD   89 (285)
T ss_dssp             CEEECCSSCCSS-CCTTC--CTTCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             eEEEcCcCCccc-CCcCC--CCCceEEEeeCCcCC-ccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence            567777777763 44433  356777777777776 45555666666666666666666665566666666666666666


Q ss_pred             cc-ccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCC
Q 002321          183 NR-FSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNL  261 (936)
Q Consensus       183 N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~  261 (936)
                      |+ ++...|..|.++++|++|+|++|.+++..|..+.++++|++|++++|++++..+..|..+++|++|+|++|+     
T Consensus        90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-----  164 (285)
T 1ozn_A           90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR-----  164 (285)
T ss_dssp             CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC-----
T ss_pred             CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCc-----
Confidence            65 555545555556666666666665555545555555555555555555554444444455555555555444     


Q ss_pred             chhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccC
Q 002321          262 PETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCM  341 (936)
Q Consensus       262 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~  341 (936)
                                         +++..+..+..+++|++|+|++|++++..|..+.++++|+.|++++|++++..+..+..++
T Consensus       165 -------------------l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  225 (285)
T 1ozn_A          165 -------------------ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR  225 (285)
T ss_dssp             -------------------CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCT
T ss_pred             -------------------ccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCc
Confidence                               4444444566667777777777777766677777777788888888887766666777778


Q ss_pred             CCCEEEccCCcCccCCCh
Q 002321          342 NLVALDFSQNSMNGDLPQ  359 (936)
Q Consensus       342 ~L~~L~Ls~N~l~~~~p~  359 (936)
                      +|+.|++++|++.++.+.
T Consensus       226 ~L~~L~l~~N~~~c~~~~  243 (285)
T 1ozn_A          226 ALQYLRLNDNPWVCDCRA  243 (285)
T ss_dssp             TCCEEECCSSCEECSGGG
T ss_pred             ccCEEeccCCCccCCCCc
Confidence            888888888877755443

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=1.5e-30  Score=283.87  Aligned_cols=269  Identities=19%  Similarity=0.203  Sum_probs=229.2

Q ss_pred             CCCCCCCCCCCCccceeEEecCCCCceEEeccCCCCCCcccccccccCccccEEeccCCccc-CcCCCchh-------hc
Q 002321           52 KLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLT-GSISPNLA-------KL  123 (936)
Q Consensus        52 ~l~sW~~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~-~~~~~~l~-------~l  123 (936)
                      ...+|..... |+.|..+.......+++.++++++.+  .+|..+...  |++|+|++|+++ ..+|..+.       ++
T Consensus        20 ~~~~~~~~~~-c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l   94 (312)
T 1wwl_A           20 PKPDWSSAFN-CLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGI   94 (312)
T ss_dssp             SSCCGGGGGG-SSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTT
T ss_pred             cccchHHHhh-hhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCc
Confidence            3567876655 66776654332336788999999999  788877665  999999999995 45666665       79


Q ss_pred             CCCcEEEccCcccccccchhhh-hcCCCCcEEEccCccCCCCCCCCcccc-----ccccccccccccccCCCCCCCCCCC
Q 002321          124 QNLRVIDLSGNSLSGSIPDEFF-KQCGSLRVISLAKNRFSGKIPSSLSLC-----STLATINLSSNRFSSPLPLGIWGLS  197 (936)
Q Consensus       124 ~~L~~L~Ls~N~l~~~i~~~~f-~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~  197 (936)
                      ++|++|+|++|++++.+|..+| ..+++|++|+|++|+|++. |..++.+     ++|++|+|++|+|++..|..|.+++
T Consensus        95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~  173 (312)
T 1wwl_A           95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP  173 (312)
T ss_dssp             SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred             CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence            9999999999999998998876 8999999999999999987 8888888     9999999999999999889999999


Q ss_pred             CCCEEecCCCCCCCC--CccCc--cCCCCcceeeccccccccc---CCcccccccCcceeeccccccCCCCc-hhhhccc
Q 002321          198 ALRTLDLSDNLLEGE--IPKGV--ESLKNLRVINLSKNMFSGS---IPDGIGSCSLLRTIDFSENSFSGNLP-ETMQKLS  269 (936)
Q Consensus       198 ~L~~L~L~~N~l~~~--~~~~~--~~l~~L~~L~L~~N~l~~~---~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~  269 (936)
                      +|++|+|++|++.+.  .+..+  .++++|++|+|++|++++.   ....+..+++|++|+|++|++++..| ..+..++
T Consensus       174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~  253 (312)
T 1wwl_A          174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS  253 (312)
T ss_dssp             SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCT
T ss_pred             CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcC
Confidence            999999999998865  23344  8899999999999999832   22445678999999999999998775 5677789


Q ss_pred             cccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccc
Q 002321          270 LCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTG  331 (936)
Q Consensus       270 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~  331 (936)
                      +|+.|+|++|.++ .+|..+.  ++|++|+|++|+|++. |. +..+++|++|+|++|++++
T Consensus       254 ~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          254 QLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             TCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             CCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            9999999999999 6777766  8999999999999976 65 8999999999999999985

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=1.5e-28  Score=282.89  Aligned_cols=229  Identities=20%  Similarity=0.220  Sum_probs=179.7

Q ss_pred             CCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEe
Q 002321          124 QNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLD  203 (936)
Q Consensus       124 ~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  203 (936)
                      ++|++|+|++|+|+ .++...|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|+++.+..|.++++|++|+
T Consensus        75 ~~l~~L~L~~n~i~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  153 (452)
T 3zyi_A           75 SNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELW  153 (452)
T ss_dssp             TTCSEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEE
T ss_pred             CCccEEECcCCcCc-eECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEE
Confidence            57899999999998 56667778888888888888888877777787788888888888887776666777777777777


Q ss_pred             cCCCCCCCCCccCccCCCCcceeeccc-ccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCcccc
Q 002321          204 LSDNLLEGEIPKGVESLKNLRVINLSK-NMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFS  282 (936)
Q Consensus       204 L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~  282 (936)
                      |++|+|+...+..|.++++|++|+|++ |.++...+..|..+++|++|+|++|+++                        
T Consensus       154 L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~------------------------  209 (452)
T 3zyi_A          154 LRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK------------------------  209 (452)
T ss_dssp             CCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS------------------------
T ss_pred             CCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc------------------------
Confidence            777777755555677777777777776 3444333345666666666666666554                        


Q ss_pred             CCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhh
Q 002321          283 GEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIF  362 (936)
Q Consensus       283 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  362 (936)
                      +. | .+..+++|++|+|++|++++..|..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..+.
T Consensus       210 ~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  287 (452)
T 3zyi_A          210 DM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFT  287 (452)
T ss_dssp             SC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSST
T ss_pred             cc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhc
Confidence            22 2 367889999999999999999999999999999999999999999999999999999999999999955444332


Q ss_pred             -ccCCccccccccccccC
Q 002321          363 -SSGLNKVSFAENKIREG  379 (936)
Q Consensus       363 -~~~l~~l~l~~n~l~~~  379 (936)
                       ...++.|++.+|.+...
T Consensus       288 ~l~~L~~L~L~~Np~~Cd  305 (452)
T 3zyi_A          288 PLRYLVELHLHHNPWNCD  305 (452)
T ss_dssp             TCTTCCEEECCSSCEECS
T ss_pred             cccCCCEEEccCCCcCCC
Confidence             36799999999988653

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=2e-28  Score=280.78  Aligned_cols=242  Identities=22%  Similarity=0.272  Sum_probs=185.4

Q ss_pred             cCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccC
Q 002321          108 SSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSS  187 (936)
Q Consensus       108 ~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  187 (936)
                      ++++++ .+|..+.  ++++.|+|++|+|+ .++...|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++
T Consensus        51 ~~~~l~-~iP~~~~--~~l~~L~L~~n~i~-~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~  126 (440)
T 3zyj_A           51 VRKNLR-EVPDGIS--TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTT  126 (440)
T ss_dssp             CSCCCS-SCCSCCC--TTCSEEECCSCCCC-EECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSS
T ss_pred             CCCCcC-cCCCCCC--CCCcEEEccCCcCC-eeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCe
Confidence            344555 4566554  67889999999988 5666777888888888888888877777777777777777777777777


Q ss_pred             CCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccc-cccccCCcccccccCcceeeccccccCCCCchhhh
Q 002321          188 PLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKN-MFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQ  266 (936)
Q Consensus       188 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~  266 (936)
                      +.+..|.++++|++|+|++|.|+...+..|.++++|++|+|++| .++...+..|..+++|++|+|++|+++        
T Consensus       127 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~--------  198 (440)
T 3zyj_A          127 IPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR--------  198 (440)
T ss_dssp             CCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS--------
T ss_pred             eCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc--------
Confidence            66667777777777777777777655566777777777777763 444333445666666666666666554        


Q ss_pred             ccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEE
Q 002321          267 KLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVAL  346 (936)
Q Consensus       267 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  346 (936)
                                       .+| .+..+++|++|+|++|++++..|..|.++++|+.|+|++|++++..+..|..+++|+.|
T Consensus       199 -----------------~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  260 (440)
T 3zyj_A          199 -----------------EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEI  260 (440)
T ss_dssp             -----------------SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEE
T ss_pred             -----------------ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEE
Confidence                             223 36678899999999999999889999999999999999999999999999999999999


Q ss_pred             EccCCcCccCCChhhh-ccCCccccccccccccC
Q 002321          347 DFSQNSMNGDLPQWIF-SSGLNKVSFAENKIREG  379 (936)
Q Consensus       347 ~Ls~N~l~~~~p~~~~-~~~l~~l~l~~n~l~~~  379 (936)
                      +|++|++++..+..+. ...++.|++.+|.+...
T Consensus       261 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd  294 (440)
T 3zyj_A          261 NLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN  294 (440)
T ss_dssp             ECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECS
T ss_pred             ECCCCCCCccChhHhccccCCCEEEcCCCCccCC
Confidence            9999999955544332 36899999999998753

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=1.7e-28  Score=268.97  Aligned_cols=289  Identities=18%  Similarity=0.238  Sum_probs=196.6

Q ss_pred             HHHhccCCCCCCCCCCCCC-CCCccceeEEecCCC--CceEEeccCCCCCCccccccc--ccCccccEEeccCCcccCcC
Q 002321           42 FKADIQDPNGKLSSWSEDD-DTPCNWFGVKCSPRS--NRVIELTLNGLSLTGRIGRGL--LQLQFLRKLSLSSNNLTGSI  116 (936)
Q Consensus        42 ~k~~~~d~~~~l~sW~~~~-~~~c~w~gv~c~~~~--~~v~~l~l~~~~l~g~~~~~l--~~l~~L~~L~L~~n~l~~~~  116 (936)
                      .|.++.|+...+..|...- .+||.|.++-|....  ..+...  .|.... .++..+  ...+.+++|+|++|+|+ .+
T Consensus        21 ~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~--~g~~~~-~~~~~l~~~~~~~l~~L~L~~n~l~-~l   96 (328)
T 4fcg_A           21 GSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETR--TGRALK-ATADLLEDATQPGRVALELRSVPLP-QF   96 (328)
T ss_dssp             --CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCS--HHHHHH-HHHHHHHHHTSTTCCEEEEESSCCS-SC
T ss_pred             ccccCchHHHHHHHHHHhccCCchhhhhhhccccccccccccc--CCcchh-hhHHHHhcccccceeEEEccCCCch-hc
Confidence            3455556666678887532 237999988874321  222111  110000 111111  23467888888888887 67


Q ss_pred             CCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCC
Q 002321          117 SPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGL  196 (936)
Q Consensus       117 ~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  196 (936)
                      |..+.++++|++|+|++|+|+ .+|. .|..+++|++|+|++|+++ .+|..++.+++|++|+|++|++.+.+|..+...
T Consensus        97 p~~l~~l~~L~~L~L~~n~l~-~lp~-~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~  173 (328)
T 4fcg_A           97 PDQAFRLSHLQHMTIDAAGLM-ELPD-TMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST  173 (328)
T ss_dssp             CSCGGGGTTCSEEEEESSCCC-CCCS-CGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE
T ss_pred             ChhhhhCCCCCEEECCCCCcc-chhH-HHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc
Confidence            777888888888888888887 6664 3466777777777777776 556667777777777777766666666554330


Q ss_pred             CCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEec
Q 002321          197 SALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNL  276 (936)
Q Consensus       197 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L  276 (936)
                                     ..+..+.++++|++|+|++|+++ .+|..++.+++|++|+|++|++++ +|..+..+++|+.|+|
T Consensus       174 ---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~L  236 (328)
T 4fcg_A          174 ---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDL  236 (328)
T ss_dssp             ---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEEC
T ss_pred             ---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEEC
Confidence                           11122445777777777777777 666677777777777777777774 4556777777777777


Q ss_pred             cCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCc
Q 002321          277 RKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMN  354 (936)
Q Consensus       277 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  354 (936)
                      ++|.+.+.+|..++.+++|++|+|++|++.+.+|..+.++++|++|+|++|.+.+.+|..+.++++|+.+++..|.+.
T Consensus       237 s~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             TTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             cCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            777777777888888888888888888888888888888888888888888888888888888888888888877664

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=5.5e-29  Score=293.38  Aligned_cols=294  Identities=27%  Similarity=0.321  Sum_probs=175.1

Q ss_pred             CCCCCCCCCCCCCCccceeEEecC------CCCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhc
Q 002321           50 NGKLSSWSEDDDTPCNWFGVKCSP------RSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKL  123 (936)
Q Consensus        50 ~~~l~sW~~~~~~~c~w~gv~c~~------~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l  123 (936)
                      ...+++|....+ ||.|+|..|.-      ....++.|++++++++ .+|..+.  ++|++|+|++|+|++ +|.   .+
T Consensus         9 ~~~w~~W~~~~~-~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~---~l   80 (622)
T 3g06_A            9 DAVWSAWRRAAP-AEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LP   80 (622)
T ss_dssp             -CHHHHHHHTCC-GGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC---CC
T ss_pred             HHHHHHHHhcCC-cchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC---cC
Confidence            345677877666 89997753311      1134666777777666 5565554  566677777766663 343   45


Q ss_pred             CCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEe
Q 002321          124 QNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLD  203 (936)
Q Consensus       124 ~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  203 (936)
                      ++|++|+|++|+|+ .+|.    .+++|++|+|++|+|++. |.   .+++|+.|+|++|+|++ +|.   .+++|++|+
T Consensus        81 ~~L~~L~Ls~N~l~-~lp~----~l~~L~~L~Ls~N~l~~l-~~---~l~~L~~L~L~~N~l~~-lp~---~l~~L~~L~  147 (622)
T 3g06_A           81 PELRTLEVSGNQLT-SLPV----LPPGLLELSIFSNPLTHL-PA---LPSGLCKLWIFGNQLTS-LPV---LPPGLQELS  147 (622)
T ss_dssp             TTCCEEEECSCCCS-CCCC----CCTTCCEEEECSCCCCCC-CC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEE
T ss_pred             CCCCEEEcCCCcCC-cCCC----CCCCCCEEECcCCcCCCC-CC---CCCCcCEEECCCCCCCc-CCC---CCCCCCEEE
Confidence            66666666666666 4553    456666666666666542 22   34556666666666554 232   135555555


Q ss_pred             cCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccC
Q 002321          204 LSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSG  283 (936)
Q Consensus       204 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~  283 (936)
                      |++|++++ +|.   .+++|+.|++++|+|++ +|   ..+++|++|+|++|+|+                        +
T Consensus       148 Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~------------------------~  195 (622)
T 3g06_A          148 VSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLA------------------------S  195 (622)
T ss_dssp             CCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS------------------------C
T ss_pred             CcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCC------------------------C
Confidence            55555553 232   12345555555555553 23   22344555555555544                        3


Q ss_pred             CCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhc
Q 002321          284 EVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFS  363 (936)
Q Consensus       284 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  363 (936)
                       +|.   .+++|+.|++++|.++ .+|.   .+++|+.|+|++|+|++ +|   ..+++|+.|++++|+|+ .+|.    
T Consensus       196 -l~~---~~~~L~~L~L~~N~l~-~l~~---~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~----  258 (622)
T 3g06_A          196 -LPT---LPSELYKLWAYNNRLT-SLPA---LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM----  258 (622)
T ss_dssp             -CCC---CCTTCCEEECCSSCCS-SCCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC----
T ss_pred             -CCC---ccchhhEEECcCCccc-ccCC---CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc----
Confidence             222   1345666666666666 3332   23567777777777774 44   34567777777777775 2221    


Q ss_pred             cCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcc
Q 002321          364 SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLK  440 (936)
Q Consensus       364 ~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  440 (936)
                                                .+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+++.+|..+..++
T Consensus       259 --------------------------~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          259 --------------------------LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             --------------------------CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             --------------------------ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence                                      2457888888888887 5677788888888888888888877777666655

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.95  E-value=1.7e-31  Score=319.42  Aligned_cols=451  Identities=14%  Similarity=0.129  Sum_probs=304.4

Q ss_pred             CccceeEEecCCCCceEEeccCCCCCCcccc-cccccCccccEEeccCCccc---CcCCC------------chhhcCCC
Q 002321           63 PCNWFGVKCSPRSNRVIELTLNGLSLTGRIG-RGLLQLQFLRKLSLSSNNLT---GSISP------------NLAKLQNL  126 (936)
Q Consensus        63 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~-~~l~~l~~L~~L~L~~n~l~---~~~~~------------~l~~l~~L  126 (936)
                      |+.|.++..    .....+++.+..  +..+ ..+..+++|++|+|+++...   +..|.            .+..+++|
T Consensus        34 ck~W~~~~~----~~~~~l~~~~~~--~~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L  107 (594)
T 2p1m_B           34 CKSWYEIER----WCRRKVFIGNCY--AVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL  107 (594)
T ss_dssp             CHHHHHHHH----HHCCEEEESSTT--SSCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred             HHHHHHhhh----hhceEEeecccc--ccCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence            558888821    223344554432  2223 23678899999999987532   11221            13578899


Q ss_pred             cEEEccCcccccccchhhhhcCCCCcEEEccCc-cCCCC-CCCCccccccccccccccccccCCCCCCCC----CCCCCC
Q 002321          127 RVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKN-RFSGK-IPSSLSLCSTLATINLSSNRFSSPLPLGIW----GLSALR  200 (936)
Q Consensus       127 ~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~----~l~~L~  200 (936)
                      ++|+|++|.+++..+..+...+++|++|+|++| .++.. ++..+..+++|++|+|++|.+++..+..+.    .+++|+
T Consensus       108 ~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~  187 (594)
T 2p1m_B          108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV  187 (594)
T ss_dssp             CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCC
T ss_pred             CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCc
Confidence            999999999987666665557999999999999 55532 334445789999999999998876554443    677999


Q ss_pred             EEecCCCC--CCCC-CccCccCCCCcceeecccc-cccccCCcccccccCcceeecccc-------ccCCCCchhhhccc
Q 002321          201 TLDLSDNL--LEGE-IPKGVESLKNLRVINLSKN-MFSGSIPDGIGSCSLLRTIDFSEN-------SFSGNLPETMQKLS  269 (936)
Q Consensus       201 ~L~L~~N~--l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~Ls~N-------~l~~~~~~~l~~l~  269 (936)
                      +|+|++|.  ++.. ++..+.++++|++|+|++| .+++ ++..+..+++|++|+++.+       .+.+ ++..+.+++
T Consensus       188 ~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~  265 (594)
T 2p1m_B          188 SLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCK  265 (594)
T ss_dssp             EEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCT
T ss_pred             EEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCC
Confidence            99999997  3211 1122345699999999998 5554 7778888999999996554       3333 344677888


Q ss_pred             cccEE-eccCccccCCCCcccccCCccceecccCceeccccCc-ccccccccceEEccCCccccc-CChhhhccCCCCEE
Q 002321          270 LCNFM-NLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPI-SIGNLQRLKVLNFSANRLTGS-LPDSMANCMNLVAL  346 (936)
Q Consensus       270 ~L~~L-~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~l~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L  346 (936)
                      +|+.| .+..... +.++..+..+++|++|+|++|.+++.... .+..+++|+.|++++| ++.. ++.....+++|+.|
T Consensus       266 ~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L  343 (594)
T 2p1m_B          266 ELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLREL  343 (594)
T ss_dssp             TCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEE
T ss_pred             CcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEE
Confidence            88888 4443322 34455556778899999999987654332 2457889999999988 4432 23334458889999


Q ss_pred             EccCC---------cCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhc-ccc
Q 002321          347 DFSQN---------SMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIG-ALS  416 (936)
Q Consensus       347 ~Ls~N---------~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~  416 (936)
                      +++++         .+++.....                       +   ...+++|+.|+++.|++++.....+. .++
T Consensus       344 ~L~~~~~~g~~~~~~l~~~~l~~-----------------------l---~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~  397 (594)
T 2p1m_B          344 RVFPSEPFVMEPNVALTEQGLVS-----------------------V---SMGCPKLESVLYFCRQMTNAALITIARNRP  397 (594)
T ss_dssp             EEECSCTTCSSCSSCCCHHHHHH-----------------------H---HHHCTTCCEEEEEESCCCHHHHHHHHHHCT
T ss_pred             EEecCcccccccCCCCCHHHHHH-----------------------H---HHhchhHHHHHHhcCCcCHHHHHHHHhhCC
Confidence            88543         222110000                       0   01257888998888888876666665 578


Q ss_pred             cCCeeecc--C----ccccCCC-----CccccCcccCCeeecCCccccccCCCCCCC-cCCCcEEEecCCccCCcCcccc
Q 002321          417 GLQLLNLS--R----NSLVGPI-----PVAIGDLKALNVLDLSENWLNGSIPPEIGG-AYSLKELRLERNFLAGKIPTSI  484 (936)
Q Consensus       417 ~L~~L~L~--~----N~l~~~~-----~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~l  484 (936)
                      +|+.|+|+  +    |.+++..     +..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+
T Consensus       398 ~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l  476 (594)
T 2p1m_B          398 NMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHV  476 (594)
T ss_dssp             TCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHH
T ss_pred             CcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHH
Confidence            99999998  4    5555221     12256778899999977 666544444444 7889999999999876655555


Q ss_pred             -ccccccccccccCccccCCCcc-cccccCCccEEEcCCCcccCCCCccc-ccccccCeeecCCCcccc
Q 002321          485 -ENCSSLVSLILSKNNLTGPIPI-AIAKLTNLQNVDLSFNSLTGGLPKQL-VNLVHLSSFNISHNHLQG  550 (936)
Q Consensus       485 -~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~~L~ls~N~l~~  550 (936)
                       ..+++|++|+|++|++++..+. ....+++|++|+|++|+++..-...+ ..+++|+...+..+.-..
T Consensus       477 ~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~~~  545 (594)
T 2p1m_B          477 LSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAPD  545 (594)
T ss_dssp             HHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSCGG
T ss_pred             HhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCccc
Confidence             6689999999999998654443 34568899999999998854333344 456777666666665443

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=8.1e-30  Score=278.69  Aligned_cols=248  Identities=21%  Similarity=0.182  Sum_probs=180.8

Q ss_pred             hccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCE
Q 002321          266 QKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVA  345 (936)
Q Consensus       266 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  345 (936)
                      ..+++|+.|+|++|.+++..|..|..+++|++|+|++|++++..+  +..+++|++|++++|++++..     ..++|+.
T Consensus        31 ~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~  103 (317)
T 3o53_A           31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIET  103 (317)
T ss_dssp             TTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCE
T ss_pred             ccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCE
Confidence            333444444444444444444445555555555555555554333  555566666666666655322     2356677


Q ss_pred             EEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccC
Q 002321          346 LDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSR  425 (936)
Q Consensus       346 L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  425 (936)
                      |++++|++.+..+                              ..+++|++|++++|++++..+..+..+++|++|+|++
T Consensus       104 L~l~~n~l~~~~~------------------------------~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~  153 (317)
T 3o53_A          104 LHAANNNISRVSC------------------------------SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL  153 (317)
T ss_dssp             EECCSSCCSEEEE------------------------------CCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTT
T ss_pred             EECCCCccCCcCc------------------------------cccCCCCEEECCCCCCCCccchhhhccCCCCEEECCC
Confidence            7777776652211                              1246788888888888887777888889999999999


Q ss_pred             ccccCCCCccc-cCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCC
Q 002321          426 NSLVGPIPVAI-GDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPI  504 (936)
Q Consensus       426 N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  504 (936)
                      |++++..+..+ ..+++|++|+|++|.+++. +. ...+++|++|+|++|++++ +|..+..+++|++|+|++|+++ .+
T Consensus       154 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l  229 (317)
T 3o53_A          154 NEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LI  229 (317)
T ss_dssp             SCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EE
T ss_pred             CCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-ch
Confidence            99987767666 4788999999999999865 33 3358899999999999994 5666999999999999999999 57


Q ss_pred             cccccccCCccEEEcCCCccc-CCCCcccccccccCeeecC-CCcccccCCC
Q 002321          505 PIAIAKLTNLQNVDLSFNSLT-GGLPKQLVNLVHLSSFNIS-HNHLQGELPA  554 (936)
Q Consensus       505 p~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~ls-~N~l~~~~p~  554 (936)
                      |..+..+++|+.|+|++|+++ +.+|..+..+++|+.|+++ .+.++|..|.
T Consensus       230 ~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~  281 (317)
T 3o53_A          230 EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE  281 (317)
T ss_dssp             CTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred             hhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence            888999999999999999998 7788999999999999998 4566765543

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.95  E-value=1.1e-27  Score=255.46  Aligned_cols=217  Identities=22%  Similarity=0.281  Sum_probs=176.0

Q ss_pred             CCccceeEEecCCCCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccc
Q 002321           62 TPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIP  141 (936)
Q Consensus        62 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~  141 (936)
                      ++|.|.|+.|.-. +.+..+++++++++ .+|..+.  ++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+|
T Consensus         3 ~~C~~~~~~C~c~-~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~i~   77 (270)
T 2o6q_A            3 ALCKKDGGVCSCN-NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLP   77 (270)
T ss_dssp             CCBGGGTCSBEEE-TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-CCC
T ss_pred             ccCCCCCCCCEeC-CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-eeC
Confidence            3899999998643 45678899999988 4676554  67999999999999877778999999999999999998 788


Q ss_pred             hhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCC
Q 002321          142 DEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLK  221 (936)
Q Consensus       142 ~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  221 (936)
                      ..+|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|.|++..+..|..++
T Consensus        78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~  157 (270)
T 2o6q_A           78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLT  157 (270)
T ss_dssp             TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCc
Confidence            88888999999999999999877777788888888888888888887777888888888888888888866666678888


Q ss_pred             CcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccC
Q 002321          222 NLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSG  283 (936)
Q Consensus       222 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~  283 (936)
                      +|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+..
T Consensus       158 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  219 (270)
T 2o6q_A          158 SLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC  219 (270)
T ss_dssp             TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             ccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence            88888888888887766677788888888888888776655566666666666666666553

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=5e-27  Score=276.72  Aligned_cols=267  Identities=27%  Similarity=0.316  Sum_probs=135.9

Q ss_pred             cccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeecc
Q 002321          174 TLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFS  253 (936)
Q Consensus       174 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls  253 (936)
                      +++.|++++|.|+ .+|..+.  ++|++|+|++|.|+ .+|.   .+++|++|+|++|+|++ +|.   .+++|++|+|+
T Consensus        41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls  109 (622)
T 3g06_A           41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIF  109 (622)
T ss_dssp             CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEEC
T ss_pred             CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECc
Confidence            4667777777776 3454443  56677777777666 3443   34566666666666663 333   44566666666


Q ss_pred             ccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccC
Q 002321          254 ENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSL  333 (936)
Q Consensus       254 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~  333 (936)
                      +|++++..+                            .+++|+.|++++|+|++ +|..   +++|++|+|++|++++ +
T Consensus       110 ~N~l~~l~~----------------------------~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l  156 (622)
T 3g06_A          110 SNPLTHLPA----------------------------LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-L  156 (622)
T ss_dssp             SCCCCCCCC----------------------------CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-C
T ss_pred             CCcCCCCCC----------------------------CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-c
Confidence            666553211                            23344444444444442 2221   2445555555555543 2


Q ss_pred             ChhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhc
Q 002321          334 PDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIG  413 (936)
Q Consensus       334 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  413 (936)
                      |.   ...+|+.|++++|.+++ +|                              ..+++|+.|+|++|+|++. |.   
T Consensus       157 ~~---~~~~L~~L~L~~N~l~~-l~------------------------------~~~~~L~~L~Ls~N~l~~l-~~---  198 (622)
T 3g06_A          157 PA---LPSELCKLWAYNNQLTS-LP------------------------------MLPSGLQELSVSDNQLASL-PT---  198 (622)
T ss_dssp             CC---CCTTCCEEECCSSCCSC-CC------------------------------CCCTTCCEEECCSSCCSCC-CC---
T ss_pred             CC---ccCCCCEEECCCCCCCC-Cc------------------------------ccCCCCcEEECCCCCCCCC-CC---
Confidence            21   12344455555554431 11                              1134555555555555532 21   


Q ss_pred             ccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccc
Q 002321          414 ALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSL  493 (936)
Q Consensus       414 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L  493 (936)
                      .+++|+.|++++|.++. +|..   +++|+.|+|++|.|++ +|   ..+++|+.|+|++|+|+ .+|.   .+++|+.|
T Consensus       199 ~~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L  266 (622)
T 3g06_A          199 LPSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSL  266 (622)
T ss_dssp             CCTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEE
T ss_pred             ccchhhEEECcCCcccc-cCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEE
Confidence            12455555555555552 2321   2455556666665553 33   23355556666666555 3443   34555555


Q ss_pred             cccCccccCCCcccccccCCccEEEcCCCcccCCCCcccccc
Q 002321          494 ILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNL  535 (936)
Q Consensus       494 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l  535 (936)
                      +|++|+|+ .+|..+.++++|+.|+|++|++++.+|..+..+
T Consensus       267 ~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L  307 (622)
T 3g06_A          267 SVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI  307 (622)
T ss_dssp             ECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHH
T ss_pred             eCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhc
Confidence            55555555 445555555556666666665555555544444

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=4.5e-29  Score=272.75  Aligned_cols=257  Identities=19%  Similarity=0.189  Sum_probs=145.9

Q ss_pred             ccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccc
Q 002321          102 LRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLS  181 (936)
Q Consensus       102 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  181 (936)
                      ++.++++.+++.......+..+++|++|+|++|+|+ .++...|..+++|++|+|++|++++..+  +..+++|++|+|+
T Consensus        12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls   88 (317)
T 3o53_A           12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN   88 (317)
T ss_dssp             EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCC-CCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred             eeEeeccccchhhhHHHHhccCCCCCEEECcCCccC-cCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence            445566666665444444555666777777777776 3555556666667777776666665443  6666666666666


Q ss_pred             cccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCC
Q 002321          182 SNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNL  261 (936)
Q Consensus       182 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~  261 (936)
                      +|+|++..     ..++|++|++++|++++..+..   +++|++|++++|++++..+..+..+++|++|+|++|.+++  
T Consensus        89 ~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--  158 (317)
T 3o53_A           89 NNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT--  158 (317)
T ss_dssp             SSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCE--
T ss_pred             CCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCc--
Confidence            66665432     2255666666666665433322   3445555555555555444455555555555555555543  


Q ss_pred             chhhhccccccEEeccCccccCCCCccc-ccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhcc
Q 002321          262 PETMQKLSLCNFMNLRKNLFSGEVPKWI-GELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANC  340 (936)
Q Consensus       262 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l  340 (936)
                                            ..+..+ ..+++|++|+|++|++++. +. ...+++|++|+|++|++++. |..+..+
T Consensus       159 ----------------------~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l-~~~~~~l  213 (317)
T 3o53_A          159 ----------------------VNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFM-GPEFQSA  213 (317)
T ss_dssp             ----------------------EEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEE-CGGGGGG
T ss_pred             ----------------------ccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcc-hhhhccc
Confidence                                  333333 2455666666666666543 21 22356666777777766643 3346666


Q ss_pred             CCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccC-CCChhhhcccccCC
Q 002321          341 MNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFS-GETPATIGALSGLQ  419 (936)
Q Consensus       341 ~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~  419 (936)
                      ++|+.|++++|++++ +|                           ..+..+++|+.|+|++|.+. +..+..+..+++|+
T Consensus       214 ~~L~~L~L~~N~l~~-l~---------------------------~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~  265 (317)
T 3o53_A          214 AGVTWISLRNNKLVL-IE---------------------------KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ  265 (317)
T ss_dssp             TTCSEEECTTSCCCE-EC---------------------------TTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHH
T ss_pred             CcccEEECcCCcccc-hh---------------------------hHhhcCCCCCEEEccCCCccCcCHHHHHhccccce
Confidence            666666666666651 11                           12234556666666666665 55566666666666


Q ss_pred             eeecc
Q 002321          420 LLNLS  424 (936)
Q Consensus       420 ~L~L~  424 (936)
                      .|+++
T Consensus       266 ~l~l~  270 (317)
T 3o53_A          266 TVAKQ  270 (317)
T ss_dssp             HHHHH
T ss_pred             EEECC
Confidence            66666

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=6.2e-29  Score=291.27  Aligned_cols=186  Identities=15%  Similarity=0.084  Sum_probs=130.9

Q ss_pred             cccccCceEEEEEEeC-CCcEEEEEEeeccCc---------cchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEE
Q 002321          697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL---------VKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  765 (936)
                      ..+.|++|.+..++.. .|+.||||++.....         ....+++.+|+++|+++ .|+||++++++++++...|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            4566777766665522 489999999965421         12246799999999999 799999999999999999999


Q ss_pred             EEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc
Q 002321          766 YEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      |||++|++|.+++.+...   ++..   +|+.||+.||+|+|++|||||||||+|||++++|.+||+|||+|+...... 
T Consensus       321 MEyv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-  393 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-  393 (569)
T ss_dssp             EECCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred             EecCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-
Confidence            999999999999987543   5554   588999999999999999999999999999999999999999998664322 


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCC
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP  892 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~P  892 (936)
                       .......||+.|||||++.+  .+..++|+||+|++++++.++..|
T Consensus       394 -~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          394 -SWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred             -ccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence             22344679999999999843  357789999999998887665444

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.94  E-value=4e-30  Score=307.46  Aligned_cols=416  Identities=15%  Similarity=0.156  Sum_probs=291.0

Q ss_pred             cEEeccCCcccCcCCCchhhcCCCcEEEccCccccccc---c-----------hhhhhcCCCCcEEEccCccCCCCCCCC
Q 002321          103 RKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSI---P-----------DEFFKQCGSLRVISLAKNRFSGKIPSS  168 (936)
Q Consensus       103 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i---~-----------~~~f~~l~~L~~L~L~~N~l~~~~p~~  168 (936)
                      +.+++++.... .....+..+++|+.|+|+++.....+   |           ..++..+++|++|+|++|.+++..+..
T Consensus        46 ~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~  124 (594)
T 2p1m_B           46 RKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLEL  124 (594)
T ss_dssp             CEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHH
T ss_pred             eEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHH
Confidence            35566544322 12245678899999999997632122   1           234567899999999999988776666


Q ss_pred             cc-ccccccccccccc-cccCC-CCCCCCCCCCCCEEecCCCCCCCCCccCcc----CCCCcceeeccccc--cccc-CC
Q 002321          169 LS-LCSTLATINLSSN-RFSSP-LPLGIWGLSALRTLDLSDNLLEGEIPKGVE----SLKNLRVINLSKNM--FSGS-IP  238 (936)
Q Consensus       169 ~~-~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~----~l~~L~~L~L~~N~--l~~~-~p  238 (936)
                      +. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+.    .+++|++|++++|.  ++.. ++
T Consensus       125 l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~  204 (594)
T 2p1m_B          125 IAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALE  204 (594)
T ss_dssp             HHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHH
T ss_pred             HHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHH
Confidence            65 6899999999998 55542 233344789999999999998865554443    66799999999887  2211 11


Q ss_pred             cccccccCcceeecccc-ccCCCCchhhhccccccEEeccCc-------cccCCCCcccccCCcccee-cccCceecccc
Q 002321          239 DGIGSCSLLRTIDFSEN-SFSGNLPETMQKLSLCNFMNLRKN-------LFSGEVPKWIGELESLETL-DLSGNKFSGAV  309 (936)
Q Consensus       239 ~~l~~l~~L~~L~Ls~N-~l~~~~~~~l~~l~~L~~L~L~~N-------~l~~~~~~~~~~l~~L~~L-~L~~N~l~~~~  309 (936)
                      ..+..+++|++|+|++| .+.+ ++..+..+++|+.|+++.+       .+.+ ++..+.++++|+.| .+.+... +.+
T Consensus       205 ~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~l  281 (594)
T 2p1m_B          205 RLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVP-AYL  281 (594)
T ss_dssp             HHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCG-GGG
T ss_pred             HHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccch-hhH
Confidence            22345689999999988 4444 7777888889999985443       4443 33467788888888 4544433 244


Q ss_pred             CcccccccccceEEccCCcccccCC-hhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCC
Q 002321          310 PISIGNLQRLKVLNFSANRLTGSLP-DSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSG  388 (936)
Q Consensus       310 ~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~  388 (936)
                      +..+..+++|++|+|++|.+++... ..+..+++|+.|++++| +.......                          ..
T Consensus       282 ~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~--------------------------l~  334 (594)
T 2p1m_B          282 PAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEV--------------------------LA  334 (594)
T ss_dssp             GGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHH--------------------------HH
T ss_pred             HHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHH--------------------------HH
Confidence            5555577888999998888765432 33557888888888877 33111000                          01


Q ss_pred             CCCCcccEEecc---------CcccCCCChhhhc-ccccCCeeeccCccccCCCCcccc-CcccCCeeecC--C----cc
Q 002321          389 SSFESLQFLDLS---------HNEFSGETPATIG-ALSGLQLLNLSRNSLVGPIPVAIG-DLKALNVLDLS--E----NW  451 (936)
Q Consensus       389 ~~l~~L~~L~Ls---------~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls--~----N~  451 (936)
                      ..+++|++|+++         .+.+++.....+. .+++|++|.++.|.+++.....+. .+++|+.|+|+  +    |.
T Consensus       335 ~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~  414 (594)
T 2p1m_B          335 STCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDY  414 (594)
T ss_dssp             HHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCT
T ss_pred             HhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccc
Confidence            235778999883         3556544334443 488999999999999865555554 58899999999  4    55


Q ss_pred             cccc-----CCCCCCCcCCCcEEEecCCccCCcCcccccc-ccccccccccCccccCCCcccc-cccCCccEEEcCCCcc
Q 002321          452 LNGS-----IPPEIGGAYSLKELRLERNFLAGKIPTSIEN-CSSLVSLILSKNNLTGPIPIAI-AKLTNLQNVDLSFNSL  524 (936)
Q Consensus       452 l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~-l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l  524 (936)
                      +++.     ++..+..+++|+.|+|++ .+++..+..++. +++|++|+|++|.+++..+..+ ..+++|++|+|++|++
T Consensus       415 l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~  493 (594)
T 2p1m_B          415 LTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF  493 (594)
T ss_dssp             TTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred             ccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence            6521     111256778999999987 777666667766 8999999999999986655555 6789999999999999


Q ss_pred             cCCCCc-ccccccccCeeecCCCcccc
Q 002321          525 TGGLPK-QLVNLVHLSSFNISHNHLQG  550 (936)
Q Consensus       525 ~~~~p~-~l~~l~~L~~L~ls~N~l~~  550 (936)
                      ++..+. .+..+++|+.|++++|+++.
T Consensus       494 ~~~~~~~~~~~l~~L~~L~l~~~~~~~  520 (594)
T 2p1m_B          494 GDKALLANASKLETMRSLWMSSCSVSF  520 (594)
T ss_dssp             CHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred             cHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence            654443 44568999999999998853

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=4.1e-28  Score=280.58  Aligned_cols=234  Identities=16%  Similarity=0.184  Sum_probs=135.8

Q ss_pred             cCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccc
Q 002321           98 QLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLAT  177 (936)
Q Consensus        98 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  177 (936)
                      .+++|++|+|++|+|++..|..|..+++|++|+|++|.|++..|   |..+++|++|+|++|.|++..     ..++|++
T Consensus        32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~  103 (487)
T 3oja_A           32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQELL-----VGPSIET  103 (487)
T ss_dssp             TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE---CTTCTTCCEEECCSSEEEEEE-----ECTTCCE
T ss_pred             cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc---cccCCCCCEEEecCCcCCCCC-----CCCCcCE
Confidence            34478888888888887777778888888888888888875444   677777777777777776432     2266666


Q ss_pred             cccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccc-cccCcceeeccccc
Q 002321          178 INLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIG-SCSLLRTIDFSENS  256 (936)
Q Consensus       178 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~  256 (936)
                      |+|++|+|++..+.   .+++|++|+|++|.+++..|..+.++++|++|+|++|.+++.+|..+. .+++|++|+|++|.
T Consensus       104 L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~  180 (487)
T 3oja_A          104 LHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF  180 (487)
T ss_dssp             EECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred             EECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence            66666666665443   245666666666666666666666666666666666666665555554 56666666666666


Q ss_pred             cCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCccc-ccCCh
Q 002321          257 FSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLT-GSLPD  335 (936)
Q Consensus       257 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~-~~~~~  335 (936)
                      |++..+  +..+++|+.|+|++|.+++..| .+..+++|+.|+|++|+|++ +|..+..+++|+.|++++|.+. +.+|.
T Consensus       181 l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~  256 (487)
T 3oja_A          181 IYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRD  256 (487)
T ss_dssp             CCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHH
T ss_pred             cccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHH
Confidence            654311  2234445555555555443222 24444444444444444442 3333444444444444444444 33333


Q ss_pred             hhhccCCCCEE
Q 002321          336 SMANCMNLVAL  346 (936)
Q Consensus       336 ~~~~l~~L~~L  346 (936)
                      .+..++.|+.+
T Consensus       257 ~~~~l~~L~~l  267 (487)
T 3oja_A          257 FFSKNQRVQTV  267 (487)
T ss_dssp             HHTTCHHHHHH
T ss_pred             HHHhCCCCcEE
Confidence            34433333333

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=7.6e-28  Score=278.37  Aligned_cols=234  Identities=21%  Similarity=0.181  Sum_probs=174.2

Q ss_pred             cccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEcc
Q 002321          270 LCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFS  349 (936)
Q Consensus       270 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  349 (936)
                      +|+.|+|++|.+++..|..|+.+++|++|+|++|.+++..|  +..+++|++|+|++|.|++..+     .++|+.|+++
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~  107 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA  107 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence            45555555555555555555666666666666666665444  6666666666666666664322     2667777777


Q ss_pred             CCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCcccc
Q 002321          350 QNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLV  429 (936)
Q Consensus       350 ~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  429 (936)
                      +|.+.+..+                              ..+++|+.|+|++|.+++..|..++.+++|++|+|++|.++
T Consensus       108 ~N~l~~~~~------------------------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  157 (487)
T 3oja_A          108 NNNISRVSC------------------------------SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID  157 (487)
T ss_dssp             SSCCCCEEE------------------------------CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCC
T ss_pred             CCcCCCCCc------------------------------cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCC
Confidence            777653221                              12467888899999988888888888899999999999998


Q ss_pred             CCCCcccc-CcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccc
Q 002321          430 GPIPVAIG-DLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAI  508 (936)
Q Consensus       430 ~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~  508 (936)
                      +.+|..+. .+++|+.|+|++|.|++. |. +..+++|+.|+|++|.|++ +|..+..+++|+.|+|++|+|++ +|..+
T Consensus       158 ~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l  233 (487)
T 3oja_A          158 TVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKAL  233 (487)
T ss_dssp             EEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTC
T ss_pred             CcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhh
Confidence            87787776 788999999999999865 32 3458899999999999985 45558889999999999999985 77788


Q ss_pred             cccCCccEEEcCCCccc-CCCCcccccccccCeeecC
Q 002321          509 AKLTNLQNVDLSFNSLT-GGLPKQLVNLVHLSSFNIS  544 (936)
Q Consensus       509 ~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~ls  544 (936)
                      ..+++|+.|+|++|++. +.+|..+..++.|+.++++
T Consensus       234 ~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             CCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             ccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence            88999999999999988 6677888888888888875

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=1.5e-25  Score=239.94  Aligned_cols=214  Identities=23%  Similarity=0.259  Sum_probs=112.6

Q ss_pred             ccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccc
Q 002321          100 QFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATIN  179 (936)
Q Consensus       100 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  179 (936)
                      ++|++|+|++|+|++..+..|.++++|++|+|++|+++ .++...|..+++|++|+|++|++++..+..|..+++|++|+
T Consensus        28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (276)
T 2z62_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV  106 (276)
T ss_dssp             TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred             CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCC-ccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEE
Confidence            35777777777777665556777777777777777766 45555555566666666666655555445555555555555


Q ss_pred             cccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCC
Q 002321          180 LSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSG  259 (936)
Q Consensus       180 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~  259 (936)
                      +++|++++..+..+..+++|++|+|++|.+++.                       .+|..|..+++|++|+|++|++++
T Consensus       107 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-----------------------~l~~~~~~l~~L~~L~Ls~N~l~~  163 (276)
T 2z62_A          107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSF-----------------------KLPEYFSNLTNLEHLDLSSNKIQS  163 (276)
T ss_dssp             CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC-----------------------CCCGGGGGCTTCCEEECCSSCCCE
T ss_pred             CCCCCccccCchhcccCCCCCEEECcCCcccee-----------------------cCchhhccCCCCCEEECCCCCCCc
Confidence            555555544443444444444444444444431                       124444444444444444444443


Q ss_pred             CCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhc
Q 002321          260 NLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMAN  339 (936)
Q Consensus       260 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~  339 (936)
                      ..+..+..+.+|+.+.+                    .|++++|++++..+..+. ..+|+.|+|++|++++..+..|..
T Consensus       164 ~~~~~~~~l~~L~~l~l--------------------~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~  222 (276)
T 2z62_A          164 IYCTDLRVLHQMPLLNL--------------------SLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDR  222 (276)
T ss_dssp             ECGGGGHHHHTCTTCCE--------------------EEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTT
T ss_pred             CCHHHhhhhhhccccce--------------------eeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcc
Confidence            33333333332221000                    344555555433333332 235666666666666554555566


Q ss_pred             cCCCCEEEccCCcCccCCC
Q 002321          340 CMNLVALDFSQNSMNGDLP  358 (936)
Q Consensus       340 l~~L~~L~Ls~N~l~~~~p  358 (936)
                      +++|+.|++++|++.+..+
T Consensus       223 l~~L~~L~l~~N~~~c~c~  241 (276)
T 2z62_A          223 LTSLQKIWLHTNPWDCSCP  241 (276)
T ss_dssp             CCSCCEEECCSSCBCCCTT
T ss_pred             cccccEEEccCCcccccCC
Confidence            6666666666666666554

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=1.5e-25  Score=239.73  Aligned_cols=204  Identities=20%  Similarity=0.203  Sum_probs=126.1

Q ss_pred             CcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeeccc
Q 002321          151 LRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSK  230 (936)
Q Consensus       151 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  230 (936)
                      |++|+|++|+|++..+..|..+++|++|+|++|+++++.+..|.++++|++|+|++|.+++..+..|.++++|++|++++
T Consensus        30 l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~  109 (276)
T 2z62_A           30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE  109 (276)
T ss_dssp             CCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred             ccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCC
Confidence            33444444444333333444444455555555544444444555555555555555555544445555555555555555


Q ss_pred             ccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccC
Q 002321          231 NMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVP  310 (936)
Q Consensus       231 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  310 (936)
                      |++++..+..+..+++|++|++++|++++.                       .+|..+..+++|++|+|++|++++..+
T Consensus       110 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-----------------------~l~~~~~~l~~L~~L~Ls~N~l~~~~~  166 (276)
T 2z62_A          110 TNLASLENFPIGHLKTLKELNVAHNLIQSF-----------------------KLPEYFSNLTNLEHLDLSSNKIQSIYC  166 (276)
T ss_dssp             SCCCCSTTCCCTTCTTCCEEECCSSCCCCC-----------------------CCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred             CCccccCchhcccCCCCCEEECcCCcccee-----------------------cCchhhccCCCCCEEECCCCCCCcCCH
Confidence            555544444555555666666665555432                       235566667777777777777776666


Q ss_pred             cccccccccc----eEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhh-ccCCcccccccccccc
Q 002321          311 ISIGNLQRLK----VLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIF-SSGLNKVSFAENKIRE  378 (936)
Q Consensus       311 ~~l~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~l~~l~l~~n~l~~  378 (936)
                      ..+..+++|+    .|++++|++++..+..+. ..+|+.|++++|++++..+..+. ...++.+++.+|.+..
T Consensus       167 ~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c  238 (276)
T 2z62_A          167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  238 (276)
T ss_dssp             GGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred             HHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence            6676666666    899999999976666555 45899999999999855443322 3689999999999874

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.93  E-value=3.6e-25  Score=236.08  Aligned_cols=209  Identities=20%  Similarity=0.237  Sum_probs=117.4

Q ss_pred             cccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccc
Q 002321           96 LLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTL  175 (936)
Q Consensus        96 l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  175 (936)
                      +.++++|++|++++|.++..  +.+..+++|++|+|++|++++ ++  .|..+++|++|+|++|+|++..+..|+.+++|
T Consensus        37 ~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  111 (272)
T 3rfs_A           37 QNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHD-IS--ALKELTNLTYLILTGNQLQSLPNGVFDKLTNL  111 (272)
T ss_dssp             HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCC-CG--GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred             cccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCC-ch--hhcCCCCCCEEECCCCccCccChhHhcCCcCC
Confidence            44556666666666666532  345666666666666666653 22  45556666666666666665555555566666


Q ss_pred             cccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeecccc
Q 002321          176 ATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSEN  255 (936)
Q Consensus       176 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N  255 (936)
                      ++|+|++|++++..+..|.++++|++|+|++|++++..+..+.++++|++|++++|++++..+..|..+++|++|+|++|
T Consensus       112 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N  191 (272)
T 3rfs_A          112 KELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN  191 (272)
T ss_dssp             CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence            66666666666555555556666666666666665555555555566666666666665555555555556666666665


Q ss_pred             ccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccc
Q 002321          256 SFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNL  316 (936)
Q Consensus       256 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l  316 (936)
                      ++++..+..+..+++|+.|+|++|.+.+.       +++|+.|++..|+++|.+|..++.+
T Consensus       192 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~  245 (272)
T 3rfs_A          192 QLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSV  245 (272)
T ss_dssp             CCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred             cCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCccccc
Confidence            55555555555555555555555554432       2344555555555555555444433

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.93  E-value=9.6e-26  Score=240.54  Aligned_cols=231  Identities=19%  Similarity=0.191  Sum_probs=187.9

Q ss_pred             cCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccc
Q 002321           98 QLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLAT  177 (936)
Q Consensus        98 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  177 (936)
                      .+..+..+++..+.+++.  ..+..+++|+.|++++|.++ .++  .+..+++|++|+|++|++++.  ..++.+++|++
T Consensus        17 ~~~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~~--~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~   89 (272)
T 3rfs_A           17 AFAETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQ--GIQYLPNVRYLALGGNKLHDI--SALKELTNLTY   89 (272)
T ss_dssp             HHHHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCC-CCT--TGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCE
T ss_pred             hHHHHHHHHhcCcccccc--cccccccceeeeeeCCCCcc-ccc--ccccCCCCcEEECCCCCCCCc--hhhcCCCCCCE
Confidence            445666778888888755  45788999999999999987 444  368899999999999999853  47888899999


Q ss_pred             cccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeecccccc
Q 002321          178 INLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSF  257 (936)
Q Consensus       178 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l  257 (936)
                      |+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|++++|++
T Consensus        90 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l  169 (272)
T 3rfs_A           90 LILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQL  169 (272)
T ss_dssp             EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             EECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCc
Confidence            99999999988787888899999999999999877777788888999999999998877777788888899999999988


Q ss_pred             CCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhh
Q 002321          258 SGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSM  337 (936)
Q Consensus       258 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~  337 (936)
                      ++..+..+..+++|+.|+|++|.+++..+..+..+++|++|+|++|.+.+.       +++|+.|+++.|.++|.+|..+
T Consensus       170 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~  242 (272)
T 3rfs_A          170 QSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSA  242 (272)
T ss_dssp             CCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTT
T ss_pred             CccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcc
Confidence            877777788888888888888888877777778888888888888877643       3467777788888888777776


Q ss_pred             hccCC
Q 002321          338 ANCMN  342 (936)
Q Consensus       338 ~~l~~  342 (936)
                      +.+..
T Consensus       243 ~~~~~  247 (272)
T 3rfs_A          243 GSVAP  247 (272)
T ss_dssp             SCBCG
T ss_pred             cccCC
Confidence            65543

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.92  E-value=1.8e-24  Score=230.54  Aligned_cols=202  Identities=23%  Similarity=0.288  Sum_probs=120.8

Q ss_pred             cccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCcccccccccccc
Q 002321          101 FLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINL  180 (936)
Q Consensus       101 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  180 (936)
                      .++.+++++++++. +|..+.  ++|++|+|++|+|+ .++...|..+++|++|+|++|+|+...+..|..+++|++|+|
T Consensus        17 ~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l   92 (270)
T 2o6q_A           17 NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWV   92 (270)
T ss_dssp             TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCS-CCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEEC
T ss_pred             CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCC-eeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEEC
Confidence            35667777777773 555443  46777777777776 456556666666666666666666555555566666666666


Q ss_pred             ccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCC
Q 002321          181 SSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGN  260 (936)
Q Consensus       181 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~  260 (936)
                      ++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++.
T Consensus        93 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  172 (270)
T 2o6q_A           93 TDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV  172 (270)
T ss_dssp             CSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence            66666665555556666666666666666655555555666666666666666554444455555555555555555544


Q ss_pred             CchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCccc
Q 002321          261 LPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLT  330 (936)
Q Consensus       261 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~  330 (936)
                      .+.                        .|..+++|++|+|++|++++..+..+..+++|+.|+|++|.+.
T Consensus       173 ~~~------------------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  218 (270)
T 2o6q_A          173 PEG------------------------AFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD  218 (270)
T ss_dssp             CTT------------------------TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             Chh------------------------HhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence            444                        4445555555555555555444444555555666666666554

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.92  E-value=9.1e-25  Score=230.03  Aligned_cols=191  Identities=23%  Similarity=0.270  Sum_probs=152.7

Q ss_pred             CccceeEEecCCCCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccch
Q 002321           63 PCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPD  142 (936)
Q Consensus        63 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~  142 (936)
                      ||.|.|.+|..   ....+++++++++ .+|..+.  +.|++|+|++|+|++..+..|.++++|++|+|++|+|+ .++.
T Consensus         4 Cp~~~gC~C~~---~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~   76 (251)
T 3m19_A            4 CETVTGCTCNE---GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSA   76 (251)
T ss_dssp             CHHHHSSEEEG---GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC-CCCT
T ss_pred             CCCCCceEcCC---CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCC-ccCH
Confidence            78999999963   3446788888887 5666655  58889999999998888888888999999999999988 4666


Q ss_pred             hhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCC
Q 002321          143 EFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKN  222 (936)
Q Consensus       143 ~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  222 (936)
                      ..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++
T Consensus        77 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  156 (251)
T 3m19_A           77 GVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN  156 (251)
T ss_dssp             TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred             hHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcC
Confidence            77888888888888888888777777888888888888888888777777778888888888888888666667777888


Q ss_pred             cceeecccccccccCCcccccccCcceeeccccccCCC
Q 002321          223 LRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGN  260 (936)
Q Consensus       223 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~  260 (936)
                      |++|+|++|++++..+..|..+++|++|+|++|.++..
T Consensus       157 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          157 LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             CCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            88888888888776666777777777777777777654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=9.5e-26  Score=262.82  Aligned_cols=187  Identities=14%  Similarity=0.195  Sum_probs=148.0

Q ss_pred             CCCcccccCceEEEEEEeCCCcEEEEEEeeccCccc-------hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          694 KDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVK-------SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       694 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..+.||+|+||+||+|+. .++.+|+|+........       ..+++.+|++++++++||||+++..++......++||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            356899999999999965 47889999874432211       1355899999999999999997777777777889999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++++|.+++..           +..++.|+++||+|||+++|+||||||+|||++.  .+||+|||+++........
T Consensus       419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred             ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence            99999999999875           4479999999999999999999999999999998  9999999999987543221


Q ss_pred             c-----ccccccCcccccCcccccCc-ccCCchhhHHHHHHHHHHHHcCCCCCC
Q 002321          847 V-----LSSKIQSALGYMAPEFACRT-VKITDKCDVYGFGVLVLEVVTGKRPLS  894 (936)
Q Consensus       847 ~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlG~~l~el~~g~~Pf~  894 (936)
                      .     ......||+.|||||++... ..|+..+|+|+..+-..+-+.++.+|.
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            1     22456789999999988431 357888999999999999998888875

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.91  E-value=2.1e-24  Score=231.96  Aligned_cols=155  Identities=23%  Similarity=0.280  Sum_probs=75.8

Q ss_pred             cccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccc
Q 002321           96 LLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTL  175 (936)
Q Consensus        96 l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  175 (936)
                      +.++++++++++++|+++ .+|..+.  ++|++|+|++|+|+ .++...|..+++|++|+|++|+|++..+.  +.+++|
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L   79 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL   79 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCS-EEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCC-ccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence            556666777777777766 3444443  46666666666666 44445556666666666666666533221  344444


Q ss_pred             cccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeecccc
Q 002321          176 ATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSEN  255 (936)
Q Consensus       176 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N  255 (936)
                      ++|+|++|+|+. +|..+.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus        80 ~~L~Ls~N~l~~-l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  158 (290)
T 1p9a_G           80 GTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN  158 (290)
T ss_dssp             CEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred             CEEECCCCcCCc-CchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence            444444444442 3334444444444444444444333333444444444444444444333333333333333333333


Q ss_pred             cc
Q 002321          256 SF  257 (936)
Q Consensus       256 ~l  257 (936)
                      +|
T Consensus       159 ~l  160 (290)
T 1p9a_G          159 NL  160 (290)
T ss_dssp             CC
T ss_pred             cC
Confidence            33

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.91  E-value=6.2e-24  Score=228.26  Aligned_cols=196  Identities=22%  Similarity=0.221  Sum_probs=101.3

Q ss_pred             ceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEc
Q 002321           77 RVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISL  156 (936)
Q Consensus        77 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L  156 (936)
                      .++.+++++++++ .+|+.+.  +.+++|+|++|+|++..+..|.++++|++|+|++|+|+ .++..  ..+++|++|+|
T Consensus        11 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~--~~l~~L~~L~L   84 (290)
T 1p9a_G           11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD--GTLPVLGTLDL   84 (290)
T ss_dssp             TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEECC--SCCTTCCEEEC
T ss_pred             CccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccC-cccCC--CCCCcCCEEEC
Confidence            3445555555554 3444332  45555555555555555555555555555555555555 23322  45555555555


Q ss_pred             cCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeeccccccccc
Q 002321          157 AKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGS  236 (936)
Q Consensus       157 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  236 (936)
                      ++|+|+ .+|..+..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++.
T Consensus        85 s~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l  163 (290)
T 1p9a_G           85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL  163 (290)
T ss_dssp             CSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCC
T ss_pred             CCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCcc
Confidence            555555 3445555555555555555555555555555555555555555555544444455555555555555555544


Q ss_pred             CCcccccccCcceeeccccccCCCCchhhhccccccEEeccCcc
Q 002321          237 IPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNL  280 (936)
Q Consensus       237 ~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~  280 (936)
                      .+..|..+++|++|+|++|+|+ .+|..+..+..|+.++|++|.
T Consensus       164 ~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np  206 (290)
T 1p9a_G          164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNP  206 (290)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCC
T ss_pred             CHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCC
Confidence            4444455555555555555554 233333333333333333333

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.91  E-value=5.2e-24  Score=231.87  Aligned_cols=224  Identities=16%  Similarity=0.219  Sum_probs=167.7

Q ss_pred             CCcEEEccCcccccccchh--hhhcCCCCcEEEccCccCCCCCCCCc--cccccccccccccccccCCCC----CCCCCC
Q 002321          125 NLRVIDLSGNSLSGSIPDE--FFKQCGSLRVISLAKNRFSGKIPSSL--SLCSTLATINLSSNRFSSPLP----LGIWGL  196 (936)
Q Consensus       125 ~L~~L~Ls~N~l~~~i~~~--~f~~l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~~l  196 (936)
                      .++.|++.++.++...-..  -+..+++|++|+|++|++++..|..+  ..+++|++|+|++|++++..+    ..+..+
T Consensus        65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~  144 (310)
T 4glp_A           65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK  144 (310)
T ss_dssp             CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred             ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence            4667777776665321111  12345668888888888887777777  778888888888888887554    344568


Q ss_pred             CCCCEEecCCCCCCCCCccCccCCCCcceeeccccccccc---C-CcccccccCcceeeccccccCCCCch----hhhcc
Q 002321          197 SALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGS---I-PDGIGSCSLLRTIDFSENSFSGNLPE----TMQKL  268 (936)
Q Consensus       197 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~-p~~l~~l~~L~~L~Ls~N~l~~~~~~----~l~~l  268 (936)
                      ++|++|+|++|++++..+..+.++++|++|+|++|++.+.   . +..+..+++|++|+|++|+++. ++.    .+..+
T Consensus       145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l  223 (310)
T 4glp_A          145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAG  223 (310)
T ss_dssp             SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHT
T ss_pred             cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcC
Confidence            8888888888888877778888888888888888887642   1 2334678888888888888863 232    35677


Q ss_pred             ccccEEeccCccccCCCCcccccC---CccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCE
Q 002321          269 SLCNFMNLRKNLFSGEVPKWIGEL---ESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVA  345 (936)
Q Consensus       269 ~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  345 (936)
                      ++|+.|+|++|++++..|..+..+   ++|++|+|++|+|+ .+|..+.  ++|+.|+|++|+|++. |. +..+++|+.
T Consensus       224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~  298 (310)
T 4glp_A          224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDN  298 (310)
T ss_dssp             CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred             CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence            888888888888888877777766   68999999999998 5666664  7899999999999864 33 677889999


Q ss_pred             EEccCCcCc
Q 002321          346 LDFSQNSMN  354 (936)
Q Consensus       346 L~Ls~N~l~  354 (936)
                      |++++|+++
T Consensus       299 L~L~~N~l~  307 (310)
T 4glp_A          299 LTLDGNPFL  307 (310)
T ss_dssp             EECSSTTTS
T ss_pred             EECcCCCCC
Confidence            999999886

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.91  E-value=2.4e-26  Score=253.78  Aligned_cols=235  Identities=21%  Similarity=0.254  Sum_probs=157.6

Q ss_pred             CccceeEEecCCCCceEEeccCCCCCCcccccccccC--ccccEEeccCCcccCcCCCchhhcCCCcEEEccCccccccc
Q 002321           63 PCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQL--QFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSI  140 (936)
Q Consensus        63 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l--~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i  140 (936)
                      |+.|.++.|++  ..+..++++++.+.   +..+..+  +.++.|++++|.+++..+. +..+++|++|+|++|.+++.-
T Consensus        36 c~~W~~~~~~~--~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~  109 (336)
T 2ast_B           36 CKRWYRLASDE--SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVST  109 (336)
T ss_dssp             CHHHHHHHTCS--TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHH
T ss_pred             HHHHHHHhcCc--hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHH
Confidence            56899999874  56788899888776   4556777  8899999999999876555 567899999999999887552


Q ss_pred             chhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccc-cccCC-CCCCCCCCCCCCEEecCCC-CCCCC-CccC
Q 002321          141 PDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSN-RFSSP-LPLGIWGLSALRTLDLSDN-LLEGE-IPKG  216 (936)
Q Consensus       141 ~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~  216 (936)
                      ....+..+++|++|+|++|++++..+..++.+++|++|+|++| .+++. .+..+.++++|++|+|++| .+++. ++..
T Consensus       110 ~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~  189 (336)
T 2ast_B          110 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA  189 (336)
T ss_dssp             HHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHH
T ss_pred             HHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHH
Confidence            3355778888888888888887766777777777777777777 56642 4445666777777777777 66643 4555


Q ss_pred             ccCCC-Ccceeecccc--ccc-ccCCcccccccCcceeeccccc-cCCCCchhhhccccccEEeccCcc-ccCCCCcccc
Q 002321          217 VESLK-NLRVINLSKN--MFS-GSIPDGIGSCSLLRTIDFSENS-FSGNLPETMQKLSLCNFMNLRKNL-FSGEVPKWIG  290 (936)
Q Consensus       217 ~~~l~-~L~~L~L~~N--~l~-~~~p~~l~~l~~L~~L~Ls~N~-l~~~~~~~l~~l~~L~~L~L~~N~-l~~~~~~~~~  290 (936)
                      +..++ +|++|+|++|  .++ +.++..+..+++|++|++++|. +++..+..+..+++|+.|++++|. +.......+.
T Consensus       190 ~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~  269 (336)
T 2ast_B          190 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELG  269 (336)
T ss_dssp             HHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGG
T ss_pred             HHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHh
Confidence            66666 7777777777  333 3344555566666666666666 554555555555555555555553 1111111344


Q ss_pred             cCCccceecccCc
Q 002321          291 ELESLETLDLSGN  303 (936)
Q Consensus       291 ~l~~L~~L~L~~N  303 (936)
                      .+++|+.|++++|
T Consensus       270 ~~~~L~~L~l~~~  282 (336)
T 2ast_B          270 EIPTLKTLQVFGI  282 (336)
T ss_dssp             GCTTCCEEECTTS
T ss_pred             cCCCCCEEeccCc
Confidence            4555555555555

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.91  E-value=1.6e-25  Score=249.39  Aligned_cols=130  Identities=16%  Similarity=0.177  Sum_probs=74.3

Q ss_pred             EEecCCCCCCCCCccCccCCCCcceeecccccccccCC----ccccccc-CcceeeccccccCCCCchhhhcc-----cc
Q 002321          201 TLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIP----DGIGSCS-LLRTIDFSENSFSGNLPETMQKL-----SL  270 (936)
Q Consensus       201 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p----~~l~~l~-~L~~L~Ls~N~l~~~~~~~l~~l-----~~  270 (936)
                      +++|++|.+++.+|..+...++|++|+|++|.+++..+    ..|..++ +|++|+|++|++++..+..+..+     ++
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            45677777777777666665667777777777775555    5566666 67777777777766666555554     55


Q ss_pred             ccEEeccCccccCCCCcccccC-----CccceecccCceeccccCccccc-----ccccceEEccCCccc
Q 002321          271 CNFMNLRKNLFSGEVPKWIGEL-----ESLETLDLSGNKFSGAVPISIGN-----LQRLKVLNFSANRLT  330 (936)
Q Consensus       271 L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~l~~-----l~~L~~L~L~~N~l~  330 (936)
                      |+.|+|++|.+++..+..+...     ++|++|+|++|++++..+..+..     .++|++|+|++|+++
T Consensus        82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~  151 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG  151 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGG
T ss_pred             ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCC
Confidence            5555555555554444433222     45555555555554433322221     134444444444444

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.91  E-value=3.5e-24  Score=223.83  Aligned_cols=178  Identities=15%  Similarity=0.175  Sum_probs=130.4

Q ss_pred             cccEEeccCCcccCcCCCchhhcCCCcEEEccCcc-cccccchhhhhcCCCCcEEEccC-ccCCCCCCCCcccccccccc
Q 002321          101 FLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNS-LSGSIPDEFFKQCGSLRVISLAK-NRFSGKIPSSLSLCSTLATI  178 (936)
Q Consensus       101 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~-l~~~i~~~~f~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L  178 (936)
                      +|++|+|++|+|+++.+..|.++++|++|+|++|+ ++ .++...|.++++|++|+|++ |+|++..+..|..+++|++|
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L  110 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL  110 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence            78899999999987777788899999999999997 77 67877888888888888888 88887777788888888888


Q ss_pred             ccccccccCCCCCCCCCCCCCC---EEecCCC-CCCCCCccCccCCCCcc-eeecccccccccCCcccccccCcceeecc
Q 002321          179 NLSSNRFSSPLPLGIWGLSALR---TLDLSDN-LLEGEIPKGVESLKNLR-VINLSKNMFSGSIPDGIGSCSLLRTIDFS  253 (936)
Q Consensus       179 ~L~~N~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls  253 (936)
                      +|++|++++ +|. |..+++|+   +|++++| ++++..+..|.++++|+ +|++++|+++...+..|.. ++|++|+|+
T Consensus       111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~  187 (239)
T 2xwt_C          111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLN  187 (239)
T ss_dssp             EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECT
T ss_pred             eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcC
Confidence            888888886 454 77777777   7888877 77765556677777777 7777777777333333433 667777777


Q ss_pred             ccc-cCCCCchhhhcc-ccccEEeccCcccc
Q 002321          254 ENS-FSGNLPETMQKL-SLCNFMNLRKNLFS  282 (936)
Q Consensus       254 ~N~-l~~~~~~~l~~l-~~L~~L~L~~N~l~  282 (936)
                      +|+ +++..+..|..+ ++|+.|++++|+++
T Consensus       188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~  218 (239)
T 2xwt_C          188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT  218 (239)
T ss_dssp             TCTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred             CCCCcccCCHHHhhccccCCcEEECCCCccc
Confidence            763 664444445544 44555555544444

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.90  E-value=7.3e-24  Score=234.74  Aligned_cols=245  Identities=14%  Similarity=0.112  Sum_probs=171.7

Q ss_pred             CCccceeEEecCCCCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccc
Q 002321           62 TPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIP  141 (936)
Q Consensus        62 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~  141 (936)
                      |-|.|..|.|+..            +++ .+|..+  .+++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+|
T Consensus         7 C~C~~~~v~C~~~------------~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~   71 (350)
T 4ay9_X            7 CHCSNRVFLCQES------------KVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE   71 (350)
T ss_dssp             SEEETTEEEEEST------------TCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEEC
T ss_pred             cEeeCCEEEecCC------------CCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccC
Confidence            3478988999752            333 455544  3679999999999997666789999999999999999987889


Q ss_pred             hhhhhcCCCCcE-EEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCC-CCCCCCCccCccC
Q 002321          142 DEFFKQCGSLRV-ISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSD-NLLEGEIPKGVES  219 (936)
Q Consensus       142 ~~~f~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~  219 (936)
                      ..+|.++++|++ +.+++|+|+...|..|..+++|++|++++|+|+...+..+....++..|++.+ |++....+..|..
T Consensus        72 ~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~  151 (350)
T 4ay9_X           72 ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG  151 (350)
T ss_dssp             TTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTT
T ss_pred             hhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhh
Confidence            999999988775 66777899988888899999999999999999887777777777888888865 5677555556666


Q ss_pred             CC-CcceeecccccccccCCcccccccCcceeeccc-cccCCCCchhhhccccccEEeccCccccCCCCcccccCCccce
Q 002321          220 LK-NLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSE-NSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLET  297 (936)
Q Consensus       220 l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  297 (936)
                      +. .++.|+|++|+|+.+ |.......+|++|++++ |.++...++.|..+++|+.|+|++|+|+...+..+.++++|+.
T Consensus       152 ~~~~l~~L~L~~N~i~~i-~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~  230 (350)
T 4ay9_X          152 LSFESVILWLNKNGIQEI-HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA  230 (350)
T ss_dssp             SBSSCEEEECCSSCCCEE-CTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEEC
T ss_pred             cchhhhhhccccccccCC-ChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhh
Confidence            64 578888888888844 44444556788888764 5565444455666666666666666666444444444444444


Q ss_pred             ecccCceeccccCcccccccccceEEccC
Q 002321          298 LDLSGNKFSGAVPISIGNLQRLKVLNFSA  326 (936)
Q Consensus       298 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~  326 (936)
                      +++.  .+. .+| .+.++++|+.+++.+
T Consensus       231 l~~~--~l~-~lP-~l~~l~~L~~l~l~~  255 (350)
T 4ay9_X          231 RSTY--NLK-KLP-TLEKLVALMEASLTY  255 (350)
T ss_dssp             TTCT--TCC-CCC-CTTTCCSCCEEECSC
T ss_pred             ccCC--CcC-cCC-CchhCcChhhCcCCC
Confidence            3332  222 233 244555555555544

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.90  E-value=4.1e-24  Score=232.65  Aligned_cols=226  Identities=19%  Similarity=0.230  Sum_probs=187.3

Q ss_pred             ccccEEeccCCcccCcCCC---chhhcCCCcEEEccCcccccccchhhh-hcCCCCcEEEccCccCCCCCC----CCccc
Q 002321          100 QFLRKLSLSSNNLTGSISP---NLAKLQNLRVIDLSGNSLSGSIPDEFF-KQCGSLRVISLAKNRFSGKIP----SSLSL  171 (936)
Q Consensus       100 ~~L~~L~L~~n~l~~~~~~---~l~~l~~L~~L~Ls~N~l~~~i~~~~f-~~l~~L~~L~L~~N~l~~~~p----~~~~~  171 (936)
                      ..++.|.+.++.++...-.   .+..+++|++|+|++|++++.+|..++ ..+++|++|+|++|++++..+    ..+..
T Consensus        64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~  143 (310)
T 4glp_A           64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL  143 (310)
T ss_dssp             CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred             cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence            4578888888887632111   233567899999999999988887766 889999999999999997655    33457


Q ss_pred             cccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCC--C--ccCccCCCCcceeecccccccccCCc----cccc
Q 002321          172 CSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGE--I--PKGVESLKNLRVINLSKNMFSGSIPD----GIGS  243 (936)
Q Consensus       172 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~--~~~~~~l~~L~~L~L~~N~l~~~~p~----~l~~  243 (936)
                      +++|++|+|++|++++..+..|.++++|++|+|++|++.+.  +  +..+..+++|++|+|++|+++. ++.    .+..
T Consensus       144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~  222 (310)
T 4glp_A          144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAA  222 (310)
T ss_dssp             CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHH
T ss_pred             ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhc
Confidence            89999999999999998889999999999999999998752  2  2334789999999999999973 333    3578


Q ss_pred             ccCcceeeccccccCCCCchhhhcc---ccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccc
Q 002321          244 CSLLRTIDFSENSFSGNLPETMQKL---SLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLK  320 (936)
Q Consensus       244 l~~L~~L~Ls~N~l~~~~~~~l~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~  320 (936)
                      +++|++|+|++|++++..|..+..+   ++|+.|+|++|+++ .+|..+.  ++|++|+|++|+|++. |. +..+++|+
T Consensus       223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~  297 (310)
T 4glp_A          223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVD  297 (310)
T ss_dssp             TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCS
T ss_pred             CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCcc
Confidence            8999999999999999888877776   69999999999999 5677664  7999999999999964 43 67889999


Q ss_pred             eEEccCCcccc
Q 002321          321 VLNFSANRLTG  331 (936)
Q Consensus       321 ~L~L~~N~l~~  331 (936)
                      .|+|++|+++.
T Consensus       298 ~L~L~~N~l~~  308 (310)
T 4glp_A          298 NLTLDGNPFLV  308 (310)
T ss_dssp             CEECSSTTTSC
T ss_pred             EEECcCCCCCC
Confidence            99999999974

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.90  E-value=3.3e-25  Score=246.87  Aligned_cols=256  Identities=17%  Similarity=0.175  Sum_probs=127.1

Q ss_pred             ccCCCCCCcccccccccCccccEEeccCCcccCcCC----CchhhcC-CCcEEEccCcccccccchhhhhcC-----CCC
Q 002321           82 TLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSIS----PNLAKLQ-NLRVIDLSGNSLSGSIPDEFFKQC-----GSL  151 (936)
Q Consensus        82 ~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~----~~l~~l~-~L~~L~Ls~N~l~~~i~~~~f~~l-----~~L  151 (936)
                      +++.++++|.+|..+...++|++|+|++|+|++..+    ..|.+++ +|++|+|++|+|++..+ ..|..+     ++|
T Consensus         4 ~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~-~~l~~~l~~~~~~L   82 (362)
T 3goz_A            4 KLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNS-DELVQILAAIPANV   82 (362)
T ss_dssp             ECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCH-HHHHHHHHTSCTTC
T ss_pred             ccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHH-HHHHHHHhccCCCc
Confidence            455555665555555555556666666666655444    4455555 56666666666653222 222332     555


Q ss_pred             cEEEccCccCCCCCCCCcccc-----ccccccccccccccCCCCCCCC----C-CCCCCEEecCCCCCCCCCccCccCCC
Q 002321          152 RVISLAKNRFSGKIPSSLSLC-----STLATINLSSNRFSSPLPLGIW----G-LSALRTLDLSDNLLEGEIPKGVESLK  221 (936)
Q Consensus       152 ~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~----~-l~~L~~L~L~~N~l~~~~~~~~~~l~  221 (936)
                      ++|+|++|+|++..+..++..     ++|++|+|++|+|++..+..+.    . .++|++|+|++|.+++..+..+    
T Consensus        83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l----  158 (362)
T 3goz_A           83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL----  158 (362)
T ss_dssp             CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHH----
T ss_pred             cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHH----
Confidence            555555555554444433322     4555555555555544332221    2 1345555555555543222111    


Q ss_pred             CcceeecccccccccCCccccccc-CcceeeccccccCCCCchhhhc----c-ccccEEeccCccccCC----CCccccc
Q 002321          222 NLRVINLSKNMFSGSIPDGIGSCS-LLRTIDFSENSFSGNLPETMQK----L-SLCNFMNLRKNLFSGE----VPKWIGE  291 (936)
Q Consensus       222 ~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~~~l~~----l-~~L~~L~L~~N~l~~~----~~~~~~~  291 (936)
                                      +..+..++ +|++|+|++|++++..+..+..    . ++|+.|+|++|.+++.    ++..+..
T Consensus       159 ----------------~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~  222 (362)
T 3goz_A          159 ----------------IQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSS  222 (362)
T ss_dssp             ----------------HHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHH
T ss_pred             ----------------HHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhc
Confidence                            11122222 4555555555554444433222    2 3555555555555432    2233333


Q ss_pred             -CCccceecccCceeccccC----cccccccccceEEccCCcccccC-------ChhhhccCCCCEEEccCCcCccCCC
Q 002321          292 -LESLETLDLSGNKFSGAVP----ISIGNLQRLKVLNFSANRLTGSL-------PDSMANCMNLVALDFSQNSMNGDLP  358 (936)
Q Consensus       292 -l~~L~~L~L~~N~l~~~~~----~~l~~l~~L~~L~L~~N~l~~~~-------~~~~~~l~~L~~L~Ls~N~l~~~~p  358 (936)
                       .++|++|+|++|++++..+    ..+..+++|+.|+|++|.+.+..       +..+..+++|+.||+++|++.+..+
T Consensus       223 ~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~  301 (362)
T 3goz_A          223 IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS  301 (362)
T ss_dssp             SCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred             CCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence             2366666666666654333    22345566777777777644322       2345566677777777777765433

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.90  E-value=7.4e-24  Score=221.36  Aligned_cols=179  Identities=15%  Similarity=0.183  Sum_probs=135.5

Q ss_pred             CCCcEEEccCcccccccchhhhhcCCCCcEEEccCcc-CCCCCCCCcccccccccccccc-ccccCCCCCCCCCCCCCCE
Q 002321          124 QNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNR-FSGKIPSSLSLCSTLATINLSS-NRFSSPLPLGIWGLSALRT  201 (936)
Q Consensus       124 ~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~  201 (936)
                      ++|++|+|++|+|+ .+|...|..+++|++|+|++|+ +++..+..|..+++|++|+|++ |+|+++.+..|.++++|++
T Consensus        31 ~~l~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~  109 (239)
T 2xwt_C           31 PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF  109 (239)
T ss_dssp             TTCCEEEEESCCCS-EECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred             CcccEEEEeCCcce-EECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence            38999999999999 6888889999999999999997 8877777899999999999998 9999877788889999999


Q ss_pred             EecCCCCCCCCCccCccCCCCcc---eeecccc-cccccCCcccccccCcc-eeeccccccCCCCchhhhccccccEEec
Q 002321          202 LDLSDNLLEGEIPKGVESLKNLR---VINLSKN-MFSGSIPDGIGSCSLLR-TIDFSENSFSGNLPETMQKLSLCNFMNL  276 (936)
Q Consensus       202 L~L~~N~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~p~~l~~l~~L~-~L~Ls~N~l~~~~~~~l~~l~~L~~L~L  276 (936)
                      |+|++|++++ +|. +..+++|+   +|++++| ++++..+..|..+++|+ +|++++|+++...+..|.. ++|+.|+|
T Consensus       110 L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L  186 (239)
T 2xwt_C          110 LGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYL  186 (239)
T ss_dssp             EEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEEC
T ss_pred             EeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEc
Confidence            9999999885 565 77777777   8888888 88877677788888888 8888888877333333333 45555555


Q ss_pred             cCcc-ccCCCCcccccC-CccceecccCceec
Q 002321          277 RKNL-FSGEVPKWIGEL-ESLETLDLSGNKFS  306 (936)
Q Consensus       277 ~~N~-l~~~~~~~~~~l-~~L~~L~L~~N~l~  306 (936)
                      ++|+ +++..+..|..+ ++|+.|++++|+++
T Consensus       187 ~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~  218 (239)
T 2xwt_C          187 NKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT  218 (239)
T ss_dssp             TTCTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred             CCCCCcccCCHHHhhccccCCcEEECCCCccc
Confidence            5552 544444444444 45555555555544

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.89  E-value=6.9e-26  Score=255.05  Aligned_cols=247  Identities=21%  Similarity=0.309  Sum_probs=134.0

Q ss_pred             cccccccCccccEEeccCCcccCcCC----CchhhcCCCcEEEccCc---ccccccchhh------hhcCCCCcEEEccC
Q 002321           92 IGRGLLQLQFLRKLSLSSNNLTGSIS----PNLAKLQNLRVIDLSGN---SLSGSIPDEF------FKQCGSLRVISLAK  158 (936)
Q Consensus        92 ~~~~l~~l~~L~~L~L~~n~l~~~~~----~~l~~l~~L~~L~Ls~N---~l~~~i~~~~------f~~l~~L~~L~L~~  158 (936)
                      ++..+..+++|++|+|++|+|++..+    ..|..+++|++|+|++|   ++++.+|..+      |..+++|++|+|++
T Consensus        24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~  103 (386)
T 2ca6_A           24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  103 (386)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence            44556667777777777777765433    33556777777777774   4444455443      35666667777776


Q ss_pred             ccCCC----CCCCCccccccccccccccccccCCCCCCCCC----C---------CCCCEEecCCCCCC-CCCc---cCc
Q 002321          159 NRFSG----KIPSSLSLCSTLATINLSSNRFSSPLPLGIWG----L---------SALRTLDLSDNLLE-GEIP---KGV  217 (936)
Q Consensus       159 N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~----l---------~~L~~L~L~~N~l~-~~~~---~~~  217 (936)
                      |+|++    .+|..+..+++|++|+|++|.|++..+..+..    +         ++|++|+|++|+++ +.++   ..+
T Consensus       104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l  183 (386)
T 2ca6_A          104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF  183 (386)
T ss_dssp             CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH
Confidence            66665    24445556666666666666665333222222    2         55555555555554 2222   234


Q ss_pred             cCCCCcceeecccccccc-----cCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccC
Q 002321          218 ESLKNLRVINLSKNMFSG-----SIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGEL  292 (936)
Q Consensus       218 ~~l~~L~~L~L~~N~l~~-----~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l  292 (936)
                      ..+++|++|+|++|+++.     ..+..+..+++|++|+|++|.++...                    ...+|..+..+
T Consensus       184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g--------------------~~~l~~~l~~~  243 (386)
T 2ca6_A          184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG--------------------SSALAIALKSW  243 (386)
T ss_dssp             HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHH--------------------HHHHHHHGGGC
T ss_pred             HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHH--------------------HHHHHHHHccC
Confidence            445555555555555541     22224444455555555555443000                    03344455555


Q ss_pred             CccceecccCceeccc----cCccc--ccccccceEEccCCcccc----cCChhh-hccCCCCEEEccCCcCccCCC
Q 002321          293 ESLETLDLSGNKFSGA----VPISI--GNLQRLKVLNFSANRLTG----SLPDSM-ANCMNLVALDFSQNSMNGDLP  358 (936)
Q Consensus       293 ~~L~~L~L~~N~l~~~----~~~~l--~~l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L~Ls~N~l~~~~p  358 (936)
                      ++|++|+|++|++++.    ++..+  +.+++|+.|+|++|.+++    .+|..+ .++++|+.|++++|++++..+
T Consensus       244 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             TTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             CCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence            5666666666665543    23333  225666666666666665    355555 446666666666666665543

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.89  E-value=3e-25  Score=249.86  Aligned_cols=245  Identities=20%  Similarity=0.275  Sum_probs=161.5

Q ss_pred             CcccccCCccceecccCceeccccC----cccccccccceEEccCC---cccccCChhh-------hccCCCCEEEccCC
Q 002321          286 PKWIGELESLETLDLSGNKFSGAVP----ISIGNLQRLKVLNFSAN---RLTGSLPDSM-------ANCMNLVALDFSQN  351 (936)
Q Consensus       286 ~~~~~~l~~L~~L~L~~N~l~~~~~----~~l~~l~~L~~L~L~~N---~l~~~~~~~~-------~~l~~L~~L~Ls~N  351 (936)
                      +..+..+++|++|+|++|++++..+    ..+..+++|++|+|++|   ++++.+|..+       ..+++|+.|+|++|
T Consensus        25 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n  104 (386)
T 2ca6_A           25 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN  104 (386)
T ss_dssp             SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred             HHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCC
Confidence            3444455555556666665554322    22445566666666653   3333444433       45666666666666


Q ss_pred             cCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcc----c---------ccC
Q 002321          352 SMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGA----L---------SGL  418 (936)
Q Consensus       352 ~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~----l---------~~L  418 (936)
                      .+.+.....                       ++..+..+++|++|+|++|.+++..+..+..    +         ++|
T Consensus       105 ~l~~~~~~~-----------------------l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L  161 (386)
T 2ca6_A          105 AFGPTAQEP-----------------------LIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPL  161 (386)
T ss_dssp             CCCTTTHHH-----------------------HHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred             cCCHHHHHH-----------------------HHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCC
Confidence            665321100                       1111223556677777777665433333332    3         778


Q ss_pred             CeeeccCcccc-CCCC---ccccCcccCCeeecCCcccc--c---cCCCCCCCcCCCcEEEecCCccC----CcCccccc
Q 002321          419 QLLNLSRNSLV-GPIP---VAIGDLKALNVLDLSENWLN--G---SIPPEIGGAYSLKELRLERNFLA----GKIPTSIE  485 (936)
Q Consensus       419 ~~L~L~~N~l~-~~~~---~~~~~l~~L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~l~  485 (936)
                      ++|+|++|+++ +.++   ..+..+++|++|+|++|+++  |   ..|..+..+++|+.|+|++|.++    +.+|..+.
T Consensus       162 ~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~  241 (386)
T 2ca6_A          162 RSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK  241 (386)
T ss_dssp             CEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGG
T ss_pred             cEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHc
Confidence            88888888876 3334   35667778888888888887  2   34557788888999999999886    56788888


Q ss_pred             cccccccccccCccccCC----Ccccc--cccCCccEEEcCCCcccC----CCCccc-ccccccCeeecCCCcccccCC
Q 002321          486 NCSSLVSLILSKNNLTGP----IPIAI--AKLTNLQNVDLSFNSLTG----GLPKQL-VNLVHLSSFNISHNHLQGELP  553 (936)
Q Consensus       486 ~l~~L~~L~L~~N~l~~~----~p~~~--~~l~~L~~L~Ls~N~l~~----~~p~~l-~~l~~L~~L~ls~N~l~~~~p  553 (936)
                      .+++|++|+|++|++++.    ++..+  +++++|++|+|++|++++    .+|..+ .++++|+.|++++|++++..|
T Consensus       242 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          242 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             GCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             cCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence            899999999999998865    45666  348999999999999986    488777 668999999999999886543

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.89  E-value=5.4e-23  Score=209.83  Aligned_cols=186  Identities=23%  Similarity=0.295  Sum_probs=144.0

Q ss_pred             CCCccceeEEecCCCCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCccccccc
Q 002321           61 DTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSI  140 (936)
Q Consensus        61 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i  140 (936)
                      .|.|.|.+|.|+..  .+          + .+|..+  .++|++|+|++|++++..+..|.++++|++|+|++|+|+ .+
T Consensus         4 ~C~C~~~~v~c~~~--~l----------~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~   67 (208)
T 2o6s_A            4 RCSCSGTTVECYSQ--GR----------T-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SL   67 (208)
T ss_dssp             TCEEETTEEECCSS--CC----------S-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CC
T ss_pred             CCEECCCEEEecCC--Cc----------c-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC-cc
Confidence            34689999999753  11          1 233332  357899999999999777777889999999999999998 67


Q ss_pred             chhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCC
Q 002321          141 PDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESL  220 (936)
Q Consensus       141 ~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  220 (936)
                      |...|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..+..+
T Consensus        68 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l  147 (208)
T 2o6s_A           68 PNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRL  147 (208)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred             ChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccC
Confidence            87888888889999998888887777777888888888888888887777777888888888888888886666667778


Q ss_pred             CCcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccc
Q 002321          221 KNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLS  269 (936)
Q Consensus       221 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~  269 (936)
                      ++|++|+|++|.+.+       .+++|++|+++.|+++|.+|..++.++
T Consensus       148 ~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~  189 (208)
T 2o6s_A          148 TSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVA  189 (208)
T ss_dssp             TTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred             CCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCcccc
Confidence            888888888887653       345677777777777777776665544

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.89  E-value=4.1e-23  Score=224.16  Aligned_cols=193  Identities=22%  Similarity=0.358  Sum_probs=80.9

Q ss_pred             hhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCC
Q 002321          121 AKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALR  200 (936)
Q Consensus       121 ~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  200 (936)
                      ..+++|++|++++|+++ .+|  .+..+++|++|+|++|++++..+  +..+++|++|+|++|++++.  ..+..+++|+
T Consensus        38 ~~l~~L~~L~l~~~~i~-~l~--~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~  110 (308)
T 1h6u_A           38 ADLDGITTLSAFGTGVT-TIE--GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIK  110 (308)
T ss_dssp             HHHHTCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCC
T ss_pred             HHcCCcCEEEeeCCCcc-Cch--hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCC
Confidence            34444444444444444 222  13344444444444444443222  44444444444444444432  1344444555


Q ss_pred             EEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCcc
Q 002321          201 TLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNL  280 (936)
Q Consensus       201 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~  280 (936)
                      +|+|++|++++. +. +..+++|++|++++|++++..+  +..+++|++|+|++|++++..+  +..+++|+.|+|++|.
T Consensus       111 ~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~  184 (308)
T 1h6u_A          111 TLDLTSTQITDV-TP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK  184 (308)
T ss_dssp             EEECTTSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             EEECCCCCCCCc-hh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCc
Confidence            555555554432 21 4444455555555554443222  4444445555554444443221  3333334444444443


Q ss_pred             ccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCccc
Q 002321          281 FSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLT  330 (936)
Q Consensus       281 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~  330 (936)
                      +++..+  +..+++|++|+|++|++++..+  +..+++|+.|+|++|+++
T Consensus       185 l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~  230 (308)
T 1h6u_A          185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT  230 (308)
T ss_dssp             CCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEE
T ss_pred             cCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeee
Confidence            332221  3344444444444444443221  334444444444444443

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.88  E-value=1.1e-22  Score=220.72  Aligned_cols=195  Identities=22%  Similarity=0.317  Sum_probs=169.9

Q ss_pred             cccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccc
Q 002321           96 LLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTL  175 (936)
Q Consensus        96 l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  175 (936)
                      ..++++|++|++++|+++. ++ .+..+++|++|+|++|+++ .++.  |..+++|++|+|++|++++.  ..+..+++|
T Consensus        37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~-~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L  109 (308)
T 1h6u_A           37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQIT-DLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSI  109 (308)
T ss_dssp             HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCC-CCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTC
T ss_pred             HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCC-CChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCC
Confidence            4578899999999999985 34 6899999999999999998 4555  89999999999999999864  368899999


Q ss_pred             cccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeecccc
Q 002321          176 ATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSEN  255 (936)
Q Consensus       176 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N  255 (936)
                      ++|+|++|++++..  .+..+++|++|+|++|++++..+  +..+++|++|+|++|++++..+  +..+++|++|++++|
T Consensus       110 ~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n  183 (308)
T 1h6u_A          110 KTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDN  183 (308)
T ss_dssp             CEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred             CEEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCC
Confidence            99999999999753  38899999999999999996544  8899999999999999986544  889999999999999


Q ss_pred             ccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceecc
Q 002321          256 SFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSG  307 (936)
Q Consensus       256 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  307 (936)
                      ++++..+  +..+++|+.|+|++|++++..+  +..+++|+.|+|++|++++
T Consensus       184 ~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          184 KISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             CCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred             ccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence            9987654  8899999999999999997653  8899999999999999984

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.88  E-value=1.4e-23  Score=244.08  Aligned_cols=208  Identities=24%  Similarity=0.387  Sum_probs=148.4

Q ss_pred             CCCCCCCCCCCc-----cceeE-EecCCCCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCC
Q 002321           53 LSSWSEDDDTPC-----NWFGV-KCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNL  126 (936)
Q Consensus        53 l~sW~~~~~~~c-----~w~gv-~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L  126 (936)
                      +.+|..+.+ +|     .|.|+ .|..  ++++.|+|+++++++ +|+.+.  ++|++|+|++|+|+ .+|   ..+++|
T Consensus        33 l~~W~~~~~-~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L  102 (571)
T 3cvr_A           33 WDKWEKQAL-PGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASL  102 (571)
T ss_dssp             HHHHHTTCC-TTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTC
T ss_pred             HHHHhccCC-ccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCC
Confidence            455765544 67     79999 7864  578899999999887 777663  78999999999988 456   457888


Q ss_pred             cEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCC
Q 002321          127 RVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSD  206 (936)
Q Consensus       127 ~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  206 (936)
                      ++|+|++|+|++ +|.  |..  +|++|+|++|+|++ +|.   .+++|++|+|++|+|++ +|.   .+++|++|+|++
T Consensus       103 ~~L~Ls~N~l~~-ip~--l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~  169 (571)
T 3cvr_A          103 EYLDACDNRLST-LPE--LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRN  169 (571)
T ss_dssp             CEEECCSSCCSC-CCC--CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCS
T ss_pred             CEEEccCCCCCC-cch--hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCC
Confidence            999999998885 776  333  88888888888886 555   56788888888888886 444   567888888888


Q ss_pred             CCCCCCCccCccCCCCcceeecccccccccCCcccccccCc-------ceeeccccccCCCCchhhhccccccEEeccCc
Q 002321          207 NLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLL-------RTIDFSENSFSGNLPETMQKLSLCNFMNLRKN  279 (936)
Q Consensus       207 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L-------~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N  279 (936)
                      |+|++ +|. |.  ++|++|+|++|+|+ .+|. |..  +|       ++|+|++|+|+ .+|..+..+++|+.|+|++|
T Consensus       170 N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N  240 (571)
T 3cvr_A          170 NQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDN  240 (571)
T ss_dssp             SCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSS
T ss_pred             CCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCC
Confidence            88885 555 55  77888888888887 5555 443  55       77777777776 34555555666666666666


Q ss_pred             cccCCCCcccccC
Q 002321          280 LFSGEVPKWIGEL  292 (936)
Q Consensus       280 ~l~~~~~~~~~~l  292 (936)
                      .+++.+|..+..+
T Consensus       241 ~l~~~~p~~l~~l  253 (571)
T 3cvr_A          241 PLSSRIRESLSQQ  253 (571)
T ss_dssp             SCCHHHHHHHHHH
T ss_pred             cCCCcCHHHHHHh
Confidence            6665555555443

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.88  E-value=3.4e-22  Score=210.32  Aligned_cols=179  Identities=18%  Similarity=0.230  Sum_probs=112.7

Q ss_pred             cccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCcccccccccccc
Q 002321          101 FLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINL  180 (936)
Q Consensus       101 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  180 (936)
                      ..+++++++++++ .+|..+.  ++|+.|+|++|+++ .++...|..+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus        15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L   90 (251)
T 3m19_A           15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLA-TLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL   90 (251)
T ss_dssp             GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcC-ccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence            4566777777776 3555444  46777777777776 455555666677777777777776666666666666666666


Q ss_pred             ccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCC
Q 002321          181 SSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGN  260 (936)
Q Consensus       181 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~  260 (936)
                      ++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|++++.
T Consensus        91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  170 (251)
T 3m19_A           91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV  170 (251)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence            66666666556666666666666666666655555556666666666666666655555566666666666666666655


Q ss_pred             CchhhhccccccEEeccCccccC
Q 002321          261 LPETMQKLSLCNFMNLRKNLFSG  283 (936)
Q Consensus       261 ~~~~l~~l~~L~~L~L~~N~l~~  283 (936)
                      .+..|..+++|+.|+|++|.+++
T Consensus       171 ~~~~~~~l~~L~~L~l~~N~~~c  193 (251)
T 3m19_A          171 PHGAFDRLGKLQTITLFGNQFDC  193 (251)
T ss_dssp             CTTTTTTCTTCCEEECCSCCBCT
T ss_pred             CHHHHhCCCCCCEEEeeCCceeC
Confidence            55555555555555555555543

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.88  E-value=1e-22  Score=225.58  Aligned_cols=241  Identities=15%  Similarity=0.118  Sum_probs=194.6

Q ss_pred             cEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCC-CCccccccccc-ccc
Q 002321          103 RKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIP-SSLSLCSTLAT-INL  180 (936)
Q Consensus       103 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~L  180 (936)
                      +.++.++++++ .+|..+  .+++++|+|++|+|+ .||.++|.++++|++|+|++|+|.+.+| ..|.++++|++ +.+
T Consensus        12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~   87 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   87 (350)
T ss_dssp             TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred             CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence            46788899998 577766  368999999999999 8999999999999999999999976555 57889988775 677


Q ss_pred             ccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeeccc-ccccccCCccccccc-CcceeeccccccC
Q 002321          181 SSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSK-NMFSGSIPDGIGSCS-LLRTIDFSENSFS  258 (936)
Q Consensus       181 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~  258 (936)
                      ++|+|+.+.|..|.++++|++|++++|+|+...+..+....++..|++.+ |+++...+..|..+. .+++|+|++|+|+
T Consensus        88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~  167 (350)
T 4ay9_X           88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ  167 (350)
T ss_dssp             EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred             cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence            78999999899999999999999999999977777777788899999965 678866667777765 6899999999999


Q ss_pred             CCCchhhhccccccEEeccC-ccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhh
Q 002321          259 GNLPETMQKLSLCNFMNLRK-NLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSM  337 (936)
Q Consensus       259 ~~~~~~l~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~  337 (936)
                      ...+..| ...+|+.|++.+ |.++...++.|..+++|++|||++|+|+...+..+.++++|+.+++  +.++ .+| .+
T Consensus       168 ~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~l  242 (350)
T 4ay9_X          168 EIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-TL  242 (350)
T ss_dssp             EECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-CT
T ss_pred             CCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-Cc
Confidence            6544444 556899999975 6777666678899999999999999999655555555554444433  3344 555 47


Q ss_pred             hccCCCCEEEccCCc
Q 002321          338 ANCMNLVALDFSQNS  352 (936)
Q Consensus       338 ~~l~~L~~L~Ls~N~  352 (936)
                      ..+++|+.++++++.
T Consensus       243 ~~l~~L~~l~l~~~~  257 (350)
T 4ay9_X          243 EKLVALMEASLTYPS  257 (350)
T ss_dssp             TTCCSCCEEECSCHH
T ss_pred             hhCcChhhCcCCCCc
Confidence            889999999997654

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.88  E-value=9.3e-24  Score=232.94  Aligned_cols=250  Identities=18%  Similarity=0.225  Sum_probs=141.3

Q ss_pred             cceeeccccccCCCCchhhhcc--ccccEEeccCccccCCCCcccccCCccceecccCceeccc-cCcccccccccceEE
Q 002321          247 LRTIDFSENSFSGNLPETMQKL--SLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGA-VPISIGNLQRLKVLN  323 (936)
Q Consensus       247 L~~L~Ls~N~l~~~~~~~l~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~l~~l~~L~~L~  323 (936)
                      ++.+++++|.+.   +..+..+  +.++.|++++|.+.+..+. +..+++|++|+|++|.+++. ++..+..+++|++|+
T Consensus        49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~  124 (336)
T 2ast_B           49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS  124 (336)
T ss_dssp             SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred             heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence            455566655554   3444444  4555555555555544443 33456666666666666543 455555566666666


Q ss_pred             ccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcc
Q 002321          324 FSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNE  403 (936)
Q Consensus       324 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~  403 (936)
                      |++|.+++..+..+..+++|+.|++++|.                                                  .
T Consensus       125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~--------------------------------------------------~  154 (336)
T 2ast_B          125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCS--------------------------------------------------G  154 (336)
T ss_dssp             CTTCBCCHHHHHHHTTCTTCSEEECTTCB--------------------------------------------------S
T ss_pred             CcCcccCHHHHHHHhcCCCCCEEECCCCC--------------------------------------------------C
Confidence            66666655555555555555555555551                                                  2


Q ss_pred             cCCC-ChhhhcccccCCeeeccCc-cccCC-CCccccCcc-cCCeeecCCc--ccc-ccCCCCCCCcCCCcEEEecCCc-
Q 002321          404 FSGE-TPATIGALSGLQLLNLSRN-SLVGP-IPVAIGDLK-ALNVLDLSEN--WLN-GSIPPEIGGAYSLKELRLERNF-  475 (936)
Q Consensus       404 l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L~~L~Ls~N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-  475 (936)
                      +++. .+..+..+++|++|+|++| .+++. ++..+..++ +|++|+|++|  .++ +.+|..+..+++|+.|+|++|. 
T Consensus       155 l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~  234 (336)
T 2ast_B          155 FSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM  234 (336)
T ss_dssp             CCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTT
T ss_pred             CCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCc
Confidence            3221 2333444444444444444 44322 233444445 5555555555  233 2344445566677777777776 


Q ss_pred             cCCcCccccccccccccccccCcc-ccCCCcccccccCCccEEEcCCCcccCCCCcccccc-cccCeeecCCCcccccCC
Q 002321          476 LAGKIPTSIENCSSLVSLILSKNN-LTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNL-VHLSSFNISHNHLQGELP  553 (936)
Q Consensus       476 l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~L~ls~N~l~~~~p  553 (936)
                      +++..+..+..+++|++|+|++|. +.......+.++++|++|+|++| ++   ...+..+ .+|+.|++++|++++..|
T Consensus       235 l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~  310 (336)
T 2ast_B          235 LKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIAR  310 (336)
T ss_dssp             CCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTC
T ss_pred             CCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccC
Confidence            555666677777778888887774 22222225777888888888888 33   2234444 347777888888888777


Q ss_pred             C
Q 002321          554 A  554 (936)
Q Consensus       554 ~  554 (936)
                      .
T Consensus       311 ~  311 (336)
T 2ast_B          311 P  311 (336)
T ss_dssp             S
T ss_pred             C
Confidence            5

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=2.2e-22  Score=214.72  Aligned_cols=144  Identities=15%  Similarity=0.120  Sum_probs=116.2

Q ss_pred             cccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCcc-----------------chHHHHHHHHHHHHcCCCCCcceee
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV-----------------KSQEDFEREVKKLGKVRHPNLVTLE  753 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~h~niv~l~  753 (936)
                      .|...+.||+|+||.||+|++.+|+.||||+++.....                 .....+.+|+.++++++  | +++.
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            34455789999999999999977999999999643211                 13467899999999999  5 6777


Q ss_pred             eEEEeCCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEee
Q 002321          754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGD  833 (936)
Q Consensus       754 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D  833 (936)
                      +++.. +..++||||++||+|.+ +..         .+...++.|+++||+|||+.||+||||||+|||++ ++.+||+|
T Consensus       168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D  235 (282)
T 1zar_A          168 KVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID  235 (282)
T ss_dssp             CEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred             eEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence            76543 45699999999999998 432         12346999999999999999999999999999999 99999999


Q ss_pred             ccCccccCCCccccccccccCcccccCcccc
Q 002321          834 YGLARLLPMLDRYVLSSKIQSALGYMAPEFA  864 (936)
Q Consensus       834 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  864 (936)
                      ||+|+..               ..|+|||++
T Consensus       236 FG~a~~~---------------~~~~a~e~l  251 (282)
T 1zar_A          236 FPQSVEV---------------GEEGWREIL  251 (282)
T ss_dssp             CTTCEET---------------TSTTHHHHH
T ss_pred             CCCCeEC---------------CCCCHHHHH
Confidence            9999743               236888877

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.86  E-value=2.3e-21  Score=197.77  Aligned_cols=178  Identities=21%  Similarity=0.237  Sum_probs=119.9

Q ss_pred             cEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCcccccccccccccc
Q 002321          103 RKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSS  182 (936)
Q Consensus       103 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  182 (936)
                      +.++.+++.++. +|..+  .++|++|+|++|+++ .++...|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus        10 ~~v~c~~~~l~~-~p~~~--~~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~   85 (208)
T 2o6s_A           10 TTVECYSQGRTS-VPTGI--PAQTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST   85 (208)
T ss_dssp             TEEECCSSCCSS-CCSCC--CTTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CEEEecCCCccC-CCCCC--CCCCcEEEcCCCccC-cCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence            456677777773 44444  357888888888887 56777777888888888888888766666677777777777777


Q ss_pred             ccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCc
Q 002321          183 NRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLP  262 (936)
Q Consensus       183 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~  262 (936)
                      |+|++..+..|.++++|++|+|++|++++..+..+.++++|++|+|++|++++..+..|..+++|++|+|++|.+.+.  
T Consensus        86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~--  163 (208)
T 2o6s_A           86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT--  163 (208)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC--
T ss_pred             CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC--
Confidence            777766666677777777777777777766555667777777777777777765555566677777777777665532  


Q ss_pred             hhhhccccccEEeccCccccCCCCccccc
Q 002321          263 ETMQKLSLCNFMNLRKNLFSGEVPKWIGE  291 (936)
Q Consensus       263 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~  291 (936)
                           ++.|++|++..|.++|.+|.+++.
T Consensus       164 -----~~~l~~L~~~~n~~~g~ip~~~~~  187 (208)
T 2o6s_A          164 -----CPGIRYLSEWINKHSGVVRNSAGS  187 (208)
T ss_dssp             -----TTTTHHHHHHHHHCTTTBBCTTSS
T ss_pred             -----CCCHHHHHHHHHhCCceeeccCcc
Confidence                 223444444444444444444443

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.84  E-value=5.2e-21  Score=222.58  Aligned_cols=196  Identities=22%  Similarity=0.363  Sum_probs=117.2

Q ss_pred             cccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCcccccccccccc
Q 002321          101 FLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINL  180 (936)
Q Consensus       101 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  180 (936)
                      +|+.|+|++|+|++ +|..+  +++|++|+|++|+|+ .+|    ..+++|++|+|++|+|++ +|. +..  +|++|+|
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip----~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~L  127 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP----ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDV  127 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC----CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEEC
T ss_pred             CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc----cccCCCCEEEccCCCCCC-cch-hhc--CCCEEEC
Confidence            67777777777765 55544  256777777777776 566    235666666666666665 444 443  6666666


Q ss_pred             ccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCC
Q 002321          181 SSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGN  260 (936)
Q Consensus       181 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~  260 (936)
                      ++|+|++ +|.   .+++|++|+|++|+|++ +|.   .+++|++|+|++|+|++ +|. |.  ++|++|+|++|+|+ .
T Consensus       128 s~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~  194 (571)
T 3cvr_A          128 DNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-S  194 (571)
T ss_dssp             CSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-S
T ss_pred             CCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-c
Confidence            6666665 333   45666666666666664 443   34566666666666664 444 43  56666666666655 2


Q ss_pred             CchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhcc
Q 002321          261 LPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANC  340 (936)
Q Consensus       261 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l  340 (936)
                      +|. +..  +|                 +...+.|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|..+..+
T Consensus       195 lp~-~~~--~L-----------------~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l  253 (571)
T 3cvr_A          195 LPA-VPV--RN-----------------HHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ  253 (571)
T ss_dssp             CCC-CC---------------------------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred             hhh-HHH--hh-----------------hcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence            222 221  11                 001122377777777777 466666667778888888888777777777665


Q ss_pred             CC
Q 002321          341 MN  342 (936)
Q Consensus       341 ~~  342 (936)
                      ..
T Consensus       254 ~~  255 (571)
T 3cvr_A          254 TA  255 (571)
T ss_dssp             HH
T ss_pred             hc
Confidence            43

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.84  E-value=4.3e-22  Score=240.66  Aligned_cols=237  Identities=19%  Similarity=0.212  Sum_probs=116.1

Q ss_pred             hhHHHHHHHHHHhccCC-CCCCCCCCCCCCCCccceeEEecCCCCceEEeccCCCCCCcccccccccCccccEEeccCCc
Q 002321           33 NDDVLGLIVFKADIQDP-NGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNN  111 (936)
Q Consensus        33 ~~~~~aLl~~k~~~~d~-~~~l~sW~~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~  111 (936)
                      ..++++|+++..+...+ ...-.+|......++.|.++.++.  .+++.|+|.++++.. ++.     ..|+.++|+.|.
T Consensus       131 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~-~~~-----~~l~~l~Ls~~~  202 (727)
T 4b8c_D          131 DCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDE-ANQ-----ALLQHKKLSQYS  202 (727)
T ss_dssp             -CCCHHHHHHHHHHHHHHTTC-----------------------------------------------------------
T ss_pred             ccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCc-chh-----hHhhcCccCccc
Confidence            46899999999877522 333456755444357899998876  789999998888765 232     335566666666


Q ss_pred             ccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCC
Q 002321          112 LTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPL  191 (936)
Q Consensus       112 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~  191 (936)
                      |++              ++++.|++.  ++.+.|..+++|+.|+|++|+|. .+|..+..+++|++|+|++|+|+ .+|.
T Consensus       203 i~~--------------~~~~~n~~~--~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~  264 (727)
T 4b8c_D          203 IDE--------------DDDIENRMV--MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPA  264 (727)
T ss_dssp             -----------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCG
T ss_pred             ccC--------------cccccccee--cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccCh
Confidence            553              344555554  45566677777777777777776 46666667778888888888877 5677


Q ss_pred             CCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhcccc-
Q 002321          192 GIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSL-  270 (936)
Q Consensus       192 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~-  270 (936)
                      .|.++++|++|+|++|.|+ .+|..|++|++|++|+|++|.|+ .+|..|+.+++|++|+|++|.|++.+|..+..+.. 
T Consensus       265 ~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~  342 (727)
T 4b8c_D          265 EIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVT  342 (727)
T ss_dssp             GGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHH
T ss_pred             hhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchh
Confidence            7778888888888888887 66777888888888888888886 66777888888888888888888777777765432 


Q ss_pred             ccEEeccCccccCCCCcccccCCccceecccCc
Q 002321          271 CNFMNLRKNLFSGEVPKWIGELESLETLDLSGN  303 (936)
Q Consensus       271 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  303 (936)
                      +..++|++|.+++.+|..      |+.|+++.|
T Consensus       343 ~~~l~l~~N~l~~~~p~~------l~~l~l~~n  369 (727)
T 4b8c_D          343 GLIFYLRDNRPEIPLPHE------RRFIEINTD  369 (727)
T ss_dssp             HHHHHHHHCCCCCCCCCC---------------
T ss_pred             hhHHhhccCcccCcCccc------cceeEeecc
Confidence            234667777777766653      445556655

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.84  E-value=1.7e-20  Score=194.13  Aligned_cols=161  Identities=23%  Similarity=0.302  Sum_probs=104.7

Q ss_pred             CCCCCCCCccceeEEecCCCCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcc
Q 002321           56 WSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNS  135 (936)
Q Consensus        56 W~~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~  135 (936)
                      |..... .|.|.+|.|+..  ++           ..+|..+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus        12 ~~~~~~-~Cs~~~v~c~~~--~l-----------~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~   75 (229)
T 3e6j_A           12 ACPSQC-SCSGTTVDCRSK--RH-----------ASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQ   75 (229)
T ss_dssp             CCCTTC-EEETTEEECTTS--CC-----------SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             cCCCCC-EEeCCEeEccCC--Cc-----------CccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCC
Confidence            433333 799999999752  22           13444333  788888999988888888888888888888888888


Q ss_pred             cccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCcc
Q 002321          136 LSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPK  215 (936)
Q Consensus       136 l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  215 (936)
                      |+ .+|...|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+.
T Consensus        76 l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~  153 (229)
T 3e6j_A           76 LG-ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHG  153 (229)
T ss_dssp             CC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTT
T ss_pred             CC-CcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHH
Confidence            86 677777777777777777777777655555566666666666666655 3444555555555555555555544444


Q ss_pred             CccCCCCcceeeccccccc
Q 002321          216 GVESLKNLRVINLSKNMFS  234 (936)
Q Consensus       216 ~~~~l~~L~~L~L~~N~l~  234 (936)
                      .|..+++|++|+|++|.+.
T Consensus       154 ~~~~l~~L~~L~l~~N~~~  172 (229)
T 3e6j_A          154 AFDRLSSLTHAYLFGNPWD  172 (229)
T ss_dssp             TTTTCTTCCEEECTTSCBC
T ss_pred             HHhCCCCCCEEEeeCCCcc
Confidence            4444555555555555444

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.83  E-value=3.7e-21  Score=197.63  Aligned_cols=180  Identities=21%  Similarity=0.196  Sum_probs=151.1

Q ss_pred             ccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCC-ccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEec
Q 002321          394 LQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIP-VAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLE  472 (936)
Q Consensus       394 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  472 (936)
                      -+.+++++|.++. +|..+.  ..+++|+|++|++++..+ ..|..+++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus        13 ~~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls   89 (220)
T 2v70_A           13 GTTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT   89 (220)
T ss_dssp             TTEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence            3689999999985 555442  457899999999997754 568999999999999999998888899999999999999


Q ss_pred             CCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCcccccC
Q 002321          473 RNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGEL  552 (936)
Q Consensus       473 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~  552 (936)
                      +|+|++..+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..+..+++|+.|+|++|++.+.+
T Consensus        90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c  169 (220)
T 2v70_A           90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC  169 (220)
T ss_dssp             SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred             CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence            99999888888999999999999999999988999999999999999999999888999999999999999999999988


Q ss_pred             CCCCccCcCCCcc-ccCCCCCCCCCC
Q 002321          553 PAGGFFNTISPSS-VLGNPSLCGSAV  577 (936)
Q Consensus       553 p~~~~~~~~~~~~-~~gn~~~c~~~~  577 (936)
                      +...+..++.... +.+|+ .|+.|.
T Consensus       170 ~l~~l~~~~~~~~~~~~~~-~C~~P~  194 (220)
T 2v70_A          170 YLAWLGEWLRKKRIVTGNP-RCQKPY  194 (220)
T ss_dssp             GGHHHHHHHHHSCCBCCCC-EEEESG
T ss_pred             chHHHHHHHHhcCccccCC-ccCCCh
Confidence            7544433332222 23443 565553

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.83  E-value=1.3e-20  Score=202.56  Aligned_cols=189  Identities=20%  Similarity=0.262  Sum_probs=108.1

Q ss_pred             ccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccc
Q 002321          102 LRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLS  181 (936)
Q Consensus       102 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  181 (936)
                      +..+.+..+.+++.  ..+..+++|++|++++|.++ .++.  +..+++|++|+|++|++++..+  +..+++|++|+|+
T Consensus        26 ~~~~~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~~~--~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~   98 (291)
T 1h6t_A           26 TIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLD   98 (291)
T ss_dssp             HHHHHTTCSCTTSE--ECHHHHHTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred             HHHHHhcCCCcccc--cchhhcCcccEEEccCCCcc-cChh--HhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECC
Confidence            34444555555433  23445666666666666665 3332  4556666666666666654333  5556666666666


Q ss_pred             cccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCC
Q 002321          182 SNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNL  261 (936)
Q Consensus       182 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~  261 (936)
                      +|++++.  ..+..+++|++|+|++|++++.  ..+..+++|++|++++|++++.  ..+..+++|++|+|++|++++..
T Consensus        99 ~n~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~  172 (291)
T 1h6t_A           99 ENKVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV  172 (291)
T ss_dssp             SSCCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG
T ss_pred             CCcCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccch
Confidence            6666542  2356666666666666666642  3456666666666666666643  45566666666666666666543


Q ss_pred             chhhhccccccEEeccCccccCCCCcccccCCccceecccCceecc
Q 002321          262 PETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSG  307 (936)
Q Consensus       262 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  307 (936)
                      +  +..+++|+.|+|++|.+++. + .+..+++|+.|++++|+++.
T Consensus       173 ~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          173 P--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             G--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred             h--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence            3  55555566666666655542 2 25556666666666666653

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.82  E-value=9.8e-21  Score=194.50  Aligned_cols=157  Identities=22%  Similarity=0.223  Sum_probs=132.4

Q ss_pred             cEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCC
Q 002321          395 QFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERN  474 (936)
Q Consensus       395 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  474 (936)
                      +.+++++|.++. +|..+.  ++|++|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            578888888874 444433  67888999999988777778888899999999999998888888999999999999999


Q ss_pred             ccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCcccccCCC
Q 002321          475 FLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPA  554 (936)
Q Consensus       475 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~  554 (936)
                      +|++..+..|.++++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..+..+++|+.|+|++|++.+...-
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~l  170 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCHL  170 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCcc
Confidence            99866666678899999999999999988888899999999999999999877777788899999999999998876554

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.82  E-value=5.3e-20  Score=189.01  Aligned_cols=132  Identities=26%  Similarity=0.344  Sum_probs=67.3

Q ss_pred             ccEEeccCCcccCcCC-CchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCcccccccccccc
Q 002321          102 LRKLSLSSNNLTGSIS-PNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINL  180 (936)
Q Consensus       102 L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  180 (936)
                      +++|+|++|+|++..+ ..|.++++|++|+|++|+|+ .++...|..+++|                        ++|+|
T Consensus        34 ~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~-~i~~~~~~~l~~L------------------------~~L~L   88 (220)
T 2v70_A           34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGV------------------------NEILL   88 (220)
T ss_dssp             CSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCC-EECTTTTTTCTTC------------------------CEEEC
T ss_pred             CCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCC-EECHHHhCCCCCC------------------------CEEEC
Confidence            4555555555554433 23555555555555555555 3444444444444                        44444


Q ss_pred             ccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccC
Q 002321          181 SSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFS  258 (936)
Q Consensus       181 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~  258 (936)
                      ++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+.
T Consensus        89 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  166 (220)
T 2v70_A           89 TSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN  166 (220)
T ss_dssp             CSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred             CCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence            444444444444445555555555555555444455555555555555555555444555555555555555555554

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.81  E-value=4e-20  Score=217.71  Aligned_cols=191  Identities=19%  Similarity=0.259  Sum_probs=111.3

Q ss_pred             cccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCcccccccccccc
Q 002321          101 FLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINL  180 (936)
Q Consensus       101 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  180 (936)
                      .+..+.++.+.+++..  .+..|++|+.|+|++|.|+ .++  .|..+++|+.|+|++|+|++..+  +..+++|++|+|
T Consensus        22 ~l~~l~l~~~~i~~~~--~~~~L~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L   94 (605)
T 1m9s_A           22 ETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIK-SVQ--GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFL   94 (605)
T ss_dssp             HHHHHHTTCSCTTSEE--CHHHHTTCCCCBCTTCCCC-CCT--TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEEC
T ss_pred             HHHHHhccCCCccccc--chhcCCCCCEEECcCCCCC-CCh--HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEEC
Confidence            3444455555555432  2455556666666666555 333  24555566666666665554333  555666666666


Q ss_pred             ccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCC
Q 002321          181 SSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGN  260 (936)
Q Consensus       181 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~  260 (936)
                      ++|+|++.  ..+..+++|++|+|++|.|++.  ..+..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|+|++.
T Consensus        95 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~  168 (605)
T 1m9s_A           95 DENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI  168 (605)
T ss_dssp             CSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCC
T ss_pred             cCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCc
Confidence            66666542  2456666666666666666642  3356666666666666666643  4566666666666666666655


Q ss_pred             CchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccc
Q 002321          261 LPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGA  308 (936)
Q Consensus       261 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  308 (936)
                      .|  +..+++|+.|+|++|.+++.  ..+..+++|+.|+|++|++.+.
T Consensus       169 ~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~  212 (605)
T 1m9s_A          169 VP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK  212 (605)
T ss_dssp             GG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred             hh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence            44  56666666666666666643  2456666677777777766643

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.81  E-value=3.1e-20  Score=199.60  Aligned_cols=188  Identities=21%  Similarity=0.271  Sum_probs=147.2

Q ss_pred             EeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCc
Q 002321           80 ELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKN  159 (936)
Q Consensus        80 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N  159 (936)
                      .+.+.+..+++..  .+.++++|++|++++|++++.  +.+..+++|++|+|++|++++ ++.  |..+++|++|+|++|
T Consensus        28 ~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~-~~~--l~~l~~L~~L~l~~n  100 (291)
T 1h6t_A           28 KDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDEN  100 (291)
T ss_dssp             HHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSS
T ss_pred             HHHhcCCCccccc--chhhcCcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCC-Ccc--cccCCCCCEEECCCC
Confidence            3344444444322  245788888888888888754  358888889999999888884 444  788888999999998


Q ss_pred             cCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCc
Q 002321          160 RFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPD  239 (936)
Q Consensus       160 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  239 (936)
                      ++++  +..+..+++|++|+|++|++++.  ..+..+++|++|+|++|++++.  ..+..+++|++|+|++|++++..+ 
T Consensus       101 ~l~~--~~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-  173 (291)
T 1h6t_A          101 KVKD--LSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-  173 (291)
T ss_dssp             CCCC--GGGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-
T ss_pred             cCCC--ChhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh-
Confidence            8885  23488888899999999988874  4678888899999999988865  568888899999999999886654 


Q ss_pred             ccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCC
Q 002321          240 GIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGE  284 (936)
Q Consensus       240 ~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~  284 (936)
                       +..+++|++|+|++|.+++. + .+..+++|+.|++++|.++..
T Consensus       174 -l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~~  215 (291)
T 1h6t_A          174 -LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNK  215 (291)
T ss_dssp             -GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEECC
T ss_pred             -hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccCC
Confidence             88888999999999988864 3 488888999999999988753

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.81  E-value=4.8e-22  Score=232.75  Aligned_cols=186  Identities=17%  Similarity=0.190  Sum_probs=111.2

Q ss_pred             ccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcc-------------cccccchhhhhcCCCCcEEE-ccCccCC
Q 002321           97 LQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNS-------------LSGSIPDEFFKQCGSLRVIS-LAKNRFS  162 (936)
Q Consensus        97 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~-------------l~~~i~~~~f~~l~~L~~L~-L~~N~l~  162 (936)
                      ..+++|+.|+|++|+|+ .+|..+++|++|+.|++++|.             +.+ .++..++.+++|+.|+ ++.|.+ 
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~-~~~~~l~~l~~L~~L~~l~~n~~-  422 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLL-YEKETLQYFSTLKAVDPMRAAYL-  422 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGG-GHHHHHHHHHHHHHHCGGGHHHH-
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhccccc-CCHHHHHHHHhcccCcchhhccc-
Confidence            56788889999999987 678889999999999987775             222 2233445555555555 444432 


Q ss_pred             CCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccc
Q 002321          163 GKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIG  242 (936)
Q Consensus       163 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~  242 (936)
                                .+|+.+.+++|.|+...+      ..|+.|+|++|.|++ +|. ++++++|+.|+|++|+|+ .+|..|+
T Consensus       423 ----------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~  483 (567)
T 1dce_A          423 ----------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALA  483 (567)
T ss_dssp             ----------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGG
T ss_pred             ----------chhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhh
Confidence                      345555555566554322      136666666666664 444 666666666666666666 5566666


Q ss_pred             cccCcceeeccccccCCCCchhhhccccccEEeccCccccCCC-CcccccCCccceecccCceec
Q 002321          243 SCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEV-PKWIGELESLETLDLSGNKFS  306 (936)
Q Consensus       243 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~  306 (936)
                      .+++|++|+|++|+|++ +| .+..+++|+.|+|++|++++.. |..++.+++|+.|+|++|+++
T Consensus       484 ~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~  546 (567)
T 1dce_A          484 ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC  546 (567)
T ss_dssp             GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             cCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCC
Confidence            66666666666666664 33 4455555555555555554443 444444444444444444444

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.81  E-value=1.4e-19  Score=212.98  Aligned_cols=198  Identities=21%  Similarity=0.267  Sum_probs=156.6

Q ss_pred             eEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEcc
Q 002321           78 VIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLA  157 (936)
Q Consensus        78 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~  157 (936)
                      +..+.+....++..++  +.+|++|+.|+|++|.|+..  +.|..+++|+.|+|++|+|++ +++  |..+++|++|+|+
T Consensus        23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l--~~l~~l~~L~~L~Ls~N~l~~-~~~--l~~l~~L~~L~Ls   95 (605)
T 1m9s_A           23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTD-IKP--LTNLKNLGWLFLD   95 (605)
T ss_dssp             HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC--TTGGGCTTCCEEECTTSCCCC-CGG--GGGCTTCCEEECC
T ss_pred             HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC--hHHccCCCCCEEEeeCCCCCC-Chh--hccCCCCCEEECc
Confidence            4444555555554333  56788889999999988854  368889999999999999985 443  7889999999999


Q ss_pred             CccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccC
Q 002321          158 KNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSI  237 (936)
Q Consensus       158 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  237 (936)
                      +|+|++  +..+..+++|++|+|++|+|+++  ..+..+++|+.|+|++|.|++.  ..+..+++|+.|+|++|+|++..
T Consensus        96 ~N~l~~--l~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~  169 (605)
T 1m9s_A           96 ENKIKD--LSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV  169 (605)
T ss_dssp             SSCCCC--CTTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCG
T ss_pred             CCCCCC--ChhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCch
Confidence            999885  34788899999999999999874  4588889999999999999865  56888899999999999998766


Q ss_pred             CcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccC
Q 002321          238 PDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGEL  292 (936)
Q Consensus       238 p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l  292 (936)
                      |  +..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|.+.+.....+..+
T Consensus       170 ~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l  220 (605)
T 1m9s_A          170 P--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNL  220 (605)
T ss_dssp             G--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCSSC
T ss_pred             h--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccccE
Confidence            6  88899999999999999864  468888999999999999886544443333

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.81  E-value=1.5e-19  Score=185.59  Aligned_cols=156  Identities=24%  Similarity=0.291  Sum_probs=79.4

Q ss_pred             CCccceeEEecCCCCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccc
Q 002321           62 TPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIP  141 (936)
Q Consensus        62 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~  141 (936)
                      |.|.|..|.|..            ++++ .+|..+.  +.|++|+|++|+|+++.+..|..+++|++|+|++|+|+ .++
T Consensus         9 C~C~~~~v~c~~------------~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~-~~~   72 (220)
T 2v9t_B            9 CTCSNNIVDCRG------------KGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELA   72 (220)
T ss_dssp             SEEETTEEECTT------------SCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCC-EEC
T ss_pred             CEECCCEEEcCC------------CCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCC-CcC
Confidence            347787777764            2232 2343332  45666666666666555556666666666666666665 343


Q ss_pred             hhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCC
Q 002321          142 DEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLK  221 (936)
Q Consensus       142 ~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  221 (936)
                      +..|.++++|++|+|++|+|+...+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..++
T Consensus        73 ~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  152 (220)
T 2v9t_B           73 PDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR  152 (220)
T ss_dssp             TTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT
T ss_pred             HHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCC
Confidence            44455555555555555555543333444444444444444444444444444444444444444444433333344444


Q ss_pred             Ccceeecccccc
Q 002321          222 NLRVINLSKNMF  233 (936)
Q Consensus       222 ~L~~L~L~~N~l  233 (936)
                      +|++|+|++|.+
T Consensus       153 ~L~~L~L~~N~~  164 (220)
T 2v9t_B          153 AIQTMHLAQNPF  164 (220)
T ss_dssp             TCCEEECCSSCE
T ss_pred             CCCEEEeCCCCc
Confidence            444444444443

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.81  E-value=7.7e-20  Score=203.21  Aligned_cols=109  Identities=27%  Similarity=0.244  Sum_probs=60.6

Q ss_pred             cccEEeccCCcccCcCCCchh-hcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccc
Q 002321          101 FLRKLSLSSNNLTGSISPNLA-KLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATIN  179 (936)
Q Consensus       101 ~L~~L~L~~n~l~~~~~~~l~-~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  179 (936)
                      .++.|+|++|+|++..+..|. ++++|++|+|++|+|+ .++...|..+++|++|+|++|+|++..+..|..+++|++|+
T Consensus        40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~-~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  118 (361)
T 2xot_A           40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLL  118 (361)
T ss_dssp             TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCC-ccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEE
Confidence            356666666666655555555 6666666666666665 45555555555555555555555544444455555555555


Q ss_pred             cccccccCCCCCCCCCCCCCCEEecCCCCCC
Q 002321          180 LSSNRFSSPLPLGIWGLSALRTLDLSDNLLE  210 (936)
Q Consensus       180 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  210 (936)
                      |++|+|+++.|..|.++++|++|+|++|+|+
T Consensus       119 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  149 (361)
T 2xot_A          119 LYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS  149 (361)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCCCcccEECHHHhCCcccCCEEECCCCcCC
Confidence            5555555444444444444444444444444

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.80  E-value=5e-22  Score=232.58  Aligned_cols=188  Identities=21%  Similarity=0.228  Sum_probs=92.0

Q ss_pred             ccCCccceecccCceeccccCcccccccccceEEccCCc-------------ccccCChhhhccCCCCEEE-ccCCcCcc
Q 002321          290 GELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANR-------------LTGSLPDSMANCMNLVALD-FSQNSMNG  355 (936)
Q Consensus       290 ~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~-------------l~~~~~~~~~~l~~L~~L~-Ls~N~l~~  355 (936)
                      ..+++|+.|+|++|+++ .+|..++++++|+.|++++|.             +.+..|..+..+++|+.|+ ++.|.+. 
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-  423 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-  423 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence            34555666666666665 555566666666666665543             3334455555555555554 3433321 


Q ss_pred             CCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCcc
Q 002321          356 DLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVA  435 (936)
Q Consensus       356 ~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  435 (936)
                                                           .|+.+.+++|.|+...+      ..|+.|+|++|+|++ +|. 
T Consensus       424 -------------------------------------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-  458 (567)
T 1dce_A          424 -------------------------------------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-  458 (567)
T ss_dssp             -------------------------------------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-
T ss_pred             -------------------------------------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-
Confidence                                                 23333334444332111      124445555555443 333 


Q ss_pred             ccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCC-cccccccCCc
Q 002321          436 IGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPI-PIAIAKLTNL  514 (936)
Q Consensus       436 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L  514 (936)
                      |+.+++|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|++ +| .++++++|++|+|++|+|++.. |..++.+++|
T Consensus       459 ~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L  535 (567)
T 1dce_A          459 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL  535 (567)
T ss_dssp             GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTC
T ss_pred             ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCC
Confidence            444555555555555554 344445555555555555555553 34 4555555555555555555443 5555555555


Q ss_pred             cEEEcCCCcccCC
Q 002321          515 QNVDLSFNSLTGG  527 (936)
Q Consensus       515 ~~L~Ls~N~l~~~  527 (936)
                      +.|+|++|+|++.
T Consensus       536 ~~L~L~~N~l~~~  548 (567)
T 1dce_A          536 VLLNLQGNSLCQE  548 (567)
T ss_dssp             CEEECTTSGGGGS
T ss_pred             CEEEecCCcCCCC
Confidence            5555555555533

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.80  E-value=9e-20  Score=202.65  Aligned_cols=163  Identities=25%  Similarity=0.243  Sum_probs=111.4

Q ss_pred             cEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhh-cCCCCcEEEccCccCCCCCCCCccccccccccccc
Q 002321          103 RKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFK-QCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLS  181 (936)
Q Consensus       103 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  181 (936)
                      +.+++++++|+. +|..+.  +.++.|+|++|+|+ .++...|. .+++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus        21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~-~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls   96 (361)
T 2xot_A           21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS   96 (361)
T ss_dssp             TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCC-EECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCC-ccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence            578888888874 565553  35788888888887 56666666 77778888888887777666777777777777777


Q ss_pred             cccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCccc---ccccCcceeeccccccC
Q 002321          182 SNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGI---GSCSLLRTIDFSENSFS  258 (936)
Q Consensus       182 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~l~~L~~L~Ls~N~l~  258 (936)
                      +|+|+++.+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|   ..+++|++|+|++|+|+
T Consensus        97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~  176 (361)
T 2xot_A           97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK  176 (361)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred             CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence            777777666667777777777777777776666667777777777777777765433334   44666666666666666


Q ss_pred             CCCchhhhccc
Q 002321          259 GNLPETMQKLS  269 (936)
Q Consensus       259 ~~~~~~l~~l~  269 (936)
                      +..+..+..++
T Consensus       177 ~l~~~~~~~l~  187 (361)
T 2xot_A          177 KLPLTDLQKLP  187 (361)
T ss_dssp             CCCHHHHHHSC
T ss_pred             ccCHHHhhhcc
Confidence            54444444444

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.79  E-value=3.9e-19  Score=183.79  Aligned_cols=158  Identities=24%  Similarity=0.211  Sum_probs=131.9

Q ss_pred             cccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEec
Q 002321          393 SLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLE  472 (936)
Q Consensus       393 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  472 (936)
                      +.+.++.++++++ .+|..+.  ++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..|.++++|+.|+|+
T Consensus        20 s~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls   96 (229)
T 3e6j_A           20 SGTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG   96 (229)
T ss_dssp             ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             eCCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence            4567888888886 4444332  778899999999988888888889999999999999886666677888999999999


Q ss_pred             CCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCcccccC
Q 002321          473 RNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGEL  552 (936)
Q Consensus       473 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~  552 (936)
                      +|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..+..+++|+.|+|++|++.+.+
T Consensus        97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c  175 (229)
T 3e6j_A           97 TNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC  175 (229)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred             CCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence            99998777777888999999999999998 67888889999999999999998666677888999999999999998877


Q ss_pred             CC
Q 002321          553 PA  554 (936)
Q Consensus       553 p~  554 (936)
                      +.
T Consensus       176 ~~  177 (229)
T 3e6j_A          176 RD  177 (229)
T ss_dssp             GG
T ss_pred             ch
Confidence            63

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.78  E-value=1.8e-19  Score=190.50  Aligned_cols=169  Identities=20%  Similarity=0.281  Sum_probs=92.8

Q ss_pred             cCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccc
Q 002321           98 QLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLAT  177 (936)
Q Consensus        98 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  177 (936)
                      ++..+..+++++|.+++..  .+..+++|++|++++|+|+ .++  .+..+++|++|+|++|+|++..+  +..+++|++
T Consensus        17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~   89 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA--GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEE   89 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCE
T ss_pred             HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch--HHhhCCCCCEEECCCCccCCChh--hccCCCCCE
Confidence            4555666666666666432  5666777777777777666 444  35566666666666666664433  556666666


Q ss_pred             cccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeecccccc
Q 002321          178 INLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSF  257 (936)
Q Consensus       178 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l  257 (936)
                      |+|++|++++..+  +.. ++|++|+|++|++++. + .+..+++|++|+|++|++++. + .+..+++|++|+|++|++
T Consensus        90 L~L~~N~l~~l~~--~~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i  162 (263)
T 1xeu_A           90 LSVNRNRLKNLNG--IPS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEI  162 (263)
T ss_dssp             EECCSSCCSCCTT--CCC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCC
T ss_pred             EECCCCccCCcCc--ccc-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcC
Confidence            6666666655322  222 5566666666666532 2 355555555555555555533 2 455555555555555555


Q ss_pred             CCCCchhhhccccccEEeccCcccc
Q 002321          258 SGNLPETMQKLSLCNFMNLRKNLFS  282 (936)
Q Consensus       258 ~~~~~~~l~~l~~L~~L~L~~N~l~  282 (936)
                      ++.  ..+..+++|+.|++++|.++
T Consensus       163 ~~~--~~l~~l~~L~~L~l~~N~~~  185 (263)
T 1xeu_A          163 TNT--GGLTRLKKVNWIDLTGQKCV  185 (263)
T ss_dssp             CBC--TTSTTCCCCCEEEEEEEEEE
T ss_pred             cch--HHhccCCCCCEEeCCCCccc
Confidence            533  33334444444444444433

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.78  E-value=4.3e-19  Score=187.56  Aligned_cols=171  Identities=19%  Similarity=0.288  Sum_probs=146.5

Q ss_pred             ceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEc
Q 002321           77 RVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISL  156 (936)
Q Consensus        77 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L  156 (936)
                      .++.+++.++.+++..  .+.++++|++|++++|+|+. ++ .+..+++|++|+|++|+|++ ++.  |..+++|++|+|
T Consensus        20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~-~~~--l~~l~~L~~L~L   92 (263)
T 1xeu_A           20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISD-LSP--LKDLTKLEELSV   92 (263)
T ss_dssp             HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG--GTTCSSCCEEEC
T ss_pred             HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCC-Chh--hccCCCCCEEEC
Confidence            4566778888777433  58899999999999999985 44 79999999999999999994 555  899999999999


Q ss_pred             cCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeeccccccccc
Q 002321          157 AKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGS  236 (936)
Q Consensus       157 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  236 (936)
                      ++|+|++. |. +.. ++|++|+|++|+|++.  ..+..+++|++|+|++|+|++. + .+..+++|++|+|++|++++.
T Consensus        93 ~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~  165 (263)
T 1xeu_A           93 NRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT  165 (263)
T ss_dssp             CSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred             CCCccCCc-Cc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch
Confidence            99999964 33 333 9999999999999975  3689999999999999999964 4 689999999999999999976


Q ss_pred             CCcccccccCcceeeccccccCCCCch
Q 002321          237 IPDGIGSCSLLRTIDFSENSFSGNLPE  263 (936)
Q Consensus       237 ~p~~l~~l~~L~~L~Ls~N~l~~~~~~  263 (936)
                        ..+..+++|++|++++|.+++....
T Consensus       166 --~~l~~l~~L~~L~l~~N~~~~~~~~  190 (263)
T 1xeu_A          166 --GGLTRLKKVNWIDLTGQKCVNEPVK  190 (263)
T ss_dssp             --TTSTTCCCCCEEEEEEEEEECCCEE
T ss_pred             --HHhccCCCCCEEeCCCCcccCCccc
Confidence              7789999999999999999866433

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.76  E-value=1.6e-18  Score=174.89  Aligned_cols=154  Identities=18%  Similarity=0.267  Sum_probs=135.5

Q ss_pred             CCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcE
Q 002321          389 SSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKE  468 (936)
Q Consensus       389 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  468 (936)
                      ..+++|++|++++|.++ .+| .+..+++|++|++++|.++  .+..+..+++|++|++++|++++..+..+..+++|+.
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~  116 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL  116 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence            35678999999999998 445 6889999999999999776  3458999999999999999999888899999999999


Q ss_pred             EEecCCccCCcCccccccccccccccccCcc-ccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCc
Q 002321          469 LRLERNFLAGKIPTSIENCSSLVSLILSKNN-LTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNH  547 (936)
Q Consensus       469 L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~  547 (936)
                      |+|++|++++..|..+..+++|++|+|++|+ ++ .+| .+..+++|++|+|++|++++ ++ .+..+++|++|++++|+
T Consensus       117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~  192 (197)
T 4ezg_A          117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT  192 (197)
T ss_dssp             EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred             EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence            9999999998889999999999999999998 55 556 78999999999999999985 44 78999999999999999


Q ss_pred             ccc
Q 002321          548 LQG  550 (936)
Q Consensus       548 l~~  550 (936)
                      +.+
T Consensus       193 i~~  195 (197)
T 4ezg_A          193 IGG  195 (197)
T ss_dssp             ---
T ss_pred             cCC
Confidence            864

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.76  E-value=4.1e-19  Score=178.23  Aligned_cols=131  Identities=24%  Similarity=0.270  Sum_probs=72.3

Q ss_pred             cEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCc-cccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecC
Q 002321          395 QFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPV-AIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLER  473 (936)
Q Consensus       395 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  473 (936)
                      +.+++++|+++ .+|..+..  +|++|+|++|++++..+. .|+.+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            56667777664 33433322  566666666666544443 355556666666666666555555555555555555555


Q ss_pred             CccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCC
Q 002321          474 NFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGL  528 (936)
Q Consensus       474 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  528 (936)
                      |+|++..|..|.++++|++|+|++|+|++..|..+..+++|++|+|++|++++..
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c  142 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC  142 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence            5555555555555555555555555555555555555555555555555555443

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.76  E-value=1.9e-18  Score=174.34  Aligned_cols=132  Identities=17%  Similarity=0.243  Sum_probs=68.8

Q ss_pred             hhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCC
Q 002321          120 LAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSAL  199 (936)
Q Consensus       120 l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  199 (936)
                      .+.+++|++|++++|+|+ .+|  .+..+++|++|++++|.++  .+..+..+++|++|+|++|++++..+..+..+++|
T Consensus        40 ~~~l~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L  114 (197)
T 4ezg_A           40 EAQMNSLTYITLANINVT-DLT--GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL  114 (197)
T ss_dssp             HHHHHTCCEEEEESSCCS-CCT--TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred             hhhcCCccEEeccCCCcc-ChH--HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence            355555666666666555 444  2455555555555555443  22345555555555555555555445555555555


Q ss_pred             CEEecCCCCCCCCCccCccCCCCcceeeccccc-ccccCCcccccccCcceeeccccccC
Q 002321          200 RTLDLSDNLLEGEIPKGVESLKNLRVINLSKNM-FSGSIPDGIGSCSLLRTIDFSENSFS  258 (936)
Q Consensus       200 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~Ls~N~l~  258 (936)
                      ++|+|++|++++..+..+..+++|++|+|++|+ ++ .+| .+..+++|++|++++|+++
T Consensus       115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~  172 (197)
T 4ezg_A          115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVH  172 (197)
T ss_dssp             CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCC
T ss_pred             CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCc
Confidence            555555555554445555555555555555554 33 222 3444555555555555544

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.76  E-value=1.1e-18  Score=183.70  Aligned_cols=137  Identities=18%  Similarity=0.228  Sum_probs=105.7

Q ss_pred             ccCCCcccccCceEEEEEEe-CCCcE--EEEEEeeccCcc-----------------------chHHHHHHHHHHHHcCC
Q 002321          692 LNKDCELGRGGFGAVYRTVL-RDGRP--VAIKKLTVSSLV-----------------------KSQEDFEREVKKLGKVR  745 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~  745 (936)
                      ++..+.||+|+||.||+|.. .+|+.  ||||+++.....                       .....+.+|++++.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            45667899999999999998 57888  999997543211                       01236889999999998


Q ss_pred             CCCc--ceeeeEEEeCCeeEEEEEecCC-C----ChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCC
Q 002321          746 HPNL--VTLEGYYWTQSLQLLIYEFVSG-G----SLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH-QSNIIHYNIK  817 (936)
Q Consensus       746 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH-~~~ivH~Dlk  817 (936)
                      |+++  ..++++    ...++||||+.+ |    +|.++...      .++..+..++.|++.|++||| +.||+|||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk  198 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAELVHADLS  198 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence            8864  333332    245899999942 3    66665432      223456789999999999999 9999999999


Q ss_pred             CCCEEEcCCCCeEEeeccCcccc
Q 002321          818 SSNVLIDGSGEPKVGDYGLARLL  840 (936)
Q Consensus       818 p~NIll~~~~~~kl~Dfg~a~~~  840 (936)
                      |+|||++.  .++|+|||+|...
T Consensus       199 p~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEET
T ss_pred             HHHEEEcC--cEEEEECcccccC
Confidence            99999998  9999999999754

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.74  E-value=3.5e-18  Score=171.35  Aligned_cols=156  Identities=24%  Similarity=0.289  Sum_probs=129.9

Q ss_pred             CeeeccCccccCCCCccccCcccCCeeecCCccccccCCC-CCCCcCCCcEEEecCCccCCcCccccccccccccccccC
Q 002321          419 QLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPP-EIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSK  497 (936)
Q Consensus       419 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~  497 (936)
                      +.+++++|+++ .+|..+..  +|++|+|++|+|++..+. .+..+++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            78899999996 56765544  899999999999876654 488999999999999999988899999999999999999


Q ss_pred             ccccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCCcccccCCCCCccCcCCCccccCCCCCCCCCC
Q 002321          498 NNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAV  577 (936)
Q Consensus       498 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~gn~~~c~~~~  577 (936)
                      |+|++..+..|..+++|++|+|++|+|++..|..+..+++|++|+|++|+++|.++...+...+....+.++...|+.|.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~  167 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS  167 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCCh
Confidence            99998888889999999999999999998888999999999999999999998887655444444445556666777665

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.74  E-value=1.1e-18  Score=210.96  Aligned_cols=188  Identities=26%  Similarity=0.297  Sum_probs=94.2

Q ss_pred             cCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCccc
Q 002321          325 SANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEF  404 (936)
Q Consensus       325 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l  404 (936)
                      ..|++. ..+..|..+..|+.|+|++|.+. .+|..+                           ..+++|++|+|++|.|
T Consensus       209 ~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~---------------------------~~l~~L~~L~Ls~N~l  259 (727)
T 4b8c_D          209 IENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANI---------------------------FKYDFLTRLYLNGNSL  259 (727)
T ss_dssp             --------------CCCCCCEEECTTSCCS-CCCGGG---------------------------GGCCSCSCCBCTTSCC
T ss_pred             ccccee-cChhhhccCCCCcEEECCCCCCC-CCChhh---------------------------cCCCCCCEEEeeCCcC
Confidence            334444 45666666777777777777665 333222                           2356677777777777


Q ss_pred             CCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCcccc
Q 002321          405 SGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSI  484 (936)
Q Consensus       405 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l  484 (936)
                      + .+|..|+.+++|++|+|++|+|+ .+|..|+.+++|++|+|++|.|+ .+|..|+.+++|+.|+|++|.|++.+|..+
T Consensus       260 ~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~  336 (727)
T 4b8c_D          260 T-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKIL  336 (727)
T ss_dssp             S-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHH
T ss_pred             c-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHH
Confidence            6 66666777777777777777777 56777777777777777777776 566667777777777777777777777666


Q ss_pred             ccccc-cccccccCccccCCCcccccccCCccEEEcCCC--------cccCCCCcccccccccCeeecCCCcccc
Q 002321          485 ENCSS-LVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFN--------SLTGGLPKQLVNLVHLSSFNISHNHLQG  550 (936)
Q Consensus       485 ~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N--------~l~~~~p~~l~~l~~L~~L~ls~N~l~~  550 (936)
                      ..+.. +..|+|++|.+++.+|..      |+.|++++|        .|.+..+..+.++..+....+++|-+.+
T Consensus       337 ~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~  405 (727)
T 4b8c_D          337 TEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQ  405 (727)
T ss_dssp             HHHHHHHHHHHHHHCCCCCCCCCC-----------------------------------------------CCCG
T ss_pred             hhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCccccccchhhcccccceeeeecccccc
Confidence            55432 234667777777666643      344556555        2333333344444555555555555543

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.73  E-value=1.5e-18  Score=190.37  Aligned_cols=240  Identities=13%  Similarity=0.075  Sum_probs=116.3

Q ss_pred             cCccccEEeccCCcccCcCCCchhh-cCCCcEEEccCcccccc-cchhhhhcCCCCcEEEccCccCCCCCCCCccc----
Q 002321           98 QLQFLRKLSLSSNNLTGSISPNLAK-LQNLRVIDLSGNSLSGS-IPDEFFKQCGSLRVISLAKNRFSGKIPSSLSL----  171 (936)
Q Consensus        98 ~l~~L~~L~L~~n~l~~~~~~~l~~-l~~L~~L~Ls~N~l~~~-i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~----  171 (936)
                      .+.+|++|.++++ +....-..+.. +++|++|||++|+|+.. .+...   ++.++.+.+..|.|   .+..|.+    
T Consensus        23 ~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~---~~~~~~~~~~~~~I---~~~aF~~~~~~   95 (329)
T 3sb4_A           23 EANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGT---YPNGKFYIYMANFV---PAYAFSNVVNG   95 (329)
T ss_dssp             HHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSS---SGGGCCEEECTTEE---CTTTTEEEETT
T ss_pred             hhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcccc---cccccccccccccc---CHHHhcccccc
Confidence            3667788877753 22211223444 67788888888887610 11111   11134444444432   2334444    


Q ss_pred             ----cccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccc----cccCCccccc
Q 002321          172 ----CSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMF----SGSIPDGIGS  243 (936)
Q Consensus       172 ----l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l----~~~~p~~l~~  243 (936)
                          +++|+.|+|.+ .++.+.+.+|.++++|+.|++++|.++...+..|.++.++..+.+..+..    .......|.+
T Consensus        96 ~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~  174 (329)
T 3sb4_A           96 VTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIE  174 (329)
T ss_dssp             EEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEE
T ss_pred             cccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccc
Confidence                55555555555 55555555555555555555555555544445555555555444443211    1111112222


Q ss_pred             --------------------------------------------------ccCcceeeccccccCCCCchhhhccccccE
Q 002321          244 --------------------------------------------------CSLLRTIDFSENSFSGNLPETMQKLSLCNF  273 (936)
Q Consensus       244 --------------------------------------------------l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~  273 (936)
                                                                        +++|+.|+|++|+++...+..|.++++|+.
T Consensus       175 ~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~  254 (329)
T 3sb4_A          175 GEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLK  254 (329)
T ss_dssp             SCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCE
T ss_pred             ccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCE
Confidence                                                              344555555555554444444555555555


Q ss_pred             EeccCccccCCCCcccccCCccc-eecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEE
Q 002321          274 MNLRKNLFSGEVPKWIGELESLE-TLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALD  347 (936)
Q Consensus       274 L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  347 (936)
                      ++|.+| ++.+.+.+|.++.+|+ .+++.+ .++...+.+|.++++|+.|++++|.++...+..|.++++|+.++
T Consensus       255 l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          255 IKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             EECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred             EECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence            555544 4434444455555555 555544 34434444455555555555555555544444555555555443

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.70  E-value=1.3e-17  Score=182.68  Aligned_cols=288  Identities=14%  Similarity=0.110  Sum_probs=177.5

Q ss_pred             hcCCCcEEEccCcccccccchhhhhc-CCCCcEEEccCccCC--CCCCCCccccccccccccccccccCCCCCCCCC---
Q 002321          122 KLQNLRVIDLSGNSLSGSIPDEFFKQ-CGSLRVISLAKNRFS--GKIPSSLSLCSTLATINLSSNRFSSPLPLGIWG---  195 (936)
Q Consensus       122 ~l~~L~~L~Ls~N~l~~~i~~~~f~~-l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~---  195 (936)
                      .+.+|+.|.++++ +. ...-..+.. +++|++|||++|+|.  ...+..+   +.+..+.+..|.|   .+.+|.+   
T Consensus        23 ~~~~l~~L~l~g~-i~-~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I---~~~aF~~~~~   94 (329)
T 3sb4_A           23 EANSITHLTLTGK-LN-AEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFV---PAYAFSNVVN   94 (329)
T ss_dssp             HHHHCSEEEEEEE-EC-HHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEE---CTTTTEEEET
T ss_pred             hhCceeEEEEecc-cc-HHHHHHHHHhhccCeEEecCcceeEEecCccccc---ccccccccccccc---CHHHhccccc
Confidence            4778999999865 22 111223344 888999999999998  3333333   2355566666643   3467777   


Q ss_pred             -----CCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeecccccc----CCCCchhhh
Q 002321          196 -----LSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSF----SGNLPETMQ  266 (936)
Q Consensus       196 -----l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l----~~~~~~~l~  266 (936)
                           +++|+.|+|.+ .++.+.+..|.++++|+.|++++|.++.+.+.+|..+.++..+.+..+..    ......   
T Consensus        95 ~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~---  170 (329)
T 3sb4_A           95 GVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHF---  170 (329)
T ss_dssp             TEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTS---
T ss_pred             ccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccc---
Confidence                 89999999988 88866677888899999999999988877778888877777776665321    111122   


Q ss_pred             ccccccEEeccCccccCCCCcccccCCccc-eecccCce-eccccCcccccccccceEEccCCcccccCChhhhccCCCC
Q 002321          267 KLSLCNFMNLRKNLFSGEVPKWIGELESLE-TLDLSGNK-FSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLV  344 (936)
Q Consensus       267 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~-l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  344 (936)
                                           .|.++.+|+ .+.+.... +.......-....+++.+.+.++-...........+++|+
T Consensus       171 ---------------------~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~  229 (329)
T 3sb4_A          171 ---------------------AFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLV  229 (329)
T ss_dssp             ---------------------CEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCC
T ss_pred             ---------------------ccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCe
Confidence                                 222333333 22222111 0000000111234555555554422211111112366777


Q ss_pred             EEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCC-eeec
Q 002321          345 ALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQ-LLNL  423 (936)
Q Consensus       345 ~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~L  423 (936)
                      .|+|++|+++ .+|...                          +..+++|+.|+|.+| ++.+.+.+|.++++|+ .+++
T Consensus       230 ~l~L~~n~i~-~I~~~a--------------------------F~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l  281 (329)
T 3sb4_A          230 SLDISKTNAT-TIPDFT--------------------------FAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLEL  281 (329)
T ss_dssp             EEECTTBCCC-EECTTT--------------------------TTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEE
T ss_pred             EEECCCCCcc-eecHhh--------------------------hhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEE
Confidence            7777776665 333222                          134667777777776 6666677778888887 8888


Q ss_pred             cCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEe
Q 002321          424 SRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRL  471 (936)
Q Consensus       424 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  471 (936)
                      .+ +++.+.+.+|.++++|+.|+++.|.++...+..|.++++|+.|+.
T Consensus       282 ~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          282 PA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             CT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             cc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence            77 666566678888888888888888887766777888888887763

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.68  E-value=1.3e-16  Score=157.83  Aligned_cols=135  Identities=22%  Similarity=0.325  Sum_probs=87.7

Q ss_pred             CCCccceeEEecCCCCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCccccccc
Q 002321           61 DTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSI  140 (936)
Q Consensus        61 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i  140 (936)
                      .|.|.|.+|.|+..  ++          + .+|..+  .++|++|++++|++++..+..|.++++|++|+|++|+|+ .+
T Consensus         4 ~C~C~~~~l~~~~~--~l----------~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~   67 (177)
T 2o6r_A            4 RCSCSGTEIRCNSK--GL----------T-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SL   67 (177)
T ss_dssp             TCEEETTEEECCSS--CC----------S-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CC
T ss_pred             CCEeCCCEEEecCC--CC----------c-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcce-Ee
Confidence            34589999999752  22          1 233222  257788888888887766666777888888888888877 56


Q ss_pred             chhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCC
Q 002321          141 PDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEG  211 (936)
Q Consensus       141 ~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  211 (936)
                      |...|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..+..+++|++|+|++|.+++
T Consensus        68 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  138 (177)
T 2o6r_A           68 PDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  138 (177)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             ChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence            66666677777777777777765555555666666666666666665444445555556666666655553

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.68  E-value=2.3e-17  Score=165.33  Aligned_cols=112  Identities=25%  Similarity=0.254  Sum_probs=57.5

Q ss_pred             cCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcC
Q 002321          441 ALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLS  520 (936)
Q Consensus       441 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  520 (936)
                      +|++|+|++|+|+ .+|..+.++++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|+
T Consensus        32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~  110 (193)
T 2wfh_A           32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH  110 (193)
T ss_dssp             TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence            3444444444443 233444444444444444444444444445555555555555555555445555555555555555


Q ss_pred             CCcccCCCCcccccccccCeeecCCCcccccCC
Q 002321          521 FNSLTGGLPKQLVNLVHLSSFNISHNHLQGELP  553 (936)
Q Consensus       521 ~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p  553 (936)
                      +|+|++..+..+..+++|+.|+|++|++.+.+.
T Consensus       111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~  143 (193)
T 2wfh_A          111 GNDISVVPEGAFNDLSALSHLAIGANPLYCDCN  143 (193)
T ss_dssp             SSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             CCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence            555554333445555666666666666655443

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.67  E-value=7e-17  Score=158.24  Aligned_cols=133  Identities=20%  Similarity=0.198  Sum_probs=87.2

Q ss_pred             CccccEEeccCCccc-CcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccc
Q 002321           99 LQFLRKLSLSSNNLT-GSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLAT  177 (936)
Q Consensus        99 l~~L~~L~L~~n~l~-~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  177 (936)
                      .++|++|+|++|+++ +.+|..+..+++|++|+|++|+|++.   ..|..+++|++|+|++|++++.+|..+..+++|++
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~---~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   99 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV---SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH   99 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC---SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred             cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh---hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence            367788888888887 66777777888888888888887743   45666777777777777776655655555666666


Q ss_pred             cccccccccCCCC-CCCCCCCCCCEEecCCCCCCCCCc---cCccCCCCcceeeccccccc
Q 002321          178 INLSSNRFSSPLP-LGIWGLSALRTLDLSDNLLEGEIP---KGVESLKNLRVINLSKNMFS  234 (936)
Q Consensus       178 L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~  234 (936)
                      |+|++|+|++... ..+..+++|++|+|++|.+++..+   ..+..+++|++|++++|.+.
T Consensus       100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            6666666665321 455666666666666666664333   24555666666666666554

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.67  E-value=1.2e-16  Score=156.57  Aligned_cols=133  Identities=23%  Similarity=0.164  Sum_probs=93.7

Q ss_pred             ccCCeeeccCcccc-CCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCcccccccccccccc
Q 002321          416 SGLQLLNLSRNSLV-GPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLI  494 (936)
Q Consensus       416 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~  494 (936)
                      ++|++|+|++|+++ +.+|..+..+++|++|+|++|.+++.  ..+..+++|+.|+|++|++++.+|..+.++++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            45566666666665 45565666666677777777766643  5567777777777777777766777777778888888


Q ss_pred             ccCccccCCC-cccccccCCccEEEcCCCcccCCCC---cccccccccCeeecCCCcccc
Q 002321          495 LSKNNLTGPI-PIAIAKLTNLQNVDLSFNSLTGGLP---KQLVNLVHLSSFNISHNHLQG  550 (936)
Q Consensus       495 L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~L~~L~ls~N~l~~  550 (936)
                      |++|++++.. +..+..+++|++|+|++|++++..+   ..+..+++|+.|++++|.+..
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~  161 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE  161 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence            8888877532 2677778888888888888875444   377778888888888887763

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.66  E-value=1.6e-16  Score=152.28  Aligned_cols=128  Identities=23%  Similarity=0.239  Sum_probs=97.1

Q ss_pred             ccCCeeeccCcccc-CCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCcccccccccccccc
Q 002321          416 SGLQLLNLSRNSLV-GPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLI  494 (936)
Q Consensus       416 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~  494 (936)
                      ++|+.|++++|.++ +.+|..+..+++|++|++++|.+++.  ..+..+++|+.|+|++|++++.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            55666777777766 56666677777777777777777754  6677788888888888888866777777788888888


Q ss_pred             ccCccccCC-CcccccccCCccEEEcCCCcccCCCC---cccccccccCeeecCC
Q 002321          495 LSKNNLTGP-IPIAIAKLTNLQNVDLSFNSLTGGLP---KQLVNLVHLSSFNISH  545 (936)
Q Consensus       495 L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~L~~L~ls~  545 (936)
                      +++|++++. .+..+..+++|++|++++|++++..+   ..+..+++|+.|++++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            888888863 34778888888888888888886555   4778888888888763

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.65  E-value=3e-15  Score=168.24  Aligned_cols=225  Identities=13%  Similarity=0.121  Sum_probs=105.0

Q ss_pred             ccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCC
Q 002321          112 LTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPL  191 (936)
Q Consensus       112 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~  191 (936)
                      ++.+-..+|.++++|+.+.|.. .++ .|+..+|.++++|+.++|.++ ++......|.++++|+.+.+..+ +..+...
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~-~i~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~  134 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPS-TVR-EIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVE  134 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCT-TCC-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred             EeEhHHHHhhCCCCceEEEeCC-Ccc-CcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecce
Confidence            4444445666666666666653 354 566666666666666666543 44444555666666666655443 3334445


Q ss_pred             CCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccc
Q 002321          192 GIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLC  271 (936)
Q Consensus       192 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L  271 (936)
                      +|.+...++.......  .......|.++++|+.+.+.++.. ......|.++.+|+.+++..| ++......|.+...|
T Consensus       135 aF~~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~~-~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L  210 (394)
T 4fs7_A          135 AFKGCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDSME-TLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILL  210 (394)
T ss_dssp             TTTTCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTTCC-EECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTC
T ss_pred             eeecccccccccCccc--cccchhhhcccCCCcEEecCCccc-eeccccccCCCCceEEEcCCC-ceEeCchhhcccccc
Confidence            5555543333222222  112334556666666666654432 244455566666666665544 332223334444444


Q ss_pred             cEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEc
Q 002321          272 NFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDF  348 (936)
Q Consensus       272 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  348 (936)
                      +.+.+..+...  +.+......+|+.+.+..+. +......+.+...|+.+.+..+... .....|..+..++.+..
T Consensus       211 ~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~  283 (394)
T 4fs7_A          211 ENMEFPNSLYY--LGDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIY  283 (394)
T ss_dssp             CBCCCCTTCCE--ECTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEE
T ss_pred             ceeecCCCceE--eehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcce-eeccccccccccceecc
Confidence            44433333211  11111222344444443321 1122333444445555555444322 33334444444444443

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.65  E-value=2.3e-16  Score=171.76  Aligned_cols=140  Identities=11%  Similarity=0.129  Sum_probs=103.0

Q ss_pred             ccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCcc-------------chH--------HHHHHHHHHHHcCCCCC
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV-------------KSQ--------EDFEREVKKLGKVRHPN  748 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------~~~--------~~~~~E~~~l~~l~h~n  748 (936)
                      ..|+....||+|+||.||+|...+|+.||||+++.....             ...        ....+|...+.++.+..
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            357788899999999999999989999999997542110             001        11345777777775554


Q ss_pred             cceeeeEEEeCCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-
Q 002321          749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG-  827 (936)
Q Consensus       749 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~-  827 (936)
                      +.-..-+...  ..++||||++|+++.++...         ....+++.|++.+|.|||+.|||||||||.|||++++| 
T Consensus       175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          175 FPVPEPIAQS--RHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             CSCCCEEEEE--TTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred             CCCCeeeecc--CceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence            4322222222  23799999999888765432         12356889999999999999999999999999998877 


Q ss_pred             ---------CeEEeeccCcccc
Q 002321          828 ---------EPKVGDYGLARLL  840 (936)
Q Consensus       828 ---------~~kl~Dfg~a~~~  840 (936)
                               .+.|+||+-+...
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEET
T ss_pred             cccccccccceEEEEeCCcccC
Confidence                     3899999987654

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.65  E-value=7.1e-16  Score=154.48  Aligned_cols=108  Identities=29%  Similarity=0.319  Sum_probs=50.5

Q ss_pred             cccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCcccccccccccc
Q 002321          101 FLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINL  180 (936)
Q Consensus       101 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  180 (936)
                      +|++|+|++|+|+ .+|..|.++++|++|+|++|+|+                         +..+..|..+++|++|+|
T Consensus        32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~-------------------------~i~~~~f~~l~~L~~L~L   85 (193)
T 2wfh_A           32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-------------------------TLSNQSFSNMTQLLTLIL   85 (193)
T ss_dssp             TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCC-------------------------CCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCC-------------------------EeCHhHccCCCCCCEEEC
Confidence            4555555555554 33444555555555555555554                         333334444444444444


Q ss_pred             ccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeeccccccc
Q 002321          181 SSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFS  234 (936)
Q Consensus       181 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  234 (936)
                      ++|+|+++.+..|.++++|++|+|++|+|+...+..|..+++|++|+|++|.+.
T Consensus        86 s~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  139 (193)
T 2wfh_A           86 SYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY  139 (193)
T ss_dssp             CSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             CCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence            444444444444444444444444444444333333444444444444444443

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.64  E-value=5.7e-16  Score=153.14  Aligned_cols=113  Identities=21%  Similarity=0.188  Sum_probs=61.8

Q ss_pred             cCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcC
Q 002321          441 ALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLS  520 (936)
Q Consensus       441 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  520 (936)
                      +|++|++++|++++..+..+..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..+..+++|++|+|+
T Consensus        29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  108 (177)
T 2o6r_A           29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALD  108 (177)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECc
Confidence            44555555555544333444555555555555555554444445555555555555555555444555566666666666


Q ss_pred             CCcccCCCCcccccccccCeeecCCCcccccCC
Q 002321          521 FNSLTGGLPKQLVNLVHLSSFNISHNHLQGELP  553 (936)
Q Consensus       521 ~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p  553 (936)
                      +|++++..+..+..+++|++|++++|++.+.+|
T Consensus       109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A          109 TNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             SSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            666654333344556666666666666665554

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.64  E-value=2.1e-15  Score=168.72  Aligned_cols=263  Identities=11%  Similarity=0.123  Sum_probs=155.2

Q ss_pred             ccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccc
Q 002321          100 QFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATIN  179 (936)
Q Consensus       100 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  179 (936)
                      ..++.+.+.+ +++.+-..+|.++ +|+.++|..| ++ .|+..+|.+. +|+.+.|.+ .++.+.+..|.++++|+.++
T Consensus       113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~-~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~  186 (401)
T 4fdw_A          113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LK-SIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKAD  186 (401)
T ss_dssp             SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CC-EECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred             CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-cc-EECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeee
Confidence            4555555553 3444445566664 5666666655 54 5666666663 566666664 55555556666666666666


Q ss_pred             cccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCC
Q 002321          180 LSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSG  259 (936)
Q Consensus       180 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~  259 (936)
                      |++|+++.+...+|. ..+|+.+.|..+ ++.+....|.++++|+.+++..| ++.+...+|.+ .+|+.+++ .|.++.
T Consensus       187 l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~  261 (401)
T 4fdw_A          187 LSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTN  261 (401)
T ss_dssp             CTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCE
T ss_pred             cCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccE
Confidence            666666665555555 366666666643 55455556666666666666654 44444555555 56666666 344554


Q ss_pred             CCchhhhccccccEEeccCcccc-----CCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCC
Q 002321          260 NLPETMQKLSLCNFMNLRKNLFS-----GEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLP  334 (936)
Q Consensus       260 ~~~~~l~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~  334 (936)
                      .....|.++++|+.+.+.+|.+.     ...+.+|..+++|+.++|.+ .++.....+|.++++|+.+.|..| ++....
T Consensus       262 I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~  339 (401)
T 4fdw_A          262 IASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINF  339 (401)
T ss_dssp             ECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECT
T ss_pred             EChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcH
Confidence            55566666666666666666554     34455666677777777763 355455566667777777777444 555556


Q ss_pred             hhhhccCCCCEEEccCCcCccCCChhhhc---cCCccccccccccc
Q 002321          335 DSMANCMNLVALDFSQNSMNGDLPQWIFS---SGLNKVSFAENKIR  377 (936)
Q Consensus       335 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~---~~l~~l~l~~n~l~  377 (936)
                      ..|.++ +|+.+++++|.+.. ++...|.   ..+..+.+..+.+.
T Consensus       340 ~aF~~~-~L~~l~l~~n~~~~-l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          340 SAFNNT-GIKEVKVEGTTPPQ-VFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             TSSSSS-CCCEEEECCSSCCB-CCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             HhCCCC-CCCEEEEcCCCCcc-cccccccCCCCCccEEEeCHHHHH
Confidence            667766 77777777766653 2222222   23455555555443

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.63  E-value=1.8e-16  Score=151.95  Aligned_cols=129  Identities=19%  Similarity=0.173  Sum_probs=116.9

Q ss_pred             CCcccEEeccCcccC-CCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEE
Q 002321          391 FESLQFLDLSHNEFS-GETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKEL  469 (936)
Q Consensus       391 l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  469 (936)
                      .++|+.|++++|.++ +.+|..+..+++|++|+|++|++++.  ..++.+++|++|+|++|++++.+|..+..+++|+.|
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            478999999999998 77888889999999999999999865  789999999999999999998788888889999999


Q ss_pred             EecCCccCCc-CccccccccccccccccCccccCCCc---ccccccCCccEEEcCC
Q 002321          470 RLERNFLAGK-IPTSIENCSSLVSLILSKNNLTGPIP---IAIAKLTNLQNVDLSF  521 (936)
Q Consensus       470 ~Ls~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~Ls~  521 (936)
                      ++++|++++. .+..+..+++|++|++++|++++..+   ..+..+++|++||+++
T Consensus        94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            9999999963 45889999999999999999997666   5799999999999874

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.62  E-value=6.7e-15  Score=164.63  Aligned_cols=268  Identities=14%  Similarity=0.128  Sum_probs=219.2

Q ss_pred             hhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCC
Q 002321          121 AKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALR  200 (936)
Q Consensus       121 ~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  200 (936)
                      ..+..++.+.+.+ .++ .|+..+|.+. +|+.+.|..| ++.+...+|.++ +|+.+.|.+ .++.+.+.+|.++++|+
T Consensus       110 ~~~~~l~~i~ip~-~i~-~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~  183 (401)
T 4fdw_A          110 EILKGYNEIILPN-SVK-SIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLK  183 (401)
T ss_dssp             EECSSCSEEECCT-TCC-EECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCC
T ss_pred             EecCCccEEEECC-ccC-EehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCC
Confidence            3457889999875 466 7899999986 7999999877 877777888884 799999986 78888889999999999


Q ss_pred             EEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCcc
Q 002321          201 TLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNL  280 (936)
Q Consensus       201 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~  280 (936)
                      .++|++|+++......|. ..+|+.+.|..+ ++.+...+|.++++|+.+++..| ++......|.+ .+|+.+.+ .+.
T Consensus       184 ~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~  258 (401)
T 4fdw_A          184 KADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNG  258 (401)
T ss_dssp             EEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETT
T ss_pred             eeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCC
Confidence            999999999955555665 689999999855 77677889999999999999975 66566777887 78999999 455


Q ss_pred             ccCCCCcccccCCccceecccCceec-----cccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCcc
Q 002321          281 FSGEVPKWIGELESLETLDLSGNKFS-----GAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNG  355 (936)
Q Consensus       281 l~~~~~~~~~~l~~L~~L~L~~N~l~-----~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  355 (936)
                      ++.+...+|.++++|+.+++.+|.+.     ...+..|.++++|+.++|. +.++......|.+|.+|+.+.|..| ++ 
T Consensus       259 i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~-  335 (401)
T 4fdw_A          259 VTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VT-  335 (401)
T ss_dssp             CCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CC-
T ss_pred             ccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-cc-
Confidence            66677889999999999999998875     4567789999999999999 4588778889999999999999655 43 


Q ss_pred             CCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccc-cCCeeeccCcccc
Q 002321          356 DLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALS-GLQLLNLSRNSLV  429 (936)
Q Consensus       356 ~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~  429 (936)
                      .++                      .+.|    ..+ +|+.+++++|.+.......|.+++ .++.|++..+.+.
T Consensus       336 ~I~----------------------~~aF----~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          336 QIN----------------------FSAF----NNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             EEC----------------------TTSS----SSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             EEc----------------------HHhC----CCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            122                      1222    345 899999999999888888888884 6889998888765

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.59  E-value=3.1e-14  Score=160.02  Aligned_cols=335  Identities=14%  Similarity=0.093  Sum_probs=182.9

Q ss_pred             ccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCc
Q 002321          135 SLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIP  214 (936)
Q Consensus       135 ~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  214 (936)
                      .++ .|...+|.++.+|+.+.|.. .++.+...+|.++++|+.++|.++ ++.+...+|.++.+|+.+.+..+ +.....
T Consensus        58 ~Vt-sIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~  133 (394)
T 4fs7_A           58 DVV-SIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGV  133 (394)
T ss_dssp             EEE-EECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECT
T ss_pred             eEe-EhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecc
Confidence            455 68889999999999999975 477677788999999999999765 66677788889999998887765 443555


Q ss_pred             cCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCc
Q 002321          215 KGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELES  294 (936)
Q Consensus       215 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  294 (936)
                      ..|.++..++.......  ......+|.++++|+.+.+.++. .......|..+.+|+.+.+..| ++.....+|.++..
T Consensus       134 ~aF~~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~  209 (394)
T 4fs7_A          134 EAFKGCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECIL  209 (394)
T ss_dssp             TTTTTCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTT
T ss_pred             eeeecccccccccCccc--cccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccc
Confidence            66766654444333332  22345678888888888886553 3234455666666666666554 33333445555566


Q ss_pred             cceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCcccccccc
Q 002321          295 LETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAEN  374 (936)
Q Consensus       295 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n  374 (936)
                      |+.+.+..+... . ........+|+.+.+..+ ++......|..+..|+.+.+..+..                     
T Consensus       210 L~~i~~~~~~~~-i-~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~---------------------  265 (394)
T 4fs7_A          210 LENMEFPNSLYY-L-GDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKL---------------------  265 (394)
T ss_dssp             CCBCCCCTTCCE-E-CTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTC---------------------
T ss_pred             cceeecCCCceE-e-ehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcc---------------------
Confidence            666655554332 1 111222344555555432 2223334444555555555444322                     


Q ss_pred             ccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccc
Q 002321          375 KIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNG  454 (936)
Q Consensus       375 ~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  454 (936)
                                                    . .....|.....++.+.+..+.+.   ...|..+.+|+.+.+.++ ++.
T Consensus       266 ------------------------------~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~  310 (394)
T 4fs7_A          266 ------------------------------R-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKF  310 (394)
T ss_dssp             ------------------------------E-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCE
T ss_pred             ------------------------------e-eeccccccccccceeccCceeec---cccccccccccccccccc-cce
Confidence                                          1 22333334444444444333221   223444444554444433 332


Q ss_pred             cCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCccccc
Q 002321          455 SIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVN  534 (936)
Q Consensus       455 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~  534 (936)
                      .-...|.++.+|+.++|.++ ++..-..+|.++.+|+.+++..| ++.....+|.++++|+.+++..+ ++ .+...+.+
T Consensus       311 I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~  386 (394)
T 4fs7_A          311 IGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFED  386 (394)
T ss_dssp             ECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCT
T ss_pred             echhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecC
Confidence            33344555555555555432 33233445555555555555544 44334445555555665555433 22 22334555


Q ss_pred             ccccCe
Q 002321          535 LVHLSS  540 (936)
Q Consensus       535 l~~L~~  540 (936)
                      .++|+.
T Consensus       387 c~~L~~  392 (394)
T 4fs7_A          387 TTKFKW  392 (394)
T ss_dssp             TCEEEE
T ss_pred             CCCCcE
Confidence            555543

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.58  E-value=3.3e-17  Score=165.34  Aligned_cols=152  Identities=24%  Similarity=0.302  Sum_probs=123.8

Q ss_pred             CcccEEeccCcccCCCChh------hhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCC
Q 002321          392 ESLQFLDLSHNEFSGETPA------TIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYS  465 (936)
Q Consensus       392 ~~L~~L~Ls~N~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  465 (936)
                      ..++.++++.|.+.+..|.      .+..+++|++|+|++|++++ +| .+..+++|++|+|++|+++ .+|..+..+++
T Consensus        18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~   94 (198)
T 1ds9_A           18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT   94 (198)
T ss_dssp             TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred             ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence            4566667777777666665      88899999999999999986 66 8888999999999999998 57777777889


Q ss_pred             CcEEEecCCccCCcCccccccccccccccccCccccCCCc-ccccccCCccEEEcCCCcccCCCCcc----------ccc
Q 002321          466 LKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIP-IAIAKLTNLQNVDLSFNSLTGGLPKQ----------LVN  534 (936)
Q Consensus       466 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------l~~  534 (936)
                      |+.|+|++|++++ +| .+..+++|++|+|++|++++..+ ..+..+++|++|++++|++++.+|..          +..
T Consensus        95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~  172 (198)
T 1ds9_A           95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKR  172 (198)
T ss_dssp             CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHH
T ss_pred             CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHh
Confidence            9999999999985 55 68889999999999999985433 47888999999999999998766653          788


Q ss_pred             ccccCeeecCCCcccc
Q 002321          535 LVHLSSFNISHNHLQG  550 (936)
Q Consensus       535 l~~L~~L~ls~N~l~~  550 (936)
                      +++|+.||  +|+++.
T Consensus       173 l~~L~~Ld--~~~i~~  186 (198)
T 1ds9_A          173 LPNLKKLD--GMPVDV  186 (198)
T ss_dssp             CSSCSEEC--CGGGTT
T ss_pred             CCCcEEEC--CcccCH
Confidence            89999887  777663

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.57  E-value=9.1e-16  Score=151.46  Aligned_cols=132  Identities=17%  Similarity=0.168  Sum_probs=82.2

Q ss_pred             ccccCCeeeccCccccCCCCccccCcc-cCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCcccccccccccc
Q 002321          414 ALSGLQLLNLSRNSLVGPIPVAIGDLK-ALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVS  492 (936)
Q Consensus       414 ~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~  492 (936)
                      .+++|++|+|++|+++. ++. +..+. +|++|+|++|.+++.  ..+..+++|+.|+|++|+|++..+..+..+++|++
T Consensus        17 ~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   92 (176)
T 1a9n_A           17 NAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE   92 (176)
T ss_dssp             CTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred             CcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCE
Confidence            34445555555555552 232 23332 666666666666643  45666667777777777776443344567777777


Q ss_pred             ccccCccccCCCcc--cccccCCccEEEcCCCcccCCCCcc----cccccccCeeecCCCccccc
Q 002321          493 LILSKNNLTGPIPI--AIAKLTNLQNVDLSFNSLTGGLPKQ----LVNLVHLSSFNISHNHLQGE  551 (936)
Q Consensus       493 L~L~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----l~~l~~L~~L~ls~N~l~~~  551 (936)
                      |+|++|+++ .+|.  .+..+++|+.|+|++|+++ .+|..    +..+++|+.||+++|.....
T Consensus        93 L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~~  155 (176)
T 1a9n_A           93 LILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKER  155 (176)
T ss_dssp             EECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHHH
T ss_pred             EECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHHH
Confidence            777777775 3454  6777777777777777776 45553    77777777777777776643

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.57  E-value=3.3e-17  Score=165.30  Aligned_cols=149  Identities=25%  Similarity=0.321  Sum_probs=89.2

Q ss_pred             ccCccccEEeccCCcccCcCCC------chhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCcc
Q 002321           97 LQLQFLRKLSLSSNNLTGSISP------NLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLS  170 (936)
Q Consensus        97 ~~l~~L~~L~L~~n~l~~~~~~------~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~  170 (936)
                      .....++.++++.++++|.+|.      .|..+++|++|+|++|+|++ +|  .|..+++|++|+|++|+|+ .+|..+.
T Consensus        15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~--~~~~l~~L~~L~l~~n~l~-~l~~~~~   90 (198)
T 1ds9_A           15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS--SLSGMENLRILSLGRNLIK-KIENLDA   90 (198)
T ss_dssp             HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC--CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred             HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc--ccccCCCCCEEECCCCCcc-cccchhh
Confidence            3444555555555555555554      66666666666666666663 55  4566666666666666666 3555555


Q ss_pred             ccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCc-cCccCCCCcceeecccccccccCCcc---------
Q 002321          171 LCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIP-KGVESLKNLRVINLSKNMFSGSIPDG---------  240 (936)
Q Consensus       171 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~---------  240 (936)
                      .+++|++|+|++|+|++ +| .+..+++|++|+|++|++++..+ ..+..+++|++|++++|.+++..|..         
T Consensus        91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~  168 (198)
T 1ds9_A           91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE  168 (198)
T ss_dssp             HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHH
T ss_pred             cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHH
Confidence            66667777777776665 23 45566666666666666664322 35566666666777666666554432         


Q ss_pred             -cccccCcceee
Q 002321          241 -IGSCSLLRTID  251 (936)
Q Consensus       241 -l~~l~~L~~L~  251 (936)
                       +..+++|++||
T Consensus       169 ~~~~l~~L~~Ld  180 (198)
T 1ds9_A          169 VVKRLPNLKKLD  180 (198)
T ss_dssp             HHHHCSSCSEEC
T ss_pred             HHHhCCCcEEEC
Confidence             45555555554

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.55  E-value=2.7e-15  Score=148.01  Aligned_cols=104  Identities=22%  Similarity=0.242  Sum_probs=53.3

Q ss_pred             CCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCcc--CccCCCCcceee
Q 002321          150 SLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPK--GVESLKNLRVIN  227 (936)
Q Consensus       150 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~  227 (936)
                      +|++|+|++|+|++.  ..|+.+++|++|+|++|+|++..+..+.++++|++|+|++|+|+ .+|.  .+..+++|++|+
T Consensus        43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~  119 (176)
T 1a9n_A           43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC  119 (176)
T ss_dssp             CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred             CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence            444444444444432  34444555555555555555433333355555555555555554 3333  455566666666


Q ss_pred             cccccccccCCcc----cccccCcceeecccccc
Q 002321          228 LSKNMFSGSIPDG----IGSCSLLRTIDFSENSF  257 (936)
Q Consensus       228 L~~N~l~~~~p~~----l~~l~~L~~L~Ls~N~l  257 (936)
                      +++|.++ .+|..    +..+++|++||+++|.+
T Consensus       120 l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~  152 (176)
T 1a9n_A          120 ILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKL  152 (176)
T ss_dssp             CCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred             ecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCH
Confidence            6666665 33332    55566666666666554

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.51  E-value=3.5e-14  Score=138.97  Aligned_cols=108  Identities=24%  Similarity=0.205  Sum_probs=64.3

Q ss_pred             CeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCC
Q 002321          443 NVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFN  522 (936)
Q Consensus       443 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  522 (936)
                      +.|++++|.++. +|..+.  ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        12 ~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A           12 TTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            445555555542 444332  45566666666666555566666666666666666666555555666666666666666


Q ss_pred             cccCCCCcccccccccCeeecCCCcccccCC
Q 002321          523 SLTGGLPKQLVNLVHLSSFNISHNHLQGELP  553 (936)
Q Consensus       523 ~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p  553 (936)
                      +|++..+..+..+++|+.|+|++|++++.++
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            6665444456666666666666666666554

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.47  E-value=9.4e-14  Score=136.34  Aligned_cols=89  Identities=25%  Similarity=0.232  Sum_probs=43.3

Q ss_pred             CCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcccccccccCeeec
Q 002321          464 YSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNI  543 (936)
Q Consensus       464 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l  543 (936)
                      ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..+..+++|+.|+|
T Consensus        33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L  112 (174)
T 2r9u_A           33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL  112 (174)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence            34444444444444444444445555555555555555433334445555555555555555333333555555555555


Q ss_pred             CCCcccccC
Q 002321          544 SHNHLQGEL  552 (936)
Q Consensus       544 s~N~l~~~~  552 (936)
                      ++|++.+.+
T Consensus       113 ~~N~~~c~~  121 (174)
T 2r9u_A          113 YNNPWDCEC  121 (174)
T ss_dssp             CSSCBCTTB
T ss_pred             CCCCccccc
Confidence            555555433

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.47  E-value=1.1e-13  Score=135.35  Aligned_cols=103  Identities=26%  Similarity=0.325  Sum_probs=42.8

Q ss_pred             cEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCC
Q 002321          127 RVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSD  206 (936)
Q Consensus       127 ~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  206 (936)
                      +.|++++|+++ .+|..++   ++|++|+|++|+|++..|..|..+++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus        12 ~~l~~s~n~l~-~ip~~~~---~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           12 TTVDCSGKSLA-SVPTGIP---TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TEEECTTSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-ccCccCC---CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            44555555554 3443221   3334444444444433344444444444444444444443333344444444444444


Q ss_pred             CCCCCCCccCccCCCCcceeecccccc
Q 002321          207 NLLEGEIPKGVESLKNLRVINLSKNMF  233 (936)
Q Consensus       207 N~l~~~~~~~~~~l~~L~~L~L~~N~l  233 (936)
                      |+|++..+..|.++++|++|+|++|.+
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~  114 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPW  114 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCB
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCC
Confidence            444433333344444444444444433

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.44  E-value=2.3e-13  Score=133.58  Aligned_cols=84  Identities=24%  Similarity=0.260  Sum_probs=33.8

Q ss_pred             CcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeeccc
Q 002321          151 LRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSK  230 (936)
Q Consensus       151 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  230 (936)
                      |++|+|++|+|++..|..|+.+++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus        35 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~  114 (174)
T 2r9u_A           35 KQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYN  114 (174)
T ss_dssp             CSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCS
T ss_pred             CcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCC
Confidence            33333333333333333444444444444444444433333334444444444444444433333344444444444444


Q ss_pred             cccc
Q 002321          231 NMFS  234 (936)
Q Consensus       231 N~l~  234 (936)
                      |.+.
T Consensus       115 N~~~  118 (174)
T 2r9u_A          115 NPWD  118 (174)
T ss_dssp             SCBC
T ss_pred             CCcc
Confidence            4433

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.40  E-value=1e-11  Score=139.29  Aligned_cols=138  Identities=12%  Similarity=0.206  Sum_probs=90.5

Q ss_pred             ccCcCCCchhhcC-CCcEEEccCcccccccchhhhhcCCCCcEEEccCcc---CCCCCCCCccccccccccccccccccC
Q 002321          112 LTGSISPNLAKLQ-NLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNR---FSGKIPSSLSLCSTLATINLSSNRFSS  187 (936)
Q Consensus       112 l~~~~~~~l~~l~-~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~---l~~~~p~~~~~l~~L~~L~L~~N~l~~  187 (936)
                      ++.+-..+|.++. .|+.+.+..+ ++ .|...+|.++.+|+.+.+..|.   ++.....+|..+.+|+.+.+..+ ++.
T Consensus        51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt-~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~  127 (394)
T 4gt6_A           51 VSKIGDRVFCNYKYVLTSVQIPDT-VT-EIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTE  127 (394)
T ss_dssp             EEEECTTTTTTCCSCCCEEEECTT-CC-EECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSE
T ss_pred             eeEcCHhhccCCCCcCEEEEECCC-ee-EEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cce
Confidence            3434456777764 5888888654 55 6777888888888888887764   55555667777788887777654 555


Q ss_pred             CCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeecccc
Q 002321          188 PLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSEN  255 (936)
Q Consensus       188 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N  255 (936)
                      +...+|.++.+|+.+.+..+. .......|..+.+|+.+.+..+ ++.+...+|.. .+|+.+.+..+
T Consensus       128 I~~~aF~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~  192 (394)
T 4gt6_A          128 IDSEAFHHCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAK  192 (394)
T ss_dssp             ECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTT
T ss_pred             ehhhhhhhhccccccccccee-eeecccceecccccccccccce-eeEeccccccc-cceeEEEECCc
Confidence            566677778888888876543 3245566777777777777654 33344444543 45666666543

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.38  E-value=4e-15  Score=164.84  Aligned_cols=135  Identities=20%  Similarity=0.215  Sum_probs=67.8

Q ss_pred             ccccEEeccCCcccCcCCCchhhc-----CCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCcc----
Q 002321          100 QFLRKLSLSSNNLTGSISPNLAKL-----QNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLS----  170 (936)
Q Consensus       100 ~~L~~L~L~~n~l~~~~~~~l~~l-----~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~----  170 (936)
                      +.|++|+|++|+|+......|..+     ++|++|||++|.|++.-...++..+++|++|+|++|+|+......++    
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            456677777777765444444443     56777777777765433334444555666666666666533222221    


Q ss_pred             -ccccccccccccccccCC----CCCCCCCCCCCCEEecCCCCCCCCC----ccCccCCCCcceeeccccccc
Q 002321          171 -LCSTLATINLSSNRFSSP----LPLGIWGLSALRTLDLSDNLLEGEI----PKGVESLKNLRVINLSKNMFS  234 (936)
Q Consensus       171 -~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~  234 (936)
                       ..++|++|+|++|.|+..    ++..+..+++|++|+|++|.|++..    +..+...++|++|+|++|.|+
T Consensus       152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~  224 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG  224 (372)
T ss_dssp             STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred             hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence             234455555555555432    1122234455555555555554211    223333444555555555444

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.38  E-value=2.1e-11  Score=136.90  Aligned_cols=335  Identities=11%  Similarity=0.128  Sum_probs=166.0

Q ss_pred             cccccchhhhhcCC-CCcEEEccCccCCCCCCCCcccccccccccccccc---ccCCCCCCCCCCCCCCEEecCCCCCCC
Q 002321          136 LSGSIPDEFFKQCG-SLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNR---FSSPLPLGIWGLSALRTLDLSDNLLEG  211 (936)
Q Consensus       136 l~~~i~~~~f~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~---l~~~~~~~~~~l~~L~~L~L~~N~l~~  211 (936)
                      ++ .|.+.+|.++. .|+.+.+..+ ++.+...+|.++++|+.+.+..|.   ++.+...+|.++.+|+.+.+..+ ++.
T Consensus        51 Vt-~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~  127 (394)
T 4gt6_A           51 VS-KIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTE  127 (394)
T ss_dssp             EE-EECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSE
T ss_pred             ee-EcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cce
Confidence            44 67888888874 5899888754 666677788888888888887764   55555667777777777766654 333


Q ss_pred             CCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCccccc
Q 002321          212 EIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGE  291 (936)
Q Consensus       212 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~  291 (936)
                      .....|.++.+|+.+.+..+ ++.+....|..+.+|+.+.+..+ ++.....                        +|..
T Consensus       128 I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~------------------------aF~~  181 (394)
T 4gt6_A          128 IDSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEER------------------------AFTG  181 (394)
T ss_dssp             ECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTT------------------------TTTT
T ss_pred             ehhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccc------------------------cccc
Confidence            44455666667777666543 23244455666666666655443 2211111                        1211


Q ss_pred             CCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCccccc
Q 002321          292 LESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSF  371 (936)
Q Consensus       292 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l  371 (936)
                       .+|+.+.+..+-.. .....|.+..+++......+......-..+............                      
T Consensus       182 -~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------  237 (394)
T 4gt6_A          182 -TALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYALIR----------------------  237 (394)
T ss_dssp             -CCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEE----------------------
T ss_pred             -cceeEEEECCcccc-cccchhhhccccceecccccccccccceeecccccccccccc----------------------
Confidence             23444443332211 222334444444444433333221100000000000000000                      


Q ss_pred             cccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCcc
Q 002321          372 AENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENW  451 (936)
Q Consensus       372 ~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  451 (936)
                                  ++    ....+..+.+. +.++.+...+|.++..|+.+.+..+..+ ....+|.++++|+.+.+. +.
T Consensus       238 ------------~~----~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~  298 (394)
T 4gt6_A          238 ------------YP----SQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SR  298 (394)
T ss_dssp             ------------CC----TTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TT
T ss_pred             ------------cc----cccccceEEcC-CcceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-Cc
Confidence                        00    01122222222 1222233445555555666655544332 334455566666666664 33


Q ss_pred             ccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcc
Q 002321          452 LNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQ  531 (936)
Q Consensus       452 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  531 (936)
                      ++......|.++.+|+.++|..+ ++..-..+|.++.+|+.+.|..+ ++.....+|.++++|+.+++.+|....   ..
T Consensus       299 i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~  373 (394)
T 4gt6_A          299 ITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NA  373 (394)
T ss_dssp             CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HT
T ss_pred             ccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hh
Confidence            44344455666666666666543 44344456666666666666543 544445566667777777776665431   34


Q ss_pred             cccccccCeeecCCCc
Q 002321          532 LVNLVHLSSFNISHNH  547 (936)
Q Consensus       532 l~~l~~L~~L~ls~N~  547 (936)
                      +....+|+.+.+..|.
T Consensus       374 ~~~~~~L~~i~i~~~~  389 (394)
T 4gt6_A          374 ISTDSGLQNLPVAPGS  389 (394)
T ss_dssp             CBCCCCC---------
T ss_pred             hhccCCCCEEEeCCCC
Confidence            4555566666655543

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.32  E-value=3.9e-14  Score=156.86  Aligned_cols=161  Identities=19%  Similarity=0.221  Sum_probs=119.6

Q ss_pred             CCcccEEeccCcccCCCChhhhccc-----ccCCeeeccCccccCCCCccc-cCcccCCeeecCCccccccCCCCC----
Q 002321          391 FESLQFLDLSHNEFSGETPATIGAL-----SGLQLLNLSRNSLVGPIPVAI-GDLKALNVLDLSENWLNGSIPPEI----  460 (936)
Q Consensus       391 l~~L~~L~Ls~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p~~~----  460 (936)
                      ++.|+.|+|++|.|+......+...     ++|++|+|++|.++......+ ..+++|+.|+|++|.|+......+    
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L  150 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL  150 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence            3568899999999876555554443     689999999998864322222 346788999999999875433333    


Q ss_pred             -CCcCCCcEEEecCCccCC----cCccccccccccccccccCccccCC----CcccccccCCccEEEcCCCcccCC----
Q 002321          461 -GGAYSLKELRLERNFLAG----KIPTSIENCSSLVSLILSKNNLTGP----IPIAIAKLTNLQNVDLSFNSLTGG----  527 (936)
Q Consensus       461 -~~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----  527 (936)
                       ...++|++|+|++|.|+.    .++..+..+++|++|+|++|+|++.    ++..+...++|++|||++|.|+..    
T Consensus       151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~  230 (372)
T 3un9_A          151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA  230 (372)
T ss_dssp             HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred             HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence             245789999999999874    3455567789999999999998753    356677788999999999999743    


Q ss_pred             CCcccccccccCeeecCCCccccc
Q 002321          528 LPKQLVNLVHLSSFNISHNHLQGE  551 (936)
Q Consensus       528 ~p~~l~~l~~L~~L~ls~N~l~~~  551 (936)
                      +...+...++|++|+|++|++++.
T Consensus       231 l~~~L~~~~~L~~L~Ls~N~i~~~  254 (372)
T 3un9_A          231 LARAAREHPSLELLHLYFNELSSE  254 (372)
T ss_dssp             HHHHHHHCSSCCEEECTTSSCCHH
T ss_pred             HHHHHHhCCCCCEEeccCCCCCHH
Confidence            445566678999999999998753

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.30  E-value=3.5e-12  Score=140.70  Aligned_cols=89  Identities=24%  Similarity=0.189  Sum_probs=44.4

Q ss_pred             ccCcccCCeeecCC-ccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCc
Q 002321          436 IGDLKALNVLDLSE-NWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNL  514 (936)
Q Consensus       436 ~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  514 (936)
                      +..+++|+.|+|++ |+|++..+..|.++++|+.|+|++|+|++..|..|.+|++|++|+|++|+|++..+..|..++ |
T Consensus        27 l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L  105 (347)
T 2ifg_A           27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-L  105 (347)
T ss_dssp             SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-C
T ss_pred             CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-c
Confidence            44444444555543 444444444445555555555555555544444555555555555555555543333444333 5


Q ss_pred             cEEEcCCCccc
Q 002321          515 QNVDLSFNSLT  525 (936)
Q Consensus       515 ~~L~Ls~N~l~  525 (936)
                      +.|+|++|+|.
T Consensus       106 ~~l~l~~N~~~  116 (347)
T 2ifg_A          106 QELVLSGNPLH  116 (347)
T ss_dssp             CEEECCSSCCC
T ss_pred             eEEEeeCCCcc
Confidence            55555555555

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.28  E-value=2.4e-12  Score=141.92  Aligned_cols=132  Identities=22%  Similarity=0.181  Sum_probs=105.1

Q ss_pred             CeeecCCc-cccccCCCCCCCcCCCcEEEecC-CccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcC
Q 002321          443 NVLDLSEN-WLNGSIPPEIGGAYSLKELRLER-NFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLS  520 (936)
Q Consensus       443 ~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  520 (936)
                      ..++++++ +|++ +|. +..+++|+.|+|++ |+|++..+..|.+|++|++|+|++|+|++..|..|.+|++|++|||+
T Consensus        11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            35688888 8884 788 99999999999996 99998888999999999999999999999999999999999999999


Q ss_pred             CCcccCCCCcccccccccCeeecCCCcccccCCCCCccCc--CCCccccCCCCCCCCCC
Q 002321          521 FNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNT--ISPSSVLGNPSLCGSAV  577 (936)
Q Consensus       521 ~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~--~~~~~~~gn~~~c~~~~  577 (936)
                      +|+|++..+..+..+. |+.|+|++|+|.+.+.-..+...  .....+..+...|..+.
T Consensus        89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~  146 (347)
T 2ifg_A           89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (347)
T ss_dssp             SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             CCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence            9999965555566565 99999999999987653322221  12223334555665543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.17  E-value=4.1e-11  Score=126.36  Aligned_cols=136  Identities=13%  Similarity=0.074  Sum_probs=106.9

Q ss_pred             cCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-CCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          693 NKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       693 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      +....++.|+.+.||++... ++.+++|+...... .....+.+|+++++.+. +..+.++++++.+.+..++||||++|
T Consensus        17 ~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   94 (263)
T 3tm0_A           17 RCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG   94 (263)
T ss_dssp             EEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred             eeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence            34445777888999999854 78999999864211 22346889999999984 67788999999988889999999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ-------------------------------------------  808 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-------------------------------------------  808 (936)
                      .++.+.+..        ......++.++++++..||+                                           
T Consensus        95 ~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T 3tm0_A           95 VLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             EEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred             eehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence            998876321        11234678899999999998                                           


Q ss_pred             ----------------CCcccCCCCCCCEEEcCCCCeEEeeccCcc
Q 002321          809 ----------------SNIIHYNIKSSNVLIDGSGEPKVGDYGLAR  838 (936)
Q Consensus       809 ----------------~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  838 (936)
                                      ..++|+|++|.||++++++.+.|+||+.+.
T Consensus       167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                            348999999999999876667799999775

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.12  E-value=4e-09  Score=117.55  Aligned_cols=127  Identities=12%  Similarity=0.087  Sum_probs=55.7

Q ss_pred             hhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCC
Q 002321          121 AKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALR  200 (936)
Q Consensus       121 ~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  200 (936)
                      ....+|+.+.+.. .++ .|++.+|.++.+|+.+.|..+ ++.+...+|.++ +|+.+.+..+ ++.+...+|.+. +|+
T Consensus        43 ~~~~~i~~v~ip~-~vt-~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L~  116 (379)
T 4h09_A           43 KDRDRISEVRVNS-GIT-SIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DLD  116 (379)
T ss_dssp             GGGGGCSEEEECT-TEE-EECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CCS
T ss_pred             ccccCCEEEEeCC-Ccc-ChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-Ccc
Confidence            3334444444432 233 344444444444444444322 333333444443 3444444322 333333444442 566


Q ss_pred             EEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccc
Q 002321          201 TLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENS  256 (936)
Q Consensus       201 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~  256 (936)
                      .+.+..+... .....|.+. +|+.+.+..+ ++......|..+.+++.+.+..+.
T Consensus       117 ~i~lp~~~~~-i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~  169 (379)
T 4h09_A          117 DFEFPGATTE-IGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNN  169 (379)
T ss_dssp             EEECCTTCCE-ECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTC
T ss_pred             cccCCCcccc-ccccccccc-eeeeeeccce-eeccccchhccccccccccccccc
Confidence            6666544222 223334332 4555544433 333444556666666666655443

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.07  E-value=2e-10  Score=120.96  Aligned_cols=125  Identities=14%  Similarity=0.127  Sum_probs=96.0

Q ss_pred             cccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCC--cceeeeEEEeCCeeEEEEEecCCCChhh
Q 002321          699 GRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPN--LVTLEGYYWTQSLQLLIYEFVSGGSLHK  776 (936)
Q Consensus       699 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~  776 (936)
                      +.|..+.||++...+|+.++||+....    ....+.+|+++++.+.+.+  +.+++++....+..++||||++|.++. 
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence            356669999998777888999997543    1245788999999985444  556888888777889999999998884 


Q ss_pred             hhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------------
Q 002321          777 HLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN----------------------------------------------  810 (936)
Q Consensus       777 ~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~----------------------------------------------  810 (936)
                       ...      ..   ...++.++++++..||+..                                              
T Consensus       104 -~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (264)
T 1nd4_A          104 -SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  173 (264)
T ss_dssp             -TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             -cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence             211      11   2256677888888888643                                              


Q ss_pred             ------------cccCCCCCCCEEEcCCCCeEEeeccCcc
Q 002321          811 ------------IIHYNIKSSNVLIDGSGEPKVGDYGLAR  838 (936)
Q Consensus       811 ------------ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  838 (936)
                                  ++|+|++|.||++++++.+.|+|||.+.
T Consensus       174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                        9999999999999877667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.05  E-value=3.7e-10  Score=124.93  Aligned_cols=139  Identities=20%  Similarity=0.275  Sum_probs=105.1

Q ss_pred             CcccccCceEEEEEEeCCCcEEEEEEee--ccCccchHHHHHHHHHHHHcCC--CCCcceeeeEEEeC---CeeEEEEEe
Q 002321          696 CELGRGGFGAVYRTVLRDGRPVAIKKLT--VSSLVKSQEDFEREVKKLGKVR--HPNLVTLEGYYWTQ---SLQLLIYEF  768 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e~  768 (936)
                      +.++.|.++.||+.... +..+++|+..  ..........+.+|+++++.+.  +..+.+++.++.+.   +..++||||
T Consensus        44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~  122 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF  122 (359)
T ss_dssp             EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred             EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence            46899999999999875 5688999876  3332233467889999999997  45678888888766   457899999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ----------------------------------------  808 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~----------------------------------------  808 (936)
                      ++|..+.+...     ..++..++..++.+++++|+.||+                                        
T Consensus       123 v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          123 VSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             CCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             cCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            99887754211     126778888999999999999996                                        


Q ss_pred             ------------------CCcccCCCCCCCEEEcCCCC--eEEeeccCcccc
Q 002321          809 ------------------SNIIHYNIKSSNVLIDGSGE--PKVGDYGLARLL  840 (936)
Q Consensus       809 ------------------~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~  840 (936)
                                        ..++|||+++.||+++.++.  +.|+||+.+..-
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                              35899999999999998753  689999998753

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.03  E-value=1.4e-08  Score=113.14  Aligned_cols=131  Identities=11%  Similarity=0.061  Sum_probs=93.3

Q ss_pred             cccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccc
Q 002321           94 RGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCS  173 (936)
Q Consensus        94 ~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~  173 (936)
                      +++....+|+.+.+.. .++.+-..+|.++++|+.++|..+ ++ .|...+|.++ +|+.+.+..+ ++......|... 
T Consensus        40 ~~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~-~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-  113 (379)
T 4h09_A           40 PWYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VT-SIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-  113 (379)
T ss_dssp             TTGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CC-EECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-
T ss_pred             cccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ce-EechhhhcCC-CCceEECCce-eeEeccceeccC-
Confidence            3456667888888874 577666788999999999999754 66 7888999987 6888877644 554555667654 


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccc
Q 002321          174 TLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMF  233 (936)
Q Consensus       174 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  233 (936)
                      +|+.+.+.++ ++.+...+|.+. +|+.+.+..+ ++......|..+.+++.+.+..+..
T Consensus       114 ~L~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~  170 (379)
T 4h09_A          114 DLDDFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNK  170 (379)
T ss_dssp             CCSEEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCS
T ss_pred             CcccccCCCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccc
Confidence            7999998765 443455566554 6777777654 4435566778888888888776544

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.99  E-value=5.2e-11  Score=130.55  Aligned_cols=84  Identities=20%  Similarity=0.307  Sum_probs=48.3

Q ss_pred             CCCCcceeecccccccccCCcccc---cccCcceeeccccccCCC----CchhhhccccccEEeccCccccCCCCccccc
Q 002321          219 SLKNLRVINLSKNMFSGSIPDGIG---SCSLLRTIDFSENSFSGN----LPETMQKLSLCNFMNLRKNLFSGEVPKWIGE  291 (936)
Q Consensus       219 ~l~~L~~L~L~~N~l~~~~p~~l~---~l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~  291 (936)
                      .+++|++|+|.+|.+++..+..+.   .+++|++|+|+.|.+++.    ++..+..+++|+.|+|+.|.++...-..+..
T Consensus       250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~  329 (362)
T 2ra8_A          250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK  329 (362)
T ss_dssp             TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHH
T ss_pred             CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHH
Confidence            356777777777766543322222   356777777777776643    2333455677777777777766433333332


Q ss_pred             -CCccceecccCce
Q 002321          292 -LESLETLDLSGNK  304 (936)
Q Consensus       292 -l~~L~~L~L~~N~  304 (936)
                       +  ...+++++++
T Consensus       330 al--g~~~~~~~~~  341 (362)
T 2ra8_A          330 SL--PMKIDVSDSQ  341 (362)
T ss_dssp             HC--CSEEECCSBC
T ss_pred             Hc--CCEEEecCCc
Confidence             2  2457777776

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.98  E-value=7.6e-12  Score=129.82  Aligned_cols=145  Identities=18%  Similarity=0.141  Sum_probs=81.3

Q ss_pred             CccceeEEecCCCCceEEeccCC---CCCCccccc-ccccCccccEEeccCCcccCcCC-CchhhcCCCcE--EEccCcc
Q 002321           63 PCNWFGVKCSPRSNRVIELTLNG---LSLTGRIGR-GLLQLQFLRKLSLSSNNLTGSIS-PNLAKLQNLRV--IDLSGNS  135 (936)
Q Consensus        63 ~c~w~gv~c~~~~~~v~~l~l~~---~~l~g~~~~-~l~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~--L~Ls~N~  135 (936)
                      .|+|.|+.|+....+|+.+-..+   ..+.|.+.+ .+..++.  .|..++|.-++.+. ..|...+.|+.  ++++.|+
T Consensus        77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~  154 (267)
T 3rw6_A           77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR  154 (267)
T ss_dssp             HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred             HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence            48999999997655776655444   234444543 2333333  23333444443322 23666666766  7778885


Q ss_pred             cccccc---hhhhhcCCCCcEEEccCccCCC--CCCCCccccccccccccccccccCCCCCCCCCCC--CCCEEecCCCC
Q 002321          136 LSGSIP---DEFFKQCGSLRVISLAKNRFSG--KIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLS--ALRTLDLSDNL  208 (936)
Q Consensus       136 l~~~i~---~~~f~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L~~N~  208 (936)
                      .. .++   ..+...+++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..+.  +|++|+|++|.
T Consensus       155 ~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Np  231 (267)
T 3rw6_A          155 RS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNS  231 (267)
T ss_dssp             HH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTST
T ss_pred             HH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCc
Confidence            44 232   2223567778888888888776  3345555666666666666666653  1122222  55555555555


Q ss_pred             CCCC
Q 002321          209 LEGE  212 (936)
Q Consensus       209 l~~~  212 (936)
                      +.+.
T Consensus       232 l~~~  235 (267)
T 3rw6_A          232 LCDT  235 (267)
T ss_dssp             TGGG
T ss_pred             Cccc
Confidence            5543

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.93  E-value=2.7e-10  Score=124.85  Aligned_cols=85  Identities=11%  Similarity=0.162  Sum_probs=56.0

Q ss_pred             cccCcceeeccccccCCCCchhhh---ccccccEEeccCccccCC----CCcccccCCccceecccCceeccccCccccc
Q 002321          243 SCSLLRTIDFSENSFSGNLPETMQ---KLSLCNFMNLRKNLFSGE----VPKWIGELESLETLDLSGNKFSGAVPISIGN  315 (936)
Q Consensus       243 ~l~~L~~L~Ls~N~l~~~~~~~l~---~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~  315 (936)
                      .+++|++|+|++|.+.+..+..+.   .+++|+.|+|+.|.+++.    ++..+..+++|+.|+|++|.|+...-..+..
T Consensus       250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~  329 (362)
T 2ra8_A          250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK  329 (362)
T ss_dssp             TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHH
T ss_pred             CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHH
Confidence            467888888888887644333333   467888888888888753    2333455688888888888877544333332


Q ss_pred             ccccceEEccCCc
Q 002321          316 LQRLKVLNFSANR  328 (936)
Q Consensus       316 l~~L~~L~L~~N~  328 (936)
                      .- ...++++.++
T Consensus       330 al-g~~~~~~~~~  341 (362)
T 2ra8_A          330 SL-PMKIDVSDSQ  341 (362)
T ss_dssp             HC-CSEEECCSBC
T ss_pred             Hc-CCEEEecCCc
Confidence            11 3567887776

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.90  E-value=8.5e-10  Score=118.92  Aligned_cols=185  Identities=16%  Similarity=0.133  Sum_probs=121.2

Q ss_pred             CcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-CCC--cceeeeEEEeCC---eeEEEEEec
Q 002321          696 CELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPN--LVTLEGYYWTQS---LQLLIYEFV  769 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~  769 (936)
                      +.++.|....||+..    ..+++|+....   .....+.+|+++++.+. +..  +.+++.+.....   ..++|||++
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            458999999999863    56899986432   33567899999998884 333  334444433322   348899999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ-----------------------------------------  808 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-----------------------------------------  808 (936)
                      +|.++.+....     .++..++..++.++++.++.||+                                         
T Consensus        99 ~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            99888753322     16677777888888888888885                                         


Q ss_pred             -----------------CCcccCCCCCCCEEEcC--CCCeEEeeccCccccCCCccccccccc---cC---------ccc
Q 002321          809 -----------------SNIIHYNIKSSNVLIDG--SGEPKVGDYGLARLLPMLDRYVLSSKI---QS---------ALG  857 (936)
Q Consensus       809 -----------------~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~---~~---------~~~  857 (936)
                                       ..++|+|++|.||++++  .+.+.++||+.+..-....+.......   .+         ..+
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                             23699999999999998  456889999988653221110000000   00         001


Q ss_pred             ccC-cccccCcccCCchhhHHHHHHHHHHHHcCCCCCCc
Q 002321          858 YMA-PEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLST  895 (936)
Q Consensus       858 y~a-PE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~  895 (936)
                      +.. |+...   ......+.|+++.++|++.+|+.+|..
T Consensus       254 ~~~~~~~~~---r~~~~~~~~~l~~~~~~~~~g~~~~~~  289 (304)
T 3sg8_A          254 HKDIPTVLE---KYRMKEKYWSFEKIIYGKEYGYMDWYE  289 (304)
T ss_dssp             CSCHHHHHH---HHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred             CCCcHHHHH---HHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence            112 23221   112346899999999999999987643

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.52  E-value=4.8e-09  Score=103.70  Aligned_cols=124  Identities=15%  Similarity=0.143  Sum_probs=71.4

Q ss_pred             ccccccccCccccEEeccCC-cccCc----CCCchhhcCCCcEEEccCcccccccc---hhhhhcCCCCcEEEccCccCC
Q 002321           91 RIGRGLLQLQFLRKLSLSSN-NLTGS----ISPNLAKLQNLRVIDLSGNSLSGSIP---DEFFKQCGSLRVISLAKNRFS  162 (936)
Q Consensus        91 ~~~~~l~~l~~L~~L~L~~n-~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~i~---~~~f~~l~~L~~L~L~~N~l~  162 (936)
                      .+...+...+.|++|+|++| +|+..    +...+...++|++|+|++|+|.+.--   ...+...++|++|+|++|.|+
T Consensus        27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~  106 (185)
T 1io0_A           27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS  106 (185)
T ss_dssp             HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence            34445667778888888888 77643    23445556778888888888763211   122344556666666666665


Q ss_pred             CCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEec--CCCCCCCC----CccCccCCCCcceeeccccccc
Q 002321          163 GKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDL--SDNLLEGE----IPKGVESLKNLRVINLSKNMFS  234 (936)
Q Consensus       163 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L--~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~  234 (936)
                      ......                    +..++...++|++|+|  ++|.|...    +...+...++|++|+|++|.+.
T Consensus       107 ~~g~~~--------------------l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          107 GSGILA--------------------LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHH--------------------HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHH--------------------HHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            321000                    1223444456666666  56666533    2233444567777777777765

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.47  E-value=1.7e-08  Score=104.73  Aligned_cols=79  Identities=23%  Similarity=0.236  Sum_probs=44.3

Q ss_pred             CcCCCcEEEecCCccCC--cCccccccccccccccccCccccCCCcccccccC--CccEEEcCCCcccCCCCc-------
Q 002321          462 GAYSLKELRLERNFLAG--KIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLT--NLQNVDLSFNSLTGGLPK-------  530 (936)
Q Consensus       462 ~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~-------  530 (936)
                      ++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..+.  +|++|+|++|.+.+.+|.       
T Consensus       168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~  245 (267)
T 3rw6_A          168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISA  245 (267)
T ss_dssp             HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHH
T ss_pred             hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHH
Confidence            34455555555555554  3345555666666666666666643  2233333  666777777776655542       


Q ss_pred             ccccccccCeee
Q 002321          531 QLVNLVHLSSFN  542 (936)
Q Consensus       531 ~l~~l~~L~~L~  542 (936)
                      .+..+++|+.||
T Consensus       246 il~~~P~L~~LD  257 (267)
T 3rw6_A          246 IRERFPKLLRLD  257 (267)
T ss_dssp             HHHHCTTCCEES
T ss_pred             HHHHCcccCeEC
Confidence            245566666654

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.44  E-value=2.2e-08  Score=98.82  Aligned_cols=93  Identities=18%  Similarity=0.263  Sum_probs=47.6

Q ss_pred             hhhhcccccCCeeeccCc-cccCC----CCccccCcccCCeeecCCcccccc----CCCCCCCcCCCcEEEecCCccCCc
Q 002321          409 PATIGALSGLQLLNLSRN-SLVGP----IPVAIGDLKALNVLDLSENWLNGS----IPPEIGGAYSLKELRLERNFLAGK  479 (936)
Q Consensus       409 ~~~~~~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~  479 (936)
                      ...+...+.|++|+|++| .+...    +...+...++|++|+|++|.|...    +...+...++|++|+|++|.|+..
T Consensus        29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~  108 (185)
T 1io0_A           29 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS  108 (185)
T ss_dssp             HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred             HHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHH
Confidence            344556677888888877 76521    233445556666666666666531    122223334555555555555431


Q ss_pred             ----Cccccccccccccccc--cCcccc
Q 002321          480 ----IPTSIENCSSLVSLIL--SKNNLT  501 (936)
Q Consensus       480 ----~p~~l~~l~~L~~L~L--~~N~l~  501 (936)
                          +...+...++|++|+|  ++|.++
T Consensus       109 g~~~l~~~L~~n~~L~~L~L~~~~N~i~  136 (185)
T 1io0_A          109 GILALVEALQSNTSLIELRIDNQSQPLG  136 (185)
T ss_dssp             HHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             HHHHHHHHHHhCCCceEEEecCCCCCCC
Confidence                2333344444444444  444443

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.33  E-value=2.4e-06  Score=91.63  Aligned_cols=133  Identities=14%  Similarity=0.099  Sum_probs=91.2

Q ss_pred             CcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCC---CcceeeeEEE-eCCeeEEEEEecCC
Q 002321          696 CELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHP---NLVTLEGYYW-TQSLQLLIYEFVSG  771 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~  771 (936)
                      +.++.|....||+.    |+.++||+...   ......+.+|+++++.+.+.   .+.+++.++. ..+..++||||++|
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            35788888899987    57789998532   12356789999999999653   3556666664 34557899999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ-------------------------------------------  808 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-------------------------------------------  808 (936)
                      ..+.+.....     ++..+...++.++++.|+.||+                                           
T Consensus        98 ~~l~~~~~~~-----l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGMAV-----LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHHTT-----SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhhhh-----CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            8886532110     3334444444444444444442                                           


Q ss_pred             -----------------CCcccCCCCCCCEEEcC---CCC-eEEeeccCcccc
Q 002321          809 -----------------SNIIHYNIKSSNVLIDG---SGE-PKVGDYGLARLL  840 (936)
Q Consensus       809 -----------------~~ivH~Dlkp~NIll~~---~~~-~kl~Dfg~a~~~  840 (936)
                                       ..++|+|+++.||+++.   ++. +.|+||+.+..-
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                             24689999999999997   455 489999988653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.33  E-value=2.8e-06  Score=89.45  Aligned_cols=131  Identities=20%  Similarity=0.216  Sum_probs=93.8

Q ss_pred             ccccCce-EEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-CCCcceeeeEEEeCCeeEEEEEecCCCCh
Q 002321          698 LGRGGFG-AVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQSLQLLIYEFVSGGSL  774 (936)
Q Consensus       698 iG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L  774 (936)
                      +..|..| .||+.... ++..++||+-...    ....+.+|...++.+. +--+.++++++.+.+..++|||+++|.++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            4445555 69988765 4678999986532    3467889999998884 33477888999999999999999999887


Q ss_pred             hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 002321          775 HKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS---------------------------------------------  809 (936)
Q Consensus       775 ~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---------------------------------------------  809 (936)
                      .+......       .....++.+++..+..||+.                                             
T Consensus       108 ~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            76543211       12233445555555555521                                             


Q ss_pred             -------------CcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          810 -------------NIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       810 -------------~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                                   .++|+|+++.||+++.++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                         158999999999999887778999998753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.08  E-value=2.7e-06  Score=93.63  Aligned_cols=81  Identities=9%  Similarity=0.028  Sum_probs=56.0

Q ss_pred             Ccc-cccCceEEEEEEeC-------CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCC-C--CCcceeeeEEEeC---
Q 002321          696 CEL-GRGGFGAVYRTVLR-------DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVR-H--PNLVTLEGYYWTQ---  759 (936)
Q Consensus       696 ~~i-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~---  759 (936)
                      +.| +.|....+|+....       +++.+++|+......  ......+.+|+++++.+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            457 78889999998754       267899998754320  001245788999988884 3  3567788777654   


Q ss_pred             CeeEEEEEecCCCChhh
Q 002321          760 SLQLLIYEFVSGGSLHK  776 (936)
Q Consensus       760 ~~~~lv~e~~~~g~L~~  776 (936)
                      +..++||||++|..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999877653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.95  E-value=1.6e-05  Score=88.78  Aligned_cols=75  Identities=16%  Similarity=0.144  Sum_probs=48.9

Q ss_pred             CcccccCceEEEEEEeC-CCcEEEEEEeeccCc------cchHHHHHHHHHHHHcCCC--CC-cceeeeEEEeCCeeEEE
Q 002321          696 CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL------VKSQEDFEREVKKLGKVRH--PN-LVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~lv  765 (936)
                      +.||.|.++.||+++.. +++.|+||.......      ....+++.+|.++++.+..  +. +.+++.+  +....++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            36899999999999754 468899998653221      0123456788888888742  33 4455543  44556899


Q ss_pred             EEecCCC
Q 002321          766 YEFVSGG  772 (936)
Q Consensus       766 ~e~~~~g  772 (936)
                      |||+++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.91  E-value=2.9e-05  Score=84.71  Aligned_cols=137  Identities=14%  Similarity=0.226  Sum_probs=79.7

Q ss_pred             cccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCC--CCCcceeee------EEEeCCeeEEEEEe
Q 002321          697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR--HPNLVTLEG------YYWTQSLQLLIYEF  768 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~------~~~~~~~~~lv~e~  768 (936)
                      .|+.|..+.||+....+| .+++|+....     ..++..|..+++.+.  .-.+.+++.      +....+..+++|||
T Consensus        39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             ECC----CEEEEEEETTE-EEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eccccccCcEEEEEeCCC-CEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            466677889999987644 5999998642     234445666665553  112333332      22356677899999


Q ss_pred             cCCCChh--------------hhhhcc--CC--C-------CCCCHHHH-------------------------------
Q 002321          769 VSGGSLH--------------KHLHEG--SG--G-------NFLSWNER-------------------------------  792 (936)
Q Consensus       769 ~~~g~L~--------------~~l~~~--~~--~-------~~~~~~~~-------------------------------  792 (936)
                      ++|..+.              ..++..  ..  .       ..-.|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              011111  00  0       01122211                               


Q ss_pred             HHHHHHHHHHHHHHH-------------hCCcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          793 FNVIQGTAKSLAHLH-------------QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       793 ~~i~~~i~~al~~LH-------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      ..+..++.+++++|+             ..+++|+|+++.||+++.++.+.++||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            011122334566665             35799999999999998888999999998854

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.77  E-value=6e-06  Score=79.15  Aligned_cols=84  Identities=14%  Similarity=0.153  Sum_probs=43.9

Q ss_pred             ccCCeeecCCccccccCCCCCCCcCCCcEEEecCCc-cCCcCccccccc----cccccccccCcc-ccCCCcccccccCC
Q 002321          440 KALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNF-LAGKIPTSIENC----SSLVSLILSKNN-LTGPIPIAIAKLTN  513 (936)
Q Consensus       440 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~l~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~  513 (936)
                      .+|+.|||+++.++..--..+.++++|+.|+|++|. |+..--..+..+    ++|++|+|++|. ++..--..+.++++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            356666666666654433445556666666666653 543333334332    245666665552 55433344455555


Q ss_pred             ccEEEcCCCc
Q 002321          514 LQNVDLSFNS  523 (936)
Q Consensus       514 L~~L~Ls~N~  523 (936)
                      |++|+|+++.
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            5555555553

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.71  E-value=7.1e-06  Score=78.64  Aligned_cols=82  Identities=10%  Similarity=0.074  Sum_probs=35.8

Q ss_pred             CCcEEEecCCccCCcCccccccccccccccccCcc-ccCCCccccccc----CCccEEEcCCCc-ccCCCCccccccccc
Q 002321          465 SLKELRLERNFLAGKIPTSIENCSSLVSLILSKNN-LTGPIPIAIAKL----TNLQNVDLSFNS-LTGGLPKQLVNLVHL  538 (936)
Q Consensus       465 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~l~~l~~L  538 (936)
                      +|+.|||+++.|+..--..+.++++|+.|+|++|. +++.--..+..+    ++|++|+|++|. ++..--..+..+++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            45555555555443333344445555555555542 433222233332    235555555542 442222334444555


Q ss_pred             CeeecCCC
Q 002321          539 SSFNISHN  546 (936)
Q Consensus       539 ~~L~ls~N  546 (936)
                      +.|+|+++
T Consensus       142 ~~L~L~~c  149 (176)
T 3e4g_A          142 KYLFLSDL  149 (176)
T ss_dssp             CEEEEESC
T ss_pred             CEEECCCC
Confidence            55555544

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.57  E-value=0.00028  Score=75.13  Aligned_cols=134  Identities=19%  Similarity=0.172  Sum_probs=91.3

Q ss_pred             CcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCC---CCCcceeeeEEEeCCeeEEEEEecCCC
Q 002321          696 CELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR---HPNLVTLEGYYWTQSLQLLIYEFVSGG  772 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g  772 (936)
                      +.|+.|.+..+|+... ++..++||+....    ....+.+|++.++.+.   ...+.++++++...+..++||||+++.
T Consensus        42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             EEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            4689999999999886 4778999987532    3567889999998883   356888898888888899999999987


Q ss_pred             Chhh-----------hhhccCC-CC------------------CCCHHHHH---HHHH----------------HHHH-H
Q 002321          773 SLHK-----------HLHEGSG-GN------------------FLSWNERF---NVIQ----------------GTAK-S  802 (936)
Q Consensus       773 ~L~~-----------~l~~~~~-~~------------------~~~~~~~~---~i~~----------------~i~~-a  802 (936)
                      .+..           .++.... ..                  .-+|.+..   ++..                +++. .
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            6521           1222111 00                  12454332   1111                1111 1


Q ss_pred             HHHHH----hCCcccCCCCCCCEEEcCCCCeEEeecc
Q 002321          803 LAHLH----QSNIIHYNIKSSNVLIDGSGEPKVGDYG  835 (936)
Q Consensus       803 l~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  835 (936)
                      ...|.    ...++|+|+.+.|++++.++ +.|.||+
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            22342    24699999999999999887 8899984

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.52  E-value=0.0002  Score=80.34  Aligned_cols=81  Identities=12%  Similarity=0.021  Sum_probs=47.9

Q ss_pred             HhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccccccCcccccCcccccCc--ccCCchhhHHHHHHHHH
Q 002321          807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT--VKITDKCDVYGFGVLVL  884 (936)
Q Consensus       807 H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwSlG~~l~  884 (936)
                      +...++|||+++.||+++.++ ++++||+.+..-+..-+... ....-...|.+|+.....  .......++.+....+|
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGA-YLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHH-HHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHH-HHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            456799999999999999877 99999998875321111000 000011235666544211  01122455567777778


Q ss_pred             HHHcC
Q 002321          885 EVVTG  889 (936)
Q Consensus       885 el~~g  889 (936)
                      +.+.+
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77765

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.34  E-value=0.00072  Score=71.49  Aligned_cols=75  Identities=23%  Similarity=0.288  Sum_probs=54.2

Q ss_pred             CCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCC---CcceeeeEEEeCCeeEEEEEecCC
Q 002321          695 DCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHP---NLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       695 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      .+.+|.|..+.||+.+..||+.|+||+..... ......+.+|++.|+.+...   -+.+++++  +.  .++||||+++
T Consensus        20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~l~~   94 (288)
T 3f7w_A           20 VAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEWVDE   94 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEECCCC
T ss_pred             EEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEeecc
Confidence            45689999999999999999999999875432 22235678999999988422   34444443  22  3789999987


Q ss_pred             CCh
Q 002321          772 GSL  774 (936)
Q Consensus       772 g~L  774 (936)
                      +..
T Consensus        95 ~~~   97 (288)
T 3f7w_A           95 RPP   97 (288)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            654

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.26  E-value=4.3e-05  Score=74.66  Aligned_cols=63  Identities=16%  Similarity=0.208  Sum_probs=30.2

Q ss_pred             CCcccEEeccCc-ccCCC----ChhhhcccccCCeeeccCccccC----CCCccccCcccCCeeecCCcccc
Q 002321          391 FESLQFLDLSHN-EFSGE----TPATIGALSGLQLLNLSRNSLVG----PIPVAIGDLKALNVLDLSENWLN  453 (936)
Q Consensus       391 l~~L~~L~Ls~N-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~  453 (936)
                      -+.|++|+|++| +|...    +.+.+..-+.|+.|+|++|+|..    .+...+..-+.|+.|+|++|.|.
T Consensus        40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig  111 (197)
T 1pgv_A           40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT  111 (197)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred             CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence            345666666664 55422    22233344555666666665542    12223333444555555555554

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.21  E-value=5.7e-05  Score=73.80  Aligned_cols=87  Identities=20%  Similarity=0.192  Sum_probs=48.1

Q ss_pred             hcccccCCeeeccCc-cccC----CCCccccCcccCCeeecCCccccccCC----CCCCCcCCCcEEEecCCccCCc---
Q 002321          412 IGALSGLQLLNLSRN-SLVG----PIPVAIGDLKALNVLDLSENWLNGSIP----PEIGGAYSLKELRLERNFLAGK---  479 (936)
Q Consensus       412 ~~~l~~L~~L~L~~N-~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~---  479 (936)
                      +.+-+.|++|+|++| +|..    .+...+..-+.|+.|+|++|+|...--    +.+..-+.|+.|+|++|.|...   
T Consensus        37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~  116 (197)
T 1pgv_A           37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA  116 (197)
T ss_dssp             HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred             HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence            344567888888875 6642    233455566677777777777764222    2223445566666666666532   


Q ss_pred             -CccccccccccccccccCc
Q 002321          480 -IPTSIENCSSLVSLILSKN  498 (936)
Q Consensus       480 -~p~~l~~l~~L~~L~L~~N  498 (936)
                       +-+.+...+.|++|+|++|
T Consensus       117 ala~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A          117 RLLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HHHHHTTTTCCCSEEECCCC
T ss_pred             HHHHHHhhCCceeEEECCCC
Confidence             2333444445555555543

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.14  E-value=0.0025  Score=68.64  Aligned_cols=139  Identities=14%  Similarity=0.110  Sum_probs=81.4

Q ss_pred             cccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCC--CcceeeeE-----EEeCCeeEEEEEec
Q 002321          697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHP--NLVTLEGY-----YWTQSLQLLIYEFV  769 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~  769 (936)
                      .++ |....||+....+|+.+++|+.....  .....+..|..+++.+...  .+++++..     ....+..+++|||+
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            456 77789999887677789999986332  1345677788888877421  23444443     22345667899999


Q ss_pred             CCCChhh-----h---------hhcc----CC--CCCCCHHHH----------------------HHHHHHHHHHHHHH-
Q 002321          770 SGGSLHK-----H---------LHEG----SG--GNFLSWNER----------------------FNVIQGTAKSLAHL-  806 (936)
Q Consensus       770 ~~g~L~~-----~---------l~~~----~~--~~~~~~~~~----------------------~~i~~~i~~al~~L-  806 (936)
                      +|..+..     .         ++..    ..  ....++...                      ...+.+++..++-. 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8754321     0         1110    00  011222111                      11111222222222 


Q ss_pred             ---HhCCcccCCCCCCCEEEcCCCCeEEeeccCcccc
Q 002321          807 ---HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL  840 (936)
Q Consensus       807 ---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  840 (936)
                         ....++|||+++.||+++ + .+.++||+.+..-
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence               234589999999999999 4 8999999887543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.13  E-value=0.00078  Score=72.48  Aligned_cols=140  Identities=12%  Similarity=0.100  Sum_probs=79.5

Q ss_pred             CcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCC--cceeeeE------EEeCCeeEEEEE
Q 002321          696 CELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPN--LVTLEGY------YWTQSLQLLIYE  767 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e  767 (936)
                      +.|+.|....+|+....+| .+++|+.....   ..+.+..|+.+++.+....  +.+++..      ....+..+++|+
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            3577888899999987655 68899886421   1234567787777763212  3333321      223456789999


Q ss_pred             ecCCCChhh--------------hhhcc--C--CCC-----CCCHHHHHH------------HHHHHHHHHHHHHh----
Q 002321          768 FVSGGSLHK--------------HLHEG--S--GGN-----FLSWNERFN------------VIQGTAKSLAHLHQ----  808 (936)
Q Consensus       768 ~~~~g~L~~--------------~l~~~--~--~~~-----~~~~~~~~~------------i~~~i~~al~~LH~----  808 (936)
                      |++|..+..              .++..  .  ...     ...|...+.            +...+.+.++++++    
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            999865421              01111  0  000     011222110            00113344555542    


Q ss_pred             ---CCcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          809 ---SNIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       809 ---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                         .+++|+|+++.||++++++.+.++||+.+..
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence               3699999999999999876668999998754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.12  E-value=0.00079  Score=72.87  Aligned_cols=138  Identities=13%  Similarity=0.062  Sum_probs=72.7

Q ss_pred             cccccCceE-EEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCC--CCcceeeeEEEeCCeeEEEEEecCCCC
Q 002321          697 ELGRGGFGA-VYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH--PNLVTLEGYYWTQSLQLLIYEFVSGGS  773 (936)
Q Consensus       697 ~iG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~  773 (936)
                      .|+.|+... +|+....+|+.+++|......    ...+..|+++++.+..  -.+.+++.+..+.+  +++||++.+..
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE----GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTT----TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCC----CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            455554444 667765446778887654321    0234567777776632  23556666543333  78999997655


Q ss_pred             hhhhhhcc---------------------CCC--CCCCHHHHH-------H-------------HHHHHHHHHHHH----
Q 002321          774 LHKHLHEG---------------------SGG--NFLSWNERF-------N-------------VIQGTAKSLAHL----  806 (936)
Q Consensus       774 L~~~l~~~---------------------~~~--~~~~~~~~~-------~-------------i~~~i~~al~~L----  806 (936)
                      +.+++...                     ...  ..++.....       .             ....+.+.++.+    
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            54433211                     000  011111100       0             001112223333    


Q ss_pred             --HhCCcccCCCCCCCEEEcCC----CCeEEeeccCcccc
Q 002321          807 --HQSNIIHYNIKSSNVLIDGS----GEPKVGDYGLARLL  840 (936)
Q Consensus       807 --H~~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~~~  840 (936)
                        +...++|||+.+.||+++.+    +.+.|+||+.+..-
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence              23469999999999999875    68999999988654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.08  E-value=0.00053  Score=73.05  Aligned_cols=71  Identities=7%  Similarity=0.062  Sum_probs=44.5

Q ss_pred             CCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCc-ceeeeEEEeCCeeEEEEEec-CCC
Q 002321          695 DCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNL-VTLEGYYWTQSLQLLIYEFV-SGG  772 (936)
Q Consensus       695 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g  772 (936)
                      .+.|+.|....+|+.     +.+++|+.......  .....+|+.+++.+....+ .+++++  +.+..++++||+ +|.
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence            456888999999998     56899987543111  1123568888777743333 355543  343457899999 665


Q ss_pred             Ch
Q 002321          773 SL  774 (936)
Q Consensus       773 ~L  774 (936)
                      ++
T Consensus        94 ~l   95 (301)
T 3dxq_A           94 TM   95 (301)
T ss_dssp             EC
T ss_pred             cC
Confidence            54

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.99  E-value=0.0013  Score=71.98  Aligned_cols=137  Identities=12%  Similarity=0.143  Sum_probs=81.6

Q ss_pred             cccccCceEEEEEEeC--------CCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-CCCcceeeeEEEeCCeeEEEEE
Q 002321          697 ELGRGGFGAVYRTVLR--------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      .+..|-...+|++...        +++.|++|+....  ......+.+|.++++.+. +.-..++++++.+    .+|||
T Consensus        57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            4666777889998864        2478999986321  223566779999998884 3333566655532    39999


Q ss_pred             ecCCCChhhh-----------------hhccC--CCCCC--CHHHHHHHHHHHHH-------------------HHHHHH
Q 002321          768 FVSGGSLHKH-----------------LHEGS--GGNFL--SWNERFNVIQGTAK-------------------SLAHLH  807 (936)
Q Consensus       768 ~~~~g~L~~~-----------------l~~~~--~~~~~--~~~~~~~i~~~i~~-------------------al~~LH  807 (936)
                      |++|..+..-                 ++...  ..+..  -+.+..++..++..                   .++.|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998655311                 01111  01111  23445555544322                   233332


Q ss_pred             ----h----CCcccCCCCCCCEEEcCC----CCeEEeeccCccc
Q 002321          808 ----Q----SNIIHYNIKSSNVLIDGS----GEPKVGDYGLARL  839 (936)
Q Consensus       808 ----~----~~ivH~Dlkp~NIll~~~----~~~kl~Dfg~a~~  839 (936)
                          .    ..++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                2    258999999999999876    7899999998864

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.92  E-value=0.0012  Score=60.17  Aligned_cols=37  Identities=24%  Similarity=0.464  Sum_probs=23.3

Q ss_pred             CCcEEEccCcccccccchhhhhcCCCCcEEEccCccCC
Q 002321          125 NLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFS  162 (936)
Q Consensus       125 ~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~  162 (936)
                      +|++|||++|+|+ .+|.++|..+++|++|+|++|.+.
T Consensus        32 ~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           32 DTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence            4566666666666 566666666666666666666553

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.81  E-value=0.0023  Score=71.64  Aligned_cols=71  Identities=13%  Similarity=0.164  Sum_probs=48.1

Q ss_pred             cccccCceEEEEEEeCC--------CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCc-ceeeeEEEeCCeeEEEEE
Q 002321          697 ELGRGGFGAVYRTVLRD--------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNL-VTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  767 (936)
                      .|+.|....||++...+        ++.+++|+.....   ..+.+.+|..+++.+...++ .++++.+.  +  .+|+|
T Consensus        80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e  152 (429)
T 1nw1_A           80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE---TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE  152 (429)
T ss_dssp             EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC---CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred             EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC---cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence            47788889999998653        4789999884321   12455689999888843333 56666543  2  48999


Q ss_pred             ecCCCCh
Q 002321          768 FVSGGSL  774 (936)
Q Consensus       768 ~~~~g~L  774 (936)
                      |++|.++
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9986444

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.77  E-value=0.0015  Score=59.58  Aligned_cols=37  Identities=30%  Similarity=0.364  Sum_probs=17.3

Q ss_pred             ccccccccCccccCCCcccccccCCccEEEcCCCccc
Q 002321          489 SLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLT  525 (936)
Q Consensus       489 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  525 (936)
                      +|+.|+|++|+|+...+..|..+++|++|+|++|.+.
T Consensus        32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            3444444444444333344444445555555555443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.56  E-value=0.0055  Score=66.28  Aligned_cols=68  Identities=10%  Similarity=0.040  Sum_probs=43.8

Q ss_pred             cccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCC---CCCcceeeeE------EEeCCeeEEEEEec
Q 002321          699 GRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR---HPNLVTLEGY------YWTQSLQLLIYEFV  769 (936)
Q Consensus       699 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~------~~~~~~~~lv~e~~  769 (936)
                      |.|....||+....+| .+++|+......       .+|+.+++.+.   -+.+++++..      ....+..+++|+|+
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i  103 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYHD-------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFI  103 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSSC-------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECC
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCccc-------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEecc
Confidence            4455678999987766 899998765431       34555555552   1224444432      23456778999999


Q ss_pred             CCCCh
Q 002321          770 SGGSL  774 (936)
Q Consensus       770 ~~g~L  774 (936)
                      +|..+
T Consensus       104 ~G~~~  108 (339)
T 3i1a_A          104 HAPNG  108 (339)
T ss_dssp             CCCBT
T ss_pred             CCCcC
Confidence            98765

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.46  E-value=0.0032  Score=69.14  Aligned_cols=72  Identities=13%  Similarity=0.079  Sum_probs=43.4

Q ss_pred             cccccCceEEEEEEeCC---------CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCC-cceeeeEEEeCCeeEEEE
Q 002321          697 ELGRGGFGAVYRTVLRD---------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPN-LVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  766 (936)
                      .++.|..-.+|+....+         ++.+++|+......  ...+..+|.++++.+.... +.++++..  .  .++||
T Consensus        40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            57778888999988653         26888998754211  1112467888888874333 44565443  2  37899


Q ss_pred             EecCCCCh
Q 002321          767 EFVSGGSL  774 (936)
Q Consensus       767 e~~~~g~L  774 (936)
                      ||++|..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=95.88  E-value=0.018  Score=64.59  Aligned_cols=73  Identities=16%  Similarity=0.083  Sum_probs=46.9

Q ss_pred             CcccccCceEEEEEEeCC-CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCc-ceeeeEEEeCCeeEEEEEecCCCC
Q 002321          696 CELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNL-VTLEGYYWTQSLQLLIYEFVSGGS  773 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~  773 (936)
                      +.|+.|-...+|++...+ +..+++|+.....  ...-+..+|..+++.+...++ .++++++.  +  .+||||++|.+
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-C--CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            357788889999998764 4788999874321  111123689999998865444 45666652  2  46999998755


Q ss_pred             h
Q 002321          774 L  774 (936)
Q Consensus       774 L  774 (936)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.90  E-value=0.029  Score=62.11  Aligned_cols=72  Identities=11%  Similarity=0.081  Sum_probs=46.4

Q ss_pred             cccccCceEEEEEEeCC--------CcEEEEEEeeccCccchHHHHHHHHHHHHcCC-CCCcceeeeEEEeCCeeEEEEE
Q 002321          697 ELGRGGFGAVYRTVLRD--------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      .+..|-...+|+....+        ++.|++|+.....  ...-+..+|.++++.+. +.-..++++.+  .  .+.|||
T Consensus        77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e  150 (424)
T 3mes_A           77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE  150 (424)
T ss_dssp             EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence            46667778899988653        5789999874321  11123467888888884 33344555433  2  278999


Q ss_pred             ecCCCCh
Q 002321          768 FVSGGSL  774 (936)
Q Consensus       768 ~~~~g~L  774 (936)
                      |++|..+
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9998654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=92.04  E-value=0.47  Score=46.44  Aligned_cols=102  Identities=10%  Similarity=0.048  Sum_probs=65.9

Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ-SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                      -+|.+.+....  .++++.++|.++.|.+.+|.-.-. +.-..+=+.|..|++..+|.+...+ +.+.            
T Consensus        33 vSL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           33 LSLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             ccHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------
Confidence            37888887643  459999999999999999877621 1112333456889999999988764 1110            


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCC
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP  892 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~P  892 (936)
                        .....+.|||...  ...+.+.=|||+|+++|.-+-=..|
T Consensus        98 --~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 --AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -----------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             --ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC
Confidence              1122367888762  3457888999999999988863333

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=89.57  E-value=0.75  Score=50.56  Aligned_cols=29  Identities=14%  Similarity=0.288  Sum_probs=24.9

Q ss_pred             cccCCCCCCCEEE------cCCCCeEEeeccCccc
Q 002321          811 IIHYNIKSSNVLI------DGSGEPKVGDYGLARL  839 (936)
Q Consensus       811 ivH~Dlkp~NIll------~~~~~~kl~Dfg~a~~  839 (936)
                      ++|+|+.+.||++      ++++.++++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      4567899999998864

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.61  E-value=1.6  Score=42.66  Aligned_cols=117  Identities=10%  Similarity=0.143  Sum_probs=76.9

Q ss_pred             CCCCcceeeeEEEeCCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc
Q 002321          745 RHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLID  824 (936)
Q Consensus       745 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~  824 (936)
                      .||++++. .+-.+.+...+.++.-+  +...+-.-.    ..+..++++++..|+....+++.+  +|--++|+||+++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~ik----~~~~~eKlr~l~ni~~l~~~~~~r--~tf~L~P~NL~f~  113 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNIK----SFTKNEKLRYLLNIKNLEEVNRTR--YTFVLAPDELFFT  113 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGGG----GSCHHHHHHHHHHGGGGGGGGGSS--EECCCSGGGEEEC
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHHH----hcCHHHHHHHHHHHHHHHHHhcCc--eEEEEecceEEEc
Confidence            57888866 46666665555444433  333332211    178899999999999888555433  6677899999999


Q ss_pred             CCCCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCc
Q 002321          825 GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLST  895 (936)
Q Consensus       825 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~  895 (936)
                      .++.+++.=.|+...                   ++|..      .+...=.-.+=+++..+++++..|..
T Consensus       114 ~~~~p~i~~RGik~~-------------------l~P~~------~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          114 RDGLPIAKTRGLQNV-------------------VDPLP------VSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             TTSCEEESCCEETTT-------------------BSCCC------CCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             CCCCEEEEEccCccC-------------------CCCCC------CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            999999987765432                   23321      12222233577888999999988865

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=84.32  E-value=2.7  Score=41.25  Aligned_cols=116  Identities=11%  Similarity=0.113  Sum_probs=75.5

Q ss_pred             CCCCcceeeeEEEeCCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCcccCCCCCCCEEE
Q 002321          745 RHPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLA-HLHQSNIIHYNIKSSNVLI  823 (936)
Q Consensus       745 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~-~LH~~~ivH~Dlkp~NIll  823 (936)
                      .||++  -..+-.+.+...+.++.-+++.=...++.      ++..++++++..++.... +++.  -+|--++|+||++
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~------~~~~eKlrll~nl~~L~~~~~~~--r~tf~l~P~NL~f  117 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK------TTLLSRIRAAIHLVSKVKHHSAR--RLIFIVCPENLMF  117 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT------SCHHHHHHHHHHHHHHHSSCCSS--SEECCCCGGGEEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh------cCHHHHHHHHHHHHHHHHHhhhC--ceeEEEeCceEEE
Confidence            57777  34455666766666665534333334433      788999999998888766 5443  4677789999999


Q ss_pred             cCCCCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCc
Q 002321          824 DGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLST  895 (936)
Q Consensus       824 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~  895 (936)
                      |.++.+++.-.|+-.                   -++|...      +...=.-.+=|++..++.++..|++
T Consensus       118 ~~~~~p~i~hRGi~~-------------------~lpP~e~------~ee~fl~qyKali~all~~K~~Fe~  164 (219)
T 4ano_A          118 NRALEPFFLHVGVKE-------------------SLPPDEW------DDERLLREVKATVLALTEGEYRFDE  164 (219)
T ss_dssp             CTTCCEEESCCEETT-------------------TBSSCSC------CHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred             eCCCcEEEEEcCCcc-------------------cCCCCCC------CHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            999999998777543                   2334322      1111233467778888888877754

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=80.67  E-value=0.31  Score=54.74  Aligned_cols=62  Identities=10%  Similarity=0.098  Sum_probs=18.5

Q ss_pred             CCCcccccCceEEEEEEeCC-CcEEEE------EEeeccCccc-hHHHHHHHHHHHHcCCCCCcceeeeEEEe
Q 002321          694 KDCELGRGGFGAVYRTVLRD-GRPVAI------KKLTVSSLVK-SQEDFEREVKKLGKVRHPNLVTLEGYYWT  758 (936)
Q Consensus       694 ~~~~iG~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~  758 (936)
                      ..+++|   ||+||+|.+.. ..+|||      |..+.....+ ....+.+|..+++..+|+|+++.+++...
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            344576   99999999864 468898      7765433332 23568889999999999999999888753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	936
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-55
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-52
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-51
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-51
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-50
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	6e-50
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-49
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-49
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-49
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-48
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-48
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-47
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-46
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-46
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-46
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-46
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-46
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-46
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	8e-46
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	9e-46
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-45
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-45
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-44
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-44
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-44
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-43
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-43
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-43
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-43
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-42
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-42
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-41
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-41
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	9e-41
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-41
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-40
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-40
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-40
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-39
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-38
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-38
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-37
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-37
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-37
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-37
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-36
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-36
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-35
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-35
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-33
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-33
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	8e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-30
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-30
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-15
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-04
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-04
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-28
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-26
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-24
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-13
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-09
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-04
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-24
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	8e-23
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-22
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-07
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-21
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-16
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-13
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-20
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	6e-13
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-12
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	4e-12
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-12
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-10
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.004
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	1e-08
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	8e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	8e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	7e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.001
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.003
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-07
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	4e-07
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	4e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	7e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.003
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.004
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-07
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	4e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	6e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	4e-06
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.002
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.003
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	5e-06
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	1e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	5e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	6e-05
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	6e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.001
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	7e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.002

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 1e-55
 Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 8/209 (3%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGY 755
            +G G FG VY+        VA+K L V++    Q + F+ EV  L K RH N++   GY
Sbjct: 15  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
                L  ++ ++  G SL+ HLH           +  ++ + TA+ + +LH  +IIH +
Sbjct: 73  STAPQL-AIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKSIIHRD 129

Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFAC--RTVKITDK 873
           +KS+N+ +      K+GD+GLA +           ++  ++ +MAPE          + +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189

Query: 874 CDVYGFGVLVLEVVTGKRPLSTWKMMWWF 902
            DVY FG+++ E++TG+ P S        
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNINNRDQI 218

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 4e-52
 Identities = 59/196 (30%), Positives = 97/196 (49%), Gaps = 6/196 (3%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
            LG G FG V+         VA+K L   S+  S + F  E   + +++H  LV L    
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
            TQ    +I E++  GSL   L   SG   L+ N+  ++    A+ +A + + N IH ++
Sbjct: 78  -TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNYIHRDL 135

Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           +++N+L+  +   K+ D+GLARL+   + Y      +  + + APE        T K DV
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEA-INYGTFTIKSDV 193

Query: 877 YGFGVLVLEVVTGKRP 892
           + FG+L+ E+VT  R 
Sbjct: 194 WSFGILLTEIVTHGRI 209

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 1e-51
 Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 4/225 (1%)

Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
            LG G +G V   V R     VA+K + +   V   E+ ++E+     + H N+V   G+
Sbjct: 12  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
               ++Q L  E+ SGG L   +    G   +   +           + +LH   I H +
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHGIGITHRD 128

Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           IK  N+L+D     K+ D+GLA +    +R  L +K+   L Y+APE   R     +  D
Sbjct: 129 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 188

Query: 876 VYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVS 920
           V+  G+++  ++ G+ P             W E+      W+ + 
Sbjct: 189 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 233

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  180 bits (457), Expect = 3e-51
 Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 14/208 (6%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLE 753
           E+G G FGAVY    +R+   VAIKK++ S    ++  +D  +EV+ L K+RHPN +   
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
           G Y  +    L+ E+  G +             L   E   V  G  + LA+LH  N+IH
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHSHNMIH 138

Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPE--FACRTVKIT 871
            ++K+ N+L+   G  K+GD+G A ++   + +V +        +MAPE   A    +  
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGT------PYWMAPEVILAMDEGQYD 192

Query: 872 DKCDVYGFGVLVLEVVTGKRPLSTWKMM 899
            K DV+  G+  +E+   K PL     M
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMNAM 220

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 2e-50
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 7/207 (3%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           ELG G FG V     R    VAIK +   S+  S+++F  E K +  + H  LV L G  
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             Q    +I E+++ G L  +L E          +   + +   +++ +L     +H ++
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESKQFLHRDL 126

Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
            + N L++  G  KV D+GL+R +   D Y  S   +  + +  PE      K + K D+
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEV-LMYSKFSSKSDI 184

Query: 877 YGFGVLVLEVVT-GKRPLSTWKMMWWF 902
           + FGVL+ E+ + GK P   +      
Sbjct: 185 WAFGVLMWEIYSLGKMPYERFTNSETA 211

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 6e-50
 Identities = 59/234 (25%), Positives = 108/234 (46%), Gaps = 13/234 (5%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           E+G G FG V+     +   VAIK +   ++  S+EDF  E + + K+ HP LV L G  
Sbjct: 12  EIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             Q+   L++EF+  G L  +L   +     +      +     + +A+L ++ +IH ++
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127

Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
            + N L+  +   KV D+G+ R +   D+Y  S+  +  + + +PE      + + K DV
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEV-FSFSRYSSKSDV 185

Query: 877 YGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVS------MRSC 924
           + FGVL+ EV +  +     +      V  +   ++  + R  S      M  C
Sbjct: 186 WSFGVLMWEVFSEGKIPYENRSNSEV-VEDISTGFRLYKPRLASTHVYQIMNHC 238

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 1e-49
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 9/217 (4%)

Query: 691 LLNKDCELGRGGFGAVYRTVLR---DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHP 747
           LL  D ELG G FG+V + V R       VAIK L   +     E+  RE + + ++ +P
Sbjct: 10  LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 69

Query: 748 NLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH 807
            +V L G    ++L +L+ E   GG LHK L        +  +    ++   +  + +L 
Sbjct: 70  YIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLE 126

Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY-VLSSKIQSALGYMAPEFACR 866
           + N +H ++ + NVL+      K+ D+GL++ L   D Y    S  +  L + APE    
Sbjct: 127 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC-IN 185

Query: 867 TVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWF 902
             K + + DV+ +GV + E ++ G++P    K     
Sbjct: 186 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 222

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 2e-49
 Identities = 46/199 (23%), Positives = 93/199 (46%), Gaps = 10/199 (5%)

Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           ELG G  G V++   +  G  +A K + +      +    RE++ L +   P +V   G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN-IIHY 814
           +++     +  E + GGSL + L +      +       V     K L +L + + I+H 
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K SN+L++  GE K+ D+G++  L       +++       YM+PE   +    + + 
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPE-RLQGTHYSVQS 184

Query: 875 DVYGFGVLVLEVVTGKRPL 893
           D++  G+ ++E+  G+ P+
Sbjct: 185 DIWSMGLSLVEMAVGRYPI 203

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 5e-49
 Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 6/196 (3%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +LG+G FG V+         VAIK L   ++  S E F +E + + K+RH  LV L    
Sbjct: 24  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVV 81

Query: 757 WTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNI 816
             + +  ++ E++S GSL   L  G  G +L   +  ++    A  +A++ + N +H ++
Sbjct: 82  SEEPI-YIVTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 139

Query: 817 KSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDV 876
           +++N+L+  +   KV D+GLARL+   + Y      +  + + APE      + T K DV
Sbjct: 140 RAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDV 197

Query: 877 YGFGVLVLEVVTGKRP 892
           + FG+L+ E+ T  R 
Sbjct: 198 WSFGILLTELTTKGRV 213

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  170 bits (432), Expect = 6e-48
 Identities = 50/223 (22%), Positives = 94/223 (42%), Gaps = 28/223 (12%)

Query: 697 ELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ++G G FG V++              VA+K L   +    Q DF+RE   + +  +PN+V
Sbjct: 20  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNF---------------------LSW 789
            L G         L++E+++ G L++ L   S                         LS 
Sbjct: 80  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139

Query: 790 NERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS 849
            E+  + +  A  +A+L +   +H ++ + N L+  +   K+ D+GL+R +   D Y   
Sbjct: 140 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAD 199

Query: 850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
                 + +M PE      + T + DV+ +GV++ E+ +    
Sbjct: 200 GNDAIPIRWMPPESI-FYNRYTTESDVWAYGVVLWEIFSYGLQ 241

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 6e-48
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 10/201 (4%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           ELG G FG VY+   ++     A K +   S  +  ED+  E+  L    HPN+V L   
Sbjct: 19  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           ++ ++   ++ EF +GG++   + E      L+ ++   V + T  +L +LH + IIH +
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDNKIIHRD 135

Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFA----CRTVKIT 871
           +K+ N+L    G+ K+ D+G++                    +MAPE       +     
Sbjct: 136 LKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 193

Query: 872 DKCDVYGFGVLVLEVVTGKRP 892
            K DV+  G+ ++E+   + P
Sbjct: 194 YKADVWSLGITLIEMAEIEPP 214

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 4e-47
 Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 21/236 (8%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
            +G+G FG V     R G  VA+K +       + + F  E   + ++RH NLV L G  
Sbjct: 14  TIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 757 WTQSLQL-LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
             +   L ++ E+++ GSL  +L    G + L  +          +++ +L  +N +H +
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 128

Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + NVL+      KV D+GL +              +  + + APE   R  K + K D
Sbjct: 129 LAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEA-LREKKFSTKSD 182

Query: 876 VYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVS------MRSC 924
           V+ FG+L+ E+ + G+ P     +        +E+ +K              M++C
Sbjct: 183 VWSFGILLWEIYSFGRVPYPRIPLKDVVP--RVEKGYKMDAPDGCPPAVYEVMKNC 236

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 1e-46
 Identities = 51/215 (23%), Positives = 99/215 (46%), Gaps = 11/215 (5%)

Query: 694 KDCELGRGGFGAVYRTVLRD---GRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNL 749
           +D ELG G FG V +   +     + VA+K L   +     +++   E   + ++ +P +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
           V + G    +S  +L+ E    G L+K+L +      +       ++   +  + +L +S
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES 126

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTV 868
           N +H ++ + NVL+      K+ D+GL++ L    + Y   +  +  + + APE      
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC-INYY 185

Query: 869 KITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWF 902
           K + K DV+ FGVL+ E  + G++P    K     
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 220

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 1e-46
 Identities = 49/225 (21%), Positives = 97/225 (43%), Gaps = 9/225 (4%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           ++G+G  G VY    +  G+ VAI+++ +    K +E    E+  + + ++PN+V     
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDS 85

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           Y       ++ E+++GGSL   + E          +   V +   ++L  LH + +IH +
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHSNQVIHRD 141

Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           IKS N+L+   G  K+ D+G    +         S +     +MAPE          K D
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEV-VTRKAYGPKVD 198

Query: 876 VYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVS 920
           ++  G++ +E++ G+ P      +    +       +      +S
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 2e-46
 Identities = 56/256 (21%), Positives = 95/256 (37%), Gaps = 29/256 (11%)

Query: 697 ELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNL 749
            LG G FG V                VA+K L  S+ +  +E    E+K L  +  H N+
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNF---------------LSWNERFN 794
           V L G        L+I E+   G L   L                       L   +  +
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQS 854
                AK +A L   N IH ++ + N+L+      K+ D+GLAR +     YV+    + 
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 209

Query: 855 ALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKA 914
            + +MAPE        T + DV+ +G+ + E+ +          +       ++E ++  
Sbjct: 210 PVKWMAPES-IFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML 268

Query: 915 EWRNVS------MRSC 924
              +        M++C
Sbjct: 269 SPEHAPAEMYDIMKTC 284

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 4e-46
 Identities = 60/235 (25%), Positives = 99/235 (42%), Gaps = 18/235 (7%)

Query: 695 DCELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTL 752
           D E+GRG F  VY+ +  +    VA  +L    L KS+ + F+ E + L  ++HPN+V  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 753 EGYYWTQSLQ----LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
              + +        +L+ E ++ G+L  +L        +      +  +   K L  LH 
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHT 130

Query: 809 SN--IIHYNIKSSNVLIDG-SGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFAC 865
               IIH ++K  N+ I G +G  K+GD GLA L         +  +     +MAPE   
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYE 186

Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVS 920
              K  +  DVY FG+ +LE+ T + P S  +                +  +   
Sbjct: 187 E--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  164 bits (417), Expect = 6e-46
 Identities = 61/241 (25%), Positives = 109/241 (45%), Gaps = 19/241 (7%)

Query: 698 LGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLE 753
           +G G FG V    L+        VAIK L      K + DF  E   +G+  HPN++ LE
Sbjct: 34  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 93

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
           G     +  ++I EF+  GSL   L +  G    +  +   +++G A  + +L   N +H
Sbjct: 94  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQF--TVIQLVGMLRGIAAGMKYLADMNYVH 151

Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLP---MLDRYVLSSKIQSALGYMAPEFACRTVKI 870
            ++ + N+L++ +   KV D+GL+R L        Y  +   +  + + AP  A +  K 
Sbjct: 152 RDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP-EAIQYRKF 210

Query: 871 TDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVS------MRS 923
           T   DV+ +G+++ EV++ G+RP          +   +E+ ++     +        M  
Sbjct: 211 TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN--AIEQDYRLPPPMDCPSALHQLMLD 268

Query: 924 C 924
           C
Sbjct: 269 C 269

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  164 bits (416), Expect = 7e-46
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 6/197 (3%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LG G +G VY  V +     VA+K L   +     E+F +E   + +++HPNLV L G 
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    +I EF++ G+L  +L E      +S      +    + ++ +L + N IH +
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 140

Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           + + N L+  +   KV D+GL+RL+   D Y   +  +  + + APE      K + K D
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPES-LAYNKFSIKSD 198

Query: 876 VYGFGVLVLEVVTGKRP 892
           V+ FGVL+ E+ T    
Sbjct: 199 VWAFGVLLWEIATYGMS 215

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 8e-46
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 11/209 (5%)

Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLE 753
            LG+G FG VY    +     +A+K L  + L K+       REV+    +RHPN++ L 
Sbjct: 13  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
           GY+   +   LI E+   G++++ L + S             I   A +L++ H   +IH
Sbjct: 73  GYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIH 129

Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            +IK  N+L+  +GE K+ D+G +   P   R      +   L Y+ PE         +K
Sbjct: 130 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMI-EGRMHDEK 184

Query: 874 CDVYGFGVLVLEVVTGKRPLSTWKMMWWF 902
            D++  GVL  E + GK P         +
Sbjct: 185 VDLWSLGVLCYEFLVGKPPFEANTYQETY 213

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 9e-46
 Identities = 49/216 (22%), Positives = 95/216 (43%), Gaps = 13/216 (6%)

Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEG 754
            +G G +G   +   + DG+ +  K+L   S+ +++ +    EV  L +++HPN+V    
Sbjct: 11  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70

Query: 755 YYWTQSLQLL--IYEFVSGGSLHKHLHEGS-GGNFLSWNERFNVIQGTAKSLAHLHQ--- 808
               ++   L  + E+  GG L   + +G+    +L       V+     +L   H+   
Sbjct: 71  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130

Query: 809 --SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
               ++H ++K +NV +DG    K+GD+GLAR+L        +        YM+PE    
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKAFVGTPYYMSPEQ-MN 187

Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF 902
            +   +K D++  G L+ E+     P + +      
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA 223

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 2e-45
 Identities = 51/242 (21%), Positives = 89/242 (36%), Gaps = 26/242 (10%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
            +G+G FG V+R   R G  VA+K  +     +     E E+ +   +RH N++      
Sbjct: 10  SIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAAD 66

Query: 757 WTQSLQL----LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS--- 809
              +       L+ ++   GSL  +L+  +    ++      +   TA  LAHLH     
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 810 -----NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY--VLSSKIQSALGYMAPE 862
                 I H ++KS N+L+  +G   + D GLA           +  +       YMAPE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 863 FA-----CRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWR 917
                   +  +   + D+Y  G++  E+          +         +       E R
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242

Query: 918 NV 919
            V
Sbjct: 243 KV 244

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 4e-45
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 9/201 (4%)

Query: 698 LGRGGFGAVYRTVLRDG-----RPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
           +G G FG VY+ +L+        PVAIK L      K + DF  E   +G+  H N++ L
Sbjct: 15  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
           EG        ++I E++  G+L K L E  G    S  +   +++G A  + +L   N +
Sbjct: 75  EGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMNYV 132

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSK-IQSALGYMAPEFACRTVKIT 871
           H ++ + N+L++ +   KV D+GL+R+L        ++   +  + + APE      K T
Sbjct: 133 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA-ISYRKFT 191

Query: 872 DKCDVYGFGVLVLEVVTGKRP 892
              DV+ FG+++ EV+T    
Sbjct: 192 SASDVWSFGIVMWEVMTYGER 212

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 2e-44
 Identities = 56/234 (23%), Positives = 91/234 (38%), Gaps = 29/234 (12%)

Query: 697 ELGRGGFGAVYRTVLRD------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNL 749
            LG G FG V                VA+K L   +    +E    E+K + ++  H N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 750 VTLEGYYWTQSLQLLIYEFVSGGSLHKHLH--------------------EGSGGNFLSW 789
           V L G         LI+E+   G L  +L                     E    N L++
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 790 NERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS 849
            +        AK +  L   + +H ++ + NVL+      K+ D+GLAR +     YV+ 
Sbjct: 164 EDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVR 223

Query: 850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWF 902
              +  + +MAPE        T K DV+ +G+L+ E+ + G  P     +   F
Sbjct: 224 GNARLPVKWMAPESL-FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 276

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  161 bits (409), Expect = 3e-44
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 10/199 (5%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           ELG G FG V+R T    G   A K +        +E   +E++ +  +RHP LV L   
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDA 91

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           +   +  ++IYEF+SGG L + + +      +S +E    ++   K L H+H++N +H +
Sbjct: 92  FEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHENNYVHLD 149

Query: 816 IKSSNVLI--DGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
           +K  N++     S E K+ D+GL      LD             + APE       +   
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPE-VAEGKPVGYY 205

Query: 874 CDVYGFGVLVLEVVTGKRP 892
            D++  GVL   +++G  P
Sbjct: 206 TDMWSVGVLSYILLSGLSP 224

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 5e-44
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 11/203 (5%)

Query: 697 ELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLV 750
           +LG G FG V R            VA+K L    L + +  +DF REV  +  + H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
            L G   T  +  ++ E    GSL   L +  G                A+ + +L    
Sbjct: 75  RLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGMGYLESKR 131

Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPEFACRTVK 869
            IH ++ + N+L+      K+GD+GL R LP   D YV+    +    + AP  + +T  
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP-ESLKTRT 190

Query: 870 ITDKCDVYGFGVLVLEVVTGKRP 892
            +   D + FGV + E+ T  + 
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQE 213

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 1e-43
 Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 10/209 (4%)

Query: 691 LLNKDCELGRGGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH 746
           +++ +  +GRG FG VY   L D        A+K L   + +     F  E   +    H
Sbjct: 28  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 747 PNLVTLEGYYW-TQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAH 805
           PN+++L G    ++   L++  ++  G L   +   +     +  +        AK +  
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKF 145

Query: 806 LHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA--LGYMAPEF 863
           L     +H ++ + N ++D     KV D+GLAR +   +   + +K  +   + +MA E 
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205

Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
             +T K T K DV+ FGVL+ E++T   P
Sbjct: 206 -LQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 2e-43
 Identities = 58/239 (24%), Positives = 96/239 (40%), Gaps = 18/239 (7%)

Query: 697 ELGRGGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTL 752
            +G G FG V++ +          VAIK     +    +E F +E   + +  HP++V L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
            G      +  +I E  + G L   L        L            + +LA+L     +
Sbjct: 74  IGVITENPV-WIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLESKRFV 130

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           H +I + NVL+  +   K+GD+GL+R +     Y  +SK +  + +MAPE      + T 
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPES-INFRRFTS 188

Query: 873 KCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVS------MRSC 924
             DV+ FGV + E++  G +P    K         +E   +     N        M  C
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG--RIENGERLPMPPNCPPTLYSLMTKC 245

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 5e-43
 Identities = 42/199 (21%), Positives = 75/199 (37%), Gaps = 7/199 (3%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLE 753
            LG G F  V     L   R  AIK L    ++K        RE   + ++ HP  V L 
Sbjct: 15  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
             +           +   G L K++ +                     +L +LH   IIH
Sbjct: 75  FTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGKGIIH 131

Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            ++K  N+L++     ++ D+G A++L    +   ++       Y++PE           
Sbjct: 132 RDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL-LTEKSACKS 190

Query: 874 CDVYGFGVLVLEVVTGKRP 892
            D++  G ++ ++V G  P
Sbjct: 191 SDLWALGCIIYQLVAGLPP 209

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 5e-43
 Identities = 49/209 (23%), Positives = 91/209 (43%), Gaps = 14/209 (6%)

Query: 697 ELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV 750
           ELG+G FG VY  V +          VAIK +  ++ ++ + +F  E   + +    ++V
Sbjct: 27  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 86

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNF-------LSWNERFNVIQGTAKSL 803
            L G        L+I E ++ G L  +L                S ++   +    A  +
Sbjct: 87  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146

Query: 804 AHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEF 863
           A+L+ +  +H ++ + N ++      K+GD+G+ R +   D Y    K    + +M+PE 
Sbjct: 147 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 206

Query: 864 ACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
             +    T   DV+ FGV++ E+ T    
Sbjct: 207 L-KDGVFTTYSDVWSFGVVLWEIATLAEQ 234

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 4e-42
 Identities = 53/228 (23%), Positives = 103/228 (45%), Gaps = 12/228 (5%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           +LGRG FG V+R V     +    K + V      Q   ++E+  L   RH N++ L   
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHES 69

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           + +    ++I+EF+SG  + + ++       L+  E  + +    ++L  LH  NI H++
Sbjct: 70  FESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHNIGHFD 127

Query: 816 IKSSNVLID--GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
           I+  N++     S   K+ ++G AR L   D +     + +A  Y APE   +   ++  
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPE-VHQHDVVSTA 183

Query: 874 CDVYGFGVLVLEVVTGKRPLSTWKMM-WWFSVTWLEEHWKKAEWRNVS 920
            D++  G LV  +++G  P           ++   E  + +  ++ +S
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 7e-42
 Identities = 46/212 (21%), Positives = 95/212 (44%), Gaps = 10/212 (4%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
            +G G +G V       +   VAIKK++        +   RE+K L + RH N++ +   
Sbjct: 15  YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74

Query: 756 YWTQSLQ----LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
               +++    + +   + G  L+K L        LS +     +    + L ++H +N+
Sbjct: 75  IRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSANV 130

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLL-PMLDRYVLSSKIQSALGYMAPEFACRTVKI 870
           +H ++K SN+L++ + + K+ D+GLAR+  P  D     ++  +   Y APE    +   
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190

Query: 871 TDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF 902
           T   D++  G ++ E+++ +        +   
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 222

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-41
 Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 9/201 (4%)

Query: 697 ELGRGGFGAVYRTVLRD-----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVT 751
            LG G FG VY+ +          PVAIK+L  ++  K+ ++   E   +  V +P++  
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75

Query: 752 LEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           L G   T ++  LI + +  G L  ++ E             N     AK + +L    +
Sbjct: 76  LLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNYLEDRRL 132

Query: 812 IHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           +H ++ + NVL+      K+ D+GLA+LL   ++   +   +  + +MA E        T
Sbjct: 133 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI-LHRIYT 191

Query: 872 DKCDVYGFGVLVLEVVTGKRP 892
            + DV+ +GV V E++T    
Sbjct: 192 HQSDVWSYGVTVWELMTFGSK 212

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  152 bits (386), Expect = 5e-41
 Identities = 50/230 (21%), Positives = 87/230 (37%), Gaps = 13/230 (5%)

Query: 697 ELGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQED-----FEREVKKLGKVRHPNLV 750
            +GRGGFG VY     D G+  A+K L    +   Q +         +  +     P +V
Sbjct: 11  IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
            +   + T      I + ++GG LH HL +       S  +           L H+H   
Sbjct: 71  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF 127

Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKI 870
           +++ ++K +N+L+D  G  ++ D GLA        +          GYMAPE   + V  
Sbjct: 128 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAPEVLQKGVAY 183

Query: 871 TDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVS 920
               D +  G ++ +++ G  P    K      +  +          + S
Sbjct: 184 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  151 bits (383), Expect = 9e-41
 Identities = 55/228 (24%), Positives = 103/228 (45%), Gaps = 11/228 (4%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           ELG G FG V+R V    GR    K +     +  +   + E+  + ++ HP L+ L   
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHPKLINLHDA 94

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           +  +   +LI EF+SGG L   +        +S  E  N ++   + L H+H+ +I+H +
Sbjct: 95  FEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMHEHSIVHLD 152

Query: 816 IKSSNVLID--GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
           IK  N++ +   +   K+ D+GLA     L+   +     +   + APE   R   +   
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATAEFAAPEIVDRE-PVGFY 208

Query: 874 CDVYGFGVLVLEVVTGKRPLSTWKMM-WWFSVTWLEEHWKKAEWRNVS 920
            D++  GVL   +++G  P +    +    +V   +  + +  + +VS
Sbjct: 209 TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 256

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  150 bits (379), Expect = 9e-41
 Identities = 57/229 (24%), Positives = 98/229 (42%), Gaps = 12/229 (5%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
            LG G F  V      R  + VAIK +   +L   +   E E+  L K++HPN+V L+  
Sbjct: 16  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           Y +     LI + VSGG L   + E     F +  +   +I     ++ +LH   I+H +
Sbjct: 76  YESGGHLYLIMQLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLGIVHRD 132

Query: 816 IKSSNVLI---DGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           +K  N+L    D   +  + D+GL+++       VLS+   +  GY+AP         + 
Sbjct: 133 LKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGT-PGYVAP-EVLAQKPYSK 188

Query: 873 KCDVYGFGVLVLEVVTGKRPLSTWKMM-WWFSVTWLEEHWKKAEWRNVS 920
             D +  GV+   ++ G  P         +  +   E  +    W ++S
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS 237

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  148 bits (375), Expect = 2e-40
 Identities = 47/197 (23%), Positives = 86/197 (43%), Gaps = 6/197 (3%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEGY 755
           ++G G +G VY+     G   A+KK+ +    +       RE+  L +++H N+V L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
             T+   +L++E +             G   L      + +      +A+ H   ++H +
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHDRRVLHRD 125

Query: 816 IKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCD 875
           +K  N+LI+  GE K+ D+GLAR   +  R      +   L Y AP+    + K +   D
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT--LWYRAPDVLMGSKKYSTTID 183

Query: 876 VYGFGVLVLEVVTGKRP 892
           ++  G +  E+V G   
Sbjct: 184 IWSVGCIFAEMVNGTPL 200

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 2e-40
 Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 21/213 (9%)

Query: 697 ELGRGGFGAVYRTVLRDG---RPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTL 752
            +G G FG V +  ++        AIK++   +      DF  E++ L K+  HPN++ L
Sbjct: 17  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 76

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHE-------------GSGGNFLSWNERFNVIQGT 799
            G    +    L  E+   G+L   L +              S  + LS  +  +     
Sbjct: 77  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 136

Query: 800 AKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYM 859
           A+ + +L Q   IH ++ + N+L+  +   K+ D+GL+R     + YV  +  +  + +M
Sbjct: 137 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWM 193

Query: 860 APEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
           A E        T   DV+ +GVL+ E+V+    
Sbjct: 194 AIES-LNYSVYTTNSDVWSYGVLLWEIVSLGGT 225

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  146 bits (370), Expect = 7e-40
 Identities = 55/240 (22%), Positives = 101/240 (42%), Gaps = 22/240 (9%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKS--------QEDFEREVKKLGKVR-H 746
            LGRG    V R       +  A+K + V+             +E   +EV  L KV  H
Sbjct: 10  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69

Query: 747 PNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHL 806
           PN++ L+  Y T +   L+++ +  G L  +L E      LS  E   +++   + +  L
Sbjct: 70  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICAL 126

Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFAC- 865
           H+ NI+H ++K  N+L+D     K+ D+G +  L   ++     ++     Y+APE    
Sbjct: 127 HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIEC 183

Query: 866 ----RTVKITDKCDVYGFGVLVLEVVTGKRPL-STWKMMWWFSVTWLEEHWKKAEWRNVS 920
                      + D++  GV++  ++ G  P     +M+    +      +   EW + S
Sbjct: 184 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS 243

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 2e-39
 Identities = 62/257 (24%), Positives = 104/257 (40%), Gaps = 32/257 (12%)

Query: 697 ELGRGGFGAVYRTVLR--------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHP 747
            LG G FG V                  VA+K L   +  K   D   E++ +  + +H 
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 748 NLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH-------------EGSGGNFLSWNERFN 794
           N++ L G         +I E+ S G+L ++L                +    LS  +  +
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 795 VIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQS 854
                A+ + +L     IH ++ + NVL+      K+ D+GLAR +  +D Y  ++  + 
Sbjct: 140 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 199

Query: 855 ALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWLEEHWKK 913
            + +MAPE        T + DV+ FGVL+ E+ T G  P     +   F    L+E  + 
Sbjct: 200 PVKWMAPEA-LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--LLKEGHRM 256

Query: 914 AEWRNVS------MRSC 924
            +  N +      MR C
Sbjct: 257 DKPSNCTNELYMMMRDC 273

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  142 bits (359), Expect = 2e-38
 Identities = 57/233 (24%), Positives = 101/233 (43%), Gaps = 13/233 (5%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLE 753
            LG GG   V+    LR  R VA+K L             F RE +    + HP +V + 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 754 GYYWTQS----LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
                ++    L  ++ E+V G +L   +H       ++      VI    ++L   HQ+
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQN 130

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM-LDRYVLSSKIQSALGYMAPEFACRTV 868
            IIH ++K +N++I  +   KV D+G+AR +    +    ++ +     Y++PE A R  
Sbjct: 131 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA-RGD 189

Query: 869 KITDKCDVYGFGVLVLEVVTGKRPLSTWKMM-WWFSVTWLEEHWKKAEWRNVS 920
            +  + DVY  G ++ EV+TG+ P +    +   +     +     A    +S
Sbjct: 190 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 3e-38
 Identities = 49/198 (24%), Positives = 87/198 (43%), Gaps = 6/198 (3%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEG 754
           ++G G +G VY+      G  VA+KK+ + +  +       RE+  L ++ HPN+V L  
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
              T++   L++EF+              G  +      + +    + LA  H   ++H 
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHSHRVLHR 126

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LI+  G  K+ D+GLAR   +  R      +   L Y APE        +   
Sbjct: 127 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT--LWYRAPEILLGCKYYSTAV 184

Query: 875 DVYGFGVLVLEVVTGKRP 892
           D++  G +  E+VT +  
Sbjct: 185 DIWSLGCIFAEMVTRRAL 202

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  140 bits (355), Expect = 2e-37
 Identities = 51/199 (25%), Positives = 87/199 (43%), Gaps = 12/199 (6%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLE 753
            LG G FG V+      +GR  A+K L    +V+ +  E    E   L  V HP ++ + 
Sbjct: 11  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
           G +       +I +++ GG L   L +                     +L +LH  +II+
Sbjct: 71  GTFQDAQQIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKDIIY 127

Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            ++K  N+L+D +G  K+ D+G A+ +P +   +          Y+APE    T      
Sbjct: 128 RDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL-----CGTPDYIAPEV-VSTKPYNKS 181

Query: 874 CDVYGFGVLVLEVVTGKRP 892
            D + FG+L+ E++ G  P
Sbjct: 182 IDWWSFGILIYEMLAGYTP 200

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 2e-37
 Identities = 49/237 (20%), Positives = 91/237 (38%), Gaps = 25/237 (10%)

Query: 698 LGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGY 755
           LG G  G V +    R     A+K L      +      REV+   +  + P++V +   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKML------QDCPKARREVELHWRASQCPHIVRIVDV 73

Query: 756 YWTQSLQ----LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNI 811
           Y          L++ E + GG L   + +  G    +  E   +++   +++ +LH  NI
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHSINI 132

Query: 812 IHYNIKSSNVLID---GSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTV 868
            H ++K  N+L      +   K+ D+G A+     +             Y+APE      
Sbjct: 133 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLGPE- 188

Query: 869 KITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS-----VTWLEEHWKKAEWRNVS 920
           K    CD++  GV++  ++ G  P  +   +         +   +  +   EW  VS
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 2e-37
 Identities = 54/251 (21%), Positives = 98/251 (39%), Gaps = 22/251 (8%)

Query: 698 LGRGGFGAVYRTVLRD-GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYY 756
           +G G FG VY+  L D G  VAIKK+      + +    RE++ + K+ H N+V L  ++
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIVRLRYFF 82

Query: 757 WTQSLQ------LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           ++   +       L+ ++V         H       L        +    +SLA++H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142

Query: 811 IIHYNIKSSNVLIDGSGE-PKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           I H +IK  N+L+D      K+ D+G A+ L   +  V       +  Y APE       
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---SYICSRYYRAPELIFGATD 199

Query: 870 ITDKCDVYGFGVLVLEVVTGKRP------LSTWKMMWWFSVTWLEEHWKKAEWRNVSMRS 923
            T   DV+  G ++ E++ G+        +     +     T   E  ++        + 
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 259

Query: 924 CKGSSRQRRRF 934
            +  +    + 
Sbjct: 260 PQIKAHPWTKV 270

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 7e-37
 Identities = 48/200 (24%), Positives = 83/200 (41%), Gaps = 10/200 (5%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKV-RHPNLVTL 752
            LG+G FG V+     +  +  AIK L    ++     E    E + L     HP L  +
Sbjct: 9   MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
              + T+     + E+++GG L  H+      +    +            L  LH   I+
Sbjct: 69  FCTFQTKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKGIV 125

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           + ++K  N+L+D  G  K+ D+G+ +   + D     +       Y+APE      K   
Sbjct: 126 YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEI-LLGQKYNH 182

Query: 873 KCDVYGFGVLVLEVVTGKRP 892
             D + FGVL+ E++ G+ P
Sbjct: 183 SVDWWSFGVLLYEMLIGQSP 202

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 8e-37
 Identities = 60/228 (26%), Positives = 87/228 (38%), Gaps = 23/228 (10%)

Query: 697 ELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGK-VRHPNL 749
            LGRG FG V              R VA+K L   +          E+K L     H N+
Sbjct: 20  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79

Query: 750 VTLEGYYWTQSLQLLI-YEFVSGGSLHKHLH-------------EGSGGNFLSWNERFNV 795
           V L G        L++  EF   G+L  +L              E    +FL+       
Sbjct: 80  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139

Query: 796 IQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA 855
               AK +  L     IH ++ + N+L+      K+ D+GLAR +     YV     +  
Sbjct: 140 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 199

Query: 856 LGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKR-PLSTWKMMWWF 902
           L +MAPE        T + DV+ FGVL+ E+ +    P    K+   F
Sbjct: 200 LKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 3e-36
 Identities = 48/202 (23%), Positives = 91/202 (45%), Gaps = 10/202 (4%)

Query: 698 LGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQED----FEREVKKLGKVRHPNLVTL 752
           LG G F  VY+   +   + VAIKK+ +    ++++       RE+K L ++ HPN++ L
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 753 EGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
              +  +S   L+++F+        +        L+ +     +  T + L +LHQ  I+
Sbjct: 66  LDAFGHKSNISLVFDFMET---DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122

Query: 813 HYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITD 872
           H ++K +N+L+D +G  K+ D+GLA+           +       Y APE          
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELLFGARMYGV 180

Query: 873 KCDVYGFGVLVLEVVTGKRPLS 894
             D++  G ++ E++     L 
Sbjct: 181 GVDMWAVGCILAELLLRVPFLP 202

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 3e-36
 Identities = 60/235 (25%), Positives = 104/235 (44%), Gaps = 18/235 (7%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQ-----EDFEREVKKLGKVRHPNLV 750
           ELG G F  V +      G   A K +       S+     ED EREV  L +++HPN++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 751 TLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
           TL   Y  ++  +LI E V+GG L   L E      L+  E    ++     + +LH   
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHSLQ 133

Query: 811 IIHYNIKSSNVLIDGSGEP----KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACR 866
           I H+++K  N+++     P    K+ D+GLA  +   + +     I     ++APE    
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEI-VN 189

Query: 867 TVKITDKCDVYGFGVLVLEVVTGKRP-LSTWKMMWWFSVTWLEEHWKKAEWRNVS 920
              +  + D++  GV+   +++G  P L   K     +V+ +   ++   + N S
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 6e-36
 Identities = 50/205 (24%), Positives = 80/205 (39%), Gaps = 15/205 (7%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSL-----VKSQEDFEREVKKLGKVR--HPN 748
            LG GGFG+VY  + + D  PVAIK +    +     + +      EV  L KV      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           ++ L  ++      +LI E               G   L      +      +++ H H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHN 128

Query: 809 SNIIHYNIKSSNVLIDGS-GEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRT 867
             ++H +IK  N+LID + GE K+ D+G   LL         +       Y  PE+    
Sbjct: 129 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYH 184

Query: 868 VKITDKCDVYGFGVLVLEVVTGKRP 892
                   V+  G+L+ ++V G  P
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIP 209

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (339), Expect = 1e-35
 Identities = 51/226 (22%), Positives = 90/226 (39%), Gaps = 14/226 (6%)

Query: 697 ELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEG 754
           ++G G +G V++   R     VA+K++ +    +       RE+  L +++H N+V L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68

Query: 755 YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHY 814
              +     L++EF                  L      + +    K L   H  N++H 
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRNVLHR 125

Query: 815 NIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKC 874
           ++K  N+LI+ +GE K+ ++GLAR   +  R    S     L Y  P+        +   
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSI 183

Query: 875 DVYGFGVLVLEVVTGKRPL-------STWKMMWWFSVTWLEEHWKK 913
           D++  G +  E+    RPL          K ++    T  EE W  
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (339), Expect = 1e-35
 Identities = 41/247 (16%), Positives = 82/247 (33%), Gaps = 18/247 (7%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
           ++G G FG +Y  T +  G  VAIK   V            E K    ++    +    +
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVK---TKHPQLHIESKIYKMMQGGVGIPTIRW 70

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
              +    ++   + G SL    +  S     S      +       + ++H  N IH +
Sbjct: 71  CGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHSKNFIHRD 128

Query: 816 IKSSNVLI---DGSGEPKVGDYGLARLLP-----MLDRYVLSSKIQSALGYMAPEFACRT 867
           +K  N L+          + D+GLA+            Y  +  +     Y +       
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN-THLG 187

Query: 868 VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVSMRSCKGS 927
           ++ + + D+   G +++    G  P   W+ +   +     E   + +        CKG 
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLP---WQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244

Query: 928 SRQRRRF 934
             +   +
Sbjct: 245 PSEFATY 251

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 6e-35
 Identities = 49/219 (22%), Positives = 94/219 (42%), Gaps = 15/219 (6%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKS-QEDFEREVKKLGKVRHPNLVTLEG 754
           ++G+G FG V++    + G+ VA+KK+ + +  +       RE+K L  ++H N+V L  
Sbjct: 17  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76

Query: 755 YYWTQSLQ--------LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHL 806
              T++           L+++F          +        + +E   V+Q     L ++
Sbjct: 77  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYI 133

Query: 807 HQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSA--LGYMAPEFA 864
           H++ I+H ++K++NVLI   G  K+ D+GLAR   +      +        L Y  PE  
Sbjct: 134 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193

Query: 865 CRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS 903
                     D++G G ++ E+ T    +         +
Sbjct: 194 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 232

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-34
 Identities = 49/207 (23%), Positives = 83/207 (40%), Gaps = 17/207 (8%)

Query: 697 ELGRGGFGAVY--RTVLRDGRPVAIKKLTVSSLVKSQE-DFEREV---KKLGKVRHPNLV 750
           E+G G +G V+  R +   GR VA+K++ V +  +       REV   + L    HPN+V
Sbjct: 14  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73

Query: 751 TLEGYYWTQSLQ-----LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAH 805
            L                L++E V              G  +      +++    + L  
Sbjct: 74  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGLDF 131

Query: 806 LHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFAC 865
           LH   ++H ++K  N+L+  SG+ K+ D+GLAR+          + +   L Y APE   
Sbjct: 132 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYRAPEV-L 187

Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRP 892
                    D++  G +  E+   K  
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPL 214

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 1e-33
 Identities = 56/251 (22%), Positives = 99/251 (39%), Gaps = 20/251 (7%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEG 754
            +G G +GAV   V  R G  VAIKKL      +   +   RE++ L  +RH N++ L  
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 755 YYWTQSLQLLIYEFV----SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN 810
            +          +F       G+    L +      L  +    ++    K L ++H + 
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK---LGEDRIQFLVYQMLKGLRYIHAAG 141

Query: 811 IIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKI 870
           IIH ++K  N+ ++   E K+ D+GLAR           +       Y APE     ++ 
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRY 196

Query: 871 TDKCDVYGFGVLVLEVVTGKRP------LSTWKMMWWFSVTWLEEHWKKAEWRNVSMRSC 924
           T   D++  G ++ E++TGK        L   K +   + T   E  ++ +         
Sbjct: 197 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 256

Query: 925 KGSSRQRRRFQ 935
                +++ F 
Sbjct: 257 GLPELEKKDFA 267

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  131 bits (329), Expect = 1e-33
 Identities = 53/229 (23%), Positives = 87/229 (37%), Gaps = 18/229 (7%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQ--EDFEREVKKLGKVRHPNLVTLE 753
            LG G FG V        G   A+K L    +VK +  E    E + L  V  P LV LE
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
             +   S   ++ E+V+GG +  HL         S             +  +LH  ++I+
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLDLIY 164

Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            ++K  N+LID  G  +V D+G A+ +      +           +APE    +      
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL-----CGTPEALAPEI-ILSKGYNKA 218

Query: 874 CDVYGFGVLVLEVVTGKRP------LSTWKMMWWFSVTWLEEHWKKAEW 916
            D +  GVL+ E+  G  P      +  ++ +    V +        + 
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKD 267

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 5e-33
 Identities = 48/199 (24%), Positives = 79/199 (39%), Gaps = 9/199 (4%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQE--DFEREVKKLGKVRHPNLVTLE 753
            LG+G FG V        GR  A+K L    ++   E      E + L   RHP L  L+
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 754 GYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIH 813
             + T      + E+ +GG L  HL         +             +L +LH  ++++
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRDVVY 128

Query: 814 YNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDK 873
            +IK  N+++D  G  K+ D+GL +                   Y+AP            
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAP-EVLEDNDYGRA 185

Query: 874 CDVYGFGVLVLEVVTGKRP 892
            D +G GV++ E++ G+ P
Sbjct: 186 VDWWGLGVVMYEMMCGRLP 204

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  125 bits (315), Expect = 2e-32
 Identities = 41/249 (16%), Positives = 90/249 (36%), Gaps = 20/249 (8%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGY 755
            +G G FG ++  T L + + VAIK     S          E +    +     +    Y
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYY 68

Query: 756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYN 815
           +  + L  ++   + G SL   L     G   S        +     +  +H+ ++++ +
Sbjct: 69  FGQEGLHNVLVIDLLGPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRD 126

Query: 816 IKSSNVLID-----GSGEPKVGDYGLARLL--PMLDRYVLSSKIQSALG---YMAPEFAC 865
           IK  N LI       +    V D+G+ +    P+  +++   + ++  G   YM+     
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN-TH 185

Query: 866 RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNVSMRSCK 925
              + + + D+   G + +  + G  P   W+ +   +     E   + +        C 
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLP---WQGLKAATNKQKYERIGEKKQSTPLRELCA 242

Query: 926 GSSRQRRRF 934
           G   +  ++
Sbjct: 243 GFPEEFYKY 251

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 8e-32
 Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 11/204 (5%)

Query: 697 ELGRGGFGAVYR----TVLRDGRPVAIKKLTVSSLV---KSQEDFEREVKKLGKVRH-PN 748
            LG G +G V+     +    G+  A+K L  +++V   K+ E    E + L  +R  P 
Sbjct: 31  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90

Query: 749 LVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
           LVTL   + T++   LI ++++GG L  HL +       + +E    +     +L HLH+
Sbjct: 91  LVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHK 147

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTV 868
             II+ +IK  N+L+D +G   + D+GL++     +         +              
Sbjct: 148 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDS 207

Query: 869 KITDKCDVYGFGVLVLEVVTGKRP 892
                 D +  GVL+ E++TG  P
Sbjct: 208 GHDKAVDWWSLGVLMYELLTGASP 231

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 3e-31
 Identities = 50/252 (19%), Positives = 101/252 (40%), Gaps = 22/252 (8%)

Query: 697 ELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEG 754
            +G G +G+V      + G  VA+KKL+     +   +   RE++ L  ++H N++ L  
Sbjct: 25  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84

Query: 755 YYWTQS-----LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS 809
            +           + +   + G  L+  +        L+ +    +I    + L ++H +
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----LTDDHVQFLIYQILRGLKYIHSA 140

Query: 810 NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVK 869
           +IIH ++K SN+ ++   E K+ D+GLAR           +   +   Y APE     + 
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMH 195

Query: 870 ITDKCDVYGFGVLVLEVVTGKRP------LSTWKMMWWFSVTWLEEHWKKAEWRNVSMRS 923
                D++  G ++ E++TG+        +   K++     T   E  KK    +     
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255

Query: 924 CKGSSRQRRRFQ 935
              +   +  F 
Sbjct: 256 QSLTQMPKMNFA 267

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  120 bits (302), Expect = 2e-30
 Identities = 42/206 (20%), Positives = 84/206 (40%), Gaps = 18/206 (8%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEG 754
           +LGRG +  V+  + + +   V +K L        ++  +RE+K L  +R  PN++TL  
Sbjct: 42  KLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLAD 97

Query: 755 YYWTQSLQL--LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNII 812
                  +   L++E V+     +          L+  +    +    K+L + H   I+
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMGIM 151

Query: 813 HYNIKSSNVLIDGSG-EPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKIT 871
           H ++K  NV+ID    + ++ D+GLA        Y   +   ++  +  PE         
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYD 208

Query: 872 DKCDVYGFGVLVLEVVTGKRPLSTWK 897
              D++  G ++  ++  K P     
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGH 234

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  120 bits (300), Expect = 2e-30
 Identities = 82/309 (26%), Positives = 122/309 (39%), Gaps = 14/309 (4%)

Query: 34  DDVLGLIVFKADIQDPNGKLSSWSEDDDTPCN--WFGVKCSPRSN--RVIELTLNGLSLT 89
            D   L+  K D+ +P   LSSW    D  CN  W GV C   +   RV  L L+GL+L 
Sbjct: 6   QDKQALLQIKKDLGNPT-TLSSWLPTTD-CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63

Query: 90  GR--IGRGLLQLQFLRKLSLSSN-NLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFK 146
               I   L  L +L  L +    NL G I P +AKL  L  + ++  +       +F  
Sbjct: 64  KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN-VSGAIPDFLS 122

Query: 147 QCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRT-LDLS 205
           Q  +L  +  + N  SG +P S+S    L  I    NR S  +P      S L T + +S
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182

Query: 206 DNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETM 265
            N L G+IP                          +              +        +
Sbjct: 183 RNRLTGKIPP--TFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV 240

Query: 266 QKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFS 325
                 N ++LR N   G +P+ + +L+ L +L++S N   G +P   GNLQR  V  ++
Sbjct: 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYA 299

Query: 326 ANRLTGSLP 334
            N+     P
Sbjct: 300 NNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 74.4 bits (181), Expect = 7e-15
 Identities = 58/263 (22%), Positives = 96/263 (36%), Gaps = 10/263 (3%)

Query: 295 LETLDLSGNKFSGAVPI--SIGNLQRLKVLNFSAN-RLTGSLPDSMANCMNLVALDFSQN 351
           +  LDLSG       PI  S+ NL  L  L       L G +P ++A    L  L  +  
Sbjct: 52  VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111

Query: 352 SMNGDLPQ-WIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPA 410
           +++G +P        L  + F+ N +   +        SS  +L  +    N  SG  P 
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI----SSLPNLVGITFDGNRISGAIPD 167

Query: 411 TIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELR 470
           + G+ S L        + +            L  +DLS N         + G+    +  
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM-LEGDASVLFGSDKNTQKI 226

Query: 471 LERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPK 530
                        +    +L  L L  N + G +P  + +L  L ++++SFN+L G +P 
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP- 285

Query: 531 QLVNLVHLSSFNISHNHLQGELP 553
           Q  NL        ++N      P
Sbjct: 286 QGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 41.3 bits (95), Expect = 4e-04
 Identities = 37/140 (26%), Positives = 62/140 (44%), Gaps = 3/140 (2%)

Query: 386 SSGSSFESLQFLDLSHNEFSG--ETPATIGALSGLQLLNLSRN-SLVGPIPVAIGDLKAL 442
            + +    +  LDLS          P+++  L  L  L +    +LVGPIP AI  L  L
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103

Query: 443 NVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTG 502
           + L ++   ++G+IP  +    +L  L    N L+G +P SI +  +LV +    N ++G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163

Query: 503 PIPIAIAKLTNLQNVDLSFN 522
            IP +    + L        
Sbjct: 164 AIPDSYGSFSKLFTSMTISR 183

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 40.5 bits (93), Expect = 7e-04
 Identities = 44/175 (25%), Positives = 74/175 (42%), Gaps = 7/175 (4%)

Query: 375 KIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVG--PI 432
           +I++ +  P   S     +    D  +  + G    T      +  L+LS  +L    PI
Sbjct: 13  QIKKDLGNPTTLSSWLPTT----DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPI 68

Query: 433 PVAIGDLKALNVLDLSENW-LNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLV 491
           P ++ +L  LN L +     L G IPP I     L  L +    ++G IP  +    +LV
Sbjct: 69  PSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128

Query: 492 SLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHN 546
           +L  S N L+G +P +I+ L NL  +    N ++G +P    +   L +      
Sbjct: 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 6e-28
 Identities = 50/235 (21%), Positives = 85/235 (36%), Gaps = 24/235 (10%)

Query: 697 ELGRGGFGAVYRTV-LRDGRPVAIKKLTVSSLVKSQ-EDFEREVKKLGKVRHPNLVTLEG 754
            +G G  G V         R VAIKKL+     ++  +   RE+  +  V H N+++L  
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 755 YYWTQS------LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ 808
            +  Q          L+ E +          E              ++      + HLH 
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLCGIKHLHS 137

Query: 809 SNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTV 868
           + IIH ++K SN+++      K+ D+GLAR           +       Y APE     +
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEV-ILGM 193

Query: 869 KITDKCDVYGFGVLVLEVVTGKRP------LSTWKMMWWFSVTWLEEHWKKAEWR 917
              +  D++  G ++ E+V  K        +  W  +     T   E  KK +  
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  108 bits (270), Expect = 8e-26
 Identities = 68/397 (17%), Positives = 129/397 (32%), Gaps = 37/397 (9%)

Query: 78  VIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLS 137
            ++  L   ++T  +      L  +  L      +  SI   +  L NL  I+ S N L+
Sbjct: 24  KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLT 79

Query: 138 GSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLS 197
              P    K    L  I +  N+ +   P +     T  T+  +      PL        
Sbjct: 80  DITP---LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL-- 134

Query: 198 ALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSF 257
               L+LS N +         +                         +L        +S 
Sbjct: 135 --NRLELSSNTISDISALSGLTSLQQLSFGNQVTDL-------KPLANLTTLERLDISSN 185

Query: 258 SGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQ 317
             +    + KL+    +    N  S   P  I    +L+ L L+GN+       ++ +L 
Sbjct: 186 KVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLT 241

Query: 318 RLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIR 377
            L  L+ + N+++   P  ++    L  L    N ++   P    ++  N          
Sbjct: 242 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLED 299

Query: 378 EGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIG 437
                         ++L +L L  N  S  +P  + +L+ LQ L  + N +      ++ 
Sbjct: 300 ISPISN-------LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLA 348

Query: 438 DLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERN 474
           +L  +N L    N ++   P  +     + +L L   
Sbjct: 349 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  105 bits (261), Expect = 1e-24
 Identities = 78/407 (19%), Positives = 157/407 (38%), Gaps = 39/407 (9%)

Query: 140 IPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSAL 199
             D    +        L K   +  +  S +    + T+        S +  G+  L+ L
Sbjct: 16  FTDTALAE---KMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS-ID-GVEYLNNL 68

Query: 200 RTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSG 259
             ++ S+N L    P  +++L  L  I ++ N  +   P    +     T+  ++ +   
Sbjct: 69  TQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDID 126

Query: 260 NLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRL 319
            L        L    N   ++ +      +                       + NL  L
Sbjct: 127 PLKNLTNLNRLELSSNTISDISALSGLTSL---------QQLSFGNQVTDLKPLANLTTL 177

Query: 320 KVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREG 379
           + L+ S+N+++      +A   NL +L  + N ++   P  I ++ L+++S   N++++ 
Sbjct: 178 ERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILTN-LDELSLNGNQLKD- 233

Query: 380 MNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDL 439
                  + +S  +L  LDL++N+ S   P  +  L+ L  L L  N +    P  +  L
Sbjct: 234 -----IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGL 284

Query: 440 KALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNN 499
            AL  L+L+EN L    P       +L  L L  N ++   P  + + + L  L  + N 
Sbjct: 285 TALTNLELNENQLEDISPISN--LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNK 340

Query: 500 LTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHN 546
           ++     ++A LTN+  +    N ++   P  L NL  ++   ++  
Sbjct: 341 VSDVS--SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 89.3 bits (220), Expect = 2e-19
 Identities = 59/323 (18%), Positives = 108/323 (33%), Gaps = 66/323 (20%)

Query: 289 IGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNL----- 343
           +  L +L  ++ S N+ +   P  + NL +L  +  + N++    P +    +       
Sbjct: 62  VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 119

Query: 344 -----------------------------VALDFSQNSMNGDLPQWIFSSGLNKVSFAEN 374
                                             +         Q      L  ++  E 
Sbjct: 120 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179

Query: 375 KIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPV 434
                      S  +   +L+ L  ++N+ S  TP  I   + L  L+L+ N L      
Sbjct: 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDIGT- 236

Query: 435 AIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIP------------- 481
            +  L  L  LDL+ N ++   P  + G   L EL+L  N ++   P             
Sbjct: 237 -LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELN 293

Query: 482 -------TSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVN 534
                  + I N  +L  L L  NN++   P  ++ LT LQ +  + N ++      L N
Sbjct: 294 ENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLAN 349

Query: 535 LVHLSSFNISHNHLQGELPAGGF 557
           L +++  +  HN +    P    
Sbjct: 350 LTNINWLSAGHNQISDLTPLANL 372

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 69.6 bits (169), Expect = 5e-13
 Identities = 57/331 (17%), Positives = 105/331 (31%), Gaps = 70/331 (21%)

Query: 275 NLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPIS-IGNLQRLKVLNFSANRLTGSL 333
            L K   +  V +   +L+ + TL            I  +  L  L  +NFS N+LT   
Sbjct: 28  VLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS---IDGVEYLNNLTQINFSNNQLTDIT 82

Query: 334 PDSMANCMNLVALDFSQNSMNGDLPQWIFSS----------------------------G 365
           P  + N   LV +  + N +    P    ++                             
Sbjct: 83  P--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELS 140

Query: 366 LNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEF------SGETPATIGALSGLQ 419
            N +S              +      +     +L+  E            + +  L+ L+
Sbjct: 141 SNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLE 200

Query: 420 LLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGK 479
            L  + N +    P+ I     L+ L L+ N L       +    +L +L L  N ++  
Sbjct: 201 SLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNL 256

Query: 480 IPTSIENCSSLVSLILSKNNLTGPIPI--------------------AIAKLTNLQNVDL 519
            P  +   + L  L L  N ++   P+                     I+ L NL  + L
Sbjct: 257 AP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTL 314

Query: 520 SFNSLTGGLPKQLVNLVHLSSFNISHNHLQG 550
            FN+++   P  + +L  L     ++N +  
Sbjct: 315 YFNNISDISP--VSSLTKLQRLFFANNKVSD 343

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 58.1 bits (139), Expect = 2e-09
 Identities = 17/111 (15%), Positives = 39/111 (35%), Gaps = 7/111 (6%)

Query: 49  PNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLS 108
           P   L++ +  +        +        +  LTL   +++      +  L  L++L  +
Sbjct: 280 PLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFA 337

Query: 109 SNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKN 159
           +N ++     +LA L N+  +    N +S   P         +  + L   
Sbjct: 338 NNKVSDV--SSLANLTNINWLSAGHNQISDLTP---LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.1 bits (95), Expect = 5e-04
 Identities = 12/75 (16%), Positives = 24/75 (32%), Gaps = 4/75 (5%)

Query: 485 ENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNIS 544
              +  +  +L K N+T  +      L  +  +      +       +  L +L+  N S
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFS 74

Query: 545 HNHLQGELPAGGFFN 559
           +N L    P      
Sbjct: 75  NNQLTDITPLKNLTK 89

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  102 bits (253), Expect = 9e-24
 Identities = 41/229 (17%), Positives = 78/229 (34%), Gaps = 23/229 (10%)

Query: 680 GDPDFSTGTHALLNKDCELGRGGFGAVYR-TVLRDGRPVAIKKLTVSSLVKSQEDFEREV 738
           G+P +    + L+ K   LG G F  V+    + +   VA+K +    +    E  E E+
Sbjct: 7   GEP-YKDARYILVRK---LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT--EAAEDEI 60

Query: 739 KKLGKVRHPNLVTLEG-------------YYWTQSLQLLIYEFVSGGSLHKHLHEGSGGN 785
           K L +V   +    +               +   +   ++  F   G     L +     
Sbjct: 61  KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR 120

Query: 786 FLSWNERFNVIQGTAKSLAHL-HQSNIIHYNIKSSNVLIDGSGEP-KVGDYGLARLLPML 843
            +       + +     L ++  +  IIH +IK  NVL++    P  +    +A L    
Sbjct: 121 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180

Query: 844 DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP 892
                 +       Y +PE            D++    L+ E++TG   
Sbjct: 181 WYDEHYTNSIQTREYRSPEV-LLGAPWGCGADIWSTACLIFELITGDFL 228

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 97.8 bits (242), Expect = 8e-23
 Identities = 50/293 (17%), Positives = 94/293 (32%), Gaps = 20/293 (6%)

Query: 164 KIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNL 223
           K+P  L      A ++L +N+ +         L  L TL L +N +    P     L  L
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 224 RVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSG 283
             + LSKN           +   LR  +        ++   + ++ +           SG
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT-NPLKSSG 140

Query: 284 EVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNL 343
                   ++ L  + ++    +    I  G    L  L+   N++T     S+    NL
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNL 197

Query: 344 VALDFSQNSMNGDLPQ-WIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHN 402
             L  S NS++         +  L ++    NK+ +   G         + +Q + L +N
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLA-----DHKYIQVVYLHNN 252

Query: 403 EFSG------ETPATIGALSGLQLLNLSRNSL--VGPIPVAIGDLKALNVLDL 447
             S         P      +    ++L  N +      P     +     + L
Sbjct: 253 NISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 95.5 bits (236), Expect = 5e-22
 Identities = 59/292 (20%), Positives = 105/292 (35%), Gaps = 24/292 (8%)

Query: 243 SCSLLRTIDFSENSFS---GNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLD 299
            C L R +  S+        +LP     L      +L+ N  +         L++L TL 
Sbjct: 9   QCHL-RVVQCSDLGLEKVPKDLPPDTALL------DLQNNKITEIKDGDFKNLKNLHTLI 61

Query: 300 LSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQ 359
           L  NK S   P +   L +L+ L  S N+L   LP+ M   +    L   +N +   + +
Sbjct: 62  LINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQE--LRVHENEITK-VRK 117

Query: 360 WIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQ 419
            +F+     +           +G    +    + L ++ ++    +       G    L 
Sbjct: 118 SVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLT 174

Query: 420 LLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGK 479
            L+L  N +      ++  L  L  L LS N ++      +     L+EL L  N L  K
Sbjct: 175 ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VK 233

Query: 480 IPTSIENCSSLVSLILSKNNLTG------PIPIAIAKLTNLQNVDLSFNSLT 525
           +P  + +   +  + L  NN++         P    K  +   V L  N + 
Sbjct: 234 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 93.6 bits (231), Expect = 2e-21
 Identities = 63/303 (20%), Positives = 117/303 (38%), Gaps = 23/303 (7%)

Query: 271 CNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLT 330
           C+ + L       +VPK +        LDL  NK +        NL+ L  L    N+++
Sbjct: 17  CSDLGLE------KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68

Query: 331 GSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSS 390
              P + A  + L  L  S+N +  +LP+ +  +   ++   EN+I +     F  +G +
Sbjct: 69  KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTL-QELRVHENEITKVRKSVF--NGLN 124

Query: 391 FESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSEN 450
              +  L  +  + SG        +  L  + ++  ++   IP  +    +L  L L  N
Sbjct: 125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGN 181

Query: 451 WLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAK 510
            +       + G  +L +L L  N ++     S+ N   L  L L+ N L   +P  +A 
Sbjct: 182 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 240

Query: 511 LTNLQNVDLSFNSLTG------GLPKQLVNLVHLSSFNISHNHLQ-GELPAGGFFNTISP 563
              +Q V L  N+++         P         S  ++  N +Q  E+    F      
Sbjct: 241 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR 300

Query: 564 SSV 566
           ++V
Sbjct: 301 AAV 303

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 87.0 bits (214), Expect = 4e-19
 Identities = 43/270 (15%), Positives = 88/270 (32%), Gaps = 13/270 (4%)

Query: 102 LRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRF 161
              L L +N +T     +   L+NL  + L  N +S   P   F     L  + L+KN+ 
Sbjct: 33  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA-FAPLVKLERLYLSKNQL 91

Query: 162 SGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLK 221
              +P  +        ++ +                 +  L  +     G      + +K
Sbjct: 92  KE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150

Query: 222 NLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLF 281
            L  I ++    + +IP G+     L  +    N  +     +++ L+    + L  N  
Sbjct: 151 KLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207

Query: 282 SGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTG------SLPD 335
           S      +     L  L L+ NK    VP  + + + ++V+    N ++         P 
Sbjct: 208 SAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 266

Query: 336 SMANCMNLVALDFSQNSMN-GDLPQWIFSS 364
                 +   +    N +   ++    F  
Sbjct: 267 YNTKKASYSGVSLFSNPVQYWEIQPSTFRC 296

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 52.3 bits (124), Expect = 1e-07
 Identities = 22/128 (17%), Positives = 38/128 (29%)

Query: 442 LNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLT 501
             +LDL  N +      +     +L  L L  N ++   P +      L  L LSKN L 
Sbjct: 33  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92

Query: 502 GPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTI 561
                    L  L+  +     +   +   L  ++ +            E  A      +
Sbjct: 93  ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL 152

Query: 562 SPSSVLGN 569
           S   +   
Sbjct: 153 SYIRIADT 160

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.6 bits (228), Expect = 4e-21
 Identities = 52/285 (18%), Positives = 98/285 (34%), Gaps = 7/285 (2%)

Query: 71  CSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVID 130
           C   +   +  +     L   +  G+      +++ L  N ++   + +    +NL ++ 
Sbjct: 6   CVCYNEPKVTTSCPQQGLQ-AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILW 62

Query: 131 LSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLP 190
           L  N L+      F       ++      +     P++      L T++L         P
Sbjct: 63  LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP 122

Query: 191 LGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTI 250
               GL+AL+ L L DN L+         L NL  + L  N  S            L  +
Sbjct: 123 GLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182

Query: 251 DFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVP 310
              +N  +   P   + L     + L  N  S    + +  L +L+ L L+ N +     
Sbjct: 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242

Query: 311 ISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNG 355
                   L+    S++ +  SLP  +A   +L     + N + G
Sbjct: 243 A-RPLWAWLQKFRGSSSEVPCSLPQRLAG-RDL--KRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.2 bits (196), Expect = 6e-17
 Identities = 59/262 (22%), Positives = 88/262 (33%), Gaps = 6/262 (2%)

Query: 293 ESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNS 352
           E   T          AVP+ I      + +    NR++     S   C NL  L    N 
Sbjct: 11  EPKVTTSCPQQGLQ-AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67

Query: 353 MNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATI 412
           +            L +     +  +     P   +      L  L L         P   
Sbjct: 68  LARIDAAAFTGLALLEQLDLSDNAQLRSVDPA--TFHGLGRLHTLHLDRCGLQELGPGLF 125

Query: 413 GALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLE 472
             L+ LQ L L  N+L         DL  L  L L  N ++        G +SL  L L 
Sbjct: 126 RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185

Query: 473 RNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQL 532
           +N +A   P +  +   L++L L  NNL+     A+A L  LQ + L+ N        + 
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARP 245

Query: 533 VNLVHLSSFNISHNHLQGELPA 554
           +    L  F  S + +   LP 
Sbjct: 246 L-WAWLQKFRGSSSEVPCSLPQ 266

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.9 bits (190), Expect = 3e-16
 Identities = 50/276 (18%), Positives = 86/276 (31%), Gaps = 29/276 (10%)

Query: 201 TLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGN 260
           T       L+  +P G+ +    + I L  N  S        +C  L  +    N  +  
Sbjct: 15  TTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71

Query: 261 LPETMQKLSLCNFMNLRKNLFSGEV-PKWIGELESLETLDLSGNKFSGAVPISIGNLQRL 319
                  L+L   ++L  N     V P     L  L TL L         P     L  L
Sbjct: 72  DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131

Query: 320 KVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFS-SGLNKVSFAENKIRE 378
           + L    N L     D+  +  NL  L    N ++    +       L+++   +N++  
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191

Query: 379 GMNGPF--------------------ASSGSSFESLQFLDLSHNEFSGETPATIGALSGL 418
                F                      + +   +LQ+L L+ N +           + L
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAWL 250

Query: 419 QLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNG 454
           Q    S + +   +P     L   ++  L+ N L G
Sbjct: 251 QKFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.3 bits (165), Expect = 6e-13
 Identities = 47/262 (17%), Positives = 78/262 (29%), Gaps = 9/262 (3%)

Query: 22  PALTRSLNPSLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPCNWFGVKCSPRSNRVIEL 81
           PA ++ +    N     +    A        L+      +          +  +      
Sbjct: 31  PAASQRIFLHGNR----ISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLD 86

Query: 82  TLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIP 141
             +   L          L  L  L L    L          L  L+ + L  N+L     
Sbjct: 87  LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPD 146

Query: 142 DEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRT 201
           D F     +L  + L  NR S     +     +L  + L  NR +   P     L  L T
Sbjct: 147 DTFRDLG-NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205

Query: 202 LDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNL 261
           L L  N L     + +  L+ L+ + L+ N +           + L+    S +    +L
Sbjct: 206 LYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSL 264

Query: 262 PETMQKLSLCNFMNLRKNLFSG 283
           P+ +    L     L  N   G
Sbjct: 265 PQRLAGRDL---KRLAANDLQG 283

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 87.5 bits (216), Expect = 3e-20
 Identities = 24/166 (14%), Positives = 50/166 (30%), Gaps = 22/166 (13%)

Query: 697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQ---------EDFEREVKKLGKVRHP 747
            +G G   AV+           +K   V      +           F     +  +    
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 748 NLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLH 807
            L  L+G    +           G ++   L +      +       V+    + +A  +
Sbjct: 67  ALQKLQGLAVPKVYA------WEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 808 QSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL------PMLDRYV 847
              I+H ++   NVL+   G   + D+  +  +       +L+R V
Sbjct: 121 HRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDV 165

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.2 bits (165), Expect = 6e-13
 Identities = 54/273 (19%), Positives = 109/273 (39%), Gaps = 15/273 (5%)

Query: 81  LTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSI 140
           L L G +L   +   LL    +       + +   ++ + +  + ++ +DLS + +  S 
Sbjct: 5   LDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62

Query: 141 PDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLS--SNRFSSPLPLGIWGLSA 198
                 QC  L+ +SL   R S  I ++L+  S L  +NLS  S      L   +   S 
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122

Query: 199 LRTLDL------SDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDF 252
           L  L+L      ++  ++  +    E++  L +    KN+    +   +  C  L  +D 
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182

Query: 253 SEN-SFSGNLPETMQKLSLCNFMNL-RKNLFSGEVPKWIGELESLETLDLSGNKFSGAVP 310
           S++     +  +   +L+    ++L R      E    +GE+ +L+TL + G    G + 
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242

Query: 311 ISIGNLQRLKVLNFSANRLTGSLPDSMANCMNL 343
           +    L  L++     +  T     ++ N  N 
Sbjct: 243 LLKEALPHLQINC---SHFTTIARPTIGNKKNQ 272

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.9 bits (159), Expect = 3e-12
 Identities = 43/252 (17%), Positives = 91/252 (36%), Gaps = 14/252 (5%)

Query: 103 RKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFS 162
           + L L+  NL   ++  L   Q +       + +   + + F      ++ + L+ +   
Sbjct: 3   QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHF--SPFRVQHMDLSNSVIE 59

Query: 163 GK-IPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLS--DNLLEGEIPKGVES 219
              +   LS CS L  ++L   R S P+   +   S L  L+LS      E  +   + S
Sbjct: 60  VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119

Query: 220 LKNLRVINL------SKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNF 273
              L  +NL      ++     ++     + + L    + +N    +L   +++      
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179

Query: 274 MNLRKN-LFSGEVPKWIGELESLETLDLSG-NKFSGAVPISIGNLQRLKVLNFSANRLTG 331
           ++L  + +   +  +   +L  L+ L LS          + +G +  LK L        G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239

Query: 332 SLPDSMANCMNL 343
           +L        +L
Sbjct: 240 TLQLLKEALPHL 251

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.5 bits (158), Expect = 4e-12
 Identities = 41/272 (15%), Positives = 92/272 (33%), Gaps = 13/272 (4%)

Query: 246 LLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKF 305
           L +T+D +  +   ++   +    +  F    ++     + +       ++ +DLS +  
Sbjct: 1   LWQTLDLTGKNLHPDVTGRLLSQGVIAF-RCPRSFMDQPLAEHFSPF-RVQHMDLSNSVI 58

Query: 306 SG-AVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSS 364
               +   +    +L+ L+    RL+  + +++A   NLV L+ S  S   +       S
Sbjct: 59  EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS 118

Query: 365 GLNKVSFA-----ENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQ 419
             +++         +   + +    A    +   L       N    +    +     L 
Sbjct: 119 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 178

Query: 420 LLNLSRNSLVGP-IPVAIGDLKALNVLDLSE-NWLNGSIPPEIGGAYSLKELRLERNFLA 477
            L+LS + ++          L  L  L LS    +      E+G   +LK L++      
Sbjct: 179 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPD 238

Query: 478 GKIPTSIENCSSLVSLILSKNNLTGPIPIAIA 509
           G +    E    L    ++ ++ T      I 
Sbjct: 239 GTLQLLKEALPHLQ---INCSHFTTIARPTIG 267

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.6 bits (122), Expect = 2e-07
 Identities = 30/153 (19%), Positives = 52/153 (33%), Gaps = 27/153 (17%)

Query: 397 LDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSI 456
           LDL+      +    + +  G+      R+ +  P+       + +  +DLS + +  S 
Sbjct: 5   LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62

Query: 457 PPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQN 516
              I                       +  CS L +L L    L+ PI   +AK +NL  
Sbjct: 63  LHGI-----------------------LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVR 99

Query: 517 VDLS--FNSLTGGLPKQLVNLVHLSSFNISHNH 547
           ++LS         L   L +   L   N+S   
Sbjct: 100 LNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF 132

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.8 bits (112), Expect = 3e-06
 Identities = 38/254 (14%), Positives = 78/254 (30%), Gaps = 18/254 (7%)

Query: 297 TLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGD 356
           TLDL+G      V   + +   +       + +   L +  +    +  +D S + +   
Sbjct: 4   TLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVS 61

Query: 357 LPQWIFS--SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGA 414
               I S  S L  +S    ++    + P  ++ +   +L  L+LS      E       
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRL----SDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL 117

Query: 415 LSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERN 474
            S  +L  L+ +         +    A     +++  L+G          S    R    
Sbjct: 118 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 177

Query: 475 FLA---------GKIPTSIENCSSLVSLILSK-NNLTGPIPIAIAKLTNLQNVDLSFNSL 524
                                 + L  L LS+  ++     + + ++  L+ + +     
Sbjct: 178 VHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVP 237

Query: 525 TGGLPKQLVNLVHL 538
            G L      L HL
Sbjct: 238 DGTLQLLKEALPHL 251

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.5 bits (158), Expect = 3e-12
 Identities = 38/208 (18%), Positives = 72/208 (34%), Gaps = 8/208 (3%)

Query: 122 KLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLS 181
           K+ +   ++    +L+ ++P +  K      ++ L++N       ++L   + L  +NL 
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDLPK---DTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 182 SNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGI 241
               +         L  L TLDLS N L+     G        V+++S N  +      +
Sbjct: 64  RAELTKLQV--DGTLPVLGTLDLSHNQLQSLPLLGQTLPAL-TVLDVSFNRLTSLPLGAL 120

Query: 242 GSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLS 301
                L+ +    N      P  +        ++L  N  +      +  LE+L+TL L 
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180

Query: 302 GNKFSGAVPISIGNLQRLKVLNFSANRL 329
            N     +P        L       N  
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.3 bits (142), Expect = 5e-10
 Identities = 41/204 (20%), Positives = 66/204 (32%), Gaps = 15/204 (7%)

Query: 271 CNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLT 330
           C+  NL        +P  + +      L LS N        ++    RL  LN     L 
Sbjct: 17  CDKRNLT------ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN-----LD 63

Query: 331 GSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSS 390
            +    +     L  L  + +  +  L                +     +      +   
Sbjct: 64  RAELTKLQVDGTLPVL-GTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRG 122

Query: 391 FESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSEN 450
              LQ L L  NE     P  +     L+ L+L+ N+L       +  L+ L+ L L EN
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182

Query: 451 WLNGSIPPEIGGAYSLKELRLERN 474
            L  +IP    G++ L    L  N
Sbjct: 183 SLY-TIPKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.2 bits (126), Expect = 4e-08
 Identities = 42/237 (17%), Positives = 76/237 (32%), Gaps = 34/237 (14%)

Query: 168 SLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVIN 227
            +S  ++   +N      ++ LP  +        L LS+NLL       +     L  +N
Sbjct: 5   EVSKVASHLEVNCDKRNLTA-LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 228 LSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPK 287
           L +          +     +       ++   +LP   Q L     +++  N  +     
Sbjct: 62  LDRAEL---TKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118

Query: 288 WIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALD 347
            +  L  L+ L L GN+     P  +    +L+ L+ + N LT      +    NL  L 
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178

Query: 348 FSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEF 404
             +NS+   +P+  F S                             L F  L  N +
Sbjct: 179 LQENSLY-TIPKGFFGS---------------------------HLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.9 bits (120), Expect = 2e-07
 Identities = 40/208 (19%), Positives = 66/208 (31%), Gaps = 25/208 (12%)

Query: 70  KCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVI 129
           + S +    +E+  +  +LT  +   L +      L LS N L       L     L  +
Sbjct: 5   EVS-KVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 130 DLSGNSLSGSIPDEFFKQCGSLRVISLAK--------------------NRFSGKIPSSL 169
           +L    L+    D      G+L +                         NR +     +L
Sbjct: 61  NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120

Query: 170 SLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLS 229
                L  + L  N   +  P  +     L  L L++N L       +  L+NL  + L 
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180

Query: 230 KNMFSGSIPDGIGSCSLLRTIDFSENSF 257
           +N    +IP G     LL       N +
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.7 bits (117), Expect = 5e-07
 Identities = 46/182 (25%), Positives = 59/182 (32%), Gaps = 26/182 (14%)

Query: 391 FESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSEN 450
            +    L LS N     + AT+   + L  LNL R           G L  L  LDLS N
Sbjct: 30  PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE--LTKLQVDGTLPVLGTLDLSHN 87

Query: 451 -----------------------WLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENC 487
                                   L       + G   L+EL L+ N L    P  +   
Sbjct: 88  QLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPT 147

Query: 488 SSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNH 547
             L  L L+ NNLT      +  L NL  + L  NSL   +PK       L    +  N 
Sbjct: 148 PKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNP 206

Query: 548 LQ 549
             
Sbjct: 207 WL 208

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 57.0 bits (137), Expect = 2e-10
 Identities = 30/128 (23%), Positives = 49/128 (38%), Gaps = 10/128 (7%)

Query: 103 RKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFS 162
           R L L+  +LT  +  +L +L  +  +DLS N L    P         L V+  + N   
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA--LAALRCLEVLQASDNAL- 55

Query: 163 GKIPSSLSLCSTLATINLSSNRFSS-PLPLGIWGLSALRTLDLSDNLL---EGEIPKGVE 218
            +    ++    L  + L +NR         +     L  L+L  N L   EG   +  E
Sbjct: 56  -ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114

Query: 219 SLKNLRVI 226
            L ++  I
Sbjct: 115 MLPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 53.2 bits (127), Expect = 4e-09
 Identities = 22/109 (20%), Positives = 39/109 (35%), Gaps = 6/109 (5%)

Query: 200 RTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSG 259
           R L L+   L   +   +E L  +  ++LS N      P  + +   L  +  S+N+   
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNAL-- 55

Query: 260 NLPETMQKLSLCNFMNLRKN-LFSGEVPKWIGELESLETLDLSGNKFSG 307
              + +  L     + L  N L      + +     L  L+L GN    
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 50.9 bits (121), Expect = 3e-08
 Identities = 28/121 (23%), Positives = 50/121 (41%), Gaps = 8/121 (6%)

Query: 419 QLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAG 478
           ++L+L+   L   +   +  L  +  LDLS N L   +PP +     L+ L+   N    
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNA--L 55

Query: 479 KIPTSIENCSSLVSLILSKNNLTG-PIPIAIAKLTNLQNVDLSFNSLTG--GLPKQLVNL 535
           +    + N   L  L+L  N L        +     L  ++L  NSL    G+ ++L  +
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

Query: 536 V 536
           +
Sbjct: 116 L 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 49.3 bits (117), Expect = 1e-07
 Identities = 20/111 (18%), Positives = 38/111 (34%), Gaps = 10/111 (9%)

Query: 224 RVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPE--TMQKLSLCNFMNLRKNLF 281
           RV++L+    +  +   +    L+  +D S N      P    ++ L +    +      
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58

Query: 282 SGEVPKWIGELESLETLDLSGNKFSGAVPI-SIGNLQRLKVLNFSANRLTG 331
            G       +      L L  N+   +  I  + +  RL +LN   N L  
Sbjct: 59  DGVANLPRLQ-----ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.2 bits (101), Expect = 1e-05
 Identities = 24/124 (19%), Positives = 38/124 (30%), Gaps = 10/124 (8%)

Query: 320 KVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREG 379
           +VL+ +   LT      +   + +  LD S N +    P       L  +          
Sbjct: 1   RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQA------SD 52

Query: 380 MNGPFASSGSSFESLQFLDLSHNEF-SGETPATIGALSGLQLLNLSRNSLVGPIPVAIGD 438
                    ++   LQ L L +N          + +   L LLNL  NSL          
Sbjct: 53  NALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQER 111

Query: 439 LKAL 442
           L  +
Sbjct: 112 LAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.4 bits (99), Expect = 3e-05
 Identities = 26/125 (20%), Positives = 43/125 (34%), Gaps = 27/125 (21%)

Query: 77  RVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNL---------- 126
           RV+ L    L++   +     QL  +  L LS N L   + P LA L+ L          
Sbjct: 1   RVLHLAHKDLTVLCHLE----QLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNAL 55

Query: 127 ------------RVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCST 174
                       + + L  N L  S   +    C  L +++L  N    +      L   
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

Query: 175 LATIN 179
           L +++
Sbjct: 116 LPSVS 120

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.1 bits (133), Expect = 1e-08
 Identities = 17/92 (18%), Positives = 33/92 (35%), Gaps = 9/92 (9%)

Query: 125 NLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGK----IPSSLSLCSTLATINL 180
           +++ +D+    LS +   E        +V+ L     +      I S+L +   LA +NL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 181 SSNRFSSPLPLGI-----WGLSALRTLDLSDN 207
            SN         +          ++ L L + 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.2 bits (128), Expect = 5e-08
 Identities = 19/91 (20%), Positives = 31/91 (34%), Gaps = 5/91 (5%)

Query: 393 SLQFLDLSHNEFSGETPATI-GALSGLQLLNLSRNSL----VGPIPVAIGDLKALNVLDL 447
            +Q LD+   E S    A +   L   Q++ L    L       I  A+    AL  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 448 SENWLNGSIPPEIGGAYSLKELRLERNFLAG 478
             N L       +         ++++  L  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.4 bits (126), Expect = 7e-08
 Identities = 12/93 (12%), Positives = 31/93 (33%), Gaps = 9/93 (9%)

Query: 102 LRKLSLSSNNLTGSISPNLAK-LQNLRVIDLSGNSLSGSIPD---EFFKQCGSLRVISLA 157
           ++ L +    L+ +    L   LQ  +V+ L    L+ +         +   +L  ++L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 158 KNRFSGKIPSSL-----SLCSTLATINLSSNRF 185
            N         +     +    +  ++L +   
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.7 bits (124), Expect = 2e-07
 Identities = 10/95 (10%), Positives = 28/95 (29%), Gaps = 5/95 (5%)

Query: 199 LRTLDLSDN-LLEGEIPKGVESLKNLRVINLSKNMFSG----SIPDGIGSCSLLRTIDFS 253
           +++LD+    L +    + +  L+  +V+ L     +      I   +     L  ++  
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 254 ENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKW 288
            N         + +        ++K          
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 98

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.7 bits (124), Expect = 2e-07
 Identities = 12/76 (15%), Positives = 27/76 (35%), Gaps = 5/76 (6%)

Query: 294 SLETLDLSGNKFSGA-VPISIGNLQRLKVLNFSANRLTG----SLPDSMANCMNLVALDF 348
            +++LD+   + S A     +  LQ+ +V+      LT      +  ++     L  L+ 
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 349 SQNSMNGDLPQWIFSS 364
             N +       +   
Sbjct: 63  RSNELGDVGVHCVLQG 78

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.3 bits (123), Expect = 2e-07
 Identities = 28/110 (25%), Positives = 39/110 (35%), Gaps = 10/110 (9%)

Query: 56  WSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSLTG--RIGRGLLQLQFLRKLSLSSNNLT 113
             ED        G+       RV+ L    +S +    +   LL    LR+L LS+N L 
Sbjct: 351 RLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410

Query: 114 GSISPNLAK-----LQNLRVIDLSGNSLSGSIPD---EFFKQCGSLRVIS 155
            +    L +        L  + L     S  + D      K   SLRVIS
Sbjct: 411 DAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.9 bits (122), Expect = 3e-07
 Identities = 22/101 (21%), Positives = 39/101 (38%), Gaps = 13/101 (12%)

Query: 139 SIPDEFFKQCGSLRVISLAKNRFSGK----IPSSLSLCSTLATINLSSNRFSSPLPLGI- 193
            +     +    LRV+ LA    S      + ++L    +L  ++LS+N       L + 
Sbjct: 359 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 418

Query: 194 ----WGLSALRTLDLSDNLLEGEIPKGVESLK----NLRVI 226
                    L  L L D     E+   +++L+    +LRVI
Sbjct: 419 ESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.7 bits (119), Expect = 5e-07
 Identities = 17/76 (22%), Positives = 32/76 (42%), Gaps = 8/76 (10%)

Query: 102 LRKLSLSSNNLTG----SISPNLAKLQNLRVIDLSGNSLSGSIPDEFFK----QCGSLRV 153
           LR L L+  +++     S++  L    +LR +DLS N L  +   +  +        L  
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 154 ISLAKNRFSGKIPSSL 169
           + L    +S ++   L
Sbjct: 431 LVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.0 bits (117), Expect = 8e-07
 Identities = 15/89 (16%), Positives = 31/89 (34%), Gaps = 10/89 (11%)

Query: 442 LNVLDLSENWLNGSIPPEIGGA-YSLKELRLERNFL----AGKIPTSIENCSSLVSLILS 496
           +  LD+    L+ +   E+       + +RL+   L       I +++    +L  L L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 497 KNNLTGPIPIAIAKL-----TNLQNVDLS 520
            N L       + +        +Q + L 
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.0 bits (117), Expect = 1e-06
 Identities = 14/80 (17%), Positives = 27/80 (33%), Gaps = 9/80 (11%)

Query: 465 SLKELRLERNFL----AGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAK-----LTNLQ 515
            L+ L L    +       +  ++    SL  L LS N L     + + +        L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 516 NVDLSFNSLTGGLPKQLVNL 535
            + L     +  +  +L  L
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.0 bits (117), Expect = 1e-06
 Identities = 16/84 (19%), Positives = 32/84 (38%), Gaps = 9/84 (10%)

Query: 194 WGLSALRTLDLSDNLLEGE----IPKGVESLKNLRVINLSKNMFSGSIPDGIGS-----C 244
              S LR L L+D  +       +   + +  +LR ++LS N    +    +        
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425

Query: 245 SLLRTIDFSENSFSGNLPETMQKL 268
            LL  +   +  +S  + + +Q L
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.8 bits (114), Expect = 2e-06
 Identities = 18/86 (20%), Positives = 28/86 (32%), Gaps = 9/86 (10%)

Query: 80  ELTLNGLSLTGRIGRGLL-QLQFLRKLSLSSNNLTG----SISPNLAKLQNLRVIDLSGN 134
            L +    L+      LL  LQ  + + L    LT      IS  L     L  ++L  N
Sbjct: 6   SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65

Query: 135 SLSG----SIPDEFFKQCGSLRVISL 156
            L       +          ++ +SL
Sbjct: 66  ELGDVGVHCVLQGLQTPSCKIQKLSL 91

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.4 bits (113), Expect = 3e-06
 Identities = 18/118 (15%), Positives = 36/118 (30%), Gaps = 9/118 (7%)

Query: 359 QWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIG----A 414
                  L            G+       G     L+ L L+  + S  + +++     A
Sbjct: 336 LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLA 395

Query: 415 LSGLQLLNLSRNSLVGPIPVAIGD-----LKALNVLDLSENWLNGSIPPEIGGAYSLK 467
              L+ L+LS N L     + + +        L  L L + + +  +   +      K
Sbjct: 396 NHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.3 bits (110), Expect = 6e-06
 Identities = 11/111 (9%), Positives = 28/111 (25%), Gaps = 10/111 (9%)

Query: 175 LATINLSSNRFS-SPLPLGIWGLSALRTLDLSDNLLEGE----IPKGVESLKNLRVINLS 229
           + ++++     S +     +  L   + + L D  L       I   +     L  +NL 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 230 KNMFSGSIPDGIGS-----CSLLRTIDFSENSFSGNLPETMQKLSLCNFMN 275
            N         +          ++ +       +G     +          
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTL 114

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.3 bits (110), Expect = 7e-06
 Identities = 15/91 (16%), Positives = 28/91 (30%), Gaps = 5/91 (5%)

Query: 465 SLKELRLERNFLAGK-IPTSIENCSSLVSLILSKNNLTG----PIPIAIAKLTNLQNVDL 519
            ++ L ++   L+       +        + L    LT      I  A+     L  ++L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 520 SFNSLTGGLPKQLVNLVHLSSFNISHNHLQG 550
             N L       ++  +   S  I    LQ 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 9e-06
 Identities = 12/77 (15%), Positives = 23/77 (29%), Gaps = 9/77 (11%)

Query: 294 SLETLDLSGNKFSGAVPISIG----NLQRLKVLNFSANRLTGSLPDSMA-----NCMNLV 344
            L  L L+    S +   S+         L+ L+ S N L  +    +          L 
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 345 ALDFSQNSMNGDLPQWI 361
            L       + ++   +
Sbjct: 430 QLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 9e-06
 Identities = 15/78 (19%), Positives = 28/78 (35%), Gaps = 9/78 (11%)

Query: 485 ENCSSLVSLILSKNNLTG----PIPIAIAKLTNLQNVDLSFNSLTGGLPKQLV-----NL 535
           +  S L  L L+  +++      +   +    +L+ +DLS N L      QLV       
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425

Query: 536 VHLSSFNISHNHLQGELP 553
             L    +   +   E+ 
Sbjct: 426 CLLEQLVLYDIYWSEEME 443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 2e-05
 Identities = 12/90 (13%), Positives = 28/90 (31%), Gaps = 2/90 (2%)

Query: 341 MNLVALDFSQNSMNGDLPQWIFSS--GLNKVSFAENKIREGMNGPFASSGSSFESLQFLD 398
           +++ +LD     ++      +         V   +  + E      +S+     +L  L+
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 399 LSHNEFSGETPATIGALSGLQLLNLSRNSL 428
           L  NE        +          + + SL
Sbjct: 62  LRSNELGDVGVHCVLQGLQTPSCKIQKLSL 91

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 2e-05
 Identities = 13/89 (14%), Positives = 28/89 (31%), Gaps = 10/89 (11%)

Query: 247 LRTIDFSENSFSGN-LPETMQKLSLCNFMNLRKNLFSGEVPKWIGE----LESLETLDLS 301
           ++++D      S     E +  L  C  + L     +    K I        +L  L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 302 GNKFSGAVPISIG-----NLQRLKVLNFS 325
            N+        +         +++ L+  
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 3e-05
 Identities = 14/68 (20%), Positives = 21/68 (30%), Gaps = 5/68 (7%)

Query: 489 SLVSLILSKNNLT-GPIPIAIAKLTNLQNVDLSFNSLTG----GLPKQLVNLVHLSSFNI 543
            + SL +    L+       +  L   Q V L    LT      +   L     L+  N+
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 544 SHNHLQGE 551
             N L   
Sbjct: 63  RSNELGDV 70

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (101), Expect = 7e-05
 Identities = 12/99 (12%), Positives = 27/99 (27%), Gaps = 10/99 (10%)

Query: 274 MNLRKNLFSGE-VPKWIGELESLETLDLSGNKFSGAVPISIG----NLQRLKVLNFSANR 328
           ++++    S     + +  L+  + + L     + A    I         L  LN  +N 
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 329 LTGSLPDSMA-----NCMNLVALDFSQNSMNGDLPQWIF 362
           L       +          +  L      + G     + 
Sbjct: 67  LGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLS 105

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (101), Expect = 7e-05
 Identities = 20/104 (19%), Positives = 35/104 (33%), Gaps = 23/104 (22%)

Query: 221 KNLRVINLSKNMFSG----SIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNL 276
             LRV+ L+    S     S+   + +   LR +D S N         + +L       +
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG---DAGILQLVES----V 421

Query: 277 RKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLK 320
           R+                LE L L    +S  +   +  L++ K
Sbjct: 422 RQPG------------CLLEQLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (101), Expect = 8e-05
 Identities = 18/105 (17%), Positives = 30/105 (28%), Gaps = 26/105 (24%)

Query: 315 NLQRLKVLNFSANRLTG----SLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVS 370
               L+VL  +   ++     SL  ++    +L  LD S N +       +  S      
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 371 FAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGAL 415
                                  L+ L L    +S E    + AL
Sbjct: 427 ----------------------LLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (97), Expect = 2e-04
 Identities = 17/92 (18%), Positives = 29/92 (31%), Gaps = 10/92 (10%)

Query: 418 LQLLNLSRNSLV-GPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAY----SLKELRLE 472
           +Q L++    L        +  L+   V+ L +  L  +   +I  A     +L EL L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 473 RNFLAGKIPTSI-----ENCSSLVSLILSKNN 499
            N L       +          +  L L    
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 3e-04
 Identities = 15/83 (18%), Positives = 24/83 (28%), Gaps = 9/83 (10%)

Query: 265 MQKLSLCNFMNLRKNLFSGEVPKWIGE----LESLETLDLSGNKFSGAVPISIG-----N 315
            Q  S+   + L     S      +        SL  LDLS N    A  + +       
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 316 LQRLKVLNFSANRLTGSLPDSMA 338
              L+ L       +  + D + 
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQ 447

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 7e-04
 Identities = 16/79 (20%), Positives = 28/79 (35%), Gaps = 9/79 (11%)

Query: 442 LNVLDLSENWLNGSIPPEIGGAY----SLKELRLERNFLAGKIPTSI-----ENCSSLVS 492
           L VL L++  ++ S    +        SL+EL L  N L       +     +    L  
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 493 LILSKNNLTGPIPIAIAKL 511
           L+L     +  +   +  L
Sbjct: 431 LVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.004
 Identities = 13/68 (19%), Positives = 24/68 (35%), Gaps = 7/68 (10%)

Query: 74  RSNRVIELTLNGLSLTG--RIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKL-----QNL 126
           +  +V+ L   GL+      I   L     L +L+L SN L       + +        +
Sbjct: 27  QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKI 86

Query: 127 RVIDLSGN 134
           + + L   
Sbjct: 87  QKLSLQNC 94

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 53.7 bits (127), Expect = 1e-08
 Identities = 37/191 (19%), Positives = 68/191 (35%), Gaps = 11/191 (5%)

Query: 224 RVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLC-NFMNLRKNLFS 282
             ++ +       IP  I        +  ++N       + +         + L++N  +
Sbjct: 11  TTVDCTGRGLK-EIPRDIPLH--TTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67

Query: 283 GEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMN 342
           G  P        ++ L L  NK           L +LK LN   N+++  +P S  +  +
Sbjct: 68  GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127

Query: 343 LVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHN 402
           L +L+ + N  N +     F+  L K S      R         + S    +Q  DL H+
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAAR-------CGAPSKVRDVQIKDLPHS 180

Query: 403 EFSGETPATIG 413
           EF   +  + G
Sbjct: 181 EFKCSSENSEG 191

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 41.3 bits (95), Expect = 2e-04
 Identities = 40/190 (21%), Positives = 67/190 (35%), Gaps = 14/190 (7%)

Query: 64  CNWFGVKCSPRS---------NRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTG 114
           C    V C+ R              EL LN   L      GL              N   
Sbjct: 8   CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67

Query: 115 SISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCST 174
            I PN  +  +       G +    I ++ F     L+ ++L  N+ S  +P S    ++
Sbjct: 68  GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127

Query: 175 LATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFS 234
           L ++NL+SN F+    L  W    LR   L+        P     ++++++ +L  + F 
Sbjct: 128 LTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEFK 183

Query: 235 GSIPDGIGSC 244
            S  +    C
Sbjct: 184 CSSEN-SEGC 192

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.5 bits (127), Expect = 2e-08
 Identities = 31/228 (13%), Positives = 74/228 (32%), Gaps = 19/228 (8%)

Query: 98  QLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLA 157
            L    K++   +N+T +++   A L  +  +   G  ++ +I     +   +L  + L 
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG--VQYLNNLIGLELK 71

Query: 158 KNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGV 217
            N+ +   P       T   ++ +  +  S +       +   T     ++        +
Sbjct: 72  DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131

Query: 218 ESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLR 277
           + L        + +  +G       S    +  D +  +    L            +   
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKL----------TTLKAD 181

Query: 278 KNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFS 325
            N  S   P  +  L +L  + L  N+ S   P++  N   L ++  +
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.0 bits (123), Expect = 8e-08
 Identities = 28/229 (12%), Positives = 65/229 (28%), Gaps = 21/229 (9%)

Query: 292 LESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQN 351
           L +   +    +  +  V  +  +L  +  L+     +T    + +    NL+ L+   N
Sbjct: 18  LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73

Query: 352 SMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPAT 411
            +          +         +          A   S            +       + 
Sbjct: 74  QIT---DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130

Query: 412 IGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRL 471
           +  L        + + L G   +                    S    +     L  L+ 
Sbjct: 131 LQVLYLDLNQITNISPLAGLTNLQYLS----------IGNAQVSDLTPLANLSKLTTLKA 180

Query: 472 ERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLS 520
           + N ++   P  + +  +L+ + L  N ++   P  +A  +NL  V L+
Sbjct: 181 DDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.8 bits (120), Expect = 2e-07
 Identities = 34/224 (15%), Positives = 70/224 (31%), Gaps = 25/224 (11%)

Query: 140 IPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSAL 199
            PD           I+  K+  +  +  + +    + T++      ++ +  G+  L+ L
Sbjct: 13  FPDPALAN---AIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNL 65

Query: 200 RTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSG 259
             L+L DN +    P    +      ++ +      +I       +L  T     +    
Sbjct: 66  IGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPL 125

Query: 260 NLPETMQKLSLCNFMNLRKNLF--------------SGEVPKWIGELESLETLDLSGNKF 305
                +Q L L        +                       +  L  L TL    NK 
Sbjct: 126 AGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKI 185

Query: 306 SGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFS 349
           S      + +L  L  ++   N+++   P  +AN  NL  +  +
Sbjct: 186 SD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.0 bits (118), Expect = 4e-07
 Identities = 27/209 (12%), Positives = 59/209 (28%), Gaps = 43/209 (20%)

Query: 275 NLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLP 334
              K+  +  V +   +L+ + TL   G   +    +    L  L  L    N++T   P
Sbjct: 25  AAGKSNVTDTVTQ--ADLDGITTLSAFGTGVTTIEGVQ--YLNNLIGLELKDNQITDLAP 80

Query: 335 DSMANCMNLVALDFSQNSMNGDLPQWIFS------------------------------- 363
                 +  + L  +       +                                     
Sbjct: 81  LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQ 140

Query: 364 ----SGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQ 419
               S L  ++  +            +  ++   L  L    N+ S  +P  + +L  L 
Sbjct: 141 ITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLI 198

Query: 420 LLNLSRNSLVGPIPVAIGDLKALNVLDLS 448
            ++L  N +    P  + +   L ++ L+
Sbjct: 199 EVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 8e-06
 Identities = 39/230 (16%), Positives = 89/230 (38%), Gaps = 21/230 (9%)

Query: 195 GLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSE 254
            L+    +    + +   + +    L  +  ++      + +I  G+   + L  ++  +
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72

Query: 255 NSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIG 314
           N     + +     +L     L  +    +    I  L+S++TLDL+  + +      + 
Sbjct: 73  N----QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQIT--DVTPLA 126

Query: 315 NLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAEN 374
            L  L+VL    N++T   P +    +  +++  +Q S    L        L  +   +N
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLS---KLTTLKADDN 183

Query: 375 KIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLS 424
           KI +       S  +S  +L  + L +N+ S  +P  +   S L ++ L+
Sbjct: 184 KISD------ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.9 bits (102), Expect = 4e-05
 Identities = 36/213 (16%), Positives = 63/213 (29%), Gaps = 45/213 (21%)

Query: 78  VIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLS 137
            I++     ++T  +      L  +  LS     +T +I   +  L NL  ++L  N ++
Sbjct: 21  AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQIT 76

Query: 138 GSIPDEFFKQCGSLRVISLAK-------------------------------------NR 160
              P +   +   L +                                            
Sbjct: 77  DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYL 136

Query: 161 FSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESL 220
              +I +   L        LS           +  LS L TL   DN +    P  + SL
Sbjct: 137 DLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASL 194

Query: 221 KNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFS 253
            NL  ++L  N  S   P  + + S L  +  +
Sbjct: 195 PNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.1 bits (100), Expect = 7e-05
 Identities = 17/62 (27%), Positives = 28/62 (45%), Gaps = 4/62 (6%)

Query: 484 IENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNI 543
           + N S L +L    N ++   P+A   L NL  V L  N ++   P  L N  +L    +
Sbjct: 169 LANLSKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

Query: 544 SH 545
           ++
Sbjct: 225 TN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 5e-04
 Identities = 14/64 (21%), Positives = 24/64 (37%), Gaps = 4/64 (6%)

Query: 143 EFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTL 202
                   L  +    N+ S   P  L+    L  ++L +N+ S   PL     S L  +
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLA--NTSNLFIV 222

Query: 203 DLSD 206
            L++
Sbjct: 223 TLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 5e-04
 Identities = 13/85 (15%), Positives = 29/85 (34%), Gaps = 10/85 (11%)

Query: 481 PTSI------ENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVN 534
           PT+I         ++ + +   K+N+T  +  A   L  +  +      +T    + +  
Sbjct: 6   PTAINVIFPDPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQY 61

Query: 535 LVHLSSFNISHNHLQGELPAGGFFN 559
           L +L    +  N +    P      
Sbjct: 62  LNNLIGLELKDNQITDLAPLKNLTK 86

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 53.7 bits (127), Expect = 5e-08
 Identities = 60/331 (18%), Positives = 100/331 (30%), Gaps = 28/331 (8%)

Query: 171 LCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSK 230
           L      + L++   SS LP        L +L  S N L  E+P   E  ++L+ + +  
Sbjct: 36  LDRQAHELELNNLGLSS-LPELP---PHLESLVASCNSLT-ELP---ELPQSLKSLLVDN 87

Query: 231 NMFSG------SIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGE 284
           N           +     S + L  +   +NS    + +                 F   
Sbjct: 88  NNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAA 147

Query: 285 VPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLV 344
               + EL  L+ L      ++    +       L + +  A          + N   L 
Sbjct: 148 GNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLT 207

Query: 345 ALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREG-----MNGPFASSGSSFESLQFLDL 399
            +    N +            LN        + E            +  S    L     
Sbjct: 208 TIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLY 267

Query: 400 SHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPE 459
             N  S E  +       L+ LN+S N L+  +P     L+    L  S N L   +P  
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHLA-EVPEL 322

Query: 460 IGGAYSLKELRLERNFLAGKIPTSIENCSSL 490
                +LK+L +E N L  + P   E+   L
Sbjct: 323 PQ---NLKQLHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.7 bits (122), Expect = 2e-07
 Identities = 18/96 (18%), Positives = 39/96 (40%), Gaps = 10/96 (10%)

Query: 179 NLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIP 238
               N  S+ +        +L  L++S+N L  E+P        L  +  S N  +  +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVP 320

Query: 239 DGIGSCSLLRTIDFSENSFSG--NLPETMQKLSLCN 272
           +   +   L+ +    N      ++PE+++ L + +
Sbjct: 321 ELPQN---LKQLHVEYNPLREFPDIPESVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 50.6 bits (119), Expect = 5e-07
 Identities = 27/90 (30%), Positives = 39/90 (43%), Gaps = 9/90 (10%)

Query: 159 NRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVE 218
           N  S +I S   L  +L  +N+S+N+    LP        L  L  S N L  E+P   E
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALP---PRLERLIASFNHLA-EVP---E 321

Query: 219 SLKNLRVINLSKNMFSGSIPDGIGSCSLLR 248
             +NL+ +++  N      PD   S   LR
Sbjct: 322 LPQNLKQLHVEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 50.2 bits (118), Expect = 7e-07
 Identities = 20/94 (21%), Positives = 33/94 (35%), Gaps = 9/94 (9%)

Query: 422 NLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIP 481
               N+    I        +L  L++S N L   +P        L+ L    N L  ++P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHL-AEVP 320

Query: 482 TSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQ 515
              +N   L  L +  N L    P     + +L+
Sbjct: 321 ELPQN---LKQLHVEYNPLRE-FPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.1 bits (110), Expect = 5e-06
 Identities = 23/83 (27%), Positives = 37/83 (44%), Gaps = 9/83 (10%)

Query: 471 LERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPK 530
              N  + +I +  +   SL  L +S N L   +P   A    L+ +  SFN L   +P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LP---ALPPRLERLIASFNHLA-EVPE 321

Query: 531 QLVNLVHLSSFNISHNHLQGELP 553
              NL  L   ++ +N L+ E P
Sbjct: 322 LPQNLKQL---HVEYNPLR-EFP 340

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.0 bits (107), Expect = 1e-05
 Identities = 17/117 (14%), Positives = 36/117 (30%), Gaps = 11/117 (9%)

Query: 56  WSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGS 115
                               + +        + +  I         L +L++S+N L   
Sbjct: 240 PELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-E 298

Query: 116 ISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSG--KIPSSLS 170
           +     +L+ L     S N L+  +P+       +L+ + +  N       IP S+ 
Sbjct: 299 LPALPPRLERL---IASFNHLA-EVPEL----PQNLKQLHVEYNPLREFPDIPESVE 347

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.8 bits (91), Expect = 0.001
 Identities = 20/99 (20%), Positives = 34/99 (34%), Gaps = 14/99 (14%)

Query: 56  WSEDDDTPCNWFGVKCSPRSNRVIELTLNGL-SLTGRIGRGLLQLQFLRKLSLSSNNLTG 114
               + +      +   P S   + ++ N L  L     R       L +L  S N+L  
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPR-------LERLIASFNHLA- 317

Query: 115 SISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRV 153
            +       QNL+ + +  N L    PD   +    LR+
Sbjct: 318 EVPELP---QNLKQLHVEYNPLR-EFPD-IPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.4 bits (90), Expect = 0.002
 Identities = 15/71 (21%), Positives = 28/71 (39%), Gaps = 9/71 (12%)

Query: 102 LRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRF 161
             +L L++  L+ S+      L++L     S NSL+  +P+       SL+ + +  N  
Sbjct: 40  AHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELP----QSLKSLLVDNNNL 90

Query: 162 SGKIPSSLSLC 172
                    L 
Sbjct: 91  KALSDLPPLLE 101

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.7 bits (88), Expect = 0.003
 Identities = 47/303 (15%), Positives = 84/303 (27%), Gaps = 21/303 (6%)

Query: 263 ETMQKLSLCNFMNLRK----NLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQR 318
             + +L  C      +    NL    +P+       LE+L  S N  +  +P    +L+ 
Sbjct: 27  MAVSRLRDCLDRQAHELELNNLGLSSLPELPP---HLESLVASCNSLT-ELPELPQSLKS 82

Query: 319 LKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIRE 378
           L V N +   L+   P      ++   L+      N    + I     +     +     
Sbjct: 83  LLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSL 142

Query: 379 GMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGD 438
                  +       LQ L      ++            L L ++   + +      + +
Sbjct: 143 EFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQN 202

Query: 439 LKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAG--------KIPTSIENCSSL 490
           L  L  +    N L                     +                     S L
Sbjct: 203 LPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSEL 262

Query: 491 VSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQG 550
              +   N  +  I        +L+ +++S N L   LP     L  L     S NHL  
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA- 317

Query: 551 ELP 553
           E+P
Sbjct: 318 EVP 320

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 52.2 bits (123), Expect = 2e-07
 Identities = 42/321 (13%), Positives = 88/321 (27%), Gaps = 30/321 (9%)

Query: 150 SLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFS----SPLPLGIWGLSALRTLDLS 205
           SL++ ++        + + L    ++  I LS N         L   I     L   + S
Sbjct: 9   SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67

Query: 206 DN---LLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLP 262
           D     ++ EIP+ +  L    +     +    S      +         S+++   +L 
Sbjct: 68  DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127

Query: 263 ETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVL 322
                L       + + L    V K       L ++    N+             +   L
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187

Query: 323 NFSANRLTGSLPDSMANCMNLVALD--------------FSQNSMNGDLPQWIFSSGLNK 368
             +   +   +       + L  L               F+    +           L +
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247

Query: 369 VSFAENKIREGMNGPFAS--SGSSFESLQFLDLSHNEFSGETPATIGA-----LSGLQLL 421
           +   +  +            S      LQ L L +NE   +   T+       +  L  L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307

Query: 422 NLSRNSLVGPIPVAIGDLKAL 442
            L+ N         + +++ +
Sbjct: 308 ELNGNRF-SEEDDVVDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 51.0 bits (120), Expect = 4e-07
 Identities = 47/335 (14%), Positives = 103/335 (30%), Gaps = 35/335 (10%)

Query: 167 SSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGE----IPKGVESLKN 222
           +  S+      ++  +      +   +    +++ + LS N +  E    + + + S K+
Sbjct: 1   ARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 60

Query: 223 LRVINLSKN----------MFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCN 272
           L +   S                 +   +  C  L T+  S+N+F     E +      +
Sbjct: 61  LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 120

Query: 273 FMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGS 332
                  L +  +    G   +    +L+ NK +   P     +     L   + +    
Sbjct: 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW-- 178

Query: 333 LPDSMANCMNLVALDFSQNSMNGDLPQWIFSSG------LNKVSFAENKIREGMNGPFAS 386
              +  +   L  +   QN +  +  + +   G      L  +   +N      +   A 
Sbjct: 179 -AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 237

Query: 387 SGSSFESLQFLDLSHNEFSGETPATIG------ALSGLQLLNLSRNSLVGPIPVAIGD-- 438
           +  S+ +L+ L L+    S    A +          GLQ L L  N +       +    
Sbjct: 238 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI 297

Query: 439 ---LKALNVLDLSENWLNGSIPPEIGGAYSLKELR 470
              +  L  L+L+ N         +     +   R
Sbjct: 298 DEKMPDLLFLELNGNRF-SEEDDVVDEIREVFSTR 331

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 49.5 bits (116), Expect = 1e-06
 Identities = 32/296 (10%), Positives = 81/296 (27%), Gaps = 28/296 (9%)

Query: 284 EVPKWIGELESLETLDLSGNKFSG----AVPISIGNLQRLKVLNFSANRLTGSLPDSMAN 339
            V   + E +S++ + LSGN         +  +I + + L++  FS         +    
Sbjct: 22  SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81

Query: 340 CMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDL 399
              L+        ++             +    +   +           +         +
Sbjct: 82  LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141

Query: 400 SHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGD----LKALNVLDLSENWLNGS 455
           +                 L+ +   RN L               + L+ + + +N +   
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201

Query: 456 IPPEIGGAYSLKELRL---------ERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPI 506
               +          L           +  +  +  ++++  +L  L L+   L+     
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261

Query: 507 AIA------KLTNLQNVDLSFNSLTGGLPKQLV-----NLVHLSSFNISHNHLQGE 551
           A+       +   LQ + L +N +     + L       +  L    ++ N    E
Sbjct: 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 47.6 bits (111), Expect = 4e-06
 Identities = 39/323 (12%), Positives = 87/323 (26%), Gaps = 30/323 (9%)

Query: 199 LRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSG----SIPDGIGSCSLLRTIDFSE 254
           L+   ++    +  +   +    +++ I LS N         + + I S   L   +FS+
Sbjct: 10  LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68

Query: 255 NS---FSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPI 311
                    +PE ++ L        + +        +    +      LS +     + +
Sbjct: 69  IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128

Query: 312 SIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSF 371
               L        +      ++     N   L ++   +N +     +    +  +    
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188

Query: 372 AENKIREGMNGPFASSGSSFESL----------QFLDLSHNEFSGETPATIGALSGLQLL 421
              K+ +    P        E L             +   +  S      + +   L+ L
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248

Query: 422 NLSRNSLVGPIPVAIGD------LKALNVLDLSENWLNGSIPPEIGGA-----YSLKELR 470
            L+   L      A+ D         L  L L  N +       +          L  L 
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308

Query: 471 LERNFLAGKIPTSIENCSSLVSL 493
           L  N    +    ++    + S 
Sbjct: 309 LNGNRF-SEEDDVVDEIREVFST 330

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 45.6 bits (106), Expect = 2e-05
 Identities = 50/309 (16%), Positives = 98/309 (31%), Gaps = 34/309 (11%)

Query: 81  LTLNGLSLTG--RIGRGLLQLQFLRKLSLSSNNLTG----SISPNLAKLQNLRVIDLSGN 134
           L L+ ++      +   LL+   ++++ LS N +       +S N+A  ++L + + S  
Sbjct: 10  LKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI 69

Query: 135 SLSGSIPDEFFKQCGSLRVISLAKNR---FSGKIPSSLSLCSTLATINLSSNRFSSPLPL 191
                + DE  +    L    L   +         +            LS +     L L
Sbjct: 70  FTG-RVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128

Query: 192 GIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFS----GSIPDGIGSCSLL 247
              GL       ++  L E  + K  ++   LR I   +N               S  LL
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188

Query: 248 RTIDFSENSFSGNLPETMQKLSLCNFMNL---------RKNLFSGEVPKWIGELESLETL 298
            T+   +N       E +    L     L           +L S  +   +    +L  L
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248

Query: 299 DLSGNKFSGAVPISIGN------LQRLKVLNFSANRLTG----SLPDSMA-NCMNLVALD 347
            L+    S     ++ +         L+ L    N +      +L   +     +L+ L+
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308

Query: 348 FSQNSMNGD 356
            + N  + +
Sbjct: 309 LNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.2 bits (92), Expect = 7e-04
 Identities = 18/91 (19%), Positives = 29/91 (31%), Gaps = 9/91 (9%)

Query: 56  WSEDDDTPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRG----LLQLQFLRKLSLSSNN 111
            +              S  + R + L    LS  G          L+   L+ L L  N 
Sbjct: 225 NTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNE 284

Query: 112 LTGSISPNLA-----KLQNLRVIDLSGNSLS 137
           +       L      K+ +L  ++L+GN  S
Sbjct: 285 IELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.7 bits (88), Expect = 0.003
 Identities = 12/86 (13%), Positives = 28/86 (32%), Gaps = 10/86 (11%)

Query: 107 LSSNNLTGSISPNLA------KLQNLRVIDLSGNSLSG----SIPDEFFKQCGSLRVISL 156
           L+   L+   +  +       +   L+ + L  N +      ++     ++   L  + L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309

Query: 157 AKNRFSGKIPSSLSLCSTLATINLSS 182
             NRFS +      +    +T     
Sbjct: 310 NGNRFSEEDDVVDEIREVFSTRGRGE 335

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 37.9 bits (86), Expect = 0.004
 Identities = 12/93 (12%), Positives = 30/93 (32%), Gaps = 8/93 (8%)

Query: 489 SLVSLILSKNNLTG----PIPIAIAKLTNLQNVDLSFNSLTG----GLPKQLVNLVHLSS 540
           S+    L  + +T      +   + +  +++ + LS N++       L + + +   L  
Sbjct: 4   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63

Query: 541 FNISHNHLQGELPAGGFFNTISPSSVLGNPSLC 573
              S                +   ++L  P L 
Sbjct: 64  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLH 96

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.8 bits (120), Expect = 2e-07
 Identities = 35/185 (18%), Positives = 66/185 (35%), Gaps = 17/185 (9%)

Query: 275 NLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLP 334
           NL+K   +  V +   EL S++ +  + +       I    L  +  L  + N+LT   P
Sbjct: 30  NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNGNKLTDIKP 85

Query: 335 DSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESL 394
            +    +  + LD ++      L        L+      + I   ++ P   S     + 
Sbjct: 86  LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNK 145

Query: 395 QFLDLSHNEFSGET-----------PATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALN 443
                  +  +                 +  L+ LQ L LS+N +   +  A+  LK L+
Sbjct: 146 ITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLD 203

Query: 444 VLDLS 448
           VL+L 
Sbjct: 204 VLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.5 bits (109), Expect = 4e-06
 Identities = 37/202 (18%), Positives = 65/202 (32%), Gaps = 27/202 (13%)

Query: 140 IPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSAL 199
             D+ F +      I     + S     + +  +++  I  +++   S    GI  L  +
Sbjct: 18  FSDDAFAET-----IKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQ--GIQYLPNV 70

Query: 200 RTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSG 259
             L L+ N L    P  + +LKNL  + L +N                 +++ +  S   
Sbjct: 71  TKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDIN 128

Query: 260 NLPETMQKLSLCNFMNLRKNLFSGEVPKW----------------IGELESLETLDLSGN 303
            L    Q  SL    N   ++                        +  L  L+ L LS N
Sbjct: 129 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKN 188

Query: 304 KFSGAVPISIGNLQRLKVLNFS 325
             S     ++  L+ L VL   
Sbjct: 189 HISD--LRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.5 bits (96), Expect = 2e-04
 Identities = 34/192 (17%), Positives = 66/192 (34%), Gaps = 23/192 (11%)

Query: 77  RVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSL 136
             I+  L   S+T  + +   +L  + ++  +++++       +  L N+  + L+GN L
Sbjct: 25  ETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKL 80

Query: 137 SGSIPDEFFKQCGSLRV---------------ISLAKNRFSGKIPSSLSLCSTLATINLS 181
           +   P    K  G L +                  + +     I     L       +L 
Sbjct: 81  TDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLY 140

Query: 182 SNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGI 241
                      +  L+ L TL L DN +   +P  +  L  L+ + LSKN  S      +
Sbjct: 141 LGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD--LRAL 196

Query: 242 GSCSLLRTIDFS 253
                L  ++  
Sbjct: 197 AGLKNLDVLELF 208

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.2 bits (110), Expect = 3e-06
 Identities = 32/236 (13%), Positives = 67/236 (28%), Gaps = 11/236 (4%)

Query: 103 RKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFS 162
           R      + +T  I  +L +  N   +      L   I    F   G L  I +++N   
Sbjct: 11  RVFLCQESKVT-EIPSDLPR--NAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVL 66

Query: 163 GKIPSSLSLCSTLATINLS---SNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVES 219
             I + +               +N             +    L  +  +        + S
Sbjct: 67  EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS 126

Query: 220 LKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKN 279
           L+ + +             +     S    I +   +    +       +  + +NL  N
Sbjct: 127 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDN 186

Query: 280 LFSGEVPKWI-GELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLP 334
               E+P  +         LD+S  +        + NL++L+  +    +    LP
Sbjct: 187 NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP 239

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.3 bits (105), Expect = 1e-05
 Identities = 18/229 (7%), Positives = 44/229 (19%), Gaps = 4/229 (1%)

Query: 200 RTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSG 259
           R     ++ +  EIP  +   +N   +                    L  I+ S+N    
Sbjct: 11  RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67

Query: 260 NLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRL 319
            +   +            +   +                 L  +         +  +  L
Sbjct: 68  VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127

Query: 320 KVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREG 379
           + +                + + L             + +    +         N     
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187

Query: 380 MNGPF-ASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNS 427
                             LD+S           +  L  L+  +     
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 6e-05
 Identities = 32/233 (13%), Positives = 68/233 (29%), Gaps = 6/233 (2%)

Query: 294 SLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSM 353
           S        +K +  +P  +   +    L F   +L      + +   +L  ++ SQN +
Sbjct: 9   SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65

Query: 354 NGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIG 413
              +   +FS+          K    +     +  +       L  +           I 
Sbjct: 66  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125

Query: 414 ALSGLQLLNLSRNSLVGPIPVAIGDLKA-LNVLDLSENWLNGSIPPEIGGAYSLKELRLE 472
           +L  + L      ++      +   L     +L L++N +         G    +    +
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185

Query: 473 RNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLT 525
            N L           S  V L +S+  +       +  L  L+    S  +L 
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA--RSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.2 bits (97), Expect = 1e-04
 Identities = 26/238 (10%), Positives = 60/238 (25%), Gaps = 7/238 (2%)

Query: 222 NLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLF 281
           + RV    ++  +  IP  +        + F                     + + +N  
Sbjct: 9   SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65

Query: 282 SGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLT-GSLPDSMANC 340
              +   +                +              +     +      LPD     
Sbjct: 66  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125

Query: 341 MNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLS 400
                L   Q+++N    +     GL+  S      + G+      + +  +  +     
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185

Query: 401 HNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPP 458
           +N             SG  +L++SR  +       + +LK L        +    +P 
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST---YNLKKLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.8 bits (96), Expect = 2e-04
 Identities = 9/48 (18%), Positives = 18/48 (37%), Gaps = 4/48 (8%)

Query: 120 LAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPS 167
                   ++D+S   +  S+P    +    LR  S    +   K+P+
Sbjct: 197 FHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPT 240

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (107), Expect = 4e-06
 Identities = 23/133 (17%), Positives = 42/133 (31%), Gaps = 8/133 (6%)

Query: 102 LRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRF 161
            R+L L    +   I    A L     ID S N +      + F     L+ + +  NR 
Sbjct: 20  DRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI---RKLDGFPLLRRLKTLLVNNNRI 75

Query: 162 SGKIPSSLSLCSTLATINLSSNRFSS-PLPLGIWGLSALRTLDLSD---NLLEGEIPKGV 217
                        L  + L++N          +  L +L  L +        +      +
Sbjct: 76  CRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVI 135

Query: 218 ESLKNLRVINLSK 230
             +  +RV++  K
Sbjct: 136 YKVPQVRVLDFQK 148

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (87), Expect = 0.002
 Identities = 21/155 (13%), Positives = 44/155 (28%), Gaps = 9/155 (5%)

Query: 204 LSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPE 263
           L+  L+E +  +   +++  R ++L        I +   +      IDFS+N       +
Sbjct: 3   LTAELIE-QAAQYTNAVR-DRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLD 57

Query: 264 TMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLN 323
               L     + +  N            L  L  L L+ N       +      +     
Sbjct: 58  GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYL 117

Query: 324 FSANRLTGSLPD----SMANCMNLVALDFSQNSMN 354
                   +        +     +  LDF +  + 
Sbjct: 118 CILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK 152

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.2 bits (85), Expect = 0.003
 Identities = 17/103 (16%), Positives = 28/103 (27%), Gaps = 5/103 (4%)

Query: 470 RLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLP 529
           +L    +         N      L L    +   I    A L     +D S N +     
Sbjct: 2   KLTAELIEQ--AAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDG 58

Query: 530 KQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSL 572
                L  L +  +++N +                 +L N SL
Sbjct: 59  FP--LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 99

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.2 bits (105), Expect = 5e-06
 Identities = 20/154 (12%), Positives = 42/154 (27%), Gaps = 7/154 (4%)

Query: 172 CSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVES-LKNLRVINLSK 230
               + +  + +         + G   L  L + +      +       L  LR + + K
Sbjct: 7   PHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65

Query: 231 NMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFS-GEVPKWI 289
           +      PD       L  ++ S N+   +L     +      + L  N        +W+
Sbjct: 66  SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWL 124

Query: 290 GELESLETLDLSGNKFSGAVPISIGNLQRLKVLN 323
              E      +   K         G L  +   +
Sbjct: 125 QRWEEEGLGGVPEQKLQCHGQ---GPLAHMPNAS 155

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.9 bits (94), Expect = 1e-04
 Identities = 22/105 (20%), Positives = 39/105 (37%), Gaps = 2/105 (1%)

Query: 105 LSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGK 164
           L  + +        +L   +NL  + +        +     +  G LR +++ K+     
Sbjct: 13  LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71

Query: 165 IPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLL 209
            P +      L+ +NLS N   S L        +L+ L LS N L
Sbjct: 72  APDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (90), Expect = 5e-04
 Identities = 20/111 (18%), Positives = 36/111 (32%), Gaps = 2/111 (1%)

Query: 464 YSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIP-IAIAKLTNLQNVDLSFN 522
           +    LR  R+         +    +L  L +        +    +  L  L+N+ +  +
Sbjct: 8   HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 523 SLTGGLPKQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLC 573
            L    P        LS  N+S N L+          ++    + GNP  C
Sbjct: 67  GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.7 bits (99), Expect = 6e-05
 Identities = 30/202 (14%), Positives = 56/202 (27%), Gaps = 33/202 (16%)

Query: 140 IPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSAL 199
             D    +        L K   +  +  S +    + T+        S +  G+  L+ L
Sbjct: 12  FTDTALAE---KMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS-ID-GVEYLNNL 64

Query: 200 RTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSG 259
             ++ S+N         +  LKNL  +       +        +     T     N+   
Sbjct: 65  TQINFSNN-----QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT 119

Query: 260 NLPETMQKLSLCNFMNLRKNLFSGEVPKW-------------------IGELESLETLDL 300
           ++       +L         +                           +  L +LE LD+
Sbjct: 120 DIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDI 179

Query: 301 SGNKFSGAVPISIGNLQRLKVL 322
           S NK S      +  L  L+ L
Sbjct: 180 SSNKVSD--ISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 6e-04
 Identities = 35/195 (17%), Positives = 63/195 (32%), Gaps = 19/195 (9%)

Query: 275 NLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLP 334
            L K   +  V +   +L+ + TL            +    L  L  +NFS N+LT   P
Sbjct: 24  VLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKSIDGVE--YLNNLTQINFSNNQLTDITP 79

Query: 335 DSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESL 394
                 +  + ++ +Q +    L                                +  +L
Sbjct: 80  LKNLTKLVDILMNNNQIADITPLANLTNL---------TGLTLFNNQITDIDPLKNLTNL 130

Query: 395 QFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNG 454
             L+LS N  S  +  +          N S N +    P  + +L  L  LD+S N ++ 
Sbjct: 131 NRLELSSNTISDISALSGLTSLQQL--NFSSNQVTDLKP--LANLTTLERLDISSNKVSD 186

Query: 455 SIPPEIGGAYSLKEL 469
                +    +L+ L
Sbjct: 187 --ISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.9 bits (89), Expect = 0.001
 Identities = 11/66 (16%), Positives = 23/66 (34%), Gaps = 4/66 (6%)

Query: 485 ENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNIS 544
              +  +  +L K N+T  +      L  +  +      +       +  L +L+  N S
Sbjct: 15  TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFS 70

Query: 545 HNHLQG 550
           +N L  
Sbjct: 71  NNQLTD 76

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.7 bits (97), Expect = 7e-05
 Identities = 25/114 (21%), Positives = 38/114 (33%), Gaps = 7/114 (6%)

Query: 442 LNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLT 501
              LDL          P++        L    +  A  +    EN   L+SL LS N L 
Sbjct: 24  QQALDLKGL----RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLY 78

Query: 502 G--PIPIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHNHLQGELP 553
               +   + K  NL+ ++LS N L        +  + L    +  N L     
Sbjct: 79  RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (95), Expect = 2e-04
 Identities = 24/141 (17%), Positives = 42/141 (29%), Gaps = 13/141 (9%)

Query: 96  LLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVIS 155
           + +     + +L    L     P+L       V++   +  +        +    L  ++
Sbjct: 16  MSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA--TLRIIEENIPELLSLN 71

Query: 156 LAKNRFSGK--IPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEI 213
           L+ NR      + S +     L  +NLS N   S   L       L  L L  N L    
Sbjct: 72  LSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTF 131

Query: 214 PKG-------VESLKNLRVIN 227
                      E    L  ++
Sbjct: 132 RDQSTYISAIRERFPKLLRLD 152

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.9 bits (87), Expect = 0.002
 Identities = 22/154 (14%), Positives = 52/154 (33%), Gaps = 13/154 (8%)

Query: 203 DLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSG--N 260
           +L    +E ++   +    +     L            + + ++   ++   +  +    
Sbjct: 3   ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAATLRI 59

Query: 261 LPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLK 320
           + E + +L   N  N R       +   + +  +L+ L+LSGN+      +      +L+
Sbjct: 60  IEENIPELLSLNLSNNRLYRLDD-MSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118

Query: 321 VLNFSANRLTGSLPDS-------MANCMNLVALD 347
            L    N L+ +  D              L+ LD
Sbjct: 119 ELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	936
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.98
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.98
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.95
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.94
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.93
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.9
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.89
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.85
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.85
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.81
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.81
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.79
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.78
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.78
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.78
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.78
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.77
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.73
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.73
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.73
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.72
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.55
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.55
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.54
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.51
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.51
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.51
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.5
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.49
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.39
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.38
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.34
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.27
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.57
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.54
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.12
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.94
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.72
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.6
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.59
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.08
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.93
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.86
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.88
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.85

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-49  Score=413.51  Aligned_cols=241  Identities=23%  Similarity=0.312  Sum_probs=200.5

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .|+..+.||+|+||+||+|+++ +|+.||||++.........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~   85 (271)
T d1nvra_           6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC   85 (271)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence            4677889999999999999986 689999999976654445577999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++|+|.+++....   .+++.++..++.|+++||+|||++||+||||||+|||+++++.+||+|||+|+...........
T Consensus        86 ~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~  162 (271)
T d1nvra_          86 SGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  162 (271)
T ss_dssp             TTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             CCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence            9999999997643   3999999999999999999999999999999999999999999999999999877544444445


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHH-------Hhhhccccceeec
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEE-------HWKKAEWRNVSMR  922 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~  922 (936)
                      ....||+.|||||++.+...++.++||||+||++|||++|+.||................       ...+++..+++.+
T Consensus       163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  242 (271)
T d1nvra_         163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK  242 (271)
T ss_dssp             CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHH
T ss_pred             cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHH
Confidence            567899999999998655456788999999999999999999997765432222211111       2234667789999


Q ss_pred             cccccccccccc
Q 002321          923 SCKGSSRQRRRF  934 (936)
Q Consensus       923 ~l~~~p~~Rp~f  934 (936)
                      ||..||.+||+.
T Consensus       243 ~L~~dP~~R~t~  254 (271)
T d1nvra_         243 ILVENPSARITI  254 (271)
T ss_dssp             HSCSSTTTSCCH
T ss_pred             HcCCChhHCcCH
Confidence            999999999986

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-47  Score=403.11  Aligned_cols=237  Identities=22%  Similarity=0.343  Sum_probs=202.4

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .|+..++||+|+||+||+|+.+ +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4788889999999999999975 699999999975543 34577999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      ++|+|.+++.+..    +++.++..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.+....  ...
T Consensus       100 ~gg~L~~~~~~~~----l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~~  173 (293)
T d1yhwa1         100 AGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKR  173 (293)
T ss_dssp             TTCBHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCB
T ss_pred             CCCcHHHHhhccC----CCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc--ccc
Confidence            9999999887643    8999999999999999999999999999999999999999999999999998764322  223


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-------HHhhhccccceeec
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-------EHWKKAEWRNVSMR  922 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~  922 (936)
                      ....||+.|+|||++. +..++.++||||+||++|||++|+.||.+.+...........       +...++.+++++.+
T Consensus       174 ~~~~gt~~Y~aPE~~~-~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  252 (293)
T d1yhwa1         174 STMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR  252 (293)
T ss_dssp             CCCCSCGGGCCHHHHS-SSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred             cccccCCCccChhhhc-CCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence            4567999999999994 457899999999999999999999999887654333221111       23345678999999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      ||..||.+||+++
T Consensus       253 ~L~~dP~~R~s~~  265 (293)
T d1yhwa1         253 CLDMDVEKRGSAK  265 (293)
T ss_dssp             HTCSSTTTSCCHH
T ss_pred             HccCChhHCcCHH
Confidence            9999999999863

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-48  Score=403.56  Aligned_cols=237  Identities=26%  Similarity=0.395  Sum_probs=202.3

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      .|+..+.||+|+||+||+|+++ +++.||||++.....  ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE   86 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   86 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence            4677889999999999999986 588999999865432  2235778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+++|+|.+++.+...   +++.++..++.||++||+|||++||+||||||+|||++.++.+||+|||+|+......   
T Consensus        87 y~~~g~L~~~l~~~~~---l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~---  160 (263)
T d2j4za1          87 YAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---  160 (263)
T ss_dssp             CCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC---
T ss_pred             ecCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc---
Confidence            9999999999987543   8999999999999999999999999999999999999999999999999998664322   


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH-H---HHHHhhhccccceeecc
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT-W---LEEHWKKAEWRNVSMRS  923 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~-~---~~~~~~~~~~~~~~~~~  923 (936)
                       .....||+.|||||++. +..++.++||||+||++|||++|+.||...+........ .   ..+...++++++++.+|
T Consensus       161 -~~~~~Gt~~Y~APE~~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  238 (263)
T d2j4za1         161 -RTTLCGTLDYLPPEMIE-GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL  238 (263)
T ss_dssp             -CEETTEEGGGCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHH
T ss_pred             -ccccCCCCcccCHHHHc-CCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence             23467999999999994 557899999999999999999999999887654332211 1   11234567889999999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..||.+||+++
T Consensus       239 L~~dp~~R~t~~  250 (263)
T d2j4za1         239 LKHNPSQRPMLR  250 (263)
T ss_dssp             TCSSGGGSCCHH
T ss_pred             ccCCHhHCcCHH
Confidence            999999999863

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-47  Score=403.59  Aligned_cols=242  Identities=25%  Similarity=0.363  Sum_probs=193.3

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCc-cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSL-VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ...|+..++||+|+||+||+|+++  ..||||+++.... ....+.+.+|++++++++|||||++++++.+ ...++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            345678889999999999999875  3699999975543 3446789999999999999999999998754 56799999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+++|+|.++++....  .+++.++.+++.|+++||+|||+++||||||||+|||++.++.+||+|||+|+.........
T Consensus        84 y~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~  161 (276)
T d1uwha_          84 WCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH  161 (276)
T ss_dssp             CCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred             cCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence            9999999999976432  38999999999999999999999999999999999999999999999999998765444444


Q ss_pred             ccccccCcccccCcccccCc--ccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH----------HHhhhcc
Q 002321          848 LSSKIQSALGYMAPEFACRT--VKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE----------EHWKKAE  915 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~----------~~~~~~~  915 (936)
                      ......||+.|||||++...  ..|+.++|||||||++|||+||+.||.+.+...........          +...++.
T Consensus       162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  241 (276)
T d1uwha_         162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA  241 (276)
T ss_dssp             ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHH
T ss_pred             cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHH
Confidence            44566799999999988532  34789999999999999999999999876553222111111          1113357


Q ss_pred             ccceeecccccccccccccC
Q 002321          916 WRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++++.+||..||.+||+|+
T Consensus       242 l~~li~~cl~~dp~~RPt~~  261 (276)
T d1uwha_         242 MKRLMAECLKKKRDERPLFP  261 (276)
T ss_dssp             HHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHcCCCHhHCcCHH
Confidence            88999999999999999984

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-47  Score=403.14  Aligned_cols=241  Identities=18%  Similarity=0.217  Sum_probs=201.0

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      .|+..+.||+|+||+||+|+.+ +|+.||||+++....  ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE   88 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS   88 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence            4788889999999999999976 689999999965432  2335779999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+++|+|.+++...+.   +++.++..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+|+.+.......
T Consensus        89 y~~gg~L~~~~~~~~~---l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          89 YAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             CCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             ccCCCCHHHhhhccCC---CCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence            9999999999887553   9999999999999999999999999999999999999999999999999998775444444


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceeecc
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSMRS  923 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  923 (936)
                      ......||+.|||||++. +..++.++||||+||++|||++|+.||...+.........    ..+...++++++++.+|
T Consensus       166 ~~~~~~GT~~Y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  244 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL  244 (288)
T ss_dssp             ----CCCCGGGCCHHHHH-TCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTT
T ss_pred             ccccccCCccccCceeec-cCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence            445567999999999984 5578999999999999999999999998876643332111    11233457788999999


Q ss_pred             cccccccccccC
Q 002321          924 CKGSSRQRRRFQ  935 (936)
Q Consensus       924 l~~~p~~Rp~f~  935 (936)
                      |..||.+||+.+
T Consensus       245 L~~dP~~R~t~~  256 (288)
T d1uu3a_         245 LVLDATKRLGCE  256 (288)
T ss_dssp             SCSSGGGSTTSG
T ss_pred             ccCCHhHCcCHH
Confidence            999999999864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=400.68  Aligned_cols=241  Identities=22%  Similarity=0.312  Sum_probs=201.9

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      +.|+..++||+|+||+||+|+++ +|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            45777889999999999999976 58999999997543 33457789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++|+|.+++.+...  .+++.++..++.|+++||+|||++||+||||||+|||++.++.+||+|||+|+.....  ...
T Consensus        91 ~~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~  166 (288)
T d2jfla1          91 CAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR  166 (288)
T ss_dssp             CTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHH
T ss_pred             CCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC--ccc
Confidence            999999999865432  3899999999999999999999999999999999999999999999999999765321  122


Q ss_pred             cccccCcccccCccccc----CcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-------HHHhhhcccc
Q 002321          849 SSKIQSALGYMAPEFAC----RTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-------EEHWKKAEWR  917 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~  917 (936)
                      .....||+.|||||++.    ....|+.++||||+||++|||++|+.||.+............       .+...+++++
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~  246 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK  246 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence            34567999999999874    244588999999999999999999999988765433321111       1233457788


Q ss_pred             ceeecccccccccccccC
Q 002321          918 NVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++.+||..||.+||+++
T Consensus       247 ~li~~~L~~dp~~R~t~~  264 (288)
T d2jfla1         247 DFLKKCLEKNVDARWTTS  264 (288)
T ss_dssp             HHHHHHSCSSTTTSCCHH
T ss_pred             HHHHHHccCChhHCcCHH
Confidence            999999999999999863

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=395.43  Aligned_cols=239  Identities=25%  Similarity=0.355  Sum_probs=189.7

Q ss_pred             cccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      .|+..++||+|+||+||+|++++++.||||+++...  ...+++.+|++++++++|||||+++|++.+++..++||||++
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            356678899999999999999888999999997543  335789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                      +|+|.+++....  ..+++..+..++.|+|+||+|||+++|+||||||+|||+++++.+||+|||+++....... ....
T Consensus        84 ~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~  160 (263)
T d1sm2a_          84 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSST  160 (263)
T ss_dssp             TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred             CCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc-eeec
Confidence            999999987643  3488999999999999999999999999999999999999999999999999987643222 2223


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHH-HHH----HHHHhhhccccceeeccc
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFS-VTW----LEEHWKKAEWRNVSMRSC  924 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~l  924 (936)
                      ...||+.|+|||++. ...++.++|||||||++|||+| |++||.......... ...    ..+...++++.+++.+||
T Consensus       161 ~~~gt~~y~aPE~l~-~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl  239 (263)
T d1sm2a_         161 GTKFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW  239 (263)
T ss_dssp             ----CTTSCCHHHHT-TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHT
T ss_pred             ceecCcccCChHHhc-CCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHc
Confidence            456889999999984 5578999999999999999999 566666554432221 111    112344577899999999


Q ss_pred             ccccccccccC
Q 002321          925 KGSSRQRRRFQ  935 (936)
Q Consensus       925 ~~~p~~Rp~f~  935 (936)
                      ..||.+||+++
T Consensus       240 ~~~p~~Rps~~  250 (263)
T d1sm2a_         240 KERPEDRPAFS  250 (263)
T ss_dssp             CSSGGGSCCHH
T ss_pred             cCCHhHCcCHH
Confidence            99999999974

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=393.33  Aligned_cols=239  Identities=24%  Similarity=0.344  Sum_probs=203.5

Q ss_pred             cccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecC
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVS  770 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  770 (936)
                      .|+..++||+|+||+||+|++++++.||||+++....  ..+++.+|+.++++++||||++++|++.+++..++||||++
T Consensus         5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            4577889999999999999998888999999976543  35789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccccc
Q 002321          771 GGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLSS  850 (936)
Q Consensus       771 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  850 (936)
                      +|++.+++.....  .+++..+.+++.|+++||+|||++||+||||||+||++++++.+||+|||+++....... ....
T Consensus        83 ~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~  159 (258)
T d1k2pa_          83 NGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSV  159 (258)
T ss_dssp             TEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCCC
T ss_pred             CCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-eeec
Confidence            9999998765432  388999999999999999999999999999999999999999999999999987654332 2334


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHH-----HHHHHhhhccccceeeccc
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVT-----WLEEHWKKAEWRNVSMRSC  924 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l  924 (936)
                      ...+|+.|+|||.+. ...++.++|||||||++|||+| |+.||............     ...+...++++.+++.+||
T Consensus       160 ~~~~t~~y~aPE~~~-~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl  238 (258)
T d1k2pa_         160 GSKFPVRWSPPEVLM-YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW  238 (258)
T ss_dssp             CSCCCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTT
T ss_pred             ccCCCCCcCCcHHhc-CCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHc
Confidence            466889999999984 4578999999999999999998 89999887664333211     1123444577999999999


Q ss_pred             ccccccccccC
Q 002321          925 KGSSRQRRRFQ  935 (936)
Q Consensus       925 ~~~p~~Rp~f~  935 (936)
                      ..||.+||+|+
T Consensus       239 ~~dP~~RPt~~  249 (258)
T d1k2pa_         239 HEKADERPTFK  249 (258)
T ss_dssp             CSSGGGSCCHH
T ss_pred             cCCHhHCcCHH
Confidence            99999999985

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=397.93  Aligned_cols=235  Identities=25%  Similarity=0.344  Sum_probs=195.7

Q ss_pred             cccccCceEEEEEEeC---CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCCCC
Q 002321          697 ELGRGGFGAVYRTVLR---DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSGGS  773 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  773 (936)
                      +||+|+||+||+|.++   ++..||||+++........+++.+|++++++++|||||++++++.++ ..++||||+++|+
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~   94 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGP   94 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEE
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCc
Confidence            5999999999999865   35579999997665555578899999999999999999999998654 5789999999999


Q ss_pred             hhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc-cccccc
Q 002321          774 LHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY-VLSSKI  852 (936)
Q Consensus       774 L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~  852 (936)
                      |.+++....  ..+++.++.+++.|+++||+|||+++|+||||||+||+++.++.+||+|||+|+.+...... ......
T Consensus        95 L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~  172 (285)
T d1u59a_          95 LHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG  172 (285)
T ss_dssp             HHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSS
T ss_pred             HHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccccccccccc
Confidence            999986543  23899999999999999999999999999999999999999999999999999877543322 233345


Q ss_pred             cCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceeeccccc
Q 002321          853 QSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSMRSCKG  926 (936)
Q Consensus       853 ~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~  926 (936)
                      .+|+.|+|||++. ...++.++|||||||++|||+| |+.||.+...........     ..+...++++.+++.+||..
T Consensus       173 ~gt~~y~aPE~~~-~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~  251 (285)
T d1u59a_         173 KWPLKWYAPECIN-FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIY  251 (285)
T ss_dssp             CCCGGGCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCS
T ss_pred             ccCccccChHHHh-CCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCC
Confidence            6889999999984 4578999999999999999998 999998876543321110     11234557789999999999


Q ss_pred             ccccccccC
Q 002321          927 SSRQRRRFQ  935 (936)
Q Consensus       927 ~p~~Rp~f~  935 (936)
                      ||.+||+|+
T Consensus       252 ~p~~RPs~~  260 (285)
T d1u59a_         252 KWEDRPDFL  260 (285)
T ss_dssp             SGGGSCCHH
T ss_pred             CHhHCcCHH
Confidence            999999984

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=396.29  Aligned_cols=242  Identities=21%  Similarity=0.357  Sum_probs=189.6

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEe--CCeeEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWT--QSLQLLIY  766 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  766 (936)
                      .|+..+.||+|+||+||+|+.+ +|+.||||++...... ...+.+.+|++++++++|||||++++++.+  ....++||
T Consensus         5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm   84 (269)
T d2java1           5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM   84 (269)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred             hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence            4677889999999999999976 6899999999765543 335678999999999999999999999865  45678999


Q ss_pred             EecCCCChhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCCEEEcCCCCeEEeeccCcccc
Q 002321          767 EFVSGGSLHKHLHEGS-GGNFLSWNERFNVIQGTAKSLAHLHQSN-----IIHYNIKSSNVLIDGSGEPKVGDYGLARLL  840 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~-----ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  840 (936)
                      ||+++|+|.+++.+.. ....+++.+++.++.|++.||+|||+++     |+||||||+|||++.++.+||+|||+|+.+
T Consensus        85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~  164 (269)
T d2java1          85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  164 (269)
T ss_dssp             ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred             ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence            9999999999986532 2234999999999999999999999876     999999999999999999999999999876


Q ss_pred             CCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-----HHHhhhcc
Q 002321          841 PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-----EEHWKKAE  915 (936)
Q Consensus       841 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~  915 (936)
                      ....  .......||+.|||||++ .+..++.++||||+||++|||++|+.||...+..........     .+...+++
T Consensus       165 ~~~~--~~~~~~~gt~~Y~APE~l-~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  241 (269)
T d2java1         165 NHDT--SFAKAFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE  241 (269)
T ss_dssp             -------------CCCSCCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred             ccCC--CccccCCCCcccCCHHHH-cCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence            4322  223456789999999998 455789999999999999999999999988765433211110     01224467


Q ss_pred             ccceeecccccccccccccC
Q 002321          916 WRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++++.+||..||.+||+++
T Consensus       242 l~~li~~~L~~dp~~Rps~~  261 (269)
T d2java1         242 LNEIITRMLNLKDYHRPSVE  261 (269)
T ss_dssp             HHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHcCCChhHCcCHH
Confidence            89999999999999999864

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.8e-46  Score=400.57  Aligned_cols=242  Identities=25%  Similarity=0.361  Sum_probs=189.7

Q ss_pred             cccCCCcccccCceEEEEEEeCC-C---cEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRD-G---RPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      .|+..+.||+|+||+||+|+++. +   ..||||++.........+++.+|++++++++|||||+++|++.+.+..++||
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~  106 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT  106 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            45667889999999999999763 3   3589999876555555678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++|+|.+++.....  .+++.++.+++.|+++||+|||+++|+||||||+|||++.++++||+|||+|+........
T Consensus       107 Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~  184 (299)
T d1jpaa_         107 EFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD  184 (299)
T ss_dssp             ECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             EecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence            99999999998876432  3899999999999999999999999999999999999999999999999999876532221


Q ss_pred             c---ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhcccc
Q 002321          847 V---LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWR  917 (936)
Q Consensus       847 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~  917 (936)
                      .   ......+|+.|||||.+. ...++.++|||||||++|||+| |+.||.+...........     ..+...++.+.
T Consensus       185 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  263 (299)
T d1jpaa_         185 PTYTSALGGKIPIRWTAPEAIQ-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH  263 (299)
T ss_dssp             -----------CGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             ceeeecccccCCccccCHHHHh-cCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHH
Confidence            1   122245788999999984 4578999999999999999998 899998876543321111     11223456789


Q ss_pred             ceeecccccccccccccC
Q 002321          918 NVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++.+||..||.+||+|+
T Consensus       264 ~li~~cl~~~P~~RPs~~  281 (299)
T d1jpaa_         264 QLMLDCWQKDRNHRPKFG  281 (299)
T ss_dssp             HHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHHcCCCHhHCcCHH
Confidence            999999999999999974

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-46  Score=394.05  Aligned_cols=241  Identities=26%  Similarity=0.337  Sum_probs=196.8

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ...|+..++||+|+||+||+|++++++.||||+++...  ...+.+.+|++++++++|||||++++++.+ +..++||||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            34567788999999999999999888899999997543  345789999999999999999999998854 556899999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++|+|.+++..... ..+++.++.+|+.||++||+|||+++|+||||||+|||+++++.+||+|||+|+...... ...
T Consensus        89 ~~~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~~  166 (272)
T d1qpca_          89 MENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTA  166 (272)
T ss_dssp             CTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EEC
T ss_pred             CCCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc-ccc
Confidence            999999998765432 238999999999999999999999999999999999999999999999999998775432 233


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCC-CCccchhHHHHH-HH----HHHHhhhccccceeec
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRP-LSTWKMMWWFSV-TW----LEEHWKKAEWRNVSMR  922 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~P-f~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~  922 (936)
                      .....+++.|||||++. ...++.++|||||||++|||+||..| |........... ..    ..+...++++++++.+
T Consensus       167 ~~~~~gt~~y~APE~~~-~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~  245 (272)
T d1qpca_         167 REGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL  245 (272)
T ss_dssp             CTTCCCCTTTSCHHHHH-HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             ccccCCcccccChHHHh-CCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHH
Confidence            34567889999999984 45689999999999999999996554 544443322211 10    1123455778999999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      ||..||.+||+|+
T Consensus       246 cl~~~P~~Rpt~~  258 (272)
T d1qpca_         246 CWKERPEDRPTFD  258 (272)
T ss_dssp             HTCSSGGGSCCHH
T ss_pred             HcCCCHhHCcCHH
Confidence            9999999999974

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-45  Score=389.44  Aligned_cols=234  Identities=25%  Similarity=0.366  Sum_probs=192.6

Q ss_pred             cCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEe----CCeeEEEE
Q 002321          693 NKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWT----QSLQLLIY  766 (936)
Q Consensus       693 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  766 (936)
                      +..++||+|+||+||+|++. +++.||||++...... ...+.+.+|++++++++|||||++++++.+    +...++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45567999999999999976 5889999999765433 335678999999999999999999999875    34578999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEc-CCCCeEEeeccCccccCCC
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSN--IIHYNIKSSNVLID-GSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~  843 (936)
                      ||+++|+|.+++.+...   +++.++..++.||++||+|||+++  |+||||||+|||++ +++.+||+|||+|+.....
T Consensus        92 E~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             ECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             eCCCCCcHHHHHhcccc---ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence            99999999999987543   899999999999999999999998  99999999999996 5789999999999864321


Q ss_pred             ccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-------HHHhhhccc
Q 002321          844 DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-------EEHWKKAEW  916 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~  916 (936)
                          ......||+.|||||++. + .++.++||||+||++|||++|+.||..............       .+...++++
T Consensus       169 ----~~~~~~GT~~Y~aPE~~~-~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (270)
T d1t4ha_         169 ----FAKAVIGTPEFMAPEMYE-E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV  242 (270)
T ss_dssp             ----SBEESCSSCCCCCGGGGG-T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred             ----ccCCcccCccccCHHHhC-C-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHH
Confidence                224567999999999884 3 489999999999999999999999976544322111110       112234678


Q ss_pred             cceeecccccccccccccC
Q 002321          917 RNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       917 ~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ++++.+||..||.+||+++
T Consensus       243 ~~li~~~l~~dp~~R~s~~  261 (270)
T d1t4ha_         243 KEIIEGCIRQNKDERYSIK  261 (270)
T ss_dssp             HHHHHHHSCSSGGGSCCHH
T ss_pred             HHHHHHHccCCHhHCcCHH
Confidence            8999999999999999863

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6e-46  Score=395.56  Aligned_cols=242  Identities=24%  Similarity=0.315  Sum_probs=199.6

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      ...|+..++||+|+||+||+|+++ +++.||||+++...  ...+++.+|++++++++|||||++++++.+.+..++|||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            345677889999999999999987 48899999986543  346789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      |+++|+|.+++.+... ..+++..+..++.|+++||+|||+++|+||||||+|||+++++.+||+|||+|+...... ..
T Consensus        94 ~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-~~  171 (287)
T d1opja_          94 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YT  171 (287)
T ss_dssp             CCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-SE
T ss_pred             cccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC-ce
Confidence            9999999999976543 348999999999999999999999999999999999999999999999999998765322 22


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCcc-chhHHHHHHH-----HHHHhhhccccceee
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTW-KMMWWFSVTW-----LEEHWKKAEWRNVSM  921 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~  921 (936)
                      ......+++.|+|||++. ...++.++|||||||++|||++|..||... +.........     ..+...++++++++.
T Consensus       172 ~~~~~~g~~~y~aPE~~~-~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  250 (287)
T d1opja_         172 AHAGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR  250 (287)
T ss_dssp             EETTEEECGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eeccccccccccChHHHc-CCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHH
Confidence            334456788999999884 457899999999999999999976665443 3332221110     112335577899999


Q ss_pred             cccccccccccccC
Q 002321          922 RSCKGSSRQRRRFQ  935 (936)
Q Consensus       922 ~~l~~~p~~Rp~f~  935 (936)
                      +||..||.+||+++
T Consensus       251 ~cl~~dP~~Rps~~  264 (287)
T d1opja_         251 ACWQWNPSDRPSFA  264 (287)
T ss_dssp             HHTCSSGGGSCCHH
T ss_pred             HHcCCCHhHCcCHH
Confidence            99999999999874

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-46  Score=395.52  Aligned_cols=235  Identities=22%  Similarity=0.301  Sum_probs=191.3

Q ss_pred             CcccccCceEEEEEEeCC---CcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEecCC
Q 002321          696 CELGRGGFGAVYRTVLRD---GRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFVSG  771 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  771 (936)
                      ++||+|+||+||+|.+++   ++.||||+++..... ...+++.+|++++++++|||||++++++.++ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            579999999999998653   468999999654333 3357899999999999999999999999654 56899999999


Q ss_pred             CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc-ccccc
Q 002321          772 GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR-YVLSS  850 (936)
Q Consensus       772 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~  850 (936)
                      |+|.++++....   +++.++.+++.||++||+|||+++|+||||||+|||++.++.+||+|||+|+.+..... .....
T Consensus        92 g~L~~~l~~~~~---l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_          92 GPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             EEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred             CcHHHHHhhccC---CCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence            999999987543   99999999999999999999999999999999999999999999999999987654322 22334


Q ss_pred             cccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHH-----HHHHhhhccccceeeccc
Q 002321          851 KIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTW-----LEEHWKKAEWRNVSMRSC  924 (936)
Q Consensus       851 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l  924 (936)
                      ...||+.|||||.+. ...++.++|||||||++|||++ |+.||.+.+.........     ..+...++++++++.+||
T Consensus       169 ~~~gt~~y~APE~l~-~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl  247 (277)
T d1xbba_         169 HGKWPVKWYAPECIN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW  247 (277)
T ss_dssp             --CCCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred             ccCCCceecCchhhc-CCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHc
Confidence            456889999999884 4578999999999999999998 899998876543332111     112334577899999999


Q ss_pred             ccccccccccC
Q 002321          925 KGSSRQRRRFQ  935 (936)
Q Consensus       925 ~~~p~~Rp~f~  935 (936)
                      ..||++||+|+
T Consensus       248 ~~dp~~RPs~~  258 (277)
T d1xbba_         248 TYDVENRPGFA  258 (277)
T ss_dssp             CSSTTTSCCHH
T ss_pred             CCCHhHCcCHH
Confidence            99999999984

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-46  Score=405.64  Aligned_cols=201  Identities=23%  Similarity=0.384  Sum_probs=177.2

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      .+.|+..++||+|+||+||+|++. +|+.||||+++........+.+.+|+.++++++|||||++++++.+....++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            345778889999999999999976 6899999999766545556789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQS-NIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      |+++|+|.+++.+...   +++..+..++.|++.||+|||++ ||+||||||+|||++.+|.+||+|||+|+....    
T Consensus        85 y~~gg~L~~~l~~~~~---l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~----  157 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----  157 (322)
T ss_dssp             CCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----
T ss_pred             cCCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC----
Confidence            9999999999987543   89999999999999999999975 999999999999999999999999999986532    


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccc
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWK  897 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~  897 (936)
                      .......||+.|||||++. +..|+.++||||+||++|||++|+.||...+
T Consensus       158 ~~~~~~~GT~~Y~APEvl~-~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         158 SMANSFVGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             HTC---CCSSCCCCHHHHH-CSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             CccccccCCccccCchHHc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            1234467999999999995 4579999999999999999999999997654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.8e-46  Score=399.61  Aligned_cols=239  Identities=23%  Similarity=0.326  Sum_probs=184.3

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      +.|+..+.||+|+||+||+|+.+ +|+.||||++.........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            44788889999999999999976 58999999997665555567788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc---CCCCeEEeeccCccccCCCcc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLID---GSGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      ++||+|.+++.+..   .+++.++..++.|++.||+|||++||+||||||+||++.   +++.+||+|||+|+...... 
T Consensus        89 ~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-  164 (307)
T d1a06a_          89 VSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-  164 (307)
T ss_dssp             CCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             cCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC-
Confidence            99999999997644   399999999999999999999999999999999999994   57899999999998654322 


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-H-----H--Hhhhcccc
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-E-----E--HWKKAEWR  917 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-~-----~--~~~~~~~~  917 (936)
                        ......||+.|||||++. +..|+.++||||+||++|||++|+.||.+............ .     +  .-.+++++
T Consensus       165 --~~~~~~GT~~y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  241 (307)
T d1a06a_         165 --VLSTACGTPGYVAPEVLA-QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK  241 (307)
T ss_dssp             ----------CTTSCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred             --eeeeeeeCccccCcHHHc-CCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence              223467999999999984 55789999999999999999999999988765433211110 0     1  12346678


Q ss_pred             ceeecccccccccccccC
Q 002321          918 NVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       918 ~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++.+||..||.+||+++
T Consensus       242 ~li~~~L~~dP~~R~s~~  259 (307)
T d1a06a_         242 DFIRHLMEKDPEKRFTCE  259 (307)
T ss_dssp             HHHHHHSCSSGGGSCCHH
T ss_pred             HHHHHHccCCHhHCcCHH
Confidence            999999999999999853

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.5e-46  Score=397.68  Aligned_cols=237  Identities=27%  Similarity=0.376  Sum_probs=198.7

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..++||+|+||+||+|+.. +|+.||||+++.....  ...+.+.+|++++++++|||||++++++.++...++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            34778889999999999999975 6889999999765432  23467899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++|++..++....   .+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....    
T Consensus        95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----  167 (309)
T ss_dssp             ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred             EecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence            9999999987766543   389999999999999999999999999999999999999999999999999986532    


Q ss_pred             cccccccCcccccCcccccC--cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH------HHHhhhccccc
Q 002321          847 VLSSKIQSALGYMAPEFACR--TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL------EEHWKKAEWRN  918 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~  918 (936)
                        .....||+.|||||++.+  ...|+.++||||+||++|||++|+.||..............      .+...++.+++
T Consensus       168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~  245 (309)
T d1u5ra_         168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN  245 (309)
T ss_dssp             --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHH
T ss_pred             --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence              234579999999998853  34589999999999999999999999987665432211110      11223467899


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..||.+||+++
T Consensus       246 li~~~L~~dP~~Rpt~~  262 (309)
T d1u5ra_         246 FVDSCLQKIPQDRPTSE  262 (309)
T ss_dssp             HHHHHTCSSGGGSCCHH
T ss_pred             HHHHHCcCChhHCcCHH
Confidence            99999999999999864

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-46  Score=404.93  Aligned_cols=246  Identities=25%  Similarity=0.326  Sum_probs=200.5

Q ss_pred             cccccCCCcccccCceEEEEEEeCC-C-----cEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCe
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRD-G-----RPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSL  761 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  761 (936)
                      ...|+..++||+|+||+||+|++.. +     ..||||++...........+.+|+.+++++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3456788899999999999999753 2     369999987655445567899999999998 89999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSG--------------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNV  821 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NI  821 (936)
                      .++||||+++|+|.++++....                    ...+++.+++.++.|+++||+|||+++|+||||||+||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni  195 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV  195 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence            9999999999999999976432                    12488999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhH
Q 002321          822 LIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMW  900 (936)
Q Consensus       822 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~  900 (936)
                      +++.++.+||+|||+|+...............+|+.|||||++. ...++.++|||||||++|||++ |+.||.+.....
T Consensus       196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~  274 (325)
T d1rjba_         196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA  274 (325)
T ss_dssp             EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc-CCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999998765544444444566899999999884 5578999999999999999998 899998765432


Q ss_pred             HHH-H-H----HHHHHhhhccccceeecccccccccccccC
Q 002321          901 WFS-V-T----WLEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       901 ~~~-~-~----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ... . .    ...+...++++++++.+||..||.+||+|+
T Consensus       275 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~  315 (325)
T d1rjba_         275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP  315 (325)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHH
Confidence            221 1 1    112345567899999999999999999984

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-45  Score=394.71  Aligned_cols=239  Identities=22%  Similarity=0.263  Sum_probs=204.0

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      +.|+..+.||+|+||+||+|+.+ +|+.||||+++....  ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            45788889999999999999975 699999999975432  233577899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++|+|.+++.+...   +++..+..++.|++.||+|||++||+||||||+|||++++|.+||+|||+|+......  
T Consensus        85 ey~~gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~--  159 (337)
T d1o6la_          85 EYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--  159 (337)
T ss_dssp             ECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--
T ss_pred             eccCCCchhhhhhcccC---CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC--
Confidence            99999999999987654   8999999999999999999999999999999999999999999999999998654322  


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceeec
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSMR  922 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  922 (936)
                      .......||+.|+|||++. +..|+.++||||+||++|||++|+.||...+.........    ..+...+++.++++.+
T Consensus       160 ~~~~~~~GT~~Y~aPE~~~-~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~  238 (337)
T d1o6la_         160 ATMKTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGS-SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             cccccceeCHHHhhhhhcc-CCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence            2234567999999999984 5578999999999999999999999999877644332221    1133455778999999


Q ss_pred             cccccccccccc
Q 002321          923 SCKGSSRQRRRF  934 (936)
Q Consensus       923 ~l~~~p~~Rp~f  934 (936)
                      ||..||.+|++.
T Consensus       239 ~L~~dP~~R~~~  250 (337)
T d1o6la_         239 LLKKDPKQRLGG  250 (337)
T ss_dssp             HTCSSTTTSTTC
T ss_pred             hccCCchhhccc
Confidence            999999999963

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-45  Score=388.81  Aligned_cols=239  Identities=24%  Similarity=0.321  Sum_probs=201.3

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-----chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-----KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  763 (936)
                      +.|+..++||+|+||+||+|+.+ +|+.||||+++.....     ...+.+.+|++++++++|||||++++++.+....+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            35788889999999999999985 6899999999654322     23678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC----CeEEeeccCccc
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG----EPKVGDYGLARL  839 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg~a~~  839 (936)
                      +||||+++|+|.+++.....   +++.++..++.|++.||+|||+++|+||||||+||+++.++    .+|++|||+|+.
T Consensus        90 iv~E~~~gg~L~~~i~~~~~---l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~  166 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  166 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEEcCCCccccchhccccc---cchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence            99999999999999987543   99999999999999999999999999999999999998877    499999999987


Q ss_pred             cCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHH-H-------HHHHHh
Q 002321          840 LPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSV-T-------WLEEHW  911 (936)
Q Consensus       840 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~-~-------~~~~~~  911 (936)
                      .....   ......+|+.|+|||++. +..++.++||||+||++|||++|+.||.+......... .       ...+..
T Consensus       167 ~~~~~---~~~~~~~t~~y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (293)
T d1jksa_         167 IDFGN---EFKNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN  242 (293)
T ss_dssp             CTTSC---BCSCCCCCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             cCCCc---cccccCCCCcccCHHHHc-CCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCC
Confidence            64332   234457899999999984 55789999999999999999999999987665332211 0       111223


Q ss_pred             hhccccceeecccccccccccccC
Q 002321          912 KKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       912 ~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      .++.+++++.+||..||.+||+++
T Consensus       243 ~s~~~~~li~~~L~~dP~~R~s~~  266 (293)
T d1jksa_         243 TSALAKDFIRRLLVKDPKKRMTIQ  266 (293)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHH
Confidence            456788999999999999999863

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-45  Score=388.25  Aligned_cols=241  Identities=26%  Similarity=0.362  Sum_probs=188.7

Q ss_pred             ccCCCcccccCceEEEEEEeCCC-----cEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLRDG-----RPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      |+..+.||+|+||+||+|+++.+     ..||||++..........++.+|++++++++|||||+++|++.+....++||
T Consensus         9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~   88 (283)
T d1mqba_           9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT   88 (283)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence            56677899999999999997642     4799999976655555678999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc-
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR-  845 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-  845 (936)
                      ||+++|++.+++.....  .+++.++.+++.|++.|++|||+++|+||||||+|||++.++.+||+|||+|+....... 
T Consensus        89 e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~  166 (283)
T d1mqba_          89 EYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  166 (283)
T ss_dssp             ECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred             EecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence            99999999998876432  389999999999999999999999999999999999999999999999999987643322 


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCC-CccchhHHHHHHH-----HHHHhhhccccce
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL-STWKMMWWFSVTW-----LEEHWKKAEWRNV  919 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf-~~~~~~~~~~~~~-----~~~~~~~~~~~~~  919 (936)
                      ........||+.|||||++ ....++.++|||||||++|||++|..|| .............     ..+...+..+.++
T Consensus       167 ~~~~~~~~gt~~Y~APE~l-~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  245 (283)
T d1mqba_         167 TYTTSGGKIPIRWTAPEAI-SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL  245 (283)
T ss_dssp             -------CCCGGGSCHHHH-HSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHH
T ss_pred             ceEeccCCCCccccCHHHH-ccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHH
Confidence            1223345678999999988 4557899999999999999999965554 4333322221100     0122344678999


Q ss_pred             eecccccccccccccC
Q 002321          920 SMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       920 ~~~~l~~~p~~Rp~f~  935 (936)
                      +.+||..||.+||+|+
T Consensus       246 i~~cl~~~p~~RPt~~  261 (283)
T d1mqba_         246 MMQCWQQERARRPKFA  261 (283)
T ss_dssp             HHHHTCSSTTTSCCHH
T ss_pred             HHHHCcCCHhHCcCHH
Confidence            9999999999999974

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.5e-44  Score=394.69  Aligned_cols=237  Identities=24%  Similarity=0.359  Sum_probs=199.0

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .|+..+.||+|+||+||+|+.+ +|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            4777889999999999999976 689999999965543 34577899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc--CCCCeEEeeccCccccCCCcccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLID--GSGEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~--~~~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      ++|+|.+++.+..  ..+++.++..++.||+.||+|||++||+||||||+|||++  .++.+||+|||+|+.+....   
T Consensus       106 ~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~---  180 (350)
T d1koaa2         106 SGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---  180 (350)
T ss_dssp             CSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS---
T ss_pred             CCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc---
Confidence            9999999986543  2399999999999999999999999999999999999995  46889999999998764322   


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH-HH-----H--Hhhhccccce
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW-LE-----E--HWKKAEWRNV  919 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~-~~-----~--~~~~~~~~~~  919 (936)
                      ......||+.|||||++. +..++.++||||+||++|||++|+.||.+.+......... ..     .  ...+++++++
T Consensus       181 ~~~~~~gT~~Y~aPEv~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  259 (350)
T d1koaa2         181 SVKVTTGTAEFAAPEVAE-GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF  259 (350)
T ss_dssp             CEEEECSCTTTCCHHHHH-TCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred             ccceecCcccccCHHHHc-CCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence            234567899999999984 5578999999999999999999999998776543321111 00     1  1234678899


Q ss_pred             eeccccccccccccc
Q 002321          920 SMRSCKGSSRQRRRF  934 (936)
Q Consensus       920 ~~~~l~~~p~~Rp~f  934 (936)
                      +.+||..||++||+.
T Consensus       260 i~~~L~~dP~~R~t~  274 (350)
T d1koaa2         260 IRKLLLADPNTRMTI  274 (350)
T ss_dssp             HHHHCCSSGGGSCCH
T ss_pred             HHHHccCChhHCcCH
Confidence            999999999999975

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.3e-44  Score=388.20  Aligned_cols=234  Identities=24%  Similarity=0.355  Sum_probs=200.4

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      ..|+..++||+|+||+||+|+.+ +|+.||||+++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            34678889999999999999975 689999999965432  234578999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||++||++..++.....   +++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.....   
T Consensus        84 E~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             eecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence            99999999999887554   788899999999999999999999999999999999999999999999999876432   


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH----HHHHHhhhccccceeec
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT----WLEEHWKKAEWRNVSMR  922 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  922 (936)
                        .....||+.|||||++ .+..|+.++||||+||++|||++|+.||...+........    ...+...++++++++.+
T Consensus       158 --~~~~~Gt~~Y~APE~l-~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  234 (316)
T d1fota_         158 --TYTLCGTPDYIAPEVV-STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR  234 (316)
T ss_dssp             --BCCCCSCTTTCCHHHH-TTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             --cccccCcccccCHHHH-cCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence              2346799999999998 4557899999999999999999999999887664333221    11123455778999999


Q ss_pred             cccccccccc
Q 002321          923 SCKGSSRQRR  932 (936)
Q Consensus       923 ~l~~~p~~Rp  932 (936)
                      ||..||.+|+
T Consensus       235 ~L~~dp~~R~  244 (316)
T d1fota_         235 LITRDLSQRL  244 (316)
T ss_dssp             HTCSCTTTCT
T ss_pred             HhhhCHHhcc
Confidence            9999999996

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.9e-44  Score=392.69  Aligned_cols=238  Identities=23%  Similarity=0.343  Sum_probs=200.4

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ..|+..++||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|++++++++|||||++++++.++...++||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            45788889999999999999975 699999999976543 3456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc--CCCCeEEeeccCccccCCCccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLID--GSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~--~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      +++|+|.+++....  ..+++.++..|+.||+.||+|||++||+||||||+|||++  .++.+||+|||+|+.+....  
T Consensus       108 ~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--  183 (352)
T d1koba_         108 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--  183 (352)
T ss_dssp             CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred             CCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC--
Confidence            99999998876543  2399999999999999999999999999999999999998  67899999999998765322  


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-H---H----Hhhhccccc
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-E---E----HWKKAEWRN  918 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-~---~----~~~~~~~~~  918 (936)
                       ......+|+.|||||++ .+..++.++||||+||++|||++|+.||.+.+.......... .   +    ...++++++
T Consensus       184 -~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  261 (352)
T d1koba_         184 -IVKVTTATAEFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD  261 (352)
T ss_dssp             -CEEEECSSGGGCCHHHH-TTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred             -ceeeccCcccccCHHHH-cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence             23446789999999998 455789999999999999999999999988766433221110 0   0    123467789


Q ss_pred             eeeccccccccccccc
Q 002321          919 VSMRSCKGSSRQRRRF  934 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f  934 (936)
                      ++.+||..||.+||+.
T Consensus       262 li~~~L~~dp~~R~s~  277 (352)
T d1koba_         262 FIKNLLQKEPRKRLTV  277 (352)
T ss_dssp             HHHTTSCSSGGGSCCH
T ss_pred             HHHHHccCChhHCcCH
Confidence            9999999999999985

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=383.77  Aligned_cols=241  Identities=26%  Similarity=0.360  Sum_probs=191.3

Q ss_pred             cccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      ...|+..+.||+|+||+||+|+++++++||||+++...  ...+.+.+|+.++++++|||||++++++.+ +..++||||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey   92 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   92 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence            34678888999999999999999988899999996553  345789999999999999999999999854 567899999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++|++..++..... ..+++.+++.++.||+.||+|||+.+|+||||||+|||++.++++||+|||+|+.+.... ...
T Consensus        93 ~~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~~  170 (285)
T d1fmka3          93 MSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTA  170 (285)
T ss_dssp             CTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             cCCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC-cee
Confidence            999999998875432 238999999999999999999999999999999999999999999999999998764322 223


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCC-CccchhHHHH-HH----HHHHHhhhccccceeec
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPL-STWKMMWWFS-VT----WLEEHWKKAEWRNVSMR  922 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf-~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~  922 (936)
                      .....+|+.|+|||++. ...++.++|||||||++|||++|..|| .......... +.    ...+...++++++++.+
T Consensus       171 ~~~~~gt~~y~aPE~~~-~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~  249 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ  249 (285)
T ss_dssp             -----CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred             eccccccccccChHHHh-CCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHH
Confidence            34456899999999984 557899999999999999999965555 4443322211 11    01123345778999999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      ||..||.+||+++
T Consensus       250 cl~~dP~~Rps~~  262 (285)
T d1fmka3         250 CWRKEPEERPTFE  262 (285)
T ss_dssp             HTCSSGGGSCCHH
T ss_pred             HcccCHhHCcCHH
Confidence            9999999999975

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-44  Score=386.78  Aligned_cols=239  Identities=21%  Similarity=0.322  Sum_probs=200.6

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHH-cCCCCCcceeeeEEEeCCeeEEEE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLG-KVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      .|+..++||+|+||+||+|+.+ +|+.||||+++....  ....+.+.+|..++. .++||||+++++++.+++..++||
T Consensus         3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm   82 (320)
T d1xjda_           3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM   82 (320)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence            3677789999999999999976 689999999965432  233456677777765 689999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+++|+|.++++....   +++.++..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+|+.....  .
T Consensus        83 Ey~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~--~  157 (320)
T d1xjda_          83 EYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--D  157 (320)
T ss_dssp             ECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--T
T ss_pred             eecCCCcHHHHhhccCC---CCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc--c
Confidence            99999999999987654   899999999999999999999999999999999999999999999999999865432  2


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceeec
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSMR  922 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  922 (936)
                      .......||+.|+|||++. +..++.++||||+||++|||++|+.||.+.+.........    ..+...++++++++.+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~  236 (320)
T d1xjda_         158 AKTNTFCGTPDYIAPEILL-GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK  236 (320)
T ss_dssp             CCBCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             ccccccCCCCCcCCHHHHc-CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            2334567999999999995 5578999999999999999999999998876644332211    1123456788999999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      ||..||.+||+.+
T Consensus       237 ~L~~dP~~R~s~~  249 (320)
T d1xjda_         237 LFVREPEKRLGVR  249 (320)
T ss_dssp             HSCSSGGGSBTTB
T ss_pred             hcccCCCCCcCHH
Confidence            9999999999974

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-44  Score=388.93  Aligned_cols=246  Identities=22%  Similarity=0.295  Sum_probs=203.1

Q ss_pred             cccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCee
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQ  762 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  762 (936)
                      .+.|+..++||+|+||+||+|+++      +++.||||+++........+++.+|++++++++||||+++++++.+....
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~   91 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM   91 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence            445788889999999999999964      35789999997665555567899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 002321          763 LLIYEFVSGGSLHKHLHEGSG---------------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNV  821 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NI  821 (936)
                      ++||||+++|+|.++++....                     ...+++.+++.|+.|++.||+|||+++||||||||+||
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NI  171 (301)
T d1lufa_          92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC  171 (301)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccce
Confidence            999999999999999975321                     22488999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCC-CCCCccchhH
Q 002321          822 LIDGSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGK-RPLSTWKMMW  900 (936)
Q Consensus       822 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~-~Pf~~~~~~~  900 (936)
                      |++.++.+||+|||+|+...............+++.|+|||.+. ...++.++|||||||++|||++|. .||...+...
T Consensus       172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e  250 (301)
T d1lufa_         172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE  250 (301)
T ss_dssp             EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc-cCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH
Confidence            99999999999999998765544444455667889999999984 557999999999999999999985 6787766543


Q ss_pred             HHHHHHHH-----HHhhhccccceeecccccccccccccC
Q 002321          901 WFSVTWLE-----EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       901 ~~~~~~~~-----~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ........     +...++++.+++.+||..||.+||+|+
T Consensus       251 ~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~  290 (301)
T d1lufa_         251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFC  290 (301)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHH
Confidence            33211100     223446789999999999999999984

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-44  Score=390.20  Aligned_cols=242  Identities=24%  Similarity=0.324  Sum_probs=194.3

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCc----EEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGR----PVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      ..|+..++||+|+||+||+|++. +|+    +||||+++.....+..+++.+|++++++++|||||++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            34778889999999999999976 343    68999887655555678899999999999999999999999865 4578


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ++||+.+|+|.+++....  ..+++..+.+++.||++||+|||+++|+||||||+|||++.++.+||+|||+|+......
T Consensus        88 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             EEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            899999999999887653  348999999999999999999999999999999999999999999999999998876544


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH-----HHHhhhccccc
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL-----EEHWKKAEWRN  918 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~  918 (936)
                      .........||+.|+|||++. ...++.++|||||||++|||+| |+.||..............     .+...++.+.+
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~-~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~  244 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM  244 (317)
T ss_dssp             C--------CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred             ccccccccccCccccChHHHh-cCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence            444444556899999999885 4478999999999999999998 8999988765433322111     12335577899


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..||.+||+|+
T Consensus       245 li~~cl~~dP~~RPs~~  261 (317)
T d1xkka_         245 IMVKCWMIDADSRPKFR  261 (317)
T ss_dssp             HHHHHTCSSGGGSCCHH
T ss_pred             HHHHhCCCChhhCcCHH
Confidence            99999999999999984

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9.2e-44  Score=375.84  Aligned_cols=240  Identities=23%  Similarity=0.319  Sum_probs=200.6

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc--------hHHHHHHHHHHHHcCC-CCCcceeeeEEEeC
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK--------SQEDFEREVKKLGKVR-HPNLVTLEGYYWTQ  759 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  759 (936)
                      ..|+..+.||+|+||+||+|+.. +|+.||||+++......        ..+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            34677889999999999999975 68999999996543221        1346889999999997 99999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          760 SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       760 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      +..++||||+++|+|.++++....   +++.++..++.||++||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~~---l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             cceEEEEEcCCCchHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence            999999999999999999987543   99999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCccccccccccCcccccCcccccC-----cccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH------
Q 002321          840 LPMLDRYVLSSKIQSALGYMAPEFACR-----TVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE------  908 (936)
Q Consensus       840 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~------  908 (936)
                      +....   ......||+.|+|||.+.+     ...++.++||||+||++|||++|+.||...............      
T Consensus       160 ~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~  236 (277)
T d1phka_         160 LDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS  236 (277)
T ss_dssp             CCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             ccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence            65322   2345678999999998742     234788999999999999999999999987764433221111      


Q ss_pred             --HHhhhccccceeecccccccccccccC
Q 002321          909 --EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 --~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                        ..-.++++++++.+||..||.+||+.+
T Consensus       237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~  265 (277)
T d1phka_         237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAE  265 (277)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHH
Confidence              112346788999999999999999853

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.7e-44  Score=392.65  Aligned_cols=238  Identities=21%  Similarity=0.300  Sum_probs=196.6

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHH---HHHHHHcCCCCCcceeeeEEEeCCeeE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFER---EVKKLGKVRHPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~  763 (936)
                      +.|+..+.||+|+||+||+|+.. +|+.||||++......  .....+.+   |+++++.++|||||++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            34677889999999999999976 5899999998643321  11233334   477778889999999999999999999


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      +||||+++|+|.+++.+...   +++.++..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+...
T Consensus        84 ivmE~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEEecCCCcHHHHHHhccc---ccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            99999999999999987543   889999999999999999999999999999999999999999999999999876432


Q ss_pred             ccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-------HHHhhhccc
Q 002321          844 DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-------EEHWKKAEW  916 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~  916 (936)
                      .    .....||+.|||||++..+..|+.++||||+||++|||++|+.||..............       .+...++++
T Consensus       161 ~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  236 (364)
T d1omwa3         161 K----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL  236 (364)
T ss_dssp             C----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHH
T ss_pred             c----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHH
Confidence            2    24457999999999986666789999999999999999999999987654322211111       012345678


Q ss_pred             cceeeccccccccccccc
Q 002321          917 RNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       917 ~~~~~~~l~~~p~~Rp~f  934 (936)
                      ++++.+||..||.+||+.
T Consensus       237 ~~li~~~L~~dP~~R~t~  254 (364)
T d1omwa3         237 RSLLEGLLQRDVNRRLGC  254 (364)
T ss_dssp             HHHHHHHTCSSTTTSTTT
T ss_pred             HHHHHHHcccCHHHhCCC
Confidence            999999999999999984

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.5e-43  Score=384.90  Aligned_cols=296  Identities=33%  Similarity=0.527  Sum_probs=263.1

Q ss_pred             CChhHHHHHHHHHHhccCCCCCCCCCCCCCCCCc--cceeEEecCCC--CceEEeccCCCCCCc--ccccccccCccccE
Q 002321           31 SLNDDVLGLIVFKADIQDPNGKLSSWSEDDDTPC--NWFGVKCSPRS--NRVIELTLNGLSLTG--RIGRGLLQLQFLRK  104 (936)
Q Consensus        31 ~~~~~~~aLl~~k~~~~d~~~~l~sW~~~~~~~c--~w~gv~c~~~~--~~v~~l~l~~~~l~g--~~~~~l~~l~~L~~  104 (936)
                      |.++|++||++||++++||. .+++|..++| ||  .|+||+|++.+  +||++|+|++++++|  .+|+++++|++|++
T Consensus         3 c~~~e~~aLl~~k~~~~~~~-~l~sW~~~~d-~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~   80 (313)
T d1ogqa_           3 CNPQDKQALLQIKKDLGNPT-TLSSWLPTTD-CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF   80 (313)
T ss_dssp             SCHHHHHHHHHHHHHTTCCG-GGTTCCTTSC-TTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred             CCHHHHHHHHHHHHHCCCCC-cCCCCCCCCC-CCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccc
Confidence            56799999999999999884 6999987776 88  59999998753  489999999999998  58899999999999


Q ss_pred             EeccC-CcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccc
Q 002321          105 LSLSS-NNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSN  183 (936)
Q Consensus       105 L~L~~-n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  183 (936)
                      |+|++ |+++|.+|++|++|++|++|||++|+|.+ ++...|..+.+|+++++++|++.+.+|..++.+++|+++++++|
T Consensus        81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~-~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n  159 (313)
T d1ogqa_          81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG-AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN  159 (313)
T ss_dssp             EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEE-ECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred             cccccccccccccccccccccccchhhhccccccc-cccccccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence            99997 89999999999999999999999999995 55567899999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCC-CEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCc
Q 002321          184 RFSSPLPLGIWGLSAL-RTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLP  262 (936)
Q Consensus       184 ~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~  262 (936)
                      ++++.+|..+..+.++ +.+++++|++++..|..+.++..+ .+++++|.+.+.+|..+..+++|+.+++++|.+++.++
T Consensus       160 ~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~  238 (313)
T d1ogqa_         160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG  238 (313)
T ss_dssp             CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc
Confidence            9999999999888886 889999999998888888877554 79999999999999999999999999999999987654


Q ss_pred             hhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCc-cccc
Q 002321          263 ETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANR-LTGS  332 (936)
Q Consensus       263 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~-l~~~  332 (936)
                       .+..+++|+.|+|++|+++|.+|.+|+++++|++|+|++|+|+|.+|. ++++++|+.+++++|+ +.|.
T Consensus       239 -~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~  307 (313)
T d1ogqa_         239 -KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS  307 (313)
T ss_dssp             -GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEEST
T ss_pred             -ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCC
Confidence             578888899999999999988999999999999999999999988874 6788888888888887 5553

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-44  Score=379.40  Aligned_cols=242  Identities=24%  Similarity=0.294  Sum_probs=189.2

Q ss_pred             cccccCCCcccccCceEEEEEEeCC----CcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEE
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLRD----GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLL  764 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  764 (936)
                      +..|+..+.||+|+||+||+|++..    +..||||+++........+.+.+|+.++++++||||+++++++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            3457788899999999999998753    35689999866555555678999999999999999999999995 456799


Q ss_pred             EEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCc
Q 002321          765 IYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLD  844 (936)
Q Consensus       765 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  844 (936)
                      ||||+++|++.+++.....  .+++.++..++.|+++||+|||+++|+||||||+||+++.++.+||+|||+|+......
T Consensus        85 v~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~  162 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  162 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EEEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence            9999999999998776442  38999999999999999999999999999999999999999999999999998764322


Q ss_pred             cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHH-----HHHhhhccccc
Q 002321          845 RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWL-----EEHWKKAEWRN  918 (936)
Q Consensus       845 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~  918 (936)
                       ........+|+.|+|||++ ....++.++|||||||++|||++ |..||..............     .+...++++.+
T Consensus       163 -~~~~~~~~gt~~y~apE~l-~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  240 (273)
T d1mp8a_         163 -YYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS  240 (273)
T ss_dssp             ---------CCGGGCCHHHH-HHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             -ceeccceecCcccchhhHh-ccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence             2233455688999999998 45578999999999999999998 8999988766443322111     12234577999


Q ss_pred             eeecccccccccccccC
Q 002321          919 VSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       919 ~~~~~l~~~p~~Rp~f~  935 (936)
                      ++.+||..||.+||+++
T Consensus       241 li~~cl~~dp~~Rps~~  257 (273)
T d1mp8a_         241 LMTKCWAYDPSRRPRFT  257 (273)
T ss_dssp             HHHHHTCSSGGGSCCHH
T ss_pred             HHHHHcCCCHhHCcCHH
Confidence            99999999999999974

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-43  Score=388.44  Aligned_cols=234  Identities=22%  Similarity=0.276  Sum_probs=200.4

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIY  766 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  766 (936)
                      +.|+..++||+|+||+||+|+++ +|+.||||++.....  ....+.+.+|++++++++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            45788889999999999999976 699999999864332  233567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccc
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRY  846 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  846 (936)
                      ||+.+|+|.+++.+...   +++.++..++.||+.||+|||+++||||||||+|||++.+|.+||+|||+|+.+...   
T Consensus       121 e~~~~g~l~~~l~~~~~---l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred             ccccccchhhhHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence            99999999999987653   899999999999999999999999999999999999999999999999999876432   


Q ss_pred             cccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----HHHHhhhccccceeec
Q 002321          847 VLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----LEEHWKKAEWRNVSMR  922 (936)
Q Consensus       847 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  922 (936)
                        .....||+.|||||++. +..++.++||||+||++|||++|+.||...+.........    ..+...++++.+++.+
T Consensus       195 --~~~~~Gt~~Y~APE~~~-~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  271 (350)
T d1rdqe_         195 --TWTLCGTPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN  271 (350)
T ss_dssp             --BCCCEECGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred             --cccccCccccCCHHHHc-CCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence              23467899999999984 5578999999999999999999999998876543332211    1123345788999999


Q ss_pred             cccccccccc
Q 002321          923 SCKGSSRQRR  932 (936)
Q Consensus       923 ~l~~~p~~Rp  932 (936)
                      ||..||.+|+
T Consensus       272 ~L~~dP~kR~  281 (350)
T d1rdqe_         272 LLQVDLTKRF  281 (350)
T ss_dssp             HSCSCTTTCT
T ss_pred             HhhhCHHhcc
Confidence            9999999995

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-44  Score=383.46  Aligned_cols=246  Identities=27%  Similarity=0.339  Sum_probs=192.2

Q ss_pred             cccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeC-C
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQ-S  760 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  760 (936)
                      ...|+..++||+|+||+||+|++.      +++.||||+++........+.+.+|..++.++ +|+||+++++++... .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            355788889999999999999964      24689999997665555567788888888887 689999999998764 4


Q ss_pred             eeEEEEEecCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSG-------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG  827 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~  827 (936)
                      ..++||||+++|+|.++++....             ...+++.++..++.||++||+|||+++|+||||||+|||+++++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~  171 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN  171 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC
Confidence            67999999999999999975421             23489999999999999999999999999999999999999999


Q ss_pred             CeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcC-CCCCCccchhHHHHHHH
Q 002321          828 EPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTG-KRPLSTWKMMWWFSVTW  906 (936)
Q Consensus       828 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g-~~Pf~~~~~~~~~~~~~  906 (936)
                      .+||+|||+|+...............||+.|||||++. +..++.++||||+||++|||++| ..||...+.........
T Consensus       172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~  250 (299)
T d1ywna1         172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL  250 (299)
T ss_dssp             CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred             cEEEccCcchhhccccccccccCceeeCccccchhHhh-cCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99999999998765555444555677999999999984 55789999999999999999986 56787765432221111


Q ss_pred             HH------HHhhhccccceeecccccccccccccC
Q 002321          907 LE------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       907 ~~------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..      +...++++.+++.+||..||.+||+++
T Consensus       251 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~  285 (299)
T d1ywna1         251 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS  285 (299)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             hcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHH
Confidence            11      233457789999999999999999974

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-43  Score=379.46  Aligned_cols=236  Identities=23%  Similarity=0.295  Sum_probs=198.3

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .|+..++||+|+||+||+|+++ +|+.||||+++...  .....+.+|++++++++||||+++++++.+++..++||||+
T Consensus         6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            4677889999999999999976 58899999997653  23466889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC--CCeEEeeccCccccCCCcccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS--GEPKVGDYGLARLLPMLDRYV  847 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~--~~~kl~Dfg~a~~~~~~~~~~  847 (936)
                      +||+|.+++....  ..+++.++..++.||+.||+|||++||+||||||+|||++.+  +.+||+|||+++......   
T Consensus        84 ~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~---  158 (321)
T d1tkia_          84 SGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---  158 (321)
T ss_dssp             CCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---
T ss_pred             CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC---
Confidence            9999999997643  238999999999999999999999999999999999999854  489999999998764322   


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH------HHHH--hhhccccce
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW------LEEH--WKKAEWRNV  919 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~------~~~~--~~~~~~~~~  919 (936)
                      ......+++.|+|||.. .+..++.++||||+||++|||++|+.||...+.........      ..+.  ..+++++++
T Consensus       159 ~~~~~~~t~~y~ape~~-~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  237 (321)
T d1tkia_         159 NFRLLFTAPEYYAPEVH-QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF  237 (321)
T ss_dssp             EEEEEESCGGGSCHHHH-TTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred             cccccccccccccchhc-cCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHH
Confidence            23445688999999988 45578999999999999999999999998876543332111      1111  235678899


Q ss_pred             eeccccccccccccc
Q 002321          920 SMRSCKGSSRQRRRF  934 (936)
Q Consensus       920 ~~~~l~~~p~~Rp~f  934 (936)
                      +.+||..||.+||+.
T Consensus       238 i~~~L~~dp~~R~s~  252 (321)
T d1tkia_         238 VDRLLVKERKSRMTA  252 (321)
T ss_dssp             HHTTSCSSGGGSCCH
T ss_pred             HHHHccCChhHCcCH
Confidence            999999999999985

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-44  Score=377.88  Aligned_cols=235  Identities=23%  Similarity=0.308  Sum_probs=188.0

Q ss_pred             ccccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEe-CCeeEEEEEe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWT-QSLQLLIYEF  768 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~  768 (936)
                      ..|+..+.||+|+||.||+|+++ |+.||||+++.+   ...+++.+|++++++++||||++++|++.+ ++..++||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            34667788999999999999986 889999999654   345779999999999999999999999865 4567999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +++|+|.+++..... ..+++..+++|+.||+.||+|||+.+|+||||||+||+++.++.+|++|||+++.....     
T Consensus        83 ~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----  156 (262)
T d1byga_          83 MAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----  156 (262)
T ss_dssp             CTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred             cCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC-----
Confidence            999999999975431 23899999999999999999999999999999999999999999999999999865322     


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHH-----HHHHHhhhccccceeec
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVT-----WLEEHWKKAEWRNVSMR  922 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  922 (936)
                      .....+++.|+|||++. +..++.++|||||||++|||++ |+.||............     ...+...++++++++.+
T Consensus       157 ~~~~~~~~~y~aPE~l~-~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~  235 (262)
T d1byga_         157 QDTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN  235 (262)
T ss_dssp             -----CCTTTSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHH
T ss_pred             CccccccccCCChHHHh-CCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence            23345788899999985 4578999999999999999998 78888877654333211     11123345788999999


Q ss_pred             ccccccccccccC
Q 002321          923 SCKGSSRQRRRFQ  935 (936)
Q Consensus       923 ~l~~~p~~Rp~f~  935 (936)
                      ||..||.+||+|+
T Consensus       236 cl~~dP~~Rps~~  248 (262)
T d1byga_         236 CWHLDAAMRPSFL  248 (262)
T ss_dssp             HTCSSGGGSCCHH
T ss_pred             HcccCHhHCcCHH
Confidence            9999999999984

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-43  Score=379.08  Aligned_cols=235  Identities=21%  Similarity=0.218  Sum_probs=189.4

Q ss_pred             CCcccccCceEEEEEEeC-CCcEEEEEEeeccCccch----HHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          695 DCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKS----QEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       695 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .+.||+|+||+||+|+++ +|+.||||+++.......    .+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            457999999999999976 589999999965433221    246889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      +++++..+.....   .+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......  ...
T Consensus        83 ~~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~~~  157 (299)
T d1ua2a_          83 ETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAY  157 (299)
T ss_dssp             SEEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CCC
T ss_pred             cchHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc--ccc
Confidence            8887776655432   38889999999999999999999999999999999999999999999999998654322  223


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH----------------------
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL----------------------  907 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~----------------------  907 (936)
                      ....+|+.|+|||++.....|+.++||||+||++|||++|+.||..............                      
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF  237 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence            3456899999999987777789999999999999999999999987665432211110                      


Q ss_pred             --------HH--Hhhhccccceeeccccccccccccc
Q 002321          908 --------EE--HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       908 --------~~--~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                              ..  ...++.+.+++.+||..||++||+-
T Consensus       238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa  274 (299)
T d1ua2a_         238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA  274 (299)
T ss_dssp             CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH
T ss_pred             ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCH
Confidence                    00  1123567788999999999999974

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-44  Score=375.60  Aligned_cols=242  Identities=26%  Similarity=0.339  Sum_probs=187.6

Q ss_pred             ccccCCCcccccCceEEEEEEeCC----CcEEEEEEeeccCc--cchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRD----GRPVAIKKLTVSSL--VKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQL  763 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  763 (936)
                      ..|+..++||+|+||+||+|+...    ...||||+++....  ....+++.+|+.++++++||||++++|++.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            346777899999999999998642    24789999865433  23357899999999999999999999999764 568


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      +||||+++|++.+++.....  .+++..+.+++.|+++||+|||+++|+||||||+||+++.++.+||+|||+++.....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  164 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             eeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence            99999999999988775432  3899999999999999999999999999999999999999999999999999877543


Q ss_pred             cc-ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHHHHHH------HHhhhcc
Q 002321          844 DR-YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSVTWLE------EHWKKAE  915 (936)
Q Consensus       844 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~~~~~------~~~~~~~  915 (936)
                      .. ........++..|+|||.+. ...++.++|||||||++|||++ |+.||...+...........      +...++.
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  243 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD  243 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHH-HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred             CCcceecCccccCcccCCHHHHh-CCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHH
Confidence            32 22334456788999999984 5578999999999999999998 89999887665433211111      1234467


Q ss_pred             ccceeecccccccccccccC
Q 002321          916 WRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       916 ~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +++++.+||..||.+||+|+
T Consensus       244 l~~li~~cl~~dp~~RPt~~  263 (273)
T d1u46a_         244 IYNVMVQCWAHKPEDRPTFV  263 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHcCCChhHCcCHH
Confidence            88999999999999999985

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-43  Score=378.77  Aligned_cols=246  Identities=25%  Similarity=0.348  Sum_probs=205.8

Q ss_pred             cccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCe
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSL  761 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  761 (936)
                      ...|+..++||+|+||.||+|+++      +++.||||+++.........++.+|+.+++++ +|||||++++++.+...
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            456778889999999999999863      35789999998766555677899999999999 69999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSG---------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS  826 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~  826 (936)
                      .++||||+++|+|.+++++...               ...+++..+.+++.||++||+|||++++|||||||+||+++.+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~  181 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG  181 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccccc
Confidence            9999999999999999976532               2248899999999999999999999999999999999999999


Q ss_pred             CCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHH-H-
Q 002321          827 GEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWF-S-  903 (936)
Q Consensus       827 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~-~-  903 (936)
                      +.+|++|||.++...............+|+.|+|||.+. ...++.++|||||||++|||++ |.+||......... . 
T Consensus       182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~  260 (311)
T d1t46a_         182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM  260 (311)
T ss_dssp             TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred             CcccccccchheeccCCCcceEeeecccChHHcCHHHhc-CCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            999999999999876655555566678899999999984 5578999999999999999999 56666555442221 1 


Q ss_pred             HHH----HHHHhhhccccceeecccccccccccccC
Q 002321          904 VTW----LEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       904 ~~~----~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +..    ..+...++.+.+++.+||..||.+||+|.
T Consensus       261 i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~  296 (311)
T d1t46a_         261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK  296 (311)
T ss_dssp             HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHH
Confidence            111    11234567899999999999999999974

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.8e-43  Score=372.58  Aligned_cols=240  Identities=24%  Similarity=0.331  Sum_probs=190.8

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc--chHHHHHHHHHHHHcCCCCCcceeeeEEEeCC----ee
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV--KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS----LQ  762 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  762 (936)
                      +.|+..+.||+|+||+||+|++. +|+.||||+++.....  ...+.+.+|++++++++||||+++++++...+    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            34677889999999999999975 6999999999754432  23467899999999999999999999997654    37


Q ss_pred             EEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCC
Q 002321          763 LLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPM  842 (936)
Q Consensus       763 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  842 (936)
                      ++||||++||+|.+++.....   +++.++..++.|++.||+|||++||+||||||+|||++.++..+++|||.+.....
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~---l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred             EEEEECCCCCEehhhhcccCC---CCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence            899999999999998877543   89999999999999999999999999999999999999999999999999876533


Q ss_pred             Cc-cccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH----H----Hhhh
Q 002321          843 LD-RYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE----E----HWKK  913 (936)
Q Consensus       843 ~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~----~----~~~~  913 (936)
                      .. .........||+.|||||++ .+..++.++||||+||++|||++|+.||...............    +    ...+
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~-~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s  242 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS  242 (277)
T ss_dssp             ---------------TTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred             ccccccccccccCcccccCHHHH-cCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence            22 22234456789999999998 4557899999999999999999999999887654333221111    0    1234


Q ss_pred             ccccceeecccccccccccc
Q 002321          914 AEWRNVSMRSCKGSSRQRRR  933 (936)
Q Consensus       914 ~~~~~~~~~~l~~~p~~Rp~  933 (936)
                      +.+.+++.+||..||.+||+
T Consensus       243 ~~l~~li~~~L~~dp~~R~~  262 (277)
T d1o6ya_         243 ADLDAVVLKALAKNPENRYQ  262 (277)
T ss_dssp             HHHHHHHHHHTCSSGGGSCS
T ss_pred             HHHHHHHHHHccCCHhHCHh
Confidence            66889999999999999993

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-43  Score=377.56  Aligned_cols=247  Identities=21%  Similarity=0.267  Sum_probs=205.6

Q ss_pred             ccccccCCCcccccCceEEEEEEeC------CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCCe
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLR------DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSL  761 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  761 (936)
                      ....|+..++||+|+||+||+|+++      +++.||||+++..........+.+|+.++++++||||+++++++.....
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence            3456788889999999999999864      2578999999766555556779999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeec
Q 002321          762 QLLIYEFVSGGSLHKHLHEGS-------GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDY  834 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df  834 (936)
                      .++||||+++|+|.+++....       ....+++..+.+++.|+++||+|||+++|+||||||+|||+++++++||+||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DF  177 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF  177 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeec
Confidence            999999999999999886431       1224789999999999999999999999999999999999999999999999


Q ss_pred             cCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcC-CCCCCccchhHHHHHHHH-----H
Q 002321          835 GLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTG-KRPLSTWKMMWWFSVTWL-----E  908 (936)
Q Consensus       835 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g-~~Pf~~~~~~~~~~~~~~-----~  908 (936)
                      |+|+...............+++.|+|||.+. ...++.++|||||||++|||+|| +.||..............     .
T Consensus       178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~-~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~  256 (308)
T d1p4oa_         178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK  256 (308)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred             ccceeccCCcceeeccceecccccCCHHHHc-cCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            9998776555444455567899999999984 55789999999999999999998 578877665433322111     1


Q ss_pred             HHhhhccccceeecccccccccccccC
Q 002321          909 EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 ~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      +...++.+.+++.+||..||.+||+++
T Consensus       257 p~~~~~~l~~li~~cl~~~P~~RPs~~  283 (308)
T d1p4oa_         257 PDNCPDMLFELMRMCWQYNPKMRPSFL  283 (308)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             cccchHHHHHHHHHHcCCChhHCcCHH
Confidence            233446799999999999999999974

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-42  Score=374.38  Aligned_cols=238  Identities=23%  Similarity=0.303  Sum_probs=192.0

Q ss_pred             CCcccccCceEEEEEEeCCC----cEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEe-CCeeEEEEEec
Q 002321          695 DCELGRGGFGAVYRTVLRDG----RPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWT-QSLQLLIYEFV  769 (936)
Q Consensus       695 ~~~iG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  769 (936)
                      .++||+|+||+||+|++.++    ..||||+++........+++.+|++++++++||||++++|++.+ ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46799999999999997642    36899999765555556889999999999999999999999876 45789999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc--cc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR--YV  847 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~  847 (936)
                      ++|+|.++++....  ..++..+++++.|+++||+|+|+.+|+||||||+|||+++++.+||+|||+++.......  ..
T Consensus       112 ~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~  189 (311)
T d1r0pa_         112 KHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH  189 (311)
T ss_dssp             TTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTT
T ss_pred             ecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccce
Confidence            99999999876443  377889999999999999999999999999999999999999999999999987643322  12


Q ss_pred             ccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchh-HHHHH-----HHHHHHhhhccccceee
Q 002321          848 LSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMM-WWFSV-----TWLEEHWKKAEWRNVSM  921 (936)
Q Consensus       848 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~-~~~~~-----~~~~~~~~~~~~~~~~~  921 (936)
                      ......+|+.|+|||.+. ...++.++||||||+++|||++|..||...... .....     +...+...++++.+++.
T Consensus       190 ~~~~~~gt~~y~aPE~~~-~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~  268 (311)
T d1r0pa_         190 NKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML  268 (311)
T ss_dssp             CTTCSSCCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ecccccccccccChHHHh-cCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHH
Confidence            233456889999999884 457899999999999999999988887654321 11110     11112445578999999


Q ss_pred             cccccccccccccC
Q 002321          922 RSCKGSSRQRRRFQ  935 (936)
Q Consensus       922 ~~l~~~p~~Rp~f~  935 (936)
                      +||..||.+||+++
T Consensus       269 ~cl~~dP~~RPs~~  282 (311)
T d1r0pa_         269 KCWHPKAEMRPSFS  282 (311)
T ss_dssp             HHTCSSGGGSCCHH
T ss_pred             HHcCCCHhHCcCHH
Confidence            99999999999974

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-43  Score=376.05  Aligned_cols=247  Identities=25%  Similarity=0.315  Sum_probs=201.8

Q ss_pred             ccccccCCCcccccCceEEEEEEeCC--------CcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEe
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLRD--------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWT  758 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  758 (936)
                      ....|+..++||+|+||.||+|+...        +..||||+++.........++.+|+..+.++ +|||||++++++.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            34567888899999999999998542        2479999997766555668889999999888 89999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC
Q 002321          759 QSLQLLIYEFVSGGSLHKHLHEGSG-------------GNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG  825 (936)
Q Consensus       759 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~  825 (936)
                      ++..++||||+++|+|.++++....             ...+++.++.+++.|++.||+|||+++||||||||+|||++.
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~  170 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE  170 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecC
Confidence            9999999999999999999975532             234899999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHc-CCCCCCccchhHHHHH
Q 002321          826 SGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVT-GKRPLSTWKMMWWFSV  904 (936)
Q Consensus       826 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~-g~~Pf~~~~~~~~~~~  904 (936)
                      ++.+||+|||+++...............+++.|+|||.+. ...|+.++|||||||++|||++ |..||.+.........
T Consensus       171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~-~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~  249 (299)
T d1fgka_         171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL  249 (299)
T ss_dssp             TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred             CCCeEeccchhhccccccccccccccCCCChhhhhhhHhc-CCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence            9999999999998776554444555677899999999884 4579999999999999999998 7999987766543322


Q ss_pred             HH-----HHHHhhhccccceeecccccccccccccC
Q 002321          905 TW-----LEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       905 ~~-----~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..     ..+...++.+++++.+||..||.+||+++
T Consensus       250 i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~  285 (299)
T d1fgka_         250 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK  285 (299)
T ss_dssp             HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHH
Confidence            11     11233457789999999999999999874

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-44  Score=376.74  Aligned_cols=237  Identities=23%  Similarity=0.313  Sum_probs=195.0

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc-----hHHHHHHHHHHHHcCC--CCCcceeeeEEEeCCe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK-----SQEDFEREVKKLGKVR--HPNLVTLEGYYWTQSL  761 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  761 (936)
                      ..|+..+.||+|+||+||+|+.. +|+.||||+++......     ...++.+|+.++++++  ||||+++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            34777889999999999999976 68999999996543221     1234678999999996  8999999999999999


Q ss_pred             eEEEEEecCC-CChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-CCeEEeeccCccc
Q 002321          762 QLLIYEFVSG-GSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGS-GEPKVGDYGLARL  839 (936)
Q Consensus       762 ~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~  839 (936)
                      .++||||+.+ +++.+++.....   +++.++..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~---l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEEEeccCcchHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence            9999999976 677888876543   8999999999999999999999999999999999999854 7999999999986


Q ss_pred             cCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHHHhhhccccce
Q 002321          840 LPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEHWKKAEWRNV  919 (936)
Q Consensus       840 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  919 (936)
                      ....    ......||+.|+|||++.+...++.++||||+||++|||++|+.||...+..  .......+...+++++++
T Consensus       161 ~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i--~~~~~~~~~~~s~~~~~l  234 (273)
T d1xwsa_         161 LKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--IRGQVFFRQRVSSECQHL  234 (273)
T ss_dssp             CCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--HHCCCCCSSCCCHHHHHH
T ss_pred             cccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH--hhcccCCCCCCCHHHHHH
Confidence            5432    2345679999999999866655678899999999999999999999875432  111111233456788999


Q ss_pred             eecccccccccccccC
Q 002321          920 SMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       920 ~~~~l~~~p~~Rp~f~  935 (936)
                      +.+||..||.+||+++
T Consensus       235 i~~~L~~dp~~R~s~~  250 (273)
T d1xwsa_         235 IRWCLALRPSDRPTFE  250 (273)
T ss_dssp             HHHHTCSSGGGSCCHH
T ss_pred             HHHHccCCHhHCcCHH
Confidence            9999999999999863

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-42  Score=372.13  Aligned_cols=241  Identities=22%  Similarity=0.290  Sum_probs=192.8

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccc-hHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVK-SQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      .|+..++||+|+||+||+|++. +|+.||||+++.....+ ..+.+.+|++++++++|||||++++++.++...++||||
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~   82 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   82 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence            4677789999999999999975 68999999996554322 256789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +.+ .+.+++.... ...+++.++..++.|++.||+|||++|||||||||+|||++.++.+||+|||.|+......  ..
T Consensus        83 ~~~-~~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--~~  158 (298)
T d1gz8a_          83 LHQ-DLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RT  158 (298)
T ss_dssp             CSE-EHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--BC
T ss_pred             cCC-chhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc--cc
Confidence            965 5555554332 2349999999999999999999999999999999999999999999999999998764322  23


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH--------------------
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE--------------------  908 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~--------------------  908 (936)
                      .....+|+.|+|||+......++.++||||+||++|||++|+.||...+...........                    
T Consensus       159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  238 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP  238 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence            345578999999998867767789999999999999999999999876543222111100                    


Q ss_pred             -------------HHhhhccccceeecccccccccccccC
Q 002321          909 -------------EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 -------------~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                                   ....++++++++.+|+..||.+||+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~  278 (298)
T d1gz8a_         239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK  278 (298)
T ss_dssp             TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHH
Confidence                         011224567889999999999999863

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-43  Score=378.93  Aligned_cols=242  Identities=23%  Similarity=0.335  Sum_probs=193.6

Q ss_pred             ccccCCCcccccCceEEEEEEeCC-Cc--EEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEeCCeeEEE
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLRD-GR--PVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  765 (936)
                      +.|+..++||+|+||+||+|++++ |.  .||||+++........+++.+|+++++++ +|||||++++++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            456777899999999999999764 43  57888886554445567899999999999 799999999999999999999


Q ss_pred             EEecCCCChhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEe
Q 002321          766 YEFVSGGSLHKHLHEGS-------------GGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVG  832 (936)
Q Consensus       766 ~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~  832 (936)
                      |||+++|+|.+++++..             ....+++.++.+++.||++||+|+|+++|+||||||+|||++.++.+||+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~  169 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA  169 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEc
Confidence            99999999999997541             23459999999999999999999999999999999999999999999999


Q ss_pred             eccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCC-CCCCccchhHHHHHH-----H
Q 002321          833 DYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGK-RPLSTWKMMWWFSVT-----W  906 (936)
Q Consensus       833 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~-~Pf~~~~~~~~~~~~-----~  906 (936)
                      |||+|+....   ........+|..|+|||.+. ...++.++|||||||++|||++|. .||...+........     .
T Consensus       170 DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~-~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~  245 (309)
T d1fvra_         170 DFGLSRGQEV---YVKKTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL  245 (309)
T ss_dssp             CTTCEESSCE---ECCC----CCTTTCCHHHHH-HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC
T ss_pred             cccccccccc---cccccceecCCcccchHHhc-cCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC
Confidence            9999975532   22223456888999999984 557899999999999999999965 567766554332111     1


Q ss_pred             HHHHhhhccccceeecccccccccccccC
Q 002321          907 LEEHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       907 ~~~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ..+...++++++++.+||..||.+||+++
T Consensus       246 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~  274 (309)
T d1fvra_         246 EKPLNCDDEVYDLMRQCWREKPYERPSFA  274 (309)
T ss_dssp             CCCTTBCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCccCCHHHHHHHHHHcCCChhHCcCHH
Confidence            11233457899999999999999999874

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-42  Score=376.01  Aligned_cols=234  Identities=21%  Similarity=0.272  Sum_probs=189.3

Q ss_pred             cccCC-CcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcC-CCCCcceeeeEEEe----CCeeE
Q 002321          691 LLNKD-CELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKV-RHPNLVTLEGYYWT----QSLQL  763 (936)
Q Consensus       691 ~~~~~-~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~  763 (936)
                      .|+.. +.||+|+||+||+|++. +++.||||+++.      ...+.+|+.++.++ +|||||++++++.+    +...+
T Consensus        12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            35554 45999999999999975 689999999853      35578899987655 89999999999875    35679


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCCeEEeeccCcccc
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG---SGEPKVGDYGLARLL  840 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~  840 (936)
                      +|||||+||+|.+++.+... ..+++.++..++.|++.||+|||++||+||||||+|||++.   ++.+||+|||+|+..
T Consensus        86 ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~  164 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  164 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeec
Confidence            99999999999999976432 34999999999999999999999999999999999999985   567999999999876


Q ss_pred             CCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHH-H---------HH--HH
Q 002321          841 PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFS-V---------TW--LE  908 (936)
Q Consensus       841 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~-~---------~~--~~  908 (936)
                      ....   ......||+.|||||++ .+..|+.++||||+||++|||++|+.||.+........ .         .+  ..
T Consensus       165 ~~~~---~~~~~~gt~~y~aPE~~-~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~  240 (335)
T d2ozaa1         165 TSHN---SLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE  240 (335)
T ss_dssp             CCCC---CCCCCSCCCSSCCCCCC-CGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred             cCCC---ccccccCCcccCCcHHH-cCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc
Confidence            4322   23456799999999998 55679999999999999999999999997754322110 0         00  11


Q ss_pred             HHhhhccccceeecccccccccccccC
Q 002321          909 EHWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       909 ~~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ....++++++++.+||..||.+||+++
T Consensus       241 ~~~~s~~~~~li~~~L~~dP~~R~s~~  267 (335)
T d2ozaa1         241 WSEVSEEVKMLIRNLLKTEPTQRMTIT  267 (335)
T ss_dssp             HHHSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHH
Confidence            123456789999999999999999863

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.8e-42  Score=368.78  Aligned_cols=239  Identities=20%  Similarity=0.224  Sum_probs=194.1

Q ss_pred             cccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEec
Q 002321          691 LLNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEFV  769 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  769 (936)
                      .|+..++||+|+||+||+|++++|+.||||+++..... ...+.+.+|+.++++++||||+++++++.+.+..+++|||+
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~   82 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence            46777889999999999999999999999999665432 23578999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcccccc
Q 002321          770 SGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVLS  849 (936)
Q Consensus       770 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  849 (936)
                      .++.+..+.....   .+++.++..++.|++.||+|||+.+||||||||+|||++.++.+|++|||.|.......  ...
T Consensus        83 ~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~  157 (286)
T d1ob3a_          83 DQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKY  157 (286)
T ss_dssp             SEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             hhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc--ccc
Confidence            8776666655443   39999999999999999999999999999999999999999999999999998764322  223


Q ss_pred             ccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-H--------------------
Q 002321          850 SKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-E--------------------  908 (936)
Q Consensus       850 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-~--------------------  908 (936)
                      ....+++.|+|||.+.+...++.++||||+||++|||++|+.||.+.+........+. .                    
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (286)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence            3446788999999987777789999999999999999999999987655332211110 0                    


Q ss_pred             ------------HHhhhccccceeeccccccccccccc
Q 002321          909 ------------EHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       909 ------------~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                  ....++.+.+++.+||..||.+||+.
T Consensus       238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~  275 (286)
T d1ob3a_         238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA  275 (286)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCH
Confidence                        00112345688999999999999985

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-42  Score=368.25  Aligned_cols=237  Identities=21%  Similarity=0.275  Sum_probs=181.3

Q ss_pred             ccCCCcccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC----eeEEEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS----LQLLIYE  767 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e  767 (936)
                      |...+.||+|+||+||+|+++ |+.||||+++...  ......++|+..+.+++||||+++++++.+..    ..++|||
T Consensus         5 ~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E   81 (303)
T d1vjya_           5 IVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             EEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence            345567999999999999974 8999999986442  11222345556667889999999999998654    5789999


Q ss_pred             ecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          768 FVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ--------SNIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       768 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~--------~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      |+++|+|.+++++..    +++..+++++.|+|.||+|+|+        ++|+||||||+|||++.++.+||+|||+++.
T Consensus        82 y~~~g~L~~~l~~~~----l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          82 YHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             CCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             cccCCCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            999999999998753    8999999999999999999996        5999999999999999999999999999987


Q ss_pred             cCCCccc--cccccccCcccccCcccccCcc-----cCCchhhHHHHHHHHHHHHcCCCCCCccchh------------H
Q 002321          840 LPMLDRY--VLSSKIQSALGYMAPEFACRTV-----KITDKCDVYGFGVLVLEVVTGKRPLSTWKMM------------W  900 (936)
Q Consensus       840 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~------------~  900 (936)
                      .......  .......||+.|+|||++.+..     .++.++|||||||++|||+||..||......            .
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            6443221  1234567899999999884432     2677999999999999999999887442210            0


Q ss_pred             HHHHHHHH----------HHh----hhccccceeecccccccccccccC
Q 002321          901 WFSVTWLE----------EHW----KKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       901 ~~~~~~~~----------~~~----~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                      ........          ..+    ....+.+++.+||..||++||+|+
T Consensus       238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~  286 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL  286 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHH
T ss_pred             HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHH
Confidence            00010000          011    113477899999999999999974

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-41  Score=366.93  Aligned_cols=236  Identities=23%  Similarity=0.246  Sum_probs=186.9

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeC------CeeE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ------SLQL  763 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  763 (936)
                      .|+..++||+|+||+||+|++. +|+.||||+++....     ...+|++++++++||||+++++++...      ...+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            4677788999999999999986 589999999965432     234799999999999999999998643      2468


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-CeEEeeccCccccCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG-EPKVGDYGLARLLPM  842 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~  842 (936)
                      +||||++++.+..+.........+++.++..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus        96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~  175 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  175 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred             EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence            9999997664444433222334599999999999999999999999999999999999999875 899999999987643


Q ss_pred             CccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH----------HHH---
Q 002321          843 LDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW----------LEE---  909 (936)
Q Consensus       843 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~----------~~~---  909 (936)
                      ..   ......+++.|+|||.+.+...++.++||||+||++|||++|+.||...+.........          ...   
T Consensus       176 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  252 (350)
T d1q5ka_         176 GE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  252 (350)
T ss_dssp             TS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred             Cc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence            22   22345788999999988777789999999999999999999999998766532221110          000   


Q ss_pred             --------------------Hhhhccccceeeccccccccccccc
Q 002321          910 --------------------HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       910 --------------------~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                          ...++++.+++.+||..||.+||+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta  297 (350)
T d1q5ka_         253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP  297 (350)
T ss_dssp             ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCH
Confidence                                0123456678999999999999984

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-41  Score=362.91  Aligned_cols=240  Identities=20%  Similarity=0.246  Sum_probs=188.0

Q ss_pred             cccccCCCcccccCceEEEEEEeC-C-CcEEEEEEeeccCccc-hHHHHHHHHHHHHcC---CCCCcceeeeEEEe----
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-D-GRPVAIKKLTVSSLVK-SQEDFEREVKKLGKV---RHPNLVTLEGYYWT----  758 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  758 (936)
                      ...|+..++||+|+||+||+|++. + ++.||||+++...... ....+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            456888899999999999999974 4 5679999996543322 233466777776665   89999999999863    


Q ss_pred             -CCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCc
Q 002321          759 -QSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLA  837 (936)
Q Consensus       759 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  837 (936)
                       ....+++|||++++.+........  ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~  163 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  163 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             cCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence             246789999998877655443322  34899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH---------
Q 002321          838 RLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE---------  908 (936)
Q Consensus       838 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~---------  908 (936)
                      +....   ........||+.|+|||++. +..|+.++||||+||++|||++|+.||...+...........         
T Consensus       164 ~~~~~---~~~~~~~~gT~~Y~APE~~~-~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         164 RIYSF---QMALTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             CCCCG---GGGGCCCCCCCTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             hhhcc---cccCCCcccChhhcCcchhc-CCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence            76532   22345567999999999984 557899999999999999999999999887654332211100         


Q ss_pred             ----------------------HHhhhccccceeeccccccccccccc
Q 002321          909 ----------------------EHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       909 ----------------------~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                            ....++.+++++.+||..||.+||+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa  287 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA  287 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCH
Confidence                                  00112456778999999999999984

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-40  Score=364.30  Aligned_cols=239  Identities=19%  Similarity=0.241  Sum_probs=191.3

Q ss_pred             ccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcceeeeEEEeCC----eeEEEE
Q 002321          692 LNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS----LQLLIY  766 (936)
Q Consensus       692 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  766 (936)
                      |+..++||+|+||+||+|+.. +|+.||||+++........+.+.+|+.++++++||||+++++++....    ..++++
T Consensus        10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~   89 (345)
T d1pmea_          10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV   89 (345)
T ss_dssp             EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence            677889999999999999975 799999999976554445678899999999999999999999997643    235556


Q ss_pred             EecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCcc-
Q 002321          767 EFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDR-  845 (936)
Q Consensus       767 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-  845 (936)
                      +|+.+|+|.+++....    +++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+....... 
T Consensus        90 ~~~~~g~L~~~l~~~~----l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~  165 (345)
T d1pmea_          90 THLMGADLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH  165 (345)
T ss_dssp             EECCCEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred             EeecCCchhhhhhcCC----CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence            6777999999997643    89999999999999999999999999999999999999999999999999987643222 


Q ss_pred             ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH-----------------
Q 002321          846 YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE-----------------  908 (936)
Q Consensus       846 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~-----------------  908 (936)
                      ........+++.|+|||++.....++.++||||+||++|||++|+.||...+...........                 
T Consensus       166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (345)
T d1pmea_         166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA  245 (345)
T ss_dssp             CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred             ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhh
Confidence            122344568999999999877777899999999999999999999999876542222111000                 


Q ss_pred             ----------------H--Hhhhccccceeeccccccccccccc
Q 002321          909 ----------------E--HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       909 ----------------~--~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                      .  ...+.++.+++.+|+..||.+||+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta  289 (345)
T d1pmea_         246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV  289 (345)
T ss_dssp             HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             hcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCH
Confidence                            0  0112457789999999999999985

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-40  Score=359.03  Aligned_cols=242  Identities=22%  Similarity=0.254  Sum_probs=190.5

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEe--------C
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWT--------Q  759 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  759 (936)
                      ..|+..++||+|+||+||+|++. +|+.||||++...... ....++.+|+.++++++||||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            45788889999999999999975 6999999998654332 335678899999999999999999999855        3


Q ss_pred             CeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          760 SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       760 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                      ...++||||++++.+........   .+++.++..++.|++.||+|||++||+||||||+|||++.++.+|++|||+++.
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~  166 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA  166 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence            45789999998776665544332   388999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCcc--ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHH-----------
Q 002321          840 LPMLDR--YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTW-----------  906 (936)
Q Consensus       840 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~-----------  906 (936)
                      +.....  ........+|+.|+|||++.....++.++||||+||++|||++|+.||.+.+.........           
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  246 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  246 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            653222  1223345689999999998777678999999999999999999999998765533221110           


Q ss_pred             -------------------------HHHHhhhccccceeeccccccccccccc
Q 002321          907 -------------------------LEEHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       907 -------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                               ......++.+.+++.+||..||.+||+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa  299 (318)
T d3blha1         247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS  299 (318)
T ss_dssp             TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCH
Confidence                                     1111223456678999999999999985

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-40  Score=361.41  Aligned_cols=236  Identities=24%  Similarity=0.262  Sum_probs=187.9

Q ss_pred             cccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCC------
Q 002321          689 HALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQS------  760 (936)
Q Consensus       689 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  760 (936)
                      ...|+..++||+|+||+||+|+++ +|+.||||+++..... ...+.+.+|++++++++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            345788889999999999999976 5999999999754332 33567899999999999999999999997654      


Q ss_pred             eeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCcccc
Q 002321          761 LQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLL  840 (936)
Q Consensus       761 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  840 (936)
                      ..++||||+ ++++..+.+...    +++..+..++.|++.||+|||++||+||||||+|||++.++.+|++|||+|+..
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~~----l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~  171 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHEK----LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA  171 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEecc-cccHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence            468999999 678888776533    999999999999999999999999999999999999999999999999999865


Q ss_pred             CCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHH-------------
Q 002321          841 PMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWL-------------  907 (936)
Q Consensus       841 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~-------------  907 (936)
                      ...     .....+|+.|+|||++.+...++.++||||+||++|||++|+.||...+..........             
T Consensus       172 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (346)
T d1cm8a_         172 DSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  246 (346)
T ss_dssp             CSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             CCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence            432     24467899999999987767789999999999999999999999988754322211000             


Q ss_pred             --------HH--------------Hhhhccccceeeccccccccccccc
Q 002321          908 --------EE--------------HWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       908 --------~~--------------~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                              ..              ...++.+.+++.+||..||.+||+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta  295 (346)
T d1cm8a_         247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA  295 (346)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCH
Confidence                    00              0112455678999999999999985

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-39  Score=349.46  Aligned_cols=240  Identities=22%  Similarity=0.243  Sum_probs=196.1

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeCCeeEEEEEe
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      .|+..++||+|+||+||+|++. +++.||||+++..... ....++.+|+.++++++||||+++++++.+....++|+|+
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~   82 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence            4677889999999999999976 6889999999765433 3467899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCCccccc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPMLDRYVL  848 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  848 (936)
                      +.++++..++.....   +++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||.|+.......  .
T Consensus        83 ~~~~~l~~~~~~~~~---~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--~  157 (292)
T d1unla_          83 CDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--C  157 (292)
T ss_dssp             CSEEHHHHHHHTTTC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--C
T ss_pred             ccccccccccccccc---cchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc--c
Confidence            999998888776543   88999999999999999999999999999999999999999999999999987654322  2


Q ss_pred             cccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHHHH------------------
Q 002321          849 SSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLEEH------------------  910 (936)
Q Consensus       849 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~------------------  910 (936)
                      .....+++.|+|||++.....++.++||||+||++|||++|+.||.................                  
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence            33445678899999887666789999999999999999999999755443221111111000                  


Q ss_pred             ----------------hhhccccceeecccccccccccccC
Q 002321          911 ----------------WKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       911 ----------------~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                                      -.++.+.+++.+|+..||.+||+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~  278 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE  278 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHH
Confidence                            0113456789999999999999853

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-40  Score=356.80  Aligned_cols=241  Identities=24%  Similarity=0.316  Sum_probs=196.6

Q ss_pred             ccccCCCcccccCceEEEEEEeC----CCcEEEEEEeeccCc---cchHHHHHHHHHHHHcCCC-CCcceeeeEEEeCCe
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR----DGRPVAIKKLTVSSL---VKSQEDFEREVKKLGKVRH-PNLVTLEGYYWTQSL  761 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  761 (936)
                      ..|+..++||+|+||+||+|+..    +|+.||||+++....   ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            44788889999999999999852    478999999865432   1234668899999999976 899999999999999


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .++||||+++|+|.+++.....   +.+..+..++.|++.|++|+|+.+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             eeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            9999999999999999987654   7888999999999999999999999999999999999999999999999998764


Q ss_pred             CCccccccccccCcccccCcccccCcc-cCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH----HHHHHH----HHhh
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTV-KITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF----SVTWLE----EHWK  912 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~----~~~~~~----~~~~  912 (936)
                      ... ........+++.|+|||.+.... .++.++||||+||++|||++|+.||.........    ......    +...
T Consensus       181 ~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (322)
T d1vzoa_         181 ADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM  259 (322)
T ss_dssp             GGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             ccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence            322 22334567889999999885443 4788999999999999999999999776542211    111110    1234


Q ss_pred             hccccceeeccccccccccccc
Q 002321          913 KAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       913 ~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                      ++++.+++.+||..||.+||+.
T Consensus       260 s~~~~~li~~~l~~dP~~R~s~  281 (322)
T d1vzoa_         260 SALAKDLIQRLLMKDPKKRLGC  281 (322)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTS
T ss_pred             CHHHHHHHHHHcccCHHHcCCC
Confidence            5678899999999999999974

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.9e-39  Score=346.99  Aligned_cols=238  Identities=14%  Similarity=0.155  Sum_probs=192.9

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCC-CCcceeeeEEEeCCeeEEEEEe
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRH-PNLVTLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~  768 (936)
                      .|+..++||+|+||+||+|++. +|+.||||+++....   .+.+.+|++.++.+.| +|++.+++++......++||||
T Consensus         6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            4677889999999999999976 589999999865432   3457789999999965 8999999999999999999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-----CCCeEEeeccCccccCCC
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG-----SGEPKVGDYGLARLLPML  843 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfg~a~~~~~~  843 (936)
                      + +++|.++++....  .+++.++..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+.....
T Consensus        83 ~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~  159 (293)
T d1csna_          83 L-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  159 (293)
T ss_dssp             C-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             c-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence            9 7899998876442  3899999999999999999999999999999999999975     578999999999876432


Q ss_pred             cc-----ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhH----HHHHHHH-H----H
Q 002321          844 DR-----YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMW----WFSVTWL-E----E  909 (936)
Q Consensus       844 ~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~----~~~~~~~-~----~  909 (936)
                      ..     ........||+.|||||.+ .+..++.++||||+||++|||++|+.||.......    ....... .    +
T Consensus       160 ~~~~~~~~~~~~~~~GT~~y~aPE~~-~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (293)
T d1csna_         160 VTKQHIPYREKKNLSGTARYMSINTH-LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR  238 (293)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHH-TTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred             ccccceeecccCceEEchhhcCHHHh-cCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence            21     1223346799999999998 45679999999999999999999999997654311    1111110 0    1


Q ss_pred             ---HhhhccccceeecccccccccccccC
Q 002321          910 ---HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       910 ---~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                         ...++++.+++..|+..+|.+||+|+
T Consensus       239 ~l~~~~p~~l~~ii~~~~~~~~~~rP~y~  267 (293)
T d1csna_         239 ELCAGFPEEFYKYMHYARNLAFDATPDYD  267 (293)
T ss_dssp             HHTTTSCHHHHHHHHHHHHCCTTCCCCHH
T ss_pred             HhcCCCCHHHHHHHHHHhcCCcccCcCHH
Confidence               12346788899999999999999875

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-39  Score=348.99  Aligned_cols=238  Identities=17%  Similarity=0.171  Sum_probs=186.2

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCcc-eeeeEEEeCCeeEEEEEe
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNLV-TLEGYYWTQSLQLLIYEF  768 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~  768 (936)
                      .|+..++||+|+||+||+|++. +|+.||||++.....   .+++.+|++++++++|++++ .+.+++.+....++||||
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            4788889999999999999975 589999999875532   24578999999999877655 455556777888999999


Q ss_pred             cCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCCeEEeeccCccccCCCcc
Q 002321          769 VSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDG---SGEPKVGDYGLARLLPMLDR  845 (936)
Q Consensus       769 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~~~  845 (936)
                      + ++++.+.+....  ..+++..+..++.|++.||+|||++||+||||||+|||++.   +..+|++|||+|+.+.....
T Consensus        85 ~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          85 L-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             C-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             c-CCchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence            9 567776665433  23899999999999999999999999999999999999864   45799999999987653322


Q ss_pred             -----ccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHH--HHHHHH-------H--
Q 002321          846 -----YVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWF--SVTWLE-------E--  909 (936)
Q Consensus       846 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~--~~~~~~-------~--  909 (936)
                           ........||+.|||||.+ .+..++.++|||||||++|||++|+.||.........  ......       +  
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTH-LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL  240 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHH-TTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred             ccceeccccCCcCCCccccCHHHH-hCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence                 1223456799999999988 4557899999999999999999999999875442111  101100       1  


Q ss_pred             -HhhhccccceeecccccccccccccC
Q 002321          910 -HWKKAEWRNVSMRSCKGSSRQRRRFQ  935 (936)
Q Consensus       910 -~~~~~~~~~~~~~~l~~~p~~Rp~f~  935 (936)
                       ...++++.+++.+||..+|.+||+|+
T Consensus       241 ~~~~p~~~~~li~~cl~~~p~~RP~~~  267 (299)
T d1ckia_         241 CKGYPSEFATYLNFCRSLRFDDKPDYS  267 (299)
T ss_dssp             TTTSCHHHHHHHHHHHHSCTTCCCCHH
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHH
Confidence             12346788999999999999999974

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.5e-39  Score=351.87  Aligned_cols=198  Identities=21%  Similarity=0.292  Sum_probs=170.6

Q ss_pred             ccccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-CCCcceeeeEEEeC--CeeE
Q 002321          688 THALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQ--SLQL  763 (936)
Q Consensus       688 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~  763 (936)
                      ..+.|+..++||+|+||+||+|+.. +|+.||||+++..    ..+++.+|+++++++. ||||+++++++...  ...+
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            3456888899999999999999975 6899999998643    3567899999999995 99999999999754  4678


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-CeEEeeccCccccCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSG-EPKVGDYGLARLLPM  842 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~  842 (936)
                      +||||+++++|..+.+      .+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus       109 ~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         109 LVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             EEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC
Confidence            9999999999987643      289999999999999999999999999999999999998765 699999999987643


Q ss_pred             CccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccch
Q 002321          843 LDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKM  898 (936)
Q Consensus       843 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~  898 (936)
                      ..   ......+|+.|+|||.+.+...++.++||||+||++|||++|+.||.....
T Consensus       183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~  235 (328)
T d3bqca1         183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD  235 (328)
T ss_dssp             TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence            22   234566889999999987777789999999999999999999999977654

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-39  Score=352.03  Aligned_cols=235  Identities=20%  Similarity=0.225  Sum_probs=189.0

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeC-----CeeE
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ-----SLQL  763 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  763 (936)
                      .|+..++||+|+||+||+|++. +|+.||||+++..... ...+.+.+|++++++++||||+++++++...     ...+
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~   98 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV   98 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred             CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence            4788889999999999999975 6999999999755432 3356788999999999999999999998643     3446


Q ss_pred             EEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccCCC
Q 002321          764 LIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLPML  843 (936)
Q Consensus       764 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  843 (936)
                      ++|+|+.+|+|.+++....    +++.++..++.|++.||+|||++||+||||||+|||++.++.+|++|||.+..... 
T Consensus        99 ~i~~~~~gg~L~~~~~~~~----l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-  173 (348)
T d2gfsa1          99 YLVTHLMGADLNNIVKCQK----LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-  173 (348)
T ss_dssp             EEEEECCSEEHHHHHTTCC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred             EEEEeecCCchhhhccccc----ccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence            7778888999999986532    99999999999999999999999999999999999999999999999999975432 


Q ss_pred             ccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHHHHH---------------
Q 002321          844 DRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVTWLE---------------  908 (936)
Q Consensus       844 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~~~~---------------  908 (936)
                          ......+++.|+|||...+...++.++||||+||++|+|++|+.||...+...........               
T Consensus       174 ----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  249 (348)
T d2gfsa1         174 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  249 (348)
T ss_dssp             ----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred             ----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence                2244568889999998867767899999999999999999999999876543222111000               


Q ss_pred             --------------------HHhhhccccceeeccccccccccccc
Q 002321          909 --------------------EHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       909 --------------------~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                                          ..-.++.+++++.+|+..||.+||+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta  295 (348)
T d2gfsa1         250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA  295 (348)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCH
Confidence                                01123557789999999999999974

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-38  Score=343.74  Aligned_cols=235  Identities=21%  Similarity=0.252  Sum_probs=179.5

Q ss_pred             ccccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCcc-chHHHHHHHHHHHHcCCCCCcceeeeEEEeC------Ce
Q 002321          690 ALLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLV-KSQEDFEREVKKLGKVRHPNLVTLEGYYWTQ------SL  761 (936)
Q Consensus       690 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  761 (936)
                      ..|+..++||+|+||+||+|++. +|+.||||+++..... ....++.+|+.++++++||||+++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            34788889999999999999976 6999999999765433 2346789999999999999999999999643      57


Q ss_pred             eEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeeccCccccC
Q 002321          762 QLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYGLARLLP  841 (936)
Q Consensus       762 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  841 (936)
                      .++||||+.++ +.+.+..     .+++.++..++.|++.||+|||++||+||||||+|||++.++.+|++|||+++...
T Consensus        97 ~~iv~Ey~~~~-l~~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             EEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             eEEEEeccchH-HHHhhhc-----CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence            79999999655 4444432     28999999999999999999999999999999999999999999999999987654


Q ss_pred             CCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCccchhHHHHHH----------------
Q 002321          842 MLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTWKMMWWFSVT----------------  905 (936)
Q Consensus       842 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~~~~~~~~~~----------------  905 (936)
                      ..   .......+|+.|+|||++. +..++.++||||+||++|||++|+.||...+........                
T Consensus       171 ~~---~~~~~~~~t~~y~aPE~l~-~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         171 TS---FMMTPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             -------------CCTTCCHHHHT-TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             cc---cccccccccccccChhhhc-CCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence            32   2334556889999999985 457899999999999999999999999766532111000                


Q ss_pred             -----HH-------------------------HHHhhhccccceeeccccccccccccc
Q 002321          906 -----WL-------------------------EEHWKKAEWRNVSMRSCKGSSRQRRRF  934 (936)
Q Consensus       906 -----~~-------------------------~~~~~~~~~~~~~~~~l~~~p~~Rp~f  934 (936)
                           ..                         .....++.+.+++.+|+..||++||+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta  305 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV  305 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCH
Confidence                 00                         011223457789999999999999984

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.98  E-value=3.7e-33  Score=308.98  Aligned_cols=198  Identities=20%  Similarity=0.179  Sum_probs=158.3

Q ss_pred             cccCCCcccccCceEEEEEEeC-CCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-----------CCCcceeeeEEEe
Q 002321          691 LLNKDCELGRGGFGAVYRTVLR-DGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-----------HPNLVTLEGYYWT  758 (936)
Q Consensus       691 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  758 (936)
                      .|+..++||+|+||+||+|+.. +|+.||||+++...  ...+.+.+|++++++++           |+||+++++++..
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            3788899999999999999975 69999999997543  23467788999988875           5789999998864


Q ss_pred             C--CeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCC------e
Q 002321          759 Q--SLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQ-SNIIHYNIKSSNVLIDGSGE------P  829 (936)
Q Consensus       759 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~ivH~Dlkp~NIll~~~~~------~  829 (936)
                      .  ...+++|+++..+..............+++..+..++.|++.|++|||+ .||+||||||+|||++.++.      +
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~  171 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI  171 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence            3  4556777777655544443333334458999999999999999999997 89999999999999987653      9


Q ss_pred             EEeeccCccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHHHHHHcCCCCCCcc
Q 002321          830 KVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLVLEVVTGKRPLSTW  896 (936)
Q Consensus       830 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l~el~~g~~Pf~~~  896 (936)
                      +++|||.+.....     ......+|+.|+|||+.. ...++.++||||+||+++||++|+.||...
T Consensus       172 kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~~g~~pF~~~  232 (362)
T d1q8ya_         172 KIADLGNACWYDE-----HYTNSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFLFEPD  232 (362)
T ss_dssp             EECCCTTCEETTB-----CCCSCCSCGGGCCHHHHH-TCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             eEeeccccccccc-----ccccccccccccChhhcc-ccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence            9999999976532     224567899999999885 456899999999999999999999999754

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.98  E-value=1.1e-32  Score=298.44  Aligned_cols=258  Identities=32%  Similarity=0.535  Sum_probs=211.6

Q ss_pred             ccceecccCceecc--ccCcccccccccceEEccC-CcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCcccc
Q 002321          294 SLETLDLSGNKFSG--AVPISIGNLQRLKVLNFSA-NRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVS  370 (936)
Q Consensus       294 ~L~~L~L~~N~l~~--~~~~~l~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~  370 (936)
                      +++.|+|++|.++|  .+|..++++++|++|+|++ |.++|.+|..|.++++|++|+|++|++.+..+..+         
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~---------  121 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL---------  121 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGG---------
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccc---------
Confidence            45666666666665  3566677777777777765 66766677777777777777777777664443321         


Q ss_pred             ccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccC-CeeecCC
Q 002321          371 FAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKAL-NVLDLSE  449 (936)
Q Consensus       371 l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~Ls~  449 (936)
                                        ..+.+|+.+++++|.+.+.+|..+..++.|+.+++++|.+.+.+|..+..+..+ +.++++.
T Consensus       122 ------------------~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~  183 (313)
T d1ogqa_         122 ------------------SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR  183 (313)
T ss_dssp             ------------------GGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCS
T ss_pred             ------------------cchhhhcccccccccccccCchhhccCcccceeecccccccccccccccccccccccccccc
Confidence                              235677888888888888888888888889999999999988888888888776 8899999


Q ss_pred             ccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCC
Q 002321          450 NWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLP  529 (936)
Q Consensus       450 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  529 (936)
                      |++++..|..+..+..+ .+++++|.+.+.+|..++.+++|+.|++++|.+++.+| .++.+++|++|+|++|+|+|.+|
T Consensus       184 n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP  261 (313)
T d1ogqa_         184 NRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLP  261 (313)
T ss_dssp             SEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCC
T ss_pred             ccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCC
Confidence            99998888877776544 79999999999999999999999999999999997655 68889999999999999999999


Q ss_pred             cccccccccCeeecCCCcccccCCCCCccCcCCCccccCCCCCCCCCCCCCC
Q 002321          530 KQLVNLVHLSSFNISHNHLQGELPAGGFFNTISPSSVLGNPSLCGSAVNKSC  581 (936)
Q Consensus       530 ~~l~~l~~L~~L~ls~N~l~~~~p~~~~~~~~~~~~~~gn~~~c~~~~~~~~  581 (936)
                      .++.++++|++|+|++|+|+|.+|+.+.+..+....+.||+.+||.|+ ++|
T Consensus       262 ~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~pl-p~c  312 (313)
T d1ogqa_         262 QGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL-PAC  312 (313)
T ss_dssp             GGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS-SCC
T ss_pred             hHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCC-CCC
Confidence            999999999999999999999999988889999999999999999998 466

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=1.2e-29  Score=283.05  Aligned_cols=357  Identities=24%  Similarity=0.321  Sum_probs=208.7

Q ss_pred             EeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCcccccccccccccccc
Q 002321          105 LSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNR  184 (936)
Q Consensus       105 L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  184 (936)
                      ..+..+++++.+.  ...+.+|++|++++|+|+ .++  -++.+++|++|+|++|+|++..  .++++++|++|++++|+
T Consensus        27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~-~l~--gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~   99 (384)
T d2omza2          27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID--GVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQ   99 (384)
T ss_dssp             HHTTCSSTTSEEC--HHHHTTCCEEECCSSCCC-CCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred             HHhCCCCCCCccC--HHHhCCCCEEECCCCCCC-Ccc--ccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccc
Confidence            4566667766543  456777888888888776 342  3566777777777777777543  26677777777777777


Q ss_pred             ccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCchh
Q 002321          185 FSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPET  264 (936)
Q Consensus       185 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~  264 (936)
                      |++..+  ++++++|+.|++++|.+++..+  ......+..+....|.+....+..................     ...
T Consensus       100 i~~i~~--l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~  170 (384)
T d2omza2         100 IADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD-----LKP  170 (384)
T ss_dssp             CCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCC-----CGG
T ss_pred             cccccc--cccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccch-----hhh
Confidence            765432  6666777777777776664333  2233455666666665543322222211111111111111     111


Q ss_pred             hhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCC
Q 002321          265 MQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLV  344 (936)
Q Consensus       265 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  344 (936)
                      +                        .............|...  ....+..+++++.+++++|.+++..|  +...++|+
T Consensus       171 ~------------------------~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~  222 (384)
T d2omza2         171 L------------------------ANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLD  222 (384)
T ss_dssp             G------------------------TTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCC
T ss_pred             h------------------------ccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCC
Confidence            2                        22222233333333322  12234445555555555555554322  33445555


Q ss_pred             EEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEeccCcccCCCChhhhcccccCCeeecc
Q 002321          345 ALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLDLSHNEFSGETPATIGALSGLQLLNLS  424 (936)
Q Consensus       345 ~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  424 (936)
                      .|++++|.++. ++                            .+..+++|+.|++++|++++..+  +..+++|++|+++
T Consensus       223 ~L~l~~n~l~~-~~----------------------------~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~  271 (384)
T d2omza2         223 ELSLNGNQLKD-IG----------------------------TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLG  271 (384)
T ss_dssp             EEECCSSCCCC-CG----------------------------GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECC
T ss_pred             EEECCCCCCCC-cc----------------------------hhhcccccchhccccCccCCCCc--ccccccCCEeecc
Confidence            55555555541 11                            11234566666666666654432  5566667777777


Q ss_pred             CccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCC
Q 002321          425 RNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPI  504 (936)
Q Consensus       425 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  504 (936)
                      +|++++..  .+..+..++.++++.|.+++  ...+..+++++.|++++|++++..  .+..+++|++|+|++|+|++ +
T Consensus       272 ~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l  344 (384)
T d2omza2         272 ANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-V  344 (384)
T ss_dssp             SSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-C
T ss_pred             CcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-C
Confidence            77766432  35666777777777777764  233666777788888888877543  37778888888888888874 3


Q ss_pred             cccccccCCccEEEcCCCcccCCCCcccccccccCeeecCCC
Q 002321          505 PIAIAKLTNLQNVDLSFNSLTGGLPKQLVNLVHLSSFNISHN  546 (936)
Q Consensus       505 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ls~N  546 (936)
                      + .+.++++|++|+|++|+|++..|  +.++++|+.|+|++|
T Consensus       345 ~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         345 S-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             G-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             h-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            3 57788888888888888885544  778888888888877

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=2.3e-29  Score=280.76  Aligned_cols=359  Identities=23%  Similarity=0.285  Sum_probs=236.7

Q ss_pred             EEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccC
Q 002321           79 IELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAK  158 (936)
Q Consensus        79 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~  158 (936)
                      +...+...++++.++  ..++.+|++|++++++|+..  +.+..|++|++|||++|+|+ .+|+  |+++++|++|++++
T Consensus        25 ~~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~-~l~~--l~~L~~L~~L~L~~   97 (384)
T d2omza2          25 MKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLT-DITP--LKNLTKLVDILMNN   97 (384)
T ss_dssp             HHHHTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCS
T ss_pred             HHHHhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCC-CCcc--ccCCcccccccccc
Confidence            345677777777665  35788999999999999864  57899999999999999999 4553  89999999999999


Q ss_pred             ccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCC
Q 002321          159 NRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIP  238 (936)
Q Consensus       159 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  238 (936)
                      |+|++..  .++.+++|+.|++++|.+++..+  ......+..+....|.+....+..................+     
T Consensus        98 n~i~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-----  168 (384)
T d2omza2          98 NQIADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL-----  168 (384)
T ss_dssp             SCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCC-----
T ss_pred             ccccccc--ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccchh-----
Confidence            9998643  38899999999999999987544  45667888999999988755444333333333332222222     


Q ss_pred             cccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccc
Q 002321          239 DGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQR  318 (936)
Q Consensus       239 ~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~  318 (936)
                      ..+.............|...  ....+..++.+..+++++|.+++.                        .|  +...++
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~------------------------~~--~~~~~~  220 (384)
T d2omza2         169 KPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDI------------------------TP--LGILTN  220 (384)
T ss_dssp             GGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCC------------------------GG--GGGCTT
T ss_pred             hhhccccccccccccccccc--cccccccccccceeeccCCccCCC------------------------Cc--ccccCC
Confidence            23444455555555555443  223344444444555554444433                        22  233445


Q ss_pred             cceEEccCCcccccCChhhhccCCCCEEEccCCcCccCCChhhhccCCccccccccccccCCCCCCCCCCCCCCcccEEe
Q 002321          319 LKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMNGDLPQWIFSSGLNKVSFAENKIREGMNGPFASSGSSFESLQFLD  398 (936)
Q Consensus       319 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~l~~l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~  398 (936)
                      |+.|++++|+++.  +..+..+++|+.|++++|.+++..+                             +..+++|++|+
T Consensus       221 L~~L~l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~~~~~-----------------------------~~~~~~L~~L~  269 (384)
T d2omza2         221 LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP-----------------------------LSGLTKLTELK  269 (384)
T ss_dssp             CCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG-----------------------------GTTCTTCSEEE
T ss_pred             CCEEECCCCCCCC--cchhhcccccchhccccCccCCCCc-----------------------------ccccccCCEee
Confidence            5555555555542  1244555555555555555542111                             12345566666


Q ss_pred             ccCcccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEEecCCccCC
Q 002321          399 LSHNEFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAG  478 (936)
Q Consensus       399 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  478 (936)
                      +++|++++..  .+..++.++.+++++|++++  ...+..+++++.|++++|++++..  .+..+++|++|++++|+|++
T Consensus       270 l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~  343 (384)
T d2omza2         270 LGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD  343 (384)
T ss_dssp             CCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC
T ss_pred             ccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC
Confidence            6666665432  25566667777777777664  234666777777777777777532  26777788888888888873


Q ss_pred             cCccccccccccccccccCccccCCCcccccccCCccEEEcCCC
Q 002321          479 KIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFN  522 (936)
Q Consensus       479 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  522 (936)
                       ++ .+.++++|++|+|++|++++..|  +.++++|++|+|++|
T Consensus       344 -l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         344 -VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             -CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             -Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence             43 57888888888888888886554  778888888888887

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=1e-26  Score=250.34  Aligned_cols=246  Identities=23%  Similarity=0.342  Sum_probs=155.2

Q ss_pred             CCccceeEEecCCCCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccc
Q 002321           62 TPCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIP  141 (936)
Q Consensus        62 ~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~  141 (936)
                      |-|.|.+|.|+..            +++ .+|+.+.  +.+++|+|++|+|+.+.+.+|.++++|++|++++|.+. .++
T Consensus         8 c~c~~~~~~C~~~------------~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~-~i~   71 (305)
T d1xkua_           8 CQCHLRVVQCSDL------------GLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KIS   71 (305)
T ss_dssp             CEEETTEEECTTS------------CCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCC-CBC
T ss_pred             CEecCCEEEecCC------------CCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhcccccccccccccccc-ccc
Confidence            3489999999752            333 4555543  57888888888888666667888888888888888888 666


Q ss_pred             hhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCC--CCCccCccC
Q 002321          142 DEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLE--GEIPKGVES  219 (936)
Q Consensus       142 ~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~  219 (936)
                      +..|..+++|++|++++|+|+. +|..+  ...|+.|++++|.+.++.+..+.....++.++...|...  ...+..+..
T Consensus        72 ~~~f~~l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~  148 (305)
T d1xkua_          72 PGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG  148 (305)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGG
T ss_pred             hhhhhCCCccCEecccCCccCc-Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCcccccc
Confidence            6778888888888888888874 44332  246777777777777666556666666777777766443  223345556


Q ss_pred             CCCcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceec
Q 002321          220 LKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLD  299 (936)
Q Consensus       220 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  299 (936)
                      +++|+++++++|.++ .+|..+  +++|++|++++|..++..+..                        +..++.++.|+
T Consensus       149 l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~------------------------~~~~~~l~~L~  201 (305)
T d1xkua_         149 MKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAAS------------------------LKGLNNLAKLG  201 (305)
T ss_dssp             CTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGG------------------------GTTCTTCCEEE
T ss_pred             ccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhH------------------------hhccccccccc
Confidence            666666666666665 233322  345555665555555444444                        44445555555


Q ss_pred             ccCceeccccCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCCcCc
Q 002321          300 LSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQNSMN  354 (936)
Q Consensus       300 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  354 (936)
                      +++|.+++..+..+.++++|++|+|++|+|+ .+|..|..+++|+.|+|++|+|+
T Consensus       202 ~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~  255 (305)
T d1xkua_         202 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS  255 (305)
T ss_dssp             CCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred             cccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC
Confidence            5555555444555555555555555555555 34445555555555555555554

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.4e-26  Score=246.17  Aligned_cols=251  Identities=20%  Similarity=0.206  Sum_probs=207.0

Q ss_pred             cCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEcc-CccC
Q 002321           83 LNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLA-KNRF  161 (936)
Q Consensus        83 l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~-~N~l  161 (936)
                      .++.+++ .+|..+.  +.+++|+|++|+|+.+.+.+|.++++|++||+++|+|. .++...|..+..++.++.. .|.+
T Consensus        18 c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~-~i~~~~~~~~~~~~~l~~~~~~~~   93 (284)
T d1ozna_          18 CPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQL   93 (284)
T ss_dssp             CCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSCTTC
T ss_pred             cCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccc-cccccccccccccccccccccccc
Confidence            3344555 5555443  56899999999999777778999999999999999998 6788888999999998764 6678


Q ss_pred             CCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCccc
Q 002321          162 SGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGI  241 (936)
Q Consensus       162 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l  241 (936)
                      +...+..|+++++|++|++++|.+....+..+....+|+.+++++|+|++..+..|..+++|++|++++|++++..+..|
T Consensus        94 ~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f  173 (284)
T d1ozna_          94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAF  173 (284)
T ss_dssp             CCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTT
T ss_pred             ccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhh
Confidence            87778889999999999999999988888888889999999999999997777888889999999999999998888889


Q ss_pred             ccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccce
Q 002321          242 GSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKV  321 (936)
Q Consensus       242 ~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~  321 (936)
                      .++++|+++++++|++++..|..|..+++|+.|++++|.+.+..+..|..+++|++|+|++|.+...-+. ..-...++.
T Consensus       174 ~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-~~l~~~l~~  252 (284)
T d1ozna_         174 RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQK  252 (284)
T ss_dssp             TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHH
T ss_pred             ccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc-hHHHHHHHh
Confidence            9999999999999999988889999999999999999999888888888889999999999988754331 122234566


Q ss_pred             EEccCCcccccCChhhh
Q 002321          322 LNFSANRLTGSLPDSMA  338 (936)
Q Consensus       322 L~L~~N~l~~~~~~~~~  338 (936)
                      +....+.++...|..+.
T Consensus       253 ~~~~~~~~~C~~p~~l~  269 (284)
T d1ozna_         253 FRGSSSEVPCSLPQRLA  269 (284)
T ss_dssp             CCSEECCCBEEESGGGT
T ss_pred             CcCCCCceEeCCchHHc
Confidence            66666777666666554

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=1.5e-25  Score=241.11  Aligned_cols=220  Identities=22%  Similarity=0.332  Sum_probs=104.9

Q ss_pred             cccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCcccccccccccc
Q 002321          101 FLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINL  180 (936)
Q Consensus       101 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  180 (936)
                      .++.++=++++++ .+|..+.  ++|++|+|++|+|+ .+|+..|.++++|++|++++|++....|..|.++++|++|++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l   86 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL   86 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEecc
Confidence            3444555555555 3344442  35555555555555 455444555555555555555555444444444444444444


Q ss_pred             ccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccC--
Q 002321          181 SSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFS--  258 (936)
Q Consensus       181 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~--  258 (936)
                      ++|+|+.                         +|..+.  ..++.|++.+|.+.+..+..+.....+..++...|...  
T Consensus        87 ~~n~l~~-------------------------l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~  139 (305)
T d1xkua_          87 SKNQLKE-------------------------LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS  139 (305)
T ss_dssp             CSSCCSB-------------------------CCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGG
T ss_pred             cCCccCc-------------------------Cccchh--hhhhhhhccccchhhhhhhhhhcccccccccccccccccc
Confidence            4444443                         222111  23344444444444333333333333444444433221  


Q ss_pred             CCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhh
Q 002321          259 GNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMA  338 (936)
Q Consensus       259 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~  338 (936)
                      ...+..+..+++|+.+++++|.++. +|..  ..++|+.|++++|.+.+..+..+.+++.+++|++++|.+++..+..+.
T Consensus       140 ~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~  216 (305)
T d1xkua_         140 GIENGAFQGMKKLSYIRIADTNITT-IPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA  216 (305)
T ss_dssp             GBCTTGGGGCTTCCEEECCSSCCCS-CCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGG
T ss_pred             CCCccccccccccCccccccCCccc-cCcc--cCCccCEEECCCCcCCCCChhHhhcccccccccccccccccccccccc
Confidence            1112233333444444444444332 2222  134566666666666655555666666666666666666655555666


Q ss_pred             ccCCCCEEEccCCcCc
Q 002321          339 NCMNLVALDFSQNSMN  354 (936)
Q Consensus       339 ~l~~L~~L~Ls~N~l~  354 (936)
                      ++++|+.|+|++|+|+
T Consensus       217 ~l~~L~~L~L~~N~L~  232 (305)
T d1xkua_         217 NTPHLRELHLNNNKLV  232 (305)
T ss_dssp             GSTTCCEEECCSSCCS
T ss_pred             ccccceeeeccccccc
Confidence            6666666666655554

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=4.7e-26  Score=242.15  Aligned_cols=228  Identities=23%  Similarity=0.270  Sum_probs=152.7

Q ss_pred             EEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCcccccccccccc-cc
Q 002321          104 KLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINL-SS  182 (936)
Q Consensus       104 ~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L-~~  182 (936)
                      .++.++++++ .+|..+.  +++++|+|++|+|+ .+|...|.++++|++|++++|+|.+..+..+..++.++.+.. ..
T Consensus        15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~   90 (284)
T d1ozna_          15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (284)
T ss_dssp             EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCC-CCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence            4567777777 4565543  56788888888887 677777777777777777777777666666666666666544 34


Q ss_pred             ccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCc
Q 002321          183 NRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLP  262 (936)
Q Consensus       183 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~  262 (936)
                      |.++.+.+..|.++++|++|++++|.+....+..+..+++|+.+++++|+|+++.+..|..+++|++|++++|+      
T Consensus        91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~------  164 (284)
T d1ozna_          91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR------  164 (284)
T ss_dssp             TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC------
T ss_pred             cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCc------
Confidence            55555555566666666666666666654444455555555555555555554444445555555555555554      


Q ss_pred             hhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCC
Q 002321          263 ETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMN  342 (936)
Q Consensus       263 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  342 (936)
                                        +++..+.+|..+++|+++++++|++++..|..|.++++|++|++++|++++..+..|..+++
T Consensus       165 ------------------l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~  226 (284)
T d1ozna_         165 ------------------ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA  226 (284)
T ss_dssp             ------------------CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred             ------------------ccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccc
Confidence                              44455566667777777777777777777777777788888888888888777777888888


Q ss_pred             CCEEEccCCcCccCCCh
Q 002321          343 LVALDFSQNSMNGDLPQ  359 (936)
Q Consensus       343 L~~L~Ls~N~l~~~~p~  359 (936)
                      |+.|++++|++.++.+.
T Consensus       227 L~~L~l~~N~l~C~C~~  243 (284)
T d1ozna_         227 LQYLRLNDNPWVCDCRA  243 (284)
T ss_dssp             CCEEECCSSCEECSGGG
T ss_pred             cCEEEecCCCCCCCccc
Confidence            88888888888766554

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=2.7e-23  Score=218.11  Aligned_cols=196  Identities=22%  Similarity=0.216  Sum_probs=121.4

Q ss_pred             eEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEcc
Q 002321           78 VIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLA  157 (936)
Q Consensus        78 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~  157 (936)
                      ..+++.++++++ .+|+.+.  ++|++|+|++|+|+++.+.+|.++++|++|+|++|+|+ .+|.  |..+++|++|+|+
T Consensus        12 ~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~--~~~l~~L~~L~Ls   85 (266)
T d1p9ag_          12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV--DGTLPVLGTLDLS   85 (266)
T ss_dssp             CCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC--CSCCTTCCEEECC
T ss_pred             CeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc--ccccccccccccc
Confidence            344566667776 4665553  46777777777777665566777777777777777776 4543  4566677777777


Q ss_pred             CccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccC
Q 002321          158 KNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSI  237 (936)
Q Consensus       158 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  237 (936)
                      +|++++ .+..+..+++|++|++++|++....+..+..+.++++|++++|.++...+..+..+++|+.|++++|+|++..
T Consensus        86 ~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~  164 (266)
T d1p9ag_          86 HNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELP  164 (266)
T ss_dssp             SSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCC
T ss_pred             cccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccC
Confidence            777663 3455666666666666666666655666666666666666666666555555555666666666666666555


Q ss_pred             CcccccccCcceeeccccccCCCCchhhhccccccEEeccCccc
Q 002321          238 PDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLF  281 (936)
Q Consensus       238 p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l  281 (936)
                      +..|..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|.+
T Consensus       165 ~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~  207 (266)
T d1p9ag_         165 AGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW  207 (266)
T ss_dssp             TTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred             ccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence            555666666666666666665 3444444444444444444443

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=3.2e-23  Score=217.48  Aligned_cols=201  Identities=22%  Similarity=0.240  Sum_probs=135.9

Q ss_pred             ccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCcccccccc
Q 002321           97 LQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLA  176 (936)
Q Consensus        97 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  176 (936)
                      .+...+.+.+.++++|+ .+|+.+.  ++|++|||++|+|+ .+|...|.++++|++|+|++|+|+.. | .++.+++|+
T Consensus         7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~   80 (266)
T d1p9ag_           7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLG   80 (266)
T ss_dssp             ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCS-EEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCC
T ss_pred             cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCC-CcCHHHhhcccccccccccccccccc-c-ccccccccc
Confidence            34556677889999998 4676664  57899999999998 67888888888899999888888743 2 345677777


Q ss_pred             ccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccc
Q 002321          177 TINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENS  256 (936)
Q Consensus       177 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~  256 (936)
                      +|+|++|++++ .+..+.++++|++|++++|.+....+..+..+.++++|++++|.++...+..+..+++|++|++++|+
T Consensus        81 ~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~  159 (266)
T d1p9ag_          81 TLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (266)
T ss_dssp             EEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             ccccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccc
Confidence            77777777775 45566677777777777777776666666666777777777777766655666666666666666666


Q ss_pred             cCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCcee
Q 002321          257 FSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKF  305 (936)
Q Consensus       257 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  305 (936)
                      |++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+
T Consensus       160 l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~  207 (266)
T d1p9ag_         160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW  207 (266)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred             ccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence            66555555555555555555555555 3444444444444444444443

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=3.7e-23  Score=205.11  Aligned_cols=170  Identities=12%  Similarity=0.096  Sum_probs=119.9

Q ss_pred             cCCCcccccCceEEEEEEeCCCcEEEEEEeeccCcc-----------------chHHHHHHHHHHHHcCCCCCcceeeeE
Q 002321          693 NKDCELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLV-----------------KSQEDFEREVKKLGKVRHPNLVTLEGY  755 (936)
Q Consensus       693 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~h~niv~l~~~  755 (936)
                      ..+++||+|+||+||+|+..+|+.||||+++.....                 .......+|+..+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            346789999999999999888999999987532110                 012345678999999999999988765


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCCeEEeecc
Q 002321          756 YWTQSLQLLIYEFVSGGSLHKHLHEGSGGNFLSWNERFNVIQGTAKSLAHLHQSNIIHYNIKSSNVLIDGSGEPKVGDYG  835 (936)
Q Consensus       756 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  835 (936)
                      .    ..+++|||++++.+.+          ++.....+++.|+++|++|||+.||+||||||+|||++++ .++++|||
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG  147 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFP  147 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred             c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECC
Confidence            3    2379999998765433          2333456789999999999999999999999999999965 48999999


Q ss_pred             CccccCCCccccccccccCcccccCcccccCcccCCchhhHHHHHHHH
Q 002321          836 LARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITDKCDVYGFGVLV  883 (936)
Q Consensus       836 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG~~l  883 (936)
                      .|+..........   ....... -.|.+  .+.|+.++|+||+.--+
T Consensus       148 ~a~~~~~~~~~~~---l~rd~~~-~~~~f--~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         148 QSVEVGEEGWREI---LERDVRN-IITYF--SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TCEETTSTTHHHH---HHHHHHH-HHHHH--HHHHCCCCCHHHHHHHH
T ss_pred             CcccCCCCCcHHH---HHHHHHH-HHHHH--cCCCCCcccHHHHHHHH
Confidence            9976532211100   0000000 01222  24578899999985433

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.85  E-value=4.7e-20  Score=201.81  Aligned_cols=53  Identities=25%  Similarity=0.308  Sum_probs=32.8

Q ss_pred             cccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCC
Q 002321          101 FLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFS  162 (936)
Q Consensus       101 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~  162 (936)
                      ++++|+|++|+++ .+|+.   +++|++|+|++|+|+ .+|..    +.+|+.|++++|+++
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~   91 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLK   91 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCS
T ss_pred             CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc----hhhhhhhhhhhcccc
Confidence            5667777777776 35543   456777777777776 55532    345666666666555

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.85  E-value=6.6e-20  Score=200.59  Aligned_cols=59  Identities=32%  Similarity=0.460  Sum_probs=32.0

Q ss_pred             CCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcc
Q 002321          464 YSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQ  531 (936)
Q Consensus       464 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  531 (936)
                      ++|++|+|++|+|+ .+|..   +++|+.|+|++|+|+ .+|..   +++|++|+|++|+|+ .+|..
T Consensus       284 ~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~  342 (353)
T d1jl5a_         284 PSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDI  342 (353)
T ss_dssp             TTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCC
T ss_pred             CCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCcc
Confidence            45555555555555 34432   345556666666665 34432   345666677777665 45543

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=3.9e-20  Score=191.02  Aligned_cols=222  Identities=14%  Similarity=0.080  Sum_probs=143.7

Q ss_pred             CccceeEEecCCCCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccch
Q 002321           63 PCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPD  142 (936)
Q Consensus        63 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~  142 (936)
                      -|.+..|.|..            .+++ .+|+.+.  +++++|+|++|+|+.+.+.+|.++++|++|+|++|.+...++.
T Consensus         7 ~C~~~~i~c~~------------~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~   71 (242)
T d1xwdc1           7 HCSNRVFLCQE------------SKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA   71 (242)
T ss_dssp             EECSSEEEEES------------CSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECS
T ss_pred             CCcCCEEEEeC------------CCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeec
Confidence            36777777864            2333 4555442  5788999999999866666788899999999999988867888


Q ss_pred             hhhhcCCCCcEEEcc-CccCCCCCCCCccccccccccccccccccCCCCC-CCCCCCCCCEEecCCCCCCCCCccCccCC
Q 002321          143 EFFKQCGSLRVISLA-KNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPL-GIWGLSALRTLDLSDNLLEGEIPKGVESL  220 (936)
Q Consensus       143 ~~f~~l~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  220 (936)
                      ..|..++++++|.+. .|.+....+..|..+++|++|++++|+++...+. .+..+..|..+..+++.+....+..|.++
T Consensus        72 ~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~  151 (242)
T d1xwdc1          72 DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGL  151 (242)
T ss_dssp             SSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccc
Confidence            888888888888875 4677777777788888888888888887754332 23345556666666667765555556555


Q ss_pred             C-CcceeecccccccccCCcccccccCcc-eeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCcccee
Q 002321          221 K-NLRVINLSKNMFSGSIPDGIGSCSLLR-TIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETL  298 (936)
Q Consensus       221 ~-~L~~L~L~~N~l~~~~p~~l~~l~~L~-~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  298 (936)
                      + .++.|++++|+++...+..|. ..+++ .+++++|+++...+..|.++++|+.|+|++|+++...+..|.++++|+.|
T Consensus       152 ~~~l~~L~l~~n~l~~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l  230 (242)
T d1xwdc1         152 SFESVILWLNKNGIQEIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR  230 (242)
T ss_dssp             BSSCEEEECCSSCCCEECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESS
T ss_pred             cccceeeeccccccccccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccC
Confidence            4 667777777777644443333 33333 33456666664444445555555555555555554333444445555444


Q ss_pred             cc
Q 002321          299 DL  300 (936)
Q Consensus       299 ~L  300 (936)
                      ++
T Consensus       231 ~~  232 (242)
T d1xwdc1         231 ST  232 (242)
T ss_dssp             SE
T ss_pred             cC
Confidence            44

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=8.1e-24  Score=241.05  Aligned_cols=62  Identities=18%  Similarity=0.244  Sum_probs=34.9

Q ss_pred             cccEEeccCCcccCcC-CCchhhcCCCcEEEccCcccccccc---hhhhhcCCCCcEEEccCccCC
Q 002321          101 FLRKLSLSSNNLTGSI-SPNLAKLQNLRVIDLSGNSLSGSIP---DEFFKQCGSLRVISLAKNRFS  162 (936)
Q Consensus       101 ~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~Ls~N~l~~~i~---~~~f~~l~~L~~L~L~~N~l~  162 (936)
                      +|++||++.|+|++.. ..-+..+++|++|+|++|+|+..--   ..++..+++|++|+|++|+|+
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~   68 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG   68 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCC
Confidence            4667777777776432 2335556677777777776652111   123455566666666666554

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=2.5e-19  Score=184.84  Aligned_cols=219  Identities=16%  Similarity=0.112  Sum_probs=159.3

Q ss_pred             cEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCC-CCCccccccccccccc
Q 002321          103 RKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKI-PSSLSLCSTLATINLS  181 (936)
Q Consensus       103 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~  181 (936)
                      +.++.++++++ .+|+.+.  +++++|||++|+|+ .+|...|.++++|++|+|++|.+...+ +..|..++++++|.+.
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~   86 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   86 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence            46778888888 6776653  58999999999998 789889999999999999999987644 5578889999999876


Q ss_pred             -cccccCCCCCCCCCCCCCCEEecCCCCCCCCCc-cCccCCCCcceeecccccccccCCccccccc-CcceeeccccccC
Q 002321          182 -SNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIP-KGVESLKNLRVINLSKNMFSGSIPDGIGSCS-LLRTIDFSENSFS  258 (936)
Q Consensus       182 -~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~  258 (936)
                       .|++....+..|.++++|++|++++|.+....+ ..+..+..+..+...++.+....+..|..++ .++.|++++|+++
T Consensus        87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~  166 (242)
T d1xwdc1          87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ  166 (242)
T ss_dssp             CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred             ccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence             477888888889999999999999998874433 2345566777777778888766666776654 7888888888887


Q ss_pred             CCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEcc
Q 002321          259 GNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFS  325 (936)
Q Consensus       259 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~  325 (936)
                      ...+..+......+.+.+++|+++...+..|..+++|++|+|++|+|+...+..|.++++|+.|++.
T Consensus       167 ~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~  233 (242)
T d1xwdc1         167 EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY  233 (242)
T ss_dssp             EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred             ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence            5544444333333444566666765445556667777777777777765444456666666665554

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.78  E-value=2.6e-19  Score=182.55  Aligned_cols=204  Identities=22%  Similarity=0.332  Sum_probs=96.6

Q ss_pred             cEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCcccccccccccccc
Q 002321          103 RKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSS  182 (936)
Q Consensus       103 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  182 (936)
                      ..++++.+++++.+  .++.+.+|+.|++++|+|+ .++  .+..+++|++|+|++|+|++..|  +..+++|++|++++
T Consensus        22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~--~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~   94 (227)
T d1h6ua2          22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE--GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG   94 (227)
T ss_dssp             HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred             HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch--hHhcCCCCcEeecCCceeecccc--cccccccccccccc
Confidence            34445555555432  4455555566666555555 332  14455555555555555543222  44555555555555


Q ss_pred             ccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCc
Q 002321          183 NRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLP  262 (936)
Q Consensus       183 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~  262 (936)
                      |.++.+  ..+.++++|++++++++...+..  .+...+.++.+.++.+.+...  ..+...++|++|++++|.+++.. 
T Consensus        95 n~~~~i--~~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~-  167 (227)
T d1h6ua2          95 NPLKNV--SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT-  167 (227)
T ss_dssp             CCCSCC--GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG-
T ss_pred             cccccc--ccccccccccccccccccccccc--hhccccchhhhhchhhhhchh--hhhccccccccccccccccccch-
Confidence            555432  23445555555555555554321  233444555555555554422  12344445555555555443221 


Q ss_pred             hhhhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEccCCcccccCChhhhccCC
Q 002321          263 ETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFSANRLTGSLPDSMANCMN  342 (936)
Q Consensus       263 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  342 (936)
                                               .++++++|+.|+|++|++++. + .+.++++|++|+|++|++++..  .+.++++
T Consensus       168 -------------------------~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~  218 (227)
T d1h6ua2         168 -------------------------PLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVS--PLANTSN  218 (227)
T ss_dssp             -------------------------GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCG--GGTTCTT
T ss_pred             -------------------------hhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCc--ccccCCC
Confidence                                     133444455555555554432 1 1445555555555555555322  2445555


Q ss_pred             CCEEEcc
Q 002321          343 LVALDFS  349 (936)
Q Consensus       343 L~~L~Ls  349 (936)
                      |+.|+++
T Consensus       219 L~~L~ls  225 (227)
T d1h6ua2         219 LFIVTLT  225 (227)
T ss_dssp             CCEEEEE
T ss_pred             CCEEEee
Confidence            5555554

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=5.1e-22  Score=225.96  Aligned_cols=86  Identities=20%  Similarity=0.173  Sum_probs=51.8

Q ss_pred             ceEEeccCCCCCCccc-ccccccCccccEEeccCCcccC----cCCCchhhcCCCcEEEccCcccccccchhhhh----c
Q 002321           77 RVIELTLNGLSLTGRI-GRGLLQLQFLRKLSLSSNNLTG----SISPNLAKLQNLRVIDLSGNSLSGSIPDEFFK----Q  147 (936)
Q Consensus        77 ~v~~l~l~~~~l~g~~-~~~l~~l~~L~~L~L~~n~l~~----~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~----~  147 (936)
                      ++.+||++++++++.. ..-+..+++++.|+|++|+|+.    .+...+..+++|++|||++|+|+..--..+..    .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            5677788777776632 3335667777788888887763    23445567777888888888775211111111    2


Q ss_pred             CCCCcEEEccCccCC
Q 002321          148 CGSLRVISLAKNRFS  162 (936)
Q Consensus       148 l~~L~~L~L~~N~l~  162 (936)
                      ..+|++|+|++|+|+
T Consensus        83 ~~~L~~L~L~~n~it   97 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLT   97 (460)
T ss_dssp             TCCCCEEECTTSCCB
T ss_pred             CCCCCEEECCCCCcc
Confidence            235666666666654

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.78  E-value=5.3e-19  Score=180.26  Aligned_cols=206  Identities=20%  Similarity=0.277  Sum_probs=158.2

Q ss_pred             ceEEeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEc
Q 002321           77 RVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISL  156 (936)
Q Consensus        77 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L  156 (936)
                      .++.+++...++++.+  .+++|.+|++|++.+|+|+..  +.+..+++|++|+|++|+|++..|   |..+++|+++++
T Consensus        20 ~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~---l~~l~~l~~l~~   92 (227)
T d1h6ua2          20 NAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP---LKNLTKITELEL   92 (227)
T ss_dssp             HHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG---GTTCCSCCEEEC
T ss_pred             HHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc---cccccccccccc
Confidence            3456677777776644  467889999999999999964  469999999999999999985433   789999999999


Q ss_pred             cCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeeccccccccc
Q 002321          157 AKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGS  236 (936)
Q Consensus       157 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  236 (936)
                      ++|.++. + ..++.+++|+.++++++.+.+.  ..+...+.++.+.++++.+....  .+.++++|++|++++|.+++.
T Consensus        93 ~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~  166 (227)
T d1h6ua2          93 SGNPLKN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDL  166 (227)
T ss_dssp             CSCCCSC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCC
T ss_pred             ccccccc-c-cccccccccccccccccccccc--chhccccchhhhhchhhhhchhh--hhccccccccccccccccccc
Confidence            9999984 2 4688999999999999998764  34678899999999999998543  377889999999999999754


Q ss_pred             CCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceeccc
Q 002321          237 IPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLS  301 (936)
Q Consensus       237 ~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  301 (936)
                        ..+..+++|++|+|++|++++. + .+.++++|++|+|++|++++..|  +.++++|++|+++
T Consensus       167 --~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls  225 (227)
T d1h6ua2         167 --TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT  225 (227)
T ss_dssp             --GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred             --hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence              3488899999999999998853 2 25555556666655555553321  4455555555554

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.78  E-value=1.9e-19  Score=178.26  Aligned_cols=175  Identities=21%  Similarity=0.262  Sum_probs=106.5

Q ss_pred             CccceeEEecCCCCceEEeccCCCCCCcccccccccCccccEEeccCCcccCcC-CCchhhcCCCcEEEccCcccccccc
Q 002321           63 PCNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSI-SPNLAKLQNLRVIDLSGNSLSGSIP  141 (936)
Q Consensus        63 ~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~Ls~N~l~~~i~  141 (936)
                      -|.|..|.|+.            ++++ .+|+.+.  +++++|+|++|+|++.+ +..|.++++|++|+|++|++. .++
T Consensus         7 ~C~~~~v~Cs~------------~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~-~~~   70 (192)
T d1w8aa_           7 HCEGTTVDCTG------------RGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIE   70 (192)
T ss_dssp             EEETTEEECTT------------SCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCC-CBC
T ss_pred             EEcCCEEEEeC------------CCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccc-ccc
Confidence            46777777754            3444 4555442  56777777777776533 456677777777777777777 556


Q ss_pred             hhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCC
Q 002321          142 DEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLK  221 (936)
Q Consensus       142 ~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  221 (936)
                      .+.|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|+++.+.+|.++++|++|+|++|.+...... ..-..
T Consensus        71 ~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~  149 (192)
T d1w8aa_          71 PNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAE  149 (192)
T ss_dssp             TTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHH
T ss_pred             ccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch-HHHhh
Confidence            66677777777777777777766666677777777777777777766666666777777777777766532221 11112


Q ss_pred             CcceeecccccccccCCcccccccCcceeecccccc
Q 002321          222 NLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSF  257 (936)
Q Consensus       222 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l  257 (936)
                      .++.+.+..|.++...|..   +..++.++|+.|.+
T Consensus       150 ~l~~~~l~~~~~~c~~p~~---l~~~~l~~L~~n~l  182 (192)
T d1w8aa_         150 WLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEF  182 (192)
T ss_dssp             HHHHHCCSGGGCBBCSSTT---TTTSBGGGSCTTTC
T ss_pred             hhhhhcccCCCeEeCCChh---hcCCEeeecCHhhC
Confidence            3444455555554433332   23344445555444

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.77  E-value=2.5e-19  Score=177.31  Aligned_cols=129  Identities=24%  Similarity=0.374  Sum_probs=88.4

Q ss_pred             cEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCcccccccccccccc
Q 002321          103 RKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSS  182 (936)
Q Consensus       103 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  182 (936)
                      +.++.++++++ .+|..+.  +++++|+|++|+|++.++...|..+++|++|+|++|++.+..+..|..+++|++|+|++
T Consensus        11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~   87 (192)
T d1w8aa_          11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence            45677777777 4565553  56777778877777566667777777777777777777766666677677777777777


Q ss_pred             ccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeeccccccc
Q 002321          183 NRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFS  234 (936)
Q Consensus       183 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  234 (936)
                      |+|+++.+.+|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+.
T Consensus        88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~  139 (192)
T d1w8aa_          88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN  139 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred             ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence            7777666666666666666666666666555556666666666666666654

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=3.3e-18  Score=171.66  Aligned_cols=180  Identities=21%  Similarity=0.312  Sum_probs=79.9

Q ss_pred             EeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCcccccccccccccccc
Q 002321          105 LSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNR  184 (936)
Q Consensus       105 L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  184 (936)
                      ..+..+.+++.++.  ..+.+|++|++++|.++ .++.  +..+++|++|+|++|+|++..  .++.+++|++|++++|+
T Consensus        29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~-~l~~--l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~  101 (210)
T d1h6ta2          29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENK  101 (210)
T ss_dssp             HHTTCSCTTSEECH--HHHHTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred             HHhCcCccCCccCH--HHhcCccEEECcCCCCC-Cchh--HhhCCCCCEEeCCCccccCcc--ccccCcccccccccccc
Confidence            34444445443321  23445555555555554 2221  344444444444444444321  13344444444444444


Q ss_pred             ccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCchh
Q 002321          185 FSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPET  264 (936)
Q Consensus       185 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~  264 (936)
                      |+++ + .+.++++|+.|++++|.+.. + ..+.++++|+.+++++|.++                        +  +..
T Consensus       102 i~~l-~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~------------------------~--~~~  151 (210)
T d1h6ta2         102 VKDL-S-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKIT------------------------D--ITV  151 (210)
T ss_dssp             CCCG-G-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCC------------------------C--CGG
T ss_pred             cccc-c-cccccccccccccccccccc-c-cccccccccccccccccccc------------------------c--ccc
Confidence            4431 1 24444444444444444431 1 12344444444444444443                        2  122


Q ss_pred             hhccccccEEeccCccccCCCCcccccCCccceecccCceeccccCcccccccccceEEcc
Q 002321          265 MQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSGAVPISIGNLQRLKVLNFS  325 (936)
Q Consensus       265 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~  325 (936)
                      +..+++|+.+++++|++++..  .++++++|++|+|++|+|++ ++ .+.++++|++|+|+
T Consensus       152 ~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         152 LSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF  208 (210)
T ss_dssp             GGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred             ccccccccccccccccccccc--cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence            333444444444444444321  14555556666666666553 23 35556666666654

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=8.4e-18  Score=167.20  Aligned_cols=162  Identities=22%  Similarity=0.320  Sum_probs=72.6

Q ss_pred             hcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCE
Q 002321          122 KLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRT  201 (936)
Q Consensus       122 ~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  201 (936)
                      .+++|++|++++|.|+ .++  .++.+++|++|+|++|+|++..|  ++.+++|++|++++|.+....  .+.++++|+.
T Consensus        38 ~l~~l~~L~l~~~~i~-~l~--~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~  110 (199)
T d2omxa2          38 DLDQVTTLQADRLGIK-SID--GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTG  110 (199)
T ss_dssp             HHTTCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSE
T ss_pred             HhcCCCEEECCCCCCC-Ccc--ccccCCCcCcCccccccccCccc--ccCCccccccccccccccccc--cccccccccc
Confidence            3344444444444443 221  13334444444444444443221  444444444444444444321  2444455555


Q ss_pred             EecCCCCCCCCCccCccCCCCcceeecccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccc
Q 002321          202 LDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLF  281 (936)
Q Consensus       202 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l  281 (936)
                      |++++|.+...  ..+..+++|+.|++++|++.. + +.+..+++|++|++++|++++..  .+.++++|+.|++++|++
T Consensus       111 L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i  184 (199)
T d2omxa2         111 LTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKV  184 (199)
T ss_dssp             EECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred             ccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCCc--cccCCCCCCEEECCCCCC
Confidence            55555544422  124444555555555555442 1 23444555555555555554321  245555555555555555


Q ss_pred             cCCCCcccccCCcccee
Q 002321          282 SGEVPKWIGELESLETL  298 (936)
Q Consensus       282 ~~~~~~~~~~l~~L~~L  298 (936)
                      ++. + .++.+++|++|
T Consensus       185 ~~i-~-~l~~L~~L~~L  199 (199)
T d2omxa2         185 SDI-S-VLAKLTNLESL  199 (199)
T ss_dssp             CCC-G-GGGGCTTCSEE
T ss_pred             CCC-c-cccCCCCCCcC
Confidence            532 2 35555555554

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=5.8e-18  Score=168.36  Aligned_cols=160  Identities=21%  Similarity=0.327  Sum_probs=75.8

Q ss_pred             CCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceee
Q 002321          148 CGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVIN  227 (936)
Q Consensus       148 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  227 (936)
                      +.+|++|++++|.|+..  +.++.+++|++|+|++|+|++..+  +.++++|++|++++|.+.. ++ .+.++++|+.|+
T Consensus        39 l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~  112 (199)
T d2omxa2          39 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLT  112 (199)
T ss_dssp             HTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEE
T ss_pred             hcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-cccccccccccc
Confidence            44555555555555421  234455555555555555554322  4455555555555555542 22 244555555555


Q ss_pred             cccccccccCCcccccccCcceeeccccccCCCCchhhhccccccEEeccCccccCCCCcccccCCccceecccCceecc
Q 002321          228 LSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLRKNLFSGEVPKWIGELESLETLDLSGNKFSG  307 (936)
Q Consensus       228 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  307 (936)
                      +++|.+...  ..+..+++|+.|++++|++...  +.+..+++++.|++.+|++++..  .++++++|++|++++|++++
T Consensus       113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~  186 (199)
T d2omxa2         113 LFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD  186 (199)
T ss_dssp             CCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred             ccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCCc--cccCCCCCCEEECCCCCCCC
Confidence            555554422  2244455555555555554421  23444555555555555554321  24455555555555555543


Q ss_pred             ccCcccccccccce
Q 002321          308 AVPISIGNLQRLKV  321 (936)
Q Consensus       308 ~~~~~l~~l~~L~~  321 (936)
                       ++ .++++++|+.
T Consensus       187 -i~-~l~~L~~L~~  198 (199)
T d2omxa2         187 -IS-VLAKLTNLES  198 (199)
T ss_dssp             -CG-GGGGCTTCSE
T ss_pred             -Cc-cccCCCCCCc
Confidence             22 2444444444

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.72  E-value=6.8e-18  Score=169.36  Aligned_cols=181  Identities=21%  Similarity=0.295  Sum_probs=138.7

Q ss_pred             EeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCc
Q 002321           80 ELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKN  159 (936)
Q Consensus        80 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N  159 (936)
                      ..++....+++.++.  .++..|++|++++|++++.  ..+..+++|++|+|++|+|++ ++.  +..+++|++|++++|
T Consensus        28 ~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~L~~n~i~~-l~~--~~~l~~L~~L~l~~n  100 (210)
T d1h6ta2          28 KDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDEN  100 (210)
T ss_dssp             HHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSS
T ss_pred             HHHhCcCccCCccCH--HHhcCccEEECcCCCCCCc--hhHhhCCCCCEEeCCCccccC-ccc--cccCccccccccccc
Confidence            345555566655543  4677899999999999864  348889999999999999984 443  578999999999999


Q ss_pred             cCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeecccccccccCCc
Q 002321          160 RFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSKNMFSGSIPD  239 (936)
Q Consensus       160 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  239 (936)
                      +|++ +| .+..+++|+.|++++|.+...  ..+.++++|+.+++++|.+++.  ..+..+++|+++++++|++++..  
T Consensus       101 ~i~~-l~-~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~--  172 (210)
T d1h6ta2         101 KVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV--  172 (210)
T ss_dssp             CCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--
T ss_pred             cccc-cc-ccccccccccccccccccccc--cccccccccccccccccccccc--ccccccccccccccccccccccc--
Confidence            9985 33 588899999999999998753  4588899999999999999843  35677889999999999988542  


Q ss_pred             ccccccCcceeeccccccCCCCchhhhccccccEEecc
Q 002321          240 GIGSCSLLRTIDFSENSFSGNLPETMQKLSLCNFMNLR  277 (936)
Q Consensus       240 ~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~  277 (936)
                      .+.++++|++|+|++|+++. ++ .+.++++|++|+|+
T Consensus       173 ~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         173 PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF  208 (210)
T ss_dssp             GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred             cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence            37788888888888888874 22 35555566655554

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=1.4e-16  Score=167.63  Aligned_cols=222  Identities=23%  Similarity=0.256  Sum_probs=122.6

Q ss_pred             EeccCCCCCCcccccccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCc
Q 002321           80 ELTLNGLSLTGRIGRGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKN  159 (936)
Q Consensus        80 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N  159 (936)
                      .+||++..+.+.....+.. ..+..+.++...+.... .......+|++|||+++.+++.....++..+++|++|+|+++
T Consensus         4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~   81 (284)
T d2astb2           4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL   81 (284)
T ss_dssp             EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred             EEECCCCCCCchHHHHHHh-ccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence            5677776664433222222 23456666666655333 233455688999999888876555667888888888888888


Q ss_pred             cCCCCCCCCccccccccccccccc-cccCCC-CCCCCCCCCCCEEecCCC-CCCCC-CccCccC-CCCcceeecccc--c
Q 002321          160 RFSGKIPSSLSLCSTLATINLSSN-RFSSPL-PLGIWGLSALRTLDLSDN-LLEGE-IPKGVES-LKNLRVINLSKN--M  232 (936)
Q Consensus       160 ~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~-~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~-l~~L~~L~L~~N--~  232 (936)
                      .+++..+..++.+++|++|+|+++ .+++.. ...+.++++|++|+++++ .+++. +...+.. .++|+.|+++++  .
T Consensus        82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~  161 (284)
T d2astb2          82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN  161 (284)
T ss_dssp             BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGG
T ss_pred             CCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccc
Confidence            887666667777788888888774 454321 112245677777777774 34321 1122222 356777777653  2


Q ss_pred             cccc-CCcccccccCcceeecccc-ccCCCCchhhhccccccEEeccCc-cccCCCCcccccCCccceecccCc
Q 002321          233 FSGS-IPDGIGSCSLLRTIDFSEN-SFSGNLPETMQKLSLCNFMNLRKN-LFSGEVPKWIGELESLETLDLSGN  303 (936)
Q Consensus       233 l~~~-~p~~l~~l~~L~~L~Ls~N-~l~~~~~~~l~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N  303 (936)
                      ++.. +...+..+++|++|++++| .+++.....+.++++|++|+|+++ .+++.....++++++|+.|+++++
T Consensus       162 i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         162 LQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             SCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             cccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            3211 1122334566666666654 344444444444444555555442 333333333444444444444443

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=1.8e-15  Score=143.95  Aligned_cols=127  Identities=23%  Similarity=0.190  Sum_probs=66.3

Q ss_pred             cccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccccc
Q 002321           96 LLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCSTL  175 (936)
Q Consensus        96 l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  175 (936)
                      +.+...|++|+|++|+|+. ++..+..+++|+.|||++|+|+ .++                          .|..+++|
T Consensus        14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~--------------------------~~~~l~~L   65 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD--------------------------GFPLLRRL   65 (162)
T ss_dssp             EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC--------------------------CCCCCSSC
T ss_pred             ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC--------------------------CcccCcch
Confidence            4455555666666666653 3444455556666666666555 332                          24444445


Q ss_pred             cccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCc-cCccCCCCcceeecccccccccCCc----ccccccCccee
Q 002321          176 ATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIP-KGVESLKNLRVINLSKNMFSGSIPD----GIGSCSLLRTI  250 (936)
Q Consensus       176 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~L  250 (936)
                      ++|+|++|+|+...+..+..+++|++|+|++|+|+.... ..+..+++|++|++++|.++. .|.    .+..+++|++|
T Consensus        66 ~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~L  144 (162)
T d1a9na_          66 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVL  144 (162)
T ss_dssp             CEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEE
T ss_pred             hhhhcccccccCCCccccccccccccceeccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCee
Confidence            555555555444333334445555555555555553211 245556666666666666652 232    35566677766


Q ss_pred             e
Q 002321          251 D  251 (936)
Q Consensus       251 ~  251 (936)
                      |
T Consensus       145 D  145 (162)
T d1a9na_         145 D  145 (162)
T ss_dssp             T
T ss_pred             C
Confidence            6

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=2.4e-15  Score=143.03  Aligned_cols=128  Identities=16%  Similarity=0.106  Sum_probs=98.5

Q ss_pred             hcCCCCcEEEccCccCCCCCCCCccccccccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcce
Q 002321          146 KQCGSLRVISLAKNRFSGKIPSSLSLCSTLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRV  225 (936)
Q Consensus       146 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  225 (936)
                      .+..+|++|+|++|+|+. ++..+..+++|++|+|++|+|+.+  +.|..+++|++|+|++|+++...+..+..+++|++
T Consensus        15 ~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~   91 (162)
T d1a9na_          15 TNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE   91 (162)
T ss_dssp             ECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred             cCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccccc
Confidence            344455555555555553 355556778888888888888864  35889999999999999999655555678999999


Q ss_pred             eecccccccccCC-cccccccCcceeeccccccCCCC---chhhhccccccEEec
Q 002321          226 INLSKNMFSGSIP-DGIGSCSLLRTIDFSENSFSGNL---PETMQKLSLCNFMNL  276 (936)
Q Consensus       226 L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~---~~~l~~l~~L~~L~L  276 (936)
                      |++++|+|+.... ..+..+++|++|++++|.++...   +..+..+++|++||-
T Consensus        92 L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~  146 (162)
T d1a9na_          92 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF  146 (162)
T ss_dssp             EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred             ceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCC
Confidence            9999999985422 46889999999999999997543   235788999999873

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.51  E-value=1.8e-14  Score=130.05  Aligned_cols=17  Identities=29%  Similarity=0.284  Sum_probs=7.1

Q ss_pred             ccccCCccEEEcCCCcc
Q 002321          508 IAKLTNLQNVDLSFNSL  524 (936)
Q Consensus       508 ~~~l~~L~~L~Ls~N~l  524 (936)
                      +..+++|++|++++|++
T Consensus        86 l~~~~~L~~L~l~~N~i  102 (124)
T d1dcea3          86 LVSCPRLVLLNLQGNSL  102 (124)
T ss_dssp             GGGCTTCCEEECTTSGG
T ss_pred             hcCCCCCCEEECCCCcC
Confidence            33344444444444444

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.51  E-value=3.3e-15  Score=156.94  Aligned_cols=211  Identities=19%  Similarity=0.204  Sum_probs=109.1

Q ss_pred             cCCccceecccCceeccc-cCcccccccccceEEccCCcccccCChhhhccCCCCEEEccCC-cCccCCChhhhccCCcc
Q 002321          291 ELESLETLDLSGNKFSGA-VPISIGNLQRLKVLNFSANRLTGSLPDSMANCMNLVALDFSQN-SMNGDLPQWIFSSGLNK  368 (936)
Q Consensus       291 ~l~~L~~L~L~~N~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~~~l~~  368 (936)
                      ...+|++||++++.+++. +...+..+++|++|+|++|.+++..+..+..+++|+.|+++++ .++...-..+       
T Consensus        44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l-------  116 (284)
T d2astb2          44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTL-------  116 (284)
T ss_dssp             CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHH-------
T ss_pred             cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchh-------
Confidence            344667777777666533 2333556667777777777666656666666666666666663 2321000000       


Q ss_pred             ccccccccccCCCCCCCCCCCCCCcccEEeccCc-ccCCC-Chhhhcc-cccCCeeeccCccccCCCCccccCcccCCee
Q 002321          369 VSFAENKIREGMNGPFASSGSSFESLQFLDLSHN-EFSGE-TPATIGA-LSGLQLLNLSRNSLVGPIPVAIGDLKALNVL  445 (936)
Q Consensus       369 l~l~~n~l~~~~~~~~~~~~~~l~~L~~L~Ls~N-~l~~~-~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  445 (936)
                                         ...+++|++|+++++ .+++. ....+.. .+.|+.|+++++..                 
T Consensus       117 -------------------~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~-----------------  160 (284)
T d2astb2         117 -------------------LSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK-----------------  160 (284)
T ss_dssp             -------------------HHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG-----------------
T ss_pred             -------------------hHHHHhccccccccccccccccchhhhcccccccchhhhccccc-----------------
Confidence                               012345555555553 23211 1111111 23445554443311                 


Q ss_pred             ecCCcccccc-CCCCCCCcCCCcEEEecCC-ccCCcCccccccccccccccccCc-cccCCCcccccccCCccEEEcCCC
Q 002321          446 DLSENWLNGS-IPPEIGGAYSLKELRLERN-FLAGKIPTSIENCSSLVSLILSKN-NLTGPIPIAIAKLTNLQNVDLSFN  522 (936)
Q Consensus       446 ~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N  522 (936)
                           .++.. +......+++|++|+|++| .+++.....+.++++|++|+|+++ .+++.....++++++|+.|+++++
T Consensus       161 -----~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         161 -----NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             -----GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             -----ccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence                 12211 1111234556666666664 355556666777777777777773 566555666777788888888776


Q ss_pred             ccc-CCCCcccccccccCeeecCCCcccccCC
Q 002321          523 SLT-GGLPKQLVNLVHLSSFNISHNHLQGELP  553 (936)
Q Consensus       523 ~l~-~~~p~~l~~l~~L~~L~ls~N~l~~~~p  553 (936)
                       ++ +.++.-...++   .|.+..+++++..+
T Consensus       236 -~~d~~l~~l~~~lp---~L~i~~~~ls~~~~  263 (284)
T d2astb2         236 -VPDGTLQLLKEALP---HLQINCSHFTTIAR  263 (284)
T ss_dssp             -SCTTCHHHHHHHST---TSEESCCCSCCTTC
T ss_pred             -CCHHHHHHHHHhCc---cccccCccCCCCCC
Confidence             32 22222222333   34466777776433

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.51  E-value=8.1e-16  Score=167.07  Aligned_cols=113  Identities=18%  Similarity=0.231  Sum_probs=59.5

Q ss_pred             CcccCCeeecCCcccccc-----CCCCCCCcCCCcEEEecCCccCCc----CccccccccccccccccCccccCCCcccc
Q 002321          438 DLKALNVLDLSENWLNGS-----IPPEIGGAYSLKELRLERNFLAGK----IPTSIENCSSLVSLILSKNNLTGPIPIAI  508 (936)
Q Consensus       438 ~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~~  508 (936)
                      ..+.|+.|+|++|.++..     +...+..+++|+.|+|++|.++..    +...+..+++|++|+|++|.|++.....+
T Consensus       184 ~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l  263 (344)
T d2ca6a1         184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV  263 (344)
T ss_dssp             HCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHH
T ss_pred             hhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHH
Confidence            334455555555554321     223344555566666666665421    33445566666666666666654322222


Q ss_pred             ----cc--cCCccEEEcCCCcccCC----CCcccc-cccccCeeecCCCcccc
Q 002321          509 ----AK--LTNLQNVDLSFNSLTGG----LPKQLV-NLVHLSSFNISHNHLQG  550 (936)
Q Consensus       509 ----~~--l~~L~~L~Ls~N~l~~~----~p~~l~-~l~~L~~L~ls~N~l~~  550 (936)
                          ..  .+.|++|||++|+|+..    +...+. ++++|+.|+|++|++..
T Consensus       264 ~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         264 VDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             HHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             HHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence                21  24577777777776532    223332 45667777777777653

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.50  E-value=3.4e-14  Score=128.19  Aligned_cols=104  Identities=27%  Similarity=0.302  Sum_probs=88.4

Q ss_pred             CeeecCCccccccCCCCCCCcCCCcEEEecCCccCCcCccccccccccccccccCccccCCCcccccccCCccEEEcCCC
Q 002321          443 NVLDLSENWLNGSIPPEIGGAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFN  522 (936)
Q Consensus       443 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  522 (936)
                      ++|||++|+|+. ++ .+..+++|++|++++|+|+ .+|..++.+++|+.|++++|+|++ +| .++.+++|++|++++|
T Consensus         1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            568888888873 44 4888889999999999998 678889999999999999999985 44 5899999999999999


Q ss_pred             cccCCC-CcccccccccCeeecCCCccccc
Q 002321          523 SLTGGL-PKQLVNLVHLSSFNISHNHLQGE  551 (936)
Q Consensus       523 ~l~~~~-p~~l~~l~~L~~L~ls~N~l~~~  551 (936)
                      +|+... ...+..+++|+.|++++|++++.
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~  105 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQE  105 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence            998543 25789999999999999999864

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.49  E-value=7.9e-16  Score=167.12  Aligned_cols=243  Identities=20%  Similarity=0.246  Sum_probs=121.1

Q ss_pred             ccccccCccccEEeccCCcccCc----CCCchhhcCCCcEEEccCccccc---ccc------hhhhhcCCCCcEEEccCc
Q 002321           93 GRGLLQLQFLRKLSLSSNNLTGS----ISPNLAKLQNLRVIDLSGNSLSG---SIP------DEFFKQCGSLRVISLAKN  159 (936)
Q Consensus        93 ~~~l~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~---~i~------~~~f~~l~~L~~L~L~~N  159 (936)
                      ...+.+...|++|+|++|.|...    +...+...++|+.|+++++.+..   ..+      ...+...++|+.|+|++|
T Consensus        24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n  103 (344)
T d2ca6a1          24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN  103 (344)
T ss_dssp             SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred             HHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccc
Confidence            34456667777777777766532    22334555677777776654431   111      112334556666666666


Q ss_pred             cCCCCCC----CCccccccccccccccccccCCCCCCC-------------CCCCCCCEEecCCCCCCCCCccCccCCCC
Q 002321          160 RFSGKIP----SSLSLCSTLATINLSSNRFSSPLPLGI-------------WGLSALRTLDLSDNLLEGEIPKGVESLKN  222 (936)
Q Consensus       160 ~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~~~~~-------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  222 (936)
                      .++....    ..+...++|++|++++|.+.......+             ...+.|+.|++++|.++.....       
T Consensus       104 ~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~-------  176 (344)
T d2ca6a1         104 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK-------  176 (344)
T ss_dssp             CCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHH-------
T ss_pred             ccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccc-------
Confidence            6553211    122334555555555554432110000             1233444444444444311110       


Q ss_pred             cceeecccccccccCCcccccccCcceeeccccccCCC-----CchhhhccccccEEeccCccccCC----CCcccccCC
Q 002321          223 LRVINLSKNMFSGSIPDGIGSCSLLRTIDFSENSFSGN-----LPETMQKLSLCNFMNLRKNLFSGE----VPKWIGELE  293 (936)
Q Consensus       223 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-----~~~~l~~l~~L~~L~L~~N~l~~~----~~~~~~~l~  293 (936)
                                   .+...+...+.|++|+|++|+++..     +...+...++|+.|+|++|.++..    +...+..++
T Consensus       177 -------------~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~  243 (344)
T d2ca6a1         177 -------------EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP  243 (344)
T ss_dssp             -------------HHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCT
T ss_pred             -------------cccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccc
Confidence                         0111223344555555555554321     112234445555555555554422    223445667


Q ss_pred             ccceecccCceeccccCccc----c--cccccceEEccCCcccccC----Chhhh-ccCCCCEEEccCCcCcc
Q 002321          294 SLETLDLSGNKFSGAVPISI----G--NLQRLKVLNFSANRLTGSL----PDSMA-NCMNLVALDFSQNSMNG  355 (936)
Q Consensus       294 ~L~~L~L~~N~l~~~~~~~l----~--~l~~L~~L~L~~N~l~~~~----~~~~~-~l~~L~~L~Ls~N~l~~  355 (936)
                      +|++|+|++|.|++.....+    .  ..+.|++|++++|+|+...    ...+. ++++|+.|+|++|.+..
T Consensus       244 ~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             TCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             cchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence            77777777777764422222    1  2356888888888876432    33332 46788888888888863

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.39  E-value=4.4e-15  Score=146.40  Aligned_cols=112  Identities=29%  Similarity=0.345  Sum_probs=53.6

Q ss_pred             cccccCccccEEeccCCcccCcCCCchhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCCCCCccccc
Q 002321           94 RGLLQLQFLRKLSLSSNNLTGSISPNLAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKIPSSLSLCS  173 (936)
Q Consensus        94 ~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~p~~~~~l~  173 (936)
                      .++..|++|++|+|++|+|+.+ + .|.++++|++|+|++|+|+ .+|                         ..+..++
T Consensus        42 ~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~-------------------------~~~~~~~   93 (198)
T d1m9la_          42 ATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIE-------------------------NLDAVAD   93 (198)
T ss_dssp             HHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCS-------------------------SHHHHHH
T ss_pred             hHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccc-------------------------ccccccc
Confidence            3455555555555555555532 2 3555555555555555554 333                         2223333


Q ss_pred             cccccccccccccCCCCCCCCCCCCCCEEecCCCCCCCCCc-cCccCCCCcceeecccccccc
Q 002321          174 TLATINLSSNRFSSPLPLGIWGLSALRTLDLSDNLLEGEIP-KGVESLKNLRVINLSKNMFSG  235 (936)
Q Consensus       174 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~  235 (936)
                      +|++|++++|+|+.+  ..+..+++|++|+|++|+|+.... ..+..+++|++|+|++|.+..
T Consensus        94 ~L~~L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~  154 (198)
T d1m9la_          94 TLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN  154 (198)
T ss_dssp             HCCEEECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred             ccccccccccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCcccc
Confidence            444444444444432  123344445555555555442211 234555555555555555543

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.38  E-value=8.9e-15  Score=144.19  Aligned_cols=144  Identities=24%  Similarity=0.305  Sum_probs=110.0

Q ss_pred             cccEEeccCc--ccCCCChhhhcccccCCeeeccCccccCCCCccccCcccCCeeecCCccccccCCCCCCCcCCCcEEE
Q 002321          393 SLQFLDLSHN--EFSGETPATIGALSGLQLLNLSRNSLVGPIPVAIGDLKALNVLDLSENWLNGSIPPEIGGAYSLKELR  470 (936)
Q Consensus       393 ~L~~L~Ls~N--~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  470 (936)
                      .++.++++.+  .+. ..+..+..+++|++|+|++|+|+. ++ .+..+++|++|+|++|+|+ .+|..+..+++|+.|+
T Consensus        24 ~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~   99 (198)
T d1m9la_          24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW   99 (198)
T ss_dssp             TCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEE
T ss_pred             ccceeeeecccCchh-hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccc
Confidence            4556666654  233 556788889999999999999984 44 5888999999999999987 4665556667899999


Q ss_pred             ecCCccCCcCccccccccccccccccCccccCCCc-ccccccCCccEEEcCCCcccCCCCcc----------cccccccC
Q 002321          471 LERNFLAGKIPTSIENCSSLVSLILSKNNLTGPIP-IAIAKLTNLQNVDLSFNSLTGGLPKQ----------LVNLVHLS  539 (936)
Q Consensus       471 Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------l~~l~~L~  539 (936)
                      +++|+|+. + ..+..+++|+.|+|++|+++.... ..+..+++|++|+|++|++....+..          +..+++|+
T Consensus       100 l~~N~i~~-l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~  177 (198)
T d1m9la_         100 ISYNQIAS-L-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLK  177 (198)
T ss_dssp             CSEEECCC-H-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCC
T ss_pred             cccccccc-c-ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcC
Confidence            99999984 3 358888999999999999985322 46888999999999999887443332          56788888


Q ss_pred             eee
Q 002321          540 SFN  542 (936)
Q Consensus       540 ~L~  542 (936)
                      .||
T Consensus       178 ~LD  180 (198)
T d1m9la_         178 KLD  180 (198)
T ss_dssp             EES
T ss_pred             EeC
Confidence            876

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.34  E-value=1.1e-12  Score=123.46  Aligned_cols=85  Identities=18%  Similarity=0.204  Sum_probs=47.1

Q ss_pred             ccceeEEecCCCCceEEeccCCCCCCcccccccccCccccEEeccCC-cccCcCCCchhhcCCCcEEEccCcccccccch
Q 002321           64 CNWFGVKCSPRSNRVIELTLNGLSLTGRIGRGLLQLQFLRKLSLSSN-NLTGSISPNLAKLQNLRVIDLSGNSLSGSIPD  142 (936)
Q Consensus        64 c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n-~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~i~~  142 (936)
                      |.+.+|+|...            +++ .+|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+ .|++
T Consensus         8 ~~~~~l~c~~~------------~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~i~~   73 (156)
T d2ifga3           8 HGSSGLRCTRD------------GAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAP   73 (156)
T ss_dssp             SSSSCEECCSS------------CCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCC-EECT
T ss_pred             CCCCeEEecCC------------CCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccC-Cccc
Confidence            35777777542            221 23444555666666666544 355444455666666666666666665 4555


Q ss_pred             hhhhcCCCCcEEEccCccCC
Q 002321          143 EFFKQCGSLRVISLAKNRFS  162 (936)
Q Consensus       143 ~~f~~l~~L~~L~L~~N~l~  162 (936)
                      .+|..+++|++|+|++|+|+
T Consensus        74 ~~f~~l~~L~~L~Ls~N~l~   93 (156)
T d2ifga3          74 DAFHFTPRLSRLNLSFNALE   93 (156)
T ss_dssp             TGGGSCSCCCEEECCSSCCS
T ss_pred             ccccccccccceeccCCCCc
Confidence            55555555555555555555

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.27  E-value=5.2e-12  Score=118.74  Aligned_cols=82  Identities=17%  Similarity=0.167  Sum_probs=37.4

Q ss_pred             cEEEccCccCCCCCCCCccccccccccccccc-cccCCCCCCCCCCCCCCEEecCCCCCCCCCccCccCCCCcceeeccc
Q 002321          152 RVISLAKNRFSGKIPSSLSLCSTLATINLSSN-RFSSPLPLGIWGLSALRTLDLSDNLLEGEIPKGVESLKNLRVINLSK  230 (936)
Q Consensus       152 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  230 (936)
                      ..++.+++.+. ..|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.+..|..+++|++|+|++
T Consensus        11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~   89 (156)
T d2ifga3          11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (156)
T ss_dssp             SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence            34444444444 23444444444444444433 24444444444444444444444444443344444444444444444


Q ss_pred             cccc
Q 002321          231 NMFS  234 (936)
Q Consensus       231 N~l~  234 (936)
                      |+|+
T Consensus        90 N~l~   93 (156)
T d2ifga3          90 NALE   93 (156)
T ss_dssp             SCCS
T ss_pred             CCCc
Confidence            4444

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.57  E-value=3e-09  Score=100.23  Aligned_cols=90  Identities=21%  Similarity=0.121  Sum_probs=48.2

Q ss_pred             hhhcCCCcEEEccCcccccccchhhhhcCCCCcEEEccCccCCCCC--CCCccccccccccccccccccCCCCCCCCCCC
Q 002321          120 LAKLQNLRVIDLSGNSLSGSIPDEFFKQCGSLRVISLAKNRFSGKI--PSSLSLCSTLATINLSSNRFSSPLPLGIWGLS  197 (936)
Q Consensus       120 l~~l~~L~~L~Ls~N~l~~~i~~~~f~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  197 (936)
                      +..+..+..|++.+|.+.  ....++..+++|++|+|++|+|+...  +..+..+++|+.|+|++|+|+...+-.+....
T Consensus        38 l~~~~~~~~l~~~~~~~~--~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~  115 (162)
T d1koha1          38 LVAQNIDVVLNRRSSMAA--TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL  115 (162)
T ss_dssp             TTTTTCCCCTTSHHHHHH--HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTC
T ss_pred             hhhccchhhcchhhhHhh--hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhcc
Confidence            444444444555444433  22345556666666666666666432  23355566666666666666654332233334


Q ss_pred             CCCEEecCCCCCCC
Q 002321          198 ALRTLDLSDNLLEG  211 (936)
Q Consensus       198 ~L~~L~L~~N~l~~  211 (936)
                      +|+.|+|++|.+..
T Consensus       116 ~L~~L~L~~Npl~~  129 (162)
T d1koha1         116 KLEELWLDGNSLSD  129 (162)
T ss_dssp             CCSSCCCTTSTTSS
T ss_pred             ccceeecCCCCcCc
Confidence            56666666666653

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.54  E-value=3.3e-09  Score=99.89  Aligned_cols=81  Identities=23%  Similarity=0.198  Sum_probs=44.3

Q ss_pred             CcCCCcEEEecCCccCCc--CccccccccccccccccCccccCCCcccccccCCccEEEcCCCcccCCCCcc-------c
Q 002321          462 GAYSLKELRLERNFLAGK--IPTSIENCSSLVSLILSKNNLTGPIPIAIAKLTNLQNVDLSFNSLTGGLPKQ-------L  532 (936)
Q Consensus       462 ~l~~L~~L~Ls~N~l~~~--~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-------l  532 (936)
                      .+++|++|+|++|+|+..  ++..+..+++|+.|+|++|+++...+..+....+|+.|+|++|++.+.....       +
T Consensus        63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~  142 (162)
T d1koha1          63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIR  142 (162)
T ss_dssp             HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHH
T ss_pred             hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHH
Confidence            344555555555555532  2344556666666666666666433323334445667777777766443321       4


Q ss_pred             ccccccCeee
Q 002321          533 VNLVHLSSFN  542 (936)
Q Consensus       533 ~~l~~L~~L~  542 (936)
                      ..+++|+.||
T Consensus       143 ~~~P~L~~LD  152 (162)
T d1koha1         143 ERFPKLLRLD  152 (162)
T ss_dssp             TTSTTCCEET
T ss_pred             HHCCCCCEEC
Confidence            4566666654

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.12  E-value=6.2e-06  Score=83.78  Aligned_cols=128  Identities=15%  Similarity=0.120  Sum_probs=86.5

Q ss_pred             cCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCC-CCCcceeeeEEEeCCeeEEEEEecCCCChhhhhh
Q 002321          701 GGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQSLQLLIYEFVSGGSLHKHLH  779 (936)
Q Consensus       701 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~  779 (936)
                      ++.+.||+... +++.++||+...... .....+.+|...+..+. +--+.+++++..+++..++||++++|.++.+...
T Consensus        25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~  102 (263)
T d1j7la_          25 MSPAKVYKLVG-ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE  102 (263)
T ss_dssp             CSSSEEEEEEC-SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT
T ss_pred             CCCCcEEEEEe-CCCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccc
Confidence            33468999865 466788898754322 22345778888888774 4446778888888888999999999887765432


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------------
Q 002321          780 EGSGGNFLSWNERFNVIQGTAKSLAHLHQS--------------------------------------------------  809 (936)
Q Consensus       780 ~~~~~~~~~~~~~~~i~~~i~~al~~LH~~--------------------------------------------------  809 (936)
                      ...     .   ..+++.++++.+..||+.                                                  
T Consensus       103 ~~~-----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (263)
T d1j7la_         103 DEQ-----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL  174 (263)
T ss_dssp             TCS-----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred             ccc-----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence            211     1   112333444444444421                                                  


Q ss_pred             ---------CcccCCCCCCCEEEcCCCCeEEeeccCcc
Q 002321          810 ---------NIIHYNIKSSNVLIDGSGEPKVGDYGLAR  838 (936)
Q Consensus       810 ---------~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  838 (936)
                               .++|+|+.|.||++++++.+-|+||+.+.
T Consensus       175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                     25899999999999987777799999875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.94  E-value=1.8e-05  Score=79.80  Aligned_cols=74  Identities=15%  Similarity=0.104  Sum_probs=53.6

Q ss_pred             ccccCc-eEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCC--CCCcceeeeEEEeCCeeEEEEEecCCCCh
Q 002321          698 LGRGGF-GAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR--HPNLVTLEGYYWTQSLQLLIYEFVSGGSL  774 (936)
Q Consensus       698 iG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L  774 (936)
                      +..|.. +.||+....++..+++|......    ...+.+|++.++.+.  .-.+.+++++..+++..++||+|++|.++
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            344543 67999988778888999865432    234677888887773  23366778888888888999999988665


Q ss_pred             h
Q 002321          775 H  775 (936)
Q Consensus       775 ~  775 (936)
                      .
T Consensus        94 ~   94 (255)
T d1nd4a_          94 L   94 (255)
T ss_dssp             T
T ss_pred             c
Confidence            3

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.72  E-value=2.8e-05  Score=83.70  Aligned_cols=76  Identities=17%  Similarity=0.138  Sum_probs=48.9

Q ss_pred             CcccccCceEEEEEEeCC-CcEEEEEEeecc------CccchHHHHHHHHHHHHcC-CC--CCcceeeeEEEeCCeeEEE
Q 002321          696 CELGRGGFGAVYRTVLRD-GRPVAIKKLTVS------SLVKSQEDFEREVKKLGKV-RH--PNLVTLEGYYWTQSLQLLI  765 (936)
Q Consensus       696 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~------~~~~~~~~~~~E~~~l~~l-~h--~niv~l~~~~~~~~~~~lv  765 (936)
                      ++||.|....||+....+ ++.|+||.-...      .......+..+|.+.++.+ .+  ..+.+++.+  +....++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            358999999999998764 678999965321      1112234566788888776 33  345555544  45566899


Q ss_pred             EEecCCCC
Q 002321          766 YEFVSGGS  773 (936)
Q Consensus       766 ~e~~~~g~  773 (936)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.60  E-value=6.9e-06  Score=76.90  Aligned_cols=114  Identities=18%  Similarity=0.213  Sum_probs=55.6

Q ss_pred             CCcccEEeccCc-ccCCC----ChhhhcccccCCeeeccCccccC----CCCccccCcccCCeeecCCccccccCCCCCC
Q 002321          391 FESLQFLDLSHN-EFSGE----TPATIGALSGLQLLNLSRNSLVG----PIPVAIGDLKALNVLDLSENWLNGSIPPEIG  461 (936)
Q Consensus       391 l~~L~~L~Ls~N-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  461 (936)
                      .++|++|+|+++ .++..    +...+...+.|++|+|++|.+..    .+...+...+.|+.|+|++|.++...-.   
T Consensus        14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~---   90 (167)
T d1pgva_          14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA---   90 (167)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH---
T ss_pred             CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHH---
Confidence            467888888763 45422    12234444556666666666642    1122233344555555555555421000   


Q ss_pred             CcCCCcEEEecCCccCCcCccccccccccccccccCccccCC-------CcccccccCCccEEEcCCCcc
Q 002321          462 GAYSLKELRLERNFLAGKIPTSIENCSSLVSLILSKNNLTGP-------IPIAIAKLTNLQNVDLSFNSL  524 (936)
Q Consensus       462 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-------~p~~~~~l~~L~~L~Ls~N~l  524 (936)
                                       .+-..+...++|++|+|++|++...       +...+..-+.|+.|+++.+..
T Consensus        91 -----------------~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~  143 (167)
T d1pgva_          91 -----------------RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  143 (167)
T ss_dssp             -----------------HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             -----------------HHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence                             1222344445555555555543321       233344456677777766543

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.59  E-value=6.6e-06  Score=77.01  Aligned_cols=88  Identities=14%  Similarity=0.081  Sum_probs=57.6

Q ss_pred             CCcCCCcEEEecCCccCC----cCccccccccccccccccCccccCC----CcccccccCCccEEEcCCCcccCC-----
Q 002321          461 GGAYSLKELRLERNFLAG----KIPTSIENCSSLVSLILSKNNLTGP----IPIAIAKLTNLQNVDLSFNSLTGG-----  527 (936)
Q Consensus       461 ~~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~-----  527 (936)
                      ...++|++|+|++|.+..    .+...+...+.|++|+|++|.++..    +-..+..-+.|++|+|++|++...     
T Consensus        41 ~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~  120 (167)
T d1pgva_          41 CNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVE  120 (167)
T ss_dssp             TTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHH
T ss_pred             hhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHH
Confidence            334456666666666552    2334455667888888888887743    233456678899999999976522     


Q ss_pred             --CCcccccccccCeeecCCCcc
Q 002321          528 --LPKQLVNLVHLSSFNISHNHL  548 (936)
Q Consensus       528 --~p~~l~~l~~L~~L~ls~N~l  548 (936)
                        +...+..-+.|+.|+++.+..
T Consensus       121 ~~l~~~L~~n~sL~~l~l~~~~~  143 (167)
T d1pgva_         121 MDMMMAIEENESLLRVGISFASM  143 (167)
T ss_dssp             HHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHHHHHhCCCccEeeCcCCCc
Confidence              344555668899999887643

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.08  E-value=1.7e-05  Score=74.04  Aligned_cols=61  Identities=25%  Similarity=0.388  Sum_probs=27.1

Q ss_pred             cCCCcEEEecCCccCC----cCcccccccccccc--ccccCccccC----CCcccccccCCccEEEcCCCc
Q 002321          463 AYSLKELRLERNFLAG----KIPTSIENCSSLVS--LILSKNNLTG----PIPIAIAKLTNLQNVDLSFNS  523 (936)
Q Consensus       463 l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~--L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~  523 (936)
                      .++++.+++++|.++.    .+...+...++|+.  |++++|++..    .+...+...++|+.|+++.|.
T Consensus        73 ~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_          73 NNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             CSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred             cccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence            3445555555555442    12234444555554  2333444432    122333445555555555544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.93  E-value=0.0015  Score=67.70  Aligned_cols=68  Identities=13%  Similarity=0.114  Sum_probs=46.2

Q ss_pred             eEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCCc--ceee-----eEEEeCCeeEEEEEecCCCC
Q 002321          704 GAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPNL--VTLE-----GYYWTQSLQLLIYEFVSGGS  773 (936)
Q Consensus       704 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~g~  773 (936)
                      -.||+++..+|+.|++|+.+...  ...+++..|...+..+....+  +..+     ......+..+.++++++|..
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC--CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            46999999899999999986542  235678889988888742222  1111     12344566788999997643

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.86  E-value=6.3e-05  Score=70.03  Aligned_cols=90  Identities=14%  Similarity=0.168  Sum_probs=63.7

Q ss_pred             CCCcCCCcEEEecCCccCCc----CccccccccccccccccCccccCC----CcccccccCCccEEEc--CCCcccC---
Q 002321          460 IGGAYSLKELRLERNFLAGK----IPTSIENCSSLVSLILSKNNLTGP----IPIAIAKLTNLQNVDL--SFNSLTG---  526 (936)
Q Consensus       460 ~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~~---  526 (936)
                      +...++|++|+|++|.++..    +-..+...+.|+.|++++|.++..    +...+...++|+.++|  ++|++..   
T Consensus        42 l~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~  121 (166)
T d1io0a_          42 LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVE  121 (166)
T ss_dssp             HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHH
T ss_pred             HhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHH
Confidence            34556677777777776642    344566789999999999998643    3356677889987555  5777753   


Q ss_pred             -CCCcccccccccCeeecCCCccc
Q 002321          527 -GLPKQLVNLVHLSSFNISHNHLQ  549 (936)
Q Consensus       527 -~~p~~l~~l~~L~~L~ls~N~l~  549 (936)
                       .+...+...+.|++|+++.|+..
T Consensus       122 ~~La~~L~~n~~L~~L~l~~~~~~  145 (166)
T d1io0a_         122 MEIANMLEKNTTLLKFGYHFTQQG  145 (166)
T ss_dssp             HHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHhCCCcCEEeCcCCCCc
Confidence             24556667899999999877643

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.88  E-value=0.0089  Score=63.52  Aligned_cols=71  Identities=11%  Similarity=0.103  Sum_probs=47.1

Q ss_pred             cccccCceEEEEEEeCC--------CcEEEEEEeeccCccchHHHHHHHHHHHHcCC-CCCcceeeeEEEeCCeeEEEEE
Q 002321          697 ELGRGGFGAVYRTVLRD--------GRPVAIKKLTVSSLVKSQEDFEREVKKLGKVR-HPNLVTLEGYYWTQSLQLLIYE  767 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  767 (936)
                      .|+-|-.=.+|++...+        .+.|.+++.-..   .......+|.++++.+. +.-..++++++.+    ++|+|
T Consensus        49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~---~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc---chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            47777778899988653        345677665422   22345678999988884 4334567776632    68999


Q ss_pred             ecCCCCh
Q 002321          768 FVSGGSL  774 (936)
Q Consensus       768 ~~~~g~L  774 (936)
                      |++|..+
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.85  E-value=0.013  Score=60.05  Aligned_cols=139  Identities=15%  Similarity=0.074  Sum_probs=73.1

Q ss_pred             cccccCceEEEEEEeCCCcEEEEEEeeccCccchHHHHHHHHHHHHcCCCCC--cceeee------EEEeCCeeEEEEEe
Q 002321          697 ELGRGGFGAVYRTVLRDGRPVAIKKLTVSSLVKSQEDFEREVKKLGKVRHPN--LVTLEG------YYWTQSLQLLIYEF  768 (936)
Q Consensus       697 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~------~~~~~~~~~lv~e~  768 (936)
                      .|..|---+.|+.+..+| .+++|++....   ..+++..|++++..+.+..  +...+.      +.........++.+
T Consensus        25 ~i~~G~~N~ny~v~t~~g-~yVLri~~~~~---~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~  100 (316)
T d2ppqa1          25 GIAEGVENSNFLLHTTKD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF  100 (316)
T ss_dssp             EECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred             cCCCCcccCeEEEEECCC-cEEEEEcCCCC---CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeee
Confidence            356677778899887655 58999885321   2345666777777774222  111111      12234455677777


Q ss_pred             cCCCChhhhh--------------hcc------CCCCCCCH------------------HHHHHHHHHHHHHHHHHHh--
Q 002321          769 VSGGSLHKHL--------------HEG------SGGNFLSW------------------NERFNVIQGTAKSLAHLHQ--  808 (936)
Q Consensus       769 ~~~g~L~~~l--------------~~~------~~~~~~~~------------------~~~~~i~~~i~~al~~LH~--  808 (936)
                      ..+......-              +..      ........                  ......+......+...+.  
T Consensus       101 ~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  180 (316)
T d2ppqa1         101 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD  180 (316)
T ss_dssp             CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred             cccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccc
Confidence            7664332110              000      00000000                  0011122222222333222  


Q ss_pred             --CCcccCCCCCCCEEEcCCCCeEEeeccCccc
Q 002321          809 --SNIIHYNIKSSNVLIDGSGEPKVGDYGLARL  839 (936)
Q Consensus       809 --~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  839 (936)
                        .|++|+|+.+.||+++++...-|.||+.+..
T Consensus       181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccccCCcchhhhhcccccceeEeccccccc
Confidence              3799999999999999888888999998853